{"edges":[{"source":"parvovirus H-1","target":"Oryx GmbH & Co.","id":"0"},{"source":"Oryx (u)","target":"Oryx GmbH & Co.","id":"1"},{"source":"bevacizumab","target":"Oryx GmbH & Co.","id":"2"},{"source":"pembrolizumab","target":"Oryx GmbH & Co.","id":"3"},{"source":"UNK : Indication","target":"parvovirus H-1","id":"4"},{"source":"UNK : Indication","target":"Oryx (u)","id":"5"},{"source":"UNK : Indication","target":"bevacizumab","id":"6"},{"source":"UNK : Indication","target":"pembrolizumab","id":"7"},{"source":"anticancer","target":"parvovirus H-1","id":"8"},{"source":"anticancer","target":"Oryx (u)","id":"9"},{"source":"anticancer","target":"bevacizumab","id":"10"},{"source":"anticancer","target":"pembrolizumab","id":"11"},{"source":"carcinoma","target":"parvovirus H-1","id":"12"},{"source":"carcinoma","target":"Oryx (u)","id":"13"},{"source":"carcinoma","target":"bevacizumab","id":"14"},{"source":"carcinoma","target":"pembrolizumab","id":"15"},{"source":"glioblastoma","target":"parvovirus H-1","id":"16"},{"source":"glioblastoma","target":"Oryx (u)","id":"17"},{"source":"glioblastoma","target":"bevacizumab","id":"18"},{"source":"glioblastoma","target":"pembrolizumab","id":"19"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"20"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"21"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22"},{"source":"Immune checkpoint inhibitor","target":"glioblastoma","id":"23"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"24"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26"},{"source":"Anticancer immunotherapy","target":"glioblastoma","id":"27"},{"source":"NA","target":"UNK : Indication","id":"28"},{"source":"NA","target":"anticancer","id":"29"},{"source":"NA","target":"carcinoma","id":"30"},{"source":"NA","target":"glioblastoma","id":"31"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"32"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"33"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"34"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"glioblastoma","id":"35"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"36"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"37"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38"},{"source":"Angiogenesis inhibitor","target":"glioblastoma","id":"39"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"40"},{"source":"CD19 antagonist","target":"anticancer","id":"41"},{"source":"CD19 antagonist","target":"carcinoma","id":"42"},{"source":"CD19 antagonist","target":"glioblastoma","id":"43"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"44"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"45"},{"source":"Oncology: CNS","target":"NA","id":"46"},{"source":"Oncology: CNS","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"47"},{"source":"Oncology: CNS","target":"Angiogenesis inhibitor","id":"48"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"49"},{"source":"Glioblastoma","target":"Immune checkpoint inhibitor","id":"50"},{"source":"Glioblastoma","target":"Anticancer immunotherapy","id":"51"},{"source":"Glioblastoma","target":"NA","id":"52"},{"source":"Glioblastoma","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"53"},{"source":"Glioblastoma","target":"Angiogenesis inhibitor","id":"54"},{"source":"Glioblastoma","target":"CD19 antagonist","id":"55"},{"source":"CVA-21 (IV) (u)","target":"Viralytics {Psiron}","id":"56"},{"source":"pembrolizumab","target":"Viralytics {Psiron}","id":"57"},{"source":"UNK : Indication","target":"CVA-21 (IV) (u)","id":"58"},{"source":"UNK : Indication","target":"pembrolizumab","id":"59"},{"source":"melanoma","target":"CVA-21 (IV) (u)","id":"60"},{"source":"melanoma","target":"pembrolizumab","id":"61"},{"source":"anticancer","target":"CVA-21 (IV) (u)","id":"62"},{"source":"anticancer","target":"pembrolizumab","id":"63"},{"source":"carcinoma","target":"CVA-21 (IV) (u)","id":"64"},{"source":"carcinoma","target":"pembrolizumab","id":"65"},{"source":"skin neoplasms","target":"CVA-21 (IV) (u)","id":"66"},{"source":"skin neoplasms","target":"pembrolizumab","id":"67"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"68"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"69"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"70"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"71"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"72"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"73"},{"source":"CD19 antagonist","target":"melanoma","id":"74"},{"source":"CD19 antagonist","target":"anticancer","id":"75"},{"source":"CD19 antagonist","target":"carcinoma","id":"76"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"77"},{"source":"Apoptosis stimulant","target":"UNK : Indication","id":"78"},{"source":"Apoptosis stimulant","target":"melanoma","id":"79"},{"source":"Apoptosis stimulant","target":"anticancer","id":"80"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"81"},{"source":"Apoptosis stimulant","target":"skin neoplasms","id":"82"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"83"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"84"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"85"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"86"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"87"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"88"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"89"},{"source":"Oncology: Melanoma","target":"Apoptosis stimulant","id":"90"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"91"},{"source":"DCVax-L","target":"University of Mainz","id":"92"},{"source":"CRC (u)","target":"University of Mainz","id":"93"},{"source":"pembrolizumab","target":"University of Mainz","id":"94"},{"source":"UNK : Indication","target":"DCVax-L","id":"95"},{"source":"UNK : Indication","target":"CRC (u)","id":"96"},{"source":"UNK : Indication","target":"pembrolizumab","id":"97"},{"source":"colorectal neoplasms","target":"DCVax-L","id":"98"},{"source":"colorectal neoplasms","target":"CRC (u)","id":"99"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"100"},{"source":"colorectal cancer","target":"DCVax-L","id":"101"},{"source":"colorectal cancer","target":"CRC (u)","id":"102"},{"source":"colorectal cancer","target":"pembrolizumab","id":"103"},{"source":"liver metastases","target":"DCVax-L","id":"104"},{"source":"liver metastases","target":"CRC (u)","id":"105"},{"source":"liver metastases","target":"pembrolizumab","id":"106"},{"source":"colonic neoplasms","target":"DCVax-L","id":"107"},{"source":"colonic neoplasms","target":"CRC (u)","id":"108"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"109"},{"source":"carcinoma","target":"DCVax-L","id":"110"},{"source":"carcinoma","target":"CRC (u)","id":"111"},{"source":"carcinoma","target":"pembrolizumab","id":"112"},{"source":"carcinoma","target":"DCVax-L","id":"113"},{"source":"carcinoma","target":"CRC (u)","id":"114"},{"source":"carcinoma","target":"pembrolizumab","id":"115"},{"source":"neoplasm metastasis","target":"DCVax-L","id":"116"},{"source":"neoplasm metastasis","target":"CRC (u)","id":"117"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"118"},{"source":"anticancer","target":"DCVax-L","id":"119"},{"source":"anticancer","target":"CRC (u)","id":"120"},{"source":"anticancer","target":"pembrolizumab","id":"121"},{"source":"liver neoplasms","target":"DCVax-L","id":"122"},{"source":"liver neoplasms","target":"CRC (u)","id":"123"},{"source":"liver neoplasms","target":"pembrolizumab","id":"124"},{"source":"colorectal neoplasms","target":"DCVax-L","id":"125"},{"source":"colorectal neoplasms","target":"CRC (u)","id":"126"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"127"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"128"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"129"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"130"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"131"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"132"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"133"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"134"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"135"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"136"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"137"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"138"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"139"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"140"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"141"},{"source":"CD19 antagonist","target":"liver metastases","id":"142"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"143"},{"source":"CD19 antagonist","target":"carcinoma","id":"144"},{"source":"CD19 antagonist","target":"carcinoma","id":"145"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"146"},{"source":"CD19 antagonist","target":"anticancer","id":"147"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"148"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"149"},{"source":"Immunostimulant","target":"UNK : Indication","id":"150"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"151"},{"source":"Immunostimulant","target":"colorectal cancer","id":"152"},{"source":"Immunostimulant","target":"liver metastases","id":"153"},{"source":"Immunostimulant","target":"colonic neoplasms","id":"154"},{"source":"Immunostimulant","target":"carcinoma","id":"155"},{"source":"Immunostimulant","target":"carcinoma","id":"156"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"157"},{"source":"Immunostimulant","target":"anticancer","id":"158"},{"source":"Immunostimulant","target":"liver neoplasms","id":"159"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"160"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"161"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"162"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"163"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"164"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"165"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"166"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"167"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"168"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"169"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"170"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"171"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"172"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"173"},{"source":"Oncology: Colorectal","target":"Immunostimulant","id":"174"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"175"},{"source":"Oncology: Metastatic Cancer","target":"Anticancer immunotherapy","id":"176"},{"source":"Oncology: Metastatic Cancer","target":"CD19 antagonist","id":"177"},{"source":"Oncology: Metastatic Cancer","target":"Immunostimulant","id":"178"},{"source":"Oncology: Metastatic Cancer","target":"Immune checkpoint inhibitor","id":"179"},{"source":"pelareorep (u)","target":"(Other Hospital/Academic/Medical Center)","id":"180"},{"source":"pelareorep (u)","target":"Merck & Co.","id":"181"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"182"},{"source":"pembrolizumab","target":"Merck & Co.","id":"183"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"184"},{"source":"UNK : Drug","target":"Merck & Co.","id":"185"},{"source":"UNK : Indication","target":"pelareorep (u)","id":"186"},{"source":"UNK : Indication","target":"pembrolizumab","id":"187"},{"source":"UNK : Indication","target":"UNK : Drug","id":"188"},{"source":"metastatic","target":"pelareorep (u)","id":"189"},{"source":"metastatic","target":"pembrolizumab","id":"190"},{"source":"metastatic","target":"UNK : Drug","id":"191"},{"source":"carcinoma","target":"pelareorep (u)","id":"192"},{"source":"carcinoma","target":"pembrolizumab","id":"193"},{"source":"carcinoma","target":"UNK : Drug","id":"194"},{"source":"carcinoma","target":"pelareorep (u)","id":"195"},{"source":"carcinoma","target":"pembrolizumab","id":"196"},{"source":"carcinoma","target":"UNK : Drug","id":"197"},{"source":"neoplasm metastasis","target":"pelareorep (u)","id":"198"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"199"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"200"},{"source":"pancreatic cancer","target":"pelareorep (u)","id":"201"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"202"},{"source":"pancreatic cancer","target":"UNK : Drug","id":"203"},{"source":"anticancer","target":"pelareorep (u)","id":"204"},{"source":"anticancer","target":"pembrolizumab","id":"205"},{"source":"anticancer","target":"UNK : Drug","id":"206"},{"source":"pancreatic neoplasms","target":"pelareorep (u)","id":"207"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"208"},{"source":"pancreatic neoplasms","target":"UNK : Drug","id":"209"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"210"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"211"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"212"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"213"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"214"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"215"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"216"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"217"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"218"},{"source":"CD19 antagonist","target":"metastatic","id":"219"},{"source":"CD19 antagonist","target":"carcinoma","id":"220"},{"source":"CD19 antagonist","target":"carcinoma","id":"221"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"222"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"223"},{"source":"CD19 antagonist","target":"anticancer","id":"224"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"225"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"226"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"227"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"228"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"229"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"230"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"231"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"232"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"233"},{"source":"NA","target":"UNK : Indication","id":"234"},{"source":"NA","target":"metastatic","id":"235"},{"source":"NA","target":"carcinoma","id":"236"},{"source":"NA","target":"carcinoma","id":"237"},{"source":"NA","target":"neoplasm metastasis","id":"238"},{"source":"NA","target":"pancreatic cancer","id":"239"},{"source":"NA","target":"anticancer","id":"240"},{"source":"NA","target":"pancreatic neoplasms","id":"241"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"242"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"243"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"244"},{"source":"Oncology: Pancreas","target":"NA","id":"245"},{"source":"eftilagimod alfa (u)","target":"Immutep {Prima Biomed/Immutep}","id":"246"},{"source":"eftilagimod alfa (u)","target":"Merck & Co.","id":"247"},{"source":"pembrolizumab","target":"Immutep {Prima Biomed/Immutep}","id":"248"},{"source":"pembrolizumab","target":"Merck & Co.","id":"249"},{"source":"non-small-cell lung","target":"eftilagimod alfa (u)","id":"250"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"251"},{"source":"head and neck cancer","target":"eftilagimod alfa (u)","id":"252"},{"source":"head and neck cancer","target":"pembrolizumab","id":"253"},{"source":"ovarian cancer","target":"eftilagimod alfa (u)","id":"254"},{"source":"ovarian cancer","target":"pembrolizumab","id":"255"},{"source":"carcinoma","target":"eftilagimod alfa (u)","id":"256"},{"source":"carcinoma","target":"pembrolizumab","id":"257"},{"source":"non-small-cell lung","target":"eftilagimod alfa (u)","id":"258"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"259"},{"source":"carcinoma","target":"eftilagimod alfa (u)","id":"260"},{"source":"carcinoma","target":"pembrolizumab","id":"261"},{"source":"anticancer","target":"eftilagimod alfa (u)","id":"262"},{"source":"anticancer","target":"pembrolizumab","id":"263"},{"source":"ovarian neoplasms","target":"eftilagimod alfa (u)","id":"264"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"265"},{"source":"head and neck neoplasms","target":"eftilagimod alfa (u)","id":"266"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"267"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"268"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"269"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"270"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"271"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"272"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"273"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"274"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"275"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"276"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"277"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"278"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"279"},{"source":"CD19 antagonist","target":"carcinoma","id":"280"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"281"},{"source":"CD19 antagonist","target":"carcinoma","id":"282"},{"source":"CD19 antagonist","target":"anticancer","id":"283"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"284"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"285"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"non-small-cell lung","id":"286"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"head and neck cancer","id":"287"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"ovarian cancer","id":"288"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"carcinoma","id":"289"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"non-small-cell lung","id":"290"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"carcinoma","id":"291"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"anticancer","id":"292"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"ovarian neoplasms","id":"293"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"head and neck neoplasms","id":"294"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"295"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"296"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"297"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"298"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"299"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"300"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"301"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"302"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"303"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"304"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"305"},{"source":"Oncology: Head/Neck","target":"Lymphocyte-activation gene 3 antagonist","id":"306"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"307"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"308"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"309"},{"source":"Oncology: Lung","target":"Lymphocyte-activation gene 3 antagonist","id":"310"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"311"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"312"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"313"},{"source":"Non-Small Cell","target":"Lymphocyte-activation gene 3 antagonist","id":"314"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"315"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"316"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"317"},{"source":"Oncology: Ovarian","target":"Lymphocyte-activation gene 3 antagonist","id":"318"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"319"},{"source":"AE-37 (u)","target":"Generex Biotechnology/Antigen Express","id":"320"},{"source":"pembrolizumab","target":"Generex Biotechnology/Antigen Express","id":"321"},{"source":"UNK : Drug","target":"Generex Biotechnology/Antigen Express","id":"322"},{"source":"UNK : Indication","target":"AE-37 (u)","id":"323"},{"source":"UNK : Indication","target":"pembrolizumab","id":"324"},{"source":"UNK : Indication","target":"UNK : Drug","id":"325"},{"source":"triple-negative breast cancer","target":"AE-37 (u)","id":"326"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"327"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"328"},{"source":"breast neoplasms","target":"AE-37 (u)","id":"329"},{"source":"breast neoplasms","target":"pembrolizumab","id":"330"},{"source":"breast neoplasms","target":"UNK : Drug","id":"331"},{"source":"metastatic","target":"AE-37 (u)","id":"332"},{"source":"metastatic","target":"pembrolizumab","id":"333"},{"source":"metastatic","target":"UNK : Drug","id":"334"},{"source":"carcinoma","target":"AE-37 (u)","id":"335"},{"source":"carcinoma","target":"pembrolizumab","id":"336"},{"source":"carcinoma","target":"UNK : Drug","id":"337"},{"source":"breast neoplasms","target":"AE-37 (u)","id":"338"},{"source":"breast neoplasms","target":"pembrolizumab","id":"339"},{"source":"breast neoplasms","target":"UNK : Drug","id":"340"},{"source":"neoplasm metastasis","target":"AE-37 (u)","id":"341"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"342"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"343"},{"source":"anticancer","target":"AE-37 (u)","id":"344"},{"source":"anticancer","target":"pembrolizumab","id":"345"},{"source":"anticancer","target":"UNK : Drug","id":"346"},{"source":"NA","target":"UNK : Indication","id":"347"},{"source":"NA","target":"triple-negative breast cancer","id":"348"},{"source":"NA","target":"breast neoplasms","id":"349"},{"source":"NA","target":"metastatic","id":"350"},{"source":"NA","target":"carcinoma","id":"351"},{"source":"NA","target":"breast neoplasms","id":"352"},{"source":"NA","target":"neoplasm metastasis","id":"353"},{"source":"NA","target":"anticancer","id":"354"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"355"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"356"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"357"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"358"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"359"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"360"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"361"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"362"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"363"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"364"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"365"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"366"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"367"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"368"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"369"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"370"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"371"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"372"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"373"},{"source":"CD19 antagonist","target":"metastatic","id":"374"},{"source":"CD19 antagonist","target":"carcinoma","id":"375"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"376"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"377"},{"source":"CD19 antagonist","target":"anticancer","id":"378"},{"source":"T helper cell stimulant","target":"UNK : Indication","id":"379"},{"source":"T helper cell stimulant","target":"triple-negative breast cancer","id":"380"},{"source":"T helper cell stimulant","target":"breast neoplasms","id":"381"},{"source":"T helper cell stimulant","target":"metastatic","id":"382"},{"source":"T helper cell stimulant","target":"carcinoma","id":"383"},{"source":"T helper cell stimulant","target":"breast neoplasms","id":"384"},{"source":"T helper cell stimulant","target":"neoplasm metastasis","id":"385"},{"source":"T helper cell stimulant","target":"anticancer","id":"386"},{"source":"Immunostimulant","target":"UNK : Indication","id":"387"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"388"},{"source":"Immunostimulant","target":"breast neoplasms","id":"389"},{"source":"Immunostimulant","target":"metastatic","id":"390"},{"source":"Immunostimulant","target":"carcinoma","id":"391"},{"source":"Immunostimulant","target":"breast neoplasms","id":"392"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"393"},{"source":"Immunostimulant","target":"anticancer","id":"394"},{"source":"Oncology: Breast","target":"NA","id":"395"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"396"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"397"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"398"},{"source":"Oncology: Breast","target":"T helper cell stimulant","id":"399"},{"source":"Oncology: Breast","target":"Immunostimulant","id":"400"},{"source":"eftilagimod alfa (u)","target":"Immutep {Prima Biomed/Immutep}","id":"401"},{"source":"eftilagimod alfa (u)","target":"Merck & Co.","id":"402"},{"source":"pembrolizumab","target":"Immutep {Prima Biomed/Immutep}","id":"403"},{"source":"pembrolizumab","target":"Merck & Co.","id":"404"},{"source":"non-small-cell lung","target":"eftilagimod alfa (u)","id":"405"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"406"},{"source":"head and neck cancer","target":"eftilagimod alfa (u)","id":"407"},{"source":"head and neck cancer","target":"pembrolizumab","id":"408"},{"source":"ovarian cancer","target":"eftilagimod alfa (u)","id":"409"},{"source":"ovarian cancer","target":"pembrolizumab","id":"410"},{"source":"carcinoma","target":"eftilagimod alfa (u)","id":"411"},{"source":"carcinoma","target":"pembrolizumab","id":"412"},{"source":"non-small-cell lung","target":"eftilagimod alfa (u)","id":"413"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"414"},{"source":"carcinoma","target":"eftilagimod alfa (u)","id":"415"},{"source":"carcinoma","target":"pembrolizumab","id":"416"},{"source":"anticancer","target":"eftilagimod alfa (u)","id":"417"},{"source":"anticancer","target":"pembrolizumab","id":"418"},{"source":"ovarian neoplasms","target":"eftilagimod alfa (u)","id":"419"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"420"},{"source":"head and neck neoplasms","target":"eftilagimod alfa (u)","id":"421"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"422"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"423"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"424"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"425"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"426"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"427"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"428"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"429"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"430"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"431"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"432"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"433"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"434"},{"source":"CD19 antagonist","target":"carcinoma","id":"435"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"436"},{"source":"CD19 antagonist","target":"carcinoma","id":"437"},{"source":"CD19 antagonist","target":"anticancer","id":"438"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"439"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"440"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"non-small-cell lung","id":"441"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"head and neck cancer","id":"442"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"ovarian cancer","id":"443"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"carcinoma","id":"444"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"non-small-cell lung","id":"445"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"carcinoma","id":"446"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"anticancer","id":"447"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"ovarian neoplasms","id":"448"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"head and neck neoplasms","id":"449"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"450"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"451"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"452"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"453"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"454"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"455"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"456"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"457"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"458"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"459"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"460"},{"source":"Oncology: Head/Neck","target":"Lymphocyte-activation gene 3 antagonist","id":"461"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"462"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"463"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"464"},{"source":"Oncology: Lung","target":"Lymphocyte-activation gene 3 antagonist","id":"465"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"466"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"467"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"468"},{"source":"Non-Small Cell","target":"Lymphocyte-activation gene 3 antagonist","id":"469"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"470"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"471"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"472"},{"source":"Oncology: Ovarian","target":"Lymphocyte-activation gene 3 antagonist","id":"473"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"474"},{"source":"pelareorep (u)","target":"(Other Hospital/Academic/Medical Center)","id":"475"},{"source":"pelareorep (u)","target":"Merck & Co.","id":"476"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"477"},{"source":"pembrolizumab","target":"Merck & Co.","id":"478"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"479"},{"source":"UNK : Drug","target":"Merck & Co.","id":"480"},{"source":"UNK : Indication","target":"pelareorep (u)","id":"481"},{"source":"UNK : Indication","target":"pembrolizumab","id":"482"},{"source":"UNK : Indication","target":"UNK : Drug","id":"483"},{"source":"metastatic","target":"pelareorep (u)","id":"484"},{"source":"metastatic","target":"pembrolizumab","id":"485"},{"source":"metastatic","target":"UNK : Drug","id":"486"},{"source":"carcinoma","target":"pelareorep (u)","id":"487"},{"source":"carcinoma","target":"pembrolizumab","id":"488"},{"source":"carcinoma","target":"UNK : Drug","id":"489"},{"source":"carcinoma","target":"pelareorep (u)","id":"490"},{"source":"carcinoma","target":"pembrolizumab","id":"491"},{"source":"carcinoma","target":"UNK : Drug","id":"492"},{"source":"neoplasm metastasis","target":"pelareorep (u)","id":"493"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"494"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"495"},{"source":"pancreatic cancer","target":"pelareorep (u)","id":"496"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"497"},{"source":"pancreatic cancer","target":"UNK : Drug","id":"498"},{"source":"anticancer","target":"pelareorep (u)","id":"499"},{"source":"anticancer","target":"pembrolizumab","id":"500"},{"source":"anticancer","target":"UNK : Drug","id":"501"},{"source":"pancreatic neoplasms","target":"pelareorep (u)","id":"502"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"503"},{"source":"pancreatic neoplasms","target":"UNK : Drug","id":"504"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"505"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"506"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"507"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"508"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"509"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"510"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"511"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"512"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"513"},{"source":"CD19 antagonist","target":"metastatic","id":"514"},{"source":"CD19 antagonist","target":"carcinoma","id":"515"},{"source":"CD19 antagonist","target":"carcinoma","id":"516"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"517"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"518"},{"source":"CD19 antagonist","target":"anticancer","id":"519"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"520"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"521"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"522"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"523"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"524"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"525"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"526"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"527"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"528"},{"source":"NA","target":"UNK : Indication","id":"529"},{"source":"NA","target":"metastatic","id":"530"},{"source":"NA","target":"carcinoma","id":"531"},{"source":"NA","target":"carcinoma","id":"532"},{"source":"NA","target":"neoplasm metastasis","id":"533"},{"source":"NA","target":"pancreatic cancer","id":"534"},{"source":"NA","target":"anticancer","id":"535"},{"source":"NA","target":"pancreatic neoplasms","id":"536"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"537"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"538"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"539"},{"source":"Oncology: Pancreas","target":"NA","id":"540"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"541"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"542"},{"source":"UNK : Indication","target":"pembrolizumab","id":"543"},{"source":"UNK : Indication","target":"UNK : Drug","id":"544"},{"source":"residual tumor","target":"pembrolizumab","id":"545"},{"source":"residual tumor","target":"UNK : Drug","id":"546"},{"source":"carcinoma","target":"pembrolizumab","id":"547"},{"source":"carcinoma","target":"UNK : Drug","id":"548"},{"source":"residual neoplasm","target":"pembrolizumab","id":"549"},{"source":"residual neoplasm","target":"UNK : Drug","id":"550"},{"source":"residual tumor","target":"pembrolizumab","id":"551"},{"source":"residual tumor","target":"UNK : Drug","id":"552"},{"source":"breast neoplasms","target":"pembrolizumab","id":"553"},{"source":"breast neoplasms","target":"UNK : Drug","id":"554"},{"source":"metastatic","target":"pembrolizumab","id":"555"},{"source":"metastatic","target":"UNK : Drug","id":"556"},{"source":"carcinoma","target":"pembrolizumab","id":"557"},{"source":"carcinoma","target":"UNK : Drug","id":"558"},{"source":"breast neoplasms","target":"pembrolizumab","id":"559"},{"source":"breast neoplasms","target":"UNK : Drug","id":"560"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"561"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"562"},{"source":"anticancer","target":"pembrolizumab","id":"563"},{"source":"anticancer","target":"UNK : Drug","id":"564"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"565"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"566"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"567"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"568"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"569"},{"source":"Anticancer immunotherapy","target":"residual neoplasm","id":"570"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"571"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"572"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"573"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"574"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"575"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"576"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"577"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"578"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"579"},{"source":"CD19 antagonist","target":"residual tumor","id":"580"},{"source":"CD19 antagonist","target":"carcinoma","id":"581"},{"source":"CD19 antagonist","target":"residual neoplasm","id":"582"},{"source":"CD19 antagonist","target":"residual tumor","id":"583"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"584"},{"source":"CD19 antagonist","target":"metastatic","id":"585"},{"source":"CD19 antagonist","target":"carcinoma","id":"586"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"587"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"588"},{"source":"CD19 antagonist","target":"anticancer","id":"589"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"590"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"591"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"592"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"593"},{"source":"Immune checkpoint inhibitor","target":"residual neoplasm","id":"594"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"595"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"596"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"597"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"598"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"599"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"600"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"601"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"602"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"603"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"604"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"605"},{"source":"galinpepimut-S (u)","target":"Merck & Co.","id":"606"},{"source":"galinpepimut-S (u)","target":"SELLAS Life Sciences Group","id":"607"},{"source":"pembrolizumab","target":"Merck & Co.","id":"608"},{"source":"pembrolizumab","target":"SELLAS Life Sciences Group","id":"609"},{"source":"UNK : Drug","target":"Merck & Co.","id":"610"},{"source":"UNK : Drug","target":"SELLAS Life Sciences Group","id":"611"},{"source":"acute","target":"galinpepimut-S (u)","id":"612"},{"source":"acute","target":"pembrolizumab","id":"613"},{"source":"acute","target":"UNK : Drug","id":"614"},{"source":"colorectal neoplasms","target":"galinpepimut-S (u)","id":"615"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"616"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"617"},{"source":"unknown primary","target":"galinpepimut-S (u)","id":"618"},{"source":"unknown primary","target":"pembrolizumab","id":"619"},{"source":"unknown primary","target":"UNK : Drug","id":"620"},{"source":"acute","target":"galinpepimut-S (u)","id":"621"},{"source":"acute","target":"pembrolizumab","id":"622"},{"source":"acute","target":"UNK : Drug","id":"623"},{"source":"carcinoma","target":"galinpepimut-S (u)","id":"624"},{"source":"carcinoma","target":"pembrolizumab","id":"625"},{"source":"carcinoma","target":"UNK : Drug","id":"626"},{"source":"acute","target":"galinpepimut-S (u)","id":"627"},{"source":"acute","target":"pembrolizumab","id":"628"},{"source":"acute","target":"UNK : Drug","id":"629"},{"source":"skin neoplasms","target":"galinpepimut-S (u)","id":"630"},{"source":"skin neoplasms","target":"pembrolizumab","id":"631"},{"source":"skin neoplasms","target":"UNK : Drug","id":"632"},{"source":"leukemia","target":"galinpepimut-S (u)","id":"633"},{"source":"leukemia","target":"pembrolizumab","id":"634"},{"source":"leukemia","target":"UNK : Drug","id":"635"},{"source":"non-small-cell lung","target":"galinpepimut-S (u)","id":"636"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"637"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"638"},{"source":"breast neoplasms","target":"galinpepimut-S (u)","id":"639"},{"source":"breast neoplasms","target":"pembrolizumab","id":"640"},{"source":"breast neoplasms","target":"UNK : Drug","id":"641"},{"source":"colonic neoplasms","target":"galinpepimut-S (u)","id":"642"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"643"},{"source":"colonic neoplasms","target":"UNK : Drug","id":"644"},{"source":"ovarian cancer","target":"galinpepimut-S (u)","id":"645"},{"source":"ovarian cancer","target":"pembrolizumab","id":"646"},{"source":"ovarian cancer","target":"UNK : Drug","id":"647"},{"source":"carcinoma","target":"galinpepimut-S (u)","id":"648"},{"source":"carcinoma","target":"pembrolizumab","id":"649"},{"source":"carcinoma","target":"UNK : Drug","id":"650"},{"source":"residual tumor","target":"galinpepimut-S (u)","id":"651"},{"source":"residual tumor","target":"pembrolizumab","id":"652"},{"source":"residual tumor","target":"UNK : Drug","id":"653"},{"source":"myeloid","target":"galinpepimut-S (u)","id":"654"},{"source":"myeloid","target":"pembrolizumab","id":"655"},{"source":"myeloid","target":"UNK : Drug","id":"656"},{"source":"anticancer","target":"galinpepimut-S (u)","id":"657"},{"source":"anticancer","target":"pembrolizumab","id":"658"},{"source":"anticancer","target":"UNK : Drug","id":"659"},{"source":"unknown primary","target":"galinpepimut-S (u)","id":"660"},{"source":"unknown primary","target":"pembrolizumab","id":"661"},{"source":"unknown primary","target":"UNK : Drug","id":"662"},{"source":"ovarian neoplasms","target":"galinpepimut-S (u)","id":"663"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"664"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"665"},{"source":"carcinoma","target":"galinpepimut-S (u)","id":"666"},{"source":"carcinoma","target":"pembrolizumab","id":"667"},{"source":"carcinoma","target":"UNK : Drug","id":"668"},{"source":"colorectal neoplasms","target":"galinpepimut-S (u)","id":"669"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"670"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"671"},{"source":"Anticancer immunotherapy","target":"acute","id":"672"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"673"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"674"},{"source":"Anticancer immunotherapy","target":"acute","id":"675"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"676"},{"source":"Anticancer immunotherapy","target":"acute","id":"677"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"678"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"679"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"680"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"681"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"682"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"683"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"684"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"685"},{"source":"Anticancer immunotherapy","target":"myeloid","id":"686"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"687"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"688"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"689"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"690"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"691"},{"source":"CD19 antagonist","target":"acute","id":"692"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"693"},{"source":"CD19 antagonist","target":"unknown primary","id":"694"},{"source":"CD19 antagonist","target":"acute","id":"695"},{"source":"CD19 antagonist","target":"carcinoma","id":"696"},{"source":"CD19 antagonist","target":"acute","id":"697"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"698"},{"source":"CD19 antagonist","target":"leukemia","id":"699"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"700"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"701"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"702"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"703"},{"source":"CD19 antagonist","target":"carcinoma","id":"704"},{"source":"CD19 antagonist","target":"residual tumor","id":"705"},{"source":"CD19 antagonist","target":"myeloid","id":"706"},{"source":"CD19 antagonist","target":"anticancer","id":"707"},{"source":"CD19 antagonist","target":"unknown primary","id":"708"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"709"},{"source":"CD19 antagonist","target":"carcinoma","id":"710"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"711"},{"source":"Immunostimulant","target":"acute","id":"712"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"713"},{"source":"Immunostimulant","target":"unknown primary","id":"714"},{"source":"Immunostimulant","target":"acute","id":"715"},{"source":"Immunostimulant","target":"carcinoma","id":"716"},{"source":"Immunostimulant","target":"acute","id":"717"},{"source":"Immunostimulant","target":"skin neoplasms","id":"718"},{"source":"Immunostimulant","target":"leukemia","id":"719"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"720"},{"source":"Immunostimulant","target":"breast neoplasms","id":"721"},{"source":"Immunostimulant","target":"colonic neoplasms","id":"722"},{"source":"Immunostimulant","target":"ovarian cancer","id":"723"},{"source":"Immunostimulant","target":"carcinoma","id":"724"},{"source":"Immunostimulant","target":"residual tumor","id":"725"},{"source":"Immunostimulant","target":"myeloid","id":"726"},{"source":"Immunostimulant","target":"anticancer","id":"727"},{"source":"Immunostimulant","target":"unknown primary","id":"728"},{"source":"Immunostimulant","target":"ovarian neoplasms","id":"729"},{"source":"Immunostimulant","target":"carcinoma","id":"730"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"731"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"732"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"733"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"734"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"735"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"736"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"737"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"738"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"739"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"740"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"741"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"742"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"743"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"744"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"745"},{"source":"Immune checkpoint inhibitor","target":"myeloid","id":"746"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"747"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"748"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"749"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"750"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"751"},{"source":"T helper cell stimulant","target":"acute","id":"752"},{"source":"T helper cell stimulant","target":"colorectal neoplasms","id":"753"},{"source":"T helper cell stimulant","target":"unknown primary","id":"754"},{"source":"T helper cell stimulant","target":"acute","id":"755"},{"source":"T helper cell stimulant","target":"carcinoma","id":"756"},{"source":"T helper cell stimulant","target":"acute","id":"757"},{"source":"T helper cell stimulant","target":"skin neoplasms","id":"758"},{"source":"T helper cell stimulant","target":"leukemia","id":"759"},{"source":"T helper cell stimulant","target":"non-small-cell lung","id":"760"},{"source":"T helper cell stimulant","target":"breast neoplasms","id":"761"},{"source":"T helper cell stimulant","target":"colonic neoplasms","id":"762"},{"source":"T helper cell stimulant","target":"ovarian cancer","id":"763"},{"source":"T helper cell stimulant","target":"carcinoma","id":"764"},{"source":"T helper cell stimulant","target":"residual tumor","id":"765"},{"source":"T helper cell stimulant","target":"myeloid","id":"766"},{"source":"T helper cell stimulant","target":"anticancer","id":"767"},{"source":"T helper cell stimulant","target":"unknown primary","id":"768"},{"source":"T helper cell stimulant","target":"ovarian neoplasms","id":"769"},{"source":"T helper cell stimulant","target":"carcinoma","id":"770"},{"source":"T helper cell stimulant","target":"colorectal neoplasms","id":"771"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"772"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"773"},{"source":"Oncology: Breast","target":"Immunostimulant","id":"774"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"775"},{"source":"Oncology: Breast","target":"T helper cell stimulant","id":"776"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"777"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"778"},{"source":"Oncology: Colorectal","target":"Immunostimulant","id":"779"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"780"},{"source":"Oncology: Colorectal","target":"T helper cell stimulant","id":"781"},{"source":"Oncology: Leukemia","target":"Anticancer immunotherapy","id":"782"},{"source":"Oncology: Leukemia","target":"CD19 antagonist","id":"783"},{"source":"Oncology: Leukemia","target":"Immunostimulant","id":"784"},{"source":"Oncology: Leukemia","target":"Immune checkpoint inhibitor","id":"785"},{"source":"Oncology: Leukemia","target":"T helper cell stimulant","id":"786"},{"source":"Acute Myelogenous","target":"Anticancer immunotherapy","id":"787"},{"source":"Acute Myelogenous","target":"CD19 antagonist","id":"788"},{"source":"Acute Myelogenous","target":"Immunostimulant","id":"789"},{"source":"Acute Myelogenous","target":"Immune checkpoint inhibitor","id":"790"},{"source":"Acute Myelogenous","target":"T helper cell stimulant","id":"791"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"792"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"793"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"794"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"795"},{"source":"Oncology: Lung","target":"T helper cell stimulant","id":"796"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"797"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"798"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"799"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"800"},{"source":"Non-Small Cell","target":"T helper cell stimulant","id":"801"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"802"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"803"},{"source":"Oncology: Ovarian","target":"Immunostimulant","id":"804"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"805"},{"source":"Oncology: Ovarian","target":"T helper cell stimulant","id":"806"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"807"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"808"},{"source":"Oncology: CNS","target":"Immunostimulant","id":"809"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"810"},{"source":"Oncology: CNS","target":"T helper cell stimulant","id":"811"},{"source":"galinpepimut-S (u)","target":"Merck & Co.","id":"812"},{"source":"galinpepimut-S (u)","target":"SELLAS Life Sciences Group","id":"813"},{"source":"pembrolizumab","target":"Merck & Co.","id":"814"},{"source":"pembrolizumab","target":"SELLAS Life Sciences Group","id":"815"},{"source":"UNK : Drug","target":"Merck & Co.","id":"816"},{"source":"UNK : Drug","target":"SELLAS Life Sciences Group","id":"817"},{"source":"acute","target":"galinpepimut-S (u)","id":"818"},{"source":"acute","target":"pembrolizumab","id":"819"},{"source":"acute","target":"UNK : Drug","id":"820"},{"source":"colorectal neoplasms","target":"galinpepimut-S (u)","id":"821"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"822"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"823"},{"source":"unknown primary","target":"galinpepimut-S (u)","id":"824"},{"source":"unknown primary","target":"pembrolizumab","id":"825"},{"source":"unknown primary","target":"UNK : Drug","id":"826"},{"source":"acute","target":"galinpepimut-S (u)","id":"827"},{"source":"acute","target":"pembrolizumab","id":"828"},{"source":"acute","target":"UNK : Drug","id":"829"},{"source":"carcinoma","target":"galinpepimut-S (u)","id":"830"},{"source":"carcinoma","target":"pembrolizumab","id":"831"},{"source":"carcinoma","target":"UNK : Drug","id":"832"},{"source":"acute","target":"galinpepimut-S (u)","id":"833"},{"source":"acute","target":"pembrolizumab","id":"834"},{"source":"acute","target":"UNK : Drug","id":"835"},{"source":"skin neoplasms","target":"galinpepimut-S (u)","id":"836"},{"source":"skin neoplasms","target":"pembrolizumab","id":"837"},{"source":"skin neoplasms","target":"UNK : Drug","id":"838"},{"source":"leukemia","target":"galinpepimut-S (u)","id":"839"},{"source":"leukemia","target":"pembrolizumab","id":"840"},{"source":"leukemia","target":"UNK : Drug","id":"841"},{"source":"non-small-cell lung","target":"galinpepimut-S (u)","id":"842"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"843"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"844"},{"source":"breast neoplasms","target":"galinpepimut-S (u)","id":"845"},{"source":"breast neoplasms","target":"pembrolizumab","id":"846"},{"source":"breast neoplasms","target":"UNK : Drug","id":"847"},{"source":"colonic neoplasms","target":"galinpepimut-S (u)","id":"848"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"849"},{"source":"colonic neoplasms","target":"UNK : Drug","id":"850"},{"source":"ovarian cancer","target":"galinpepimut-S (u)","id":"851"},{"source":"ovarian cancer","target":"pembrolizumab","id":"852"},{"source":"ovarian cancer","target":"UNK : Drug","id":"853"},{"source":"carcinoma","target":"galinpepimut-S (u)","id":"854"},{"source":"carcinoma","target":"pembrolizumab","id":"855"},{"source":"carcinoma","target":"UNK : Drug","id":"856"},{"source":"residual tumor","target":"galinpepimut-S (u)","id":"857"},{"source":"residual tumor","target":"pembrolizumab","id":"858"},{"source":"residual tumor","target":"UNK : Drug","id":"859"},{"source":"myeloid","target":"galinpepimut-S (u)","id":"860"},{"source":"myeloid","target":"pembrolizumab","id":"861"},{"source":"myeloid","target":"UNK : Drug","id":"862"},{"source":"anticancer","target":"galinpepimut-S (u)","id":"863"},{"source":"anticancer","target":"pembrolizumab","id":"864"},{"source":"anticancer","target":"UNK : Drug","id":"865"},{"source":"unknown primary","target":"galinpepimut-S (u)","id":"866"},{"source":"unknown primary","target":"pembrolizumab","id":"867"},{"source":"unknown primary","target":"UNK : Drug","id":"868"},{"source":"ovarian neoplasms","target":"galinpepimut-S (u)","id":"869"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"870"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"871"},{"source":"carcinoma","target":"galinpepimut-S (u)","id":"872"},{"source":"carcinoma","target":"pembrolizumab","id":"873"},{"source":"carcinoma","target":"UNK : Drug","id":"874"},{"source":"colorectal neoplasms","target":"galinpepimut-S (u)","id":"875"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"876"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"877"},{"source":"Anticancer immunotherapy","target":"acute","id":"878"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"879"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"880"},{"source":"Anticancer immunotherapy","target":"acute","id":"881"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"882"},{"source":"Anticancer immunotherapy","target":"acute","id":"883"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"884"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"885"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"886"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"887"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"888"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"889"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"890"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"891"},{"source":"Anticancer immunotherapy","target":"myeloid","id":"892"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"893"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"894"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"895"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"896"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"897"},{"source":"CD19 antagonist","target":"acute","id":"898"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"899"},{"source":"CD19 antagonist","target":"unknown primary","id":"900"},{"source":"CD19 antagonist","target":"acute","id":"901"},{"source":"CD19 antagonist","target":"carcinoma","id":"902"},{"source":"CD19 antagonist","target":"acute","id":"903"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"904"},{"source":"CD19 antagonist","target":"leukemia","id":"905"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"906"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"907"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"908"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"909"},{"source":"CD19 antagonist","target":"carcinoma","id":"910"},{"source":"CD19 antagonist","target":"residual tumor","id":"911"},{"source":"CD19 antagonist","target":"myeloid","id":"912"},{"source":"CD19 antagonist","target":"anticancer","id":"913"},{"source":"CD19 antagonist","target":"unknown primary","id":"914"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"915"},{"source":"CD19 antagonist","target":"carcinoma","id":"916"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"917"},{"source":"Immunostimulant","target":"acute","id":"918"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"919"},{"source":"Immunostimulant","target":"unknown primary","id":"920"},{"source":"Immunostimulant","target":"acute","id":"921"},{"source":"Immunostimulant","target":"carcinoma","id":"922"},{"source":"Immunostimulant","target":"acute","id":"923"},{"source":"Immunostimulant","target":"skin neoplasms","id":"924"},{"source":"Immunostimulant","target":"leukemia","id":"925"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"926"},{"source":"Immunostimulant","target":"breast neoplasms","id":"927"},{"source":"Immunostimulant","target":"colonic neoplasms","id":"928"},{"source":"Immunostimulant","target":"ovarian cancer","id":"929"},{"source":"Immunostimulant","target":"carcinoma","id":"930"},{"source":"Immunostimulant","target":"residual tumor","id":"931"},{"source":"Immunostimulant","target":"myeloid","id":"932"},{"source":"Immunostimulant","target":"anticancer","id":"933"},{"source":"Immunostimulant","target":"unknown primary","id":"934"},{"source":"Immunostimulant","target":"ovarian neoplasms","id":"935"},{"source":"Immunostimulant","target":"carcinoma","id":"936"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"937"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"938"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"939"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"940"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"941"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"942"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"943"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"944"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"945"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"946"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"947"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"948"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"949"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"950"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"951"},{"source":"Immune checkpoint inhibitor","target":"myeloid","id":"952"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"953"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"954"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"955"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"956"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"957"},{"source":"T helper cell stimulant","target":"acute","id":"958"},{"source":"T helper cell stimulant","target":"colorectal neoplasms","id":"959"},{"source":"T helper cell stimulant","target":"unknown primary","id":"960"},{"source":"T helper cell stimulant","target":"acute","id":"961"},{"source":"T helper cell stimulant","target":"carcinoma","id":"962"},{"source":"T helper cell stimulant","target":"acute","id":"963"},{"source":"T helper cell stimulant","target":"skin neoplasms","id":"964"},{"source":"T helper cell stimulant","target":"leukemia","id":"965"},{"source":"T helper cell stimulant","target":"non-small-cell lung","id":"966"},{"source":"T helper cell stimulant","target":"breast neoplasms","id":"967"},{"source":"T helper cell stimulant","target":"colonic neoplasms","id":"968"},{"source":"T helper cell stimulant","target":"ovarian cancer","id":"969"},{"source":"T helper cell stimulant","target":"carcinoma","id":"970"},{"source":"T helper cell stimulant","target":"residual tumor","id":"971"},{"source":"T helper cell stimulant","target":"myeloid","id":"972"},{"source":"T helper cell stimulant","target":"anticancer","id":"973"},{"source":"T helper cell stimulant","target":"unknown primary","id":"974"},{"source":"T helper cell stimulant","target":"ovarian neoplasms","id":"975"},{"source":"T helper cell stimulant","target":"carcinoma","id":"976"},{"source":"T helper cell stimulant","target":"colorectal neoplasms","id":"977"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"978"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"979"},{"source":"Oncology: Breast","target":"Immunostimulant","id":"980"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"981"},{"source":"Oncology: Breast","target":"T helper cell stimulant","id":"982"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"983"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"984"},{"source":"Oncology: Colorectal","target":"Immunostimulant","id":"985"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"986"},{"source":"Oncology: Colorectal","target":"T helper cell stimulant","id":"987"},{"source":"Oncology: Leukemia","target":"Anticancer immunotherapy","id":"988"},{"source":"Oncology: Leukemia","target":"CD19 antagonist","id":"989"},{"source":"Oncology: Leukemia","target":"Immunostimulant","id":"990"},{"source":"Oncology: Leukemia","target":"Immune checkpoint inhibitor","id":"991"},{"source":"Oncology: Leukemia","target":"T helper cell stimulant","id":"992"},{"source":"Acute Myelogenous","target":"Anticancer immunotherapy","id":"993"},{"source":"Acute Myelogenous","target":"CD19 antagonist","id":"994"},{"source":"Acute Myelogenous","target":"Immunostimulant","id":"995"},{"source":"Acute Myelogenous","target":"Immune checkpoint inhibitor","id":"996"},{"source":"Acute Myelogenous","target":"T helper cell stimulant","id":"997"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"998"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"999"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"1000"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"1001"},{"source":"Oncology: Lung","target":"T helper cell stimulant","id":"1002"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"1003"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"1004"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"1005"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"1006"},{"source":"Non-Small Cell","target":"T helper cell stimulant","id":"1007"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"1008"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"1009"},{"source":"Oncology: Ovarian","target":"Immunostimulant","id":"1010"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"1011"},{"source":"Oncology: Ovarian","target":"T helper cell stimulant","id":"1012"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"1013"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"1014"},{"source":"Oncology: CNS","target":"Immunostimulant","id":"1015"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"1016"},{"source":"Oncology: CNS","target":"T helper cell stimulant","id":"1017"},{"source":"Lm-LLO-PSA vaccine","target":"Advaxis","id":"1018"},{"source":"Lm-LLO-PSA vaccine","target":"Merck & Co.","id":"1019"},{"source":"Advaxis (u)","target":"Advaxis","id":"1020"},{"source":"Advaxis (u)","target":"Merck & Co.","id":"1021"},{"source":"pembrolizumab","target":"Advaxis","id":"1022"},{"source":"pembrolizumab","target":"Merck & Co.","id":"1023"},{"source":"undisclosed - analgesic","target":"Advaxis","id":"1024"},{"source":"undisclosed - analgesic","target":"Merck & Co.","id":"1025"},{"source":"undisclosed - antiemetic agent","target":"Advaxis","id":"1026"},{"source":"undisclosed - antiemetic agent","target":"Merck & Co.","id":"1027"},{"source":"undisclosed - antihistamine","target":"Advaxis","id":"1028"},{"source":"undisclosed - antihistamine","target":"Merck & Co.","id":"1029"},{"source":"UNK : Indication","target":"Lm-LLO-PSA vaccine","id":"1030"},{"source":"UNK : Indication","target":"Advaxis (u)","id":"1031"},{"source":"UNK : Indication","target":"pembrolizumab","id":"1032"},{"source":"UNK : Indication","target":"undisclosed - analgesic","id":"1033"},{"source":"UNK : Indication","target":"undisclosed - antiemetic agent","id":"1034"},{"source":"UNK : Indication","target":"undisclosed - antihistamine","id":"1035"},{"source":"prostate cancer","target":"Lm-LLO-PSA vaccine","id":"1036"},{"source":"prostate cancer","target":"Advaxis (u)","id":"1037"},{"source":"prostate cancer","target":"pembrolizumab","id":"1038"},{"source":"prostate cancer","target":"undisclosed - analgesic","id":"1039"},{"source":"prostate cancer","target":"undisclosed - antiemetic agent","id":"1040"},{"source":"prostate cancer","target":"undisclosed - antihistamine","id":"1041"},{"source":"castration-resistant prostatic neoplasms","target":"Lm-LLO-PSA vaccine","id":"1042"},{"source":"castration-resistant prostatic neoplasms","target":"Advaxis (u)","id":"1043"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"1044"},{"source":"castration-resistant prostatic neoplasms","target":"undisclosed - analgesic","id":"1045"},{"source":"castration-resistant prostatic neoplasms","target":"undisclosed - antiemetic agent","id":"1046"},{"source":"castration-resistant prostatic neoplasms","target":"undisclosed - antihistamine","id":"1047"},{"source":"bone diseases","target":"Lm-LLO-PSA vaccine","id":"1048"},{"source":"bone diseases","target":"Advaxis (u)","id":"1049"},{"source":"bone diseases","target":"pembrolizumab","id":"1050"},{"source":"bone diseases","target":"undisclosed - analgesic","id":"1051"},{"source":"bone diseases","target":"undisclosed - antiemetic agent","id":"1052"},{"source":"bone diseases","target":"undisclosed - antihistamine","id":"1053"},{"source":"liver metastases","target":"Lm-LLO-PSA vaccine","id":"1054"},{"source":"liver metastases","target":"Advaxis (u)","id":"1055"},{"source":"liver metastases","target":"pembrolizumab","id":"1056"},{"source":"liver metastases","target":"undisclosed - analgesic","id":"1057"},{"source":"liver metastases","target":"undisclosed - antiemetic agent","id":"1058"},{"source":"liver metastases","target":"undisclosed - antihistamine","id":"1059"},{"source":"anti-inflammatory","target":"Lm-LLO-PSA vaccine","id":"1060"},{"source":"anti-inflammatory","target":"Advaxis (u)","id":"1061"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"1062"},{"source":"anti-inflammatory","target":"undisclosed - analgesic","id":"1063"},{"source":"anti-inflammatory","target":"undisclosed - antiemetic agent","id":"1064"},{"source":"anti-inflammatory","target":"undisclosed - antihistamine","id":"1065"},{"source":"asthma","target":"Lm-LLO-PSA vaccine","id":"1066"},{"source":"asthma","target":"Advaxis (u)","id":"1067"},{"source":"asthma","target":"pembrolizumab","id":"1068"},{"source":"asthma","target":"undisclosed - analgesic","id":"1069"},{"source":"asthma","target":"undisclosed - antiemetic agent","id":"1070"},{"source":"asthma","target":"undisclosed - antihistamine","id":"1071"},{"source":"antiallergic","target":"Lm-LLO-PSA vaccine","id":"1072"},{"source":"antiallergic","target":"Advaxis (u)","id":"1073"},{"source":"antiallergic","target":"pembrolizumab","id":"1074"},{"source":"antiallergic","target":"undisclosed - analgesic","id":"1075"},{"source":"antiallergic","target":"undisclosed - antiemetic agent","id":"1076"},{"source":"antiallergic","target":"undisclosed - antihistamine","id":"1077"},{"source":"hypersensitivity","target":"Lm-LLO-PSA vaccine","id":"1078"},{"source":"hypersensitivity","target":"Advaxis (u)","id":"1079"},{"source":"hypersensitivity","target":"pembrolizumab","id":"1080"},{"source":"hypersensitivity","target":"undisclosed - analgesic","id":"1081"},{"source":"hypersensitivity","target":"undisclosed - antiemetic agent","id":"1082"},{"source":"hypersensitivity","target":"undisclosed - antihistamine","id":"1083"},{"source":"inflammation","target":"Lm-LLO-PSA vaccine","id":"1084"},{"source":"inflammation","target":"Advaxis (u)","id":"1085"},{"source":"inflammation","target":"pembrolizumab","id":"1086"},{"source":"inflammation","target":"undisclosed - analgesic","id":"1087"},{"source":"inflammation","target":"undisclosed - antiemetic agent","id":"1088"},{"source":"inflammation","target":"undisclosed - antihistamine","id":"1089"},{"source":"analgesic","target":"Lm-LLO-PSA vaccine","id":"1090"},{"source":"analgesic","target":"Advaxis (u)","id":"1091"},{"source":"analgesic","target":"pembrolizumab","id":"1092"},{"source":"analgesic","target":"undisclosed - analgesic","id":"1093"},{"source":"analgesic","target":"undisclosed - antiemetic agent","id":"1094"},{"source":"analgesic","target":"undisclosed - antihistamine","id":"1095"},{"source":"prostate cancer","target":"Lm-LLO-PSA vaccine","id":"1096"},{"source":"prostate cancer","target":"Advaxis (u)","id":"1097"},{"source":"prostate cancer","target":"pembrolizumab","id":"1098"},{"source":"prostate cancer","target":"undisclosed - analgesic","id":"1099"},{"source":"prostate cancer","target":"undisclosed - antiemetic agent","id":"1100"},{"source":"prostate cancer","target":"undisclosed - antihistamine","id":"1101"},{"source":"castration-resistant prostatic neoplasms","target":"Lm-LLO-PSA vaccine","id":"1102"},{"source":"castration-resistant prostatic neoplasms","target":"Advaxis (u)","id":"1103"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"1104"},{"source":"castration-resistant prostatic neoplasms","target":"undisclosed - analgesic","id":"1105"},{"source":"castration-resistant prostatic neoplasms","target":"undisclosed - antiemetic agent","id":"1106"},{"source":"castration-resistant prostatic neoplasms","target":"undisclosed - antihistamine","id":"1107"},{"source":"antiemetic","target":"Lm-LLO-PSA vaccine","id":"1108"},{"source":"antiemetic","target":"Advaxis (u)","id":"1109"},{"source":"antiemetic","target":"pembrolizumab","id":"1110"},{"source":"antiemetic","target":"undisclosed - analgesic","id":"1111"},{"source":"antiemetic","target":"undisclosed - antiemetic agent","id":"1112"},{"source":"antiemetic","target":"undisclosed - antihistamine","id":"1113"},{"source":"pain","target":"Lm-LLO-PSA vaccine","id":"1114"},{"source":"pain","target":"Advaxis (u)","id":"1115"},{"source":"pain","target":"pembrolizumab","id":"1116"},{"source":"pain","target":"undisclosed - analgesic","id":"1117"},{"source":"pain","target":"undisclosed - antiemetic agent","id":"1118"},{"source":"pain","target":"undisclosed - antihistamine","id":"1119"},{"source":"vomiting","target":"Lm-LLO-PSA vaccine","id":"1120"},{"source":"vomiting","target":"Advaxis (u)","id":"1121"},{"source":"vomiting","target":"pembrolizumab","id":"1122"},{"source":"vomiting","target":"undisclosed - analgesic","id":"1123"},{"source":"vomiting","target":"undisclosed - antiemetic agent","id":"1124"},{"source":"vomiting","target":"undisclosed - antihistamine","id":"1125"},{"source":"metastatic","target":"Lm-LLO-PSA vaccine","id":"1126"},{"source":"metastatic","target":"Advaxis (u)","id":"1127"},{"source":"metastatic","target":"pembrolizumab","id":"1128"},{"source":"metastatic","target":"undisclosed - analgesic","id":"1129"},{"source":"metastatic","target":"undisclosed - antiemetic agent","id":"1130"},{"source":"metastatic","target":"undisclosed - antihistamine","id":"1131"},{"source":"carcinoma","target":"Lm-LLO-PSA vaccine","id":"1132"},{"source":"carcinoma","target":"Advaxis (u)","id":"1133"},{"source":"carcinoma","target":"pembrolizumab","id":"1134"},{"source":"carcinoma","target":"undisclosed - analgesic","id":"1135"},{"source":"carcinoma","target":"undisclosed - antiemetic agent","id":"1136"},{"source":"carcinoma","target":"undisclosed - antihistamine","id":"1137"},{"source":"neoplasm metastasis","target":"Lm-LLO-PSA vaccine","id":"1138"},{"source":"neoplasm metastasis","target":"Advaxis (u)","id":"1139"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"1140"},{"source":"neoplasm metastasis","target":"undisclosed - analgesic","id":"1141"},{"source":"neoplasm metastasis","target":"undisclosed - antiemetic agent","id":"1142"},{"source":"neoplasm metastasis","target":"undisclosed - antihistamine","id":"1143"},{"source":"bone diseases","target":"Lm-LLO-PSA vaccine","id":"1144"},{"source":"bone diseases","target":"Advaxis (u)","id":"1145"},{"source":"bone diseases","target":"pembrolizumab","id":"1146"},{"source":"bone diseases","target":"undisclosed - analgesic","id":"1147"},{"source":"bone diseases","target":"undisclosed - antiemetic agent","id":"1148"},{"source":"bone diseases","target":"undisclosed - antihistamine","id":"1149"},{"source":"prostate cancer","target":"Lm-LLO-PSA vaccine","id":"1150"},{"source":"prostate cancer","target":"Advaxis (u)","id":"1151"},{"source":"prostate cancer","target":"pembrolizumab","id":"1152"},{"source":"prostate cancer","target":"undisclosed - analgesic","id":"1153"},{"source":"prostate cancer","target":"undisclosed - antiemetic agent","id":"1154"},{"source":"prostate cancer","target":"undisclosed - antihistamine","id":"1155"},{"source":"anti-tumor","target":"Lm-LLO-PSA vaccine","id":"1156"},{"source":"anti-tumor","target":"Advaxis (u)","id":"1157"},{"source":"anti-tumor","target":"pembrolizumab","id":"1158"},{"source":"anti-tumor","target":"undisclosed - analgesic","id":"1159"},{"source":"anti-tumor","target":"undisclosed - antiemetic agent","id":"1160"},{"source":"anti-tumor","target":"undisclosed - antihistamine","id":"1161"},{"source":"anticancer","target":"Lm-LLO-PSA vaccine","id":"1162"},{"source":"anticancer","target":"Advaxis (u)","id":"1163"},{"source":"anticancer","target":"pembrolizumab","id":"1164"},{"source":"anticancer","target":"undisclosed - analgesic","id":"1165"},{"source":"anticancer","target":"undisclosed - antiemetic agent","id":"1166"},{"source":"anticancer","target":"undisclosed - antihistamine","id":"1167"},{"source":"Histamine receptor antagonist","target":"UNK : Indication","id":"1168"},{"source":"Histamine receptor antagonist","target":"prostate cancer","id":"1169"},{"source":"Histamine receptor antagonist","target":"castration-resistant prostatic neoplasms","id":"1170"},{"source":"Histamine receptor antagonist","target":"bone diseases","id":"1171"},{"source":"Histamine receptor antagonist","target":"liver metastases","id":"1172"},{"source":"Histamine receptor antagonist","target":"anti-inflammatory","id":"1173"},{"source":"Histamine receptor antagonist","target":"asthma","id":"1174"},{"source":"Histamine receptor antagonist","target":"antiallergic","id":"1175"},{"source":"Histamine receptor antagonist","target":"hypersensitivity","id":"1176"},{"source":"Histamine receptor antagonist","target":"inflammation","id":"1177"},{"source":"Histamine receptor antagonist","target":"analgesic","id":"1178"},{"source":"Histamine receptor antagonist","target":"prostate cancer","id":"1179"},{"source":"Histamine receptor antagonist","target":"castration-resistant prostatic neoplasms","id":"1180"},{"source":"Histamine receptor antagonist","target":"antiemetic","id":"1181"},{"source":"Histamine receptor antagonist","target":"pain","id":"1182"},{"source":"Histamine receptor antagonist","target":"vomiting","id":"1183"},{"source":"Histamine receptor antagonist","target":"metastatic","id":"1184"},{"source":"Histamine receptor antagonist","target":"carcinoma","id":"1185"},{"source":"Histamine receptor antagonist","target":"neoplasm metastasis","id":"1186"},{"source":"Histamine receptor antagonist","target":"bone diseases","id":"1187"},{"source":"Histamine receptor antagonist","target":"prostate cancer","id":"1188"},{"source":"Histamine receptor antagonist","target":"anti-tumor","id":"1189"},{"source":"Histamine receptor antagonist","target":"anticancer","id":"1190"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"1191"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"1192"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"1193"},{"source":"Immune checkpoint inhibitor","target":"bone diseases","id":"1194"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"1195"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"1196"},{"source":"Immune checkpoint inhibitor","target":"asthma","id":"1197"},{"source":"Immune checkpoint inhibitor","target":"antiallergic","id":"1198"},{"source":"Immune checkpoint inhibitor","target":"hypersensitivity","id":"1199"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"1200"},{"source":"Immune checkpoint inhibitor","target":"analgesic","id":"1201"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"1202"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"1203"},{"source":"Immune checkpoint inhibitor","target":"antiemetic","id":"1204"},{"source":"Immune checkpoint inhibitor","target":"pain","id":"1205"},{"source":"Immune checkpoint inhibitor","target":"vomiting","id":"1206"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"1207"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1208"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"1209"},{"source":"Immune checkpoint inhibitor","target":"bone diseases","id":"1210"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"1211"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"1212"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"1213"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"1214"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"1215"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"1216"},{"source":"Anticancer immunotherapy","target":"bone diseases","id":"1217"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"1218"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"1219"},{"source":"Anticancer immunotherapy","target":"asthma","id":"1220"},{"source":"Anticancer immunotherapy","target":"antiallergic","id":"1221"},{"source":"Anticancer immunotherapy","target":"hypersensitivity","id":"1222"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"1223"},{"source":"Anticancer immunotherapy","target":"analgesic","id":"1224"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"1225"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"1226"},{"source":"Anticancer immunotherapy","target":"antiemetic","id":"1227"},{"source":"Anticancer immunotherapy","target":"pain","id":"1228"},{"source":"Anticancer immunotherapy","target":"vomiting","id":"1229"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"1230"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1231"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"1232"},{"source":"Anticancer immunotherapy","target":"bone diseases","id":"1233"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"1234"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"1235"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"1236"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"1237"},{"source":"CD19 antagonist","target":"prostate cancer","id":"1238"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"1239"},{"source":"CD19 antagonist","target":"bone diseases","id":"1240"},{"source":"CD19 antagonist","target":"liver metastases","id":"1241"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"1242"},{"source":"CD19 antagonist","target":"asthma","id":"1243"},{"source":"CD19 antagonist","target":"antiallergic","id":"1244"},{"source":"CD19 antagonist","target":"hypersensitivity","id":"1245"},{"source":"CD19 antagonist","target":"inflammation","id":"1246"},{"source":"CD19 antagonist","target":"analgesic","id":"1247"},{"source":"CD19 antagonist","target":"prostate cancer","id":"1248"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"1249"},{"source":"CD19 antagonist","target":"antiemetic","id":"1250"},{"source":"CD19 antagonist","target":"pain","id":"1251"},{"source":"CD19 antagonist","target":"vomiting","id":"1252"},{"source":"CD19 antagonist","target":"metastatic","id":"1253"},{"source":"CD19 antagonist","target":"carcinoma","id":"1254"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"1255"},{"source":"CD19 antagonist","target":"bone diseases","id":"1256"},{"source":"CD19 antagonist","target":"prostate cancer","id":"1257"},{"source":"CD19 antagonist","target":"anti-tumor","id":"1258"},{"source":"CD19 antagonist","target":"anticancer","id":"1259"},{"source":"UPA","target":"UNK : Indication","id":"1260"},{"source":"UPA","target":"prostate cancer","id":"1261"},{"source":"UPA","target":"castration-resistant prostatic neoplasms","id":"1262"},{"source":"UPA","target":"bone diseases","id":"1263"},{"source":"UPA","target":"liver metastases","id":"1264"},{"source":"UPA","target":"anti-inflammatory","id":"1265"},{"source":"UPA","target":"asthma","id":"1266"},{"source":"UPA","target":"antiallergic","id":"1267"},{"source":"UPA","target":"hypersensitivity","id":"1268"},{"source":"UPA","target":"inflammation","id":"1269"},{"source":"UPA","target":"analgesic","id":"1270"},{"source":"UPA","target":"prostate cancer","id":"1271"},{"source":"UPA","target":"castration-resistant prostatic neoplasms","id":"1272"},{"source":"UPA","target":"antiemetic","id":"1273"},{"source":"UPA","target":"pain","id":"1274"},{"source":"UPA","target":"vomiting","id":"1275"},{"source":"UPA","target":"metastatic","id":"1276"},{"source":"UPA","target":"carcinoma","id":"1277"},{"source":"UPA","target":"neoplasm metastasis","id":"1278"},{"source":"UPA","target":"bone diseases","id":"1279"},{"source":"UPA","target":"prostate cancer","id":"1280"},{"source":"UPA","target":"anti-tumor","id":"1281"},{"source":"UPA","target":"anticancer","id":"1282"},{"source":"Immunostimulant","target":"UNK : Indication","id":"1283"},{"source":"Immunostimulant","target":"prostate cancer","id":"1284"},{"source":"Immunostimulant","target":"castration-resistant prostatic neoplasms","id":"1285"},{"source":"Immunostimulant","target":"bone diseases","id":"1286"},{"source":"Immunostimulant","target":"liver metastases","id":"1287"},{"source":"Immunostimulant","target":"anti-inflammatory","id":"1288"},{"source":"Immunostimulant","target":"asthma","id":"1289"},{"source":"Immunostimulant","target":"antiallergic","id":"1290"},{"source":"Immunostimulant","target":"hypersensitivity","id":"1291"},{"source":"Immunostimulant","target":"inflammation","id":"1292"},{"source":"Immunostimulant","target":"analgesic","id":"1293"},{"source":"Immunostimulant","target":"prostate cancer","id":"1294"},{"source":"Immunostimulant","target":"castration-resistant prostatic neoplasms","id":"1295"},{"source":"Immunostimulant","target":"antiemetic","id":"1296"},{"source":"Immunostimulant","target":"pain","id":"1297"},{"source":"Immunostimulant","target":"vomiting","id":"1298"},{"source":"Immunostimulant","target":"metastatic","id":"1299"},{"source":"Immunostimulant","target":"carcinoma","id":"1300"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"1301"},{"source":"Immunostimulant","target":"bone diseases","id":"1302"},{"source":"Immunostimulant","target":"prostate cancer","id":"1303"},{"source":"Immunostimulant","target":"anti-tumor","id":"1304"},{"source":"Immunostimulant","target":"anticancer","id":"1305"},{"source":"Oncology: Prostate","target":"Histamine receptor antagonist","id":"1306"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"1307"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"1308"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"1309"},{"source":"Oncology: Prostate","target":"UPA","id":"1310"},{"source":"Oncology: Prostate","target":"Immunostimulant","id":"1311"},{"source":"AE-37 (u)","target":"Generex Biotechnology/Antigen Express","id":"1312"},{"source":"pembrolizumab","target":"Generex Biotechnology/Antigen Express","id":"1313"},{"source":"UNK : Drug","target":"Generex Biotechnology/Antigen Express","id":"1314"},{"source":"UNK : Indication","target":"AE-37 (u)","id":"1315"},{"source":"UNK : Indication","target":"pembrolizumab","id":"1316"},{"source":"UNK : Indication","target":"UNK : Drug","id":"1317"},{"source":"triple-negative breast cancer","target":"AE-37 (u)","id":"1318"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"1319"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"1320"},{"source":"breast neoplasms","target":"AE-37 (u)","id":"1321"},{"source":"breast neoplasms","target":"pembrolizumab","id":"1322"},{"source":"breast neoplasms","target":"UNK : Drug","id":"1323"},{"source":"metastatic","target":"AE-37 (u)","id":"1324"},{"source":"metastatic","target":"pembrolizumab","id":"1325"},{"source":"metastatic","target":"UNK : Drug","id":"1326"},{"source":"carcinoma","target":"AE-37 (u)","id":"1327"},{"source":"carcinoma","target":"pembrolizumab","id":"1328"},{"source":"carcinoma","target":"UNK : Drug","id":"1329"},{"source":"breast neoplasms","target":"AE-37 (u)","id":"1330"},{"source":"breast neoplasms","target":"pembrolizumab","id":"1331"},{"source":"breast neoplasms","target":"UNK : Drug","id":"1332"},{"source":"neoplasm metastasis","target":"AE-37 (u)","id":"1333"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"1334"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"1335"},{"source":"anticancer","target":"AE-37 (u)","id":"1336"},{"source":"anticancer","target":"pembrolizumab","id":"1337"},{"source":"anticancer","target":"UNK : Drug","id":"1338"},{"source":"NA","target":"UNK : Indication","id":"1339"},{"source":"NA","target":"triple-negative breast cancer","id":"1340"},{"source":"NA","target":"breast neoplasms","id":"1341"},{"source":"NA","target":"metastatic","id":"1342"},{"source":"NA","target":"carcinoma","id":"1343"},{"source":"NA","target":"breast neoplasms","id":"1344"},{"source":"NA","target":"neoplasm metastasis","id":"1345"},{"source":"NA","target":"anticancer","id":"1346"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"1347"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"1348"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"1349"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"1350"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1351"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"1352"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"1353"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"1354"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"1355"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"1356"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"1357"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"1358"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1359"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"1360"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"1361"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"1362"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"1363"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"1364"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"1365"},{"source":"CD19 antagonist","target":"metastatic","id":"1366"},{"source":"CD19 antagonist","target":"carcinoma","id":"1367"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"1368"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"1369"},{"source":"CD19 antagonist","target":"anticancer","id":"1370"},{"source":"T helper cell stimulant","target":"UNK : Indication","id":"1371"},{"source":"T helper cell stimulant","target":"triple-negative breast cancer","id":"1372"},{"source":"T helper cell stimulant","target":"breast neoplasms","id":"1373"},{"source":"T helper cell stimulant","target":"metastatic","id":"1374"},{"source":"T helper cell stimulant","target":"carcinoma","id":"1375"},{"source":"T helper cell stimulant","target":"breast neoplasms","id":"1376"},{"source":"T helper cell stimulant","target":"neoplasm metastasis","id":"1377"},{"source":"T helper cell stimulant","target":"anticancer","id":"1378"},{"source":"Immunostimulant","target":"UNK : Indication","id":"1379"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"1380"},{"source":"Immunostimulant","target":"breast neoplasms","id":"1381"},{"source":"Immunostimulant","target":"metastatic","id":"1382"},{"source":"Immunostimulant","target":"carcinoma","id":"1383"},{"source":"Immunostimulant","target":"breast neoplasms","id":"1384"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"1385"},{"source":"Immunostimulant","target":"anticancer","id":"1386"},{"source":"Oncology: Breast","target":"NA","id":"1387"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"1388"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"1389"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"1390"},{"source":"Oncology: Breast","target":"T helper cell stimulant","id":"1391"},{"source":"Oncology: Breast","target":"Immunostimulant","id":"1392"},{"source":"CH-296 (u)","target":"(Other Hospital/Academic/Medical Center)","id":"1393"},{"source":"nivolumab (a)","target":"(Other Hospital/Academic/Medical Center)","id":"1394"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"1395"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"1396"},{"source":"UNK : Indication","target":"CH-296 (u)","id":"1397"},{"source":"UNK : Indication","target":"nivolumab (a)","id":"1398"},{"source":"UNK : Indication","target":"pembrolizumab","id":"1399"},{"source":"UNK : Indication","target":"UNK : Drug","id":"1400"},{"source":"kidney neoplasms","target":"CH-296 (u)","id":"1401"},{"source":"kidney neoplasms","target":"nivolumab (a)","id":"1402"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"1403"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"1404"},{"source":"renal cancer","target":"CH-296 (u)","id":"1405"},{"source":"renal cancer","target":"nivolumab (a)","id":"1406"},{"source":"renal cancer","target":"pembrolizumab","id":"1407"},{"source":"renal cancer","target":"UNK : Drug","id":"1408"},{"source":"carcinoma","target":"CH-296 (u)","id":"1409"},{"source":"carcinoma","target":"nivolumab (a)","id":"1410"},{"source":"carcinoma","target":"pembrolizumab","id":"1411"},{"source":"carcinoma","target":"UNK : Drug","id":"1412"},{"source":"carcinoma","target":"CH-296 (u)","id":"1413"},{"source":"carcinoma","target":"nivolumab (a)","id":"1414"},{"source":"carcinoma","target":"pembrolizumab","id":"1415"},{"source":"carcinoma","target":"UNK : Drug","id":"1416"},{"source":"anticancer","target":"CH-296 (u)","id":"1417"},{"source":"anticancer","target":"nivolumab (a)","id":"1418"},{"source":"anticancer","target":"pembrolizumab","id":"1419"},{"source":"anticancer","target":"UNK : Drug","id":"1420"},{"source":"renal cancer","target":"CH-296 (u)","id":"1421"},{"source":"renal cancer","target":"nivolumab (a)","id":"1422"},{"source":"renal cancer","target":"pembrolizumab","id":"1423"},{"source":"renal cancer","target":"UNK : Drug","id":"1424"},{"source":"renal cell","target":"CH-296 (u)","id":"1425"},{"source":"renal cell","target":"nivolumab (a)","id":"1426"},{"source":"renal cell","target":"pembrolizumab","id":"1427"},{"source":"renal cell","target":"UNK : Drug","id":"1428"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"1429"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"1430"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"1431"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1432"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1433"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"1434"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"1435"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"1436"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"1437"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"1438"},{"source":"CD19 antagonist","target":"renal cancer","id":"1439"},{"source":"CD19 antagonist","target":"carcinoma","id":"1440"},{"source":"CD19 antagonist","target":"carcinoma","id":"1441"},{"source":"CD19 antagonist","target":"anticancer","id":"1442"},{"source":"CD19 antagonist","target":"renal cancer","id":"1443"},{"source":"CD19 antagonist","target":"renal cell","id":"1444"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"1445"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"1446"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"1447"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1448"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1449"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"1450"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"1451"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"1452"},{"source":"T helper cell stimulant","target":"UNK : Indication","id":"1453"},{"source":"T helper cell stimulant","target":"kidney neoplasms","id":"1454"},{"source":"T helper cell stimulant","target":"renal cancer","id":"1455"},{"source":"T helper cell stimulant","target":"carcinoma","id":"1456"},{"source":"T helper cell stimulant","target":"carcinoma","id":"1457"},{"source":"T helper cell stimulant","target":"anticancer","id":"1458"},{"source":"T helper cell stimulant","target":"renal cancer","id":"1459"},{"source":"T helper cell stimulant","target":"renal cell","id":"1460"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"1461"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"1462"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"1463"},{"source":"Oncology: Renal","target":"T helper cell stimulant","id":"1464"},{"source":"birinapant (u)","target":"Medivir","id":"1465"},{"source":"birinapant (u)","target":"Merck & Co.","id":"1466"},{"source":"pembrolizumab","target":"Medivir","id":"1467"},{"source":"pembrolizumab","target":"Merck & Co.","id":"1468"},{"source":"UNK : Indication","target":"birinapant (u)","id":"1469"},{"source":"UNK : Indication","target":"pembrolizumab","id":"1470"},{"source":"carcinoma","target":"birinapant (u)","id":"1471"},{"source":"carcinoma","target":"pembrolizumab","id":"1472"},{"source":"colorectal neoplasms","target":"birinapant (u)","id":"1473"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"1474"},{"source":"ovarian cancer","target":"birinapant (u)","id":"1475"},{"source":"ovarian cancer","target":"pembrolizumab","id":"1476"},{"source":"ovarian cancer","target":"birinapant (u)","id":"1477"},{"source":"ovarian cancer","target":"pembrolizumab","id":"1478"},{"source":"carcinoma","target":"birinapant (u)","id":"1479"},{"source":"carcinoma","target":"pembrolizumab","id":"1480"},{"source":"primary peritoneal cancer","target":"birinapant (u)","id":"1481"},{"source":"primary peritoneal cancer","target":"pembrolizumab","id":"1482"},{"source":"anti-hiv","target":"birinapant (u)","id":"1483"},{"source":"anti-hiv","target":"pembrolizumab","id":"1484"},{"source":"squamous cell neoplasms","target":"birinapant (u)","id":"1485"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"1486"},{"source":"hiv infections","target":"birinapant (u)","id":"1487"},{"source":"hiv infections","target":"pembrolizumab","id":"1488"},{"source":"liver neoplasms","target":"birinapant (u)","id":"1489"},{"source":"liver neoplasms","target":"pembrolizumab","id":"1490"},{"source":"carcinoma","target":"birinapant (u)","id":"1491"},{"source":"carcinoma","target":"pembrolizumab","id":"1492"},{"source":"head and neck neoplasms","target":"birinapant (u)","id":"1493"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"1494"},{"source":"carcinoma","target":"birinapant (u)","id":"1495"},{"source":"carcinoma","target":"pembrolizumab","id":"1496"},{"source":"uterine cervical neoplasms","target":"birinapant (u)","id":"1497"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"1498"},{"source":"anticancer","target":"birinapant (u)","id":"1499"},{"source":"anticancer","target":"pembrolizumab","id":"1500"},{"source":"mesothelial","target":"birinapant (u)","id":"1501"},{"source":"mesothelial","target":"pembrolizumab","id":"1502"},{"source":"solid tumors","target":"birinapant (u)","id":"1503"},{"source":"solid tumors","target":"pembrolizumab","id":"1504"},{"source":"carcinoma","target":"birinapant (u)","id":"1505"},{"source":"carcinoma","target":"pembrolizumab","id":"1506"},{"source":"acquired immunodeficiency syndrome","target":"birinapant (u)","id":"1507"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"1508"},{"source":"colonic neoplasms","target":"birinapant (u)","id":"1509"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"1510"},{"source":"carcinoma","target":"birinapant (u)","id":"1511"},{"source":"carcinoma","target":"pembrolizumab","id":"1512"},{"source":"esophageal cancer","target":"birinapant (u)","id":"1513"},{"source":"esophageal cancer","target":"pembrolizumab","id":"1514"},{"source":"liver cancer","target":"birinapant (u)","id":"1515"},{"source":"liver cancer","target":"pembrolizumab","id":"1516"},{"source":"ovarian neoplasms","target":"birinapant (u)","id":"1517"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"1518"},{"source":"cervical cancer","target":"birinapant (u)","id":"1519"},{"source":"cervical cancer","target":"pembrolizumab","id":"1520"},{"source":"pharyngeal neoplasms","target":"birinapant (u)","id":"1521"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"1522"},{"source":"skin neoplasms","target":"birinapant (u)","id":"1523"},{"source":"skin neoplasms","target":"pembrolizumab","id":"1524"},{"source":"mesothelial","target":"birinapant (u)","id":"1525"},{"source":"mesothelial","target":"pembrolizumab","id":"1526"},{"source":"colorectal cancer","target":"birinapant (u)","id":"1527"},{"source":"colorectal cancer","target":"pembrolizumab","id":"1528"},{"source":"mesothelial","target":"birinapant (u)","id":"1529"},{"source":"mesothelial","target":"pembrolizumab","id":"1530"},{"source":"skin neoplasms","target":"birinapant (u)","id":"1531"},{"source":"skin neoplasms","target":"pembrolizumab","id":"1532"},{"source":"peritoneal neoplasms","target":"birinapant (u)","id":"1533"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"1534"},{"source":"metastatic","target":"birinapant (u)","id":"1535"},{"source":"metastatic","target":"pembrolizumab","id":"1536"},{"source":"carcinoma","target":"birinapant (u)","id":"1537"},{"source":"carcinoma","target":"pembrolizumab","id":"1538"},{"source":"neoplasm metastasis","target":"birinapant (u)","id":"1539"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"1540"},{"source":"unknown primary","target":"birinapant (u)","id":"1541"},{"source":"unknown primary","target":"pembrolizumab","id":"1542"},{"source":"non-small-cell lung","target":"birinapant (u)","id":"1543"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"1544"},{"source":"ovarian cancer","target":"birinapant (u)","id":"1545"},{"source":"ovarian cancer","target":"pembrolizumab","id":"1546"},{"source":"colorectal neoplasms","target":"birinapant (u)","id":"1547"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"1548"},{"source":"stomach neoplasms","target":"birinapant (u)","id":"1549"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"1550"},{"source":"sclc","target":"birinapant (u)","id":"1551"},{"source":"sclc","target":"pembrolizumab","id":"1552"},{"source":"hepatocellular","target":"birinapant (u)","id":"1553"},{"source":"hepatocellular","target":"pembrolizumab","id":"1554"},{"source":"carcinoma","target":"birinapant (u)","id":"1555"},{"source":"carcinoma","target":"pembrolizumab","id":"1556"},{"source":"solid tumors","target":"birinapant (u)","id":"1557"},{"source":"solid tumors","target":"pembrolizumab","id":"1558"},{"source":"carcinoma","target":"birinapant (u)","id":"1559"},{"source":"carcinoma","target":"pembrolizumab","id":"1560"},{"source":"carcinoma","target":"birinapant (u)","id":"1561"},{"source":"carcinoma","target":"pembrolizumab","id":"1562"},{"source":"solid malignancy","target":"birinapant (u)","id":"1563"},{"source":"solid malignancy","target":"pembrolizumab","id":"1564"},{"source":"anticancer","target":"birinapant (u)","id":"1565"},{"source":"anticancer","target":"pembrolizumab","id":"1566"},{"source":"unknown primary","target":"birinapant (u)","id":"1567"},{"source":"unknown primary","target":"pembrolizumab","id":"1568"},{"source":"solid tumors","target":"birinapant (u)","id":"1569"},{"source":"solid tumors","target":"pembrolizumab","id":"1570"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"1571"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1572"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"1573"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"1574"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"1575"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1576"},{"source":"Anticancer immunotherapy","target":"primary peritoneal cancer","id":"1577"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"1578"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"1579"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"1580"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"1581"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1582"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"1583"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1584"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"1585"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"1586"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"1587"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"1588"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1589"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"1590"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"1591"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1592"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"1593"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"1594"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"1595"},{"source":"Anticancer immunotherapy","target":"cervical cancer","id":"1596"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"1597"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"1598"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"1599"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"1600"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"1601"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"1602"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"1603"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"1604"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1605"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"1606"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"1607"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"1608"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"1609"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"1610"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"1611"},{"source":"Anticancer immunotherapy","target":"sclc","id":"1612"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"1613"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1614"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"1615"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1616"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1617"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"1618"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"1619"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"1620"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"1621"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"1622"},{"source":"CD19 antagonist","target":"carcinoma","id":"1623"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"1624"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"1625"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"1626"},{"source":"CD19 antagonist","target":"carcinoma","id":"1627"},{"source":"CD19 antagonist","target":"primary peritoneal cancer","id":"1628"},{"source":"CD19 antagonist","target":"anti-hiv","id":"1629"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"1630"},{"source":"CD19 antagonist","target":"hiv infections","id":"1631"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"1632"},{"source":"CD19 antagonist","target":"carcinoma","id":"1633"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"1634"},{"source":"CD19 antagonist","target":"carcinoma","id":"1635"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"1636"},{"source":"CD19 antagonist","target":"anticancer","id":"1637"},{"source":"CD19 antagonist","target":"mesothelial","id":"1638"},{"source":"CD19 antagonist","target":"solid tumors","id":"1639"},{"source":"CD19 antagonist","target":"carcinoma","id":"1640"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"1641"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"1642"},{"source":"CD19 antagonist","target":"carcinoma","id":"1643"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"1644"},{"source":"CD19 antagonist","target":"liver cancer","id":"1645"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"1646"},{"source":"CD19 antagonist","target":"cervical cancer","id":"1647"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"1648"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"1649"},{"source":"CD19 antagonist","target":"mesothelial","id":"1650"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"1651"},{"source":"CD19 antagonist","target":"mesothelial","id":"1652"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"1653"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"1654"},{"source":"CD19 antagonist","target":"metastatic","id":"1655"},{"source":"CD19 antagonist","target":"carcinoma","id":"1656"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"1657"},{"source":"CD19 antagonist","target":"unknown primary","id":"1658"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"1659"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"1660"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"1661"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"1662"},{"source":"CD19 antagonist","target":"sclc","id":"1663"},{"source":"CD19 antagonist","target":"hepatocellular","id":"1664"},{"source":"CD19 antagonist","target":"carcinoma","id":"1665"},{"source":"CD19 antagonist","target":"solid tumors","id":"1666"},{"source":"CD19 antagonist","target":"carcinoma","id":"1667"},{"source":"CD19 antagonist","target":"carcinoma","id":"1668"},{"source":"CD19 antagonist","target":"solid malignancy","id":"1669"},{"source":"CD19 antagonist","target":"anticancer","id":"1670"},{"source":"CD19 antagonist","target":"unknown primary","id":"1671"},{"source":"CD19 antagonist","target":"solid tumors","id":"1672"},{"source":"IAP antagonist","target":"UNK : Indication","id":"1673"},{"source":"IAP antagonist","target":"carcinoma","id":"1674"},{"source":"IAP antagonist","target":"colorectal neoplasms","id":"1675"},{"source":"IAP antagonist","target":"ovarian cancer","id":"1676"},{"source":"IAP antagonist","target":"ovarian cancer","id":"1677"},{"source":"IAP antagonist","target":"carcinoma","id":"1678"},{"source":"IAP antagonist","target":"primary peritoneal cancer","id":"1679"},{"source":"IAP antagonist","target":"anti-hiv","id":"1680"},{"source":"IAP antagonist","target":"squamous cell neoplasms","id":"1681"},{"source":"IAP antagonist","target":"hiv infections","id":"1682"},{"source":"IAP antagonist","target":"liver neoplasms","id":"1683"},{"source":"IAP antagonist","target":"carcinoma","id":"1684"},{"source":"IAP antagonist","target":"head and neck neoplasms","id":"1685"},{"source":"IAP antagonist","target":"carcinoma","id":"1686"},{"source":"IAP antagonist","target":"uterine cervical neoplasms","id":"1687"},{"source":"IAP antagonist","target":"anticancer","id":"1688"},{"source":"IAP antagonist","target":"mesothelial","id":"1689"},{"source":"IAP antagonist","target":"solid tumors","id":"1690"},{"source":"IAP antagonist","target":"carcinoma","id":"1691"},{"source":"IAP antagonist","target":"acquired immunodeficiency syndrome","id":"1692"},{"source":"IAP antagonist","target":"colonic neoplasms","id":"1693"},{"source":"IAP antagonist","target":"carcinoma","id":"1694"},{"source":"IAP antagonist","target":"esophageal cancer","id":"1695"},{"source":"IAP antagonist","target":"liver cancer","id":"1696"},{"source":"IAP antagonist","target":"ovarian neoplasms","id":"1697"},{"source":"IAP antagonist","target":"cervical cancer","id":"1698"},{"source":"IAP antagonist","target":"pharyngeal neoplasms","id":"1699"},{"source":"IAP antagonist","target":"skin neoplasms","id":"1700"},{"source":"IAP antagonist","target":"mesothelial","id":"1701"},{"source":"IAP antagonist","target":"colorectal cancer","id":"1702"},{"source":"IAP antagonist","target":"mesothelial","id":"1703"},{"source":"IAP antagonist","target":"skin neoplasms","id":"1704"},{"source":"IAP antagonist","target":"peritoneal neoplasms","id":"1705"},{"source":"IAP antagonist","target":"metastatic","id":"1706"},{"source":"IAP antagonist","target":"carcinoma","id":"1707"},{"source":"IAP antagonist","target":"neoplasm metastasis","id":"1708"},{"source":"IAP antagonist","target":"unknown primary","id":"1709"},{"source":"IAP antagonist","target":"non-small-cell lung","id":"1710"},{"source":"IAP antagonist","target":"ovarian cancer","id":"1711"},{"source":"IAP antagonist","target":"colorectal neoplasms","id":"1712"},{"source":"IAP antagonist","target":"stomach neoplasms","id":"1713"},{"source":"IAP antagonist","target":"sclc","id":"1714"},{"source":"IAP antagonist","target":"hepatocellular","id":"1715"},{"source":"IAP antagonist","target":"carcinoma","id":"1716"},{"source":"IAP antagonist","target":"solid tumors","id":"1717"},{"source":"IAP antagonist","target":"carcinoma","id":"1718"},{"source":"IAP antagonist","target":"carcinoma","id":"1719"},{"source":"IAP antagonist","target":"solid malignancy","id":"1720"},{"source":"IAP antagonist","target":"anticancer","id":"1721"},{"source":"IAP antagonist","target":"unknown primary","id":"1722"},{"source":"IAP antagonist","target":"solid tumors","id":"1723"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"1724"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1725"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"1726"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"1727"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"1728"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1729"},{"source":"Immune checkpoint inhibitor","target":"primary peritoneal cancer","id":"1730"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"1731"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"1732"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"1733"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"1734"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1735"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"1736"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1737"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"1738"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"1739"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"1740"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"1741"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1742"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"1743"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"1744"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1745"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"1746"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"1747"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"1748"},{"source":"Immune checkpoint inhibitor","target":"cervical cancer","id":"1749"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"1750"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"1751"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"1752"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"1753"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"1754"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"1755"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"1756"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"1757"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1758"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"1759"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"1760"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"1761"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"1762"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"1763"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"1764"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"1765"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"1766"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1767"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"1768"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1769"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1770"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"1771"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"1772"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"1773"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"1774"},{"source":"Oncology: Cervical","target":"Anticancer immunotherapy","id":"1775"},{"source":"Oncology: Cervical","target":"CD19 antagonist","id":"1776"},{"source":"Oncology: Cervical","target":"IAP antagonist","id":"1777"},{"source":"Oncology: Cervical","target":"Immune checkpoint inhibitor","id":"1778"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"1779"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"1780"},{"source":"Oncology: Colorectal","target":"IAP antagonist","id":"1781"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"1782"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"1783"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"1784"},{"source":"Oncology: Esophageal","target":"IAP antagonist","id":"1785"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"1786"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"1787"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"1788"},{"source":"Oncology: Gastric","target":"IAP antagonist","id":"1789"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"1790"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"1791"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"1792"},{"source":"Oncology: Head/Neck","target":"IAP antagonist","id":"1793"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"1794"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"1795"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"1796"},{"source":"Oncology: Liver","target":"IAP antagonist","id":"1797"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"1798"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"1799"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"1800"},{"source":"Oncology: Lung","target":"IAP antagonist","id":"1801"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"1802"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"1803"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"1804"},{"source":"Non-Small Cell","target":"IAP antagonist","id":"1805"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"1806"},{"source":"Oncology: Mesothelioma","target":"Anticancer immunotherapy","id":"1807"},{"source":"Oncology: Mesothelioma","target":"CD19 antagonist","id":"1808"},{"source":"Oncology: Mesothelioma","target":"IAP antagonist","id":"1809"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint inhibitor","id":"1810"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"1811"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"1812"},{"source":"Oncology: Ovarian","target":"IAP antagonist","id":"1813"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"1814"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"1815"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"1816"},{"source":"Oncology: CNS","target":"IAP antagonist","id":"1817"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"1818"},{"source":"margetuximab (u)","target":"MacroGenics","id":"1819"},{"source":"margetuximab (u)","target":"Merck & Co.","id":"1820"},{"source":"pembrolizumab","target":"MacroGenics","id":"1821"},{"source":"pembrolizumab","target":"Merck & Co.","id":"1822"},{"source":"UNK : Indication","target":"margetuximab (u)","id":"1823"},{"source":"UNK : Indication","target":"pembrolizumab","id":"1824"},{"source":"pharyngeal neoplasms","target":"margetuximab (u)","id":"1825"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"1826"},{"source":"anticancer","target":"margetuximab (u)","id":"1827"},{"source":"anticancer","target":"pembrolizumab","id":"1828"},{"source":"carcinoma","target":"margetuximab (u)","id":"1829"},{"source":"carcinoma","target":"pembrolizumab","id":"1830"},{"source":"residual tumor","target":"margetuximab (u)","id":"1831"},{"source":"residual tumor","target":"pembrolizumab","id":"1832"},{"source":"gastric cancer","target":"margetuximab (u)","id":"1833"},{"source":"gastric cancer","target":"pembrolizumab","id":"1834"},{"source":"anti-tumor","target":"margetuximab (u)","id":"1835"},{"source":"anti-tumor","target":"pembrolizumab","id":"1836"},{"source":"metastatic","target":"margetuximab (u)","id":"1837"},{"source":"metastatic","target":"pembrolizumab","id":"1838"},{"source":"carcinoma","target":"margetuximab (u)","id":"1839"},{"source":"carcinoma","target":"pembrolizumab","id":"1840"},{"source":"stomach neoplasms","target":"margetuximab (u)","id":"1841"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"1842"},{"source":"neoplasm metastasis","target":"margetuximab (u)","id":"1843"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"1844"},{"source":"esophageal cancer","target":"margetuximab (u)","id":"1845"},{"source":"esophageal cancer","target":"pembrolizumab","id":"1846"},{"source":"anticancer","target":"margetuximab (u)","id":"1847"},{"source":"anticancer","target":"pembrolizumab","id":"1848"},{"source":"carcinoma","target":"margetuximab (u)","id":"1849"},{"source":"carcinoma","target":"pembrolizumab","id":"1850"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"1851"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"1852"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"1853"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1854"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"1855"},{"source":"Anticancer immunotherapy","target":"gastric cancer","id":"1856"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"1857"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"1858"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1859"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"1860"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"1861"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"1862"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"1863"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1864"},{"source":"ErbB-2 antagonist","target":"UNK : Indication","id":"1865"},{"source":"ErbB-2 antagonist","target":"pharyngeal neoplasms","id":"1866"},{"source":"ErbB-2 antagonist","target":"anticancer","id":"1867"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"1868"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"1869"},{"source":"ErbB-2 antagonist","target":"gastric cancer","id":"1870"},{"source":"ErbB-2 antagonist","target":"anti-tumor","id":"1871"},{"source":"ErbB-2 antagonist","target":"metastatic","id":"1872"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"1873"},{"source":"ErbB-2 antagonist","target":"stomach neoplasms","id":"1874"},{"source":"ErbB-2 antagonist","target":"neoplasm metastasis","id":"1875"},{"source":"ErbB-2 antagonist","target":"esophageal cancer","id":"1876"},{"source":"ErbB-2 antagonist","target":"anticancer","id":"1877"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"1878"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"1879"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"1880"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"1881"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1882"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"1883"},{"source":"Immune checkpoint inhibitor","target":"gastric cancer","id":"1884"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"1885"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"1886"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1887"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"1888"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"1889"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"1890"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"1891"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"1892"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"1893"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"1894"},{"source":"CD19 antagonist","target":"anticancer","id":"1895"},{"source":"CD19 antagonist","target":"carcinoma","id":"1896"},{"source":"CD19 antagonist","target":"residual tumor","id":"1897"},{"source":"CD19 antagonist","target":"gastric cancer","id":"1898"},{"source":"CD19 antagonist","target":"anti-tumor","id":"1899"},{"source":"CD19 antagonist","target":"metastatic","id":"1900"},{"source":"CD19 antagonist","target":"carcinoma","id":"1901"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"1902"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"1903"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"1904"},{"source":"CD19 antagonist","target":"anticancer","id":"1905"},{"source":"CD19 antagonist","target":"carcinoma","id":"1906"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"1907"},{"source":"Oncology: Esophageal","target":"ErbB-2 antagonist","id":"1908"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"1909"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"1910"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"1911"},{"source":"Oncology: Gastric","target":"ErbB-2 antagonist","id":"1912"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"1913"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"1914"},{"source":"CIN vaccine","target":"Genexine","id":"1915"},{"source":"CIN vaccine","target":"Merck & Co.","id":"1916"},{"source":"Genexine (u)","target":"Genexine","id":"1917"},{"source":"Genexine (u)","target":"Merck & Co.","id":"1918"},{"source":"pembrolizumab","target":"Genexine","id":"1919"},{"source":"pembrolizumab","target":"Merck & Co.","id":"1920"},{"source":"pembrolizumab","target":"Genexine","id":"1921"},{"source":"pembrolizumab","target":"Merck & Co.","id":"1922"},{"source":"UNK : Indication","target":"CIN vaccine","id":"1923"},{"source":"UNK : Indication","target":"Genexine (u)","id":"1924"},{"source":"UNK : Indication","target":"pembrolizumab","id":"1925"},{"source":"UNK : Indication","target":"pembrolizumab","id":"1926"},{"source":"residual tumor","target":"CIN vaccine","id":"1927"},{"source":"residual tumor","target":"Genexine (u)","id":"1928"},{"source":"residual tumor","target":"pembrolizumab","id":"1929"},{"source":"residual tumor","target":"pembrolizumab","id":"1930"},{"source":"hpv type","target":"CIN vaccine","id":"1931"},{"source":"hpv type","target":"Genexine (u)","id":"1932"},{"source":"hpv type","target":"pembrolizumab","id":"1933"},{"source":"hpv type","target":"pembrolizumab","id":"1934"},{"source":"uterine cervical neoplasms","target":"CIN vaccine","id":"1935"},{"source":"uterine cervical neoplasms","target":"Genexine (u)","id":"1936"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"1937"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"1938"},{"source":"infectious disease","target":"CIN vaccine","id":"1939"},{"source":"infectious disease","target":"Genexine (u)","id":"1940"},{"source":"infectious disease","target":"pembrolizumab","id":"1941"},{"source":"infectious disease","target":"pembrolizumab","id":"1942"},{"source":"hpv type","target":"CIN vaccine","id":"1943"},{"source":"hpv type","target":"Genexine (u)","id":"1944"},{"source":"hpv type","target":"pembrolizumab","id":"1945"},{"source":"hpv type","target":"pembrolizumab","id":"1946"},{"source":"papilloma","target":"CIN vaccine","id":"1947"},{"source":"papilloma","target":"Genexine (u)","id":"1948"},{"source":"papilloma","target":"pembrolizumab","id":"1949"},{"source":"papilloma","target":"pembrolizumab","id":"1950"},{"source":"metastatic","target":"CIN vaccine","id":"1951"},{"source":"metastatic","target":"Genexine (u)","id":"1952"},{"source":"metastatic","target":"pembrolizumab","id":"1953"},{"source":"metastatic","target":"pembrolizumab","id":"1954"},{"source":"carcinoma","target":"CIN vaccine","id":"1955"},{"source":"carcinoma","target":"Genexine (u)","id":"1956"},{"source":"carcinoma","target":"pembrolizumab","id":"1957"},{"source":"carcinoma","target":"pembrolizumab","id":"1958"},{"source":"neoplasm metastasis","target":"CIN vaccine","id":"1959"},{"source":"neoplasm metastasis","target":"Genexine (u)","id":"1960"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"1961"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"1962"},{"source":"anti-tumor","target":"CIN vaccine","id":"1963"},{"source":"anti-tumor","target":"Genexine (u)","id":"1964"},{"source":"anti-tumor","target":"pembrolizumab","id":"1965"},{"source":"anti-tumor","target":"pembrolizumab","id":"1966"},{"source":"anticancer","target":"CIN vaccine","id":"1967"},{"source":"anticancer","target":"Genexine (u)","id":"1968"},{"source":"anticancer","target":"pembrolizumab","id":"1969"},{"source":"anticancer","target":"pembrolizumab","id":"1970"},{"source":"papilloma","target":"CIN vaccine","id":"1971"},{"source":"papilloma","target":"Genexine (u)","id":"1972"},{"source":"papilloma","target":"pembrolizumab","id":"1973"},{"source":"papilloma","target":"pembrolizumab","id":"1974"},{"source":"cervical cancer","target":"CIN vaccine","id":"1975"},{"source":"cervical cancer","target":"Genexine (u)","id":"1976"},{"source":"cervical cancer","target":"pembrolizumab","id":"1977"},{"source":"cervical cancer","target":"pembrolizumab","id":"1978"},{"source":"communicable diseases","target":"CIN vaccine","id":"1979"},{"source":"communicable diseases","target":"Genexine (u)","id":"1980"},{"source":"communicable diseases","target":"pembrolizumab","id":"1981"},{"source":"communicable diseases","target":"pembrolizumab","id":"1982"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"1983"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"1984"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"1985"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"1986"},{"source":"Anticancer immunotherapy","target":"infectious disease","id":"1987"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"1988"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"1989"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"1990"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"1991"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"1992"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"1993"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"1994"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"1995"},{"source":"Anticancer immunotherapy","target":"cervical cancer","id":"1996"},{"source":"Anticancer immunotherapy","target":"communicable diseases","id":"1997"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"1998"},{"source":"CD19 antagonist","target":"residual tumor","id":"1999"},{"source":"CD19 antagonist","target":"hpv type","id":"2000"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"2001"},{"source":"CD19 antagonist","target":"infectious disease","id":"2002"},{"source":"CD19 antagonist","target":"hpv type","id":"2003"},{"source":"CD19 antagonist","target":"papilloma","id":"2004"},{"source":"CD19 antagonist","target":"metastatic","id":"2005"},{"source":"CD19 antagonist","target":"carcinoma","id":"2006"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"2007"},{"source":"CD19 antagonist","target":"anti-tumor","id":"2008"},{"source":"CD19 antagonist","target":"anticancer","id":"2009"},{"source":"CD19 antagonist","target":"papilloma","id":"2010"},{"source":"CD19 antagonist","target":"cervical cancer","id":"2011"},{"source":"CD19 antagonist","target":"communicable diseases","id":"2012"},{"source":"Immunostimulant","target":"UNK : Indication","id":"2013"},{"source":"Immunostimulant","target":"residual tumor","id":"2014"},{"source":"Immunostimulant","target":"hpv type","id":"2015"},{"source":"Immunostimulant","target":"uterine cervical neoplasms","id":"2016"},{"source":"Immunostimulant","target":"infectious disease","id":"2017"},{"source":"Immunostimulant","target":"hpv type","id":"2018"},{"source":"Immunostimulant","target":"papilloma","id":"2019"},{"source":"Immunostimulant","target":"metastatic","id":"2020"},{"source":"Immunostimulant","target":"carcinoma","id":"2021"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"2022"},{"source":"Immunostimulant","target":"anti-tumor","id":"2023"},{"source":"Immunostimulant","target":"anticancer","id":"2024"},{"source":"Immunostimulant","target":"papilloma","id":"2025"},{"source":"Immunostimulant","target":"cervical cancer","id":"2026"},{"source":"Immunostimulant","target":"communicable diseases","id":"2027"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"2028"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"2029"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"2030"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"2031"},{"source":"Immune checkpoint inhibitor","target":"infectious disease","id":"2032"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"2033"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"2034"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"2035"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2036"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"2037"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"2038"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"2039"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"2040"},{"source":"Immune checkpoint inhibitor","target":"cervical cancer","id":"2041"},{"source":"Immune checkpoint inhibitor","target":"communicable diseases","id":"2042"},{"source":"Infectious Disease: HPV","target":"Anticancer immunotherapy","id":"2043"},{"source":"Infectious Disease: HPV","target":"CD19 antagonist","id":"2044"},{"source":"Infectious Disease: HPV","target":"Immunostimulant","id":"2045"},{"source":"Infectious Disease: HPV","target":"Immune checkpoint inhibitor","id":"2046"},{"source":"Oncology: Cervical","target":"Anticancer immunotherapy","id":"2047"},{"source":"Oncology: Cervical","target":"CD19 antagonist","id":"2048"},{"source":"Oncology: Cervical","target":"Immunostimulant","id":"2049"},{"source":"Oncology: Cervical","target":"Immune checkpoint inhibitor","id":"2050"},{"source":"Infectious Disease: HPV","target":"Anticancer immunotherapy","id":"2051"},{"source":"Infectious Disease: HPV","target":"CD19 antagonist","id":"2052"},{"source":"Infectious Disease: HPV","target":"Immunostimulant","id":"2053"},{"source":"Infectious Disease: HPV","target":"Immune checkpoint inhibitor","id":"2054"},{"source":"GR-MD-02 (u)","target":"(Other Cooperative Group)","id":"2055"},{"source":"GR-MD-02 (u)","target":"Earle A. Chiles Research Institute - EACRI","id":"2056"},{"source":"GR-MD-02 (u)","target":"Galectin Therapeutics {Pro-Pharmaceuticals}","id":"2057"},{"source":"GR-MD-02 (u)","target":"Providence Cancer Center at Providence Portland Medical Center","id":"2058"},{"source":"pembrolizumab","target":"(Other Cooperative Group)","id":"2059"},{"source":"pembrolizumab","target":"Earle A. Chiles Research Institute - EACRI","id":"2060"},{"source":"pembrolizumab","target":"Galectin Therapeutics {Pro-Pharmaceuticals}","id":"2061"},{"source":"pembrolizumab","target":"Providence Cancer Center at Providence Portland Medical Center","id":"2062"},{"source":"UNK : Indication","target":"GR-MD-02 (u)","id":"2063"},{"source":"UNK : Indication","target":"pembrolizumab","id":"2064"},{"source":"melanoma","target":"GR-MD-02 (u)","id":"2065"},{"source":"melanoma","target":"pembrolizumab","id":"2066"},{"source":"squamous cell neoplasms","target":"GR-MD-02 (u)","id":"2067"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"2068"},{"source":"non-small-cell lung","target":"GR-MD-02 (u)","id":"2069"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"2070"},{"source":"hypertension","target":"GR-MD-02 (u)","id":"2071"},{"source":"hypertension","target":"pembrolizumab","id":"2072"},{"source":"hemorrhage","target":"GR-MD-02 (u)","id":"2073"},{"source":"hemorrhage","target":"pembrolizumab","id":"2074"},{"source":"carcinoma","target":"GR-MD-02 (u)","id":"2075"},{"source":"carcinoma","target":"pembrolizumab","id":"2076"},{"source":"head and neck neoplasms","target":"GR-MD-02 (u)","id":"2077"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"2078"},{"source":"carcinoma","target":"GR-MD-02 (u)","id":"2079"},{"source":"carcinoma","target":"pembrolizumab","id":"2080"},{"source":"non-small-cell lung","target":"GR-MD-02 (u)","id":"2081"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"2082"},{"source":"melanoma","target":"GR-MD-02 (u)","id":"2083"},{"source":"melanoma","target":"pembrolizumab","id":"2084"},{"source":"carcinoma","target":"GR-MD-02 (u)","id":"2085"},{"source":"carcinoma","target":"pembrolizumab","id":"2086"},{"source":"bleeding","target":"GR-MD-02 (u)","id":"2087"},{"source":"bleeding","target":"pembrolizumab","id":"2088"},{"source":"hypersensitivity","target":"GR-MD-02 (u)","id":"2089"},{"source":"hypersensitivity","target":"pembrolizumab","id":"2090"},{"source":"sclc","target":"GR-MD-02 (u)","id":"2091"},{"source":"sclc","target":"pembrolizumab","id":"2092"},{"source":"antiallergic","target":"GR-MD-02 (u)","id":"2093"},{"source":"antiallergic","target":"pembrolizumab","id":"2094"},{"source":"psoriasis","target":"GR-MD-02 (u)","id":"2095"},{"source":"psoriasis","target":"pembrolizumab","id":"2096"},{"source":"antihypertensive","target":"GR-MD-02 (u)","id":"2097"},{"source":"antihypertensive","target":"pembrolizumab","id":"2098"},{"source":"carcinoma","target":"GR-MD-02 (u)","id":"2099"},{"source":"carcinoma","target":"pembrolizumab","id":"2100"},{"source":"solid tumors","target":"GR-MD-02 (u)","id":"2101"},{"source":"solid tumors","target":"pembrolizumab","id":"2102"},{"source":"carcinoma","target":"GR-MD-02 (u)","id":"2103"},{"source":"carcinoma","target":"pembrolizumab","id":"2104"},{"source":"neoplasm metastasis","target":"GR-MD-02 (u)","id":"2105"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"2106"},{"source":"lung neoplasms","target":"GR-MD-02 (u)","id":"2107"},{"source":"lung neoplasms","target":"pembrolizumab","id":"2108"},{"source":"carcinoma","target":"GR-MD-02 (u)","id":"2109"},{"source":"carcinoma","target":"pembrolizumab","id":"2110"},{"source":"squamous cell neoplasms","target":"GR-MD-02 (u)","id":"2111"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"2112"},{"source":"antiarrhythmic","target":"GR-MD-02 (u)","id":"2113"},{"source":"antiarrhythmic","target":"pembrolizumab","id":"2114"},{"source":"cardiac arrhythmias","target":"GR-MD-02 (u)","id":"2115"},{"source":"cardiac arrhythmias","target":"pembrolizumab","id":"2116"},{"source":"skin neoplasms","target":"GR-MD-02 (u)","id":"2117"},{"source":"skin neoplasms","target":"pembrolizumab","id":"2118"},{"source":"metastatic","target":"GR-MD-02 (u)","id":"2119"},{"source":"metastatic","target":"pembrolizumab","id":"2120"},{"source":"psoriasis","target":"GR-MD-02 (u)","id":"2121"},{"source":"psoriasis","target":"pembrolizumab","id":"2122"},{"source":"anticancer","target":"GR-MD-02 (u)","id":"2123"},{"source":"anticancer","target":"pembrolizumab","id":"2124"},{"source":"melanoma","target":"GR-MD-02 (u)","id":"2125"},{"source":"melanoma","target":"pembrolizumab","id":"2126"},{"source":"solid tumors","target":"GR-MD-02 (u)","id":"2127"},{"source":"solid tumors","target":"pembrolizumab","id":"2128"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"2129"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"2130"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"2131"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"2132"},{"source":"Anticancer immunotherapy","target":"hypertension","id":"2133"},{"source":"Anticancer immunotherapy","target":"hemorrhage","id":"2134"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2135"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"2136"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2137"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"2138"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"2139"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2140"},{"source":"Anticancer immunotherapy","target":"bleeding","id":"2141"},{"source":"Anticancer immunotherapy","target":"hypersensitivity","id":"2142"},{"source":"Anticancer immunotherapy","target":"sclc","id":"2143"},{"source":"Anticancer immunotherapy","target":"antiallergic","id":"2144"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"2145"},{"source":"Anticancer immunotherapy","target":"antihypertensive","id":"2146"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2147"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"2148"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2149"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"2150"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"2151"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2152"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"2153"},{"source":"Anticancer immunotherapy","target":"antiarrhythmic","id":"2154"},{"source":"Anticancer immunotherapy","target":"cardiac arrhythmias","id":"2155"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"2156"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"2157"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"2158"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"2159"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"2160"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"2161"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"2162"},{"source":"CD19 antagonist","target":"melanoma","id":"2163"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"2164"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"2165"},{"source":"CD19 antagonist","target":"hypertension","id":"2166"},{"source":"CD19 antagonist","target":"hemorrhage","id":"2167"},{"source":"CD19 antagonist","target":"carcinoma","id":"2168"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"2169"},{"source":"CD19 antagonist","target":"carcinoma","id":"2170"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"2171"},{"source":"CD19 antagonist","target":"melanoma","id":"2172"},{"source":"CD19 antagonist","target":"carcinoma","id":"2173"},{"source":"CD19 antagonist","target":"bleeding","id":"2174"},{"source":"CD19 antagonist","target":"hypersensitivity","id":"2175"},{"source":"CD19 antagonist","target":"sclc","id":"2176"},{"source":"CD19 antagonist","target":"antiallergic","id":"2177"},{"source":"CD19 antagonist","target":"psoriasis","id":"2178"},{"source":"CD19 antagonist","target":"antihypertensive","id":"2179"},{"source":"CD19 antagonist","target":"carcinoma","id":"2180"},{"source":"CD19 antagonist","target":"solid tumors","id":"2181"},{"source":"CD19 antagonist","target":"carcinoma","id":"2182"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"2183"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"2184"},{"source":"CD19 antagonist","target":"carcinoma","id":"2185"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"2186"},{"source":"CD19 antagonist","target":"antiarrhythmic","id":"2187"},{"source":"CD19 antagonist","target":"cardiac arrhythmias","id":"2188"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"2189"},{"source":"CD19 antagonist","target":"metastatic","id":"2190"},{"source":"CD19 antagonist","target":"psoriasis","id":"2191"},{"source":"CD19 antagonist","target":"anticancer","id":"2192"},{"source":"CD19 antagonist","target":"melanoma","id":"2193"},{"source":"CD19 antagonist","target":"solid tumors","id":"2194"},{"source":"Galectin-3 antagonist","target":"UNK : Indication","id":"2195"},{"source":"Galectin-3 antagonist","target":"melanoma","id":"2196"},{"source":"Galectin-3 antagonist","target":"squamous cell neoplasms","id":"2197"},{"source":"Galectin-3 antagonist","target":"non-small-cell lung","id":"2198"},{"source":"Galectin-3 antagonist","target":"hypertension","id":"2199"},{"source":"Galectin-3 antagonist","target":"hemorrhage","id":"2200"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2201"},{"source":"Galectin-3 antagonist","target":"head and neck neoplasms","id":"2202"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2203"},{"source":"Galectin-3 antagonist","target":"non-small-cell lung","id":"2204"},{"source":"Galectin-3 antagonist","target":"melanoma","id":"2205"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2206"},{"source":"Galectin-3 antagonist","target":"bleeding","id":"2207"},{"source":"Galectin-3 antagonist","target":"hypersensitivity","id":"2208"},{"source":"Galectin-3 antagonist","target":"sclc","id":"2209"},{"source":"Galectin-3 antagonist","target":"antiallergic","id":"2210"},{"source":"Galectin-3 antagonist","target":"psoriasis","id":"2211"},{"source":"Galectin-3 antagonist","target":"antihypertensive","id":"2212"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2213"},{"source":"Galectin-3 antagonist","target":"solid tumors","id":"2214"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2215"},{"source":"Galectin-3 antagonist","target":"neoplasm metastasis","id":"2216"},{"source":"Galectin-3 antagonist","target":"lung neoplasms","id":"2217"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2218"},{"source":"Galectin-3 antagonist","target":"squamous cell neoplasms","id":"2219"},{"source":"Galectin-3 antagonist","target":"antiarrhythmic","id":"2220"},{"source":"Galectin-3 antagonist","target":"cardiac arrhythmias","id":"2221"},{"source":"Galectin-3 antagonist","target":"skin neoplasms","id":"2222"},{"source":"Galectin-3 antagonist","target":"metastatic","id":"2223"},{"source":"Galectin-3 antagonist","target":"psoriasis","id":"2224"},{"source":"Galectin-3 antagonist","target":"anticancer","id":"2225"},{"source":"Galectin-3 antagonist","target":"melanoma","id":"2226"},{"source":"Galectin-3 antagonist","target":"solid tumors","id":"2227"},{"source":"Galectin-3 antagonist","target":"UNK : Indication","id":"2228"},{"source":"Galectin-3 antagonist","target":"melanoma","id":"2229"},{"source":"Galectin-3 antagonist","target":"squamous cell neoplasms","id":"2230"},{"source":"Galectin-3 antagonist","target":"non-small-cell lung","id":"2231"},{"source":"Galectin-3 antagonist","target":"hypertension","id":"2232"},{"source":"Galectin-3 antagonist","target":"hemorrhage","id":"2233"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2234"},{"source":"Galectin-3 antagonist","target":"head and neck neoplasms","id":"2235"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2236"},{"source":"Galectin-3 antagonist","target":"non-small-cell lung","id":"2237"},{"source":"Galectin-3 antagonist","target":"melanoma","id":"2238"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2239"},{"source":"Galectin-3 antagonist","target":"bleeding","id":"2240"},{"source":"Galectin-3 antagonist","target":"hypersensitivity","id":"2241"},{"source":"Galectin-3 antagonist","target":"sclc","id":"2242"},{"source":"Galectin-3 antagonist","target":"antiallergic","id":"2243"},{"source":"Galectin-3 antagonist","target":"psoriasis","id":"2244"},{"source":"Galectin-3 antagonist","target":"antihypertensive","id":"2245"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2246"},{"source":"Galectin-3 antagonist","target":"solid tumors","id":"2247"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2248"},{"source":"Galectin-3 antagonist","target":"neoplasm metastasis","id":"2249"},{"source":"Galectin-3 antagonist","target":"lung neoplasms","id":"2250"},{"source":"Galectin-3 antagonist","target":"carcinoma","id":"2251"},{"source":"Galectin-3 antagonist","target":"squamous cell neoplasms","id":"2252"},{"source":"Galectin-3 antagonist","target":"antiarrhythmic","id":"2253"},{"source":"Galectin-3 antagonist","target":"cardiac arrhythmias","id":"2254"},{"source":"Galectin-3 antagonist","target":"skin neoplasms","id":"2255"},{"source":"Galectin-3 antagonist","target":"metastatic","id":"2256"},{"source":"Galectin-3 antagonist","target":"psoriasis","id":"2257"},{"source":"Galectin-3 antagonist","target":"anticancer","id":"2258"},{"source":"Galectin-3 antagonist","target":"melanoma","id":"2259"},{"source":"Galectin-3 antagonist","target":"solid tumors","id":"2260"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"2261"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"2262"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"2263"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"2264"},{"source":"Immune checkpoint inhibitor","target":"hypertension","id":"2265"},{"source":"Immune checkpoint inhibitor","target":"hemorrhage","id":"2266"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2267"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"2268"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2269"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"2270"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"2271"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2272"},{"source":"Immune checkpoint inhibitor","target":"bleeding","id":"2273"},{"source":"Immune checkpoint inhibitor","target":"hypersensitivity","id":"2274"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"2275"},{"source":"Immune checkpoint inhibitor","target":"antiallergic","id":"2276"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"2277"},{"source":"Immune checkpoint inhibitor","target":"antihypertensive","id":"2278"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2279"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"2280"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2281"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"2282"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"2283"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2284"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"2285"},{"source":"Immune checkpoint inhibitor","target":"antiarrhythmic","id":"2286"},{"source":"Immune checkpoint inhibitor","target":"cardiac arrhythmias","id":"2287"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"2288"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"2289"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"2290"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"2291"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"2292"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"2293"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"2294"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"2295"},{"source":"Oncology: Head/Neck","target":"Galectin-3 antagonist","id":"2296"},{"source":"Oncology: Head/Neck","target":"Galectin-3 antagonist","id":"2297"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"2298"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"2299"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"2300"},{"source":"Oncology: Lung","target":"Galectin-3 antagonist","id":"2301"},{"source":"Oncology: Lung","target":"Galectin-3 antagonist","id":"2302"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"2303"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"2304"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"2305"},{"source":"Non-Small Cell","target":"Galectin-3 antagonist","id":"2306"},{"source":"Non-Small Cell","target":"Galectin-3 antagonist","id":"2307"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"2308"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"2309"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"2310"},{"source":"Oncology: Melanoma","target":"Galectin-3 antagonist","id":"2311"},{"source":"Oncology: Melanoma","target":"Galectin-3 antagonist","id":"2312"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"2313"},{"source":"IO-102 (u)","target":"IO Biotech","id":"2314"},{"source":"pembrolizumab","target":"IO Biotech","id":"2315"},{"source":"undisclosed - chemotherapy","target":"IO Biotech","id":"2316"},{"source":"non-small-cell lung","target":"IO-102 (u)","id":"2317"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"2318"},{"source":"non-small-cell lung","target":"undisclosed - chemotherapy","id":"2319"},{"source":"non-small-cell lung","target":"IO-102 (u)","id":"2320"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"2321"},{"source":"non-small-cell lung","target":"undisclosed - chemotherapy","id":"2322"},{"source":"carcinoma","target":"IO-102 (u)","id":"2323"},{"source":"carcinoma","target":"pembrolizumab","id":"2324"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"2325"},{"source":"metastatic","target":"IO-102 (u)","id":"2326"},{"source":"metastatic","target":"pembrolizumab","id":"2327"},{"source":"metastatic","target":"undisclosed - chemotherapy","id":"2328"},{"source":"carcinoma","target":"IO-102 (u)","id":"2329"},{"source":"carcinoma","target":"pembrolizumab","id":"2330"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"2331"},{"source":"neoplasm metastasis","target":"IO-102 (u)","id":"2332"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"2333"},{"source":"neoplasm metastasis","target":"undisclosed - chemotherapy","id":"2334"},{"source":"anticancer","target":"IO-102 (u)","id":"2335"},{"source":"anticancer","target":"pembrolizumab","id":"2336"},{"source":"anticancer","target":"undisclosed - chemotherapy","id":"2337"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"2338"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"2339"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2340"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"2341"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2342"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"2343"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"2344"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"2345"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"2346"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2347"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"2348"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2349"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"2350"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"2351"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"2352"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"2353"},{"source":"CD19 antagonist","target":"carcinoma","id":"2354"},{"source":"CD19 antagonist","target":"metastatic","id":"2355"},{"source":"CD19 antagonist","target":"carcinoma","id":"2356"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"2357"},{"source":"CD19 antagonist","target":"anticancer","id":"2358"},{"source":"UPA","target":"non-small-cell lung","id":"2359"},{"source":"UPA","target":"non-small-cell lung","id":"2360"},{"source":"UPA","target":"carcinoma","id":"2361"},{"source":"UPA","target":"metastatic","id":"2362"},{"source":"UPA","target":"carcinoma","id":"2363"},{"source":"UPA","target":"neoplasm metastasis","id":"2364"},{"source":"UPA","target":"anticancer","id":"2365"},{"source":"NA","target":"non-small-cell lung","id":"2366"},{"source":"NA","target":"non-small-cell lung","id":"2367"},{"source":"NA","target":"carcinoma","id":"2368"},{"source":"NA","target":"metastatic","id":"2369"},{"source":"NA","target":"carcinoma","id":"2370"},{"source":"NA","target":"neoplasm metastasis","id":"2371"},{"source":"NA","target":"anticancer","id":"2372"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"2373"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"2374"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"2375"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"2376"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"2377"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"2378"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"2379"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"2380"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"2381"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"2382"},{"source":"Oncology: Lung","target":"UPA","id":"2383"},{"source":"Oncology: Lung","target":"NA","id":"2384"},{"source":"Oncology: Lung","target":"Indoleamine-pyrrole 2","id":"2385"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"2386"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"2387"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"2388"},{"source":"Non-Small Cell","target":"UPA","id":"2389"},{"source":"Non-Small Cell","target":"NA","id":"2390"},{"source":"Non-Small Cell","target":"Indoleamine-pyrrole 2","id":"2391"},{"source":"IO-102 (u)","target":"IO Biotech","id":"2392"},{"source":"pembrolizumab","target":"IO Biotech","id":"2393"},{"source":"undisclosed - chemotherapy","target":"IO Biotech","id":"2394"},{"source":"non-small-cell lung","target":"IO-102 (u)","id":"2395"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"2396"},{"source":"non-small-cell lung","target":"undisclosed - chemotherapy","id":"2397"},{"source":"non-small-cell lung","target":"IO-102 (u)","id":"2398"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"2399"},{"source":"non-small-cell lung","target":"undisclosed - chemotherapy","id":"2400"},{"source":"carcinoma","target":"IO-102 (u)","id":"2401"},{"source":"carcinoma","target":"pembrolizumab","id":"2402"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"2403"},{"source":"metastatic","target":"IO-102 (u)","id":"2404"},{"source":"metastatic","target":"pembrolizumab","id":"2405"},{"source":"metastatic","target":"undisclosed - chemotherapy","id":"2406"},{"source":"carcinoma","target":"IO-102 (u)","id":"2407"},{"source":"carcinoma","target":"pembrolizumab","id":"2408"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"2409"},{"source":"neoplasm metastasis","target":"IO-102 (u)","id":"2410"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"2411"},{"source":"neoplasm metastasis","target":"undisclosed - chemotherapy","id":"2412"},{"source":"anticancer","target":"IO-102 (u)","id":"2413"},{"source":"anticancer","target":"pembrolizumab","id":"2414"},{"source":"anticancer","target":"undisclosed - chemotherapy","id":"2415"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"2416"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"2417"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2418"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"2419"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2420"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"2421"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"2422"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"2423"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"2424"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2425"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"2426"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2427"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"2428"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"2429"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"2430"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"2431"},{"source":"CD19 antagonist","target":"carcinoma","id":"2432"},{"source":"CD19 antagonist","target":"metastatic","id":"2433"},{"source":"CD19 antagonist","target":"carcinoma","id":"2434"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"2435"},{"source":"CD19 antagonist","target":"anticancer","id":"2436"},{"source":"UPA","target":"non-small-cell lung","id":"2437"},{"source":"UPA","target":"non-small-cell lung","id":"2438"},{"source":"UPA","target":"carcinoma","id":"2439"},{"source":"UPA","target":"metastatic","id":"2440"},{"source":"UPA","target":"carcinoma","id":"2441"},{"source":"UPA","target":"neoplasm metastasis","id":"2442"},{"source":"UPA","target":"anticancer","id":"2443"},{"source":"NA","target":"non-small-cell lung","id":"2444"},{"source":"NA","target":"non-small-cell lung","id":"2445"},{"source":"NA","target":"carcinoma","id":"2446"},{"source":"NA","target":"metastatic","id":"2447"},{"source":"NA","target":"carcinoma","id":"2448"},{"source":"NA","target":"neoplasm metastasis","id":"2449"},{"source":"NA","target":"anticancer","id":"2450"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"2451"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"2452"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"2453"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"2454"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"2455"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"2456"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"2457"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"2458"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"2459"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"2460"},{"source":"Oncology: Lung","target":"UPA","id":"2461"},{"source":"Oncology: Lung","target":"NA","id":"2462"},{"source":"Oncology: Lung","target":"Indoleamine-pyrrole 2","id":"2463"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"2464"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"2465"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"2466"},{"source":"Non-Small Cell","target":"UPA","id":"2467"},{"source":"Non-Small Cell","target":"NA","id":"2468"},{"source":"Non-Small Cell","target":"Indoleamine-pyrrole 2","id":"2469"},{"source":"NEO-PV-01 (u)","target":"Merck & Co.","id":"2470"},{"source":"NEO-PV-01 (u)","target":"Neon Therapeutics","id":"2471"},{"source":"pembrolizumab","target":"Merck & Co.","id":"2472"},{"source":"pembrolizumab","target":"Neon Therapeutics","id":"2473"},{"source":"carboplatin","target":"Merck & Co.","id":"2474"},{"source":"carboplatin","target":"Neon Therapeutics","id":"2475"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"2476"},{"source":"pemetrexed disodium","target":"Neon Therapeutics","id":"2477"},{"source":"poly-ICLC","target":"Merck & Co.","id":"2478"},{"source":"poly-ICLC","target":"Neon Therapeutics","id":"2479"},{"source":"UNK : Indication","target":"NEO-PV-01 (u)","id":"2480"},{"source":"UNK : Indication","target":"pembrolizumab","id":"2481"},{"source":"UNK : Indication","target":"carboplatin","id":"2482"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"2483"},{"source":"UNK : Indication","target":"poly-ICLC","id":"2484"},{"source":"anticancer","target":"NEO-PV-01 (u)","id":"2485"},{"source":"anticancer","target":"pembrolizumab","id":"2486"},{"source":"anticancer","target":"carboplatin","id":"2487"},{"source":"anticancer","target":"pemetrexed disodium","id":"2488"},{"source":"anticancer","target":"poly-ICLC","id":"2489"},{"source":"antiarthritic","target":"NEO-PV-01 (u)","id":"2490"},{"source":"antiarthritic","target":"pembrolizumab","id":"2491"},{"source":"antiarthritic","target":"carboplatin","id":"2492"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"2493"},{"source":"antiarthritic","target":"poly-ICLC","id":"2494"},{"source":"non-small-cell lung","target":"NEO-PV-01 (u)","id":"2495"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"2496"},{"source":"non-small-cell lung","target":"carboplatin","id":"2497"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"2498"},{"source":"non-small-cell lung","target":"poly-ICLC","id":"2499"},{"source":"psoriasis","target":"NEO-PV-01 (u)","id":"2500"},{"source":"psoriasis","target":"pembrolizumab","id":"2501"},{"source":"psoriasis","target":"carboplatin","id":"2502"},{"source":"psoriasis","target":"pemetrexed disodium","id":"2503"},{"source":"psoriasis","target":"poly-ICLC","id":"2504"},{"source":"hypopigmentation","target":"NEO-PV-01 (u)","id":"2505"},{"source":"hypopigmentation","target":"pembrolizumab","id":"2506"},{"source":"hypopigmentation","target":"carboplatin","id":"2507"},{"source":"hypopigmentation","target":"pemetrexed disodium","id":"2508"},{"source":"hypopigmentation","target":"poly-ICLC","id":"2509"},{"source":"gilbert disease","target":"NEO-PV-01 (u)","id":"2510"},{"source":"gilbert disease","target":"pembrolizumab","id":"2511"},{"source":"gilbert disease","target":"carboplatin","id":"2512"},{"source":"gilbert disease","target":"pemetrexed disodium","id":"2513"},{"source":"gilbert disease","target":"poly-ICLC","id":"2514"},{"source":"liver neoplasms","target":"NEO-PV-01 (u)","id":"2515"},{"source":"liver neoplasms","target":"pembrolizumab","id":"2516"},{"source":"liver neoplasms","target":"carboplatin","id":"2517"},{"source":"liver neoplasms","target":"pemetrexed disodium","id":"2518"},{"source":"liver neoplasms","target":"poly-ICLC","id":"2519"},{"source":"non-small-cell lung","target":"NEO-PV-01 (u)","id":"2520"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"2521"},{"source":"non-small-cell lung","target":"carboplatin","id":"2522"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"2523"},{"source":"non-small-cell lung","target":"poly-ICLC","id":"2524"},{"source":"liver metastases","target":"NEO-PV-01 (u)","id":"2525"},{"source":"liver metastases","target":"pembrolizumab","id":"2526"},{"source":"liver metastases","target":"carboplatin","id":"2527"},{"source":"liver metastases","target":"pemetrexed disodium","id":"2528"},{"source":"liver metastases","target":"poly-ICLC","id":"2529"},{"source":"sclc","target":"NEO-PV-01 (u)","id":"2530"},{"source":"sclc","target":"pembrolizumab","id":"2531"},{"source":"sclc","target":"carboplatin","id":"2532"},{"source":"sclc","target":"pemetrexed disodium","id":"2533"},{"source":"sclc","target":"poly-ICLC","id":"2534"},{"source":"multiple sclerosis","target":"NEO-PV-01 (u)","id":"2535"},{"source":"multiple sclerosis","target":"pembrolizumab","id":"2536"},{"source":"multiple sclerosis","target":"carboplatin","id":"2537"},{"source":"multiple sclerosis","target":"pemetrexed disodium","id":"2538"},{"source":"multiple sclerosis","target":"poly-ICLC","id":"2539"},{"source":"psoriasis","target":"NEO-PV-01 (u)","id":"2540"},{"source":"psoriasis","target":"pembrolizumab","id":"2541"},{"source":"psoriasis","target":"carboplatin","id":"2542"},{"source":"psoriasis","target":"pemetrexed disodium","id":"2543"},{"source":"psoriasis","target":"poly-ICLC","id":"2544"},{"source":"alopecia","target":"NEO-PV-01 (u)","id":"2545"},{"source":"alopecia","target":"pembrolizumab","id":"2546"},{"source":"alopecia","target":"carboplatin","id":"2547"},{"source":"alopecia","target":"pemetrexed disodium","id":"2548"},{"source":"alopecia","target":"poly-ICLC","id":"2549"},{"source":"arthritis","target":"NEO-PV-01 (u)","id":"2550"},{"source":"arthritis","target":"pembrolizumab","id":"2551"},{"source":"arthritis","target":"carboplatin","id":"2552"},{"source":"arthritis","target":"pemetrexed disodium","id":"2553"},{"source":"arthritis","target":"poly-ICLC","id":"2554"},{"source":"vitiligo","target":"NEO-PV-01 (u)","id":"2555"},{"source":"vitiligo","target":"pembrolizumab","id":"2556"},{"source":"vitiligo","target":"carboplatin","id":"2557"},{"source":"vitiligo","target":"pemetrexed disodium","id":"2558"},{"source":"vitiligo","target":"poly-ICLC","id":"2559"},{"source":"carcinoma","target":"NEO-PV-01 (u)","id":"2560"},{"source":"carcinoma","target":"pembrolizumab","id":"2561"},{"source":"carcinoma","target":"carboplatin","id":"2562"},{"source":"carcinoma","target":"pemetrexed disodium","id":"2563"},{"source":"carcinoma","target":"poly-ICLC","id":"2564"},{"source":"metastatic","target":"NEO-PV-01 (u)","id":"2565"},{"source":"metastatic","target":"pembrolizumab","id":"2566"},{"source":"metastatic","target":"carboplatin","id":"2567"},{"source":"metastatic","target":"pemetrexed disodium","id":"2568"},{"source":"metastatic","target":"poly-ICLC","id":"2569"},{"source":"carcinoma","target":"NEO-PV-01 (u)","id":"2570"},{"source":"carcinoma","target":"pembrolizumab","id":"2571"},{"source":"carcinoma","target":"carboplatin","id":"2572"},{"source":"carcinoma","target":"pemetrexed disodium","id":"2573"},{"source":"carcinoma","target":"poly-ICLC","id":"2574"},{"source":"gilbert syndrome","target":"NEO-PV-01 (u)","id":"2575"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"2576"},{"source":"gilbert syndrome","target":"carboplatin","id":"2577"},{"source":"gilbert syndrome","target":"pemetrexed disodium","id":"2578"},{"source":"gilbert syndrome","target":"poly-ICLC","id":"2579"},{"source":"neoplasm metastasis","target":"NEO-PV-01 (u)","id":"2580"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"2581"},{"source":"neoplasm metastasis","target":"carboplatin","id":"2582"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"2583"},{"source":"neoplasm metastasis","target":"poly-ICLC","id":"2584"},{"source":"lung neoplasms","target":"NEO-PV-01 (u)","id":"2585"},{"source":"lung neoplasms","target":"pembrolizumab","id":"2586"},{"source":"lung neoplasms","target":"carboplatin","id":"2587"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"2588"},{"source":"lung neoplasms","target":"poly-ICLC","id":"2589"},{"source":"residual tumor","target":"NEO-PV-01 (u)","id":"2590"},{"source":"residual tumor","target":"pembrolizumab","id":"2591"},{"source":"residual tumor","target":"carboplatin","id":"2592"},{"source":"residual tumor","target":"pemetrexed disodium","id":"2593"},{"source":"residual tumor","target":"poly-ICLC","id":"2594"},{"source":"anticancer","target":"NEO-PV-01 (u)","id":"2595"},{"source":"anticancer","target":"pembrolizumab","id":"2596"},{"source":"anticancer","target":"carboplatin","id":"2597"},{"source":"anticancer","target":"pemetrexed disodium","id":"2598"},{"source":"anticancer","target":"poly-ICLC","id":"2599"},{"source":"lung cancer","target":"NEO-PV-01 (u)","id":"2600"},{"source":"lung cancer","target":"pembrolizumab","id":"2601"},{"source":"lung cancer","target":"carboplatin","id":"2602"},{"source":"lung cancer","target":"pemetrexed disodium","id":"2603"},{"source":"lung cancer","target":"poly-ICLC","id":"2604"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"2605"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"2606"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"2607"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"2608"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"2609"},{"source":"Dihydrofolate reductase inhibitor","target":"hypopigmentation","id":"2610"},{"source":"Dihydrofolate reductase inhibitor","target":"gilbert disease","id":"2611"},{"source":"Dihydrofolate reductase inhibitor","target":"liver neoplasms","id":"2612"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"2613"},{"source":"Dihydrofolate reductase inhibitor","target":"liver metastases","id":"2614"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"2615"},{"source":"Dihydrofolate reductase inhibitor","target":"multiple sclerosis","id":"2616"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"2617"},{"source":"Dihydrofolate reductase inhibitor","target":"alopecia","id":"2618"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"2619"},{"source":"Dihydrofolate reductase inhibitor","target":"vitiligo","id":"2620"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"2621"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"2622"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"2623"},{"source":"Dihydrofolate reductase inhibitor","target":"gilbert syndrome","id":"2624"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"2625"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"2626"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"2627"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"2628"},{"source":"Dihydrofolate reductase inhibitor","target":"lung cancer","id":"2629"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"2630"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"2631"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"2632"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"2633"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"2634"},{"source":"Immune checkpoint inhibitor","target":"hypopigmentation","id":"2635"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"2636"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"2637"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"2638"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"2639"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"2640"},{"source":"Immune checkpoint inhibitor","target":"multiple sclerosis","id":"2641"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"2642"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"2643"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"2644"},{"source":"Immune checkpoint inhibitor","target":"vitiligo","id":"2645"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2646"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"2647"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2648"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"2649"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"2650"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"2651"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"2652"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"2653"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"2654"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"2655"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"2656"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"2657"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"2658"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"2659"},{"source":"Anticancer immunotherapy","target":"hypopigmentation","id":"2660"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"2661"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"2662"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"2663"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"2664"},{"source":"Anticancer immunotherapy","target":"sclc","id":"2665"},{"source":"Anticancer immunotherapy","target":"multiple sclerosis","id":"2666"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"2667"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"2668"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"2669"},{"source":"Anticancer immunotherapy","target":"vitiligo","id":"2670"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2671"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"2672"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2673"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"2674"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"2675"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"2676"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"2677"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"2678"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"2679"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"2680"},{"source":"CD19 antagonist","target":"anticancer","id":"2681"},{"source":"CD19 antagonist","target":"antiarthritic","id":"2682"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"2683"},{"source":"CD19 antagonist","target":"psoriasis","id":"2684"},{"source":"CD19 antagonist","target":"hypopigmentation","id":"2685"},{"source":"CD19 antagonist","target":"gilbert disease","id":"2686"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"2687"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"2688"},{"source":"CD19 antagonist","target":"liver metastases","id":"2689"},{"source":"CD19 antagonist","target":"sclc","id":"2690"},{"source":"CD19 antagonist","target":"multiple sclerosis","id":"2691"},{"source":"CD19 antagonist","target":"psoriasis","id":"2692"},{"source":"CD19 antagonist","target":"alopecia","id":"2693"},{"source":"CD19 antagonist","target":"arthritis","id":"2694"},{"source":"CD19 antagonist","target":"vitiligo","id":"2695"},{"source":"CD19 antagonist","target":"carcinoma","id":"2696"},{"source":"CD19 antagonist","target":"metastatic","id":"2697"},{"source":"CD19 antagonist","target":"carcinoma","id":"2698"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"2699"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"2700"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"2701"},{"source":"CD19 antagonist","target":"residual tumor","id":"2702"},{"source":"CD19 antagonist","target":"anticancer","id":"2703"},{"source":"CD19 antagonist","target":"lung cancer","id":"2704"},{"source":"NA","target":"UNK : Indication","id":"2705"},{"source":"NA","target":"anticancer","id":"2706"},{"source":"NA","target":"antiarthritic","id":"2707"},{"source":"NA","target":"non-small-cell lung","id":"2708"},{"source":"NA","target":"psoriasis","id":"2709"},{"source":"NA","target":"hypopigmentation","id":"2710"},{"source":"NA","target":"gilbert disease","id":"2711"},{"source":"NA","target":"liver neoplasms","id":"2712"},{"source":"NA","target":"non-small-cell lung","id":"2713"},{"source":"NA","target":"liver metastases","id":"2714"},{"source":"NA","target":"sclc","id":"2715"},{"source":"NA","target":"multiple sclerosis","id":"2716"},{"source":"NA","target":"psoriasis","id":"2717"},{"source":"NA","target":"alopecia","id":"2718"},{"source":"NA","target":"arthritis","id":"2719"},{"source":"NA","target":"vitiligo","id":"2720"},{"source":"NA","target":"carcinoma","id":"2721"},{"source":"NA","target":"metastatic","id":"2722"},{"source":"NA","target":"carcinoma","id":"2723"},{"source":"NA","target":"gilbert syndrome","id":"2724"},{"source":"NA","target":"neoplasm metastasis","id":"2725"},{"source":"NA","target":"lung neoplasms","id":"2726"},{"source":"NA","target":"residual tumor","id":"2727"},{"source":"NA","target":"anticancer","id":"2728"},{"source":"NA","target":"lung cancer","id":"2729"},{"source":"Immunostimulant","target":"UNK : Indication","id":"2730"},{"source":"Immunostimulant","target":"anticancer","id":"2731"},{"source":"Immunostimulant","target":"antiarthritic","id":"2732"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"2733"},{"source":"Immunostimulant","target":"psoriasis","id":"2734"},{"source":"Immunostimulant","target":"hypopigmentation","id":"2735"},{"source":"Immunostimulant","target":"gilbert disease","id":"2736"},{"source":"Immunostimulant","target":"liver neoplasms","id":"2737"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"2738"},{"source":"Immunostimulant","target":"liver metastases","id":"2739"},{"source":"Immunostimulant","target":"sclc","id":"2740"},{"source":"Immunostimulant","target":"multiple sclerosis","id":"2741"},{"source":"Immunostimulant","target":"psoriasis","id":"2742"},{"source":"Immunostimulant","target":"alopecia","id":"2743"},{"source":"Immunostimulant","target":"arthritis","id":"2744"},{"source":"Immunostimulant","target":"vitiligo","id":"2745"},{"source":"Immunostimulant","target":"carcinoma","id":"2746"},{"source":"Immunostimulant","target":"metastatic","id":"2747"},{"source":"Immunostimulant","target":"carcinoma","id":"2748"},{"source":"Immunostimulant","target":"gilbert syndrome","id":"2749"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"2750"},{"source":"Immunostimulant","target":"lung neoplasms","id":"2751"},{"source":"Immunostimulant","target":"residual tumor","id":"2752"},{"source":"Immunostimulant","target":"anticancer","id":"2753"},{"source":"Immunostimulant","target":"lung cancer","id":"2754"},{"source":"NA","target":"UNK : Indication","id":"2755"},{"source":"NA","target":"anticancer","id":"2756"},{"source":"NA","target":"antiarthritic","id":"2757"},{"source":"NA","target":"non-small-cell lung","id":"2758"},{"source":"NA","target":"psoriasis","id":"2759"},{"source":"NA","target":"hypopigmentation","id":"2760"},{"source":"NA","target":"gilbert disease","id":"2761"},{"source":"NA","target":"liver neoplasms","id":"2762"},{"source":"NA","target":"non-small-cell lung","id":"2763"},{"source":"NA","target":"liver metastases","id":"2764"},{"source":"NA","target":"sclc","id":"2765"},{"source":"NA","target":"multiple sclerosis","id":"2766"},{"source":"NA","target":"psoriasis","id":"2767"},{"source":"NA","target":"alopecia","id":"2768"},{"source":"NA","target":"arthritis","id":"2769"},{"source":"NA","target":"vitiligo","id":"2770"},{"source":"NA","target":"carcinoma","id":"2771"},{"source":"NA","target":"metastatic","id":"2772"},{"source":"NA","target":"carcinoma","id":"2773"},{"source":"NA","target":"gilbert syndrome","id":"2774"},{"source":"NA","target":"neoplasm metastasis","id":"2775"},{"source":"NA","target":"lung neoplasms","id":"2776"},{"source":"NA","target":"residual tumor","id":"2777"},{"source":"NA","target":"anticancer","id":"2778"},{"source":"NA","target":"lung cancer","id":"2779"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"2780"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"2781"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"2782"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"2783"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"2784"},{"source":"Thymidylate synthase inhibitor","target":"hypopigmentation","id":"2785"},{"source":"Thymidylate synthase inhibitor","target":"gilbert disease","id":"2786"},{"source":"Thymidylate synthase inhibitor","target":"liver neoplasms","id":"2787"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"2788"},{"source":"Thymidylate synthase inhibitor","target":"liver metastases","id":"2789"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"2790"},{"source":"Thymidylate synthase inhibitor","target":"multiple sclerosis","id":"2791"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"2792"},{"source":"Thymidylate synthase inhibitor","target":"alopecia","id":"2793"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"2794"},{"source":"Thymidylate synthase inhibitor","target":"vitiligo","id":"2795"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"2796"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"2797"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"2798"},{"source":"Thymidylate synthase inhibitor","target":"gilbert syndrome","id":"2799"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"2800"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"2801"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"2802"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"2803"},{"source":"Thymidylate synthase inhibitor","target":"lung cancer","id":"2804"},{"source":"NA","target":"UNK : Indication","id":"2805"},{"source":"NA","target":"anticancer","id":"2806"},{"source":"NA","target":"antiarthritic","id":"2807"},{"source":"NA","target":"non-small-cell lung","id":"2808"},{"source":"NA","target":"psoriasis","id":"2809"},{"source":"NA","target":"hypopigmentation","id":"2810"},{"source":"NA","target":"gilbert disease","id":"2811"},{"source":"NA","target":"liver neoplasms","id":"2812"},{"source":"NA","target":"non-small-cell lung","id":"2813"},{"source":"NA","target":"liver metastases","id":"2814"},{"source":"NA","target":"sclc","id":"2815"},{"source":"NA","target":"multiple sclerosis","id":"2816"},{"source":"NA","target":"psoriasis","id":"2817"},{"source":"NA","target":"alopecia","id":"2818"},{"source":"NA","target":"arthritis","id":"2819"},{"source":"NA","target":"vitiligo","id":"2820"},{"source":"NA","target":"carcinoma","id":"2821"},{"source":"NA","target":"metastatic","id":"2822"},{"source":"NA","target":"carcinoma","id":"2823"},{"source":"NA","target":"gilbert syndrome","id":"2824"},{"source":"NA","target":"neoplasm metastasis","id":"2825"},{"source":"NA","target":"lung neoplasms","id":"2826"},{"source":"NA","target":"residual tumor","id":"2827"},{"source":"NA","target":"anticancer","id":"2828"},{"source":"NA","target":"lung cancer","id":"2829"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"2830"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"2831"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"2832"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"2833"},{"source":"Oncology: Lung","target":"NA","id":"2834"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"2835"},{"source":"Oncology: Lung","target":"NA","id":"2836"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"2837"},{"source":"Oncology: Lung","target":"NA","id":"2838"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"2839"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"2840"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"2841"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"2842"},{"source":"Non-Small Cell","target":"NA","id":"2843"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"2844"},{"source":"Non-Small Cell","target":"NA","id":"2845"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"2846"},{"source":"Non-Small Cell","target":"NA","id":"2847"},{"source":"olaptesed pegol (IV) (u)","target":"Merck & Co.","id":"2848"},{"source":"olaptesed pegol (IV) (u)","target":"NOXXON Pharm AG","id":"2849"},{"source":"pembrolizumab","target":"Merck & Co.","id":"2850"},{"source":"pembrolizumab","target":"NOXXON Pharm AG","id":"2851"},{"source":"UNK : Indication","target":"olaptesed pegol (IV) (u)","id":"2852"},{"source":"UNK : Indication","target":"pembrolizumab","id":"2853"},{"source":"colorectal neoplasms","target":"olaptesed pegol (IV) (u)","id":"2854"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"2855"},{"source":"colorectal cancer","target":"olaptesed pegol (IV) (u)","id":"2856"},{"source":"colorectal cancer","target":"pembrolizumab","id":"2857"},{"source":"liver metastases","target":"olaptesed pegol (IV) (u)","id":"2858"},{"source":"liver metastases","target":"pembrolizumab","id":"2859"},{"source":"pancreatic cancer","target":"olaptesed pegol (IV) (u)","id":"2860"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"2861"},{"source":"pancreatic cancer","target":"olaptesed pegol (IV) (u)","id":"2862"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"2863"},{"source":"liver metastases","target":"olaptesed pegol (IV) (u)","id":"2864"},{"source":"liver metastases","target":"pembrolizumab","id":"2865"},{"source":"carcinoma","target":"olaptesed pegol (IV) (u)","id":"2866"},{"source":"carcinoma","target":"pembrolizumab","id":"2867"},{"source":"residual tumor","target":"olaptesed pegol (IV) (u)","id":"2868"},{"source":"residual tumor","target":"pembrolizumab","id":"2869"},{"source":"liver metastases","target":"olaptesed pegol (IV) (u)","id":"2870"},{"source":"liver metastases","target":"pembrolizumab","id":"2871"},{"source":"colonic neoplasms","target":"olaptesed pegol (IV) (u)","id":"2872"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"2873"},{"source":"metastatic","target":"olaptesed pegol (IV) (u)","id":"2874"},{"source":"metastatic","target":"pembrolizumab","id":"2875"},{"source":"carcinoma","target":"olaptesed pegol (IV) (u)","id":"2876"},{"source":"carcinoma","target":"pembrolizumab","id":"2877"},{"source":"carcinoma","target":"olaptesed pegol (IV) (u)","id":"2878"},{"source":"carcinoma","target":"pembrolizumab","id":"2879"},{"source":"neoplasm metastasis","target":"olaptesed pegol (IV) (u)","id":"2880"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"2881"},{"source":"diabetes mellitus","target":"olaptesed pegol (IV) (u)","id":"2882"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"2883"},{"source":"anticancer","target":"olaptesed pegol (IV) (u)","id":"2884"},{"source":"anticancer","target":"pembrolizumab","id":"2885"},{"source":"antidiabetic","target":"olaptesed pegol (IV) (u)","id":"2886"},{"source":"antidiabetic","target":"pembrolizumab","id":"2887"},{"source":"liver neoplasms","target":"olaptesed pegol (IV) (u)","id":"2888"},{"source":"liver neoplasms","target":"pembrolizumab","id":"2889"},{"source":"pancreatic neoplasms","target":"olaptesed pegol (IV) (u)","id":"2890"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"2891"},{"source":"colorectal neoplasms","target":"olaptesed pegol (IV) (u)","id":"2892"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"2893"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"2894"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"2895"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"2896"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"2897"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"2898"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"2899"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"2900"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2901"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"2902"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"2903"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"2904"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"2905"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2906"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"2907"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"2908"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"2909"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"2910"},{"source":"Anticancer immunotherapy","target":"antidiabetic","id":"2911"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"2912"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"2913"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"2914"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"2915"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"2916"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"2917"},{"source":"CD19 antagonist","target":"liver metastases","id":"2918"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"2919"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"2920"},{"source":"CD19 antagonist","target":"liver metastases","id":"2921"},{"source":"CD19 antagonist","target":"carcinoma","id":"2922"},{"source":"CD19 antagonist","target":"residual tumor","id":"2923"},{"source":"CD19 antagonist","target":"liver metastases","id":"2924"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"2925"},{"source":"CD19 antagonist","target":"metastatic","id":"2926"},{"source":"CD19 antagonist","target":"carcinoma","id":"2927"},{"source":"CD19 antagonist","target":"carcinoma","id":"2928"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"2929"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"2930"},{"source":"CD19 antagonist","target":"anticancer","id":"2931"},{"source":"CD19 antagonist","target":"antidiabetic","id":"2932"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"2933"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"2934"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"2935"},{"source":"Stromal cell-derived factor 1 antagonist","target":"UNK : Indication","id":"2936"},{"source":"Stromal cell-derived factor 1 antagonist","target":"colorectal neoplasms","id":"2937"},{"source":"Stromal cell-derived factor 1 antagonist","target":"colorectal cancer","id":"2938"},{"source":"Stromal cell-derived factor 1 antagonist","target":"liver metastases","id":"2939"},{"source":"Stromal cell-derived factor 1 antagonist","target":"pancreatic cancer","id":"2940"},{"source":"Stromal cell-derived factor 1 antagonist","target":"pancreatic cancer","id":"2941"},{"source":"Stromal cell-derived factor 1 antagonist","target":"liver metastases","id":"2942"},{"source":"Stromal cell-derived factor 1 antagonist","target":"carcinoma","id":"2943"},{"source":"Stromal cell-derived factor 1 antagonist","target":"residual tumor","id":"2944"},{"source":"Stromal cell-derived factor 1 antagonist","target":"liver metastases","id":"2945"},{"source":"Stromal cell-derived factor 1 antagonist","target":"colonic neoplasms","id":"2946"},{"source":"Stromal cell-derived factor 1 antagonist","target":"metastatic","id":"2947"},{"source":"Stromal cell-derived factor 1 antagonist","target":"carcinoma","id":"2948"},{"source":"Stromal cell-derived factor 1 antagonist","target":"carcinoma","id":"2949"},{"source":"Stromal cell-derived factor 1 antagonist","target":"neoplasm metastasis","id":"2950"},{"source":"Stromal cell-derived factor 1 antagonist","target":"diabetes mellitus","id":"2951"},{"source":"Stromal cell-derived factor 1 antagonist","target":"anticancer","id":"2952"},{"source":"Stromal cell-derived factor 1 antagonist","target":"antidiabetic","id":"2953"},{"source":"Stromal cell-derived factor 1 antagonist","target":"liver neoplasms","id":"2954"},{"source":"Stromal cell-derived factor 1 antagonist","target":"pancreatic neoplasms","id":"2955"},{"source":"Stromal cell-derived factor 1 antagonist","target":"colorectal neoplasms","id":"2956"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"2957"},{"source":"Angiogenesis inhibitor","target":"colorectal neoplasms","id":"2958"},{"source":"Angiogenesis inhibitor","target":"colorectal cancer","id":"2959"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"2960"},{"source":"Angiogenesis inhibitor","target":"pancreatic cancer","id":"2961"},{"source":"Angiogenesis inhibitor","target":"pancreatic cancer","id":"2962"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"2963"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"2964"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"2965"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"2966"},{"source":"Angiogenesis inhibitor","target":"colonic neoplasms","id":"2967"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"2968"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"2969"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"2970"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"2971"},{"source":"Angiogenesis inhibitor","target":"diabetes mellitus","id":"2972"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"2973"},{"source":"Angiogenesis inhibitor","target":"antidiabetic","id":"2974"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"2975"},{"source":"Angiogenesis inhibitor","target":"pancreatic neoplasms","id":"2976"},{"source":"Angiogenesis inhibitor","target":"colorectal neoplasms","id":"2977"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"2978"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"2979"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"2980"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"2981"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"2982"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"2983"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"2984"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2985"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"2986"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"2987"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"2988"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"2989"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2990"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"2991"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"2992"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"2993"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"2994"},{"source":"Immune checkpoint inhibitor","target":"antidiabetic","id":"2995"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"2996"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"2997"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"2998"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"2999"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"3000"},{"source":"Oncology: Colorectal","target":"Stromal cell-derived factor 1 antagonist","id":"3001"},{"source":"Oncology: Colorectal","target":"Angiogenesis inhibitor","id":"3002"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"3003"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"3004"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"3005"},{"source":"Oncology: Pancreas","target":"Stromal cell-derived factor 1 antagonist","id":"3006"},{"source":"Oncology: Pancreas","target":"Angiogenesis inhibitor","id":"3007"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"3008"},{"source":"cemiplimab (u)","target":"Regeneron","id":"3009"},{"source":"cemiplimab (u)","target":"Sanofi {Sanofi-Aventis}","id":"3010"},{"source":"carboplatin","target":"Regeneron","id":"3011"},{"source":"carboplatin","target":"Sanofi {Sanofi-Aventis}","id":"3012"},{"source":"cisplatin","target":"Regeneron","id":"3013"},{"source":"cisplatin","target":"Sanofi {Sanofi-Aventis}","id":"3014"},{"source":"ipilimumab","target":"Regeneron","id":"3015"},{"source":"ipilimumab","target":"Sanofi {Sanofi-Aventis}","id":"3016"},{"source":"pembrolizumab","target":"Regeneron","id":"3017"},{"source":"pembrolizumab","target":"Sanofi {Sanofi-Aventis}","id":"3018"},{"source":"UNK : Indication","target":"cemiplimab (u)","id":"3019"},{"source":"UNK : Indication","target":"carboplatin","id":"3020"},{"source":"UNK : Indication","target":"cisplatin","id":"3021"},{"source":"UNK : Indication","target":"ipilimumab","id":"3022"},{"source":"UNK : Indication","target":"pembrolizumab","id":"3023"},{"source":"residual tumor","target":"cemiplimab (u)","id":"3024"},{"source":"residual tumor","target":"carboplatin","id":"3025"},{"source":"residual tumor","target":"cisplatin","id":"3026"},{"source":"residual tumor","target":"ipilimumab","id":"3027"},{"source":"residual tumor","target":"pembrolizumab","id":"3028"},{"source":"anti-hiv","target":"cemiplimab (u)","id":"3029"},{"source":"anti-hiv","target":"carboplatin","id":"3030"},{"source":"anti-hiv","target":"cisplatin","id":"3031"},{"source":"anti-hiv","target":"ipilimumab","id":"3032"},{"source":"anti-hiv","target":"pembrolizumab","id":"3033"},{"source":"non-small-cell lung","target":"cemiplimab (u)","id":"3034"},{"source":"non-small-cell lung","target":"carboplatin","id":"3035"},{"source":"non-small-cell lung","target":"cisplatin","id":"3036"},{"source":"non-small-cell lung","target":"ipilimumab","id":"3037"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"3038"},{"source":"sclc","target":"cemiplimab (u)","id":"3039"},{"source":"sclc","target":"carboplatin","id":"3040"},{"source":"sclc","target":"cisplatin","id":"3041"},{"source":"sclc","target":"ipilimumab","id":"3042"},{"source":"sclc","target":"pembrolizumab","id":"3043"},{"source":"carcinoma","target":"cemiplimab (u)","id":"3044"},{"source":"carcinoma","target":"carboplatin","id":"3045"},{"source":"carcinoma","target":"cisplatin","id":"3046"},{"source":"carcinoma","target":"ipilimumab","id":"3047"},{"source":"carcinoma","target":"pembrolizumab","id":"3048"},{"source":"metastatic","target":"cemiplimab (u)","id":"3049"},{"source":"metastatic","target":"carboplatin","id":"3050"},{"source":"metastatic","target":"cisplatin","id":"3051"},{"source":"metastatic","target":"ipilimumab","id":"3052"},{"source":"metastatic","target":"pembrolizumab","id":"3053"},{"source":"carcinoma","target":"cemiplimab (u)","id":"3054"},{"source":"carcinoma","target":"carboplatin","id":"3055"},{"source":"carcinoma","target":"cisplatin","id":"3056"},{"source":"carcinoma","target":"ipilimumab","id":"3057"},{"source":"carcinoma","target":"pembrolizumab","id":"3058"},{"source":"non-small-cell lung","target":"cemiplimab (u)","id":"3059"},{"source":"non-small-cell lung","target":"carboplatin","id":"3060"},{"source":"non-small-cell lung","target":"cisplatin","id":"3061"},{"source":"non-small-cell lung","target":"ipilimumab","id":"3062"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"3063"},{"source":"neoplasm metastasis","target":"cemiplimab (u)","id":"3064"},{"source":"neoplasm metastasis","target":"carboplatin","id":"3065"},{"source":"neoplasm metastasis","target":"cisplatin","id":"3066"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"3067"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"3068"},{"source":"anticancer","target":"cemiplimab (u)","id":"3069"},{"source":"anticancer","target":"carboplatin","id":"3070"},{"source":"anticancer","target":"cisplatin","id":"3071"},{"source":"anticancer","target":"ipilimumab","id":"3072"},{"source":"anticancer","target":"pembrolizumab","id":"3073"},{"source":"hiv infections","target":"cemiplimab (u)","id":"3074"},{"source":"hiv infections","target":"carboplatin","id":"3075"},{"source":"hiv infections","target":"cisplatin","id":"3076"},{"source":"hiv infections","target":"ipilimumab","id":"3077"},{"source":"hiv infections","target":"pembrolizumab","id":"3078"},{"source":"lung neoplasms","target":"cemiplimab (u)","id":"3079"},{"source":"lung neoplasms","target":"carboplatin","id":"3080"},{"source":"lung neoplasms","target":"cisplatin","id":"3081"},{"source":"lung neoplasms","target":"ipilimumab","id":"3082"},{"source":"lung neoplasms","target":"pembrolizumab","id":"3083"},{"source":"acquired immunodeficiency syndrome","target":"cemiplimab (u)","id":"3084"},{"source":"acquired immunodeficiency syndrome","target":"carboplatin","id":"3085"},{"source":"acquired immunodeficiency syndrome","target":"cisplatin","id":"3086"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"3087"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"3088"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"3089"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"3090"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"3091"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"3092"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"3093"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3094"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"3095"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3096"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"3097"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"3098"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"3099"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"3100"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"3101"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"3102"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"3103"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"3104"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"3105"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"3106"},{"source":"Anticancer immunotherapy","target":"sclc","id":"3107"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3108"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"3109"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3110"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"3111"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"3112"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"3113"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"3114"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"3115"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"3116"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"3117"},{"source":"CD19 antagonist","target":"residual tumor","id":"3118"},{"source":"CD19 antagonist","target":"anti-hiv","id":"3119"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"3120"},{"source":"CD19 antagonist","target":"sclc","id":"3121"},{"source":"CD19 antagonist","target":"carcinoma","id":"3122"},{"source":"CD19 antagonist","target":"metastatic","id":"3123"},{"source":"CD19 antagonist","target":"carcinoma","id":"3124"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"3125"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"3126"},{"source":"CD19 antagonist","target":"anticancer","id":"3127"},{"source":"CD19 antagonist","target":"hiv infections","id":"3128"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"3129"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"3130"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"3131"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"3132"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"3133"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"3134"},{"source":"CTLA4 antagonist","target":"sclc","id":"3135"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"3136"},{"source":"CTLA4 antagonist","target":"metastatic","id":"3137"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"3138"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"3139"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"3140"},{"source":"CTLA4 antagonist","target":"anticancer","id":"3141"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"3142"},{"source":"CTLA4 antagonist","target":"lung neoplasms","id":"3143"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"3144"},{"source":"NA","target":"UNK : Indication","id":"3145"},{"source":"NA","target":"residual tumor","id":"3146"},{"source":"NA","target":"anti-hiv","id":"3147"},{"source":"NA","target":"non-small-cell lung","id":"3148"},{"source":"NA","target":"sclc","id":"3149"},{"source":"NA","target":"carcinoma","id":"3150"},{"source":"NA","target":"metastatic","id":"3151"},{"source":"NA","target":"carcinoma","id":"3152"},{"source":"NA","target":"non-small-cell lung","id":"3153"},{"source":"NA","target":"neoplasm metastasis","id":"3154"},{"source":"NA","target":"anticancer","id":"3155"},{"source":"NA","target":"hiv infections","id":"3156"},{"source":"NA","target":"lung neoplasms","id":"3157"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"3158"},{"source":"NA","target":"UNK : Indication","id":"3159"},{"source":"NA","target":"residual tumor","id":"3160"},{"source":"NA","target":"anti-hiv","id":"3161"},{"source":"NA","target":"non-small-cell lung","id":"3162"},{"source":"NA","target":"sclc","id":"3163"},{"source":"NA","target":"carcinoma","id":"3164"},{"source":"NA","target":"metastatic","id":"3165"},{"source":"NA","target":"carcinoma","id":"3166"},{"source":"NA","target":"non-small-cell lung","id":"3167"},{"source":"NA","target":"neoplasm metastasis","id":"3168"},{"source":"NA","target":"anticancer","id":"3169"},{"source":"NA","target":"hiv infections","id":"3170"},{"source":"NA","target":"lung neoplasms","id":"3171"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"3172"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"3173"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"3174"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"3175"},{"source":"Oncology: Lung","target":"CTLA4 antagonist","id":"3176"},{"source":"Oncology: Lung","target":"NA","id":"3177"},{"source":"Oncology: Lung","target":"NA","id":"3178"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"3179"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"3180"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"3181"},{"source":"Non-Small Cell","target":"CTLA4 antagonist","id":"3182"},{"source":"Non-Small Cell","target":"NA","id":"3183"},{"source":"Non-Small Cell","target":"NA","id":"3184"},{"source":"cemiplimab (u)","target":"Regeneron","id":"3185"},{"source":"cemiplimab (u)","target":"Sanofi {Sanofi-Aventis}","id":"3186"},{"source":"carboplatin","target":"Regeneron","id":"3187"},{"source":"carboplatin","target":"Sanofi {Sanofi-Aventis}","id":"3188"},{"source":"cisplatin","target":"Regeneron","id":"3189"},{"source":"cisplatin","target":"Sanofi {Sanofi-Aventis}","id":"3190"},{"source":"ipilimumab","target":"Regeneron","id":"3191"},{"source":"ipilimumab","target":"Sanofi {Sanofi-Aventis}","id":"3192"},{"source":"pembrolizumab","target":"Regeneron","id":"3193"},{"source":"pembrolizumab","target":"Sanofi {Sanofi-Aventis}","id":"3194"},{"source":"UNK : Indication","target":"cemiplimab (u)","id":"3195"},{"source":"UNK : Indication","target":"carboplatin","id":"3196"},{"source":"UNK : Indication","target":"cisplatin","id":"3197"},{"source":"UNK : Indication","target":"ipilimumab","id":"3198"},{"source":"UNK : Indication","target":"pembrolizumab","id":"3199"},{"source":"residual tumor","target":"cemiplimab (u)","id":"3200"},{"source":"residual tumor","target":"carboplatin","id":"3201"},{"source":"residual tumor","target":"cisplatin","id":"3202"},{"source":"residual tumor","target":"ipilimumab","id":"3203"},{"source":"residual tumor","target":"pembrolizumab","id":"3204"},{"source":"anti-hiv","target":"cemiplimab (u)","id":"3205"},{"source":"anti-hiv","target":"carboplatin","id":"3206"},{"source":"anti-hiv","target":"cisplatin","id":"3207"},{"source":"anti-hiv","target":"ipilimumab","id":"3208"},{"source":"anti-hiv","target":"pembrolizumab","id":"3209"},{"source":"non-small-cell lung","target":"cemiplimab (u)","id":"3210"},{"source":"non-small-cell lung","target":"carboplatin","id":"3211"},{"source":"non-small-cell lung","target":"cisplatin","id":"3212"},{"source":"non-small-cell lung","target":"ipilimumab","id":"3213"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"3214"},{"source":"sclc","target":"cemiplimab (u)","id":"3215"},{"source":"sclc","target":"carboplatin","id":"3216"},{"source":"sclc","target":"cisplatin","id":"3217"},{"source":"sclc","target":"ipilimumab","id":"3218"},{"source":"sclc","target":"pembrolizumab","id":"3219"},{"source":"carcinoma","target":"cemiplimab (u)","id":"3220"},{"source":"carcinoma","target":"carboplatin","id":"3221"},{"source":"carcinoma","target":"cisplatin","id":"3222"},{"source":"carcinoma","target":"ipilimumab","id":"3223"},{"source":"carcinoma","target":"pembrolizumab","id":"3224"},{"source":"metastatic","target":"cemiplimab (u)","id":"3225"},{"source":"metastatic","target":"carboplatin","id":"3226"},{"source":"metastatic","target":"cisplatin","id":"3227"},{"source":"metastatic","target":"ipilimumab","id":"3228"},{"source":"metastatic","target":"pembrolizumab","id":"3229"},{"source":"carcinoma","target":"cemiplimab (u)","id":"3230"},{"source":"carcinoma","target":"carboplatin","id":"3231"},{"source":"carcinoma","target":"cisplatin","id":"3232"},{"source":"carcinoma","target":"ipilimumab","id":"3233"},{"source":"carcinoma","target":"pembrolizumab","id":"3234"},{"source":"non-small-cell lung","target":"cemiplimab (u)","id":"3235"},{"source":"non-small-cell lung","target":"carboplatin","id":"3236"},{"source":"non-small-cell lung","target":"cisplatin","id":"3237"},{"source":"non-small-cell lung","target":"ipilimumab","id":"3238"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"3239"},{"source":"neoplasm metastasis","target":"cemiplimab (u)","id":"3240"},{"source":"neoplasm metastasis","target":"carboplatin","id":"3241"},{"source":"neoplasm metastasis","target":"cisplatin","id":"3242"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"3243"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"3244"},{"source":"anticancer","target":"cemiplimab (u)","id":"3245"},{"source":"anticancer","target":"carboplatin","id":"3246"},{"source":"anticancer","target":"cisplatin","id":"3247"},{"source":"anticancer","target":"ipilimumab","id":"3248"},{"source":"anticancer","target":"pembrolizumab","id":"3249"},{"source":"hiv infections","target":"cemiplimab (u)","id":"3250"},{"source":"hiv infections","target":"carboplatin","id":"3251"},{"source":"hiv infections","target":"cisplatin","id":"3252"},{"source":"hiv infections","target":"ipilimumab","id":"3253"},{"source":"hiv infections","target":"pembrolizumab","id":"3254"},{"source":"lung neoplasms","target":"cemiplimab (u)","id":"3255"},{"source":"lung neoplasms","target":"carboplatin","id":"3256"},{"source":"lung neoplasms","target":"cisplatin","id":"3257"},{"source":"lung neoplasms","target":"ipilimumab","id":"3258"},{"source":"lung neoplasms","target":"pembrolizumab","id":"3259"},{"source":"acquired immunodeficiency syndrome","target":"cemiplimab (u)","id":"3260"},{"source":"acquired immunodeficiency syndrome","target":"carboplatin","id":"3261"},{"source":"acquired immunodeficiency syndrome","target":"cisplatin","id":"3262"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"3263"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"3264"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"3265"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"3266"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"3267"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"3268"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"3269"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3270"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"3271"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3272"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"3273"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"3274"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"3275"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"3276"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"3277"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"3278"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"3279"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"3280"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"3281"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"3282"},{"source":"Anticancer immunotherapy","target":"sclc","id":"3283"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3284"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"3285"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3286"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"3287"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"3288"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"3289"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"3290"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"3291"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"3292"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"3293"},{"source":"CD19 antagonist","target":"residual tumor","id":"3294"},{"source":"CD19 antagonist","target":"anti-hiv","id":"3295"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"3296"},{"source":"CD19 antagonist","target":"sclc","id":"3297"},{"source":"CD19 antagonist","target":"carcinoma","id":"3298"},{"source":"CD19 antagonist","target":"metastatic","id":"3299"},{"source":"CD19 antagonist","target":"carcinoma","id":"3300"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"3301"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"3302"},{"source":"CD19 antagonist","target":"anticancer","id":"3303"},{"source":"CD19 antagonist","target":"hiv infections","id":"3304"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"3305"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"3306"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"3307"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"3308"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"3309"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"3310"},{"source":"CTLA4 antagonist","target":"sclc","id":"3311"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"3312"},{"source":"CTLA4 antagonist","target":"metastatic","id":"3313"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"3314"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"3315"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"3316"},{"source":"CTLA4 antagonist","target":"anticancer","id":"3317"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"3318"},{"source":"CTLA4 antagonist","target":"lung neoplasms","id":"3319"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"3320"},{"source":"NA","target":"UNK : Indication","id":"3321"},{"source":"NA","target":"residual tumor","id":"3322"},{"source":"NA","target":"anti-hiv","id":"3323"},{"source":"NA","target":"non-small-cell lung","id":"3324"},{"source":"NA","target":"sclc","id":"3325"},{"source":"NA","target":"carcinoma","id":"3326"},{"source":"NA","target":"metastatic","id":"3327"},{"source":"NA","target":"carcinoma","id":"3328"},{"source":"NA","target":"non-small-cell lung","id":"3329"},{"source":"NA","target":"neoplasm metastasis","id":"3330"},{"source":"NA","target":"anticancer","id":"3331"},{"source":"NA","target":"hiv infections","id":"3332"},{"source":"NA","target":"lung neoplasms","id":"3333"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"3334"},{"source":"NA","target":"UNK : Indication","id":"3335"},{"source":"NA","target":"residual tumor","id":"3336"},{"source":"NA","target":"anti-hiv","id":"3337"},{"source":"NA","target":"non-small-cell lung","id":"3338"},{"source":"NA","target":"sclc","id":"3339"},{"source":"NA","target":"carcinoma","id":"3340"},{"source":"NA","target":"metastatic","id":"3341"},{"source":"NA","target":"carcinoma","id":"3342"},{"source":"NA","target":"non-small-cell lung","id":"3343"},{"source":"NA","target":"neoplasm metastasis","id":"3344"},{"source":"NA","target":"anticancer","id":"3345"},{"source":"NA","target":"hiv infections","id":"3346"},{"source":"NA","target":"lung neoplasms","id":"3347"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"3348"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"3349"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"3350"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"3351"},{"source":"Oncology: Lung","target":"CTLA4 antagonist","id":"3352"},{"source":"Oncology: Lung","target":"NA","id":"3353"},{"source":"Oncology: Lung","target":"NA","id":"3354"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"3355"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"3356"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"3357"},{"source":"Non-Small Cell","target":"CTLA4 antagonist","id":"3358"},{"source":"Non-Small Cell","target":"NA","id":"3359"},{"source":"Non-Small Cell","target":"NA","id":"3360"},{"source":"bemcentinib (u)","target":"BerGenBio","id":"3361"},{"source":"bemcentinib (u)","target":"Merck & Co.","id":"3362"},{"source":"pembrolizumab","target":"BerGenBio","id":"3363"},{"source":"pembrolizumab","target":"Merck & Co.","id":"3364"},{"source":"UNK : Indication","target":"bemcentinib (u)","id":"3365"},{"source":"UNK : Indication","target":"pembrolizumab","id":"3366"},{"source":"inflammatory breast cancer","target":"bemcentinib (u)","id":"3367"},{"source":"inflammatory breast cancer","target":"pembrolizumab","id":"3368"},{"source":"alopecia","target":"bemcentinib (u)","id":"3369"},{"source":"alopecia","target":"pembrolizumab","id":"3370"},{"source":"triple-negative breast cancer","target":"bemcentinib (u)","id":"3371"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"3372"},{"source":"residual tumor","target":"bemcentinib (u)","id":"3373"},{"source":"residual tumor","target":"pembrolizumab","id":"3374"},{"source":"anti-tumor","target":"bemcentinib (u)","id":"3375"},{"source":"anti-tumor","target":"pembrolizumab","id":"3376"},{"source":"breast neoplasms","target":"bemcentinib (u)","id":"3377"},{"source":"breast neoplasms","target":"pembrolizumab","id":"3378"},{"source":"residual tumor","target":"bemcentinib (u)","id":"3379"},{"source":"residual tumor","target":"pembrolizumab","id":"3380"},{"source":"liver metastases","target":"bemcentinib (u)","id":"3381"},{"source":"liver metastases","target":"pembrolizumab","id":"3382"},{"source":"metastatic","target":"bemcentinib (u)","id":"3383"},{"source":"metastatic","target":"pembrolizumab","id":"3384"},{"source":"carcinoma","target":"bemcentinib (u)","id":"3385"},{"source":"carcinoma","target":"pembrolizumab","id":"3386"},{"source":"breast neoplasms","target":"bemcentinib (u)","id":"3387"},{"source":"breast neoplasms","target":"pembrolizumab","id":"3388"},{"source":"neoplasm metastasis","target":"bemcentinib (u)","id":"3389"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"3390"},{"source":"anticancer","target":"bemcentinib (u)","id":"3391"},{"source":"anticancer","target":"pembrolizumab","id":"3392"},{"source":"tnbc","target":"bemcentinib (u)","id":"3393"},{"source":"tnbc","target":"pembrolizumab","id":"3394"},{"source":"triple-negative breast cancer","target":"bemcentinib (u)","id":"3395"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"3396"},{"source":"liver neoplasms","target":"bemcentinib (u)","id":"3397"},{"source":"liver neoplasms","target":"pembrolizumab","id":"3398"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"3399"},{"source":"Anticancer immunotherapy","target":"inflammatory breast cancer","id":"3400"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"3401"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"3402"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"3403"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"3404"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"3405"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"3406"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"3407"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"3408"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3409"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"3410"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"3411"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"3412"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"3413"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"3414"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"3415"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"3416"},{"source":"CD19 antagonist","target":"inflammatory breast cancer","id":"3417"},{"source":"CD19 antagonist","target":"alopecia","id":"3418"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"3419"},{"source":"CD19 antagonist","target":"residual tumor","id":"3420"},{"source":"CD19 antagonist","target":"anti-tumor","id":"3421"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"3422"},{"source":"CD19 antagonist","target":"residual tumor","id":"3423"},{"source":"CD19 antagonist","target":"liver metastases","id":"3424"},{"source":"CD19 antagonist","target":"metastatic","id":"3425"},{"source":"CD19 antagonist","target":"carcinoma","id":"3426"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"3427"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"3428"},{"source":"CD19 antagonist","target":"anticancer","id":"3429"},{"source":"CD19 antagonist","target":"tnbc","id":"3430"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"3431"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"3432"},{"source":"NA","target":"UNK : Indication","id":"3433"},{"source":"NA","target":"inflammatory breast cancer","id":"3434"},{"source":"NA","target":"alopecia","id":"3435"},{"source":"NA","target":"triple-negative breast cancer","id":"3436"},{"source":"NA","target":"residual tumor","id":"3437"},{"source":"NA","target":"anti-tumor","id":"3438"},{"source":"NA","target":"breast neoplasms","id":"3439"},{"source":"NA","target":"residual tumor","id":"3440"},{"source":"NA","target":"liver metastases","id":"3441"},{"source":"NA","target":"metastatic","id":"3442"},{"source":"NA","target":"carcinoma","id":"3443"},{"source":"NA","target":"breast neoplasms","id":"3444"},{"source":"NA","target":"neoplasm metastasis","id":"3445"},{"source":"NA","target":"anticancer","id":"3446"},{"source":"NA","target":"tnbc","id":"3447"},{"source":"NA","target":"triple-negative breast cancer","id":"3448"},{"source":"NA","target":"liver neoplasms","id":"3449"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"3450"},{"source":"Immune checkpoint inhibitor","target":"inflammatory breast cancer","id":"3451"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"3452"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"3453"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"3454"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"3455"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"3456"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"3457"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"3458"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"3459"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3460"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"3461"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"3462"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"3463"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"3464"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"3465"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"3466"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"3467"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"3468"},{"source":"Oncology: Breast","target":"NA","id":"3469"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"3470"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"3471"},{"source":"aspirin","target":"(Other Hospital/Academic/Medical Center)","id":"3472"},{"source":"curcumin","target":"(Other Hospital/Academic/Medical Center)","id":"3473"},{"source":"cyclophosphamide","target":"(Other Hospital/Academic/Medical Center)","id":"3474"},{"source":"lansoprazole","target":"(Other Hospital/Academic/Medical Center)","id":"3475"},{"source":"radiation therapy","target":"(Other Hospital/Academic/Medical Center)","id":"3476"},{"source":"undisclosed - vitamin D analog","target":"(Other Hospital/Academic/Medical Center)","id":"3477"},{"source":"UNK : Indication","target":"pembrolizumab","id":"3478"},{"source":"UNK : Indication","target":"aspirin","id":"3479"},{"source":"UNK : Indication","target":"curcumin","id":"3480"},{"source":"UNK : Indication","target":"cyclophosphamide","id":"3481"},{"source":"UNK : Indication","target":"lansoprazole","id":"3482"},{"source":"UNK : Indication","target":"radiation therapy","id":"3483"},{"source":"UNK : Indication","target":"undisclosed - vitamin D analog","id":"3484"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"3485"},{"source":"anti-inflammatory","target":"aspirin","id":"3486"},{"source":"anti-inflammatory","target":"curcumin","id":"3487"},{"source":"anti-inflammatory","target":"cyclophosphamide","id":"3488"},{"source":"anti-inflammatory","target":"lansoprazole","id":"3489"},{"source":"anti-inflammatory","target":"radiation therapy","id":"3490"},{"source":"anti-inflammatory","target":"undisclosed - vitamin D analog","id":"3491"},{"source":"sarcoma","target":"pembrolizumab","id":"3492"},{"source":"sarcoma","target":"aspirin","id":"3493"},{"source":"sarcoma","target":"curcumin","id":"3494"},{"source":"sarcoma","target":"cyclophosphamide","id":"3495"},{"source":"sarcoma","target":"lansoprazole","id":"3496"},{"source":"sarcoma","target":"radiation therapy","id":"3497"},{"source":"sarcoma","target":"undisclosed - vitamin D analog","id":"3498"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"3499"},{"source":"uterine cervical neoplasms","target":"aspirin","id":"3500"},{"source":"uterine cervical neoplasms","target":"curcumin","id":"3501"},{"source":"uterine cervical neoplasms","target":"cyclophosphamide","id":"3502"},{"source":"uterine cervical neoplasms","target":"lansoprazole","id":"3503"},{"source":"uterine cervical neoplasms","target":"radiation therapy","id":"3504"},{"source":"uterine cervical neoplasms","target":"undisclosed - vitamin D analog","id":"3505"},{"source":"carcinoma","target":"pembrolizumab","id":"3506"},{"source":"carcinoma","target":"aspirin","id":"3507"},{"source":"carcinoma","target":"curcumin","id":"3508"},{"source":"carcinoma","target":"cyclophosphamide","id":"3509"},{"source":"carcinoma","target":"lansoprazole","id":"3510"},{"source":"carcinoma","target":"radiation therapy","id":"3511"},{"source":"carcinoma","target":"undisclosed - vitamin D analog","id":"3512"},{"source":"antiallergic","target":"pembrolizumab","id":"3513"},{"source":"antiallergic","target":"aspirin","id":"3514"},{"source":"antiallergic","target":"curcumin","id":"3515"},{"source":"antiallergic","target":"cyclophosphamide","id":"3516"},{"source":"antiallergic","target":"lansoprazole","id":"3517"},{"source":"antiallergic","target":"radiation therapy","id":"3518"},{"source":"antiallergic","target":"undisclosed - vitamin D analog","id":"3519"},{"source":"spasm","target":"pembrolizumab","id":"3520"},{"source":"spasm","target":"aspirin","id":"3521"},{"source":"spasm","target":"curcumin","id":"3522"},{"source":"spasm","target":"cyclophosphamide","id":"3523"},{"source":"spasm","target":"lansoprazole","id":"3524"},{"source":"spasm","target":"radiation therapy","id":"3525"},{"source":"spasm","target":"undisclosed - vitamin D analog","id":"3526"},{"source":"carcinoma","target":"pembrolizumab","id":"3527"},{"source":"carcinoma","target":"aspirin","id":"3528"},{"source":"carcinoma","target":"curcumin","id":"3529"},{"source":"carcinoma","target":"cyclophosphamide","id":"3530"},{"source":"carcinoma","target":"lansoprazole","id":"3531"},{"source":"carcinoma","target":"radiation therapy","id":"3532"},{"source":"carcinoma","target":"undisclosed - vitamin D analog","id":"3533"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"3534"},{"source":"inflammatory bowel diseases","target":"aspirin","id":"3535"},{"source":"inflammatory bowel diseases","target":"curcumin","id":"3536"},{"source":"inflammatory bowel diseases","target":"cyclophosphamide","id":"3537"},{"source":"inflammatory bowel diseases","target":"lansoprazole","id":"3538"},{"source":"inflammatory bowel diseases","target":"radiation therapy","id":"3539"},{"source":"inflammatory bowel diseases","target":"undisclosed - vitamin D analog","id":"3540"},{"source":"peptic ulcer","target":"pembrolizumab","id":"3541"},{"source":"peptic ulcer","target":"aspirin","id":"3542"},{"source":"peptic ulcer","target":"curcumin","id":"3543"},{"source":"peptic ulcer","target":"cyclophosphamide","id":"3544"},{"source":"peptic ulcer","target":"lansoprazole","id":"3545"},{"source":"peptic ulcer","target":"radiation therapy","id":"3546"},{"source":"peptic ulcer","target":"undisclosed - vitamin D analog","id":"3547"},{"source":"spasm","target":"pembrolizumab","id":"3548"},{"source":"spasm","target":"aspirin","id":"3549"},{"source":"spasm","target":"curcumin","id":"3550"},{"source":"spasm","target":"cyclophosphamide","id":"3551"},{"source":"spasm","target":"lansoprazole","id":"3552"},{"source":"spasm","target":"radiation therapy","id":"3553"},{"source":"spasm","target":"undisclosed - vitamin D analog","id":"3554"},{"source":"sarcoma","target":"pembrolizumab","id":"3555"},{"source":"sarcoma","target":"aspirin","id":"3556"},{"source":"sarcoma","target":"curcumin","id":"3557"},{"source":"sarcoma","target":"cyclophosphamide","id":"3558"},{"source":"sarcoma","target":"lansoprazole","id":"3559"},{"source":"sarcoma","target":"radiation therapy","id":"3560"},{"source":"sarcoma","target":"undisclosed - vitamin D analog","id":"3561"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"3562"},{"source":"inflammatory bowel diseases","target":"aspirin","id":"3563"},{"source":"inflammatory bowel diseases","target":"curcumin","id":"3564"},{"source":"inflammatory bowel diseases","target":"cyclophosphamide","id":"3565"},{"source":"inflammatory bowel diseases","target":"lansoprazole","id":"3566"},{"source":"inflammatory bowel diseases","target":"radiation therapy","id":"3567"},{"source":"inflammatory bowel diseases","target":"undisclosed - vitamin D analog","id":"3568"},{"source":"inflammation","target":"pembrolizumab","id":"3569"},{"source":"inflammation","target":"aspirin","id":"3570"},{"source":"inflammation","target":"curcumin","id":"3571"},{"source":"inflammation","target":"cyclophosphamide","id":"3572"},{"source":"inflammation","target":"lansoprazole","id":"3573"},{"source":"inflammation","target":"radiation therapy","id":"3574"},{"source":"inflammation","target":"undisclosed - vitamin D analog","id":"3575"},{"source":"analgesic","target":"pembrolizumab","id":"3576"},{"source":"analgesic","target":"aspirin","id":"3577"},{"source":"analgesic","target":"curcumin","id":"3578"},{"source":"analgesic","target":"cyclophosphamide","id":"3579"},{"source":"analgesic","target":"lansoprazole","id":"3580"},{"source":"analgesic","target":"radiation therapy","id":"3581"},{"source":"analgesic","target":"undisclosed - vitamin D analog","id":"3582"},{"source":"endometrial neoplasms","target":"pembrolizumab","id":"3583"},{"source":"endometrial neoplasms","target":"aspirin","id":"3584"},{"source":"endometrial neoplasms","target":"curcumin","id":"3585"},{"source":"endometrial neoplasms","target":"cyclophosphamide","id":"3586"},{"source":"endometrial neoplasms","target":"lansoprazole","id":"3587"},{"source":"endometrial neoplasms","target":"radiation therapy","id":"3588"},{"source":"endometrial neoplasms","target":"undisclosed - vitamin D analog","id":"3589"},{"source":"cervical cancer","target":"pembrolizumab","id":"3590"},{"source":"cervical cancer","target":"aspirin","id":"3591"},{"source":"cervical cancer","target":"curcumin","id":"3592"},{"source":"cervical cancer","target":"cyclophosphamide","id":"3593"},{"source":"cervical cancer","target":"lansoprazole","id":"3594"},{"source":"cervical cancer","target":"radiation therapy","id":"3595"},{"source":"cervical cancer","target":"undisclosed - vitamin D analog","id":"3596"},{"source":"pain","target":"pembrolizumab","id":"3597"},{"source":"pain","target":"aspirin","id":"3598"},{"source":"pain","target":"curcumin","id":"3599"},{"source":"pain","target":"cyclophosphamide","id":"3600"},{"source":"pain","target":"lansoprazole","id":"3601"},{"source":"pain","target":"radiation therapy","id":"3602"},{"source":"pain","target":"undisclosed - vitamin D analog","id":"3603"},{"source":"endometrioid","target":"pembrolizumab","id":"3604"},{"source":"endometrioid","target":"aspirin","id":"3605"},{"source":"endometrioid","target":"curcumin","id":"3606"},{"source":"endometrioid","target":"cyclophosphamide","id":"3607"},{"source":"endometrioid","target":"lansoprazole","id":"3608"},{"source":"endometrioid","target":"radiation therapy","id":"3609"},{"source":"endometrioid","target":"undisclosed - vitamin D analog","id":"3610"},{"source":"carcinoma","target":"pembrolizumab","id":"3611"},{"source":"carcinoma","target":"aspirin","id":"3612"},{"source":"carcinoma","target":"curcumin","id":"3613"},{"source":"carcinoma","target":"cyclophosphamide","id":"3614"},{"source":"carcinoma","target":"lansoprazole","id":"3615"},{"source":"carcinoma","target":"radiation therapy","id":"3616"},{"source":"carcinoma","target":"undisclosed - vitamin D analog","id":"3617"},{"source":"antiulcer","target":"pembrolizumab","id":"3618"},{"source":"antiulcer","target":"aspirin","id":"3619"},{"source":"antiulcer","target":"curcumin","id":"3620"},{"source":"antiulcer","target":"cyclophosphamide","id":"3621"},{"source":"antiulcer","target":"lansoprazole","id":"3622"},{"source":"antiulcer","target":"radiation therapy","id":"3623"},{"source":"antiulcer","target":"undisclosed - vitamin D analog","id":"3624"},{"source":"carcinoma","target":"pembrolizumab","id":"3625"},{"source":"carcinoma","target":"aspirin","id":"3626"},{"source":"carcinoma","target":"curcumin","id":"3627"},{"source":"carcinoma","target":"cyclophosphamide","id":"3628"},{"source":"carcinoma","target":"lansoprazole","id":"3629"},{"source":"carcinoma","target":"radiation therapy","id":"3630"},{"source":"carcinoma","target":"undisclosed - vitamin D analog","id":"3631"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"3632"},{"source":"soft tissue neoplasms","target":"aspirin","id":"3633"},{"source":"soft tissue neoplasms","target":"curcumin","id":"3634"},{"source":"soft tissue neoplasms","target":"cyclophosphamide","id":"3635"},{"source":"soft tissue neoplasms","target":"lansoprazole","id":"3636"},{"source":"soft tissue neoplasms","target":"radiation therapy","id":"3637"},{"source":"soft tissue neoplasms","target":"undisclosed - vitamin D analog","id":"3638"},{"source":"antithrombotic","target":"pembrolizumab","id":"3639"},{"source":"antithrombotic","target":"aspirin","id":"3640"},{"source":"antithrombotic","target":"curcumin","id":"3641"},{"source":"antithrombotic","target":"cyclophosphamide","id":"3642"},{"source":"antithrombotic","target":"lansoprazole","id":"3643"},{"source":"antithrombotic","target":"radiation therapy","id":"3644"},{"source":"antithrombotic","target":"undisclosed - vitamin D analog","id":"3645"},{"source":"thrombosis","target":"pembrolizumab","id":"3646"},{"source":"thrombosis","target":"aspirin","id":"3647"},{"source":"thrombosis","target":"curcumin","id":"3648"},{"source":"thrombosis","target":"cyclophosphamide","id":"3649"},{"source":"thrombosis","target":"lansoprazole","id":"3650"},{"source":"thrombosis","target":"radiation therapy","id":"3651"},{"source":"thrombosis","target":"undisclosed - vitamin D analog","id":"3652"},{"source":"uterine cancer","target":"pembrolizumab","id":"3653"},{"source":"uterine cancer","target":"aspirin","id":"3654"},{"source":"uterine cancer","target":"curcumin","id":"3655"},{"source":"uterine cancer","target":"cyclophosphamide","id":"3656"},{"source":"uterine cancer","target":"lansoprazole","id":"3657"},{"source":"uterine cancer","target":"radiation therapy","id":"3658"},{"source":"uterine cancer","target":"undisclosed - vitamin D analog","id":"3659"},{"source":"residual tumor","target":"pembrolizumab","id":"3660"},{"source":"residual tumor","target":"aspirin","id":"3661"},{"source":"residual tumor","target":"curcumin","id":"3662"},{"source":"residual tumor","target":"cyclophosphamide","id":"3663"},{"source":"residual tumor","target":"lansoprazole","id":"3664"},{"source":"residual tumor","target":"radiation therapy","id":"3665"},{"source":"residual tumor","target":"undisclosed - vitamin D analog","id":"3666"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"3667"},{"source":"uterine cervical neoplasms","target":"aspirin","id":"3668"},{"source":"uterine cervical neoplasms","target":"curcumin","id":"3669"},{"source":"uterine cervical neoplasms","target":"cyclophosphamide","id":"3670"},{"source":"uterine cervical neoplasms","target":"lansoprazole","id":"3671"},{"source":"uterine cervical neoplasms","target":"radiation therapy","id":"3672"},{"source":"uterine cervical neoplasms","target":"undisclosed - vitamin D analog","id":"3673"},{"source":"anticancer","target":"pembrolizumab","id":"3674"},{"source":"anticancer","target":"aspirin","id":"3675"},{"source":"anticancer","target":"curcumin","id":"3676"},{"source":"anticancer","target":"cyclophosphamide","id":"3677"},{"source":"anticancer","target":"lansoprazole","id":"3678"},{"source":"anticancer","target":"radiation therapy","id":"3679"},{"source":"anticancer","target":"undisclosed - vitamin D analog","id":"3680"},{"source":"Immunosuppressant","target":"UNK : Indication","id":"3681"},{"source":"Immunosuppressant","target":"anti-inflammatory","id":"3682"},{"source":"Immunosuppressant","target":"sarcoma","id":"3683"},{"source":"Immunosuppressant","target":"uterine cervical neoplasms","id":"3684"},{"source":"Immunosuppressant","target":"carcinoma","id":"3685"},{"source":"Immunosuppressant","target":"antiallergic","id":"3686"},{"source":"Immunosuppressant","target":"spasm","id":"3687"},{"source":"Immunosuppressant","target":"carcinoma","id":"3688"},{"source":"Immunosuppressant","target":"inflammatory bowel diseases","id":"3689"},{"source":"Immunosuppressant","target":"peptic ulcer","id":"3690"},{"source":"Immunosuppressant","target":"spasm","id":"3691"},{"source":"Immunosuppressant","target":"sarcoma","id":"3692"},{"source":"Immunosuppressant","target":"inflammatory bowel diseases","id":"3693"},{"source":"Immunosuppressant","target":"inflammation","id":"3694"},{"source":"Immunosuppressant","target":"analgesic","id":"3695"},{"source":"Immunosuppressant","target":"endometrial neoplasms","id":"3696"},{"source":"Immunosuppressant","target":"cervical cancer","id":"3697"},{"source":"Immunosuppressant","target":"pain","id":"3698"},{"source":"Immunosuppressant","target":"endometrioid","id":"3699"},{"source":"Immunosuppressant","target":"carcinoma","id":"3700"},{"source":"Immunosuppressant","target":"antiulcer","id":"3701"},{"source":"Immunosuppressant","target":"carcinoma","id":"3702"},{"source":"Immunosuppressant","target":"soft tissue neoplasms","id":"3703"},{"source":"Immunosuppressant","target":"antithrombotic","id":"3704"},{"source":"Immunosuppressant","target":"thrombosis","id":"3705"},{"source":"Immunosuppressant","target":"uterine cancer","id":"3706"},{"source":"Immunosuppressant","target":"residual tumor","id":"3707"},{"source":"Immunosuppressant","target":"uterine cervical neoplasms","id":"3708"},{"source":"Immunosuppressant","target":"anticancer","id":"3709"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"3710"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"3711"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"3712"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"3713"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3714"},{"source":"Immune checkpoint inhibitor","target":"antiallergic","id":"3715"},{"source":"Immune checkpoint inhibitor","target":"spasm","id":"3716"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3717"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"3718"},{"source":"Immune checkpoint inhibitor","target":"peptic ulcer","id":"3719"},{"source":"Immune checkpoint inhibitor","target":"spasm","id":"3720"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"3721"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"3722"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"3723"},{"source":"Immune checkpoint inhibitor","target":"analgesic","id":"3724"},{"source":"Immune checkpoint inhibitor","target":"endometrial neoplasms","id":"3725"},{"source":"Immune checkpoint inhibitor","target":"cervical cancer","id":"3726"},{"source":"Immune checkpoint inhibitor","target":"pain","id":"3727"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"3728"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3729"},{"source":"Immune checkpoint inhibitor","target":"antiulcer","id":"3730"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"3731"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"3732"},{"source":"Immune checkpoint inhibitor","target":"antithrombotic","id":"3733"},{"source":"Immune checkpoint inhibitor","target":"thrombosis","id":"3734"},{"source":"Immune checkpoint inhibitor","target":"uterine cancer","id":"3735"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"3736"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"3737"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"3738"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"3739"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"3740"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"3741"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"3742"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3743"},{"source":"Anticancer immunotherapy","target":"antiallergic","id":"3744"},{"source":"Anticancer immunotherapy","target":"spasm","id":"3745"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3746"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"3747"},{"source":"Anticancer immunotherapy","target":"peptic ulcer","id":"3748"},{"source":"Anticancer immunotherapy","target":"spasm","id":"3749"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"3750"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"3751"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"3752"},{"source":"Anticancer immunotherapy","target":"analgesic","id":"3753"},{"source":"Anticancer immunotherapy","target":"endometrial neoplasms","id":"3754"},{"source":"Anticancer immunotherapy","target":"cervical cancer","id":"3755"},{"source":"Anticancer immunotherapy","target":"pain","id":"3756"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"3757"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3758"},{"source":"Anticancer immunotherapy","target":"antiulcer","id":"3759"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"3760"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"3761"},{"source":"Anticancer immunotherapy","target":"antithrombotic","id":"3762"},{"source":"Anticancer immunotherapy","target":"thrombosis","id":"3763"},{"source":"Anticancer immunotherapy","target":"uterine cancer","id":"3764"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"3765"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"3766"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"3767"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"3768"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"3769"},{"source":"CD19 antagonist","target":"sarcoma","id":"3770"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"3771"},{"source":"CD19 antagonist","target":"carcinoma","id":"3772"},{"source":"CD19 antagonist","target":"antiallergic","id":"3773"},{"source":"CD19 antagonist","target":"spasm","id":"3774"},{"source":"CD19 antagonist","target":"carcinoma","id":"3775"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"3776"},{"source":"CD19 antagonist","target":"peptic ulcer","id":"3777"},{"source":"CD19 antagonist","target":"spasm","id":"3778"},{"source":"CD19 antagonist","target":"sarcoma","id":"3779"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"3780"},{"source":"CD19 antagonist","target":"inflammation","id":"3781"},{"source":"CD19 antagonist","target":"analgesic","id":"3782"},{"source":"CD19 antagonist","target":"endometrial neoplasms","id":"3783"},{"source":"CD19 antagonist","target":"cervical cancer","id":"3784"},{"source":"CD19 antagonist","target":"pain","id":"3785"},{"source":"CD19 antagonist","target":"endometrioid","id":"3786"},{"source":"CD19 antagonist","target":"carcinoma","id":"3787"},{"source":"CD19 antagonist","target":"antiulcer","id":"3788"},{"source":"CD19 antagonist","target":"carcinoma","id":"3789"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"3790"},{"source":"CD19 antagonist","target":"antithrombotic","id":"3791"},{"source":"CD19 antagonist","target":"thrombosis","id":"3792"},{"source":"CD19 antagonist","target":"uterine cancer","id":"3793"},{"source":"CD19 antagonist","target":"residual tumor","id":"3794"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"3795"},{"source":"CD19 antagonist","target":"anticancer","id":"3796"},{"source":"NA","target":"UNK : Indication","id":"3797"},{"source":"NA","target":"anti-inflammatory","id":"3798"},{"source":"NA","target":"sarcoma","id":"3799"},{"source":"NA","target":"uterine cervical neoplasms","id":"3800"},{"source":"NA","target":"carcinoma","id":"3801"},{"source":"NA","target":"antiallergic","id":"3802"},{"source":"NA","target":"spasm","id":"3803"},{"source":"NA","target":"carcinoma","id":"3804"},{"source":"NA","target":"inflammatory bowel diseases","id":"3805"},{"source":"NA","target":"peptic ulcer","id":"3806"},{"source":"NA","target":"spasm","id":"3807"},{"source":"NA","target":"sarcoma","id":"3808"},{"source":"NA","target":"inflammatory bowel diseases","id":"3809"},{"source":"NA","target":"inflammation","id":"3810"},{"source":"NA","target":"analgesic","id":"3811"},{"source":"NA","target":"endometrial neoplasms","id":"3812"},{"source":"NA","target":"cervical cancer","id":"3813"},{"source":"NA","target":"pain","id":"3814"},{"source":"NA","target":"endometrioid","id":"3815"},{"source":"NA","target":"carcinoma","id":"3816"},{"source":"NA","target":"antiulcer","id":"3817"},{"source":"NA","target":"carcinoma","id":"3818"},{"source":"NA","target":"soft tissue neoplasms","id":"3819"},{"source":"NA","target":"antithrombotic","id":"3820"},{"source":"NA","target":"thrombosis","id":"3821"},{"source":"NA","target":"uterine cancer","id":"3822"},{"source":"NA","target":"residual tumor","id":"3823"},{"source":"NA","target":"uterine cervical neoplasms","id":"3824"},{"source":"NA","target":"anticancer","id":"3825"},{"source":"Platelet aggregation inhibitor","target":"UNK : Indication","id":"3826"},{"source":"Platelet aggregation inhibitor","target":"anti-inflammatory","id":"3827"},{"source":"Platelet aggregation inhibitor","target":"sarcoma","id":"3828"},{"source":"Platelet aggregation inhibitor","target":"uterine cervical neoplasms","id":"3829"},{"source":"Platelet aggregation inhibitor","target":"carcinoma","id":"3830"},{"source":"Platelet aggregation inhibitor","target":"antiallergic","id":"3831"},{"source":"Platelet aggregation inhibitor","target":"spasm","id":"3832"},{"source":"Platelet aggregation inhibitor","target":"carcinoma","id":"3833"},{"source":"Platelet aggregation inhibitor","target":"inflammatory bowel diseases","id":"3834"},{"source":"Platelet aggregation inhibitor","target":"peptic ulcer","id":"3835"},{"source":"Platelet aggregation inhibitor","target":"spasm","id":"3836"},{"source":"Platelet aggregation inhibitor","target":"sarcoma","id":"3837"},{"source":"Platelet aggregation inhibitor","target":"inflammatory bowel diseases","id":"3838"},{"source":"Platelet aggregation inhibitor","target":"inflammation","id":"3839"},{"source":"Platelet aggregation inhibitor","target":"analgesic","id":"3840"},{"source":"Platelet aggregation inhibitor","target":"endometrial neoplasms","id":"3841"},{"source":"Platelet aggregation inhibitor","target":"cervical cancer","id":"3842"},{"source":"Platelet aggregation inhibitor","target":"pain","id":"3843"},{"source":"Platelet aggregation inhibitor","target":"endometrioid","id":"3844"},{"source":"Platelet aggregation inhibitor","target":"carcinoma","id":"3845"},{"source":"Platelet aggregation inhibitor","target":"antiulcer","id":"3846"},{"source":"Platelet aggregation inhibitor","target":"carcinoma","id":"3847"},{"source":"Platelet aggregation inhibitor","target":"soft tissue neoplasms","id":"3848"},{"source":"Platelet aggregation inhibitor","target":"antithrombotic","id":"3849"},{"source":"Platelet aggregation inhibitor","target":"thrombosis","id":"3850"},{"source":"Platelet aggregation inhibitor","target":"uterine cancer","id":"3851"},{"source":"Platelet aggregation inhibitor","target":"residual tumor","id":"3852"},{"source":"Platelet aggregation inhibitor","target":"uterine cervical neoplasms","id":"3853"},{"source":"Platelet aggregation inhibitor","target":"anticancer","id":"3854"},{"source":"UPA","target":"UNK : Indication","id":"3855"},{"source":"UPA","target":"anti-inflammatory","id":"3856"},{"source":"UPA","target":"sarcoma","id":"3857"},{"source":"UPA","target":"uterine cervical neoplasms","id":"3858"},{"source":"UPA","target":"carcinoma","id":"3859"},{"source":"UPA","target":"antiallergic","id":"3860"},{"source":"UPA","target":"spasm","id":"3861"},{"source":"UPA","target":"carcinoma","id":"3862"},{"source":"UPA","target":"inflammatory bowel diseases","id":"3863"},{"source":"UPA","target":"peptic ulcer","id":"3864"},{"source":"UPA","target":"spasm","id":"3865"},{"source":"UPA","target":"sarcoma","id":"3866"},{"source":"UPA","target":"inflammatory bowel diseases","id":"3867"},{"source":"UPA","target":"inflammation","id":"3868"},{"source":"UPA","target":"analgesic","id":"3869"},{"source":"UPA","target":"endometrial neoplasms","id":"3870"},{"source":"UPA","target":"cervical cancer","id":"3871"},{"source":"UPA","target":"pain","id":"3872"},{"source":"UPA","target":"endometrioid","id":"3873"},{"source":"UPA","target":"carcinoma","id":"3874"},{"source":"UPA","target":"antiulcer","id":"3875"},{"source":"UPA","target":"carcinoma","id":"3876"},{"source":"UPA","target":"soft tissue neoplasms","id":"3877"},{"source":"UPA","target":"antithrombotic","id":"3878"},{"source":"UPA","target":"thrombosis","id":"3879"},{"source":"UPA","target":"uterine cancer","id":"3880"},{"source":"UPA","target":"residual tumor","id":"3881"},{"source":"UPA","target":"uterine cervical neoplasms","id":"3882"},{"source":"UPA","target":"anticancer","id":"3883"},{"source":"Thromboxane synthase inhibitor","target":"UNK : Indication","id":"3884"},{"source":"Thromboxane synthase inhibitor","target":"anti-inflammatory","id":"3885"},{"source":"Thromboxane synthase inhibitor","target":"sarcoma","id":"3886"},{"source":"Thromboxane synthase inhibitor","target":"uterine cervical neoplasms","id":"3887"},{"source":"Thromboxane synthase inhibitor","target":"carcinoma","id":"3888"},{"source":"Thromboxane synthase inhibitor","target":"antiallergic","id":"3889"},{"source":"Thromboxane synthase inhibitor","target":"spasm","id":"3890"},{"source":"Thromboxane synthase inhibitor","target":"carcinoma","id":"3891"},{"source":"Thromboxane synthase inhibitor","target":"inflammatory bowel diseases","id":"3892"},{"source":"Thromboxane synthase inhibitor","target":"peptic ulcer","id":"3893"},{"source":"Thromboxane synthase inhibitor","target":"spasm","id":"3894"},{"source":"Thromboxane synthase inhibitor","target":"sarcoma","id":"3895"},{"source":"Thromboxane synthase inhibitor","target":"inflammatory bowel diseases","id":"3896"},{"source":"Thromboxane synthase inhibitor","target":"inflammation","id":"3897"},{"source":"Thromboxane synthase inhibitor","target":"analgesic","id":"3898"},{"source":"Thromboxane synthase inhibitor","target":"endometrial neoplasms","id":"3899"},{"source":"Thromboxane synthase inhibitor","target":"cervical cancer","id":"3900"},{"source":"Thromboxane synthase inhibitor","target":"pain","id":"3901"},{"source":"Thromboxane synthase inhibitor","target":"endometrioid","id":"3902"},{"source":"Thromboxane synthase inhibitor","target":"carcinoma","id":"3903"},{"source":"Thromboxane synthase inhibitor","target":"antiulcer","id":"3904"},{"source":"Thromboxane synthase inhibitor","target":"carcinoma","id":"3905"},{"source":"Thromboxane synthase inhibitor","target":"soft tissue neoplasms","id":"3906"},{"source":"Thromboxane synthase inhibitor","target":"antithrombotic","id":"3907"},{"source":"Thromboxane synthase inhibitor","target":"thrombosis","id":"3908"},{"source":"Thromboxane synthase inhibitor","target":"uterine cancer","id":"3909"},{"source":"Thromboxane synthase inhibitor","target":"residual tumor","id":"3910"},{"source":"Thromboxane synthase inhibitor","target":"uterine cervical neoplasms","id":"3911"},{"source":"Thromboxane synthase inhibitor","target":"anticancer","id":"3912"},{"source":"NA","target":"UNK : Indication","id":"3913"},{"source":"NA","target":"anti-inflammatory","id":"3914"},{"source":"NA","target":"sarcoma","id":"3915"},{"source":"NA","target":"uterine cervical neoplasms","id":"3916"},{"source":"NA","target":"carcinoma","id":"3917"},{"source":"NA","target":"antiallergic","id":"3918"},{"source":"NA","target":"spasm","id":"3919"},{"source":"NA","target":"carcinoma","id":"3920"},{"source":"NA","target":"inflammatory bowel diseases","id":"3921"},{"source":"NA","target":"peptic ulcer","id":"3922"},{"source":"NA","target":"spasm","id":"3923"},{"source":"NA","target":"sarcoma","id":"3924"},{"source":"NA","target":"inflammatory bowel diseases","id":"3925"},{"source":"NA","target":"inflammation","id":"3926"},{"source":"NA","target":"analgesic","id":"3927"},{"source":"NA","target":"endometrial neoplasms","id":"3928"},{"source":"NA","target":"cervical cancer","id":"3929"},{"source":"NA","target":"pain","id":"3930"},{"source":"NA","target":"endometrioid","id":"3931"},{"source":"NA","target":"carcinoma","id":"3932"},{"source":"NA","target":"antiulcer","id":"3933"},{"source":"NA","target":"carcinoma","id":"3934"},{"source":"NA","target":"soft tissue neoplasms","id":"3935"},{"source":"NA","target":"antithrombotic","id":"3936"},{"source":"NA","target":"thrombosis","id":"3937"},{"source":"NA","target":"uterine cancer","id":"3938"},{"source":"NA","target":"residual tumor","id":"3939"},{"source":"NA","target":"uterine cervical neoplasms","id":"3940"},{"source":"NA","target":"anticancer","id":"3941"},{"source":"Free radical scavenger","target":"UNK : Indication","id":"3942"},{"source":"Free radical scavenger","target":"anti-inflammatory","id":"3943"},{"source":"Free radical scavenger","target":"sarcoma","id":"3944"},{"source":"Free radical scavenger","target":"uterine cervical neoplasms","id":"3945"},{"source":"Free radical scavenger","target":"carcinoma","id":"3946"},{"source":"Free radical scavenger","target":"antiallergic","id":"3947"},{"source":"Free radical scavenger","target":"spasm","id":"3948"},{"source":"Free radical scavenger","target":"carcinoma","id":"3949"},{"source":"Free radical scavenger","target":"inflammatory bowel diseases","id":"3950"},{"source":"Free radical scavenger","target":"peptic ulcer","id":"3951"},{"source":"Free radical scavenger","target":"spasm","id":"3952"},{"source":"Free radical scavenger","target":"sarcoma","id":"3953"},{"source":"Free radical scavenger","target":"inflammatory bowel diseases","id":"3954"},{"source":"Free radical scavenger","target":"inflammation","id":"3955"},{"source":"Free radical scavenger","target":"analgesic","id":"3956"},{"source":"Free radical scavenger","target":"endometrial neoplasms","id":"3957"},{"source":"Free radical scavenger","target":"cervical cancer","id":"3958"},{"source":"Free radical scavenger","target":"pain","id":"3959"},{"source":"Free radical scavenger","target":"endometrioid","id":"3960"},{"source":"Free radical scavenger","target":"carcinoma","id":"3961"},{"source":"Free radical scavenger","target":"antiulcer","id":"3962"},{"source":"Free radical scavenger","target":"carcinoma","id":"3963"},{"source":"Free radical scavenger","target":"soft tissue neoplasms","id":"3964"},{"source":"Free radical scavenger","target":"antithrombotic","id":"3965"},{"source":"Free radical scavenger","target":"thrombosis","id":"3966"},{"source":"Free radical scavenger","target":"uterine cancer","id":"3967"},{"source":"Free radical scavenger","target":"residual tumor","id":"3968"},{"source":"Free radical scavenger","target":"uterine cervical neoplasms","id":"3969"},{"source":"Free radical scavenger","target":"anticancer","id":"3970"},{"source":"Reducing agent","target":"UNK : Indication","id":"3971"},{"source":"Reducing agent","target":"anti-inflammatory","id":"3972"},{"source":"Reducing agent","target":"sarcoma","id":"3973"},{"source":"Reducing agent","target":"uterine cervical neoplasms","id":"3974"},{"source":"Reducing agent","target":"carcinoma","id":"3975"},{"source":"Reducing agent","target":"antiallergic","id":"3976"},{"source":"Reducing agent","target":"spasm","id":"3977"},{"source":"Reducing agent","target":"carcinoma","id":"3978"},{"source":"Reducing agent","target":"inflammatory bowel diseases","id":"3979"},{"source":"Reducing agent","target":"peptic ulcer","id":"3980"},{"source":"Reducing agent","target":"spasm","id":"3981"},{"source":"Reducing agent","target":"sarcoma","id":"3982"},{"source":"Reducing agent","target":"inflammatory bowel diseases","id":"3983"},{"source":"Reducing agent","target":"inflammation","id":"3984"},{"source":"Reducing agent","target":"analgesic","id":"3985"},{"source":"Reducing agent","target":"endometrial neoplasms","id":"3986"},{"source":"Reducing agent","target":"cervical cancer","id":"3987"},{"source":"Reducing agent","target":"pain","id":"3988"},{"source":"Reducing agent","target":"endometrioid","id":"3989"},{"source":"Reducing agent","target":"carcinoma","id":"3990"},{"source":"Reducing agent","target":"antiulcer","id":"3991"},{"source":"Reducing agent","target":"carcinoma","id":"3992"},{"source":"Reducing agent","target":"soft tissue neoplasms","id":"3993"},{"source":"Reducing agent","target":"antithrombotic","id":"3994"},{"source":"Reducing agent","target":"thrombosis","id":"3995"},{"source":"Reducing agent","target":"uterine cancer","id":"3996"},{"source":"Reducing agent","target":"residual tumor","id":"3997"},{"source":"Reducing agent","target":"uterine cervical neoplasms","id":"3998"},{"source":"Reducing agent","target":"anticancer","id":"3999"},{"source":"Prostaglandin synthase inhibitor","target":"UNK : Indication","id":"4000"},{"source":"Prostaglandin synthase inhibitor","target":"anti-inflammatory","id":"4001"},{"source":"Prostaglandin synthase inhibitor","target":"sarcoma","id":"4002"},{"source":"Prostaglandin synthase inhibitor","target":"uterine cervical neoplasms","id":"4003"},{"source":"Prostaglandin synthase inhibitor","target":"carcinoma","id":"4004"},{"source":"Prostaglandin synthase inhibitor","target":"antiallergic","id":"4005"},{"source":"Prostaglandin synthase inhibitor","target":"spasm","id":"4006"},{"source":"Prostaglandin synthase inhibitor","target":"carcinoma","id":"4007"},{"source":"Prostaglandin synthase inhibitor","target":"inflammatory bowel diseases","id":"4008"},{"source":"Prostaglandin synthase inhibitor","target":"peptic ulcer","id":"4009"},{"source":"Prostaglandin synthase inhibitor","target":"spasm","id":"4010"},{"source":"Prostaglandin synthase inhibitor","target":"sarcoma","id":"4011"},{"source":"Prostaglandin synthase inhibitor","target":"inflammatory bowel diseases","id":"4012"},{"source":"Prostaglandin synthase inhibitor","target":"inflammation","id":"4013"},{"source":"Prostaglandin synthase inhibitor","target":"analgesic","id":"4014"},{"source":"Prostaglandin synthase inhibitor","target":"endometrial neoplasms","id":"4015"},{"source":"Prostaglandin synthase inhibitor","target":"cervical cancer","id":"4016"},{"source":"Prostaglandin synthase inhibitor","target":"pain","id":"4017"},{"source":"Prostaglandin synthase inhibitor","target":"endometrioid","id":"4018"},{"source":"Prostaglandin synthase inhibitor","target":"carcinoma","id":"4019"},{"source":"Prostaglandin synthase inhibitor","target":"antiulcer","id":"4020"},{"source":"Prostaglandin synthase inhibitor","target":"carcinoma","id":"4021"},{"source":"Prostaglandin synthase inhibitor","target":"soft tissue neoplasms","id":"4022"},{"source":"Prostaglandin synthase inhibitor","target":"antithrombotic","id":"4023"},{"source":"Prostaglandin synthase inhibitor","target":"thrombosis","id":"4024"},{"source":"Prostaglandin synthase inhibitor","target":"uterine cancer","id":"4025"},{"source":"Prostaglandin synthase inhibitor","target":"residual tumor","id":"4026"},{"source":"Prostaglandin synthase inhibitor","target":"uterine cervical neoplasms","id":"4027"},{"source":"Prostaglandin synthase inhibitor","target":"anticancer","id":"4028"},{"source":"H+ K+ transporting ATPase inhibitor","target":"UNK : Indication","id":"4029"},{"source":"H+ K+ transporting ATPase inhibitor","target":"anti-inflammatory","id":"4030"},{"source":"H+ K+ transporting ATPase inhibitor","target":"sarcoma","id":"4031"},{"source":"H+ K+ transporting ATPase inhibitor","target":"uterine cervical neoplasms","id":"4032"},{"source":"H+ K+ transporting ATPase inhibitor","target":"carcinoma","id":"4033"},{"source":"H+ K+ transporting ATPase inhibitor","target":"antiallergic","id":"4034"},{"source":"H+ K+ transporting ATPase inhibitor","target":"spasm","id":"4035"},{"source":"H+ K+ transporting ATPase inhibitor","target":"carcinoma","id":"4036"},{"source":"H+ K+ transporting ATPase inhibitor","target":"inflammatory bowel diseases","id":"4037"},{"source":"H+ K+ transporting ATPase inhibitor","target":"peptic ulcer","id":"4038"},{"source":"H+ K+ transporting ATPase inhibitor","target":"spasm","id":"4039"},{"source":"H+ K+ transporting ATPase inhibitor","target":"sarcoma","id":"4040"},{"source":"H+ K+ transporting ATPase inhibitor","target":"inflammatory bowel diseases","id":"4041"},{"source":"H+ K+ transporting ATPase inhibitor","target":"inflammation","id":"4042"},{"source":"H+ K+ transporting ATPase inhibitor","target":"analgesic","id":"4043"},{"source":"H+ K+ transporting ATPase inhibitor","target":"endometrial neoplasms","id":"4044"},{"source":"H+ K+ transporting ATPase inhibitor","target":"cervical cancer","id":"4045"},{"source":"H+ K+ transporting ATPase inhibitor","target":"pain","id":"4046"},{"source":"H+ K+ transporting ATPase inhibitor","target":"endometrioid","id":"4047"},{"source":"H+ K+ transporting ATPase inhibitor","target":"carcinoma","id":"4048"},{"source":"H+ K+ transporting ATPase inhibitor","target":"antiulcer","id":"4049"},{"source":"H+ K+ transporting ATPase inhibitor","target":"carcinoma","id":"4050"},{"source":"H+ K+ transporting ATPase inhibitor","target":"soft tissue neoplasms","id":"4051"},{"source":"H+ K+ transporting ATPase inhibitor","target":"antithrombotic","id":"4052"},{"source":"H+ K+ transporting ATPase inhibitor","target":"thrombosis","id":"4053"},{"source":"H+ K+ transporting ATPase inhibitor","target":"uterine cancer","id":"4054"},{"source":"H+ K+ transporting ATPase inhibitor","target":"residual tumor","id":"4055"},{"source":"H+ K+ transporting ATPase inhibitor","target":"uterine cervical neoplasms","id":"4056"},{"source":"H+ K+ transporting ATPase inhibitor","target":"anticancer","id":"4057"},{"source":"Vitamin D agonist","target":"UNK : Indication","id":"4058"},{"source":"Vitamin D agonist","target":"anti-inflammatory","id":"4059"},{"source":"Vitamin D agonist","target":"sarcoma","id":"4060"},{"source":"Vitamin D agonist","target":"uterine cervical neoplasms","id":"4061"},{"source":"Vitamin D agonist","target":"carcinoma","id":"4062"},{"source":"Vitamin D agonist","target":"antiallergic","id":"4063"},{"source":"Vitamin D agonist","target":"spasm","id":"4064"},{"source":"Vitamin D agonist","target":"carcinoma","id":"4065"},{"source":"Vitamin D agonist","target":"inflammatory bowel diseases","id":"4066"},{"source":"Vitamin D agonist","target":"peptic ulcer","id":"4067"},{"source":"Vitamin D agonist","target":"spasm","id":"4068"},{"source":"Vitamin D agonist","target":"sarcoma","id":"4069"},{"source":"Vitamin D agonist","target":"inflammatory bowel diseases","id":"4070"},{"source":"Vitamin D agonist","target":"inflammation","id":"4071"},{"source":"Vitamin D agonist","target":"analgesic","id":"4072"},{"source":"Vitamin D agonist","target":"endometrial neoplasms","id":"4073"},{"source":"Vitamin D agonist","target":"cervical cancer","id":"4074"},{"source":"Vitamin D agonist","target":"pain","id":"4075"},{"source":"Vitamin D agonist","target":"endometrioid","id":"4076"},{"source":"Vitamin D agonist","target":"carcinoma","id":"4077"},{"source":"Vitamin D agonist","target":"antiulcer","id":"4078"},{"source":"Vitamin D agonist","target":"carcinoma","id":"4079"},{"source":"Vitamin D agonist","target":"soft tissue neoplasms","id":"4080"},{"source":"Vitamin D agonist","target":"antithrombotic","id":"4081"},{"source":"Vitamin D agonist","target":"thrombosis","id":"4082"},{"source":"Vitamin D agonist","target":"uterine cancer","id":"4083"},{"source":"Vitamin D agonist","target":"residual tumor","id":"4084"},{"source":"Vitamin D agonist","target":"uterine cervical neoplasms","id":"4085"},{"source":"Vitamin D agonist","target":"anticancer","id":"4086"},{"source":"Oncology: Cervical","target":"Immunosuppressant","id":"4087"},{"source":"Oncology: Cervical","target":"Immune checkpoint inhibitor","id":"4088"},{"source":"Oncology: Cervical","target":"Anticancer immunotherapy","id":"4089"},{"source":"Oncology: Cervical","target":"CD19 antagonist","id":"4090"},{"source":"Oncology: Cervical","target":"NA","id":"4091"},{"source":"Oncology: Cervical","target":"Platelet aggregation inhibitor","id":"4092"},{"source":"Oncology: Cervical","target":"UPA","id":"4093"},{"source":"Oncology: Cervical","target":"Thromboxane synthase inhibitor","id":"4094"},{"source":"Oncology: Cervical","target":"NA","id":"4095"},{"source":"Oncology: Cervical","target":"Free radical scavenger","id":"4096"},{"source":"Oncology: Cervical","target":"Reducing agent","id":"4097"},{"source":"Oncology: Cervical","target":"Prostaglandin synthase inhibitor","id":"4098"},{"source":"Oncology: Cervical","target":"H+ K+ transporting ATPase inhibitor","id":"4099"},{"source":"Oncology: Cervical","target":"Vitamin D agonist","id":"4100"},{"source":"Oncology: Endometrial","target":"Immunosuppressant","id":"4101"},{"source":"Oncology: Endometrial","target":"Immune checkpoint inhibitor","id":"4102"},{"source":"Oncology: Endometrial","target":"Anticancer immunotherapy","id":"4103"},{"source":"Oncology: Endometrial","target":"CD19 antagonist","id":"4104"},{"source":"Oncology: Endometrial","target":"NA","id":"4105"},{"source":"Oncology: Endometrial","target":"Platelet aggregation inhibitor","id":"4106"},{"source":"Oncology: Endometrial","target":"UPA","id":"4107"},{"source":"Oncology: Endometrial","target":"Thromboxane synthase inhibitor","id":"4108"},{"source":"Oncology: Endometrial","target":"NA","id":"4109"},{"source":"Oncology: Endometrial","target":"Free radical scavenger","id":"4110"},{"source":"Oncology: Endometrial","target":"Reducing agent","id":"4111"},{"source":"Oncology: Endometrial","target":"Prostaglandin synthase inhibitor","id":"4112"},{"source":"Oncology: Endometrial","target":"H+ K+ transporting ATPase inhibitor","id":"4113"},{"source":"Oncology: Endometrial","target":"Vitamin D agonist","id":"4114"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immunosuppressant","id":"4115"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"4116"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"4117"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"4118"},{"source":"Oncology: Soft Tissue Sarcoma","target":"NA","id":"4119"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Platelet aggregation inhibitor","id":"4120"},{"source":"Oncology: Soft Tissue Sarcoma","target":"UPA","id":"4121"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Thromboxane synthase inhibitor","id":"4122"},{"source":"Oncology: Soft Tissue Sarcoma","target":"NA","id":"4123"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Free radical scavenger","id":"4124"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Reducing agent","id":"4125"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Prostaglandin synthase inhibitor","id":"4126"},{"source":"Oncology: Soft Tissue Sarcoma","target":"H+ K+ transporting ATPase inhibitor","id":"4127"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Vitamin D agonist","id":"4128"},{"source":"NEO-PV-01 (u)","target":"Merck & Co.","id":"4129"},{"source":"NEO-PV-01 (u)","target":"Neon Therapeutics","id":"4130"},{"source":"pembrolizumab","target":"Merck & Co.","id":"4131"},{"source":"pembrolizumab","target":"Neon Therapeutics","id":"4132"},{"source":"carboplatin","target":"Merck & Co.","id":"4133"},{"source":"carboplatin","target":"Neon Therapeutics","id":"4134"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"4135"},{"source":"pemetrexed disodium","target":"Neon Therapeutics","id":"4136"},{"source":"poly-ICLC","target":"Merck & Co.","id":"4137"},{"source":"poly-ICLC","target":"Neon Therapeutics","id":"4138"},{"source":"UNK : Indication","target":"NEO-PV-01 (u)","id":"4139"},{"source":"UNK : Indication","target":"pembrolizumab","id":"4140"},{"source":"UNK : Indication","target":"carboplatin","id":"4141"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"4142"},{"source":"UNK : Indication","target":"poly-ICLC","id":"4143"},{"source":"anticancer","target":"NEO-PV-01 (u)","id":"4144"},{"source":"anticancer","target":"pembrolizumab","id":"4145"},{"source":"anticancer","target":"carboplatin","id":"4146"},{"source":"anticancer","target":"pemetrexed disodium","id":"4147"},{"source":"anticancer","target":"poly-ICLC","id":"4148"},{"source":"antiarthritic","target":"NEO-PV-01 (u)","id":"4149"},{"source":"antiarthritic","target":"pembrolizumab","id":"4150"},{"source":"antiarthritic","target":"carboplatin","id":"4151"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"4152"},{"source":"antiarthritic","target":"poly-ICLC","id":"4153"},{"source":"non-small-cell lung","target":"NEO-PV-01 (u)","id":"4154"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"4155"},{"source":"non-small-cell lung","target":"carboplatin","id":"4156"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"4157"},{"source":"non-small-cell lung","target":"poly-ICLC","id":"4158"},{"source":"psoriasis","target":"NEO-PV-01 (u)","id":"4159"},{"source":"psoriasis","target":"pembrolizumab","id":"4160"},{"source":"psoriasis","target":"carboplatin","id":"4161"},{"source":"psoriasis","target":"pemetrexed disodium","id":"4162"},{"source":"psoriasis","target":"poly-ICLC","id":"4163"},{"source":"hypopigmentation","target":"NEO-PV-01 (u)","id":"4164"},{"source":"hypopigmentation","target":"pembrolizumab","id":"4165"},{"source":"hypopigmentation","target":"carboplatin","id":"4166"},{"source":"hypopigmentation","target":"pemetrexed disodium","id":"4167"},{"source":"hypopigmentation","target":"poly-ICLC","id":"4168"},{"source":"gilbert disease","target":"NEO-PV-01 (u)","id":"4169"},{"source":"gilbert disease","target":"pembrolizumab","id":"4170"},{"source":"gilbert disease","target":"carboplatin","id":"4171"},{"source":"gilbert disease","target":"pemetrexed disodium","id":"4172"},{"source":"gilbert disease","target":"poly-ICLC","id":"4173"},{"source":"liver neoplasms","target":"NEO-PV-01 (u)","id":"4174"},{"source":"liver neoplasms","target":"pembrolizumab","id":"4175"},{"source":"liver neoplasms","target":"carboplatin","id":"4176"},{"source":"liver neoplasms","target":"pemetrexed disodium","id":"4177"},{"source":"liver neoplasms","target":"poly-ICLC","id":"4178"},{"source":"non-small-cell lung","target":"NEO-PV-01 (u)","id":"4179"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"4180"},{"source":"non-small-cell lung","target":"carboplatin","id":"4181"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"4182"},{"source":"non-small-cell lung","target":"poly-ICLC","id":"4183"},{"source":"liver metastases","target":"NEO-PV-01 (u)","id":"4184"},{"source":"liver metastases","target":"pembrolizumab","id":"4185"},{"source":"liver metastases","target":"carboplatin","id":"4186"},{"source":"liver metastases","target":"pemetrexed disodium","id":"4187"},{"source":"liver metastases","target":"poly-ICLC","id":"4188"},{"source":"sclc","target":"NEO-PV-01 (u)","id":"4189"},{"source":"sclc","target":"pembrolizumab","id":"4190"},{"source":"sclc","target":"carboplatin","id":"4191"},{"source":"sclc","target":"pemetrexed disodium","id":"4192"},{"source":"sclc","target":"poly-ICLC","id":"4193"},{"source":"multiple sclerosis","target":"NEO-PV-01 (u)","id":"4194"},{"source":"multiple sclerosis","target":"pembrolizumab","id":"4195"},{"source":"multiple sclerosis","target":"carboplatin","id":"4196"},{"source":"multiple sclerosis","target":"pemetrexed disodium","id":"4197"},{"source":"multiple sclerosis","target":"poly-ICLC","id":"4198"},{"source":"psoriasis","target":"NEO-PV-01 (u)","id":"4199"},{"source":"psoriasis","target":"pembrolizumab","id":"4200"},{"source":"psoriasis","target":"carboplatin","id":"4201"},{"source":"psoriasis","target":"pemetrexed disodium","id":"4202"},{"source":"psoriasis","target":"poly-ICLC","id":"4203"},{"source":"alopecia","target":"NEO-PV-01 (u)","id":"4204"},{"source":"alopecia","target":"pembrolizumab","id":"4205"},{"source":"alopecia","target":"carboplatin","id":"4206"},{"source":"alopecia","target":"pemetrexed disodium","id":"4207"},{"source":"alopecia","target":"poly-ICLC","id":"4208"},{"source":"arthritis","target":"NEO-PV-01 (u)","id":"4209"},{"source":"arthritis","target":"pembrolizumab","id":"4210"},{"source":"arthritis","target":"carboplatin","id":"4211"},{"source":"arthritis","target":"pemetrexed disodium","id":"4212"},{"source":"arthritis","target":"poly-ICLC","id":"4213"},{"source":"vitiligo","target":"NEO-PV-01 (u)","id":"4214"},{"source":"vitiligo","target":"pembrolizumab","id":"4215"},{"source":"vitiligo","target":"carboplatin","id":"4216"},{"source":"vitiligo","target":"pemetrexed disodium","id":"4217"},{"source":"vitiligo","target":"poly-ICLC","id":"4218"},{"source":"carcinoma","target":"NEO-PV-01 (u)","id":"4219"},{"source":"carcinoma","target":"pembrolizumab","id":"4220"},{"source":"carcinoma","target":"carboplatin","id":"4221"},{"source":"carcinoma","target":"pemetrexed disodium","id":"4222"},{"source":"carcinoma","target":"poly-ICLC","id":"4223"},{"source":"metastatic","target":"NEO-PV-01 (u)","id":"4224"},{"source":"metastatic","target":"pembrolizumab","id":"4225"},{"source":"metastatic","target":"carboplatin","id":"4226"},{"source":"metastatic","target":"pemetrexed disodium","id":"4227"},{"source":"metastatic","target":"poly-ICLC","id":"4228"},{"source":"carcinoma","target":"NEO-PV-01 (u)","id":"4229"},{"source":"carcinoma","target":"pembrolizumab","id":"4230"},{"source":"carcinoma","target":"carboplatin","id":"4231"},{"source":"carcinoma","target":"pemetrexed disodium","id":"4232"},{"source":"carcinoma","target":"poly-ICLC","id":"4233"},{"source":"gilbert syndrome","target":"NEO-PV-01 (u)","id":"4234"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"4235"},{"source":"gilbert syndrome","target":"carboplatin","id":"4236"},{"source":"gilbert syndrome","target":"pemetrexed disodium","id":"4237"},{"source":"gilbert syndrome","target":"poly-ICLC","id":"4238"},{"source":"neoplasm metastasis","target":"NEO-PV-01 (u)","id":"4239"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"4240"},{"source":"neoplasm metastasis","target":"carboplatin","id":"4241"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"4242"},{"source":"neoplasm metastasis","target":"poly-ICLC","id":"4243"},{"source":"lung neoplasms","target":"NEO-PV-01 (u)","id":"4244"},{"source":"lung neoplasms","target":"pembrolizumab","id":"4245"},{"source":"lung neoplasms","target":"carboplatin","id":"4246"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"4247"},{"source":"lung neoplasms","target":"poly-ICLC","id":"4248"},{"source":"residual tumor","target":"NEO-PV-01 (u)","id":"4249"},{"source":"residual tumor","target":"pembrolizumab","id":"4250"},{"source":"residual tumor","target":"carboplatin","id":"4251"},{"source":"residual tumor","target":"pemetrexed disodium","id":"4252"},{"source":"residual tumor","target":"poly-ICLC","id":"4253"},{"source":"anticancer","target":"NEO-PV-01 (u)","id":"4254"},{"source":"anticancer","target":"pembrolizumab","id":"4255"},{"source":"anticancer","target":"carboplatin","id":"4256"},{"source":"anticancer","target":"pemetrexed disodium","id":"4257"},{"source":"anticancer","target":"poly-ICLC","id":"4258"},{"source":"lung cancer","target":"NEO-PV-01 (u)","id":"4259"},{"source":"lung cancer","target":"pembrolizumab","id":"4260"},{"source":"lung cancer","target":"carboplatin","id":"4261"},{"source":"lung cancer","target":"pemetrexed disodium","id":"4262"},{"source":"lung cancer","target":"poly-ICLC","id":"4263"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"4264"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"4265"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"4266"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"4267"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"4268"},{"source":"Dihydrofolate reductase inhibitor","target":"hypopigmentation","id":"4269"},{"source":"Dihydrofolate reductase inhibitor","target":"gilbert disease","id":"4270"},{"source":"Dihydrofolate reductase inhibitor","target":"liver neoplasms","id":"4271"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"4272"},{"source":"Dihydrofolate reductase inhibitor","target":"liver metastases","id":"4273"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"4274"},{"source":"Dihydrofolate reductase inhibitor","target":"multiple sclerosis","id":"4275"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"4276"},{"source":"Dihydrofolate reductase inhibitor","target":"alopecia","id":"4277"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"4278"},{"source":"Dihydrofolate reductase inhibitor","target":"vitiligo","id":"4279"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"4280"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"4281"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"4282"},{"source":"Dihydrofolate reductase inhibitor","target":"gilbert syndrome","id":"4283"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"4284"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"4285"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"4286"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"4287"},{"source":"Dihydrofolate reductase inhibitor","target":"lung cancer","id":"4288"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"4289"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"4290"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"4291"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"4292"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"4293"},{"source":"Immune checkpoint inhibitor","target":"hypopigmentation","id":"4294"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"4295"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"4296"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"4297"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"4298"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"4299"},{"source":"Immune checkpoint inhibitor","target":"multiple sclerosis","id":"4300"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"4301"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"4302"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"4303"},{"source":"Immune checkpoint inhibitor","target":"vitiligo","id":"4304"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"4305"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"4306"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"4307"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"4308"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"4309"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"4310"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"4311"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"4312"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"4313"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"4314"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"4315"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"4316"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"4317"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"4318"},{"source":"Anticancer immunotherapy","target":"hypopigmentation","id":"4319"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"4320"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"4321"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"4322"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"4323"},{"source":"Anticancer immunotherapy","target":"sclc","id":"4324"},{"source":"Anticancer immunotherapy","target":"multiple sclerosis","id":"4325"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"4326"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"4327"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"4328"},{"source":"Anticancer immunotherapy","target":"vitiligo","id":"4329"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"4330"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"4331"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"4332"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"4333"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"4334"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"4335"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"4336"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"4337"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"4338"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"4339"},{"source":"CD19 antagonist","target":"anticancer","id":"4340"},{"source":"CD19 antagonist","target":"antiarthritic","id":"4341"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"4342"},{"source":"CD19 antagonist","target":"psoriasis","id":"4343"},{"source":"CD19 antagonist","target":"hypopigmentation","id":"4344"},{"source":"CD19 antagonist","target":"gilbert disease","id":"4345"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"4346"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"4347"},{"source":"CD19 antagonist","target":"liver metastases","id":"4348"},{"source":"CD19 antagonist","target":"sclc","id":"4349"},{"source":"CD19 antagonist","target":"multiple sclerosis","id":"4350"},{"source":"CD19 antagonist","target":"psoriasis","id":"4351"},{"source":"CD19 antagonist","target":"alopecia","id":"4352"},{"source":"CD19 antagonist","target":"arthritis","id":"4353"},{"source":"CD19 antagonist","target":"vitiligo","id":"4354"},{"source":"CD19 antagonist","target":"carcinoma","id":"4355"},{"source":"CD19 antagonist","target":"metastatic","id":"4356"},{"source":"CD19 antagonist","target":"carcinoma","id":"4357"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"4358"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"4359"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"4360"},{"source":"CD19 antagonist","target":"residual tumor","id":"4361"},{"source":"CD19 antagonist","target":"anticancer","id":"4362"},{"source":"CD19 antagonist","target":"lung cancer","id":"4363"},{"source":"NA","target":"UNK : Indication","id":"4364"},{"source":"NA","target":"anticancer","id":"4365"},{"source":"NA","target":"antiarthritic","id":"4366"},{"source":"NA","target":"non-small-cell lung","id":"4367"},{"source":"NA","target":"psoriasis","id":"4368"},{"source":"NA","target":"hypopigmentation","id":"4369"},{"source":"NA","target":"gilbert disease","id":"4370"},{"source":"NA","target":"liver neoplasms","id":"4371"},{"source":"NA","target":"non-small-cell lung","id":"4372"},{"source":"NA","target":"liver metastases","id":"4373"},{"source":"NA","target":"sclc","id":"4374"},{"source":"NA","target":"multiple sclerosis","id":"4375"},{"source":"NA","target":"psoriasis","id":"4376"},{"source":"NA","target":"alopecia","id":"4377"},{"source":"NA","target":"arthritis","id":"4378"},{"source":"NA","target":"vitiligo","id":"4379"},{"source":"NA","target":"carcinoma","id":"4380"},{"source":"NA","target":"metastatic","id":"4381"},{"source":"NA","target":"carcinoma","id":"4382"},{"source":"NA","target":"gilbert syndrome","id":"4383"},{"source":"NA","target":"neoplasm metastasis","id":"4384"},{"source":"NA","target":"lung neoplasms","id":"4385"},{"source":"NA","target":"residual tumor","id":"4386"},{"source":"NA","target":"anticancer","id":"4387"},{"source":"NA","target":"lung cancer","id":"4388"},{"source":"Immunostimulant","target":"UNK : Indication","id":"4389"},{"source":"Immunostimulant","target":"anticancer","id":"4390"},{"source":"Immunostimulant","target":"antiarthritic","id":"4391"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"4392"},{"source":"Immunostimulant","target":"psoriasis","id":"4393"},{"source":"Immunostimulant","target":"hypopigmentation","id":"4394"},{"source":"Immunostimulant","target":"gilbert disease","id":"4395"},{"source":"Immunostimulant","target":"liver neoplasms","id":"4396"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"4397"},{"source":"Immunostimulant","target":"liver metastases","id":"4398"},{"source":"Immunostimulant","target":"sclc","id":"4399"},{"source":"Immunostimulant","target":"multiple sclerosis","id":"4400"},{"source":"Immunostimulant","target":"psoriasis","id":"4401"},{"source":"Immunostimulant","target":"alopecia","id":"4402"},{"source":"Immunostimulant","target":"arthritis","id":"4403"},{"source":"Immunostimulant","target":"vitiligo","id":"4404"},{"source":"Immunostimulant","target":"carcinoma","id":"4405"},{"source":"Immunostimulant","target":"metastatic","id":"4406"},{"source":"Immunostimulant","target":"carcinoma","id":"4407"},{"source":"Immunostimulant","target":"gilbert syndrome","id":"4408"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"4409"},{"source":"Immunostimulant","target":"lung neoplasms","id":"4410"},{"source":"Immunostimulant","target":"residual tumor","id":"4411"},{"source":"Immunostimulant","target":"anticancer","id":"4412"},{"source":"Immunostimulant","target":"lung cancer","id":"4413"},{"source":"NA","target":"UNK : Indication","id":"4414"},{"source":"NA","target":"anticancer","id":"4415"},{"source":"NA","target":"antiarthritic","id":"4416"},{"source":"NA","target":"non-small-cell lung","id":"4417"},{"source":"NA","target":"psoriasis","id":"4418"},{"source":"NA","target":"hypopigmentation","id":"4419"},{"source":"NA","target":"gilbert disease","id":"4420"},{"source":"NA","target":"liver neoplasms","id":"4421"},{"source":"NA","target":"non-small-cell lung","id":"4422"},{"source":"NA","target":"liver metastases","id":"4423"},{"source":"NA","target":"sclc","id":"4424"},{"source":"NA","target":"multiple sclerosis","id":"4425"},{"source":"NA","target":"psoriasis","id":"4426"},{"source":"NA","target":"alopecia","id":"4427"},{"source":"NA","target":"arthritis","id":"4428"},{"source":"NA","target":"vitiligo","id":"4429"},{"source":"NA","target":"carcinoma","id":"4430"},{"source":"NA","target":"metastatic","id":"4431"},{"source":"NA","target":"carcinoma","id":"4432"},{"source":"NA","target":"gilbert syndrome","id":"4433"},{"source":"NA","target":"neoplasm metastasis","id":"4434"},{"source":"NA","target":"lung neoplasms","id":"4435"},{"source":"NA","target":"residual tumor","id":"4436"},{"source":"NA","target":"anticancer","id":"4437"},{"source":"NA","target":"lung cancer","id":"4438"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"4439"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"4440"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"4441"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"4442"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"4443"},{"source":"Thymidylate synthase inhibitor","target":"hypopigmentation","id":"4444"},{"source":"Thymidylate synthase inhibitor","target":"gilbert disease","id":"4445"},{"source":"Thymidylate synthase inhibitor","target":"liver neoplasms","id":"4446"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"4447"},{"source":"Thymidylate synthase inhibitor","target":"liver metastases","id":"4448"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"4449"},{"source":"Thymidylate synthase inhibitor","target":"multiple sclerosis","id":"4450"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"4451"},{"source":"Thymidylate synthase inhibitor","target":"alopecia","id":"4452"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"4453"},{"source":"Thymidylate synthase inhibitor","target":"vitiligo","id":"4454"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"4455"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"4456"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"4457"},{"source":"Thymidylate synthase inhibitor","target":"gilbert syndrome","id":"4458"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"4459"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"4460"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"4461"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"4462"},{"source":"Thymidylate synthase inhibitor","target":"lung cancer","id":"4463"},{"source":"NA","target":"UNK : Indication","id":"4464"},{"source":"NA","target":"anticancer","id":"4465"},{"source":"NA","target":"antiarthritic","id":"4466"},{"source":"NA","target":"non-small-cell lung","id":"4467"},{"source":"NA","target":"psoriasis","id":"4468"},{"source":"NA","target":"hypopigmentation","id":"4469"},{"source":"NA","target":"gilbert disease","id":"4470"},{"source":"NA","target":"liver neoplasms","id":"4471"},{"source":"NA","target":"non-small-cell lung","id":"4472"},{"source":"NA","target":"liver metastases","id":"4473"},{"source":"NA","target":"sclc","id":"4474"},{"source":"NA","target":"multiple sclerosis","id":"4475"},{"source":"NA","target":"psoriasis","id":"4476"},{"source":"NA","target":"alopecia","id":"4477"},{"source":"NA","target":"arthritis","id":"4478"},{"source":"NA","target":"vitiligo","id":"4479"},{"source":"NA","target":"carcinoma","id":"4480"},{"source":"NA","target":"metastatic","id":"4481"},{"source":"NA","target":"carcinoma","id":"4482"},{"source":"NA","target":"gilbert syndrome","id":"4483"},{"source":"NA","target":"neoplasm metastasis","id":"4484"},{"source":"NA","target":"lung neoplasms","id":"4485"},{"source":"NA","target":"residual tumor","id":"4486"},{"source":"NA","target":"anticancer","id":"4487"},{"source":"NA","target":"lung cancer","id":"4488"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"4489"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"4490"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"4491"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"4492"},{"source":"Oncology: Lung","target":"NA","id":"4493"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"4494"},{"source":"Oncology: Lung","target":"NA","id":"4495"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"4496"},{"source":"Oncology: Lung","target":"NA","id":"4497"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"4498"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"4499"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"4500"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"4501"},{"source":"Non-Small Cell","target":"NA","id":"4502"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"4503"},{"source":"Non-Small Cell","target":"NA","id":"4504"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"4505"},{"source":"Non-Small Cell","target":"NA","id":"4506"},{"source":"olaratumab (a)","target":"Eli Lilly","id":"4507"},{"source":"olaratumab (a)","target":"Merck & Co.","id":"4508"},{"source":"pembrolizumab","target":"Eli Lilly","id":"4509"},{"source":"pembrolizumab","target":"Merck & Co.","id":"4510"},{"source":"UNK : Drug","target":"Eli Lilly","id":"4511"},{"source":"UNK : Drug","target":"Merck & Co.","id":"4512"},{"source":"sarcoma","target":"olaratumab (a)","id":"4513"},{"source":"sarcoma","target":"pembrolizumab","id":"4514"},{"source":"sarcoma","target":"UNK : Drug","id":"4515"},{"source":"solid tumors","target":"olaratumab (a)","id":"4516"},{"source":"solid tumors","target":"pembrolizumab","id":"4517"},{"source":"solid tumors","target":"UNK : Drug","id":"4518"},{"source":"glioblastoma","target":"olaratumab (a)","id":"4519"},{"source":"glioblastoma","target":"pembrolizumab","id":"4520"},{"source":"glioblastoma","target":"UNK : Drug","id":"4521"},{"source":"skin neoplasms","target":"olaratumab (a)","id":"4522"},{"source":"skin neoplasms","target":"pembrolizumab","id":"4523"},{"source":"skin neoplasms","target":"UNK : Drug","id":"4524"},{"source":"residual tumor","target":"olaratumab (a)","id":"4525"},{"source":"residual tumor","target":"pembrolizumab","id":"4526"},{"source":"residual tumor","target":"UNK : Drug","id":"4527"},{"source":"metastatic","target":"olaratumab (a)","id":"4528"},{"source":"metastatic","target":"pembrolizumab","id":"4529"},{"source":"metastatic","target":"UNK : Drug","id":"4530"},{"source":"carcinoma","target":"olaratumab (a)","id":"4531"},{"source":"carcinoma","target":"pembrolizumab","id":"4532"},{"source":"carcinoma","target":"UNK : Drug","id":"4533"},{"source":"lipomatous","target":"olaratumab (a)","id":"4534"},{"source":"lipomatous","target":"pembrolizumab","id":"4535"},{"source":"lipomatous","target":"UNK : Drug","id":"4536"},{"source":"soft tissue neoplasms","target":"olaratumab (a)","id":"4537"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"4538"},{"source":"soft tissue neoplasms","target":"UNK : Drug","id":"4539"},{"source":"sarcoma","target":"olaratumab (a)","id":"4540"},{"source":"sarcoma","target":"pembrolizumab","id":"4541"},{"source":"sarcoma","target":"UNK : Drug","id":"4542"},{"source":"neoplasm metastasis","target":"olaratumab (a)","id":"4543"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"4544"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"4545"},{"source":"sarcoma","target":"olaratumab (a)","id":"4546"},{"source":"sarcoma","target":"pembrolizumab","id":"4547"},{"source":"sarcoma","target":"UNK : Drug","id":"4548"},{"source":"anticancer","target":"olaratumab (a)","id":"4549"},{"source":"anticancer","target":"pembrolizumab","id":"4550"},{"source":"anticancer","target":"UNK : Drug","id":"4551"},{"source":"lipomatous","target":"olaratumab (a)","id":"4552"},{"source":"lipomatous","target":"pembrolizumab","id":"4553"},{"source":"lipomatous","target":"UNK : Drug","id":"4554"},{"source":"solid tumors","target":"olaratumab (a)","id":"4555"},{"source":"solid tumors","target":"pembrolizumab","id":"4556"},{"source":"solid tumors","target":"UNK : Drug","id":"4557"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"4558"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"4559"},{"source":"Anticancer immunotherapy","target":"glioblastoma","id":"4560"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"4561"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"4562"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"4563"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"4564"},{"source":"Anticancer immunotherapy","target":"lipomatous","id":"4565"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"4566"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"4567"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"4568"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"4569"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"4570"},{"source":"Anticancer immunotherapy","target":"lipomatous","id":"4571"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"4572"},{"source":"CD19 antagonist","target":"sarcoma","id":"4573"},{"source":"CD19 antagonist","target":"solid tumors","id":"4574"},{"source":"CD19 antagonist","target":"glioblastoma","id":"4575"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"4576"},{"source":"CD19 antagonist","target":"residual tumor","id":"4577"},{"source":"CD19 antagonist","target":"metastatic","id":"4578"},{"source":"CD19 antagonist","target":"carcinoma","id":"4579"},{"source":"CD19 antagonist","target":"lipomatous","id":"4580"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"4581"},{"source":"CD19 antagonist","target":"sarcoma","id":"4582"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"4583"},{"source":"CD19 antagonist","target":"sarcoma","id":"4584"},{"source":"CD19 antagonist","target":"anticancer","id":"4585"},{"source":"CD19 antagonist","target":"lipomatous","id":"4586"},{"source":"CD19 antagonist","target":"solid tumors","id":"4587"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"sarcoma","id":"4588"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"solid tumors","id":"4589"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"glioblastoma","id":"4590"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"skin neoplasms","id":"4591"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"residual tumor","id":"4592"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"metastatic","id":"4593"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"carcinoma","id":"4594"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"lipomatous","id":"4595"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"soft tissue neoplasms","id":"4596"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"sarcoma","id":"4597"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"neoplasm metastasis","id":"4598"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"sarcoma","id":"4599"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"anticancer","id":"4600"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"lipomatous","id":"4601"},{"source":"Platelet-derived growth factor (PDGF) receptor antagonist","target":"solid tumors","id":"4602"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"4603"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"4604"},{"source":"Immune checkpoint inhibitor","target":"glioblastoma","id":"4605"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"4606"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"4607"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"4608"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"4609"},{"source":"Immune checkpoint inhibitor","target":"lipomatous","id":"4610"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"4611"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"4612"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"4613"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"4614"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"4615"},{"source":"Immune checkpoint inhibitor","target":"lipomatous","id":"4616"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"4617"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"4618"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"4619"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Platelet-derived growth factor (PDGF) receptor antagonist","id":"4620"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"4621"},{"source":"pembrolizumab","target":"MD Anderson Cancer Center","id":"4622"},{"source":"pembrolizumab","target":"University of Texas","id":"4623"},{"source":"pembrolizumab","target":"Merck & Co.","id":"4624"},{"source":"gemcitabine hydrochloride","target":"MD Anderson Cancer Center","id":"4625"},{"source":"gemcitabine hydrochloride","target":"University of Texas","id":"4626"},{"source":"gemcitabine hydrochloride","target":"Merck & Co.","id":"4627"},{"source":"nab-paclitaxel (IV)","target":"MD Anderson Cancer Center","id":"4628"},{"source":"nab-paclitaxel (IV)","target":"University of Texas","id":"4629"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"4630"},{"source":"paricalcitol","target":"MD Anderson Cancer Center","id":"4631"},{"source":"paricalcitol","target":"University of Texas","id":"4632"},{"source":"paricalcitol","target":"Merck & Co.","id":"4633"},{"source":"injectable","target":"MD Anderson Cancer Center","id":"4634"},{"source":"injectable","target":"University of Texas","id":"4635"},{"source":"injectable","target":"Merck & Co.","id":"4636"},{"source":"AbbVie","target":"MD Anderson Cancer Center","id":"4637"},{"source":"AbbVie","target":"University of Texas","id":"4638"},{"source":"AbbVie","target":"Merck & Co.","id":"4639"},{"source":"surgical intervention","target":"MD Anderson Cancer Center","id":"4640"},{"source":"surgical intervention","target":"University of Texas","id":"4641"},{"source":"surgical intervention","target":"Merck & Co.","id":"4642"},{"source":"UNK : Indication","target":"pembrolizumab","id":"4643"},{"source":"UNK : Indication","target":"gemcitabine hydrochloride","id":"4644"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"4645"},{"source":"UNK : Indication","target":"paricalcitol","id":"4646"},{"source":"UNK : Indication","target":"injectable","id":"4647"},{"source":"UNK : Indication","target":"AbbVie","id":"4648"},{"source":"UNK : Indication","target":"surgical intervention","id":"4649"},{"source":"liver metastases","target":"pembrolizumab","id":"4650"},{"source":"liver metastases","target":"gemcitabine hydrochloride","id":"4651"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"4652"},{"source":"liver metastases","target":"paricalcitol","id":"4653"},{"source":"liver metastases","target":"injectable","id":"4654"},{"source":"liver metastases","target":"AbbVie","id":"4655"},{"source":"liver metastases","target":"surgical intervention","id":"4656"},{"source":"anticancer","target":"pembrolizumab","id":"4657"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"4658"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"4659"},{"source":"anticancer","target":"paricalcitol","id":"4660"},{"source":"anticancer","target":"injectable","id":"4661"},{"source":"anticancer","target":"AbbVie","id":"4662"},{"source":"anticancer","target":"surgical intervention","id":"4663"},{"source":"heart failure","target":"pembrolizumab","id":"4664"},{"source":"heart failure","target":"gemcitabine hydrochloride","id":"4665"},{"source":"heart failure","target":"nab-paclitaxel (IV)","id":"4666"},{"source":"heart failure","target":"paricalcitol","id":"4667"},{"source":"heart failure","target":"injectable","id":"4668"},{"source":"heart failure","target":"AbbVie","id":"4669"},{"source":"heart failure","target":"surgical intervention","id":"4670"},{"source":"heart failure","target":"pembrolizumab","id":"4671"},{"source":"heart failure","target":"gemcitabine hydrochloride","id":"4672"},{"source":"heart failure","target":"nab-paclitaxel (IV)","id":"4673"},{"source":"heart failure","target":"paricalcitol","id":"4674"},{"source":"heart failure","target":"injectable","id":"4675"},{"source":"heart failure","target":"AbbVie","id":"4676"},{"source":"heart failure","target":"surgical intervention","id":"4677"},{"source":"carcinoma","target":"pembrolizumab","id":"4678"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"4679"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"4680"},{"source":"carcinoma","target":"paricalcitol","id":"4681"},{"source":"carcinoma","target":"injectable","id":"4682"},{"source":"carcinoma","target":"AbbVie","id":"4683"},{"source":"carcinoma","target":"surgical intervention","id":"4684"},{"source":"carcinoma","target":"pembrolizumab","id":"4685"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"4686"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"4687"},{"source":"carcinoma","target":"paricalcitol","id":"4688"},{"source":"carcinoma","target":"injectable","id":"4689"},{"source":"carcinoma","target":"AbbVie","id":"4690"},{"source":"carcinoma","target":"surgical intervention","id":"4691"},{"source":"carcinoma","target":"pembrolizumab","id":"4692"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"4693"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"4694"},{"source":"carcinoma","target":"paricalcitol","id":"4695"},{"source":"carcinoma","target":"injectable","id":"4696"},{"source":"carcinoma","target":"AbbVie","id":"4697"},{"source":"carcinoma","target":"surgical intervention","id":"4698"},{"source":"unstable angina","target":"pembrolizumab","id":"4699"},{"source":"unstable angina","target":"gemcitabine hydrochloride","id":"4700"},{"source":"unstable angina","target":"nab-paclitaxel (IV)","id":"4701"},{"source":"unstable angina","target":"paricalcitol","id":"4702"},{"source":"unstable angina","target":"injectable","id":"4703"},{"source":"unstable angina","target":"AbbVie","id":"4704"},{"source":"unstable angina","target":"surgical intervention","id":"4705"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"4706"},{"source":"pancreatic cancer","target":"gemcitabine hydrochloride","id":"4707"},{"source":"pancreatic cancer","target":"nab-paclitaxel (IV)","id":"4708"},{"source":"pancreatic cancer","target":"paricalcitol","id":"4709"},{"source":"pancreatic cancer","target":"injectable","id":"4710"},{"source":"pancreatic cancer","target":"AbbVie","id":"4711"},{"source":"pancreatic cancer","target":"surgical intervention","id":"4712"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"4713"},{"source":"neoplasm metastasis","target":"gemcitabine hydrochloride","id":"4714"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"4715"},{"source":"neoplasm metastasis","target":"paricalcitol","id":"4716"},{"source":"neoplasm metastasis","target":"injectable","id":"4717"},{"source":"neoplasm metastasis","target":"AbbVie","id":"4718"},{"source":"neoplasm metastasis","target":"surgical intervention","id":"4719"},{"source":"myocardial infarction","target":"pembrolizumab","id":"4720"},{"source":"myocardial infarction","target":"gemcitabine hydrochloride","id":"4721"},{"source":"myocardial infarction","target":"nab-paclitaxel (IV)","id":"4722"},{"source":"myocardial infarction","target":"paricalcitol","id":"4723"},{"source":"myocardial infarction","target":"injectable","id":"4724"},{"source":"myocardial infarction","target":"AbbVie","id":"4725"},{"source":"myocardial infarction","target":"surgical intervention","id":"4726"},{"source":"anticancer","target":"pembrolizumab","id":"4727"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"4728"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"4729"},{"source":"anticancer","target":"paricalcitol","id":"4730"},{"source":"anticancer","target":"injectable","id":"4731"},{"source":"anticancer","target":"AbbVie","id":"4732"},{"source":"anticancer","target":"surgical intervention","id":"4733"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"4734"},{"source":"pancreatic neoplasms","target":"gemcitabine hydrochloride","id":"4735"},{"source":"pancreatic neoplasms","target":"nab-paclitaxel (IV)","id":"4736"},{"source":"pancreatic neoplasms","target":"paricalcitol","id":"4737"},{"source":"pancreatic neoplasms","target":"injectable","id":"4738"},{"source":"pancreatic neoplasms","target":"AbbVie","id":"4739"},{"source":"pancreatic neoplasms","target":"surgical intervention","id":"4740"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"4741"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"4742"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"4743"},{"source":"Immune checkpoint inhibitor","target":"heart failure","id":"4744"},{"source":"Immune checkpoint inhibitor","target":"heart failure","id":"4745"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"4746"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"4747"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"4748"},{"source":"Immune checkpoint inhibitor","target":"unstable angina","id":"4749"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"4750"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"4751"},{"source":"Immune checkpoint inhibitor","target":"myocardial infarction","id":"4752"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"4753"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"4754"},{"source":"NA","target":"UNK : Indication","id":"4755"},{"source":"NA","target":"liver metastases","id":"4756"},{"source":"NA","target":"anticancer","id":"4757"},{"source":"NA","target":"heart failure","id":"4758"},{"source":"NA","target":"heart failure","id":"4759"},{"source":"NA","target":"carcinoma","id":"4760"},{"source":"NA","target":"carcinoma","id":"4761"},{"source":"NA","target":"carcinoma","id":"4762"},{"source":"NA","target":"unstable angina","id":"4763"},{"source":"NA","target":"pancreatic cancer","id":"4764"},{"source":"NA","target":"neoplasm metastasis","id":"4765"},{"source":"NA","target":"myocardial infarction","id":"4766"},{"source":"NA","target":"anticancer","id":"4767"},{"source":"NA","target":"pancreatic neoplasms","id":"4768"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"4769"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"4770"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"4771"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"4772"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"4773"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"4774"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"4775"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"4776"},{"source":"Anticancer immunotherapy","target":"unstable angina","id":"4777"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"4778"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"4779"},{"source":"Anticancer immunotherapy","target":"myocardial infarction","id":"4780"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"4781"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"4782"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"4783"},{"source":"CD19 antagonist","target":"liver metastases","id":"4784"},{"source":"CD19 antagonist","target":"anticancer","id":"4785"},{"source":"CD19 antagonist","target":"heart failure","id":"4786"},{"source":"CD19 antagonist","target":"heart failure","id":"4787"},{"source":"CD19 antagonist","target":"carcinoma","id":"4788"},{"source":"CD19 antagonist","target":"carcinoma","id":"4789"},{"source":"CD19 antagonist","target":"carcinoma","id":"4790"},{"source":"CD19 antagonist","target":"unstable angina","id":"4791"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"4792"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"4793"},{"source":"CD19 antagonist","target":"myocardial infarction","id":"4794"},{"source":"CD19 antagonist","target":"anticancer","id":"4795"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"4796"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"4797"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"4798"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"4799"},{"source":"Beta tubulin antagonist","target":"heart failure","id":"4800"},{"source":"Beta tubulin antagonist","target":"heart failure","id":"4801"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"4802"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"4803"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"4804"},{"source":"Beta tubulin antagonist","target":"unstable angina","id":"4805"},{"source":"Beta tubulin antagonist","target":"pancreatic cancer","id":"4806"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"4807"},{"source":"Beta tubulin antagonist","target":"myocardial infarction","id":"4808"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"4809"},{"source":"Beta tubulin antagonist","target":"pancreatic neoplasms","id":"4810"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"4811"},{"source":"Microtubule stimulant","target":"liver metastases","id":"4812"},{"source":"Microtubule stimulant","target":"anticancer","id":"4813"},{"source":"Microtubule stimulant","target":"heart failure","id":"4814"},{"source":"Microtubule stimulant","target":"heart failure","id":"4815"},{"source":"Microtubule stimulant","target":"carcinoma","id":"4816"},{"source":"Microtubule stimulant","target":"carcinoma","id":"4817"},{"source":"Microtubule stimulant","target":"carcinoma","id":"4818"},{"source":"Microtubule stimulant","target":"unstable angina","id":"4819"},{"source":"Microtubule stimulant","target":"pancreatic cancer","id":"4820"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"4821"},{"source":"Microtubule stimulant","target":"myocardial infarction","id":"4822"},{"source":"Microtubule stimulant","target":"anticancer","id":"4823"},{"source":"Microtubule stimulant","target":"pancreatic neoplasms","id":"4824"},{"source":"NA","target":"UNK : Indication","id":"4825"},{"source":"NA","target":"liver metastases","id":"4826"},{"source":"NA","target":"anticancer","id":"4827"},{"source":"NA","target":"heart failure","id":"4828"},{"source":"NA","target":"heart failure","id":"4829"},{"source":"NA","target":"carcinoma","id":"4830"},{"source":"NA","target":"carcinoma","id":"4831"},{"source":"NA","target":"carcinoma","id":"4832"},{"source":"NA","target":"unstable angina","id":"4833"},{"source":"NA","target":"pancreatic cancer","id":"4834"},{"source":"NA","target":"neoplasm metastasis","id":"4835"},{"source":"NA","target":"myocardial infarction","id":"4836"},{"source":"NA","target":"anticancer","id":"4837"},{"source":"NA","target":"pancreatic neoplasms","id":"4838"},{"source":"NA","target":"UNK : Indication","id":"4839"},{"source":"NA","target":"liver metastases","id":"4840"},{"source":"NA","target":"anticancer","id":"4841"},{"source":"NA","target":"heart failure","id":"4842"},{"source":"NA","target":"heart failure","id":"4843"},{"source":"NA","target":"carcinoma","id":"4844"},{"source":"NA","target":"carcinoma","id":"4845"},{"source":"NA","target":"carcinoma","id":"4846"},{"source":"NA","target":"unstable angina","id":"4847"},{"source":"NA","target":"pancreatic cancer","id":"4848"},{"source":"NA","target":"neoplasm metastasis","id":"4849"},{"source":"NA","target":"myocardial infarction","id":"4850"},{"source":"NA","target":"anticancer","id":"4851"},{"source":"NA","target":"pancreatic neoplasms","id":"4852"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"4853"},{"source":"Cell cycle inhibitor","target":"liver metastases","id":"4854"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"4855"},{"source":"Cell cycle inhibitor","target":"heart failure","id":"4856"},{"source":"Cell cycle inhibitor","target":"heart failure","id":"4857"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"4858"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"4859"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"4860"},{"source":"Cell cycle inhibitor","target":"unstable angina","id":"4861"},{"source":"Cell cycle inhibitor","target":"pancreatic cancer","id":"4862"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"4863"},{"source":"Cell cycle inhibitor","target":"myocardial infarction","id":"4864"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"4865"},{"source":"Cell cycle inhibitor","target":"pancreatic neoplasms","id":"4866"},{"source":"Taxane","target":"UNK : Indication","id":"4867"},{"source":"Taxane","target":"liver metastases","id":"4868"},{"source":"Taxane","target":"anticancer","id":"4869"},{"source":"Taxane","target":"heart failure","id":"4870"},{"source":"Taxane","target":"heart failure","id":"4871"},{"source":"Taxane","target":"carcinoma","id":"4872"},{"source":"Taxane","target":"carcinoma","id":"4873"},{"source":"Taxane","target":"carcinoma","id":"4874"},{"source":"Taxane","target":"unstable angina","id":"4875"},{"source":"Taxane","target":"pancreatic cancer","id":"4876"},{"source":"Taxane","target":"neoplasm metastasis","id":"4877"},{"source":"Taxane","target":"myocardial infarction","id":"4878"},{"source":"Taxane","target":"anticancer","id":"4879"},{"source":"Taxane","target":"pancreatic neoplasms","id":"4880"},{"source":"Vitamin D agonist","target":"UNK : Indication","id":"4881"},{"source":"Vitamin D agonist","target":"liver metastases","id":"4882"},{"source":"Vitamin D agonist","target":"anticancer","id":"4883"},{"source":"Vitamin D agonist","target":"heart failure","id":"4884"},{"source":"Vitamin D agonist","target":"heart failure","id":"4885"},{"source":"Vitamin D agonist","target":"carcinoma","id":"4886"},{"source":"Vitamin D agonist","target":"carcinoma","id":"4887"},{"source":"Vitamin D agonist","target":"carcinoma","id":"4888"},{"source":"Vitamin D agonist","target":"unstable angina","id":"4889"},{"source":"Vitamin D agonist","target":"pancreatic cancer","id":"4890"},{"source":"Vitamin D agonist","target":"neoplasm metastasis","id":"4891"},{"source":"Vitamin D agonist","target":"myocardial infarction","id":"4892"},{"source":"Vitamin D agonist","target":"anticancer","id":"4893"},{"source":"Vitamin D agonist","target":"pancreatic neoplasms","id":"4894"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"4895"},{"source":"Oncology: Pancreas","target":"NA","id":"4896"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"4897"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"4898"},{"source":"Oncology: Pancreas","target":"Beta tubulin antagonist","id":"4899"},{"source":"Oncology: Pancreas","target":"Microtubule stimulant","id":"4900"},{"source":"Oncology: Pancreas","target":"NA","id":"4901"},{"source":"Oncology: Pancreas","target":"NA","id":"4902"},{"source":"Oncology: Pancreas","target":"Cell cycle inhibitor","id":"4903"},{"source":"Oncology: Pancreas","target":"Taxane","id":"4904"},{"source":"Oncology: Pancreas","target":"Vitamin D agonist","id":"4905"},{"source":"CVA-21 (IV) (u)","target":"Merck & Co.","id":"4906"},{"source":"CVA-21 (IV) (u)","target":"Viralytics {Psiron}","id":"4907"},{"source":"carboplatin","target":"Merck & Co.","id":"4908"},{"source":"carboplatin","target":"Viralytics {Psiron}","id":"4909"},{"source":"docetaxel","target":"Merck & Co.","id":"4910"},{"source":"docetaxel","target":"Viralytics {Psiron}","id":"4911"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"4912"},{"source":"nab-paclitaxel (IV)","target":"Viralytics {Psiron}","id":"4913"},{"source":"pembrolizumab","target":"Merck & Co.","id":"4914"},{"source":"pembrolizumab","target":"Viralytics {Psiron}","id":"4915"},{"source":"UNK : Indication","target":"CVA-21 (IV) (u)","id":"4916"},{"source":"UNK : Indication","target":"carboplatin","id":"4917"},{"source":"UNK : Indication","target":"docetaxel","id":"4918"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"4919"},{"source":"UNK : Indication","target":"pembrolizumab","id":"4920"},{"source":"prostate cancer","target":"CVA-21 (IV) (u)","id":"4921"},{"source":"prostate cancer","target":"carboplatin","id":"4922"},{"source":"prostate cancer","target":"docetaxel","id":"4923"},{"source":"prostate cancer","target":"nab-paclitaxel (IV)","id":"4924"},{"source":"prostate cancer","target":"pembrolizumab","id":"4925"},{"source":"castration-resistant prostatic neoplasms","target":"CVA-21 (IV) (u)","id":"4926"},{"source":"castration-resistant prostatic neoplasms","target":"carboplatin","id":"4927"},{"source":"castration-resistant prostatic neoplasms","target":"docetaxel","id":"4928"},{"source":"castration-resistant prostatic neoplasms","target":"nab-paclitaxel (IV)","id":"4929"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"4930"},{"source":"solid tumors","target":"CVA-21 (IV) (u)","id":"4931"},{"source":"solid tumors","target":"carboplatin","id":"4932"},{"source":"solid tumors","target":"docetaxel","id":"4933"},{"source":"solid tumors","target":"nab-paclitaxel (IV)","id":"4934"},{"source":"solid tumors","target":"pembrolizumab","id":"4935"},{"source":"malignancies","target":"CVA-21 (IV) (u)","id":"4936"},{"source":"malignancies","target":"carboplatin","id":"4937"},{"source":"malignancies","target":"docetaxel","id":"4938"},{"source":"malignancies","target":"nab-paclitaxel (IV)","id":"4939"},{"source":"malignancies","target":"pembrolizumab","id":"4940"},{"source":"residual tumor","target":"CVA-21 (IV) (u)","id":"4941"},{"source":"residual tumor","target":"carboplatin","id":"4942"},{"source":"residual tumor","target":"docetaxel","id":"4943"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"4944"},{"source":"residual tumor","target":"pembrolizumab","id":"4945"},{"source":"solid tumors","target":"CVA-21 (IV) (u)","id":"4946"},{"source":"solid tumors","target":"carboplatin","id":"4947"},{"source":"solid tumors","target":"docetaxel","id":"4948"},{"source":"solid tumors","target":"nab-paclitaxel (IV)","id":"4949"},{"source":"solid tumors","target":"pembrolizumab","id":"4950"},{"source":"melanoma","target":"CVA-21 (IV) (u)","id":"4951"},{"source":"melanoma","target":"carboplatin","id":"4952"},{"source":"melanoma","target":"docetaxel","id":"4953"},{"source":"melanoma","target":"nab-paclitaxel (IV)","id":"4954"},{"source":"melanoma","target":"pembrolizumab","id":"4955"},{"source":"bladder cancer","target":"CVA-21 (IV) (u)","id":"4956"},{"source":"bladder cancer","target":"carboplatin","id":"4957"},{"source":"bladder cancer","target":"docetaxel","id":"4958"},{"source":"bladder cancer","target":"nab-paclitaxel (IV)","id":"4959"},{"source":"bladder cancer","target":"pembrolizumab","id":"4960"},{"source":"anticancer","target":"CVA-21 (IV) (u)","id":"4961"},{"source":"anticancer","target":"carboplatin","id":"4962"},{"source":"anticancer","target":"docetaxel","id":"4963"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"4964"},{"source":"anticancer","target":"pembrolizumab","id":"4965"},{"source":"solid tumors","target":"CVA-21 (IV) (u)","id":"4966"},{"source":"solid tumors","target":"carboplatin","id":"4967"},{"source":"solid tumors","target":"docetaxel","id":"4968"},{"source":"solid tumors","target":"nab-paclitaxel (IV)","id":"4969"},{"source":"solid tumors","target":"pembrolizumab","id":"4970"},{"source":"sclc","target":"CVA-21 (IV) (u)","id":"4971"},{"source":"sclc","target":"carboplatin","id":"4972"},{"source":"sclc","target":"docetaxel","id":"4973"},{"source":"sclc","target":"nab-paclitaxel (IV)","id":"4974"},{"source":"sclc","target":"pembrolizumab","id":"4975"},{"source":"malaria","target":"CVA-21 (IV) (u)","id":"4976"},{"source":"malaria","target":"carboplatin","id":"4977"},{"source":"malaria","target":"docetaxel","id":"4978"},{"source":"malaria","target":"nab-paclitaxel (IV)","id":"4979"},{"source":"malaria","target":"pembrolizumab","id":"4980"},{"source":"carcinoma","target":"CVA-21 (IV) (u)","id":"4981"},{"source":"carcinoma","target":"carboplatin","id":"4982"},{"source":"carcinoma","target":"docetaxel","id":"4983"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"4984"},{"source":"carcinoma","target":"pembrolizumab","id":"4985"},{"source":"non-small-cell lung","target":"CVA-21 (IV) (u)","id":"4986"},{"source":"non-small-cell lung","target":"carboplatin","id":"4987"},{"source":"non-small-cell lung","target":"docetaxel","id":"4988"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"4989"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"4990"},{"source":"malaria","target":"CVA-21 (IV) (u)","id":"4991"},{"source":"malaria","target":"carboplatin","id":"4992"},{"source":"malaria","target":"docetaxel","id":"4993"},{"source":"malaria","target":"nab-paclitaxel (IV)","id":"4994"},{"source":"malaria","target":"pembrolizumab","id":"4995"},{"source":"carcinoma","target":"CVA-21 (IV) (u)","id":"4996"},{"source":"carcinoma","target":"carboplatin","id":"4997"},{"source":"carcinoma","target":"docetaxel","id":"4998"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"4999"},{"source":"carcinoma","target":"pembrolizumab","id":"5000"},{"source":"bladder cancer","target":"CVA-21 (IV) (u)","id":"5001"},{"source":"bladder cancer","target":"carboplatin","id":"5002"},{"source":"bladder cancer","target":"docetaxel","id":"5003"},{"source":"bladder cancer","target":"nab-paclitaxel (IV)","id":"5004"},{"source":"bladder cancer","target":"pembrolizumab","id":"5005"},{"source":"neoplasm metastasis","target":"CVA-21 (IV) (u)","id":"5006"},{"source":"neoplasm metastasis","target":"carboplatin","id":"5007"},{"source":"neoplasm metastasis","target":"docetaxel","id":"5008"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"5009"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"5010"},{"source":"residual tumor","target":"CVA-21 (IV) (u)","id":"5011"},{"source":"residual tumor","target":"carboplatin","id":"5012"},{"source":"residual tumor","target":"docetaxel","id":"5013"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"5014"},{"source":"residual tumor","target":"pembrolizumab","id":"5015"},{"source":"skin neoplasms","target":"CVA-21 (IV) (u)","id":"5016"},{"source":"skin neoplasms","target":"carboplatin","id":"5017"},{"source":"skin neoplasms","target":"docetaxel","id":"5018"},{"source":"skin neoplasms","target":"nab-paclitaxel (IV)","id":"5019"},{"source":"skin neoplasms","target":"pembrolizumab","id":"5020"},{"source":"residual tumor","target":"CVA-21 (IV) (u)","id":"5021"},{"source":"residual tumor","target":"carboplatin","id":"5022"},{"source":"residual tumor","target":"docetaxel","id":"5023"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"5024"},{"source":"residual tumor","target":"pembrolizumab","id":"5025"},{"source":"metastatic","target":"CVA-21 (IV) (u)","id":"5026"},{"source":"metastatic","target":"carboplatin","id":"5027"},{"source":"metastatic","target":"docetaxel","id":"5028"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"5029"},{"source":"metastatic","target":"pembrolizumab","id":"5030"},{"source":"anticancer","target":"CVA-21 (IV) (u)","id":"5031"},{"source":"anticancer","target":"carboplatin","id":"5032"},{"source":"anticancer","target":"docetaxel","id":"5033"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"5034"},{"source":"anticancer","target":"pembrolizumab","id":"5035"},{"source":"urinary bladder neoplasms","target":"CVA-21 (IV) (u)","id":"5036"},{"source":"urinary bladder neoplasms","target":"carboplatin","id":"5037"},{"source":"urinary bladder neoplasms","target":"docetaxel","id":"5038"},{"source":"urinary bladder neoplasms","target":"nab-paclitaxel (IV)","id":"5039"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"5040"},{"source":"solid tumors","target":"CVA-21 (IV) (u)","id":"5041"},{"source":"solid tumors","target":"carboplatin","id":"5042"},{"source":"solid tumors","target":"docetaxel","id":"5043"},{"source":"solid tumors","target":"nab-paclitaxel (IV)","id":"5044"},{"source":"solid tumors","target":"pembrolizumab","id":"5045"},{"source":"Apoptosis stimulant","target":"UNK : Indication","id":"5046"},{"source":"Apoptosis stimulant","target":"prostate cancer","id":"5047"},{"source":"Apoptosis stimulant","target":"castration-resistant prostatic neoplasms","id":"5048"},{"source":"Apoptosis stimulant","target":"solid tumors","id":"5049"},{"source":"Apoptosis stimulant","target":"malignancies","id":"5050"},{"source":"Apoptosis stimulant","target":"residual tumor","id":"5051"},{"source":"Apoptosis stimulant","target":"solid tumors","id":"5052"},{"source":"Apoptosis stimulant","target":"melanoma","id":"5053"},{"source":"Apoptosis stimulant","target":"bladder cancer","id":"5054"},{"source":"Apoptosis stimulant","target":"anticancer","id":"5055"},{"source":"Apoptosis stimulant","target":"solid tumors","id":"5056"},{"source":"Apoptosis stimulant","target":"sclc","id":"5057"},{"source":"Apoptosis stimulant","target":"malaria","id":"5058"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"5059"},{"source":"Apoptosis stimulant","target":"non-small-cell lung","id":"5060"},{"source":"Apoptosis stimulant","target":"malaria","id":"5061"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"5062"},{"source":"Apoptosis stimulant","target":"bladder cancer","id":"5063"},{"source":"Apoptosis stimulant","target":"neoplasm metastasis","id":"5064"},{"source":"Apoptosis stimulant","target":"residual tumor","id":"5065"},{"source":"Apoptosis stimulant","target":"skin neoplasms","id":"5066"},{"source":"Apoptosis stimulant","target":"residual tumor","id":"5067"},{"source":"Apoptosis stimulant","target":"metastatic","id":"5068"},{"source":"Apoptosis stimulant","target":"anticancer","id":"5069"},{"source":"Apoptosis stimulant","target":"urinary bladder neoplasms","id":"5070"},{"source":"Apoptosis stimulant","target":"solid tumors","id":"5071"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"5072"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"5073"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"5074"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"5075"},{"source":"Immune checkpoint inhibitor","target":"malignancies","id":"5076"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"5077"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"5078"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"5079"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"5080"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"5081"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"5082"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"5083"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"5084"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5085"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"5086"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"5087"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5088"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"5089"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"5090"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"5091"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"5092"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"5093"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"5094"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"5095"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"5096"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"5097"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"5098"},{"source":"Beta tubulin antagonist","target":"prostate cancer","id":"5099"},{"source":"Beta tubulin antagonist","target":"castration-resistant prostatic neoplasms","id":"5100"},{"source":"Beta tubulin antagonist","target":"solid tumors","id":"5101"},{"source":"Beta tubulin antagonist","target":"malignancies","id":"5102"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"5103"},{"source":"Beta tubulin antagonist","target":"solid tumors","id":"5104"},{"source":"Beta tubulin antagonist","target":"melanoma","id":"5105"},{"source":"Beta tubulin antagonist","target":"bladder cancer","id":"5106"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"5107"},{"source":"Beta tubulin antagonist","target":"solid tumors","id":"5108"},{"source":"Beta tubulin antagonist","target":"sclc","id":"5109"},{"source":"Beta tubulin antagonist","target":"malaria","id":"5110"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"5111"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"5112"},{"source":"Beta tubulin antagonist","target":"malaria","id":"5113"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"5114"},{"source":"Beta tubulin antagonist","target":"bladder cancer","id":"5115"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"5116"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"5117"},{"source":"Beta tubulin antagonist","target":"skin neoplasms","id":"5118"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"5119"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"5120"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"5121"},{"source":"Beta tubulin antagonist","target":"urinary bladder neoplasms","id":"5122"},{"source":"Beta tubulin antagonist","target":"solid tumors","id":"5123"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"5124"},{"source":"CD19 antagonist","target":"prostate cancer","id":"5125"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"5126"},{"source":"CD19 antagonist","target":"solid tumors","id":"5127"},{"source":"CD19 antagonist","target":"malignancies","id":"5128"},{"source":"CD19 antagonist","target":"residual tumor","id":"5129"},{"source":"CD19 antagonist","target":"solid tumors","id":"5130"},{"source":"CD19 antagonist","target":"melanoma","id":"5131"},{"source":"CD19 antagonist","target":"bladder cancer","id":"5132"},{"source":"CD19 antagonist","target":"anticancer","id":"5133"},{"source":"CD19 antagonist","target":"solid tumors","id":"5134"},{"source":"CD19 antagonist","target":"sclc","id":"5135"},{"source":"CD19 antagonist","target":"malaria","id":"5136"},{"source":"CD19 antagonist","target":"carcinoma","id":"5137"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"5138"},{"source":"CD19 antagonist","target":"malaria","id":"5139"},{"source":"CD19 antagonist","target":"carcinoma","id":"5140"},{"source":"CD19 antagonist","target":"bladder cancer","id":"5141"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"5142"},{"source":"CD19 antagonist","target":"residual tumor","id":"5143"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"5144"},{"source":"CD19 antagonist","target":"residual tumor","id":"5145"},{"source":"CD19 antagonist","target":"metastatic","id":"5146"},{"source":"CD19 antagonist","target":"anticancer","id":"5147"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"5148"},{"source":"CD19 antagonist","target":"solid tumors","id":"5149"},{"source":"NA","target":"UNK : Indication","id":"5150"},{"source":"NA","target":"prostate cancer","id":"5151"},{"source":"NA","target":"castration-resistant prostatic neoplasms","id":"5152"},{"source":"NA","target":"solid tumors","id":"5153"},{"source":"NA","target":"malignancies","id":"5154"},{"source":"NA","target":"residual tumor","id":"5155"},{"source":"NA","target":"solid tumors","id":"5156"},{"source":"NA","target":"melanoma","id":"5157"},{"source":"NA","target":"bladder cancer","id":"5158"},{"source":"NA","target":"anticancer","id":"5159"},{"source":"NA","target":"solid tumors","id":"5160"},{"source":"NA","target":"sclc","id":"5161"},{"source":"NA","target":"malaria","id":"5162"},{"source":"NA","target":"carcinoma","id":"5163"},{"source":"NA","target":"non-small-cell lung","id":"5164"},{"source":"NA","target":"malaria","id":"5165"},{"source":"NA","target":"carcinoma","id":"5166"},{"source":"NA","target":"bladder cancer","id":"5167"},{"source":"NA","target":"neoplasm metastasis","id":"5168"},{"source":"NA","target":"residual tumor","id":"5169"},{"source":"NA","target":"skin neoplasms","id":"5170"},{"source":"NA","target":"residual tumor","id":"5171"},{"source":"NA","target":"metastatic","id":"5172"},{"source":"NA","target":"anticancer","id":"5173"},{"source":"NA","target":"urinary bladder neoplasms","id":"5174"},{"source":"NA","target":"solid tumors","id":"5175"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"5176"},{"source":"Microtubule stimulant","target":"prostate cancer","id":"5177"},{"source":"Microtubule stimulant","target":"castration-resistant prostatic neoplasms","id":"5178"},{"source":"Microtubule stimulant","target":"solid tumors","id":"5179"},{"source":"Microtubule stimulant","target":"malignancies","id":"5180"},{"source":"Microtubule stimulant","target":"residual tumor","id":"5181"},{"source":"Microtubule stimulant","target":"solid tumors","id":"5182"},{"source":"Microtubule stimulant","target":"melanoma","id":"5183"},{"source":"Microtubule stimulant","target":"bladder cancer","id":"5184"},{"source":"Microtubule stimulant","target":"anticancer","id":"5185"},{"source":"Microtubule stimulant","target":"solid tumors","id":"5186"},{"source":"Microtubule stimulant","target":"sclc","id":"5187"},{"source":"Microtubule stimulant","target":"malaria","id":"5188"},{"source":"Microtubule stimulant","target":"carcinoma","id":"5189"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"5190"},{"source":"Microtubule stimulant","target":"malaria","id":"5191"},{"source":"Microtubule stimulant","target":"carcinoma","id":"5192"},{"source":"Microtubule stimulant","target":"bladder cancer","id":"5193"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"5194"},{"source":"Microtubule stimulant","target":"residual tumor","id":"5195"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"5196"},{"source":"Microtubule stimulant","target":"residual tumor","id":"5197"},{"source":"Microtubule stimulant","target":"metastatic","id":"5198"},{"source":"Microtubule stimulant","target":"anticancer","id":"5199"},{"source":"Microtubule stimulant","target":"urinary bladder neoplasms","id":"5200"},{"source":"Microtubule stimulant","target":"solid tumors","id":"5201"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"5202"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"5203"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"5204"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"5205"},{"source":"Anticancer immunotherapy","target":"malignancies","id":"5206"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"5207"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"5208"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"5209"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"5210"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"5211"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"5212"},{"source":"Anticancer immunotherapy","target":"sclc","id":"5213"},{"source":"Anticancer immunotherapy","target":"malaria","id":"5214"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5215"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"5216"},{"source":"Anticancer immunotherapy","target":"malaria","id":"5217"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5218"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"5219"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"5220"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"5221"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"5222"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"5223"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"5224"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"5225"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"5226"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"5227"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"5228"},{"source":"Tubulin inhibitor","target":"prostate cancer","id":"5229"},{"source":"Tubulin inhibitor","target":"castration-resistant prostatic neoplasms","id":"5230"},{"source":"Tubulin inhibitor","target":"solid tumors","id":"5231"},{"source":"Tubulin inhibitor","target":"malignancies","id":"5232"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"5233"},{"source":"Tubulin inhibitor","target":"solid tumors","id":"5234"},{"source":"Tubulin inhibitor","target":"melanoma","id":"5235"},{"source":"Tubulin inhibitor","target":"bladder cancer","id":"5236"},{"source":"Tubulin inhibitor","target":"anticancer","id":"5237"},{"source":"Tubulin inhibitor","target":"solid tumors","id":"5238"},{"source":"Tubulin inhibitor","target":"sclc","id":"5239"},{"source":"Tubulin inhibitor","target":"malaria","id":"5240"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"5241"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"5242"},{"source":"Tubulin inhibitor","target":"malaria","id":"5243"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"5244"},{"source":"Tubulin inhibitor","target":"bladder cancer","id":"5245"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"5246"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"5247"},{"source":"Tubulin inhibitor","target":"skin neoplasms","id":"5248"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"5249"},{"source":"Tubulin inhibitor","target":"metastatic","id":"5250"},{"source":"Tubulin inhibitor","target":"anticancer","id":"5251"},{"source":"Tubulin inhibitor","target":"urinary bladder neoplasms","id":"5252"},{"source":"Tubulin inhibitor","target":"solid tumors","id":"5253"},{"source":"Taxane","target":"UNK : Indication","id":"5254"},{"source":"Taxane","target":"prostate cancer","id":"5255"},{"source":"Taxane","target":"castration-resistant prostatic neoplasms","id":"5256"},{"source":"Taxane","target":"solid tumors","id":"5257"},{"source":"Taxane","target":"malignancies","id":"5258"},{"source":"Taxane","target":"residual tumor","id":"5259"},{"source":"Taxane","target":"solid tumors","id":"5260"},{"source":"Taxane","target":"melanoma","id":"5261"},{"source":"Taxane","target":"bladder cancer","id":"5262"},{"source":"Taxane","target":"anticancer","id":"5263"},{"source":"Taxane","target":"solid tumors","id":"5264"},{"source":"Taxane","target":"sclc","id":"5265"},{"source":"Taxane","target":"malaria","id":"5266"},{"source":"Taxane","target":"carcinoma","id":"5267"},{"source":"Taxane","target":"non-small-cell lung","id":"5268"},{"source":"Taxane","target":"malaria","id":"5269"},{"source":"Taxane","target":"carcinoma","id":"5270"},{"source":"Taxane","target":"bladder cancer","id":"5271"},{"source":"Taxane","target":"neoplasm metastasis","id":"5272"},{"source":"Taxane","target":"residual tumor","id":"5273"},{"source":"Taxane","target":"skin neoplasms","id":"5274"},{"source":"Taxane","target":"residual tumor","id":"5275"},{"source":"Taxane","target":"metastatic","id":"5276"},{"source":"Taxane","target":"anticancer","id":"5277"},{"source":"Taxane","target":"urinary bladder neoplasms","id":"5278"},{"source":"Taxane","target":"solid tumors","id":"5279"},{"source":"Oncology: Bladder","target":"Apoptosis stimulant","id":"5280"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"5281"},{"source":"Oncology: Bladder","target":"Beta tubulin antagonist","id":"5282"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"5283"},{"source":"Oncology: Bladder","target":"NA","id":"5284"},{"source":"Oncology: Bladder","target":"Microtubule stimulant","id":"5285"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"5286"},{"source":"Oncology: Bladder","target":"Tubulin inhibitor","id":"5287"},{"source":"Oncology: Bladder","target":"Taxane","id":"5288"},{"source":"Oncology: Lung","target":"Apoptosis stimulant","id":"5289"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"5290"},{"source":"Oncology: Lung","target":"Beta tubulin antagonist","id":"5291"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"5292"},{"source":"Oncology: Lung","target":"NA","id":"5293"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"5294"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"5295"},{"source":"Oncology: Lung","target":"Tubulin inhibitor","id":"5296"},{"source":"Oncology: Lung","target":"Taxane","id":"5297"},{"source":"Non-Small Cell","target":"Apoptosis stimulant","id":"5298"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"5299"},{"source":"Non-Small Cell","target":"Beta tubulin antagonist","id":"5300"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"5301"},{"source":"Non-Small Cell","target":"NA","id":"5302"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"5303"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"5304"},{"source":"Non-Small Cell","target":"Tubulin inhibitor","id":"5305"},{"source":"Non-Small Cell","target":"Taxane","id":"5306"},{"source":"Oncology: Melanoma","target":"Apoptosis stimulant","id":"5307"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"5308"},{"source":"Oncology: Melanoma","target":"Beta tubulin antagonist","id":"5309"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"5310"},{"source":"Oncology: Melanoma","target":"NA","id":"5311"},{"source":"Oncology: Melanoma","target":"Microtubule stimulant","id":"5312"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"5313"},{"source":"Oncology: Melanoma","target":"Tubulin inhibitor","id":"5314"},{"source":"Oncology: Melanoma","target":"Taxane","id":"5315"},{"source":"Oncology: Prostate","target":"Apoptosis stimulant","id":"5316"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"5317"},{"source":"Oncology: Prostate","target":"Beta tubulin antagonist","id":"5318"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"5319"},{"source":"Oncology: Prostate","target":"NA","id":"5320"},{"source":"Oncology: Prostate","target":"Microtubule stimulant","id":"5321"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"5322"},{"source":"Oncology: Prostate","target":"Tubulin inhibitor","id":"5323"},{"source":"Oncology: Prostate","target":"Taxane","id":"5324"},{"source":"entinostat (u)","target":"Merck & Co.","id":"5325"},{"source":"entinostat (u)","target":"Syndax","id":"5326"},{"source":"pembrolizumab","target":"Merck & Co.","id":"5327"},{"source":"pembrolizumab","target":"Syndax","id":"5328"},{"source":"UNK : Drug","target":"Merck & Co.","id":"5329"},{"source":"UNK : Drug","target":"Syndax","id":"5330"},{"source":"UNK : Indication","target":"entinostat (u)","id":"5331"},{"source":"UNK : Indication","target":"pembrolizumab","id":"5332"},{"source":"UNK : Indication","target":"UNK : Drug","id":"5333"},{"source":"colorectal neoplasms","target":"entinostat (u)","id":"5334"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"5335"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"5336"},{"source":"melanoma","target":"entinostat (u)","id":"5337"},{"source":"melanoma","target":"pembrolizumab","id":"5338"},{"source":"melanoma","target":"UNK : Drug","id":"5339"},{"source":"non-small-cell lung","target":"entinostat (u)","id":"5340"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"5341"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"5342"},{"source":"brain metastases","target":"entinostat (u)","id":"5343"},{"source":"brain metastases","target":"pembrolizumab","id":"5344"},{"source":"brain metastases","target":"UNK : Drug","id":"5345"},{"source":"non-small-cell lung","target":"entinostat (u)","id":"5346"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"5347"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"5348"},{"source":"melanoma","target":"entinostat (u)","id":"5349"},{"source":"melanoma","target":"pembrolizumab","id":"5350"},{"source":"melanoma","target":"UNK : Drug","id":"5351"},{"source":"microsatellite instability","target":"entinostat (u)","id":"5352"},{"source":"microsatellite instability","target":"pembrolizumab","id":"5353"},{"source":"microsatellite instability","target":"UNK : Drug","id":"5354"},{"source":"colonic neoplasms","target":"entinostat (u)","id":"5355"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"5356"},{"source":"colonic neoplasms","target":"UNK : Drug","id":"5357"},{"source":"carcinoma","target":"entinostat (u)","id":"5358"},{"source":"carcinoma","target":"pembrolizumab","id":"5359"},{"source":"carcinoma","target":"UNK : Drug","id":"5360"},{"source":"sclc","target":"entinostat (u)","id":"5361"},{"source":"sclc","target":"pembrolizumab","id":"5362"},{"source":"sclc","target":"UNK : Drug","id":"5363"},{"source":"neurologic dysfunction","target":"entinostat (u)","id":"5364"},{"source":"neurologic dysfunction","target":"pembrolizumab","id":"5365"},{"source":"neurologic dysfunction","target":"UNK : Drug","id":"5366"},{"source":"colorectal cancer","target":"entinostat (u)","id":"5367"},{"source":"colorectal cancer","target":"pembrolizumab","id":"5368"},{"source":"colorectal cancer","target":"UNK : Drug","id":"5369"},{"source":"alopecia","target":"entinostat (u)","id":"5370"},{"source":"alopecia","target":"pembrolizumab","id":"5371"},{"source":"alopecia","target":"UNK : Drug","id":"5372"},{"source":"neurologic manifestations","target":"entinostat (u)","id":"5373"},{"source":"neurologic manifestations","target":"pembrolizumab","id":"5374"},{"source":"neurologic manifestations","target":"UNK : Drug","id":"5375"},{"source":"colon cancer","target":"entinostat (u)","id":"5376"},{"source":"colon cancer","target":"pembrolizumab","id":"5377"},{"source":"colon cancer","target":"UNK : Drug","id":"5378"},{"source":"carcinoma","target":"entinostat (u)","id":"5379"},{"source":"carcinoma","target":"pembrolizumab","id":"5380"},{"source":"carcinoma","target":"UNK : Drug","id":"5381"},{"source":"cerebellar neoplasms","target":"entinostat (u)","id":"5382"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"5383"},{"source":"cerebellar neoplasms","target":"UNK : Drug","id":"5384"},{"source":"carcinoma","target":"entinostat (u)","id":"5385"},{"source":"carcinoma","target":"pembrolizumab","id":"5386"},{"source":"carcinoma","target":"UNK : Drug","id":"5387"},{"source":"neoplasm metastasis","target":"entinostat (u)","id":"5388"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"5389"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"5390"},{"source":"lymphoma","target":"entinostat (u)","id":"5391"},{"source":"lymphoma","target":"pembrolizumab","id":"5392"},{"source":"lymphoma","target":"UNK : Drug","id":"5393"},{"source":"lung neoplasms","target":"entinostat (u)","id":"5394"},{"source":"lung neoplasms","target":"pembrolizumab","id":"5395"},{"source":"lung neoplasms","target":"UNK : Drug","id":"5396"},{"source":"colorectal neoplasms","target":"entinostat (u)","id":"5397"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"5398"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"5399"},{"source":"ovarian neoplasms","target":"entinostat (u)","id":"5400"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"5401"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"5402"},{"source":"skin neoplasms","target":"entinostat (u)","id":"5403"},{"source":"skin neoplasms","target":"pembrolizumab","id":"5404"},{"source":"skin neoplasms","target":"UNK : Drug","id":"5405"},{"source":"residual tumor","target":"entinostat (u)","id":"5406"},{"source":"residual tumor","target":"pembrolizumab","id":"5407"},{"source":"residual tumor","target":"UNK : Drug","id":"5408"},{"source":"metastatic","target":"entinostat (u)","id":"5409"},{"source":"metastatic","target":"pembrolizumab","id":"5410"},{"source":"metastatic","target":"UNK : Drug","id":"5411"},{"source":"anticancer","target":"entinostat (u)","id":"5412"},{"source":"anticancer","target":"pembrolizumab","id":"5413"},{"source":"anticancer","target":"UNK : Drug","id":"5414"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"5415"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"5416"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"5417"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"5418"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"5419"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"5420"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"5421"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"5422"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"5423"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5424"},{"source":"Anticancer immunotherapy","target":"sclc","id":"5425"},{"source":"Anticancer immunotherapy","target":"neurologic dysfunction","id":"5426"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"5427"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"5428"},{"source":"Anticancer immunotherapy","target":"neurologic manifestations","id":"5429"},{"source":"Anticancer immunotherapy","target":"colon cancer","id":"5430"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5431"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"5432"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5433"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"5434"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"5435"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"5436"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"5437"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"5438"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"5439"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"5440"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"5441"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"5442"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"5443"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"5444"},{"source":"CD19 antagonist","target":"melanoma","id":"5445"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"5446"},{"source":"CD19 antagonist","target":"brain metastases","id":"5447"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"5448"},{"source":"CD19 antagonist","target":"melanoma","id":"5449"},{"source":"CD19 antagonist","target":"microsatellite instability","id":"5450"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"5451"},{"source":"CD19 antagonist","target":"carcinoma","id":"5452"},{"source":"CD19 antagonist","target":"sclc","id":"5453"},{"source":"CD19 antagonist","target":"neurologic dysfunction","id":"5454"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"5455"},{"source":"CD19 antagonist","target":"alopecia","id":"5456"},{"source":"CD19 antagonist","target":"neurologic manifestations","id":"5457"},{"source":"CD19 antagonist","target":"colon cancer","id":"5458"},{"source":"CD19 antagonist","target":"carcinoma","id":"5459"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"5460"},{"source":"CD19 antagonist","target":"carcinoma","id":"5461"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"5462"},{"source":"CD19 antagonist","target":"lymphoma","id":"5463"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"5464"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"5465"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"5466"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"5467"},{"source":"CD19 antagonist","target":"residual tumor","id":"5468"},{"source":"CD19 antagonist","target":"metastatic","id":"5469"},{"source":"CD19 antagonist","target":"anticancer","id":"5470"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"5471"},{"source":"Cell cycle inhibitor","target":"colorectal neoplasms","id":"5472"},{"source":"Cell cycle inhibitor","target":"melanoma","id":"5473"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"5474"},{"source":"Cell cycle inhibitor","target":"brain metastases","id":"5475"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"5476"},{"source":"Cell cycle inhibitor","target":"melanoma","id":"5477"},{"source":"Cell cycle inhibitor","target":"microsatellite instability","id":"5478"},{"source":"Cell cycle inhibitor","target":"colonic neoplasms","id":"5479"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"5480"},{"source":"Cell cycle inhibitor","target":"sclc","id":"5481"},{"source":"Cell cycle inhibitor","target":"neurologic dysfunction","id":"5482"},{"source":"Cell cycle inhibitor","target":"colorectal cancer","id":"5483"},{"source":"Cell cycle inhibitor","target":"alopecia","id":"5484"},{"source":"Cell cycle inhibitor","target":"neurologic manifestations","id":"5485"},{"source":"Cell cycle inhibitor","target":"colon cancer","id":"5486"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"5487"},{"source":"Cell cycle inhibitor","target":"cerebellar neoplasms","id":"5488"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"5489"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"5490"},{"source":"Cell cycle inhibitor","target":"lymphoma","id":"5491"},{"source":"Cell cycle inhibitor","target":"lung neoplasms","id":"5492"},{"source":"Cell cycle inhibitor","target":"colorectal neoplasms","id":"5493"},{"source":"Cell cycle inhibitor","target":"ovarian neoplasms","id":"5494"},{"source":"Cell cycle inhibitor","target":"skin neoplasms","id":"5495"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"5496"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"5497"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"5498"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"5499"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"5500"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"5501"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"5502"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"5503"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"5504"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"5505"},{"source":"Immune checkpoint inhibitor","target":"microsatellite instability","id":"5506"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"5507"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5508"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"5509"},{"source":"Immune checkpoint inhibitor","target":"neurologic dysfunction","id":"5510"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"5511"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"5512"},{"source":"Immune checkpoint inhibitor","target":"neurologic manifestations","id":"5513"},{"source":"Immune checkpoint inhibitor","target":"colon cancer","id":"5514"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5515"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"5516"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5517"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"5518"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"5519"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"5520"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"5521"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"5522"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"5523"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"5524"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"5525"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"5526"},{"source":"Histone deacetylase inhibitor","target":"UNK : Indication","id":"5527"},{"source":"Histone deacetylase inhibitor","target":"colorectal neoplasms","id":"5528"},{"source":"Histone deacetylase inhibitor","target":"melanoma","id":"5529"},{"source":"Histone deacetylase inhibitor","target":"non-small-cell lung","id":"5530"},{"source":"Histone deacetylase inhibitor","target":"brain metastases","id":"5531"},{"source":"Histone deacetylase inhibitor","target":"non-small-cell lung","id":"5532"},{"source":"Histone deacetylase inhibitor","target":"melanoma","id":"5533"},{"source":"Histone deacetylase inhibitor","target":"microsatellite instability","id":"5534"},{"source":"Histone deacetylase inhibitor","target":"colonic neoplasms","id":"5535"},{"source":"Histone deacetylase inhibitor","target":"carcinoma","id":"5536"},{"source":"Histone deacetylase inhibitor","target":"sclc","id":"5537"},{"source":"Histone deacetylase inhibitor","target":"neurologic dysfunction","id":"5538"},{"source":"Histone deacetylase inhibitor","target":"colorectal cancer","id":"5539"},{"source":"Histone deacetylase inhibitor","target":"alopecia","id":"5540"},{"source":"Histone deacetylase inhibitor","target":"neurologic manifestations","id":"5541"},{"source":"Histone deacetylase inhibitor","target":"colon cancer","id":"5542"},{"source":"Histone deacetylase inhibitor","target":"carcinoma","id":"5543"},{"source":"Histone deacetylase inhibitor","target":"cerebellar neoplasms","id":"5544"},{"source":"Histone deacetylase inhibitor","target":"carcinoma","id":"5545"},{"source":"Histone deacetylase inhibitor","target":"neoplasm metastasis","id":"5546"},{"source":"Histone deacetylase inhibitor","target":"lymphoma","id":"5547"},{"source":"Histone deacetylase inhibitor","target":"lung neoplasms","id":"5548"},{"source":"Histone deacetylase inhibitor","target":"colorectal neoplasms","id":"5549"},{"source":"Histone deacetylase inhibitor","target":"ovarian neoplasms","id":"5550"},{"source":"Histone deacetylase inhibitor","target":"skin neoplasms","id":"5551"},{"source":"Histone deacetylase inhibitor","target":"residual tumor","id":"5552"},{"source":"Histone deacetylase inhibitor","target":"metastatic","id":"5553"},{"source":"Histone deacetylase inhibitor","target":"anticancer","id":"5554"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"5555"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"5556"},{"source":"Oncology: Colorectal","target":"Cell cycle inhibitor","id":"5557"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"5558"},{"source":"Oncology: Colorectal","target":"Histone deacetylase inhibitor","id":"5559"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"5560"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"5561"},{"source":"Oncology: Lung","target":"Cell cycle inhibitor","id":"5562"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"5563"},{"source":"Oncology: Lung","target":"Histone deacetylase inhibitor","id":"5564"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"5565"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"5566"},{"source":"Non-Small Cell","target":"Cell cycle inhibitor","id":"5567"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"5568"},{"source":"Non-Small Cell","target":"Histone deacetylase inhibitor","id":"5569"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"5570"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"5571"},{"source":"Oncology: Melanoma","target":"Cell cycle inhibitor","id":"5572"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"5573"},{"source":"Oncology: Melanoma","target":"Histone deacetylase inhibitor","id":"5574"},{"source":"breast cancer vaccine","target":"BriaCell","id":"5575"},{"source":"BriaCell (u)","target":"BriaCell","id":"5576"},{"source":"cyclophosphamide","target":"BriaCell","id":"5577"},{"source":"interferon alpha-2b","target":"BriaCell","id":"5578"},{"source":"unspecified","target":"BriaCell","id":"5579"},{"source":"ipilimumab","target":"BriaCell","id":"5580"},{"source":"pembrolizumab","target":"BriaCell","id":"5581"},{"source":"metastatic","target":"breast cancer vaccine","id":"5582"},{"source":"metastatic","target":"BriaCell (u)","id":"5583"},{"source":"metastatic","target":"cyclophosphamide","id":"5584"},{"source":"metastatic","target":"interferon alpha-2b","id":"5585"},{"source":"metastatic","target":"unspecified","id":"5586"},{"source":"metastatic","target":"ipilimumab","id":"5587"},{"source":"metastatic","target":"pembrolizumab","id":"5588"},{"source":"ovarian neoplasms","target":"breast cancer vaccine","id":"5589"},{"source":"ovarian neoplasms","target":"BriaCell (u)","id":"5590"},{"source":"ovarian neoplasms","target":"cyclophosphamide","id":"5591"},{"source":"ovarian neoplasms","target":"interferon alpha-2b","id":"5592"},{"source":"ovarian neoplasms","target":"unspecified","id":"5593"},{"source":"ovarian neoplasms","target":"ipilimumab","id":"5594"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"5595"},{"source":"anti-hiv","target":"breast cancer vaccine","id":"5596"},{"source":"anti-hiv","target":"BriaCell (u)","id":"5597"},{"source":"anti-hiv","target":"cyclophosphamide","id":"5598"},{"source":"anti-hiv","target":"interferon alpha-2b","id":"5599"},{"source":"anti-hiv","target":"unspecified","id":"5600"},{"source":"anti-hiv","target":"ipilimumab","id":"5601"},{"source":"anti-hiv","target":"pembrolizumab","id":"5602"},{"source":"metastatic","target":"breast cancer vaccine","id":"5603"},{"source":"metastatic","target":"BriaCell (u)","id":"5604"},{"source":"metastatic","target":"cyclophosphamide","id":"5605"},{"source":"metastatic","target":"interferon alpha-2b","id":"5606"},{"source":"metastatic","target":"unspecified","id":"5607"},{"source":"metastatic","target":"ipilimumab","id":"5608"},{"source":"metastatic","target":"pembrolizumab","id":"5609"},{"source":"residual tumor","target":"breast cancer vaccine","id":"5610"},{"source":"residual tumor","target":"BriaCell (u)","id":"5611"},{"source":"residual tumor","target":"cyclophosphamide","id":"5612"},{"source":"residual tumor","target":"interferon alpha-2b","id":"5613"},{"source":"residual tumor","target":"unspecified","id":"5614"},{"source":"residual tumor","target":"ipilimumab","id":"5615"},{"source":"residual tumor","target":"pembrolizumab","id":"5616"},{"source":"residual tumor","target":"breast cancer vaccine","id":"5617"},{"source":"residual tumor","target":"BriaCell (u)","id":"5618"},{"source":"residual tumor","target":"cyclophosphamide","id":"5619"},{"source":"residual tumor","target":"interferon alpha-2b","id":"5620"},{"source":"residual tumor","target":"unspecified","id":"5621"},{"source":"residual tumor","target":"ipilimumab","id":"5622"},{"source":"residual tumor","target":"pembrolizumab","id":"5623"},{"source":"breast neoplasms","target":"breast cancer vaccine","id":"5624"},{"source":"breast neoplasms","target":"BriaCell (u)","id":"5625"},{"source":"breast neoplasms","target":"cyclophosphamide","id":"5626"},{"source":"breast neoplasms","target":"interferon alpha-2b","id":"5627"},{"source":"breast neoplasms","target":"unspecified","id":"5628"},{"source":"breast neoplasms","target":"ipilimumab","id":"5629"},{"source":"breast neoplasms","target":"pembrolizumab","id":"5630"},{"source":"cerebellar neoplasms","target":"breast cancer vaccine","id":"5631"},{"source":"cerebellar neoplasms","target":"BriaCell (u)","id":"5632"},{"source":"cerebellar neoplasms","target":"cyclophosphamide","id":"5633"},{"source":"cerebellar neoplasms","target":"interferon alpha-2b","id":"5634"},{"source":"cerebellar neoplasms","target":"unspecified","id":"5635"},{"source":"cerebellar neoplasms","target":"ipilimumab","id":"5636"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"5637"},{"source":"carcinoma","target":"breast cancer vaccine","id":"5638"},{"source":"carcinoma","target":"BriaCell (u)","id":"5639"},{"source":"carcinoma","target":"cyclophosphamide","id":"5640"},{"source":"carcinoma","target":"interferon alpha-2b","id":"5641"},{"source":"carcinoma","target":"unspecified","id":"5642"},{"source":"carcinoma","target":"ipilimumab","id":"5643"},{"source":"carcinoma","target":"pembrolizumab","id":"5644"},{"source":"brain metastases","target":"breast cancer vaccine","id":"5645"},{"source":"brain metastases","target":"BriaCell (u)","id":"5646"},{"source":"brain metastases","target":"cyclophosphamide","id":"5647"},{"source":"brain metastases","target":"interferon alpha-2b","id":"5648"},{"source":"brain metastases","target":"unspecified","id":"5649"},{"source":"brain metastases","target":"ipilimumab","id":"5650"},{"source":"brain metastases","target":"pembrolizumab","id":"5651"},{"source":"neoplasm metastasis","target":"breast cancer vaccine","id":"5652"},{"source":"neoplasm metastasis","target":"BriaCell (u)","id":"5653"},{"source":"neoplasm metastasis","target":"cyclophosphamide","id":"5654"},{"source":"neoplasm metastasis","target":"interferon alpha-2b","id":"5655"},{"source":"neoplasm metastasis","target":"unspecified","id":"5656"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"5657"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"5658"},{"source":"anticancer","target":"breast cancer vaccine","id":"5659"},{"source":"anticancer","target":"BriaCell (u)","id":"5660"},{"source":"anticancer","target":"cyclophosphamide","id":"5661"},{"source":"anticancer","target":"interferon alpha-2b","id":"5662"},{"source":"anticancer","target":"unspecified","id":"5663"},{"source":"anticancer","target":"ipilimumab","id":"5664"},{"source":"anticancer","target":"pembrolizumab","id":"5665"},{"source":"hiv infections","target":"breast cancer vaccine","id":"5666"},{"source":"hiv infections","target":"BriaCell (u)","id":"5667"},{"source":"hiv infections","target":"cyclophosphamide","id":"5668"},{"source":"hiv infections","target":"interferon alpha-2b","id":"5669"},{"source":"hiv infections","target":"unspecified","id":"5670"},{"source":"hiv infections","target":"ipilimumab","id":"5671"},{"source":"hiv infections","target":"pembrolizumab","id":"5672"},{"source":"triple-negative breast cancer","target":"breast cancer vaccine","id":"5673"},{"source":"triple-negative breast cancer","target":"BriaCell (u)","id":"5674"},{"source":"triple-negative breast cancer","target":"cyclophosphamide","id":"5675"},{"source":"triple-negative breast cancer","target":"interferon alpha-2b","id":"5676"},{"source":"triple-negative breast cancer","target":"unspecified","id":"5677"},{"source":"triple-negative breast cancer","target":"ipilimumab","id":"5678"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"5679"},{"source":"acquired immunodeficiency syndrome","target":"breast cancer vaccine","id":"5680"},{"source":"acquired immunodeficiency syndrome","target":"BriaCell (u)","id":"5681"},{"source":"acquired immunodeficiency syndrome","target":"cyclophosphamide","id":"5682"},{"source":"acquired immunodeficiency syndrome","target":"interferon alpha-2b","id":"5683"},{"source":"acquired immunodeficiency syndrome","target":"unspecified","id":"5684"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"5685"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"5686"},{"source":"Immunosuppressant","target":"metastatic","id":"5687"},{"source":"Immunosuppressant","target":"ovarian neoplasms","id":"5688"},{"source":"Immunosuppressant","target":"anti-hiv","id":"5689"},{"source":"Immunosuppressant","target":"metastatic","id":"5690"},{"source":"Immunosuppressant","target":"residual tumor","id":"5691"},{"source":"Immunosuppressant","target":"residual tumor","id":"5692"},{"source":"Immunosuppressant","target":"breast neoplasms","id":"5693"},{"source":"Immunosuppressant","target":"cerebellar neoplasms","id":"5694"},{"source":"Immunosuppressant","target":"carcinoma","id":"5695"},{"source":"Immunosuppressant","target":"brain metastases","id":"5696"},{"source":"Immunosuppressant","target":"neoplasm metastasis","id":"5697"},{"source":"Immunosuppressant","target":"anticancer","id":"5698"},{"source":"Immunosuppressant","target":"hiv infections","id":"5699"},{"source":"Immunosuppressant","target":"triple-negative breast cancer","id":"5700"},{"source":"Immunosuppressant","target":"acquired immunodeficiency syndrome","id":"5701"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"5702"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"5703"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"5704"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"5705"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"5706"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"5707"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"5708"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"5709"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5710"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"5711"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"5712"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"5713"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"5714"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"5715"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"5716"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"5717"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"5718"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"5719"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"5720"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"5721"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"5722"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"5723"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"5724"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5725"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"5726"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"5727"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"5728"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"5729"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"5730"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"5731"},{"source":"CD19 antagonist","target":"metastatic","id":"5732"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"5733"},{"source":"CD19 antagonist","target":"anti-hiv","id":"5734"},{"source":"CD19 antagonist","target":"metastatic","id":"5735"},{"source":"CD19 antagonist","target":"residual tumor","id":"5736"},{"source":"CD19 antagonist","target":"residual tumor","id":"5737"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"5738"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"5739"},{"source":"CD19 antagonist","target":"carcinoma","id":"5740"},{"source":"CD19 antagonist","target":"brain metastases","id":"5741"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"5742"},{"source":"CD19 antagonist","target":"anticancer","id":"5743"},{"source":"CD19 antagonist","target":"hiv infections","id":"5744"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"5745"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"5746"},{"source":"NA","target":"metastatic","id":"5747"},{"source":"NA","target":"ovarian neoplasms","id":"5748"},{"source":"NA","target":"anti-hiv","id":"5749"},{"source":"NA","target":"metastatic","id":"5750"},{"source":"NA","target":"residual tumor","id":"5751"},{"source":"NA","target":"residual tumor","id":"5752"},{"source":"NA","target":"breast neoplasms","id":"5753"},{"source":"NA","target":"cerebellar neoplasms","id":"5754"},{"source":"NA","target":"carcinoma","id":"5755"},{"source":"NA","target":"brain metastases","id":"5756"},{"source":"NA","target":"neoplasm metastasis","id":"5757"},{"source":"NA","target":"anticancer","id":"5758"},{"source":"NA","target":"hiv infections","id":"5759"},{"source":"NA","target":"triple-negative breast cancer","id":"5760"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"5761"},{"source":"Interferon receptor agonist","target":"metastatic","id":"5762"},{"source":"Interferon receptor agonist","target":"ovarian neoplasms","id":"5763"},{"source":"Interferon receptor agonist","target":"anti-hiv","id":"5764"},{"source":"Interferon receptor agonist","target":"metastatic","id":"5765"},{"source":"Interferon receptor agonist","target":"residual tumor","id":"5766"},{"source":"Interferon receptor agonist","target":"residual tumor","id":"5767"},{"source":"Interferon receptor agonist","target":"breast neoplasms","id":"5768"},{"source":"Interferon receptor agonist","target":"cerebellar neoplasms","id":"5769"},{"source":"Interferon receptor agonist","target":"carcinoma","id":"5770"},{"source":"Interferon receptor agonist","target":"brain metastases","id":"5771"},{"source":"Interferon receptor agonist","target":"neoplasm metastasis","id":"5772"},{"source":"Interferon receptor agonist","target":"anticancer","id":"5773"},{"source":"Interferon receptor agonist","target":"hiv infections","id":"5774"},{"source":"Interferon receptor agonist","target":"triple-negative breast cancer","id":"5775"},{"source":"Interferon receptor agonist","target":"acquired immunodeficiency syndrome","id":"5776"},{"source":"CTLA4 antagonist","target":"metastatic","id":"5777"},{"source":"CTLA4 antagonist","target":"ovarian neoplasms","id":"5778"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"5779"},{"source":"CTLA4 antagonist","target":"metastatic","id":"5780"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"5781"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"5782"},{"source":"CTLA4 antagonist","target":"breast neoplasms","id":"5783"},{"source":"CTLA4 antagonist","target":"cerebellar neoplasms","id":"5784"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"5785"},{"source":"CTLA4 antagonist","target":"brain metastases","id":"5786"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"5787"},{"source":"CTLA4 antagonist","target":"anticancer","id":"5788"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"5789"},{"source":"CTLA4 antagonist","target":"triple-negative breast cancer","id":"5790"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"5791"},{"source":"T helper cell stimulant","target":"metastatic","id":"5792"},{"source":"T helper cell stimulant","target":"ovarian neoplasms","id":"5793"},{"source":"T helper cell stimulant","target":"anti-hiv","id":"5794"},{"source":"T helper cell stimulant","target":"metastatic","id":"5795"},{"source":"T helper cell stimulant","target":"residual tumor","id":"5796"},{"source":"T helper cell stimulant","target":"residual tumor","id":"5797"},{"source":"T helper cell stimulant","target":"breast neoplasms","id":"5798"},{"source":"T helper cell stimulant","target":"cerebellar neoplasms","id":"5799"},{"source":"T helper cell stimulant","target":"carcinoma","id":"5800"},{"source":"T helper cell stimulant","target":"brain metastases","id":"5801"},{"source":"T helper cell stimulant","target":"neoplasm metastasis","id":"5802"},{"source":"T helper cell stimulant","target":"anticancer","id":"5803"},{"source":"T helper cell stimulant","target":"hiv infections","id":"5804"},{"source":"T helper cell stimulant","target":"triple-negative breast cancer","id":"5805"},{"source":"T helper cell stimulant","target":"acquired immunodeficiency syndrome","id":"5806"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"metastatic","id":"5807"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"ovarian neoplasms","id":"5808"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anti-hiv","id":"5809"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"metastatic","id":"5810"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"5811"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"5812"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"breast neoplasms","id":"5813"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"cerebellar neoplasms","id":"5814"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"5815"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"brain metastases","id":"5816"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"neoplasm metastasis","id":"5817"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"5818"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"hiv infections","id":"5819"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"triple-negative breast cancer","id":"5820"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"acquired immunodeficiency syndrome","id":"5821"},{"source":"Oncology: Breast","target":"Immunosuppressant","id":"5822"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"5823"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"5824"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"5825"},{"source":"Oncology: Breast","target":"NA","id":"5826"},{"source":"Oncology: Breast","target":"Interferon receptor agonist","id":"5827"},{"source":"Oncology: Breast","target":"CTLA4 antagonist","id":"5828"},{"source":"Oncology: Breast","target":"T helper cell stimulant","id":"5829"},{"source":"Oncology: Breast","target":"Granulocyte macrophage colony stimulating factor agonist","id":"5830"},{"source":"pembrolizumab","target":"MD Anderson Cancer Center","id":"5831"},{"source":"pembrolizumab","target":"University of Texas","id":"5832"},{"source":"pembrolizumab","target":"Merck & Co.","id":"5833"},{"source":"UNK : Drug","target":"MD Anderson Cancer Center","id":"5834"},{"source":"UNK : Drug","target":"University of Texas","id":"5835"},{"source":"UNK : Drug","target":"Merck & Co.","id":"5836"},{"source":"UNK : Indication","target":"pembrolizumab","id":"5837"},{"source":"UNK : Indication","target":"UNK : Drug","id":"5838"},{"source":"plasma cell","target":"pembrolizumab","id":"5839"},{"source":"plasma cell","target":"UNK : Drug","id":"5840"},{"source":"skin neoplasms","target":"pembrolizumab","id":"5841"},{"source":"skin neoplasms","target":"UNK : Drug","id":"5842"},{"source":"plasma cell","target":"pembrolizumab","id":"5843"},{"source":"plasma cell","target":"UNK : Drug","id":"5844"},{"source":"multiple myeloma","target":"pembrolizumab","id":"5845"},{"source":"multiple myeloma","target":"UNK : Drug","id":"5846"},{"source":"carcinoma","target":"pembrolizumab","id":"5847"},{"source":"carcinoma","target":"UNK : Drug","id":"5848"},{"source":"proteinuria","target":"pembrolizumab","id":"5849"},{"source":"proteinuria","target":"UNK : Drug","id":"5850"},{"source":"anticancer","target":"pembrolizumab","id":"5851"},{"source":"anticancer","target":"UNK : Drug","id":"5852"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"5853"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"5854"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"5855"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"5856"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"5857"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5858"},{"source":"Anticancer immunotherapy","target":"proteinuria","id":"5859"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"5860"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"5861"},{"source":"CD19 antagonist","target":"plasma cell","id":"5862"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"5863"},{"source":"CD19 antagonist","target":"plasma cell","id":"5864"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"5865"},{"source":"CD19 antagonist","target":"carcinoma","id":"5866"},{"source":"CD19 antagonist","target":"proteinuria","id":"5867"},{"source":"CD19 antagonist","target":"anticancer","id":"5868"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"5869"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"5870"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"5871"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"5872"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"5873"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5874"},{"source":"Immune checkpoint inhibitor","target":"proteinuria","id":"5875"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"5876"},{"source":"Oncology: Multiple Myeloma","target":"Anticancer immunotherapy","id":"5877"},{"source":"Oncology: Multiple Myeloma","target":"CD19 antagonist","id":"5878"},{"source":"Oncology: Multiple Myeloma","target":"Immune checkpoint inhibitor","id":"5879"},{"source":"pelareorep (u)","target":"Oncolytics Biotech","id":"5880"},{"source":"pembrolizumab","target":"Oncolytics Biotech","id":"5881"},{"source":"neoplastic","target":"pelareorep (u)","id":"5882"},{"source":"neoplastic","target":"pembrolizumab","id":"5883"},{"source":"Immune checkpoint inhibitor","target":"neoplastic","id":"5884"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"5885"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"5886"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"5887"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"5888"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5889"},{"source":"Immune checkpoint inhibitor","target":"proteinuria","id":"5890"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"5891"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"5892"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"5893"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"5894"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"5895"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"5896"},{"source":"NA","target":"neoplastic","id":"5897"},{"source":"NA","target":"liver metastases","id":"5898"},{"source":"NA","target":"alopecia","id":"5899"},{"source":"NA","target":"residual tumor","id":"5900"},{"source":"NA","target":"metastatic","id":"5901"},{"source":"NA","target":"carcinoma","id":"5902"},{"source":"NA","target":"proteinuria","id":"5903"},{"source":"NA","target":"pancreatic cancer","id":"5904"},{"source":"NA","target":"neoplasm metastasis","id":"5905"},{"source":"NA","target":"carcinoma","id":"5906"},{"source":"NA","target":"anticancer","id":"5907"},{"source":"NA","target":"liver neoplasms","id":"5908"},{"source":"NA","target":"pancreatic neoplasms","id":"5909"},{"source":"Anticancer immunotherapy","target":"neoplastic","id":"5910"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"5911"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"5912"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"5913"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"5914"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5915"},{"source":"Anticancer immunotherapy","target":"proteinuria","id":"5916"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"5917"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"5918"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"5919"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"5920"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"5921"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"5922"},{"source":"CD19 antagonist","target":"neoplastic","id":"5923"},{"source":"CD19 antagonist","target":"liver metastases","id":"5924"},{"source":"CD19 antagonist","target":"alopecia","id":"5925"},{"source":"CD19 antagonist","target":"residual tumor","id":"5926"},{"source":"CD19 antagonist","target":"metastatic","id":"5927"},{"source":"CD19 antagonist","target":"carcinoma","id":"5928"},{"source":"CD19 antagonist","target":"proteinuria","id":"5929"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"5930"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"5931"},{"source":"CD19 antagonist","target":"carcinoma","id":"5932"},{"source":"CD19 antagonist","target":"anticancer","id":"5933"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"5934"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"5935"},{"source":"NA","target":"neoplastic","id":"5936"},{"source":"NA","target":"liver metastases","id":"5937"},{"source":"NA","target":"alopecia","id":"5938"},{"source":"NA","target":"residual tumor","id":"5939"},{"source":"NA","target":"metastatic","id":"5940"},{"source":"NA","target":"carcinoma","id":"5941"},{"source":"NA","target":"proteinuria","id":"5942"},{"source":"NA","target":"pancreatic cancer","id":"5943"},{"source":"NA","target":"neoplasm metastasis","id":"5944"},{"source":"NA","target":"carcinoma","id":"5945"},{"source":"NA","target":"anticancer","id":"5946"},{"source":"NA","target":"liver neoplasms","id":"5947"},{"source":"NA","target":"pancreatic neoplasms","id":"5948"},{"source":"NA","target":"neoplastic","id":"5949"},{"source":"NA","target":"liver metastases","id":"5950"},{"source":"NA","target":"alopecia","id":"5951"},{"source":"NA","target":"residual tumor","id":"5952"},{"source":"NA","target":"metastatic","id":"5953"},{"source":"NA","target":"carcinoma","id":"5954"},{"source":"NA","target":"proteinuria","id":"5955"},{"source":"NA","target":"pancreatic cancer","id":"5956"},{"source":"NA","target":"neoplasm metastasis","id":"5957"},{"source":"NA","target":"carcinoma","id":"5958"},{"source":"NA","target":"anticancer","id":"5959"},{"source":"NA","target":"liver neoplasms","id":"5960"},{"source":"NA","target":"pancreatic neoplasms","id":"5961"},{"source":"NA","target":"neoplastic","id":"5962"},{"source":"NA","target":"liver metastases","id":"5963"},{"source":"NA","target":"alopecia","id":"5964"},{"source":"NA","target":"residual tumor","id":"5965"},{"source":"NA","target":"metastatic","id":"5966"},{"source":"NA","target":"carcinoma","id":"5967"},{"source":"NA","target":"proteinuria","id":"5968"},{"source":"NA","target":"pancreatic cancer","id":"5969"},{"source":"NA","target":"neoplasm metastasis","id":"5970"},{"source":"NA","target":"carcinoma","id":"5971"},{"source":"NA","target":"anticancer","id":"5972"},{"source":"NA","target":"liver neoplasms","id":"5973"},{"source":"NA","target":"pancreatic neoplasms","id":"5974"},{"source":"NA","target":"neoplastic","id":"5975"},{"source":"NA","target":"liver metastases","id":"5976"},{"source":"NA","target":"alopecia","id":"5977"},{"source":"NA","target":"residual tumor","id":"5978"},{"source":"NA","target":"metastatic","id":"5979"},{"source":"NA","target":"carcinoma","id":"5980"},{"source":"NA","target":"proteinuria","id":"5981"},{"source":"NA","target":"pancreatic cancer","id":"5982"},{"source":"NA","target":"neoplasm metastasis","id":"5983"},{"source":"NA","target":"carcinoma","id":"5984"},{"source":"NA","target":"anticancer","id":"5985"},{"source":"NA","target":"liver neoplasms","id":"5986"},{"source":"NA","target":"pancreatic neoplasms","id":"5987"},{"source":"Cell cycle inhibitor","target":"neoplastic","id":"5988"},{"source":"Cell cycle inhibitor","target":"liver metastases","id":"5989"},{"source":"Cell cycle inhibitor","target":"alopecia","id":"5990"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"5991"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"5992"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"5993"},{"source":"Cell cycle inhibitor","target":"proteinuria","id":"5994"},{"source":"Cell cycle inhibitor","target":"pancreatic cancer","id":"5995"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"5996"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"5997"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"5998"},{"source":"Cell cycle inhibitor","target":"liver neoplasms","id":"5999"},{"source":"Cell cycle inhibitor","target":"pancreatic neoplasms","id":"6000"},{"source":"Thymidylate synthase inhibitor","target":"neoplastic","id":"6001"},{"source":"Thymidylate synthase inhibitor","target":"liver metastases","id":"6002"},{"source":"Thymidylate synthase inhibitor","target":"alopecia","id":"6003"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"6004"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"6005"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"6006"},{"source":"Thymidylate synthase inhibitor","target":"proteinuria","id":"6007"},{"source":"Thymidylate synthase inhibitor","target":"pancreatic cancer","id":"6008"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"6009"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"6010"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"6011"},{"source":"Thymidylate synthase inhibitor","target":"liver neoplasms","id":"6012"},{"source":"Thymidylate synthase inhibitor","target":"pancreatic neoplasms","id":"6013"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"6014"},{"source":"Oncology: Pancreas","target":"NA","id":"6015"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"6016"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"6017"},{"source":"Oncology: Pancreas","target":"NA","id":"6018"},{"source":"Oncology: Pancreas","target":"NA","id":"6019"},{"source":"Oncology: Pancreas","target":"NA","id":"6020"},{"source":"Oncology: Pancreas","target":"NA","id":"6021"},{"source":"Oncology: Pancreas","target":"Cell cycle inhibitor","id":"6022"},{"source":"Oncology: Pancreas","target":"Thymidylate synthase inhibitor","id":"6023"},{"source":"X4P-001 (u)","target":"X4 Pharmaceuticals","id":"6024"},{"source":"pembrolizumab","target":"X4 Pharmaceuticals","id":"6025"},{"source":"surgical intervention","target":"X4 Pharmaceuticals","id":"6026"},{"source":"UNK : Indication","target":"X4P-001 (u)","id":"6027"},{"source":"UNK : Indication","target":"pembrolizumab","id":"6028"},{"source":"UNK : Indication","target":"surgical intervention","id":"6029"},{"source":"anti-hiv","target":"X4P-001 (u)","id":"6030"},{"source":"anti-hiv","target":"pembrolizumab","id":"6031"},{"source":"anti-hiv","target":"surgical intervention","id":"6032"},{"source":"anti-inflammatory","target":"X4P-001 (u)","id":"6033"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"6034"},{"source":"anti-inflammatory","target":"surgical intervention","id":"6035"},{"source":"melanoma","target":"X4P-001 (u)","id":"6036"},{"source":"melanoma","target":"pembrolizumab","id":"6037"},{"source":"melanoma","target":"surgical intervention","id":"6038"},{"source":"melanoma","target":"X4P-001 (u)","id":"6039"},{"source":"melanoma","target":"pembrolizumab","id":"6040"},{"source":"melanoma","target":"surgical intervention","id":"6041"},{"source":"arthritis","target":"X4P-001 (u)","id":"6042"},{"source":"arthritis","target":"pembrolizumab","id":"6043"},{"source":"arthritis","target":"surgical intervention","id":"6044"},{"source":"skin neoplasms","target":"X4P-001 (u)","id":"6045"},{"source":"skin neoplasms","target":"pembrolizumab","id":"6046"},{"source":"skin neoplasms","target":"surgical intervention","id":"6047"},{"source":"residual tumor","target":"X4P-001 (u)","id":"6048"},{"source":"residual tumor","target":"pembrolizumab","id":"6049"},{"source":"residual tumor","target":"surgical intervention","id":"6050"},{"source":"carcinoma","target":"X4P-001 (u)","id":"6051"},{"source":"carcinoma","target":"pembrolizumab","id":"6052"},{"source":"carcinoma","target":"surgical intervention","id":"6053"},{"source":"inflammation","target":"X4P-001 (u)","id":"6054"},{"source":"inflammation","target":"pembrolizumab","id":"6055"},{"source":"inflammation","target":"surgical intervention","id":"6056"},{"source":"anti-inflammatory","target":"X4P-001 (u)","id":"6057"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"6058"},{"source":"anti-inflammatory","target":"surgical intervention","id":"6059"},{"source":"anticancer","target":"X4P-001 (u)","id":"6060"},{"source":"anticancer","target":"pembrolizumab","id":"6061"},{"source":"anticancer","target":"surgical intervention","id":"6062"},{"source":"hiv infections","target":"X4P-001 (u)","id":"6063"},{"source":"hiv infections","target":"pembrolizumab","id":"6064"},{"source":"hiv infections","target":"surgical intervention","id":"6065"},{"source":"antiarthritic","target":"X4P-001 (u)","id":"6066"},{"source":"antiarthritic","target":"pembrolizumab","id":"6067"},{"source":"antiarthritic","target":"surgical intervention","id":"6068"},{"source":"acquired immunodeficiency syndrome","target":"X4P-001 (u)","id":"6069"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"6070"},{"source":"acquired immunodeficiency syndrome","target":"surgical intervention","id":"6071"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"6072"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"6073"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"6074"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"6075"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"6076"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"6077"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"6078"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"6079"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6080"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"6081"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"6082"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"6083"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"6084"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"6085"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"6086"},{"source":"NA","target":"UNK : Indication","id":"6087"},{"source":"NA","target":"anti-hiv","id":"6088"},{"source":"NA","target":"anti-inflammatory","id":"6089"},{"source":"NA","target":"melanoma","id":"6090"},{"source":"NA","target":"melanoma","id":"6091"},{"source":"NA","target":"arthritis","id":"6092"},{"source":"NA","target":"skin neoplasms","id":"6093"},{"source":"NA","target":"residual tumor","id":"6094"},{"source":"NA","target":"carcinoma","id":"6095"},{"source":"NA","target":"inflammation","id":"6096"},{"source":"NA","target":"anti-inflammatory","id":"6097"},{"source":"NA","target":"anticancer","id":"6098"},{"source":"NA","target":"hiv infections","id":"6099"},{"source":"NA","target":"antiarthritic","id":"6100"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"6101"},{"source":"CXC chemokine receptor 4 antagonist","target":"UNK : Indication","id":"6102"},{"source":"CXC chemokine receptor 4 antagonist","target":"anti-hiv","id":"6103"},{"source":"CXC chemokine receptor 4 antagonist","target":"anti-inflammatory","id":"6104"},{"source":"CXC chemokine receptor 4 antagonist","target":"melanoma","id":"6105"},{"source":"CXC chemokine receptor 4 antagonist","target":"melanoma","id":"6106"},{"source":"CXC chemokine receptor 4 antagonist","target":"arthritis","id":"6107"},{"source":"CXC chemokine receptor 4 antagonist","target":"skin neoplasms","id":"6108"},{"source":"CXC chemokine receptor 4 antagonist","target":"residual tumor","id":"6109"},{"source":"CXC chemokine receptor 4 antagonist","target":"carcinoma","id":"6110"},{"source":"CXC chemokine receptor 4 antagonist","target":"inflammation","id":"6111"},{"source":"CXC chemokine receptor 4 antagonist","target":"anti-inflammatory","id":"6112"},{"source":"CXC chemokine receptor 4 antagonist","target":"anticancer","id":"6113"},{"source":"CXC chemokine receptor 4 antagonist","target":"hiv infections","id":"6114"},{"source":"CXC chemokine receptor 4 antagonist","target":"antiarthritic","id":"6115"},{"source":"CXC chemokine receptor 4 antagonist","target":"acquired immunodeficiency syndrome","id":"6116"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"6117"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"6118"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"6119"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"6120"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"6121"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"6122"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"6123"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"6124"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6125"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"6126"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"6127"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"6128"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"6129"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"6130"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"6131"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"6132"},{"source":"CD19 antagonist","target":"anti-hiv","id":"6133"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"6134"},{"source":"CD19 antagonist","target":"melanoma","id":"6135"},{"source":"CD19 antagonist","target":"melanoma","id":"6136"},{"source":"CD19 antagonist","target":"arthritis","id":"6137"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"6138"},{"source":"CD19 antagonist","target":"residual tumor","id":"6139"},{"source":"CD19 antagonist","target":"carcinoma","id":"6140"},{"source":"CD19 antagonist","target":"inflammation","id":"6141"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"6142"},{"source":"CD19 antagonist","target":"anticancer","id":"6143"},{"source":"CD19 antagonist","target":"hiv infections","id":"6144"},{"source":"CD19 antagonist","target":"antiarthritic","id":"6145"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"6146"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"6147"},{"source":"Oncology: Melanoma","target":"NA","id":"6148"},{"source":"Oncology: Melanoma","target":"CXC chemokine receptor 4 antagonist","id":"6149"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"6150"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"6151"},{"source":"bemcentinib (u)","target":"BerGenBio","id":"6152"},{"source":"bemcentinib (u)","target":"Merck & Co.","id":"6153"},{"source":"pembrolizumab","target":"BerGenBio","id":"6154"},{"source":"pembrolizumab","target":"Merck & Co.","id":"6155"},{"source":"UNK : Indication","target":"bemcentinib (u)","id":"6156"},{"source":"UNK : Indication","target":"pembrolizumab","id":"6157"},{"source":"residual tumor","target":"bemcentinib (u)","id":"6158"},{"source":"residual tumor","target":"pembrolizumab","id":"6159"},{"source":"amenorrheic","target":"bemcentinib (u)","id":"6160"},{"source":"amenorrheic","target":"pembrolizumab","id":"6161"},{"source":"infertility","target":"bemcentinib (u)","id":"6162"},{"source":"infertility","target":"pembrolizumab","id":"6163"},{"source":"alopecia","target":"bemcentinib (u)","id":"6164"},{"source":"alopecia","target":"pembrolizumab","id":"6165"},{"source":"carcinoma","target":"bemcentinib (u)","id":"6166"},{"source":"carcinoma","target":"pembrolizumab","id":"6167"},{"source":"non-small-cell lung","target":"bemcentinib (u)","id":"6168"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"6169"},{"source":"sclc","target":"bemcentinib (u)","id":"6170"},{"source":"sclc","target":"pembrolizumab","id":"6171"},{"source":"anti-tumor","target":"bemcentinib (u)","id":"6172"},{"source":"anti-tumor","target":"pembrolizumab","id":"6173"},{"source":"carcinoma","target":"bemcentinib (u)","id":"6174"},{"source":"carcinoma","target":"pembrolizumab","id":"6175"},{"source":"anticancer","target":"bemcentinib (u)","id":"6176"},{"source":"anticancer","target":"pembrolizumab","id":"6177"},{"source":"liver metastases","target":"bemcentinib (u)","id":"6178"},{"source":"liver metastases","target":"pembrolizumab","id":"6179"},{"source":"non-small-cell lung","target":"bemcentinib (u)","id":"6180"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"6181"},{"source":"carcinoma","target":"bemcentinib (u)","id":"6182"},{"source":"carcinoma","target":"pembrolizumab","id":"6183"},{"source":"amenorrheic","target":"bemcentinib (u)","id":"6184"},{"source":"amenorrheic","target":"pembrolizumab","id":"6185"},{"source":"carcinoma","target":"bemcentinib (u)","id":"6186"},{"source":"carcinoma","target":"pembrolizumab","id":"6187"},{"source":"carcinoma","target":"bemcentinib (u)","id":"6188"},{"source":"carcinoma","target":"pembrolizumab","id":"6189"},{"source":"lung neoplasms","target":"bemcentinib (u)","id":"6190"},{"source":"lung neoplasms","target":"pembrolizumab","id":"6191"},{"source":"liver neoplasms","target":"bemcentinib (u)","id":"6192"},{"source":"liver neoplasms","target":"pembrolizumab","id":"6193"},{"source":"sterility","target":"bemcentinib (u)","id":"6194"},{"source":"sterility","target":"pembrolizumab","id":"6195"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"6196"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"6197"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"6198"},{"source":"Anticancer immunotherapy","target":"infertility","id":"6199"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"6200"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6201"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"6202"},{"source":"Anticancer immunotherapy","target":"sclc","id":"6203"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"6204"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6205"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"6206"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"6207"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"6208"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6209"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"6210"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6211"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6212"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"6213"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"6214"},{"source":"Anticancer immunotherapy","target":"sterility","id":"6215"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"6216"},{"source":"CD19 antagonist","target":"residual tumor","id":"6217"},{"source":"CD19 antagonist","target":"amenorrheic","id":"6218"},{"source":"CD19 antagonist","target":"infertility","id":"6219"},{"source":"CD19 antagonist","target":"alopecia","id":"6220"},{"source":"CD19 antagonist","target":"carcinoma","id":"6221"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"6222"},{"source":"CD19 antagonist","target":"sclc","id":"6223"},{"source":"CD19 antagonist","target":"anti-tumor","id":"6224"},{"source":"CD19 antagonist","target":"carcinoma","id":"6225"},{"source":"CD19 antagonist","target":"anticancer","id":"6226"},{"source":"CD19 antagonist","target":"liver metastases","id":"6227"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"6228"},{"source":"CD19 antagonist","target":"carcinoma","id":"6229"},{"source":"CD19 antagonist","target":"amenorrheic","id":"6230"},{"source":"CD19 antagonist","target":"carcinoma","id":"6231"},{"source":"CD19 antagonist","target":"carcinoma","id":"6232"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"6233"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"6234"},{"source":"CD19 antagonist","target":"sterility","id":"6235"},{"source":"NA","target":"UNK : Indication","id":"6236"},{"source":"NA","target":"residual tumor","id":"6237"},{"source":"NA","target":"amenorrheic","id":"6238"},{"source":"NA","target":"infertility","id":"6239"},{"source":"NA","target":"alopecia","id":"6240"},{"source":"NA","target":"carcinoma","id":"6241"},{"source":"NA","target":"non-small-cell lung","id":"6242"},{"source":"NA","target":"sclc","id":"6243"},{"source":"NA","target":"anti-tumor","id":"6244"},{"source":"NA","target":"carcinoma","id":"6245"},{"source":"NA","target":"anticancer","id":"6246"},{"source":"NA","target":"liver metastases","id":"6247"},{"source":"NA","target":"non-small-cell lung","id":"6248"},{"source":"NA","target":"carcinoma","id":"6249"},{"source":"NA","target":"amenorrheic","id":"6250"},{"source":"NA","target":"carcinoma","id":"6251"},{"source":"NA","target":"carcinoma","id":"6252"},{"source":"NA","target":"lung neoplasms","id":"6253"},{"source":"NA","target":"liver neoplasms","id":"6254"},{"source":"NA","target":"sterility","id":"6255"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"6256"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"6257"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"6258"},{"source":"Immune checkpoint inhibitor","target":"infertility","id":"6259"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"6260"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6261"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"6262"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"6263"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"6264"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6265"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"6266"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"6267"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"6268"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6269"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"6270"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6271"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6272"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"6273"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"6274"},{"source":"Immune checkpoint inhibitor","target":"sterility","id":"6275"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"6276"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"6277"},{"source":"Oncology: Lung","target":"NA","id":"6278"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"6279"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"6280"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"6281"},{"source":"Non-Small Cell","target":"NA","id":"6282"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"6283"},{"source":"breast cancer vaccine","target":"BriaCell","id":"6284"},{"source":"BriaCell (u)","target":"BriaCell","id":"6285"},{"source":"cyclophosphamide","target":"BriaCell","id":"6286"},{"source":"interferon alpha-2b","target":"BriaCell","id":"6287"},{"source":"unspecified","target":"BriaCell","id":"6288"},{"source":"ipilimumab","target":"BriaCell","id":"6289"},{"source":"pembrolizumab","target":"BriaCell","id":"6290"},{"source":"metastatic","target":"breast cancer vaccine","id":"6291"},{"source":"metastatic","target":"BriaCell (u)","id":"6292"},{"source":"metastatic","target":"cyclophosphamide","id":"6293"},{"source":"metastatic","target":"interferon alpha-2b","id":"6294"},{"source":"metastatic","target":"unspecified","id":"6295"},{"source":"metastatic","target":"ipilimumab","id":"6296"},{"source":"metastatic","target":"pembrolizumab","id":"6297"},{"source":"ovarian neoplasms","target":"breast cancer vaccine","id":"6298"},{"source":"ovarian neoplasms","target":"BriaCell (u)","id":"6299"},{"source":"ovarian neoplasms","target":"cyclophosphamide","id":"6300"},{"source":"ovarian neoplasms","target":"interferon alpha-2b","id":"6301"},{"source":"ovarian neoplasms","target":"unspecified","id":"6302"},{"source":"ovarian neoplasms","target":"ipilimumab","id":"6303"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"6304"},{"source":"anti-hiv","target":"breast cancer vaccine","id":"6305"},{"source":"anti-hiv","target":"BriaCell (u)","id":"6306"},{"source":"anti-hiv","target":"cyclophosphamide","id":"6307"},{"source":"anti-hiv","target":"interferon alpha-2b","id":"6308"},{"source":"anti-hiv","target":"unspecified","id":"6309"},{"source":"anti-hiv","target":"ipilimumab","id":"6310"},{"source":"anti-hiv","target":"pembrolizumab","id":"6311"},{"source":"metastatic","target":"breast cancer vaccine","id":"6312"},{"source":"metastatic","target":"BriaCell (u)","id":"6313"},{"source":"metastatic","target":"cyclophosphamide","id":"6314"},{"source":"metastatic","target":"interferon alpha-2b","id":"6315"},{"source":"metastatic","target":"unspecified","id":"6316"},{"source":"metastatic","target":"ipilimumab","id":"6317"},{"source":"metastatic","target":"pembrolizumab","id":"6318"},{"source":"residual tumor","target":"breast cancer vaccine","id":"6319"},{"source":"residual tumor","target":"BriaCell (u)","id":"6320"},{"source":"residual tumor","target":"cyclophosphamide","id":"6321"},{"source":"residual tumor","target":"interferon alpha-2b","id":"6322"},{"source":"residual tumor","target":"unspecified","id":"6323"},{"source":"residual tumor","target":"ipilimumab","id":"6324"},{"source":"residual tumor","target":"pembrolizumab","id":"6325"},{"source":"residual tumor","target":"breast cancer vaccine","id":"6326"},{"source":"residual tumor","target":"BriaCell (u)","id":"6327"},{"source":"residual tumor","target":"cyclophosphamide","id":"6328"},{"source":"residual tumor","target":"interferon alpha-2b","id":"6329"},{"source":"residual tumor","target":"unspecified","id":"6330"},{"source":"residual tumor","target":"ipilimumab","id":"6331"},{"source":"residual tumor","target":"pembrolizumab","id":"6332"},{"source":"breast neoplasms","target":"breast cancer vaccine","id":"6333"},{"source":"breast neoplasms","target":"BriaCell (u)","id":"6334"},{"source":"breast neoplasms","target":"cyclophosphamide","id":"6335"},{"source":"breast neoplasms","target":"interferon alpha-2b","id":"6336"},{"source":"breast neoplasms","target":"unspecified","id":"6337"},{"source":"breast neoplasms","target":"ipilimumab","id":"6338"},{"source":"breast neoplasms","target":"pembrolizumab","id":"6339"},{"source":"cerebellar neoplasms","target":"breast cancer vaccine","id":"6340"},{"source":"cerebellar neoplasms","target":"BriaCell (u)","id":"6341"},{"source":"cerebellar neoplasms","target":"cyclophosphamide","id":"6342"},{"source":"cerebellar neoplasms","target":"interferon alpha-2b","id":"6343"},{"source":"cerebellar neoplasms","target":"unspecified","id":"6344"},{"source":"cerebellar neoplasms","target":"ipilimumab","id":"6345"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"6346"},{"source":"carcinoma","target":"breast cancer vaccine","id":"6347"},{"source":"carcinoma","target":"BriaCell (u)","id":"6348"},{"source":"carcinoma","target":"cyclophosphamide","id":"6349"},{"source":"carcinoma","target":"interferon alpha-2b","id":"6350"},{"source":"carcinoma","target":"unspecified","id":"6351"},{"source":"carcinoma","target":"ipilimumab","id":"6352"},{"source":"carcinoma","target":"pembrolizumab","id":"6353"},{"source":"brain metastases","target":"breast cancer vaccine","id":"6354"},{"source":"brain metastases","target":"BriaCell (u)","id":"6355"},{"source":"brain metastases","target":"cyclophosphamide","id":"6356"},{"source":"brain metastases","target":"interferon alpha-2b","id":"6357"},{"source":"brain metastases","target":"unspecified","id":"6358"},{"source":"brain metastases","target":"ipilimumab","id":"6359"},{"source":"brain metastases","target":"pembrolizumab","id":"6360"},{"source":"neoplasm metastasis","target":"breast cancer vaccine","id":"6361"},{"source":"neoplasm metastasis","target":"BriaCell (u)","id":"6362"},{"source":"neoplasm metastasis","target":"cyclophosphamide","id":"6363"},{"source":"neoplasm metastasis","target":"interferon alpha-2b","id":"6364"},{"source":"neoplasm metastasis","target":"unspecified","id":"6365"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"6366"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"6367"},{"source":"anticancer","target":"breast cancer vaccine","id":"6368"},{"source":"anticancer","target":"BriaCell (u)","id":"6369"},{"source":"anticancer","target":"cyclophosphamide","id":"6370"},{"source":"anticancer","target":"interferon alpha-2b","id":"6371"},{"source":"anticancer","target":"unspecified","id":"6372"},{"source":"anticancer","target":"ipilimumab","id":"6373"},{"source":"anticancer","target":"pembrolizumab","id":"6374"},{"source":"hiv infections","target":"breast cancer vaccine","id":"6375"},{"source":"hiv infections","target":"BriaCell (u)","id":"6376"},{"source":"hiv infections","target":"cyclophosphamide","id":"6377"},{"source":"hiv infections","target":"interferon alpha-2b","id":"6378"},{"source":"hiv infections","target":"unspecified","id":"6379"},{"source":"hiv infections","target":"ipilimumab","id":"6380"},{"source":"hiv infections","target":"pembrolizumab","id":"6381"},{"source":"triple-negative breast cancer","target":"breast cancer vaccine","id":"6382"},{"source":"triple-negative breast cancer","target":"BriaCell (u)","id":"6383"},{"source":"triple-negative breast cancer","target":"cyclophosphamide","id":"6384"},{"source":"triple-negative breast cancer","target":"interferon alpha-2b","id":"6385"},{"source":"triple-negative breast cancer","target":"unspecified","id":"6386"},{"source":"triple-negative breast cancer","target":"ipilimumab","id":"6387"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"6388"},{"source":"acquired immunodeficiency syndrome","target":"breast cancer vaccine","id":"6389"},{"source":"acquired immunodeficiency syndrome","target":"BriaCell (u)","id":"6390"},{"source":"acquired immunodeficiency syndrome","target":"cyclophosphamide","id":"6391"},{"source":"acquired immunodeficiency syndrome","target":"interferon alpha-2b","id":"6392"},{"source":"acquired immunodeficiency syndrome","target":"unspecified","id":"6393"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"6394"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"6395"},{"source":"Immunosuppressant","target":"metastatic","id":"6396"},{"source":"Immunosuppressant","target":"ovarian neoplasms","id":"6397"},{"source":"Immunosuppressant","target":"anti-hiv","id":"6398"},{"source":"Immunosuppressant","target":"metastatic","id":"6399"},{"source":"Immunosuppressant","target":"residual tumor","id":"6400"},{"source":"Immunosuppressant","target":"residual tumor","id":"6401"},{"source":"Immunosuppressant","target":"breast neoplasms","id":"6402"},{"source":"Immunosuppressant","target":"cerebellar neoplasms","id":"6403"},{"source":"Immunosuppressant","target":"carcinoma","id":"6404"},{"source":"Immunosuppressant","target":"brain metastases","id":"6405"},{"source":"Immunosuppressant","target":"neoplasm metastasis","id":"6406"},{"source":"Immunosuppressant","target":"anticancer","id":"6407"},{"source":"Immunosuppressant","target":"hiv infections","id":"6408"},{"source":"Immunosuppressant","target":"triple-negative breast cancer","id":"6409"},{"source":"Immunosuppressant","target":"acquired immunodeficiency syndrome","id":"6410"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"6411"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"6412"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"6413"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"6414"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"6415"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"6416"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"6417"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"6418"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6419"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"6420"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"6421"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"6422"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"6423"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"6424"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"6425"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"6426"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"6427"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"6428"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"6429"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"6430"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"6431"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"6432"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"6433"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6434"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"6435"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"6436"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"6437"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"6438"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"6439"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"6440"},{"source":"CD19 antagonist","target":"metastatic","id":"6441"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"6442"},{"source":"CD19 antagonist","target":"anti-hiv","id":"6443"},{"source":"CD19 antagonist","target":"metastatic","id":"6444"},{"source":"CD19 antagonist","target":"residual tumor","id":"6445"},{"source":"CD19 antagonist","target":"residual tumor","id":"6446"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"6447"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"6448"},{"source":"CD19 antagonist","target":"carcinoma","id":"6449"},{"source":"CD19 antagonist","target":"brain metastases","id":"6450"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"6451"},{"source":"CD19 antagonist","target":"anticancer","id":"6452"},{"source":"CD19 antagonist","target":"hiv infections","id":"6453"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"6454"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"6455"},{"source":"NA","target":"metastatic","id":"6456"},{"source":"NA","target":"ovarian neoplasms","id":"6457"},{"source":"NA","target":"anti-hiv","id":"6458"},{"source":"NA","target":"metastatic","id":"6459"},{"source":"NA","target":"residual tumor","id":"6460"},{"source":"NA","target":"residual tumor","id":"6461"},{"source":"NA","target":"breast neoplasms","id":"6462"},{"source":"NA","target":"cerebellar neoplasms","id":"6463"},{"source":"NA","target":"carcinoma","id":"6464"},{"source":"NA","target":"brain metastases","id":"6465"},{"source":"NA","target":"neoplasm metastasis","id":"6466"},{"source":"NA","target":"anticancer","id":"6467"},{"source":"NA","target":"hiv infections","id":"6468"},{"source":"NA","target":"triple-negative breast cancer","id":"6469"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"6470"},{"source":"Interferon receptor agonist","target":"metastatic","id":"6471"},{"source":"Interferon receptor agonist","target":"ovarian neoplasms","id":"6472"},{"source":"Interferon receptor agonist","target":"anti-hiv","id":"6473"},{"source":"Interferon receptor agonist","target":"metastatic","id":"6474"},{"source":"Interferon receptor agonist","target":"residual tumor","id":"6475"},{"source":"Interferon receptor agonist","target":"residual tumor","id":"6476"},{"source":"Interferon receptor agonist","target":"breast neoplasms","id":"6477"},{"source":"Interferon receptor agonist","target":"cerebellar neoplasms","id":"6478"},{"source":"Interferon receptor agonist","target":"carcinoma","id":"6479"},{"source":"Interferon receptor agonist","target":"brain metastases","id":"6480"},{"source":"Interferon receptor agonist","target":"neoplasm metastasis","id":"6481"},{"source":"Interferon receptor agonist","target":"anticancer","id":"6482"},{"source":"Interferon receptor agonist","target":"hiv infections","id":"6483"},{"source":"Interferon receptor agonist","target":"triple-negative breast cancer","id":"6484"},{"source":"Interferon receptor agonist","target":"acquired immunodeficiency syndrome","id":"6485"},{"source":"CTLA4 antagonist","target":"metastatic","id":"6486"},{"source":"CTLA4 antagonist","target":"ovarian neoplasms","id":"6487"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"6488"},{"source":"CTLA4 antagonist","target":"metastatic","id":"6489"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"6490"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"6491"},{"source":"CTLA4 antagonist","target":"breast neoplasms","id":"6492"},{"source":"CTLA4 antagonist","target":"cerebellar neoplasms","id":"6493"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"6494"},{"source":"CTLA4 antagonist","target":"brain metastases","id":"6495"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"6496"},{"source":"CTLA4 antagonist","target":"anticancer","id":"6497"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"6498"},{"source":"CTLA4 antagonist","target":"triple-negative breast cancer","id":"6499"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"6500"},{"source":"T helper cell stimulant","target":"metastatic","id":"6501"},{"source":"T helper cell stimulant","target":"ovarian neoplasms","id":"6502"},{"source":"T helper cell stimulant","target":"anti-hiv","id":"6503"},{"source":"T helper cell stimulant","target":"metastatic","id":"6504"},{"source":"T helper cell stimulant","target":"residual tumor","id":"6505"},{"source":"T helper cell stimulant","target":"residual tumor","id":"6506"},{"source":"T helper cell stimulant","target":"breast neoplasms","id":"6507"},{"source":"T helper cell stimulant","target":"cerebellar neoplasms","id":"6508"},{"source":"T helper cell stimulant","target":"carcinoma","id":"6509"},{"source":"T helper cell stimulant","target":"brain metastases","id":"6510"},{"source":"T helper cell stimulant","target":"neoplasm metastasis","id":"6511"},{"source":"T helper cell stimulant","target":"anticancer","id":"6512"},{"source":"T helper cell stimulant","target":"hiv infections","id":"6513"},{"source":"T helper cell stimulant","target":"triple-negative breast cancer","id":"6514"},{"source":"T helper cell stimulant","target":"acquired immunodeficiency syndrome","id":"6515"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"metastatic","id":"6516"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"ovarian neoplasms","id":"6517"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anti-hiv","id":"6518"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"metastatic","id":"6519"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"6520"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"6521"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"breast neoplasms","id":"6522"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"cerebellar neoplasms","id":"6523"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"6524"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"brain metastases","id":"6525"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"neoplasm metastasis","id":"6526"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"6527"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"hiv infections","id":"6528"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"triple-negative breast cancer","id":"6529"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"acquired immunodeficiency syndrome","id":"6530"},{"source":"Oncology: Breast","target":"Immunosuppressant","id":"6531"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"6532"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"6533"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"6534"},{"source":"Oncology: Breast","target":"NA","id":"6535"},{"source":"Oncology: Breast","target":"Interferon receptor agonist","id":"6536"},{"source":"Oncology: Breast","target":"CTLA4 antagonist","id":"6537"},{"source":"Oncology: Breast","target":"T helper cell stimulant","id":"6538"},{"source":"Oncology: Breast","target":"Granulocyte macrophage colony stimulating factor agonist","id":"6539"},{"source":"pembrolizumab","target":"(Other Cooperative Group)","id":"6540"},{"source":"bevacizumab","target":"(Other Cooperative Group)","id":"6541"},{"source":"carboplatin","target":"(Other Cooperative Group)","id":"6542"},{"source":"nab-paclitaxel (IV)","target":"(Other Cooperative Group)","id":"6543"},{"source":"UNK : Indication","target":"pembrolizumab","id":"6544"},{"source":"UNK : Indication","target":"bevacizumab","id":"6545"},{"source":"UNK : Indication","target":"carboplatin","id":"6546"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"6547"},{"source":"abdominal metastasis","target":"pembrolizumab","id":"6548"},{"source":"abdominal metastasis","target":"bevacizumab","id":"6549"},{"source":"abdominal metastasis","target":"carboplatin","id":"6550"},{"source":"abdominal metastasis","target":"nab-paclitaxel (IV)","id":"6551"},{"source":"carcinoma","target":"pembrolizumab","id":"6552"},{"source":"carcinoma","target":"bevacizumab","id":"6553"},{"source":"carcinoma","target":"carboplatin","id":"6554"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"6555"},{"source":"ovarian cancer","target":"pembrolizumab","id":"6556"},{"source":"ovarian cancer","target":"bevacizumab","id":"6557"},{"source":"ovarian cancer","target":"carboplatin","id":"6558"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"6559"},{"source":"ovarian cancer","target":"pembrolizumab","id":"6560"},{"source":"ovarian cancer","target":"bevacizumab","id":"6561"},{"source":"ovarian cancer","target":"carboplatin","id":"6562"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"6563"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"6564"},{"source":"ovarian neoplasms","target":"bevacizumab","id":"6565"},{"source":"ovarian neoplasms","target":"carboplatin","id":"6566"},{"source":"ovarian neoplasms","target":"nab-paclitaxel (IV)","id":"6567"},{"source":"liver metastases","target":"pembrolizumab","id":"6568"},{"source":"liver metastases","target":"bevacizumab","id":"6569"},{"source":"liver metastases","target":"carboplatin","id":"6570"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"6571"},{"source":"carcinoma","target":"pembrolizumab","id":"6572"},{"source":"carcinoma","target":"bevacizumab","id":"6573"},{"source":"carcinoma","target":"carboplatin","id":"6574"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"6575"},{"source":"liver metastases","target":"pembrolizumab","id":"6576"},{"source":"liver metastases","target":"bevacizumab","id":"6577"},{"source":"liver metastases","target":"carboplatin","id":"6578"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"6579"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"6580"},{"source":"peritoneal neoplasms","target":"bevacizumab","id":"6581"},{"source":"peritoneal neoplasms","target":"carboplatin","id":"6582"},{"source":"peritoneal neoplasms","target":"nab-paclitaxel (IV)","id":"6583"},{"source":"abdominal neoplasms","target":"pembrolizumab","id":"6584"},{"source":"abdominal neoplasms","target":"bevacizumab","id":"6585"},{"source":"abdominal neoplasms","target":"carboplatin","id":"6586"},{"source":"abdominal neoplasms","target":"nab-paclitaxel (IV)","id":"6587"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"6588"},{"source":"fallopian tube neoplasms","target":"bevacizumab","id":"6589"},{"source":"fallopian tube neoplasms","target":"carboplatin","id":"6590"},{"source":"fallopian tube neoplasms","target":"nab-paclitaxel (IV)","id":"6591"},{"source":"carcinoma","target":"pembrolizumab","id":"6592"},{"source":"carcinoma","target":"bevacizumab","id":"6593"},{"source":"carcinoma","target":"carboplatin","id":"6594"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"6595"},{"source":"residual tumor","target":"pembrolizumab","id":"6596"},{"source":"residual tumor","target":"bevacizumab","id":"6597"},{"source":"residual tumor","target":"carboplatin","id":"6598"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"6599"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"6600"},{"source":"neoplasm metastasis","target":"bevacizumab","id":"6601"},{"source":"neoplasm metastasis","target":"carboplatin","id":"6602"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"6603"},{"source":"anticancer","target":"pembrolizumab","id":"6604"},{"source":"anticancer","target":"bevacizumab","id":"6605"},{"source":"anticancer","target":"carboplatin","id":"6606"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"6607"},{"source":"liver neoplasms","target":"pembrolizumab","id":"6608"},{"source":"liver neoplasms","target":"bevacizumab","id":"6609"},{"source":"liver neoplasms","target":"carboplatin","id":"6610"},{"source":"liver neoplasms","target":"nab-paclitaxel (IV)","id":"6611"},{"source":"carcinoma","target":"pembrolizumab","id":"6612"},{"source":"carcinoma","target":"bevacizumab","id":"6613"},{"source":"carcinoma","target":"carboplatin","id":"6614"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"6615"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"6616"},{"source":"Immune checkpoint inhibitor","target":"abdominal metastasis","id":"6617"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6618"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"6619"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"6620"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"6621"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"6622"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6623"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"6624"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"6625"},{"source":"Immune checkpoint inhibitor","target":"abdominal neoplasms","id":"6626"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"6627"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6628"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"6629"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"6630"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"6631"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"6632"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6633"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"6634"},{"source":"Anticancer immunotherapy","target":"abdominal metastasis","id":"6635"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6636"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"6637"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"6638"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"6639"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"6640"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6641"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"6642"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"6643"},{"source":"Anticancer immunotherapy","target":"abdominal neoplasms","id":"6644"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"6645"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6646"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"6647"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"6648"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"6649"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"6650"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6651"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"6652"},{"source":"CD19 antagonist","target":"abdominal metastasis","id":"6653"},{"source":"CD19 antagonist","target":"carcinoma","id":"6654"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"6655"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"6656"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"6657"},{"source":"CD19 antagonist","target":"liver metastases","id":"6658"},{"source":"CD19 antagonist","target":"carcinoma","id":"6659"},{"source":"CD19 antagonist","target":"liver metastases","id":"6660"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"6661"},{"source":"CD19 antagonist","target":"abdominal neoplasms","id":"6662"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"6663"},{"source":"CD19 antagonist","target":"carcinoma","id":"6664"},{"source":"CD19 antagonist","target":"residual tumor","id":"6665"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"6666"},{"source":"CD19 antagonist","target":"anticancer","id":"6667"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"6668"},{"source":"CD19 antagonist","target":"carcinoma","id":"6669"},{"source":"NA","target":"UNK : Indication","id":"6670"},{"source":"NA","target":"abdominal metastasis","id":"6671"},{"source":"NA","target":"carcinoma","id":"6672"},{"source":"NA","target":"ovarian cancer","id":"6673"},{"source":"NA","target":"ovarian cancer","id":"6674"},{"source":"NA","target":"ovarian neoplasms","id":"6675"},{"source":"NA","target":"liver metastases","id":"6676"},{"source":"NA","target":"carcinoma","id":"6677"},{"source":"NA","target":"liver metastases","id":"6678"},{"source":"NA","target":"peritoneal neoplasms","id":"6679"},{"source":"NA","target":"abdominal neoplasms","id":"6680"},{"source":"NA","target":"fallopian tube neoplasms","id":"6681"},{"source":"NA","target":"carcinoma","id":"6682"},{"source":"NA","target":"residual tumor","id":"6683"},{"source":"NA","target":"neoplasm metastasis","id":"6684"},{"source":"NA","target":"anticancer","id":"6685"},{"source":"NA","target":"liver neoplasms","id":"6686"},{"source":"NA","target":"carcinoma","id":"6687"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"6688"},{"source":"Beta tubulin antagonist","target":"abdominal metastasis","id":"6689"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"6690"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"6691"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"6692"},{"source":"Beta tubulin antagonist","target":"ovarian neoplasms","id":"6693"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"6694"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"6695"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"6696"},{"source":"Beta tubulin antagonist","target":"peritoneal neoplasms","id":"6697"},{"source":"Beta tubulin antagonist","target":"abdominal neoplasms","id":"6698"},{"source":"Beta tubulin antagonist","target":"fallopian tube neoplasms","id":"6699"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"6700"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"6701"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"6702"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"6703"},{"source":"Beta tubulin antagonist","target":"liver neoplasms","id":"6704"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"6705"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"6706"},{"source":"Microtubule stimulant","target":"abdominal metastasis","id":"6707"},{"source":"Microtubule stimulant","target":"carcinoma","id":"6708"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"6709"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"6710"},{"source":"Microtubule stimulant","target":"ovarian neoplasms","id":"6711"},{"source":"Microtubule stimulant","target":"liver metastases","id":"6712"},{"source":"Microtubule stimulant","target":"carcinoma","id":"6713"},{"source":"Microtubule stimulant","target":"liver metastases","id":"6714"},{"source":"Microtubule stimulant","target":"peritoneal neoplasms","id":"6715"},{"source":"Microtubule stimulant","target":"abdominal neoplasms","id":"6716"},{"source":"Microtubule stimulant","target":"fallopian tube neoplasms","id":"6717"},{"source":"Microtubule stimulant","target":"carcinoma","id":"6718"},{"source":"Microtubule stimulant","target":"residual tumor","id":"6719"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"6720"},{"source":"Microtubule stimulant","target":"anticancer","id":"6721"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"6722"},{"source":"Microtubule stimulant","target":"carcinoma","id":"6723"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"6724"},{"source":"Angiogenesis inhibitor","target":"abdominal metastasis","id":"6725"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"6726"},{"source":"Angiogenesis inhibitor","target":"ovarian cancer","id":"6727"},{"source":"Angiogenesis inhibitor","target":"ovarian cancer","id":"6728"},{"source":"Angiogenesis inhibitor","target":"ovarian neoplasms","id":"6729"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"6730"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"6731"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"6732"},{"source":"Angiogenesis inhibitor","target":"peritoneal neoplasms","id":"6733"},{"source":"Angiogenesis inhibitor","target":"abdominal neoplasms","id":"6734"},{"source":"Angiogenesis inhibitor","target":"fallopian tube neoplasms","id":"6735"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"6736"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"6737"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"6738"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"6739"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"6740"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"6741"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"6742"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"abdominal metastasis","id":"6743"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"6744"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian cancer","id":"6745"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian cancer","id":"6746"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian neoplasms","id":"6747"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver metastases","id":"6748"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"6749"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver metastases","id":"6750"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"peritoneal neoplasms","id":"6751"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"abdominal neoplasms","id":"6752"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"fallopian tube neoplasms","id":"6753"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"6754"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"6755"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"neoplasm metastasis","id":"6756"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"6757"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver neoplasms","id":"6758"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"6759"},{"source":"Taxane","target":"UNK : Indication","id":"6760"},{"source":"Taxane","target":"abdominal metastasis","id":"6761"},{"source":"Taxane","target":"carcinoma","id":"6762"},{"source":"Taxane","target":"ovarian cancer","id":"6763"},{"source":"Taxane","target":"ovarian cancer","id":"6764"},{"source":"Taxane","target":"ovarian neoplasms","id":"6765"},{"source":"Taxane","target":"liver metastases","id":"6766"},{"source":"Taxane","target":"carcinoma","id":"6767"},{"source":"Taxane","target":"liver metastases","id":"6768"},{"source":"Taxane","target":"peritoneal neoplasms","id":"6769"},{"source":"Taxane","target":"abdominal neoplasms","id":"6770"},{"source":"Taxane","target":"fallopian tube neoplasms","id":"6771"},{"source":"Taxane","target":"carcinoma","id":"6772"},{"source":"Taxane","target":"residual tumor","id":"6773"},{"source":"Taxane","target":"neoplasm metastasis","id":"6774"},{"source":"Taxane","target":"anticancer","id":"6775"},{"source":"Taxane","target":"liver neoplasms","id":"6776"},{"source":"Taxane","target":"carcinoma","id":"6777"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"6778"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"6779"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"6780"},{"source":"Oncology: (N/A)","target":"NA","id":"6781"},{"source":"Oncology: (N/A)","target":"Beta tubulin antagonist","id":"6782"},{"source":"Oncology: (N/A)","target":"Microtubule stimulant","id":"6783"},{"source":"Oncology: (N/A)","target":"Angiogenesis inhibitor","id":"6784"},{"source":"Oncology: (N/A)","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"6785"},{"source":"Oncology: (N/A)","target":"Taxane","id":"6786"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"6787"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"6788"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"6789"},{"source":"Oncology: Ovarian","target":"NA","id":"6790"},{"source":"Oncology: Ovarian","target":"Beta tubulin antagonist","id":"6791"},{"source":"Oncology: Ovarian","target":"Microtubule stimulant","id":"6792"},{"source":"Oncology: Ovarian","target":"Angiogenesis inhibitor","id":"6793"},{"source":"Oncology: Ovarian","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"6794"},{"source":"Oncology: Ovarian","target":"Taxane","id":"6795"},{"source":"pembrolizumab","target":"(Other Cooperative Group)","id":"6796"},{"source":"bevacizumab","target":"(Other Cooperative Group)","id":"6797"},{"source":"carboplatin","target":"(Other Cooperative Group)","id":"6798"},{"source":"nab-paclitaxel (IV)","target":"(Other Cooperative Group)","id":"6799"},{"source":"UNK : Indication","target":"pembrolizumab","id":"6800"},{"source":"UNK : Indication","target":"bevacizumab","id":"6801"},{"source":"UNK : Indication","target":"carboplatin","id":"6802"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"6803"},{"source":"abdominal metastasis","target":"pembrolizumab","id":"6804"},{"source":"abdominal metastasis","target":"bevacizumab","id":"6805"},{"source":"abdominal metastasis","target":"carboplatin","id":"6806"},{"source":"abdominal metastasis","target":"nab-paclitaxel (IV)","id":"6807"},{"source":"carcinoma","target":"pembrolizumab","id":"6808"},{"source":"carcinoma","target":"bevacizumab","id":"6809"},{"source":"carcinoma","target":"carboplatin","id":"6810"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"6811"},{"source":"ovarian cancer","target":"pembrolizumab","id":"6812"},{"source":"ovarian cancer","target":"bevacizumab","id":"6813"},{"source":"ovarian cancer","target":"carboplatin","id":"6814"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"6815"},{"source":"ovarian cancer","target":"pembrolizumab","id":"6816"},{"source":"ovarian cancer","target":"bevacizumab","id":"6817"},{"source":"ovarian cancer","target":"carboplatin","id":"6818"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"6819"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"6820"},{"source":"ovarian neoplasms","target":"bevacizumab","id":"6821"},{"source":"ovarian neoplasms","target":"carboplatin","id":"6822"},{"source":"ovarian neoplasms","target":"nab-paclitaxel (IV)","id":"6823"},{"source":"liver metastases","target":"pembrolizumab","id":"6824"},{"source":"liver metastases","target":"bevacizumab","id":"6825"},{"source":"liver metastases","target":"carboplatin","id":"6826"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"6827"},{"source":"carcinoma","target":"pembrolizumab","id":"6828"},{"source":"carcinoma","target":"bevacizumab","id":"6829"},{"source":"carcinoma","target":"carboplatin","id":"6830"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"6831"},{"source":"liver metastases","target":"pembrolizumab","id":"6832"},{"source":"liver metastases","target":"bevacizumab","id":"6833"},{"source":"liver metastases","target":"carboplatin","id":"6834"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"6835"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"6836"},{"source":"peritoneal neoplasms","target":"bevacizumab","id":"6837"},{"source":"peritoneal neoplasms","target":"carboplatin","id":"6838"},{"source":"peritoneal neoplasms","target":"nab-paclitaxel (IV)","id":"6839"},{"source":"abdominal neoplasms","target":"pembrolizumab","id":"6840"},{"source":"abdominal neoplasms","target":"bevacizumab","id":"6841"},{"source":"abdominal neoplasms","target":"carboplatin","id":"6842"},{"source":"abdominal neoplasms","target":"nab-paclitaxel (IV)","id":"6843"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"6844"},{"source":"fallopian tube neoplasms","target":"bevacizumab","id":"6845"},{"source":"fallopian tube neoplasms","target":"carboplatin","id":"6846"},{"source":"fallopian tube neoplasms","target":"nab-paclitaxel (IV)","id":"6847"},{"source":"carcinoma","target":"pembrolizumab","id":"6848"},{"source":"carcinoma","target":"bevacizumab","id":"6849"},{"source":"carcinoma","target":"carboplatin","id":"6850"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"6851"},{"source":"residual tumor","target":"pembrolizumab","id":"6852"},{"source":"residual tumor","target":"bevacizumab","id":"6853"},{"source":"residual tumor","target":"carboplatin","id":"6854"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"6855"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"6856"},{"source":"neoplasm metastasis","target":"bevacizumab","id":"6857"},{"source":"neoplasm metastasis","target":"carboplatin","id":"6858"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"6859"},{"source":"anticancer","target":"pembrolizumab","id":"6860"},{"source":"anticancer","target":"bevacizumab","id":"6861"},{"source":"anticancer","target":"carboplatin","id":"6862"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"6863"},{"source":"liver neoplasms","target":"pembrolizumab","id":"6864"},{"source":"liver neoplasms","target":"bevacizumab","id":"6865"},{"source":"liver neoplasms","target":"carboplatin","id":"6866"},{"source":"liver neoplasms","target":"nab-paclitaxel (IV)","id":"6867"},{"source":"carcinoma","target":"pembrolizumab","id":"6868"},{"source":"carcinoma","target":"bevacizumab","id":"6869"},{"source":"carcinoma","target":"carboplatin","id":"6870"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"6871"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"6872"},{"source":"Immune checkpoint inhibitor","target":"abdominal metastasis","id":"6873"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6874"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"6875"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"6876"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"6877"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"6878"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6879"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"6880"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"6881"},{"source":"Immune checkpoint inhibitor","target":"abdominal neoplasms","id":"6882"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"6883"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6884"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"6885"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"6886"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"6887"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"6888"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"6889"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"6890"},{"source":"Anticancer immunotherapy","target":"abdominal metastasis","id":"6891"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6892"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"6893"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"6894"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"6895"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"6896"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6897"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"6898"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"6899"},{"source":"Anticancer immunotherapy","target":"abdominal neoplasms","id":"6900"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"6901"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6902"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"6903"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"6904"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"6905"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"6906"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"6907"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"6908"},{"source":"CD19 antagonist","target":"abdominal metastasis","id":"6909"},{"source":"CD19 antagonist","target":"carcinoma","id":"6910"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"6911"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"6912"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"6913"},{"source":"CD19 antagonist","target":"liver metastases","id":"6914"},{"source":"CD19 antagonist","target":"carcinoma","id":"6915"},{"source":"CD19 antagonist","target":"liver metastases","id":"6916"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"6917"},{"source":"CD19 antagonist","target":"abdominal neoplasms","id":"6918"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"6919"},{"source":"CD19 antagonist","target":"carcinoma","id":"6920"},{"source":"CD19 antagonist","target":"residual tumor","id":"6921"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"6922"},{"source":"CD19 antagonist","target":"anticancer","id":"6923"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"6924"},{"source":"CD19 antagonist","target":"carcinoma","id":"6925"},{"source":"NA","target":"UNK : Indication","id":"6926"},{"source":"NA","target":"abdominal metastasis","id":"6927"},{"source":"NA","target":"carcinoma","id":"6928"},{"source":"NA","target":"ovarian cancer","id":"6929"},{"source":"NA","target":"ovarian cancer","id":"6930"},{"source":"NA","target":"ovarian neoplasms","id":"6931"},{"source":"NA","target":"liver metastases","id":"6932"},{"source":"NA","target":"carcinoma","id":"6933"},{"source":"NA","target":"liver metastases","id":"6934"},{"source":"NA","target":"peritoneal neoplasms","id":"6935"},{"source":"NA","target":"abdominal neoplasms","id":"6936"},{"source":"NA","target":"fallopian tube neoplasms","id":"6937"},{"source":"NA","target":"carcinoma","id":"6938"},{"source":"NA","target":"residual tumor","id":"6939"},{"source":"NA","target":"neoplasm metastasis","id":"6940"},{"source":"NA","target":"anticancer","id":"6941"},{"source":"NA","target":"liver neoplasms","id":"6942"},{"source":"NA","target":"carcinoma","id":"6943"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"6944"},{"source":"Beta tubulin antagonist","target":"abdominal metastasis","id":"6945"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"6946"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"6947"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"6948"},{"source":"Beta tubulin antagonist","target":"ovarian neoplasms","id":"6949"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"6950"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"6951"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"6952"},{"source":"Beta tubulin antagonist","target":"peritoneal neoplasms","id":"6953"},{"source":"Beta tubulin antagonist","target":"abdominal neoplasms","id":"6954"},{"source":"Beta tubulin antagonist","target":"fallopian tube neoplasms","id":"6955"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"6956"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"6957"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"6958"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"6959"},{"source":"Beta tubulin antagonist","target":"liver neoplasms","id":"6960"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"6961"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"6962"},{"source":"Microtubule stimulant","target":"abdominal metastasis","id":"6963"},{"source":"Microtubule stimulant","target":"carcinoma","id":"6964"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"6965"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"6966"},{"source":"Microtubule stimulant","target":"ovarian neoplasms","id":"6967"},{"source":"Microtubule stimulant","target":"liver metastases","id":"6968"},{"source":"Microtubule stimulant","target":"carcinoma","id":"6969"},{"source":"Microtubule stimulant","target":"liver metastases","id":"6970"},{"source":"Microtubule stimulant","target":"peritoneal neoplasms","id":"6971"},{"source":"Microtubule stimulant","target":"abdominal neoplasms","id":"6972"},{"source":"Microtubule stimulant","target":"fallopian tube neoplasms","id":"6973"},{"source":"Microtubule stimulant","target":"carcinoma","id":"6974"},{"source":"Microtubule stimulant","target":"residual tumor","id":"6975"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"6976"},{"source":"Microtubule stimulant","target":"anticancer","id":"6977"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"6978"},{"source":"Microtubule stimulant","target":"carcinoma","id":"6979"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"6980"},{"source":"Angiogenesis inhibitor","target":"abdominal metastasis","id":"6981"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"6982"},{"source":"Angiogenesis inhibitor","target":"ovarian cancer","id":"6983"},{"source":"Angiogenesis inhibitor","target":"ovarian cancer","id":"6984"},{"source":"Angiogenesis inhibitor","target":"ovarian neoplasms","id":"6985"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"6986"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"6987"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"6988"},{"source":"Angiogenesis inhibitor","target":"peritoneal neoplasms","id":"6989"},{"source":"Angiogenesis inhibitor","target":"abdominal neoplasms","id":"6990"},{"source":"Angiogenesis inhibitor","target":"fallopian tube neoplasms","id":"6991"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"6992"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"6993"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"6994"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"6995"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"6996"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"6997"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"6998"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"abdominal metastasis","id":"6999"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"7000"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian cancer","id":"7001"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian cancer","id":"7002"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian neoplasms","id":"7003"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver metastases","id":"7004"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"7005"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver metastases","id":"7006"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"peritoneal neoplasms","id":"7007"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"abdominal neoplasms","id":"7008"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"fallopian tube neoplasms","id":"7009"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"7010"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"7011"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"neoplasm metastasis","id":"7012"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"7013"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver neoplasms","id":"7014"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"7015"},{"source":"Taxane","target":"UNK : Indication","id":"7016"},{"source":"Taxane","target":"abdominal metastasis","id":"7017"},{"source":"Taxane","target":"carcinoma","id":"7018"},{"source":"Taxane","target":"ovarian cancer","id":"7019"},{"source":"Taxane","target":"ovarian cancer","id":"7020"},{"source":"Taxane","target":"ovarian neoplasms","id":"7021"},{"source":"Taxane","target":"liver metastases","id":"7022"},{"source":"Taxane","target":"carcinoma","id":"7023"},{"source":"Taxane","target":"liver metastases","id":"7024"},{"source":"Taxane","target":"peritoneal neoplasms","id":"7025"},{"source":"Taxane","target":"abdominal neoplasms","id":"7026"},{"source":"Taxane","target":"fallopian tube neoplasms","id":"7027"},{"source":"Taxane","target":"carcinoma","id":"7028"},{"source":"Taxane","target":"residual tumor","id":"7029"},{"source":"Taxane","target":"neoplasm metastasis","id":"7030"},{"source":"Taxane","target":"anticancer","id":"7031"},{"source":"Taxane","target":"liver neoplasms","id":"7032"},{"source":"Taxane","target":"carcinoma","id":"7033"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"7034"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"7035"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"7036"},{"source":"Oncology: (N/A)","target":"NA","id":"7037"},{"source":"Oncology: (N/A)","target":"Beta tubulin antagonist","id":"7038"},{"source":"Oncology: (N/A)","target":"Microtubule stimulant","id":"7039"},{"source":"Oncology: (N/A)","target":"Angiogenesis inhibitor","id":"7040"},{"source":"Oncology: (N/A)","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"7041"},{"source":"Oncology: (N/A)","target":"Taxane","id":"7042"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"7043"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"7044"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"7045"},{"source":"Oncology: Ovarian","target":"NA","id":"7046"},{"source":"Oncology: Ovarian","target":"Beta tubulin antagonist","id":"7047"},{"source":"Oncology: Ovarian","target":"Microtubule stimulant","id":"7048"},{"source":"Oncology: Ovarian","target":"Angiogenesis inhibitor","id":"7049"},{"source":"Oncology: Ovarian","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"7050"},{"source":"Oncology: Ovarian","target":"Taxane","id":"7051"},{"source":"BKT-140 (u)","target":"BioLineRx","id":"7052"},{"source":"BKT-140 (u)","target":"MD Anderson Cancer Center","id":"7053"},{"source":"BKT-140 (u)","target":"University of Texas","id":"7054"},{"source":"BKT-140 (u)","target":"Merck & Co.","id":"7055"},{"source":"pembrolizumab","target":"BioLineRx","id":"7056"},{"source":"pembrolizumab","target":"MD Anderson Cancer Center","id":"7057"},{"source":"pembrolizumab","target":"University of Texas","id":"7058"},{"source":"pembrolizumab","target":"Merck & Co.","id":"7059"},{"source":"antianaemic","target":"BKT-140 (u)","id":"7060"},{"source":"antianaemic","target":"pembrolizumab","id":"7061"},{"source":"residual tumor","target":"BKT-140 (u)","id":"7062"},{"source":"residual tumor","target":"pembrolizumab","id":"7063"},{"source":"dehydration","target":"BKT-140 (u)","id":"7064"},{"source":"dehydration","target":"pembrolizumab","id":"7065"},{"source":"metastatic","target":"BKT-140 (u)","id":"7066"},{"source":"metastatic","target":"pembrolizumab","id":"7067"},{"source":"carcinoma","target":"BKT-140 (u)","id":"7068"},{"source":"carcinoma","target":"pembrolizumab","id":"7069"},{"source":"anti-tumor","target":"BKT-140 (u)","id":"7070"},{"source":"anti-tumor","target":"pembrolizumab","id":"7071"},{"source":"pancreatic cancer","target":"BKT-140 (u)","id":"7072"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"7073"},{"source":"neoplasm metastasis","target":"BKT-140 (u)","id":"7074"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"7075"},{"source":"carcinoma","target":"BKT-140 (u)","id":"7076"},{"source":"carcinoma","target":"pembrolizumab","id":"7077"},{"source":"anticancer","target":"BKT-140 (u)","id":"7078"},{"source":"anticancer","target":"pembrolizumab","id":"7079"},{"source":"pancreatic neoplasms","target":"BKT-140 (u)","id":"7080"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"7081"},{"source":"anemia","target":"BKT-140 (u)","id":"7082"},{"source":"anemia","target":"pembrolizumab","id":"7083"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"7084"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"7085"},{"source":"Anticancer immunotherapy","target":"dehydration","id":"7086"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"7087"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7088"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"7089"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"7090"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"7091"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7092"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7093"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"7094"},{"source":"Anticancer immunotherapy","target":"anemia","id":"7095"},{"source":"CD19 antagonist","target":"antianaemic","id":"7096"},{"source":"CD19 antagonist","target":"residual tumor","id":"7097"},{"source":"CD19 antagonist","target":"dehydration","id":"7098"},{"source":"CD19 antagonist","target":"metastatic","id":"7099"},{"source":"CD19 antagonist","target":"carcinoma","id":"7100"},{"source":"CD19 antagonist","target":"anti-tumor","id":"7101"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"7102"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"7103"},{"source":"CD19 antagonist","target":"carcinoma","id":"7104"},{"source":"CD19 antagonist","target":"anticancer","id":"7105"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"7106"},{"source":"CD19 antagonist","target":"anemia","id":"7107"},{"source":"CXC chemokine receptor 4 antagonist","target":"antianaemic","id":"7108"},{"source":"CXC chemokine receptor 4 antagonist","target":"residual tumor","id":"7109"},{"source":"CXC chemokine receptor 4 antagonist","target":"dehydration","id":"7110"},{"source":"CXC chemokine receptor 4 antagonist","target":"metastatic","id":"7111"},{"source":"CXC chemokine receptor 4 antagonist","target":"carcinoma","id":"7112"},{"source":"CXC chemokine receptor 4 antagonist","target":"anti-tumor","id":"7113"},{"source":"CXC chemokine receptor 4 antagonist","target":"pancreatic cancer","id":"7114"},{"source":"CXC chemokine receptor 4 antagonist","target":"neoplasm metastasis","id":"7115"},{"source":"CXC chemokine receptor 4 antagonist","target":"carcinoma","id":"7116"},{"source":"CXC chemokine receptor 4 antagonist","target":"anticancer","id":"7117"},{"source":"CXC chemokine receptor 4 antagonist","target":"pancreatic neoplasms","id":"7118"},{"source":"CXC chemokine receptor 4 antagonist","target":"anemia","id":"7119"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"7120"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"7121"},{"source":"Immune checkpoint inhibitor","target":"dehydration","id":"7122"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"7123"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7124"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"7125"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"7126"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"7127"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7128"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7129"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"7130"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"7131"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"7132"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"7133"},{"source":"Oncology: Pancreas","target":"CXC chemokine receptor 4 antagonist","id":"7134"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"7135"},{"source":"pembrolizumab","target":"Abramson Cancer Center at  University of Pennsylvania Medical Center","id":"7136"},{"source":"UNK : Drug","target":"Abramson Cancer Center at  University of Pennsylvania Medical Center","id":"7137"},{"source":"UNK : Indication","target":"pembrolizumab","id":"7138"},{"source":"UNK : Indication","target":"UNK : Drug","id":"7139"},{"source":"residual tumor","target":"pembrolizumab","id":"7140"},{"source":"residual tumor","target":"UNK : Drug","id":"7141"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"7142"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"7143"},{"source":"sclc","target":"pembrolizumab","id":"7144"},{"source":"sclc","target":"UNK : Drug","id":"7145"},{"source":"carcinoma","target":"pembrolizumab","id":"7146"},{"source":"carcinoma","target":"UNK : Drug","id":"7147"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"7148"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"7149"},{"source":"carcinoma","target":"pembrolizumab","id":"7150"},{"source":"carcinoma","target":"UNK : Drug","id":"7151"},{"source":"anti-tumor","target":"pembrolizumab","id":"7152"},{"source":"anti-tumor","target":"UNK : Drug","id":"7153"},{"source":"anticancer","target":"pembrolizumab","id":"7154"},{"source":"anticancer","target":"UNK : Drug","id":"7155"},{"source":"lung neoplasms","target":"pembrolizumab","id":"7156"},{"source":"lung neoplasms","target":"UNK : Drug","id":"7157"},{"source":"malignancies","target":"pembrolizumab","id":"7158"},{"source":"malignancies","target":"UNK : Drug","id":"7159"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"7160"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"7161"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"7162"},{"source":"Anticancer immunotherapy","target":"sclc","id":"7163"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7164"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"7165"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7166"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"7167"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7168"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"7169"},{"source":"Anticancer immunotherapy","target":"malignancies","id":"7170"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"7171"},{"source":"CD19 antagonist","target":"residual tumor","id":"7172"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"7173"},{"source":"CD19 antagonist","target":"sclc","id":"7174"},{"source":"CD19 antagonist","target":"carcinoma","id":"7175"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"7176"},{"source":"CD19 antagonist","target":"carcinoma","id":"7177"},{"source":"CD19 antagonist","target":"anti-tumor","id":"7178"},{"source":"CD19 antagonist","target":"anticancer","id":"7179"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"7180"},{"source":"CD19 antagonist","target":"malignancies","id":"7181"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"7182"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"7183"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"7184"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"7185"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7186"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"7187"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7188"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"7189"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7190"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"7191"},{"source":"Immune checkpoint inhibitor","target":"malignancies","id":"7192"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"7193"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"7194"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"7195"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"7196"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"7197"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"7198"},{"source":"CIN vaccine","target":"IO Biotech","id":"7199"},{"source":"CIN vaccine","target":"Merck & Co.","id":"7200"},{"source":"Aduro (u)","target":"IO Biotech","id":"7201"},{"source":"Aduro (u)","target":"Merck & Co.","id":"7202"},{"source":"pembrolizumab","target":"IO Biotech","id":"7203"},{"source":"pembrolizumab","target":"Merck & Co.","id":"7204"},{"source":"UNK : Indication","target":"CIN vaccine","id":"7205"},{"source":"UNK : Indication","target":"Aduro (u)","id":"7206"},{"source":"UNK : Indication","target":"pembrolizumab","id":"7207"},{"source":"gilbert disease","target":"CIN vaccine","id":"7208"},{"source":"gilbert disease","target":"Aduro (u)","id":"7209"},{"source":"gilbert disease","target":"pembrolizumab","id":"7210"},{"source":"mesothelial","target":"CIN vaccine","id":"7211"},{"source":"mesothelial","target":"Aduro (u)","id":"7212"},{"source":"mesothelial","target":"pembrolizumab","id":"7213"},{"source":"mesothelial","target":"CIN vaccine","id":"7214"},{"source":"mesothelial","target":"Aduro (u)","id":"7215"},{"source":"mesothelial","target":"pembrolizumab","id":"7216"},{"source":"mesothelial","target":"CIN vaccine","id":"7217"},{"source":"mesothelial","target":"Aduro (u)","id":"7218"},{"source":"mesothelial","target":"pembrolizumab","id":"7219"},{"source":"residual tumor","target":"CIN vaccine","id":"7220"},{"source":"residual tumor","target":"Aduro (u)","id":"7221"},{"source":"residual tumor","target":"pembrolizumab","id":"7222"},{"source":"skin neoplasms","target":"CIN vaccine","id":"7223"},{"source":"skin neoplasms","target":"Aduro (u)","id":"7224"},{"source":"skin neoplasms","target":"pembrolizumab","id":"7225"},{"source":"anticancer","target":"CIN vaccine","id":"7226"},{"source":"anticancer","target":"Aduro (u)","id":"7227"},{"source":"anticancer","target":"pembrolizumab","id":"7228"},{"source":"liver metastases","target":"CIN vaccine","id":"7229"},{"source":"liver metastases","target":"Aduro (u)","id":"7230"},{"source":"liver metastases","target":"pembrolizumab","id":"7231"},{"source":"carcinoma","target":"CIN vaccine","id":"7232"},{"source":"carcinoma","target":"Aduro (u)","id":"7233"},{"source":"carcinoma","target":"pembrolizumab","id":"7234"},{"source":"gilbert disease","target":"CIN vaccine","id":"7235"},{"source":"gilbert disease","target":"Aduro (u)","id":"7236"},{"source":"gilbert disease","target":"pembrolizumab","id":"7237"},{"source":"pleural mesothelioma","target":"CIN vaccine","id":"7238"},{"source":"pleural mesothelioma","target":"Aduro (u)","id":"7239"},{"source":"pleural mesothelioma","target":"pembrolizumab","id":"7240"},{"source":"anticancer","target":"CIN vaccine","id":"7241"},{"source":"anticancer","target":"Aduro (u)","id":"7242"},{"source":"anticancer","target":"pembrolizumab","id":"7243"},{"source":"liver neoplasms","target":"CIN vaccine","id":"7244"},{"source":"liver neoplasms","target":"Aduro (u)","id":"7245"},{"source":"liver neoplasms","target":"pembrolizumab","id":"7246"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"7247"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"7248"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"7249"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"7250"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"7251"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"7252"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"7253"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7254"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"7255"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7256"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"7257"},{"source":"Anticancer immunotherapy","target":"pleural mesothelioma","id":"7258"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7259"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"7260"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"7261"},{"source":"CD19 antagonist","target":"gilbert disease","id":"7262"},{"source":"CD19 antagonist","target":"mesothelial","id":"7263"},{"source":"CD19 antagonist","target":"mesothelial","id":"7264"},{"source":"CD19 antagonist","target":"mesothelial","id":"7265"},{"source":"CD19 antagonist","target":"residual tumor","id":"7266"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"7267"},{"source":"CD19 antagonist","target":"anticancer","id":"7268"},{"source":"CD19 antagonist","target":"liver metastases","id":"7269"},{"source":"CD19 antagonist","target":"carcinoma","id":"7270"},{"source":"CD19 antagonist","target":"gilbert disease","id":"7271"},{"source":"CD19 antagonist","target":"pleural mesothelioma","id":"7272"},{"source":"CD19 antagonist","target":"anticancer","id":"7273"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"7274"},{"source":"Immunostimulant","target":"UNK : Indication","id":"7275"},{"source":"Immunostimulant","target":"gilbert disease","id":"7276"},{"source":"Immunostimulant","target":"mesothelial","id":"7277"},{"source":"Immunostimulant","target":"mesothelial","id":"7278"},{"source":"Immunostimulant","target":"mesothelial","id":"7279"},{"source":"Immunostimulant","target":"residual tumor","id":"7280"},{"source":"Immunostimulant","target":"skin neoplasms","id":"7281"},{"source":"Immunostimulant","target":"anticancer","id":"7282"},{"source":"Immunostimulant","target":"liver metastases","id":"7283"},{"source":"Immunostimulant","target":"carcinoma","id":"7284"},{"source":"Immunostimulant","target":"gilbert disease","id":"7285"},{"source":"Immunostimulant","target":"pleural mesothelioma","id":"7286"},{"source":"Immunostimulant","target":"anticancer","id":"7287"},{"source":"Immunostimulant","target":"liver neoplasms","id":"7288"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"7289"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"7290"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"7291"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"7292"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"7293"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"7294"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"7295"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7296"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"7297"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7298"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"7299"},{"source":"Immune checkpoint inhibitor","target":"pleural mesothelioma","id":"7300"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7301"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"7302"},{"source":"Oncology: Mesothelioma","target":"Anticancer immunotherapy","id":"7303"},{"source":"Oncology: Mesothelioma","target":"CD19 antagonist","id":"7304"},{"source":"Oncology: Mesothelioma","target":"Immunostimulant","id":"7305"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint inhibitor","id":"7306"},{"source":"atezolizumab (a)","target":"Nektar Therapeutics","id":"7307"},{"source":"NKTR-214 (u)","target":"Nektar Therapeutics","id":"7308"},{"source":"pembrolizumab","target":"Nektar Therapeutics","id":"7309"},{"source":"UNK : Drug","target":"Nektar Therapeutics","id":"7310"},{"source":"anticancer","target":"atezolizumab (a)","id":"7311"},{"source":"anticancer","target":"NKTR-214 (u)","id":"7312"},{"source":"anticancer","target":"pembrolizumab","id":"7313"},{"source":"anticancer","target":"UNK : Drug","id":"7314"},{"source":"melanoma","target":"atezolizumab (a)","id":"7315"},{"source":"melanoma","target":"NKTR-214 (u)","id":"7316"},{"source":"melanoma","target":"pembrolizumab","id":"7317"},{"source":"melanoma","target":"UNK : Drug","id":"7318"},{"source":"melanoma","target":"atezolizumab (a)","id":"7319"},{"source":"melanoma","target":"NKTR-214 (u)","id":"7320"},{"source":"melanoma","target":"pembrolizumab","id":"7321"},{"source":"melanoma","target":"UNK : Drug","id":"7322"},{"source":"skin neoplasms","target":"atezolizumab (a)","id":"7323"},{"source":"skin neoplasms","target":"NKTR-214 (u)","id":"7324"},{"source":"skin neoplasms","target":"pembrolizumab","id":"7325"},{"source":"skin neoplasms","target":"UNK : Drug","id":"7326"},{"source":"non-small-cell lung","target":"atezolizumab (a)","id":"7327"},{"source":"non-small-cell lung","target":"NKTR-214 (u)","id":"7328"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"7329"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"7330"},{"source":"non-small-cell lung","target":"atezolizumab (a)","id":"7331"},{"source":"non-small-cell lung","target":"NKTR-214 (u)","id":"7332"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"7333"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"7334"},{"source":"melanoma","target":"atezolizumab (a)","id":"7335"},{"source":"melanoma","target":"NKTR-214 (u)","id":"7336"},{"source":"melanoma","target":"pembrolizumab","id":"7337"},{"source":"melanoma","target":"UNK : Drug","id":"7338"},{"source":"bladder cancer","target":"atezolizumab (a)","id":"7339"},{"source":"bladder cancer","target":"NKTR-214 (u)","id":"7340"},{"source":"bladder cancer","target":"pembrolizumab","id":"7341"},{"source":"bladder cancer","target":"UNK : Drug","id":"7342"},{"source":"anticancer","target":"atezolizumab (a)","id":"7343"},{"source":"anticancer","target":"NKTR-214 (u)","id":"7344"},{"source":"anticancer","target":"pembrolizumab","id":"7345"},{"source":"anticancer","target":"UNK : Drug","id":"7346"},{"source":"sclc","target":"atezolizumab (a)","id":"7347"},{"source":"sclc","target":"NKTR-214 (u)","id":"7348"},{"source":"sclc","target":"pembrolizumab","id":"7349"},{"source":"sclc","target":"UNK : Drug","id":"7350"},{"source":"unknown primary","target":"atezolizumab (a)","id":"7351"},{"source":"unknown primary","target":"NKTR-214 (u)","id":"7352"},{"source":"unknown primary","target":"pembrolizumab","id":"7353"},{"source":"unknown primary","target":"UNK : Drug","id":"7354"},{"source":"carcinoma","target":"atezolizumab (a)","id":"7355"},{"source":"carcinoma","target":"NKTR-214 (u)","id":"7356"},{"source":"carcinoma","target":"pembrolizumab","id":"7357"},{"source":"carcinoma","target":"UNK : Drug","id":"7358"},{"source":"solid tumors","target":"atezolizumab (a)","id":"7359"},{"source":"solid tumors","target":"NKTR-214 (u)","id":"7360"},{"source":"solid tumors","target":"pembrolizumab","id":"7361"},{"source":"solid tumors","target":"UNK : Drug","id":"7362"},{"source":"carcinoma","target":"atezolizumab (a)","id":"7363"},{"source":"carcinoma","target":"NKTR-214 (u)","id":"7364"},{"source":"carcinoma","target":"pembrolizumab","id":"7365"},{"source":"carcinoma","target":"UNK : Drug","id":"7366"},{"source":"neoplasm metastasis","target":"atezolizumab (a)","id":"7367"},{"source":"neoplasm metastasis","target":"NKTR-214 (u)","id":"7368"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"7369"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"7370"},{"source":"lymphoma","target":"atezolizumab (a)","id":"7371"},{"source":"lymphoma","target":"NKTR-214 (u)","id":"7372"},{"source":"lymphoma","target":"pembrolizumab","id":"7373"},{"source":"lymphoma","target":"UNK : Drug","id":"7374"},{"source":"urinary bladder neoplasms","target":"atezolizumab (a)","id":"7375"},{"source":"urinary bladder neoplasms","target":"NKTR-214 (u)","id":"7376"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"7377"},{"source":"urinary bladder neoplasms","target":"UNK : Drug","id":"7378"},{"source":"skin neoplasms","target":"atezolizumab (a)","id":"7379"},{"source":"skin neoplasms","target":"NKTR-214 (u)","id":"7380"},{"source":"skin neoplasms","target":"pembrolizumab","id":"7381"},{"source":"skin neoplasms","target":"UNK : Drug","id":"7382"},{"source":"residual tumor","target":"atezolizumab (a)","id":"7383"},{"source":"residual tumor","target":"NKTR-214 (u)","id":"7384"},{"source":"residual tumor","target":"pembrolizumab","id":"7385"},{"source":"residual tumor","target":"UNK : Drug","id":"7386"},{"source":"metastatic","target":"atezolizumab (a)","id":"7387"},{"source":"metastatic","target":"NKTR-214 (u)","id":"7388"},{"source":"metastatic","target":"pembrolizumab","id":"7389"},{"source":"metastatic","target":"UNK : Drug","id":"7390"},{"source":"anticancer","target":"atezolizumab (a)","id":"7391"},{"source":"anticancer","target":"NKTR-214 (u)","id":"7392"},{"source":"anticancer","target":"pembrolizumab","id":"7393"},{"source":"anticancer","target":"UNK : Drug","id":"7394"},{"source":"unknown primary","target":"atezolizumab (a)","id":"7395"},{"source":"unknown primary","target":"NKTR-214 (u)","id":"7396"},{"source":"unknown primary","target":"pembrolizumab","id":"7397"},{"source":"unknown primary","target":"UNK : Drug","id":"7398"},{"source":"solid tumors","target":"atezolizumab (a)","id":"7399"},{"source":"solid tumors","target":"NKTR-214 (u)","id":"7400"},{"source":"solid tumors","target":"pembrolizumab","id":"7401"},{"source":"solid tumors","target":"UNK : Drug","id":"7402"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7403"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"7404"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"7405"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"7406"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"7407"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"7408"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"7409"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"7410"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7411"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"7412"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"7413"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7414"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"7415"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7416"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"7417"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"7418"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"7419"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"7420"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"7421"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"7422"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7423"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"7424"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"7425"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"7426"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"7427"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"7428"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"7429"},{"source":"Immune checkpoint stimulant","target":"non-small-cell lung","id":"7430"},{"source":"Immune checkpoint stimulant","target":"non-small-cell lung","id":"7431"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"7432"},{"source":"Immune checkpoint stimulant","target":"bladder cancer","id":"7433"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"7434"},{"source":"Immune checkpoint stimulant","target":"sclc","id":"7435"},{"source":"Immune checkpoint stimulant","target":"unknown primary","id":"7436"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"7437"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"7438"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"7439"},{"source":"Immune checkpoint stimulant","target":"neoplasm metastasis","id":"7440"},{"source":"Immune checkpoint stimulant","target":"lymphoma","id":"7441"},{"source":"Immune checkpoint stimulant","target":"urinary bladder neoplasms","id":"7442"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"7443"},{"source":"Immune checkpoint stimulant","target":"residual tumor","id":"7444"},{"source":"Immune checkpoint stimulant","target":"metastatic","id":"7445"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"7446"},{"source":"Immune checkpoint stimulant","target":"unknown primary","id":"7447"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"7448"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7449"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"7450"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"7451"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"7452"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"7453"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"7454"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"7455"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"7456"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7457"},{"source":"Anticancer immunotherapy","target":"sclc","id":"7458"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"7459"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7460"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"7461"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7462"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"7463"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"7464"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"7465"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"7466"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"7467"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"7468"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7469"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"7470"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"7471"},{"source":"CD19 antagonist","target":"anticancer","id":"7472"},{"source":"CD19 antagonist","target":"melanoma","id":"7473"},{"source":"CD19 antagonist","target":"melanoma","id":"7474"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"7475"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"7476"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"7477"},{"source":"CD19 antagonist","target":"melanoma","id":"7478"},{"source":"CD19 antagonist","target":"bladder cancer","id":"7479"},{"source":"CD19 antagonist","target":"anticancer","id":"7480"},{"source":"CD19 antagonist","target":"sclc","id":"7481"},{"source":"CD19 antagonist","target":"unknown primary","id":"7482"},{"source":"CD19 antagonist","target":"carcinoma","id":"7483"},{"source":"CD19 antagonist","target":"solid tumors","id":"7484"},{"source":"CD19 antagonist","target":"carcinoma","id":"7485"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"7486"},{"source":"CD19 antagonist","target":"lymphoma","id":"7487"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"7488"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"7489"},{"source":"CD19 antagonist","target":"residual tumor","id":"7490"},{"source":"CD19 antagonist","target":"metastatic","id":"7491"},{"source":"CD19 antagonist","target":"anticancer","id":"7492"},{"source":"CD19 antagonist","target":"unknown primary","id":"7493"},{"source":"CD19 antagonist","target":"solid tumors","id":"7494"},{"source":"PD-1 antagonist","target":"anticancer","id":"7495"},{"source":"PD-1 antagonist","target":"melanoma","id":"7496"},{"source":"PD-1 antagonist","target":"melanoma","id":"7497"},{"source":"PD-1 antagonist","target":"skin neoplasms","id":"7498"},{"source":"PD-1 antagonist","target":"non-small-cell lung","id":"7499"},{"source":"PD-1 antagonist","target":"non-small-cell lung","id":"7500"},{"source":"PD-1 antagonist","target":"melanoma","id":"7501"},{"source":"PD-1 antagonist","target":"bladder cancer","id":"7502"},{"source":"PD-1 antagonist","target":"anticancer","id":"7503"},{"source":"PD-1 antagonist","target":"sclc","id":"7504"},{"source":"PD-1 antagonist","target":"unknown primary","id":"7505"},{"source":"PD-1 antagonist","target":"carcinoma","id":"7506"},{"source":"PD-1 antagonist","target":"solid tumors","id":"7507"},{"source":"PD-1 antagonist","target":"carcinoma","id":"7508"},{"source":"PD-1 antagonist","target":"neoplasm metastasis","id":"7509"},{"source":"PD-1 antagonist","target":"lymphoma","id":"7510"},{"source":"PD-1 antagonist","target":"urinary bladder neoplasms","id":"7511"},{"source":"PD-1 antagonist","target":"skin neoplasms","id":"7512"},{"source":"PD-1 antagonist","target":"residual tumor","id":"7513"},{"source":"PD-1 antagonist","target":"metastatic","id":"7514"},{"source":"PD-1 antagonist","target":"anticancer","id":"7515"},{"source":"PD-1 antagonist","target":"unknown primary","id":"7516"},{"source":"PD-1 antagonist","target":"solid tumors","id":"7517"},{"source":"Immunostimulant","target":"anticancer","id":"7518"},{"source":"Immunostimulant","target":"melanoma","id":"7519"},{"source":"Immunostimulant","target":"melanoma","id":"7520"},{"source":"Immunostimulant","target":"skin neoplasms","id":"7521"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"7522"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"7523"},{"source":"Immunostimulant","target":"melanoma","id":"7524"},{"source":"Immunostimulant","target":"bladder cancer","id":"7525"},{"source":"Immunostimulant","target":"anticancer","id":"7526"},{"source":"Immunostimulant","target":"sclc","id":"7527"},{"source":"Immunostimulant","target":"unknown primary","id":"7528"},{"source":"Immunostimulant","target":"carcinoma","id":"7529"},{"source":"Immunostimulant","target":"solid tumors","id":"7530"},{"source":"Immunostimulant","target":"carcinoma","id":"7531"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"7532"},{"source":"Immunostimulant","target":"lymphoma","id":"7533"},{"source":"Immunostimulant","target":"urinary bladder neoplasms","id":"7534"},{"source":"Immunostimulant","target":"skin neoplasms","id":"7535"},{"source":"Immunostimulant","target":"residual tumor","id":"7536"},{"source":"Immunostimulant","target":"metastatic","id":"7537"},{"source":"Immunostimulant","target":"anticancer","id":"7538"},{"source":"Immunostimulant","target":"unknown primary","id":"7539"},{"source":"Immunostimulant","target":"solid tumors","id":"7540"},{"source":"Interleukin 2 receptor agonist","target":"anticancer","id":"7541"},{"source":"Interleukin 2 receptor agonist","target":"melanoma","id":"7542"},{"source":"Interleukin 2 receptor agonist","target":"melanoma","id":"7543"},{"source":"Interleukin 2 receptor agonist","target":"skin neoplasms","id":"7544"},{"source":"Interleukin 2 receptor agonist","target":"non-small-cell lung","id":"7545"},{"source":"Interleukin 2 receptor agonist","target":"non-small-cell lung","id":"7546"},{"source":"Interleukin 2 receptor agonist","target":"melanoma","id":"7547"},{"source":"Interleukin 2 receptor agonist","target":"bladder cancer","id":"7548"},{"source":"Interleukin 2 receptor agonist","target":"anticancer","id":"7549"},{"source":"Interleukin 2 receptor agonist","target":"sclc","id":"7550"},{"source":"Interleukin 2 receptor agonist","target":"unknown primary","id":"7551"},{"source":"Interleukin 2 receptor agonist","target":"carcinoma","id":"7552"},{"source":"Interleukin 2 receptor agonist","target":"solid tumors","id":"7553"},{"source":"Interleukin 2 receptor agonist","target":"carcinoma","id":"7554"},{"source":"Interleukin 2 receptor agonist","target":"neoplasm metastasis","id":"7555"},{"source":"Interleukin 2 receptor agonist","target":"lymphoma","id":"7556"},{"source":"Interleukin 2 receptor agonist","target":"urinary bladder neoplasms","id":"7557"},{"source":"Interleukin 2 receptor agonist","target":"skin neoplasms","id":"7558"},{"source":"Interleukin 2 receptor agonist","target":"residual tumor","id":"7559"},{"source":"Interleukin 2 receptor agonist","target":"metastatic","id":"7560"},{"source":"Interleukin 2 receptor agonist","target":"anticancer","id":"7561"},{"source":"Interleukin 2 receptor agonist","target":"unknown primary","id":"7562"},{"source":"Interleukin 2 receptor agonist","target":"solid tumors","id":"7563"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"7564"},{"source":"Oncology: Bladder","target":"Immune checkpoint stimulant","id":"7565"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"7566"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"7567"},{"source":"Oncology: Bladder","target":"PD-1 antagonist","id":"7568"},{"source":"Oncology: Bladder","target":"Immunostimulant","id":"7569"},{"source":"Oncology: Bladder","target":"Interleukin 2 receptor agonist","id":"7570"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"7571"},{"source":"Oncology: Lung","target":"Immune checkpoint stimulant","id":"7572"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"7573"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"7574"},{"source":"Oncology: Lung","target":"PD-1 antagonist","id":"7575"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"7576"},{"source":"Oncology: Lung","target":"Interleukin 2 receptor agonist","id":"7577"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"7578"},{"source":"Non-Small Cell","target":"Immune checkpoint stimulant","id":"7579"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"7580"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"7581"},{"source":"Non-Small Cell","target":"PD-1 antagonist","id":"7582"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"7583"},{"source":"Non-Small Cell","target":"Interleukin 2 receptor agonist","id":"7584"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"7585"},{"source":"Oncology: Melanoma","target":"Immune checkpoint stimulant","id":"7586"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"7587"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"7588"},{"source":"Oncology: Melanoma","target":"PD-1 antagonist","id":"7589"},{"source":"Oncology: Melanoma","target":"Immunostimulant","id":"7590"},{"source":"Oncology: Melanoma","target":"Interleukin 2 receptor agonist","id":"7591"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"7592"},{"source":"Oncology: CNS","target":"Immune checkpoint stimulant","id":"7593"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"7594"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"7595"},{"source":"Oncology: CNS","target":"PD-1 antagonist","id":"7596"},{"source":"Oncology: CNS","target":"Immunostimulant","id":"7597"},{"source":"Oncology: CNS","target":"Interleukin 2 receptor agonist","id":"7598"},{"source":"metformin 500mg (u)","target":"Merck & Co.","id":"7599"},{"source":"pembrolizumab","target":"Merck & Co.","id":"7600"},{"source":"UNK : Indication","target":"metformin 500mg (u)","id":"7601"},{"source":"UNK : Indication","target":"pembrolizumab","id":"7602"},{"source":"ovarian neoplasms","target":"metformin 500mg (u)","id":"7603"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"7604"},{"source":"melanoma","target":"metformin 500mg (u)","id":"7605"},{"source":"melanoma","target":"pembrolizumab","id":"7606"},{"source":"brain metastases","target":"metformin 500mg (u)","id":"7607"},{"source":"brain metastases","target":"pembrolizumab","id":"7608"},{"source":"vascular headaches","target":"metformin 500mg (u)","id":"7609"},{"source":"vascular headaches","target":"pembrolizumab","id":"7610"},{"source":"brain disease","target":"metformin 500mg (u)","id":"7611"},{"source":"brain disease","target":"pembrolizumab","id":"7612"},{"source":"liver metastases","target":"metformin 500mg (u)","id":"7613"},{"source":"liver metastases","target":"pembrolizumab","id":"7614"},{"source":"migraine disorders","target":"metformin 500mg (u)","id":"7615"},{"source":"migraine disorders","target":"pembrolizumab","id":"7616"},{"source":"residual tumor","target":"metformin 500mg (u)","id":"7617"},{"source":"residual tumor","target":"pembrolizumab","id":"7618"},{"source":"central nervous system diseases","target":"metformin 500mg (u)","id":"7619"},{"source":"central nervous system diseases","target":"pembrolizumab","id":"7620"},{"source":"cerebellar neoplasms","target":"metformin 500mg (u)","id":"7621"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"7622"},{"source":"carcinoma","target":"metformin 500mg (u)","id":"7623"},{"source":"carcinoma","target":"pembrolizumab","id":"7624"},{"source":"brain disease","target":"metformin 500mg (u)","id":"7625"},{"source":"brain disease","target":"pembrolizumab","id":"7626"},{"source":"anticancer","target":"metformin 500mg (u)","id":"7627"},{"source":"anticancer","target":"pembrolizumab","id":"7628"},{"source":"skin neoplasms","target":"metformin 500mg (u)","id":"7629"},{"source":"skin neoplasms","target":"pembrolizumab","id":"7630"},{"source":"antimigraine","target":"metformin 500mg (u)","id":"7631"},{"source":"antimigraine","target":"pembrolizumab","id":"7632"},{"source":"liver neoplasms","target":"metformin 500mg (u)","id":"7633"},{"source":"liver neoplasms","target":"pembrolizumab","id":"7634"},{"source":"vascular headaches","target":"metformin 500mg (u)","id":"7635"},{"source":"vascular headaches","target":"pembrolizumab","id":"7636"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"7637"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"7638"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"7639"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"7640"},{"source":"Anticancer immunotherapy","target":"vascular headaches","id":"7641"},{"source":"Anticancer immunotherapy","target":"brain disease","id":"7642"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"7643"},{"source":"Anticancer immunotherapy","target":"migraine disorders","id":"7644"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"7645"},{"source":"Anticancer immunotherapy","target":"central nervous system diseases","id":"7646"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"7647"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7648"},{"source":"Anticancer immunotherapy","target":"brain disease","id":"7649"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7650"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"7651"},{"source":"Anticancer immunotherapy","target":"antimigraine","id":"7652"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"7653"},{"source":"Anticancer immunotherapy","target":"vascular headaches","id":"7654"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"7655"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"7656"},{"source":"CD19 antagonist","target":"melanoma","id":"7657"},{"source":"CD19 antagonist","target":"brain metastases","id":"7658"},{"source":"CD19 antagonist","target":"vascular headaches","id":"7659"},{"source":"CD19 antagonist","target":"brain disease","id":"7660"},{"source":"CD19 antagonist","target":"liver metastases","id":"7661"},{"source":"CD19 antagonist","target":"migraine disorders","id":"7662"},{"source":"CD19 antagonist","target":"residual tumor","id":"7663"},{"source":"CD19 antagonist","target":"central nervous system diseases","id":"7664"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"7665"},{"source":"CD19 antagonist","target":"carcinoma","id":"7666"},{"source":"CD19 antagonist","target":"brain disease","id":"7667"},{"source":"CD19 antagonist","target":"anticancer","id":"7668"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"7669"},{"source":"CD19 antagonist","target":"antimigraine","id":"7670"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"7671"},{"source":"CD19 antagonist","target":"vascular headaches","id":"7672"},{"source":"Biguanide","target":"UNK : Indication","id":"7673"},{"source":"Biguanide","target":"ovarian neoplasms","id":"7674"},{"source":"Biguanide","target":"melanoma","id":"7675"},{"source":"Biguanide","target":"brain metastases","id":"7676"},{"source":"Biguanide","target":"vascular headaches","id":"7677"},{"source":"Biguanide","target":"brain disease","id":"7678"},{"source":"Biguanide","target":"liver metastases","id":"7679"},{"source":"Biguanide","target":"migraine disorders","id":"7680"},{"source":"Biguanide","target":"residual tumor","id":"7681"},{"source":"Biguanide","target":"central nervous system diseases","id":"7682"},{"source":"Biguanide","target":"cerebellar neoplasms","id":"7683"},{"source":"Biguanide","target":"carcinoma","id":"7684"},{"source":"Biguanide","target":"brain disease","id":"7685"},{"source":"Biguanide","target":"anticancer","id":"7686"},{"source":"Biguanide","target":"skin neoplasms","id":"7687"},{"source":"Biguanide","target":"antimigraine","id":"7688"},{"source":"Biguanide","target":"liver neoplasms","id":"7689"},{"source":"Biguanide","target":"vascular headaches","id":"7690"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"7691"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"7692"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"7693"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"7694"},{"source":"Immune checkpoint inhibitor","target":"vascular headaches","id":"7695"},{"source":"Immune checkpoint inhibitor","target":"brain disease","id":"7696"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"7697"},{"source":"Immune checkpoint inhibitor","target":"migraine disorders","id":"7698"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"7699"},{"source":"Immune checkpoint inhibitor","target":"central nervous system diseases","id":"7700"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"7701"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7702"},{"source":"Immune checkpoint inhibitor","target":"brain disease","id":"7703"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7704"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"7705"},{"source":"Immune checkpoint inhibitor","target":"antimigraine","id":"7706"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"7707"},{"source":"Immune checkpoint inhibitor","target":"vascular headaches","id":"7708"},{"source":"Gluconeogenesis inhibitor","target":"UNK : Indication","id":"7709"},{"source":"Gluconeogenesis inhibitor","target":"ovarian neoplasms","id":"7710"},{"source":"Gluconeogenesis inhibitor","target":"melanoma","id":"7711"},{"source":"Gluconeogenesis inhibitor","target":"brain metastases","id":"7712"},{"source":"Gluconeogenesis inhibitor","target":"vascular headaches","id":"7713"},{"source":"Gluconeogenesis inhibitor","target":"brain disease","id":"7714"},{"source":"Gluconeogenesis inhibitor","target":"liver metastases","id":"7715"},{"source":"Gluconeogenesis inhibitor","target":"migraine disorders","id":"7716"},{"source":"Gluconeogenesis inhibitor","target":"residual tumor","id":"7717"},{"source":"Gluconeogenesis inhibitor","target":"central nervous system diseases","id":"7718"},{"source":"Gluconeogenesis inhibitor","target":"cerebellar neoplasms","id":"7719"},{"source":"Gluconeogenesis inhibitor","target":"carcinoma","id":"7720"},{"source":"Gluconeogenesis inhibitor","target":"brain disease","id":"7721"},{"source":"Gluconeogenesis inhibitor","target":"anticancer","id":"7722"},{"source":"Gluconeogenesis inhibitor","target":"skin neoplasms","id":"7723"},{"source":"Gluconeogenesis inhibitor","target":"antimigraine","id":"7724"},{"source":"Gluconeogenesis inhibitor","target":"liver neoplasms","id":"7725"},{"source":"Gluconeogenesis inhibitor","target":"vascular headaches","id":"7726"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"7727"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"7728"},{"source":"Oncology: Melanoma","target":"Biguanide","id":"7729"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"7730"},{"source":"Oncology: Melanoma","target":"Gluconeogenesis inhibitor","id":"7731"},{"source":"metformin 500mg (u)","target":"Merck & Co.","id":"7732"},{"source":"pembrolizumab","target":"Merck & Co.","id":"7733"},{"source":"UNK : Indication","target":"metformin 500mg (u)","id":"7734"},{"source":"UNK : Indication","target":"pembrolizumab","id":"7735"},{"source":"ovarian neoplasms","target":"metformin 500mg (u)","id":"7736"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"7737"},{"source":"melanoma","target":"metformin 500mg (u)","id":"7738"},{"source":"melanoma","target":"pembrolizumab","id":"7739"},{"source":"brain metastases","target":"metformin 500mg (u)","id":"7740"},{"source":"brain metastases","target":"pembrolizumab","id":"7741"},{"source":"vascular headaches","target":"metformin 500mg (u)","id":"7742"},{"source":"vascular headaches","target":"pembrolizumab","id":"7743"},{"source":"brain disease","target":"metformin 500mg (u)","id":"7744"},{"source":"brain disease","target":"pembrolizumab","id":"7745"},{"source":"liver metastases","target":"metformin 500mg (u)","id":"7746"},{"source":"liver metastases","target":"pembrolizumab","id":"7747"},{"source":"migraine disorders","target":"metformin 500mg (u)","id":"7748"},{"source":"migraine disorders","target":"pembrolizumab","id":"7749"},{"source":"residual tumor","target":"metformin 500mg (u)","id":"7750"},{"source":"residual tumor","target":"pembrolizumab","id":"7751"},{"source":"central nervous system diseases","target":"metformin 500mg (u)","id":"7752"},{"source":"central nervous system diseases","target":"pembrolizumab","id":"7753"},{"source":"cerebellar neoplasms","target":"metformin 500mg (u)","id":"7754"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"7755"},{"source":"carcinoma","target":"metformin 500mg (u)","id":"7756"},{"source":"carcinoma","target":"pembrolizumab","id":"7757"},{"source":"brain disease","target":"metformin 500mg (u)","id":"7758"},{"source":"brain disease","target":"pembrolizumab","id":"7759"},{"source":"anticancer","target":"metformin 500mg (u)","id":"7760"},{"source":"anticancer","target":"pembrolizumab","id":"7761"},{"source":"skin neoplasms","target":"metformin 500mg (u)","id":"7762"},{"source":"skin neoplasms","target":"pembrolizumab","id":"7763"},{"source":"antimigraine","target":"metformin 500mg (u)","id":"7764"},{"source":"antimigraine","target":"pembrolizumab","id":"7765"},{"source":"liver neoplasms","target":"metformin 500mg (u)","id":"7766"},{"source":"liver neoplasms","target":"pembrolizumab","id":"7767"},{"source":"vascular headaches","target":"metformin 500mg (u)","id":"7768"},{"source":"vascular headaches","target":"pembrolizumab","id":"7769"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"7770"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"7771"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"7772"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"7773"},{"source":"Anticancer immunotherapy","target":"vascular headaches","id":"7774"},{"source":"Anticancer immunotherapy","target":"brain disease","id":"7775"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"7776"},{"source":"Anticancer immunotherapy","target":"migraine disorders","id":"7777"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"7778"},{"source":"Anticancer immunotherapy","target":"central nervous system diseases","id":"7779"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"7780"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7781"},{"source":"Anticancer immunotherapy","target":"brain disease","id":"7782"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7783"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"7784"},{"source":"Anticancer immunotherapy","target":"antimigraine","id":"7785"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"7786"},{"source":"Anticancer immunotherapy","target":"vascular headaches","id":"7787"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"7788"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"7789"},{"source":"CD19 antagonist","target":"melanoma","id":"7790"},{"source":"CD19 antagonist","target":"brain metastases","id":"7791"},{"source":"CD19 antagonist","target":"vascular headaches","id":"7792"},{"source":"CD19 antagonist","target":"brain disease","id":"7793"},{"source":"CD19 antagonist","target":"liver metastases","id":"7794"},{"source":"CD19 antagonist","target":"migraine disorders","id":"7795"},{"source":"CD19 antagonist","target":"residual tumor","id":"7796"},{"source":"CD19 antagonist","target":"central nervous system diseases","id":"7797"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"7798"},{"source":"CD19 antagonist","target":"carcinoma","id":"7799"},{"source":"CD19 antagonist","target":"brain disease","id":"7800"},{"source":"CD19 antagonist","target":"anticancer","id":"7801"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"7802"},{"source":"CD19 antagonist","target":"antimigraine","id":"7803"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"7804"},{"source":"CD19 antagonist","target":"vascular headaches","id":"7805"},{"source":"Biguanide","target":"UNK : Indication","id":"7806"},{"source":"Biguanide","target":"ovarian neoplasms","id":"7807"},{"source":"Biguanide","target":"melanoma","id":"7808"},{"source":"Biguanide","target":"brain metastases","id":"7809"},{"source":"Biguanide","target":"vascular headaches","id":"7810"},{"source":"Biguanide","target":"brain disease","id":"7811"},{"source":"Biguanide","target":"liver metastases","id":"7812"},{"source":"Biguanide","target":"migraine disorders","id":"7813"},{"source":"Biguanide","target":"residual tumor","id":"7814"},{"source":"Biguanide","target":"central nervous system diseases","id":"7815"},{"source":"Biguanide","target":"cerebellar neoplasms","id":"7816"},{"source":"Biguanide","target":"carcinoma","id":"7817"},{"source":"Biguanide","target":"brain disease","id":"7818"},{"source":"Biguanide","target":"anticancer","id":"7819"},{"source":"Biguanide","target":"skin neoplasms","id":"7820"},{"source":"Biguanide","target":"antimigraine","id":"7821"},{"source":"Biguanide","target":"liver neoplasms","id":"7822"},{"source":"Biguanide","target":"vascular headaches","id":"7823"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"7824"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"7825"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"7826"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"7827"},{"source":"Immune checkpoint inhibitor","target":"vascular headaches","id":"7828"},{"source":"Immune checkpoint inhibitor","target":"brain disease","id":"7829"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"7830"},{"source":"Immune checkpoint inhibitor","target":"migraine disorders","id":"7831"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"7832"},{"source":"Immune checkpoint inhibitor","target":"central nervous system diseases","id":"7833"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"7834"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"7835"},{"source":"Immune checkpoint inhibitor","target":"brain disease","id":"7836"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"7837"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"7838"},{"source":"Immune checkpoint inhibitor","target":"antimigraine","id":"7839"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"7840"},{"source":"Immune checkpoint inhibitor","target":"vascular headaches","id":"7841"},{"source":"Gluconeogenesis inhibitor","target":"UNK : Indication","id":"7842"},{"source":"Gluconeogenesis inhibitor","target":"ovarian neoplasms","id":"7843"},{"source":"Gluconeogenesis inhibitor","target":"melanoma","id":"7844"},{"source":"Gluconeogenesis inhibitor","target":"brain metastases","id":"7845"},{"source":"Gluconeogenesis inhibitor","target":"vascular headaches","id":"7846"},{"source":"Gluconeogenesis inhibitor","target":"brain disease","id":"7847"},{"source":"Gluconeogenesis inhibitor","target":"liver metastases","id":"7848"},{"source":"Gluconeogenesis inhibitor","target":"migraine disorders","id":"7849"},{"source":"Gluconeogenesis inhibitor","target":"residual tumor","id":"7850"},{"source":"Gluconeogenesis inhibitor","target":"central nervous system diseases","id":"7851"},{"source":"Gluconeogenesis inhibitor","target":"cerebellar neoplasms","id":"7852"},{"source":"Gluconeogenesis inhibitor","target":"carcinoma","id":"7853"},{"source":"Gluconeogenesis inhibitor","target":"brain disease","id":"7854"},{"source":"Gluconeogenesis inhibitor","target":"anticancer","id":"7855"},{"source":"Gluconeogenesis inhibitor","target":"skin neoplasms","id":"7856"},{"source":"Gluconeogenesis inhibitor","target":"antimigraine","id":"7857"},{"source":"Gluconeogenesis inhibitor","target":"liver neoplasms","id":"7858"},{"source":"Gluconeogenesis inhibitor","target":"vascular headaches","id":"7859"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"7860"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"7861"},{"source":"Oncology: Melanoma","target":"Biguanide","id":"7862"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"7863"},{"source":"Oncology: Melanoma","target":"Gluconeogenesis inhibitor","id":"7864"},{"source":"Ad5/3-D24-RGD cancer therapy","target":"Targovax {Oncos Therapeutics}","id":"7865"},{"source":"Oncos Therapeutics (u)","target":"Targovax {Oncos Therapeutics}","id":"7866"},{"source":"cyclophosphamide","target":"Targovax {Oncos Therapeutics}","id":"7867"},{"source":"unspecified","target":"Targovax {Oncos Therapeutics}","id":"7868"},{"source":"pembrolizumab","target":"Targovax {Oncos Therapeutics}","id":"7869"},{"source":"ovarian neoplasms","target":"Ad5/3-D24-RGD cancer therapy","id":"7870"},{"source":"ovarian neoplasms","target":"Oncos Therapeutics (u)","id":"7871"},{"source":"ovarian neoplasms","target":"cyclophosphamide","id":"7872"},{"source":"ovarian neoplasms","target":"unspecified","id":"7873"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"7874"},{"source":"anti-inflammatory","target":"Ad5/3-D24-RGD cancer therapy","id":"7875"},{"source":"anti-inflammatory","target":"Oncos Therapeutics (u)","id":"7876"},{"source":"anti-inflammatory","target":"cyclophosphamide","id":"7877"},{"source":"anti-inflammatory","target":"unspecified","id":"7878"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"7879"},{"source":"melanoma","target":"Ad5/3-D24-RGD cancer therapy","id":"7880"},{"source":"melanoma","target":"Oncos Therapeutics (u)","id":"7881"},{"source":"melanoma","target":"cyclophosphamide","id":"7882"},{"source":"melanoma","target":"unspecified","id":"7883"},{"source":"melanoma","target":"pembrolizumab","id":"7884"},{"source":"anticancer","target":"Ad5/3-D24-RGD cancer therapy","id":"7885"},{"source":"anticancer","target":"Oncos Therapeutics (u)","id":"7886"},{"source":"anticancer","target":"cyclophosphamide","id":"7887"},{"source":"anticancer","target":"unspecified","id":"7888"},{"source":"anticancer","target":"pembrolizumab","id":"7889"},{"source":"melanoma","target":"Ad5/3-D24-RGD cancer therapy","id":"7890"},{"source":"melanoma","target":"Oncos Therapeutics (u)","id":"7891"},{"source":"melanoma","target":"cyclophosphamide","id":"7892"},{"source":"melanoma","target":"unspecified","id":"7893"},{"source":"melanoma","target":"pembrolizumab","id":"7894"},{"source":"alopecia","target":"Ad5/3-D24-RGD cancer therapy","id":"7895"},{"source":"alopecia","target":"Oncos Therapeutics (u)","id":"7896"},{"source":"alopecia","target":"cyclophosphamide","id":"7897"},{"source":"alopecia","target":"unspecified","id":"7898"},{"source":"alopecia","target":"pembrolizumab","id":"7899"},{"source":"skin neoplasms","target":"Ad5/3-D24-RGD cancer therapy","id":"7900"},{"source":"skin neoplasms","target":"Oncos Therapeutics (u)","id":"7901"},{"source":"skin neoplasms","target":"cyclophosphamide","id":"7902"},{"source":"skin neoplasms","target":"unspecified","id":"7903"},{"source":"skin neoplasms","target":"pembrolizumab","id":"7904"},{"source":"cerebellar neoplasms","target":"Ad5/3-D24-RGD cancer therapy","id":"7905"},{"source":"cerebellar neoplasms","target":"Oncos Therapeutics (u)","id":"7906"},{"source":"cerebellar neoplasms","target":"cyclophosphamide","id":"7907"},{"source":"cerebellar neoplasms","target":"unspecified","id":"7908"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"7909"},{"source":"carcinoma","target":"Ad5/3-D24-RGD cancer therapy","id":"7910"},{"source":"carcinoma","target":"Oncos Therapeutics (u)","id":"7911"},{"source":"carcinoma","target":"cyclophosphamide","id":"7912"},{"source":"carcinoma","target":"unspecified","id":"7913"},{"source":"carcinoma","target":"pembrolizumab","id":"7914"},{"source":"inflammation","target":"Ad5/3-D24-RGD cancer therapy","id":"7915"},{"source":"inflammation","target":"Oncos Therapeutics (u)","id":"7916"},{"source":"inflammation","target":"cyclophosphamide","id":"7917"},{"source":"inflammation","target":"unspecified","id":"7918"},{"source":"inflammation","target":"pembrolizumab","id":"7919"},{"source":"brain metastases","target":"Ad5/3-D24-RGD cancer therapy","id":"7920"},{"source":"brain metastases","target":"Oncos Therapeutics (u)","id":"7921"},{"source":"brain metastases","target":"cyclophosphamide","id":"7922"},{"source":"brain metastases","target":"unspecified","id":"7923"},{"source":"brain metastases","target":"pembrolizumab","id":"7924"},{"source":"gilbert disease","target":"Ad5/3-D24-RGD cancer therapy","id":"7925"},{"source":"gilbert disease","target":"Oncos Therapeutics (u)","id":"7926"},{"source":"gilbert disease","target":"cyclophosphamide","id":"7927"},{"source":"gilbert disease","target":"unspecified","id":"7928"},{"source":"gilbert disease","target":"pembrolizumab","id":"7929"},{"source":"anti-tumor","target":"Ad5/3-D24-RGD cancer therapy","id":"7930"},{"source":"anti-tumor","target":"Oncos Therapeutics (u)","id":"7931"},{"source":"anti-tumor","target":"cyclophosphamide","id":"7932"},{"source":"anti-tumor","target":"unspecified","id":"7933"},{"source":"anti-tumor","target":"pembrolizumab","id":"7934"},{"source":"anticancer","target":"Ad5/3-D24-RGD cancer therapy","id":"7935"},{"source":"anticancer","target":"Oncos Therapeutics (u)","id":"7936"},{"source":"anticancer","target":"cyclophosphamide","id":"7937"},{"source":"anticancer","target":"unspecified","id":"7938"},{"source":"anticancer","target":"pembrolizumab","id":"7939"},{"source":"lymphoma","target":"Ad5/3-D24-RGD cancer therapy","id":"7940"},{"source":"lymphoma","target":"Oncos Therapeutics (u)","id":"7941"},{"source":"lymphoma","target":"cyclophosphamide","id":"7942"},{"source":"lymphoma","target":"unspecified","id":"7943"},{"source":"lymphoma","target":"pembrolizumab","id":"7944"},{"source":"gilbert disease","target":"Ad5/3-D24-RGD cancer therapy","id":"7945"},{"source":"gilbert disease","target":"Oncos Therapeutics (u)","id":"7946"},{"source":"gilbert disease","target":"cyclophosphamide","id":"7947"},{"source":"gilbert disease","target":"unspecified","id":"7948"},{"source":"gilbert disease","target":"pembrolizumab","id":"7949"},{"source":"lymph node metastasis","target":"Ad5/3-D24-RGD cancer therapy","id":"7950"},{"source":"lymph node metastasis","target":"Oncos Therapeutics (u)","id":"7951"},{"source":"lymph node metastasis","target":"cyclophosphamide","id":"7952"},{"source":"lymph node metastasis","target":"unspecified","id":"7953"},{"source":"lymph node metastasis","target":"pembrolizumab","id":"7954"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"7955"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"7956"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"7957"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7958"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"7959"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"7960"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"7961"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"7962"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"7963"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"7964"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"7965"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"7966"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"7967"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"7968"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"7969"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"7970"},{"source":"Anticancer immunotherapy","target":"lymph node metastasis","id":"7971"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"7972"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"7973"},{"source":"CD19 antagonist","target":"melanoma","id":"7974"},{"source":"CD19 antagonist","target":"anticancer","id":"7975"},{"source":"CD19 antagonist","target":"melanoma","id":"7976"},{"source":"CD19 antagonist","target":"alopecia","id":"7977"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"7978"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"7979"},{"source":"CD19 antagonist","target":"carcinoma","id":"7980"},{"source":"CD19 antagonist","target":"inflammation","id":"7981"},{"source":"CD19 antagonist","target":"brain metastases","id":"7982"},{"source":"CD19 antagonist","target":"gilbert disease","id":"7983"},{"source":"CD19 antagonist","target":"anti-tumor","id":"7984"},{"source":"CD19 antagonist","target":"anticancer","id":"7985"},{"source":"CD19 antagonist","target":"lymphoma","id":"7986"},{"source":"CD19 antagonist","target":"gilbert disease","id":"7987"},{"source":"CD19 antagonist","target":"lymph node metastasis","id":"7988"},{"source":"NA","target":"ovarian neoplasms","id":"7989"},{"source":"NA","target":"anti-inflammatory","id":"7990"},{"source":"NA","target":"melanoma","id":"7991"},{"source":"NA","target":"anticancer","id":"7992"},{"source":"NA","target":"melanoma","id":"7993"},{"source":"NA","target":"alopecia","id":"7994"},{"source":"NA","target":"skin neoplasms","id":"7995"},{"source":"NA","target":"cerebellar neoplasms","id":"7996"},{"source":"NA","target":"carcinoma","id":"7997"},{"source":"NA","target":"inflammation","id":"7998"},{"source":"NA","target":"brain metastases","id":"7999"},{"source":"NA","target":"gilbert disease","id":"8000"},{"source":"NA","target":"anti-tumor","id":"8001"},{"source":"NA","target":"anticancer","id":"8002"},{"source":"NA","target":"lymphoma","id":"8003"},{"source":"NA","target":"gilbert disease","id":"8004"},{"source":"NA","target":"lymph node metastasis","id":"8005"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"ovarian neoplasms","id":"8006"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anti-inflammatory","id":"8007"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"melanoma","id":"8008"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"8009"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"melanoma","id":"8010"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"alopecia","id":"8011"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"skin neoplasms","id":"8012"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"cerebellar neoplasms","id":"8013"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"8014"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"inflammation","id":"8015"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"brain metastases","id":"8016"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"gilbert disease","id":"8017"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anti-tumor","id":"8018"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"8019"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"lymphoma","id":"8020"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"gilbert disease","id":"8021"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"lymph node metastasis","id":"8022"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"8023"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"8024"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"8025"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"8026"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"8027"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"8028"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"8029"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"8030"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8031"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"8032"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"8033"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"8034"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"8035"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"8036"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"8037"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"8038"},{"source":"Immune checkpoint inhibitor","target":"lymph node metastasis","id":"8039"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"8040"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"8041"},{"source":"Oncology: Melanoma","target":"NA","id":"8042"},{"source":"Oncology: Melanoma","target":"Granulocyte macrophage colony stimulating factor agonist","id":"8043"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"8044"},{"source":"binimetinib (u)","target":"Array BioPharma","id":"8045"},{"source":"binimetinib (u)","target":"Merck & Co.","id":"8046"},{"source":"pembrolizumab","target":"Array BioPharma","id":"8047"},{"source":"pembrolizumab","target":"Merck & Co.","id":"8048"},{"source":"5-fluorouracil","target":"Array BioPharma","id":"8049"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"8050"},{"source":"irinotecan (IV)","target":"Array BioPharma","id":"8051"},{"source":"irinotecan (IV)","target":"Merck & Co.","id":"8052"},{"source":"leucovorin","target":"Array BioPharma","id":"8053"},{"source":"leucovorin","target":"Merck & Co.","id":"8054"},{"source":"oxaliplatin (IV)","target":"Array BioPharma","id":"8055"},{"source":"oxaliplatin (IV)","target":"Merck & Co.","id":"8056"},{"source":"UNK : Indication","target":"binimetinib (u)","id":"8057"},{"source":"UNK : Indication","target":"pembrolizumab","id":"8058"},{"source":"UNK : Indication","target":"5-fluorouracil","id":"8059"},{"source":"UNK : Indication","target":"irinotecan (IV)","id":"8060"},{"source":"UNK : Indication","target":"leucovorin","id":"8061"},{"source":"UNK : Indication","target":"oxaliplatin (IV)","id":"8062"},{"source":"colorectal neoplasms","target":"binimetinib (u)","id":"8063"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"8064"},{"source":"colorectal neoplasms","target":"5-fluorouracil","id":"8065"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"8066"},{"source":"colorectal neoplasms","target":"leucovorin","id":"8067"},{"source":"colorectal neoplasms","target":"oxaliplatin (IV)","id":"8068"},{"source":"anticancer","target":"binimetinib (u)","id":"8069"},{"source":"anticancer","target":"pembrolizumab","id":"8070"},{"source":"anticancer","target":"5-fluorouracil","id":"8071"},{"source":"anticancer","target":"irinotecan (IV)","id":"8072"},{"source":"anticancer","target":"leucovorin","id":"8073"},{"source":"anticancer","target":"oxaliplatin (IV)","id":"8074"},{"source":"antiarthritic","target":"binimetinib (u)","id":"8075"},{"source":"antiarthritic","target":"pembrolizumab","id":"8076"},{"source":"antiarthritic","target":"5-fluorouracil","id":"8077"},{"source":"antiarthritic","target":"irinotecan (IV)","id":"8078"},{"source":"antiarthritic","target":"leucovorin","id":"8079"},{"source":"antiarthritic","target":"oxaliplatin (IV)","id":"8080"},{"source":"depression","target":"binimetinib (u)","id":"8081"},{"source":"depression","target":"pembrolizumab","id":"8082"},{"source":"depression","target":"5-fluorouracil","id":"8083"},{"source":"depression","target":"irinotecan (IV)","id":"8084"},{"source":"depression","target":"leucovorin","id":"8085"},{"source":"depression","target":"oxaliplatin (IV)","id":"8086"},{"source":"inflammatory bowel diseases","target":"binimetinib (u)","id":"8087"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"8088"},{"source":"inflammatory bowel diseases","target":"5-fluorouracil","id":"8089"},{"source":"inflammatory bowel diseases","target":"irinotecan (IV)","id":"8090"},{"source":"inflammatory bowel diseases","target":"leucovorin","id":"8091"},{"source":"inflammatory bowel diseases","target":"oxaliplatin (IV)","id":"8092"},{"source":"antianaemic","target":"binimetinib (u)","id":"8093"},{"source":"antianaemic","target":"pembrolizumab","id":"8094"},{"source":"antianaemic","target":"5-fluorouracil","id":"8095"},{"source":"antianaemic","target":"irinotecan (IV)","id":"8096"},{"source":"antianaemic","target":"leucovorin","id":"8097"},{"source":"antianaemic","target":"oxaliplatin (IV)","id":"8098"},{"source":"inflammatory bowel diseases","target":"binimetinib (u)","id":"8099"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"8100"},{"source":"inflammatory bowel diseases","target":"5-fluorouracil","id":"8101"},{"source":"inflammatory bowel diseases","target":"irinotecan (IV)","id":"8102"},{"source":"inflammatory bowel diseases","target":"leucovorin","id":"8103"},{"source":"inflammatory bowel diseases","target":"oxaliplatin (IV)","id":"8104"},{"source":"microsatellite instability","target":"binimetinib (u)","id":"8105"},{"source":"microsatellite instability","target":"pembrolizumab","id":"8106"},{"source":"microsatellite instability","target":"5-fluorouracil","id":"8107"},{"source":"microsatellite instability","target":"irinotecan (IV)","id":"8108"},{"source":"microsatellite instability","target":"leucovorin","id":"8109"},{"source":"microsatellite instability","target":"oxaliplatin (IV)","id":"8110"},{"source":"colonic neoplasms","target":"binimetinib (u)","id":"8111"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"8112"},{"source":"colonic neoplasms","target":"5-fluorouracil","id":"8113"},{"source":"colonic neoplasms","target":"irinotecan (IV)","id":"8114"},{"source":"colonic neoplasms","target":"leucovorin","id":"8115"},{"source":"colonic neoplasms","target":"oxaliplatin (IV)","id":"8116"},{"source":"anemia","target":"binimetinib (u)","id":"8117"},{"source":"anemia","target":"pembrolizumab","id":"8118"},{"source":"anemia","target":"5-fluorouracil","id":"8119"},{"source":"anemia","target":"irinotecan (IV)","id":"8120"},{"source":"anemia","target":"leucovorin","id":"8121"},{"source":"anemia","target":"oxaliplatin (IV)","id":"8122"},{"source":"colorectal cancer","target":"binimetinib (u)","id":"8123"},{"source":"colorectal cancer","target":"pembrolizumab","id":"8124"},{"source":"colorectal cancer","target":"5-fluorouracil","id":"8125"},{"source":"colorectal cancer","target":"irinotecan (IV)","id":"8126"},{"source":"colorectal cancer","target":"leucovorin","id":"8127"},{"source":"colorectal cancer","target":"oxaliplatin (IV)","id":"8128"},{"source":"copd","target":"binimetinib (u)","id":"8129"},{"source":"copd","target":"pembrolizumab","id":"8130"},{"source":"copd","target":"5-fluorouracil","id":"8131"},{"source":"copd","target":"irinotecan (IV)","id":"8132"},{"source":"copd","target":"leucovorin","id":"8133"},{"source":"copd","target":"oxaliplatin (IV)","id":"8134"},{"source":"arthritis","target":"binimetinib (u)","id":"8135"},{"source":"arthritis","target":"pembrolizumab","id":"8136"},{"source":"arthritis","target":"5-fluorouracil","id":"8137"},{"source":"arthritis","target":"irinotecan (IV)","id":"8138"},{"source":"arthritis","target":"leucovorin","id":"8139"},{"source":"arthritis","target":"oxaliplatin (IV)","id":"8140"},{"source":"metastatic","target":"binimetinib (u)","id":"8141"},{"source":"metastatic","target":"pembrolizumab","id":"8142"},{"source":"metastatic","target":"5-fluorouracil","id":"8143"},{"source":"metastatic","target":"irinotecan (IV)","id":"8144"},{"source":"metastatic","target":"leucovorin","id":"8145"},{"source":"metastatic","target":"oxaliplatin (IV)","id":"8146"},{"source":"carcinoma","target":"binimetinib (u)","id":"8147"},{"source":"carcinoma","target":"pembrolizumab","id":"8148"},{"source":"carcinoma","target":"5-fluorouracil","id":"8149"},{"source":"carcinoma","target":"irinotecan (IV)","id":"8150"},{"source":"carcinoma","target":"leucovorin","id":"8151"},{"source":"carcinoma","target":"oxaliplatin (IV)","id":"8152"},{"source":"neoplasm metastasis","target":"binimetinib (u)","id":"8153"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"8154"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"8155"},{"source":"neoplasm metastasis","target":"irinotecan (IV)","id":"8156"},{"source":"neoplasm metastasis","target":"leucovorin","id":"8157"},{"source":"neoplasm metastasis","target":"oxaliplatin (IV)","id":"8158"},{"source":"colorectal neoplasms","target":"binimetinib (u)","id":"8159"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"8160"},{"source":"colorectal neoplasms","target":"5-fluorouracil","id":"8161"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"8162"},{"source":"colorectal neoplasms","target":"leucovorin","id":"8163"},{"source":"colorectal neoplasms","target":"oxaliplatin (IV)","id":"8164"},{"source":"antidepressant","target":"binimetinib (u)","id":"8165"},{"source":"antidepressant","target":"pembrolizumab","id":"8166"},{"source":"antidepressant","target":"5-fluorouracil","id":"8167"},{"source":"antidepressant","target":"irinotecan (IV)","id":"8168"},{"source":"antidepressant","target":"leucovorin","id":"8169"},{"source":"antidepressant","target":"oxaliplatin (IV)","id":"8170"},{"source":"residual tumor","target":"binimetinib (u)","id":"8171"},{"source":"residual tumor","target":"pembrolizumab","id":"8172"},{"source":"residual tumor","target":"5-fluorouracil","id":"8173"},{"source":"residual tumor","target":"irinotecan (IV)","id":"8174"},{"source":"residual tumor","target":"leucovorin","id":"8175"},{"source":"residual tumor","target":"oxaliplatin (IV)","id":"8176"},{"source":"anti-tumor","target":"binimetinib (u)","id":"8177"},{"source":"anti-tumor","target":"pembrolizumab","id":"8178"},{"source":"anti-tumor","target":"5-fluorouracil","id":"8179"},{"source":"anti-tumor","target":"irinotecan (IV)","id":"8180"},{"source":"anti-tumor","target":"leucovorin","id":"8181"},{"source":"anti-tumor","target":"oxaliplatin (IV)","id":"8182"},{"source":"chronic obstructive pulmonary disease","target":"binimetinib (u)","id":"8183"},{"source":"chronic obstructive pulmonary disease","target":"pembrolizumab","id":"8184"},{"source":"chronic obstructive pulmonary disease","target":"5-fluorouracil","id":"8185"},{"source":"chronic obstructive pulmonary disease","target":"irinotecan (IV)","id":"8186"},{"source":"chronic obstructive pulmonary disease","target":"leucovorin","id":"8187"},{"source":"chronic obstructive pulmonary disease","target":"oxaliplatin (IV)","id":"8188"},{"source":"anticancer","target":"binimetinib (u)","id":"8189"},{"source":"anticancer","target":"pembrolizumab","id":"8190"},{"source":"anticancer","target":"5-fluorouracil","id":"8191"},{"source":"anticancer","target":"irinotecan (IV)","id":"8192"},{"source":"anticancer","target":"leucovorin","id":"8193"},{"source":"anticancer","target":"oxaliplatin (IV)","id":"8194"},{"source":"NA","target":"UNK : Indication","id":"8195"},{"source":"NA","target":"colorectal neoplasms","id":"8196"},{"source":"NA","target":"anticancer","id":"8197"},{"source":"NA","target":"antiarthritic","id":"8198"},{"source":"NA","target":"depression","id":"8199"},{"source":"NA","target":"inflammatory bowel diseases","id":"8200"},{"source":"NA","target":"antianaemic","id":"8201"},{"source":"NA","target":"inflammatory bowel diseases","id":"8202"},{"source":"NA","target":"microsatellite instability","id":"8203"},{"source":"NA","target":"colonic neoplasms","id":"8204"},{"source":"NA","target":"anemia","id":"8205"},{"source":"NA","target":"colorectal cancer","id":"8206"},{"source":"NA","target":"copd","id":"8207"},{"source":"NA","target":"arthritis","id":"8208"},{"source":"NA","target":"metastatic","id":"8209"},{"source":"NA","target":"carcinoma","id":"8210"},{"source":"NA","target":"neoplasm metastasis","id":"8211"},{"source":"NA","target":"colorectal neoplasms","id":"8212"},{"source":"NA","target":"antidepressant","id":"8213"},{"source":"NA","target":"residual tumor","id":"8214"},{"source":"NA","target":"anti-tumor","id":"8215"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"8216"},{"source":"NA","target":"anticancer","id":"8217"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"8218"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"8219"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"8220"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"8221"},{"source":"Immune checkpoint inhibitor","target":"depression","id":"8222"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"8223"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"8224"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"8225"},{"source":"Immune checkpoint inhibitor","target":"microsatellite instability","id":"8226"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"8227"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"8228"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"8229"},{"source":"Immune checkpoint inhibitor","target":"copd","id":"8230"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"8231"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"8232"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8233"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"8234"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"8235"},{"source":"Immune checkpoint inhibitor","target":"antidepressant","id":"8236"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"8237"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"8238"},{"source":"Immune checkpoint inhibitor","target":"chronic obstructive pulmonary disease","id":"8239"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"8240"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"8241"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"8242"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"8243"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"8244"},{"source":"Anticancer immunotherapy","target":"depression","id":"8245"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"8246"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"8247"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"8248"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"8249"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"8250"},{"source":"Anticancer immunotherapy","target":"anemia","id":"8251"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"8252"},{"source":"Anticancer immunotherapy","target":"copd","id":"8253"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"8254"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"8255"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8256"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"8257"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"8258"},{"source":"Anticancer immunotherapy","target":"antidepressant","id":"8259"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"8260"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"8261"},{"source":"Anticancer immunotherapy","target":"chronic obstructive pulmonary disease","id":"8262"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"8263"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"8264"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"8265"},{"source":"CD19 antagonist","target":"anticancer","id":"8266"},{"source":"CD19 antagonist","target":"antiarthritic","id":"8267"},{"source":"CD19 antagonist","target":"depression","id":"8268"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"8269"},{"source":"CD19 antagonist","target":"antianaemic","id":"8270"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"8271"},{"source":"CD19 antagonist","target":"microsatellite instability","id":"8272"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"8273"},{"source":"CD19 antagonist","target":"anemia","id":"8274"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"8275"},{"source":"CD19 antagonist","target":"copd","id":"8276"},{"source":"CD19 antagonist","target":"arthritis","id":"8277"},{"source":"CD19 antagonist","target":"metastatic","id":"8278"},{"source":"CD19 antagonist","target":"carcinoma","id":"8279"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"8280"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"8281"},{"source":"CD19 antagonist","target":"antidepressant","id":"8282"},{"source":"CD19 antagonist","target":"residual tumor","id":"8283"},{"source":"CD19 antagonist","target":"anti-tumor","id":"8284"},{"source":"CD19 antagonist","target":"chronic obstructive pulmonary disease","id":"8285"},{"source":"CD19 antagonist","target":"anticancer","id":"8286"},{"source":"UPA","target":"UNK : Indication","id":"8287"},{"source":"UPA","target":"colorectal neoplasms","id":"8288"},{"source":"UPA","target":"anticancer","id":"8289"},{"source":"UPA","target":"antiarthritic","id":"8290"},{"source":"UPA","target":"depression","id":"8291"},{"source":"UPA","target":"inflammatory bowel diseases","id":"8292"},{"source":"UPA","target":"antianaemic","id":"8293"},{"source":"UPA","target":"inflammatory bowel diseases","id":"8294"},{"source":"UPA","target":"microsatellite instability","id":"8295"},{"source":"UPA","target":"colonic neoplasms","id":"8296"},{"source":"UPA","target":"anemia","id":"8297"},{"source":"UPA","target":"colorectal cancer","id":"8298"},{"source":"UPA","target":"copd","id":"8299"},{"source":"UPA","target":"arthritis","id":"8300"},{"source":"UPA","target":"metastatic","id":"8301"},{"source":"UPA","target":"carcinoma","id":"8302"},{"source":"UPA","target":"neoplasm metastasis","id":"8303"},{"source":"UPA","target":"colorectal neoplasms","id":"8304"},{"source":"UPA","target":"antidepressant","id":"8305"},{"source":"UPA","target":"residual tumor","id":"8306"},{"source":"UPA","target":"anti-tumor","id":"8307"},{"source":"UPA","target":"chronic obstructive pulmonary disease","id":"8308"},{"source":"UPA","target":"anticancer","id":"8309"},{"source":"NA","target":"UNK : Indication","id":"8310"},{"source":"NA","target":"colorectal neoplasms","id":"8311"},{"source":"NA","target":"anticancer","id":"8312"},{"source":"NA","target":"antiarthritic","id":"8313"},{"source":"NA","target":"depression","id":"8314"},{"source":"NA","target":"inflammatory bowel diseases","id":"8315"},{"source":"NA","target":"antianaemic","id":"8316"},{"source":"NA","target":"inflammatory bowel diseases","id":"8317"},{"source":"NA","target":"microsatellite instability","id":"8318"},{"source":"NA","target":"colonic neoplasms","id":"8319"},{"source":"NA","target":"anemia","id":"8320"},{"source":"NA","target":"colorectal cancer","id":"8321"},{"source":"NA","target":"copd","id":"8322"},{"source":"NA","target":"arthritis","id":"8323"},{"source":"NA","target":"metastatic","id":"8324"},{"source":"NA","target":"carcinoma","id":"8325"},{"source":"NA","target":"neoplasm metastasis","id":"8326"},{"source":"NA","target":"colorectal neoplasms","id":"8327"},{"source":"NA","target":"antidepressant","id":"8328"},{"source":"NA","target":"residual tumor","id":"8329"},{"source":"NA","target":"anti-tumor","id":"8330"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"8331"},{"source":"NA","target":"anticancer","id":"8332"},{"source":"MEK inhibitor","target":"UNK : Indication","id":"8333"},{"source":"MEK inhibitor","target":"colorectal neoplasms","id":"8334"},{"source":"MEK inhibitor","target":"anticancer","id":"8335"},{"source":"MEK inhibitor","target":"antiarthritic","id":"8336"},{"source":"MEK inhibitor","target":"depression","id":"8337"},{"source":"MEK inhibitor","target":"inflammatory bowel diseases","id":"8338"},{"source":"MEK inhibitor","target":"antianaemic","id":"8339"},{"source":"MEK inhibitor","target":"inflammatory bowel diseases","id":"8340"},{"source":"MEK inhibitor","target":"microsatellite instability","id":"8341"},{"source":"MEK inhibitor","target":"colonic neoplasms","id":"8342"},{"source":"MEK inhibitor","target":"anemia","id":"8343"},{"source":"MEK inhibitor","target":"colorectal cancer","id":"8344"},{"source":"MEK inhibitor","target":"copd","id":"8345"},{"source":"MEK inhibitor","target":"arthritis","id":"8346"},{"source":"MEK inhibitor","target":"metastatic","id":"8347"},{"source":"MEK inhibitor","target":"carcinoma","id":"8348"},{"source":"MEK inhibitor","target":"neoplasm metastasis","id":"8349"},{"source":"MEK inhibitor","target":"colorectal neoplasms","id":"8350"},{"source":"MEK inhibitor","target":"antidepressant","id":"8351"},{"source":"MEK inhibitor","target":"residual tumor","id":"8352"},{"source":"MEK inhibitor","target":"anti-tumor","id":"8353"},{"source":"MEK inhibitor","target":"chronic obstructive pulmonary disease","id":"8354"},{"source":"MEK inhibitor","target":"anticancer","id":"8355"},{"source":"NA","target":"UNK : Indication","id":"8356"},{"source":"NA","target":"colorectal neoplasms","id":"8357"},{"source":"NA","target":"anticancer","id":"8358"},{"source":"NA","target":"antiarthritic","id":"8359"},{"source":"NA","target":"depression","id":"8360"},{"source":"NA","target":"inflammatory bowel diseases","id":"8361"},{"source":"NA","target":"antianaemic","id":"8362"},{"source":"NA","target":"inflammatory bowel diseases","id":"8363"},{"source":"NA","target":"microsatellite instability","id":"8364"},{"source":"NA","target":"colonic neoplasms","id":"8365"},{"source":"NA","target":"anemia","id":"8366"},{"source":"NA","target":"colorectal cancer","id":"8367"},{"source":"NA","target":"copd","id":"8368"},{"source":"NA","target":"arthritis","id":"8369"},{"source":"NA","target":"metastatic","id":"8370"},{"source":"NA","target":"carcinoma","id":"8371"},{"source":"NA","target":"neoplasm metastasis","id":"8372"},{"source":"NA","target":"colorectal neoplasms","id":"8373"},{"source":"NA","target":"antidepressant","id":"8374"},{"source":"NA","target":"residual tumor","id":"8375"},{"source":"NA","target":"anti-tumor","id":"8376"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"8377"},{"source":"NA","target":"anticancer","id":"8378"},{"source":"NA","target":"UNK : Indication","id":"8379"},{"source":"NA","target":"colorectal neoplasms","id":"8380"},{"source":"NA","target":"anticancer","id":"8381"},{"source":"NA","target":"antiarthritic","id":"8382"},{"source":"NA","target":"depression","id":"8383"},{"source":"NA","target":"inflammatory bowel diseases","id":"8384"},{"source":"NA","target":"antianaemic","id":"8385"},{"source":"NA","target":"inflammatory bowel diseases","id":"8386"},{"source":"NA","target":"microsatellite instability","id":"8387"},{"source":"NA","target":"colonic neoplasms","id":"8388"},{"source":"NA","target":"anemia","id":"8389"},{"source":"NA","target":"colorectal cancer","id":"8390"},{"source":"NA","target":"copd","id":"8391"},{"source":"NA","target":"arthritis","id":"8392"},{"source":"NA","target":"metastatic","id":"8393"},{"source":"NA","target":"carcinoma","id":"8394"},{"source":"NA","target":"neoplasm metastasis","id":"8395"},{"source":"NA","target":"colorectal neoplasms","id":"8396"},{"source":"NA","target":"antidepressant","id":"8397"},{"source":"NA","target":"residual tumor","id":"8398"},{"source":"NA","target":"anti-tumor","id":"8399"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"8400"},{"source":"NA","target":"anticancer","id":"8401"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"8402"},{"source":"Thymidylate synthase inhibitor","target":"colorectal neoplasms","id":"8403"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"8404"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"8405"},{"source":"Thymidylate synthase inhibitor","target":"depression","id":"8406"},{"source":"Thymidylate synthase inhibitor","target":"inflammatory bowel diseases","id":"8407"},{"source":"Thymidylate synthase inhibitor","target":"antianaemic","id":"8408"},{"source":"Thymidylate synthase inhibitor","target":"inflammatory bowel diseases","id":"8409"},{"source":"Thymidylate synthase inhibitor","target":"microsatellite instability","id":"8410"},{"source":"Thymidylate synthase inhibitor","target":"colonic neoplasms","id":"8411"},{"source":"Thymidylate synthase inhibitor","target":"anemia","id":"8412"},{"source":"Thymidylate synthase inhibitor","target":"colorectal cancer","id":"8413"},{"source":"Thymidylate synthase inhibitor","target":"copd","id":"8414"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"8415"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"8416"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"8417"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"8418"},{"source":"Thymidylate synthase inhibitor","target":"colorectal neoplasms","id":"8419"},{"source":"Thymidylate synthase inhibitor","target":"antidepressant","id":"8420"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"8421"},{"source":"Thymidylate synthase inhibitor","target":"anti-tumor","id":"8422"},{"source":"Thymidylate synthase inhibitor","target":"chronic obstructive pulmonary disease","id":"8423"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"8424"},{"source":"Oncology: Colorectal","target":"NA","id":"8425"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"8426"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"8427"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"8428"},{"source":"Oncology: Colorectal","target":"UPA","id":"8429"},{"source":"Oncology: Colorectal","target":"NA","id":"8430"},{"source":"Oncology: Colorectal","target":"MEK inhibitor","id":"8431"},{"source":"Oncology: Colorectal","target":"NA","id":"8432"},{"source":"Oncology: Colorectal","target":"NA","id":"8433"},{"source":"Oncology: Colorectal","target":"Thymidylate synthase inhibitor","id":"8434"},{"source":"bevacizumab","target":"National Institutes of Health/National Cancer Institute","id":"8435"},{"source":"bevacizumab","target":"Roswell Park Cancer Institute","id":"8436"},{"source":"cyclophosphamide","target":"National Institutes of Health/National Cancer Institute","id":"8437"},{"source":"cyclophosphamide","target":"Roswell Park Cancer Institute","id":"8438"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"8439"},{"source":"pembrolizumab","target":"Roswell Park Cancer Institute","id":"8440"},{"source":"UNK : Drug","target":"National Institutes of Health/National Cancer Institute","id":"8441"},{"source":"UNK : Drug","target":"Roswell Park Cancer Institute","id":"8442"},{"source":"UNK : Indication","target":"bevacizumab","id":"8443"},{"source":"UNK : Indication","target":"cyclophosphamide","id":"8444"},{"source":"UNK : Indication","target":"pembrolizumab","id":"8445"},{"source":"UNK : Indication","target":"UNK : Drug","id":"8446"},{"source":"clear cell","target":"bevacizumab","id":"8447"},{"source":"clear cell","target":"cyclophosphamide","id":"8448"},{"source":"clear cell","target":"pembrolizumab","id":"8449"},{"source":"clear cell","target":"UNK : Drug","id":"8450"},{"source":"carcinoma","target":"bevacizumab","id":"8451"},{"source":"carcinoma","target":"cyclophosphamide","id":"8452"},{"source":"carcinoma","target":"pembrolizumab","id":"8453"},{"source":"carcinoma","target":"UNK : Drug","id":"8454"},{"source":"ovarian cancer","target":"bevacizumab","id":"8455"},{"source":"ovarian cancer","target":"cyclophosphamide","id":"8456"},{"source":"ovarian cancer","target":"pembrolizumab","id":"8457"},{"source":"ovarian cancer","target":"UNK : Drug","id":"8458"},{"source":"skin neoplasms","target":"bevacizumab","id":"8459"},{"source":"skin neoplasms","target":"cyclophosphamide","id":"8460"},{"source":"skin neoplasms","target":"pembrolizumab","id":"8461"},{"source":"skin neoplasms","target":"UNK : Drug","id":"8462"},{"source":"primary peritoneal cancer","target":"bevacizumab","id":"8463"},{"source":"primary peritoneal cancer","target":"cyclophosphamide","id":"8464"},{"source":"primary peritoneal cancer","target":"pembrolizumab","id":"8465"},{"source":"primary peritoneal cancer","target":"UNK : Drug","id":"8466"},{"source":"liver neoplasms","target":"bevacizumab","id":"8467"},{"source":"liver neoplasms","target":"cyclophosphamide","id":"8468"},{"source":"liver neoplasms","target":"pembrolizumab","id":"8469"},{"source":"liver neoplasms","target":"UNK : Drug","id":"8470"},{"source":"glandular and epithelial","target":"bevacizumab","id":"8471"},{"source":"glandular and epithelial","target":"cyclophosphamide","id":"8472"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"8473"},{"source":"glandular and epithelial","target":"UNK : Drug","id":"8474"},{"source":"carcinoma","target":"bevacizumab","id":"8475"},{"source":"carcinoma","target":"cyclophosphamide","id":"8476"},{"source":"carcinoma","target":"pembrolizumab","id":"8477"},{"source":"carcinoma","target":"UNK : Drug","id":"8478"},{"source":"liver metastases","target":"bevacizumab","id":"8479"},{"source":"liver metastases","target":"cyclophosphamide","id":"8480"},{"source":"liver metastases","target":"pembrolizumab","id":"8481"},{"source":"liver metastases","target":"UNK : Drug","id":"8482"},{"source":"serous","target":"bevacizumab","id":"8483"},{"source":"serous","target":"cyclophosphamide","id":"8484"},{"source":"serous","target":"pembrolizumab","id":"8485"},{"source":"serous","target":"UNK : Drug","id":"8486"},{"source":"carcinoma","target":"bevacizumab","id":"8487"},{"source":"carcinoma","target":"cyclophosphamide","id":"8488"},{"source":"carcinoma","target":"pembrolizumab","id":"8489"},{"source":"carcinoma","target":"UNK : Drug","id":"8490"},{"source":"ovarian neoplasms","target":"bevacizumab","id":"8491"},{"source":"ovarian neoplasms","target":"cyclophosphamide","id":"8492"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"8493"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"8494"},{"source":"endometrioid","target":"bevacizumab","id":"8495"},{"source":"endometrioid","target":"cyclophosphamide","id":"8496"},{"source":"endometrioid","target":"pembrolizumab","id":"8497"},{"source":"endometrioid","target":"UNK : Drug","id":"8498"},{"source":"carcinoma","target":"bevacizumab","id":"8499"},{"source":"carcinoma","target":"cyclophosphamide","id":"8500"},{"source":"carcinoma","target":"pembrolizumab","id":"8501"},{"source":"carcinoma","target":"UNK : Drug","id":"8502"},{"source":"mucinous","target":"bevacizumab","id":"8503"},{"source":"mucinous","target":"cyclophosphamide","id":"8504"},{"source":"mucinous","target":"pembrolizumab","id":"8505"},{"source":"mucinous","target":"UNK : Drug","id":"8506"},{"source":"anti-tumor","target":"bevacizumab","id":"8507"},{"source":"anti-tumor","target":"cyclophosphamide","id":"8508"},{"source":"anti-tumor","target":"pembrolizumab","id":"8509"},{"source":"anti-tumor","target":"UNK : Drug","id":"8510"},{"source":"peritoneal neoplasms","target":"bevacizumab","id":"8511"},{"source":"peritoneal neoplasms","target":"cyclophosphamide","id":"8512"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"8513"},{"source":"peritoneal neoplasms","target":"UNK : Drug","id":"8514"},{"source":"fallopian tube neoplasms","target":"bevacizumab","id":"8515"},{"source":"fallopian tube neoplasms","target":"cyclophosphamide","id":"8516"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"8517"},{"source":"fallopian tube neoplasms","target":"UNK : Drug","id":"8518"},{"source":"carcinoma","target":"bevacizumab","id":"8519"},{"source":"carcinoma","target":"cyclophosphamide","id":"8520"},{"source":"carcinoma","target":"pembrolizumab","id":"8521"},{"source":"carcinoma","target":"UNK : Drug","id":"8522"},{"source":"glandular and epithelial","target":"bevacizumab","id":"8523"},{"source":"glandular and epithelial","target":"cyclophosphamide","id":"8524"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"8525"},{"source":"glandular and epithelial","target":"UNK : Drug","id":"8526"},{"source":"carcinoma","target":"bevacizumab","id":"8527"},{"source":"carcinoma","target":"cyclophosphamide","id":"8528"},{"source":"carcinoma","target":"pembrolizumab","id":"8529"},{"source":"carcinoma","target":"UNK : Drug","id":"8530"},{"source":"residual tumor","target":"bevacizumab","id":"8531"},{"source":"residual tumor","target":"cyclophosphamide","id":"8532"},{"source":"residual tumor","target":"pembrolizumab","id":"8533"},{"source":"residual tumor","target":"UNK : Drug","id":"8534"},{"source":"anticancer","target":"bevacizumab","id":"8535"},{"source":"anticancer","target":"cyclophosphamide","id":"8536"},{"source":"anticancer","target":"pembrolizumab","id":"8537"},{"source":"anticancer","target":"UNK : Drug","id":"8538"},{"source":"carcinoma","target":"bevacizumab","id":"8539"},{"source":"carcinoma","target":"cyclophosphamide","id":"8540"},{"source":"carcinoma","target":"pembrolizumab","id":"8541"},{"source":"carcinoma","target":"UNK : Drug","id":"8542"},{"source":"Immunosuppressant","target":"UNK : Indication","id":"8543"},{"source":"Immunosuppressant","target":"clear cell","id":"8544"},{"source":"Immunosuppressant","target":"carcinoma","id":"8545"},{"source":"Immunosuppressant","target":"ovarian cancer","id":"8546"},{"source":"Immunosuppressant","target":"skin neoplasms","id":"8547"},{"source":"Immunosuppressant","target":"primary peritoneal cancer","id":"8548"},{"source":"Immunosuppressant","target":"liver neoplasms","id":"8549"},{"source":"Immunosuppressant","target":"glandular and epithelial","id":"8550"},{"source":"Immunosuppressant","target":"carcinoma","id":"8551"},{"source":"Immunosuppressant","target":"liver metastases","id":"8552"},{"source":"Immunosuppressant","target":"serous","id":"8553"},{"source":"Immunosuppressant","target":"carcinoma","id":"8554"},{"source":"Immunosuppressant","target":"ovarian neoplasms","id":"8555"},{"source":"Immunosuppressant","target":"endometrioid","id":"8556"},{"source":"Immunosuppressant","target":"carcinoma","id":"8557"},{"source":"Immunosuppressant","target":"mucinous","id":"8558"},{"source":"Immunosuppressant","target":"anti-tumor","id":"8559"},{"source":"Immunosuppressant","target":"peritoneal neoplasms","id":"8560"},{"source":"Immunosuppressant","target":"fallopian tube neoplasms","id":"8561"},{"source":"Immunosuppressant","target":"carcinoma","id":"8562"},{"source":"Immunosuppressant","target":"glandular and epithelial","id":"8563"},{"source":"Immunosuppressant","target":"carcinoma","id":"8564"},{"source":"Immunosuppressant","target":"residual tumor","id":"8565"},{"source":"Immunosuppressant","target":"anticancer","id":"8566"},{"source":"Immunosuppressant","target":"carcinoma","id":"8567"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"8568"},{"source":"Immune checkpoint inhibitor","target":"clear cell","id":"8569"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8570"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"8571"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"8572"},{"source":"Immune checkpoint inhibitor","target":"primary peritoneal cancer","id":"8573"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"8574"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"8575"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8576"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"8577"},{"source":"Immune checkpoint inhibitor","target":"serous","id":"8578"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8579"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"8580"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"8581"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8582"},{"source":"Immune checkpoint inhibitor","target":"mucinous","id":"8583"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"8584"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"8585"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"8586"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8587"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"8588"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8589"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"8590"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"8591"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8592"},{"source":"NA","target":"UNK : Indication","id":"8593"},{"source":"NA","target":"clear cell","id":"8594"},{"source":"NA","target":"carcinoma","id":"8595"},{"source":"NA","target":"ovarian cancer","id":"8596"},{"source":"NA","target":"skin neoplasms","id":"8597"},{"source":"NA","target":"primary peritoneal cancer","id":"8598"},{"source":"NA","target":"liver neoplasms","id":"8599"},{"source":"NA","target":"glandular and epithelial","id":"8600"},{"source":"NA","target":"carcinoma","id":"8601"},{"source":"NA","target":"liver metastases","id":"8602"},{"source":"NA","target":"serous","id":"8603"},{"source":"NA","target":"carcinoma","id":"8604"},{"source":"NA","target":"ovarian neoplasms","id":"8605"},{"source":"NA","target":"endometrioid","id":"8606"},{"source":"NA","target":"carcinoma","id":"8607"},{"source":"NA","target":"mucinous","id":"8608"},{"source":"NA","target":"anti-tumor","id":"8609"},{"source":"NA","target":"peritoneal neoplasms","id":"8610"},{"source":"NA","target":"fallopian tube neoplasms","id":"8611"},{"source":"NA","target":"carcinoma","id":"8612"},{"source":"NA","target":"glandular and epithelial","id":"8613"},{"source":"NA","target":"carcinoma","id":"8614"},{"source":"NA","target":"residual tumor","id":"8615"},{"source":"NA","target":"anticancer","id":"8616"},{"source":"NA","target":"carcinoma","id":"8617"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"8618"},{"source":"CD19 antagonist","target":"clear cell","id":"8619"},{"source":"CD19 antagonist","target":"carcinoma","id":"8620"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"8621"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"8622"},{"source":"CD19 antagonist","target":"primary peritoneal cancer","id":"8623"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"8624"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"8625"},{"source":"CD19 antagonist","target":"carcinoma","id":"8626"},{"source":"CD19 antagonist","target":"liver metastases","id":"8627"},{"source":"CD19 antagonist","target":"serous","id":"8628"},{"source":"CD19 antagonist","target":"carcinoma","id":"8629"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"8630"},{"source":"CD19 antagonist","target":"endometrioid","id":"8631"},{"source":"CD19 antagonist","target":"carcinoma","id":"8632"},{"source":"CD19 antagonist","target":"mucinous","id":"8633"},{"source":"CD19 antagonist","target":"anti-tumor","id":"8634"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"8635"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"8636"},{"source":"CD19 antagonist","target":"carcinoma","id":"8637"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"8638"},{"source":"CD19 antagonist","target":"carcinoma","id":"8639"},{"source":"CD19 antagonist","target":"residual tumor","id":"8640"},{"source":"CD19 antagonist","target":"anticancer","id":"8641"},{"source":"CD19 antagonist","target":"carcinoma","id":"8642"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"8643"},{"source":"Anticancer immunotherapy","target":"clear cell","id":"8644"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8645"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"8646"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"8647"},{"source":"Anticancer immunotherapy","target":"primary peritoneal cancer","id":"8648"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"8649"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"8650"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8651"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"8652"},{"source":"Anticancer immunotherapy","target":"serous","id":"8653"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8654"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"8655"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"8656"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8657"},{"source":"Anticancer immunotherapy","target":"mucinous","id":"8658"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"8659"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"8660"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"8661"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8662"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"8663"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8664"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"8665"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"8666"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8667"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"8668"},{"source":"Angiogenesis inhibitor","target":"clear cell","id":"8669"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"8670"},{"source":"Angiogenesis inhibitor","target":"ovarian cancer","id":"8671"},{"source":"Angiogenesis inhibitor","target":"skin neoplasms","id":"8672"},{"source":"Angiogenesis inhibitor","target":"primary peritoneal cancer","id":"8673"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"8674"},{"source":"Angiogenesis inhibitor","target":"glandular and epithelial","id":"8675"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"8676"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"8677"},{"source":"Angiogenesis inhibitor","target":"serous","id":"8678"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"8679"},{"source":"Angiogenesis inhibitor","target":"ovarian neoplasms","id":"8680"},{"source":"Angiogenesis inhibitor","target":"endometrioid","id":"8681"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"8682"},{"source":"Angiogenesis inhibitor","target":"mucinous","id":"8683"},{"source":"Angiogenesis inhibitor","target":"anti-tumor","id":"8684"},{"source":"Angiogenesis inhibitor","target":"peritoneal neoplasms","id":"8685"},{"source":"Angiogenesis inhibitor","target":"fallopian tube neoplasms","id":"8686"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"8687"},{"source":"Angiogenesis inhibitor","target":"glandular and epithelial","id":"8688"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"8689"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"8690"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"8691"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"8692"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"8693"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"clear cell","id":"8694"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"8695"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian cancer","id":"8696"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"skin neoplasms","id":"8697"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"primary peritoneal cancer","id":"8698"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver neoplasms","id":"8699"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"glandular and epithelial","id":"8700"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"8701"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver metastases","id":"8702"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"serous","id":"8703"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"8704"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian neoplasms","id":"8705"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"endometrioid","id":"8706"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"8707"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"mucinous","id":"8708"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anti-tumor","id":"8709"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"peritoneal neoplasms","id":"8710"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"fallopian tube neoplasms","id":"8711"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"8712"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"glandular and epithelial","id":"8713"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"8714"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"8715"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"8716"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"8717"},{"source":"Oncology: (N/A)","target":"Immunosuppressant","id":"8718"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"8719"},{"source":"Oncology: (N/A)","target":"NA","id":"8720"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"8721"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"8722"},{"source":"Oncology: (N/A)","target":"Angiogenesis inhibitor","id":"8723"},{"source":"Oncology: (N/A)","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"8724"},{"source":"Oncology: Ovarian","target":"Immunosuppressant","id":"8725"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"8726"},{"source":"Oncology: Ovarian","target":"NA","id":"8727"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"8728"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"8729"},{"source":"Oncology: Ovarian","target":"Angiogenesis inhibitor","id":"8730"},{"source":"Oncology: Ovarian","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"8731"},{"source":"pembrolizumab","target":"Merck & Co.","id":"8732"},{"source":"cisplatin","target":"Merck & Co.","id":"8733"},{"source":"radiation therapy","target":"Merck & Co.","id":"8734"},{"source":"carcinoma","target":"pembrolizumab","id":"8735"},{"source":"carcinoma","target":"cisplatin","id":"8736"},{"source":"carcinoma","target":"radiation therapy","id":"8737"},{"source":"esophageal neoplasms","target":"pembrolizumab","id":"8738"},{"source":"esophageal neoplasms","target":"cisplatin","id":"8739"},{"source":"esophageal neoplasms","target":"radiation therapy","id":"8740"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"8741"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"8742"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"8743"},{"source":"UNK : Indication","target":"pembrolizumab","id":"8744"},{"source":"UNK : Indication","target":"cisplatin","id":"8745"},{"source":"UNK : Indication","target":"radiation therapy","id":"8746"},{"source":"carcinoma","target":"pembrolizumab","id":"8747"},{"source":"carcinoma","target":"cisplatin","id":"8748"},{"source":"carcinoma","target":"radiation therapy","id":"8749"},{"source":"carcinoma","target":"pembrolizumab","id":"8750"},{"source":"carcinoma","target":"cisplatin","id":"8751"},{"source":"carcinoma","target":"radiation therapy","id":"8752"},{"source":"carcinoma","target":"pembrolizumab","id":"8753"},{"source":"carcinoma","target":"cisplatin","id":"8754"},{"source":"carcinoma","target":"radiation therapy","id":"8755"},{"source":"skin neoplasms","target":"pembrolizumab","id":"8756"},{"source":"skin neoplasms","target":"cisplatin","id":"8757"},{"source":"skin neoplasms","target":"radiation therapy","id":"8758"},{"source":"mouth neoplasms","target":"pembrolizumab","id":"8759"},{"source":"mouth neoplasms","target":"cisplatin","id":"8760"},{"source":"mouth neoplasms","target":"radiation therapy","id":"8761"},{"source":"carcinoma","target":"pembrolizumab","id":"8762"},{"source":"carcinoma","target":"cisplatin","id":"8763"},{"source":"carcinoma","target":"radiation therapy","id":"8764"},{"source":"carcinoma","target":"pembrolizumab","id":"8765"},{"source":"carcinoma","target":"cisplatin","id":"8766"},{"source":"carcinoma","target":"radiation therapy","id":"8767"},{"source":"carcinoma","target":"pembrolizumab","id":"8768"},{"source":"carcinoma","target":"cisplatin","id":"8769"},{"source":"carcinoma","target":"radiation therapy","id":"8770"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"8771"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"8772"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"8773"},{"source":"anticancer","target":"pembrolizumab","id":"8774"},{"source":"anticancer","target":"cisplatin","id":"8775"},{"source":"anticancer","target":"radiation therapy","id":"8776"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"8777"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"8778"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"8779"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"8780"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"8781"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"8782"},{"source":"carcinoma","target":"pembrolizumab","id":"8783"},{"source":"carcinoma","target":"cisplatin","id":"8784"},{"source":"carcinoma","target":"radiation therapy","id":"8785"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"8786"},{"source":"head and neck neoplasms","target":"cisplatin","id":"8787"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"8788"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8789"},{"source":"Immune checkpoint inhibitor","target":"esophageal neoplasms","id":"8790"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"8791"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"8792"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8793"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8794"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8795"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"8796"},{"source":"Immune checkpoint inhibitor","target":"mouth neoplasms","id":"8797"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8798"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8799"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8800"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"8801"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"8802"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"8803"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"8804"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8805"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"8806"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8807"},{"source":"Anticancer immunotherapy","target":"esophageal neoplasms","id":"8808"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"8809"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"8810"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8811"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8812"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8813"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"8814"},{"source":"Anticancer immunotherapy","target":"mouth neoplasms","id":"8815"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8816"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8817"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8818"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"8819"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"8820"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"8821"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"8822"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8823"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"8824"},{"source":"CD19 antagonist","target":"carcinoma","id":"8825"},{"source":"CD19 antagonist","target":"esophageal neoplasms","id":"8826"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"8827"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"8828"},{"source":"CD19 antagonist","target":"carcinoma","id":"8829"},{"source":"CD19 antagonist","target":"carcinoma","id":"8830"},{"source":"CD19 antagonist","target":"carcinoma","id":"8831"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"8832"},{"source":"CD19 antagonist","target":"mouth neoplasms","id":"8833"},{"source":"CD19 antagonist","target":"carcinoma","id":"8834"},{"source":"CD19 antagonist","target":"carcinoma","id":"8835"},{"source":"CD19 antagonist","target":"carcinoma","id":"8836"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"8837"},{"source":"CD19 antagonist","target":"anticancer","id":"8838"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"8839"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"8840"},{"source":"CD19 antagonist","target":"carcinoma","id":"8841"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"8842"},{"source":"UPA","target":"carcinoma","id":"8843"},{"source":"UPA","target":"esophageal neoplasms","id":"8844"},{"source":"UPA","target":"squamous cell neoplasms","id":"8845"},{"source":"UPA","target":"UNK : Indication","id":"8846"},{"source":"UPA","target":"carcinoma","id":"8847"},{"source":"UPA","target":"carcinoma","id":"8848"},{"source":"UPA","target":"carcinoma","id":"8849"},{"source":"UPA","target":"skin neoplasms","id":"8850"},{"source":"UPA","target":"mouth neoplasms","id":"8851"},{"source":"UPA","target":"carcinoma","id":"8852"},{"source":"UPA","target":"carcinoma","id":"8853"},{"source":"UPA","target":"carcinoma","id":"8854"},{"source":"UPA","target":"pharyngeal neoplasms","id":"8855"},{"source":"UPA","target":"anticancer","id":"8856"},{"source":"UPA","target":"squamous cell neoplasms","id":"8857"},{"source":"UPA","target":"pharyngeal neoplasms","id":"8858"},{"source":"UPA","target":"carcinoma","id":"8859"},{"source":"UPA","target":"head and neck neoplasms","id":"8860"},{"source":"NA","target":"carcinoma","id":"8861"},{"source":"NA","target":"esophageal neoplasms","id":"8862"},{"source":"NA","target":"squamous cell neoplasms","id":"8863"},{"source":"NA","target":"UNK : Indication","id":"8864"},{"source":"NA","target":"carcinoma","id":"8865"},{"source":"NA","target":"carcinoma","id":"8866"},{"source":"NA","target":"carcinoma","id":"8867"},{"source":"NA","target":"skin neoplasms","id":"8868"},{"source":"NA","target":"mouth neoplasms","id":"8869"},{"source":"NA","target":"carcinoma","id":"8870"},{"source":"NA","target":"carcinoma","id":"8871"},{"source":"NA","target":"carcinoma","id":"8872"},{"source":"NA","target":"pharyngeal neoplasms","id":"8873"},{"source":"NA","target":"anticancer","id":"8874"},{"source":"NA","target":"squamous cell neoplasms","id":"8875"},{"source":"NA","target":"pharyngeal neoplasms","id":"8876"},{"source":"NA","target":"carcinoma","id":"8877"},{"source":"NA","target":"head and neck neoplasms","id":"8878"},{"source":"NA","target":"carcinoma","id":"8879"},{"source":"NA","target":"esophageal neoplasms","id":"8880"},{"source":"NA","target":"squamous cell neoplasms","id":"8881"},{"source":"NA","target":"UNK : Indication","id":"8882"},{"source":"NA","target":"carcinoma","id":"8883"},{"source":"NA","target":"carcinoma","id":"8884"},{"source":"NA","target":"carcinoma","id":"8885"},{"source":"NA","target":"skin neoplasms","id":"8886"},{"source":"NA","target":"mouth neoplasms","id":"8887"},{"source":"NA","target":"carcinoma","id":"8888"},{"source":"NA","target":"carcinoma","id":"8889"},{"source":"NA","target":"carcinoma","id":"8890"},{"source":"NA","target":"pharyngeal neoplasms","id":"8891"},{"source":"NA","target":"anticancer","id":"8892"},{"source":"NA","target":"squamous cell neoplasms","id":"8893"},{"source":"NA","target":"pharyngeal neoplasms","id":"8894"},{"source":"NA","target":"carcinoma","id":"8895"},{"source":"NA","target":"head and neck neoplasms","id":"8896"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"8897"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"8898"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"8899"},{"source":"Oncology: Head/Neck","target":"UPA","id":"8900"},{"source":"Oncology: Head/Neck","target":"NA","id":"8901"},{"source":"Oncology: Head/Neck","target":"NA","id":"8902"},{"source":"pembrolizumab","target":"Merck & Co.","id":"8903"},{"source":"cisplatin","target":"Merck & Co.","id":"8904"},{"source":"radiation therapy","target":"Merck & Co.","id":"8905"},{"source":"carcinoma","target":"pembrolizumab","id":"8906"},{"source":"carcinoma","target":"cisplatin","id":"8907"},{"source":"carcinoma","target":"radiation therapy","id":"8908"},{"source":"esophageal neoplasms","target":"pembrolizumab","id":"8909"},{"source":"esophageal neoplasms","target":"cisplatin","id":"8910"},{"source":"esophageal neoplasms","target":"radiation therapy","id":"8911"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"8912"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"8913"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"8914"},{"source":"UNK : Indication","target":"pembrolizumab","id":"8915"},{"source":"UNK : Indication","target":"cisplatin","id":"8916"},{"source":"UNK : Indication","target":"radiation therapy","id":"8917"},{"source":"carcinoma","target":"pembrolizumab","id":"8918"},{"source":"carcinoma","target":"cisplatin","id":"8919"},{"source":"carcinoma","target":"radiation therapy","id":"8920"},{"source":"carcinoma","target":"pembrolizumab","id":"8921"},{"source":"carcinoma","target":"cisplatin","id":"8922"},{"source":"carcinoma","target":"radiation therapy","id":"8923"},{"source":"carcinoma","target":"pembrolizumab","id":"8924"},{"source":"carcinoma","target":"cisplatin","id":"8925"},{"source":"carcinoma","target":"radiation therapy","id":"8926"},{"source":"skin neoplasms","target":"pembrolizumab","id":"8927"},{"source":"skin neoplasms","target":"cisplatin","id":"8928"},{"source":"skin neoplasms","target":"radiation therapy","id":"8929"},{"source":"mouth neoplasms","target":"pembrolizumab","id":"8930"},{"source":"mouth neoplasms","target":"cisplatin","id":"8931"},{"source":"mouth neoplasms","target":"radiation therapy","id":"8932"},{"source":"carcinoma","target":"pembrolizumab","id":"8933"},{"source":"carcinoma","target":"cisplatin","id":"8934"},{"source":"carcinoma","target":"radiation therapy","id":"8935"},{"source":"carcinoma","target":"pembrolizumab","id":"8936"},{"source":"carcinoma","target":"cisplatin","id":"8937"},{"source":"carcinoma","target":"radiation therapy","id":"8938"},{"source":"carcinoma","target":"pembrolizumab","id":"8939"},{"source":"carcinoma","target":"cisplatin","id":"8940"},{"source":"carcinoma","target":"radiation therapy","id":"8941"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"8942"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"8943"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"8944"},{"source":"anticancer","target":"pembrolizumab","id":"8945"},{"source":"anticancer","target":"cisplatin","id":"8946"},{"source":"anticancer","target":"radiation therapy","id":"8947"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"8948"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"8949"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"8950"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"8951"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"8952"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"8953"},{"source":"carcinoma","target":"pembrolizumab","id":"8954"},{"source":"carcinoma","target":"cisplatin","id":"8955"},{"source":"carcinoma","target":"radiation therapy","id":"8956"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"8957"},{"source":"head and neck neoplasms","target":"cisplatin","id":"8958"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"8959"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8960"},{"source":"Immune checkpoint inhibitor","target":"esophageal neoplasms","id":"8961"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"8962"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"8963"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8964"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8965"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8966"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"8967"},{"source":"Immune checkpoint inhibitor","target":"mouth neoplasms","id":"8968"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8969"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8970"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8971"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"8972"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"8973"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"8974"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"8975"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"8976"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"8977"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8978"},{"source":"Anticancer immunotherapy","target":"esophageal neoplasms","id":"8979"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"8980"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"8981"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8982"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8983"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8984"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"8985"},{"source":"Anticancer immunotherapy","target":"mouth neoplasms","id":"8986"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8987"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8988"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8989"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"8990"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"8991"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"8992"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"8993"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"8994"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"8995"},{"source":"CD19 antagonist","target":"carcinoma","id":"8996"},{"source":"CD19 antagonist","target":"esophageal neoplasms","id":"8997"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"8998"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"8999"},{"source":"CD19 antagonist","target":"carcinoma","id":"9000"},{"source":"CD19 antagonist","target":"carcinoma","id":"9001"},{"source":"CD19 antagonist","target":"carcinoma","id":"9002"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"9003"},{"source":"CD19 antagonist","target":"mouth neoplasms","id":"9004"},{"source":"CD19 antagonist","target":"carcinoma","id":"9005"},{"source":"CD19 antagonist","target":"carcinoma","id":"9006"},{"source":"CD19 antagonist","target":"carcinoma","id":"9007"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"9008"},{"source":"CD19 antagonist","target":"anticancer","id":"9009"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"9010"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"9011"},{"source":"CD19 antagonist","target":"carcinoma","id":"9012"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"9013"},{"source":"UPA","target":"carcinoma","id":"9014"},{"source":"UPA","target":"esophageal neoplasms","id":"9015"},{"source":"UPA","target":"squamous cell neoplasms","id":"9016"},{"source":"UPA","target":"UNK : Indication","id":"9017"},{"source":"UPA","target":"carcinoma","id":"9018"},{"source":"UPA","target":"carcinoma","id":"9019"},{"source":"UPA","target":"carcinoma","id":"9020"},{"source":"UPA","target":"skin neoplasms","id":"9021"},{"source":"UPA","target":"mouth neoplasms","id":"9022"},{"source":"UPA","target":"carcinoma","id":"9023"},{"source":"UPA","target":"carcinoma","id":"9024"},{"source":"UPA","target":"carcinoma","id":"9025"},{"source":"UPA","target":"pharyngeal neoplasms","id":"9026"},{"source":"UPA","target":"anticancer","id":"9027"},{"source":"UPA","target":"squamous cell neoplasms","id":"9028"},{"source":"UPA","target":"pharyngeal neoplasms","id":"9029"},{"source":"UPA","target":"carcinoma","id":"9030"},{"source":"UPA","target":"head and neck neoplasms","id":"9031"},{"source":"NA","target":"carcinoma","id":"9032"},{"source":"NA","target":"esophageal neoplasms","id":"9033"},{"source":"NA","target":"squamous cell neoplasms","id":"9034"},{"source":"NA","target":"UNK : Indication","id":"9035"},{"source":"NA","target":"carcinoma","id":"9036"},{"source":"NA","target":"carcinoma","id":"9037"},{"source":"NA","target":"carcinoma","id":"9038"},{"source":"NA","target":"skin neoplasms","id":"9039"},{"source":"NA","target":"mouth neoplasms","id":"9040"},{"source":"NA","target":"carcinoma","id":"9041"},{"source":"NA","target":"carcinoma","id":"9042"},{"source":"NA","target":"carcinoma","id":"9043"},{"source":"NA","target":"pharyngeal neoplasms","id":"9044"},{"source":"NA","target":"anticancer","id":"9045"},{"source":"NA","target":"squamous cell neoplasms","id":"9046"},{"source":"NA","target":"pharyngeal neoplasms","id":"9047"},{"source":"NA","target":"carcinoma","id":"9048"},{"source":"NA","target":"head and neck neoplasms","id":"9049"},{"source":"NA","target":"carcinoma","id":"9050"},{"source":"NA","target":"esophageal neoplasms","id":"9051"},{"source":"NA","target":"squamous cell neoplasms","id":"9052"},{"source":"NA","target":"UNK : Indication","id":"9053"},{"source":"NA","target":"carcinoma","id":"9054"},{"source":"NA","target":"carcinoma","id":"9055"},{"source":"NA","target":"carcinoma","id":"9056"},{"source":"NA","target":"skin neoplasms","id":"9057"},{"source":"NA","target":"mouth neoplasms","id":"9058"},{"source":"NA","target":"carcinoma","id":"9059"},{"source":"NA","target":"carcinoma","id":"9060"},{"source":"NA","target":"carcinoma","id":"9061"},{"source":"NA","target":"pharyngeal neoplasms","id":"9062"},{"source":"NA","target":"anticancer","id":"9063"},{"source":"NA","target":"squamous cell neoplasms","id":"9064"},{"source":"NA","target":"pharyngeal neoplasms","id":"9065"},{"source":"NA","target":"carcinoma","id":"9066"},{"source":"NA","target":"head and neck neoplasms","id":"9067"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"9068"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"9069"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"9070"},{"source":"Oncology: Head/Neck","target":"UPA","id":"9071"},{"source":"Oncology: Head/Neck","target":"NA","id":"9072"},{"source":"Oncology: Head/Neck","target":"NA","id":"9073"},{"source":"binimetinib (u)","target":"Array BioPharma","id":"9074"},{"source":"binimetinib (u)","target":"Merck & Co.","id":"9075"},{"source":"pembrolizumab","target":"Array BioPharma","id":"9076"},{"source":"pembrolizumab","target":"Merck & Co.","id":"9077"},{"source":"5-fluorouracil","target":"Array BioPharma","id":"9078"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"9079"},{"source":"irinotecan (IV)","target":"Array BioPharma","id":"9080"},{"source":"irinotecan (IV)","target":"Merck & Co.","id":"9081"},{"source":"leucovorin","target":"Array BioPharma","id":"9082"},{"source":"leucovorin","target":"Merck & Co.","id":"9083"},{"source":"oxaliplatin (IV)","target":"Array BioPharma","id":"9084"},{"source":"oxaliplatin (IV)","target":"Merck & Co.","id":"9085"},{"source":"UNK : Indication","target":"binimetinib (u)","id":"9086"},{"source":"UNK : Indication","target":"pembrolizumab","id":"9087"},{"source":"UNK : Indication","target":"5-fluorouracil","id":"9088"},{"source":"UNK : Indication","target":"irinotecan (IV)","id":"9089"},{"source":"UNK : Indication","target":"leucovorin","id":"9090"},{"source":"UNK : Indication","target":"oxaliplatin (IV)","id":"9091"},{"source":"colorectal neoplasms","target":"binimetinib (u)","id":"9092"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"9093"},{"source":"colorectal neoplasms","target":"5-fluorouracil","id":"9094"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"9095"},{"source":"colorectal neoplasms","target":"leucovorin","id":"9096"},{"source":"colorectal neoplasms","target":"oxaliplatin (IV)","id":"9097"},{"source":"anticancer","target":"binimetinib (u)","id":"9098"},{"source":"anticancer","target":"pembrolizumab","id":"9099"},{"source":"anticancer","target":"5-fluorouracil","id":"9100"},{"source":"anticancer","target":"irinotecan (IV)","id":"9101"},{"source":"anticancer","target":"leucovorin","id":"9102"},{"source":"anticancer","target":"oxaliplatin (IV)","id":"9103"},{"source":"antiarthritic","target":"binimetinib (u)","id":"9104"},{"source":"antiarthritic","target":"pembrolizumab","id":"9105"},{"source":"antiarthritic","target":"5-fluorouracil","id":"9106"},{"source":"antiarthritic","target":"irinotecan (IV)","id":"9107"},{"source":"antiarthritic","target":"leucovorin","id":"9108"},{"source":"antiarthritic","target":"oxaliplatin (IV)","id":"9109"},{"source":"depression","target":"binimetinib (u)","id":"9110"},{"source":"depression","target":"pembrolizumab","id":"9111"},{"source":"depression","target":"5-fluorouracil","id":"9112"},{"source":"depression","target":"irinotecan (IV)","id":"9113"},{"source":"depression","target":"leucovorin","id":"9114"},{"source":"depression","target":"oxaliplatin (IV)","id":"9115"},{"source":"inflammatory bowel diseases","target":"binimetinib (u)","id":"9116"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"9117"},{"source":"inflammatory bowel diseases","target":"5-fluorouracil","id":"9118"},{"source":"inflammatory bowel diseases","target":"irinotecan (IV)","id":"9119"},{"source":"inflammatory bowel diseases","target":"leucovorin","id":"9120"},{"source":"inflammatory bowel diseases","target":"oxaliplatin (IV)","id":"9121"},{"source":"antianaemic","target":"binimetinib (u)","id":"9122"},{"source":"antianaemic","target":"pembrolizumab","id":"9123"},{"source":"antianaemic","target":"5-fluorouracil","id":"9124"},{"source":"antianaemic","target":"irinotecan (IV)","id":"9125"},{"source":"antianaemic","target":"leucovorin","id":"9126"},{"source":"antianaemic","target":"oxaliplatin (IV)","id":"9127"},{"source":"inflammatory bowel diseases","target":"binimetinib (u)","id":"9128"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"9129"},{"source":"inflammatory bowel diseases","target":"5-fluorouracil","id":"9130"},{"source":"inflammatory bowel diseases","target":"irinotecan (IV)","id":"9131"},{"source":"inflammatory bowel diseases","target":"leucovorin","id":"9132"},{"source":"inflammatory bowel diseases","target":"oxaliplatin (IV)","id":"9133"},{"source":"microsatellite instability","target":"binimetinib (u)","id":"9134"},{"source":"microsatellite instability","target":"pembrolizumab","id":"9135"},{"source":"microsatellite instability","target":"5-fluorouracil","id":"9136"},{"source":"microsatellite instability","target":"irinotecan (IV)","id":"9137"},{"source":"microsatellite instability","target":"leucovorin","id":"9138"},{"source":"microsatellite instability","target":"oxaliplatin (IV)","id":"9139"},{"source":"colonic neoplasms","target":"binimetinib (u)","id":"9140"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"9141"},{"source":"colonic neoplasms","target":"5-fluorouracil","id":"9142"},{"source":"colonic neoplasms","target":"irinotecan (IV)","id":"9143"},{"source":"colonic neoplasms","target":"leucovorin","id":"9144"},{"source":"colonic neoplasms","target":"oxaliplatin (IV)","id":"9145"},{"source":"anemia","target":"binimetinib (u)","id":"9146"},{"source":"anemia","target":"pembrolizumab","id":"9147"},{"source":"anemia","target":"5-fluorouracil","id":"9148"},{"source":"anemia","target":"irinotecan (IV)","id":"9149"},{"source":"anemia","target":"leucovorin","id":"9150"},{"source":"anemia","target":"oxaliplatin (IV)","id":"9151"},{"source":"colorectal cancer","target":"binimetinib (u)","id":"9152"},{"source":"colorectal cancer","target":"pembrolizumab","id":"9153"},{"source":"colorectal cancer","target":"5-fluorouracil","id":"9154"},{"source":"colorectal cancer","target":"irinotecan (IV)","id":"9155"},{"source":"colorectal cancer","target":"leucovorin","id":"9156"},{"source":"colorectal cancer","target":"oxaliplatin (IV)","id":"9157"},{"source":"copd","target":"binimetinib (u)","id":"9158"},{"source":"copd","target":"pembrolizumab","id":"9159"},{"source":"copd","target":"5-fluorouracil","id":"9160"},{"source":"copd","target":"irinotecan (IV)","id":"9161"},{"source":"copd","target":"leucovorin","id":"9162"},{"source":"copd","target":"oxaliplatin (IV)","id":"9163"},{"source":"arthritis","target":"binimetinib (u)","id":"9164"},{"source":"arthritis","target":"pembrolizumab","id":"9165"},{"source":"arthritis","target":"5-fluorouracil","id":"9166"},{"source":"arthritis","target":"irinotecan (IV)","id":"9167"},{"source":"arthritis","target":"leucovorin","id":"9168"},{"source":"arthritis","target":"oxaliplatin (IV)","id":"9169"},{"source":"metastatic","target":"binimetinib (u)","id":"9170"},{"source":"metastatic","target":"pembrolizumab","id":"9171"},{"source":"metastatic","target":"5-fluorouracil","id":"9172"},{"source":"metastatic","target":"irinotecan (IV)","id":"9173"},{"source":"metastatic","target":"leucovorin","id":"9174"},{"source":"metastatic","target":"oxaliplatin (IV)","id":"9175"},{"source":"carcinoma","target":"binimetinib (u)","id":"9176"},{"source":"carcinoma","target":"pembrolizumab","id":"9177"},{"source":"carcinoma","target":"5-fluorouracil","id":"9178"},{"source":"carcinoma","target":"irinotecan (IV)","id":"9179"},{"source":"carcinoma","target":"leucovorin","id":"9180"},{"source":"carcinoma","target":"oxaliplatin (IV)","id":"9181"},{"source":"neoplasm metastasis","target":"binimetinib (u)","id":"9182"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"9183"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"9184"},{"source":"neoplasm metastasis","target":"irinotecan (IV)","id":"9185"},{"source":"neoplasm metastasis","target":"leucovorin","id":"9186"},{"source":"neoplasm metastasis","target":"oxaliplatin (IV)","id":"9187"},{"source":"colorectal neoplasms","target":"binimetinib (u)","id":"9188"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"9189"},{"source":"colorectal neoplasms","target":"5-fluorouracil","id":"9190"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"9191"},{"source":"colorectal neoplasms","target":"leucovorin","id":"9192"},{"source":"colorectal neoplasms","target":"oxaliplatin (IV)","id":"9193"},{"source":"antidepressant","target":"binimetinib (u)","id":"9194"},{"source":"antidepressant","target":"pembrolizumab","id":"9195"},{"source":"antidepressant","target":"5-fluorouracil","id":"9196"},{"source":"antidepressant","target":"irinotecan (IV)","id":"9197"},{"source":"antidepressant","target":"leucovorin","id":"9198"},{"source":"antidepressant","target":"oxaliplatin (IV)","id":"9199"},{"source":"residual tumor","target":"binimetinib (u)","id":"9200"},{"source":"residual tumor","target":"pembrolizumab","id":"9201"},{"source":"residual tumor","target":"5-fluorouracil","id":"9202"},{"source":"residual tumor","target":"irinotecan (IV)","id":"9203"},{"source":"residual tumor","target":"leucovorin","id":"9204"},{"source":"residual tumor","target":"oxaliplatin (IV)","id":"9205"},{"source":"anti-tumor","target":"binimetinib (u)","id":"9206"},{"source":"anti-tumor","target":"pembrolizumab","id":"9207"},{"source":"anti-tumor","target":"5-fluorouracil","id":"9208"},{"source":"anti-tumor","target":"irinotecan (IV)","id":"9209"},{"source":"anti-tumor","target":"leucovorin","id":"9210"},{"source":"anti-tumor","target":"oxaliplatin (IV)","id":"9211"},{"source":"chronic obstructive pulmonary disease","target":"binimetinib (u)","id":"9212"},{"source":"chronic obstructive pulmonary disease","target":"pembrolizumab","id":"9213"},{"source":"chronic obstructive pulmonary disease","target":"5-fluorouracil","id":"9214"},{"source":"chronic obstructive pulmonary disease","target":"irinotecan (IV)","id":"9215"},{"source":"chronic obstructive pulmonary disease","target":"leucovorin","id":"9216"},{"source":"chronic obstructive pulmonary disease","target":"oxaliplatin (IV)","id":"9217"},{"source":"anticancer","target":"binimetinib (u)","id":"9218"},{"source":"anticancer","target":"pembrolizumab","id":"9219"},{"source":"anticancer","target":"5-fluorouracil","id":"9220"},{"source":"anticancer","target":"irinotecan (IV)","id":"9221"},{"source":"anticancer","target":"leucovorin","id":"9222"},{"source":"anticancer","target":"oxaliplatin (IV)","id":"9223"},{"source":"NA","target":"UNK : Indication","id":"9224"},{"source":"NA","target":"colorectal neoplasms","id":"9225"},{"source":"NA","target":"anticancer","id":"9226"},{"source":"NA","target":"antiarthritic","id":"9227"},{"source":"NA","target":"depression","id":"9228"},{"source":"NA","target":"inflammatory bowel diseases","id":"9229"},{"source":"NA","target":"antianaemic","id":"9230"},{"source":"NA","target":"inflammatory bowel diseases","id":"9231"},{"source":"NA","target":"microsatellite instability","id":"9232"},{"source":"NA","target":"colonic neoplasms","id":"9233"},{"source":"NA","target":"anemia","id":"9234"},{"source":"NA","target":"colorectal cancer","id":"9235"},{"source":"NA","target":"copd","id":"9236"},{"source":"NA","target":"arthritis","id":"9237"},{"source":"NA","target":"metastatic","id":"9238"},{"source":"NA","target":"carcinoma","id":"9239"},{"source":"NA","target":"neoplasm metastasis","id":"9240"},{"source":"NA","target":"colorectal neoplasms","id":"9241"},{"source":"NA","target":"antidepressant","id":"9242"},{"source":"NA","target":"residual tumor","id":"9243"},{"source":"NA","target":"anti-tumor","id":"9244"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"9245"},{"source":"NA","target":"anticancer","id":"9246"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"9247"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"9248"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"9249"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"9250"},{"source":"Immune checkpoint inhibitor","target":"depression","id":"9251"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"9252"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"9253"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"9254"},{"source":"Immune checkpoint inhibitor","target":"microsatellite instability","id":"9255"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"9256"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"9257"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"9258"},{"source":"Immune checkpoint inhibitor","target":"copd","id":"9259"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"9260"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"9261"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"9262"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"9263"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"9264"},{"source":"Immune checkpoint inhibitor","target":"antidepressant","id":"9265"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"9266"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"9267"},{"source":"Immune checkpoint inhibitor","target":"chronic obstructive pulmonary disease","id":"9268"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"9269"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"9270"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"9271"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"9272"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"9273"},{"source":"Anticancer immunotherapy","target":"depression","id":"9274"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"9275"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"9276"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"9277"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"9278"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"9279"},{"source":"Anticancer immunotherapy","target":"anemia","id":"9280"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"9281"},{"source":"Anticancer immunotherapy","target":"copd","id":"9282"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"9283"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"9284"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"9285"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"9286"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"9287"},{"source":"Anticancer immunotherapy","target":"antidepressant","id":"9288"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"9289"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"9290"},{"source":"Anticancer immunotherapy","target":"chronic obstructive pulmonary disease","id":"9291"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"9292"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"9293"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"9294"},{"source":"CD19 antagonist","target":"anticancer","id":"9295"},{"source":"CD19 antagonist","target":"antiarthritic","id":"9296"},{"source":"CD19 antagonist","target":"depression","id":"9297"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"9298"},{"source":"CD19 antagonist","target":"antianaemic","id":"9299"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"9300"},{"source":"CD19 antagonist","target":"microsatellite instability","id":"9301"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"9302"},{"source":"CD19 antagonist","target":"anemia","id":"9303"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"9304"},{"source":"CD19 antagonist","target":"copd","id":"9305"},{"source":"CD19 antagonist","target":"arthritis","id":"9306"},{"source":"CD19 antagonist","target":"metastatic","id":"9307"},{"source":"CD19 antagonist","target":"carcinoma","id":"9308"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"9309"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"9310"},{"source":"CD19 antagonist","target":"antidepressant","id":"9311"},{"source":"CD19 antagonist","target":"residual tumor","id":"9312"},{"source":"CD19 antagonist","target":"anti-tumor","id":"9313"},{"source":"CD19 antagonist","target":"chronic obstructive pulmonary disease","id":"9314"},{"source":"CD19 antagonist","target":"anticancer","id":"9315"},{"source":"UPA","target":"UNK : Indication","id":"9316"},{"source":"UPA","target":"colorectal neoplasms","id":"9317"},{"source":"UPA","target":"anticancer","id":"9318"},{"source":"UPA","target":"antiarthritic","id":"9319"},{"source":"UPA","target":"depression","id":"9320"},{"source":"UPA","target":"inflammatory bowel diseases","id":"9321"},{"source":"UPA","target":"antianaemic","id":"9322"},{"source":"UPA","target":"inflammatory bowel diseases","id":"9323"},{"source":"UPA","target":"microsatellite instability","id":"9324"},{"source":"UPA","target":"colonic neoplasms","id":"9325"},{"source":"UPA","target":"anemia","id":"9326"},{"source":"UPA","target":"colorectal cancer","id":"9327"},{"source":"UPA","target":"copd","id":"9328"},{"source":"UPA","target":"arthritis","id":"9329"},{"source":"UPA","target":"metastatic","id":"9330"},{"source":"UPA","target":"carcinoma","id":"9331"},{"source":"UPA","target":"neoplasm metastasis","id":"9332"},{"source":"UPA","target":"colorectal neoplasms","id":"9333"},{"source":"UPA","target":"antidepressant","id":"9334"},{"source":"UPA","target":"residual tumor","id":"9335"},{"source":"UPA","target":"anti-tumor","id":"9336"},{"source":"UPA","target":"chronic obstructive pulmonary disease","id":"9337"},{"source":"UPA","target":"anticancer","id":"9338"},{"source":"NA","target":"UNK : Indication","id":"9339"},{"source":"NA","target":"colorectal neoplasms","id":"9340"},{"source":"NA","target":"anticancer","id":"9341"},{"source":"NA","target":"antiarthritic","id":"9342"},{"source":"NA","target":"depression","id":"9343"},{"source":"NA","target":"inflammatory bowel diseases","id":"9344"},{"source":"NA","target":"antianaemic","id":"9345"},{"source":"NA","target":"inflammatory bowel diseases","id":"9346"},{"source":"NA","target":"microsatellite instability","id":"9347"},{"source":"NA","target":"colonic neoplasms","id":"9348"},{"source":"NA","target":"anemia","id":"9349"},{"source":"NA","target":"colorectal cancer","id":"9350"},{"source":"NA","target":"copd","id":"9351"},{"source":"NA","target":"arthritis","id":"9352"},{"source":"NA","target":"metastatic","id":"9353"},{"source":"NA","target":"carcinoma","id":"9354"},{"source":"NA","target":"neoplasm metastasis","id":"9355"},{"source":"NA","target":"colorectal neoplasms","id":"9356"},{"source":"NA","target":"antidepressant","id":"9357"},{"source":"NA","target":"residual tumor","id":"9358"},{"source":"NA","target":"anti-tumor","id":"9359"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"9360"},{"source":"NA","target":"anticancer","id":"9361"},{"source":"MEK inhibitor","target":"UNK : Indication","id":"9362"},{"source":"MEK inhibitor","target":"colorectal neoplasms","id":"9363"},{"source":"MEK inhibitor","target":"anticancer","id":"9364"},{"source":"MEK inhibitor","target":"antiarthritic","id":"9365"},{"source":"MEK inhibitor","target":"depression","id":"9366"},{"source":"MEK inhibitor","target":"inflammatory bowel diseases","id":"9367"},{"source":"MEK inhibitor","target":"antianaemic","id":"9368"},{"source":"MEK inhibitor","target":"inflammatory bowel diseases","id":"9369"},{"source":"MEK inhibitor","target":"microsatellite instability","id":"9370"},{"source":"MEK inhibitor","target":"colonic neoplasms","id":"9371"},{"source":"MEK inhibitor","target":"anemia","id":"9372"},{"source":"MEK inhibitor","target":"colorectal cancer","id":"9373"},{"source":"MEK inhibitor","target":"copd","id":"9374"},{"source":"MEK inhibitor","target":"arthritis","id":"9375"},{"source":"MEK inhibitor","target":"metastatic","id":"9376"},{"source":"MEK inhibitor","target":"carcinoma","id":"9377"},{"source":"MEK inhibitor","target":"neoplasm metastasis","id":"9378"},{"source":"MEK inhibitor","target":"colorectal neoplasms","id":"9379"},{"source":"MEK inhibitor","target":"antidepressant","id":"9380"},{"source":"MEK inhibitor","target":"residual tumor","id":"9381"},{"source":"MEK inhibitor","target":"anti-tumor","id":"9382"},{"source":"MEK inhibitor","target":"chronic obstructive pulmonary disease","id":"9383"},{"source":"MEK inhibitor","target":"anticancer","id":"9384"},{"source":"NA","target":"UNK : Indication","id":"9385"},{"source":"NA","target":"colorectal neoplasms","id":"9386"},{"source":"NA","target":"anticancer","id":"9387"},{"source":"NA","target":"antiarthritic","id":"9388"},{"source":"NA","target":"depression","id":"9389"},{"source":"NA","target":"inflammatory bowel diseases","id":"9390"},{"source":"NA","target":"antianaemic","id":"9391"},{"source":"NA","target":"inflammatory bowel diseases","id":"9392"},{"source":"NA","target":"microsatellite instability","id":"9393"},{"source":"NA","target":"colonic neoplasms","id":"9394"},{"source":"NA","target":"anemia","id":"9395"},{"source":"NA","target":"colorectal cancer","id":"9396"},{"source":"NA","target":"copd","id":"9397"},{"source":"NA","target":"arthritis","id":"9398"},{"source":"NA","target":"metastatic","id":"9399"},{"source":"NA","target":"carcinoma","id":"9400"},{"source":"NA","target":"neoplasm metastasis","id":"9401"},{"source":"NA","target":"colorectal neoplasms","id":"9402"},{"source":"NA","target":"antidepressant","id":"9403"},{"source":"NA","target":"residual tumor","id":"9404"},{"source":"NA","target":"anti-tumor","id":"9405"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"9406"},{"source":"NA","target":"anticancer","id":"9407"},{"source":"NA","target":"UNK : Indication","id":"9408"},{"source":"NA","target":"colorectal neoplasms","id":"9409"},{"source":"NA","target":"anticancer","id":"9410"},{"source":"NA","target":"antiarthritic","id":"9411"},{"source":"NA","target":"depression","id":"9412"},{"source":"NA","target":"inflammatory bowel diseases","id":"9413"},{"source":"NA","target":"antianaemic","id":"9414"},{"source":"NA","target":"inflammatory bowel diseases","id":"9415"},{"source":"NA","target":"microsatellite instability","id":"9416"},{"source":"NA","target":"colonic neoplasms","id":"9417"},{"source":"NA","target":"anemia","id":"9418"},{"source":"NA","target":"colorectal cancer","id":"9419"},{"source":"NA","target":"copd","id":"9420"},{"source":"NA","target":"arthritis","id":"9421"},{"source":"NA","target":"metastatic","id":"9422"},{"source":"NA","target":"carcinoma","id":"9423"},{"source":"NA","target":"neoplasm metastasis","id":"9424"},{"source":"NA","target":"colorectal neoplasms","id":"9425"},{"source":"NA","target":"antidepressant","id":"9426"},{"source":"NA","target":"residual tumor","id":"9427"},{"source":"NA","target":"anti-tumor","id":"9428"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"9429"},{"source":"NA","target":"anticancer","id":"9430"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"9431"},{"source":"Thymidylate synthase inhibitor","target":"colorectal neoplasms","id":"9432"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"9433"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"9434"},{"source":"Thymidylate synthase inhibitor","target":"depression","id":"9435"},{"source":"Thymidylate synthase inhibitor","target":"inflammatory bowel diseases","id":"9436"},{"source":"Thymidylate synthase inhibitor","target":"antianaemic","id":"9437"},{"source":"Thymidylate synthase inhibitor","target":"inflammatory bowel diseases","id":"9438"},{"source":"Thymidylate synthase inhibitor","target":"microsatellite instability","id":"9439"},{"source":"Thymidylate synthase inhibitor","target":"colonic neoplasms","id":"9440"},{"source":"Thymidylate synthase inhibitor","target":"anemia","id":"9441"},{"source":"Thymidylate synthase inhibitor","target":"colorectal cancer","id":"9442"},{"source":"Thymidylate synthase inhibitor","target":"copd","id":"9443"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"9444"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"9445"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"9446"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"9447"},{"source":"Thymidylate synthase inhibitor","target":"colorectal neoplasms","id":"9448"},{"source":"Thymidylate synthase inhibitor","target":"antidepressant","id":"9449"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"9450"},{"source":"Thymidylate synthase inhibitor","target":"anti-tumor","id":"9451"},{"source":"Thymidylate synthase inhibitor","target":"chronic obstructive pulmonary disease","id":"9452"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"9453"},{"source":"Oncology: Colorectal","target":"NA","id":"9454"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"9455"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"9456"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"9457"},{"source":"Oncology: Colorectal","target":"UPA","id":"9458"},{"source":"Oncology: Colorectal","target":"NA","id":"9459"},{"source":"Oncology: Colorectal","target":"MEK inhibitor","id":"9460"},{"source":"Oncology: Colorectal","target":"NA","id":"9461"},{"source":"Oncology: Colorectal","target":"NA","id":"9462"},{"source":"Oncology: Colorectal","target":"Thymidylate synthase inhibitor","id":"9463"},{"source":"pembrolizumab","target":"European Institute of Oncology","id":"9464"},{"source":"pembrolizumab","target":"Merck & Co.","id":"9465"},{"source":"bleomycin","target":"European Institute of Oncology","id":"9466"},{"source":"bleomycin","target":"Merck & Co.","id":"9467"},{"source":"electrochemotherapy","target":"European Institute of Oncology","id":"9468"},{"source":"electrochemotherapy","target":"Merck & Co.","id":"9469"},{"source":"UNK : Indication","target":"pembrolizumab","id":"9470"},{"source":"UNK : Indication","target":"bleomycin","id":"9471"},{"source":"UNK : Indication","target":"electrochemotherapy","id":"9472"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"9473"},{"source":"ovarian neoplasms","target":"bleomycin","id":"9474"},{"source":"ovarian neoplasms","target":"electrochemotherapy","id":"9475"},{"source":"brain metastases","target":"pembrolizumab","id":"9476"},{"source":"brain metastases","target":"bleomycin","id":"9477"},{"source":"brain metastases","target":"electrochemotherapy","id":"9478"},{"source":"melanoma","target":"pembrolizumab","id":"9479"},{"source":"melanoma","target":"bleomycin","id":"9480"},{"source":"melanoma","target":"electrochemotherapy","id":"9481"},{"source":"bleeding","target":"pembrolizumab","id":"9482"},{"source":"bleeding","target":"bleomycin","id":"9483"},{"source":"bleeding","target":"electrochemotherapy","id":"9484"},{"source":"skin neoplasms","target":"pembrolizumab","id":"9485"},{"source":"skin neoplasms","target":"bleomycin","id":"9486"},{"source":"skin neoplasms","target":"electrochemotherapy","id":"9487"},{"source":"residual tumor","target":"pembrolizumab","id":"9488"},{"source":"residual tumor","target":"bleomycin","id":"9489"},{"source":"residual tumor","target":"electrochemotherapy","id":"9490"},{"source":"liver metastases","target":"pembrolizumab","id":"9491"},{"source":"liver metastases","target":"bleomycin","id":"9492"},{"source":"liver metastases","target":"electrochemotherapy","id":"9493"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"9494"},{"source":"cerebellar neoplasms","target":"bleomycin","id":"9495"},{"source":"cerebellar neoplasms","target":"electrochemotherapy","id":"9496"},{"source":"carcinoma","target":"pembrolizumab","id":"9497"},{"source":"carcinoma","target":"bleomycin","id":"9498"},{"source":"carcinoma","target":"electrochemotherapy","id":"9499"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"9500"},{"source":"neoplasm metastasis","target":"bleomycin","id":"9501"},{"source":"neoplasm metastasis","target":"electrochemotherapy","id":"9502"},{"source":"hemorrhage","target":"pembrolizumab","id":"9503"},{"source":"hemorrhage","target":"bleomycin","id":"9504"},{"source":"hemorrhage","target":"electrochemotherapy","id":"9505"},{"source":"anticancer","target":"pembrolizumab","id":"9506"},{"source":"anticancer","target":"bleomycin","id":"9507"},{"source":"anticancer","target":"electrochemotherapy","id":"9508"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"9509"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"9510"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"9511"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"9512"},{"source":"Anticancer immunotherapy","target":"bleeding","id":"9513"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"9514"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"9515"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"9516"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"9517"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"9518"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"9519"},{"source":"Anticancer immunotherapy","target":"hemorrhage","id":"9520"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"9521"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"9522"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"9523"},{"source":"CD19 antagonist","target":"brain metastases","id":"9524"},{"source":"CD19 antagonist","target":"melanoma","id":"9525"},{"source":"CD19 antagonist","target":"bleeding","id":"9526"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"9527"},{"source":"CD19 antagonist","target":"residual tumor","id":"9528"},{"source":"CD19 antagonist","target":"liver metastases","id":"9529"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"9530"},{"source":"CD19 antagonist","target":"carcinoma","id":"9531"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"9532"},{"source":"CD19 antagonist","target":"hemorrhage","id":"9533"},{"source":"CD19 antagonist","target":"anticancer","id":"9534"},{"source":"NA","target":"UNK : Indication","id":"9535"},{"source":"NA","target":"ovarian neoplasms","id":"9536"},{"source":"NA","target":"brain metastases","id":"9537"},{"source":"NA","target":"melanoma","id":"9538"},{"source":"NA","target":"bleeding","id":"9539"},{"source":"NA","target":"skin neoplasms","id":"9540"},{"source":"NA","target":"residual tumor","id":"9541"},{"source":"NA","target":"liver metastases","id":"9542"},{"source":"NA","target":"cerebellar neoplasms","id":"9543"},{"source":"NA","target":"carcinoma","id":"9544"},{"source":"NA","target":"neoplasm metastasis","id":"9545"},{"source":"NA","target":"hemorrhage","id":"9546"},{"source":"NA","target":"anticancer","id":"9547"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"9548"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"9549"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"9550"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"9551"},{"source":"Immune checkpoint inhibitor","target":"bleeding","id":"9552"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"9553"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"9554"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"9555"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"9556"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"9557"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"9558"},{"source":"Immune checkpoint inhibitor","target":"hemorrhage","id":"9559"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"9560"},{"source":"NA","target":"UNK : Indication","id":"9561"},{"source":"NA","target":"ovarian neoplasms","id":"9562"},{"source":"NA","target":"brain metastases","id":"9563"},{"source":"NA","target":"melanoma","id":"9564"},{"source":"NA","target":"bleeding","id":"9565"},{"source":"NA","target":"skin neoplasms","id":"9566"},{"source":"NA","target":"residual tumor","id":"9567"},{"source":"NA","target":"liver metastases","id":"9568"},{"source":"NA","target":"cerebellar neoplasms","id":"9569"},{"source":"NA","target":"carcinoma","id":"9570"},{"source":"NA","target":"neoplasm metastasis","id":"9571"},{"source":"NA","target":"hemorrhage","id":"9572"},{"source":"NA","target":"anticancer","id":"9573"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"9574"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"9575"},{"source":"Oncology: Melanoma","target":"NA","id":"9576"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"9577"},{"source":"Oncology: Melanoma","target":"NA","id":"9578"},{"source":"pembrolizumab","target":"European Institute of Oncology","id":"9579"},{"source":"pembrolizumab","target":"Merck & Co.","id":"9580"},{"source":"bleomycin","target":"European Institute of Oncology","id":"9581"},{"source":"bleomycin","target":"Merck & Co.","id":"9582"},{"source":"electrochemotherapy","target":"European Institute of Oncology","id":"9583"},{"source":"electrochemotherapy","target":"Merck & Co.","id":"9584"},{"source":"UNK : Indication","target":"pembrolizumab","id":"9585"},{"source":"UNK : Indication","target":"bleomycin","id":"9586"},{"source":"UNK : Indication","target":"electrochemotherapy","id":"9587"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"9588"},{"source":"ovarian neoplasms","target":"bleomycin","id":"9589"},{"source":"ovarian neoplasms","target":"electrochemotherapy","id":"9590"},{"source":"brain metastases","target":"pembrolizumab","id":"9591"},{"source":"brain metastases","target":"bleomycin","id":"9592"},{"source":"brain metastases","target":"electrochemotherapy","id":"9593"},{"source":"melanoma","target":"pembrolizumab","id":"9594"},{"source":"melanoma","target":"bleomycin","id":"9595"},{"source":"melanoma","target":"electrochemotherapy","id":"9596"},{"source":"bleeding","target":"pembrolizumab","id":"9597"},{"source":"bleeding","target":"bleomycin","id":"9598"},{"source":"bleeding","target":"electrochemotherapy","id":"9599"},{"source":"skin neoplasms","target":"pembrolizumab","id":"9600"},{"source":"skin neoplasms","target":"bleomycin","id":"9601"},{"source":"skin neoplasms","target":"electrochemotherapy","id":"9602"},{"source":"residual tumor","target":"pembrolizumab","id":"9603"},{"source":"residual tumor","target":"bleomycin","id":"9604"},{"source":"residual tumor","target":"electrochemotherapy","id":"9605"},{"source":"liver metastases","target":"pembrolizumab","id":"9606"},{"source":"liver metastases","target":"bleomycin","id":"9607"},{"source":"liver metastases","target":"electrochemotherapy","id":"9608"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"9609"},{"source":"cerebellar neoplasms","target":"bleomycin","id":"9610"},{"source":"cerebellar neoplasms","target":"electrochemotherapy","id":"9611"},{"source":"carcinoma","target":"pembrolizumab","id":"9612"},{"source":"carcinoma","target":"bleomycin","id":"9613"},{"source":"carcinoma","target":"electrochemotherapy","id":"9614"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"9615"},{"source":"neoplasm metastasis","target":"bleomycin","id":"9616"},{"source":"neoplasm metastasis","target":"electrochemotherapy","id":"9617"},{"source":"hemorrhage","target":"pembrolizumab","id":"9618"},{"source":"hemorrhage","target":"bleomycin","id":"9619"},{"source":"hemorrhage","target":"electrochemotherapy","id":"9620"},{"source":"anticancer","target":"pembrolizumab","id":"9621"},{"source":"anticancer","target":"bleomycin","id":"9622"},{"source":"anticancer","target":"electrochemotherapy","id":"9623"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"9624"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"9625"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"9626"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"9627"},{"source":"Anticancer immunotherapy","target":"bleeding","id":"9628"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"9629"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"9630"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"9631"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"9632"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"9633"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"9634"},{"source":"Anticancer immunotherapy","target":"hemorrhage","id":"9635"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"9636"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"9637"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"9638"},{"source":"CD19 antagonist","target":"brain metastases","id":"9639"},{"source":"CD19 antagonist","target":"melanoma","id":"9640"},{"source":"CD19 antagonist","target":"bleeding","id":"9641"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"9642"},{"source":"CD19 antagonist","target":"residual tumor","id":"9643"},{"source":"CD19 antagonist","target":"liver metastases","id":"9644"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"9645"},{"source":"CD19 antagonist","target":"carcinoma","id":"9646"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"9647"},{"source":"CD19 antagonist","target":"hemorrhage","id":"9648"},{"source":"CD19 antagonist","target":"anticancer","id":"9649"},{"source":"NA","target":"UNK : Indication","id":"9650"},{"source":"NA","target":"ovarian neoplasms","id":"9651"},{"source":"NA","target":"brain metastases","id":"9652"},{"source":"NA","target":"melanoma","id":"9653"},{"source":"NA","target":"bleeding","id":"9654"},{"source":"NA","target":"skin neoplasms","id":"9655"},{"source":"NA","target":"residual tumor","id":"9656"},{"source":"NA","target":"liver metastases","id":"9657"},{"source":"NA","target":"cerebellar neoplasms","id":"9658"},{"source":"NA","target":"carcinoma","id":"9659"},{"source":"NA","target":"neoplasm metastasis","id":"9660"},{"source":"NA","target":"hemorrhage","id":"9661"},{"source":"NA","target":"anticancer","id":"9662"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"9663"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"9664"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"9665"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"9666"},{"source":"Immune checkpoint inhibitor","target":"bleeding","id":"9667"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"9668"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"9669"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"9670"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"9671"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"9672"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"9673"},{"source":"Immune checkpoint inhibitor","target":"hemorrhage","id":"9674"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"9675"},{"source":"NA","target":"UNK : Indication","id":"9676"},{"source":"NA","target":"ovarian neoplasms","id":"9677"},{"source":"NA","target":"brain metastases","id":"9678"},{"source":"NA","target":"melanoma","id":"9679"},{"source":"NA","target":"bleeding","id":"9680"},{"source":"NA","target":"skin neoplasms","id":"9681"},{"source":"NA","target":"residual tumor","id":"9682"},{"source":"NA","target":"liver metastases","id":"9683"},{"source":"NA","target":"cerebellar neoplasms","id":"9684"},{"source":"NA","target":"carcinoma","id":"9685"},{"source":"NA","target":"neoplasm metastasis","id":"9686"},{"source":"NA","target":"hemorrhage","id":"9687"},{"source":"NA","target":"anticancer","id":"9688"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"9689"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"9690"},{"source":"Oncology: Melanoma","target":"NA","id":"9691"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"9692"},{"source":"Oncology: Melanoma","target":"NA","id":"9693"},{"source":"aldesleukin (a)","target":"H. Lee Moffitt Cancer Center and Research Institute","id":"9694"},{"source":"aldesleukin (a)","target":"Merck & Co.","id":"9695"},{"source":"aldesleukin (a)","target":"Nestle Health Science/Prometheus Laboratories","id":"9696"},{"source":"pembrolizumab","target":"H. Lee Moffitt Cancer Center and Research Institute","id":"9697"},{"source":"pembrolizumab","target":"Merck & Co.","id":"9698"},{"source":"pembrolizumab","target":"Nestle Health Science/Prometheus Laboratories","id":"9699"},{"source":"UNK : Drug","target":"H. Lee Moffitt Cancer Center and Research Institute","id":"9700"},{"source":"UNK : Drug","target":"Merck & Co.","id":"9701"},{"source":"UNK : Drug","target":"Nestle Health Science/Prometheus Laboratories","id":"9702"},{"source":"solid tumors","target":"aldesleukin (a)","id":"9703"},{"source":"solid tumors","target":"pembrolizumab","id":"9704"},{"source":"solid tumors","target":"UNK : Drug","id":"9705"},{"source":"atrial fibrillation","target":"aldesleukin (a)","id":"9706"},{"source":"atrial fibrillation","target":"pembrolizumab","id":"9707"},{"source":"atrial fibrillation","target":"UNK : Drug","id":"9708"},{"source":"kidney neoplasms","target":"aldesleukin (a)","id":"9709"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"9710"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"9711"},{"source":"renal cancer","target":"aldesleukin (a)","id":"9712"},{"source":"renal cancer","target":"pembrolizumab","id":"9713"},{"source":"renal cancer","target":"UNK : Drug","id":"9714"},{"source":"carcinoma","target":"aldesleukin (a)","id":"9715"},{"source":"carcinoma","target":"pembrolizumab","id":"9716"},{"source":"carcinoma","target":"UNK : Drug","id":"9717"},{"source":"liver metastases","target":"aldesleukin (a)","id":"9718"},{"source":"liver metastases","target":"pembrolizumab","id":"9719"},{"source":"liver metastases","target":"UNK : Drug","id":"9720"},{"source":"metastatic","target":"aldesleukin (a)","id":"9721"},{"source":"metastatic","target":"pembrolizumab","id":"9722"},{"source":"metastatic","target":"UNK : Drug","id":"9723"},{"source":"carcinoma","target":"aldesleukin (a)","id":"9724"},{"source":"carcinoma","target":"pembrolizumab","id":"9725"},{"source":"carcinoma","target":"UNK : Drug","id":"9726"},{"source":"kidney cancer","target":"aldesleukin (a)","id":"9727"},{"source":"kidney cancer","target":"pembrolizumab","id":"9728"},{"source":"kidney cancer","target":"UNK : Drug","id":"9729"},{"source":"neoplasm metastasis","target":"aldesleukin (a)","id":"9730"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"9731"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"9732"},{"source":"anticancer","target":"aldesleukin (a)","id":"9733"},{"source":"anticancer","target":"pembrolizumab","id":"9734"},{"source":"anticancer","target":"UNK : Drug","id":"9735"},{"source":"liver neoplasms","target":"aldesleukin (a)","id":"9736"},{"source":"liver neoplasms","target":"pembrolizumab","id":"9737"},{"source":"liver neoplasms","target":"UNK : Drug","id":"9738"},{"source":"renal cell","target":"aldesleukin (a)","id":"9739"},{"source":"renal cell","target":"pembrolizumab","id":"9740"},{"source":"renal cell","target":"UNK : Drug","id":"9741"},{"source":"solid tumors","target":"aldesleukin (a)","id":"9742"},{"source":"solid tumors","target":"pembrolizumab","id":"9743"},{"source":"solid tumors","target":"UNK : Drug","id":"9744"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"9745"},{"source":"Immune checkpoint inhibitor","target":"atrial fibrillation","id":"9746"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"9747"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"9748"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"9749"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"9750"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"9751"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"9752"},{"source":"Immune checkpoint inhibitor","target":"kidney cancer","id":"9753"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"9754"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"9755"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"9756"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"9757"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"9758"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"9759"},{"source":"Anticancer immunotherapy","target":"atrial fibrillation","id":"9760"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"9761"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"9762"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"9763"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"9764"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"9765"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"9766"},{"source":"Anticancer immunotherapy","target":"kidney cancer","id":"9767"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"9768"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"9769"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"9770"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"9771"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"9772"},{"source":"CD19 antagonist","target":"solid tumors","id":"9773"},{"source":"CD19 antagonist","target":"atrial fibrillation","id":"9774"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"9775"},{"source":"CD19 antagonist","target":"renal cancer","id":"9776"},{"source":"CD19 antagonist","target":"carcinoma","id":"9777"},{"source":"CD19 antagonist","target":"liver metastases","id":"9778"},{"source":"CD19 antagonist","target":"metastatic","id":"9779"},{"source":"CD19 antagonist","target":"carcinoma","id":"9780"},{"source":"CD19 antagonist","target":"kidney cancer","id":"9781"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"9782"},{"source":"CD19 antagonist","target":"anticancer","id":"9783"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"9784"},{"source":"CD19 antagonist","target":"renal cell","id":"9785"},{"source":"CD19 antagonist","target":"solid tumors","id":"9786"},{"source":"T helper cell stimulant","target":"solid tumors","id":"9787"},{"source":"T helper cell stimulant","target":"atrial fibrillation","id":"9788"},{"source":"T helper cell stimulant","target":"kidney neoplasms","id":"9789"},{"source":"T helper cell stimulant","target":"renal cancer","id":"9790"},{"source":"T helper cell stimulant","target":"carcinoma","id":"9791"},{"source":"T helper cell stimulant","target":"liver metastases","id":"9792"},{"source":"T helper cell stimulant","target":"metastatic","id":"9793"},{"source":"T helper cell stimulant","target":"carcinoma","id":"9794"},{"source":"T helper cell stimulant","target":"kidney cancer","id":"9795"},{"source":"T helper cell stimulant","target":"neoplasm metastasis","id":"9796"},{"source":"T helper cell stimulant","target":"anticancer","id":"9797"},{"source":"T helper cell stimulant","target":"liver neoplasms","id":"9798"},{"source":"T helper cell stimulant","target":"renal cell","id":"9799"},{"source":"T helper cell stimulant","target":"solid tumors","id":"9800"},{"source":"Immunostimulant","target":"solid tumors","id":"9801"},{"source":"Immunostimulant","target":"atrial fibrillation","id":"9802"},{"source":"Immunostimulant","target":"kidney neoplasms","id":"9803"},{"source":"Immunostimulant","target":"renal cancer","id":"9804"},{"source":"Immunostimulant","target":"carcinoma","id":"9805"},{"source":"Immunostimulant","target":"liver metastases","id":"9806"},{"source":"Immunostimulant","target":"metastatic","id":"9807"},{"source":"Immunostimulant","target":"carcinoma","id":"9808"},{"source":"Immunostimulant","target":"kidney cancer","id":"9809"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"9810"},{"source":"Immunostimulant","target":"anticancer","id":"9811"},{"source":"Immunostimulant","target":"liver neoplasms","id":"9812"},{"source":"Immunostimulant","target":"renal cell","id":"9813"},{"source":"Immunostimulant","target":"solid tumors","id":"9814"},{"source":"Interleukin 2 receptor agonist","target":"solid tumors","id":"9815"},{"source":"Interleukin 2 receptor agonist","target":"atrial fibrillation","id":"9816"},{"source":"Interleukin 2 receptor agonist","target":"kidney neoplasms","id":"9817"},{"source":"Interleukin 2 receptor agonist","target":"renal cancer","id":"9818"},{"source":"Interleukin 2 receptor agonist","target":"carcinoma","id":"9819"},{"source":"Interleukin 2 receptor agonist","target":"liver metastases","id":"9820"},{"source":"Interleukin 2 receptor agonist","target":"metastatic","id":"9821"},{"source":"Interleukin 2 receptor agonist","target":"carcinoma","id":"9822"},{"source":"Interleukin 2 receptor agonist","target":"kidney cancer","id":"9823"},{"source":"Interleukin 2 receptor agonist","target":"neoplasm metastasis","id":"9824"},{"source":"Interleukin 2 receptor agonist","target":"anticancer","id":"9825"},{"source":"Interleukin 2 receptor agonist","target":"liver neoplasms","id":"9826"},{"source":"Interleukin 2 receptor agonist","target":"renal cell","id":"9827"},{"source":"Interleukin 2 receptor agonist","target":"solid tumors","id":"9828"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"9829"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"9830"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"9831"},{"source":"Oncology: Renal","target":"T helper cell stimulant","id":"9832"},{"source":"Oncology: Renal","target":"Immunostimulant","id":"9833"},{"source":"Oncology: Renal","target":"Interleukin 2 receptor agonist","id":"9834"},{"source":"pembrolizumab","target":"Merck & Co.","id":"9835"},{"source":"carboplatin","target":"Merck & Co.","id":"9836"},{"source":"carboplatin","target":"Merck & Co.","id":"9837"},{"source":"cisplatin","target":"Merck & Co.","id":"9838"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"9839"},{"source":"sodium chloride 0.9%","target":"Merck & Co.","id":"9840"},{"source":"psoriasis","target":"pembrolizumab","id":"9841"},{"source":"psoriasis","target":"carboplatin","id":"9842"},{"source":"psoriasis","target":"carboplatin","id":"9843"},{"source":"psoriasis","target":"cisplatin","id":"9844"},{"source":"psoriasis","target":"pemetrexed disodium","id":"9845"},{"source":"psoriasis","target":"sodium chloride 0.9%","id":"9846"},{"source":"UNK : Indication","target":"pembrolizumab","id":"9847"},{"source":"UNK : Indication","target":"carboplatin","id":"9848"},{"source":"UNK : Indication","target":"carboplatin","id":"9849"},{"source":"UNK : Indication","target":"cisplatin","id":"9850"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"9851"},{"source":"UNK : Indication","target":"sodium chloride 0.9%","id":"9852"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"9853"},{"source":"non-small-cell lung","target":"carboplatin","id":"9854"},{"source":"non-small-cell lung","target":"carboplatin","id":"9855"},{"source":"non-small-cell lung","target":"cisplatin","id":"9856"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"9857"},{"source":"non-small-cell lung","target":"sodium chloride 0.9%","id":"9858"},{"source":"neoplastic","target":"pembrolizumab","id":"9859"},{"source":"neoplastic","target":"carboplatin","id":"9860"},{"source":"neoplastic","target":"carboplatin","id":"9861"},{"source":"neoplastic","target":"cisplatin","id":"9862"},{"source":"neoplastic","target":"pemetrexed disodium","id":"9863"},{"source":"neoplastic","target":"sodium chloride 0.9%","id":"9864"},{"source":"residual tumor","target":"pembrolizumab","id":"9865"},{"source":"residual tumor","target":"carboplatin","id":"9866"},{"source":"residual tumor","target":"carboplatin","id":"9867"},{"source":"residual tumor","target":"cisplatin","id":"9868"},{"source":"residual tumor","target":"pemetrexed disodium","id":"9869"},{"source":"residual tumor","target":"sodium chloride 0.9%","id":"9870"},{"source":"arthritis","target":"pembrolizumab","id":"9871"},{"source":"arthritis","target":"carboplatin","id":"9872"},{"source":"arthritis","target":"carboplatin","id":"9873"},{"source":"arthritis","target":"cisplatin","id":"9874"},{"source":"arthritis","target":"pemetrexed disodium","id":"9875"},{"source":"arthritis","target":"sodium chloride 0.9%","id":"9876"},{"source":"sclc","target":"pembrolizumab","id":"9877"},{"source":"sclc","target":"carboplatin","id":"9878"},{"source":"sclc","target":"carboplatin","id":"9879"},{"source":"sclc","target":"cisplatin","id":"9880"},{"source":"sclc","target":"pemetrexed disodium","id":"9881"},{"source":"sclc","target":"sodium chloride 0.9%","id":"9882"},{"source":"carcinoma","target":"pembrolizumab","id":"9883"},{"source":"carcinoma","target":"carboplatin","id":"9884"},{"source":"carcinoma","target":"carboplatin","id":"9885"},{"source":"carcinoma","target":"cisplatin","id":"9886"},{"source":"carcinoma","target":"pemetrexed disodium","id":"9887"},{"source":"carcinoma","target":"sodium chloride 0.9%","id":"9888"},{"source":"metastatic","target":"pembrolizumab","id":"9889"},{"source":"metastatic","target":"carboplatin","id":"9890"},{"source":"metastatic","target":"carboplatin","id":"9891"},{"source":"metastatic","target":"cisplatin","id":"9892"},{"source":"metastatic","target":"pemetrexed disodium","id":"9893"},{"source":"metastatic","target":"sodium chloride 0.9%","id":"9894"},{"source":"carcinoma","target":"pembrolizumab","id":"9895"},{"source":"carcinoma","target":"carboplatin","id":"9896"},{"source":"carcinoma","target":"carboplatin","id":"9897"},{"source":"carcinoma","target":"cisplatin","id":"9898"},{"source":"carcinoma","target":"pemetrexed disodium","id":"9899"},{"source":"carcinoma","target":"sodium chloride 0.9%","id":"9900"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"9901"},{"source":"non-small-cell lung","target":"carboplatin","id":"9902"},{"source":"non-small-cell lung","target":"carboplatin","id":"9903"},{"source":"non-small-cell lung","target":"cisplatin","id":"9904"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"9905"},{"source":"non-small-cell lung","target":"sodium chloride 0.9%","id":"9906"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"9907"},{"source":"neoplasm metastasis","target":"carboplatin","id":"9908"},{"source":"neoplasm metastasis","target":"carboplatin","id":"9909"},{"source":"neoplasm metastasis","target":"cisplatin","id":"9910"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"9911"},{"source":"neoplasm metastasis","target":"sodium chloride 0.9%","id":"9912"},{"source":"psoriasis","target":"pembrolizumab","id":"9913"},{"source":"psoriasis","target":"carboplatin","id":"9914"},{"source":"psoriasis","target":"carboplatin","id":"9915"},{"source":"psoriasis","target":"cisplatin","id":"9916"},{"source":"psoriasis","target":"pemetrexed disodium","id":"9917"},{"source":"psoriasis","target":"sodium chloride 0.9%","id":"9918"},{"source":"anticancer","target":"pembrolizumab","id":"9919"},{"source":"anticancer","target":"carboplatin","id":"9920"},{"source":"anticancer","target":"carboplatin","id":"9921"},{"source":"anticancer","target":"cisplatin","id":"9922"},{"source":"anticancer","target":"pemetrexed disodium","id":"9923"},{"source":"anticancer","target":"sodium chloride 0.9%","id":"9924"},{"source":"antiarthritic","target":"pembrolizumab","id":"9925"},{"source":"antiarthritic","target":"carboplatin","id":"9926"},{"source":"antiarthritic","target":"carboplatin","id":"9927"},{"source":"antiarthritic","target":"cisplatin","id":"9928"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"9929"},{"source":"antiarthritic","target":"sodium chloride 0.9%","id":"9930"},{"source":"lung neoplasms","target":"pembrolizumab","id":"9931"},{"source":"lung neoplasms","target":"carboplatin","id":"9932"},{"source":"lung neoplasms","target":"carboplatin","id":"9933"},{"source":"lung neoplasms","target":"cisplatin","id":"9934"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"9935"},{"source":"lung neoplasms","target":"sodium chloride 0.9%","id":"9936"},{"source":"residual tumor","target":"pembrolizumab","id":"9937"},{"source":"residual tumor","target":"carboplatin","id":"9938"},{"source":"residual tumor","target":"carboplatin","id":"9939"},{"source":"residual tumor","target":"cisplatin","id":"9940"},{"source":"residual tumor","target":"pemetrexed disodium","id":"9941"},{"source":"residual tumor","target":"sodium chloride 0.9%","id":"9942"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"9943"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"9944"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"9945"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplastic","id":"9946"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"9947"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"9948"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"9949"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"9950"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"9951"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"9952"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"9953"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"9954"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"9955"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"9956"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"9957"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"9958"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"9959"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"9960"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"9961"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"9962"},{"source":"Immune checkpoint inhibitor","target":"neoplastic","id":"9963"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"9964"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"9965"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"9966"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"9967"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"9968"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"9969"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"9970"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"9971"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"9972"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"9973"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"9974"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"9975"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"9976"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"9977"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"9978"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"9979"},{"source":"Anticancer immunotherapy","target":"neoplastic","id":"9980"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"9981"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"9982"},{"source":"Anticancer immunotherapy","target":"sclc","id":"9983"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"9984"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"9985"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"9986"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"9987"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"9988"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"9989"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"9990"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"9991"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"9992"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"9993"},{"source":"CD19 antagonist","target":"psoriasis","id":"9994"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"9995"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"9996"},{"source":"CD19 antagonist","target":"neoplastic","id":"9997"},{"source":"CD19 antagonist","target":"residual tumor","id":"9998"},{"source":"CD19 antagonist","target":"arthritis","id":"9999"},{"source":"CD19 antagonist","target":"sclc","id":"10000"},{"source":"CD19 antagonist","target":"carcinoma","id":"10001"},{"source":"CD19 antagonist","target":"metastatic","id":"10002"},{"source":"CD19 antagonist","target":"carcinoma","id":"10003"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"10004"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"10005"},{"source":"CD19 antagonist","target":"psoriasis","id":"10006"},{"source":"CD19 antagonist","target":"anticancer","id":"10007"},{"source":"CD19 antagonist","target":"antiarthritic","id":"10008"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"10009"},{"source":"CD19 antagonist","target":"residual tumor","id":"10010"},{"source":"UPA","target":"psoriasis","id":"10011"},{"source":"UPA","target":"UNK : Indication","id":"10012"},{"source":"UPA","target":"non-small-cell lung","id":"10013"},{"source":"UPA","target":"neoplastic","id":"10014"},{"source":"UPA","target":"residual tumor","id":"10015"},{"source":"UPA","target":"arthritis","id":"10016"},{"source":"UPA","target":"sclc","id":"10017"},{"source":"UPA","target":"carcinoma","id":"10018"},{"source":"UPA","target":"metastatic","id":"10019"},{"source":"UPA","target":"carcinoma","id":"10020"},{"source":"UPA","target":"non-small-cell lung","id":"10021"},{"source":"UPA","target":"neoplasm metastasis","id":"10022"},{"source":"UPA","target":"psoriasis","id":"10023"},{"source":"UPA","target":"anticancer","id":"10024"},{"source":"UPA","target":"antiarthritic","id":"10025"},{"source":"UPA","target":"lung neoplasms","id":"10026"},{"source":"UPA","target":"residual tumor","id":"10027"},{"source":"NA","target":"psoriasis","id":"10028"},{"source":"NA","target":"UNK : Indication","id":"10029"},{"source":"NA","target":"non-small-cell lung","id":"10030"},{"source":"NA","target":"neoplastic","id":"10031"},{"source":"NA","target":"residual tumor","id":"10032"},{"source":"NA","target":"arthritis","id":"10033"},{"source":"NA","target":"sclc","id":"10034"},{"source":"NA","target":"carcinoma","id":"10035"},{"source":"NA","target":"metastatic","id":"10036"},{"source":"NA","target":"carcinoma","id":"10037"},{"source":"NA","target":"non-small-cell lung","id":"10038"},{"source":"NA","target":"neoplasm metastasis","id":"10039"},{"source":"NA","target":"psoriasis","id":"10040"},{"source":"NA","target":"anticancer","id":"10041"},{"source":"NA","target":"antiarthritic","id":"10042"},{"source":"NA","target":"lung neoplasms","id":"10043"},{"source":"NA","target":"residual tumor","id":"10044"},{"source":"NA","target":"psoriasis","id":"10045"},{"source":"NA","target":"UNK : Indication","id":"10046"},{"source":"NA","target":"non-small-cell lung","id":"10047"},{"source":"NA","target":"neoplastic","id":"10048"},{"source":"NA","target":"residual tumor","id":"10049"},{"source":"NA","target":"arthritis","id":"10050"},{"source":"NA","target":"sclc","id":"10051"},{"source":"NA","target":"carcinoma","id":"10052"},{"source":"NA","target":"metastatic","id":"10053"},{"source":"NA","target":"carcinoma","id":"10054"},{"source":"NA","target":"non-small-cell lung","id":"10055"},{"source":"NA","target":"neoplasm metastasis","id":"10056"},{"source":"NA","target":"psoriasis","id":"10057"},{"source":"NA","target":"anticancer","id":"10058"},{"source":"NA","target":"antiarthritic","id":"10059"},{"source":"NA","target":"lung neoplasms","id":"10060"},{"source":"NA","target":"residual tumor","id":"10061"},{"source":"NA","target":"psoriasis","id":"10062"},{"source":"NA","target":"UNK : Indication","id":"10063"},{"source":"NA","target":"non-small-cell lung","id":"10064"},{"source":"NA","target":"neoplastic","id":"10065"},{"source":"NA","target":"residual tumor","id":"10066"},{"source":"NA","target":"arthritis","id":"10067"},{"source":"NA","target":"sclc","id":"10068"},{"source":"NA","target":"carcinoma","id":"10069"},{"source":"NA","target":"metastatic","id":"10070"},{"source":"NA","target":"carcinoma","id":"10071"},{"source":"NA","target":"non-small-cell lung","id":"10072"},{"source":"NA","target":"neoplasm metastasis","id":"10073"},{"source":"NA","target":"psoriasis","id":"10074"},{"source":"NA","target":"anticancer","id":"10075"},{"source":"NA","target":"antiarthritic","id":"10076"},{"source":"NA","target":"lung neoplasms","id":"10077"},{"source":"NA","target":"residual tumor","id":"10078"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"10079"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"10080"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"10081"},{"source":"Thymidylate synthase inhibitor","target":"neoplastic","id":"10082"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"10083"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"10084"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"10085"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"10086"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"10087"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"10088"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"10089"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"10090"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"10091"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"10092"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"10093"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"10094"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"10095"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"10096"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"10097"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"10098"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"10099"},{"source":"Oncology: Lung","target":"UPA","id":"10100"},{"source":"Oncology: Lung","target":"NA","id":"10101"},{"source":"Oncology: Lung","target":"NA","id":"10102"},{"source":"Oncology: Lung","target":"NA","id":"10103"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"10104"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"10105"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"10106"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"10107"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"10108"},{"source":"Non-Small Cell","target":"UPA","id":"10109"},{"source":"Non-Small Cell","target":"NA","id":"10110"},{"source":"Non-Small Cell","target":"NA","id":"10111"},{"source":"Non-Small Cell","target":"NA","id":"10112"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"10113"},{"source":"Resimmune (u)","target":"(Other Academic Cancer Center)","id":"10114"},{"source":"Resimmune (u)","target":"Angimmune","id":"10115"},{"source":"pembrolizumab","target":"(Other Academic Cancer Center)","id":"10116"},{"source":"pembrolizumab","target":"Angimmune","id":"10117"},{"source":"radiation therapy","target":"(Other Academic Cancer Center)","id":"10118"},{"source":"radiation therapy","target":"Angimmune","id":"10119"},{"source":"UNK : Indication","target":"Resimmune (u)","id":"10120"},{"source":"UNK : Indication","target":"pembrolizumab","id":"10121"},{"source":"UNK : Indication","target":"radiation therapy","id":"10122"},{"source":"ovarian neoplasms","target":"Resimmune (u)","id":"10123"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"10124"},{"source":"ovarian neoplasms","target":"radiation therapy","id":"10125"},{"source":"brain metastases","target":"Resimmune (u)","id":"10126"},{"source":"brain metastases","target":"pembrolizumab","id":"10127"},{"source":"brain metastases","target":"radiation therapy","id":"10128"},{"source":"melanoma","target":"Resimmune (u)","id":"10129"},{"source":"melanoma","target":"pembrolizumab","id":"10130"},{"source":"melanoma","target":"radiation therapy","id":"10131"},{"source":"melanoma","target":"Resimmune (u)","id":"10132"},{"source":"melanoma","target":"pembrolizumab","id":"10133"},{"source":"melanoma","target":"radiation therapy","id":"10134"},{"source":"skin neoplasms","target":"Resimmune (u)","id":"10135"},{"source":"skin neoplasms","target":"pembrolizumab","id":"10136"},{"source":"skin neoplasms","target":"radiation therapy","id":"10137"},{"source":"residual tumor","target":"Resimmune (u)","id":"10138"},{"source":"residual tumor","target":"pembrolizumab","id":"10139"},{"source":"residual tumor","target":"radiation therapy","id":"10140"},{"source":"cerebellar neoplasms","target":"Resimmune (u)","id":"10141"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"10142"},{"source":"cerebellar neoplasms","target":"radiation therapy","id":"10143"},{"source":"carcinoma","target":"Resimmune (u)","id":"10144"},{"source":"carcinoma","target":"pembrolizumab","id":"10145"},{"source":"carcinoma","target":"radiation therapy","id":"10146"},{"source":"metastatic","target":"Resimmune (u)","id":"10147"},{"source":"metastatic","target":"pembrolizumab","id":"10148"},{"source":"metastatic","target":"radiation therapy","id":"10149"},{"source":"neoplasm metastasis","target":"Resimmune (u)","id":"10150"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"10151"},{"source":"neoplasm metastasis","target":"radiation therapy","id":"10152"},{"source":"anticancer","target":"Resimmune (u)","id":"10153"},{"source":"anticancer","target":"pembrolizumab","id":"10154"},{"source":"anticancer","target":"radiation therapy","id":"10155"},{"source":"hypertrophy","target":"Resimmune (u)","id":"10156"},{"source":"hypertrophy","target":"pembrolizumab","id":"10157"},{"source":"hypertrophy","target":"radiation therapy","id":"10158"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"10159"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"10160"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"10161"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"10162"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"10163"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"10164"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"10165"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"10166"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10167"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"10168"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"10169"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"10170"},{"source":"Anticancer immunotherapy","target":"hypertrophy","id":"10171"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"10172"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"10173"},{"source":"CD19 antagonist","target":"brain metastases","id":"10174"},{"source":"CD19 antagonist","target":"melanoma","id":"10175"},{"source":"CD19 antagonist","target":"melanoma","id":"10176"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"10177"},{"source":"CD19 antagonist","target":"residual tumor","id":"10178"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"10179"},{"source":"CD19 antagonist","target":"carcinoma","id":"10180"},{"source":"CD19 antagonist","target":"metastatic","id":"10181"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"10182"},{"source":"CD19 antagonist","target":"anticancer","id":"10183"},{"source":"CD19 antagonist","target":"hypertrophy","id":"10184"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"10185"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"10186"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"10187"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"10188"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"10189"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"10190"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"10191"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"10192"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"10193"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"10194"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"10195"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"10196"},{"source":"Immune checkpoint inhibitor","target":"hypertrophy","id":"10197"},{"source":"UPA","target":"UNK : Indication","id":"10198"},{"source":"UPA","target":"ovarian neoplasms","id":"10199"},{"source":"UPA","target":"brain metastases","id":"10200"},{"source":"UPA","target":"melanoma","id":"10201"},{"source":"UPA","target":"melanoma","id":"10202"},{"source":"UPA","target":"skin neoplasms","id":"10203"},{"source":"UPA","target":"residual tumor","id":"10204"},{"source":"UPA","target":"cerebellar neoplasms","id":"10205"},{"source":"UPA","target":"carcinoma","id":"10206"},{"source":"UPA","target":"metastatic","id":"10207"},{"source":"UPA","target":"neoplasm metastasis","id":"10208"},{"source":"UPA","target":"anticancer","id":"10209"},{"source":"UPA","target":"hypertrophy","id":"10210"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"10211"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"10212"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"10213"},{"source":"Oncology: Melanoma","target":"UPA","id":"10214"},{"source":"cyclophosphamide","target":"(Other Cooperative Group)","id":"10215"},{"source":"cyclophosphamide","target":"Karyopharm Therapeutics","id":"10216"},{"source":"cyclophosphamide","target":"University of Leeds","id":"10217"},{"source":"cyclophosphamide","target":"University of Leeds","id":"10218"},{"source":"cyclophosphamide","target":"UK","id":"10219"},{"source":"lenalidomide (a)","target":"(Other Cooperative Group)","id":"10220"},{"source":"lenalidomide (a)","target":"Karyopharm Therapeutics","id":"10221"},{"source":"lenalidomide (a)","target":"University of Leeds","id":"10222"},{"source":"lenalidomide (a)","target":"University of Leeds","id":"10223"},{"source":"lenalidomide (a)","target":"UK","id":"10224"},{"source":"pembrolizumab","target":"(Other Cooperative Group)","id":"10225"},{"source":"pembrolizumab","target":"Karyopharm Therapeutics","id":"10226"},{"source":"pembrolizumab","target":"University of Leeds","id":"10227"},{"source":"pembrolizumab","target":"University of Leeds","id":"10228"},{"source":"pembrolizumab","target":"UK","id":"10229"},{"source":"UNK : Drug","target":"(Other Cooperative Group)","id":"10230"},{"source":"UNK : Drug","target":"Karyopharm Therapeutics","id":"10231"},{"source":"UNK : Drug","target":"University of Leeds","id":"10232"},{"source":"UNK : Drug","target":"University of Leeds","id":"10233"},{"source":"UNK : Drug","target":"UK","id":"10234"},{"source":"inflammatory bowel diseases","target":"cyclophosphamide","id":"10235"},{"source":"inflammatory bowel diseases","target":"lenalidomide (a)","id":"10236"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"10237"},{"source":"inflammatory bowel diseases","target":"UNK : Drug","id":"10238"},{"source":"refractory myeloma","target":"cyclophosphamide","id":"10239"},{"source":"refractory myeloma","target":"lenalidomide (a)","id":"10240"},{"source":"refractory myeloma","target":"pembrolizumab","id":"10241"},{"source":"refractory myeloma","target":"UNK : Drug","id":"10242"},{"source":"pain","target":"cyclophosphamide","id":"10243"},{"source":"pain","target":"lenalidomide (a)","id":"10244"},{"source":"pain","target":"pembrolizumab","id":"10245"},{"source":"pain","target":"UNK : Drug","id":"10246"},{"source":"plasma cell","target":"cyclophosphamide","id":"10247"},{"source":"plasma cell","target":"lenalidomide (a)","id":"10248"},{"source":"plasma cell","target":"pembrolizumab","id":"10249"},{"source":"plasma cell","target":"UNK : Drug","id":"10250"},{"source":"multiple myeloma","target":"cyclophosphamide","id":"10251"},{"source":"multiple myeloma","target":"lenalidomide (a)","id":"10252"},{"source":"multiple myeloma","target":"pembrolizumab","id":"10253"},{"source":"multiple myeloma","target":"UNK : Drug","id":"10254"},{"source":"skin neoplasms","target":"cyclophosphamide","id":"10255"},{"source":"skin neoplasms","target":"lenalidomide (a)","id":"10256"},{"source":"skin neoplasms","target":"pembrolizumab","id":"10257"},{"source":"skin neoplasms","target":"UNK : Drug","id":"10258"},{"source":"arthritis","target":"cyclophosphamide","id":"10259"},{"source":"arthritis","target":"lenalidomide (a)","id":"10260"},{"source":"arthritis","target":"pembrolizumab","id":"10261"},{"source":"arthritis","target":"UNK : Drug","id":"10262"},{"source":"plasma cell","target":"cyclophosphamide","id":"10263"},{"source":"plasma cell","target":"lenalidomide (a)","id":"10264"},{"source":"plasma cell","target":"pembrolizumab","id":"10265"},{"source":"plasma cell","target":"UNK : Drug","id":"10266"},{"source":"multiple myeloma","target":"cyclophosphamide","id":"10267"},{"source":"multiple myeloma","target":"lenalidomide (a)","id":"10268"},{"source":"multiple myeloma","target":"pembrolizumab","id":"10269"},{"source":"multiple myeloma","target":"UNK : Drug","id":"10270"},{"source":"antiarthritic","target":"cyclophosphamide","id":"10271"},{"source":"antiarthritic","target":"lenalidomide (a)","id":"10272"},{"source":"antiarthritic","target":"pembrolizumab","id":"10273"},{"source":"antiarthritic","target":"UNK : Drug","id":"10274"},{"source":"inflammatory bowel diseases","target":"cyclophosphamide","id":"10275"},{"source":"inflammatory bowel diseases","target":"lenalidomide (a)","id":"10276"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"10277"},{"source":"inflammatory bowel diseases","target":"UNK : Drug","id":"10278"},{"source":"carcinoma","target":"cyclophosphamide","id":"10279"},{"source":"carcinoma","target":"lenalidomide (a)","id":"10280"},{"source":"carcinoma","target":"pembrolizumab","id":"10281"},{"source":"carcinoma","target":"UNK : Drug","id":"10282"},{"source":"analgesic","target":"cyclophosphamide","id":"10283"},{"source":"analgesic","target":"lenalidomide (a)","id":"10284"},{"source":"analgesic","target":"pembrolizumab","id":"10285"},{"source":"analgesic","target":"UNK : Drug","id":"10286"},{"source":"diabetes mellitus","target":"cyclophosphamide","id":"10287"},{"source":"diabetes mellitus","target":"lenalidomide (a)","id":"10288"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"10289"},{"source":"diabetes mellitus","target":"UNK : Drug","id":"10290"},{"source":"anticancer","target":"cyclophosphamide","id":"10291"},{"source":"anticancer","target":"lenalidomide (a)","id":"10292"},{"source":"anticancer","target":"pembrolizumab","id":"10293"},{"source":"anticancer","target":"UNK : Drug","id":"10294"},{"source":"antidiabetic","target":"cyclophosphamide","id":"10295"},{"source":"antidiabetic","target":"lenalidomide (a)","id":"10296"},{"source":"antidiabetic","target":"pembrolizumab","id":"10297"},{"source":"antidiabetic","target":"UNK : Drug","id":"10298"},{"source":"antianaemic","target":"cyclophosphamide","id":"10299"},{"source":"antianaemic","target":"lenalidomide (a)","id":"10300"},{"source":"antianaemic","target":"pembrolizumab","id":"10301"},{"source":"antianaemic","target":"UNK : Drug","id":"10302"},{"source":"anemia","target":"cyclophosphamide","id":"10303"},{"source":"anemia","target":"lenalidomide (a)","id":"10304"},{"source":"anemia","target":"pembrolizumab","id":"10305"},{"source":"anemia","target":"UNK : Drug","id":"10306"},{"source":"Immunosuppressant","target":"inflammatory bowel diseases","id":"10307"},{"source":"Immunosuppressant","target":"refractory myeloma","id":"10308"},{"source":"Immunosuppressant","target":"pain","id":"10309"},{"source":"Immunosuppressant","target":"plasma cell","id":"10310"},{"source":"Immunosuppressant","target":"multiple myeloma","id":"10311"},{"source":"Immunosuppressant","target":"skin neoplasms","id":"10312"},{"source":"Immunosuppressant","target":"arthritis","id":"10313"},{"source":"Immunosuppressant","target":"plasma cell","id":"10314"},{"source":"Immunosuppressant","target":"multiple myeloma","id":"10315"},{"source":"Immunosuppressant","target":"antiarthritic","id":"10316"},{"source":"Immunosuppressant","target":"inflammatory bowel diseases","id":"10317"},{"source":"Immunosuppressant","target":"carcinoma","id":"10318"},{"source":"Immunosuppressant","target":"analgesic","id":"10319"},{"source":"Immunosuppressant","target":"diabetes mellitus","id":"10320"},{"source":"Immunosuppressant","target":"anticancer","id":"10321"},{"source":"Immunosuppressant","target":"antidiabetic","id":"10322"},{"source":"Immunosuppressant","target":"antianaemic","id":"10323"},{"source":"Immunosuppressant","target":"anemia","id":"10324"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"10325"},{"source":"Immune checkpoint inhibitor","target":"refractory myeloma","id":"10326"},{"source":"Immune checkpoint inhibitor","target":"pain","id":"10327"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"10328"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"10329"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"10330"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"10331"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"10332"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"10333"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"10334"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"10335"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"10336"},{"source":"Immune checkpoint inhibitor","target":"analgesic","id":"10337"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"10338"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"10339"},{"source":"Immune checkpoint inhibitor","target":"antidiabetic","id":"10340"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"10341"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"10342"},{"source":"NA","target":"inflammatory bowel diseases","id":"10343"},{"source":"NA","target":"refractory myeloma","id":"10344"},{"source":"NA","target":"pain","id":"10345"},{"source":"NA","target":"plasma cell","id":"10346"},{"source":"NA","target":"multiple myeloma","id":"10347"},{"source":"NA","target":"skin neoplasms","id":"10348"},{"source":"NA","target":"arthritis","id":"10349"},{"source":"NA","target":"plasma cell","id":"10350"},{"source":"NA","target":"multiple myeloma","id":"10351"},{"source":"NA","target":"antiarthritic","id":"10352"},{"source":"NA","target":"inflammatory bowel diseases","id":"10353"},{"source":"NA","target":"carcinoma","id":"10354"},{"source":"NA","target":"analgesic","id":"10355"},{"source":"NA","target":"diabetes mellitus","id":"10356"},{"source":"NA","target":"anticancer","id":"10357"},{"source":"NA","target":"antidiabetic","id":"10358"},{"source":"NA","target":"antianaemic","id":"10359"},{"source":"NA","target":"anemia","id":"10360"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"10361"},{"source":"CD19 antagonist","target":"refractory myeloma","id":"10362"},{"source":"CD19 antagonist","target":"pain","id":"10363"},{"source":"CD19 antagonist","target":"plasma cell","id":"10364"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"10365"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"10366"},{"source":"CD19 antagonist","target":"arthritis","id":"10367"},{"source":"CD19 antagonist","target":"plasma cell","id":"10368"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"10369"},{"source":"CD19 antagonist","target":"antiarthritic","id":"10370"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"10371"},{"source":"CD19 antagonist","target":"carcinoma","id":"10372"},{"source":"CD19 antagonist","target":"analgesic","id":"10373"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"10374"},{"source":"CD19 antagonist","target":"anticancer","id":"10375"},{"source":"CD19 antagonist","target":"antidiabetic","id":"10376"},{"source":"CD19 antagonist","target":"antianaemic","id":"10377"},{"source":"CD19 antagonist","target":"anemia","id":"10378"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"10379"},{"source":"Anticancer immunotherapy","target":"refractory myeloma","id":"10380"},{"source":"Anticancer immunotherapy","target":"pain","id":"10381"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"10382"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"10383"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"10384"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"10385"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"10386"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"10387"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"10388"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"10389"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10390"},{"source":"Anticancer immunotherapy","target":"analgesic","id":"10391"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"10392"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"10393"},{"source":"Anticancer immunotherapy","target":"antidiabetic","id":"10394"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"10395"},{"source":"Anticancer immunotherapy","target":"anemia","id":"10396"},{"source":"Angiogenesis inhibitor","target":"inflammatory bowel diseases","id":"10397"},{"source":"Angiogenesis inhibitor","target":"refractory myeloma","id":"10398"},{"source":"Angiogenesis inhibitor","target":"pain","id":"10399"},{"source":"Angiogenesis inhibitor","target":"plasma cell","id":"10400"},{"source":"Angiogenesis inhibitor","target":"multiple myeloma","id":"10401"},{"source":"Angiogenesis inhibitor","target":"skin neoplasms","id":"10402"},{"source":"Angiogenesis inhibitor","target":"arthritis","id":"10403"},{"source":"Angiogenesis inhibitor","target":"plasma cell","id":"10404"},{"source":"Angiogenesis inhibitor","target":"multiple myeloma","id":"10405"},{"source":"Angiogenesis inhibitor","target":"antiarthritic","id":"10406"},{"source":"Angiogenesis inhibitor","target":"inflammatory bowel diseases","id":"10407"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"10408"},{"source":"Angiogenesis inhibitor","target":"analgesic","id":"10409"},{"source":"Angiogenesis inhibitor","target":"diabetes mellitus","id":"10410"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"10411"},{"source":"Angiogenesis inhibitor","target":"antidiabetic","id":"10412"},{"source":"Angiogenesis inhibitor","target":"antianaemic","id":"10413"},{"source":"Angiogenesis inhibitor","target":"anemia","id":"10414"},{"source":"Tumour necrosis factor alpha antagonist","target":"inflammatory bowel diseases","id":"10415"},{"source":"Tumour necrosis factor alpha antagonist","target":"refractory myeloma","id":"10416"},{"source":"Tumour necrosis factor alpha antagonist","target":"pain","id":"10417"},{"source":"Tumour necrosis factor alpha antagonist","target":"plasma cell","id":"10418"},{"source":"Tumour necrosis factor alpha antagonist","target":"multiple myeloma","id":"10419"},{"source":"Tumour necrosis factor alpha antagonist","target":"skin neoplasms","id":"10420"},{"source":"Tumour necrosis factor alpha antagonist","target":"arthritis","id":"10421"},{"source":"Tumour necrosis factor alpha antagonist","target":"plasma cell","id":"10422"},{"source":"Tumour necrosis factor alpha antagonist","target":"multiple myeloma","id":"10423"},{"source":"Tumour necrosis factor alpha antagonist","target":"antiarthritic","id":"10424"},{"source":"Tumour necrosis factor alpha antagonist","target":"inflammatory bowel diseases","id":"10425"},{"source":"Tumour necrosis factor alpha antagonist","target":"carcinoma","id":"10426"},{"source":"Tumour necrosis factor alpha antagonist","target":"analgesic","id":"10427"},{"source":"Tumour necrosis factor alpha antagonist","target":"diabetes mellitus","id":"10428"},{"source":"Tumour necrosis factor alpha antagonist","target":"anticancer","id":"10429"},{"source":"Tumour necrosis factor alpha antagonist","target":"antidiabetic","id":"10430"},{"source":"Tumour necrosis factor alpha antagonist","target":"antianaemic","id":"10431"},{"source":"Tumour necrosis factor alpha antagonist","target":"anemia","id":"10432"},{"source":"Oncology: Multiple Myeloma","target":"Immunosuppressant","id":"10433"},{"source":"Oncology: Multiple Myeloma","target":"Immune checkpoint inhibitor","id":"10434"},{"source":"Oncology: Multiple Myeloma","target":"NA","id":"10435"},{"source":"Oncology: Multiple Myeloma","target":"CD19 antagonist","id":"10436"},{"source":"Oncology: Multiple Myeloma","target":"Anticancer immunotherapy","id":"10437"},{"source":"Oncology: Multiple Myeloma","target":"Angiogenesis inhibitor","id":"10438"},{"source":"Oncology: Multiple Myeloma","target":"Tumour necrosis factor alpha antagonist","id":"10439"},{"source":"pembrolizumab","target":"MD Anderson Cancer Center","id":"10440"},{"source":"pembrolizumab","target":"University of Texas","id":"10441"},{"source":"UNK : Drug","target":"MD Anderson Cancer Center","id":"10442"},{"source":"UNK : Drug","target":"University of Texas","id":"10443"},{"source":"UNK : Indication","target":"pembrolizumab","id":"10444"},{"source":"UNK : Indication","target":"UNK : Drug","id":"10445"},{"source":"carcinoma","target":"pembrolizumab","id":"10446"},{"source":"carcinoma","target":"UNK : Drug","id":"10447"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"10448"},{"source":"anti-inflammatory","target":"UNK : Drug","id":"10449"},{"source":"pleural effusion","target":"pembrolizumab","id":"10450"},{"source":"pleural effusion","target":"UNK : Drug","id":"10451"},{"source":"inflammatory breast cancer","target":"pembrolizumab","id":"10452"},{"source":"inflammatory breast cancer","target":"UNK : Drug","id":"10453"},{"source":"edema","target":"pembrolizumab","id":"10454"},{"source":"edema","target":"UNK : Drug","id":"10455"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"10456"},{"source":"fallopian tube neoplasms","target":"UNK : Drug","id":"10457"},{"source":"breast neoplasms","target":"pembrolizumab","id":"10458"},{"source":"breast neoplasms","target":"UNK : Drug","id":"10459"},{"source":"hydrothorax","target":"pembrolizumab","id":"10460"},{"source":"hydrothorax","target":"UNK : Drug","id":"10461"},{"source":"liver neoplasms","target":"pembrolizumab","id":"10462"},{"source":"liver neoplasms","target":"UNK : Drug","id":"10463"},{"source":"carcinoma","target":"pembrolizumab","id":"10464"},{"source":"carcinoma","target":"UNK : Drug","id":"10465"},{"source":"bone metastasis","target":"pembrolizumab","id":"10466"},{"source":"bone metastasis","target":"UNK : Drug","id":"10467"},{"source":"peau d'orange","target":"pembrolizumab","id":"10468"},{"source":"peau d'orange","target":"UNK : Drug","id":"10469"},{"source":"breast neoplasms","target":"pembrolizumab","id":"10470"},{"source":"breast neoplasms","target":"UNK : Drug","id":"10471"},{"source":"liver metastases","target":"pembrolizumab","id":"10472"},{"source":"liver metastases","target":"UNK : Drug","id":"10473"},{"source":"inflammation","target":"pembrolizumab","id":"10474"},{"source":"inflammation","target":"UNK : Drug","id":"10475"},{"source":"tnbc","target":"pembrolizumab","id":"10476"},{"source":"tnbc","target":"UNK : Drug","id":"10477"},{"source":"erythema exudativum multiforme","target":"pembrolizumab","id":"10478"},{"source":"erythema exudativum multiforme","target":"UNK : Drug","id":"10479"},{"source":"metastatic","target":"pembrolizumab","id":"10480"},{"source":"metastatic","target":"UNK : Drug","id":"10481"},{"source":"carcinoma","target":"pembrolizumab","id":"10482"},{"source":"carcinoma","target":"UNK : Drug","id":"10483"},{"source":"erythema exudativum multiforme","target":"pembrolizumab","id":"10484"},{"source":"erythema exudativum multiforme","target":"UNK : Drug","id":"10485"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"10486"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"10487"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"10488"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"10489"},{"source":"residual tumor","target":"pembrolizumab","id":"10490"},{"source":"residual tumor","target":"UNK : Drug","id":"10491"},{"source":"inflammatory breast cancer","target":"pembrolizumab","id":"10492"},{"source":"inflammatory breast cancer","target":"UNK : Drug","id":"10493"},{"source":"anticancer","target":"pembrolizumab","id":"10494"},{"source":"anticancer","target":"UNK : Drug","id":"10495"},{"source":"breast neoplasms","target":"pembrolizumab","id":"10496"},{"source":"breast neoplasms","target":"UNK : Drug","id":"10497"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"10498"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10499"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"10500"},{"source":"Anticancer immunotherapy","target":"pleural effusion","id":"10501"},{"source":"Anticancer immunotherapy","target":"inflammatory breast cancer","id":"10502"},{"source":"Anticancer immunotherapy","target":"edema","id":"10503"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"10504"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"10505"},{"source":"Anticancer immunotherapy","target":"hydrothorax","id":"10506"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"10507"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10508"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"10509"},{"source":"Anticancer immunotherapy","target":"peau d'orange","id":"10510"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"10511"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"10512"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"10513"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"10514"},{"source":"Anticancer immunotherapy","target":"erythema exudativum multiforme","id":"10515"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"10516"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10517"},{"source":"Anticancer immunotherapy","target":"erythema exudativum multiforme","id":"10518"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"10519"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"10520"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"10521"},{"source":"Anticancer immunotherapy","target":"inflammatory breast cancer","id":"10522"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"10523"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"10524"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"10525"},{"source":"CD19 antagonist","target":"carcinoma","id":"10526"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"10527"},{"source":"CD19 antagonist","target":"pleural effusion","id":"10528"},{"source":"CD19 antagonist","target":"inflammatory breast cancer","id":"10529"},{"source":"CD19 antagonist","target":"edema","id":"10530"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"10531"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"10532"},{"source":"CD19 antagonist","target":"hydrothorax","id":"10533"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"10534"},{"source":"CD19 antagonist","target":"carcinoma","id":"10535"},{"source":"CD19 antagonist","target":"bone metastasis","id":"10536"},{"source":"CD19 antagonist","target":"peau d'orange","id":"10537"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"10538"},{"source":"CD19 antagonist","target":"liver metastases","id":"10539"},{"source":"CD19 antagonist","target":"inflammation","id":"10540"},{"source":"CD19 antagonist","target":"tnbc","id":"10541"},{"source":"CD19 antagonist","target":"erythema exudativum multiforme","id":"10542"},{"source":"CD19 antagonist","target":"metastatic","id":"10543"},{"source":"CD19 antagonist","target":"carcinoma","id":"10544"},{"source":"CD19 antagonist","target":"erythema exudativum multiforme","id":"10545"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"10546"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"10547"},{"source":"CD19 antagonist","target":"residual tumor","id":"10548"},{"source":"CD19 antagonist","target":"inflammatory breast cancer","id":"10549"},{"source":"CD19 antagonist","target":"anticancer","id":"10550"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"10551"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"10552"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"10553"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"10554"},{"source":"Immune checkpoint inhibitor","target":"pleural effusion","id":"10555"},{"source":"Immune checkpoint inhibitor","target":"inflammatory breast cancer","id":"10556"},{"source":"Immune checkpoint inhibitor","target":"edema","id":"10557"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"10558"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"10559"},{"source":"Immune checkpoint inhibitor","target":"hydrothorax","id":"10560"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"10561"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"10562"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"10563"},{"source":"Immune checkpoint inhibitor","target":"peau d'orange","id":"10564"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"10565"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"10566"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"10567"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"10568"},{"source":"Immune checkpoint inhibitor","target":"erythema exudativum multiforme","id":"10569"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"10570"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"10571"},{"source":"Immune checkpoint inhibitor","target":"erythema exudativum multiforme","id":"10572"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"10573"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"10574"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"10575"},{"source":"Immune checkpoint inhibitor","target":"inflammatory breast cancer","id":"10576"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"10577"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"10578"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"10579"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"10580"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"10581"},{"source":"pembrolizumab","target":"Merck & Co.","id":"10582"},{"source":"carboplatin","target":"Merck & Co.","id":"10583"},{"source":"carboplatin","target":"Merck & Co.","id":"10584"},{"source":"cisplatin","target":"Merck & Co.","id":"10585"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"10586"},{"source":"sodium chloride 0.9%","target":"Merck & Co.","id":"10587"},{"source":"psoriasis","target":"pembrolizumab","id":"10588"},{"source":"psoriasis","target":"carboplatin","id":"10589"},{"source":"psoriasis","target":"carboplatin","id":"10590"},{"source":"psoriasis","target":"cisplatin","id":"10591"},{"source":"psoriasis","target":"pemetrexed disodium","id":"10592"},{"source":"psoriasis","target":"sodium chloride 0.9%","id":"10593"},{"source":"UNK : Indication","target":"pembrolizumab","id":"10594"},{"source":"UNK : Indication","target":"carboplatin","id":"10595"},{"source":"UNK : Indication","target":"carboplatin","id":"10596"},{"source":"UNK : Indication","target":"cisplatin","id":"10597"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"10598"},{"source":"UNK : Indication","target":"sodium chloride 0.9%","id":"10599"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"10600"},{"source":"non-small-cell lung","target":"carboplatin","id":"10601"},{"source":"non-small-cell lung","target":"carboplatin","id":"10602"},{"source":"non-small-cell lung","target":"cisplatin","id":"10603"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"10604"},{"source":"non-small-cell lung","target":"sodium chloride 0.9%","id":"10605"},{"source":"neoplastic","target":"pembrolizumab","id":"10606"},{"source":"neoplastic","target":"carboplatin","id":"10607"},{"source":"neoplastic","target":"carboplatin","id":"10608"},{"source":"neoplastic","target":"cisplatin","id":"10609"},{"source":"neoplastic","target":"pemetrexed disodium","id":"10610"},{"source":"neoplastic","target":"sodium chloride 0.9%","id":"10611"},{"source":"residual tumor","target":"pembrolizumab","id":"10612"},{"source":"residual tumor","target":"carboplatin","id":"10613"},{"source":"residual tumor","target":"carboplatin","id":"10614"},{"source":"residual tumor","target":"cisplatin","id":"10615"},{"source":"residual tumor","target":"pemetrexed disodium","id":"10616"},{"source":"residual tumor","target":"sodium chloride 0.9%","id":"10617"},{"source":"arthritis","target":"pembrolizumab","id":"10618"},{"source":"arthritis","target":"carboplatin","id":"10619"},{"source":"arthritis","target":"carboplatin","id":"10620"},{"source":"arthritis","target":"cisplatin","id":"10621"},{"source":"arthritis","target":"pemetrexed disodium","id":"10622"},{"source":"arthritis","target":"sodium chloride 0.9%","id":"10623"},{"source":"sclc","target":"pembrolizumab","id":"10624"},{"source":"sclc","target":"carboplatin","id":"10625"},{"source":"sclc","target":"carboplatin","id":"10626"},{"source":"sclc","target":"cisplatin","id":"10627"},{"source":"sclc","target":"pemetrexed disodium","id":"10628"},{"source":"sclc","target":"sodium chloride 0.9%","id":"10629"},{"source":"carcinoma","target":"pembrolizumab","id":"10630"},{"source":"carcinoma","target":"carboplatin","id":"10631"},{"source":"carcinoma","target":"carboplatin","id":"10632"},{"source":"carcinoma","target":"cisplatin","id":"10633"},{"source":"carcinoma","target":"pemetrexed disodium","id":"10634"},{"source":"carcinoma","target":"sodium chloride 0.9%","id":"10635"},{"source":"metastatic","target":"pembrolizumab","id":"10636"},{"source":"metastatic","target":"carboplatin","id":"10637"},{"source":"metastatic","target":"carboplatin","id":"10638"},{"source":"metastatic","target":"cisplatin","id":"10639"},{"source":"metastatic","target":"pemetrexed disodium","id":"10640"},{"source":"metastatic","target":"sodium chloride 0.9%","id":"10641"},{"source":"carcinoma","target":"pembrolizumab","id":"10642"},{"source":"carcinoma","target":"carboplatin","id":"10643"},{"source":"carcinoma","target":"carboplatin","id":"10644"},{"source":"carcinoma","target":"cisplatin","id":"10645"},{"source":"carcinoma","target":"pemetrexed disodium","id":"10646"},{"source":"carcinoma","target":"sodium chloride 0.9%","id":"10647"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"10648"},{"source":"non-small-cell lung","target":"carboplatin","id":"10649"},{"source":"non-small-cell lung","target":"carboplatin","id":"10650"},{"source":"non-small-cell lung","target":"cisplatin","id":"10651"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"10652"},{"source":"non-small-cell lung","target":"sodium chloride 0.9%","id":"10653"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"10654"},{"source":"neoplasm metastasis","target":"carboplatin","id":"10655"},{"source":"neoplasm metastasis","target":"carboplatin","id":"10656"},{"source":"neoplasm metastasis","target":"cisplatin","id":"10657"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"10658"},{"source":"neoplasm metastasis","target":"sodium chloride 0.9%","id":"10659"},{"source":"psoriasis","target":"pembrolizumab","id":"10660"},{"source":"psoriasis","target":"carboplatin","id":"10661"},{"source":"psoriasis","target":"carboplatin","id":"10662"},{"source":"psoriasis","target":"cisplatin","id":"10663"},{"source":"psoriasis","target":"pemetrexed disodium","id":"10664"},{"source":"psoriasis","target":"sodium chloride 0.9%","id":"10665"},{"source":"anticancer","target":"pembrolizumab","id":"10666"},{"source":"anticancer","target":"carboplatin","id":"10667"},{"source":"anticancer","target":"carboplatin","id":"10668"},{"source":"anticancer","target":"cisplatin","id":"10669"},{"source":"anticancer","target":"pemetrexed disodium","id":"10670"},{"source":"anticancer","target":"sodium chloride 0.9%","id":"10671"},{"source":"antiarthritic","target":"pembrolizumab","id":"10672"},{"source":"antiarthritic","target":"carboplatin","id":"10673"},{"source":"antiarthritic","target":"carboplatin","id":"10674"},{"source":"antiarthritic","target":"cisplatin","id":"10675"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"10676"},{"source":"antiarthritic","target":"sodium chloride 0.9%","id":"10677"},{"source":"lung neoplasms","target":"pembrolizumab","id":"10678"},{"source":"lung neoplasms","target":"carboplatin","id":"10679"},{"source":"lung neoplasms","target":"carboplatin","id":"10680"},{"source":"lung neoplasms","target":"cisplatin","id":"10681"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"10682"},{"source":"lung neoplasms","target":"sodium chloride 0.9%","id":"10683"},{"source":"residual tumor","target":"pembrolizumab","id":"10684"},{"source":"residual tumor","target":"carboplatin","id":"10685"},{"source":"residual tumor","target":"carboplatin","id":"10686"},{"source":"residual tumor","target":"cisplatin","id":"10687"},{"source":"residual tumor","target":"pemetrexed disodium","id":"10688"},{"source":"residual tumor","target":"sodium chloride 0.9%","id":"10689"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"10690"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"10691"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"10692"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplastic","id":"10693"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"10694"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"10695"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"10696"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"10697"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"10698"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"10699"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"10700"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"10701"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"10702"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"10703"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"10704"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"10705"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"10706"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"10707"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"10708"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"10709"},{"source":"Immune checkpoint inhibitor","target":"neoplastic","id":"10710"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"10711"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"10712"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"10713"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"10714"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"10715"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"10716"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"10717"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"10718"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"10719"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"10720"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"10721"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"10722"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"10723"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"10724"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"10725"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"10726"},{"source":"Anticancer immunotherapy","target":"neoplastic","id":"10727"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"10728"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"10729"},{"source":"Anticancer immunotherapy","target":"sclc","id":"10730"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10731"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"10732"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10733"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"10734"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"10735"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"10736"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"10737"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"10738"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"10739"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"10740"},{"source":"CD19 antagonist","target":"psoriasis","id":"10741"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"10742"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"10743"},{"source":"CD19 antagonist","target":"neoplastic","id":"10744"},{"source":"CD19 antagonist","target":"residual tumor","id":"10745"},{"source":"CD19 antagonist","target":"arthritis","id":"10746"},{"source":"CD19 antagonist","target":"sclc","id":"10747"},{"source":"CD19 antagonist","target":"carcinoma","id":"10748"},{"source":"CD19 antagonist","target":"metastatic","id":"10749"},{"source":"CD19 antagonist","target":"carcinoma","id":"10750"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"10751"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"10752"},{"source":"CD19 antagonist","target":"psoriasis","id":"10753"},{"source":"CD19 antagonist","target":"anticancer","id":"10754"},{"source":"CD19 antagonist","target":"antiarthritic","id":"10755"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"10756"},{"source":"CD19 antagonist","target":"residual tumor","id":"10757"},{"source":"UPA","target":"psoriasis","id":"10758"},{"source":"UPA","target":"UNK : Indication","id":"10759"},{"source":"UPA","target":"non-small-cell lung","id":"10760"},{"source":"UPA","target":"neoplastic","id":"10761"},{"source":"UPA","target":"residual tumor","id":"10762"},{"source":"UPA","target":"arthritis","id":"10763"},{"source":"UPA","target":"sclc","id":"10764"},{"source":"UPA","target":"carcinoma","id":"10765"},{"source":"UPA","target":"metastatic","id":"10766"},{"source":"UPA","target":"carcinoma","id":"10767"},{"source":"UPA","target":"non-small-cell lung","id":"10768"},{"source":"UPA","target":"neoplasm metastasis","id":"10769"},{"source":"UPA","target":"psoriasis","id":"10770"},{"source":"UPA","target":"anticancer","id":"10771"},{"source":"UPA","target":"antiarthritic","id":"10772"},{"source":"UPA","target":"lung neoplasms","id":"10773"},{"source":"UPA","target":"residual tumor","id":"10774"},{"source":"NA","target":"psoriasis","id":"10775"},{"source":"NA","target":"UNK : Indication","id":"10776"},{"source":"NA","target":"non-small-cell lung","id":"10777"},{"source":"NA","target":"neoplastic","id":"10778"},{"source":"NA","target":"residual tumor","id":"10779"},{"source":"NA","target":"arthritis","id":"10780"},{"source":"NA","target":"sclc","id":"10781"},{"source":"NA","target":"carcinoma","id":"10782"},{"source":"NA","target":"metastatic","id":"10783"},{"source":"NA","target":"carcinoma","id":"10784"},{"source":"NA","target":"non-small-cell lung","id":"10785"},{"source":"NA","target":"neoplasm metastasis","id":"10786"},{"source":"NA","target":"psoriasis","id":"10787"},{"source":"NA","target":"anticancer","id":"10788"},{"source":"NA","target":"antiarthritic","id":"10789"},{"source":"NA","target":"lung neoplasms","id":"10790"},{"source":"NA","target":"residual tumor","id":"10791"},{"source":"NA","target":"psoriasis","id":"10792"},{"source":"NA","target":"UNK : Indication","id":"10793"},{"source":"NA","target":"non-small-cell lung","id":"10794"},{"source":"NA","target":"neoplastic","id":"10795"},{"source":"NA","target":"residual tumor","id":"10796"},{"source":"NA","target":"arthritis","id":"10797"},{"source":"NA","target":"sclc","id":"10798"},{"source":"NA","target":"carcinoma","id":"10799"},{"source":"NA","target":"metastatic","id":"10800"},{"source":"NA","target":"carcinoma","id":"10801"},{"source":"NA","target":"non-small-cell lung","id":"10802"},{"source":"NA","target":"neoplasm metastasis","id":"10803"},{"source":"NA","target":"psoriasis","id":"10804"},{"source":"NA","target":"anticancer","id":"10805"},{"source":"NA","target":"antiarthritic","id":"10806"},{"source":"NA","target":"lung neoplasms","id":"10807"},{"source":"NA","target":"residual tumor","id":"10808"},{"source":"NA","target":"psoriasis","id":"10809"},{"source":"NA","target":"UNK : Indication","id":"10810"},{"source":"NA","target":"non-small-cell lung","id":"10811"},{"source":"NA","target":"neoplastic","id":"10812"},{"source":"NA","target":"residual tumor","id":"10813"},{"source":"NA","target":"arthritis","id":"10814"},{"source":"NA","target":"sclc","id":"10815"},{"source":"NA","target":"carcinoma","id":"10816"},{"source":"NA","target":"metastatic","id":"10817"},{"source":"NA","target":"carcinoma","id":"10818"},{"source":"NA","target":"non-small-cell lung","id":"10819"},{"source":"NA","target":"neoplasm metastasis","id":"10820"},{"source":"NA","target":"psoriasis","id":"10821"},{"source":"NA","target":"anticancer","id":"10822"},{"source":"NA","target":"antiarthritic","id":"10823"},{"source":"NA","target":"lung neoplasms","id":"10824"},{"source":"NA","target":"residual tumor","id":"10825"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"10826"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"10827"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"10828"},{"source":"Thymidylate synthase inhibitor","target":"neoplastic","id":"10829"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"10830"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"10831"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"10832"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"10833"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"10834"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"10835"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"10836"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"10837"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"10838"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"10839"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"10840"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"10841"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"10842"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"10843"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"10844"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"10845"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"10846"},{"source":"Oncology: Lung","target":"UPA","id":"10847"},{"source":"Oncology: Lung","target":"NA","id":"10848"},{"source":"Oncology: Lung","target":"NA","id":"10849"},{"source":"Oncology: Lung","target":"NA","id":"10850"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"10851"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"10852"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"10853"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"10854"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"10855"},{"source":"Non-Small Cell","target":"UPA","id":"10856"},{"source":"Non-Small Cell","target":"NA","id":"10857"},{"source":"Non-Small Cell","target":"NA","id":"10858"},{"source":"Non-Small Cell","target":"NA","id":"10859"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"10860"},{"source":"enoblituzumab (u)","target":"MacroGenics","id":"10861"},{"source":"pembrolizumab","target":"MacroGenics","id":"10862"},{"source":"UNK : Indication","target":"enoblituzumab (u)","id":"10863"},{"source":"UNK : Indication","target":"pembrolizumab","id":"10864"},{"source":"colorectal neoplasms","target":"enoblituzumab (u)","id":"10865"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"10866"},{"source":"prostate cancer","target":"enoblituzumab (u)","id":"10867"},{"source":"prostate cancer","target":"pembrolizumab","id":"10868"},{"source":"anticancer","target":"enoblituzumab (u)","id":"10869"},{"source":"anticancer","target":"pembrolizumab","id":"10870"},{"source":"melanoma","target":"enoblituzumab (u)","id":"10871"},{"source":"melanoma","target":"pembrolizumab","id":"10872"},{"source":"castration-resistant prostatic neoplasms","target":"enoblituzumab (u)","id":"10873"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"10874"},{"source":"skin neoplasms","target":"enoblituzumab (u)","id":"10875"},{"source":"skin neoplasms","target":"pembrolizumab","id":"10876"},{"source":"renal cancer","target":"enoblituzumab (u)","id":"10877"},{"source":"renal cancer","target":"pembrolizumab","id":"10878"},{"source":"carcinoma","target":"enoblituzumab (u)","id":"10879"},{"source":"carcinoma","target":"pembrolizumab","id":"10880"},{"source":"squamous cell neoplasms","target":"enoblituzumab (u)","id":"10881"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"10882"},{"source":"non-small-cell lung","target":"enoblituzumab (u)","id":"10883"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"10884"},{"source":"pancreatic cancer","target":"enoblituzumab (u)","id":"10885"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"10886"},{"source":"sarcoma","target":"enoblituzumab (u)","id":"10887"},{"source":"sarcoma","target":"pembrolizumab","id":"10888"},{"source":"skin neoplasms","target":"enoblituzumab (u)","id":"10889"},{"source":"skin neoplasms","target":"pembrolizumab","id":"10890"},{"source":"head and neck neoplasms","target":"enoblituzumab (u)","id":"10891"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"10892"},{"source":"carcinoma","target":"enoblituzumab (u)","id":"10893"},{"source":"carcinoma","target":"pembrolizumab","id":"10894"},{"source":"non-small-cell lung","target":"enoblituzumab (u)","id":"10895"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"10896"},{"source":"melanoma","target":"enoblituzumab (u)","id":"10897"},{"source":"melanoma","target":"pembrolizumab","id":"10898"},{"source":"mesothelial","target":"enoblituzumab (u)","id":"10899"},{"source":"mesothelial","target":"pembrolizumab","id":"10900"},{"source":"non-small-cell lung","target":"enoblituzumab (u)","id":"10901"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"10902"},{"source":"sarcoma","target":"enoblituzumab (u)","id":"10903"},{"source":"sarcoma","target":"pembrolizumab","id":"10904"},{"source":"breast neoplasms","target":"enoblituzumab (u)","id":"10905"},{"source":"breast neoplasms","target":"pembrolizumab","id":"10906"},{"source":"colonic neoplasms","target":"enoblituzumab (u)","id":"10907"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"10908"},{"source":"carcinoma","target":"enoblituzumab (u)","id":"10909"},{"source":"carcinoma","target":"pembrolizumab","id":"10910"},{"source":"anticancer","target":"enoblituzumab (u)","id":"10911"},{"source":"anticancer","target":"pembrolizumab","id":"10912"},{"source":"sclc","target":"enoblituzumab (u)","id":"10913"},{"source":"sclc","target":"pembrolizumab","id":"10914"},{"source":"ovarian neoplasms","target":"enoblituzumab (u)","id":"10915"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"10916"},{"source":"renal cell","target":"enoblituzumab (u)","id":"10917"},{"source":"renal cell","target":"pembrolizumab","id":"10918"},{"source":"mesothelial","target":"enoblituzumab (u)","id":"10919"},{"source":"mesothelial","target":"pembrolizumab","id":"10920"},{"source":"mesothelial","target":"enoblituzumab (u)","id":"10921"},{"source":"mesothelial","target":"pembrolizumab","id":"10922"},{"source":"kidney neoplasms","target":"enoblituzumab (u)","id":"10923"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"10924"},{"source":"thyroid neoplasms","target":"enoblituzumab (u)","id":"10925"},{"source":"thyroid neoplasms","target":"pembrolizumab","id":"10926"},{"source":"colon cancer","target":"enoblituzumab (u)","id":"10927"},{"source":"colon cancer","target":"pembrolizumab","id":"10928"},{"source":"carcinoma","target":"enoblituzumab (u)","id":"10929"},{"source":"carcinoma","target":"pembrolizumab","id":"10930"},{"source":"metastatic","target":"enoblituzumab (u)","id":"10931"},{"source":"metastatic","target":"pembrolizumab","id":"10932"},{"source":"carcinoma","target":"enoblituzumab (u)","id":"10933"},{"source":"carcinoma","target":"pembrolizumab","id":"10934"},{"source":"soft tissue neoplasms","target":"enoblituzumab (u)","id":"10935"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"10936"},{"source":"ovarian cancer","target":"enoblituzumab (u)","id":"10937"},{"source":"ovarian cancer","target":"pembrolizumab","id":"10938"},{"source":"neoplasm metastasis","target":"enoblituzumab (u)","id":"10939"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"10940"},{"source":"head and neck cancer","target":"enoblituzumab (u)","id":"10941"},{"source":"head and neck cancer","target":"pembrolizumab","id":"10942"},{"source":"lung neoplasms","target":"enoblituzumab (u)","id":"10943"},{"source":"lung neoplasms","target":"pembrolizumab","id":"10944"},{"source":"carcinoma","target":"enoblituzumab (u)","id":"10945"},{"source":"carcinoma","target":"pembrolizumab","id":"10946"},{"source":"pancreatic neoplasms","target":"enoblituzumab (u)","id":"10947"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"10948"},{"source":"colorectal neoplasms","target":"enoblituzumab (u)","id":"10949"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"10950"},{"source":"thyroid cancer","target":"enoblituzumab (u)","id":"10951"},{"source":"thyroid cancer","target":"pembrolizumab","id":"10952"},{"source":"carcinoma","target":"enoblituzumab (u)","id":"10953"},{"source":"carcinoma","target":"pembrolizumab","id":"10954"},{"source":"anti-tumor","target":"enoblituzumab (u)","id":"10955"},{"source":"anti-tumor","target":"pembrolizumab","id":"10956"},{"source":"peritoneal mesothelioma","target":"enoblituzumab (u)","id":"10957"},{"source":"peritoneal mesothelioma","target":"pembrolizumab","id":"10958"},{"source":"anticancer","target":"enoblituzumab (u)","id":"10959"},{"source":"anticancer","target":"pembrolizumab","id":"10960"},{"source":"urinary bladder neoplasms","target":"enoblituzumab (u)","id":"10961"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"10962"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"10963"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"10964"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"10965"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"10966"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"10967"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"10968"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"10969"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"10970"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10971"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"10972"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"10973"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"10974"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"10975"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"10976"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"10977"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10978"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"10979"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"10980"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"10981"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"10982"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"10983"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"10984"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"10985"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10986"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"10987"},{"source":"Anticancer immunotherapy","target":"sclc","id":"10988"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"10989"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"10990"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"10991"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"10992"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"10993"},{"source":"Anticancer immunotherapy","target":"thyroid neoplasms","id":"10994"},{"source":"Anticancer immunotherapy","target":"colon cancer","id":"10995"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10996"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"10997"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"10998"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"10999"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"11000"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"11001"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"11002"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"11003"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11004"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"11005"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"11006"},{"source":"Anticancer immunotherapy","target":"thyroid cancer","id":"11007"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11008"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"11009"},{"source":"Anticancer immunotherapy","target":"peritoneal mesothelioma","id":"11010"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"11011"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"11012"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"11013"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"11014"},{"source":"CD19 antagonist","target":"prostate cancer","id":"11015"},{"source":"CD19 antagonist","target":"anticancer","id":"11016"},{"source":"CD19 antagonist","target":"melanoma","id":"11017"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"11018"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"11019"},{"source":"CD19 antagonist","target":"renal cancer","id":"11020"},{"source":"CD19 antagonist","target":"carcinoma","id":"11021"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"11022"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"11023"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"11024"},{"source":"CD19 antagonist","target":"sarcoma","id":"11025"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"11026"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"11027"},{"source":"CD19 antagonist","target":"carcinoma","id":"11028"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"11029"},{"source":"CD19 antagonist","target":"melanoma","id":"11030"},{"source":"CD19 antagonist","target":"mesothelial","id":"11031"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"11032"},{"source":"CD19 antagonist","target":"sarcoma","id":"11033"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"11034"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"11035"},{"source":"CD19 antagonist","target":"carcinoma","id":"11036"},{"source":"CD19 antagonist","target":"anticancer","id":"11037"},{"source":"CD19 antagonist","target":"sclc","id":"11038"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"11039"},{"source":"CD19 antagonist","target":"renal cell","id":"11040"},{"source":"CD19 antagonist","target":"mesothelial","id":"11041"},{"source":"CD19 antagonist","target":"mesothelial","id":"11042"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"11043"},{"source":"CD19 antagonist","target":"thyroid neoplasms","id":"11044"},{"source":"CD19 antagonist","target":"colon cancer","id":"11045"},{"source":"CD19 antagonist","target":"carcinoma","id":"11046"},{"source":"CD19 antagonist","target":"metastatic","id":"11047"},{"source":"CD19 antagonist","target":"carcinoma","id":"11048"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"11049"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"11050"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"11051"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"11052"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"11053"},{"source":"CD19 antagonist","target":"carcinoma","id":"11054"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"11055"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"11056"},{"source":"CD19 antagonist","target":"thyroid cancer","id":"11057"},{"source":"CD19 antagonist","target":"carcinoma","id":"11058"},{"source":"CD19 antagonist","target":"anti-tumor","id":"11059"},{"source":"CD19 antagonist","target":"peritoneal mesothelioma","id":"11060"},{"source":"CD19 antagonist","target":"anticancer","id":"11061"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"11062"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"11063"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"11064"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"11065"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11066"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"11067"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"11068"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"11069"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"11070"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11071"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"11072"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"11073"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"11074"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"11075"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"11076"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"11077"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11078"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"11079"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"11080"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"11081"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"11082"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"11083"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"11084"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"11085"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11086"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11087"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"11088"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"11089"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"11090"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"11091"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"11092"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"11093"},{"source":"Immune checkpoint inhibitor","target":"thyroid neoplasms","id":"11094"},{"source":"Immune checkpoint inhibitor","target":"colon cancer","id":"11095"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11096"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"11097"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11098"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"11099"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"11100"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"11101"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"11102"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"11103"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11104"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"11105"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"11106"},{"source":"Immune checkpoint inhibitor","target":"thyroid cancer","id":"11107"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11108"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"11109"},{"source":"Immune checkpoint inhibitor","target":"peritoneal mesothelioma","id":"11110"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11111"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"11112"},{"source":"B7-H3 antagonist","target":"UNK : Indication","id":"11113"},{"source":"B7-H3 antagonist","target":"colorectal neoplasms","id":"11114"},{"source":"B7-H3 antagonist","target":"prostate cancer","id":"11115"},{"source":"B7-H3 antagonist","target":"anticancer","id":"11116"},{"source":"B7-H3 antagonist","target":"melanoma","id":"11117"},{"source":"B7-H3 antagonist","target":"castration-resistant prostatic neoplasms","id":"11118"},{"source":"B7-H3 antagonist","target":"skin neoplasms","id":"11119"},{"source":"B7-H3 antagonist","target":"renal cancer","id":"11120"},{"source":"B7-H3 antagonist","target":"carcinoma","id":"11121"},{"source":"B7-H3 antagonist","target":"squamous cell neoplasms","id":"11122"},{"source":"B7-H3 antagonist","target":"non-small-cell lung","id":"11123"},{"source":"B7-H3 antagonist","target":"pancreatic cancer","id":"11124"},{"source":"B7-H3 antagonist","target":"sarcoma","id":"11125"},{"source":"B7-H3 antagonist","target":"skin neoplasms","id":"11126"},{"source":"B7-H3 antagonist","target":"head and neck neoplasms","id":"11127"},{"source":"B7-H3 antagonist","target":"carcinoma","id":"11128"},{"source":"B7-H3 antagonist","target":"non-small-cell lung","id":"11129"},{"source":"B7-H3 antagonist","target":"melanoma","id":"11130"},{"source":"B7-H3 antagonist","target":"mesothelial","id":"11131"},{"source":"B7-H3 antagonist","target":"non-small-cell lung","id":"11132"},{"source":"B7-H3 antagonist","target":"sarcoma","id":"11133"},{"source":"B7-H3 antagonist","target":"breast neoplasms","id":"11134"},{"source":"B7-H3 antagonist","target":"colonic neoplasms","id":"11135"},{"source":"B7-H3 antagonist","target":"carcinoma","id":"11136"},{"source":"B7-H3 antagonist","target":"anticancer","id":"11137"},{"source":"B7-H3 antagonist","target":"sclc","id":"11138"},{"source":"B7-H3 antagonist","target":"ovarian neoplasms","id":"11139"},{"source":"B7-H3 antagonist","target":"renal cell","id":"11140"},{"source":"B7-H3 antagonist","target":"mesothelial","id":"11141"},{"source":"B7-H3 antagonist","target":"mesothelial","id":"11142"},{"source":"B7-H3 antagonist","target":"kidney neoplasms","id":"11143"},{"source":"B7-H3 antagonist","target":"thyroid neoplasms","id":"11144"},{"source":"B7-H3 antagonist","target":"colon cancer","id":"11145"},{"source":"B7-H3 antagonist","target":"carcinoma","id":"11146"},{"source":"B7-H3 antagonist","target":"metastatic","id":"11147"},{"source":"B7-H3 antagonist","target":"carcinoma","id":"11148"},{"source":"B7-H3 antagonist","target":"soft tissue neoplasms","id":"11149"},{"source":"B7-H3 antagonist","target":"ovarian cancer","id":"11150"},{"source":"B7-H3 antagonist","target":"neoplasm metastasis","id":"11151"},{"source":"B7-H3 antagonist","target":"head and neck cancer","id":"11152"},{"source":"B7-H3 antagonist","target":"lung neoplasms","id":"11153"},{"source":"B7-H3 antagonist","target":"carcinoma","id":"11154"},{"source":"B7-H3 antagonist","target":"pancreatic neoplasms","id":"11155"},{"source":"B7-H3 antagonist","target":"colorectal neoplasms","id":"11156"},{"source":"B7-H3 antagonist","target":"thyroid cancer","id":"11157"},{"source":"B7-H3 antagonist","target":"carcinoma","id":"11158"},{"source":"B7-H3 antagonist","target":"anti-tumor","id":"11159"},{"source":"B7-H3 antagonist","target":"peritoneal mesothelioma","id":"11160"},{"source":"B7-H3 antagonist","target":"anticancer","id":"11161"},{"source":"B7-H3 antagonist","target":"urinary bladder neoplasms","id":"11162"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"11163"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"11164"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"11165"},{"source":"Oncology: Bladder","target":"B7-H3 antagonist","id":"11166"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"11167"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"11168"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"11169"},{"source":"Oncology: Breast","target":"B7-H3 antagonist","id":"11170"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"11171"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"11172"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"11173"},{"source":"Oncology: Colorectal","target":"B7-H3 antagonist","id":"11174"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"11175"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"11176"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"11177"},{"source":"Oncology: Head/Neck","target":"B7-H3 antagonist","id":"11178"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"11179"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"11180"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"11181"},{"source":"Oncology: Lung","target":"B7-H3 antagonist","id":"11182"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"11183"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"11184"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"11185"},{"source":"Non-Small Cell","target":"B7-H3 antagonist","id":"11186"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"11187"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"11188"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"11189"},{"source":"Oncology: Melanoma","target":"B7-H3 antagonist","id":"11190"},{"source":"Oncology: Mesothelioma","target":"Anticancer immunotherapy","id":"11191"},{"source":"Oncology: Mesothelioma","target":"CD19 antagonist","id":"11192"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint inhibitor","id":"11193"},{"source":"Oncology: Mesothelioma","target":"B7-H3 antagonist","id":"11194"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"11195"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"11196"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"11197"},{"source":"Oncology: Ovarian","target":"B7-H3 antagonist","id":"11198"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"11199"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"11200"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"11201"},{"source":"Oncology: Pancreas","target":"B7-H3 antagonist","id":"11202"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"11203"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"11204"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"11205"},{"source":"Oncology: Prostate","target":"B7-H3 antagonist","id":"11206"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"11207"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"11208"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"11209"},{"source":"Oncology: Renal","target":"B7-H3 antagonist","id":"11210"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"11211"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"11212"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"11213"},{"source":"Oncology: Soft Tissue Sarcoma","target":"B7-H3 antagonist","id":"11214"},{"source":"Oncology: Thyroid","target":"Anticancer immunotherapy","id":"11215"},{"source":"Oncology: Thyroid","target":"CD19 antagonist","id":"11216"},{"source":"Oncology: Thyroid","target":"Immune checkpoint inhibitor","id":"11217"},{"source":"Oncology: Thyroid","target":"B7-H3 antagonist","id":"11218"},{"source":"pembrolizumab","target":"Merck & Co.","id":"11219"},{"source":"UNK : Drug","target":"Merck & Co.","id":"11220"},{"source":"metastatic","target":"pembrolizumab","id":"11221"},{"source":"metastatic","target":"UNK : Drug","id":"11222"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"11223"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"11224"},{"source":"brain metastases","target":"pembrolizumab","id":"11225"},{"source":"brain metastases","target":"UNK : Drug","id":"11226"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"11227"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"11228"},{"source":"residual tumor","target":"pembrolizumab","id":"11229"},{"source":"residual tumor","target":"UNK : Drug","id":"11230"},{"source":"anticancer","target":"pembrolizumab","id":"11231"},{"source":"anticancer","target":"UNK : Drug","id":"11232"},{"source":"residual tumor","target":"pembrolizumab","id":"11233"},{"source":"residual tumor","target":"UNK : Drug","id":"11234"},{"source":"breast neoplasms","target":"pembrolizumab","id":"11235"},{"source":"breast neoplasms","target":"UNK : Drug","id":"11236"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"11237"},{"source":"cerebellar neoplasms","target":"UNK : Drug","id":"11238"},{"source":"carcinoma","target":"pembrolizumab","id":"11239"},{"source":"carcinoma","target":"UNK : Drug","id":"11240"},{"source":"metastatic","target":"pembrolizumab","id":"11241"},{"source":"metastatic","target":"UNK : Drug","id":"11242"},{"source":"breast neoplasms","target":"pembrolizumab","id":"11243"},{"source":"breast neoplasms","target":"UNK : Drug","id":"11244"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"11245"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"11246"},{"source":"anticancer","target":"pembrolizumab","id":"11247"},{"source":"anticancer","target":"UNK : Drug","id":"11248"},{"source":"tnbc","target":"pembrolizumab","id":"11249"},{"source":"tnbc","target":"UNK : Drug","id":"11250"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"11251"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"11252"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"11253"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"11254"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"11255"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"11256"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"11257"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"11258"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"11259"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"11260"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"11261"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11262"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"11263"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"11264"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"11265"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"11266"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"11267"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"11268"},{"source":"CD19 antagonist","target":"metastatic","id":"11269"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"11270"},{"source":"CD19 antagonist","target":"brain metastases","id":"11271"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"11272"},{"source":"CD19 antagonist","target":"residual tumor","id":"11273"},{"source":"CD19 antagonist","target":"anticancer","id":"11274"},{"source":"CD19 antagonist","target":"residual tumor","id":"11275"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"11276"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"11277"},{"source":"CD19 antagonist","target":"carcinoma","id":"11278"},{"source":"CD19 antagonist","target":"metastatic","id":"11279"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"11280"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"11281"},{"source":"CD19 antagonist","target":"anticancer","id":"11282"},{"source":"CD19 antagonist","target":"tnbc","id":"11283"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"11284"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"11285"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"11286"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"11287"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"11288"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"11289"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11290"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"11291"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"11292"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"11293"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11294"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"11295"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"11296"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"11297"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11298"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"11299"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"11300"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"11301"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"11302"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"11303"},{"source":"SD-101 (intratumoral) (u)","target":"Dynavax Technologies","id":"11304"},{"source":"SD-101 (intratumoral) (u)","target":"Merck & Co.","id":"11305"},{"source":"pembrolizumab","target":"Dynavax Technologies","id":"11306"},{"source":"pembrolizumab","target":"Merck & Co.","id":"11307"},{"source":"carcinoma","target":"SD-101 (intratumoral) (u)","id":"11308"},{"source":"carcinoma","target":"pembrolizumab","id":"11309"},{"source":"UNK : Indication","target":"SD-101 (intratumoral) (u)","id":"11310"},{"source":"UNK : Indication","target":"pembrolizumab","id":"11311"},{"source":"squamous cell neoplasms","target":"SD-101 (intratumoral) (u)","id":"11312"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"11313"},{"source":"melanoma","target":"SD-101 (intratumoral) (u)","id":"11314"},{"source":"melanoma","target":"pembrolizumab","id":"11315"},{"source":"melanoma","target":"SD-101 (intratumoral) (u)","id":"11316"},{"source":"melanoma","target":"pembrolizumab","id":"11317"},{"source":"skin neoplasms","target":"SD-101 (intratumoral) (u)","id":"11318"},{"source":"skin neoplasms","target":"pembrolizumab","id":"11319"},{"source":"carcinoma","target":"SD-101 (intratumoral) (u)","id":"11320"},{"source":"carcinoma","target":"pembrolizumab","id":"11321"},{"source":"squamous cell neoplasms","target":"SD-101 (intratumoral) (u)","id":"11322"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"11323"},{"source":"metastatic","target":"SD-101 (intratumoral) (u)","id":"11324"},{"source":"metastatic","target":"pembrolizumab","id":"11325"},{"source":"carcinoma","target":"SD-101 (intratumoral) (u)","id":"11326"},{"source":"carcinoma","target":"pembrolizumab","id":"11327"},{"source":"neoplasm metastasis","target":"SD-101 (intratumoral) (u)","id":"11328"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"11329"},{"source":"anticancer","target":"SD-101 (intratumoral) (u)","id":"11330"},{"source":"anticancer","target":"pembrolizumab","id":"11331"},{"source":"carcinoma","target":"SD-101 (intratumoral) (u)","id":"11332"},{"source":"carcinoma","target":"pembrolizumab","id":"11333"},{"source":"head and neck neoplasms","target":"SD-101 (intratumoral) (u)","id":"11334"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"11335"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11336"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"11337"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"11338"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"11339"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"11340"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"11341"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11342"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"11343"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"11344"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11345"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"11346"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"11347"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11348"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"11349"},{"source":"CD19 antagonist","target":"carcinoma","id":"11350"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"11351"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"11352"},{"source":"CD19 antagonist","target":"melanoma","id":"11353"},{"source":"CD19 antagonist","target":"melanoma","id":"11354"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"11355"},{"source":"CD19 antagonist","target":"carcinoma","id":"11356"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"11357"},{"source":"CD19 antagonist","target":"metastatic","id":"11358"},{"source":"CD19 antagonist","target":"carcinoma","id":"11359"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"11360"},{"source":"CD19 antagonist","target":"anticancer","id":"11361"},{"source":"CD19 antagonist","target":"carcinoma","id":"11362"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"11363"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"11364"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"11365"},{"source":"Toll-like receptor 9 agonist","target":"squamous cell neoplasms","id":"11366"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"11367"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"11368"},{"source":"Toll-like receptor 9 agonist","target":"skin neoplasms","id":"11369"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"11370"},{"source":"Toll-like receptor 9 agonist","target":"squamous cell neoplasms","id":"11371"},{"source":"Toll-like receptor 9 agonist","target":"metastatic","id":"11372"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"11373"},{"source":"Toll-like receptor 9 agonist","target":"neoplasm metastasis","id":"11374"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"11375"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"11376"},{"source":"Toll-like receptor 9 agonist","target":"head and neck neoplasms","id":"11377"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11378"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"11379"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"11380"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"11381"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"11382"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"11383"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11384"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"11385"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"11386"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11387"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"11388"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11389"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11390"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"11391"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"11392"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"11393"},{"source":"Oncology: Head/Neck","target":"Toll-like receptor 9 agonist","id":"11394"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"11395"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"11396"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"11397"},{"source":"Oncology: Melanoma","target":"Toll-like receptor 9 agonist","id":"11398"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"11399"},{"source":"pembrolizumab","target":"MD Anderson Cancer Center","id":"11400"},{"source":"pembrolizumab","target":"University of Texas","id":"11401"},{"source":"pembrolizumab","target":"Merck & Co.","id":"11402"},{"source":"radiation therapy","target":"MD Anderson Cancer Center","id":"11403"},{"source":"radiation therapy","target":"University of Texas","id":"11404"},{"source":"radiation therapy","target":"Merck & Co.","id":"11405"},{"source":"radiosurgery","target":"MD Anderson Cancer Center","id":"11406"},{"source":"radiosurgery","target":"University of Texas","id":"11407"},{"source":"radiosurgery","target":"Merck & Co.","id":"11408"},{"source":"UNK : Indication","target":"pembrolizumab","id":"11409"},{"source":"UNK : Indication","target":"radiation therapy","id":"11410"},{"source":"UNK : Indication","target":"radiosurgery","id":"11411"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"11412"},{"source":"ovarian neoplasms","target":"radiation therapy","id":"11413"},{"source":"ovarian neoplasms","target":"radiosurgery","id":"11414"},{"source":"brain metastases","target":"pembrolizumab","id":"11415"},{"source":"brain metastases","target":"radiation therapy","id":"11416"},{"source":"brain metastases","target":"radiosurgery","id":"11417"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"11418"},{"source":"non-small-cell lung","target":"radiation therapy","id":"11419"},{"source":"non-small-cell lung","target":"radiosurgery","id":"11420"},{"source":"neurologic symptoms","target":"pembrolizumab","id":"11421"},{"source":"neurologic symptoms","target":"radiation therapy","id":"11422"},{"source":"neurologic symptoms","target":"radiosurgery","id":"11423"},{"source":"sclc","target":"pembrolizumab","id":"11424"},{"source":"sclc","target":"radiation therapy","id":"11425"},{"source":"sclc","target":"radiosurgery","id":"11426"},{"source":"neurologic manifestations","target":"pembrolizumab","id":"11427"},{"source":"neurologic manifestations","target":"radiation therapy","id":"11428"},{"source":"neurologic manifestations","target":"radiosurgery","id":"11429"},{"source":"carcinoma","target":"pembrolizumab","id":"11430"},{"source":"carcinoma","target":"radiation therapy","id":"11431"},{"source":"carcinoma","target":"radiosurgery","id":"11432"},{"source":"liver metastases","target":"pembrolizumab","id":"11433"},{"source":"liver metastases","target":"radiation therapy","id":"11434"},{"source":"liver metastases","target":"radiosurgery","id":"11435"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"11436"},{"source":"cerebellar neoplasms","target":"radiation therapy","id":"11437"},{"source":"cerebellar neoplasms","target":"radiosurgery","id":"11438"},{"source":"carcinoma","target":"pembrolizumab","id":"11439"},{"source":"carcinoma","target":"radiation therapy","id":"11440"},{"source":"carcinoma","target":"radiosurgery","id":"11441"},{"source":"metastatic","target":"pembrolizumab","id":"11442"},{"source":"metastatic","target":"radiation therapy","id":"11443"},{"source":"metastatic","target":"radiosurgery","id":"11444"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"11445"},{"source":"non-small-cell lung","target":"radiation therapy","id":"11446"},{"source":"non-small-cell lung","target":"radiosurgery","id":"11447"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"11448"},{"source":"neoplasm metastasis","target":"radiation therapy","id":"11449"},{"source":"neoplasm metastasis","target":"radiosurgery","id":"11450"},{"source":"anticancer","target":"pembrolizumab","id":"11451"},{"source":"anticancer","target":"radiation therapy","id":"11452"},{"source":"anticancer","target":"radiosurgery","id":"11453"},{"source":"lung cancer","target":"pembrolizumab","id":"11454"},{"source":"lung cancer","target":"radiation therapy","id":"11455"},{"source":"lung cancer","target":"radiosurgery","id":"11456"},{"source":"lung neoplasms","target":"pembrolizumab","id":"11457"},{"source":"lung neoplasms","target":"radiation therapy","id":"11458"},{"source":"lung neoplasms","target":"radiosurgery","id":"11459"},{"source":"liver neoplasms","target":"pembrolizumab","id":"11460"},{"source":"liver neoplasms","target":"radiation therapy","id":"11461"},{"source":"liver neoplasms","target":"radiosurgery","id":"11462"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"11463"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"11464"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"11465"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"11466"},{"source":"Anticancer immunotherapy","target":"neurologic symptoms","id":"11467"},{"source":"Anticancer immunotherapy","target":"sclc","id":"11468"},{"source":"Anticancer immunotherapy","target":"neurologic manifestations","id":"11469"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11470"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"11471"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"11472"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11473"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"11474"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"11475"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"11476"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"11477"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"11478"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"11479"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"11480"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"11481"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"11482"},{"source":"CD19 antagonist","target":"brain metastases","id":"11483"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"11484"},{"source":"CD19 antagonist","target":"neurologic symptoms","id":"11485"},{"source":"CD19 antagonist","target":"sclc","id":"11486"},{"source":"CD19 antagonist","target":"neurologic manifestations","id":"11487"},{"source":"CD19 antagonist","target":"carcinoma","id":"11488"},{"source":"CD19 antagonist","target":"liver metastases","id":"11489"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"11490"},{"source":"CD19 antagonist","target":"carcinoma","id":"11491"},{"source":"CD19 antagonist","target":"metastatic","id":"11492"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"11493"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"11494"},{"source":"CD19 antagonist","target":"anticancer","id":"11495"},{"source":"CD19 antagonist","target":"lung cancer","id":"11496"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"11497"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"11498"},{"source":"NA","target":"UNK : Indication","id":"11499"},{"source":"NA","target":"ovarian neoplasms","id":"11500"},{"source":"NA","target":"brain metastases","id":"11501"},{"source":"NA","target":"non-small-cell lung","id":"11502"},{"source":"NA","target":"neurologic symptoms","id":"11503"},{"source":"NA","target":"sclc","id":"11504"},{"source":"NA","target":"neurologic manifestations","id":"11505"},{"source":"NA","target":"carcinoma","id":"11506"},{"source":"NA","target":"liver metastases","id":"11507"},{"source":"NA","target":"cerebellar neoplasms","id":"11508"},{"source":"NA","target":"carcinoma","id":"11509"},{"source":"NA","target":"metastatic","id":"11510"},{"source":"NA","target":"non-small-cell lung","id":"11511"},{"source":"NA","target":"neoplasm metastasis","id":"11512"},{"source":"NA","target":"anticancer","id":"11513"},{"source":"NA","target":"lung cancer","id":"11514"},{"source":"NA","target":"lung neoplasms","id":"11515"},{"source":"NA","target":"liver neoplasms","id":"11516"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"11517"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"11518"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"11519"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"11520"},{"source":"Immune checkpoint inhibitor","target":"neurologic symptoms","id":"11521"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"11522"},{"source":"Immune checkpoint inhibitor","target":"neurologic manifestations","id":"11523"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11524"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"11525"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"11526"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11527"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"11528"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"11529"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"11530"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11531"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"11532"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"11533"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"11534"},{"source":"UPA","target":"UNK : Indication","id":"11535"},{"source":"UPA","target":"ovarian neoplasms","id":"11536"},{"source":"UPA","target":"brain metastases","id":"11537"},{"source":"UPA","target":"non-small-cell lung","id":"11538"},{"source":"UPA","target":"neurologic symptoms","id":"11539"},{"source":"UPA","target":"sclc","id":"11540"},{"source":"UPA","target":"neurologic manifestations","id":"11541"},{"source":"UPA","target":"carcinoma","id":"11542"},{"source":"UPA","target":"liver metastases","id":"11543"},{"source":"UPA","target":"cerebellar neoplasms","id":"11544"},{"source":"UPA","target":"carcinoma","id":"11545"},{"source":"UPA","target":"metastatic","id":"11546"},{"source":"UPA","target":"non-small-cell lung","id":"11547"},{"source":"UPA","target":"neoplasm metastasis","id":"11548"},{"source":"UPA","target":"anticancer","id":"11549"},{"source":"UPA","target":"lung cancer","id":"11550"},{"source":"UPA","target":"lung neoplasms","id":"11551"},{"source":"UPA","target":"liver neoplasms","id":"11552"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"11553"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"11554"},{"source":"Oncology: Lung","target":"NA","id":"11555"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"11556"},{"source":"Oncology: Lung","target":"UPA","id":"11557"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"11558"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"11559"},{"source":"Non-Small Cell","target":"NA","id":"11560"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"11561"},{"source":"Non-Small Cell","target":"UPA","id":"11562"},{"source":"GSK-3359609 (u)","target":"GlaxoSmithKline","id":"11563"},{"source":"GSK-3359609 (u)","target":"Institut National de la Sante et de la Recherche Medicale (INSERM)","id":"11564"},{"source":"GSK-3359609 (u)","target":"Merck & Co.","id":"11565"},{"source":"pembrolizumab","target":"GlaxoSmithKline","id":"11566"},{"source":"pembrolizumab","target":"Institut National de la Sante et de la Recherche Medicale (INSERM)","id":"11567"},{"source":"pembrolizumab","target":"Merck & Co.","id":"11568"},{"source":"UNK : Indication","target":"GSK-3359609 (u)","id":"11569"},{"source":"UNK : Indication","target":"pembrolizumab","id":"11570"},{"source":"colorectal neoplasms","target":"GSK-3359609 (u)","id":"11571"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"11572"},{"source":"hematologic neoplasms","target":"GSK-3359609 (u)","id":"11573"},{"source":"hematologic neoplasms","target":"pembrolizumab","id":"11574"},{"source":"basal cell neoplasms","target":"GSK-3359609 (u)","id":"11575"},{"source":"basal cell neoplasms","target":"pembrolizumab","id":"11576"},{"source":"castration-resistant prostatic neoplasms","target":"GSK-3359609 (u)","id":"11577"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"11578"},{"source":"skin neoplasms","target":"GSK-3359609 (u)","id":"11579"},{"source":"skin neoplasms","target":"pembrolizumab","id":"11580"},{"source":"epstein-barr","target":"GSK-3359609 (u)","id":"11581"},{"source":"epstein-barr","target":"pembrolizumab","id":"11582"},{"source":"infectious mononucleosis","target":"GSK-3359609 (u)","id":"11583"},{"source":"infectious mononucleosis","target":"pembrolizumab","id":"11584"},{"source":"carcinoma","target":"GSK-3359609 (u)","id":"11585"},{"source":"carcinoma","target":"pembrolizumab","id":"11586"},{"source":"papilloma","target":"GSK-3359609 (u)","id":"11587"},{"source":"papilloma","target":"pembrolizumab","id":"11588"},{"source":"head and neck neoplasms","target":"GSK-3359609 (u)","id":"11589"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"11590"},{"source":"non-small-cell lung","target":"GSK-3359609 (u)","id":"11591"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"11592"},{"source":"melanoma","target":"GSK-3359609 (u)","id":"11593"},{"source":"melanoma","target":"pembrolizumab","id":"11594"},{"source":"bladder cancer","target":"GSK-3359609 (u)","id":"11595"},{"source":"bladder cancer","target":"pembrolizumab","id":"11596"},{"source":"hpv type","target":"GSK-3359609 (u)","id":"11597"},{"source":"hpv type","target":"pembrolizumab","id":"11598"},{"source":"microsatellite instability","target":"GSK-3359609 (u)","id":"11599"},{"source":"microsatellite instability","target":"pembrolizumab","id":"11600"},{"source":"colonic neoplasms","target":"GSK-3359609 (u)","id":"11601"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"11602"},{"source":"esophageal cancer","target":"GSK-3359609 (u)","id":"11603"},{"source":"esophageal cancer","target":"pembrolizumab","id":"11604"},{"source":"sclc","target":"GSK-3359609 (u)","id":"11605"},{"source":"sclc","target":"pembrolizumab","id":"11606"},{"source":"papilloma","target":"GSK-3359609 (u)","id":"11607"},{"source":"papilloma","target":"pembrolizumab","id":"11608"},{"source":"non-small-cell lung","target":"GSK-3359609 (u)","id":"11609"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"11610"},{"source":"pharyngeal neoplasms","target":"GSK-3359609 (u)","id":"11611"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"11612"},{"source":"mesothelial","target":"GSK-3359609 (u)","id":"11613"},{"source":"mesothelial","target":"pembrolizumab","id":"11614"},{"source":"carcinoma","target":"GSK-3359609 (u)","id":"11615"},{"source":"carcinoma","target":"pembrolizumab","id":"11616"},{"source":"mesothelial","target":"GSK-3359609 (u)","id":"11617"},{"source":"mesothelial","target":"pembrolizumab","id":"11618"},{"source":"anti-tumor","target":"GSK-3359609 (u)","id":"11619"},{"source":"anti-tumor","target":"pembrolizumab","id":"11620"},{"source":"carcinoma","target":"GSK-3359609 (u)","id":"11621"},{"source":"carcinoma","target":"pembrolizumab","id":"11622"},{"source":"solid tumors","target":"GSK-3359609 (u)","id":"11623"},{"source":"solid tumors","target":"pembrolizumab","id":"11624"},{"source":"carcinoma","target":"GSK-3359609 (u)","id":"11625"},{"source":"carcinoma","target":"pembrolizumab","id":"11626"},{"source":"neoplasm metastasis","target":"GSK-3359609 (u)","id":"11627"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"11628"},{"source":"head and neck cancer","target":"GSK-3359609 (u)","id":"11629"},{"source":"head and neck cancer","target":"pembrolizumab","id":"11630"},{"source":"colorectal neoplasms","target":"GSK-3359609 (u)","id":"11631"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"11632"},{"source":"bundle branch block","target":"GSK-3359609 (u)","id":"11633"},{"source":"bundle branch block","target":"pembrolizumab","id":"11634"},{"source":"pleural mesothelioma","target":"GSK-3359609 (u)","id":"11635"},{"source":"pleural mesothelioma","target":"pembrolizumab","id":"11636"},{"source":"solid malignancy","target":"GSK-3359609 (u)","id":"11637"},{"source":"solid malignancy","target":"pembrolizumab","id":"11638"},{"source":"bundle branch block","target":"GSK-3359609 (u)","id":"11639"},{"source":"bundle branch block","target":"pembrolizumab","id":"11640"},{"source":"skin neoplasms","target":"GSK-3359609 (u)","id":"11641"},{"source":"skin neoplasms","target":"pembrolizumab","id":"11642"},{"source":"residual tumor","target":"GSK-3359609 (u)","id":"11643"},{"source":"residual tumor","target":"pembrolizumab","id":"11644"},{"source":"mesothelial","target":"GSK-3359609 (u)","id":"11645"},{"source":"mesothelial","target":"pembrolizumab","id":"11646"},{"source":"metastatic","target":"GSK-3359609 (u)","id":"11647"},{"source":"metastatic","target":"pembrolizumab","id":"11648"},{"source":"anticancer","target":"GSK-3359609 (u)","id":"11649"},{"source":"anticancer","target":"pembrolizumab","id":"11650"},{"source":"basal cell neoplasms","target":"GSK-3359609 (u)","id":"11651"},{"source":"basal cell neoplasms","target":"pembrolizumab","id":"11652"},{"source":"anticancer","target":"GSK-3359609 (u)","id":"11653"},{"source":"anticancer","target":"pembrolizumab","id":"11654"},{"source":"urinary bladder neoplasms","target":"GSK-3359609 (u)","id":"11655"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"11656"},{"source":"solid tumors","target":"GSK-3359609 (u)","id":"11657"},{"source":"solid tumors","target":"pembrolizumab","id":"11658"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"11659"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"11660"},{"source":"Anticancer immunotherapy","target":"hematologic neoplasms","id":"11661"},{"source":"Anticancer immunotherapy","target":"basal cell neoplasms","id":"11662"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"11663"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"11664"},{"source":"Anticancer immunotherapy","target":"epstein-barr","id":"11665"},{"source":"Anticancer immunotherapy","target":"infectious mononucleosis","id":"11666"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11667"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"11668"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"11669"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"11670"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"11671"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"11672"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"11673"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"11674"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"11675"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"11676"},{"source":"Anticancer immunotherapy","target":"sclc","id":"11677"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"11678"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"11679"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"11680"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"11681"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11682"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"11683"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"11684"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11685"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"11686"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"11687"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"11688"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"11689"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"11690"},{"source":"Anticancer immunotherapy","target":"bundle branch block","id":"11691"},{"source":"Anticancer immunotherapy","target":"pleural mesothelioma","id":"11692"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"11693"},{"source":"Anticancer immunotherapy","target":"bundle branch block","id":"11694"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"11695"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"11696"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"11697"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"11698"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"11699"},{"source":"Anticancer immunotherapy","target":"basal cell neoplasms","id":"11700"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"11701"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"11702"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"11703"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"11704"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"11705"},{"source":"CD19 antagonist","target":"hematologic neoplasms","id":"11706"},{"source":"CD19 antagonist","target":"basal cell neoplasms","id":"11707"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"11708"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"11709"},{"source":"CD19 antagonist","target":"epstein-barr","id":"11710"},{"source":"CD19 antagonist","target":"infectious mononucleosis","id":"11711"},{"source":"CD19 antagonist","target":"carcinoma","id":"11712"},{"source":"CD19 antagonist","target":"papilloma","id":"11713"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"11714"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"11715"},{"source":"CD19 antagonist","target":"melanoma","id":"11716"},{"source":"CD19 antagonist","target":"bladder cancer","id":"11717"},{"source":"CD19 antagonist","target":"hpv type","id":"11718"},{"source":"CD19 antagonist","target":"microsatellite instability","id":"11719"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"11720"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"11721"},{"source":"CD19 antagonist","target":"sclc","id":"11722"},{"source":"CD19 antagonist","target":"papilloma","id":"11723"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"11724"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"11725"},{"source":"CD19 antagonist","target":"mesothelial","id":"11726"},{"source":"CD19 antagonist","target":"carcinoma","id":"11727"},{"source":"CD19 antagonist","target":"mesothelial","id":"11728"},{"source":"CD19 antagonist","target":"anti-tumor","id":"11729"},{"source":"CD19 antagonist","target":"carcinoma","id":"11730"},{"source":"CD19 antagonist","target":"solid tumors","id":"11731"},{"source":"CD19 antagonist","target":"carcinoma","id":"11732"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"11733"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"11734"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"11735"},{"source":"CD19 antagonist","target":"bundle branch block","id":"11736"},{"source":"CD19 antagonist","target":"pleural mesothelioma","id":"11737"},{"source":"CD19 antagonist","target":"solid malignancy","id":"11738"},{"source":"CD19 antagonist","target":"bundle branch block","id":"11739"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"11740"},{"source":"CD19 antagonist","target":"residual tumor","id":"11741"},{"source":"CD19 antagonist","target":"mesothelial","id":"11742"},{"source":"CD19 antagonist","target":"metastatic","id":"11743"},{"source":"CD19 antagonist","target":"anticancer","id":"11744"},{"source":"CD19 antagonist","target":"basal cell neoplasms","id":"11745"},{"source":"CD19 antagonist","target":"anticancer","id":"11746"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"11747"},{"source":"CD19 antagonist","target":"solid tumors","id":"11748"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"11749"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"11750"},{"source":"Immune checkpoint inhibitor","target":"hematologic neoplasms","id":"11751"},{"source":"Immune checkpoint inhibitor","target":"basal cell neoplasms","id":"11752"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"11753"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"11754"},{"source":"Immune checkpoint inhibitor","target":"epstein-barr","id":"11755"},{"source":"Immune checkpoint inhibitor","target":"infectious mononucleosis","id":"11756"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11757"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"11758"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"11759"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"11760"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"11761"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"11762"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"11763"},{"source":"Immune checkpoint inhibitor","target":"microsatellite instability","id":"11764"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"11765"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"11766"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"11767"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"11768"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"11769"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"11770"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"11771"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11772"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"11773"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"11774"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11775"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"11776"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"11777"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"11778"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"11779"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"11780"},{"source":"Immune checkpoint inhibitor","target":"bundle branch block","id":"11781"},{"source":"Immune checkpoint inhibitor","target":"pleural mesothelioma","id":"11782"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"11783"},{"source":"Immune checkpoint inhibitor","target":"bundle branch block","id":"11784"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"11785"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"11786"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"11787"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"11788"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11789"},{"source":"Immune checkpoint inhibitor","target":"basal cell neoplasms","id":"11790"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"11791"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"11792"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"11793"},{"source":"Inducible T-cell costimulator agonist","target":"UNK : Indication","id":"11794"},{"source":"Inducible T-cell costimulator agonist","target":"colorectal neoplasms","id":"11795"},{"source":"Inducible T-cell costimulator agonist","target":"hematologic neoplasms","id":"11796"},{"source":"Inducible T-cell costimulator agonist","target":"basal cell neoplasms","id":"11797"},{"source":"Inducible T-cell costimulator agonist","target":"castration-resistant prostatic neoplasms","id":"11798"},{"source":"Inducible T-cell costimulator agonist","target":"skin neoplasms","id":"11799"},{"source":"Inducible T-cell costimulator agonist","target":"epstein-barr","id":"11800"},{"source":"Inducible T-cell costimulator agonist","target":"infectious mononucleosis","id":"11801"},{"source":"Inducible T-cell costimulator agonist","target":"carcinoma","id":"11802"},{"source":"Inducible T-cell costimulator agonist","target":"papilloma","id":"11803"},{"source":"Inducible T-cell costimulator agonist","target":"head and neck neoplasms","id":"11804"},{"source":"Inducible T-cell costimulator agonist","target":"non-small-cell lung","id":"11805"},{"source":"Inducible T-cell costimulator agonist","target":"melanoma","id":"11806"},{"source":"Inducible T-cell costimulator agonist","target":"bladder cancer","id":"11807"},{"source":"Inducible T-cell costimulator agonist","target":"hpv type","id":"11808"},{"source":"Inducible T-cell costimulator agonist","target":"microsatellite instability","id":"11809"},{"source":"Inducible T-cell costimulator agonist","target":"colonic neoplasms","id":"11810"},{"source":"Inducible T-cell costimulator agonist","target":"esophageal cancer","id":"11811"},{"source":"Inducible T-cell costimulator agonist","target":"sclc","id":"11812"},{"source":"Inducible T-cell costimulator agonist","target":"papilloma","id":"11813"},{"source":"Inducible T-cell costimulator agonist","target":"non-small-cell lung","id":"11814"},{"source":"Inducible T-cell costimulator agonist","target":"pharyngeal neoplasms","id":"11815"},{"source":"Inducible T-cell costimulator agonist","target":"mesothelial","id":"11816"},{"source":"Inducible T-cell costimulator agonist","target":"carcinoma","id":"11817"},{"source":"Inducible T-cell costimulator agonist","target":"mesothelial","id":"11818"},{"source":"Inducible T-cell costimulator agonist","target":"anti-tumor","id":"11819"},{"source":"Inducible T-cell costimulator agonist","target":"carcinoma","id":"11820"},{"source":"Inducible T-cell costimulator agonist","target":"solid tumors","id":"11821"},{"source":"Inducible T-cell costimulator agonist","target":"carcinoma","id":"11822"},{"source":"Inducible T-cell costimulator agonist","target":"neoplasm metastasis","id":"11823"},{"source":"Inducible T-cell costimulator agonist","target":"head and neck cancer","id":"11824"},{"source":"Inducible T-cell costimulator agonist","target":"colorectal neoplasms","id":"11825"},{"source":"Inducible T-cell costimulator agonist","target":"bundle branch block","id":"11826"},{"source":"Inducible T-cell costimulator agonist","target":"pleural mesothelioma","id":"11827"},{"source":"Inducible T-cell costimulator agonist","target":"solid malignancy","id":"11828"},{"source":"Inducible T-cell costimulator agonist","target":"bundle branch block","id":"11829"},{"source":"Inducible T-cell costimulator agonist","target":"skin neoplasms","id":"11830"},{"source":"Inducible T-cell costimulator agonist","target":"residual tumor","id":"11831"},{"source":"Inducible T-cell costimulator agonist","target":"mesothelial","id":"11832"},{"source":"Inducible T-cell costimulator agonist","target":"metastatic","id":"11833"},{"source":"Inducible T-cell costimulator agonist","target":"anticancer","id":"11834"},{"source":"Inducible T-cell costimulator agonist","target":"basal cell neoplasms","id":"11835"},{"source":"Inducible T-cell costimulator agonist","target":"anticancer","id":"11836"},{"source":"Inducible T-cell costimulator agonist","target":"urinary bladder neoplasms","id":"11837"},{"source":"Inducible T-cell costimulator agonist","target":"solid tumors","id":"11838"},{"source":"Immune checkpoint stimulant","target":"UNK : Indication","id":"11839"},{"source":"Immune checkpoint stimulant","target":"colorectal neoplasms","id":"11840"},{"source":"Immune checkpoint stimulant","target":"hematologic neoplasms","id":"11841"},{"source":"Immune checkpoint stimulant","target":"basal cell neoplasms","id":"11842"},{"source":"Immune checkpoint stimulant","target":"castration-resistant prostatic neoplasms","id":"11843"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"11844"},{"source":"Immune checkpoint stimulant","target":"epstein-barr","id":"11845"},{"source":"Immune checkpoint stimulant","target":"infectious mononucleosis","id":"11846"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"11847"},{"source":"Immune checkpoint stimulant","target":"papilloma","id":"11848"},{"source":"Immune checkpoint stimulant","target":"head and neck neoplasms","id":"11849"},{"source":"Immune checkpoint stimulant","target":"non-small-cell lung","id":"11850"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"11851"},{"source":"Immune checkpoint stimulant","target":"bladder cancer","id":"11852"},{"source":"Immune checkpoint stimulant","target":"hpv type","id":"11853"},{"source":"Immune checkpoint stimulant","target":"microsatellite instability","id":"11854"},{"source":"Immune checkpoint stimulant","target":"colonic neoplasms","id":"11855"},{"source":"Immune checkpoint stimulant","target":"esophageal cancer","id":"11856"},{"source":"Immune checkpoint stimulant","target":"sclc","id":"11857"},{"source":"Immune checkpoint stimulant","target":"papilloma","id":"11858"},{"source":"Immune checkpoint stimulant","target":"non-small-cell lung","id":"11859"},{"source":"Immune checkpoint stimulant","target":"pharyngeal neoplasms","id":"11860"},{"source":"Immune checkpoint stimulant","target":"mesothelial","id":"11861"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"11862"},{"source":"Immune checkpoint stimulant","target":"mesothelial","id":"11863"},{"source":"Immune checkpoint stimulant","target":"anti-tumor","id":"11864"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"11865"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"11866"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"11867"},{"source":"Immune checkpoint stimulant","target":"neoplasm metastasis","id":"11868"},{"source":"Immune checkpoint stimulant","target":"head and neck cancer","id":"11869"},{"source":"Immune checkpoint stimulant","target":"colorectal neoplasms","id":"11870"},{"source":"Immune checkpoint stimulant","target":"bundle branch block","id":"11871"},{"source":"Immune checkpoint stimulant","target":"pleural mesothelioma","id":"11872"},{"source":"Immune checkpoint stimulant","target":"solid malignancy","id":"11873"},{"source":"Immune checkpoint stimulant","target":"bundle branch block","id":"11874"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"11875"},{"source":"Immune checkpoint stimulant","target":"residual tumor","id":"11876"},{"source":"Immune checkpoint stimulant","target":"mesothelial","id":"11877"},{"source":"Immune checkpoint stimulant","target":"metastatic","id":"11878"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"11879"},{"source":"Immune checkpoint stimulant","target":"basal cell neoplasms","id":"11880"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"11881"},{"source":"Immune checkpoint stimulant","target":"urinary bladder neoplasms","id":"11882"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"11883"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"11884"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"11885"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"11886"},{"source":"Oncology: Bladder","target":"Inducible T-cell costimulator agonist","id":"11887"},{"source":"Oncology: Bladder","target":"Immune checkpoint stimulant","id":"11888"},{"source":"Oncology: Cervical","target":"Anticancer immunotherapy","id":"11889"},{"source":"Oncology: Cervical","target":"CD19 antagonist","id":"11890"},{"source":"Oncology: Cervical","target":"Immune checkpoint inhibitor","id":"11891"},{"source":"Oncology: Cervical","target":"Inducible T-cell costimulator agonist","id":"11892"},{"source":"Oncology: Cervical","target":"Immune checkpoint stimulant","id":"11893"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"11894"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"11895"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"11896"},{"source":"Oncology: Colorectal","target":"Inducible T-cell costimulator agonist","id":"11897"},{"source":"Oncology: Colorectal","target":"Immune checkpoint stimulant","id":"11898"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"11899"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"11900"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"11901"},{"source":"Oncology: Esophageal","target":"Inducible T-cell costimulator agonist","id":"11902"},{"source":"Oncology: Esophageal","target":"Immune checkpoint stimulant","id":"11903"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"11904"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"11905"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"11906"},{"source":"Oncology: Head/Neck","target":"Inducible T-cell costimulator agonist","id":"11907"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint stimulant","id":"11908"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"11909"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"11910"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"11911"},{"source":"Oncology: Lung","target":"Inducible T-cell costimulator agonist","id":"11912"},{"source":"Oncology: Lung","target":"Immune checkpoint stimulant","id":"11913"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"11914"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"11915"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"11916"},{"source":"Non-Small Cell","target":"Inducible T-cell costimulator agonist","id":"11917"},{"source":"Non-Small Cell","target":"Immune checkpoint stimulant","id":"11918"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"11919"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"11920"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"11921"},{"source":"Oncology: Melanoma","target":"Inducible T-cell costimulator agonist","id":"11922"},{"source":"Oncology: Melanoma","target":"Immune checkpoint stimulant","id":"11923"},{"source":"Oncology: Mesothelioma","target":"Anticancer immunotherapy","id":"11924"},{"source":"Oncology: Mesothelioma","target":"CD19 antagonist","id":"11925"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint inhibitor","id":"11926"},{"source":"Oncology: Mesothelioma","target":"Inducible T-cell costimulator agonist","id":"11927"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint stimulant","id":"11928"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"11929"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"11930"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"11931"},{"source":"Oncology: Prostate","target":"Inducible T-cell costimulator agonist","id":"11932"},{"source":"Oncology: Prostate","target":"Immune checkpoint stimulant","id":"11933"},{"source":"Oncology: Skin","target":"Anticancer immunotherapy","id":"11934"},{"source":"Oncology: Skin","target":"CD19 antagonist","id":"11935"},{"source":"Oncology: Skin","target":"Immune checkpoint inhibitor","id":"11936"},{"source":"Oncology: Skin","target":"Inducible T-cell costimulator agonist","id":"11937"},{"source":"Oncology: Skin","target":"Immune checkpoint stimulant","id":"11938"},{"source":"Basal Cell Carcinoma","target":"Anticancer immunotherapy","id":"11939"},{"source":"Basal Cell Carcinoma","target":"CD19 antagonist","id":"11940"},{"source":"Basal Cell Carcinoma","target":"Immune checkpoint inhibitor","id":"11941"},{"source":"Basal Cell Carcinoma","target":"Inducible T-cell costimulator agonist","id":"11942"},{"source":"Basal Cell Carcinoma","target":"Immune checkpoint stimulant","id":"11943"},{"source":"pembrolizumab","target":"Merck & Co.","id":"11944"},{"source":"docetaxel","target":"Merck & Co.","id":"11945"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"11946"},{"source":"vinflunine (iv)","target":"Merck & Co.","id":"11947"},{"source":"UNK : Indication","target":"pembrolizumab","id":"11948"},{"source":"UNK : Indication","target":"docetaxel","id":"11949"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"11950"},{"source":"UNK : Indication","target":"vinflunine (iv)","id":"11951"},{"source":"anticancer","target":"pembrolizumab","id":"11952"},{"source":"anticancer","target":"docetaxel","id":"11953"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"11954"},{"source":"anticancer","target":"vinflunine (iv)","id":"11955"},{"source":"malaria","target":"pembrolizumab","id":"11956"},{"source":"malaria","target":"docetaxel","id":"11957"},{"source":"malaria","target":"nab-paclitaxel (IV)","id":"11958"},{"source":"malaria","target":"vinflunine (iv)","id":"11959"},{"source":"bladder cancer","target":"pembrolizumab","id":"11960"},{"source":"bladder cancer","target":"docetaxel","id":"11961"},{"source":"bladder cancer","target":"nab-paclitaxel (IV)","id":"11962"},{"source":"bladder cancer","target":"vinflunine (iv)","id":"11963"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"11964"},{"source":"kidney neoplasms","target":"docetaxel","id":"11965"},{"source":"kidney neoplasms","target":"nab-paclitaxel (IV)","id":"11966"},{"source":"kidney neoplasms","target":"vinflunine (iv)","id":"11967"},{"source":"renal cancer","target":"pembrolizumab","id":"11968"},{"source":"renal cancer","target":"docetaxel","id":"11969"},{"source":"renal cancer","target":"nab-paclitaxel (IV)","id":"11970"},{"source":"renal cancer","target":"vinflunine (iv)","id":"11971"},{"source":"carcinoma","target":"pembrolizumab","id":"11972"},{"source":"carcinoma","target":"docetaxel","id":"11973"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"11974"},{"source":"carcinoma","target":"vinflunine (iv)","id":"11975"},{"source":"urologic neoplasms","target":"pembrolizumab","id":"11976"},{"source":"urologic neoplasms","target":"docetaxel","id":"11977"},{"source":"urologic neoplasms","target":"nab-paclitaxel (IV)","id":"11978"},{"source":"urologic neoplasms","target":"vinflunine (iv)","id":"11979"},{"source":"cancer of the urinary tract","target":"pembrolizumab","id":"11980"},{"source":"cancer of the urinary tract","target":"docetaxel","id":"11981"},{"source":"cancer of the urinary tract","target":"nab-paclitaxel (IV)","id":"11982"},{"source":"cancer of the urinary tract","target":"vinflunine (iv)","id":"11983"},{"source":"residual tumor","target":"pembrolizumab","id":"11984"},{"source":"residual tumor","target":"docetaxel","id":"11985"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"11986"},{"source":"residual tumor","target":"vinflunine (iv)","id":"11987"},{"source":"malaria","target":"pembrolizumab","id":"11988"},{"source":"malaria","target":"docetaxel","id":"11989"},{"source":"malaria","target":"nab-paclitaxel (IV)","id":"11990"},{"source":"malaria","target":"vinflunine (iv)","id":"11991"},{"source":"carcinoma","target":"pembrolizumab","id":"11992"},{"source":"carcinoma","target":"docetaxel","id":"11993"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"11994"},{"source":"carcinoma","target":"vinflunine (iv)","id":"11995"},{"source":"metastatic","target":"pembrolizumab","id":"11996"},{"source":"metastatic","target":"docetaxel","id":"11997"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"11998"},{"source":"metastatic","target":"vinflunine (iv)","id":"11999"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"12000"},{"source":"neoplasm metastasis","target":"docetaxel","id":"12001"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"12002"},{"source":"neoplasm metastasis","target":"vinflunine (iv)","id":"12003"},{"source":"renal cancer","target":"pembrolizumab","id":"12004"},{"source":"renal cancer","target":"docetaxel","id":"12005"},{"source":"renal cancer","target":"nab-paclitaxel (IV)","id":"12006"},{"source":"renal cancer","target":"vinflunine (iv)","id":"12007"},{"source":"anticancer","target":"pembrolizumab","id":"12008"},{"source":"anticancer","target":"docetaxel","id":"12009"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"12010"},{"source":"anticancer","target":"vinflunine (iv)","id":"12011"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"12012"},{"source":"urinary bladder neoplasms","target":"docetaxel","id":"12013"},{"source":"urinary bladder neoplasms","target":"nab-paclitaxel (IV)","id":"12014"},{"source":"urinary bladder neoplasms","target":"vinflunine (iv)","id":"12015"},{"source":"renal cell","target":"pembrolizumab","id":"12016"},{"source":"renal cell","target":"docetaxel","id":"12017"},{"source":"renal cell","target":"nab-paclitaxel (IV)","id":"12018"},{"source":"renal cell","target":"vinflunine (iv)","id":"12019"},{"source":"Vinca alkaloid","target":"UNK : Indication","id":"12020"},{"source":"Vinca alkaloid","target":"anticancer","id":"12021"},{"source":"Vinca alkaloid","target":"malaria","id":"12022"},{"source":"Vinca alkaloid","target":"bladder cancer","id":"12023"},{"source":"Vinca alkaloid","target":"kidney neoplasms","id":"12024"},{"source":"Vinca alkaloid","target":"renal cancer","id":"12025"},{"source":"Vinca alkaloid","target":"carcinoma","id":"12026"},{"source":"Vinca alkaloid","target":"urologic neoplasms","id":"12027"},{"source":"Vinca alkaloid","target":"cancer of the urinary tract","id":"12028"},{"source":"Vinca alkaloid","target":"residual tumor","id":"12029"},{"source":"Vinca alkaloid","target":"malaria","id":"12030"},{"source":"Vinca alkaloid","target":"carcinoma","id":"12031"},{"source":"Vinca alkaloid","target":"metastatic","id":"12032"},{"source":"Vinca alkaloid","target":"neoplasm metastasis","id":"12033"},{"source":"Vinca alkaloid","target":"renal cancer","id":"12034"},{"source":"Vinca alkaloid","target":"anticancer","id":"12035"},{"source":"Vinca alkaloid","target":"urinary bladder neoplasms","id":"12036"},{"source":"Vinca alkaloid","target":"renal cell","id":"12037"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"12038"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"12039"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"12040"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"12041"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"12042"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"12043"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12044"},{"source":"Immune checkpoint inhibitor","target":"urologic neoplasms","id":"12045"},{"source":"Immune checkpoint inhibitor","target":"cancer of the urinary tract","id":"12046"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"12047"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"12048"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12049"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"12050"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"12051"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"12052"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"12053"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"12054"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"12055"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"12056"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"12057"},{"source":"Anticancer immunotherapy","target":"malaria","id":"12058"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"12059"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"12060"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"12061"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12062"},{"source":"Anticancer immunotherapy","target":"urologic neoplasms","id":"12063"},{"source":"Anticancer immunotherapy","target":"cancer of the urinary tract","id":"12064"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"12065"},{"source":"Anticancer immunotherapy","target":"malaria","id":"12066"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12067"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"12068"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"12069"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"12070"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"12071"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"12072"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"12073"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"12074"},{"source":"CD19 antagonist","target":"anticancer","id":"12075"},{"source":"CD19 antagonist","target":"malaria","id":"12076"},{"source":"CD19 antagonist","target":"bladder cancer","id":"12077"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"12078"},{"source":"CD19 antagonist","target":"renal cancer","id":"12079"},{"source":"CD19 antagonist","target":"carcinoma","id":"12080"},{"source":"CD19 antagonist","target":"urologic neoplasms","id":"12081"},{"source":"CD19 antagonist","target":"cancer of the urinary tract","id":"12082"},{"source":"CD19 antagonist","target":"residual tumor","id":"12083"},{"source":"CD19 antagonist","target":"malaria","id":"12084"},{"source":"CD19 antagonist","target":"carcinoma","id":"12085"},{"source":"CD19 antagonist","target":"metastatic","id":"12086"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"12087"},{"source":"CD19 antagonist","target":"renal cancer","id":"12088"},{"source":"CD19 antagonist","target":"anticancer","id":"12089"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"12090"},{"source":"CD19 antagonist","target":"renal cell","id":"12091"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"12092"},{"source":"Tubulin inhibitor","target":"anticancer","id":"12093"},{"source":"Tubulin inhibitor","target":"malaria","id":"12094"},{"source":"Tubulin inhibitor","target":"bladder cancer","id":"12095"},{"source":"Tubulin inhibitor","target":"kidney neoplasms","id":"12096"},{"source":"Tubulin inhibitor","target":"renal cancer","id":"12097"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"12098"},{"source":"Tubulin inhibitor","target":"urologic neoplasms","id":"12099"},{"source":"Tubulin inhibitor","target":"cancer of the urinary tract","id":"12100"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"12101"},{"source":"Tubulin inhibitor","target":"malaria","id":"12102"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"12103"},{"source":"Tubulin inhibitor","target":"metastatic","id":"12104"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"12105"},{"source":"Tubulin inhibitor","target":"renal cancer","id":"12106"},{"source":"Tubulin inhibitor","target":"anticancer","id":"12107"},{"source":"Tubulin inhibitor","target":"urinary bladder neoplasms","id":"12108"},{"source":"Tubulin inhibitor","target":"renal cell","id":"12109"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"12110"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"12111"},{"source":"Beta tubulin antagonist","target":"malaria","id":"12112"},{"source":"Beta tubulin antagonist","target":"bladder cancer","id":"12113"},{"source":"Beta tubulin antagonist","target":"kidney neoplasms","id":"12114"},{"source":"Beta tubulin antagonist","target":"renal cancer","id":"12115"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"12116"},{"source":"Beta tubulin antagonist","target":"urologic neoplasms","id":"12117"},{"source":"Beta tubulin antagonist","target":"cancer of the urinary tract","id":"12118"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"12119"},{"source":"Beta tubulin antagonist","target":"malaria","id":"12120"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"12121"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"12122"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"12123"},{"source":"Beta tubulin antagonist","target":"renal cancer","id":"12124"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"12125"},{"source":"Beta tubulin antagonist","target":"urinary bladder neoplasms","id":"12126"},{"source":"Beta tubulin antagonist","target":"renal cell","id":"12127"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"12128"},{"source":"Microtubule stimulant","target":"anticancer","id":"12129"},{"source":"Microtubule stimulant","target":"malaria","id":"12130"},{"source":"Microtubule stimulant","target":"bladder cancer","id":"12131"},{"source":"Microtubule stimulant","target":"kidney neoplasms","id":"12132"},{"source":"Microtubule stimulant","target":"renal cancer","id":"12133"},{"source":"Microtubule stimulant","target":"carcinoma","id":"12134"},{"source":"Microtubule stimulant","target":"urologic neoplasms","id":"12135"},{"source":"Microtubule stimulant","target":"cancer of the urinary tract","id":"12136"},{"source":"Microtubule stimulant","target":"residual tumor","id":"12137"},{"source":"Microtubule stimulant","target":"malaria","id":"12138"},{"source":"Microtubule stimulant","target":"carcinoma","id":"12139"},{"source":"Microtubule stimulant","target":"metastatic","id":"12140"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"12141"},{"source":"Microtubule stimulant","target":"renal cancer","id":"12142"},{"source":"Microtubule stimulant","target":"anticancer","id":"12143"},{"source":"Microtubule stimulant","target":"urinary bladder neoplasms","id":"12144"},{"source":"Microtubule stimulant","target":"renal cell","id":"12145"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"12146"},{"source":"Tubulin inhibitor","target":"anticancer","id":"12147"},{"source":"Tubulin inhibitor","target":"malaria","id":"12148"},{"source":"Tubulin inhibitor","target":"bladder cancer","id":"12149"},{"source":"Tubulin inhibitor","target":"kidney neoplasms","id":"12150"},{"source":"Tubulin inhibitor","target":"renal cancer","id":"12151"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"12152"},{"source":"Tubulin inhibitor","target":"urologic neoplasms","id":"12153"},{"source":"Tubulin inhibitor","target":"cancer of the urinary tract","id":"12154"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"12155"},{"source":"Tubulin inhibitor","target":"malaria","id":"12156"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"12157"},{"source":"Tubulin inhibitor","target":"metastatic","id":"12158"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"12159"},{"source":"Tubulin inhibitor","target":"renal cancer","id":"12160"},{"source":"Tubulin inhibitor","target":"anticancer","id":"12161"},{"source":"Tubulin inhibitor","target":"urinary bladder neoplasms","id":"12162"},{"source":"Tubulin inhibitor","target":"renal cell","id":"12163"},{"source":"Taxane","target":"UNK : Indication","id":"12164"},{"source":"Taxane","target":"anticancer","id":"12165"},{"source":"Taxane","target":"malaria","id":"12166"},{"source":"Taxane","target":"bladder cancer","id":"12167"},{"source":"Taxane","target":"kidney neoplasms","id":"12168"},{"source":"Taxane","target":"renal cancer","id":"12169"},{"source":"Taxane","target":"carcinoma","id":"12170"},{"source":"Taxane","target":"urologic neoplasms","id":"12171"},{"source":"Taxane","target":"cancer of the urinary tract","id":"12172"},{"source":"Taxane","target":"residual tumor","id":"12173"},{"source":"Taxane","target":"malaria","id":"12174"},{"source":"Taxane","target":"carcinoma","id":"12175"},{"source":"Taxane","target":"metastatic","id":"12176"},{"source":"Taxane","target":"neoplasm metastasis","id":"12177"},{"source":"Taxane","target":"renal cancer","id":"12178"},{"source":"Taxane","target":"anticancer","id":"12179"},{"source":"Taxane","target":"urinary bladder neoplasms","id":"12180"},{"source":"Taxane","target":"renal cell","id":"12181"},{"source":"Oncology: (N/A)","target":"Vinca alkaloid","id":"12182"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"12183"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"12184"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"12185"},{"source":"Oncology: (N/A)","target":"Tubulin inhibitor","id":"12186"},{"source":"Oncology: (N/A)","target":"Beta tubulin antagonist","id":"12187"},{"source":"Oncology: (N/A)","target":"Microtubule stimulant","id":"12188"},{"source":"Oncology: (N/A)","target":"Tubulin inhibitor","id":"12189"},{"source":"Oncology: (N/A)","target":"Taxane","id":"12190"},{"source":"Oncology: Bladder","target":"Vinca alkaloid","id":"12191"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"12192"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"12193"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"12194"},{"source":"Oncology: Bladder","target":"Tubulin inhibitor","id":"12195"},{"source":"Oncology: Bladder","target":"Beta tubulin antagonist","id":"12196"},{"source":"Oncology: Bladder","target":"Microtubule stimulant","id":"12197"},{"source":"Oncology: Bladder","target":"Tubulin inhibitor","id":"12198"},{"source":"Oncology: Bladder","target":"Taxane","id":"12199"},{"source":"Oncology: Renal","target":"Vinca alkaloid","id":"12200"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"12201"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"12202"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"12203"},{"source":"Oncology: Renal","target":"Tubulin inhibitor","id":"12204"},{"source":"Oncology: Renal","target":"Beta tubulin antagonist","id":"12205"},{"source":"Oncology: Renal","target":"Microtubule stimulant","id":"12206"},{"source":"Oncology: Renal","target":"Tubulin inhibitor","id":"12207"},{"source":"Oncology: Renal","target":"Taxane","id":"12208"},{"source":"acalabrutinib (a)","target":"AstraZeneca/Acerta Pharma","id":"12209"},{"source":"acalabrutinib (a)","target":"Merck & Co.","id":"12210"},{"source":"pembrolizumab","target":"AstraZeneca/Acerta Pharma","id":"12211"},{"source":"pembrolizumab","target":"Merck & Co.","id":"12212"},{"source":"UNK : Indication","target":"acalabrutinib (a)","id":"12213"},{"source":"UNK : Indication","target":"pembrolizumab","id":"12214"},{"source":"essential thrombocythemia","target":"acalabrutinib (a)","id":"12215"},{"source":"essential thrombocythemia","target":"pembrolizumab","id":"12216"},{"source":"hematologic neoplasms","target":"acalabrutinib (a)","id":"12217"},{"source":"hematologic neoplasms","target":"pembrolizumab","id":"12218"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12219"},{"source":"lymphoma","target":"pembrolizumab","id":"12220"},{"source":"skin neoplasms","target":"acalabrutinib (a)","id":"12221"},{"source":"skin neoplasms","target":"pembrolizumab","id":"12222"},{"source":"lymphocytic","target":"acalabrutinib (a)","id":"12223"},{"source":"lymphocytic","target":"pembrolizumab","id":"12224"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12225"},{"source":"lymphoma","target":"pembrolizumab","id":"12226"},{"source":"antiarthritic","target":"acalabrutinib (a)","id":"12227"},{"source":"antiarthritic","target":"pembrolizumab","id":"12228"},{"source":"chronic obstructive pulmonary disease","target":"acalabrutinib (a)","id":"12229"},{"source":"chronic obstructive pulmonary disease","target":"pembrolizumab","id":"12230"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12231"},{"source":"lymphoma","target":"pembrolizumab","id":"12232"},{"source":"leukemia","target":"acalabrutinib (a)","id":"12233"},{"source":"leukemia","target":"pembrolizumab","id":"12234"},{"source":"myelofibrosis","target":"acalabrutinib (a)","id":"12235"},{"source":"myelofibrosis","target":"pembrolizumab","id":"12236"},{"source":"malignancies","target":"acalabrutinib (a)","id":"12237"},{"source":"malignancies","target":"pembrolizumab","id":"12238"},{"source":"anticancer","target":"acalabrutinib (a)","id":"12239"},{"source":"anticancer","target":"pembrolizumab","id":"12240"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12241"},{"source":"lymphoma","target":"pembrolizumab","id":"12242"},{"source":"b-cell","target":"acalabrutinib (a)","id":"12243"},{"source":"b-cell","target":"pembrolizumab","id":"12244"},{"source":"dlbcl","target":"acalabrutinib (a)","id":"12245"},{"source":"dlbcl","target":"pembrolizumab","id":"12246"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12247"},{"source":"lymphoma","target":"pembrolizumab","id":"12248"},{"source":"leukemia","target":"acalabrutinib (a)","id":"12249"},{"source":"leukemia","target":"pembrolizumab","id":"12250"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12251"},{"source":"lymphoma","target":"pembrolizumab","id":"12252"},{"source":"skin neoplasms","target":"acalabrutinib (a)","id":"12253"},{"source":"skin neoplasms","target":"pembrolizumab","id":"12254"},{"source":"plasma cell","target":"acalabrutinib (a)","id":"12255"},{"source":"plasma cell","target":"pembrolizumab","id":"12256"},{"source":"wm","target":"acalabrutinib (a)","id":"12257"},{"source":"wm","target":"pembrolizumab","id":"12258"},{"source":"alopecia","target":"acalabrutinib (a)","id":"12259"},{"source":"alopecia","target":"pembrolizumab","id":"12260"},{"source":"b-cell","target":"acalabrutinib (a)","id":"12261"},{"source":"b-cell","target":"pembrolizumab","id":"12262"},{"source":"lymphoid","target":"acalabrutinib (a)","id":"12263"},{"source":"lymphoid","target":"pembrolizumab","id":"12264"},{"source":"arthritis","target":"acalabrutinib (a)","id":"12265"},{"source":"arthritis","target":"pembrolizumab","id":"12266"},{"source":"lymphadenopathy","target":"acalabrutinib (a)","id":"12267"},{"source":"lymphadenopathy","target":"pembrolizumab","id":"12268"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12269"},{"source":"lymphoma","target":"pembrolizumab","id":"12270"},{"source":"multiple myeloma","target":"acalabrutinib (a)","id":"12271"},{"source":"multiple myeloma","target":"pembrolizumab","id":"12272"},{"source":"waldenstrom macroglobulinemia","target":"acalabrutinib (a)","id":"12273"},{"source":"waldenstrom macroglobulinemia","target":"pembrolizumab","id":"12274"},{"source":"polycythemia vera","target":"acalabrutinib (a)","id":"12275"},{"source":"polycythemia vera","target":"pembrolizumab","id":"12276"},{"source":"thrombocytopenia","target":"acalabrutinib (a)","id":"12277"},{"source":"thrombocytopenia","target":"pembrolizumab","id":"12278"},{"source":"lymphatic diseases","target":"acalabrutinib (a)","id":"12279"},{"source":"lymphatic diseases","target":"pembrolizumab","id":"12280"},{"source":"leukemia","target":"acalabrutinib (a)","id":"12281"},{"source":"leukemia","target":"pembrolizumab","id":"12282"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12283"},{"source":"lymphoma","target":"pembrolizumab","id":"12284"},{"source":"waldenstrom macroglobulinemia","target":"acalabrutinib (a)","id":"12285"},{"source":"waldenstrom macroglobulinemia","target":"pembrolizumab","id":"12286"},{"source":"anemia","target":"acalabrutinib (a)","id":"12287"},{"source":"anemia","target":"pembrolizumab","id":"12288"},{"source":"leukemia","target":"acalabrutinib (a)","id":"12289"},{"source":"leukemia","target":"pembrolizumab","id":"12290"},{"source":"neuropathy","target":"acalabrutinib (a)","id":"12291"},{"source":"neuropathy","target":"pembrolizumab","id":"12292"},{"source":"myelofibrosis","target":"acalabrutinib (a)","id":"12293"},{"source":"myelofibrosis","target":"pembrolizumab","id":"12294"},{"source":"solid malignancy","target":"acalabrutinib (a)","id":"12295"},{"source":"solid malignancy","target":"pembrolizumab","id":"12296"},{"source":"lymphoma","target":"acalabrutinib (a)","id":"12297"},{"source":"lymphoma","target":"pembrolizumab","id":"12298"},{"source":"residual tumor","target":"acalabrutinib (a)","id":"12299"},{"source":"residual tumor","target":"pembrolizumab","id":"12300"},{"source":"splenomegaly","target":"acalabrutinib (a)","id":"12301"},{"source":"splenomegaly","target":"pembrolizumab","id":"12302"},{"source":"hodgkin disease","target":"acalabrutinib (a)","id":"12303"},{"source":"hodgkin disease","target":"pembrolizumab","id":"12304"},{"source":"hematologic malignancy","target":"acalabrutinib (a)","id":"12305"},{"source":"hematologic malignancy","target":"pembrolizumab","id":"12306"},{"source":"non-hodgkin","target":"acalabrutinib (a)","id":"12307"},{"source":"non-hodgkin","target":"pembrolizumab","id":"12308"},{"source":"insulinoma","target":"acalabrutinib (a)","id":"12309"},{"source":"insulinoma","target":"pembrolizumab","id":"12310"},{"source":"anticancer","target":"acalabrutinib (a)","id":"12311"},{"source":"anticancer","target":"pembrolizumab","id":"12312"},{"source":"carcinoma","target":"acalabrutinib (a)","id":"12313"},{"source":"carcinoma","target":"pembrolizumab","id":"12314"},{"source":"plasma cell","target":"acalabrutinib (a)","id":"12315"},{"source":"plasma cell","target":"pembrolizumab","id":"12316"},{"source":"leukemia","target":"acalabrutinib (a)","id":"12317"},{"source":"leukemia","target":"pembrolizumab","id":"12318"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"12319"},{"source":"Anticancer immunotherapy","target":"essential thrombocythemia","id":"12320"},{"source":"Anticancer immunotherapy","target":"hematologic neoplasms","id":"12321"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12322"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"12323"},{"source":"Anticancer immunotherapy","target":"lymphocytic","id":"12324"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12325"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"12326"},{"source":"Anticancer immunotherapy","target":"chronic obstructive pulmonary disease","id":"12327"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12328"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"12329"},{"source":"Anticancer immunotherapy","target":"myelofibrosis","id":"12330"},{"source":"Anticancer immunotherapy","target":"malignancies","id":"12331"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"12332"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12333"},{"source":"Anticancer immunotherapy","target":"b-cell","id":"12334"},{"source":"Anticancer immunotherapy","target":"dlbcl","id":"12335"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12336"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"12337"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12338"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"12339"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"12340"},{"source":"Anticancer immunotherapy","target":"wm","id":"12341"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"12342"},{"source":"Anticancer immunotherapy","target":"b-cell","id":"12343"},{"source":"Anticancer immunotherapy","target":"lymphoid","id":"12344"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"12345"},{"source":"Anticancer immunotherapy","target":"lymphadenopathy","id":"12346"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12347"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"12348"},{"source":"Anticancer immunotherapy","target":"waldenstrom macroglobulinemia","id":"12349"},{"source":"Anticancer immunotherapy","target":"polycythemia vera","id":"12350"},{"source":"Anticancer immunotherapy","target":"thrombocytopenia","id":"12351"},{"source":"Anticancer immunotherapy","target":"lymphatic diseases","id":"12352"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"12353"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12354"},{"source":"Anticancer immunotherapy","target":"waldenstrom macroglobulinemia","id":"12355"},{"source":"Anticancer immunotherapy","target":"anemia","id":"12356"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"12357"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"12358"},{"source":"Anticancer immunotherapy","target":"myelofibrosis","id":"12359"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"12360"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"12361"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"12362"},{"source":"Anticancer immunotherapy","target":"splenomegaly","id":"12363"},{"source":"Anticancer immunotherapy","target":"hodgkin disease","id":"12364"},{"source":"Anticancer immunotherapy","target":"hematologic malignancy","id":"12365"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"12366"},{"source":"Anticancer immunotherapy","target":"insulinoma","id":"12367"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"12368"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12369"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"12370"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"12371"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"12372"},{"source":"CD19 antagonist","target":"essential thrombocythemia","id":"12373"},{"source":"CD19 antagonist","target":"hematologic neoplasms","id":"12374"},{"source":"CD19 antagonist","target":"lymphoma","id":"12375"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"12376"},{"source":"CD19 antagonist","target":"lymphocytic","id":"12377"},{"source":"CD19 antagonist","target":"lymphoma","id":"12378"},{"source":"CD19 antagonist","target":"antiarthritic","id":"12379"},{"source":"CD19 antagonist","target":"chronic obstructive pulmonary disease","id":"12380"},{"source":"CD19 antagonist","target":"lymphoma","id":"12381"},{"source":"CD19 antagonist","target":"leukemia","id":"12382"},{"source":"CD19 antagonist","target":"myelofibrosis","id":"12383"},{"source":"CD19 antagonist","target":"malignancies","id":"12384"},{"source":"CD19 antagonist","target":"anticancer","id":"12385"},{"source":"CD19 antagonist","target":"lymphoma","id":"12386"},{"source":"CD19 antagonist","target":"b-cell","id":"12387"},{"source":"CD19 antagonist","target":"dlbcl","id":"12388"},{"source":"CD19 antagonist","target":"lymphoma","id":"12389"},{"source":"CD19 antagonist","target":"leukemia","id":"12390"},{"source":"CD19 antagonist","target":"lymphoma","id":"12391"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"12392"},{"source":"CD19 antagonist","target":"plasma cell","id":"12393"},{"source":"CD19 antagonist","target":"wm","id":"12394"},{"source":"CD19 antagonist","target":"alopecia","id":"12395"},{"source":"CD19 antagonist","target":"b-cell","id":"12396"},{"source":"CD19 antagonist","target":"lymphoid","id":"12397"},{"source":"CD19 antagonist","target":"arthritis","id":"12398"},{"source":"CD19 antagonist","target":"lymphadenopathy","id":"12399"},{"source":"CD19 antagonist","target":"lymphoma","id":"12400"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"12401"},{"source":"CD19 antagonist","target":"waldenstrom macroglobulinemia","id":"12402"},{"source":"CD19 antagonist","target":"polycythemia vera","id":"12403"},{"source":"CD19 antagonist","target":"thrombocytopenia","id":"12404"},{"source":"CD19 antagonist","target":"lymphatic diseases","id":"12405"},{"source":"CD19 antagonist","target":"leukemia","id":"12406"},{"source":"CD19 antagonist","target":"lymphoma","id":"12407"},{"source":"CD19 antagonist","target":"waldenstrom macroglobulinemia","id":"12408"},{"source":"CD19 antagonist","target":"anemia","id":"12409"},{"source":"CD19 antagonist","target":"leukemia","id":"12410"},{"source":"CD19 antagonist","target":"neuropathy","id":"12411"},{"source":"CD19 antagonist","target":"myelofibrosis","id":"12412"},{"source":"CD19 antagonist","target":"solid malignancy","id":"12413"},{"source":"CD19 antagonist","target":"lymphoma","id":"12414"},{"source":"CD19 antagonist","target":"residual tumor","id":"12415"},{"source":"CD19 antagonist","target":"splenomegaly","id":"12416"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"12417"},{"source":"CD19 antagonist","target":"hematologic malignancy","id":"12418"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"12419"},{"source":"CD19 antagonist","target":"insulinoma","id":"12420"},{"source":"CD19 antagonist","target":"anticancer","id":"12421"},{"source":"CD19 antagonist","target":"carcinoma","id":"12422"},{"source":"CD19 antagonist","target":"plasma cell","id":"12423"},{"source":"CD19 antagonist","target":"leukemia","id":"12424"},{"source":"NA","target":"UNK : Indication","id":"12425"},{"source":"NA","target":"essential thrombocythemia","id":"12426"},{"source":"NA","target":"hematologic neoplasms","id":"12427"},{"source":"NA","target":"lymphoma","id":"12428"},{"source":"NA","target":"skin neoplasms","id":"12429"},{"source":"NA","target":"lymphocytic","id":"12430"},{"source":"NA","target":"lymphoma","id":"12431"},{"source":"NA","target":"antiarthritic","id":"12432"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"12433"},{"source":"NA","target":"lymphoma","id":"12434"},{"source":"NA","target":"leukemia","id":"12435"},{"source":"NA","target":"myelofibrosis","id":"12436"},{"source":"NA","target":"malignancies","id":"12437"},{"source":"NA","target":"anticancer","id":"12438"},{"source":"NA","target":"lymphoma","id":"12439"},{"source":"NA","target":"b-cell","id":"12440"},{"source":"NA","target":"dlbcl","id":"12441"},{"source":"NA","target":"lymphoma","id":"12442"},{"source":"NA","target":"leukemia","id":"12443"},{"source":"NA","target":"lymphoma","id":"12444"},{"source":"NA","target":"skin neoplasms","id":"12445"},{"source":"NA","target":"plasma cell","id":"12446"},{"source":"NA","target":"wm","id":"12447"},{"source":"NA","target":"alopecia","id":"12448"},{"source":"NA","target":"b-cell","id":"12449"},{"source":"NA","target":"lymphoid","id":"12450"},{"source":"NA","target":"arthritis","id":"12451"},{"source":"NA","target":"lymphadenopathy","id":"12452"},{"source":"NA","target":"lymphoma","id":"12453"},{"source":"NA","target":"multiple myeloma","id":"12454"},{"source":"NA","target":"waldenstrom macroglobulinemia","id":"12455"},{"source":"NA","target":"polycythemia vera","id":"12456"},{"source":"NA","target":"thrombocytopenia","id":"12457"},{"source":"NA","target":"lymphatic diseases","id":"12458"},{"source":"NA","target":"leukemia","id":"12459"},{"source":"NA","target":"lymphoma","id":"12460"},{"source":"NA","target":"waldenstrom macroglobulinemia","id":"12461"},{"source":"NA","target":"anemia","id":"12462"},{"source":"NA","target":"leukemia","id":"12463"},{"source":"NA","target":"neuropathy","id":"12464"},{"source":"NA","target":"myelofibrosis","id":"12465"},{"source":"NA","target":"solid malignancy","id":"12466"},{"source":"NA","target":"lymphoma","id":"12467"},{"source":"NA","target":"residual tumor","id":"12468"},{"source":"NA","target":"splenomegaly","id":"12469"},{"source":"NA","target":"hodgkin disease","id":"12470"},{"source":"NA","target":"hematologic malignancy","id":"12471"},{"source":"NA","target":"non-hodgkin","id":"12472"},{"source":"NA","target":"insulinoma","id":"12473"},{"source":"NA","target":"anticancer","id":"12474"},{"source":"NA","target":"carcinoma","id":"12475"},{"source":"NA","target":"plasma cell","id":"12476"},{"source":"NA","target":"leukemia","id":"12477"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"12478"},{"source":"Immune checkpoint inhibitor","target":"essential thrombocythemia","id":"12479"},{"source":"Immune checkpoint inhibitor","target":"hematologic neoplasms","id":"12480"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12481"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"12482"},{"source":"Immune checkpoint inhibitor","target":"lymphocytic","id":"12483"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12484"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"12485"},{"source":"Immune checkpoint inhibitor","target":"chronic obstructive pulmonary disease","id":"12486"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12487"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"12488"},{"source":"Immune checkpoint inhibitor","target":"myelofibrosis","id":"12489"},{"source":"Immune checkpoint inhibitor","target":"malignancies","id":"12490"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"12491"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12492"},{"source":"Immune checkpoint inhibitor","target":"b-cell","id":"12493"},{"source":"Immune checkpoint inhibitor","target":"dlbcl","id":"12494"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12495"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"12496"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12497"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"12498"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"12499"},{"source":"Immune checkpoint inhibitor","target":"wm","id":"12500"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"12501"},{"source":"Immune checkpoint inhibitor","target":"b-cell","id":"12502"},{"source":"Immune checkpoint inhibitor","target":"lymphoid","id":"12503"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"12504"},{"source":"Immune checkpoint inhibitor","target":"lymphadenopathy","id":"12505"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12506"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"12507"},{"source":"Immune checkpoint inhibitor","target":"waldenstrom macroglobulinemia","id":"12508"},{"source":"Immune checkpoint inhibitor","target":"polycythemia vera","id":"12509"},{"source":"Immune checkpoint inhibitor","target":"thrombocytopenia","id":"12510"},{"source":"Immune checkpoint inhibitor","target":"lymphatic diseases","id":"12511"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"12512"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12513"},{"source":"Immune checkpoint inhibitor","target":"waldenstrom macroglobulinemia","id":"12514"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"12515"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"12516"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"12517"},{"source":"Immune checkpoint inhibitor","target":"myelofibrosis","id":"12518"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"12519"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"12520"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"12521"},{"source":"Immune checkpoint inhibitor","target":"splenomegaly","id":"12522"},{"source":"Immune checkpoint inhibitor","target":"hodgkin disease","id":"12523"},{"source":"Immune checkpoint inhibitor","target":"hematologic malignancy","id":"12524"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"12525"},{"source":"Immune checkpoint inhibitor","target":"insulinoma","id":"12526"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"12527"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12528"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"12529"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"12530"},{"source":"Oncology: Leukemia","target":"Anticancer immunotherapy","id":"12531"},{"source":"Oncology: Leukemia","target":"CD19 antagonist","id":"12532"},{"source":"Oncology: Leukemia","target":"NA","id":"12533"},{"source":"Oncology: Leukemia","target":"Immune checkpoint inhibitor","id":"12534"},{"source":"Chronic Lymphocytic","target":"Anticancer immunotherapy","id":"12535"},{"source":"Chronic Lymphocytic","target":"CD19 antagonist","id":"12536"},{"source":"Chronic Lymphocytic","target":"NA","id":"12537"},{"source":"Chronic Lymphocytic","target":"Immune checkpoint inhibitor","id":"12538"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"12539"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"12540"},{"source":"Oncology: Lymphoma","target":"NA","id":"12541"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"12542"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"12543"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"12544"},{"source":"Hodgkin's","target":"NA","id":"12545"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"12546"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"12547"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"12548"},{"source":"Oncology: Lymphoma","target":"NA","id":"12549"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"12550"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"12551"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"12552"},{"source":"Hodgkin's","target":"NA","id":"12553"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"12554"},{"source":"Oncology: Multiple Myeloma","target":"Anticancer immunotherapy","id":"12555"},{"source":"Oncology: Multiple Myeloma","target":"CD19 antagonist","id":"12556"},{"source":"Oncology: Multiple Myeloma","target":"NA","id":"12557"},{"source":"Oncology: Multiple Myeloma","target":"Immune checkpoint inhibitor","id":"12558"},{"source":"pexidartinib (u)","target":"Daiichi Sankyo/Plexxikon","id":"12559"},{"source":"pexidartinib (u)","target":"Merck & Co.","id":"12560"},{"source":"pembrolizumab","target":"Daiichi Sankyo/Plexxikon","id":"12561"},{"source":"pembrolizumab","target":"Merck & Co.","id":"12562"},{"source":"UNK : Indication","target":"pexidartinib (u)","id":"12563"},{"source":"UNK : Indication","target":"pembrolizumab","id":"12564"},{"source":"colorectal neoplasms","target":"pexidartinib (u)","id":"12565"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"12566"},{"source":"anticancer","target":"pexidartinib (u)","id":"12567"},{"source":"anticancer","target":"pembrolizumab","id":"12568"},{"source":"triple-negative breast cancer","target":"pexidartinib (u)","id":"12569"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"12570"},{"source":"ovarian cancer","target":"pexidartinib (u)","id":"12571"},{"source":"ovarian cancer","target":"pembrolizumab","id":"12572"},{"source":"non-small-cell lung","target":"pexidartinib (u)","id":"12573"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"12574"},{"source":"skin neoplasms","target":"pexidartinib (u)","id":"12575"},{"source":"skin neoplasms","target":"pembrolizumab","id":"12576"},{"source":"squamous cell neoplasms","target":"pexidartinib (u)","id":"12577"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"12578"},{"source":"non-small-cell lung","target":"pexidartinib (u)","id":"12579"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"12580"},{"source":"anti-inflammatory","target":"pexidartinib (u)","id":"12581"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"12582"},{"source":"breast neoplasms","target":"pexidartinib (u)","id":"12583"},{"source":"breast neoplasms","target":"pembrolizumab","id":"12584"},{"source":"pancreatic cancer","target":"pexidartinib (u)","id":"12585"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"12586"},{"source":"sarcoma","target":"pexidartinib (u)","id":"12587"},{"source":"sarcoma","target":"pembrolizumab","id":"12588"},{"source":"skin neoplasms","target":"pexidartinib (u)","id":"12589"},{"source":"skin neoplasms","target":"pembrolizumab","id":"12590"},{"source":"pancreatic cancer","target":"pexidartinib (u)","id":"12591"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"12592"},{"source":"liver neoplasms","target":"pexidartinib (u)","id":"12593"},{"source":"liver neoplasms","target":"pembrolizumab","id":"12594"},{"source":"head and neck neoplasms","target":"pexidartinib (u)","id":"12595"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"12596"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12597"},{"source":"carcinoma","target":"pembrolizumab","id":"12598"},{"source":"non-small-cell lung","target":"pexidartinib (u)","id":"12599"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"12600"},{"source":"melanoma","target":"pexidartinib (u)","id":"12601"},{"source":"melanoma","target":"pembrolizumab","id":"12602"},{"source":"bladder cancer","target":"pexidartinib (u)","id":"12603"},{"source":"bladder cancer","target":"pembrolizumab","id":"12604"},{"source":"solid tumors","target":"pexidartinib (u)","id":"12605"},{"source":"solid tumors","target":"pembrolizumab","id":"12606"},{"source":"antiallergic","target":"pexidartinib (u)","id":"12607"},{"source":"antiallergic","target":"pembrolizumab","id":"12608"},{"source":"gastrointestinal stromal tumors","target":"pexidartinib (u)","id":"12609"},{"source":"gastrointestinal stromal tumors","target":"pembrolizumab","id":"12610"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12611"},{"source":"carcinoma","target":"pembrolizumab","id":"12612"},{"source":"sarcoma","target":"pexidartinib (u)","id":"12613"},{"source":"sarcoma","target":"pembrolizumab","id":"12614"},{"source":"breast neoplasms","target":"pexidartinib (u)","id":"12615"},{"source":"breast neoplasms","target":"pembrolizumab","id":"12616"},{"source":"colonic neoplasms","target":"pexidartinib (u)","id":"12617"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"12618"},{"source":"hypersensitivity","target":"pexidartinib (u)","id":"12619"},{"source":"hypersensitivity","target":"pembrolizumab","id":"12620"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12621"},{"source":"carcinoma","target":"pembrolizumab","id":"12622"},{"source":"inflammation","target":"pexidartinib (u)","id":"12623"},{"source":"inflammation","target":"pembrolizumab","id":"12624"},{"source":"gastrointestinal stromal tumors","target":"pexidartinib (u)","id":"12625"},{"source":"gastrointestinal stromal tumors","target":"pembrolizumab","id":"12626"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12627"},{"source":"carcinoma","target":"pembrolizumab","id":"12628"},{"source":"sclc","target":"pexidartinib (u)","id":"12629"},{"source":"sclc","target":"pembrolizumab","id":"12630"},{"source":"multiple sclerosis","target":"pexidartinib (u)","id":"12631"},{"source":"multiple sclerosis","target":"pembrolizumab","id":"12632"},{"source":"liver cancer","target":"pexidartinib (u)","id":"12633"},{"source":"liver cancer","target":"pembrolizumab","id":"12634"},{"source":"ovarian neoplasms","target":"pexidartinib (u)","id":"12635"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"12636"},{"source":"cancer squamous cell","target":"pexidartinib (u)","id":"12637"},{"source":"cancer squamous cell","target":"pembrolizumab","id":"12638"},{"source":"ovarian cancer","target":"pexidartinib (u)","id":"12639"},{"source":"ovarian cancer","target":"pembrolizumab","id":"12640"},{"source":"arthritis","target":"pexidartinib (u)","id":"12641"},{"source":"arthritis","target":"pembrolizumab","id":"12642"},{"source":"unknown primary","target":"pexidartinib (u)","id":"12643"},{"source":"unknown primary","target":"pembrolizumab","id":"12644"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12645"},{"source":"carcinoma","target":"pembrolizumab","id":"12646"},{"source":"gastric cancer","target":"pexidartinib (u)","id":"12647"},{"source":"gastric cancer","target":"pembrolizumab","id":"12648"},{"source":"hepatocellular","target":"pexidartinib (u)","id":"12649"},{"source":"hepatocellular","target":"pembrolizumab","id":"12650"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12651"},{"source":"carcinoma","target":"pembrolizumab","id":"12652"},{"source":"soft tissue neoplasms","target":"pexidartinib (u)","id":"12653"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"12654"},{"source":"neoplasm metastasis","target":"pexidartinib (u)","id":"12655"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"12656"},{"source":"asthma","target":"pexidartinib (u)","id":"12657"},{"source":"asthma","target":"pembrolizumab","id":"12658"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12659"},{"source":"carcinoma","target":"pembrolizumab","id":"12660"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12661"},{"source":"carcinoma","target":"pembrolizumab","id":"12662"},{"source":"pancreatic neoplasms","target":"pexidartinib (u)","id":"12663"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"12664"},{"source":"colorectal neoplasms","target":"pexidartinib (u)","id":"12665"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"12666"},{"source":"stomach neoplasms","target":"pexidartinib (u)","id":"12667"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"12668"},{"source":"urinary bladder neoplasms","target":"pexidartinib (u)","id":"12669"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"12670"},{"source":"triple-negative breast cancer","target":"pexidartinib (u)","id":"12671"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"12672"},{"source":"residual tumor","target":"pexidartinib (u)","id":"12673"},{"source":"residual tumor","target":"pembrolizumab","id":"12674"},{"source":"solid malignancy","target":"pexidartinib (u)","id":"12675"},{"source":"solid malignancy","target":"pembrolizumab","id":"12676"},{"source":"carcinoma","target":"pexidartinib (u)","id":"12677"},{"source":"carcinoma","target":"pembrolizumab","id":"12678"},{"source":"residual tumor","target":"pexidartinib (u)","id":"12679"},{"source":"residual tumor","target":"pembrolizumab","id":"12680"},{"source":"metastatic","target":"pexidartinib (u)","id":"12681"},{"source":"metastatic","target":"pembrolizumab","id":"12682"},{"source":"squamous cell neoplasms","target":"pexidartinib (u)","id":"12683"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"12684"},{"source":"anticancer","target":"pexidartinib (u)","id":"12685"},{"source":"anticancer","target":"pembrolizumab","id":"12686"},{"source":"unknown primary","target":"pexidartinib (u)","id":"12687"},{"source":"unknown primary","target":"pembrolizumab","id":"12688"},{"source":"antiarthritic","target":"pexidartinib (u)","id":"12689"},{"source":"antiarthritic","target":"pembrolizumab","id":"12690"},{"source":"solid tumors","target":"pexidartinib (u)","id":"12691"},{"source":"solid tumors","target":"pembrolizumab","id":"12692"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"12693"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"12694"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"12695"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"12696"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"12697"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"12698"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"12699"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"12700"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"12701"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"12702"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"12703"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"12704"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"12705"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"12706"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"12707"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"12708"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"12709"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12710"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"12711"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"12712"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"12713"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"12714"},{"source":"Immune checkpoint inhibitor","target":"antiallergic","id":"12715"},{"source":"Immune checkpoint inhibitor","target":"gastrointestinal stromal tumors","id":"12716"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12717"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"12718"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"12719"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"12720"},{"source":"Immune checkpoint inhibitor","target":"hypersensitivity","id":"12721"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12722"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"12723"},{"source":"Immune checkpoint inhibitor","target":"gastrointestinal stromal tumors","id":"12724"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12725"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"12726"},{"source":"Immune checkpoint inhibitor","target":"multiple sclerosis","id":"12727"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"12728"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"12729"},{"source":"Immune checkpoint inhibitor","target":"cancer squamous cell","id":"12730"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"12731"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"12732"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"12733"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12734"},{"source":"Immune checkpoint inhibitor","target":"gastric cancer","id":"12735"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"12736"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12737"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"12738"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"12739"},{"source":"Immune checkpoint inhibitor","target":"asthma","id":"12740"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12741"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12742"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"12743"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"12744"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"12745"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"12746"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"12747"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"12748"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"12749"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"12750"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"12751"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"12752"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"12753"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"12754"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"12755"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"12756"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"12757"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"12758"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"12759"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"12760"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"12761"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"12762"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"12763"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"12764"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"12765"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"12766"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"12767"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"12768"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"12769"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"12770"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"12771"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"12772"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"12773"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"12774"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12775"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"12776"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"12777"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"12778"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"12779"},{"source":"Anticancer immunotherapy","target":"antiallergic","id":"12780"},{"source":"Anticancer immunotherapy","target":"gastrointestinal stromal tumors","id":"12781"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12782"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"12783"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"12784"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"12785"},{"source":"Anticancer immunotherapy","target":"hypersensitivity","id":"12786"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12787"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"12788"},{"source":"Anticancer immunotherapy","target":"gastrointestinal stromal tumors","id":"12789"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12790"},{"source":"Anticancer immunotherapy","target":"sclc","id":"12791"},{"source":"Anticancer immunotherapy","target":"multiple sclerosis","id":"12792"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"12793"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"12794"},{"source":"Anticancer immunotherapy","target":"cancer squamous cell","id":"12795"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"12796"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"12797"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"12798"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12799"},{"source":"Anticancer immunotherapy","target":"gastric cancer","id":"12800"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"12801"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12802"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"12803"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"12804"},{"source":"Anticancer immunotherapy","target":"asthma","id":"12805"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12806"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12807"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"12808"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"12809"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"12810"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"12811"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"12812"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"12813"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"12814"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"12815"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"12816"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"12817"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"12818"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"12819"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"12820"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"12821"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"12822"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"12823"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"12824"},{"source":"CD19 antagonist","target":"anticancer","id":"12825"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"12826"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"12827"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"12828"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"12829"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"12830"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"12831"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"12832"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"12833"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"12834"},{"source":"CD19 antagonist","target":"sarcoma","id":"12835"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"12836"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"12837"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"12838"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"12839"},{"source":"CD19 antagonist","target":"carcinoma","id":"12840"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"12841"},{"source":"CD19 antagonist","target":"melanoma","id":"12842"},{"source":"CD19 antagonist","target":"bladder cancer","id":"12843"},{"source":"CD19 antagonist","target":"solid tumors","id":"12844"},{"source":"CD19 antagonist","target":"antiallergic","id":"12845"},{"source":"CD19 antagonist","target":"gastrointestinal stromal tumors","id":"12846"},{"source":"CD19 antagonist","target":"carcinoma","id":"12847"},{"source":"CD19 antagonist","target":"sarcoma","id":"12848"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"12849"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"12850"},{"source":"CD19 antagonist","target":"hypersensitivity","id":"12851"},{"source":"CD19 antagonist","target":"carcinoma","id":"12852"},{"source":"CD19 antagonist","target":"inflammation","id":"12853"},{"source":"CD19 antagonist","target":"gastrointestinal stromal tumors","id":"12854"},{"source":"CD19 antagonist","target":"carcinoma","id":"12855"},{"source":"CD19 antagonist","target":"sclc","id":"12856"},{"source":"CD19 antagonist","target":"multiple sclerosis","id":"12857"},{"source":"CD19 antagonist","target":"liver cancer","id":"12858"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"12859"},{"source":"CD19 antagonist","target":"cancer squamous cell","id":"12860"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"12861"},{"source":"CD19 antagonist","target":"arthritis","id":"12862"},{"source":"CD19 antagonist","target":"unknown primary","id":"12863"},{"source":"CD19 antagonist","target":"carcinoma","id":"12864"},{"source":"CD19 antagonist","target":"gastric cancer","id":"12865"},{"source":"CD19 antagonist","target":"hepatocellular","id":"12866"},{"source":"CD19 antagonist","target":"carcinoma","id":"12867"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"12868"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"12869"},{"source":"CD19 antagonist","target":"asthma","id":"12870"},{"source":"CD19 antagonist","target":"carcinoma","id":"12871"},{"source":"CD19 antagonist","target":"carcinoma","id":"12872"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"12873"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"12874"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"12875"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"12876"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"12877"},{"source":"CD19 antagonist","target":"residual tumor","id":"12878"},{"source":"CD19 antagonist","target":"solid malignancy","id":"12879"},{"source":"CD19 antagonist","target":"carcinoma","id":"12880"},{"source":"CD19 antagonist","target":"residual tumor","id":"12881"},{"source":"CD19 antagonist","target":"metastatic","id":"12882"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"12883"},{"source":"CD19 antagonist","target":"anticancer","id":"12884"},{"source":"CD19 antagonist","target":"unknown primary","id":"12885"},{"source":"CD19 antagonist","target":"antiarthritic","id":"12886"},{"source":"CD19 antagonist","target":"solid tumors","id":"12887"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"UNK : Indication","id":"12888"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colorectal neoplasms","id":"12889"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"12890"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"triple-negative breast cancer","id":"12891"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"ovarian cancer","id":"12892"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"non-small-cell lung","id":"12893"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"skin neoplasms","id":"12894"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"squamous cell neoplasms","id":"12895"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"non-small-cell lung","id":"12896"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anti-inflammatory","id":"12897"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"breast neoplasms","id":"12898"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"pancreatic cancer","id":"12899"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"sarcoma","id":"12900"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"skin neoplasms","id":"12901"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"pancreatic cancer","id":"12902"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"liver neoplasms","id":"12903"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"head and neck neoplasms","id":"12904"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12905"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"non-small-cell lung","id":"12906"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"melanoma","id":"12907"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"bladder cancer","id":"12908"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"12909"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antiallergic","id":"12910"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"gastrointestinal stromal tumors","id":"12911"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12912"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"sarcoma","id":"12913"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"breast neoplasms","id":"12914"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colonic neoplasms","id":"12915"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"hypersensitivity","id":"12916"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12917"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"inflammation","id":"12918"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"gastrointestinal stromal tumors","id":"12919"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12920"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"sclc","id":"12921"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"multiple sclerosis","id":"12922"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"liver cancer","id":"12923"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"ovarian neoplasms","id":"12924"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"cancer squamous cell","id":"12925"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"ovarian cancer","id":"12926"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"arthritis","id":"12927"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"unknown primary","id":"12928"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12929"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"gastric cancer","id":"12930"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"hepatocellular","id":"12931"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12932"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"soft tissue neoplasms","id":"12933"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"neoplasm metastasis","id":"12934"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"asthma","id":"12935"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12936"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12937"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"pancreatic neoplasms","id":"12938"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colorectal neoplasms","id":"12939"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"stomach neoplasms","id":"12940"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"urinary bladder neoplasms","id":"12941"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"triple-negative breast cancer","id":"12942"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"12943"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid malignancy","id":"12944"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"12945"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"12946"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"metastatic","id":"12947"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"squamous cell neoplasms","id":"12948"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"12949"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"unknown primary","id":"12950"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antiarthritic","id":"12951"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"12952"},{"source":"NA","target":"UNK : Indication","id":"12953"},{"source":"NA","target":"colorectal neoplasms","id":"12954"},{"source":"NA","target":"anticancer","id":"12955"},{"source":"NA","target":"triple-negative breast cancer","id":"12956"},{"source":"NA","target":"ovarian cancer","id":"12957"},{"source":"NA","target":"non-small-cell lung","id":"12958"},{"source":"NA","target":"skin neoplasms","id":"12959"},{"source":"NA","target":"squamous cell neoplasms","id":"12960"},{"source":"NA","target":"non-small-cell lung","id":"12961"},{"source":"NA","target":"anti-inflammatory","id":"12962"},{"source":"NA","target":"breast neoplasms","id":"12963"},{"source":"NA","target":"pancreatic cancer","id":"12964"},{"source":"NA","target":"sarcoma","id":"12965"},{"source":"NA","target":"skin neoplasms","id":"12966"},{"source":"NA","target":"pancreatic cancer","id":"12967"},{"source":"NA","target":"liver neoplasms","id":"12968"},{"source":"NA","target":"head and neck neoplasms","id":"12969"},{"source":"NA","target":"carcinoma","id":"12970"},{"source":"NA","target":"non-small-cell lung","id":"12971"},{"source":"NA","target":"melanoma","id":"12972"},{"source":"NA","target":"bladder cancer","id":"12973"},{"source":"NA","target":"solid tumors","id":"12974"},{"source":"NA","target":"antiallergic","id":"12975"},{"source":"NA","target":"gastrointestinal stromal tumors","id":"12976"},{"source":"NA","target":"carcinoma","id":"12977"},{"source":"NA","target":"sarcoma","id":"12978"},{"source":"NA","target":"breast neoplasms","id":"12979"},{"source":"NA","target":"colonic neoplasms","id":"12980"},{"source":"NA","target":"hypersensitivity","id":"12981"},{"source":"NA","target":"carcinoma","id":"12982"},{"source":"NA","target":"inflammation","id":"12983"},{"source":"NA","target":"gastrointestinal stromal tumors","id":"12984"},{"source":"NA","target":"carcinoma","id":"12985"},{"source":"NA","target":"sclc","id":"12986"},{"source":"NA","target":"multiple sclerosis","id":"12987"},{"source":"NA","target":"liver cancer","id":"12988"},{"source":"NA","target":"ovarian neoplasms","id":"12989"},{"source":"NA","target":"cancer squamous cell","id":"12990"},{"source":"NA","target":"ovarian cancer","id":"12991"},{"source":"NA","target":"arthritis","id":"12992"},{"source":"NA","target":"unknown primary","id":"12993"},{"source":"NA","target":"carcinoma","id":"12994"},{"source":"NA","target":"gastric cancer","id":"12995"},{"source":"NA","target":"hepatocellular","id":"12996"},{"source":"NA","target":"carcinoma","id":"12997"},{"source":"NA","target":"soft tissue neoplasms","id":"12998"},{"source":"NA","target":"neoplasm metastasis","id":"12999"},{"source":"NA","target":"asthma","id":"13000"},{"source":"NA","target":"carcinoma","id":"13001"},{"source":"NA","target":"carcinoma","id":"13002"},{"source":"NA","target":"pancreatic neoplasms","id":"13003"},{"source":"NA","target":"colorectal neoplasms","id":"13004"},{"source":"NA","target":"stomach neoplasms","id":"13005"},{"source":"NA","target":"urinary bladder neoplasms","id":"13006"},{"source":"NA","target":"triple-negative breast cancer","id":"13007"},{"source":"NA","target":"residual tumor","id":"13008"},{"source":"NA","target":"solid malignancy","id":"13009"},{"source":"NA","target":"carcinoma","id":"13010"},{"source":"NA","target":"residual tumor","id":"13011"},{"source":"NA","target":"metastatic","id":"13012"},{"source":"NA","target":"squamous cell neoplasms","id":"13013"},{"source":"NA","target":"anticancer","id":"13014"},{"source":"NA","target":"unknown primary","id":"13015"},{"source":"NA","target":"antiarthritic","id":"13016"},{"source":"NA","target":"solid tumors","id":"13017"},{"source":"C-kit inhibitor","target":"UNK : Indication","id":"13018"},{"source":"C-kit inhibitor","target":"colorectal neoplasms","id":"13019"},{"source":"C-kit inhibitor","target":"anticancer","id":"13020"},{"source":"C-kit inhibitor","target":"triple-negative breast cancer","id":"13021"},{"source":"C-kit inhibitor","target":"ovarian cancer","id":"13022"},{"source":"C-kit inhibitor","target":"non-small-cell lung","id":"13023"},{"source":"C-kit inhibitor","target":"skin neoplasms","id":"13024"},{"source":"C-kit inhibitor","target":"squamous cell neoplasms","id":"13025"},{"source":"C-kit inhibitor","target":"non-small-cell lung","id":"13026"},{"source":"C-kit inhibitor","target":"anti-inflammatory","id":"13027"},{"source":"C-kit inhibitor","target":"breast neoplasms","id":"13028"},{"source":"C-kit inhibitor","target":"pancreatic cancer","id":"13029"},{"source":"C-kit inhibitor","target":"sarcoma","id":"13030"},{"source":"C-kit inhibitor","target":"skin neoplasms","id":"13031"},{"source":"C-kit inhibitor","target":"pancreatic cancer","id":"13032"},{"source":"C-kit inhibitor","target":"liver neoplasms","id":"13033"},{"source":"C-kit inhibitor","target":"head and neck neoplasms","id":"13034"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13035"},{"source":"C-kit inhibitor","target":"non-small-cell lung","id":"13036"},{"source":"C-kit inhibitor","target":"melanoma","id":"13037"},{"source":"C-kit inhibitor","target":"bladder cancer","id":"13038"},{"source":"C-kit inhibitor","target":"solid tumors","id":"13039"},{"source":"C-kit inhibitor","target":"antiallergic","id":"13040"},{"source":"C-kit inhibitor","target":"gastrointestinal stromal tumors","id":"13041"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13042"},{"source":"C-kit inhibitor","target":"sarcoma","id":"13043"},{"source":"C-kit inhibitor","target":"breast neoplasms","id":"13044"},{"source":"C-kit inhibitor","target":"colonic neoplasms","id":"13045"},{"source":"C-kit inhibitor","target":"hypersensitivity","id":"13046"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13047"},{"source":"C-kit inhibitor","target":"inflammation","id":"13048"},{"source":"C-kit inhibitor","target":"gastrointestinal stromal tumors","id":"13049"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13050"},{"source":"C-kit inhibitor","target":"sclc","id":"13051"},{"source":"C-kit inhibitor","target":"multiple sclerosis","id":"13052"},{"source":"C-kit inhibitor","target":"liver cancer","id":"13053"},{"source":"C-kit inhibitor","target":"ovarian neoplasms","id":"13054"},{"source":"C-kit inhibitor","target":"cancer squamous cell","id":"13055"},{"source":"C-kit inhibitor","target":"ovarian cancer","id":"13056"},{"source":"C-kit inhibitor","target":"arthritis","id":"13057"},{"source":"C-kit inhibitor","target":"unknown primary","id":"13058"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13059"},{"source":"C-kit inhibitor","target":"gastric cancer","id":"13060"},{"source":"C-kit inhibitor","target":"hepatocellular","id":"13061"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13062"},{"source":"C-kit inhibitor","target":"soft tissue neoplasms","id":"13063"},{"source":"C-kit inhibitor","target":"neoplasm metastasis","id":"13064"},{"source":"C-kit inhibitor","target":"asthma","id":"13065"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13066"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13067"},{"source":"C-kit inhibitor","target":"pancreatic neoplasms","id":"13068"},{"source":"C-kit inhibitor","target":"colorectal neoplasms","id":"13069"},{"source":"C-kit inhibitor","target":"stomach neoplasms","id":"13070"},{"source":"C-kit inhibitor","target":"urinary bladder neoplasms","id":"13071"},{"source":"C-kit inhibitor","target":"triple-negative breast cancer","id":"13072"},{"source":"C-kit inhibitor","target":"residual tumor","id":"13073"},{"source":"C-kit inhibitor","target":"solid malignancy","id":"13074"},{"source":"C-kit inhibitor","target":"carcinoma","id":"13075"},{"source":"C-kit inhibitor","target":"residual tumor","id":"13076"},{"source":"C-kit inhibitor","target":"metastatic","id":"13077"},{"source":"C-kit inhibitor","target":"squamous cell neoplasms","id":"13078"},{"source":"C-kit inhibitor","target":"anticancer","id":"13079"},{"source":"C-kit inhibitor","target":"unknown primary","id":"13080"},{"source":"C-kit inhibitor","target":"antiarthritic","id":"13081"},{"source":"C-kit inhibitor","target":"solid tumors","id":"13082"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"13083"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"13084"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"13085"},{"source":"Oncology: Bladder","target":"Colony stimulating factor 1 receptor antagonist","id":"13086"},{"source":"Oncology: Bladder","target":"NA","id":"13087"},{"source":"Oncology: Bladder","target":"C-kit inhibitor","id":"13088"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"13089"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"13090"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"13091"},{"source":"Oncology: Breast","target":"Colony stimulating factor 1 receptor antagonist","id":"13092"},{"source":"Oncology: Breast","target":"NA","id":"13093"},{"source":"Oncology: Breast","target":"C-kit inhibitor","id":"13094"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"13095"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"13096"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"13097"},{"source":"Oncology: Colorectal","target":"Colony stimulating factor 1 receptor antagonist","id":"13098"},{"source":"Oncology: Colorectal","target":"NA","id":"13099"},{"source":"Oncology: Colorectal","target":"C-kit inhibitor","id":"13100"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"13101"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"13102"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"13103"},{"source":"Oncology: Gastric","target":"Colony stimulating factor 1 receptor antagonist","id":"13104"},{"source":"Oncology: Gastric","target":"NA","id":"13105"},{"source":"Oncology: Gastric","target":"C-kit inhibitor","id":"13106"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"13107"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"13108"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"13109"},{"source":"Oncology: Gastric","target":"Colony stimulating factor 1 receptor antagonist","id":"13110"},{"source":"Oncology: Gastric","target":"NA","id":"13111"},{"source":"Oncology: Gastric","target":"C-kit inhibitor","id":"13112"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"13113"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"13114"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"13115"},{"source":"Oncology: Head/Neck","target":"Colony stimulating factor 1 receptor antagonist","id":"13116"},{"source":"Oncology: Head/Neck","target":"NA","id":"13117"},{"source":"Oncology: Head/Neck","target":"C-kit inhibitor","id":"13118"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"13119"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"13120"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"13121"},{"source":"Oncology: Liver","target":"Colony stimulating factor 1 receptor antagonist","id":"13122"},{"source":"Oncology: Liver","target":"NA","id":"13123"},{"source":"Oncology: Liver","target":"C-kit inhibitor","id":"13124"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"13125"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"13126"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"13127"},{"source":"Oncology: Lung","target":"Colony stimulating factor 1 receptor antagonist","id":"13128"},{"source":"Oncology: Lung","target":"NA","id":"13129"},{"source":"Oncology: Lung","target":"C-kit inhibitor","id":"13130"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"13131"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"13132"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"13133"},{"source":"Non-Small Cell","target":"Colony stimulating factor 1 receptor antagonist","id":"13134"},{"source":"Non-Small Cell","target":"NA","id":"13135"},{"source":"Non-Small Cell","target":"C-kit inhibitor","id":"13136"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"13137"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"13138"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"13139"},{"source":"Oncology: Melanoma","target":"Colony stimulating factor 1 receptor antagonist","id":"13140"},{"source":"Oncology: Melanoma","target":"NA","id":"13141"},{"source":"Oncology: Melanoma","target":"C-kit inhibitor","id":"13142"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"13143"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"13144"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"13145"},{"source":"Oncology: Ovarian","target":"Colony stimulating factor 1 receptor antagonist","id":"13146"},{"source":"Oncology: Ovarian","target":"NA","id":"13147"},{"source":"Oncology: Ovarian","target":"C-kit inhibitor","id":"13148"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"13149"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"13150"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"13151"},{"source":"Oncology: Pancreas","target":"Colony stimulating factor 1 receptor antagonist","id":"13152"},{"source":"Oncology: Pancreas","target":"NA","id":"13153"},{"source":"Oncology: Pancreas","target":"C-kit inhibitor","id":"13154"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"13155"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"13156"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"13157"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Colony stimulating factor 1 receptor antagonist","id":"13158"},{"source":"Oncology: Soft Tissue Sarcoma","target":"NA","id":"13159"},{"source":"Oncology: Soft Tissue Sarcoma","target":"C-kit inhibitor","id":"13160"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"13161"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"13162"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"13163"},{"source":"Oncology: CNS","target":"Colony stimulating factor 1 receptor antagonist","id":"13164"},{"source":"Oncology: CNS","target":"NA","id":"13165"},{"source":"Oncology: CNS","target":"C-kit inhibitor","id":"13166"},{"source":"pembrolizumab","target":"Merck & Co.","id":"13167"},{"source":"cetuximab","target":"Merck & Co.","id":"13168"},{"source":"docetaxel","target":"Merck & Co.","id":"13169"},{"source":"methotrexate (IV)","target":"Merck & Co.","id":"13170"},{"source":"UNK : Indication","target":"pembrolizumab","id":"13171"},{"source":"UNK : Indication","target":"cetuximab","id":"13172"},{"source":"UNK : Indication","target":"docetaxel","id":"13173"},{"source":"UNK : Indication","target":"methotrexate (IV)","id":"13174"},{"source":"larynx cancer","target":"pembrolizumab","id":"13175"},{"source":"larynx cancer","target":"cetuximab","id":"13176"},{"source":"larynx cancer","target":"docetaxel","id":"13177"},{"source":"larynx cancer","target":"methotrexate (IV)","id":"13178"},{"source":"skin neoplasms","target":"pembrolizumab","id":"13179"},{"source":"skin neoplasms","target":"cetuximab","id":"13180"},{"source":"skin neoplasms","target":"docetaxel","id":"13181"},{"source":"skin neoplasms","target":"methotrexate (IV)","id":"13182"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"13183"},{"source":"squamous cell neoplasms","target":"cetuximab","id":"13184"},{"source":"squamous cell neoplasms","target":"docetaxel","id":"13185"},{"source":"squamous cell neoplasms","target":"methotrexate (IV)","id":"13186"},{"source":"psoriasis","target":"pembrolizumab","id":"13187"},{"source":"psoriasis","target":"cetuximab","id":"13188"},{"source":"psoriasis","target":"docetaxel","id":"13189"},{"source":"psoriasis","target":"methotrexate (IV)","id":"13190"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"13191"},{"source":"squamous cell neoplasms","target":"cetuximab","id":"13192"},{"source":"squamous cell neoplasms","target":"docetaxel","id":"13193"},{"source":"squamous cell neoplasms","target":"methotrexate (IV)","id":"13194"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"13195"},{"source":"head and neck neoplasms","target":"cetuximab","id":"13196"},{"source":"head and neck neoplasms","target":"docetaxel","id":"13197"},{"source":"head and neck neoplasms","target":"methotrexate (IV)","id":"13198"},{"source":"carcinoma","target":"pembrolizumab","id":"13199"},{"source":"carcinoma","target":"cetuximab","id":"13200"},{"source":"carcinoma","target":"docetaxel","id":"13201"},{"source":"carcinoma","target":"methotrexate (IV)","id":"13202"},{"source":"head and neck cancer","target":"pembrolizumab","id":"13203"},{"source":"head and neck cancer","target":"cetuximab","id":"13204"},{"source":"head and neck cancer","target":"docetaxel","id":"13205"},{"source":"head and neck cancer","target":"methotrexate (IV)","id":"13206"},{"source":"carcinoma","target":"pembrolizumab","id":"13207"},{"source":"carcinoma","target":"cetuximab","id":"13208"},{"source":"carcinoma","target":"docetaxel","id":"13209"},{"source":"carcinoma","target":"methotrexate (IV)","id":"13210"},{"source":"hpv type","target":"pembrolizumab","id":"13211"},{"source":"hpv type","target":"cetuximab","id":"13212"},{"source":"hpv type","target":"docetaxel","id":"13213"},{"source":"hpv type","target":"methotrexate (IV)","id":"13214"},{"source":"oropharyngeal cancer","target":"pembrolizumab","id":"13215"},{"source":"oropharyngeal cancer","target":"cetuximab","id":"13216"},{"source":"oropharyngeal cancer","target":"docetaxel","id":"13217"},{"source":"oropharyngeal cancer","target":"methotrexate (IV)","id":"13218"},{"source":"psoriasis","target":"pembrolizumab","id":"13219"},{"source":"psoriasis","target":"cetuximab","id":"13220"},{"source":"psoriasis","target":"docetaxel","id":"13221"},{"source":"psoriasis","target":"methotrexate (IV)","id":"13222"},{"source":"papilloma","target":"pembrolizumab","id":"13223"},{"source":"papilloma","target":"cetuximab","id":"13224"},{"source":"papilloma","target":"docetaxel","id":"13225"},{"source":"papilloma","target":"methotrexate (IV)","id":"13226"},{"source":"malaria","target":"pembrolizumab","id":"13227"},{"source":"malaria","target":"cetuximab","id":"13228"},{"source":"malaria","target":"docetaxel","id":"13229"},{"source":"malaria","target":"methotrexate (IV)","id":"13230"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"13231"},{"source":"pharyngeal neoplasms","target":"cetuximab","id":"13232"},{"source":"pharyngeal neoplasms","target":"docetaxel","id":"13233"},{"source":"pharyngeal neoplasms","target":"methotrexate (IV)","id":"13234"},{"source":"arthritis","target":"pembrolizumab","id":"13235"},{"source":"arthritis","target":"cetuximab","id":"13236"},{"source":"arthritis","target":"docetaxel","id":"13237"},{"source":"arthritis","target":"methotrexate (IV)","id":"13238"},{"source":"mouth neoplasms","target":"pembrolizumab","id":"13239"},{"source":"mouth neoplasms","target":"cetuximab","id":"13240"},{"source":"mouth neoplasms","target":"docetaxel","id":"13241"},{"source":"mouth neoplasms","target":"methotrexate (IV)","id":"13242"},{"source":"malaria","target":"pembrolizumab","id":"13243"},{"source":"malaria","target":"cetuximab","id":"13244"},{"source":"malaria","target":"docetaxel","id":"13245"},{"source":"malaria","target":"methotrexate (IV)","id":"13246"},{"source":"carcinoma","target":"pembrolizumab","id":"13247"},{"source":"carcinoma","target":"cetuximab","id":"13248"},{"source":"carcinoma","target":"docetaxel","id":"13249"},{"source":"carcinoma","target":"methotrexate (IV)","id":"13250"},{"source":"hpv testing","target":"pembrolizumab","id":"13251"},{"source":"hpv testing","target":"cetuximab","id":"13252"},{"source":"hpv testing","target":"docetaxel","id":"13253"},{"source":"hpv testing","target":"methotrexate (IV)","id":"13254"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"13255"},{"source":"neoplasm metastasis","target":"cetuximab","id":"13256"},{"source":"neoplasm metastasis","target":"docetaxel","id":"13257"},{"source":"neoplasm metastasis","target":"methotrexate (IV)","id":"13258"},{"source":"carcinoma","target":"pembrolizumab","id":"13259"},{"source":"carcinoma","target":"cetuximab","id":"13260"},{"source":"carcinoma","target":"docetaxel","id":"13261"},{"source":"carcinoma","target":"methotrexate (IV)","id":"13262"},{"source":"antiarthritic","target":"pembrolizumab","id":"13263"},{"source":"antiarthritic","target":"cetuximab","id":"13264"},{"source":"antiarthritic","target":"docetaxel","id":"13265"},{"source":"antiarthritic","target":"methotrexate (IV)","id":"13266"},{"source":"head and neck cancer","target":"pembrolizumab","id":"13267"},{"source":"head and neck cancer","target":"cetuximab","id":"13268"},{"source":"head and neck cancer","target":"docetaxel","id":"13269"},{"source":"head and neck cancer","target":"methotrexate (IV)","id":"13270"},{"source":"larynx cancer","target":"pembrolizumab","id":"13271"},{"source":"larynx cancer","target":"cetuximab","id":"13272"},{"source":"larynx cancer","target":"docetaxel","id":"13273"},{"source":"larynx cancer","target":"methotrexate (IV)","id":"13274"},{"source":"carcinoma","target":"pembrolizumab","id":"13275"},{"source":"carcinoma","target":"cetuximab","id":"13276"},{"source":"carcinoma","target":"docetaxel","id":"13277"},{"source":"carcinoma","target":"methotrexate (IV)","id":"13278"},{"source":"residual tumor","target":"pembrolizumab","id":"13279"},{"source":"residual tumor","target":"cetuximab","id":"13280"},{"source":"residual tumor","target":"docetaxel","id":"13281"},{"source":"residual tumor","target":"methotrexate (IV)","id":"13282"},{"source":"metastatic","target":"pembrolizumab","id":"13283"},{"source":"metastatic","target":"cetuximab","id":"13284"},{"source":"metastatic","target":"docetaxel","id":"13285"},{"source":"metastatic","target":"methotrexate (IV)","id":"13286"},{"source":"anticancer","target":"pembrolizumab","id":"13287"},{"source":"anticancer","target":"cetuximab","id":"13288"},{"source":"anticancer","target":"docetaxel","id":"13289"},{"source":"anticancer","target":"methotrexate (IV)","id":"13290"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"13291"},{"source":"pharyngeal neoplasms","target":"cetuximab","id":"13292"},{"source":"pharyngeal neoplasms","target":"docetaxel","id":"13293"},{"source":"pharyngeal neoplasms","target":"methotrexate (IV)","id":"13294"},{"source":"Immunosuppressant","target":"UNK : Indication","id":"13295"},{"source":"Immunosuppressant","target":"larynx cancer","id":"13296"},{"source":"Immunosuppressant","target":"skin neoplasms","id":"13297"},{"source":"Immunosuppressant","target":"squamous cell neoplasms","id":"13298"},{"source":"Immunosuppressant","target":"psoriasis","id":"13299"},{"source":"Immunosuppressant","target":"squamous cell neoplasms","id":"13300"},{"source":"Immunosuppressant","target":"head and neck neoplasms","id":"13301"},{"source":"Immunosuppressant","target":"carcinoma","id":"13302"},{"source":"Immunosuppressant","target":"head and neck cancer","id":"13303"},{"source":"Immunosuppressant","target":"carcinoma","id":"13304"},{"source":"Immunosuppressant","target":"hpv type","id":"13305"},{"source":"Immunosuppressant","target":"oropharyngeal cancer","id":"13306"},{"source":"Immunosuppressant","target":"psoriasis","id":"13307"},{"source":"Immunosuppressant","target":"papilloma","id":"13308"},{"source":"Immunosuppressant","target":"malaria","id":"13309"},{"source":"Immunosuppressant","target":"pharyngeal neoplasms","id":"13310"},{"source":"Immunosuppressant","target":"arthritis","id":"13311"},{"source":"Immunosuppressant","target":"mouth neoplasms","id":"13312"},{"source":"Immunosuppressant","target":"malaria","id":"13313"},{"source":"Immunosuppressant","target":"carcinoma","id":"13314"},{"source":"Immunosuppressant","target":"hpv testing","id":"13315"},{"source":"Immunosuppressant","target":"neoplasm metastasis","id":"13316"},{"source":"Immunosuppressant","target":"carcinoma","id":"13317"},{"source":"Immunosuppressant","target":"antiarthritic","id":"13318"},{"source":"Immunosuppressant","target":"head and neck cancer","id":"13319"},{"source":"Immunosuppressant","target":"larynx cancer","id":"13320"},{"source":"Immunosuppressant","target":"carcinoma","id":"13321"},{"source":"Immunosuppressant","target":"residual tumor","id":"13322"},{"source":"Immunosuppressant","target":"metastatic","id":"13323"},{"source":"Immunosuppressant","target":"anticancer","id":"13324"},{"source":"Immunosuppressant","target":"pharyngeal neoplasms","id":"13325"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"13326"},{"source":"Dihydrofolate reductase inhibitor","target":"larynx cancer","id":"13327"},{"source":"Dihydrofolate reductase inhibitor","target":"skin neoplasms","id":"13328"},{"source":"Dihydrofolate reductase inhibitor","target":"squamous cell neoplasms","id":"13329"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"13330"},{"source":"Dihydrofolate reductase inhibitor","target":"squamous cell neoplasms","id":"13331"},{"source":"Dihydrofolate reductase inhibitor","target":"head and neck neoplasms","id":"13332"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"13333"},{"source":"Dihydrofolate reductase inhibitor","target":"head and neck cancer","id":"13334"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"13335"},{"source":"Dihydrofolate reductase inhibitor","target":"hpv type","id":"13336"},{"source":"Dihydrofolate reductase inhibitor","target":"oropharyngeal cancer","id":"13337"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"13338"},{"source":"Dihydrofolate reductase inhibitor","target":"papilloma","id":"13339"},{"source":"Dihydrofolate reductase inhibitor","target":"malaria","id":"13340"},{"source":"Dihydrofolate reductase inhibitor","target":"pharyngeal neoplasms","id":"13341"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"13342"},{"source":"Dihydrofolate reductase inhibitor","target":"mouth neoplasms","id":"13343"},{"source":"Dihydrofolate reductase inhibitor","target":"malaria","id":"13344"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"13345"},{"source":"Dihydrofolate reductase inhibitor","target":"hpv testing","id":"13346"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"13347"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"13348"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"13349"},{"source":"Dihydrofolate reductase inhibitor","target":"head and neck cancer","id":"13350"},{"source":"Dihydrofolate reductase inhibitor","target":"larynx cancer","id":"13351"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"13352"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"13353"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"13354"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"13355"},{"source":"Dihydrofolate reductase inhibitor","target":"pharyngeal neoplasms","id":"13356"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"13357"},{"source":"Immune checkpoint inhibitor","target":"larynx cancer","id":"13358"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"13359"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"13360"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"13361"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"13362"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"13363"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"13364"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"13365"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"13366"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"13367"},{"source":"Immune checkpoint inhibitor","target":"oropharyngeal cancer","id":"13368"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"13369"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"13370"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"13371"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"13372"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"13373"},{"source":"Immune checkpoint inhibitor","target":"mouth neoplasms","id":"13374"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"13375"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"13376"},{"source":"Immune checkpoint inhibitor","target":"hpv testing","id":"13377"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"13378"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"13379"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"13380"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"13381"},{"source":"Immune checkpoint inhibitor","target":"larynx cancer","id":"13382"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"13383"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"13384"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"13385"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"13386"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"13387"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"13388"},{"source":"Anticancer immunotherapy","target":"larynx cancer","id":"13389"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"13390"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"13391"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"13392"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"13393"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"13394"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"13395"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"13396"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"13397"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"13398"},{"source":"Anticancer immunotherapy","target":"oropharyngeal cancer","id":"13399"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"13400"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"13401"},{"source":"Anticancer immunotherapy","target":"malaria","id":"13402"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"13403"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"13404"},{"source":"Anticancer immunotherapy","target":"mouth neoplasms","id":"13405"},{"source":"Anticancer immunotherapy","target":"malaria","id":"13406"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"13407"},{"source":"Anticancer immunotherapy","target":"hpv testing","id":"13408"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"13409"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"13410"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"13411"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"13412"},{"source":"Anticancer immunotherapy","target":"larynx cancer","id":"13413"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"13414"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"13415"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"13416"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"13417"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"13418"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"13419"},{"source":"CD19 antagonist","target":"larynx cancer","id":"13420"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"13421"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"13422"},{"source":"CD19 antagonist","target":"psoriasis","id":"13423"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"13424"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"13425"},{"source":"CD19 antagonist","target":"carcinoma","id":"13426"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"13427"},{"source":"CD19 antagonist","target":"carcinoma","id":"13428"},{"source":"CD19 antagonist","target":"hpv type","id":"13429"},{"source":"CD19 antagonist","target":"oropharyngeal cancer","id":"13430"},{"source":"CD19 antagonist","target":"psoriasis","id":"13431"},{"source":"CD19 antagonist","target":"papilloma","id":"13432"},{"source":"CD19 antagonist","target":"malaria","id":"13433"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"13434"},{"source":"CD19 antagonist","target":"arthritis","id":"13435"},{"source":"CD19 antagonist","target":"mouth neoplasms","id":"13436"},{"source":"CD19 antagonist","target":"malaria","id":"13437"},{"source":"CD19 antagonist","target":"carcinoma","id":"13438"},{"source":"CD19 antagonist","target":"hpv testing","id":"13439"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"13440"},{"source":"CD19 antagonist","target":"carcinoma","id":"13441"},{"source":"CD19 antagonist","target":"antiarthritic","id":"13442"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"13443"},{"source":"CD19 antagonist","target":"larynx cancer","id":"13444"},{"source":"CD19 antagonist","target":"carcinoma","id":"13445"},{"source":"CD19 antagonist","target":"residual tumor","id":"13446"},{"source":"CD19 antagonist","target":"metastatic","id":"13447"},{"source":"CD19 antagonist","target":"anticancer","id":"13448"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"13449"},{"source":"Disease modifying antirheumatic drug","target":"UNK : Indication","id":"13450"},{"source":"Disease modifying antirheumatic drug","target":"larynx cancer","id":"13451"},{"source":"Disease modifying antirheumatic drug","target":"skin neoplasms","id":"13452"},{"source":"Disease modifying antirheumatic drug","target":"squamous cell neoplasms","id":"13453"},{"source":"Disease modifying antirheumatic drug","target":"psoriasis","id":"13454"},{"source":"Disease modifying antirheumatic drug","target":"squamous cell neoplasms","id":"13455"},{"source":"Disease modifying antirheumatic drug","target":"head and neck neoplasms","id":"13456"},{"source":"Disease modifying antirheumatic drug","target":"carcinoma","id":"13457"},{"source":"Disease modifying antirheumatic drug","target":"head and neck cancer","id":"13458"},{"source":"Disease modifying antirheumatic drug","target":"carcinoma","id":"13459"},{"source":"Disease modifying antirheumatic drug","target":"hpv type","id":"13460"},{"source":"Disease modifying antirheumatic drug","target":"oropharyngeal cancer","id":"13461"},{"source":"Disease modifying antirheumatic drug","target":"psoriasis","id":"13462"},{"source":"Disease modifying antirheumatic drug","target":"papilloma","id":"13463"},{"source":"Disease modifying antirheumatic drug","target":"malaria","id":"13464"},{"source":"Disease modifying antirheumatic drug","target":"pharyngeal neoplasms","id":"13465"},{"source":"Disease modifying antirheumatic drug","target":"arthritis","id":"13466"},{"source":"Disease modifying antirheumatic drug","target":"mouth neoplasms","id":"13467"},{"source":"Disease modifying antirheumatic drug","target":"malaria","id":"13468"},{"source":"Disease modifying antirheumatic drug","target":"carcinoma","id":"13469"},{"source":"Disease modifying antirheumatic drug","target":"hpv testing","id":"13470"},{"source":"Disease modifying antirheumatic drug","target":"neoplasm metastasis","id":"13471"},{"source":"Disease modifying antirheumatic drug","target":"carcinoma","id":"13472"},{"source":"Disease modifying antirheumatic drug","target":"antiarthritic","id":"13473"},{"source":"Disease modifying antirheumatic drug","target":"head and neck cancer","id":"13474"},{"source":"Disease modifying antirheumatic drug","target":"larynx cancer","id":"13475"},{"source":"Disease modifying antirheumatic drug","target":"carcinoma","id":"13476"},{"source":"Disease modifying antirheumatic drug","target":"residual tumor","id":"13477"},{"source":"Disease modifying antirheumatic drug","target":"metastatic","id":"13478"},{"source":"Disease modifying antirheumatic drug","target":"anticancer","id":"13479"},{"source":"Disease modifying antirheumatic drug","target":"pharyngeal neoplasms","id":"13480"},{"source":"Taxane","target":"UNK : Indication","id":"13481"},{"source":"Taxane","target":"larynx cancer","id":"13482"},{"source":"Taxane","target":"skin neoplasms","id":"13483"},{"source":"Taxane","target":"squamous cell neoplasms","id":"13484"},{"source":"Taxane","target":"psoriasis","id":"13485"},{"source":"Taxane","target":"squamous cell neoplasms","id":"13486"},{"source":"Taxane","target":"head and neck neoplasms","id":"13487"},{"source":"Taxane","target":"carcinoma","id":"13488"},{"source":"Taxane","target":"head and neck cancer","id":"13489"},{"source":"Taxane","target":"carcinoma","id":"13490"},{"source":"Taxane","target":"hpv type","id":"13491"},{"source":"Taxane","target":"oropharyngeal cancer","id":"13492"},{"source":"Taxane","target":"psoriasis","id":"13493"},{"source":"Taxane","target":"papilloma","id":"13494"},{"source":"Taxane","target":"malaria","id":"13495"},{"source":"Taxane","target":"pharyngeal neoplasms","id":"13496"},{"source":"Taxane","target":"arthritis","id":"13497"},{"source":"Taxane","target":"mouth neoplasms","id":"13498"},{"source":"Taxane","target":"malaria","id":"13499"},{"source":"Taxane","target":"carcinoma","id":"13500"},{"source":"Taxane","target":"hpv testing","id":"13501"},{"source":"Taxane","target":"neoplasm metastasis","id":"13502"},{"source":"Taxane","target":"carcinoma","id":"13503"},{"source":"Taxane","target":"antiarthritic","id":"13504"},{"source":"Taxane","target":"head and neck cancer","id":"13505"},{"source":"Taxane","target":"larynx cancer","id":"13506"},{"source":"Taxane","target":"carcinoma","id":"13507"},{"source":"Taxane","target":"residual tumor","id":"13508"},{"source":"Taxane","target":"metastatic","id":"13509"},{"source":"Taxane","target":"anticancer","id":"13510"},{"source":"Taxane","target":"pharyngeal neoplasms","id":"13511"},{"source":"EGFR antagonist","target":"UNK : Indication","id":"13512"},{"source":"EGFR antagonist","target":"larynx cancer","id":"13513"},{"source":"EGFR antagonist","target":"skin neoplasms","id":"13514"},{"source":"EGFR antagonist","target":"squamous cell neoplasms","id":"13515"},{"source":"EGFR antagonist","target":"psoriasis","id":"13516"},{"source":"EGFR antagonist","target":"squamous cell neoplasms","id":"13517"},{"source":"EGFR antagonist","target":"head and neck neoplasms","id":"13518"},{"source":"EGFR antagonist","target":"carcinoma","id":"13519"},{"source":"EGFR antagonist","target":"head and neck cancer","id":"13520"},{"source":"EGFR antagonist","target":"carcinoma","id":"13521"},{"source":"EGFR antagonist","target":"hpv type","id":"13522"},{"source":"EGFR antagonist","target":"oropharyngeal cancer","id":"13523"},{"source":"EGFR antagonist","target":"psoriasis","id":"13524"},{"source":"EGFR antagonist","target":"papilloma","id":"13525"},{"source":"EGFR antagonist","target":"malaria","id":"13526"},{"source":"EGFR antagonist","target":"pharyngeal neoplasms","id":"13527"},{"source":"EGFR antagonist","target":"arthritis","id":"13528"},{"source":"EGFR antagonist","target":"mouth neoplasms","id":"13529"},{"source":"EGFR antagonist","target":"malaria","id":"13530"},{"source":"EGFR antagonist","target":"carcinoma","id":"13531"},{"source":"EGFR antagonist","target":"hpv testing","id":"13532"},{"source":"EGFR antagonist","target":"neoplasm metastasis","id":"13533"},{"source":"EGFR antagonist","target":"carcinoma","id":"13534"},{"source":"EGFR antagonist","target":"antiarthritic","id":"13535"},{"source":"EGFR antagonist","target":"head and neck cancer","id":"13536"},{"source":"EGFR antagonist","target":"larynx cancer","id":"13537"},{"source":"EGFR antagonist","target":"carcinoma","id":"13538"},{"source":"EGFR antagonist","target":"residual tumor","id":"13539"},{"source":"EGFR antagonist","target":"metastatic","id":"13540"},{"source":"EGFR antagonist","target":"anticancer","id":"13541"},{"source":"EGFR antagonist","target":"pharyngeal neoplasms","id":"13542"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"13543"},{"source":"Microtubule stimulant","target":"larynx cancer","id":"13544"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"13545"},{"source":"Microtubule stimulant","target":"squamous cell neoplasms","id":"13546"},{"source":"Microtubule stimulant","target":"psoriasis","id":"13547"},{"source":"Microtubule stimulant","target":"squamous cell neoplasms","id":"13548"},{"source":"Microtubule stimulant","target":"head and neck neoplasms","id":"13549"},{"source":"Microtubule stimulant","target":"carcinoma","id":"13550"},{"source":"Microtubule stimulant","target":"head and neck cancer","id":"13551"},{"source":"Microtubule stimulant","target":"carcinoma","id":"13552"},{"source":"Microtubule stimulant","target":"hpv type","id":"13553"},{"source":"Microtubule stimulant","target":"oropharyngeal cancer","id":"13554"},{"source":"Microtubule stimulant","target":"psoriasis","id":"13555"},{"source":"Microtubule stimulant","target":"papilloma","id":"13556"},{"source":"Microtubule stimulant","target":"malaria","id":"13557"},{"source":"Microtubule stimulant","target":"pharyngeal neoplasms","id":"13558"},{"source":"Microtubule stimulant","target":"arthritis","id":"13559"},{"source":"Microtubule stimulant","target":"mouth neoplasms","id":"13560"},{"source":"Microtubule stimulant","target":"malaria","id":"13561"},{"source":"Microtubule stimulant","target":"carcinoma","id":"13562"},{"source":"Microtubule stimulant","target":"hpv testing","id":"13563"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"13564"},{"source":"Microtubule stimulant","target":"carcinoma","id":"13565"},{"source":"Microtubule stimulant","target":"antiarthritic","id":"13566"},{"source":"Microtubule stimulant","target":"head and neck cancer","id":"13567"},{"source":"Microtubule stimulant","target":"larynx cancer","id":"13568"},{"source":"Microtubule stimulant","target":"carcinoma","id":"13569"},{"source":"Microtubule stimulant","target":"residual tumor","id":"13570"},{"source":"Microtubule stimulant","target":"metastatic","id":"13571"},{"source":"Microtubule stimulant","target":"anticancer","id":"13572"},{"source":"Microtubule stimulant","target":"pharyngeal neoplasms","id":"13573"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"13574"},{"source":"Tubulin inhibitor","target":"larynx cancer","id":"13575"},{"source":"Tubulin inhibitor","target":"skin neoplasms","id":"13576"},{"source":"Tubulin inhibitor","target":"squamous cell neoplasms","id":"13577"},{"source":"Tubulin inhibitor","target":"psoriasis","id":"13578"},{"source":"Tubulin inhibitor","target":"squamous cell neoplasms","id":"13579"},{"source":"Tubulin inhibitor","target":"head and neck neoplasms","id":"13580"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"13581"},{"source":"Tubulin inhibitor","target":"head and neck cancer","id":"13582"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"13583"},{"source":"Tubulin inhibitor","target":"hpv type","id":"13584"},{"source":"Tubulin inhibitor","target":"oropharyngeal cancer","id":"13585"},{"source":"Tubulin inhibitor","target":"psoriasis","id":"13586"},{"source":"Tubulin inhibitor","target":"papilloma","id":"13587"},{"source":"Tubulin inhibitor","target":"malaria","id":"13588"},{"source":"Tubulin inhibitor","target":"pharyngeal neoplasms","id":"13589"},{"source":"Tubulin inhibitor","target":"arthritis","id":"13590"},{"source":"Tubulin inhibitor","target":"mouth neoplasms","id":"13591"},{"source":"Tubulin inhibitor","target":"malaria","id":"13592"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"13593"},{"source":"Tubulin inhibitor","target":"hpv testing","id":"13594"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"13595"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"13596"},{"source":"Tubulin inhibitor","target":"antiarthritic","id":"13597"},{"source":"Tubulin inhibitor","target":"head and neck cancer","id":"13598"},{"source":"Tubulin inhibitor","target":"larynx cancer","id":"13599"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"13600"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"13601"},{"source":"Tubulin inhibitor","target":"metastatic","id":"13602"},{"source":"Tubulin inhibitor","target":"anticancer","id":"13603"},{"source":"Tubulin inhibitor","target":"pharyngeal neoplasms","id":"13604"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"13605"},{"source":"Thymidylate synthase inhibitor","target":"larynx cancer","id":"13606"},{"source":"Thymidylate synthase inhibitor","target":"skin neoplasms","id":"13607"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"13608"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"13609"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"13610"},{"source":"Thymidylate synthase inhibitor","target":"head and neck neoplasms","id":"13611"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"13612"},{"source":"Thymidylate synthase inhibitor","target":"head and neck cancer","id":"13613"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"13614"},{"source":"Thymidylate synthase inhibitor","target":"hpv type","id":"13615"},{"source":"Thymidylate synthase inhibitor","target":"oropharyngeal cancer","id":"13616"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"13617"},{"source":"Thymidylate synthase inhibitor","target":"papilloma","id":"13618"},{"source":"Thymidylate synthase inhibitor","target":"malaria","id":"13619"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"13620"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"13621"},{"source":"Thymidylate synthase inhibitor","target":"mouth neoplasms","id":"13622"},{"source":"Thymidylate synthase inhibitor","target":"malaria","id":"13623"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"13624"},{"source":"Thymidylate synthase inhibitor","target":"hpv testing","id":"13625"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"13626"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"13627"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"13628"},{"source":"Thymidylate synthase inhibitor","target":"head and neck cancer","id":"13629"},{"source":"Thymidylate synthase inhibitor","target":"larynx cancer","id":"13630"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"13631"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"13632"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"13633"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"13634"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"13635"},{"source":"Oncology: Head/Neck","target":"Immunosuppressant","id":"13636"},{"source":"Oncology: Head/Neck","target":"Dihydrofolate reductase inhibitor","id":"13637"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"13638"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"13639"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"13640"},{"source":"Oncology: Head/Neck","target":"Disease modifying antirheumatic drug","id":"13641"},{"source":"Oncology: Head/Neck","target":"Taxane","id":"13642"},{"source":"Oncology: Head/Neck","target":"EGFR antagonist","id":"13643"},{"source":"Oncology: Head/Neck","target":"Microtubule stimulant","id":"13644"},{"source":"Oncology: Head/Neck","target":"Tubulin inhibitor","id":"13645"},{"source":"Oncology: Head/Neck","target":"Thymidylate synthase inhibitor","id":"13646"},{"source":"pembrolizumab","target":"Merck & Co.","id":"13647"},{"source":"docetaxel","target":"Merck & Co.","id":"13648"},{"source":"pembrolizumab","target":"Merck & Co.","id":"13649"},{"source":"companion diagnostic","target":"Merck & Co.","id":"13650"},{"source":"UNK : Indication","target":"pembrolizumab","id":"13651"},{"source":"UNK : Indication","target":"docetaxel","id":"13652"},{"source":"UNK : Indication","target":"pembrolizumab","id":"13653"},{"source":"UNK : Indication","target":"companion diagnostic","id":"13654"},{"source":"residual tumor","target":"pembrolizumab","id":"13655"},{"source":"residual tumor","target":"docetaxel","id":"13656"},{"source":"residual tumor","target":"pembrolizumab","id":"13657"},{"source":"residual tumor","target":"companion diagnostic","id":"13658"},{"source":"solid tumors","target":"pembrolizumab","id":"13659"},{"source":"solid tumors","target":"docetaxel","id":"13660"},{"source":"solid tumors","target":"pembrolizumab","id":"13661"},{"source":"solid tumors","target":"companion diagnostic","id":"13662"},{"source":"malaria","target":"pembrolizumab","id":"13663"},{"source":"malaria","target":"docetaxel","id":"13664"},{"source":"malaria","target":"pembrolizumab","id":"13665"},{"source":"malaria","target":"companion diagnostic","id":"13666"},{"source":"alopecia","target":"pembrolizumab","id":"13667"},{"source":"alopecia","target":"docetaxel","id":"13668"},{"source":"alopecia","target":"pembrolizumab","id":"13669"},{"source":"alopecia","target":"companion diagnostic","id":"13670"},{"source":"residual tumor","target":"pembrolizumab","id":"13671"},{"source":"residual tumor","target":"docetaxel","id":"13672"},{"source":"residual tumor","target":"pembrolizumab","id":"13673"},{"source":"residual tumor","target":"companion diagnostic","id":"13674"},{"source":"carcinoma","target":"pembrolizumab","id":"13675"},{"source":"carcinoma","target":"docetaxel","id":"13676"},{"source":"carcinoma","target":"pembrolizumab","id":"13677"},{"source":"carcinoma","target":"companion diagnostic","id":"13678"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"13679"},{"source":"non-small-cell lung","target":"docetaxel","id":"13680"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"13681"},{"source":"non-small-cell lung","target":"companion diagnostic","id":"13682"},{"source":"malaria","target":"pembrolizumab","id":"13683"},{"source":"malaria","target":"docetaxel","id":"13684"},{"source":"malaria","target":"pembrolizumab","id":"13685"},{"source":"malaria","target":"companion diagnostic","id":"13686"},{"source":"carcinoma","target":"pembrolizumab","id":"13687"},{"source":"carcinoma","target":"docetaxel","id":"13688"},{"source":"carcinoma","target":"pembrolizumab","id":"13689"},{"source":"carcinoma","target":"companion diagnostic","id":"13690"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"13691"},{"source":"non-small-cell lung","target":"docetaxel","id":"13692"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"13693"},{"source":"non-small-cell lung","target":"companion diagnostic","id":"13694"},{"source":"anticancer","target":"pembrolizumab","id":"13695"},{"source":"anticancer","target":"docetaxel","id":"13696"},{"source":"anticancer","target":"pembrolizumab","id":"13697"},{"source":"anticancer","target":"companion diagnostic","id":"13698"},{"source":"lung neoplasms","target":"pembrolizumab","id":"13699"},{"source":"lung neoplasms","target":"docetaxel","id":"13700"},{"source":"lung neoplasms","target":"pembrolizumab","id":"13701"},{"source":"lung neoplasms","target":"companion diagnostic","id":"13702"},{"source":"sclc","target":"pembrolizumab","id":"13703"},{"source":"sclc","target":"docetaxel","id":"13704"},{"source":"sclc","target":"pembrolizumab","id":"13705"},{"source":"sclc","target":"companion diagnostic","id":"13706"},{"source":"solid tumors","target":"pembrolizumab","id":"13707"},{"source":"solid tumors","target":"docetaxel","id":"13708"},{"source":"solid tumors","target":"pembrolizumab","id":"13709"},{"source":"solid tumors","target":"companion diagnostic","id":"13710"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"13711"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"13712"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"13713"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"13714"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"13715"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"13716"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"13717"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"13718"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"13719"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"13720"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"13721"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"13722"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"13723"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"13724"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"13725"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"13726"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"13727"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"13728"},{"source":"Anticancer immunotherapy","target":"malaria","id":"13729"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"13730"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"13731"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"13732"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"13733"},{"source":"Anticancer immunotherapy","target":"malaria","id":"13734"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"13735"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"13736"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"13737"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"13738"},{"source":"Anticancer immunotherapy","target":"sclc","id":"13739"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"13740"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"13741"},{"source":"CD19 antagonist","target":"residual tumor","id":"13742"},{"source":"CD19 antagonist","target":"solid tumors","id":"13743"},{"source":"CD19 antagonist","target":"malaria","id":"13744"},{"source":"CD19 antagonist","target":"alopecia","id":"13745"},{"source":"CD19 antagonist","target":"residual tumor","id":"13746"},{"source":"CD19 antagonist","target":"carcinoma","id":"13747"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"13748"},{"source":"CD19 antagonist","target":"malaria","id":"13749"},{"source":"CD19 antagonist","target":"carcinoma","id":"13750"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"13751"},{"source":"CD19 antagonist","target":"anticancer","id":"13752"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"13753"},{"source":"CD19 antagonist","target":"sclc","id":"13754"},{"source":"CD19 antagonist","target":"solid tumors","id":"13755"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"13756"},{"source":"Microtubule stimulant","target":"residual tumor","id":"13757"},{"source":"Microtubule stimulant","target":"solid tumors","id":"13758"},{"source":"Microtubule stimulant","target":"malaria","id":"13759"},{"source":"Microtubule stimulant","target":"alopecia","id":"13760"},{"source":"Microtubule stimulant","target":"residual tumor","id":"13761"},{"source":"Microtubule stimulant","target":"carcinoma","id":"13762"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"13763"},{"source":"Microtubule stimulant","target":"malaria","id":"13764"},{"source":"Microtubule stimulant","target":"carcinoma","id":"13765"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"13766"},{"source":"Microtubule stimulant","target":"anticancer","id":"13767"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"13768"},{"source":"Microtubule stimulant","target":"sclc","id":"13769"},{"source":"Microtubule stimulant","target":"solid tumors","id":"13770"},{"source":"NA","target":"UNK : Indication","id":"13771"},{"source":"NA","target":"residual tumor","id":"13772"},{"source":"NA","target":"solid tumors","id":"13773"},{"source":"NA","target":"malaria","id":"13774"},{"source":"NA","target":"alopecia","id":"13775"},{"source":"NA","target":"residual tumor","id":"13776"},{"source":"NA","target":"carcinoma","id":"13777"},{"source":"NA","target":"non-small-cell lung","id":"13778"},{"source":"NA","target":"malaria","id":"13779"},{"source":"NA","target":"carcinoma","id":"13780"},{"source":"NA","target":"non-small-cell lung","id":"13781"},{"source":"NA","target":"anticancer","id":"13782"},{"source":"NA","target":"lung neoplasms","id":"13783"},{"source":"NA","target":"sclc","id":"13784"},{"source":"NA","target":"solid tumors","id":"13785"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"13786"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"13787"},{"source":"Tubulin inhibitor","target":"solid tumors","id":"13788"},{"source":"Tubulin inhibitor","target":"malaria","id":"13789"},{"source":"Tubulin inhibitor","target":"alopecia","id":"13790"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"13791"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"13792"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"13793"},{"source":"Tubulin inhibitor","target":"malaria","id":"13794"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"13795"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"13796"},{"source":"Tubulin inhibitor","target":"anticancer","id":"13797"},{"source":"Tubulin inhibitor","target":"lung neoplasms","id":"13798"},{"source":"Tubulin inhibitor","target":"sclc","id":"13799"},{"source":"Tubulin inhibitor","target":"solid tumors","id":"13800"},{"source":"Taxane","target":"UNK : Indication","id":"13801"},{"source":"Taxane","target":"residual tumor","id":"13802"},{"source":"Taxane","target":"solid tumors","id":"13803"},{"source":"Taxane","target":"malaria","id":"13804"},{"source":"Taxane","target":"alopecia","id":"13805"},{"source":"Taxane","target":"residual tumor","id":"13806"},{"source":"Taxane","target":"carcinoma","id":"13807"},{"source":"Taxane","target":"non-small-cell lung","id":"13808"},{"source":"Taxane","target":"malaria","id":"13809"},{"source":"Taxane","target":"carcinoma","id":"13810"},{"source":"Taxane","target":"non-small-cell lung","id":"13811"},{"source":"Taxane","target":"anticancer","id":"13812"},{"source":"Taxane","target":"lung neoplasms","id":"13813"},{"source":"Taxane","target":"sclc","id":"13814"},{"source":"Taxane","target":"solid tumors","id":"13815"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"13816"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"13817"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"13818"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"13819"},{"source":"Oncology: Lung","target":"NA","id":"13820"},{"source":"Oncology: Lung","target":"Tubulin inhibitor","id":"13821"},{"source":"Oncology: Lung","target":"Taxane","id":"13822"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"13823"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"13824"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"13825"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"13826"},{"source":"Non-Small Cell","target":"NA","id":"13827"},{"source":"Non-Small Cell","target":"Tubulin inhibitor","id":"13828"},{"source":"Non-Small Cell","target":"Taxane","id":"13829"},{"source":"lenvatinib (capsule) (a)","target":"Eisai","id":"13830"},{"source":"UNK : Drug","target":"Eisai","id":"13831"},{"source":"hepatocellular","target":"lenvatinib (capsule) (a)","id":"13832"},{"source":"hepatocellular","target":"UNK : Drug","id":"13833"},{"source":"antihypertensive","target":"lenvatinib (capsule) (a)","id":"13834"},{"source":"antihypertensive","target":"UNK : Drug","id":"13835"},{"source":"anticancer","target":"lenvatinib (capsule) (a)","id":"13836"},{"source":"anticancer","target":"UNK : Drug","id":"13837"},{"source":"chronic hepatitis b","target":"lenvatinib (capsule) (a)","id":"13838"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"13839"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"13840"},{"source":"solid tumors","target":"UNK : Drug","id":"13841"},{"source":"myelofibrosis","target":"lenvatinib (capsule) (a)","id":"13842"},{"source":"myelofibrosis","target":"UNK : Drug","id":"13843"},{"source":"residual tumor","target":"lenvatinib (capsule) (a)","id":"13844"},{"source":"residual tumor","target":"UNK : Drug","id":"13845"},{"source":"hcc","target":"lenvatinib (capsule) (a)","id":"13846"},{"source":"hcc","target":"UNK : Drug","id":"13847"},{"source":"liver diseases","target":"lenvatinib (capsule) (a)","id":"13848"},{"source":"liver diseases","target":"UNK : Drug","id":"13849"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"13850"},{"source":"carcinoma","target":"UNK : Drug","id":"13851"},{"source":"chronic hepatitis b","target":"lenvatinib (capsule) (a)","id":"13852"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"13853"},{"source":"liver cirrhosis","target":"lenvatinib (capsule) (a)","id":"13854"},{"source":"liver cirrhosis","target":"UNK : Drug","id":"13855"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"13856"},{"source":"carcinoma","target":"UNK : Drug","id":"13857"},{"source":"hypertension","target":"lenvatinib (capsule) (a)","id":"13858"},{"source":"hypertension","target":"UNK : Drug","id":"13859"},{"source":"liver cirrhosis","target":"lenvatinib (capsule) (a)","id":"13860"},{"source":"liver cirrhosis","target":"UNK : Drug","id":"13861"},{"source":"liver cancer","target":"lenvatinib (capsule) (a)","id":"13862"},{"source":"liver cancer","target":"UNK : Drug","id":"13863"},{"source":"liver neoplasms","target":"lenvatinib (capsule) (a)","id":"13864"},{"source":"liver neoplasms","target":"UNK : Drug","id":"13865"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"13866"},{"source":"solid tumors","target":"UNK : Drug","id":"13867"},{"source":"NA","target":"hepatocellular","id":"13868"},{"source":"NA","target":"antihypertensive","id":"13869"},{"source":"NA","target":"anticancer","id":"13870"},{"source":"NA","target":"chronic hepatitis b","id":"13871"},{"source":"NA","target":"solid tumors","id":"13872"},{"source":"NA","target":"myelofibrosis","id":"13873"},{"source":"NA","target":"residual tumor","id":"13874"},{"source":"NA","target":"hcc","id":"13875"},{"source":"NA","target":"liver diseases","id":"13876"},{"source":"NA","target":"carcinoma","id":"13877"},{"source":"NA","target":"chronic hepatitis b","id":"13878"},{"source":"NA","target":"liver cirrhosis","id":"13879"},{"source":"NA","target":"carcinoma","id":"13880"},{"source":"NA","target":"hypertension","id":"13881"},{"source":"NA","target":"liver cirrhosis","id":"13882"},{"source":"NA","target":"liver cancer","id":"13883"},{"source":"NA","target":"liver neoplasms","id":"13884"},{"source":"NA","target":"solid tumors","id":"13885"},{"source":"NA","target":"hepatocellular","id":"13886"},{"source":"NA","target":"antihypertensive","id":"13887"},{"source":"NA","target":"anticancer","id":"13888"},{"source":"NA","target":"chronic hepatitis b","id":"13889"},{"source":"NA","target":"solid tumors","id":"13890"},{"source":"NA","target":"myelofibrosis","id":"13891"},{"source":"NA","target":"residual tumor","id":"13892"},{"source":"NA","target":"hcc","id":"13893"},{"source":"NA","target":"liver diseases","id":"13894"},{"source":"NA","target":"carcinoma","id":"13895"},{"source":"NA","target":"chronic hepatitis b","id":"13896"},{"source":"NA","target":"liver cirrhosis","id":"13897"},{"source":"NA","target":"carcinoma","id":"13898"},{"source":"NA","target":"hypertension","id":"13899"},{"source":"NA","target":"liver cirrhosis","id":"13900"},{"source":"NA","target":"liver cancer","id":"13901"},{"source":"NA","target":"liver neoplasms","id":"13902"},{"source":"NA","target":"solid tumors","id":"13903"},{"source":"NA","target":"hepatocellular","id":"13904"},{"source":"NA","target":"antihypertensive","id":"13905"},{"source":"NA","target":"anticancer","id":"13906"},{"source":"NA","target":"chronic hepatitis b","id":"13907"},{"source":"NA","target":"solid tumors","id":"13908"},{"source":"NA","target":"myelofibrosis","id":"13909"},{"source":"NA","target":"residual tumor","id":"13910"},{"source":"NA","target":"hcc","id":"13911"},{"source":"NA","target":"liver diseases","id":"13912"},{"source":"NA","target":"carcinoma","id":"13913"},{"source":"NA","target":"chronic hepatitis b","id":"13914"},{"source":"NA","target":"liver cirrhosis","id":"13915"},{"source":"NA","target":"carcinoma","id":"13916"},{"source":"NA","target":"hypertension","id":"13917"},{"source":"NA","target":"liver cirrhosis","id":"13918"},{"source":"NA","target":"liver cancer","id":"13919"},{"source":"NA","target":"liver neoplasms","id":"13920"},{"source":"NA","target":"solid tumors","id":"13921"},{"source":"NA","target":"hepatocellular","id":"13922"},{"source":"NA","target":"antihypertensive","id":"13923"},{"source":"NA","target":"anticancer","id":"13924"},{"source":"NA","target":"chronic hepatitis b","id":"13925"},{"source":"NA","target":"solid tumors","id":"13926"},{"source":"NA","target":"myelofibrosis","id":"13927"},{"source":"NA","target":"residual tumor","id":"13928"},{"source":"NA","target":"hcc","id":"13929"},{"source":"NA","target":"liver diseases","id":"13930"},{"source":"NA","target":"carcinoma","id":"13931"},{"source":"NA","target":"chronic hepatitis b","id":"13932"},{"source":"NA","target":"liver cirrhosis","id":"13933"},{"source":"NA","target":"carcinoma","id":"13934"},{"source":"NA","target":"hypertension","id":"13935"},{"source":"NA","target":"liver cirrhosis","id":"13936"},{"source":"NA","target":"liver cancer","id":"13937"},{"source":"NA","target":"liver neoplasms","id":"13938"},{"source":"NA","target":"solid tumors","id":"13939"},{"source":"NA","target":"hepatocellular","id":"13940"},{"source":"NA","target":"antihypertensive","id":"13941"},{"source":"NA","target":"anticancer","id":"13942"},{"source":"NA","target":"chronic hepatitis b","id":"13943"},{"source":"NA","target":"solid tumors","id":"13944"},{"source":"NA","target":"myelofibrosis","id":"13945"},{"source":"NA","target":"residual tumor","id":"13946"},{"source":"NA","target":"hcc","id":"13947"},{"source":"NA","target":"liver diseases","id":"13948"},{"source":"NA","target":"carcinoma","id":"13949"},{"source":"NA","target":"chronic hepatitis b","id":"13950"},{"source":"NA","target":"liver cirrhosis","id":"13951"},{"source":"NA","target":"carcinoma","id":"13952"},{"source":"NA","target":"hypertension","id":"13953"},{"source":"NA","target":"liver cirrhosis","id":"13954"},{"source":"NA","target":"liver cancer","id":"13955"},{"source":"NA","target":"liver neoplasms","id":"13956"},{"source":"NA","target":"solid tumors","id":"13957"},{"source":"NA","target":"hepatocellular","id":"13958"},{"source":"NA","target":"antihypertensive","id":"13959"},{"source":"NA","target":"anticancer","id":"13960"},{"source":"NA","target":"chronic hepatitis b","id":"13961"},{"source":"NA","target":"solid tumors","id":"13962"},{"source":"NA","target":"myelofibrosis","id":"13963"},{"source":"NA","target":"residual tumor","id":"13964"},{"source":"NA","target":"hcc","id":"13965"},{"source":"NA","target":"liver diseases","id":"13966"},{"source":"NA","target":"carcinoma","id":"13967"},{"source":"NA","target":"chronic hepatitis b","id":"13968"},{"source":"NA","target":"liver cirrhosis","id":"13969"},{"source":"NA","target":"carcinoma","id":"13970"},{"source":"NA","target":"hypertension","id":"13971"},{"source":"NA","target":"liver cirrhosis","id":"13972"},{"source":"NA","target":"liver cancer","id":"13973"},{"source":"NA","target":"liver neoplasms","id":"13974"},{"source":"NA","target":"solid tumors","id":"13975"},{"source":"Angiopoietin inhibitor","target":"hepatocellular","id":"13976"},{"source":"Angiopoietin inhibitor","target":"antihypertensive","id":"13977"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"13978"},{"source":"Angiopoietin inhibitor","target":"chronic hepatitis b","id":"13979"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"13980"},{"source":"Angiopoietin inhibitor","target":"myelofibrosis","id":"13981"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"13982"},{"source":"Angiopoietin inhibitor","target":"hcc","id":"13983"},{"source":"Angiopoietin inhibitor","target":"liver diseases","id":"13984"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"13985"},{"source":"Angiopoietin inhibitor","target":"chronic hepatitis b","id":"13986"},{"source":"Angiopoietin inhibitor","target":"liver cirrhosis","id":"13987"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"13988"},{"source":"Angiopoietin inhibitor","target":"hypertension","id":"13989"},{"source":"Angiopoietin inhibitor","target":"liver cirrhosis","id":"13990"},{"source":"Angiopoietin inhibitor","target":"liver cancer","id":"13991"},{"source":"Angiopoietin inhibitor","target":"liver neoplasms","id":"13992"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"13993"},{"source":"NA","target":"hepatocellular","id":"13994"},{"source":"NA","target":"antihypertensive","id":"13995"},{"source":"NA","target":"anticancer","id":"13996"},{"source":"NA","target":"chronic hepatitis b","id":"13997"},{"source":"NA","target":"solid tumors","id":"13998"},{"source":"NA","target":"myelofibrosis","id":"13999"},{"source":"NA","target":"residual tumor","id":"14000"},{"source":"NA","target":"hcc","id":"14001"},{"source":"NA","target":"liver diseases","id":"14002"},{"source":"NA","target":"carcinoma","id":"14003"},{"source":"NA","target":"chronic hepatitis b","id":"14004"},{"source":"NA","target":"liver cirrhosis","id":"14005"},{"source":"NA","target":"carcinoma","id":"14006"},{"source":"NA","target":"hypertension","id":"14007"},{"source":"NA","target":"liver cirrhosis","id":"14008"},{"source":"NA","target":"liver cancer","id":"14009"},{"source":"NA","target":"liver neoplasms","id":"14010"},{"source":"NA","target":"solid tumors","id":"14011"},{"source":"NA","target":"hepatocellular","id":"14012"},{"source":"NA","target":"antihypertensive","id":"14013"},{"source":"NA","target":"anticancer","id":"14014"},{"source":"NA","target":"chronic hepatitis b","id":"14015"},{"source":"NA","target":"solid tumors","id":"14016"},{"source":"NA","target":"myelofibrosis","id":"14017"},{"source":"NA","target":"residual tumor","id":"14018"},{"source":"NA","target":"hcc","id":"14019"},{"source":"NA","target":"liver diseases","id":"14020"},{"source":"NA","target":"carcinoma","id":"14021"},{"source":"NA","target":"chronic hepatitis b","id":"14022"},{"source":"NA","target":"liver cirrhosis","id":"14023"},{"source":"NA","target":"carcinoma","id":"14024"},{"source":"NA","target":"hypertension","id":"14025"},{"source":"NA","target":"liver cirrhosis","id":"14026"},{"source":"NA","target":"liver cancer","id":"14027"},{"source":"NA","target":"liver neoplasms","id":"14028"},{"source":"NA","target":"solid tumors","id":"14029"},{"source":"NA","target":"hepatocellular","id":"14030"},{"source":"NA","target":"antihypertensive","id":"14031"},{"source":"NA","target":"anticancer","id":"14032"},{"source":"NA","target":"chronic hepatitis b","id":"14033"},{"source":"NA","target":"solid tumors","id":"14034"},{"source":"NA","target":"myelofibrosis","id":"14035"},{"source":"NA","target":"residual tumor","id":"14036"},{"source":"NA","target":"hcc","id":"14037"},{"source":"NA","target":"liver diseases","id":"14038"},{"source":"NA","target":"carcinoma","id":"14039"},{"source":"NA","target":"chronic hepatitis b","id":"14040"},{"source":"NA","target":"liver cirrhosis","id":"14041"},{"source":"NA","target":"carcinoma","id":"14042"},{"source":"NA","target":"hypertension","id":"14043"},{"source":"NA","target":"liver cirrhosis","id":"14044"},{"source":"NA","target":"liver cancer","id":"14045"},{"source":"NA","target":"liver neoplasms","id":"14046"},{"source":"NA","target":"solid tumors","id":"14047"},{"source":"Angiogenesis inhibitor","target":"hepatocellular","id":"14048"},{"source":"Angiogenesis inhibitor","target":"antihypertensive","id":"14049"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"14050"},{"source":"Angiogenesis inhibitor","target":"chronic hepatitis b","id":"14051"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"14052"},{"source":"Angiogenesis inhibitor","target":"myelofibrosis","id":"14053"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"14054"},{"source":"Angiogenesis inhibitor","target":"hcc","id":"14055"},{"source":"Angiogenesis inhibitor","target":"liver diseases","id":"14056"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"14057"},{"source":"Angiogenesis inhibitor","target":"chronic hepatitis b","id":"14058"},{"source":"Angiogenesis inhibitor","target":"liver cirrhosis","id":"14059"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"14060"},{"source":"Angiogenesis inhibitor","target":"hypertension","id":"14061"},{"source":"Angiogenesis inhibitor","target":"liver cirrhosis","id":"14062"},{"source":"Angiogenesis inhibitor","target":"liver cancer","id":"14063"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"14064"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"14065"},{"source":"C-kit inhibitor","target":"hepatocellular","id":"14066"},{"source":"C-kit inhibitor","target":"antihypertensive","id":"14067"},{"source":"C-kit inhibitor","target":"anticancer","id":"14068"},{"source":"C-kit inhibitor","target":"chronic hepatitis b","id":"14069"},{"source":"C-kit inhibitor","target":"solid tumors","id":"14070"},{"source":"C-kit inhibitor","target":"myelofibrosis","id":"14071"},{"source":"C-kit inhibitor","target":"residual tumor","id":"14072"},{"source":"C-kit inhibitor","target":"hcc","id":"14073"},{"source":"C-kit inhibitor","target":"liver diseases","id":"14074"},{"source":"C-kit inhibitor","target":"carcinoma","id":"14075"},{"source":"C-kit inhibitor","target":"chronic hepatitis b","id":"14076"},{"source":"C-kit inhibitor","target":"liver cirrhosis","id":"14077"},{"source":"C-kit inhibitor","target":"carcinoma","id":"14078"},{"source":"C-kit inhibitor","target":"hypertension","id":"14079"},{"source":"C-kit inhibitor","target":"liver cirrhosis","id":"14080"},{"source":"C-kit inhibitor","target":"liver cancer","id":"14081"},{"source":"C-kit inhibitor","target":"liver neoplasms","id":"14082"},{"source":"C-kit inhibitor","target":"solid tumors","id":"14083"},{"source":"Oncology: Liver","target":"NA","id":"14084"},{"source":"Oncology: Liver","target":"NA","id":"14085"},{"source":"Oncology: Liver","target":"NA","id":"14086"},{"source":"Oncology: Liver","target":"NA","id":"14087"},{"source":"Oncology: Liver","target":"NA","id":"14088"},{"source":"Oncology: Liver","target":"NA","id":"14089"},{"source":"Oncology: Liver","target":"Angiopoietin inhibitor","id":"14090"},{"source":"Oncology: Liver","target":"NA","id":"14091"},{"source":"Oncology: Liver","target":"NA","id":"14092"},{"source":"Oncology: Liver","target":"NA","id":"14093"},{"source":"Oncology: Liver","target":"Angiogenesis inhibitor","id":"14094"},{"source":"Oncology: Liver","target":"C-kit inhibitor","id":"14095"},{"source":"lenvatinib (capsule) (a)","target":"Eisai","id":"14096"},{"source":"UNK : Drug","target":"Eisai","id":"14097"},{"source":"hepatocellular","target":"lenvatinib (capsule) (a)","id":"14098"},{"source":"hepatocellular","target":"UNK : Drug","id":"14099"},{"source":"antihypertensive","target":"lenvatinib (capsule) (a)","id":"14100"},{"source":"antihypertensive","target":"UNK : Drug","id":"14101"},{"source":"anticancer","target":"lenvatinib (capsule) (a)","id":"14102"},{"source":"anticancer","target":"UNK : Drug","id":"14103"},{"source":"chronic hepatitis b","target":"lenvatinib (capsule) (a)","id":"14104"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"14105"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"14106"},{"source":"solid tumors","target":"UNK : Drug","id":"14107"},{"source":"myelofibrosis","target":"lenvatinib (capsule) (a)","id":"14108"},{"source":"myelofibrosis","target":"UNK : Drug","id":"14109"},{"source":"residual tumor","target":"lenvatinib (capsule) (a)","id":"14110"},{"source":"residual tumor","target":"UNK : Drug","id":"14111"},{"source":"hcc","target":"lenvatinib (capsule) (a)","id":"14112"},{"source":"hcc","target":"UNK : Drug","id":"14113"},{"source":"liver diseases","target":"lenvatinib (capsule) (a)","id":"14114"},{"source":"liver diseases","target":"UNK : Drug","id":"14115"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"14116"},{"source":"carcinoma","target":"UNK : Drug","id":"14117"},{"source":"chronic hepatitis b","target":"lenvatinib (capsule) (a)","id":"14118"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"14119"},{"source":"liver cirrhosis","target":"lenvatinib (capsule) (a)","id":"14120"},{"source":"liver cirrhosis","target":"UNK : Drug","id":"14121"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"14122"},{"source":"carcinoma","target":"UNK : Drug","id":"14123"},{"source":"hypertension","target":"lenvatinib (capsule) (a)","id":"14124"},{"source":"hypertension","target":"UNK : Drug","id":"14125"},{"source":"liver cirrhosis","target":"lenvatinib (capsule) (a)","id":"14126"},{"source":"liver cirrhosis","target":"UNK : Drug","id":"14127"},{"source":"liver cancer","target":"lenvatinib (capsule) (a)","id":"14128"},{"source":"liver cancer","target":"UNK : Drug","id":"14129"},{"source":"liver neoplasms","target":"lenvatinib (capsule) (a)","id":"14130"},{"source":"liver neoplasms","target":"UNK : Drug","id":"14131"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"14132"},{"source":"solid tumors","target":"UNK : Drug","id":"14133"},{"source":"NA","target":"hepatocellular","id":"14134"},{"source":"NA","target":"antihypertensive","id":"14135"},{"source":"NA","target":"anticancer","id":"14136"},{"source":"NA","target":"chronic hepatitis b","id":"14137"},{"source":"NA","target":"solid tumors","id":"14138"},{"source":"NA","target":"myelofibrosis","id":"14139"},{"source":"NA","target":"residual tumor","id":"14140"},{"source":"NA","target":"hcc","id":"14141"},{"source":"NA","target":"liver diseases","id":"14142"},{"source":"NA","target":"carcinoma","id":"14143"},{"source":"NA","target":"chronic hepatitis b","id":"14144"},{"source":"NA","target":"liver cirrhosis","id":"14145"},{"source":"NA","target":"carcinoma","id":"14146"},{"source":"NA","target":"hypertension","id":"14147"},{"source":"NA","target":"liver cirrhosis","id":"14148"},{"source":"NA","target":"liver cancer","id":"14149"},{"source":"NA","target":"liver neoplasms","id":"14150"},{"source":"NA","target":"solid tumors","id":"14151"},{"source":"NA","target":"hepatocellular","id":"14152"},{"source":"NA","target":"antihypertensive","id":"14153"},{"source":"NA","target":"anticancer","id":"14154"},{"source":"NA","target":"chronic hepatitis b","id":"14155"},{"source":"NA","target":"solid tumors","id":"14156"},{"source":"NA","target":"myelofibrosis","id":"14157"},{"source":"NA","target":"residual tumor","id":"14158"},{"source":"NA","target":"hcc","id":"14159"},{"source":"NA","target":"liver diseases","id":"14160"},{"source":"NA","target":"carcinoma","id":"14161"},{"source":"NA","target":"chronic hepatitis b","id":"14162"},{"source":"NA","target":"liver cirrhosis","id":"14163"},{"source":"NA","target":"carcinoma","id":"14164"},{"source":"NA","target":"hypertension","id":"14165"},{"source":"NA","target":"liver cirrhosis","id":"14166"},{"source":"NA","target":"liver cancer","id":"14167"},{"source":"NA","target":"liver neoplasms","id":"14168"},{"source":"NA","target":"solid tumors","id":"14169"},{"source":"NA","target":"hepatocellular","id":"14170"},{"source":"NA","target":"antihypertensive","id":"14171"},{"source":"NA","target":"anticancer","id":"14172"},{"source":"NA","target":"chronic hepatitis b","id":"14173"},{"source":"NA","target":"solid tumors","id":"14174"},{"source":"NA","target":"myelofibrosis","id":"14175"},{"source":"NA","target":"residual tumor","id":"14176"},{"source":"NA","target":"hcc","id":"14177"},{"source":"NA","target":"liver diseases","id":"14178"},{"source":"NA","target":"carcinoma","id":"14179"},{"source":"NA","target":"chronic hepatitis b","id":"14180"},{"source":"NA","target":"liver cirrhosis","id":"14181"},{"source":"NA","target":"carcinoma","id":"14182"},{"source":"NA","target":"hypertension","id":"14183"},{"source":"NA","target":"liver cirrhosis","id":"14184"},{"source":"NA","target":"liver cancer","id":"14185"},{"source":"NA","target":"liver neoplasms","id":"14186"},{"source":"NA","target":"solid tumors","id":"14187"},{"source":"NA","target":"hepatocellular","id":"14188"},{"source":"NA","target":"antihypertensive","id":"14189"},{"source":"NA","target":"anticancer","id":"14190"},{"source":"NA","target":"chronic hepatitis b","id":"14191"},{"source":"NA","target":"solid tumors","id":"14192"},{"source":"NA","target":"myelofibrosis","id":"14193"},{"source":"NA","target":"residual tumor","id":"14194"},{"source":"NA","target":"hcc","id":"14195"},{"source":"NA","target":"liver diseases","id":"14196"},{"source":"NA","target":"carcinoma","id":"14197"},{"source":"NA","target":"chronic hepatitis b","id":"14198"},{"source":"NA","target":"liver cirrhosis","id":"14199"},{"source":"NA","target":"carcinoma","id":"14200"},{"source":"NA","target":"hypertension","id":"14201"},{"source":"NA","target":"liver cirrhosis","id":"14202"},{"source":"NA","target":"liver cancer","id":"14203"},{"source":"NA","target":"liver neoplasms","id":"14204"},{"source":"NA","target":"solid tumors","id":"14205"},{"source":"NA","target":"hepatocellular","id":"14206"},{"source":"NA","target":"antihypertensive","id":"14207"},{"source":"NA","target":"anticancer","id":"14208"},{"source":"NA","target":"chronic hepatitis b","id":"14209"},{"source":"NA","target":"solid tumors","id":"14210"},{"source":"NA","target":"myelofibrosis","id":"14211"},{"source":"NA","target":"residual tumor","id":"14212"},{"source":"NA","target":"hcc","id":"14213"},{"source":"NA","target":"liver diseases","id":"14214"},{"source":"NA","target":"carcinoma","id":"14215"},{"source":"NA","target":"chronic hepatitis b","id":"14216"},{"source":"NA","target":"liver cirrhosis","id":"14217"},{"source":"NA","target":"carcinoma","id":"14218"},{"source":"NA","target":"hypertension","id":"14219"},{"source":"NA","target":"liver cirrhosis","id":"14220"},{"source":"NA","target":"liver cancer","id":"14221"},{"source":"NA","target":"liver neoplasms","id":"14222"},{"source":"NA","target":"solid tumors","id":"14223"},{"source":"NA","target":"hepatocellular","id":"14224"},{"source":"NA","target":"antihypertensive","id":"14225"},{"source":"NA","target":"anticancer","id":"14226"},{"source":"NA","target":"chronic hepatitis b","id":"14227"},{"source":"NA","target":"solid tumors","id":"14228"},{"source":"NA","target":"myelofibrosis","id":"14229"},{"source":"NA","target":"residual tumor","id":"14230"},{"source":"NA","target":"hcc","id":"14231"},{"source":"NA","target":"liver diseases","id":"14232"},{"source":"NA","target":"carcinoma","id":"14233"},{"source":"NA","target":"chronic hepatitis b","id":"14234"},{"source":"NA","target":"liver cirrhosis","id":"14235"},{"source":"NA","target":"carcinoma","id":"14236"},{"source":"NA","target":"hypertension","id":"14237"},{"source":"NA","target":"liver cirrhosis","id":"14238"},{"source":"NA","target":"liver cancer","id":"14239"},{"source":"NA","target":"liver neoplasms","id":"14240"},{"source":"NA","target":"solid tumors","id":"14241"},{"source":"Angiopoietin inhibitor","target":"hepatocellular","id":"14242"},{"source":"Angiopoietin inhibitor","target":"antihypertensive","id":"14243"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"14244"},{"source":"Angiopoietin inhibitor","target":"chronic hepatitis b","id":"14245"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"14246"},{"source":"Angiopoietin inhibitor","target":"myelofibrosis","id":"14247"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"14248"},{"source":"Angiopoietin inhibitor","target":"hcc","id":"14249"},{"source":"Angiopoietin inhibitor","target":"liver diseases","id":"14250"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"14251"},{"source":"Angiopoietin inhibitor","target":"chronic hepatitis b","id":"14252"},{"source":"Angiopoietin inhibitor","target":"liver cirrhosis","id":"14253"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"14254"},{"source":"Angiopoietin inhibitor","target":"hypertension","id":"14255"},{"source":"Angiopoietin inhibitor","target":"liver cirrhosis","id":"14256"},{"source":"Angiopoietin inhibitor","target":"liver cancer","id":"14257"},{"source":"Angiopoietin inhibitor","target":"liver neoplasms","id":"14258"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"14259"},{"source":"NA","target":"hepatocellular","id":"14260"},{"source":"NA","target":"antihypertensive","id":"14261"},{"source":"NA","target":"anticancer","id":"14262"},{"source":"NA","target":"chronic hepatitis b","id":"14263"},{"source":"NA","target":"solid tumors","id":"14264"},{"source":"NA","target":"myelofibrosis","id":"14265"},{"source":"NA","target":"residual tumor","id":"14266"},{"source":"NA","target":"hcc","id":"14267"},{"source":"NA","target":"liver diseases","id":"14268"},{"source":"NA","target":"carcinoma","id":"14269"},{"source":"NA","target":"chronic hepatitis b","id":"14270"},{"source":"NA","target":"liver cirrhosis","id":"14271"},{"source":"NA","target":"carcinoma","id":"14272"},{"source":"NA","target":"hypertension","id":"14273"},{"source":"NA","target":"liver cirrhosis","id":"14274"},{"source":"NA","target":"liver cancer","id":"14275"},{"source":"NA","target":"liver neoplasms","id":"14276"},{"source":"NA","target":"solid tumors","id":"14277"},{"source":"NA","target":"hepatocellular","id":"14278"},{"source":"NA","target":"antihypertensive","id":"14279"},{"source":"NA","target":"anticancer","id":"14280"},{"source":"NA","target":"chronic hepatitis b","id":"14281"},{"source":"NA","target":"solid tumors","id":"14282"},{"source":"NA","target":"myelofibrosis","id":"14283"},{"source":"NA","target":"residual tumor","id":"14284"},{"source":"NA","target":"hcc","id":"14285"},{"source":"NA","target":"liver diseases","id":"14286"},{"source":"NA","target":"carcinoma","id":"14287"},{"source":"NA","target":"chronic hepatitis b","id":"14288"},{"source":"NA","target":"liver cirrhosis","id":"14289"},{"source":"NA","target":"carcinoma","id":"14290"},{"source":"NA","target":"hypertension","id":"14291"},{"source":"NA","target":"liver cirrhosis","id":"14292"},{"source":"NA","target":"liver cancer","id":"14293"},{"source":"NA","target":"liver neoplasms","id":"14294"},{"source":"NA","target":"solid tumors","id":"14295"},{"source":"NA","target":"hepatocellular","id":"14296"},{"source":"NA","target":"antihypertensive","id":"14297"},{"source":"NA","target":"anticancer","id":"14298"},{"source":"NA","target":"chronic hepatitis b","id":"14299"},{"source":"NA","target":"solid tumors","id":"14300"},{"source":"NA","target":"myelofibrosis","id":"14301"},{"source":"NA","target":"residual tumor","id":"14302"},{"source":"NA","target":"hcc","id":"14303"},{"source":"NA","target":"liver diseases","id":"14304"},{"source":"NA","target":"carcinoma","id":"14305"},{"source":"NA","target":"chronic hepatitis b","id":"14306"},{"source":"NA","target":"liver cirrhosis","id":"14307"},{"source":"NA","target":"carcinoma","id":"14308"},{"source":"NA","target":"hypertension","id":"14309"},{"source":"NA","target":"liver cirrhosis","id":"14310"},{"source":"NA","target":"liver cancer","id":"14311"},{"source":"NA","target":"liver neoplasms","id":"14312"},{"source":"NA","target":"solid tumors","id":"14313"},{"source":"Angiogenesis inhibitor","target":"hepatocellular","id":"14314"},{"source":"Angiogenesis inhibitor","target":"antihypertensive","id":"14315"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"14316"},{"source":"Angiogenesis inhibitor","target":"chronic hepatitis b","id":"14317"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"14318"},{"source":"Angiogenesis inhibitor","target":"myelofibrosis","id":"14319"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"14320"},{"source":"Angiogenesis inhibitor","target":"hcc","id":"14321"},{"source":"Angiogenesis inhibitor","target":"liver diseases","id":"14322"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"14323"},{"source":"Angiogenesis inhibitor","target":"chronic hepatitis b","id":"14324"},{"source":"Angiogenesis inhibitor","target":"liver cirrhosis","id":"14325"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"14326"},{"source":"Angiogenesis inhibitor","target":"hypertension","id":"14327"},{"source":"Angiogenesis inhibitor","target":"liver cirrhosis","id":"14328"},{"source":"Angiogenesis inhibitor","target":"liver cancer","id":"14329"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"14330"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"14331"},{"source":"C-kit inhibitor","target":"hepatocellular","id":"14332"},{"source":"C-kit inhibitor","target":"antihypertensive","id":"14333"},{"source":"C-kit inhibitor","target":"anticancer","id":"14334"},{"source":"C-kit inhibitor","target":"chronic hepatitis b","id":"14335"},{"source":"C-kit inhibitor","target":"solid tumors","id":"14336"},{"source":"C-kit inhibitor","target":"myelofibrosis","id":"14337"},{"source":"C-kit inhibitor","target":"residual tumor","id":"14338"},{"source":"C-kit inhibitor","target":"hcc","id":"14339"},{"source":"C-kit inhibitor","target":"liver diseases","id":"14340"},{"source":"C-kit inhibitor","target":"carcinoma","id":"14341"},{"source":"C-kit inhibitor","target":"chronic hepatitis b","id":"14342"},{"source":"C-kit inhibitor","target":"liver cirrhosis","id":"14343"},{"source":"C-kit inhibitor","target":"carcinoma","id":"14344"},{"source":"C-kit inhibitor","target":"hypertension","id":"14345"},{"source":"C-kit inhibitor","target":"liver cirrhosis","id":"14346"},{"source":"C-kit inhibitor","target":"liver cancer","id":"14347"},{"source":"C-kit inhibitor","target":"liver neoplasms","id":"14348"},{"source":"C-kit inhibitor","target":"solid tumors","id":"14349"},{"source":"Oncology: Liver","target":"NA","id":"14350"},{"source":"Oncology: Liver","target":"NA","id":"14351"},{"source":"Oncology: Liver","target":"NA","id":"14352"},{"source":"Oncology: Liver","target":"NA","id":"14353"},{"source":"Oncology: Liver","target":"NA","id":"14354"},{"source":"Oncology: Liver","target":"NA","id":"14355"},{"source":"Oncology: Liver","target":"Angiopoietin inhibitor","id":"14356"},{"source":"Oncology: Liver","target":"NA","id":"14357"},{"source":"Oncology: Liver","target":"NA","id":"14358"},{"source":"Oncology: Liver","target":"NA","id":"14359"},{"source":"Oncology: Liver","target":"Angiogenesis inhibitor","id":"14360"},{"source":"Oncology: Liver","target":"C-kit inhibitor","id":"14361"},{"source":"PDS-0101 (u)","target":"PDS Biotechnology","id":"14362"},{"source":"pembrolizumab","target":"PDS Biotechnology","id":"14363"},{"source":"UNK : Indication","target":"PDS-0101 (u)","id":"14364"},{"source":"UNK : Indication","target":"pembrolizumab","id":"14365"},{"source":"infectious disease","target":"PDS-0101 (u)","id":"14366"},{"source":"infectious disease","target":"pembrolizumab","id":"14367"},{"source":"head and neck cancer","target":"PDS-0101 (u)","id":"14368"},{"source":"head and neck cancer","target":"pembrolizumab","id":"14369"},{"source":"papilloma","target":"PDS-0101 (u)","id":"14370"},{"source":"papilloma","target":"pembrolizumab","id":"14371"},{"source":"papilloma","target":"PDS-0101 (u)","id":"14372"},{"source":"papilloma","target":"pembrolizumab","id":"14373"},{"source":"metastatic","target":"PDS-0101 (u)","id":"14374"},{"source":"metastatic","target":"pembrolizumab","id":"14375"},{"source":"carcinoma","target":"PDS-0101 (u)","id":"14376"},{"source":"carcinoma","target":"pembrolizumab","id":"14377"},{"source":"head and neck neoplasms","target":"PDS-0101 (u)","id":"14378"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"14379"},{"source":"neoplasm metastasis","target":"PDS-0101 (u)","id":"14380"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"14381"},{"source":"anticancer","target":"PDS-0101 (u)","id":"14382"},{"source":"anticancer","target":"pembrolizumab","id":"14383"},{"source":"papilloma","target":"PDS-0101 (u)","id":"14384"},{"source":"papilloma","target":"pembrolizumab","id":"14385"},{"source":"condylomata acuminata","target":"PDS-0101 (u)","id":"14386"},{"source":"condylomata acuminata","target":"pembrolizumab","id":"14387"},{"source":"communicable diseases","target":"PDS-0101 (u)","id":"14388"},{"source":"communicable diseases","target":"pembrolizumab","id":"14389"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"14390"},{"source":"Anticancer immunotherapy","target":"infectious disease","id":"14391"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"14392"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"14393"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"14394"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"14395"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"14396"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"14397"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"14398"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"14399"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"14400"},{"source":"Anticancer immunotherapy","target":"condylomata acuminata","id":"14401"},{"source":"Anticancer immunotherapy","target":"communicable diseases","id":"14402"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"14403"},{"source":"CD19 antagonist","target":"infectious disease","id":"14404"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"14405"},{"source":"CD19 antagonist","target":"papilloma","id":"14406"},{"source":"CD19 antagonist","target":"papilloma","id":"14407"},{"source":"CD19 antagonist","target":"metastatic","id":"14408"},{"source":"CD19 antagonist","target":"carcinoma","id":"14409"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"14410"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"14411"},{"source":"CD19 antagonist","target":"anticancer","id":"14412"},{"source":"CD19 antagonist","target":"papilloma","id":"14413"},{"source":"CD19 antagonist","target":"condylomata acuminata","id":"14414"},{"source":"CD19 antagonist","target":"communicable diseases","id":"14415"},{"source":"Immunostimulant","target":"UNK : Indication","id":"14416"},{"source":"Immunostimulant","target":"infectious disease","id":"14417"},{"source":"Immunostimulant","target":"head and neck cancer","id":"14418"},{"source":"Immunostimulant","target":"papilloma","id":"14419"},{"source":"Immunostimulant","target":"papilloma","id":"14420"},{"source":"Immunostimulant","target":"metastatic","id":"14421"},{"source":"Immunostimulant","target":"carcinoma","id":"14422"},{"source":"Immunostimulant","target":"head and neck neoplasms","id":"14423"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"14424"},{"source":"Immunostimulant","target":"anticancer","id":"14425"},{"source":"Immunostimulant","target":"papilloma","id":"14426"},{"source":"Immunostimulant","target":"condylomata acuminata","id":"14427"},{"source":"Immunostimulant","target":"communicable diseases","id":"14428"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"14429"},{"source":"Immune checkpoint inhibitor","target":"infectious disease","id":"14430"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"14431"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"14432"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"14433"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"14434"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"14435"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"14436"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"14437"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"14438"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"14439"},{"source":"Immune checkpoint inhibitor","target":"condylomata acuminata","id":"14440"},{"source":"Immune checkpoint inhibitor","target":"communicable diseases","id":"14441"},{"source":"Infectious Disease: HPV","target":"Anticancer immunotherapy","id":"14442"},{"source":"Infectious Disease: HPV","target":"CD19 antagonist","id":"14443"},{"source":"Infectious Disease: HPV","target":"Immunostimulant","id":"14444"},{"source":"Infectious Disease: HPV","target":"Immune checkpoint inhibitor","id":"14445"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"14446"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"14447"},{"source":"Oncology: Head/Neck","target":"Immunostimulant","id":"14448"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"14449"},{"source":"Infectious Disease: HPV","target":"Anticancer immunotherapy","id":"14450"},{"source":"Infectious Disease: HPV","target":"CD19 antagonist","id":"14451"},{"source":"Infectious Disease: HPV","target":"Immunostimulant","id":"14452"},{"source":"Infectious Disease: HPV","target":"Immune checkpoint inhibitor","id":"14453"},{"source":"pembrolizumab","target":"Merck & Co.","id":"14454"},{"source":"carboplatin","target":"Merck & Co.","id":"14455"},{"source":"cisplatin","target":"Merck & Co.","id":"14456"},{"source":"docetaxel","target":"Merck & Co.","id":"14457"},{"source":"gemcitabine hydrochloride","target":"Merck & Co.","id":"14458"},{"source":"irinotecan (IV)","target":"Merck & Co.","id":"14459"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"14460"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"14461"},{"source":"vinorelbine","target":"Merck & Co.","id":"14462"},{"source":"UNK : Indication","target":"pembrolizumab","id":"14463"},{"source":"UNK : Indication","target":"carboplatin","id":"14464"},{"source":"UNK : Indication","target":"cisplatin","id":"14465"},{"source":"UNK : Indication","target":"docetaxel","id":"14466"},{"source":"UNK : Indication","target":"gemcitabine hydrochloride","id":"14467"},{"source":"UNK : Indication","target":"irinotecan (IV)","id":"14468"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"14469"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"14470"},{"source":"UNK : Indication","target":"vinorelbine","id":"14471"},{"source":"carcinoma","target":"pembrolizumab","id":"14472"},{"source":"carcinoma","target":"carboplatin","id":"14473"},{"source":"carcinoma","target":"cisplatin","id":"14474"},{"source":"carcinoma","target":"docetaxel","id":"14475"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"14476"},{"source":"carcinoma","target":"irinotecan (IV)","id":"14477"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"14478"},{"source":"carcinoma","target":"pemetrexed disodium","id":"14479"},{"source":"carcinoma","target":"vinorelbine","id":"14480"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"14481"},{"source":"squamous cell neoplasms","target":"carboplatin","id":"14482"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"14483"},{"source":"squamous cell neoplasms","target":"docetaxel","id":"14484"},{"source":"squamous cell neoplasms","target":"gemcitabine hydrochloride","id":"14485"},{"source":"squamous cell neoplasms","target":"irinotecan (IV)","id":"14486"},{"source":"squamous cell neoplasms","target":"nab-paclitaxel (IV)","id":"14487"},{"source":"squamous cell neoplasms","target":"pemetrexed disodium","id":"14488"},{"source":"squamous cell neoplasms","target":"vinorelbine","id":"14489"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"14490"},{"source":"non-small-cell lung","target":"carboplatin","id":"14491"},{"source":"non-small-cell lung","target":"cisplatin","id":"14492"},{"source":"non-small-cell lung","target":"docetaxel","id":"14493"},{"source":"non-small-cell lung","target":"gemcitabine hydrochloride","id":"14494"},{"source":"non-small-cell lung","target":"irinotecan (IV)","id":"14495"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"14496"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"14497"},{"source":"non-small-cell lung","target":"vinorelbine","id":"14498"},{"source":"psoriasis","target":"pembrolizumab","id":"14499"},{"source":"psoriasis","target":"carboplatin","id":"14500"},{"source":"psoriasis","target":"cisplatin","id":"14501"},{"source":"psoriasis","target":"docetaxel","id":"14502"},{"source":"psoriasis","target":"gemcitabine hydrochloride","id":"14503"},{"source":"psoriasis","target":"irinotecan (IV)","id":"14504"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"14505"},{"source":"psoriasis","target":"pemetrexed disodium","id":"14506"},{"source":"psoriasis","target":"vinorelbine","id":"14507"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"14508"},{"source":"uterine cervical neoplasms","target":"carboplatin","id":"14509"},{"source":"uterine cervical neoplasms","target":"cisplatin","id":"14510"},{"source":"uterine cervical neoplasms","target":"docetaxel","id":"14511"},{"source":"uterine cervical neoplasms","target":"gemcitabine hydrochloride","id":"14512"},{"source":"uterine cervical neoplasms","target":"irinotecan (IV)","id":"14513"},{"source":"uterine cervical neoplasms","target":"nab-paclitaxel (IV)","id":"14514"},{"source":"uterine cervical neoplasms","target":"pemetrexed disodium","id":"14515"},{"source":"uterine cervical neoplasms","target":"vinorelbine","id":"14516"},{"source":"carcinoma","target":"pembrolizumab","id":"14517"},{"source":"carcinoma","target":"carboplatin","id":"14518"},{"source":"carcinoma","target":"cisplatin","id":"14519"},{"source":"carcinoma","target":"docetaxel","id":"14520"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"14521"},{"source":"carcinoma","target":"irinotecan (IV)","id":"14522"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"14523"},{"source":"carcinoma","target":"pemetrexed disodium","id":"14524"},{"source":"carcinoma","target":"vinorelbine","id":"14525"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"14526"},{"source":"non-small-cell lung","target":"carboplatin","id":"14527"},{"source":"non-small-cell lung","target":"cisplatin","id":"14528"},{"source":"non-small-cell lung","target":"docetaxel","id":"14529"},{"source":"non-small-cell lung","target":"gemcitabine hydrochloride","id":"14530"},{"source":"non-small-cell lung","target":"irinotecan (IV)","id":"14531"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"14532"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"14533"},{"source":"non-small-cell lung","target":"vinorelbine","id":"14534"},{"source":"malaria","target":"pembrolizumab","id":"14535"},{"source":"malaria","target":"carboplatin","id":"14536"},{"source":"malaria","target":"cisplatin","id":"14537"},{"source":"malaria","target":"docetaxel","id":"14538"},{"source":"malaria","target":"gemcitabine hydrochloride","id":"14539"},{"source":"malaria","target":"irinotecan (IV)","id":"14540"},{"source":"malaria","target":"nab-paclitaxel (IV)","id":"14541"},{"source":"malaria","target":"pemetrexed disodium","id":"14542"},{"source":"malaria","target":"vinorelbine","id":"14543"},{"source":"bladder cancer","target":"pembrolizumab","id":"14544"},{"source":"bladder cancer","target":"carboplatin","id":"14545"},{"source":"bladder cancer","target":"cisplatin","id":"14546"},{"source":"bladder cancer","target":"docetaxel","id":"14547"},{"source":"bladder cancer","target":"gemcitabine hydrochloride","id":"14548"},{"source":"bladder cancer","target":"irinotecan (IV)","id":"14549"},{"source":"bladder cancer","target":"nab-paclitaxel (IV)","id":"14550"},{"source":"bladder cancer","target":"pemetrexed disodium","id":"14551"},{"source":"bladder cancer","target":"vinorelbine","id":"14552"},{"source":"sclc","target":"pembrolizumab","id":"14553"},{"source":"sclc","target":"carboplatin","id":"14554"},{"source":"sclc","target":"cisplatin","id":"14555"},{"source":"sclc","target":"docetaxel","id":"14556"},{"source":"sclc","target":"gemcitabine hydrochloride","id":"14557"},{"source":"sclc","target":"irinotecan (IV)","id":"14558"},{"source":"sclc","target":"nab-paclitaxel (IV)","id":"14559"},{"source":"sclc","target":"pemetrexed disodium","id":"14560"},{"source":"sclc","target":"vinorelbine","id":"14561"},{"source":"cervical cancer","target":"pembrolizumab","id":"14562"},{"source":"cervical cancer","target":"carboplatin","id":"14563"},{"source":"cervical cancer","target":"cisplatin","id":"14564"},{"source":"cervical cancer","target":"docetaxel","id":"14565"},{"source":"cervical cancer","target":"gemcitabine hydrochloride","id":"14566"},{"source":"cervical cancer","target":"irinotecan (IV)","id":"14567"},{"source":"cervical cancer","target":"nab-paclitaxel (IV)","id":"14568"},{"source":"cervical cancer","target":"pemetrexed disodium","id":"14569"},{"source":"cervical cancer","target":"vinorelbine","id":"14570"},{"source":"psoriasis","target":"pembrolizumab","id":"14571"},{"source":"psoriasis","target":"carboplatin","id":"14572"},{"source":"psoriasis","target":"cisplatin","id":"14573"},{"source":"psoriasis","target":"docetaxel","id":"14574"},{"source":"psoriasis","target":"gemcitabine hydrochloride","id":"14575"},{"source":"psoriasis","target":"irinotecan (IV)","id":"14576"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"14577"},{"source":"psoriasis","target":"pemetrexed disodium","id":"14578"},{"source":"psoriasis","target":"vinorelbine","id":"14579"},{"source":"basal cell neoplasms","target":"pembrolizumab","id":"14580"},{"source":"basal cell neoplasms","target":"carboplatin","id":"14581"},{"source":"basal cell neoplasms","target":"cisplatin","id":"14582"},{"source":"basal cell neoplasms","target":"docetaxel","id":"14583"},{"source":"basal cell neoplasms","target":"gemcitabine hydrochloride","id":"14584"},{"source":"basal cell neoplasms","target":"irinotecan (IV)","id":"14585"},{"source":"basal cell neoplasms","target":"nab-paclitaxel (IV)","id":"14586"},{"source":"basal cell neoplasms","target":"pemetrexed disodium","id":"14587"},{"source":"basal cell neoplasms","target":"vinorelbine","id":"14588"},{"source":"carcinoma","target":"pembrolizumab","id":"14589"},{"source":"carcinoma","target":"carboplatin","id":"14590"},{"source":"carcinoma","target":"cisplatin","id":"14591"},{"source":"carcinoma","target":"docetaxel","id":"14592"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"14593"},{"source":"carcinoma","target":"irinotecan (IV)","id":"14594"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"14595"},{"source":"carcinoma","target":"pemetrexed disodium","id":"14596"},{"source":"carcinoma","target":"vinorelbine","id":"14597"},{"source":"arthritis","target":"pembrolizumab","id":"14598"},{"source":"arthritis","target":"carboplatin","id":"14599"},{"source":"arthritis","target":"cisplatin","id":"14600"},{"source":"arthritis","target":"docetaxel","id":"14601"},{"source":"arthritis","target":"gemcitabine hydrochloride","id":"14602"},{"source":"arthritis","target":"irinotecan (IV)","id":"14603"},{"source":"arthritis","target":"nab-paclitaxel (IV)","id":"14604"},{"source":"arthritis","target":"pemetrexed disodium","id":"14605"},{"source":"arthritis","target":"vinorelbine","id":"14606"},{"source":"carcinoma","target":"pembrolizumab","id":"14607"},{"source":"carcinoma","target":"carboplatin","id":"14608"},{"source":"carcinoma","target":"cisplatin","id":"14609"},{"source":"carcinoma","target":"docetaxel","id":"14610"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"14611"},{"source":"carcinoma","target":"irinotecan (IV)","id":"14612"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"14613"},{"source":"carcinoma","target":"pemetrexed disodium","id":"14614"},{"source":"carcinoma","target":"vinorelbine","id":"14615"},{"source":"malaria","target":"pembrolizumab","id":"14616"},{"source":"malaria","target":"carboplatin","id":"14617"},{"source":"malaria","target":"cisplatin","id":"14618"},{"source":"malaria","target":"docetaxel","id":"14619"},{"source":"malaria","target":"gemcitabine hydrochloride","id":"14620"},{"source":"malaria","target":"irinotecan (IV)","id":"14621"},{"source":"malaria","target":"nab-paclitaxel (IV)","id":"14622"},{"source":"malaria","target":"pemetrexed disodium","id":"14623"},{"source":"malaria","target":"vinorelbine","id":"14624"},{"source":"carcinoma","target":"pembrolizumab","id":"14625"},{"source":"carcinoma","target":"carboplatin","id":"14626"},{"source":"carcinoma","target":"cisplatin","id":"14627"},{"source":"carcinoma","target":"docetaxel","id":"14628"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"14629"},{"source":"carcinoma","target":"irinotecan (IV)","id":"14630"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"14631"},{"source":"carcinoma","target":"pemetrexed disodium","id":"14632"},{"source":"carcinoma","target":"vinorelbine","id":"14633"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"14634"},{"source":"neoplasm metastasis","target":"carboplatin","id":"14635"},{"source":"neoplasm metastasis","target":"cisplatin","id":"14636"},{"source":"neoplasm metastasis","target":"docetaxel","id":"14637"},{"source":"neoplasm metastasis","target":"gemcitabine hydrochloride","id":"14638"},{"source":"neoplasm metastasis","target":"irinotecan (IV)","id":"14639"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"14640"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"14641"},{"source":"neoplasm metastasis","target":"vinorelbine","id":"14642"},{"source":"lymphoma","target":"pembrolizumab","id":"14643"},{"source":"lymphoma","target":"carboplatin","id":"14644"},{"source":"lymphoma","target":"cisplatin","id":"14645"},{"source":"lymphoma","target":"docetaxel","id":"14646"},{"source":"lymphoma","target":"gemcitabine hydrochloride","id":"14647"},{"source":"lymphoma","target":"irinotecan (IV)","id":"14648"},{"source":"lymphoma","target":"nab-paclitaxel (IV)","id":"14649"},{"source":"lymphoma","target":"pemetrexed disodium","id":"14650"},{"source":"lymphoma","target":"vinorelbine","id":"14651"},{"source":"lung neoplasms","target":"pembrolizumab","id":"14652"},{"source":"lung neoplasms","target":"carboplatin","id":"14653"},{"source":"lung neoplasms","target":"cisplatin","id":"14654"},{"source":"lung neoplasms","target":"docetaxel","id":"14655"},{"source":"lung neoplasms","target":"gemcitabine hydrochloride","id":"14656"},{"source":"lung neoplasms","target":"irinotecan (IV)","id":"14657"},{"source":"lung neoplasms","target":"nab-paclitaxel (IV)","id":"14658"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"14659"},{"source":"lung neoplasms","target":"vinorelbine","id":"14660"},{"source":"solid malignancy","target":"pembrolizumab","id":"14661"},{"source":"solid malignancy","target":"carboplatin","id":"14662"},{"source":"solid malignancy","target":"cisplatin","id":"14663"},{"source":"solid malignancy","target":"docetaxel","id":"14664"},{"source":"solid malignancy","target":"gemcitabine hydrochloride","id":"14665"},{"source":"solid malignancy","target":"irinotecan (IV)","id":"14666"},{"source":"solid malignancy","target":"nab-paclitaxel (IV)","id":"14667"},{"source":"solid malignancy","target":"pemetrexed disodium","id":"14668"},{"source":"solid malignancy","target":"vinorelbine","id":"14669"},{"source":"skin neoplasms","target":"pembrolizumab","id":"14670"},{"source":"skin neoplasms","target":"carboplatin","id":"14671"},{"source":"skin neoplasms","target":"cisplatin","id":"14672"},{"source":"skin neoplasms","target":"docetaxel","id":"14673"},{"source":"skin neoplasms","target":"gemcitabine hydrochloride","id":"14674"},{"source":"skin neoplasms","target":"irinotecan (IV)","id":"14675"},{"source":"skin neoplasms","target":"nab-paclitaxel (IV)","id":"14676"},{"source":"skin neoplasms","target":"pemetrexed disodium","id":"14677"},{"source":"skin neoplasms","target":"vinorelbine","id":"14678"},{"source":"residual tumor","target":"pembrolizumab","id":"14679"},{"source":"residual tumor","target":"carboplatin","id":"14680"},{"source":"residual tumor","target":"cisplatin","id":"14681"},{"source":"residual tumor","target":"docetaxel","id":"14682"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"14683"},{"source":"residual tumor","target":"irinotecan (IV)","id":"14684"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"14685"},{"source":"residual tumor","target":"pemetrexed disodium","id":"14686"},{"source":"residual tumor","target":"vinorelbine","id":"14687"},{"source":"metastatic","target":"pembrolizumab","id":"14688"},{"source":"metastatic","target":"carboplatin","id":"14689"},{"source":"metastatic","target":"cisplatin","id":"14690"},{"source":"metastatic","target":"docetaxel","id":"14691"},{"source":"metastatic","target":"gemcitabine hydrochloride","id":"14692"},{"source":"metastatic","target":"irinotecan (IV)","id":"14693"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"14694"},{"source":"metastatic","target":"pemetrexed disodium","id":"14695"},{"source":"metastatic","target":"vinorelbine","id":"14696"},{"source":"anticancer","target":"pembrolizumab","id":"14697"},{"source":"anticancer","target":"carboplatin","id":"14698"},{"source":"anticancer","target":"cisplatin","id":"14699"},{"source":"anticancer","target":"docetaxel","id":"14700"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"14701"},{"source":"anticancer","target":"irinotecan (IV)","id":"14702"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"14703"},{"source":"anticancer","target":"pemetrexed disodium","id":"14704"},{"source":"anticancer","target":"vinorelbine","id":"14705"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"14706"},{"source":"urinary bladder neoplasms","target":"carboplatin","id":"14707"},{"source":"urinary bladder neoplasms","target":"cisplatin","id":"14708"},{"source":"urinary bladder neoplasms","target":"docetaxel","id":"14709"},{"source":"urinary bladder neoplasms","target":"gemcitabine hydrochloride","id":"14710"},{"source":"urinary bladder neoplasms","target":"irinotecan (IV)","id":"14711"},{"source":"urinary bladder neoplasms","target":"nab-paclitaxel (IV)","id":"14712"},{"source":"urinary bladder neoplasms","target":"pemetrexed disodium","id":"14713"},{"source":"urinary bladder neoplasms","target":"vinorelbine","id":"14714"},{"source":"antiarthritic","target":"pembrolizumab","id":"14715"},{"source":"antiarthritic","target":"carboplatin","id":"14716"},{"source":"antiarthritic","target":"cisplatin","id":"14717"},{"source":"antiarthritic","target":"docetaxel","id":"14718"},{"source":"antiarthritic","target":"gemcitabine hydrochloride","id":"14719"},{"source":"antiarthritic","target":"irinotecan (IV)","id":"14720"},{"source":"antiarthritic","target":"nab-paclitaxel (IV)","id":"14721"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"14722"},{"source":"antiarthritic","target":"vinorelbine","id":"14723"},{"source":"Vinca alkaloid","target":"UNK : Indication","id":"14724"},{"source":"Vinca alkaloid","target":"carcinoma","id":"14725"},{"source":"Vinca alkaloid","target":"squamous cell neoplasms","id":"14726"},{"source":"Vinca alkaloid","target":"non-small-cell lung","id":"14727"},{"source":"Vinca alkaloid","target":"psoriasis","id":"14728"},{"source":"Vinca alkaloid","target":"uterine cervical neoplasms","id":"14729"},{"source":"Vinca alkaloid","target":"carcinoma","id":"14730"},{"source":"Vinca alkaloid","target":"non-small-cell lung","id":"14731"},{"source":"Vinca alkaloid","target":"malaria","id":"14732"},{"source":"Vinca alkaloid","target":"bladder cancer","id":"14733"},{"source":"Vinca alkaloid","target":"sclc","id":"14734"},{"source":"Vinca alkaloid","target":"cervical cancer","id":"14735"},{"source":"Vinca alkaloid","target":"psoriasis","id":"14736"},{"source":"Vinca alkaloid","target":"basal cell neoplasms","id":"14737"},{"source":"Vinca alkaloid","target":"carcinoma","id":"14738"},{"source":"Vinca alkaloid","target":"arthritis","id":"14739"},{"source":"Vinca alkaloid","target":"carcinoma","id":"14740"},{"source":"Vinca alkaloid","target":"malaria","id":"14741"},{"source":"Vinca alkaloid","target":"carcinoma","id":"14742"},{"source":"Vinca alkaloid","target":"neoplasm metastasis","id":"14743"},{"source":"Vinca alkaloid","target":"lymphoma","id":"14744"},{"source":"Vinca alkaloid","target":"lung neoplasms","id":"14745"},{"source":"Vinca alkaloid","target":"solid malignancy","id":"14746"},{"source":"Vinca alkaloid","target":"skin neoplasms","id":"14747"},{"source":"Vinca alkaloid","target":"residual tumor","id":"14748"},{"source":"Vinca alkaloid","target":"metastatic","id":"14749"},{"source":"Vinca alkaloid","target":"anticancer","id":"14750"},{"source":"Vinca alkaloid","target":"urinary bladder neoplasms","id":"14751"},{"source":"Vinca alkaloid","target":"antiarthritic","id":"14752"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"14753"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"14754"},{"source":"Dihydrofolate reductase inhibitor","target":"squamous cell neoplasms","id":"14755"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"14756"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"14757"},{"source":"Dihydrofolate reductase inhibitor","target":"uterine cervical neoplasms","id":"14758"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"14759"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"14760"},{"source":"Dihydrofolate reductase inhibitor","target":"malaria","id":"14761"},{"source":"Dihydrofolate reductase inhibitor","target":"bladder cancer","id":"14762"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"14763"},{"source":"Dihydrofolate reductase inhibitor","target":"cervical cancer","id":"14764"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"14765"},{"source":"Dihydrofolate reductase inhibitor","target":"basal cell neoplasms","id":"14766"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"14767"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"14768"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"14769"},{"source":"Dihydrofolate reductase inhibitor","target":"malaria","id":"14770"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"14771"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"14772"},{"source":"Dihydrofolate reductase inhibitor","target":"lymphoma","id":"14773"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"14774"},{"source":"Dihydrofolate reductase inhibitor","target":"solid malignancy","id":"14775"},{"source":"Dihydrofolate reductase inhibitor","target":"skin neoplasms","id":"14776"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"14777"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"14778"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"14779"},{"source":"Dihydrofolate reductase inhibitor","target":"urinary bladder neoplasms","id":"14780"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"14781"},{"source":"Apoptosis stimulant","target":"UNK : Indication","id":"14782"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"14783"},{"source":"Apoptosis stimulant","target":"squamous cell neoplasms","id":"14784"},{"source":"Apoptosis stimulant","target":"non-small-cell lung","id":"14785"},{"source":"Apoptosis stimulant","target":"psoriasis","id":"14786"},{"source":"Apoptosis stimulant","target":"uterine cervical neoplasms","id":"14787"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"14788"},{"source":"Apoptosis stimulant","target":"non-small-cell lung","id":"14789"},{"source":"Apoptosis stimulant","target":"malaria","id":"14790"},{"source":"Apoptosis stimulant","target":"bladder cancer","id":"14791"},{"source":"Apoptosis stimulant","target":"sclc","id":"14792"},{"source":"Apoptosis stimulant","target":"cervical cancer","id":"14793"},{"source":"Apoptosis stimulant","target":"psoriasis","id":"14794"},{"source":"Apoptosis stimulant","target":"basal cell neoplasms","id":"14795"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"14796"},{"source":"Apoptosis stimulant","target":"arthritis","id":"14797"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"14798"},{"source":"Apoptosis stimulant","target":"malaria","id":"14799"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"14800"},{"source":"Apoptosis stimulant","target":"neoplasm metastasis","id":"14801"},{"source":"Apoptosis stimulant","target":"lymphoma","id":"14802"},{"source":"Apoptosis stimulant","target":"lung neoplasms","id":"14803"},{"source":"Apoptosis stimulant","target":"solid malignancy","id":"14804"},{"source":"Apoptosis stimulant","target":"skin neoplasms","id":"14805"},{"source":"Apoptosis stimulant","target":"residual tumor","id":"14806"},{"source":"Apoptosis stimulant","target":"metastatic","id":"14807"},{"source":"Apoptosis stimulant","target":"anticancer","id":"14808"},{"source":"Apoptosis stimulant","target":"urinary bladder neoplasms","id":"14809"},{"source":"Apoptosis stimulant","target":"antiarthritic","id":"14810"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"14811"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"14812"},{"source":"Cell cycle inhibitor","target":"squamous cell neoplasms","id":"14813"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"14814"},{"source":"Cell cycle inhibitor","target":"psoriasis","id":"14815"},{"source":"Cell cycle inhibitor","target":"uterine cervical neoplasms","id":"14816"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"14817"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"14818"},{"source":"Cell cycle inhibitor","target":"malaria","id":"14819"},{"source":"Cell cycle inhibitor","target":"bladder cancer","id":"14820"},{"source":"Cell cycle inhibitor","target":"sclc","id":"14821"},{"source":"Cell cycle inhibitor","target":"cervical cancer","id":"14822"},{"source":"Cell cycle inhibitor","target":"psoriasis","id":"14823"},{"source":"Cell cycle inhibitor","target":"basal cell neoplasms","id":"14824"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"14825"},{"source":"Cell cycle inhibitor","target":"arthritis","id":"14826"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"14827"},{"source":"Cell cycle inhibitor","target":"malaria","id":"14828"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"14829"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"14830"},{"source":"Cell cycle inhibitor","target":"lymphoma","id":"14831"},{"source":"Cell cycle inhibitor","target":"lung neoplasms","id":"14832"},{"source":"Cell cycle inhibitor","target":"solid malignancy","id":"14833"},{"source":"Cell cycle inhibitor","target":"skin neoplasms","id":"14834"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"14835"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"14836"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"14837"},{"source":"Cell cycle inhibitor","target":"urinary bladder neoplasms","id":"14838"},{"source":"Cell cycle inhibitor","target":"antiarthritic","id":"14839"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"14840"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"14841"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"14842"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"14843"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"14844"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"14845"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"14846"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"14847"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"14848"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"14849"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"14850"},{"source":"Immune checkpoint inhibitor","target":"cervical cancer","id":"14851"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"14852"},{"source":"Immune checkpoint inhibitor","target":"basal cell neoplasms","id":"14853"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"14854"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"14855"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"14856"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"14857"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"14858"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"14859"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"14860"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"14861"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"14862"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"14863"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"14864"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"14865"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"14866"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"14867"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"14868"},{"source":"NA","target":"UNK : Indication","id":"14869"},{"source":"NA","target":"carcinoma","id":"14870"},{"source":"NA","target":"squamous cell neoplasms","id":"14871"},{"source":"NA","target":"non-small-cell lung","id":"14872"},{"source":"NA","target":"psoriasis","id":"14873"},{"source":"NA","target":"uterine cervical neoplasms","id":"14874"},{"source":"NA","target":"carcinoma","id":"14875"},{"source":"NA","target":"non-small-cell lung","id":"14876"},{"source":"NA","target":"malaria","id":"14877"},{"source":"NA","target":"bladder cancer","id":"14878"},{"source":"NA","target":"sclc","id":"14879"},{"source":"NA","target":"cervical cancer","id":"14880"},{"source":"NA","target":"psoriasis","id":"14881"},{"source":"NA","target":"basal cell neoplasms","id":"14882"},{"source":"NA","target":"carcinoma","id":"14883"},{"source":"NA","target":"arthritis","id":"14884"},{"source":"NA","target":"carcinoma","id":"14885"},{"source":"NA","target":"malaria","id":"14886"},{"source":"NA","target":"carcinoma","id":"14887"},{"source":"NA","target":"neoplasm metastasis","id":"14888"},{"source":"NA","target":"lymphoma","id":"14889"},{"source":"NA","target":"lung neoplasms","id":"14890"},{"source":"NA","target":"solid malignancy","id":"14891"},{"source":"NA","target":"skin neoplasms","id":"14892"},{"source":"NA","target":"residual tumor","id":"14893"},{"source":"NA","target":"metastatic","id":"14894"},{"source":"NA","target":"anticancer","id":"14895"},{"source":"NA","target":"urinary bladder neoplasms","id":"14896"},{"source":"NA","target":"antiarthritic","id":"14897"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"14898"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"14899"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"14900"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"14901"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"14902"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"14903"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"14904"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"14905"},{"source":"Anticancer immunotherapy","target":"malaria","id":"14906"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"14907"},{"source":"Anticancer immunotherapy","target":"sclc","id":"14908"},{"source":"Anticancer immunotherapy","target":"cervical cancer","id":"14909"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"14910"},{"source":"Anticancer immunotherapy","target":"basal cell neoplasms","id":"14911"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"14912"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"14913"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"14914"},{"source":"Anticancer immunotherapy","target":"malaria","id":"14915"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"14916"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"14917"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"14918"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"14919"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"14920"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"14921"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"14922"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"14923"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"14924"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"14925"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"14926"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"14927"},{"source":"CD19 antagonist","target":"carcinoma","id":"14928"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"14929"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"14930"},{"source":"CD19 antagonist","target":"psoriasis","id":"14931"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"14932"},{"source":"CD19 antagonist","target":"carcinoma","id":"14933"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"14934"},{"source":"CD19 antagonist","target":"malaria","id":"14935"},{"source":"CD19 antagonist","target":"bladder cancer","id":"14936"},{"source":"CD19 antagonist","target":"sclc","id":"14937"},{"source":"CD19 antagonist","target":"cervical cancer","id":"14938"},{"source":"CD19 antagonist","target":"psoriasis","id":"14939"},{"source":"CD19 antagonist","target":"basal cell neoplasms","id":"14940"},{"source":"CD19 antagonist","target":"carcinoma","id":"14941"},{"source":"CD19 antagonist","target":"arthritis","id":"14942"},{"source":"CD19 antagonist","target":"carcinoma","id":"14943"},{"source":"CD19 antagonist","target":"malaria","id":"14944"},{"source":"CD19 antagonist","target":"carcinoma","id":"14945"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"14946"},{"source":"CD19 antagonist","target":"lymphoma","id":"14947"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"14948"},{"source":"CD19 antagonist","target":"solid malignancy","id":"14949"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"14950"},{"source":"CD19 antagonist","target":"residual tumor","id":"14951"},{"source":"CD19 antagonist","target":"metastatic","id":"14952"},{"source":"CD19 antagonist","target":"anticancer","id":"14953"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"14954"},{"source":"CD19 antagonist","target":"antiarthritic","id":"14955"},{"source":"NA","target":"UNK : Indication","id":"14956"},{"source":"NA","target":"carcinoma","id":"14957"},{"source":"NA","target":"squamous cell neoplasms","id":"14958"},{"source":"NA","target":"non-small-cell lung","id":"14959"},{"source":"NA","target":"psoriasis","id":"14960"},{"source":"NA","target":"uterine cervical neoplasms","id":"14961"},{"source":"NA","target":"carcinoma","id":"14962"},{"source":"NA","target":"non-small-cell lung","id":"14963"},{"source":"NA","target":"malaria","id":"14964"},{"source":"NA","target":"bladder cancer","id":"14965"},{"source":"NA","target":"sclc","id":"14966"},{"source":"NA","target":"cervical cancer","id":"14967"},{"source":"NA","target":"psoriasis","id":"14968"},{"source":"NA","target":"basal cell neoplasms","id":"14969"},{"source":"NA","target":"carcinoma","id":"14970"},{"source":"NA","target":"arthritis","id":"14971"},{"source":"NA","target":"carcinoma","id":"14972"},{"source":"NA","target":"malaria","id":"14973"},{"source":"NA","target":"carcinoma","id":"14974"},{"source":"NA","target":"neoplasm metastasis","id":"14975"},{"source":"NA","target":"lymphoma","id":"14976"},{"source":"NA","target":"lung neoplasms","id":"14977"},{"source":"NA","target":"solid malignancy","id":"14978"},{"source":"NA","target":"skin neoplasms","id":"14979"},{"source":"NA","target":"residual tumor","id":"14980"},{"source":"NA","target":"metastatic","id":"14981"},{"source":"NA","target":"anticancer","id":"14982"},{"source":"NA","target":"urinary bladder neoplasms","id":"14983"},{"source":"NA","target":"antiarthritic","id":"14984"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"14985"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"14986"},{"source":"Tubulin inhibitor","target":"squamous cell neoplasms","id":"14987"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"14988"},{"source":"Tubulin inhibitor","target":"psoriasis","id":"14989"},{"source":"Tubulin inhibitor","target":"uterine cervical neoplasms","id":"14990"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"14991"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"14992"},{"source":"Tubulin inhibitor","target":"malaria","id":"14993"},{"source":"Tubulin inhibitor","target":"bladder cancer","id":"14994"},{"source":"Tubulin inhibitor","target":"sclc","id":"14995"},{"source":"Tubulin inhibitor","target":"cervical cancer","id":"14996"},{"source":"Tubulin inhibitor","target":"psoriasis","id":"14997"},{"source":"Tubulin inhibitor","target":"basal cell neoplasms","id":"14998"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"14999"},{"source":"Tubulin inhibitor","target":"arthritis","id":"15000"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"15001"},{"source":"Tubulin inhibitor","target":"malaria","id":"15002"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"15003"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"15004"},{"source":"Tubulin inhibitor","target":"lymphoma","id":"15005"},{"source":"Tubulin inhibitor","target":"lung neoplasms","id":"15006"},{"source":"Tubulin inhibitor","target":"solid malignancy","id":"15007"},{"source":"Tubulin inhibitor","target":"skin neoplasms","id":"15008"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"15009"},{"source":"Tubulin inhibitor","target":"metastatic","id":"15010"},{"source":"Tubulin inhibitor","target":"anticancer","id":"15011"},{"source":"Tubulin inhibitor","target":"urinary bladder neoplasms","id":"15012"},{"source":"Tubulin inhibitor","target":"antiarthritic","id":"15013"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"15014"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"15015"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"15016"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"15017"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"15018"},{"source":"Thymidylate synthase inhibitor","target":"uterine cervical neoplasms","id":"15019"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"15020"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"15021"},{"source":"Thymidylate synthase inhibitor","target":"malaria","id":"15022"},{"source":"Thymidylate synthase inhibitor","target":"bladder cancer","id":"15023"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"15024"},{"source":"Thymidylate synthase inhibitor","target":"cervical cancer","id":"15025"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"15026"},{"source":"Thymidylate synthase inhibitor","target":"basal cell neoplasms","id":"15027"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"15028"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"15029"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"15030"},{"source":"Thymidylate synthase inhibitor","target":"malaria","id":"15031"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"15032"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"15033"},{"source":"Thymidylate synthase inhibitor","target":"lymphoma","id":"15034"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"15035"},{"source":"Thymidylate synthase inhibitor","target":"solid malignancy","id":"15036"},{"source":"Thymidylate synthase inhibitor","target":"skin neoplasms","id":"15037"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"15038"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"15039"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"15040"},{"source":"Thymidylate synthase inhibitor","target":"urinary bladder neoplasms","id":"15041"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"15042"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"15043"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"15044"},{"source":"Beta tubulin antagonist","target":"squamous cell neoplasms","id":"15045"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"15046"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"15047"},{"source":"Beta tubulin antagonist","target":"uterine cervical neoplasms","id":"15048"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"15049"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"15050"},{"source":"Beta tubulin antagonist","target":"malaria","id":"15051"},{"source":"Beta tubulin antagonist","target":"bladder cancer","id":"15052"},{"source":"Beta tubulin antagonist","target":"sclc","id":"15053"},{"source":"Beta tubulin antagonist","target":"cervical cancer","id":"15054"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"15055"},{"source":"Beta tubulin antagonist","target":"basal cell neoplasms","id":"15056"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"15057"},{"source":"Beta tubulin antagonist","target":"arthritis","id":"15058"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"15059"},{"source":"Beta tubulin antagonist","target":"malaria","id":"15060"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"15061"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"15062"},{"source":"Beta tubulin antagonist","target":"lymphoma","id":"15063"},{"source":"Beta tubulin antagonist","target":"lung neoplasms","id":"15064"},{"source":"Beta tubulin antagonist","target":"solid malignancy","id":"15065"},{"source":"Beta tubulin antagonist","target":"skin neoplasms","id":"15066"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"15067"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"15068"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"15069"},{"source":"Beta tubulin antagonist","target":"urinary bladder neoplasms","id":"15070"},{"source":"Beta tubulin antagonist","target":"antiarthritic","id":"15071"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"15072"},{"source":"Microtubule stimulant","target":"carcinoma","id":"15073"},{"source":"Microtubule stimulant","target":"squamous cell neoplasms","id":"15074"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"15075"},{"source":"Microtubule stimulant","target":"psoriasis","id":"15076"},{"source":"Microtubule stimulant","target":"uterine cervical neoplasms","id":"15077"},{"source":"Microtubule stimulant","target":"carcinoma","id":"15078"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"15079"},{"source":"Microtubule stimulant","target":"malaria","id":"15080"},{"source":"Microtubule stimulant","target":"bladder cancer","id":"15081"},{"source":"Microtubule stimulant","target":"sclc","id":"15082"},{"source":"Microtubule stimulant","target":"cervical cancer","id":"15083"},{"source":"Microtubule stimulant","target":"psoriasis","id":"15084"},{"source":"Microtubule stimulant","target":"basal cell neoplasms","id":"15085"},{"source":"Microtubule stimulant","target":"carcinoma","id":"15086"},{"source":"Microtubule stimulant","target":"arthritis","id":"15087"},{"source":"Microtubule stimulant","target":"carcinoma","id":"15088"},{"source":"Microtubule stimulant","target":"malaria","id":"15089"},{"source":"Microtubule stimulant","target":"carcinoma","id":"15090"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"15091"},{"source":"Microtubule stimulant","target":"lymphoma","id":"15092"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"15093"},{"source":"Microtubule stimulant","target":"solid malignancy","id":"15094"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"15095"},{"source":"Microtubule stimulant","target":"residual tumor","id":"15096"},{"source":"Microtubule stimulant","target":"metastatic","id":"15097"},{"source":"Microtubule stimulant","target":"anticancer","id":"15098"},{"source":"Microtubule stimulant","target":"urinary bladder neoplasms","id":"15099"},{"source":"Microtubule stimulant","target":"antiarthritic","id":"15100"},{"source":"NA","target":"UNK : Indication","id":"15101"},{"source":"NA","target":"carcinoma","id":"15102"},{"source":"NA","target":"squamous cell neoplasms","id":"15103"},{"source":"NA","target":"non-small-cell lung","id":"15104"},{"source":"NA","target":"psoriasis","id":"15105"},{"source":"NA","target":"uterine cervical neoplasms","id":"15106"},{"source":"NA","target":"carcinoma","id":"15107"},{"source":"NA","target":"non-small-cell lung","id":"15108"},{"source":"NA","target":"malaria","id":"15109"},{"source":"NA","target":"bladder cancer","id":"15110"},{"source":"NA","target":"sclc","id":"15111"},{"source":"NA","target":"cervical cancer","id":"15112"},{"source":"NA","target":"psoriasis","id":"15113"},{"source":"NA","target":"basal cell neoplasms","id":"15114"},{"source":"NA","target":"carcinoma","id":"15115"},{"source":"NA","target":"arthritis","id":"15116"},{"source":"NA","target":"carcinoma","id":"15117"},{"source":"NA","target":"malaria","id":"15118"},{"source":"NA","target":"carcinoma","id":"15119"},{"source":"NA","target":"neoplasm metastasis","id":"15120"},{"source":"NA","target":"lymphoma","id":"15121"},{"source":"NA","target":"lung neoplasms","id":"15122"},{"source":"NA","target":"solid malignancy","id":"15123"},{"source":"NA","target":"skin neoplasms","id":"15124"},{"source":"NA","target":"residual tumor","id":"15125"},{"source":"NA","target":"metastatic","id":"15126"},{"source":"NA","target":"anticancer","id":"15127"},{"source":"NA","target":"urinary bladder neoplasms","id":"15128"},{"source":"NA","target":"antiarthritic","id":"15129"},{"source":"NA","target":"UNK : Indication","id":"15130"},{"source":"NA","target":"carcinoma","id":"15131"},{"source":"NA","target":"squamous cell neoplasms","id":"15132"},{"source":"NA","target":"non-small-cell lung","id":"15133"},{"source":"NA","target":"psoriasis","id":"15134"},{"source":"NA","target":"uterine cervical neoplasms","id":"15135"},{"source":"NA","target":"carcinoma","id":"15136"},{"source":"NA","target":"non-small-cell lung","id":"15137"},{"source":"NA","target":"malaria","id":"15138"},{"source":"NA","target":"bladder cancer","id":"15139"},{"source":"NA","target":"sclc","id":"15140"},{"source":"NA","target":"cervical cancer","id":"15141"},{"source":"NA","target":"psoriasis","id":"15142"},{"source":"NA","target":"basal cell neoplasms","id":"15143"},{"source":"NA","target":"carcinoma","id":"15144"},{"source":"NA","target":"arthritis","id":"15145"},{"source":"NA","target":"carcinoma","id":"15146"},{"source":"NA","target":"malaria","id":"15147"},{"source":"NA","target":"carcinoma","id":"15148"},{"source":"NA","target":"neoplasm metastasis","id":"15149"},{"source":"NA","target":"lymphoma","id":"15150"},{"source":"NA","target":"lung neoplasms","id":"15151"},{"source":"NA","target":"solid malignancy","id":"15152"},{"source":"NA","target":"skin neoplasms","id":"15153"},{"source":"NA","target":"residual tumor","id":"15154"},{"source":"NA","target":"metastatic","id":"15155"},{"source":"NA","target":"anticancer","id":"15156"},{"source":"NA","target":"urinary bladder neoplasms","id":"15157"},{"source":"NA","target":"antiarthritic","id":"15158"},{"source":"NA","target":"UNK : Indication","id":"15159"},{"source":"NA","target":"carcinoma","id":"15160"},{"source":"NA","target":"squamous cell neoplasms","id":"15161"},{"source":"NA","target":"non-small-cell lung","id":"15162"},{"source":"NA","target":"psoriasis","id":"15163"},{"source":"NA","target":"uterine cervical neoplasms","id":"15164"},{"source":"NA","target":"carcinoma","id":"15165"},{"source":"NA","target":"non-small-cell lung","id":"15166"},{"source":"NA","target":"malaria","id":"15167"},{"source":"NA","target":"bladder cancer","id":"15168"},{"source":"NA","target":"sclc","id":"15169"},{"source":"NA","target":"cervical cancer","id":"15170"},{"source":"NA","target":"psoriasis","id":"15171"},{"source":"NA","target":"basal cell neoplasms","id":"15172"},{"source":"NA","target":"carcinoma","id":"15173"},{"source":"NA","target":"arthritis","id":"15174"},{"source":"NA","target":"carcinoma","id":"15175"},{"source":"NA","target":"malaria","id":"15176"},{"source":"NA","target":"carcinoma","id":"15177"},{"source":"NA","target":"neoplasm metastasis","id":"15178"},{"source":"NA","target":"lymphoma","id":"15179"},{"source":"NA","target":"lung neoplasms","id":"15180"},{"source":"NA","target":"solid malignancy","id":"15181"},{"source":"NA","target":"skin neoplasms","id":"15182"},{"source":"NA","target":"residual tumor","id":"15183"},{"source":"NA","target":"metastatic","id":"15184"},{"source":"NA","target":"anticancer","id":"15185"},{"source":"NA","target":"urinary bladder neoplasms","id":"15186"},{"source":"NA","target":"antiarthritic","id":"15187"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"15188"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"15189"},{"source":"Tubulin inhibitor","target":"squamous cell neoplasms","id":"15190"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"15191"},{"source":"Tubulin inhibitor","target":"psoriasis","id":"15192"},{"source":"Tubulin inhibitor","target":"uterine cervical neoplasms","id":"15193"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"15194"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"15195"},{"source":"Tubulin inhibitor","target":"malaria","id":"15196"},{"source":"Tubulin inhibitor","target":"bladder cancer","id":"15197"},{"source":"Tubulin inhibitor","target":"sclc","id":"15198"},{"source":"Tubulin inhibitor","target":"cervical cancer","id":"15199"},{"source":"Tubulin inhibitor","target":"psoriasis","id":"15200"},{"source":"Tubulin inhibitor","target":"basal cell neoplasms","id":"15201"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"15202"},{"source":"Tubulin inhibitor","target":"arthritis","id":"15203"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"15204"},{"source":"Tubulin inhibitor","target":"malaria","id":"15205"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"15206"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"15207"},{"source":"Tubulin inhibitor","target":"lymphoma","id":"15208"},{"source":"Tubulin inhibitor","target":"lung neoplasms","id":"15209"},{"source":"Tubulin inhibitor","target":"solid malignancy","id":"15210"},{"source":"Tubulin inhibitor","target":"skin neoplasms","id":"15211"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"15212"},{"source":"Tubulin inhibitor","target":"metastatic","id":"15213"},{"source":"Tubulin inhibitor","target":"anticancer","id":"15214"},{"source":"Tubulin inhibitor","target":"urinary bladder neoplasms","id":"15215"},{"source":"Tubulin inhibitor","target":"antiarthritic","id":"15216"},{"source":"Taxane","target":"UNK : Indication","id":"15217"},{"source":"Taxane","target":"carcinoma","id":"15218"},{"source":"Taxane","target":"squamous cell neoplasms","id":"15219"},{"source":"Taxane","target":"non-small-cell lung","id":"15220"},{"source":"Taxane","target":"psoriasis","id":"15221"},{"source":"Taxane","target":"uterine cervical neoplasms","id":"15222"},{"source":"Taxane","target":"carcinoma","id":"15223"},{"source":"Taxane","target":"non-small-cell lung","id":"15224"},{"source":"Taxane","target":"malaria","id":"15225"},{"source":"Taxane","target":"bladder cancer","id":"15226"},{"source":"Taxane","target":"sclc","id":"15227"},{"source":"Taxane","target":"cervical cancer","id":"15228"},{"source":"Taxane","target":"psoriasis","id":"15229"},{"source":"Taxane","target":"basal cell neoplasms","id":"15230"},{"source":"Taxane","target":"carcinoma","id":"15231"},{"source":"Taxane","target":"arthritis","id":"15232"},{"source":"Taxane","target":"carcinoma","id":"15233"},{"source":"Taxane","target":"malaria","id":"15234"},{"source":"Taxane","target":"carcinoma","id":"15235"},{"source":"Taxane","target":"neoplasm metastasis","id":"15236"},{"source":"Taxane","target":"lymphoma","id":"15237"},{"source":"Taxane","target":"lung neoplasms","id":"15238"},{"source":"Taxane","target":"solid malignancy","id":"15239"},{"source":"Taxane","target":"skin neoplasms","id":"15240"},{"source":"Taxane","target":"residual tumor","id":"15241"},{"source":"Taxane","target":"metastatic","id":"15242"},{"source":"Taxane","target":"anticancer","id":"15243"},{"source":"Taxane","target":"urinary bladder neoplasms","id":"15244"},{"source":"Taxane","target":"antiarthritic","id":"15245"},{"source":"Oncology: Lung","target":"Vinca alkaloid","id":"15246"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"15247"},{"source":"Oncology: Lung","target":"Apoptosis stimulant","id":"15248"},{"source":"Oncology: Lung","target":"Cell cycle inhibitor","id":"15249"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"15250"},{"source":"Oncology: Lung","target":"NA","id":"15251"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"15252"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"15253"},{"source":"Oncology: Lung","target":"NA","id":"15254"},{"source":"Oncology: Lung","target":"Tubulin inhibitor","id":"15255"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"15256"},{"source":"Oncology: Lung","target":"Beta tubulin antagonist","id":"15257"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"15258"},{"source":"Oncology: Lung","target":"NA","id":"15259"},{"source":"Oncology: Lung","target":"NA","id":"15260"},{"source":"Oncology: Lung","target":"NA","id":"15261"},{"source":"Oncology: Lung","target":"Tubulin inhibitor","id":"15262"},{"source":"Oncology: Lung","target":"Taxane","id":"15263"},{"source":"Non-Small Cell","target":"Vinca alkaloid","id":"15264"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"15265"},{"source":"Non-Small Cell","target":"Apoptosis stimulant","id":"15266"},{"source":"Non-Small Cell","target":"Cell cycle inhibitor","id":"15267"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"15268"},{"source":"Non-Small Cell","target":"NA","id":"15269"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"15270"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"15271"},{"source":"Non-Small Cell","target":"NA","id":"15272"},{"source":"Non-Small Cell","target":"Tubulin inhibitor","id":"15273"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"15274"},{"source":"Non-Small Cell","target":"Beta tubulin antagonist","id":"15275"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"15276"},{"source":"Non-Small Cell","target":"NA","id":"15277"},{"source":"Non-Small Cell","target":"NA","id":"15278"},{"source":"Non-Small Cell","target":"NA","id":"15279"},{"source":"Non-Small Cell","target":"Tubulin inhibitor","id":"15280"},{"source":"Non-Small Cell","target":"Taxane","id":"15281"},{"source":"pembrolizumab","target":"Merck & Co.","id":"15282"},{"source":"ipilimumab","target":"Merck & Co.","id":"15283"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"15284"},{"source":"ovarian neoplasms","target":"ipilimumab","id":"15285"},{"source":"anti-hiv","target":"pembrolizumab","id":"15286"},{"source":"anti-hiv","target":"ipilimumab","id":"15287"},{"source":"melanoma","target":"pembrolizumab","id":"15288"},{"source":"melanoma","target":"ipilimumab","id":"15289"},{"source":"melanoma","target":"pembrolizumab","id":"15290"},{"source":"melanoma","target":"ipilimumab","id":"15291"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"15292"},{"source":"autoimmune diseases","target":"ipilimumab","id":"15293"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"15294"},{"source":"autoimmune diseases","target":"ipilimumab","id":"15295"},{"source":"skin neoplasms","target":"pembrolizumab","id":"15296"},{"source":"skin neoplasms","target":"ipilimumab","id":"15297"},{"source":"residual tumor","target":"pembrolizumab","id":"15298"},{"source":"residual tumor","target":"ipilimumab","id":"15299"},{"source":"melanoma","target":"pembrolizumab","id":"15300"},{"source":"melanoma","target":"ipilimumab","id":"15301"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"15302"},{"source":"cerebellar neoplasms","target":"ipilimumab","id":"15303"},{"source":"carcinoma","target":"pembrolizumab","id":"15304"},{"source":"carcinoma","target":"ipilimumab","id":"15305"},{"source":"brain metastases","target":"pembrolizumab","id":"15306"},{"source":"brain metastases","target":"ipilimumab","id":"15307"},{"source":"anticancer","target":"pembrolizumab","id":"15308"},{"source":"anticancer","target":"ipilimumab","id":"15309"},{"source":"hiv infections","target":"pembrolizumab","id":"15310"},{"source":"hiv infections","target":"ipilimumab","id":"15311"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"15312"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"15313"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"15314"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"15315"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"15316"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"15317"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"15318"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"15319"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"15320"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"15321"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"15322"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"15323"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"15324"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"15325"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"15326"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"15327"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"15328"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"15329"},{"source":"CD19 antagonist","target":"anti-hiv","id":"15330"},{"source":"CD19 antagonist","target":"melanoma","id":"15331"},{"source":"CD19 antagonist","target":"melanoma","id":"15332"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"15333"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"15334"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"15335"},{"source":"CD19 antagonist","target":"residual tumor","id":"15336"},{"source":"CD19 antagonist","target":"melanoma","id":"15337"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"15338"},{"source":"CD19 antagonist","target":"carcinoma","id":"15339"},{"source":"CD19 antagonist","target":"brain metastases","id":"15340"},{"source":"CD19 antagonist","target":"anticancer","id":"15341"},{"source":"CD19 antagonist","target":"hiv infections","id":"15342"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"15343"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"15344"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"15345"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"15346"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"15347"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"15348"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"15349"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"15350"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"15351"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"15352"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"15353"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"15354"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"15355"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"15356"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"15357"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"15358"},{"source":"CTLA4 antagonist","target":"ovarian neoplasms","id":"15359"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"15360"},{"source":"CTLA4 antagonist","target":"melanoma","id":"15361"},{"source":"CTLA4 antagonist","target":"melanoma","id":"15362"},{"source":"CTLA4 antagonist","target":"autoimmune diseases","id":"15363"},{"source":"CTLA4 antagonist","target":"autoimmune diseases","id":"15364"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"15365"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"15366"},{"source":"CTLA4 antagonist","target":"melanoma","id":"15367"},{"source":"CTLA4 antagonist","target":"cerebellar neoplasms","id":"15368"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"15369"},{"source":"CTLA4 antagonist","target":"brain metastases","id":"15370"},{"source":"CTLA4 antagonist","target":"anticancer","id":"15371"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"15372"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"15373"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"15374"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"15375"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"15376"},{"source":"Oncology: Melanoma","target":"CTLA4 antagonist","id":"15377"},{"source":"glasdegib (oral) (u)","target":"Pfizer","id":"15378"},{"source":"azacitidine (iv)","target":"Pfizer","id":"15379"},{"source":"azacitidine (iv)","target":"Pfizer","id":"15380"},{"source":"cytarabine","target":"Pfizer","id":"15381"},{"source":"daunorubicin","target":"Pfizer","id":"15382"},{"source":"UNK : Indication","target":"glasdegib (oral) (u)","id":"15383"},{"source":"UNK : Indication","target":"azacitidine (iv)","id":"15384"},{"source":"UNK : Indication","target":"azacitidine (iv)","id":"15385"},{"source":"UNK : Indication","target":"cytarabine","id":"15386"},{"source":"UNK : Indication","target":"daunorubicin","id":"15387"},{"source":"acute","target":"glasdegib (oral) (u)","id":"15388"},{"source":"acute","target":"azacitidine (iv)","id":"15389"},{"source":"acute","target":"azacitidine (iv)","id":"15390"},{"source":"acute","target":"cytarabine","id":"15391"},{"source":"acute","target":"daunorubicin","id":"15392"},{"source":"aml","target":"glasdegib (oral) (u)","id":"15393"},{"source":"aml","target":"azacitidine (iv)","id":"15394"},{"source":"aml","target":"azacitidine (iv)","id":"15395"},{"source":"aml","target":"cytarabine","id":"15396"},{"source":"aml","target":"daunorubicin","id":"15397"},{"source":"hematologic diseases","target":"glasdegib (oral) (u)","id":"15398"},{"source":"hematologic diseases","target":"azacitidine (iv)","id":"15399"},{"source":"hematologic diseases","target":"azacitidine (iv)","id":"15400"},{"source":"hematologic diseases","target":"cytarabine","id":"15401"},{"source":"hematologic diseases","target":"daunorubicin","id":"15402"},{"source":"acute","target":"glasdegib (oral) (u)","id":"15403"},{"source":"acute","target":"azacitidine (iv)","id":"15404"},{"source":"acute","target":"azacitidine (iv)","id":"15405"},{"source":"acute","target":"cytarabine","id":"15406"},{"source":"acute","target":"daunorubicin","id":"15407"},{"source":"acute","target":"glasdegib (oral) (u)","id":"15408"},{"source":"acute","target":"azacitidine (iv)","id":"15409"},{"source":"acute","target":"azacitidine (iv)","id":"15410"},{"source":"acute","target":"cytarabine","id":"15411"},{"source":"acute","target":"daunorubicin","id":"15412"},{"source":"solid malignancy","target":"glasdegib (oral) (u)","id":"15413"},{"source":"solid malignancy","target":"azacitidine (iv)","id":"15414"},{"source":"solid malignancy","target":"azacitidine (iv)","id":"15415"},{"source":"solid malignancy","target":"cytarabine","id":"15416"},{"source":"solid malignancy","target":"daunorubicin","id":"15417"},{"source":"leukemia","target":"glasdegib (oral) (u)","id":"15418"},{"source":"leukemia","target":"azacitidine (iv)","id":"15419"},{"source":"leukemia","target":"azacitidine (iv)","id":"15420"},{"source":"leukemia","target":"cytarabine","id":"15421"},{"source":"leukemia","target":"daunorubicin","id":"15422"},{"source":"leukemia","target":"glasdegib (oral) (u)","id":"15423"},{"source":"leukemia","target":"azacitidine (iv)","id":"15424"},{"source":"leukemia","target":"azacitidine (iv)","id":"15425"},{"source":"leukemia","target":"cytarabine","id":"15426"},{"source":"leukemia","target":"daunorubicin","id":"15427"},{"source":"gilbert syndrome","target":"glasdegib (oral) (u)","id":"15428"},{"source":"gilbert syndrome","target":"azacitidine (iv)","id":"15429"},{"source":"gilbert syndrome","target":"azacitidine (iv)","id":"15430"},{"source":"gilbert syndrome","target":"cytarabine","id":"15431"},{"source":"gilbert syndrome","target":"daunorubicin","id":"15432"},{"source":"hematologic diseases","target":"glasdegib (oral) (u)","id":"15433"},{"source":"hematologic diseases","target":"azacitidine (iv)","id":"15434"},{"source":"hematologic diseases","target":"azacitidine (iv)","id":"15435"},{"source":"hematologic diseases","target":"cytarabine","id":"15436"},{"source":"hematologic diseases","target":"daunorubicin","id":"15437"},{"source":"carcinoma","target":"glasdegib (oral) (u)","id":"15438"},{"source":"carcinoma","target":"azacitidine (iv)","id":"15439"},{"source":"carcinoma","target":"azacitidine (iv)","id":"15440"},{"source":"carcinoma","target":"cytarabine","id":"15441"},{"source":"carcinoma","target":"daunorubicin","id":"15442"},{"source":"gilbert disease","target":"glasdegib (oral) (u)","id":"15443"},{"source":"gilbert disease","target":"azacitidine (iv)","id":"15444"},{"source":"gilbert disease","target":"azacitidine (iv)","id":"15445"},{"source":"gilbert disease","target":"cytarabine","id":"15446"},{"source":"gilbert disease","target":"daunorubicin","id":"15447"},{"source":"myeloid","target":"glasdegib (oral) (u)","id":"15448"},{"source":"myeloid","target":"azacitidine (iv)","id":"15449"},{"source":"myeloid","target":"azacitidine (iv)","id":"15450"},{"source":"myeloid","target":"cytarabine","id":"15451"},{"source":"myeloid","target":"daunorubicin","id":"15452"},{"source":"anticancer","target":"glasdegib (oral) (u)","id":"15453"},{"source":"anticancer","target":"azacitidine (iv)","id":"15454"},{"source":"anticancer","target":"azacitidine (iv)","id":"15455"},{"source":"anticancer","target":"cytarabine","id":"15456"},{"source":"anticancer","target":"daunorubicin","id":"15457"},{"source":"anticancer","target":"glasdegib (oral) (u)","id":"15458"},{"source":"anticancer","target":"azacitidine (iv)","id":"15459"},{"source":"anticancer","target":"azacitidine (iv)","id":"15460"},{"source":"anticancer","target":"cytarabine","id":"15461"},{"source":"anticancer","target":"daunorubicin","id":"15462"},{"source":"NA","target":"UNK : Indication","id":"15463"},{"source":"NA","target":"acute","id":"15464"},{"source":"NA","target":"aml","id":"15465"},{"source":"NA","target":"hematologic diseases","id":"15466"},{"source":"NA","target":"acute","id":"15467"},{"source":"NA","target":"acute","id":"15468"},{"source":"NA","target":"solid malignancy","id":"15469"},{"source":"NA","target":"leukemia","id":"15470"},{"source":"NA","target":"leukemia","id":"15471"},{"source":"NA","target":"gilbert syndrome","id":"15472"},{"source":"NA","target":"hematologic diseases","id":"15473"},{"source":"NA","target":"carcinoma","id":"15474"},{"source":"NA","target":"gilbert disease","id":"15475"},{"source":"NA","target":"myeloid","id":"15476"},{"source":"NA","target":"anticancer","id":"15477"},{"source":"NA","target":"anticancer","id":"15478"},{"source":"NA","target":"UNK : Indication","id":"15479"},{"source":"NA","target":"acute","id":"15480"},{"source":"NA","target":"aml","id":"15481"},{"source":"NA","target":"hematologic diseases","id":"15482"},{"source":"NA","target":"acute","id":"15483"},{"source":"NA","target":"acute","id":"15484"},{"source":"NA","target":"solid malignancy","id":"15485"},{"source":"NA","target":"leukemia","id":"15486"},{"source":"NA","target":"leukemia","id":"15487"},{"source":"NA","target":"gilbert syndrome","id":"15488"},{"source":"NA","target":"hematologic diseases","id":"15489"},{"source":"NA","target":"carcinoma","id":"15490"},{"source":"NA","target":"gilbert disease","id":"15491"},{"source":"NA","target":"myeloid","id":"15492"},{"source":"NA","target":"anticancer","id":"15493"},{"source":"NA","target":"anticancer","id":"15494"},{"source":"Hedgehog pathway inhibitor","target":"UNK : Indication","id":"15495"},{"source":"Hedgehog pathway inhibitor","target":"acute","id":"15496"},{"source":"Hedgehog pathway inhibitor","target":"aml","id":"15497"},{"source":"Hedgehog pathway inhibitor","target":"hematologic diseases","id":"15498"},{"source":"Hedgehog pathway inhibitor","target":"acute","id":"15499"},{"source":"Hedgehog pathway inhibitor","target":"acute","id":"15500"},{"source":"Hedgehog pathway inhibitor","target":"solid malignancy","id":"15501"},{"source":"Hedgehog pathway inhibitor","target":"leukemia","id":"15502"},{"source":"Hedgehog pathway inhibitor","target":"leukemia","id":"15503"},{"source":"Hedgehog pathway inhibitor","target":"gilbert syndrome","id":"15504"},{"source":"Hedgehog pathway inhibitor","target":"hematologic diseases","id":"15505"},{"source":"Hedgehog pathway inhibitor","target":"carcinoma","id":"15506"},{"source":"Hedgehog pathway inhibitor","target":"gilbert disease","id":"15507"},{"source":"Hedgehog pathway inhibitor","target":"myeloid","id":"15508"},{"source":"Hedgehog pathway inhibitor","target":"anticancer","id":"15509"},{"source":"Hedgehog pathway inhibitor","target":"anticancer","id":"15510"},{"source":"NA","target":"UNK : Indication","id":"15511"},{"source":"NA","target":"acute","id":"15512"},{"source":"NA","target":"aml","id":"15513"},{"source":"NA","target":"hematologic diseases","id":"15514"},{"source":"NA","target":"acute","id":"15515"},{"source":"NA","target":"acute","id":"15516"},{"source":"NA","target":"solid malignancy","id":"15517"},{"source":"NA","target":"leukemia","id":"15518"},{"source":"NA","target":"leukemia","id":"15519"},{"source":"NA","target":"gilbert syndrome","id":"15520"},{"source":"NA","target":"hematologic diseases","id":"15521"},{"source":"NA","target":"carcinoma","id":"15522"},{"source":"NA","target":"gilbert disease","id":"15523"},{"source":"NA","target":"myeloid","id":"15524"},{"source":"NA","target":"anticancer","id":"15525"},{"source":"NA","target":"anticancer","id":"15526"},{"source":"NA","target":"UNK : Indication","id":"15527"},{"source":"NA","target":"acute","id":"15528"},{"source":"NA","target":"aml","id":"15529"},{"source":"NA","target":"hematologic diseases","id":"15530"},{"source":"NA","target":"acute","id":"15531"},{"source":"NA","target":"acute","id":"15532"},{"source":"NA","target":"solid malignancy","id":"15533"},{"source":"NA","target":"leukemia","id":"15534"},{"source":"NA","target":"leukemia","id":"15535"},{"source":"NA","target":"gilbert syndrome","id":"15536"},{"source":"NA","target":"hematologic diseases","id":"15537"},{"source":"NA","target":"carcinoma","id":"15538"},{"source":"NA","target":"gilbert disease","id":"15539"},{"source":"NA","target":"myeloid","id":"15540"},{"source":"NA","target":"anticancer","id":"15541"},{"source":"NA","target":"anticancer","id":"15542"},{"source":"Radical formation stimulant","target":"UNK : Indication","id":"15543"},{"source":"Radical formation stimulant","target":"acute","id":"15544"},{"source":"Radical formation stimulant","target":"aml","id":"15545"},{"source":"Radical formation stimulant","target":"hematologic diseases","id":"15546"},{"source":"Radical formation stimulant","target":"acute","id":"15547"},{"source":"Radical formation stimulant","target":"acute","id":"15548"},{"source":"Radical formation stimulant","target":"solid malignancy","id":"15549"},{"source":"Radical formation stimulant","target":"leukemia","id":"15550"},{"source":"Radical formation stimulant","target":"leukemia","id":"15551"},{"source":"Radical formation stimulant","target":"gilbert syndrome","id":"15552"},{"source":"Radical formation stimulant","target":"hematologic diseases","id":"15553"},{"source":"Radical formation stimulant","target":"carcinoma","id":"15554"},{"source":"Radical formation stimulant","target":"gilbert disease","id":"15555"},{"source":"Radical formation stimulant","target":"myeloid","id":"15556"},{"source":"Radical formation stimulant","target":"anticancer","id":"15557"},{"source":"Radical formation stimulant","target":"anticancer","id":"15558"},{"source":"Oncology: Leukemia","target":"NA","id":"15559"},{"source":"Oncology: Leukemia","target":"NA","id":"15560"},{"source":"Oncology: Leukemia","target":"Hedgehog pathway inhibitor","id":"15561"},{"source":"Oncology: Leukemia","target":"NA","id":"15562"},{"source":"Oncology: Leukemia","target":"NA","id":"15563"},{"source":"Oncology: Leukemia","target":"Radical formation stimulant","id":"15564"},{"source":"Acute Myelogenous","target":"NA","id":"15565"},{"source":"Acute Myelogenous","target":"NA","id":"15566"},{"source":"Acute Myelogenous","target":"Hedgehog pathway inhibitor","id":"15567"},{"source":"Acute Myelogenous","target":"NA","id":"15568"},{"source":"Acute Myelogenous","target":"NA","id":"15569"},{"source":"Acute Myelogenous","target":"Radical formation stimulant","id":"15570"},{"source":"BTH-1677 (u)","target":"(Other Academic Cancer Center)","id":"15571"},{"source":"BTH-1677 (u)","target":"Biothera","id":"15572"},{"source":"BTH-1677 (u)","target":"Merck & Co.","id":"15573"},{"source":"pembrolizumab","target":"(Other Academic Cancer Center)","id":"15574"},{"source":"pembrolizumab","target":"Biothera","id":"15575"},{"source":"pembrolizumab","target":"Merck & Co.","id":"15576"},{"source":"UNK : Indication","target":"BTH-1677 (u)","id":"15577"},{"source":"UNK : Indication","target":"pembrolizumab","id":"15578"},{"source":"hepatic metastases","target":"BTH-1677 (u)","id":"15579"},{"source":"hepatic metastases","target":"pembrolizumab","id":"15580"},{"source":"non-small-cell lung","target":"BTH-1677 (u)","id":"15581"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"15582"},{"source":"anticancer","target":"BTH-1677 (u)","id":"15583"},{"source":"anticancer","target":"pembrolizumab","id":"15584"},{"source":"bleeding","target":"BTH-1677 (u)","id":"15585"},{"source":"bleeding","target":"pembrolizumab","id":"15586"},{"source":"anticancer","target":"BTH-1677 (u)","id":"15587"},{"source":"anticancer","target":"pembrolizumab","id":"15588"},{"source":"sclc","target":"BTH-1677 (u)","id":"15589"},{"source":"sclc","target":"pembrolizumab","id":"15590"},{"source":"carcinoma","target":"BTH-1677 (u)","id":"15591"},{"source":"carcinoma","target":"pembrolizumab","id":"15592"},{"source":"gilbert disease","target":"BTH-1677 (u)","id":"15593"},{"source":"gilbert disease","target":"pembrolizumab","id":"15594"},{"source":"gilbert syndrome","target":"BTH-1677 (u)","id":"15595"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"15596"},{"source":"metastatic","target":"BTH-1677 (u)","id":"15597"},{"source":"metastatic","target":"pembrolizumab","id":"15598"},{"source":"carcinoma","target":"BTH-1677 (u)","id":"15599"},{"source":"carcinoma","target":"pembrolizumab","id":"15600"},{"source":"non-small-cell lung","target":"BTH-1677 (u)","id":"15601"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"15602"},{"source":"neoplasm metastasis","target":"BTH-1677 (u)","id":"15603"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"15604"},{"source":"hemorrhage","target":"BTH-1677 (u)","id":"15605"},{"source":"hemorrhage","target":"pembrolizumab","id":"15606"},{"source":"lung neoplasms","target":"BTH-1677 (u)","id":"15607"},{"source":"lung neoplasms","target":"pembrolizumab","id":"15608"},{"source":"liver neoplasms","target":"BTH-1677 (u)","id":"15609"},{"source":"liver neoplasms","target":"pembrolizumab","id":"15610"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"15611"},{"source":"Immune checkpoint inhibitor","target":"hepatic metastases","id":"15612"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"15613"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"15614"},{"source":"Immune checkpoint inhibitor","target":"bleeding","id":"15615"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"15616"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"15617"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"15618"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"15619"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"15620"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"15621"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"15622"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"15623"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"15624"},{"source":"Immune checkpoint inhibitor","target":"hemorrhage","id":"15625"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"15626"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"15627"},{"source":"Macrophage stimulant","target":"UNK : Indication","id":"15628"},{"source":"Macrophage stimulant","target":"hepatic metastases","id":"15629"},{"source":"Macrophage stimulant","target":"non-small-cell lung","id":"15630"},{"source":"Macrophage stimulant","target":"anticancer","id":"15631"},{"source":"Macrophage stimulant","target":"bleeding","id":"15632"},{"source":"Macrophage stimulant","target":"anticancer","id":"15633"},{"source":"Macrophage stimulant","target":"sclc","id":"15634"},{"source":"Macrophage stimulant","target":"carcinoma","id":"15635"},{"source":"Macrophage stimulant","target":"gilbert disease","id":"15636"},{"source":"Macrophage stimulant","target":"gilbert syndrome","id":"15637"},{"source":"Macrophage stimulant","target":"metastatic","id":"15638"},{"source":"Macrophage stimulant","target":"carcinoma","id":"15639"},{"source":"Macrophage stimulant","target":"non-small-cell lung","id":"15640"},{"source":"Macrophage stimulant","target":"neoplasm metastasis","id":"15641"},{"source":"Macrophage stimulant","target":"hemorrhage","id":"15642"},{"source":"Macrophage stimulant","target":"lung neoplasms","id":"15643"},{"source":"Macrophage stimulant","target":"liver neoplasms","id":"15644"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"15645"},{"source":"Anticancer immunotherapy","target":"hepatic metastases","id":"15646"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"15647"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"15648"},{"source":"Anticancer immunotherapy","target":"bleeding","id":"15649"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"15650"},{"source":"Anticancer immunotherapy","target":"sclc","id":"15651"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"15652"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"15653"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"15654"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"15655"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"15656"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"15657"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"15658"},{"source":"Anticancer immunotherapy","target":"hemorrhage","id":"15659"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"15660"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"15661"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"15662"},{"source":"CD19 antagonist","target":"hepatic metastases","id":"15663"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"15664"},{"source":"CD19 antagonist","target":"anticancer","id":"15665"},{"source":"CD19 antagonist","target":"bleeding","id":"15666"},{"source":"CD19 antagonist","target":"anticancer","id":"15667"},{"source":"CD19 antagonist","target":"sclc","id":"15668"},{"source":"CD19 antagonist","target":"carcinoma","id":"15669"},{"source":"CD19 antagonist","target":"gilbert disease","id":"15670"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"15671"},{"source":"CD19 antagonist","target":"metastatic","id":"15672"},{"source":"CD19 antagonist","target":"carcinoma","id":"15673"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"15674"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"15675"},{"source":"CD19 antagonist","target":"hemorrhage","id":"15676"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"15677"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"15678"},{"source":"Immunostimulant","target":"UNK : Indication","id":"15679"},{"source":"Immunostimulant","target":"hepatic metastases","id":"15680"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"15681"},{"source":"Immunostimulant","target":"anticancer","id":"15682"},{"source":"Immunostimulant","target":"bleeding","id":"15683"},{"source":"Immunostimulant","target":"anticancer","id":"15684"},{"source":"Immunostimulant","target":"sclc","id":"15685"},{"source":"Immunostimulant","target":"carcinoma","id":"15686"},{"source":"Immunostimulant","target":"gilbert disease","id":"15687"},{"source":"Immunostimulant","target":"gilbert syndrome","id":"15688"},{"source":"Immunostimulant","target":"metastatic","id":"15689"},{"source":"Immunostimulant","target":"carcinoma","id":"15690"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"15691"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"15692"},{"source":"Immunostimulant","target":"hemorrhage","id":"15693"},{"source":"Immunostimulant","target":"lung neoplasms","id":"15694"},{"source":"Immunostimulant","target":"liver neoplasms","id":"15695"},{"source":"NA","target":"UNK : Indication","id":"15696"},{"source":"NA","target":"hepatic metastases","id":"15697"},{"source":"NA","target":"non-small-cell lung","id":"15698"},{"source":"NA","target":"anticancer","id":"15699"},{"source":"NA","target":"bleeding","id":"15700"},{"source":"NA","target":"anticancer","id":"15701"},{"source":"NA","target":"sclc","id":"15702"},{"source":"NA","target":"carcinoma","id":"15703"},{"source":"NA","target":"gilbert disease","id":"15704"},{"source":"NA","target":"gilbert syndrome","id":"15705"},{"source":"NA","target":"metastatic","id":"15706"},{"source":"NA","target":"carcinoma","id":"15707"},{"source":"NA","target":"non-small-cell lung","id":"15708"},{"source":"NA","target":"neoplasm metastasis","id":"15709"},{"source":"NA","target":"hemorrhage","id":"15710"},{"source":"NA","target":"lung neoplasms","id":"15711"},{"source":"NA","target":"liver neoplasms","id":"15712"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"15713"},{"source":"Oncology: Lung","target":"Macrophage stimulant","id":"15714"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"15715"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"15716"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"15717"},{"source":"Oncology: Lung","target":"NA","id":"15718"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"15719"},{"source":"Non-Small Cell","target":"Macrophage stimulant","id":"15720"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"15721"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"15722"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"15723"},{"source":"Non-Small Cell","target":"NA","id":"15724"},{"source":"glasdegib (oral) (u)","target":"Pfizer","id":"15725"},{"source":"azacitidine (iv)","target":"Pfizer","id":"15726"},{"source":"azacitidine (iv)","target":"Pfizer","id":"15727"},{"source":"cytarabine","target":"Pfizer","id":"15728"},{"source":"daunorubicin","target":"Pfizer","id":"15729"},{"source":"UNK : Indication","target":"glasdegib (oral) (u)","id":"15730"},{"source":"UNK : Indication","target":"azacitidine (iv)","id":"15731"},{"source":"UNK : Indication","target":"azacitidine (iv)","id":"15732"},{"source":"UNK : Indication","target":"cytarabine","id":"15733"},{"source":"UNK : Indication","target":"daunorubicin","id":"15734"},{"source":"acute","target":"glasdegib (oral) (u)","id":"15735"},{"source":"acute","target":"azacitidine (iv)","id":"15736"},{"source":"acute","target":"azacitidine (iv)","id":"15737"},{"source":"acute","target":"cytarabine","id":"15738"},{"source":"acute","target":"daunorubicin","id":"15739"},{"source":"aml","target":"glasdegib (oral) (u)","id":"15740"},{"source":"aml","target":"azacitidine (iv)","id":"15741"},{"source":"aml","target":"azacitidine (iv)","id":"15742"},{"source":"aml","target":"cytarabine","id":"15743"},{"source":"aml","target":"daunorubicin","id":"15744"},{"source":"hematologic diseases","target":"glasdegib (oral) (u)","id":"15745"},{"source":"hematologic diseases","target":"azacitidine (iv)","id":"15746"},{"source":"hematologic diseases","target":"azacitidine (iv)","id":"15747"},{"source":"hematologic diseases","target":"cytarabine","id":"15748"},{"source":"hematologic diseases","target":"daunorubicin","id":"15749"},{"source":"acute","target":"glasdegib (oral) (u)","id":"15750"},{"source":"acute","target":"azacitidine (iv)","id":"15751"},{"source":"acute","target":"azacitidine (iv)","id":"15752"},{"source":"acute","target":"cytarabine","id":"15753"},{"source":"acute","target":"daunorubicin","id":"15754"},{"source":"acute","target":"glasdegib (oral) (u)","id":"15755"},{"source":"acute","target":"azacitidine (iv)","id":"15756"},{"source":"acute","target":"azacitidine (iv)","id":"15757"},{"source":"acute","target":"cytarabine","id":"15758"},{"source":"acute","target":"daunorubicin","id":"15759"},{"source":"solid malignancy","target":"glasdegib (oral) (u)","id":"15760"},{"source":"solid malignancy","target":"azacitidine (iv)","id":"15761"},{"source":"solid malignancy","target":"azacitidine (iv)","id":"15762"},{"source":"solid malignancy","target":"cytarabine","id":"15763"},{"source":"solid malignancy","target":"daunorubicin","id":"15764"},{"source":"leukemia","target":"glasdegib (oral) (u)","id":"15765"},{"source":"leukemia","target":"azacitidine (iv)","id":"15766"},{"source":"leukemia","target":"azacitidine (iv)","id":"15767"},{"source":"leukemia","target":"cytarabine","id":"15768"},{"source":"leukemia","target":"daunorubicin","id":"15769"},{"source":"leukemia","target":"glasdegib (oral) (u)","id":"15770"},{"source":"leukemia","target":"azacitidine (iv)","id":"15771"},{"source":"leukemia","target":"azacitidine (iv)","id":"15772"},{"source":"leukemia","target":"cytarabine","id":"15773"},{"source":"leukemia","target":"daunorubicin","id":"15774"},{"source":"gilbert syndrome","target":"glasdegib (oral) (u)","id":"15775"},{"source":"gilbert syndrome","target":"azacitidine (iv)","id":"15776"},{"source":"gilbert syndrome","target":"azacitidine (iv)","id":"15777"},{"source":"gilbert syndrome","target":"cytarabine","id":"15778"},{"source":"gilbert syndrome","target":"daunorubicin","id":"15779"},{"source":"hematologic diseases","target":"glasdegib (oral) (u)","id":"15780"},{"source":"hematologic diseases","target":"azacitidine (iv)","id":"15781"},{"source":"hematologic diseases","target":"azacitidine (iv)","id":"15782"},{"source":"hematologic diseases","target":"cytarabine","id":"15783"},{"source":"hematologic diseases","target":"daunorubicin","id":"15784"},{"source":"carcinoma","target":"glasdegib (oral) (u)","id":"15785"},{"source":"carcinoma","target":"azacitidine (iv)","id":"15786"},{"source":"carcinoma","target":"azacitidine (iv)","id":"15787"},{"source":"carcinoma","target":"cytarabine","id":"15788"},{"source":"carcinoma","target":"daunorubicin","id":"15789"},{"source":"gilbert disease","target":"glasdegib (oral) (u)","id":"15790"},{"source":"gilbert disease","target":"azacitidine (iv)","id":"15791"},{"source":"gilbert disease","target":"azacitidine (iv)","id":"15792"},{"source":"gilbert disease","target":"cytarabine","id":"15793"},{"source":"gilbert disease","target":"daunorubicin","id":"15794"},{"source":"myeloid","target":"glasdegib (oral) (u)","id":"15795"},{"source":"myeloid","target":"azacitidine (iv)","id":"15796"},{"source":"myeloid","target":"azacitidine (iv)","id":"15797"},{"source":"myeloid","target":"cytarabine","id":"15798"},{"source":"myeloid","target":"daunorubicin","id":"15799"},{"source":"anticancer","target":"glasdegib (oral) (u)","id":"15800"},{"source":"anticancer","target":"azacitidine (iv)","id":"15801"},{"source":"anticancer","target":"azacitidine (iv)","id":"15802"},{"source":"anticancer","target":"cytarabine","id":"15803"},{"source":"anticancer","target":"daunorubicin","id":"15804"},{"source":"anticancer","target":"glasdegib (oral) (u)","id":"15805"},{"source":"anticancer","target":"azacitidine (iv)","id":"15806"},{"source":"anticancer","target":"azacitidine (iv)","id":"15807"},{"source":"anticancer","target":"cytarabine","id":"15808"},{"source":"anticancer","target":"daunorubicin","id":"15809"},{"source":"NA","target":"UNK : Indication","id":"15810"},{"source":"NA","target":"acute","id":"15811"},{"source":"NA","target":"aml","id":"15812"},{"source":"NA","target":"hematologic diseases","id":"15813"},{"source":"NA","target":"acute","id":"15814"},{"source":"NA","target":"acute","id":"15815"},{"source":"NA","target":"solid malignancy","id":"15816"},{"source":"NA","target":"leukemia","id":"15817"},{"source":"NA","target":"leukemia","id":"15818"},{"source":"NA","target":"gilbert syndrome","id":"15819"},{"source":"NA","target":"hematologic diseases","id":"15820"},{"source":"NA","target":"carcinoma","id":"15821"},{"source":"NA","target":"gilbert disease","id":"15822"},{"source":"NA","target":"myeloid","id":"15823"},{"source":"NA","target":"anticancer","id":"15824"},{"source":"NA","target":"anticancer","id":"15825"},{"source":"NA","target":"UNK : Indication","id":"15826"},{"source":"NA","target":"acute","id":"15827"},{"source":"NA","target":"aml","id":"15828"},{"source":"NA","target":"hematologic diseases","id":"15829"},{"source":"NA","target":"acute","id":"15830"},{"source":"NA","target":"acute","id":"15831"},{"source":"NA","target":"solid malignancy","id":"15832"},{"source":"NA","target":"leukemia","id":"15833"},{"source":"NA","target":"leukemia","id":"15834"},{"source":"NA","target":"gilbert syndrome","id":"15835"},{"source":"NA","target":"hematologic diseases","id":"15836"},{"source":"NA","target":"carcinoma","id":"15837"},{"source":"NA","target":"gilbert disease","id":"15838"},{"source":"NA","target":"myeloid","id":"15839"},{"source":"NA","target":"anticancer","id":"15840"},{"source":"NA","target":"anticancer","id":"15841"},{"source":"Hedgehog pathway inhibitor","target":"UNK : Indication","id":"15842"},{"source":"Hedgehog pathway inhibitor","target":"acute","id":"15843"},{"source":"Hedgehog pathway inhibitor","target":"aml","id":"15844"},{"source":"Hedgehog pathway inhibitor","target":"hematologic diseases","id":"15845"},{"source":"Hedgehog pathway inhibitor","target":"acute","id":"15846"},{"source":"Hedgehog pathway inhibitor","target":"acute","id":"15847"},{"source":"Hedgehog pathway inhibitor","target":"solid malignancy","id":"15848"},{"source":"Hedgehog pathway inhibitor","target":"leukemia","id":"15849"},{"source":"Hedgehog pathway inhibitor","target":"leukemia","id":"15850"},{"source":"Hedgehog pathway inhibitor","target":"gilbert syndrome","id":"15851"},{"source":"Hedgehog pathway inhibitor","target":"hematologic diseases","id":"15852"},{"source":"Hedgehog pathway inhibitor","target":"carcinoma","id":"15853"},{"source":"Hedgehog pathway inhibitor","target":"gilbert disease","id":"15854"},{"source":"Hedgehog pathway inhibitor","target":"myeloid","id":"15855"},{"source":"Hedgehog pathway inhibitor","target":"anticancer","id":"15856"},{"source":"Hedgehog pathway inhibitor","target":"anticancer","id":"15857"},{"source":"NA","target":"UNK : Indication","id":"15858"},{"source":"NA","target":"acute","id":"15859"},{"source":"NA","target":"aml","id":"15860"},{"source":"NA","target":"hematologic diseases","id":"15861"},{"source":"NA","target":"acute","id":"15862"},{"source":"NA","target":"acute","id":"15863"},{"source":"NA","target":"solid malignancy","id":"15864"},{"source":"NA","target":"leukemia","id":"15865"},{"source":"NA","target":"leukemia","id":"15866"},{"source":"NA","target":"gilbert syndrome","id":"15867"},{"source":"NA","target":"hematologic diseases","id":"15868"},{"source":"NA","target":"carcinoma","id":"15869"},{"source":"NA","target":"gilbert disease","id":"15870"},{"source":"NA","target":"myeloid","id":"15871"},{"source":"NA","target":"anticancer","id":"15872"},{"source":"NA","target":"anticancer","id":"15873"},{"source":"NA","target":"UNK : Indication","id":"15874"},{"source":"NA","target":"acute","id":"15875"},{"source":"NA","target":"aml","id":"15876"},{"source":"NA","target":"hematologic diseases","id":"15877"},{"source":"NA","target":"acute","id":"15878"},{"source":"NA","target":"acute","id":"15879"},{"source":"NA","target":"solid malignancy","id":"15880"},{"source":"NA","target":"leukemia","id":"15881"},{"source":"NA","target":"leukemia","id":"15882"},{"source":"NA","target":"gilbert syndrome","id":"15883"},{"source":"NA","target":"hematologic diseases","id":"15884"},{"source":"NA","target":"carcinoma","id":"15885"},{"source":"NA","target":"gilbert disease","id":"15886"},{"source":"NA","target":"myeloid","id":"15887"},{"source":"NA","target":"anticancer","id":"15888"},{"source":"NA","target":"anticancer","id":"15889"},{"source":"Radical formation stimulant","target":"UNK : Indication","id":"15890"},{"source":"Radical formation stimulant","target":"acute","id":"15891"},{"source":"Radical formation stimulant","target":"aml","id":"15892"},{"source":"Radical formation stimulant","target":"hematologic diseases","id":"15893"},{"source":"Radical formation stimulant","target":"acute","id":"15894"},{"source":"Radical formation stimulant","target":"acute","id":"15895"},{"source":"Radical formation stimulant","target":"solid malignancy","id":"15896"},{"source":"Radical formation stimulant","target":"leukemia","id":"15897"},{"source":"Radical formation stimulant","target":"leukemia","id":"15898"},{"source":"Radical formation stimulant","target":"gilbert syndrome","id":"15899"},{"source":"Radical formation stimulant","target":"hematologic diseases","id":"15900"},{"source":"Radical formation stimulant","target":"carcinoma","id":"15901"},{"source":"Radical formation stimulant","target":"gilbert disease","id":"15902"},{"source":"Radical formation stimulant","target":"myeloid","id":"15903"},{"source":"Radical formation stimulant","target":"anticancer","id":"15904"},{"source":"Radical formation stimulant","target":"anticancer","id":"15905"},{"source":"Oncology: Leukemia","target":"NA","id":"15906"},{"source":"Oncology: Leukemia","target":"NA","id":"15907"},{"source":"Oncology: Leukemia","target":"Hedgehog pathway inhibitor","id":"15908"},{"source":"Oncology: Leukemia","target":"NA","id":"15909"},{"source":"Oncology: Leukemia","target":"NA","id":"15910"},{"source":"Oncology: Leukemia","target":"Radical formation stimulant","id":"15911"},{"source":"Acute Myelogenous","target":"NA","id":"15912"},{"source":"Acute Myelogenous","target":"NA","id":"15913"},{"source":"Acute Myelogenous","target":"Hedgehog pathway inhibitor","id":"15914"},{"source":"Acute Myelogenous","target":"NA","id":"15915"},{"source":"Acute Myelogenous","target":"NA","id":"15916"},{"source":"Acute Myelogenous","target":"Radical formation stimulant","id":"15917"},{"source":"pembrolizumab","target":"Merck & Co.","id":"15918"},{"source":"UNK : Drug","target":"Merck & Co.","id":"15919"},{"source":"UNK : Indication","target":"pembrolizumab","id":"15920"},{"source":"UNK : Indication","target":"UNK : Drug","id":"15921"},{"source":"anticancer","target":"pembrolizumab","id":"15922"},{"source":"anticancer","target":"UNK : Drug","id":"15923"},{"source":"renal cancer","target":"pembrolizumab","id":"15924"},{"source":"renal cancer","target":"UNK : Drug","id":"15925"},{"source":"carcinoma","target":"pembrolizumab","id":"15926"},{"source":"carcinoma","target":"UNK : Drug","id":"15927"},{"source":"breast neoplasms","target":"pembrolizumab","id":"15928"},{"source":"breast neoplasms","target":"UNK : Drug","id":"15929"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"15930"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"15931"},{"source":"solid tumors","target":"pembrolizumab","id":"15932"},{"source":"solid tumors","target":"UNK : Drug","id":"15933"},{"source":"head and neck cancer","target":"pembrolizumab","id":"15934"},{"source":"head and neck cancer","target":"UNK : Drug","id":"15935"},{"source":"hpv type","target":"pembrolizumab","id":"15936"},{"source":"hpv type","target":"UNK : Drug","id":"15937"},{"source":"breast neoplasms","target":"pembrolizumab","id":"15938"},{"source":"breast neoplasms","target":"UNK : Drug","id":"15939"},{"source":"esophageal cancer","target":"pembrolizumab","id":"15940"},{"source":"esophageal cancer","target":"UNK : Drug","id":"15941"},{"source":"inflammation","target":"pembrolizumab","id":"15942"},{"source":"inflammation","target":"UNK : Drug","id":"15943"},{"source":"papilloma","target":"pembrolizumab","id":"15944"},{"source":"papilloma","target":"UNK : Drug","id":"15945"},{"source":"renal cell","target":"pembrolizumab","id":"15946"},{"source":"renal cell","target":"UNK : Drug","id":"15947"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"15948"},{"source":"pharyngeal neoplasms","target":"UNK : Drug","id":"15949"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"15950"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"15951"},{"source":"carcinoma","target":"pembrolizumab","id":"15952"},{"source":"carcinoma","target":"UNK : Drug","id":"15953"},{"source":"carcinoma","target":"pembrolizumab","id":"15954"},{"source":"carcinoma","target":"UNK : Drug","id":"15955"},{"source":"gastric cancer","target":"pembrolizumab","id":"15956"},{"source":"gastric cancer","target":"UNK : Drug","id":"15957"},{"source":"metastatic","target":"pembrolizumab","id":"15958"},{"source":"metastatic","target":"UNK : Drug","id":"15959"},{"source":"carcinoma","target":"pembrolizumab","id":"15960"},{"source":"carcinoma","target":"UNK : Drug","id":"15961"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"15962"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"15963"},{"source":"renal cancer","target":"pembrolizumab","id":"15964"},{"source":"renal cancer","target":"UNK : Drug","id":"15965"},{"source":"carcinoma","target":"pembrolizumab","id":"15966"},{"source":"carcinoma","target":"UNK : Drug","id":"15967"},{"source":"head and neck cancer","target":"pembrolizumab","id":"15968"},{"source":"head and neck cancer","target":"UNK : Drug","id":"15969"},{"source":"carcinoma","target":"pembrolizumab","id":"15970"},{"source":"carcinoma","target":"UNK : Drug","id":"15971"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"15972"},{"source":"stomach neoplasms","target":"UNK : Drug","id":"15973"},{"source":"tnbc","target":"pembrolizumab","id":"15974"},{"source":"tnbc","target":"UNK : Drug","id":"15975"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"15976"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"15977"},{"source":"inflamed","target":"pembrolizumab","id":"15978"},{"source":"inflamed","target":"UNK : Drug","id":"15979"},{"source":"carcinoma","target":"pembrolizumab","id":"15980"},{"source":"carcinoma","target":"UNK : Drug","id":"15981"},{"source":"residual tumor","target":"pembrolizumab","id":"15982"},{"source":"residual tumor","target":"UNK : Drug","id":"15983"},{"source":"anti-tumor","target":"pembrolizumab","id":"15984"},{"source":"anti-tumor","target":"UNK : Drug","id":"15985"},{"source":"anticancer","target":"pembrolizumab","id":"15986"},{"source":"anticancer","target":"UNK : Drug","id":"15987"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"15988"},{"source":"urinary bladder neoplasms","target":"UNK : Drug","id":"15989"},{"source":"solid tumors","target":"pembrolizumab","id":"15990"},{"source":"solid tumors","target":"UNK : Drug","id":"15991"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"15992"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"15993"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"15994"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"15995"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"15996"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"15997"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"15998"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"15999"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"16000"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"16001"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"16002"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"16003"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"16004"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"16005"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"16006"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"16007"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16008"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16009"},{"source":"Anticancer immunotherapy","target":"gastric cancer","id":"16010"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"16011"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16012"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"16013"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"16014"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16015"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"16016"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16017"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"16018"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"16019"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"16020"},{"source":"Anticancer immunotherapy","target":"inflamed","id":"16021"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16022"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"16023"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"16024"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"16025"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"16026"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"16027"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"16028"},{"source":"CD19 antagonist","target":"anticancer","id":"16029"},{"source":"CD19 antagonist","target":"renal cancer","id":"16030"},{"source":"CD19 antagonist","target":"carcinoma","id":"16031"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"16032"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"16033"},{"source":"CD19 antagonist","target":"solid tumors","id":"16034"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"16035"},{"source":"CD19 antagonist","target":"hpv type","id":"16036"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"16037"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"16038"},{"source":"CD19 antagonist","target":"inflammation","id":"16039"},{"source":"CD19 antagonist","target":"papilloma","id":"16040"},{"source":"CD19 antagonist","target":"renal cell","id":"16041"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"16042"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"16043"},{"source":"CD19 antagonist","target":"carcinoma","id":"16044"},{"source":"CD19 antagonist","target":"carcinoma","id":"16045"},{"source":"CD19 antagonist","target":"gastric cancer","id":"16046"},{"source":"CD19 antagonist","target":"metastatic","id":"16047"},{"source":"CD19 antagonist","target":"carcinoma","id":"16048"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"16049"},{"source":"CD19 antagonist","target":"renal cancer","id":"16050"},{"source":"CD19 antagonist","target":"carcinoma","id":"16051"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"16052"},{"source":"CD19 antagonist","target":"carcinoma","id":"16053"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"16054"},{"source":"CD19 antagonist","target":"tnbc","id":"16055"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"16056"},{"source":"CD19 antagonist","target":"inflamed","id":"16057"},{"source":"CD19 antagonist","target":"carcinoma","id":"16058"},{"source":"CD19 antagonist","target":"residual tumor","id":"16059"},{"source":"CD19 antagonist","target":"anti-tumor","id":"16060"},{"source":"CD19 antagonist","target":"anticancer","id":"16061"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"16062"},{"source":"CD19 antagonist","target":"solid tumors","id":"16063"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"16064"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"16065"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"16066"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16067"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"16068"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"16069"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"16070"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"16071"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"16072"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"16073"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"16074"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"16075"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"16076"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"16077"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"16078"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"16079"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16080"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16081"},{"source":"Immune checkpoint inhibitor","target":"gastric cancer","id":"16082"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"16083"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16084"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"16085"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"16086"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16087"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"16088"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16089"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"16090"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"16091"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"16092"},{"source":"Immune checkpoint inhibitor","target":"inflamed","id":"16093"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16094"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"16095"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"16096"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"16097"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"16098"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"16099"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"16100"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"16101"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"16102"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"16103"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"16104"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"16105"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"16106"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"16107"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"16108"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"16109"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"16110"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"16111"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"16112"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"16113"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"16114"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"16115"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"16116"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"16117"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"16118"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"16119"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"16120"},{"source":"eftilagimod alfa (u)","target":"Immutep {Prima Biomed/Immutep}","id":"16121"},{"source":"pembrolizumab","target":"Immutep {Prima Biomed/Immutep}","id":"16122"},{"source":"UNK : Indication","target":"eftilagimod alfa (u)","id":"16123"},{"source":"UNK : Indication","target":"pembrolizumab","id":"16124"},{"source":"melanoma","target":"eftilagimod alfa (u)","id":"16125"},{"source":"melanoma","target":"pembrolizumab","id":"16126"},{"source":"alopecia","target":"eftilagimod alfa (u)","id":"16127"},{"source":"alopecia","target":"pembrolizumab","id":"16128"},{"source":"skin neoplasms","target":"eftilagimod alfa (u)","id":"16129"},{"source":"skin neoplasms","target":"pembrolizumab","id":"16130"},{"source":"gilbert disease","target":"eftilagimod alfa (u)","id":"16131"},{"source":"gilbert disease","target":"pembrolizumab","id":"16132"},{"source":"liver metastases","target":"eftilagimod alfa (u)","id":"16133"},{"source":"liver metastases","target":"pembrolizumab","id":"16134"},{"source":"metastatic","target":"eftilagimod alfa (u)","id":"16135"},{"source":"metastatic","target":"pembrolizumab","id":"16136"},{"source":"carcinoma","target":"eftilagimod alfa (u)","id":"16137"},{"source":"carcinoma","target":"pembrolizumab","id":"16138"},{"source":"melanoma","target":"eftilagimod alfa (u)","id":"16139"},{"source":"melanoma","target":"pembrolizumab","id":"16140"},{"source":"neoplasm metastasis","target":"eftilagimod alfa (u)","id":"16141"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"16142"},{"source":"anticancer","target":"eftilagimod alfa (u)","id":"16143"},{"source":"anticancer","target":"pembrolizumab","id":"16144"},{"source":"solid tumors","target":"eftilagimod alfa (u)","id":"16145"},{"source":"solid tumors","target":"pembrolizumab","id":"16146"},{"source":"gilbert disease","target":"eftilagimod alfa (u)","id":"16147"},{"source":"gilbert disease","target":"pembrolizumab","id":"16148"},{"source":"liver neoplasms","target":"eftilagimod alfa (u)","id":"16149"},{"source":"liver neoplasms","target":"pembrolizumab","id":"16150"},{"source":"solid tumors","target":"eftilagimod alfa (u)","id":"16151"},{"source":"solid tumors","target":"pembrolizumab","id":"16152"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"16153"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"16154"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"16155"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"16156"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"16157"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"16158"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"16159"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16160"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"16161"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"16162"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"16163"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"16164"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"16165"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"16166"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"16167"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"16168"},{"source":"CD19 antagonist","target":"melanoma","id":"16169"},{"source":"CD19 antagonist","target":"alopecia","id":"16170"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"16171"},{"source":"CD19 antagonist","target":"gilbert disease","id":"16172"},{"source":"CD19 antagonist","target":"liver metastases","id":"16173"},{"source":"CD19 antagonist","target":"metastatic","id":"16174"},{"source":"CD19 antagonist","target":"carcinoma","id":"16175"},{"source":"CD19 antagonist","target":"melanoma","id":"16176"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"16177"},{"source":"CD19 antagonist","target":"anticancer","id":"16178"},{"source":"CD19 antagonist","target":"solid tumors","id":"16179"},{"source":"CD19 antagonist","target":"gilbert disease","id":"16180"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"16181"},{"source":"CD19 antagonist","target":"solid tumors","id":"16182"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"UNK : Indication","id":"16183"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"melanoma","id":"16184"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"alopecia","id":"16185"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"skin neoplasms","id":"16186"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"gilbert disease","id":"16187"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"liver metastases","id":"16188"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"metastatic","id":"16189"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"carcinoma","id":"16190"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"melanoma","id":"16191"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"neoplasm metastasis","id":"16192"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"anticancer","id":"16193"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"solid tumors","id":"16194"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"gilbert disease","id":"16195"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"liver neoplasms","id":"16196"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"solid tumors","id":"16197"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"16198"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"16199"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"16200"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"16201"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"16202"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"16203"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"16204"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16205"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"16206"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"16207"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"16208"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"16209"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"16210"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"16211"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"16212"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"16213"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"16214"},{"source":"Oncology: Melanoma","target":"Lymphocyte-activation gene 3 antagonist","id":"16215"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"16216"},{"source":"pembrolizumab","target":"Merck & Co.","id":"16217"},{"source":"carboplatin","target":"Merck & Co.","id":"16218"},{"source":"cisplatin","target":"Merck & Co.","id":"16219"},{"source":"dexamethasone","target":"Merck & Co.","id":"16220"},{"source":"folic acid","target":"Merck & Co.","id":"16221"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"16222"},{"source":"vitamin B12","target":"Merck & Co.","id":"16223"},{"source":"psoriasis","target":"pembrolizumab","id":"16224"},{"source":"psoriasis","target":"carboplatin","id":"16225"},{"source":"psoriasis","target":"cisplatin","id":"16226"},{"source":"psoriasis","target":"dexamethasone","id":"16227"},{"source":"psoriasis","target":"folic acid","id":"16228"},{"source":"psoriasis","target":"pemetrexed disodium","id":"16229"},{"source":"psoriasis","target":"vitamin B12","id":"16230"},{"source":"residual tumor","target":"pembrolizumab","id":"16231"},{"source":"residual tumor","target":"carboplatin","id":"16232"},{"source":"residual tumor","target":"cisplatin","id":"16233"},{"source":"residual tumor","target":"dexamethasone","id":"16234"},{"source":"residual tumor","target":"folic acid","id":"16235"},{"source":"residual tumor","target":"pemetrexed disodium","id":"16236"},{"source":"residual tumor","target":"vitamin B12","id":"16237"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"16238"},{"source":"non-small-cell lung","target":"carboplatin","id":"16239"},{"source":"non-small-cell lung","target":"cisplatin","id":"16240"},{"source":"non-small-cell lung","target":"dexamethasone","id":"16241"},{"source":"non-small-cell lung","target":"folic acid","id":"16242"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"16243"},{"source":"non-small-cell lung","target":"vitamin B12","id":"16244"},{"source":"antiarthritic","target":"pembrolizumab","id":"16245"},{"source":"antiarthritic","target":"carboplatin","id":"16246"},{"source":"antiarthritic","target":"cisplatin","id":"16247"},{"source":"antiarthritic","target":"dexamethasone","id":"16248"},{"source":"antiarthritic","target":"folic acid","id":"16249"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"16250"},{"source":"antiarthritic","target":"vitamin B12","id":"16251"},{"source":"arthritis","target":"pembrolizumab","id":"16252"},{"source":"arthritis","target":"carboplatin","id":"16253"},{"source":"arthritis","target":"cisplatin","id":"16254"},{"source":"arthritis","target":"dexamethasone","id":"16255"},{"source":"arthritis","target":"folic acid","id":"16256"},{"source":"arthritis","target":"pemetrexed disodium","id":"16257"},{"source":"arthritis","target":"vitamin B12","id":"16258"},{"source":"antianaemic","target":"pembrolizumab","id":"16259"},{"source":"antianaemic","target":"carboplatin","id":"16260"},{"source":"antianaemic","target":"cisplatin","id":"16261"},{"source":"antianaemic","target":"dexamethasone","id":"16262"},{"source":"antianaemic","target":"folic acid","id":"16263"},{"source":"antianaemic","target":"pemetrexed disodium","id":"16264"},{"source":"antianaemic","target":"vitamin B12","id":"16265"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"16266"},{"source":"anti-inflammatory","target":"carboplatin","id":"16267"},{"source":"anti-inflammatory","target":"cisplatin","id":"16268"},{"source":"anti-inflammatory","target":"dexamethasone","id":"16269"},{"source":"anti-inflammatory","target":"folic acid","id":"16270"},{"source":"anti-inflammatory","target":"pemetrexed disodium","id":"16271"},{"source":"anti-inflammatory","target":"vitamin B12","id":"16272"},{"source":"carcinoma","target":"pembrolizumab","id":"16273"},{"source":"carcinoma","target":"carboplatin","id":"16274"},{"source":"carcinoma","target":"cisplatin","id":"16275"},{"source":"carcinoma","target":"dexamethasone","id":"16276"},{"source":"carcinoma","target":"folic acid","id":"16277"},{"source":"carcinoma","target":"pemetrexed disodium","id":"16278"},{"source":"carcinoma","target":"vitamin B12","id":"16279"},{"source":"metastatic","target":"pembrolizumab","id":"16280"},{"source":"metastatic","target":"carboplatin","id":"16281"},{"source":"metastatic","target":"cisplatin","id":"16282"},{"source":"metastatic","target":"dexamethasone","id":"16283"},{"source":"metastatic","target":"folic acid","id":"16284"},{"source":"metastatic","target":"pemetrexed disodium","id":"16285"},{"source":"metastatic","target":"vitamin B12","id":"16286"},{"source":"carcinoma","target":"pembrolizumab","id":"16287"},{"source":"carcinoma","target":"carboplatin","id":"16288"},{"source":"carcinoma","target":"cisplatin","id":"16289"},{"source":"carcinoma","target":"dexamethasone","id":"16290"},{"source":"carcinoma","target":"folic acid","id":"16291"},{"source":"carcinoma","target":"pemetrexed disodium","id":"16292"},{"source":"carcinoma","target":"vitamin B12","id":"16293"},{"source":"inflammation","target":"pembrolizumab","id":"16294"},{"source":"inflammation","target":"carboplatin","id":"16295"},{"source":"inflammation","target":"cisplatin","id":"16296"},{"source":"inflammation","target":"dexamethasone","id":"16297"},{"source":"inflammation","target":"folic acid","id":"16298"},{"source":"inflammation","target":"pemetrexed disodium","id":"16299"},{"source":"inflammation","target":"vitamin B12","id":"16300"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"16301"},{"source":"non-small-cell lung","target":"carboplatin","id":"16302"},{"source":"non-small-cell lung","target":"cisplatin","id":"16303"},{"source":"non-small-cell lung","target":"dexamethasone","id":"16304"},{"source":"non-small-cell lung","target":"folic acid","id":"16305"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"16306"},{"source":"non-small-cell lung","target":"vitamin B12","id":"16307"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"16308"},{"source":"neoplasm metastasis","target":"carboplatin","id":"16309"},{"source":"neoplasm metastasis","target":"cisplatin","id":"16310"},{"source":"neoplasm metastasis","target":"dexamethasone","id":"16311"},{"source":"neoplasm metastasis","target":"folic acid","id":"16312"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"16313"},{"source":"neoplasm metastasis","target":"vitamin B12","id":"16314"},{"source":"psoriasis","target":"pembrolizumab","id":"16315"},{"source":"psoriasis","target":"carboplatin","id":"16316"},{"source":"psoriasis","target":"cisplatin","id":"16317"},{"source":"psoriasis","target":"dexamethasone","id":"16318"},{"source":"psoriasis","target":"folic acid","id":"16319"},{"source":"psoriasis","target":"pemetrexed disodium","id":"16320"},{"source":"psoriasis","target":"vitamin B12","id":"16321"},{"source":"anticancer","target":"pembrolizumab","id":"16322"},{"source":"anticancer","target":"carboplatin","id":"16323"},{"source":"anticancer","target":"cisplatin","id":"16324"},{"source":"anticancer","target":"dexamethasone","id":"16325"},{"source":"anticancer","target":"folic acid","id":"16326"},{"source":"anticancer","target":"pemetrexed disodium","id":"16327"},{"source":"anticancer","target":"vitamin B12","id":"16328"},{"source":"lymphoma","target":"pembrolizumab","id":"16329"},{"source":"lymphoma","target":"carboplatin","id":"16330"},{"source":"lymphoma","target":"cisplatin","id":"16331"},{"source":"lymphoma","target":"dexamethasone","id":"16332"},{"source":"lymphoma","target":"folic acid","id":"16333"},{"source":"lymphoma","target":"pemetrexed disodium","id":"16334"},{"source":"lymphoma","target":"vitamin B12","id":"16335"},{"source":"lung neoplasms","target":"pembrolizumab","id":"16336"},{"source":"lung neoplasms","target":"carboplatin","id":"16337"},{"source":"lung neoplasms","target":"cisplatin","id":"16338"},{"source":"lung neoplasms","target":"dexamethasone","id":"16339"},{"source":"lung neoplasms","target":"folic acid","id":"16340"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"16341"},{"source":"lung neoplasms","target":"vitamin B12","id":"16342"},{"source":"sclc","target":"pembrolizumab","id":"16343"},{"source":"sclc","target":"carboplatin","id":"16344"},{"source":"sclc","target":"cisplatin","id":"16345"},{"source":"sclc","target":"dexamethasone","id":"16346"},{"source":"sclc","target":"folic acid","id":"16347"},{"source":"sclc","target":"pemetrexed disodium","id":"16348"},{"source":"sclc","target":"vitamin B12","id":"16349"},{"source":"anemia","target":"pembrolizumab","id":"16350"},{"source":"anemia","target":"carboplatin","id":"16351"},{"source":"anemia","target":"cisplatin","id":"16352"},{"source":"anemia","target":"dexamethasone","id":"16353"},{"source":"anemia","target":"folic acid","id":"16354"},{"source":"anemia","target":"pemetrexed disodium","id":"16355"},{"source":"anemia","target":"vitamin B12","id":"16356"},{"source":"Immunosuppressant","target":"psoriasis","id":"16357"},{"source":"Immunosuppressant","target":"residual tumor","id":"16358"},{"source":"Immunosuppressant","target":"non-small-cell lung","id":"16359"},{"source":"Immunosuppressant","target":"antiarthritic","id":"16360"},{"source":"Immunosuppressant","target":"arthritis","id":"16361"},{"source":"Immunosuppressant","target":"antianaemic","id":"16362"},{"source":"Immunosuppressant","target":"anti-inflammatory","id":"16363"},{"source":"Immunosuppressant","target":"carcinoma","id":"16364"},{"source":"Immunosuppressant","target":"metastatic","id":"16365"},{"source":"Immunosuppressant","target":"carcinoma","id":"16366"},{"source":"Immunosuppressant","target":"inflammation","id":"16367"},{"source":"Immunosuppressant","target":"non-small-cell lung","id":"16368"},{"source":"Immunosuppressant","target":"neoplasm metastasis","id":"16369"},{"source":"Immunosuppressant","target":"psoriasis","id":"16370"},{"source":"Immunosuppressant","target":"anticancer","id":"16371"},{"source":"Immunosuppressant","target":"lymphoma","id":"16372"},{"source":"Immunosuppressant","target":"lung neoplasms","id":"16373"},{"source":"Immunosuppressant","target":"sclc","id":"16374"},{"source":"Immunosuppressant","target":"anemia","id":"16375"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"16376"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"16377"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"16378"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"16379"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"16380"},{"source":"Dihydrofolate reductase inhibitor","target":"antianaemic","id":"16381"},{"source":"Dihydrofolate reductase inhibitor","target":"anti-inflammatory","id":"16382"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"16383"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"16384"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"16385"},{"source":"Dihydrofolate reductase inhibitor","target":"inflammation","id":"16386"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"16387"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"16388"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"16389"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"16390"},{"source":"Dihydrofolate reductase inhibitor","target":"lymphoma","id":"16391"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"16392"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"16393"},{"source":"Dihydrofolate reductase inhibitor","target":"anemia","id":"16394"},{"source":"Corticosteroid agonist","target":"psoriasis","id":"16395"},{"source":"Corticosteroid agonist","target":"residual tumor","id":"16396"},{"source":"Corticosteroid agonist","target":"non-small-cell lung","id":"16397"},{"source":"Corticosteroid agonist","target":"antiarthritic","id":"16398"},{"source":"Corticosteroid agonist","target":"arthritis","id":"16399"},{"source":"Corticosteroid agonist","target":"antianaemic","id":"16400"},{"source":"Corticosteroid agonist","target":"anti-inflammatory","id":"16401"},{"source":"Corticosteroid agonist","target":"carcinoma","id":"16402"},{"source":"Corticosteroid agonist","target":"metastatic","id":"16403"},{"source":"Corticosteroid agonist","target":"carcinoma","id":"16404"},{"source":"Corticosteroid agonist","target":"inflammation","id":"16405"},{"source":"Corticosteroid agonist","target":"non-small-cell lung","id":"16406"},{"source":"Corticosteroid agonist","target":"neoplasm metastasis","id":"16407"},{"source":"Corticosteroid agonist","target":"psoriasis","id":"16408"},{"source":"Corticosteroid agonist","target":"anticancer","id":"16409"},{"source":"Corticosteroid agonist","target":"lymphoma","id":"16410"},{"source":"Corticosteroid agonist","target":"lung neoplasms","id":"16411"},{"source":"Corticosteroid agonist","target":"sclc","id":"16412"},{"source":"Corticosteroid agonist","target":"anemia","id":"16413"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"16414"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"16415"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"16416"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"16417"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"16418"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"16419"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"16420"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16421"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"16422"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16423"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"16424"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"16425"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"16426"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"16427"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"16428"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"16429"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"16430"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"16431"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"16432"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"16433"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"16434"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"16435"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"16436"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"16437"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"16438"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"16439"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16440"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"16441"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"16442"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"16443"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"16444"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"16445"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"16446"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"16447"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"16448"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"16449"},{"source":"Anticancer immunotherapy","target":"sclc","id":"16450"},{"source":"Anticancer immunotherapy","target":"anemia","id":"16451"},{"source":"CD19 antagonist","target":"psoriasis","id":"16452"},{"source":"CD19 antagonist","target":"residual tumor","id":"16453"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"16454"},{"source":"CD19 antagonist","target":"antiarthritic","id":"16455"},{"source":"CD19 antagonist","target":"arthritis","id":"16456"},{"source":"CD19 antagonist","target":"antianaemic","id":"16457"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"16458"},{"source":"CD19 antagonist","target":"carcinoma","id":"16459"},{"source":"CD19 antagonist","target":"metastatic","id":"16460"},{"source":"CD19 antagonist","target":"carcinoma","id":"16461"},{"source":"CD19 antagonist","target":"inflammation","id":"16462"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"16463"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"16464"},{"source":"CD19 antagonist","target":"psoriasis","id":"16465"},{"source":"CD19 antagonist","target":"anticancer","id":"16466"},{"source":"CD19 antagonist","target":"lymphoma","id":"16467"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"16468"},{"source":"CD19 antagonist","target":"sclc","id":"16469"},{"source":"CD19 antagonist","target":"anemia","id":"16470"},{"source":"UPA","target":"psoriasis","id":"16471"},{"source":"UPA","target":"residual tumor","id":"16472"},{"source":"UPA","target":"non-small-cell lung","id":"16473"},{"source":"UPA","target":"antiarthritic","id":"16474"},{"source":"UPA","target":"arthritis","id":"16475"},{"source":"UPA","target":"antianaemic","id":"16476"},{"source":"UPA","target":"anti-inflammatory","id":"16477"},{"source":"UPA","target":"carcinoma","id":"16478"},{"source":"UPA","target":"metastatic","id":"16479"},{"source":"UPA","target":"carcinoma","id":"16480"},{"source":"UPA","target":"inflammation","id":"16481"},{"source":"UPA","target":"non-small-cell lung","id":"16482"},{"source":"UPA","target":"neoplasm metastasis","id":"16483"},{"source":"UPA","target":"psoriasis","id":"16484"},{"source":"UPA","target":"anticancer","id":"16485"},{"source":"UPA","target":"lymphoma","id":"16486"},{"source":"UPA","target":"lung neoplasms","id":"16487"},{"source":"UPA","target":"sclc","id":"16488"},{"source":"UPA","target":"anemia","id":"16489"},{"source":"NA","target":"psoriasis","id":"16490"},{"source":"NA","target":"residual tumor","id":"16491"},{"source":"NA","target":"non-small-cell lung","id":"16492"},{"source":"NA","target":"antiarthritic","id":"16493"},{"source":"NA","target":"arthritis","id":"16494"},{"source":"NA","target":"antianaemic","id":"16495"},{"source":"NA","target":"anti-inflammatory","id":"16496"},{"source":"NA","target":"carcinoma","id":"16497"},{"source":"NA","target":"metastatic","id":"16498"},{"source":"NA","target":"carcinoma","id":"16499"},{"source":"NA","target":"inflammation","id":"16500"},{"source":"NA","target":"non-small-cell lung","id":"16501"},{"source":"NA","target":"neoplasm metastasis","id":"16502"},{"source":"NA","target":"psoriasis","id":"16503"},{"source":"NA","target":"anticancer","id":"16504"},{"source":"NA","target":"lymphoma","id":"16505"},{"source":"NA","target":"lung neoplasms","id":"16506"},{"source":"NA","target":"sclc","id":"16507"},{"source":"NA","target":"anemia","id":"16508"},{"source":"NA","target":"psoriasis","id":"16509"},{"source":"NA","target":"residual tumor","id":"16510"},{"source":"NA","target":"non-small-cell lung","id":"16511"},{"source":"NA","target":"antiarthritic","id":"16512"},{"source":"NA","target":"arthritis","id":"16513"},{"source":"NA","target":"antianaemic","id":"16514"},{"source":"NA","target":"anti-inflammatory","id":"16515"},{"source":"NA","target":"carcinoma","id":"16516"},{"source":"NA","target":"metastatic","id":"16517"},{"source":"NA","target":"carcinoma","id":"16518"},{"source":"NA","target":"inflammation","id":"16519"},{"source":"NA","target":"non-small-cell lung","id":"16520"},{"source":"NA","target":"neoplasm metastasis","id":"16521"},{"source":"NA","target":"psoriasis","id":"16522"},{"source":"NA","target":"anticancer","id":"16523"},{"source":"NA","target":"lymphoma","id":"16524"},{"source":"NA","target":"lung neoplasms","id":"16525"},{"source":"NA","target":"sclc","id":"16526"},{"source":"NA","target":"anemia","id":"16527"},{"source":"NA","target":"psoriasis","id":"16528"},{"source":"NA","target":"residual tumor","id":"16529"},{"source":"NA","target":"non-small-cell lung","id":"16530"},{"source":"NA","target":"antiarthritic","id":"16531"},{"source":"NA","target":"arthritis","id":"16532"},{"source":"NA","target":"antianaemic","id":"16533"},{"source":"NA","target":"anti-inflammatory","id":"16534"},{"source":"NA","target":"carcinoma","id":"16535"},{"source":"NA","target":"metastatic","id":"16536"},{"source":"NA","target":"carcinoma","id":"16537"},{"source":"NA","target":"inflammation","id":"16538"},{"source":"NA","target":"non-small-cell lung","id":"16539"},{"source":"NA","target":"neoplasm metastasis","id":"16540"},{"source":"NA","target":"psoriasis","id":"16541"},{"source":"NA","target":"anticancer","id":"16542"},{"source":"NA","target":"lymphoma","id":"16543"},{"source":"NA","target":"lung neoplasms","id":"16544"},{"source":"NA","target":"sclc","id":"16545"},{"source":"NA","target":"anemia","id":"16546"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"16547"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"16548"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"16549"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"16550"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"16551"},{"source":"Thymidylate synthase inhibitor","target":"antianaemic","id":"16552"},{"source":"Thymidylate synthase inhibitor","target":"anti-inflammatory","id":"16553"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"16554"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"16555"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"16556"},{"source":"Thymidylate synthase inhibitor","target":"inflammation","id":"16557"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"16558"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"16559"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"16560"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"16561"},{"source":"Thymidylate synthase inhibitor","target":"lymphoma","id":"16562"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"16563"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"16564"},{"source":"Thymidylate synthase inhibitor","target":"anemia","id":"16565"},{"source":"Vitamin D agonist","target":"psoriasis","id":"16566"},{"source":"Vitamin D agonist","target":"residual tumor","id":"16567"},{"source":"Vitamin D agonist","target":"non-small-cell lung","id":"16568"},{"source":"Vitamin D agonist","target":"antiarthritic","id":"16569"},{"source":"Vitamin D agonist","target":"arthritis","id":"16570"},{"source":"Vitamin D agonist","target":"antianaemic","id":"16571"},{"source":"Vitamin D agonist","target":"anti-inflammatory","id":"16572"},{"source":"Vitamin D agonist","target":"carcinoma","id":"16573"},{"source":"Vitamin D agonist","target":"metastatic","id":"16574"},{"source":"Vitamin D agonist","target":"carcinoma","id":"16575"},{"source":"Vitamin D agonist","target":"inflammation","id":"16576"},{"source":"Vitamin D agonist","target":"non-small-cell lung","id":"16577"},{"source":"Vitamin D agonist","target":"neoplasm metastasis","id":"16578"},{"source":"Vitamin D agonist","target":"psoriasis","id":"16579"},{"source":"Vitamin D agonist","target":"anticancer","id":"16580"},{"source":"Vitamin D agonist","target":"lymphoma","id":"16581"},{"source":"Vitamin D agonist","target":"lung neoplasms","id":"16582"},{"source":"Vitamin D agonist","target":"sclc","id":"16583"},{"source":"Vitamin D agonist","target":"anemia","id":"16584"},{"source":"Oncology: Lung","target":"Immunosuppressant","id":"16585"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"16586"},{"source":"Oncology: Lung","target":"Corticosteroid agonist","id":"16587"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"16588"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"16589"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"16590"},{"source":"Oncology: Lung","target":"UPA","id":"16591"},{"source":"Oncology: Lung","target":"NA","id":"16592"},{"source":"Oncology: Lung","target":"NA","id":"16593"},{"source":"Oncology: Lung","target":"NA","id":"16594"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"16595"},{"source":"Oncology: Lung","target":"Vitamin D agonist","id":"16596"},{"source":"Non-Small Cell","target":"Immunosuppressant","id":"16597"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"16598"},{"source":"Non-Small Cell","target":"Corticosteroid agonist","id":"16599"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"16600"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"16601"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"16602"},{"source":"Non-Small Cell","target":"UPA","id":"16603"},{"source":"Non-Small Cell","target":"NA","id":"16604"},{"source":"Non-Small Cell","target":"NA","id":"16605"},{"source":"Non-Small Cell","target":"NA","id":"16606"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"16607"},{"source":"Non-Small Cell","target":"Vitamin D agonist","id":"16608"},{"source":"pneumococcal polyvalent polysaccharide vaccine (im)","target":"Merck & Co.","id":"16609"},{"source":"Merck (a)","target":"Merck & Co.","id":"16610"},{"source":"pneumococcal polyvalent polysaccharide vaccine (im)","target":"Merck & Co.","id":"16611"},{"source":"15-valent","target":"Merck & Co.","id":"16612"},{"source":"Merck (u)","target":"Merck & Co.","id":"16613"},{"source":"pneumococcal polyvalent polysaccharide vaccine (im)","target":"Merck & Co.","id":"16614"},{"source":"13-valent (IM)","target":"Merck & Co.","id":"16615"},{"source":"Wyeth","target":"Merck & Co.","id":"16616"},{"source":"UNK : Indication","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16617"},{"source":"UNK : Indication","target":"Merck (a)","id":"16618"},{"source":"UNK : Indication","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16619"},{"source":"UNK : Indication","target":"15-valent","id":"16620"},{"source":"UNK : Indication","target":"Merck (u)","id":"16621"},{"source":"UNK : Indication","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16622"},{"source":"UNK : Indication","target":"13-valent (IM)","id":"16623"},{"source":"UNK : Indication","target":"Wyeth","id":"16624"},{"source":"infectious disease","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16625"},{"source":"infectious disease","target":"Merck (a)","id":"16626"},{"source":"infectious disease","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16627"},{"source":"infectious disease","target":"15-valent","id":"16628"},{"source":"infectious disease","target":"Merck (u)","id":"16629"},{"source":"infectious disease","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16630"},{"source":"infectious disease","target":"13-valent (IM)","id":"16631"},{"source":"infectious disease","target":"Wyeth","id":"16632"},{"source":"anti-hiv","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16633"},{"source":"anti-hiv","target":"Merck (a)","id":"16634"},{"source":"anti-hiv","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16635"},{"source":"anti-hiv","target":"15-valent","id":"16636"},{"source":"anti-hiv","target":"Merck (u)","id":"16637"},{"source":"anti-hiv","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16638"},{"source":"anti-hiv","target":"13-valent (IM)","id":"16639"},{"source":"anti-hiv","target":"Wyeth","id":"16640"},{"source":"human immunodeficiency virus","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16641"},{"source":"human immunodeficiency virus","target":"Merck (a)","id":"16642"},{"source":"human immunodeficiency virus","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16643"},{"source":"human immunodeficiency virus","target":"15-valent","id":"16644"},{"source":"human immunodeficiency virus","target":"Merck (u)","id":"16645"},{"source":"human immunodeficiency virus","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16646"},{"source":"human immunodeficiency virus","target":"13-valent (IM)","id":"16647"},{"source":"human immunodeficiency virus","target":"Wyeth","id":"16648"},{"source":"respiratory tract infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16649"},{"source":"respiratory tract infections","target":"Merck (a)","id":"16650"},{"source":"respiratory tract infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16651"},{"source":"respiratory tract infections","target":"15-valent","id":"16652"},{"source":"respiratory tract infections","target":"Merck (u)","id":"16653"},{"source":"respiratory tract infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16654"},{"source":"respiratory tract infections","target":"13-valent (IM)","id":"16655"},{"source":"respiratory tract infections","target":"Wyeth","id":"16656"},{"source":"infected with hiv","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16657"},{"source":"infected with hiv","target":"Merck (a)","id":"16658"},{"source":"infected with hiv","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16659"},{"source":"infected with hiv","target":"15-valent","id":"16660"},{"source":"infected with hiv","target":"Merck (u)","id":"16661"},{"source":"infected with hiv","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16662"},{"source":"infected with hiv","target":"13-valent (IM)","id":"16663"},{"source":"infected with hiv","target":"Wyeth","id":"16664"},{"source":"hiv infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16665"},{"source":"hiv infections","target":"Merck (a)","id":"16666"},{"source":"hiv infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16667"},{"source":"hiv infections","target":"15-valent","id":"16668"},{"source":"hiv infections","target":"Merck (u)","id":"16669"},{"source":"hiv infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16670"},{"source":"hiv infections","target":"13-valent (IM)","id":"16671"},{"source":"hiv infections","target":"Wyeth","id":"16672"},{"source":"pneumococcal infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16673"},{"source":"pneumococcal infections","target":"Merck (a)","id":"16674"},{"source":"pneumococcal infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16675"},{"source":"pneumococcal infections","target":"15-valent","id":"16676"},{"source":"pneumococcal infections","target":"Merck (u)","id":"16677"},{"source":"pneumococcal infections","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16678"},{"source":"pneumococcal infections","target":"13-valent (IM)","id":"16679"},{"source":"pneumococcal infections","target":"Wyeth","id":"16680"},{"source":"acquired immunodeficiency syndrome","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16681"},{"source":"acquired immunodeficiency syndrome","target":"Merck (a)","id":"16682"},{"source":"acquired immunodeficiency syndrome","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16683"},{"source":"acquired immunodeficiency syndrome","target":"15-valent","id":"16684"},{"source":"acquired immunodeficiency syndrome","target":"Merck (u)","id":"16685"},{"source":"acquired immunodeficiency syndrome","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16686"},{"source":"acquired immunodeficiency syndrome","target":"13-valent (IM)","id":"16687"},{"source":"acquired immunodeficiency syndrome","target":"Wyeth","id":"16688"},{"source":"communicable diseases","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16689"},{"source":"communicable diseases","target":"Merck (a)","id":"16690"},{"source":"communicable diseases","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16691"},{"source":"communicable diseases","target":"15-valent","id":"16692"},{"source":"communicable diseases","target":"Merck (u)","id":"16693"},{"source":"communicable diseases","target":"pneumococcal polyvalent polysaccharide vaccine (im)","id":"16694"},{"source":"communicable diseases","target":"13-valent (IM)","id":"16695"},{"source":"communicable diseases","target":"Wyeth","id":"16696"},{"source":"Immunostimulant","target":"UNK : Indication","id":"16697"},{"source":"Immunostimulant","target":"infectious disease","id":"16698"},{"source":"Immunostimulant","target":"anti-hiv","id":"16699"},{"source":"Immunostimulant","target":"human immunodeficiency virus","id":"16700"},{"source":"Immunostimulant","target":"respiratory tract infections","id":"16701"},{"source":"Immunostimulant","target":"infected with hiv","id":"16702"},{"source":"Immunostimulant","target":"hiv infections","id":"16703"},{"source":"Immunostimulant","target":"pneumococcal infections","id":"16704"},{"source":"Immunostimulant","target":"acquired immunodeficiency syndrome","id":"16705"},{"source":"Immunostimulant","target":"communicable diseases","id":"16706"},{"source":"Infectious Disease: Respiratory Infections","target":"Immunostimulant","id":"16707"},{"source":"Vaccines (Infectious Disease): Respiratory Vaccines","target":"Immunostimulant","id":"16708"},{"source":"pembrolizumab","target":"Merck & Co.","id":"16709"},{"source":"bevacizumab","target":"Merck & Co.","id":"16710"},{"source":"carboplatin","target":"Merck & Co.","id":"16711"},{"source":"erlotinib","target":"Merck & Co.","id":"16712"},{"source":"gefitinib","target":"Merck & Co.","id":"16713"},{"source":"ipilimumab","target":"Merck & Co.","id":"16714"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"16715"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"16716"},{"source":"UNK : Indication","target":"pembrolizumab","id":"16717"},{"source":"UNK : Indication","target":"bevacizumab","id":"16718"},{"source":"UNK : Indication","target":"carboplatin","id":"16719"},{"source":"UNK : Indication","target":"erlotinib","id":"16720"},{"source":"UNK : Indication","target":"gefitinib","id":"16721"},{"source":"UNK : Indication","target":"ipilimumab","id":"16722"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"16723"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"16724"},{"source":"anti-hiv","target":"pembrolizumab","id":"16725"},{"source":"anti-hiv","target":"bevacizumab","id":"16726"},{"source":"anti-hiv","target":"carboplatin","id":"16727"},{"source":"anti-hiv","target":"erlotinib","id":"16728"},{"source":"anti-hiv","target":"gefitinib","id":"16729"},{"source":"anti-hiv","target":"ipilimumab","id":"16730"},{"source":"anti-hiv","target":"nab-paclitaxel (IV)","id":"16731"},{"source":"anti-hiv","target":"pemetrexed disodium","id":"16732"},{"source":"antiarthritic","target":"pembrolizumab","id":"16733"},{"source":"antiarthritic","target":"bevacizumab","id":"16734"},{"source":"antiarthritic","target":"carboplatin","id":"16735"},{"source":"antiarthritic","target":"erlotinib","id":"16736"},{"source":"antiarthritic","target":"gefitinib","id":"16737"},{"source":"antiarthritic","target":"ipilimumab","id":"16738"},{"source":"antiarthritic","target":"nab-paclitaxel (IV)","id":"16739"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"16740"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"16741"},{"source":"non-small-cell lung","target":"bevacizumab","id":"16742"},{"source":"non-small-cell lung","target":"carboplatin","id":"16743"},{"source":"non-small-cell lung","target":"erlotinib","id":"16744"},{"source":"non-small-cell lung","target":"gefitinib","id":"16745"},{"source":"non-small-cell lung","target":"ipilimumab","id":"16746"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"16747"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"16748"},{"source":"psoriasis","target":"pembrolizumab","id":"16749"},{"source":"psoriasis","target":"bevacizumab","id":"16750"},{"source":"psoriasis","target":"carboplatin","id":"16751"},{"source":"psoriasis","target":"erlotinib","id":"16752"},{"source":"psoriasis","target":"gefitinib","id":"16753"},{"source":"psoriasis","target":"ipilimumab","id":"16754"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"16755"},{"source":"psoriasis","target":"pemetrexed disodium","id":"16756"},{"source":"hiv infections","target":"pembrolizumab","id":"16757"},{"source":"hiv infections","target":"bevacizumab","id":"16758"},{"source":"hiv infections","target":"carboplatin","id":"16759"},{"source":"hiv infections","target":"erlotinib","id":"16760"},{"source":"hiv infections","target":"gefitinib","id":"16761"},{"source":"hiv infections","target":"ipilimumab","id":"16762"},{"source":"hiv infections","target":"nab-paclitaxel (IV)","id":"16763"},{"source":"hiv infections","target":"pemetrexed disodium","id":"16764"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"16765"},{"source":"acquired immunodeficiency syndrome","target":"bevacizumab","id":"16766"},{"source":"acquired immunodeficiency syndrome","target":"carboplatin","id":"16767"},{"source":"acquired immunodeficiency syndrome","target":"erlotinib","id":"16768"},{"source":"acquired immunodeficiency syndrome","target":"gefitinib","id":"16769"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"16770"},{"source":"acquired immunodeficiency syndrome","target":"nab-paclitaxel (IV)","id":"16771"},{"source":"acquired immunodeficiency syndrome","target":"pemetrexed disodium","id":"16772"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"16773"},{"source":"non-small-cell lung","target":"bevacizumab","id":"16774"},{"source":"non-small-cell lung","target":"carboplatin","id":"16775"},{"source":"non-small-cell lung","target":"erlotinib","id":"16776"},{"source":"non-small-cell lung","target":"gefitinib","id":"16777"},{"source":"non-small-cell lung","target":"ipilimumab","id":"16778"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"16779"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"16780"},{"source":"interstitial lung diseases","target":"pembrolizumab","id":"16781"},{"source":"interstitial lung diseases","target":"bevacizumab","id":"16782"},{"source":"interstitial lung diseases","target":"carboplatin","id":"16783"},{"source":"interstitial lung diseases","target":"erlotinib","id":"16784"},{"source":"interstitial lung diseases","target":"gefitinib","id":"16785"},{"source":"interstitial lung diseases","target":"ipilimumab","id":"16786"},{"source":"interstitial lung diseases","target":"nab-paclitaxel (IV)","id":"16787"},{"source":"interstitial lung diseases","target":"pemetrexed disodium","id":"16788"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"16789"},{"source":"autoimmune diseases","target":"bevacizumab","id":"16790"},{"source":"autoimmune diseases","target":"carboplatin","id":"16791"},{"source":"autoimmune diseases","target":"erlotinib","id":"16792"},{"source":"autoimmune diseases","target":"gefitinib","id":"16793"},{"source":"autoimmune diseases","target":"ipilimumab","id":"16794"},{"source":"autoimmune diseases","target":"nab-paclitaxel (IV)","id":"16795"},{"source":"autoimmune diseases","target":"pemetrexed disodium","id":"16796"},{"source":"alopecia","target":"pembrolizumab","id":"16797"},{"source":"alopecia","target":"bevacizumab","id":"16798"},{"source":"alopecia","target":"carboplatin","id":"16799"},{"source":"alopecia","target":"erlotinib","id":"16800"},{"source":"alopecia","target":"gefitinib","id":"16801"},{"source":"alopecia","target":"ipilimumab","id":"16802"},{"source":"alopecia","target":"nab-paclitaxel (IV)","id":"16803"},{"source":"alopecia","target":"pemetrexed disodium","id":"16804"},{"source":"sclc","target":"pembrolizumab","id":"16805"},{"source":"sclc","target":"bevacizumab","id":"16806"},{"source":"sclc","target":"carboplatin","id":"16807"},{"source":"sclc","target":"erlotinib","id":"16808"},{"source":"sclc","target":"gefitinib","id":"16809"},{"source":"sclc","target":"ipilimumab","id":"16810"},{"source":"sclc","target":"nab-paclitaxel (IV)","id":"16811"},{"source":"sclc","target":"pemetrexed disodium","id":"16812"},{"source":"carcinoma","target":"pembrolizumab","id":"16813"},{"source":"carcinoma","target":"bevacizumab","id":"16814"},{"source":"carcinoma","target":"carboplatin","id":"16815"},{"source":"carcinoma","target":"erlotinib","id":"16816"},{"source":"carcinoma","target":"gefitinib","id":"16817"},{"source":"carcinoma","target":"ipilimumab","id":"16818"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"16819"},{"source":"carcinoma","target":"pemetrexed disodium","id":"16820"},{"source":"psoriasis","target":"pembrolizumab","id":"16821"},{"source":"psoriasis","target":"bevacizumab","id":"16822"},{"source":"psoriasis","target":"carboplatin","id":"16823"},{"source":"psoriasis","target":"erlotinib","id":"16824"},{"source":"psoriasis","target":"gefitinib","id":"16825"},{"source":"psoriasis","target":"ipilimumab","id":"16826"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"16827"},{"source":"psoriasis","target":"pemetrexed disodium","id":"16828"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"16829"},{"source":"autoimmune diseases","target":"bevacizumab","id":"16830"},{"source":"autoimmune diseases","target":"carboplatin","id":"16831"},{"source":"autoimmune diseases","target":"erlotinib","id":"16832"},{"source":"autoimmune diseases","target":"gefitinib","id":"16833"},{"source":"autoimmune diseases","target":"ipilimumab","id":"16834"},{"source":"autoimmune diseases","target":"nab-paclitaxel (IV)","id":"16835"},{"source":"autoimmune diseases","target":"pemetrexed disodium","id":"16836"},{"source":"arthritis","target":"pembrolizumab","id":"16837"},{"source":"arthritis","target":"bevacizumab","id":"16838"},{"source":"arthritis","target":"carboplatin","id":"16839"},{"source":"arthritis","target":"erlotinib","id":"16840"},{"source":"arthritis","target":"gefitinib","id":"16841"},{"source":"arthritis","target":"ipilimumab","id":"16842"},{"source":"arthritis","target":"nab-paclitaxel (IV)","id":"16843"},{"source":"arthritis","target":"pemetrexed disodium","id":"16844"},{"source":"carcinoma","target":"pembrolizumab","id":"16845"},{"source":"carcinoma","target":"bevacizumab","id":"16846"},{"source":"carcinoma","target":"carboplatin","id":"16847"},{"source":"carcinoma","target":"erlotinib","id":"16848"},{"source":"carcinoma","target":"gefitinib","id":"16849"},{"source":"carcinoma","target":"ipilimumab","id":"16850"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"16851"},{"source":"carcinoma","target":"pemetrexed disodium","id":"16852"},{"source":"metastatic","target":"pembrolizumab","id":"16853"},{"source":"metastatic","target":"bevacizumab","id":"16854"},{"source":"metastatic","target":"carboplatin","id":"16855"},{"source":"metastatic","target":"erlotinib","id":"16856"},{"source":"metastatic","target":"gefitinib","id":"16857"},{"source":"metastatic","target":"ipilimumab","id":"16858"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"16859"},{"source":"metastatic","target":"pemetrexed disodium","id":"16860"},{"source":"carcinoma","target":"pembrolizumab","id":"16861"},{"source":"carcinoma","target":"bevacizumab","id":"16862"},{"source":"carcinoma","target":"carboplatin","id":"16863"},{"source":"carcinoma","target":"erlotinib","id":"16864"},{"source":"carcinoma","target":"gefitinib","id":"16865"},{"source":"carcinoma","target":"ipilimumab","id":"16866"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"16867"},{"source":"carcinoma","target":"pemetrexed disodium","id":"16868"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"16869"},{"source":"neoplasm metastasis","target":"bevacizumab","id":"16870"},{"source":"neoplasm metastasis","target":"carboplatin","id":"16871"},{"source":"neoplasm metastasis","target":"erlotinib","id":"16872"},{"source":"neoplasm metastasis","target":"gefitinib","id":"16873"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"16874"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"16875"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"16876"},{"source":"interstitial lung diseases","target":"pembrolizumab","id":"16877"},{"source":"interstitial lung diseases","target":"bevacizumab","id":"16878"},{"source":"interstitial lung diseases","target":"carboplatin","id":"16879"},{"source":"interstitial lung diseases","target":"erlotinib","id":"16880"},{"source":"interstitial lung diseases","target":"gefitinib","id":"16881"},{"source":"interstitial lung diseases","target":"ipilimumab","id":"16882"},{"source":"interstitial lung diseases","target":"nab-paclitaxel (IV)","id":"16883"},{"source":"interstitial lung diseases","target":"pemetrexed disodium","id":"16884"},{"source":"lung neoplasms","target":"pembrolizumab","id":"16885"},{"source":"lung neoplasms","target":"bevacizumab","id":"16886"},{"source":"lung neoplasms","target":"carboplatin","id":"16887"},{"source":"lung neoplasms","target":"erlotinib","id":"16888"},{"source":"lung neoplasms","target":"gefitinib","id":"16889"},{"source":"lung neoplasms","target":"ipilimumab","id":"16890"},{"source":"lung neoplasms","target":"nab-paclitaxel (IV)","id":"16891"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"16892"},{"source":"anti-tumor","target":"pembrolizumab","id":"16893"},{"source":"anti-tumor","target":"bevacizumab","id":"16894"},{"source":"anti-tumor","target":"carboplatin","id":"16895"},{"source":"anti-tumor","target":"erlotinib","id":"16896"},{"source":"anti-tumor","target":"gefitinib","id":"16897"},{"source":"anti-tumor","target":"ipilimumab","id":"16898"},{"source":"anti-tumor","target":"nab-paclitaxel (IV)","id":"16899"},{"source":"anti-tumor","target":"pemetrexed disodium","id":"16900"},{"source":"liver metastases","target":"pembrolizumab","id":"16901"},{"source":"liver metastases","target":"bevacizumab","id":"16902"},{"source":"liver metastases","target":"carboplatin","id":"16903"},{"source":"liver metastases","target":"erlotinib","id":"16904"},{"source":"liver metastases","target":"gefitinib","id":"16905"},{"source":"liver metastases","target":"ipilimumab","id":"16906"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"16907"},{"source":"liver metastases","target":"pemetrexed disodium","id":"16908"},{"source":"anticancer","target":"pembrolizumab","id":"16909"},{"source":"anticancer","target":"bevacizumab","id":"16910"},{"source":"anticancer","target":"carboplatin","id":"16911"},{"source":"anticancer","target":"erlotinib","id":"16912"},{"source":"anticancer","target":"gefitinib","id":"16913"},{"source":"anticancer","target":"ipilimumab","id":"16914"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"16915"},{"source":"anticancer","target":"pemetrexed disodium","id":"16916"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"16917"},{"source":"Dihydrofolate reductase inhibitor","target":"anti-hiv","id":"16918"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"16919"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"16920"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"16921"},{"source":"Dihydrofolate reductase inhibitor","target":"hiv infections","id":"16922"},{"source":"Dihydrofolate reductase inhibitor","target":"acquired immunodeficiency syndrome","id":"16923"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"16924"},{"source":"Dihydrofolate reductase inhibitor","target":"interstitial lung diseases","id":"16925"},{"source":"Dihydrofolate reductase inhibitor","target":"autoimmune diseases","id":"16926"},{"source":"Dihydrofolate reductase inhibitor","target":"alopecia","id":"16927"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"16928"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"16929"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"16930"},{"source":"Dihydrofolate reductase inhibitor","target":"autoimmune diseases","id":"16931"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"16932"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"16933"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"16934"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"16935"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"16936"},{"source":"Dihydrofolate reductase inhibitor","target":"interstitial lung diseases","id":"16937"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"16938"},{"source":"Dihydrofolate reductase inhibitor","target":"anti-tumor","id":"16939"},{"source":"Dihydrofolate reductase inhibitor","target":"liver metastases","id":"16940"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"16941"},{"source":"NA","target":"UNK : Indication","id":"16942"},{"source":"NA","target":"anti-hiv","id":"16943"},{"source":"NA","target":"antiarthritic","id":"16944"},{"source":"NA","target":"non-small-cell lung","id":"16945"},{"source":"NA","target":"psoriasis","id":"16946"},{"source":"NA","target":"hiv infections","id":"16947"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"16948"},{"source":"NA","target":"non-small-cell lung","id":"16949"},{"source":"NA","target":"interstitial lung diseases","id":"16950"},{"source":"NA","target":"autoimmune diseases","id":"16951"},{"source":"NA","target":"alopecia","id":"16952"},{"source":"NA","target":"sclc","id":"16953"},{"source":"NA","target":"carcinoma","id":"16954"},{"source":"NA","target":"psoriasis","id":"16955"},{"source":"NA","target":"autoimmune diseases","id":"16956"},{"source":"NA","target":"arthritis","id":"16957"},{"source":"NA","target":"carcinoma","id":"16958"},{"source":"NA","target":"metastatic","id":"16959"},{"source":"NA","target":"carcinoma","id":"16960"},{"source":"NA","target":"neoplasm metastasis","id":"16961"},{"source":"NA","target":"interstitial lung diseases","id":"16962"},{"source":"NA","target":"lung neoplasms","id":"16963"},{"source":"NA","target":"anti-tumor","id":"16964"},{"source":"NA","target":"liver metastases","id":"16965"},{"source":"NA","target":"anticancer","id":"16966"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"16967"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"16968"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"16969"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"16970"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"16971"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"16972"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"16973"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"16974"},{"source":"Immune checkpoint inhibitor","target":"interstitial lung diseases","id":"16975"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"16976"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"16977"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"16978"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16979"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"16980"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"16981"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"16982"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16983"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"16984"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"16985"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"16986"},{"source":"Immune checkpoint inhibitor","target":"interstitial lung diseases","id":"16987"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"16988"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"16989"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"16990"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"16991"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"16992"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"16993"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"16994"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"16995"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"16996"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"16997"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"16998"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"16999"},{"source":"Anticancer immunotherapy","target":"interstitial lung diseases","id":"17000"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"17001"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"17002"},{"source":"Anticancer immunotherapy","target":"sclc","id":"17003"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17004"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"17005"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"17006"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"17007"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17008"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"17009"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17010"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"17011"},{"source":"Anticancer immunotherapy","target":"interstitial lung diseases","id":"17012"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"17013"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"17014"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"17015"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"17016"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"17017"},{"source":"CD19 antagonist","target":"anti-hiv","id":"17018"},{"source":"CD19 antagonist","target":"antiarthritic","id":"17019"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"17020"},{"source":"CD19 antagonist","target":"psoriasis","id":"17021"},{"source":"CD19 antagonist","target":"hiv infections","id":"17022"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"17023"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"17024"},{"source":"CD19 antagonist","target":"interstitial lung diseases","id":"17025"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"17026"},{"source":"CD19 antagonist","target":"alopecia","id":"17027"},{"source":"CD19 antagonist","target":"sclc","id":"17028"},{"source":"CD19 antagonist","target":"carcinoma","id":"17029"},{"source":"CD19 antagonist","target":"psoriasis","id":"17030"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"17031"},{"source":"CD19 antagonist","target":"arthritis","id":"17032"},{"source":"CD19 antagonist","target":"carcinoma","id":"17033"},{"source":"CD19 antagonist","target":"metastatic","id":"17034"},{"source":"CD19 antagonist","target":"carcinoma","id":"17035"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"17036"},{"source":"CD19 antagonist","target":"interstitial lung diseases","id":"17037"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"17038"},{"source":"CD19 antagonist","target":"anti-tumor","id":"17039"},{"source":"CD19 antagonist","target":"liver metastases","id":"17040"},{"source":"CD19 antagonist","target":"anticancer","id":"17041"},{"source":"NA","target":"UNK : Indication","id":"17042"},{"source":"NA","target":"anti-hiv","id":"17043"},{"source":"NA","target":"antiarthritic","id":"17044"},{"source":"NA","target":"non-small-cell lung","id":"17045"},{"source":"NA","target":"psoriasis","id":"17046"},{"source":"NA","target":"hiv infections","id":"17047"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"17048"},{"source":"NA","target":"non-small-cell lung","id":"17049"},{"source":"NA","target":"interstitial lung diseases","id":"17050"},{"source":"NA","target":"autoimmune diseases","id":"17051"},{"source":"NA","target":"alopecia","id":"17052"},{"source":"NA","target":"sclc","id":"17053"},{"source":"NA","target":"carcinoma","id":"17054"},{"source":"NA","target":"psoriasis","id":"17055"},{"source":"NA","target":"autoimmune diseases","id":"17056"},{"source":"NA","target":"arthritis","id":"17057"},{"source":"NA","target":"carcinoma","id":"17058"},{"source":"NA","target":"metastatic","id":"17059"},{"source":"NA","target":"carcinoma","id":"17060"},{"source":"NA","target":"neoplasm metastasis","id":"17061"},{"source":"NA","target":"interstitial lung diseases","id":"17062"},{"source":"NA","target":"lung neoplasms","id":"17063"},{"source":"NA","target":"anti-tumor","id":"17064"},{"source":"NA","target":"liver metastases","id":"17065"},{"source":"NA","target":"anticancer","id":"17066"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"17067"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anti-hiv","id":"17068"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"antiarthritic","id":"17069"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"non-small-cell lung","id":"17070"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"psoriasis","id":"17071"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"hiv infections","id":"17072"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"acquired immunodeficiency syndrome","id":"17073"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"non-small-cell lung","id":"17074"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"interstitial lung diseases","id":"17075"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"autoimmune diseases","id":"17076"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"alopecia","id":"17077"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"sclc","id":"17078"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"17079"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"psoriasis","id":"17080"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"autoimmune diseases","id":"17081"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"arthritis","id":"17082"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"17083"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"metastatic","id":"17084"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"17085"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"neoplasm metastasis","id":"17086"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"interstitial lung diseases","id":"17087"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"lung neoplasms","id":"17088"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anti-tumor","id":"17089"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver metastases","id":"17090"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"17091"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"17092"},{"source":"Thymidylate synthase inhibitor","target":"anti-hiv","id":"17093"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"17094"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"17095"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"17096"},{"source":"Thymidylate synthase inhibitor","target":"hiv infections","id":"17097"},{"source":"Thymidylate synthase inhibitor","target":"acquired immunodeficiency syndrome","id":"17098"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"17099"},{"source":"Thymidylate synthase inhibitor","target":"interstitial lung diseases","id":"17100"},{"source":"Thymidylate synthase inhibitor","target":"autoimmune diseases","id":"17101"},{"source":"Thymidylate synthase inhibitor","target":"alopecia","id":"17102"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"17103"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"17104"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"17105"},{"source":"Thymidylate synthase inhibitor","target":"autoimmune diseases","id":"17106"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"17107"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"17108"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"17109"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"17110"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"17111"},{"source":"Thymidylate synthase inhibitor","target":"interstitial lung diseases","id":"17112"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"17113"},{"source":"Thymidylate synthase inhibitor","target":"anti-tumor","id":"17114"},{"source":"Thymidylate synthase inhibitor","target":"liver metastases","id":"17115"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"17116"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"17117"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"17118"},{"source":"CTLA4 antagonist","target":"antiarthritic","id":"17119"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"17120"},{"source":"CTLA4 antagonist","target":"psoriasis","id":"17121"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"17122"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"17123"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"17124"},{"source":"CTLA4 antagonist","target":"interstitial lung diseases","id":"17125"},{"source":"CTLA4 antagonist","target":"autoimmune diseases","id":"17126"},{"source":"CTLA4 antagonist","target":"alopecia","id":"17127"},{"source":"CTLA4 antagonist","target":"sclc","id":"17128"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"17129"},{"source":"CTLA4 antagonist","target":"psoriasis","id":"17130"},{"source":"CTLA4 antagonist","target":"autoimmune diseases","id":"17131"},{"source":"CTLA4 antagonist","target":"arthritis","id":"17132"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"17133"},{"source":"CTLA4 antagonist","target":"metastatic","id":"17134"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"17135"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"17136"},{"source":"CTLA4 antagonist","target":"interstitial lung diseases","id":"17137"},{"source":"CTLA4 antagonist","target":"lung neoplasms","id":"17138"},{"source":"CTLA4 antagonist","target":"anti-tumor","id":"17139"},{"source":"CTLA4 antagonist","target":"liver metastases","id":"17140"},{"source":"CTLA4 antagonist","target":"anticancer","id":"17141"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"17142"},{"source":"Beta tubulin antagonist","target":"anti-hiv","id":"17143"},{"source":"Beta tubulin antagonist","target":"antiarthritic","id":"17144"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"17145"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"17146"},{"source":"Beta tubulin antagonist","target":"hiv infections","id":"17147"},{"source":"Beta tubulin antagonist","target":"acquired immunodeficiency syndrome","id":"17148"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"17149"},{"source":"Beta tubulin antagonist","target":"interstitial lung diseases","id":"17150"},{"source":"Beta tubulin antagonist","target":"autoimmune diseases","id":"17151"},{"source":"Beta tubulin antagonist","target":"alopecia","id":"17152"},{"source":"Beta tubulin antagonist","target":"sclc","id":"17153"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"17154"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"17155"},{"source":"Beta tubulin antagonist","target":"autoimmune diseases","id":"17156"},{"source":"Beta tubulin antagonist","target":"arthritis","id":"17157"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"17158"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"17159"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"17160"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"17161"},{"source":"Beta tubulin antagonist","target":"interstitial lung diseases","id":"17162"},{"source":"Beta tubulin antagonist","target":"lung neoplasms","id":"17163"},{"source":"Beta tubulin antagonist","target":"anti-tumor","id":"17164"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"17165"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"17166"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"17167"},{"source":"Microtubule stimulant","target":"anti-hiv","id":"17168"},{"source":"Microtubule stimulant","target":"antiarthritic","id":"17169"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"17170"},{"source":"Microtubule stimulant","target":"psoriasis","id":"17171"},{"source":"Microtubule stimulant","target":"hiv infections","id":"17172"},{"source":"Microtubule stimulant","target":"acquired immunodeficiency syndrome","id":"17173"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"17174"},{"source":"Microtubule stimulant","target":"interstitial lung diseases","id":"17175"},{"source":"Microtubule stimulant","target":"autoimmune diseases","id":"17176"},{"source":"Microtubule stimulant","target":"alopecia","id":"17177"},{"source":"Microtubule stimulant","target":"sclc","id":"17178"},{"source":"Microtubule stimulant","target":"carcinoma","id":"17179"},{"source":"Microtubule stimulant","target":"psoriasis","id":"17180"},{"source":"Microtubule stimulant","target":"autoimmune diseases","id":"17181"},{"source":"Microtubule stimulant","target":"arthritis","id":"17182"},{"source":"Microtubule stimulant","target":"carcinoma","id":"17183"},{"source":"Microtubule stimulant","target":"metastatic","id":"17184"},{"source":"Microtubule stimulant","target":"carcinoma","id":"17185"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"17186"},{"source":"Microtubule stimulant","target":"interstitial lung diseases","id":"17187"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"17188"},{"source":"Microtubule stimulant","target":"anti-tumor","id":"17189"},{"source":"Microtubule stimulant","target":"liver metastases","id":"17190"},{"source":"Microtubule stimulant","target":"anticancer","id":"17191"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"17192"},{"source":"Angiogenesis inhibitor","target":"anti-hiv","id":"17193"},{"source":"Angiogenesis inhibitor","target":"antiarthritic","id":"17194"},{"source":"Angiogenesis inhibitor","target":"non-small-cell lung","id":"17195"},{"source":"Angiogenesis inhibitor","target":"psoriasis","id":"17196"},{"source":"Angiogenesis inhibitor","target":"hiv infections","id":"17197"},{"source":"Angiogenesis inhibitor","target":"acquired immunodeficiency syndrome","id":"17198"},{"source":"Angiogenesis inhibitor","target":"non-small-cell lung","id":"17199"},{"source":"Angiogenesis inhibitor","target":"interstitial lung diseases","id":"17200"},{"source":"Angiogenesis inhibitor","target":"autoimmune diseases","id":"17201"},{"source":"Angiogenesis inhibitor","target":"alopecia","id":"17202"},{"source":"Angiogenesis inhibitor","target":"sclc","id":"17203"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"17204"},{"source":"Angiogenesis inhibitor","target":"psoriasis","id":"17205"},{"source":"Angiogenesis inhibitor","target":"autoimmune diseases","id":"17206"},{"source":"Angiogenesis inhibitor","target":"arthritis","id":"17207"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"17208"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"17209"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"17210"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"17211"},{"source":"Angiogenesis inhibitor","target":"interstitial lung diseases","id":"17212"},{"source":"Angiogenesis inhibitor","target":"lung neoplasms","id":"17213"},{"source":"Angiogenesis inhibitor","target":"anti-tumor","id":"17214"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"17215"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"17216"},{"source":"NA","target":"UNK : Indication","id":"17217"},{"source":"NA","target":"anti-hiv","id":"17218"},{"source":"NA","target":"antiarthritic","id":"17219"},{"source":"NA","target":"non-small-cell lung","id":"17220"},{"source":"NA","target":"psoriasis","id":"17221"},{"source":"NA","target":"hiv infections","id":"17222"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"17223"},{"source":"NA","target":"non-small-cell lung","id":"17224"},{"source":"NA","target":"interstitial lung diseases","id":"17225"},{"source":"NA","target":"autoimmune diseases","id":"17226"},{"source":"NA","target":"alopecia","id":"17227"},{"source":"NA","target":"sclc","id":"17228"},{"source":"NA","target":"carcinoma","id":"17229"},{"source":"NA","target":"psoriasis","id":"17230"},{"source":"NA","target":"autoimmune diseases","id":"17231"},{"source":"NA","target":"arthritis","id":"17232"},{"source":"NA","target":"carcinoma","id":"17233"},{"source":"NA","target":"metastatic","id":"17234"},{"source":"NA","target":"carcinoma","id":"17235"},{"source":"NA","target":"neoplasm metastasis","id":"17236"},{"source":"NA","target":"interstitial lung diseases","id":"17237"},{"source":"NA","target":"lung neoplasms","id":"17238"},{"source":"NA","target":"anti-tumor","id":"17239"},{"source":"NA","target":"liver metastases","id":"17240"},{"source":"NA","target":"anticancer","id":"17241"},{"source":"NA","target":"UNK : Indication","id":"17242"},{"source":"NA","target":"anti-hiv","id":"17243"},{"source":"NA","target":"antiarthritic","id":"17244"},{"source":"NA","target":"non-small-cell lung","id":"17245"},{"source":"NA","target":"psoriasis","id":"17246"},{"source":"NA","target":"hiv infections","id":"17247"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"17248"},{"source":"NA","target":"non-small-cell lung","id":"17249"},{"source":"NA","target":"interstitial lung diseases","id":"17250"},{"source":"NA","target":"autoimmune diseases","id":"17251"},{"source":"NA","target":"alopecia","id":"17252"},{"source":"NA","target":"sclc","id":"17253"},{"source":"NA","target":"carcinoma","id":"17254"},{"source":"NA","target":"psoriasis","id":"17255"},{"source":"NA","target":"autoimmune diseases","id":"17256"},{"source":"NA","target":"arthritis","id":"17257"},{"source":"NA","target":"carcinoma","id":"17258"},{"source":"NA","target":"metastatic","id":"17259"},{"source":"NA","target":"carcinoma","id":"17260"},{"source":"NA","target":"neoplasm metastasis","id":"17261"},{"source":"NA","target":"interstitial lung diseases","id":"17262"},{"source":"NA","target":"lung neoplasms","id":"17263"},{"source":"NA","target":"anti-tumor","id":"17264"},{"source":"NA","target":"liver metastases","id":"17265"},{"source":"NA","target":"anticancer","id":"17266"},{"source":"Taxane","target":"UNK : Indication","id":"17267"},{"source":"Taxane","target":"anti-hiv","id":"17268"},{"source":"Taxane","target":"antiarthritic","id":"17269"},{"source":"Taxane","target":"non-small-cell lung","id":"17270"},{"source":"Taxane","target":"psoriasis","id":"17271"},{"source":"Taxane","target":"hiv infections","id":"17272"},{"source":"Taxane","target":"acquired immunodeficiency syndrome","id":"17273"},{"source":"Taxane","target":"non-small-cell lung","id":"17274"},{"source":"Taxane","target":"interstitial lung diseases","id":"17275"},{"source":"Taxane","target":"autoimmune diseases","id":"17276"},{"source":"Taxane","target":"alopecia","id":"17277"},{"source":"Taxane","target":"sclc","id":"17278"},{"source":"Taxane","target":"carcinoma","id":"17279"},{"source":"Taxane","target":"psoriasis","id":"17280"},{"source":"Taxane","target":"autoimmune diseases","id":"17281"},{"source":"Taxane","target":"arthritis","id":"17282"},{"source":"Taxane","target":"carcinoma","id":"17283"},{"source":"Taxane","target":"metastatic","id":"17284"},{"source":"Taxane","target":"carcinoma","id":"17285"},{"source":"Taxane","target":"neoplasm metastasis","id":"17286"},{"source":"Taxane","target":"interstitial lung diseases","id":"17287"},{"source":"Taxane","target":"lung neoplasms","id":"17288"},{"source":"Taxane","target":"anti-tumor","id":"17289"},{"source":"Taxane","target":"liver metastases","id":"17290"},{"source":"Taxane","target":"anticancer","id":"17291"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"17292"},{"source":"Oncology: Lung","target":"NA","id":"17293"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"17294"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"17295"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"17296"},{"source":"Oncology: Lung","target":"NA","id":"17297"},{"source":"Oncology: Lung","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"17298"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"17299"},{"source":"Oncology: Lung","target":"CTLA4 antagonist","id":"17300"},{"source":"Oncology: Lung","target":"Beta tubulin antagonist","id":"17301"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"17302"},{"source":"Oncology: Lung","target":"Angiogenesis inhibitor","id":"17303"},{"source":"Oncology: Lung","target":"NA","id":"17304"},{"source":"Oncology: Lung","target":"NA","id":"17305"},{"source":"Oncology: Lung","target":"Taxane","id":"17306"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"17307"},{"source":"Non-Small Cell","target":"NA","id":"17308"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"17309"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"17310"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"17311"},{"source":"Non-Small Cell","target":"NA","id":"17312"},{"source":"Non-Small Cell","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"17313"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"17314"},{"source":"Non-Small Cell","target":"CTLA4 antagonist","id":"17315"},{"source":"Non-Small Cell","target":"Beta tubulin antagonist","id":"17316"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"17317"},{"source":"Non-Small Cell","target":"Angiogenesis inhibitor","id":"17318"},{"source":"Non-Small Cell","target":"NA","id":"17319"},{"source":"Non-Small Cell","target":"NA","id":"17320"},{"source":"Non-Small Cell","target":"Taxane","id":"17321"},{"source":"pembrolizumab","target":"Merck & Co.","id":"17322"},{"source":"carboplatin","target":"Merck & Co.","id":"17323"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"17324"},{"source":"surgical intervention","target":"Merck & Co.","id":"17325"},{"source":"UNK : Indication","target":"pembrolizumab","id":"17326"},{"source":"UNK : Indication","target":"carboplatin","id":"17327"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"17328"},{"source":"UNK : Indication","target":"surgical intervention","id":"17329"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"17330"},{"source":"glandular and epithelial","target":"carboplatin","id":"17331"},{"source":"glandular and epithelial","target":"nab-paclitaxel (IV)","id":"17332"},{"source":"glandular and epithelial","target":"surgical intervention","id":"17333"},{"source":"carcinoma","target":"pembrolizumab","id":"17334"},{"source":"carcinoma","target":"carboplatin","id":"17335"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"17336"},{"source":"carcinoma","target":"surgical intervention","id":"17337"},{"source":"ovarian cancer","target":"pembrolizumab","id":"17338"},{"source":"ovarian cancer","target":"carboplatin","id":"17339"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"17340"},{"source":"ovarian cancer","target":"surgical intervention","id":"17341"},{"source":"skin neoplasms","target":"pembrolizumab","id":"17342"},{"source":"skin neoplasms","target":"carboplatin","id":"17343"},{"source":"skin neoplasms","target":"nab-paclitaxel (IV)","id":"17344"},{"source":"skin neoplasms","target":"surgical intervention","id":"17345"},{"source":"liver metastases","target":"pembrolizumab","id":"17346"},{"source":"liver metastases","target":"carboplatin","id":"17347"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"17348"},{"source":"liver metastases","target":"surgical intervention","id":"17349"},{"source":"liver neoplasms","target":"pembrolizumab","id":"17350"},{"source":"liver neoplasms","target":"carboplatin","id":"17351"},{"source":"liver neoplasms","target":"nab-paclitaxel (IV)","id":"17352"},{"source":"liver neoplasms","target":"surgical intervention","id":"17353"},{"source":"carcinoma","target":"pembrolizumab","id":"17354"},{"source":"carcinoma","target":"carboplatin","id":"17355"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"17356"},{"source":"carcinoma","target":"surgical intervention","id":"17357"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"17358"},{"source":"fallopian tube neoplasms","target":"carboplatin","id":"17359"},{"source":"fallopian tube neoplasms","target":"nab-paclitaxel (IV)","id":"17360"},{"source":"fallopian tube neoplasms","target":"surgical intervention","id":"17361"},{"source":"carcinoma","target":"pembrolizumab","id":"17362"},{"source":"carcinoma","target":"carboplatin","id":"17363"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"17364"},{"source":"carcinoma","target":"surgical intervention","id":"17365"},{"source":"residual tumor","target":"pembrolizumab","id":"17366"},{"source":"residual tumor","target":"carboplatin","id":"17367"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"17368"},{"source":"residual tumor","target":"surgical intervention","id":"17369"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"17370"},{"source":"glandular and epithelial","target":"carboplatin","id":"17371"},{"source":"glandular and epithelial","target":"nab-paclitaxel (IV)","id":"17372"},{"source":"glandular and epithelial","target":"surgical intervention","id":"17373"},{"source":"anticancer","target":"pembrolizumab","id":"17374"},{"source":"anticancer","target":"carboplatin","id":"17375"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"17376"},{"source":"anticancer","target":"surgical intervention","id":"17377"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"17378"},{"source":"peritoneal neoplasms","target":"carboplatin","id":"17379"},{"source":"peritoneal neoplasms","target":"nab-paclitaxel (IV)","id":"17380"},{"source":"peritoneal neoplasms","target":"surgical intervention","id":"17381"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"17382"},{"source":"ovarian neoplasms","target":"carboplatin","id":"17383"},{"source":"ovarian neoplasms","target":"nab-paclitaxel (IV)","id":"17384"},{"source":"ovarian neoplasms","target":"surgical intervention","id":"17385"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"17386"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"17387"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17388"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"17389"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"17390"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"17391"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"17392"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17393"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"17394"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17395"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"17396"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"17397"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"17398"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"17399"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"17400"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"17401"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"17402"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17403"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"17404"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"17405"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"17406"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"17407"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17408"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"17409"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17410"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"17411"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"17412"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"17413"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"17414"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"17415"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"17416"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"17417"},{"source":"CD19 antagonist","target":"carcinoma","id":"17418"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"17419"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"17420"},{"source":"CD19 antagonist","target":"liver metastases","id":"17421"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"17422"},{"source":"CD19 antagonist","target":"carcinoma","id":"17423"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"17424"},{"source":"CD19 antagonist","target":"carcinoma","id":"17425"},{"source":"CD19 antagonist","target":"residual tumor","id":"17426"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"17427"},{"source":"CD19 antagonist","target":"anticancer","id":"17428"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"17429"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"17430"},{"source":"NA","target":"UNK : Indication","id":"17431"},{"source":"NA","target":"glandular and epithelial","id":"17432"},{"source":"NA","target":"carcinoma","id":"17433"},{"source":"NA","target":"ovarian cancer","id":"17434"},{"source":"NA","target":"skin neoplasms","id":"17435"},{"source":"NA","target":"liver metastases","id":"17436"},{"source":"NA","target":"liver neoplasms","id":"17437"},{"source":"NA","target":"carcinoma","id":"17438"},{"source":"NA","target":"fallopian tube neoplasms","id":"17439"},{"source":"NA","target":"carcinoma","id":"17440"},{"source":"NA","target":"residual tumor","id":"17441"},{"source":"NA","target":"glandular and epithelial","id":"17442"},{"source":"NA","target":"anticancer","id":"17443"},{"source":"NA","target":"peritoneal neoplasms","id":"17444"},{"source":"NA","target":"ovarian neoplasms","id":"17445"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"17446"},{"source":"Beta tubulin antagonist","target":"glandular and epithelial","id":"17447"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"17448"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"17449"},{"source":"Beta tubulin antagonist","target":"skin neoplasms","id":"17450"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"17451"},{"source":"Beta tubulin antagonist","target":"liver neoplasms","id":"17452"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"17453"},{"source":"Beta tubulin antagonist","target":"fallopian tube neoplasms","id":"17454"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"17455"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"17456"},{"source":"Beta tubulin antagonist","target":"glandular and epithelial","id":"17457"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"17458"},{"source":"Beta tubulin antagonist","target":"peritoneal neoplasms","id":"17459"},{"source":"Beta tubulin antagonist","target":"ovarian neoplasms","id":"17460"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"17461"},{"source":"Microtubule stimulant","target":"glandular and epithelial","id":"17462"},{"source":"Microtubule stimulant","target":"carcinoma","id":"17463"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"17464"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"17465"},{"source":"Microtubule stimulant","target":"liver metastases","id":"17466"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"17467"},{"source":"Microtubule stimulant","target":"carcinoma","id":"17468"},{"source":"Microtubule stimulant","target":"fallopian tube neoplasms","id":"17469"},{"source":"Microtubule stimulant","target":"carcinoma","id":"17470"},{"source":"Microtubule stimulant","target":"residual tumor","id":"17471"},{"source":"Microtubule stimulant","target":"glandular and epithelial","id":"17472"},{"source":"Microtubule stimulant","target":"anticancer","id":"17473"},{"source":"Microtubule stimulant","target":"peritoneal neoplasms","id":"17474"},{"source":"Microtubule stimulant","target":"ovarian neoplasms","id":"17475"},{"source":"NA","target":"UNK : Indication","id":"17476"},{"source":"NA","target":"glandular and epithelial","id":"17477"},{"source":"NA","target":"carcinoma","id":"17478"},{"source":"NA","target":"ovarian cancer","id":"17479"},{"source":"NA","target":"skin neoplasms","id":"17480"},{"source":"NA","target":"liver metastases","id":"17481"},{"source":"NA","target":"liver neoplasms","id":"17482"},{"source":"NA","target":"carcinoma","id":"17483"},{"source":"NA","target":"fallopian tube neoplasms","id":"17484"},{"source":"NA","target":"carcinoma","id":"17485"},{"source":"NA","target":"residual tumor","id":"17486"},{"source":"NA","target":"glandular and epithelial","id":"17487"},{"source":"NA","target":"anticancer","id":"17488"},{"source":"NA","target":"peritoneal neoplasms","id":"17489"},{"source":"NA","target":"ovarian neoplasms","id":"17490"},{"source":"Taxane","target":"UNK : Indication","id":"17491"},{"source":"Taxane","target":"glandular and epithelial","id":"17492"},{"source":"Taxane","target":"carcinoma","id":"17493"},{"source":"Taxane","target":"ovarian cancer","id":"17494"},{"source":"Taxane","target":"skin neoplasms","id":"17495"},{"source":"Taxane","target":"liver metastases","id":"17496"},{"source":"Taxane","target":"liver neoplasms","id":"17497"},{"source":"Taxane","target":"carcinoma","id":"17498"},{"source":"Taxane","target":"fallopian tube neoplasms","id":"17499"},{"source":"Taxane","target":"carcinoma","id":"17500"},{"source":"Taxane","target":"residual tumor","id":"17501"},{"source":"Taxane","target":"glandular and epithelial","id":"17502"},{"source":"Taxane","target":"anticancer","id":"17503"},{"source":"Taxane","target":"peritoneal neoplasms","id":"17504"},{"source":"Taxane","target":"ovarian neoplasms","id":"17505"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"17506"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"17507"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"17508"},{"source":"Oncology: (N/A)","target":"NA","id":"17509"},{"source":"Oncology: (N/A)","target":"Beta tubulin antagonist","id":"17510"},{"source":"Oncology: (N/A)","target":"Microtubule stimulant","id":"17511"},{"source":"Oncology: (N/A)","target":"NA","id":"17512"},{"source":"Oncology: (N/A)","target":"Taxane","id":"17513"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"17514"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"17515"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"17516"},{"source":"Oncology: Ovarian","target":"NA","id":"17517"},{"source":"Oncology: Ovarian","target":"Beta tubulin antagonist","id":"17518"},{"source":"Oncology: Ovarian","target":"Microtubule stimulant","id":"17519"},{"source":"Oncology: Ovarian","target":"NA","id":"17520"},{"source":"Oncology: Ovarian","target":"Taxane","id":"17521"},{"source":"indoximod (u)","target":"NewLink Genetics","id":"17522"},{"source":"nivolumab (a)","target":"NewLink Genetics","id":"17523"},{"source":"pembrolizumab","target":"NewLink Genetics","id":"17524"},{"source":"melanoma","target":"indoximod (u)","id":"17525"},{"source":"melanoma","target":"nivolumab (a)","id":"17526"},{"source":"melanoma","target":"pembrolizumab","id":"17527"},{"source":"melanoma","target":"indoximod (u)","id":"17528"},{"source":"melanoma","target":"nivolumab (a)","id":"17529"},{"source":"melanoma","target":"pembrolizumab","id":"17530"},{"source":"melanoma","target":"indoximod (u)","id":"17531"},{"source":"melanoma","target":"nivolumab (a)","id":"17532"},{"source":"melanoma","target":"pembrolizumab","id":"17533"},{"source":"skin neoplasms","target":"indoximod (u)","id":"17534"},{"source":"skin neoplasms","target":"nivolumab (a)","id":"17535"},{"source":"skin neoplasms","target":"pembrolizumab","id":"17536"},{"source":"metastatic","target":"indoximod (u)","id":"17537"},{"source":"metastatic","target":"nivolumab (a)","id":"17538"},{"source":"metastatic","target":"pembrolizumab","id":"17539"},{"source":"carcinoma","target":"indoximod (u)","id":"17540"},{"source":"carcinoma","target":"nivolumab (a)","id":"17541"},{"source":"carcinoma","target":"pembrolizumab","id":"17542"},{"source":"neoplasm metastasis","target":"indoximod (u)","id":"17543"},{"source":"neoplasm metastasis","target":"nivolumab (a)","id":"17544"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"17545"},{"source":"anticancer","target":"indoximod (u)","id":"17546"},{"source":"anticancer","target":"nivolumab (a)","id":"17547"},{"source":"anticancer","target":"pembrolizumab","id":"17548"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"17549"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"17550"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"17551"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"17552"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"17553"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17554"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"17555"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"17556"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"17557"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"17558"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"17559"},{"source":"Indoleamine-pyrrole 2","target":"skin neoplasms","id":"17560"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"17561"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"17562"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"17563"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"17564"},{"source":"NA","target":"melanoma","id":"17565"},{"source":"NA","target":"melanoma","id":"17566"},{"source":"NA","target":"melanoma","id":"17567"},{"source":"NA","target":"skin neoplasms","id":"17568"},{"source":"NA","target":"metastatic","id":"17569"},{"source":"NA","target":"carcinoma","id":"17570"},{"source":"NA","target":"neoplasm metastasis","id":"17571"},{"source":"NA","target":"anticancer","id":"17572"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"17573"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"17574"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"17575"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"17576"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"17577"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17578"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"17579"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"17580"},{"source":"CD19 antagonist","target":"melanoma","id":"17581"},{"source":"CD19 antagonist","target":"melanoma","id":"17582"},{"source":"CD19 antagonist","target":"melanoma","id":"17583"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"17584"},{"source":"CD19 antagonist","target":"metastatic","id":"17585"},{"source":"CD19 antagonist","target":"carcinoma","id":"17586"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"17587"},{"source":"CD19 antagonist","target":"anticancer","id":"17588"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"17589"},{"source":"Oncology: Melanoma","target":"Indoleamine-pyrrole 2","id":"17590"},{"source":"Oncology: Melanoma","target":"NA","id":"17591"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"17592"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"17593"},{"source":"BTH-1677 (u)","target":"Biothera","id":"17594"},{"source":"BTH-1677 (u)","target":"Merck & Co.","id":"17595"},{"source":"pembrolizumab","target":"Biothera","id":"17596"},{"source":"pembrolizumab","target":"Merck & Co.","id":"17597"},{"source":"UNK : Drug","target":"Biothera","id":"17598"},{"source":"UNK : Drug","target":"Merck & Co.","id":"17599"},{"source":"bleeding","target":"BTH-1677 (u)","id":"17600"},{"source":"bleeding","target":"pembrolizumab","id":"17601"},{"source":"bleeding","target":"UNK : Drug","id":"17602"},{"source":"squamous cell neoplasms","target":"BTH-1677 (u)","id":"17603"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"17604"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"17605"},{"source":"breast neoplasms","target":"BTH-1677 (u)","id":"17606"},{"source":"breast neoplasms","target":"pembrolizumab","id":"17607"},{"source":"breast neoplasms","target":"UNK : Drug","id":"17608"},{"source":"hemorrhage","target":"BTH-1677 (u)","id":"17609"},{"source":"hemorrhage","target":"pembrolizumab","id":"17610"},{"source":"hemorrhage","target":"UNK : Drug","id":"17611"},{"source":"skin neoplasms","target":"BTH-1677 (u)","id":"17612"},{"source":"skin neoplasms","target":"pembrolizumab","id":"17613"},{"source":"skin neoplasms","target":"UNK : Drug","id":"17614"},{"source":"liver neoplasms","target":"BTH-1677 (u)","id":"17615"},{"source":"liver neoplasms","target":"pembrolizumab","id":"17616"},{"source":"liver neoplasms","target":"UNK : Drug","id":"17617"},{"source":"head and neck neoplasms","target":"BTH-1677 (u)","id":"17618"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"17619"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"17620"},{"source":"carcinoma","target":"BTH-1677 (u)","id":"17621"},{"source":"carcinoma","target":"pembrolizumab","id":"17622"},{"source":"carcinoma","target":"UNK : Drug","id":"17623"},{"source":"non-small-cell lung","target":"BTH-1677 (u)","id":"17624"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"17625"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"17626"},{"source":"melanoma","target":"BTH-1677 (u)","id":"17627"},{"source":"melanoma","target":"pembrolizumab","id":"17628"},{"source":"melanoma","target":"UNK : Drug","id":"17629"},{"source":"head and neck cancer","target":"BTH-1677 (u)","id":"17630"},{"source":"head and neck cancer","target":"pembrolizumab","id":"17631"},{"source":"head and neck cancer","target":"UNK : Drug","id":"17632"},{"source":"non-small-cell lung","target":"BTH-1677 (u)","id":"17633"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"17634"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"17635"},{"source":"alopecia","target":"BTH-1677 (u)","id":"17636"},{"source":"alopecia","target":"pembrolizumab","id":"17637"},{"source":"alopecia","target":"UNK : Drug","id":"17638"},{"source":"carcinoma","target":"BTH-1677 (u)","id":"17639"},{"source":"carcinoma","target":"pembrolizumab","id":"17640"},{"source":"carcinoma","target":"UNK : Drug","id":"17641"},{"source":"metastatic","target":"BTH-1677 (u)","id":"17642"},{"source":"metastatic","target":"pembrolizumab","id":"17643"},{"source":"metastatic","target":"UNK : Drug","id":"17644"},{"source":"carcinoma","target":"BTH-1677 (u)","id":"17645"},{"source":"carcinoma","target":"pembrolizumab","id":"17646"},{"source":"carcinoma","target":"UNK : Drug","id":"17647"},{"source":"neoplasm metastasis","target":"BTH-1677 (u)","id":"17648"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"17649"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"17650"},{"source":"carcinoma","target":"BTH-1677 (u)","id":"17651"},{"source":"carcinoma","target":"pembrolizumab","id":"17652"},{"source":"carcinoma","target":"UNK : Drug","id":"17653"},{"source":"head and neck cancer","target":"BTH-1677 (u)","id":"17654"},{"source":"head and neck cancer","target":"pembrolizumab","id":"17655"},{"source":"head and neck cancer","target":"UNK : Drug","id":"17656"},{"source":"hepatic metastases","target":"BTH-1677 (u)","id":"17657"},{"source":"hepatic metastases","target":"pembrolizumab","id":"17658"},{"source":"hepatic metastases","target":"UNK : Drug","id":"17659"},{"source":"squamous cell neoplasms","target":"BTH-1677 (u)","id":"17660"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"17661"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"17662"},{"source":"neuropathy","target":"BTH-1677 (u)","id":"17663"},{"source":"neuropathy","target":"pembrolizumab","id":"17664"},{"source":"neuropathy","target":"UNK : Drug","id":"17665"},{"source":"triple-negative breast cancer","target":"BTH-1677 (u)","id":"17666"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"17667"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"17668"},{"source":"carcinoma","target":"BTH-1677 (u)","id":"17669"},{"source":"carcinoma","target":"pembrolizumab","id":"17670"},{"source":"carcinoma","target":"UNK : Drug","id":"17671"},{"source":"residual tumor","target":"BTH-1677 (u)","id":"17672"},{"source":"residual tumor","target":"pembrolizumab","id":"17673"},{"source":"residual tumor","target":"UNK : Drug","id":"17674"},{"source":"anticancer","target":"BTH-1677 (u)","id":"17675"},{"source":"anticancer","target":"pembrolizumab","id":"17676"},{"source":"anticancer","target":"UNK : Drug","id":"17677"},{"source":"Immune checkpoint inhibitor","target":"bleeding","id":"17678"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"17679"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"17680"},{"source":"Immune checkpoint inhibitor","target":"hemorrhage","id":"17681"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"17682"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"17683"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"17684"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17685"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"17686"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"17687"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"17688"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"17689"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"17690"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17691"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"17692"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17693"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"17694"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17695"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"17696"},{"source":"Immune checkpoint inhibitor","target":"hepatic metastases","id":"17697"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"17698"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"17699"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"17700"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17701"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"17702"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"17703"},{"source":"Macrophage stimulant","target":"bleeding","id":"17704"},{"source":"Macrophage stimulant","target":"squamous cell neoplasms","id":"17705"},{"source":"Macrophage stimulant","target":"breast neoplasms","id":"17706"},{"source":"Macrophage stimulant","target":"hemorrhage","id":"17707"},{"source":"Macrophage stimulant","target":"skin neoplasms","id":"17708"},{"source":"Macrophage stimulant","target":"liver neoplasms","id":"17709"},{"source":"Macrophage stimulant","target":"head and neck neoplasms","id":"17710"},{"source":"Macrophage stimulant","target":"carcinoma","id":"17711"},{"source":"Macrophage stimulant","target":"non-small-cell lung","id":"17712"},{"source":"Macrophage stimulant","target":"melanoma","id":"17713"},{"source":"Macrophage stimulant","target":"head and neck cancer","id":"17714"},{"source":"Macrophage stimulant","target":"non-small-cell lung","id":"17715"},{"source":"Macrophage stimulant","target":"alopecia","id":"17716"},{"source":"Macrophage stimulant","target":"carcinoma","id":"17717"},{"source":"Macrophage stimulant","target":"metastatic","id":"17718"},{"source":"Macrophage stimulant","target":"carcinoma","id":"17719"},{"source":"Macrophage stimulant","target":"neoplasm metastasis","id":"17720"},{"source":"Macrophage stimulant","target":"carcinoma","id":"17721"},{"source":"Macrophage stimulant","target":"head and neck cancer","id":"17722"},{"source":"Macrophage stimulant","target":"hepatic metastases","id":"17723"},{"source":"Macrophage stimulant","target":"squamous cell neoplasms","id":"17724"},{"source":"Macrophage stimulant","target":"neuropathy","id":"17725"},{"source":"Macrophage stimulant","target":"triple-negative breast cancer","id":"17726"},{"source":"Macrophage stimulant","target":"carcinoma","id":"17727"},{"source":"Macrophage stimulant","target":"residual tumor","id":"17728"},{"source":"Macrophage stimulant","target":"anticancer","id":"17729"},{"source":"Anticancer immunotherapy","target":"bleeding","id":"17730"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"17731"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"17732"},{"source":"Anticancer immunotherapy","target":"hemorrhage","id":"17733"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"17734"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"17735"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"17736"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17737"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"17738"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"17739"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"17740"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"17741"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"17742"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17743"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"17744"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17745"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"17746"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17747"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"17748"},{"source":"Anticancer immunotherapy","target":"hepatic metastases","id":"17749"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"17750"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"17751"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"17752"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17753"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"17754"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"17755"},{"source":"CD19 antagonist","target":"bleeding","id":"17756"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"17757"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"17758"},{"source":"CD19 antagonist","target":"hemorrhage","id":"17759"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"17760"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"17761"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"17762"},{"source":"CD19 antagonist","target":"carcinoma","id":"17763"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"17764"},{"source":"CD19 antagonist","target":"melanoma","id":"17765"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"17766"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"17767"},{"source":"CD19 antagonist","target":"alopecia","id":"17768"},{"source":"CD19 antagonist","target":"carcinoma","id":"17769"},{"source":"CD19 antagonist","target":"metastatic","id":"17770"},{"source":"CD19 antagonist","target":"carcinoma","id":"17771"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"17772"},{"source":"CD19 antagonist","target":"carcinoma","id":"17773"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"17774"},{"source":"CD19 antagonist","target":"hepatic metastases","id":"17775"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"17776"},{"source":"CD19 antagonist","target":"neuropathy","id":"17777"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"17778"},{"source":"CD19 antagonist","target":"carcinoma","id":"17779"},{"source":"CD19 antagonist","target":"residual tumor","id":"17780"},{"source":"CD19 antagonist","target":"anticancer","id":"17781"},{"source":"Immunostimulant","target":"bleeding","id":"17782"},{"source":"Immunostimulant","target":"squamous cell neoplasms","id":"17783"},{"source":"Immunostimulant","target":"breast neoplasms","id":"17784"},{"source":"Immunostimulant","target":"hemorrhage","id":"17785"},{"source":"Immunostimulant","target":"skin neoplasms","id":"17786"},{"source":"Immunostimulant","target":"liver neoplasms","id":"17787"},{"source":"Immunostimulant","target":"head and neck neoplasms","id":"17788"},{"source":"Immunostimulant","target":"carcinoma","id":"17789"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"17790"},{"source":"Immunostimulant","target":"melanoma","id":"17791"},{"source":"Immunostimulant","target":"head and neck cancer","id":"17792"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"17793"},{"source":"Immunostimulant","target":"alopecia","id":"17794"},{"source":"Immunostimulant","target":"carcinoma","id":"17795"},{"source":"Immunostimulant","target":"metastatic","id":"17796"},{"source":"Immunostimulant","target":"carcinoma","id":"17797"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"17798"},{"source":"Immunostimulant","target":"carcinoma","id":"17799"},{"source":"Immunostimulant","target":"head and neck cancer","id":"17800"},{"source":"Immunostimulant","target":"hepatic metastases","id":"17801"},{"source":"Immunostimulant","target":"squamous cell neoplasms","id":"17802"},{"source":"Immunostimulant","target":"neuropathy","id":"17803"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"17804"},{"source":"Immunostimulant","target":"carcinoma","id":"17805"},{"source":"Immunostimulant","target":"residual tumor","id":"17806"},{"source":"Immunostimulant","target":"anticancer","id":"17807"},{"source":"NA","target":"bleeding","id":"17808"},{"source":"NA","target":"squamous cell neoplasms","id":"17809"},{"source":"NA","target":"breast neoplasms","id":"17810"},{"source":"NA","target":"hemorrhage","id":"17811"},{"source":"NA","target":"skin neoplasms","id":"17812"},{"source":"NA","target":"liver neoplasms","id":"17813"},{"source":"NA","target":"head and neck neoplasms","id":"17814"},{"source":"NA","target":"carcinoma","id":"17815"},{"source":"NA","target":"non-small-cell lung","id":"17816"},{"source":"NA","target":"melanoma","id":"17817"},{"source":"NA","target":"head and neck cancer","id":"17818"},{"source":"NA","target":"non-small-cell lung","id":"17819"},{"source":"NA","target":"alopecia","id":"17820"},{"source":"NA","target":"carcinoma","id":"17821"},{"source":"NA","target":"metastatic","id":"17822"},{"source":"NA","target":"carcinoma","id":"17823"},{"source":"NA","target":"neoplasm metastasis","id":"17824"},{"source":"NA","target":"carcinoma","id":"17825"},{"source":"NA","target":"head and neck cancer","id":"17826"},{"source":"NA","target":"hepatic metastases","id":"17827"},{"source":"NA","target":"squamous cell neoplasms","id":"17828"},{"source":"NA","target":"neuropathy","id":"17829"},{"source":"NA","target":"triple-negative breast cancer","id":"17830"},{"source":"NA","target":"carcinoma","id":"17831"},{"source":"NA","target":"residual tumor","id":"17832"},{"source":"NA","target":"anticancer","id":"17833"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"17834"},{"source":"Oncology: Head/Neck","target":"Macrophage stimulant","id":"17835"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"17836"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"17837"},{"source":"Oncology: Head/Neck","target":"Immunostimulant","id":"17838"},{"source":"Oncology: Head/Neck","target":"NA","id":"17839"},{"source":"epacadostat (u)","target":"Incyte Corporation","id":"17840"},{"source":"epacadostat (u)","target":"Merck & Co.","id":"17841"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"17842"},{"source":"pembrolizumab","target":"Merck & Co.","id":"17843"},{"source":"carboplatin","target":"Incyte Corporation","id":"17844"},{"source":"carboplatin","target":"Merck & Co.","id":"17845"},{"source":"cisplatin","target":"Incyte Corporation","id":"17846"},{"source":"cisplatin","target":"Merck & Co.","id":"17847"},{"source":"nab-paclitaxel (IV)","target":"Incyte Corporation","id":"17848"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"17849"},{"source":"pemetrexed disodium","target":"Incyte Corporation","id":"17850"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"17851"},{"source":"psoriasis","target":"epacadostat (u)","id":"17852"},{"source":"psoriasis","target":"pembrolizumab","id":"17853"},{"source":"psoriasis","target":"carboplatin","id":"17854"},{"source":"psoriasis","target":"cisplatin","id":"17855"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"17856"},{"source":"psoriasis","target":"pemetrexed disodium","id":"17857"},{"source":"residual tumor","target":"epacadostat (u)","id":"17858"},{"source":"residual tumor","target":"pembrolizumab","id":"17859"},{"source":"residual tumor","target":"carboplatin","id":"17860"},{"source":"residual tumor","target":"cisplatin","id":"17861"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"17862"},{"source":"residual tumor","target":"pemetrexed disodium","id":"17863"},{"source":"non-small-cell lung","target":"epacadostat (u)","id":"17864"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"17865"},{"source":"non-small-cell lung","target":"carboplatin","id":"17866"},{"source":"non-small-cell lung","target":"cisplatin","id":"17867"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"17868"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"17869"},{"source":"arthritis","target":"epacadostat (u)","id":"17870"},{"source":"arthritis","target":"pembrolizumab","id":"17871"},{"source":"arthritis","target":"carboplatin","id":"17872"},{"source":"arthritis","target":"cisplatin","id":"17873"},{"source":"arthritis","target":"nab-paclitaxel (IV)","id":"17874"},{"source":"arthritis","target":"pemetrexed disodium","id":"17875"},{"source":"antiarthritic","target":"epacadostat (u)","id":"17876"},{"source":"antiarthritic","target":"pembrolizumab","id":"17877"},{"source":"antiarthritic","target":"carboplatin","id":"17878"},{"source":"antiarthritic","target":"cisplatin","id":"17879"},{"source":"antiarthritic","target":"nab-paclitaxel (IV)","id":"17880"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"17881"},{"source":"carcinoma","target":"epacadostat (u)","id":"17882"},{"source":"carcinoma","target":"pembrolizumab","id":"17883"},{"source":"carcinoma","target":"carboplatin","id":"17884"},{"source":"carcinoma","target":"cisplatin","id":"17885"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"17886"},{"source":"carcinoma","target":"pemetrexed disodium","id":"17887"},{"source":"metastatic","target":"epacadostat (u)","id":"17888"},{"source":"metastatic","target":"pembrolizumab","id":"17889"},{"source":"metastatic","target":"carboplatin","id":"17890"},{"source":"metastatic","target":"cisplatin","id":"17891"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"17892"},{"source":"metastatic","target":"pemetrexed disodium","id":"17893"},{"source":"carcinoma","target":"epacadostat (u)","id":"17894"},{"source":"carcinoma","target":"pembrolizumab","id":"17895"},{"source":"carcinoma","target":"carboplatin","id":"17896"},{"source":"carcinoma","target":"cisplatin","id":"17897"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"17898"},{"source":"carcinoma","target":"pemetrexed disodium","id":"17899"},{"source":"non-small-cell lung","target":"epacadostat (u)","id":"17900"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"17901"},{"source":"non-small-cell lung","target":"carboplatin","id":"17902"},{"source":"non-small-cell lung","target":"cisplatin","id":"17903"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"17904"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"17905"},{"source":"neoplasm metastasis","target":"epacadostat (u)","id":"17906"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"17907"},{"source":"neoplasm metastasis","target":"carboplatin","id":"17908"},{"source":"neoplasm metastasis","target":"cisplatin","id":"17909"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"17910"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"17911"},{"source":"psoriasis","target":"epacadostat (u)","id":"17912"},{"source":"psoriasis","target":"pembrolizumab","id":"17913"},{"source":"psoriasis","target":"carboplatin","id":"17914"},{"source":"psoriasis","target":"cisplatin","id":"17915"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"17916"},{"source":"psoriasis","target":"pemetrexed disodium","id":"17917"},{"source":"anticancer","target":"epacadostat (u)","id":"17918"},{"source":"anticancer","target":"pembrolizumab","id":"17919"},{"source":"anticancer","target":"carboplatin","id":"17920"},{"source":"anticancer","target":"cisplatin","id":"17921"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"17922"},{"source":"anticancer","target":"pemetrexed disodium","id":"17923"},{"source":"lung neoplasms","target":"epacadostat (u)","id":"17924"},{"source":"lung neoplasms","target":"pembrolizumab","id":"17925"},{"source":"lung neoplasms","target":"carboplatin","id":"17926"},{"source":"lung neoplasms","target":"cisplatin","id":"17927"},{"source":"lung neoplasms","target":"nab-paclitaxel (IV)","id":"17928"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"17929"},{"source":"sclc","target":"epacadostat (u)","id":"17930"},{"source":"sclc","target":"pembrolizumab","id":"17931"},{"source":"sclc","target":"carboplatin","id":"17932"},{"source":"sclc","target":"cisplatin","id":"17933"},{"source":"sclc","target":"nab-paclitaxel (IV)","id":"17934"},{"source":"sclc","target":"pemetrexed disodium","id":"17935"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"17936"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"17937"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"17938"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"17939"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"17940"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"17941"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"17942"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"17943"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"17944"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"17945"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"17946"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"17947"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"17948"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"17949"},{"source":"NA","target":"psoriasis","id":"17950"},{"source":"NA","target":"residual tumor","id":"17951"},{"source":"NA","target":"non-small-cell lung","id":"17952"},{"source":"NA","target":"arthritis","id":"17953"},{"source":"NA","target":"antiarthritic","id":"17954"},{"source":"NA","target":"carcinoma","id":"17955"},{"source":"NA","target":"metastatic","id":"17956"},{"source":"NA","target":"carcinoma","id":"17957"},{"source":"NA","target":"non-small-cell lung","id":"17958"},{"source":"NA","target":"neoplasm metastasis","id":"17959"},{"source":"NA","target":"psoriasis","id":"17960"},{"source":"NA","target":"anticancer","id":"17961"},{"source":"NA","target":"lung neoplasms","id":"17962"},{"source":"NA","target":"sclc","id":"17963"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"17964"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"17965"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"17966"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"17967"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"17968"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17969"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"17970"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"17971"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"17972"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"17973"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"17974"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"17975"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"17976"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"17977"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"17978"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"17979"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"17980"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"17981"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"17982"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17983"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"17984"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"17985"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"17986"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"17987"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"17988"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"17989"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"17990"},{"source":"Anticancer immunotherapy","target":"sclc","id":"17991"},{"source":"CD19 antagonist","target":"psoriasis","id":"17992"},{"source":"CD19 antagonist","target":"residual tumor","id":"17993"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"17994"},{"source":"CD19 antagonist","target":"arthritis","id":"17995"},{"source":"CD19 antagonist","target":"antiarthritic","id":"17996"},{"source":"CD19 antagonist","target":"carcinoma","id":"17997"},{"source":"CD19 antagonist","target":"metastatic","id":"17998"},{"source":"CD19 antagonist","target":"carcinoma","id":"17999"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"18000"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"18001"},{"source":"CD19 antagonist","target":"psoriasis","id":"18002"},{"source":"CD19 antagonist","target":"anticancer","id":"18003"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"18004"},{"source":"CD19 antagonist","target":"sclc","id":"18005"},{"source":"NA","target":"psoriasis","id":"18006"},{"source":"NA","target":"residual tumor","id":"18007"},{"source":"NA","target":"non-small-cell lung","id":"18008"},{"source":"NA","target":"arthritis","id":"18009"},{"source":"NA","target":"antiarthritic","id":"18010"},{"source":"NA","target":"carcinoma","id":"18011"},{"source":"NA","target":"metastatic","id":"18012"},{"source":"NA","target":"carcinoma","id":"18013"},{"source":"NA","target":"non-small-cell lung","id":"18014"},{"source":"NA","target":"neoplasm metastasis","id":"18015"},{"source":"NA","target":"psoriasis","id":"18016"},{"source":"NA","target":"anticancer","id":"18017"},{"source":"NA","target":"lung neoplasms","id":"18018"},{"source":"NA","target":"sclc","id":"18019"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"18020"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"18021"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"18022"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"18023"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"18024"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"18025"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"18026"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"18027"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"18028"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"18029"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"18030"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"18031"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"18032"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"18033"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"18034"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"18035"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"18036"},{"source":"Beta tubulin antagonist","target":"arthritis","id":"18037"},{"source":"Beta tubulin antagonist","target":"antiarthritic","id":"18038"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"18039"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"18040"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"18041"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"18042"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"18043"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"18044"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"18045"},{"source":"Beta tubulin antagonist","target":"lung neoplasms","id":"18046"},{"source":"Beta tubulin antagonist","target":"sclc","id":"18047"},{"source":"NA","target":"psoriasis","id":"18048"},{"source":"NA","target":"residual tumor","id":"18049"},{"source":"NA","target":"non-small-cell lung","id":"18050"},{"source":"NA","target":"arthritis","id":"18051"},{"source":"NA","target":"antiarthritic","id":"18052"},{"source":"NA","target":"carcinoma","id":"18053"},{"source":"NA","target":"metastatic","id":"18054"},{"source":"NA","target":"carcinoma","id":"18055"},{"source":"NA","target":"non-small-cell lung","id":"18056"},{"source":"NA","target":"neoplasm metastasis","id":"18057"},{"source":"NA","target":"psoriasis","id":"18058"},{"source":"NA","target":"anticancer","id":"18059"},{"source":"NA","target":"lung neoplasms","id":"18060"},{"source":"NA","target":"sclc","id":"18061"},{"source":"Microtubule stimulant","target":"psoriasis","id":"18062"},{"source":"Microtubule stimulant","target":"residual tumor","id":"18063"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"18064"},{"source":"Microtubule stimulant","target":"arthritis","id":"18065"},{"source":"Microtubule stimulant","target":"antiarthritic","id":"18066"},{"source":"Microtubule stimulant","target":"carcinoma","id":"18067"},{"source":"Microtubule stimulant","target":"metastatic","id":"18068"},{"source":"Microtubule stimulant","target":"carcinoma","id":"18069"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"18070"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"18071"},{"source":"Microtubule stimulant","target":"psoriasis","id":"18072"},{"source":"Microtubule stimulant","target":"anticancer","id":"18073"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"18074"},{"source":"Microtubule stimulant","target":"sclc","id":"18075"},{"source":"NA","target":"psoriasis","id":"18076"},{"source":"NA","target":"residual tumor","id":"18077"},{"source":"NA","target":"non-small-cell lung","id":"18078"},{"source":"NA","target":"arthritis","id":"18079"},{"source":"NA","target":"antiarthritic","id":"18080"},{"source":"NA","target":"carcinoma","id":"18081"},{"source":"NA","target":"metastatic","id":"18082"},{"source":"NA","target":"carcinoma","id":"18083"},{"source":"NA","target":"non-small-cell lung","id":"18084"},{"source":"NA","target":"neoplasm metastasis","id":"18085"},{"source":"NA","target":"psoriasis","id":"18086"},{"source":"NA","target":"anticancer","id":"18087"},{"source":"NA","target":"lung neoplasms","id":"18088"},{"source":"NA","target":"sclc","id":"18089"},{"source":"Indoleamine-pyrrole 2","target":"psoriasis","id":"18090"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"18091"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"18092"},{"source":"Indoleamine-pyrrole 2","target":"arthritis","id":"18093"},{"source":"Indoleamine-pyrrole 2","target":"antiarthritic","id":"18094"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"18095"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"18096"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"18097"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"18098"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"18099"},{"source":"Indoleamine-pyrrole 2","target":"psoriasis","id":"18100"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"18101"},{"source":"Indoleamine-pyrrole 2","target":"lung neoplasms","id":"18102"},{"source":"Indoleamine-pyrrole 2","target":"sclc","id":"18103"},{"source":"Taxane","target":"psoriasis","id":"18104"},{"source":"Taxane","target":"residual tumor","id":"18105"},{"source":"Taxane","target":"non-small-cell lung","id":"18106"},{"source":"Taxane","target":"arthritis","id":"18107"},{"source":"Taxane","target":"antiarthritic","id":"18108"},{"source":"Taxane","target":"carcinoma","id":"18109"},{"source":"Taxane","target":"metastatic","id":"18110"},{"source":"Taxane","target":"carcinoma","id":"18111"},{"source":"Taxane","target":"non-small-cell lung","id":"18112"},{"source":"Taxane","target":"neoplasm metastasis","id":"18113"},{"source":"Taxane","target":"psoriasis","id":"18114"},{"source":"Taxane","target":"anticancer","id":"18115"},{"source":"Taxane","target":"lung neoplasms","id":"18116"},{"source":"Taxane","target":"sclc","id":"18117"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"18118"},{"source":"Oncology: Lung","target":"NA","id":"18119"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"18120"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"18121"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"18122"},{"source":"Oncology: Lung","target":"NA","id":"18123"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"18124"},{"source":"Oncology: Lung","target":"Beta tubulin antagonist","id":"18125"},{"source":"Oncology: Lung","target":"NA","id":"18126"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"18127"},{"source":"Oncology: Lung","target":"NA","id":"18128"},{"source":"Oncology: Lung","target":"Indoleamine-pyrrole 2","id":"18129"},{"source":"Oncology: Lung","target":"Taxane","id":"18130"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"18131"},{"source":"Non-Small Cell","target":"NA","id":"18132"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"18133"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"18134"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"18135"},{"source":"Non-Small Cell","target":"NA","id":"18136"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"18137"},{"source":"Non-Small Cell","target":"Beta tubulin antagonist","id":"18138"},{"source":"Non-Small Cell","target":"NA","id":"18139"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"18140"},{"source":"Non-Small Cell","target":"NA","id":"18141"},{"source":"Non-Small Cell","target":"Indoleamine-pyrrole 2","id":"18142"},{"source":"Non-Small Cell","target":"Taxane","id":"18143"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"18144"},{"source":"pembrolizumab","target":"University of Wisconsin","id":"18145"},{"source":"pTVG-HP (u)","target":"National Institutes of Health/National Cancer Institute","id":"18146"},{"source":"pTVG-HP (u)","target":"University of Wisconsin","id":"18147"},{"source":"undisclosed - GnRH analog","target":"National Institutes of Health/National Cancer Institute","id":"18148"},{"source":"undisclosed - GnRH analog","target":"University of Wisconsin","id":"18149"},{"source":"UNK : Indication","target":"pembrolizumab","id":"18150"},{"source":"UNK : Indication","target":"pTVG-HP (u)","id":"18151"},{"source":"UNK : Indication","target":"undisclosed - GnRH analog","id":"18152"},{"source":"prostate cancer","target":"pembrolizumab","id":"18153"},{"source":"prostate cancer","target":"pTVG-HP (u)","id":"18154"},{"source":"prostate cancer","target":"undisclosed - GnRH analog","id":"18155"},{"source":"bone diseases","target":"pembrolizumab","id":"18156"},{"source":"bone diseases","target":"pTVG-HP (u)","id":"18157"},{"source":"bone diseases","target":"undisclosed - GnRH analog","id":"18158"},{"source":"human immunodeficiency virus","target":"pembrolizumab","id":"18159"},{"source":"human immunodeficiency virus","target":"pTVG-HP (u)","id":"18160"},{"source":"human immunodeficiency virus","target":"undisclosed - GnRH analog","id":"18161"},{"source":"bone diseases","target":"pembrolizumab","id":"18162"},{"source":"bone diseases","target":"pTVG-HP (u)","id":"18163"},{"source":"bone diseases","target":"undisclosed - GnRH analog","id":"18164"},{"source":"skin neoplasms","target":"pembrolizumab","id":"18165"},{"source":"skin neoplasms","target":"pTVG-HP (u)","id":"18166"},{"source":"skin neoplasms","target":"undisclosed - GnRH analog","id":"18167"},{"source":"second primary neoplasms","target":"pembrolizumab","id":"18168"},{"source":"second primary neoplasms","target":"pTVG-HP (u)","id":"18169"},{"source":"second primary neoplasms","target":"undisclosed - GnRH analog","id":"18170"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"18171"},{"source":"fallopian tube neoplasms","target":"pTVG-HP (u)","id":"18172"},{"source":"fallopian tube neoplasms","target":"undisclosed - GnRH analog","id":"18173"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"18174"},{"source":"chronic hepatitis b","target":"pTVG-HP (u)","id":"18175"},{"source":"chronic hepatitis b","target":"undisclosed - GnRH analog","id":"18176"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"18177"},{"source":"chronic hepatitis b","target":"pTVG-HP (u)","id":"18178"},{"source":"chronic hepatitis b","target":"undisclosed - GnRH analog","id":"18179"},{"source":"hiv infections","target":"pembrolizumab","id":"18180"},{"source":"hiv infections","target":"pTVG-HP (u)","id":"18181"},{"source":"hiv infections","target":"undisclosed - GnRH analog","id":"18182"},{"source":"bone diseases","target":"pembrolizumab","id":"18183"},{"source":"bone diseases","target":"pTVG-HP (u)","id":"18184"},{"source":"bone diseases","target":"undisclosed - GnRH analog","id":"18185"},{"source":"allergies","target":"pembrolizumab","id":"18186"},{"source":"allergies","target":"pTVG-HP (u)","id":"18187"},{"source":"allergies","target":"undisclosed - GnRH analog","id":"18188"},{"source":"hypersensitivity","target":"pembrolizumab","id":"18189"},{"source":"hypersensitivity","target":"pTVG-HP (u)","id":"18190"},{"source":"hypersensitivity","target":"undisclosed - GnRH analog","id":"18191"},{"source":"carcinoma","target":"pembrolizumab","id":"18192"},{"source":"carcinoma","target":"pTVG-HP (u)","id":"18193"},{"source":"carcinoma","target":"undisclosed - GnRH analog","id":"18194"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"18195"},{"source":"castration-resistant prostatic neoplasms","target":"pTVG-HP (u)","id":"18196"},{"source":"castration-resistant prostatic neoplasms","target":"undisclosed - GnRH analog","id":"18197"},{"source":"hiv) 1","target":"pembrolizumab","id":"18198"},{"source":"hiv) 1","target":"pTVG-HP (u)","id":"18199"},{"source":"hiv) 1","target":"undisclosed - GnRH analog","id":"18200"},{"source":"solid tumors","target":"pembrolizumab","id":"18201"},{"source":"solid tumors","target":"pTVG-HP (u)","id":"18202"},{"source":"solid tumors","target":"undisclosed - GnRH analog","id":"18203"},{"source":"carcinoma","target":"pembrolizumab","id":"18204"},{"source":"carcinoma","target":"pTVG-HP (u)","id":"18205"},{"source":"carcinoma","target":"undisclosed - GnRH analog","id":"18206"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"18207"},{"source":"neoplasm metastasis","target":"pTVG-HP (u)","id":"18208"},{"source":"neoplasm metastasis","target":"undisclosed - GnRH analog","id":"18209"},{"source":"residual tumor","target":"pembrolizumab","id":"18210"},{"source":"residual tumor","target":"pTVG-HP (u)","id":"18211"},{"source":"residual tumor","target":"undisclosed - GnRH analog","id":"18212"},{"source":"metastatic","target":"pembrolizumab","id":"18213"},{"source":"metastatic","target":"pTVG-HP (u)","id":"18214"},{"source":"metastatic","target":"undisclosed - GnRH analog","id":"18215"},{"source":"second primary neoplasms","target":"pembrolizumab","id":"18216"},{"source":"second primary neoplasms","target":"pTVG-HP (u)","id":"18217"},{"source":"second primary neoplasms","target":"undisclosed - GnRH analog","id":"18218"},{"source":"anticancer","target":"pembrolizumab","id":"18219"},{"source":"anticancer","target":"pTVG-HP (u)","id":"18220"},{"source":"anticancer","target":"undisclosed - GnRH analog","id":"18221"},{"source":"bone metastasis","target":"pembrolizumab","id":"18222"},{"source":"bone metastasis","target":"pTVG-HP (u)","id":"18223"},{"source":"bone metastasis","target":"undisclosed - GnRH analog","id":"18224"},{"source":"solid tumors","target":"pembrolizumab","id":"18225"},{"source":"solid tumors","target":"pTVG-HP (u)","id":"18226"},{"source":"solid tumors","target":"undisclosed - GnRH analog","id":"18227"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"18228"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"18229"},{"source":"Anticancer immunotherapy","target":"bone diseases","id":"18230"},{"source":"Anticancer immunotherapy","target":"human immunodeficiency virus","id":"18231"},{"source":"Anticancer immunotherapy","target":"bone diseases","id":"18232"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"18233"},{"source":"Anticancer immunotherapy","target":"second primary neoplasms","id":"18234"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"18235"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"18236"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"18237"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"18238"},{"source":"Anticancer immunotherapy","target":"bone diseases","id":"18239"},{"source":"Anticancer immunotherapy","target":"allergies","id":"18240"},{"source":"Anticancer immunotherapy","target":"hypersensitivity","id":"18241"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"18242"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"18243"},{"source":"Anticancer immunotherapy","target":"hiv) 1","id":"18244"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"18245"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"18246"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"18247"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"18248"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"18249"},{"source":"Anticancer immunotherapy","target":"second primary neoplasms","id":"18250"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"18251"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"18252"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"18253"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"18254"},{"source":"CD19 antagonist","target":"prostate cancer","id":"18255"},{"source":"CD19 antagonist","target":"bone diseases","id":"18256"},{"source":"CD19 antagonist","target":"human immunodeficiency virus","id":"18257"},{"source":"CD19 antagonist","target":"bone diseases","id":"18258"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"18259"},{"source":"CD19 antagonist","target":"second primary neoplasms","id":"18260"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"18261"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"18262"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"18263"},{"source":"CD19 antagonist","target":"hiv infections","id":"18264"},{"source":"CD19 antagonist","target":"bone diseases","id":"18265"},{"source":"CD19 antagonist","target":"allergies","id":"18266"},{"source":"CD19 antagonist","target":"hypersensitivity","id":"18267"},{"source":"CD19 antagonist","target":"carcinoma","id":"18268"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"18269"},{"source":"CD19 antagonist","target":"hiv) 1","id":"18270"},{"source":"CD19 antagonist","target":"solid tumors","id":"18271"},{"source":"CD19 antagonist","target":"carcinoma","id":"18272"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"18273"},{"source":"CD19 antagonist","target":"residual tumor","id":"18274"},{"source":"CD19 antagonist","target":"metastatic","id":"18275"},{"source":"CD19 antagonist","target":"second primary neoplasms","id":"18276"},{"source":"CD19 antagonist","target":"anticancer","id":"18277"},{"source":"CD19 antagonist","target":"bone metastasis","id":"18278"},{"source":"CD19 antagonist","target":"solid tumors","id":"18279"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"UNK : Indication","id":"18280"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"prostate cancer","id":"18281"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"bone diseases","id":"18282"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"human immunodeficiency virus","id":"18283"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"bone diseases","id":"18284"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"skin neoplasms","id":"18285"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"second primary neoplasms","id":"18286"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"fallopian tube neoplasms","id":"18287"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"chronic hepatitis b","id":"18288"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"chronic hepatitis b","id":"18289"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"hiv infections","id":"18290"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"bone diseases","id":"18291"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"allergies","id":"18292"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"hypersensitivity","id":"18293"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"carcinoma","id":"18294"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"castration-resistant prostatic neoplasms","id":"18295"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"hiv) 1","id":"18296"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"solid tumors","id":"18297"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"carcinoma","id":"18298"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"neoplasm metastasis","id":"18299"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"residual tumor","id":"18300"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"metastatic","id":"18301"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"second primary neoplasms","id":"18302"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"anticancer","id":"18303"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"bone metastasis","id":"18304"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"solid tumors","id":"18305"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"18306"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"18307"},{"source":"Immune checkpoint inhibitor","target":"bone diseases","id":"18308"},{"source":"Immune checkpoint inhibitor","target":"human immunodeficiency virus","id":"18309"},{"source":"Immune checkpoint inhibitor","target":"bone diseases","id":"18310"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"18311"},{"source":"Immune checkpoint inhibitor","target":"second primary neoplasms","id":"18312"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"18313"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"18314"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"18315"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"18316"},{"source":"Immune checkpoint inhibitor","target":"bone diseases","id":"18317"},{"source":"Immune checkpoint inhibitor","target":"allergies","id":"18318"},{"source":"Immune checkpoint inhibitor","target":"hypersensitivity","id":"18319"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18320"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"18321"},{"source":"Immune checkpoint inhibitor","target":"hiv) 1","id":"18322"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"18323"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18324"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"18325"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"18326"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"18327"},{"source":"Immune checkpoint inhibitor","target":"second primary neoplasms","id":"18328"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"18329"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"18330"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"18331"},{"source":"UPA","target":"UNK : Indication","id":"18332"},{"source":"UPA","target":"prostate cancer","id":"18333"},{"source":"UPA","target":"bone diseases","id":"18334"},{"source":"UPA","target":"human immunodeficiency virus","id":"18335"},{"source":"UPA","target":"bone diseases","id":"18336"},{"source":"UPA","target":"skin neoplasms","id":"18337"},{"source":"UPA","target":"second primary neoplasms","id":"18338"},{"source":"UPA","target":"fallopian tube neoplasms","id":"18339"},{"source":"UPA","target":"chronic hepatitis b","id":"18340"},{"source":"UPA","target":"chronic hepatitis b","id":"18341"},{"source":"UPA","target":"hiv infections","id":"18342"},{"source":"UPA","target":"bone diseases","id":"18343"},{"source":"UPA","target":"allergies","id":"18344"},{"source":"UPA","target":"hypersensitivity","id":"18345"},{"source":"UPA","target":"carcinoma","id":"18346"},{"source":"UPA","target":"castration-resistant prostatic neoplasms","id":"18347"},{"source":"UPA","target":"hiv) 1","id":"18348"},{"source":"UPA","target":"solid tumors","id":"18349"},{"source":"UPA","target":"carcinoma","id":"18350"},{"source":"UPA","target":"neoplasm metastasis","id":"18351"},{"source":"UPA","target":"residual tumor","id":"18352"},{"source":"UPA","target":"metastatic","id":"18353"},{"source":"UPA","target":"second primary neoplasms","id":"18354"},{"source":"UPA","target":"anticancer","id":"18355"},{"source":"UPA","target":"bone metastasis","id":"18356"},{"source":"UPA","target":"solid tumors","id":"18357"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"18358"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"18359"},{"source":"Oncology: Prostate","target":"Luteinizing hormone releasing hormone (LHRH) agonist","id":"18360"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"18361"},{"source":"Oncology: Prostate","target":"UPA","id":"18362"},{"source":"peginterferon alfa-2b (a)","target":"Merck & Co.","id":"18363"},{"source":"pembrolizumab","target":"Merck & Co.","id":"18364"},{"source":"ipilimumab","target":"Merck & Co.","id":"18365"},{"source":"UNK : Indication","target":"peginterferon alfa-2b (a)","id":"18366"},{"source":"UNK : Indication","target":"pembrolizumab","id":"18367"},{"source":"UNK : Indication","target":"ipilimumab","id":"18368"},{"source":"anti-hiv","target":"peginterferon alfa-2b (a)","id":"18369"},{"source":"anti-hiv","target":"pembrolizumab","id":"18370"},{"source":"anti-hiv","target":"ipilimumab","id":"18371"},{"source":"anticancer","target":"peginterferon alfa-2b (a)","id":"18372"},{"source":"anticancer","target":"pembrolizumab","id":"18373"},{"source":"anticancer","target":"ipilimumab","id":"18374"},{"source":"gilbert syndrome","target":"peginterferon alfa-2b (a)","id":"18375"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"18376"},{"source":"gilbert syndrome","target":"ipilimumab","id":"18377"},{"source":"renal cancer","target":"peginterferon alfa-2b (a)","id":"18378"},{"source":"renal cancer","target":"pembrolizumab","id":"18379"},{"source":"renal cancer","target":"ipilimumab","id":"18380"},{"source":"carcinoma","target":"peginterferon alfa-2b (a)","id":"18381"},{"source":"carcinoma","target":"pembrolizumab","id":"18382"},{"source":"carcinoma","target":"ipilimumab","id":"18383"},{"source":"gilbert disease","target":"peginterferon alfa-2b (a)","id":"18384"},{"source":"gilbert disease","target":"pembrolizumab","id":"18385"},{"source":"gilbert disease","target":"ipilimumab","id":"18386"},{"source":"hiv infections","target":"peginterferon alfa-2b (a)","id":"18387"},{"source":"hiv infections","target":"pembrolizumab","id":"18388"},{"source":"hiv infections","target":"ipilimumab","id":"18389"},{"source":"liver neoplasms","target":"peginterferon alfa-2b (a)","id":"18390"},{"source":"liver neoplasms","target":"pembrolizumab","id":"18391"},{"source":"liver neoplasms","target":"ipilimumab","id":"18392"},{"source":"melanoma","target":"peginterferon alfa-2b (a)","id":"18393"},{"source":"melanoma","target":"pembrolizumab","id":"18394"},{"source":"melanoma","target":"ipilimumab","id":"18395"},{"source":"acquired immunodeficiency syndrome","target":"peginterferon alfa-2b (a)","id":"18396"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"18397"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"18398"},{"source":"liver metastases","target":"peginterferon alfa-2b (a)","id":"18399"},{"source":"liver metastases","target":"pembrolizumab","id":"18400"},{"source":"liver metastases","target":"ipilimumab","id":"18401"},{"source":"renal cell","target":"peginterferon alfa-2b (a)","id":"18402"},{"source":"renal cell","target":"pembrolizumab","id":"18403"},{"source":"renal cell","target":"ipilimumab","id":"18404"},{"source":"rcc","target":"peginterferon alfa-2b (a)","id":"18405"},{"source":"rcc","target":"pembrolizumab","id":"18406"},{"source":"rcc","target":"ipilimumab","id":"18407"},{"source":"alopecia","target":"peginterferon alfa-2b (a)","id":"18408"},{"source":"alopecia","target":"pembrolizumab","id":"18409"},{"source":"alopecia","target":"ipilimumab","id":"18410"},{"source":"kidney neoplasms","target":"peginterferon alfa-2b (a)","id":"18411"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"18412"},{"source":"kidney neoplasms","target":"ipilimumab","id":"18413"},{"source":"anti-tumor","target":"peginterferon alfa-2b (a)","id":"18414"},{"source":"anti-tumor","target":"pembrolizumab","id":"18415"},{"source":"anti-tumor","target":"ipilimumab","id":"18416"},{"source":"metastatic","target":"peginterferon alfa-2b (a)","id":"18417"},{"source":"metastatic","target":"pembrolizumab","id":"18418"},{"source":"metastatic","target":"ipilimumab","id":"18419"},{"source":"carcinoma","target":"peginterferon alfa-2b (a)","id":"18420"},{"source":"carcinoma","target":"pembrolizumab","id":"18421"},{"source":"carcinoma","target":"ipilimumab","id":"18422"},{"source":"neoplasm metastasis","target":"peginterferon alfa-2b (a)","id":"18423"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"18424"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"18425"},{"source":"skin neoplasms","target":"peginterferon alfa-2b (a)","id":"18426"},{"source":"skin neoplasms","target":"pembrolizumab","id":"18427"},{"source":"skin neoplasms","target":"ipilimumab","id":"18428"},{"source":"residual tumor","target":"peginterferon alfa-2b (a)","id":"18429"},{"source":"residual tumor","target":"pembrolizumab","id":"18430"},{"source":"residual tumor","target":"ipilimumab","id":"18431"},{"source":"anticancer","target":"peginterferon alfa-2b (a)","id":"18432"},{"source":"anticancer","target":"pembrolizumab","id":"18433"},{"source":"anticancer","target":"ipilimumab","id":"18434"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"18435"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"18436"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"18437"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"18438"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"18439"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18440"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"18441"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"18442"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"18443"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"18444"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"18445"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"18446"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"18447"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"18448"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"18449"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"18450"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"18451"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"18452"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18453"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"18454"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"18455"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"18456"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"18457"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"18458"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"18459"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"18460"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"18461"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"18462"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"18463"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"18464"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"18465"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"18466"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"18467"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"18468"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"18469"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"18470"},{"source":"Anticancer immunotherapy","target":"rcc","id":"18471"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"18472"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"18473"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"18474"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"18475"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"18476"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"18477"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"18478"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"18479"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"18480"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"18481"},{"source":"CD19 antagonist","target":"anti-hiv","id":"18482"},{"source":"CD19 antagonist","target":"anticancer","id":"18483"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"18484"},{"source":"CD19 antagonist","target":"renal cancer","id":"18485"},{"source":"CD19 antagonist","target":"carcinoma","id":"18486"},{"source":"CD19 antagonist","target":"gilbert disease","id":"18487"},{"source":"CD19 antagonist","target":"hiv infections","id":"18488"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"18489"},{"source":"CD19 antagonist","target":"melanoma","id":"18490"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"18491"},{"source":"CD19 antagonist","target":"liver metastases","id":"18492"},{"source":"CD19 antagonist","target":"renal cell","id":"18493"},{"source":"CD19 antagonist","target":"rcc","id":"18494"},{"source":"CD19 antagonist","target":"alopecia","id":"18495"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"18496"},{"source":"CD19 antagonist","target":"anti-tumor","id":"18497"},{"source":"CD19 antagonist","target":"metastatic","id":"18498"},{"source":"CD19 antagonist","target":"carcinoma","id":"18499"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"18500"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"18501"},{"source":"CD19 antagonist","target":"residual tumor","id":"18502"},{"source":"CD19 antagonist","target":"anticancer","id":"18503"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"18504"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"18505"},{"source":"CTLA4 antagonist","target":"anticancer","id":"18506"},{"source":"CTLA4 antagonist","target":"gilbert syndrome","id":"18507"},{"source":"CTLA4 antagonist","target":"renal cancer","id":"18508"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"18509"},{"source":"CTLA4 antagonist","target":"gilbert disease","id":"18510"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"18511"},{"source":"CTLA4 antagonist","target":"liver neoplasms","id":"18512"},{"source":"CTLA4 antagonist","target":"melanoma","id":"18513"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"18514"},{"source":"CTLA4 antagonist","target":"liver metastases","id":"18515"},{"source":"CTLA4 antagonist","target":"renal cell","id":"18516"},{"source":"CTLA4 antagonist","target":"rcc","id":"18517"},{"source":"CTLA4 antagonist","target":"alopecia","id":"18518"},{"source":"CTLA4 antagonist","target":"kidney neoplasms","id":"18519"},{"source":"CTLA4 antagonist","target":"anti-tumor","id":"18520"},{"source":"CTLA4 antagonist","target":"metastatic","id":"18521"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"18522"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"18523"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"18524"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"18525"},{"source":"CTLA4 antagonist","target":"anticancer","id":"18526"},{"source":"Interferon receptor agonist","target":"UNK : Indication","id":"18527"},{"source":"Interferon receptor agonist","target":"anti-hiv","id":"18528"},{"source":"Interferon receptor agonist","target":"anticancer","id":"18529"},{"source":"Interferon receptor agonist","target":"gilbert syndrome","id":"18530"},{"source":"Interferon receptor agonist","target":"renal cancer","id":"18531"},{"source":"Interferon receptor agonist","target":"carcinoma","id":"18532"},{"source":"Interferon receptor agonist","target":"gilbert disease","id":"18533"},{"source":"Interferon receptor agonist","target":"hiv infections","id":"18534"},{"source":"Interferon receptor agonist","target":"liver neoplasms","id":"18535"},{"source":"Interferon receptor agonist","target":"melanoma","id":"18536"},{"source":"Interferon receptor agonist","target":"acquired immunodeficiency syndrome","id":"18537"},{"source":"Interferon receptor agonist","target":"liver metastases","id":"18538"},{"source":"Interferon receptor agonist","target":"renal cell","id":"18539"},{"source":"Interferon receptor agonist","target":"rcc","id":"18540"},{"source":"Interferon receptor agonist","target":"alopecia","id":"18541"},{"source":"Interferon receptor agonist","target":"kidney neoplasms","id":"18542"},{"source":"Interferon receptor agonist","target":"anti-tumor","id":"18543"},{"source":"Interferon receptor agonist","target":"metastatic","id":"18544"},{"source":"Interferon receptor agonist","target":"carcinoma","id":"18545"},{"source":"Interferon receptor agonist","target":"neoplasm metastasis","id":"18546"},{"source":"Interferon receptor agonist","target":"skin neoplasms","id":"18547"},{"source":"Interferon receptor agonist","target":"residual tumor","id":"18548"},{"source":"Interferon receptor agonist","target":"anticancer","id":"18549"},{"source":"Interferon alpha 2b agonist","target":"UNK : Indication","id":"18550"},{"source":"Interferon alpha 2b agonist","target":"anti-hiv","id":"18551"},{"source":"Interferon alpha 2b agonist","target":"anticancer","id":"18552"},{"source":"Interferon alpha 2b agonist","target":"gilbert syndrome","id":"18553"},{"source":"Interferon alpha 2b agonist","target":"renal cancer","id":"18554"},{"source":"Interferon alpha 2b agonist","target":"carcinoma","id":"18555"},{"source":"Interferon alpha 2b agonist","target":"gilbert disease","id":"18556"},{"source":"Interferon alpha 2b agonist","target":"hiv infections","id":"18557"},{"source":"Interferon alpha 2b agonist","target":"liver neoplasms","id":"18558"},{"source":"Interferon alpha 2b agonist","target":"melanoma","id":"18559"},{"source":"Interferon alpha 2b agonist","target":"acquired immunodeficiency syndrome","id":"18560"},{"source":"Interferon alpha 2b agonist","target":"liver metastases","id":"18561"},{"source":"Interferon alpha 2b agonist","target":"renal cell","id":"18562"},{"source":"Interferon alpha 2b agonist","target":"rcc","id":"18563"},{"source":"Interferon alpha 2b agonist","target":"alopecia","id":"18564"},{"source":"Interferon alpha 2b agonist","target":"kidney neoplasms","id":"18565"},{"source":"Interferon alpha 2b agonist","target":"anti-tumor","id":"18566"},{"source":"Interferon alpha 2b agonist","target":"metastatic","id":"18567"},{"source":"Interferon alpha 2b agonist","target":"carcinoma","id":"18568"},{"source":"Interferon alpha 2b agonist","target":"neoplasm metastasis","id":"18569"},{"source":"Interferon alpha 2b agonist","target":"skin neoplasms","id":"18570"},{"source":"Interferon alpha 2b agonist","target":"residual tumor","id":"18571"},{"source":"Interferon alpha 2b agonist","target":"anticancer","id":"18572"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"18573"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"18574"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"18575"},{"source":"Oncology: Melanoma","target":"CTLA4 antagonist","id":"18576"},{"source":"Oncology: Melanoma","target":"Interferon receptor agonist","id":"18577"},{"source":"Oncology: Melanoma","target":"Interferon alpha 2b agonist","id":"18578"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"18579"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"18580"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"18581"},{"source":"Oncology: Renal","target":"CTLA4 antagonist","id":"18582"},{"source":"Oncology: Renal","target":"Interferon receptor agonist","id":"18583"},{"source":"Oncology: Renal","target":"Interferon alpha 2b agonist","id":"18584"},{"source":"epacadostat (u)","target":"Incyte Corporation","id":"18585"},{"source":"epacadostat (u)","target":"Merck & Co.","id":"18586"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"18587"},{"source":"pembrolizumab","target":"Merck & Co.","id":"18588"},{"source":"carboplatin","target":"Incyte Corporation","id":"18589"},{"source":"carboplatin","target":"Merck & Co.","id":"18590"},{"source":"cetuximab","target":"Incyte Corporation","id":"18591"},{"source":"cetuximab","target":"Merck & Co.","id":"18592"},{"source":"cisplatin","target":"Incyte Corporation","id":"18593"},{"source":"cisplatin","target":"Merck & Co.","id":"18594"},{"source":"5-fluorouracil","target":"Incyte Corporation","id":"18595"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"18596"},{"source":"UNK : Indication","target":"epacadostat (u)","id":"18597"},{"source":"UNK : Indication","target":"pembrolizumab","id":"18598"},{"source":"UNK : Indication","target":"carboplatin","id":"18599"},{"source":"UNK : Indication","target":"cetuximab","id":"18600"},{"source":"UNK : Indication","target":"cisplatin","id":"18601"},{"source":"UNK : Indication","target":"5-fluorouracil","id":"18602"},{"source":"carcinoma","target":"epacadostat (u)","id":"18603"},{"source":"carcinoma","target":"pembrolizumab","id":"18604"},{"source":"carcinoma","target":"carboplatin","id":"18605"},{"source":"carcinoma","target":"cetuximab","id":"18606"},{"source":"carcinoma","target":"cisplatin","id":"18607"},{"source":"carcinoma","target":"5-fluorouracil","id":"18608"},{"source":"squamous cell neoplasms","target":"epacadostat (u)","id":"18609"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"18610"},{"source":"squamous cell neoplasms","target":"carboplatin","id":"18611"},{"source":"squamous cell neoplasms","target":"cetuximab","id":"18612"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"18613"},{"source":"squamous cell neoplasms","target":"5-fluorouracil","id":"18614"},{"source":"hpv type","target":"epacadostat (u)","id":"18615"},{"source":"hpv type","target":"pembrolizumab","id":"18616"},{"source":"hpv type","target":"carboplatin","id":"18617"},{"source":"hpv type","target":"cetuximab","id":"18618"},{"source":"hpv type","target":"cisplatin","id":"18619"},{"source":"hpv type","target":"5-fluorouracil","id":"18620"},{"source":"bone metastasis","target":"epacadostat (u)","id":"18621"},{"source":"bone metastasis","target":"pembrolizumab","id":"18622"},{"source":"bone metastasis","target":"carboplatin","id":"18623"},{"source":"bone metastasis","target":"cetuximab","id":"18624"},{"source":"bone metastasis","target":"cisplatin","id":"18625"},{"source":"bone metastasis","target":"5-fluorouracil","id":"18626"},{"source":"carcinoma","target":"epacadostat (u)","id":"18627"},{"source":"carcinoma","target":"pembrolizumab","id":"18628"},{"source":"carcinoma","target":"carboplatin","id":"18629"},{"source":"carcinoma","target":"cetuximab","id":"18630"},{"source":"carcinoma","target":"cisplatin","id":"18631"},{"source":"carcinoma","target":"5-fluorouracil","id":"18632"},{"source":"carcinoma","target":"epacadostat (u)","id":"18633"},{"source":"carcinoma","target":"pembrolizumab","id":"18634"},{"source":"carcinoma","target":"carboplatin","id":"18635"},{"source":"carcinoma","target":"cetuximab","id":"18636"},{"source":"carcinoma","target":"cisplatin","id":"18637"},{"source":"carcinoma","target":"5-fluorouracil","id":"18638"},{"source":"squamous cell neoplasms","target":"epacadostat (u)","id":"18639"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"18640"},{"source":"squamous cell neoplasms","target":"carboplatin","id":"18641"},{"source":"squamous cell neoplasms","target":"cetuximab","id":"18642"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"18643"},{"source":"squamous cell neoplasms","target":"5-fluorouracil","id":"18644"},{"source":"residual tumor","target":"epacadostat (u)","id":"18645"},{"source":"residual tumor","target":"pembrolizumab","id":"18646"},{"source":"residual tumor","target":"carboplatin","id":"18647"},{"source":"residual tumor","target":"cetuximab","id":"18648"},{"source":"residual tumor","target":"cisplatin","id":"18649"},{"source":"residual tumor","target":"5-fluorouracil","id":"18650"},{"source":"fallopian tube neoplasms","target":"epacadostat (u)","id":"18651"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"18652"},{"source":"fallopian tube neoplasms","target":"carboplatin","id":"18653"},{"source":"fallopian tube neoplasms","target":"cetuximab","id":"18654"},{"source":"fallopian tube neoplasms","target":"cisplatin","id":"18655"},{"source":"fallopian tube neoplasms","target":"5-fluorouracil","id":"18656"},{"source":"metastatic","target":"epacadostat (u)","id":"18657"},{"source":"metastatic","target":"pembrolizumab","id":"18658"},{"source":"metastatic","target":"carboplatin","id":"18659"},{"source":"metastatic","target":"cetuximab","id":"18660"},{"source":"metastatic","target":"cisplatin","id":"18661"},{"source":"metastatic","target":"5-fluorouracil","id":"18662"},{"source":"carcinoma","target":"epacadostat (u)","id":"18663"},{"source":"carcinoma","target":"pembrolizumab","id":"18664"},{"source":"carcinoma","target":"carboplatin","id":"18665"},{"source":"carcinoma","target":"cetuximab","id":"18666"},{"source":"carcinoma","target":"cisplatin","id":"18667"},{"source":"carcinoma","target":"5-fluorouracil","id":"18668"},{"source":"oropharyngeal cancer","target":"epacadostat (u)","id":"18669"},{"source":"oropharyngeal cancer","target":"pembrolizumab","id":"18670"},{"source":"oropharyngeal cancer","target":"carboplatin","id":"18671"},{"source":"oropharyngeal cancer","target":"cetuximab","id":"18672"},{"source":"oropharyngeal cancer","target":"cisplatin","id":"18673"},{"source":"oropharyngeal cancer","target":"5-fluorouracil","id":"18674"},{"source":"neoplasm metastasis","target":"epacadostat (u)","id":"18675"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"18676"},{"source":"neoplasm metastasis","target":"carboplatin","id":"18677"},{"source":"neoplasm metastasis","target":"cetuximab","id":"18678"},{"source":"neoplasm metastasis","target":"cisplatin","id":"18679"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"18680"},{"source":"anticancer","target":"epacadostat (u)","id":"18681"},{"source":"anticancer","target":"pembrolizumab","id":"18682"},{"source":"anticancer","target":"carboplatin","id":"18683"},{"source":"anticancer","target":"cetuximab","id":"18684"},{"source":"anticancer","target":"cisplatin","id":"18685"},{"source":"anticancer","target":"5-fluorouracil","id":"18686"},{"source":"papilloma","target":"epacadostat (u)","id":"18687"},{"source":"papilloma","target":"pembrolizumab","id":"18688"},{"source":"papilloma","target":"carboplatin","id":"18689"},{"source":"papilloma","target":"cetuximab","id":"18690"},{"source":"papilloma","target":"cisplatin","id":"18691"},{"source":"papilloma","target":"5-fluorouracil","id":"18692"},{"source":"pharyngeal neoplasms","target":"epacadostat (u)","id":"18693"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"18694"},{"source":"pharyngeal neoplasms","target":"carboplatin","id":"18695"},{"source":"pharyngeal neoplasms","target":"cetuximab","id":"18696"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"18697"},{"source":"pharyngeal neoplasms","target":"5-fluorouracil","id":"18698"},{"source":"papilloma","target":"epacadostat (u)","id":"18699"},{"source":"papilloma","target":"pembrolizumab","id":"18700"},{"source":"papilloma","target":"carboplatin","id":"18701"},{"source":"papilloma","target":"cetuximab","id":"18702"},{"source":"papilloma","target":"cisplatin","id":"18703"},{"source":"papilloma","target":"5-fluorouracil","id":"18704"},{"source":"head and neck neoplasms","target":"epacadostat (u)","id":"18705"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"18706"},{"source":"head and neck neoplasms","target":"carboplatin","id":"18707"},{"source":"head and neck neoplasms","target":"cetuximab","id":"18708"},{"source":"head and neck neoplasms","target":"cisplatin","id":"18709"},{"source":"head and neck neoplasms","target":"5-fluorouracil","id":"18710"},{"source":"EGFR antagonist","target":"UNK : Indication","id":"18711"},{"source":"EGFR antagonist","target":"carcinoma","id":"18712"},{"source":"EGFR antagonist","target":"squamous cell neoplasms","id":"18713"},{"source":"EGFR antagonist","target":"hpv type","id":"18714"},{"source":"EGFR antagonist","target":"bone metastasis","id":"18715"},{"source":"EGFR antagonist","target":"carcinoma","id":"18716"},{"source":"EGFR antagonist","target":"carcinoma","id":"18717"},{"source":"EGFR antagonist","target":"squamous cell neoplasms","id":"18718"},{"source":"EGFR antagonist","target":"residual tumor","id":"18719"},{"source":"EGFR antagonist","target":"fallopian tube neoplasms","id":"18720"},{"source":"EGFR antagonist","target":"metastatic","id":"18721"},{"source":"EGFR antagonist","target":"carcinoma","id":"18722"},{"source":"EGFR antagonist","target":"oropharyngeal cancer","id":"18723"},{"source":"EGFR antagonist","target":"neoplasm metastasis","id":"18724"},{"source":"EGFR antagonist","target":"anticancer","id":"18725"},{"source":"EGFR antagonist","target":"papilloma","id":"18726"},{"source":"EGFR antagonist","target":"pharyngeal neoplasms","id":"18727"},{"source":"EGFR antagonist","target":"papilloma","id":"18728"},{"source":"EGFR antagonist","target":"head and neck neoplasms","id":"18729"},{"source":"NA","target":"UNK : Indication","id":"18730"},{"source":"NA","target":"carcinoma","id":"18731"},{"source":"NA","target":"squamous cell neoplasms","id":"18732"},{"source":"NA","target":"hpv type","id":"18733"},{"source":"NA","target":"bone metastasis","id":"18734"},{"source":"NA","target":"carcinoma","id":"18735"},{"source":"NA","target":"carcinoma","id":"18736"},{"source":"NA","target":"squamous cell neoplasms","id":"18737"},{"source":"NA","target":"residual tumor","id":"18738"},{"source":"NA","target":"fallopian tube neoplasms","id":"18739"},{"source":"NA","target":"metastatic","id":"18740"},{"source":"NA","target":"carcinoma","id":"18741"},{"source":"NA","target":"oropharyngeal cancer","id":"18742"},{"source":"NA","target":"neoplasm metastasis","id":"18743"},{"source":"NA","target":"anticancer","id":"18744"},{"source":"NA","target":"papilloma","id":"18745"},{"source":"NA","target":"pharyngeal neoplasms","id":"18746"},{"source":"NA","target":"papilloma","id":"18747"},{"source":"NA","target":"head and neck neoplasms","id":"18748"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"18749"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18750"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"18751"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"18752"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"18753"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18754"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18755"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"18756"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"18757"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"18758"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"18759"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18760"},{"source":"Immune checkpoint inhibitor","target":"oropharyngeal cancer","id":"18761"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"18762"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"18763"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"18764"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"18765"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"18766"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"18767"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"18768"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"18769"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"18770"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"18771"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"18772"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"18773"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"18774"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"18775"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"18776"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"18777"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"18778"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"18779"},{"source":"Anticancer immunotherapy","target":"oropharyngeal cancer","id":"18780"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"18781"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"18782"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"18783"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"18784"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"18785"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"18786"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"18787"},{"source":"CD19 antagonist","target":"carcinoma","id":"18788"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"18789"},{"source":"CD19 antagonist","target":"hpv type","id":"18790"},{"source":"CD19 antagonist","target":"bone metastasis","id":"18791"},{"source":"CD19 antagonist","target":"carcinoma","id":"18792"},{"source":"CD19 antagonist","target":"carcinoma","id":"18793"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"18794"},{"source":"CD19 antagonist","target":"residual tumor","id":"18795"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"18796"},{"source":"CD19 antagonist","target":"metastatic","id":"18797"},{"source":"CD19 antagonist","target":"carcinoma","id":"18798"},{"source":"CD19 antagonist","target":"oropharyngeal cancer","id":"18799"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"18800"},{"source":"CD19 antagonist","target":"anticancer","id":"18801"},{"source":"CD19 antagonist","target":"papilloma","id":"18802"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"18803"},{"source":"CD19 antagonist","target":"papilloma","id":"18804"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"18805"},{"source":"NA","target":"UNK : Indication","id":"18806"},{"source":"NA","target":"carcinoma","id":"18807"},{"source":"NA","target":"squamous cell neoplasms","id":"18808"},{"source":"NA","target":"hpv type","id":"18809"},{"source":"NA","target":"bone metastasis","id":"18810"},{"source":"NA","target":"carcinoma","id":"18811"},{"source":"NA","target":"carcinoma","id":"18812"},{"source":"NA","target":"squamous cell neoplasms","id":"18813"},{"source":"NA","target":"residual tumor","id":"18814"},{"source":"NA","target":"fallopian tube neoplasms","id":"18815"},{"source":"NA","target":"metastatic","id":"18816"},{"source":"NA","target":"carcinoma","id":"18817"},{"source":"NA","target":"oropharyngeal cancer","id":"18818"},{"source":"NA","target":"neoplasm metastasis","id":"18819"},{"source":"NA","target":"anticancer","id":"18820"},{"source":"NA","target":"papilloma","id":"18821"},{"source":"NA","target":"pharyngeal neoplasms","id":"18822"},{"source":"NA","target":"papilloma","id":"18823"},{"source":"NA","target":"head and neck neoplasms","id":"18824"},{"source":"NA","target":"UNK : Indication","id":"18825"},{"source":"NA","target":"carcinoma","id":"18826"},{"source":"NA","target":"squamous cell neoplasms","id":"18827"},{"source":"NA","target":"hpv type","id":"18828"},{"source":"NA","target":"bone metastasis","id":"18829"},{"source":"NA","target":"carcinoma","id":"18830"},{"source":"NA","target":"carcinoma","id":"18831"},{"source":"NA","target":"squamous cell neoplasms","id":"18832"},{"source":"NA","target":"residual tumor","id":"18833"},{"source":"NA","target":"fallopian tube neoplasms","id":"18834"},{"source":"NA","target":"metastatic","id":"18835"},{"source":"NA","target":"carcinoma","id":"18836"},{"source":"NA","target":"oropharyngeal cancer","id":"18837"},{"source":"NA","target":"neoplasm metastasis","id":"18838"},{"source":"NA","target":"anticancer","id":"18839"},{"source":"NA","target":"papilloma","id":"18840"},{"source":"NA","target":"pharyngeal neoplasms","id":"18841"},{"source":"NA","target":"papilloma","id":"18842"},{"source":"NA","target":"head and neck neoplasms","id":"18843"},{"source":"NA","target":"UNK : Indication","id":"18844"},{"source":"NA","target":"carcinoma","id":"18845"},{"source":"NA","target":"squamous cell neoplasms","id":"18846"},{"source":"NA","target":"hpv type","id":"18847"},{"source":"NA","target":"bone metastasis","id":"18848"},{"source":"NA","target":"carcinoma","id":"18849"},{"source":"NA","target":"carcinoma","id":"18850"},{"source":"NA","target":"squamous cell neoplasms","id":"18851"},{"source":"NA","target":"residual tumor","id":"18852"},{"source":"NA","target":"fallopian tube neoplasms","id":"18853"},{"source":"NA","target":"metastatic","id":"18854"},{"source":"NA","target":"carcinoma","id":"18855"},{"source":"NA","target":"oropharyngeal cancer","id":"18856"},{"source":"NA","target":"neoplasm metastasis","id":"18857"},{"source":"NA","target":"anticancer","id":"18858"},{"source":"NA","target":"papilloma","id":"18859"},{"source":"NA","target":"pharyngeal neoplasms","id":"18860"},{"source":"NA","target":"papilloma","id":"18861"},{"source":"NA","target":"head and neck neoplasms","id":"18862"},{"source":"Indoleamine-pyrrole 2","target":"UNK : Indication","id":"18863"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"18864"},{"source":"Indoleamine-pyrrole 2","target":"squamous cell neoplasms","id":"18865"},{"source":"Indoleamine-pyrrole 2","target":"hpv type","id":"18866"},{"source":"Indoleamine-pyrrole 2","target":"bone metastasis","id":"18867"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"18868"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"18869"},{"source":"Indoleamine-pyrrole 2","target":"squamous cell neoplasms","id":"18870"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"18871"},{"source":"Indoleamine-pyrrole 2","target":"fallopian tube neoplasms","id":"18872"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"18873"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"18874"},{"source":"Indoleamine-pyrrole 2","target":"oropharyngeal cancer","id":"18875"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"18876"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"18877"},{"source":"Indoleamine-pyrrole 2","target":"papilloma","id":"18878"},{"source":"Indoleamine-pyrrole 2","target":"pharyngeal neoplasms","id":"18879"},{"source":"Indoleamine-pyrrole 2","target":"papilloma","id":"18880"},{"source":"Indoleamine-pyrrole 2","target":"head and neck neoplasms","id":"18881"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"18882"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"18883"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"18884"},{"source":"Thymidylate synthase inhibitor","target":"hpv type","id":"18885"},{"source":"Thymidylate synthase inhibitor","target":"bone metastasis","id":"18886"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"18887"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"18888"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"18889"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"18890"},{"source":"Thymidylate synthase inhibitor","target":"fallopian tube neoplasms","id":"18891"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"18892"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"18893"},{"source":"Thymidylate synthase inhibitor","target":"oropharyngeal cancer","id":"18894"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"18895"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"18896"},{"source":"Thymidylate synthase inhibitor","target":"papilloma","id":"18897"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"18898"},{"source":"Thymidylate synthase inhibitor","target":"papilloma","id":"18899"},{"source":"Thymidylate synthase inhibitor","target":"head and neck neoplasms","id":"18900"},{"source":"Oncology: Head/Neck","target":"EGFR antagonist","id":"18901"},{"source":"Oncology: Head/Neck","target":"NA","id":"18902"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"18903"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"18904"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"18905"},{"source":"Oncology: Head/Neck","target":"NA","id":"18906"},{"source":"Oncology: Head/Neck","target":"NA","id":"18907"},{"source":"Oncology: Head/Neck","target":"NA","id":"18908"},{"source":"Oncology: Head/Neck","target":"Indoleamine-pyrrole 2","id":"18909"},{"source":"Oncology: Head/Neck","target":"Thymidylate synthase inhibitor","id":"18910"},{"source":"BTH-1677 (u)","target":"Biothera","id":"18911"},{"source":"BTH-1677 (u)","target":"Merck & Co.","id":"18912"},{"source":"pembrolizumab","target":"Biothera","id":"18913"},{"source":"pembrolizumab","target":"Merck & Co.","id":"18914"},{"source":"UNK : Drug","target":"Biothera","id":"18915"},{"source":"UNK : Drug","target":"Merck & Co.","id":"18916"},{"source":"UNK : Indication","target":"BTH-1677 (u)","id":"18917"},{"source":"UNK : Indication","target":"pembrolizumab","id":"18918"},{"source":"UNK : Indication","target":"UNK : Drug","id":"18919"},{"source":"residual tumor","target":"BTH-1677 (u)","id":"18920"},{"source":"residual tumor","target":"pembrolizumab","id":"18921"},{"source":"residual tumor","target":"UNK : Drug","id":"18922"},{"source":"melanoma","target":"BTH-1677 (u)","id":"18923"},{"source":"melanoma","target":"pembrolizumab","id":"18924"},{"source":"melanoma","target":"UNK : Drug","id":"18925"},{"source":"anticancer","target":"BTH-1677 (u)","id":"18926"},{"source":"anticancer","target":"pembrolizumab","id":"18927"},{"source":"anticancer","target":"UNK : Drug","id":"18928"},{"source":"neuropathy","target":"BTH-1677 (u)","id":"18929"},{"source":"neuropathy","target":"pembrolizumab","id":"18930"},{"source":"neuropathy","target":"UNK : Drug","id":"18931"},{"source":"alopecia","target":"BTH-1677 (u)","id":"18932"},{"source":"alopecia","target":"pembrolizumab","id":"18933"},{"source":"alopecia","target":"UNK : Drug","id":"18934"},{"source":"triple-negative breast cancer","target":"BTH-1677 (u)","id":"18935"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"18936"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"18937"},{"source":"skin neoplasms","target":"BTH-1677 (u)","id":"18938"},{"source":"skin neoplasms","target":"pembrolizumab","id":"18939"},{"source":"skin neoplasms","target":"UNK : Drug","id":"18940"},{"source":"hepatic metastases","target":"BTH-1677 (u)","id":"18941"},{"source":"hepatic metastases","target":"pembrolizumab","id":"18942"},{"source":"hepatic metastases","target":"UNK : Drug","id":"18943"},{"source":"breast neoplasms","target":"BTH-1677 (u)","id":"18944"},{"source":"breast neoplasms","target":"pembrolizumab","id":"18945"},{"source":"breast neoplasms","target":"UNK : Drug","id":"18946"},{"source":"metastatic","target":"BTH-1677 (u)","id":"18947"},{"source":"metastatic","target":"pembrolizumab","id":"18948"},{"source":"metastatic","target":"UNK : Drug","id":"18949"},{"source":"carcinoma","target":"BTH-1677 (u)","id":"18950"},{"source":"carcinoma","target":"pembrolizumab","id":"18951"},{"source":"carcinoma","target":"UNK : Drug","id":"18952"},{"source":"melanoma","target":"BTH-1677 (u)","id":"18953"},{"source":"melanoma","target":"pembrolizumab","id":"18954"},{"source":"melanoma","target":"UNK : Drug","id":"18955"},{"source":"breast neoplasms","target":"BTH-1677 (u)","id":"18956"},{"source":"breast neoplasms","target":"pembrolizumab","id":"18957"},{"source":"breast neoplasms","target":"UNK : Drug","id":"18958"},{"source":"neoplasm metastasis","target":"BTH-1677 (u)","id":"18959"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"18960"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"18961"},{"source":"bleeding","target":"BTH-1677 (u)","id":"18962"},{"source":"bleeding","target":"pembrolizumab","id":"18963"},{"source":"bleeding","target":"UNK : Drug","id":"18964"},{"source":"hemorrhage","target":"BTH-1677 (u)","id":"18965"},{"source":"hemorrhage","target":"pembrolizumab","id":"18966"},{"source":"hemorrhage","target":"UNK : Drug","id":"18967"},{"source":"tnbc","target":"BTH-1677 (u)","id":"18968"},{"source":"tnbc","target":"pembrolizumab","id":"18969"},{"source":"tnbc","target":"UNK : Drug","id":"18970"},{"source":"liver neoplasms","target":"BTH-1677 (u)","id":"18971"},{"source":"liver neoplasms","target":"pembrolizumab","id":"18972"},{"source":"liver neoplasms","target":"UNK : Drug","id":"18973"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"18974"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"18975"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"18976"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"18977"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"18978"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"18979"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"18980"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"18981"},{"source":"Immune checkpoint inhibitor","target":"hepatic metastases","id":"18982"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"18983"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"18984"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"18985"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"18986"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"18987"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"18988"},{"source":"Immune checkpoint inhibitor","target":"bleeding","id":"18989"},{"source":"Immune checkpoint inhibitor","target":"hemorrhage","id":"18990"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"18991"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"18992"},{"source":"Macrophage stimulant","target":"UNK : Indication","id":"18993"},{"source":"Macrophage stimulant","target":"residual tumor","id":"18994"},{"source":"Macrophage stimulant","target":"melanoma","id":"18995"},{"source":"Macrophage stimulant","target":"anticancer","id":"18996"},{"source":"Macrophage stimulant","target":"neuropathy","id":"18997"},{"source":"Macrophage stimulant","target":"alopecia","id":"18998"},{"source":"Macrophage stimulant","target":"triple-negative breast cancer","id":"18999"},{"source":"Macrophage stimulant","target":"skin neoplasms","id":"19000"},{"source":"Macrophage stimulant","target":"hepatic metastases","id":"19001"},{"source":"Macrophage stimulant","target":"breast neoplasms","id":"19002"},{"source":"Macrophage stimulant","target":"metastatic","id":"19003"},{"source":"Macrophage stimulant","target":"carcinoma","id":"19004"},{"source":"Macrophage stimulant","target":"melanoma","id":"19005"},{"source":"Macrophage stimulant","target":"breast neoplasms","id":"19006"},{"source":"Macrophage stimulant","target":"neoplasm metastasis","id":"19007"},{"source":"Macrophage stimulant","target":"bleeding","id":"19008"},{"source":"Macrophage stimulant","target":"hemorrhage","id":"19009"},{"source":"Macrophage stimulant","target":"tnbc","id":"19010"},{"source":"Macrophage stimulant","target":"liver neoplasms","id":"19011"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"19012"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"19013"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"19014"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"19015"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"19016"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"19017"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"19018"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"19019"},{"source":"Anticancer immunotherapy","target":"hepatic metastases","id":"19020"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"19021"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"19022"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"19023"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"19024"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"19025"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"19026"},{"source":"Anticancer immunotherapy","target":"bleeding","id":"19027"},{"source":"Anticancer immunotherapy","target":"hemorrhage","id":"19028"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"19029"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"19030"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"19031"},{"source":"CD19 antagonist","target":"residual tumor","id":"19032"},{"source":"CD19 antagonist","target":"melanoma","id":"19033"},{"source":"CD19 antagonist","target":"anticancer","id":"19034"},{"source":"CD19 antagonist","target":"neuropathy","id":"19035"},{"source":"CD19 antagonist","target":"alopecia","id":"19036"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"19037"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"19038"},{"source":"CD19 antagonist","target":"hepatic metastases","id":"19039"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"19040"},{"source":"CD19 antagonist","target":"metastatic","id":"19041"},{"source":"CD19 antagonist","target":"carcinoma","id":"19042"},{"source":"CD19 antagonist","target":"melanoma","id":"19043"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"19044"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"19045"},{"source":"CD19 antagonist","target":"bleeding","id":"19046"},{"source":"CD19 antagonist","target":"hemorrhage","id":"19047"},{"source":"CD19 antagonist","target":"tnbc","id":"19048"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"19049"},{"source":"Immunostimulant","target":"UNK : Indication","id":"19050"},{"source":"Immunostimulant","target":"residual tumor","id":"19051"},{"source":"Immunostimulant","target":"melanoma","id":"19052"},{"source":"Immunostimulant","target":"anticancer","id":"19053"},{"source":"Immunostimulant","target":"neuropathy","id":"19054"},{"source":"Immunostimulant","target":"alopecia","id":"19055"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"19056"},{"source":"Immunostimulant","target":"skin neoplasms","id":"19057"},{"source":"Immunostimulant","target":"hepatic metastases","id":"19058"},{"source":"Immunostimulant","target":"breast neoplasms","id":"19059"},{"source":"Immunostimulant","target":"metastatic","id":"19060"},{"source":"Immunostimulant","target":"carcinoma","id":"19061"},{"source":"Immunostimulant","target":"melanoma","id":"19062"},{"source":"Immunostimulant","target":"breast neoplasms","id":"19063"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"19064"},{"source":"Immunostimulant","target":"bleeding","id":"19065"},{"source":"Immunostimulant","target":"hemorrhage","id":"19066"},{"source":"Immunostimulant","target":"tnbc","id":"19067"},{"source":"Immunostimulant","target":"liver neoplasms","id":"19068"},{"source":"NA","target":"UNK : Indication","id":"19069"},{"source":"NA","target":"residual tumor","id":"19070"},{"source":"NA","target":"melanoma","id":"19071"},{"source":"NA","target":"anticancer","id":"19072"},{"source":"NA","target":"neuropathy","id":"19073"},{"source":"NA","target":"alopecia","id":"19074"},{"source":"NA","target":"triple-negative breast cancer","id":"19075"},{"source":"NA","target":"skin neoplasms","id":"19076"},{"source":"NA","target":"hepatic metastases","id":"19077"},{"source":"NA","target":"breast neoplasms","id":"19078"},{"source":"NA","target":"metastatic","id":"19079"},{"source":"NA","target":"carcinoma","id":"19080"},{"source":"NA","target":"melanoma","id":"19081"},{"source":"NA","target":"breast neoplasms","id":"19082"},{"source":"NA","target":"neoplasm metastasis","id":"19083"},{"source":"NA","target":"bleeding","id":"19084"},{"source":"NA","target":"hemorrhage","id":"19085"},{"source":"NA","target":"tnbc","id":"19086"},{"source":"NA","target":"liver neoplasms","id":"19087"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"19088"},{"source":"Oncology: Breast","target":"Macrophage stimulant","id":"19089"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"19090"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"19091"},{"source":"Oncology: Breast","target":"Immunostimulant","id":"19092"},{"source":"Oncology: Breast","target":"NA","id":"19093"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"19094"},{"source":"Oncology: Melanoma","target":"Macrophage stimulant","id":"19095"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"19096"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"19097"},{"source":"Oncology: Melanoma","target":"Immunostimulant","id":"19098"},{"source":"Oncology: Melanoma","target":"NA","id":"19099"},{"source":"pembrolizumab","target":"EORTC Melanoma Group","id":"19100"},{"source":"pembrolizumab","target":"Merck & Co.","id":"19101"},{"source":"UNK : Drug","target":"EORTC Melanoma Group","id":"19102"},{"source":"UNK : Drug","target":"Merck & Co.","id":"19103"},{"source":"UNK : Indication","target":"pembrolizumab","id":"19104"},{"source":"UNK : Indication","target":"UNK : Drug","id":"19105"},{"source":"carcinoma","target":"pembrolizumab","id":"19106"},{"source":"carcinoma","target":"UNK : Drug","id":"19107"},{"source":"typhoid fever","target":"pembrolizumab","id":"19108"},{"source":"typhoid fever","target":"UNK : Drug","id":"19109"},{"source":"brain metastases","target":"pembrolizumab","id":"19110"},{"source":"brain metastases","target":"UNK : Drug","id":"19111"},{"source":"human immunodeficiency virus","target":"pembrolizumab","id":"19112"},{"source":"human immunodeficiency virus","target":"UNK : Drug","id":"19113"},{"source":"liver metastases","target":"pembrolizumab","id":"19114"},{"source":"liver metastases","target":"UNK : Drug","id":"19115"},{"source":"immunologic deficiency syndromes","target":"pembrolizumab","id":"19116"},{"source":"immunologic deficiency syndromes","target":"UNK : Drug","id":"19117"},{"source":"pituitary insufficiency","target":"pembrolizumab","id":"19118"},{"source":"pituitary insufficiency","target":"UNK : Drug","id":"19119"},{"source":"hypothyroidism","target":"pembrolizumab","id":"19120"},{"source":"hypothyroidism","target":"UNK : Drug","id":"19121"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"19122"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"19123"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"19124"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"19125"},{"source":"thyroid diseases","target":"pembrolizumab","id":"19126"},{"source":"thyroid diseases","target":"UNK : Drug","id":"19127"},{"source":"hiv infections","target":"pembrolizumab","id":"19128"},{"source":"hiv infections","target":"UNK : Drug","id":"19129"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"19130"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"19131"},{"source":"yellow fever","target":"pembrolizumab","id":"19132"},{"source":"yellow fever","target":"UNK : Drug","id":"19133"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"19134"},{"source":"uterine cervical neoplasms","target":"UNK : Drug","id":"19135"},{"source":"melanoma","target":"pembrolizumab","id":"19136"},{"source":"melanoma","target":"UNK : Drug","id":"19137"},{"source":"parotitis","target":"pembrolizumab","id":"19138"},{"source":"parotitis","target":"UNK : Drug","id":"19139"},{"source":"influenza a (h1n1)","target":"pembrolizumab","id":"19140"},{"source":"influenza a (h1n1)","target":"UNK : Drug","id":"19141"},{"source":"interstitial lung diseases","target":"pembrolizumab","id":"19142"},{"source":"interstitial lung diseases","target":"UNK : Drug","id":"19143"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"19144"},{"source":"autoimmune diseases","target":"UNK : Drug","id":"19145"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"19146"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"19147"},{"source":"shingles","target":"pembrolizumab","id":"19148"},{"source":"shingles","target":"UNK : Drug","id":"19149"},{"source":"pneumonitis","target":"pembrolizumab","id":"19150"},{"source":"pneumonitis","target":"UNK : Drug","id":"19151"},{"source":"mumps","target":"pembrolizumab","id":"19152"},{"source":"mumps","target":"UNK : Drug","id":"19153"},{"source":"chickenpox","target":"pembrolizumab","id":"19154"},{"source":"chickenpox","target":"UNK : Drug","id":"19155"},{"source":"cervical cancer","target":"pembrolizumab","id":"19156"},{"source":"cervical cancer","target":"UNK : Drug","id":"19157"},{"source":"rubella","target":"pembrolizumab","id":"19158"},{"source":"rubella","target":"UNK : Drug","id":"19159"},{"source":"chickenpox","target":"pembrolizumab","id":"19160"},{"source":"chickenpox","target":"UNK : Drug","id":"19161"},{"source":"rabies","target":"pembrolizumab","id":"19162"},{"source":"rabies","target":"UNK : Drug","id":"19163"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"19164"},{"source":"autoimmune diseases","target":"UNK : Drug","id":"19165"},{"source":"measles","target":"pembrolizumab","id":"19166"},{"source":"measles","target":"UNK : Drug","id":"19167"},{"source":"influenza a (h1n1)","target":"pembrolizumab","id":"19168"},{"source":"influenza a (h1n1)","target":"UNK : Drug","id":"19169"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"19170"},{"source":"cerebellar neoplasms","target":"UNK : Drug","id":"19171"},{"source":"carcinoma","target":"pembrolizumab","id":"19172"},{"source":"carcinoma","target":"UNK : Drug","id":"19173"},{"source":"typhoid fever","target":"pembrolizumab","id":"19174"},{"source":"typhoid fever","target":"UNK : Drug","id":"19175"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"19176"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"19177"},{"source":"interstitial lung diseases","target":"pembrolizumab","id":"19178"},{"source":"interstitial lung diseases","target":"UNK : Drug","id":"19179"},{"source":"anti-hiv","target":"pembrolizumab","id":"19180"},{"source":"anti-hiv","target":"UNK : Drug","id":"19181"},{"source":"skin cancer","target":"pembrolizumab","id":"19182"},{"source":"skin cancer","target":"UNK : Drug","id":"19183"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"19184"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"19185"},{"source":"hypothyroidism","target":"pembrolizumab","id":"19186"},{"source":"hypothyroidism","target":"UNK : Drug","id":"19187"},{"source":"cancer in situ","target":"pembrolizumab","id":"19188"},{"source":"cancer in situ","target":"UNK : Drug","id":"19189"},{"source":"edema","target":"pembrolizumab","id":"19190"},{"source":"edema","target":"UNK : Drug","id":"19191"},{"source":"hypopituitarism","target":"pembrolizumab","id":"19192"},{"source":"hypopituitarism","target":"UNK : Drug","id":"19193"},{"source":"solid malignancy","target":"pembrolizumab","id":"19194"},{"source":"solid malignancy","target":"UNK : Drug","id":"19195"},{"source":"influenza a (h1n1)","target":"pembrolizumab","id":"19196"},{"source":"influenza a (h1n1)","target":"UNK : Drug","id":"19197"},{"source":"skin neoplasms","target":"pembrolizumab","id":"19198"},{"source":"skin neoplasms","target":"UNK : Drug","id":"19199"},{"source":"residual tumor","target":"pembrolizumab","id":"19200"},{"source":"residual tumor","target":"UNK : Drug","id":"19201"},{"source":"pneumonia","target":"pembrolizumab","id":"19202"},{"source":"pneumonia","target":"UNK : Drug","id":"19203"},{"source":"metastatic","target":"pembrolizumab","id":"19204"},{"source":"metastatic","target":"UNK : Drug","id":"19205"},{"source":"herpes zoster","target":"pembrolizumab","id":"19206"},{"source":"herpes zoster","target":"UNK : Drug","id":"19207"},{"source":"liver metastases","target":"pembrolizumab","id":"19208"},{"source":"liver metastases","target":"UNK : Drug","id":"19209"},{"source":"anticancer","target":"pembrolizumab","id":"19210"},{"source":"anticancer","target":"UNK : Drug","id":"19211"},{"source":"influenza a (h1n1)","target":"pembrolizumab","id":"19212"},{"source":"influenza a (h1n1)","target":"UNK : Drug","id":"19213"},{"source":"melanoma","target":"pembrolizumab","id":"19214"},{"source":"melanoma","target":"UNK : Drug","id":"19215"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"19216"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"19217"},{"source":"Anticancer immunotherapy","target":"typhoid fever","id":"19218"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"19219"},{"source":"Anticancer immunotherapy","target":"human immunodeficiency virus","id":"19220"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"19221"},{"source":"Anticancer immunotherapy","target":"immunologic deficiency syndromes","id":"19222"},{"source":"Anticancer immunotherapy","target":"pituitary insufficiency","id":"19223"},{"source":"Anticancer immunotherapy","target":"hypothyroidism","id":"19224"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"19225"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"19226"},{"source":"Anticancer immunotherapy","target":"thyroid diseases","id":"19227"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"19228"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"19229"},{"source":"Anticancer immunotherapy","target":"yellow fever","id":"19230"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"19231"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"19232"},{"source":"Anticancer immunotherapy","target":"parotitis","id":"19233"},{"source":"Anticancer immunotherapy","target":"influenza a (h1n1)","id":"19234"},{"source":"Anticancer immunotherapy","target":"interstitial lung diseases","id":"19235"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"19236"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"19237"},{"source":"Anticancer immunotherapy","target":"shingles","id":"19238"},{"source":"Anticancer immunotherapy","target":"pneumonitis","id":"19239"},{"source":"Anticancer immunotherapy","target":"mumps","id":"19240"},{"source":"Anticancer immunotherapy","target":"chickenpox","id":"19241"},{"source":"Anticancer immunotherapy","target":"cervical cancer","id":"19242"},{"source":"Anticancer immunotherapy","target":"rubella","id":"19243"},{"source":"Anticancer immunotherapy","target":"chickenpox","id":"19244"},{"source":"Anticancer immunotherapy","target":"rabies","id":"19245"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"19246"},{"source":"Anticancer immunotherapy","target":"measles","id":"19247"},{"source":"Anticancer immunotherapy","target":"influenza a (h1n1)","id":"19248"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"19249"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"19250"},{"source":"Anticancer immunotherapy","target":"typhoid fever","id":"19251"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"19252"},{"source":"Anticancer immunotherapy","target":"interstitial lung diseases","id":"19253"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"19254"},{"source":"Anticancer immunotherapy","target":"skin cancer","id":"19255"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"19256"},{"source":"Anticancer immunotherapy","target":"hypothyroidism","id":"19257"},{"source":"Anticancer immunotherapy","target":"cancer in situ","id":"19258"},{"source":"Anticancer immunotherapy","target":"edema","id":"19259"},{"source":"Anticancer immunotherapy","target":"hypopituitarism","id":"19260"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"19261"},{"source":"Anticancer immunotherapy","target":"influenza a (h1n1)","id":"19262"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"19263"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"19264"},{"source":"Anticancer immunotherapy","target":"pneumonia","id":"19265"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"19266"},{"source":"Anticancer immunotherapy","target":"herpes zoster","id":"19267"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"19268"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"19269"},{"source":"Anticancer immunotherapy","target":"influenza a (h1n1)","id":"19270"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"19271"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"19272"},{"source":"CD19 antagonist","target":"carcinoma","id":"19273"},{"source":"CD19 antagonist","target":"typhoid fever","id":"19274"},{"source":"CD19 antagonist","target":"brain metastases","id":"19275"},{"source":"CD19 antagonist","target":"human immunodeficiency virus","id":"19276"},{"source":"CD19 antagonist","target":"liver metastases","id":"19277"},{"source":"CD19 antagonist","target":"immunologic deficiency syndromes","id":"19278"},{"source":"CD19 antagonist","target":"pituitary insufficiency","id":"19279"},{"source":"CD19 antagonist","target":"hypothyroidism","id":"19280"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"19281"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"19282"},{"source":"CD19 antagonist","target":"thyroid diseases","id":"19283"},{"source":"CD19 antagonist","target":"hiv infections","id":"19284"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"19285"},{"source":"CD19 antagonist","target":"yellow fever","id":"19286"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"19287"},{"source":"CD19 antagonist","target":"melanoma","id":"19288"},{"source":"CD19 antagonist","target":"parotitis","id":"19289"},{"source":"CD19 antagonist","target":"influenza a (h1n1)","id":"19290"},{"source":"CD19 antagonist","target":"interstitial lung diseases","id":"19291"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"19292"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"19293"},{"source":"CD19 antagonist","target":"shingles","id":"19294"},{"source":"CD19 antagonist","target":"pneumonitis","id":"19295"},{"source":"CD19 antagonist","target":"mumps","id":"19296"},{"source":"CD19 antagonist","target":"chickenpox","id":"19297"},{"source":"CD19 antagonist","target":"cervical cancer","id":"19298"},{"source":"CD19 antagonist","target":"rubella","id":"19299"},{"source":"CD19 antagonist","target":"chickenpox","id":"19300"},{"source":"CD19 antagonist","target":"rabies","id":"19301"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"19302"},{"source":"CD19 antagonist","target":"measles","id":"19303"},{"source":"CD19 antagonist","target":"influenza a (h1n1)","id":"19304"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"19305"},{"source":"CD19 antagonist","target":"carcinoma","id":"19306"},{"source":"CD19 antagonist","target":"typhoid fever","id":"19307"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"19308"},{"source":"CD19 antagonist","target":"interstitial lung diseases","id":"19309"},{"source":"CD19 antagonist","target":"anti-hiv","id":"19310"},{"source":"CD19 antagonist","target":"skin cancer","id":"19311"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"19312"},{"source":"CD19 antagonist","target":"hypothyroidism","id":"19313"},{"source":"CD19 antagonist","target":"cancer in situ","id":"19314"},{"source":"CD19 antagonist","target":"edema","id":"19315"},{"source":"CD19 antagonist","target":"hypopituitarism","id":"19316"},{"source":"CD19 antagonist","target":"solid malignancy","id":"19317"},{"source":"CD19 antagonist","target":"influenza a (h1n1)","id":"19318"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"19319"},{"source":"CD19 antagonist","target":"residual tumor","id":"19320"},{"source":"CD19 antagonist","target":"pneumonia","id":"19321"},{"source":"CD19 antagonist","target":"metastatic","id":"19322"},{"source":"CD19 antagonist","target":"herpes zoster","id":"19323"},{"source":"CD19 antagonist","target":"liver metastases","id":"19324"},{"source":"CD19 antagonist","target":"anticancer","id":"19325"},{"source":"CD19 antagonist","target":"influenza a (h1n1)","id":"19326"},{"source":"CD19 antagonist","target":"melanoma","id":"19327"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"19328"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"19329"},{"source":"Immune checkpoint inhibitor","target":"typhoid fever","id":"19330"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"19331"},{"source":"Immune checkpoint inhibitor","target":"human immunodeficiency virus","id":"19332"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"19333"},{"source":"Immune checkpoint inhibitor","target":"immunologic deficiency syndromes","id":"19334"},{"source":"Immune checkpoint inhibitor","target":"pituitary insufficiency","id":"19335"},{"source":"Immune checkpoint inhibitor","target":"hypothyroidism","id":"19336"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"19337"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"19338"},{"source":"Immune checkpoint inhibitor","target":"thyroid diseases","id":"19339"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"19340"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"19341"},{"source":"Immune checkpoint inhibitor","target":"yellow fever","id":"19342"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"19343"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"19344"},{"source":"Immune checkpoint inhibitor","target":"parotitis","id":"19345"},{"source":"Immune checkpoint inhibitor","target":"influenza a (h1n1)","id":"19346"},{"source":"Immune checkpoint inhibitor","target":"interstitial lung diseases","id":"19347"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"19348"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"19349"},{"source":"Immune checkpoint inhibitor","target":"shingles","id":"19350"},{"source":"Immune checkpoint inhibitor","target":"pneumonitis","id":"19351"},{"source":"Immune checkpoint inhibitor","target":"mumps","id":"19352"},{"source":"Immune checkpoint inhibitor","target":"chickenpox","id":"19353"},{"source":"Immune checkpoint inhibitor","target":"cervical cancer","id":"19354"},{"source":"Immune checkpoint inhibitor","target":"rubella","id":"19355"},{"source":"Immune checkpoint inhibitor","target":"chickenpox","id":"19356"},{"source":"Immune checkpoint inhibitor","target":"rabies","id":"19357"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"19358"},{"source":"Immune checkpoint inhibitor","target":"measles","id":"19359"},{"source":"Immune checkpoint inhibitor","target":"influenza a (h1n1)","id":"19360"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"19361"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"19362"},{"source":"Immune checkpoint inhibitor","target":"typhoid fever","id":"19363"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"19364"},{"source":"Immune checkpoint inhibitor","target":"interstitial lung diseases","id":"19365"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"19366"},{"source":"Immune checkpoint inhibitor","target":"skin cancer","id":"19367"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"19368"},{"source":"Immune checkpoint inhibitor","target":"hypothyroidism","id":"19369"},{"source":"Immune checkpoint inhibitor","target":"cancer in situ","id":"19370"},{"source":"Immune checkpoint inhibitor","target":"edema","id":"19371"},{"source":"Immune checkpoint inhibitor","target":"hypopituitarism","id":"19372"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"19373"},{"source":"Immune checkpoint inhibitor","target":"influenza a (h1n1)","id":"19374"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"19375"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"19376"},{"source":"Immune checkpoint inhibitor","target":"pneumonia","id":"19377"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"19378"},{"source":"Immune checkpoint inhibitor","target":"herpes zoster","id":"19379"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"19380"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"19381"},{"source":"Immune checkpoint inhibitor","target":"influenza a (h1n1)","id":"19382"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"19383"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"19384"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"19385"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"19386"},{"source":"epacadostat (u)","target":"Incyte Corporation","id":"19387"},{"source":"epacadostat (u)","target":"Merck & Co.","id":"19388"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"19389"},{"source":"pembrolizumab","target":"Merck & Co.","id":"19390"},{"source":"pazopanib (tablet)","target":"Incyte Corporation","id":"19391"},{"source":"pazopanib (tablet)","target":"Merck & Co.","id":"19392"},{"source":"sunitinib malate","target":"Incyte Corporation","id":"19393"},{"source":"sunitinib malate","target":"Merck & Co.","id":"19394"},{"source":"UNK : Indication","target":"epacadostat (u)","id":"19395"},{"source":"UNK : Indication","target":"pembrolizumab","id":"19396"},{"source":"UNK : Indication","target":"pazopanib (tablet)","id":"19397"},{"source":"UNK : Indication","target":"sunitinib malate","id":"19398"},{"source":"psoriasis","target":"epacadostat (u)","id":"19399"},{"source":"psoriasis","target":"pembrolizumab","id":"19400"},{"source":"psoriasis","target":"pazopanib (tablet)","id":"19401"},{"source":"psoriasis","target":"sunitinib malate","id":"19402"},{"source":"anticancer","target":"epacadostat (u)","id":"19403"},{"source":"anticancer","target":"pembrolizumab","id":"19404"},{"source":"anticancer","target":"pazopanib (tablet)","id":"19405"},{"source":"anticancer","target":"sunitinib malate","id":"19406"},{"source":"psoriasis","target":"epacadostat (u)","id":"19407"},{"source":"psoriasis","target":"pembrolizumab","id":"19408"},{"source":"psoriasis","target":"pazopanib (tablet)","id":"19409"},{"source":"psoriasis","target":"sunitinib malate","id":"19410"},{"source":"kidney neoplasms","target":"epacadostat (u)","id":"19411"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"19412"},{"source":"kidney neoplasms","target":"pazopanib (tablet)","id":"19413"},{"source":"kidney neoplasms","target":"sunitinib malate","id":"19414"},{"source":"antianaemic","target":"epacadostat (u)","id":"19415"},{"source":"antianaemic","target":"pembrolizumab","id":"19416"},{"source":"antianaemic","target":"pazopanib (tablet)","id":"19417"},{"source":"antianaemic","target":"sunitinib malate","id":"19418"},{"source":"renal cancer","target":"epacadostat (u)","id":"19419"},{"source":"renal cancer","target":"pembrolizumab","id":"19420"},{"source":"renal cancer","target":"pazopanib (tablet)","id":"19421"},{"source":"renal cancer","target":"sunitinib malate","id":"19422"},{"source":"carcinoma","target":"epacadostat (u)","id":"19423"},{"source":"carcinoma","target":"pembrolizumab","id":"19424"},{"source":"carcinoma","target":"pazopanib (tablet)","id":"19425"},{"source":"carcinoma","target":"sunitinib malate","id":"19426"},{"source":"residual tumor","target":"epacadostat (u)","id":"19427"},{"source":"residual tumor","target":"pembrolizumab","id":"19428"},{"source":"residual tumor","target":"pazopanib (tablet)","id":"19429"},{"source":"residual tumor","target":"sunitinib malate","id":"19430"},{"source":"metastatic","target":"epacadostat (u)","id":"19431"},{"source":"metastatic","target":"pembrolizumab","id":"19432"},{"source":"metastatic","target":"pazopanib (tablet)","id":"19433"},{"source":"metastatic","target":"sunitinib malate","id":"19434"},{"source":"carcinoma","target":"epacadostat (u)","id":"19435"},{"source":"carcinoma","target":"pembrolizumab","id":"19436"},{"source":"carcinoma","target":"pazopanib (tablet)","id":"19437"},{"source":"carcinoma","target":"sunitinib malate","id":"19438"},{"source":"neoplasm metastasis","target":"epacadostat (u)","id":"19439"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"19440"},{"source":"neoplasm metastasis","target":"pazopanib (tablet)","id":"19441"},{"source":"neoplasm metastasis","target":"sunitinib malate","id":"19442"},{"source":"sarcoma","target":"epacadostat (u)","id":"19443"},{"source":"sarcoma","target":"pembrolizumab","id":"19444"},{"source":"sarcoma","target":"pazopanib (tablet)","id":"19445"},{"source":"sarcoma","target":"sunitinib malate","id":"19446"},{"source":"anticancer","target":"epacadostat (u)","id":"19447"},{"source":"anticancer","target":"pembrolizumab","id":"19448"},{"source":"anticancer","target":"pazopanib (tablet)","id":"19449"},{"source":"anticancer","target":"sunitinib malate","id":"19450"},{"source":"rcc","target":"epacadostat (u)","id":"19451"},{"source":"rcc","target":"pembrolizumab","id":"19452"},{"source":"rcc","target":"pazopanib (tablet)","id":"19453"},{"source":"rcc","target":"sunitinib malate","id":"19454"},{"source":"sarcoma","target":"epacadostat (u)","id":"19455"},{"source":"sarcoma","target":"pembrolizumab","id":"19456"},{"source":"sarcoma","target":"pazopanib (tablet)","id":"19457"},{"source":"sarcoma","target":"sunitinib malate","id":"19458"},{"source":"renal cell","target":"epacadostat (u)","id":"19459"},{"source":"renal cell","target":"pembrolizumab","id":"19460"},{"source":"renal cell","target":"pazopanib (tablet)","id":"19461"},{"source":"renal cell","target":"sunitinib malate","id":"19462"},{"source":"anemia","target":"epacadostat (u)","id":"19463"},{"source":"anemia","target":"pembrolizumab","id":"19464"},{"source":"anemia","target":"pazopanib (tablet)","id":"19465"},{"source":"anemia","target":"sunitinib malate","id":"19466"},{"source":"NA","target":"UNK : Indication","id":"19467"},{"source":"NA","target":"psoriasis","id":"19468"},{"source":"NA","target":"anticancer","id":"19469"},{"source":"NA","target":"psoriasis","id":"19470"},{"source":"NA","target":"kidney neoplasms","id":"19471"},{"source":"NA","target":"antianaemic","id":"19472"},{"source":"NA","target":"renal cancer","id":"19473"},{"source":"NA","target":"carcinoma","id":"19474"},{"source":"NA","target":"residual tumor","id":"19475"},{"source":"NA","target":"metastatic","id":"19476"},{"source":"NA","target":"carcinoma","id":"19477"},{"source":"NA","target":"neoplasm metastasis","id":"19478"},{"source":"NA","target":"sarcoma","id":"19479"},{"source":"NA","target":"anticancer","id":"19480"},{"source":"NA","target":"rcc","id":"19481"},{"source":"NA","target":"sarcoma","id":"19482"},{"source":"NA","target":"renal cell","id":"19483"},{"source":"NA","target":"anemia","id":"19484"},{"source":"NA","target":"UNK : Indication","id":"19485"},{"source":"NA","target":"psoriasis","id":"19486"},{"source":"NA","target":"anticancer","id":"19487"},{"source":"NA","target":"psoriasis","id":"19488"},{"source":"NA","target":"kidney neoplasms","id":"19489"},{"source":"NA","target":"antianaemic","id":"19490"},{"source":"NA","target":"renal cancer","id":"19491"},{"source":"NA","target":"carcinoma","id":"19492"},{"source":"NA","target":"residual tumor","id":"19493"},{"source":"NA","target":"metastatic","id":"19494"},{"source":"NA","target":"carcinoma","id":"19495"},{"source":"NA","target":"neoplasm metastasis","id":"19496"},{"source":"NA","target":"sarcoma","id":"19497"},{"source":"NA","target":"anticancer","id":"19498"},{"source":"NA","target":"rcc","id":"19499"},{"source":"NA","target":"sarcoma","id":"19500"},{"source":"NA","target":"renal cell","id":"19501"},{"source":"NA","target":"anemia","id":"19502"},{"source":"NA","target":"UNK : Indication","id":"19503"},{"source":"NA","target":"psoriasis","id":"19504"},{"source":"NA","target":"anticancer","id":"19505"},{"source":"NA","target":"psoriasis","id":"19506"},{"source":"NA","target":"kidney neoplasms","id":"19507"},{"source":"NA","target":"antianaemic","id":"19508"},{"source":"NA","target":"renal cancer","id":"19509"},{"source":"NA","target":"carcinoma","id":"19510"},{"source":"NA","target":"residual tumor","id":"19511"},{"source":"NA","target":"metastatic","id":"19512"},{"source":"NA","target":"carcinoma","id":"19513"},{"source":"NA","target":"neoplasm metastasis","id":"19514"},{"source":"NA","target":"sarcoma","id":"19515"},{"source":"NA","target":"anticancer","id":"19516"},{"source":"NA","target":"rcc","id":"19517"},{"source":"NA","target":"sarcoma","id":"19518"},{"source":"NA","target":"renal cell","id":"19519"},{"source":"NA","target":"anemia","id":"19520"},{"source":"NA","target":"UNK : Indication","id":"19521"},{"source":"NA","target":"psoriasis","id":"19522"},{"source":"NA","target":"anticancer","id":"19523"},{"source":"NA","target":"psoriasis","id":"19524"},{"source":"NA","target":"kidney neoplasms","id":"19525"},{"source":"NA","target":"antianaemic","id":"19526"},{"source":"NA","target":"renal cancer","id":"19527"},{"source":"NA","target":"carcinoma","id":"19528"},{"source":"NA","target":"residual tumor","id":"19529"},{"source":"NA","target":"metastatic","id":"19530"},{"source":"NA","target":"carcinoma","id":"19531"},{"source":"NA","target":"neoplasm metastasis","id":"19532"},{"source":"NA","target":"sarcoma","id":"19533"},{"source":"NA","target":"anticancer","id":"19534"},{"source":"NA","target":"rcc","id":"19535"},{"source":"NA","target":"sarcoma","id":"19536"},{"source":"NA","target":"renal cell","id":"19537"},{"source":"NA","target":"anemia","id":"19538"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"19539"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"19540"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"19541"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"19542"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"19543"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"19544"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"19545"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"19546"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"19547"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"19548"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"19549"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"19550"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"19551"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"19552"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"19553"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"19554"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"19555"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"19556"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"19557"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"19558"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"19559"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"19560"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"19561"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"19562"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"19563"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"19564"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"19565"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"19566"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"19567"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"19568"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"19569"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"19570"},{"source":"Anticancer immunotherapy","target":"rcc","id":"19571"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"19572"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"19573"},{"source":"Anticancer immunotherapy","target":"anemia","id":"19574"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"19575"},{"source":"CD19 antagonist","target":"psoriasis","id":"19576"},{"source":"CD19 antagonist","target":"anticancer","id":"19577"},{"source":"CD19 antagonist","target":"psoriasis","id":"19578"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"19579"},{"source":"CD19 antagonist","target":"antianaemic","id":"19580"},{"source":"CD19 antagonist","target":"renal cancer","id":"19581"},{"source":"CD19 antagonist","target":"carcinoma","id":"19582"},{"source":"CD19 antagonist","target":"residual tumor","id":"19583"},{"source":"CD19 antagonist","target":"metastatic","id":"19584"},{"source":"CD19 antagonist","target":"carcinoma","id":"19585"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"19586"},{"source":"CD19 antagonist","target":"sarcoma","id":"19587"},{"source":"CD19 antagonist","target":"anticancer","id":"19588"},{"source":"CD19 antagonist","target":"rcc","id":"19589"},{"source":"CD19 antagonist","target":"sarcoma","id":"19590"},{"source":"CD19 antagonist","target":"renal cell","id":"19591"},{"source":"CD19 antagonist","target":"anemia","id":"19592"},{"source":"NA","target":"UNK : Indication","id":"19593"},{"source":"NA","target":"psoriasis","id":"19594"},{"source":"NA","target":"anticancer","id":"19595"},{"source":"NA","target":"psoriasis","id":"19596"},{"source":"NA","target":"kidney neoplasms","id":"19597"},{"source":"NA","target":"antianaemic","id":"19598"},{"source":"NA","target":"renal cancer","id":"19599"},{"source":"NA","target":"carcinoma","id":"19600"},{"source":"NA","target":"residual tumor","id":"19601"},{"source":"NA","target":"metastatic","id":"19602"},{"source":"NA","target":"carcinoma","id":"19603"},{"source":"NA","target":"neoplasm metastasis","id":"19604"},{"source":"NA","target":"sarcoma","id":"19605"},{"source":"NA","target":"anticancer","id":"19606"},{"source":"NA","target":"rcc","id":"19607"},{"source":"NA","target":"sarcoma","id":"19608"},{"source":"NA","target":"renal cell","id":"19609"},{"source":"NA","target":"anemia","id":"19610"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"UNK : Indication","id":"19611"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"psoriasis","id":"19612"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"19613"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"psoriasis","id":"19614"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"kidney neoplasms","id":"19615"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antianaemic","id":"19616"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"renal cancer","id":"19617"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"19618"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"19619"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"metastatic","id":"19620"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"19621"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"neoplasm metastasis","id":"19622"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"sarcoma","id":"19623"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"19624"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"rcc","id":"19625"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"sarcoma","id":"19626"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"renal cell","id":"19627"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anemia","id":"19628"},{"source":"NA","target":"UNK : Indication","id":"19629"},{"source":"NA","target":"psoriasis","id":"19630"},{"source":"NA","target":"anticancer","id":"19631"},{"source":"NA","target":"psoriasis","id":"19632"},{"source":"NA","target":"kidney neoplasms","id":"19633"},{"source":"NA","target":"antianaemic","id":"19634"},{"source":"NA","target":"renal cancer","id":"19635"},{"source":"NA","target":"carcinoma","id":"19636"},{"source":"NA","target":"residual tumor","id":"19637"},{"source":"NA","target":"metastatic","id":"19638"},{"source":"NA","target":"carcinoma","id":"19639"},{"source":"NA","target":"neoplasm metastasis","id":"19640"},{"source":"NA","target":"sarcoma","id":"19641"},{"source":"NA","target":"anticancer","id":"19642"},{"source":"NA","target":"rcc","id":"19643"},{"source":"NA","target":"sarcoma","id":"19644"},{"source":"NA","target":"renal cell","id":"19645"},{"source":"NA","target":"anemia","id":"19646"},{"source":"NA","target":"UNK : Indication","id":"19647"},{"source":"NA","target":"psoriasis","id":"19648"},{"source":"NA","target":"anticancer","id":"19649"},{"source":"NA","target":"psoriasis","id":"19650"},{"source":"NA","target":"kidney neoplasms","id":"19651"},{"source":"NA","target":"antianaemic","id":"19652"},{"source":"NA","target":"renal cancer","id":"19653"},{"source":"NA","target":"carcinoma","id":"19654"},{"source":"NA","target":"residual tumor","id":"19655"},{"source":"NA","target":"metastatic","id":"19656"},{"source":"NA","target":"carcinoma","id":"19657"},{"source":"NA","target":"neoplasm metastasis","id":"19658"},{"source":"NA","target":"sarcoma","id":"19659"},{"source":"NA","target":"anticancer","id":"19660"},{"source":"NA","target":"rcc","id":"19661"},{"source":"NA","target":"sarcoma","id":"19662"},{"source":"NA","target":"renal cell","id":"19663"},{"source":"NA","target":"anemia","id":"19664"},{"source":"NA","target":"UNK : Indication","id":"19665"},{"source":"NA","target":"psoriasis","id":"19666"},{"source":"NA","target":"anticancer","id":"19667"},{"source":"NA","target":"psoriasis","id":"19668"},{"source":"NA","target":"kidney neoplasms","id":"19669"},{"source":"NA","target":"antianaemic","id":"19670"},{"source":"NA","target":"renal cancer","id":"19671"},{"source":"NA","target":"carcinoma","id":"19672"},{"source":"NA","target":"residual tumor","id":"19673"},{"source":"NA","target":"metastatic","id":"19674"},{"source":"NA","target":"carcinoma","id":"19675"},{"source":"NA","target":"neoplasm metastasis","id":"19676"},{"source":"NA","target":"sarcoma","id":"19677"},{"source":"NA","target":"anticancer","id":"19678"},{"source":"NA","target":"rcc","id":"19679"},{"source":"NA","target":"sarcoma","id":"19680"},{"source":"NA","target":"renal cell","id":"19681"},{"source":"NA","target":"anemia","id":"19682"},{"source":"NA","target":"UNK : Indication","id":"19683"},{"source":"NA","target":"psoriasis","id":"19684"},{"source":"NA","target":"anticancer","id":"19685"},{"source":"NA","target":"psoriasis","id":"19686"},{"source":"NA","target":"kidney neoplasms","id":"19687"},{"source":"NA","target":"antianaemic","id":"19688"},{"source":"NA","target":"renal cancer","id":"19689"},{"source":"NA","target":"carcinoma","id":"19690"},{"source":"NA","target":"residual tumor","id":"19691"},{"source":"NA","target":"metastatic","id":"19692"},{"source":"NA","target":"carcinoma","id":"19693"},{"source":"NA","target":"neoplasm metastasis","id":"19694"},{"source":"NA","target":"sarcoma","id":"19695"},{"source":"NA","target":"anticancer","id":"19696"},{"source":"NA","target":"rcc","id":"19697"},{"source":"NA","target":"sarcoma","id":"19698"},{"source":"NA","target":"renal cell","id":"19699"},{"source":"NA","target":"anemia","id":"19700"},{"source":"NA","target":"UNK : Indication","id":"19701"},{"source":"NA","target":"psoriasis","id":"19702"},{"source":"NA","target":"anticancer","id":"19703"},{"source":"NA","target":"psoriasis","id":"19704"},{"source":"NA","target":"kidney neoplasms","id":"19705"},{"source":"NA","target":"antianaemic","id":"19706"},{"source":"NA","target":"renal cancer","id":"19707"},{"source":"NA","target":"carcinoma","id":"19708"},{"source":"NA","target":"residual tumor","id":"19709"},{"source":"NA","target":"metastatic","id":"19710"},{"source":"NA","target":"carcinoma","id":"19711"},{"source":"NA","target":"neoplasm metastasis","id":"19712"},{"source":"NA","target":"sarcoma","id":"19713"},{"source":"NA","target":"anticancer","id":"19714"},{"source":"NA","target":"rcc","id":"19715"},{"source":"NA","target":"sarcoma","id":"19716"},{"source":"NA","target":"renal cell","id":"19717"},{"source":"NA","target":"anemia","id":"19718"},{"source":"NA","target":"UNK : Indication","id":"19719"},{"source":"NA","target":"psoriasis","id":"19720"},{"source":"NA","target":"anticancer","id":"19721"},{"source":"NA","target":"psoriasis","id":"19722"},{"source":"NA","target":"kidney neoplasms","id":"19723"},{"source":"NA","target":"antianaemic","id":"19724"},{"source":"NA","target":"renal cancer","id":"19725"},{"source":"NA","target":"carcinoma","id":"19726"},{"source":"NA","target":"residual tumor","id":"19727"},{"source":"NA","target":"metastatic","id":"19728"},{"source":"NA","target":"carcinoma","id":"19729"},{"source":"NA","target":"neoplasm metastasis","id":"19730"},{"source":"NA","target":"sarcoma","id":"19731"},{"source":"NA","target":"anticancer","id":"19732"},{"source":"NA","target":"rcc","id":"19733"},{"source":"NA","target":"sarcoma","id":"19734"},{"source":"NA","target":"renal cell","id":"19735"},{"source":"NA","target":"anemia","id":"19736"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"19737"},{"source":"Angiogenesis inhibitor","target":"psoriasis","id":"19738"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"19739"},{"source":"Angiogenesis inhibitor","target":"psoriasis","id":"19740"},{"source":"Angiogenesis inhibitor","target":"kidney neoplasms","id":"19741"},{"source":"Angiogenesis inhibitor","target":"antianaemic","id":"19742"},{"source":"Angiogenesis inhibitor","target":"renal cancer","id":"19743"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"19744"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"19745"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"19746"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"19747"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"19748"},{"source":"Angiogenesis inhibitor","target":"sarcoma","id":"19749"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"19750"},{"source":"Angiogenesis inhibitor","target":"rcc","id":"19751"},{"source":"Angiogenesis inhibitor","target":"sarcoma","id":"19752"},{"source":"Angiogenesis inhibitor","target":"renal cell","id":"19753"},{"source":"Angiogenesis inhibitor","target":"anemia","id":"19754"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"19755"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"psoriasis","id":"19756"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"19757"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"psoriasis","id":"19758"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"kidney neoplasms","id":"19759"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"antianaemic","id":"19760"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cancer","id":"19761"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"19762"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"19763"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"metastatic","id":"19764"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"19765"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"neoplasm metastasis","id":"19766"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"sarcoma","id":"19767"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"19768"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"rcc","id":"19769"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"sarcoma","id":"19770"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cell","id":"19771"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anemia","id":"19772"},{"source":"Indoleamine-pyrrole 2","target":"UNK : Indication","id":"19773"},{"source":"Indoleamine-pyrrole 2","target":"psoriasis","id":"19774"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"19775"},{"source":"Indoleamine-pyrrole 2","target":"psoriasis","id":"19776"},{"source":"Indoleamine-pyrrole 2","target":"kidney neoplasms","id":"19777"},{"source":"Indoleamine-pyrrole 2","target":"antianaemic","id":"19778"},{"source":"Indoleamine-pyrrole 2","target":"renal cancer","id":"19779"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"19780"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"19781"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"19782"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"19783"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"19784"},{"source":"Indoleamine-pyrrole 2","target":"sarcoma","id":"19785"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"19786"},{"source":"Indoleamine-pyrrole 2","target":"rcc","id":"19787"},{"source":"Indoleamine-pyrrole 2","target":"sarcoma","id":"19788"},{"source":"Indoleamine-pyrrole 2","target":"renal cell","id":"19789"},{"source":"Indoleamine-pyrrole 2","target":"anemia","id":"19790"},{"source":"NA","target":"UNK : Indication","id":"19791"},{"source":"NA","target":"psoriasis","id":"19792"},{"source":"NA","target":"anticancer","id":"19793"},{"source":"NA","target":"psoriasis","id":"19794"},{"source":"NA","target":"kidney neoplasms","id":"19795"},{"source":"NA","target":"antianaemic","id":"19796"},{"source":"NA","target":"renal cancer","id":"19797"},{"source":"NA","target":"carcinoma","id":"19798"},{"source":"NA","target":"residual tumor","id":"19799"},{"source":"NA","target":"metastatic","id":"19800"},{"source":"NA","target":"carcinoma","id":"19801"},{"source":"NA","target":"neoplasm metastasis","id":"19802"},{"source":"NA","target":"sarcoma","id":"19803"},{"source":"NA","target":"anticancer","id":"19804"},{"source":"NA","target":"rcc","id":"19805"},{"source":"NA","target":"sarcoma","id":"19806"},{"source":"NA","target":"renal cell","id":"19807"},{"source":"NA","target":"anemia","id":"19808"},{"source":"C-kit inhibitor","target":"UNK : Indication","id":"19809"},{"source":"C-kit inhibitor","target":"psoriasis","id":"19810"},{"source":"C-kit inhibitor","target":"anticancer","id":"19811"},{"source":"C-kit inhibitor","target":"psoriasis","id":"19812"},{"source":"C-kit inhibitor","target":"kidney neoplasms","id":"19813"},{"source":"C-kit inhibitor","target":"antianaemic","id":"19814"},{"source":"C-kit inhibitor","target":"renal cancer","id":"19815"},{"source":"C-kit inhibitor","target":"carcinoma","id":"19816"},{"source":"C-kit inhibitor","target":"residual tumor","id":"19817"},{"source":"C-kit inhibitor","target":"metastatic","id":"19818"},{"source":"C-kit inhibitor","target":"carcinoma","id":"19819"},{"source":"C-kit inhibitor","target":"neoplasm metastasis","id":"19820"},{"source":"C-kit inhibitor","target":"sarcoma","id":"19821"},{"source":"C-kit inhibitor","target":"anticancer","id":"19822"},{"source":"C-kit inhibitor","target":"rcc","id":"19823"},{"source":"C-kit inhibitor","target":"sarcoma","id":"19824"},{"source":"C-kit inhibitor","target":"renal cell","id":"19825"},{"source":"C-kit inhibitor","target":"anemia","id":"19826"},{"source":"NA","target":"UNK : Indication","id":"19827"},{"source":"NA","target":"psoriasis","id":"19828"},{"source":"NA","target":"anticancer","id":"19829"},{"source":"NA","target":"psoriasis","id":"19830"},{"source":"NA","target":"kidney neoplasms","id":"19831"},{"source":"NA","target":"antianaemic","id":"19832"},{"source":"NA","target":"renal cancer","id":"19833"},{"source":"NA","target":"carcinoma","id":"19834"},{"source":"NA","target":"residual tumor","id":"19835"},{"source":"NA","target":"metastatic","id":"19836"},{"source":"NA","target":"carcinoma","id":"19837"},{"source":"NA","target":"neoplasm metastasis","id":"19838"},{"source":"NA","target":"sarcoma","id":"19839"},{"source":"NA","target":"anticancer","id":"19840"},{"source":"NA","target":"rcc","id":"19841"},{"source":"NA","target":"sarcoma","id":"19842"},{"source":"NA","target":"renal cell","id":"19843"},{"source":"NA","target":"anemia","id":"19844"},{"source":"Oncology: Renal","target":"NA","id":"19845"},{"source":"Oncology: Renal","target":"NA","id":"19846"},{"source":"Oncology: Renal","target":"NA","id":"19847"},{"source":"Oncology: Renal","target":"NA","id":"19848"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"19849"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"19850"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"19851"},{"source":"Oncology: Renal","target":"NA","id":"19852"},{"source":"Oncology: Renal","target":"Colony stimulating factor 1 receptor antagonist","id":"19853"},{"source":"Oncology: Renal","target":"NA","id":"19854"},{"source":"Oncology: Renal","target":"NA","id":"19855"},{"source":"Oncology: Renal","target":"NA","id":"19856"},{"source":"Oncology: Renal","target":"NA","id":"19857"},{"source":"Oncology: Renal","target":"NA","id":"19858"},{"source":"Oncology: Renal","target":"NA","id":"19859"},{"source":"Oncology: Renal","target":"Angiogenesis inhibitor","id":"19860"},{"source":"Oncology: Renal","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"19861"},{"source":"Oncology: Renal","target":"Indoleamine-pyrrole 2","id":"19862"},{"source":"Oncology: Renal","target":"NA","id":"19863"},{"source":"Oncology: Renal","target":"C-kit inhibitor","id":"19864"},{"source":"Oncology: Renal","target":"NA","id":"19865"},{"source":"epacadostat (u)","target":"Incyte Corporation","id":"19866"},{"source":"epacadostat (u)","target":"Merck & Co.","id":"19867"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"19868"},{"source":"pembrolizumab","target":"Merck & Co.","id":"19869"},{"source":"carboplatin","target":"Incyte Corporation","id":"19870"},{"source":"carboplatin","target":"Merck & Co.","id":"19871"},{"source":"cetuximab","target":"Incyte Corporation","id":"19872"},{"source":"cetuximab","target":"Merck & Co.","id":"19873"},{"source":"cisplatin","target":"Incyte Corporation","id":"19874"},{"source":"cisplatin","target":"Merck & Co.","id":"19875"},{"source":"5-fluorouracil","target":"Incyte Corporation","id":"19876"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"19877"},{"source":"UNK : Indication","target":"epacadostat (u)","id":"19878"},{"source":"UNK : Indication","target":"pembrolizumab","id":"19879"},{"source":"UNK : Indication","target":"carboplatin","id":"19880"},{"source":"UNK : Indication","target":"cetuximab","id":"19881"},{"source":"UNK : Indication","target":"cisplatin","id":"19882"},{"source":"UNK : Indication","target":"5-fluorouracil","id":"19883"},{"source":"carcinoma","target":"epacadostat (u)","id":"19884"},{"source":"carcinoma","target":"pembrolizumab","id":"19885"},{"source":"carcinoma","target":"carboplatin","id":"19886"},{"source":"carcinoma","target":"cetuximab","id":"19887"},{"source":"carcinoma","target":"cisplatin","id":"19888"},{"source":"carcinoma","target":"5-fluorouracil","id":"19889"},{"source":"squamous cell neoplasms","target":"epacadostat (u)","id":"19890"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"19891"},{"source":"squamous cell neoplasms","target":"carboplatin","id":"19892"},{"source":"squamous cell neoplasms","target":"cetuximab","id":"19893"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"19894"},{"source":"squamous cell neoplasms","target":"5-fluorouracil","id":"19895"},{"source":"hpv type","target":"epacadostat (u)","id":"19896"},{"source":"hpv type","target":"pembrolizumab","id":"19897"},{"source":"hpv type","target":"carboplatin","id":"19898"},{"source":"hpv type","target":"cetuximab","id":"19899"},{"source":"hpv type","target":"cisplatin","id":"19900"},{"source":"hpv type","target":"5-fluorouracil","id":"19901"},{"source":"bone metastasis","target":"epacadostat (u)","id":"19902"},{"source":"bone metastasis","target":"pembrolizumab","id":"19903"},{"source":"bone metastasis","target":"carboplatin","id":"19904"},{"source":"bone metastasis","target":"cetuximab","id":"19905"},{"source":"bone metastasis","target":"cisplatin","id":"19906"},{"source":"bone metastasis","target":"5-fluorouracil","id":"19907"},{"source":"carcinoma","target":"epacadostat (u)","id":"19908"},{"source":"carcinoma","target":"pembrolizumab","id":"19909"},{"source":"carcinoma","target":"carboplatin","id":"19910"},{"source":"carcinoma","target":"cetuximab","id":"19911"},{"source":"carcinoma","target":"cisplatin","id":"19912"},{"source":"carcinoma","target":"5-fluorouracil","id":"19913"},{"source":"carcinoma","target":"epacadostat (u)","id":"19914"},{"source":"carcinoma","target":"pembrolizumab","id":"19915"},{"source":"carcinoma","target":"carboplatin","id":"19916"},{"source":"carcinoma","target":"cetuximab","id":"19917"},{"source":"carcinoma","target":"cisplatin","id":"19918"},{"source":"carcinoma","target":"5-fluorouracil","id":"19919"},{"source":"squamous cell neoplasms","target":"epacadostat (u)","id":"19920"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"19921"},{"source":"squamous cell neoplasms","target":"carboplatin","id":"19922"},{"source":"squamous cell neoplasms","target":"cetuximab","id":"19923"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"19924"},{"source":"squamous cell neoplasms","target":"5-fluorouracil","id":"19925"},{"source":"residual tumor","target":"epacadostat (u)","id":"19926"},{"source":"residual tumor","target":"pembrolizumab","id":"19927"},{"source":"residual tumor","target":"carboplatin","id":"19928"},{"source":"residual tumor","target":"cetuximab","id":"19929"},{"source":"residual tumor","target":"cisplatin","id":"19930"},{"source":"residual tumor","target":"5-fluorouracil","id":"19931"},{"source":"fallopian tube neoplasms","target":"epacadostat (u)","id":"19932"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"19933"},{"source":"fallopian tube neoplasms","target":"carboplatin","id":"19934"},{"source":"fallopian tube neoplasms","target":"cetuximab","id":"19935"},{"source":"fallopian tube neoplasms","target":"cisplatin","id":"19936"},{"source":"fallopian tube neoplasms","target":"5-fluorouracil","id":"19937"},{"source":"metastatic","target":"epacadostat (u)","id":"19938"},{"source":"metastatic","target":"pembrolizumab","id":"19939"},{"source":"metastatic","target":"carboplatin","id":"19940"},{"source":"metastatic","target":"cetuximab","id":"19941"},{"source":"metastatic","target":"cisplatin","id":"19942"},{"source":"metastatic","target":"5-fluorouracil","id":"19943"},{"source":"carcinoma","target":"epacadostat (u)","id":"19944"},{"source":"carcinoma","target":"pembrolizumab","id":"19945"},{"source":"carcinoma","target":"carboplatin","id":"19946"},{"source":"carcinoma","target":"cetuximab","id":"19947"},{"source":"carcinoma","target":"cisplatin","id":"19948"},{"source":"carcinoma","target":"5-fluorouracil","id":"19949"},{"source":"oropharyngeal cancer","target":"epacadostat (u)","id":"19950"},{"source":"oropharyngeal cancer","target":"pembrolizumab","id":"19951"},{"source":"oropharyngeal cancer","target":"carboplatin","id":"19952"},{"source":"oropharyngeal cancer","target":"cetuximab","id":"19953"},{"source":"oropharyngeal cancer","target":"cisplatin","id":"19954"},{"source":"oropharyngeal cancer","target":"5-fluorouracil","id":"19955"},{"source":"neoplasm metastasis","target":"epacadostat (u)","id":"19956"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"19957"},{"source":"neoplasm metastasis","target":"carboplatin","id":"19958"},{"source":"neoplasm metastasis","target":"cetuximab","id":"19959"},{"source":"neoplasm metastasis","target":"cisplatin","id":"19960"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"19961"},{"source":"anticancer","target":"epacadostat (u)","id":"19962"},{"source":"anticancer","target":"pembrolizumab","id":"19963"},{"source":"anticancer","target":"carboplatin","id":"19964"},{"source":"anticancer","target":"cetuximab","id":"19965"},{"source":"anticancer","target":"cisplatin","id":"19966"},{"source":"anticancer","target":"5-fluorouracil","id":"19967"},{"source":"papilloma","target":"epacadostat (u)","id":"19968"},{"source":"papilloma","target":"pembrolizumab","id":"19969"},{"source":"papilloma","target":"carboplatin","id":"19970"},{"source":"papilloma","target":"cetuximab","id":"19971"},{"source":"papilloma","target":"cisplatin","id":"19972"},{"source":"papilloma","target":"5-fluorouracil","id":"19973"},{"source":"pharyngeal neoplasms","target":"epacadostat (u)","id":"19974"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"19975"},{"source":"pharyngeal neoplasms","target":"carboplatin","id":"19976"},{"source":"pharyngeal neoplasms","target":"cetuximab","id":"19977"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"19978"},{"source":"pharyngeal neoplasms","target":"5-fluorouracil","id":"19979"},{"source":"papilloma","target":"epacadostat (u)","id":"19980"},{"source":"papilloma","target":"pembrolizumab","id":"19981"},{"source":"papilloma","target":"carboplatin","id":"19982"},{"source":"papilloma","target":"cetuximab","id":"19983"},{"source":"papilloma","target":"cisplatin","id":"19984"},{"source":"papilloma","target":"5-fluorouracil","id":"19985"},{"source":"head and neck neoplasms","target":"epacadostat (u)","id":"19986"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"19987"},{"source":"head and neck neoplasms","target":"carboplatin","id":"19988"},{"source":"head and neck neoplasms","target":"cetuximab","id":"19989"},{"source":"head and neck neoplasms","target":"cisplatin","id":"19990"},{"source":"head and neck neoplasms","target":"5-fluorouracil","id":"19991"},{"source":"EGFR antagonist","target":"UNK : Indication","id":"19992"},{"source":"EGFR antagonist","target":"carcinoma","id":"19993"},{"source":"EGFR antagonist","target":"squamous cell neoplasms","id":"19994"},{"source":"EGFR antagonist","target":"hpv type","id":"19995"},{"source":"EGFR antagonist","target":"bone metastasis","id":"19996"},{"source":"EGFR antagonist","target":"carcinoma","id":"19997"},{"source":"EGFR antagonist","target":"carcinoma","id":"19998"},{"source":"EGFR antagonist","target":"squamous cell neoplasms","id":"19999"},{"source":"EGFR antagonist","target":"residual tumor","id":"20000"},{"source":"EGFR antagonist","target":"fallopian tube neoplasms","id":"20001"},{"source":"EGFR antagonist","target":"metastatic","id":"20002"},{"source":"EGFR antagonist","target":"carcinoma","id":"20003"},{"source":"EGFR antagonist","target":"oropharyngeal cancer","id":"20004"},{"source":"EGFR antagonist","target":"neoplasm metastasis","id":"20005"},{"source":"EGFR antagonist","target":"anticancer","id":"20006"},{"source":"EGFR antagonist","target":"papilloma","id":"20007"},{"source":"EGFR antagonist","target":"pharyngeal neoplasms","id":"20008"},{"source":"EGFR antagonist","target":"papilloma","id":"20009"},{"source":"EGFR antagonist","target":"head and neck neoplasms","id":"20010"},{"source":"NA","target":"UNK : Indication","id":"20011"},{"source":"NA","target":"carcinoma","id":"20012"},{"source":"NA","target":"squamous cell neoplasms","id":"20013"},{"source":"NA","target":"hpv type","id":"20014"},{"source":"NA","target":"bone metastasis","id":"20015"},{"source":"NA","target":"carcinoma","id":"20016"},{"source":"NA","target":"carcinoma","id":"20017"},{"source":"NA","target":"squamous cell neoplasms","id":"20018"},{"source":"NA","target":"residual tumor","id":"20019"},{"source":"NA","target":"fallopian tube neoplasms","id":"20020"},{"source":"NA","target":"metastatic","id":"20021"},{"source":"NA","target":"carcinoma","id":"20022"},{"source":"NA","target":"oropharyngeal cancer","id":"20023"},{"source":"NA","target":"neoplasm metastasis","id":"20024"},{"source":"NA","target":"anticancer","id":"20025"},{"source":"NA","target":"papilloma","id":"20026"},{"source":"NA","target":"pharyngeal neoplasms","id":"20027"},{"source":"NA","target":"papilloma","id":"20028"},{"source":"NA","target":"head and neck neoplasms","id":"20029"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"20030"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20031"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"20032"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"20033"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"20034"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20035"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20036"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"20037"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"20038"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"20039"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"20040"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20041"},{"source":"Immune checkpoint inhibitor","target":"oropharyngeal cancer","id":"20042"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"20043"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"20044"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"20045"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"20046"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"20047"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"20048"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"20049"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20050"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"20051"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"20052"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"20053"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20054"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20055"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"20056"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"20057"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"20058"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"20059"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20060"},{"source":"Anticancer immunotherapy","target":"oropharyngeal cancer","id":"20061"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"20062"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"20063"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"20064"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"20065"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"20066"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"20067"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"20068"},{"source":"CD19 antagonist","target":"carcinoma","id":"20069"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"20070"},{"source":"CD19 antagonist","target":"hpv type","id":"20071"},{"source":"CD19 antagonist","target":"bone metastasis","id":"20072"},{"source":"CD19 antagonist","target":"carcinoma","id":"20073"},{"source":"CD19 antagonist","target":"carcinoma","id":"20074"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"20075"},{"source":"CD19 antagonist","target":"residual tumor","id":"20076"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"20077"},{"source":"CD19 antagonist","target":"metastatic","id":"20078"},{"source":"CD19 antagonist","target":"carcinoma","id":"20079"},{"source":"CD19 antagonist","target":"oropharyngeal cancer","id":"20080"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"20081"},{"source":"CD19 antagonist","target":"anticancer","id":"20082"},{"source":"CD19 antagonist","target":"papilloma","id":"20083"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"20084"},{"source":"CD19 antagonist","target":"papilloma","id":"20085"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"20086"},{"source":"NA","target":"UNK : Indication","id":"20087"},{"source":"NA","target":"carcinoma","id":"20088"},{"source":"NA","target":"squamous cell neoplasms","id":"20089"},{"source":"NA","target":"hpv type","id":"20090"},{"source":"NA","target":"bone metastasis","id":"20091"},{"source":"NA","target":"carcinoma","id":"20092"},{"source":"NA","target":"carcinoma","id":"20093"},{"source":"NA","target":"squamous cell neoplasms","id":"20094"},{"source":"NA","target":"residual tumor","id":"20095"},{"source":"NA","target":"fallopian tube neoplasms","id":"20096"},{"source":"NA","target":"metastatic","id":"20097"},{"source":"NA","target":"carcinoma","id":"20098"},{"source":"NA","target":"oropharyngeal cancer","id":"20099"},{"source":"NA","target":"neoplasm metastasis","id":"20100"},{"source":"NA","target":"anticancer","id":"20101"},{"source":"NA","target":"papilloma","id":"20102"},{"source":"NA","target":"pharyngeal neoplasms","id":"20103"},{"source":"NA","target":"papilloma","id":"20104"},{"source":"NA","target":"head and neck neoplasms","id":"20105"},{"source":"NA","target":"UNK : Indication","id":"20106"},{"source":"NA","target":"carcinoma","id":"20107"},{"source":"NA","target":"squamous cell neoplasms","id":"20108"},{"source":"NA","target":"hpv type","id":"20109"},{"source":"NA","target":"bone metastasis","id":"20110"},{"source":"NA","target":"carcinoma","id":"20111"},{"source":"NA","target":"carcinoma","id":"20112"},{"source":"NA","target":"squamous cell neoplasms","id":"20113"},{"source":"NA","target":"residual tumor","id":"20114"},{"source":"NA","target":"fallopian tube neoplasms","id":"20115"},{"source":"NA","target":"metastatic","id":"20116"},{"source":"NA","target":"carcinoma","id":"20117"},{"source":"NA","target":"oropharyngeal cancer","id":"20118"},{"source":"NA","target":"neoplasm metastasis","id":"20119"},{"source":"NA","target":"anticancer","id":"20120"},{"source":"NA","target":"papilloma","id":"20121"},{"source":"NA","target":"pharyngeal neoplasms","id":"20122"},{"source":"NA","target":"papilloma","id":"20123"},{"source":"NA","target":"head and neck neoplasms","id":"20124"},{"source":"NA","target":"UNK : Indication","id":"20125"},{"source":"NA","target":"carcinoma","id":"20126"},{"source":"NA","target":"squamous cell neoplasms","id":"20127"},{"source":"NA","target":"hpv type","id":"20128"},{"source":"NA","target":"bone metastasis","id":"20129"},{"source":"NA","target":"carcinoma","id":"20130"},{"source":"NA","target":"carcinoma","id":"20131"},{"source":"NA","target":"squamous cell neoplasms","id":"20132"},{"source":"NA","target":"residual tumor","id":"20133"},{"source":"NA","target":"fallopian tube neoplasms","id":"20134"},{"source":"NA","target":"metastatic","id":"20135"},{"source":"NA","target":"carcinoma","id":"20136"},{"source":"NA","target":"oropharyngeal cancer","id":"20137"},{"source":"NA","target":"neoplasm metastasis","id":"20138"},{"source":"NA","target":"anticancer","id":"20139"},{"source":"NA","target":"papilloma","id":"20140"},{"source":"NA","target":"pharyngeal neoplasms","id":"20141"},{"source":"NA","target":"papilloma","id":"20142"},{"source":"NA","target":"head and neck neoplasms","id":"20143"},{"source":"Indoleamine-pyrrole 2","target":"UNK : Indication","id":"20144"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"20145"},{"source":"Indoleamine-pyrrole 2","target":"squamous cell neoplasms","id":"20146"},{"source":"Indoleamine-pyrrole 2","target":"hpv type","id":"20147"},{"source":"Indoleamine-pyrrole 2","target":"bone metastasis","id":"20148"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"20149"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"20150"},{"source":"Indoleamine-pyrrole 2","target":"squamous cell neoplasms","id":"20151"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"20152"},{"source":"Indoleamine-pyrrole 2","target":"fallopian tube neoplasms","id":"20153"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"20154"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"20155"},{"source":"Indoleamine-pyrrole 2","target":"oropharyngeal cancer","id":"20156"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"20157"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"20158"},{"source":"Indoleamine-pyrrole 2","target":"papilloma","id":"20159"},{"source":"Indoleamine-pyrrole 2","target":"pharyngeal neoplasms","id":"20160"},{"source":"Indoleamine-pyrrole 2","target":"papilloma","id":"20161"},{"source":"Indoleamine-pyrrole 2","target":"head and neck neoplasms","id":"20162"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"20163"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"20164"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"20165"},{"source":"Thymidylate synthase inhibitor","target":"hpv type","id":"20166"},{"source":"Thymidylate synthase inhibitor","target":"bone metastasis","id":"20167"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"20168"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"20169"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"20170"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"20171"},{"source":"Thymidylate synthase inhibitor","target":"fallopian tube neoplasms","id":"20172"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"20173"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"20174"},{"source":"Thymidylate synthase inhibitor","target":"oropharyngeal cancer","id":"20175"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"20176"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"20177"},{"source":"Thymidylate synthase inhibitor","target":"papilloma","id":"20178"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"20179"},{"source":"Thymidylate synthase inhibitor","target":"papilloma","id":"20180"},{"source":"Thymidylate synthase inhibitor","target":"head and neck neoplasms","id":"20181"},{"source":"Oncology: Head/Neck","target":"EGFR antagonist","id":"20182"},{"source":"Oncology: Head/Neck","target":"NA","id":"20183"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"20184"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"20185"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"20186"},{"source":"Oncology: Head/Neck","target":"NA","id":"20187"},{"source":"Oncology: Head/Neck","target":"NA","id":"20188"},{"source":"Oncology: Head/Neck","target":"NA","id":"20189"},{"source":"Oncology: Head/Neck","target":"Indoleamine-pyrrole 2","id":"20190"},{"source":"Oncology: Head/Neck","target":"Thymidylate synthase inhibitor","id":"20191"},{"source":"pembrolizumab","target":"Merck & Co.","id":"20192"},{"source":"UNK : Drug","target":"Merck & Co.","id":"20193"},{"source":"UNK : Indication","target":"pembrolizumab","id":"20194"},{"source":"UNK : Indication","target":"UNK : Drug","id":"20195"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"20196"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"20197"},{"source":"esophageal cancer","target":"pembrolizumab","id":"20198"},{"source":"esophageal cancer","target":"UNK : Drug","id":"20199"},{"source":"astrocytoma","target":"pembrolizumab","id":"20200"},{"source":"astrocytoma","target":"UNK : Drug","id":"20201"},{"source":"skin neoplasms","target":"pembrolizumab","id":"20202"},{"source":"skin neoplasms","target":"UNK : Drug","id":"20203"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"20204"},{"source":"castration-resistant prostatic neoplasms","target":"UNK : Drug","id":"20205"},{"source":"carcinoma","target":"pembrolizumab","id":"20206"},{"source":"carcinoma","target":"UNK : Drug","id":"20207"},{"source":"glioblastoma","target":"pembrolizumab","id":"20208"},{"source":"glioblastoma","target":"UNK : Drug","id":"20209"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"20210"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"20211"},{"source":"glioblastoma","target":"pembrolizumab","id":"20212"},{"source":"glioblastoma","target":"UNK : Drug","id":"20213"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"20214"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"20215"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"20216"},{"source":"pancreatic cancer","target":"UNK : Drug","id":"20217"},{"source":"sarcoma","target":"pembrolizumab","id":"20218"},{"source":"sarcoma","target":"UNK : Drug","id":"20219"},{"source":"liver neoplasms","target":"pembrolizumab","id":"20220"},{"source":"liver neoplasms","target":"UNK : Drug","id":"20221"},{"source":"carcinoma","target":"pembrolizumab","id":"20222"},{"source":"carcinoma","target":"UNK : Drug","id":"20223"},{"source":"endometrial neoplasms","target":"pembrolizumab","id":"20224"},{"source":"endometrial neoplasms","target":"UNK : Drug","id":"20225"},{"source":"carcinoma","target":"pembrolizumab","id":"20226"},{"source":"carcinoma","target":"UNK : Drug","id":"20227"},{"source":"carcinoma","target":"pembrolizumab","id":"20228"},{"source":"carcinoma","target":"UNK : Drug","id":"20229"},{"source":"solid tumors","target":"pembrolizumab","id":"20230"},{"source":"solid tumors","target":"UNK : Drug","id":"20231"},{"source":"carcinoma","target":"pembrolizumab","id":"20232"},{"source":"carcinoma","target":"UNK : Drug","id":"20233"},{"source":"anticancer","target":"pembrolizumab","id":"20234"},{"source":"anticancer","target":"UNK : Drug","id":"20235"},{"source":"mesothelial","target":"pembrolizumab","id":"20236"},{"source":"mesothelial","target":"UNK : Drug","id":"20237"},{"source":"liver metastases","target":"pembrolizumab","id":"20238"},{"source":"liver metastases","target":"UNK : Drug","id":"20239"},{"source":"sarcoma","target":"pembrolizumab","id":"20240"},{"source":"sarcoma","target":"UNK : Drug","id":"20241"},{"source":"breast neoplasms","target":"pembrolizumab","id":"20242"},{"source":"breast neoplasms","target":"UNK : Drug","id":"20243"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"20244"},{"source":"colonic neoplasms","target":"UNK : Drug","id":"20245"},{"source":"carcinoma","target":"pembrolizumab","id":"20246"},{"source":"carcinoma","target":"UNK : Drug","id":"20247"},{"source":"carcinoma","target":"pembrolizumab","id":"20248"},{"source":"carcinoma","target":"UNK : Drug","id":"20249"},{"source":"inflammation","target":"pembrolizumab","id":"20250"},{"source":"inflammation","target":"UNK : Drug","id":"20251"},{"source":"carcinoma","target":"pembrolizumab","id":"20252"},{"source":"carcinoma","target":"UNK : Drug","id":"20253"},{"source":"endometrioid","target":"pembrolizumab","id":"20254"},{"source":"endometrioid","target":"UNK : Drug","id":"20255"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"20256"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"20257"},{"source":"liver cancer","target":"pembrolizumab","id":"20258"},{"source":"liver cancer","target":"UNK : Drug","id":"20259"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"20260"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"20261"},{"source":"carcinoma","target":"pembrolizumab","id":"20262"},{"source":"carcinoma","target":"UNK : Drug","id":"20263"},{"source":"esophageal neoplasms","target":"pembrolizumab","id":"20264"},{"source":"esophageal neoplasms","target":"UNK : Drug","id":"20265"},{"source":"carcinoma","target":"pembrolizumab","id":"20266"},{"source":"carcinoma","target":"UNK : Drug","id":"20267"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"20268"},{"source":"pharyngeal neoplasms","target":"UNK : Drug","id":"20269"},{"source":"neuroendocrine tumors","target":"pembrolizumab","id":"20270"},{"source":"neuroendocrine tumors","target":"UNK : Drug","id":"20271"},{"source":"mesothelial","target":"pembrolizumab","id":"20272"},{"source":"mesothelial","target":"UNK : Drug","id":"20273"},{"source":"cancer squamous cell","target":"pembrolizumab","id":"20274"},{"source":"cancer squamous cell","target":"UNK : Drug","id":"20275"},{"source":"carcinoma","target":"pembrolizumab","id":"20276"},{"source":"carcinoma","target":"UNK : Drug","id":"20277"},{"source":"anti-tumor","target":"pembrolizumab","id":"20278"},{"source":"anti-tumor","target":"UNK : Drug","id":"20279"},{"source":"carcinoid tumors","target":"pembrolizumab","id":"20280"},{"source":"carcinoid tumors","target":"UNK : Drug","id":"20281"},{"source":"mesothelial","target":"pembrolizumab","id":"20282"},{"source":"mesothelial","target":"UNK : Drug","id":"20283"},{"source":"salivary gland neoplasms","target":"pembrolizumab","id":"20284"},{"source":"salivary gland neoplasms","target":"UNK : Drug","id":"20285"},{"source":"thyroid neoplasms","target":"pembrolizumab","id":"20286"},{"source":"thyroid neoplasms","target":"UNK : Drug","id":"20287"},{"source":"lung cancer","target":"pembrolizumab","id":"20288"},{"source":"lung cancer","target":"UNK : Drug","id":"20289"},{"source":"npc","target":"pembrolizumab","id":"20290"},{"source":"npc","target":"UNK : Drug","id":"20291"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"20292"},{"source":"peritoneal neoplasms","target":"UNK : Drug","id":"20293"},{"source":"ovarian cancer","target":"pembrolizumab","id":"20294"},{"source":"ovarian cancer","target":"UNK : Drug","id":"20295"},{"source":"metastatic","target":"pembrolizumab","id":"20296"},{"source":"metastatic","target":"UNK : Drug","id":"20297"},{"source":"carcinoma","target":"pembrolizumab","id":"20298"},{"source":"carcinoma","target":"UNK : Drug","id":"20299"},{"source":"sclc","target":"pembrolizumab","id":"20300"},{"source":"sclc","target":"UNK : Drug","id":"20301"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"20302"},{"source":"soft tissue neoplasms","target":"UNK : Drug","id":"20303"},{"source":"sarcoma","target":"pembrolizumab","id":"20304"},{"source":"sarcoma","target":"UNK : Drug","id":"20305"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"20306"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"20307"},{"source":"carcinoma","target":"pembrolizumab","id":"20308"},{"source":"carcinoma","target":"UNK : Drug","id":"20309"},{"source":"carcinoma","target":"pembrolizumab","id":"20310"},{"source":"carcinoma","target":"UNK : Drug","id":"20311"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"20312"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"20313"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"20314"},{"source":"pancreatic neoplasms","target":"UNK : Drug","id":"20315"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"20316"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"20317"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"20318"},{"source":"stomach neoplasms","target":"UNK : Drug","id":"20319"},{"source":"solid malignancy","target":"pembrolizumab","id":"20320"},{"source":"solid malignancy","target":"UNK : Drug","id":"20321"},{"source":"hepatocellular","target":"pembrolizumab","id":"20322"},{"source":"hepatocellular","target":"UNK : Drug","id":"20323"},{"source":"pleural mesothelioma","target":"pembrolizumab","id":"20324"},{"source":"pleural mesothelioma","target":"UNK : Drug","id":"20325"},{"source":"sarcoma","target":"pembrolizumab","id":"20326"},{"source":"sarcoma","target":"UNK : Drug","id":"20327"},{"source":"carcinoma","target":"pembrolizumab","id":"20328"},{"source":"carcinoma","target":"UNK : Drug","id":"20329"},{"source":"carcinoma","target":"pembrolizumab","id":"20330"},{"source":"carcinoma","target":"UNK : Drug","id":"20331"},{"source":"gbm","target":"pembrolizumab","id":"20332"},{"source":"gbm","target":"UNK : Drug","id":"20333"},{"source":"inflamed","target":"pembrolizumab","id":"20334"},{"source":"inflamed","target":"UNK : Drug","id":"20335"},{"source":"skin neoplasms","target":"pembrolizumab","id":"20336"},{"source":"skin neoplasms","target":"UNK : Drug","id":"20337"},{"source":"residual tumor","target":"pembrolizumab","id":"20338"},{"source":"residual tumor","target":"UNK : Drug","id":"20339"},{"source":"carcinoma","target":"pembrolizumab","id":"20340"},{"source":"carcinoma","target":"UNK : Drug","id":"20341"},{"source":"parotid neoplasms","target":"pembrolizumab","id":"20342"},{"source":"parotid neoplasms","target":"UNK : Drug","id":"20343"},{"source":"carcinoid tumors","target":"pembrolizumab","id":"20344"},{"source":"carcinoid tumors","target":"UNK : Drug","id":"20345"},{"source":"anticancer","target":"pembrolizumab","id":"20346"},{"source":"anticancer","target":"UNK : Drug","id":"20347"},{"source":"residual tumor","target":"pembrolizumab","id":"20348"},{"source":"residual tumor","target":"UNK : Drug","id":"20349"},{"source":"neuroendocrine tumors","target":"pembrolizumab","id":"20350"},{"source":"neuroendocrine tumors","target":"UNK : Drug","id":"20351"},{"source":"solid tumors","target":"pembrolizumab","id":"20352"},{"source":"solid tumors","target":"UNK : Drug","id":"20353"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"20354"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"20355"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"20356"},{"source":"Anticancer immunotherapy","target":"astrocytoma","id":"20357"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"20358"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"20359"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20360"},{"source":"Anticancer immunotherapy","target":"glioblastoma","id":"20361"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"20362"},{"source":"Anticancer immunotherapy","target":"glioblastoma","id":"20363"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"20364"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"20365"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"20366"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"20367"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20368"},{"source":"Anticancer immunotherapy","target":"endometrial neoplasms","id":"20369"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20370"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20371"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"20372"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20373"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"20374"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"20375"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"20376"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"20377"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"20378"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"20379"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20380"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20381"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"20382"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20383"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"20384"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"20385"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"20386"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"20387"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20388"},{"source":"Anticancer immunotherapy","target":"esophageal neoplasms","id":"20389"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20390"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"20391"},{"source":"Anticancer immunotherapy","target":"neuroendocrine tumors","id":"20392"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"20393"},{"source":"Anticancer immunotherapy","target":"cancer squamous cell","id":"20394"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20395"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"20396"},{"source":"Anticancer immunotherapy","target":"carcinoid tumors","id":"20397"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"20398"},{"source":"Anticancer immunotherapy","target":"salivary gland neoplasms","id":"20399"},{"source":"Anticancer immunotherapy","target":"thyroid neoplasms","id":"20400"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"20401"},{"source":"Anticancer immunotherapy","target":"npc","id":"20402"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"20403"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"20404"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"20405"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20406"},{"source":"Anticancer immunotherapy","target":"sclc","id":"20407"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"20408"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"20409"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"20410"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20411"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20412"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"20413"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"20414"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"20415"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"20416"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"20417"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"20418"},{"source":"Anticancer immunotherapy","target":"pleural mesothelioma","id":"20419"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"20420"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20421"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20422"},{"source":"Anticancer immunotherapy","target":"gbm","id":"20423"},{"source":"Anticancer immunotherapy","target":"inflamed","id":"20424"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"20425"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"20426"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20427"},{"source":"Anticancer immunotherapy","target":"parotid neoplasms","id":"20428"},{"source":"Anticancer immunotherapy","target":"carcinoid tumors","id":"20429"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"20430"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"20431"},{"source":"Anticancer immunotherapy","target":"neuroendocrine tumors","id":"20432"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"20433"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"20434"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"20435"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"20436"},{"source":"CD19 antagonist","target":"astrocytoma","id":"20437"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"20438"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"20439"},{"source":"CD19 antagonist","target":"carcinoma","id":"20440"},{"source":"CD19 antagonist","target":"glioblastoma","id":"20441"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"20442"},{"source":"CD19 antagonist","target":"glioblastoma","id":"20443"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"20444"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"20445"},{"source":"CD19 antagonist","target":"sarcoma","id":"20446"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"20447"},{"source":"CD19 antagonist","target":"carcinoma","id":"20448"},{"source":"CD19 antagonist","target":"endometrial neoplasms","id":"20449"},{"source":"CD19 antagonist","target":"carcinoma","id":"20450"},{"source":"CD19 antagonist","target":"carcinoma","id":"20451"},{"source":"CD19 antagonist","target":"solid tumors","id":"20452"},{"source":"CD19 antagonist","target":"carcinoma","id":"20453"},{"source":"CD19 antagonist","target":"anticancer","id":"20454"},{"source":"CD19 antagonist","target":"mesothelial","id":"20455"},{"source":"CD19 antagonist","target":"liver metastases","id":"20456"},{"source":"CD19 antagonist","target":"sarcoma","id":"20457"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"20458"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"20459"},{"source":"CD19 antagonist","target":"carcinoma","id":"20460"},{"source":"CD19 antagonist","target":"carcinoma","id":"20461"},{"source":"CD19 antagonist","target":"inflammation","id":"20462"},{"source":"CD19 antagonist","target":"carcinoma","id":"20463"},{"source":"CD19 antagonist","target":"endometrioid","id":"20464"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"20465"},{"source":"CD19 antagonist","target":"liver cancer","id":"20466"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"20467"},{"source":"CD19 antagonist","target":"carcinoma","id":"20468"},{"source":"CD19 antagonist","target":"esophageal neoplasms","id":"20469"},{"source":"CD19 antagonist","target":"carcinoma","id":"20470"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"20471"},{"source":"CD19 antagonist","target":"neuroendocrine tumors","id":"20472"},{"source":"CD19 antagonist","target":"mesothelial","id":"20473"},{"source":"CD19 antagonist","target":"cancer squamous cell","id":"20474"},{"source":"CD19 antagonist","target":"carcinoma","id":"20475"},{"source":"CD19 antagonist","target":"anti-tumor","id":"20476"},{"source":"CD19 antagonist","target":"carcinoid tumors","id":"20477"},{"source":"CD19 antagonist","target":"mesothelial","id":"20478"},{"source":"CD19 antagonist","target":"salivary gland neoplasms","id":"20479"},{"source":"CD19 antagonist","target":"thyroid neoplasms","id":"20480"},{"source":"CD19 antagonist","target":"lung cancer","id":"20481"},{"source":"CD19 antagonist","target":"npc","id":"20482"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"20483"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"20484"},{"source":"CD19 antagonist","target":"metastatic","id":"20485"},{"source":"CD19 antagonist","target":"carcinoma","id":"20486"},{"source":"CD19 antagonist","target":"sclc","id":"20487"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"20488"},{"source":"CD19 antagonist","target":"sarcoma","id":"20489"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"20490"},{"source":"CD19 antagonist","target":"carcinoma","id":"20491"},{"source":"CD19 antagonist","target":"carcinoma","id":"20492"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"20493"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"20494"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"20495"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"20496"},{"source":"CD19 antagonist","target":"solid malignancy","id":"20497"},{"source":"CD19 antagonist","target":"hepatocellular","id":"20498"},{"source":"CD19 antagonist","target":"pleural mesothelioma","id":"20499"},{"source":"CD19 antagonist","target":"sarcoma","id":"20500"},{"source":"CD19 antagonist","target":"carcinoma","id":"20501"},{"source":"CD19 antagonist","target":"carcinoma","id":"20502"},{"source":"CD19 antagonist","target":"gbm","id":"20503"},{"source":"CD19 antagonist","target":"inflamed","id":"20504"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"20505"},{"source":"CD19 antagonist","target":"residual tumor","id":"20506"},{"source":"CD19 antagonist","target":"carcinoma","id":"20507"},{"source":"CD19 antagonist","target":"parotid neoplasms","id":"20508"},{"source":"CD19 antagonist","target":"carcinoid tumors","id":"20509"},{"source":"CD19 antagonist","target":"anticancer","id":"20510"},{"source":"CD19 antagonist","target":"residual tumor","id":"20511"},{"source":"CD19 antagonist","target":"neuroendocrine tumors","id":"20512"},{"source":"CD19 antagonist","target":"solid tumors","id":"20513"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"20514"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"20515"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"20516"},{"source":"Immune checkpoint inhibitor","target":"astrocytoma","id":"20517"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"20518"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"20519"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20520"},{"source":"Immune checkpoint inhibitor","target":"glioblastoma","id":"20521"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"20522"},{"source":"Immune checkpoint inhibitor","target":"glioblastoma","id":"20523"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"20524"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"20525"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"20526"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"20527"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20528"},{"source":"Immune checkpoint inhibitor","target":"endometrial neoplasms","id":"20529"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20530"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20531"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"20532"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20533"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"20534"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"20535"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"20536"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"20537"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"20538"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"20539"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20540"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20541"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"20542"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20543"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"20544"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"20545"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"20546"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"20547"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20548"},{"source":"Immune checkpoint inhibitor","target":"esophageal neoplasms","id":"20549"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20550"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"20551"},{"source":"Immune checkpoint inhibitor","target":"neuroendocrine tumors","id":"20552"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"20553"},{"source":"Immune checkpoint inhibitor","target":"cancer squamous cell","id":"20554"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20555"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"20556"},{"source":"Immune checkpoint inhibitor","target":"carcinoid tumors","id":"20557"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"20558"},{"source":"Immune checkpoint inhibitor","target":"salivary gland neoplasms","id":"20559"},{"source":"Immune checkpoint inhibitor","target":"thyroid neoplasms","id":"20560"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"20561"},{"source":"Immune checkpoint inhibitor","target":"npc","id":"20562"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"20563"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"20564"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"20565"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20566"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"20567"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"20568"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"20569"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"20570"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20571"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20572"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"20573"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"20574"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"20575"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"20576"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"20577"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"20578"},{"source":"Immune checkpoint inhibitor","target":"pleural mesothelioma","id":"20579"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"20580"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20581"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20582"},{"source":"Immune checkpoint inhibitor","target":"gbm","id":"20583"},{"source":"Immune checkpoint inhibitor","target":"inflamed","id":"20584"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"20585"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"20586"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20587"},{"source":"Immune checkpoint inhibitor","target":"parotid neoplasms","id":"20588"},{"source":"Immune checkpoint inhibitor","target":"carcinoid tumors","id":"20589"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"20590"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"20591"},{"source":"Immune checkpoint inhibitor","target":"neuroendocrine tumors","id":"20592"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"20593"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"20594"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"20595"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"20596"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"20597"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"20598"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"20599"},{"source":"Oncology: Cervical","target":"Anticancer immunotherapy","id":"20600"},{"source":"Oncology: Cervical","target":"CD19 antagonist","id":"20601"},{"source":"Oncology: Cervical","target":"Immune checkpoint inhibitor","id":"20602"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"20603"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"20604"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"20605"},{"source":"Glioblastoma","target":"Anticancer immunotherapy","id":"20606"},{"source":"Glioblastoma","target":"CD19 antagonist","id":"20607"},{"source":"Glioblastoma","target":"Immune checkpoint inhibitor","id":"20608"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"20609"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"20610"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"20611"},{"source":"Oncology: Endometrial","target":"Anticancer immunotherapy","id":"20612"},{"source":"Oncology: Endometrial","target":"CD19 antagonist","id":"20613"},{"source":"Oncology: Endometrial","target":"Immune checkpoint inhibitor","id":"20614"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"20615"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"20616"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"20617"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"20618"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"20619"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"20620"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"20621"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"20622"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"20623"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"20624"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"20625"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"20626"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"20627"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"20628"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"20629"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"20630"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"20631"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"20632"},{"source":"Oncology: Mesothelioma","target":"Anticancer immunotherapy","id":"20633"},{"source":"Oncology: Mesothelioma","target":"CD19 antagonist","id":"20634"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint inhibitor","id":"20635"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"20636"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"20637"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"20638"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"20639"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"20640"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"20641"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"20642"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"20643"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"20644"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"20645"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"20646"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"20647"},{"source":"Oncology: Thyroid","target":"Anticancer immunotherapy","id":"20648"},{"source":"Oncology: Thyroid","target":"CD19 antagonist","id":"20649"},{"source":"Oncology: Thyroid","target":"Immune checkpoint inhibitor","id":"20650"},{"source":"CVA-21 (intratumoral) (u)","target":"Viralytics {Psiron}","id":"20651"},{"source":"pembrolizumab","target":"Viralytics {Psiron}","id":"20652"},{"source":"UNK : Indication","target":"CVA-21 (intratumoral) (u)","id":"20653"},{"source":"UNK : Indication","target":"pembrolizumab","id":"20654"},{"source":"melanoma","target":"CVA-21 (intratumoral) (u)","id":"20655"},{"source":"melanoma","target":"pembrolizumab","id":"20656"},{"source":"anticancer","target":"CVA-21 (intratumoral) (u)","id":"20657"},{"source":"anticancer","target":"pembrolizumab","id":"20658"},{"source":"skin neoplasms","target":"CVA-21 (intratumoral) (u)","id":"20659"},{"source":"skin neoplasms","target":"pembrolizumab","id":"20660"},{"source":"residual tumor","target":"CVA-21 (intratumoral) (u)","id":"20661"},{"source":"residual tumor","target":"pembrolizumab","id":"20662"},{"source":"anti-tumor","target":"CVA-21 (intratumoral) (u)","id":"20663"},{"source":"anti-tumor","target":"pembrolizumab","id":"20664"},{"source":"metastatic","target":"CVA-21 (intratumoral) (u)","id":"20665"},{"source":"metastatic","target":"pembrolizumab","id":"20666"},{"source":"carcinoma","target":"CVA-21 (intratumoral) (u)","id":"20667"},{"source":"carcinoma","target":"pembrolizumab","id":"20668"},{"source":"neoplasm metastasis","target":"CVA-21 (intratumoral) (u)","id":"20669"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"20670"},{"source":"anticancer","target":"CVA-21 (intratumoral) (u)","id":"20671"},{"source":"anticancer","target":"pembrolizumab","id":"20672"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"20673"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"20674"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"20675"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"20676"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"20677"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"20678"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"20679"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20680"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"20681"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"20682"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"20683"},{"source":"CD19 antagonist","target":"melanoma","id":"20684"},{"source":"CD19 antagonist","target":"anticancer","id":"20685"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"20686"},{"source":"CD19 antagonist","target":"residual tumor","id":"20687"},{"source":"CD19 antagonist","target":"anti-tumor","id":"20688"},{"source":"CD19 antagonist","target":"metastatic","id":"20689"},{"source":"CD19 antagonist","target":"carcinoma","id":"20690"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"20691"},{"source":"CD19 antagonist","target":"anticancer","id":"20692"},{"source":"Apoptosis stimulant","target":"UNK : Indication","id":"20693"},{"source":"Apoptosis stimulant","target":"melanoma","id":"20694"},{"source":"Apoptosis stimulant","target":"anticancer","id":"20695"},{"source":"Apoptosis stimulant","target":"skin neoplasms","id":"20696"},{"source":"Apoptosis stimulant","target":"residual tumor","id":"20697"},{"source":"Apoptosis stimulant","target":"anti-tumor","id":"20698"},{"source":"Apoptosis stimulant","target":"metastatic","id":"20699"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"20700"},{"source":"Apoptosis stimulant","target":"neoplasm metastasis","id":"20701"},{"source":"Apoptosis stimulant","target":"anticancer","id":"20702"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"20703"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"20704"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"20705"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"20706"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"20707"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"20708"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"20709"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20710"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"20711"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"20712"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"20713"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"20714"},{"source":"Oncology: Melanoma","target":"Apoptosis stimulant","id":"20715"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"20716"},{"source":"APX-005M (u)","target":"Apexigen","id":"20717"},{"source":"APX-005M (u)","target":"MD Anderson Cancer Center","id":"20718"},{"source":"APX-005M (u)","target":"University of Texas","id":"20719"},{"source":"pembrolizumab","target":"Apexigen","id":"20720"},{"source":"pembrolizumab","target":"MD Anderson Cancer Center","id":"20721"},{"source":"pembrolizumab","target":"University of Texas","id":"20722"},{"source":"UNK : Indication","target":"APX-005M (u)","id":"20723"},{"source":"UNK : Indication","target":"pembrolizumab","id":"20724"},{"source":"melanoma","target":"APX-005M (u)","id":"20725"},{"source":"melanoma","target":"pembrolizumab","id":"20726"},{"source":"anti-hiv","target":"APX-005M (u)","id":"20727"},{"source":"anti-hiv","target":"pembrolizumab","id":"20728"},{"source":"melanoma","target":"APX-005M (u)","id":"20729"},{"source":"melanoma","target":"pembrolizumab","id":"20730"},{"source":"melanoma","target":"APX-005M (u)","id":"20731"},{"source":"melanoma","target":"pembrolizumab","id":"20732"},{"source":"melanoma","target":"APX-005M (u)","id":"20733"},{"source":"melanoma","target":"pembrolizumab","id":"20734"},{"source":"skin neoplasms","target":"APX-005M (u)","id":"20735"},{"source":"skin neoplasms","target":"pembrolizumab","id":"20736"},{"source":"residual tumor","target":"APX-005M (u)","id":"20737"},{"source":"residual tumor","target":"pembrolizumab","id":"20738"},{"source":"melanoma","target":"APX-005M (u)","id":"20739"},{"source":"melanoma","target":"pembrolizumab","id":"20740"},{"source":"gilbert syndrome","target":"APX-005M (u)","id":"20741"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"20742"},{"source":"carcinoma","target":"APX-005M (u)","id":"20743"},{"source":"carcinoma","target":"pembrolizumab","id":"20744"},{"source":"gilbert disease","target":"APX-005M (u)","id":"20745"},{"source":"gilbert disease","target":"pembrolizumab","id":"20746"},{"source":"anticancer","target":"APX-005M (u)","id":"20747"},{"source":"anticancer","target":"pembrolizumab","id":"20748"},{"source":"hiv infections","target":"APX-005M (u)","id":"20749"},{"source":"hiv infections","target":"pembrolizumab","id":"20750"},{"source":"acquired immunodeficiency syndrome","target":"APX-005M (u)","id":"20751"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"20752"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"20753"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"20754"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"20755"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"20756"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"20757"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"20758"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"20759"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"20760"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"20761"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"20762"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"20763"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"20764"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"20765"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"20766"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"20767"},{"source":"CD40 agonist","target":"UNK : Indication","id":"20768"},{"source":"CD40 agonist","target":"melanoma","id":"20769"},{"source":"CD40 agonist","target":"anti-hiv","id":"20770"},{"source":"CD40 agonist","target":"melanoma","id":"20771"},{"source":"CD40 agonist","target":"melanoma","id":"20772"},{"source":"CD40 agonist","target":"melanoma","id":"20773"},{"source":"CD40 agonist","target":"skin neoplasms","id":"20774"},{"source":"CD40 agonist","target":"residual tumor","id":"20775"},{"source":"CD40 agonist","target":"melanoma","id":"20776"},{"source":"CD40 agonist","target":"gilbert syndrome","id":"20777"},{"source":"CD40 agonist","target":"carcinoma","id":"20778"},{"source":"CD40 agonist","target":"gilbert disease","id":"20779"},{"source":"CD40 agonist","target":"anticancer","id":"20780"},{"source":"CD40 agonist","target":"hiv infections","id":"20781"},{"source":"CD40 agonist","target":"acquired immunodeficiency syndrome","id":"20782"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"20783"},{"source":"CD19 antagonist","target":"melanoma","id":"20784"},{"source":"CD19 antagonist","target":"anti-hiv","id":"20785"},{"source":"CD19 antagonist","target":"melanoma","id":"20786"},{"source":"CD19 antagonist","target":"melanoma","id":"20787"},{"source":"CD19 antagonist","target":"melanoma","id":"20788"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"20789"},{"source":"CD19 antagonist","target":"residual tumor","id":"20790"},{"source":"CD19 antagonist","target":"melanoma","id":"20791"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"20792"},{"source":"CD19 antagonist","target":"carcinoma","id":"20793"},{"source":"CD19 antagonist","target":"gilbert disease","id":"20794"},{"source":"CD19 antagonist","target":"anticancer","id":"20795"},{"source":"CD19 antagonist","target":"hiv infections","id":"20796"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"20797"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"20798"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"20799"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"20800"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"20801"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"20802"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"20803"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"20804"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"20805"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"20806"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"20807"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"20808"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"20809"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"20810"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"20811"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"20812"},{"source":"Immune checkpoint stimulant","target":"UNK : Indication","id":"20813"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"20814"},{"source":"Immune checkpoint stimulant","target":"anti-hiv","id":"20815"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"20816"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"20817"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"20818"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"20819"},{"source":"Immune checkpoint stimulant","target":"residual tumor","id":"20820"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"20821"},{"source":"Immune checkpoint stimulant","target":"gilbert syndrome","id":"20822"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"20823"},{"source":"Immune checkpoint stimulant","target":"gilbert disease","id":"20824"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"20825"},{"source":"Immune checkpoint stimulant","target":"hiv infections","id":"20826"},{"source":"Immune checkpoint stimulant","target":"acquired immunodeficiency syndrome","id":"20827"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"20828"},{"source":"Oncology: Melanoma","target":"CD40 agonist","id":"20829"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"20830"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"20831"},{"source":"Oncology: Melanoma","target":"Immune checkpoint stimulant","id":"20832"},{"source":"PEGPH20","target":"Halozyme Therapeutics","id":"20833"},{"source":"Halozyme (u)","target":"Halozyme Therapeutics","id":"20834"},{"source":"PEGPH20","target":"Halozyme Therapeutics","id":"20835"},{"source":"companion diagnostic","target":"Halozyme Therapeutics","id":"20836"},{"source":"Halozyme (u)","target":"Halozyme Therapeutics","id":"20837"},{"source":"pembrolizumab","target":"Halozyme Therapeutics","id":"20838"},{"source":"piroxicam","target":"Halozyme Therapeutics","id":"20839"},{"source":"proton pump inhibitors","target":"Halozyme Therapeutics","id":"20840"},{"source":"unspecified","target":"Halozyme Therapeutics","id":"20841"},{"source":"UNK : Indication","target":"PEGPH20","id":"20842"},{"source":"UNK : Indication","target":"Halozyme (u)","id":"20843"},{"source":"UNK : Indication","target":"PEGPH20","id":"20844"},{"source":"UNK : Indication","target":"companion diagnostic","id":"20845"},{"source":"UNK : Indication","target":"Halozyme (u)","id":"20846"},{"source":"UNK : Indication","target":"pembrolizumab","id":"20847"},{"source":"UNK : Indication","target":"piroxicam","id":"20848"},{"source":"UNK : Indication","target":"proton pump inhibitors","id":"20849"},{"source":"UNK : Indication","target":"unspecified","id":"20850"},{"source":"anti-inflammatory","target":"PEGPH20","id":"20851"},{"source":"anti-inflammatory","target":"Halozyme (u)","id":"20852"},{"source":"anti-inflammatory","target":"PEGPH20","id":"20853"},{"source":"anti-inflammatory","target":"companion diagnostic","id":"20854"},{"source":"anti-inflammatory","target":"Halozyme (u)","id":"20855"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"20856"},{"source":"anti-inflammatory","target":"piroxicam","id":"20857"},{"source":"anti-inflammatory","target":"proton pump inhibitors","id":"20858"},{"source":"anti-inflammatory","target":"unspecified","id":"20859"},{"source":"non-small-cell lung","target":"PEGPH20","id":"20860"},{"source":"non-small-cell lung","target":"Halozyme (u)","id":"20861"},{"source":"non-small-cell lung","target":"PEGPH20","id":"20862"},{"source":"non-small-cell lung","target":"companion diagnostic","id":"20863"},{"source":"non-small-cell lung","target":"Halozyme (u)","id":"20864"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"20865"},{"source":"non-small-cell lung","target":"piroxicam","id":"20866"},{"source":"non-small-cell lung","target":"proton pump inhibitors","id":"20867"},{"source":"non-small-cell lung","target":"unspecified","id":"20868"},{"source":"antiallergic","target":"PEGPH20","id":"20869"},{"source":"antiallergic","target":"Halozyme (u)","id":"20870"},{"source":"antiallergic","target":"PEGPH20","id":"20871"},{"source":"antiallergic","target":"companion diagnostic","id":"20872"},{"source":"antiallergic","target":"Halozyme (u)","id":"20873"},{"source":"antiallergic","target":"pembrolizumab","id":"20874"},{"source":"antiallergic","target":"piroxicam","id":"20875"},{"source":"antiallergic","target":"proton pump inhibitors","id":"20876"},{"source":"antiallergic","target":"unspecified","id":"20877"},{"source":"spasm","target":"PEGPH20","id":"20878"},{"source":"spasm","target":"Halozyme (u)","id":"20879"},{"source":"spasm","target":"PEGPH20","id":"20880"},{"source":"spasm","target":"companion diagnostic","id":"20881"},{"source":"spasm","target":"Halozyme (u)","id":"20882"},{"source":"spasm","target":"pembrolizumab","id":"20883"},{"source":"spasm","target":"piroxicam","id":"20884"},{"source":"spasm","target":"proton pump inhibitors","id":"20885"},{"source":"spasm","target":"unspecified","id":"20886"},{"source":"inflammatory bowel diseases","target":"PEGPH20","id":"20887"},{"source":"inflammatory bowel diseases","target":"Halozyme (u)","id":"20888"},{"source":"inflammatory bowel diseases","target":"PEGPH20","id":"20889"},{"source":"inflammatory bowel diseases","target":"companion diagnostic","id":"20890"},{"source":"inflammatory bowel diseases","target":"Halozyme (u)","id":"20891"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"20892"},{"source":"inflammatory bowel diseases","target":"piroxicam","id":"20893"},{"source":"inflammatory bowel diseases","target":"proton pump inhibitors","id":"20894"},{"source":"inflammatory bowel diseases","target":"unspecified","id":"20895"},{"source":"non-small-cell lung","target":"PEGPH20","id":"20896"},{"source":"non-small-cell lung","target":"Halozyme (u)","id":"20897"},{"source":"non-small-cell lung","target":"PEGPH20","id":"20898"},{"source":"non-small-cell lung","target":"companion diagnostic","id":"20899"},{"source":"non-small-cell lung","target":"Halozyme (u)","id":"20900"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"20901"},{"source":"non-small-cell lung","target":"piroxicam","id":"20902"},{"source":"non-small-cell lung","target":"proton pump inhibitors","id":"20903"},{"source":"non-small-cell lung","target":"unspecified","id":"20904"},{"source":"peptic ulcer","target":"PEGPH20","id":"20905"},{"source":"peptic ulcer","target":"Halozyme (u)","id":"20906"},{"source":"peptic ulcer","target":"PEGPH20","id":"20907"},{"source":"peptic ulcer","target":"companion diagnostic","id":"20908"},{"source":"peptic ulcer","target":"Halozyme (u)","id":"20909"},{"source":"peptic ulcer","target":"pembrolizumab","id":"20910"},{"source":"peptic ulcer","target":"piroxicam","id":"20911"},{"source":"peptic ulcer","target":"proton pump inhibitors","id":"20912"},{"source":"peptic ulcer","target":"unspecified","id":"20913"},{"source":"spasm","target":"PEGPH20","id":"20914"},{"source":"spasm","target":"Halozyme (u)","id":"20915"},{"source":"spasm","target":"PEGPH20","id":"20916"},{"source":"spasm","target":"companion diagnostic","id":"20917"},{"source":"spasm","target":"Halozyme (u)","id":"20918"},{"source":"spasm","target":"pembrolizumab","id":"20919"},{"source":"spasm","target":"piroxicam","id":"20920"},{"source":"spasm","target":"proton pump inhibitors","id":"20921"},{"source":"spasm","target":"unspecified","id":"20922"},{"source":"inflammatory bowel diseases","target":"PEGPH20","id":"20923"},{"source":"inflammatory bowel diseases","target":"Halozyme (u)","id":"20924"},{"source":"inflammatory bowel diseases","target":"PEGPH20","id":"20925"},{"source":"inflammatory bowel diseases","target":"companion diagnostic","id":"20926"},{"source":"inflammatory bowel diseases","target":"Halozyme (u)","id":"20927"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"20928"},{"source":"inflammatory bowel diseases","target":"piroxicam","id":"20929"},{"source":"inflammatory bowel diseases","target":"proton pump inhibitors","id":"20930"},{"source":"inflammatory bowel diseases","target":"unspecified","id":"20931"},{"source":"inflammation","target":"PEGPH20","id":"20932"},{"source":"inflammation","target":"Halozyme (u)","id":"20933"},{"source":"inflammation","target":"PEGPH20","id":"20934"},{"source":"inflammation","target":"companion diagnostic","id":"20935"},{"source":"inflammation","target":"Halozyme (u)","id":"20936"},{"source":"inflammation","target":"pembrolizumab","id":"20937"},{"source":"inflammation","target":"piroxicam","id":"20938"},{"source":"inflammation","target":"proton pump inhibitors","id":"20939"},{"source":"inflammation","target":"unspecified","id":"20940"},{"source":"analgesic","target":"PEGPH20","id":"20941"},{"source":"analgesic","target":"Halozyme (u)","id":"20942"},{"source":"analgesic","target":"PEGPH20","id":"20943"},{"source":"analgesic","target":"companion diagnostic","id":"20944"},{"source":"analgesic","target":"Halozyme (u)","id":"20945"},{"source":"analgesic","target":"pembrolizumab","id":"20946"},{"source":"analgesic","target":"piroxicam","id":"20947"},{"source":"analgesic","target":"proton pump inhibitors","id":"20948"},{"source":"analgesic","target":"unspecified","id":"20949"},{"source":"sclc","target":"PEGPH20","id":"20950"},{"source":"sclc","target":"Halozyme (u)","id":"20951"},{"source":"sclc","target":"PEGPH20","id":"20952"},{"source":"sclc","target":"companion diagnostic","id":"20953"},{"source":"sclc","target":"Halozyme (u)","id":"20954"},{"source":"sclc","target":"pembrolizumab","id":"20955"},{"source":"sclc","target":"piroxicam","id":"20956"},{"source":"sclc","target":"proton pump inhibitors","id":"20957"},{"source":"sclc","target":"unspecified","id":"20958"},{"source":"pain","target":"PEGPH20","id":"20959"},{"source":"pain","target":"Halozyme (u)","id":"20960"},{"source":"pain","target":"PEGPH20","id":"20961"},{"source":"pain","target":"companion diagnostic","id":"20962"},{"source":"pain","target":"Halozyme (u)","id":"20963"},{"source":"pain","target":"pembrolizumab","id":"20964"},{"source":"pain","target":"piroxicam","id":"20965"},{"source":"pain","target":"proton pump inhibitors","id":"20966"},{"source":"pain","target":"unspecified","id":"20967"},{"source":"antiulcer","target":"PEGPH20","id":"20968"},{"source":"antiulcer","target":"Halozyme (u)","id":"20969"},{"source":"antiulcer","target":"PEGPH20","id":"20970"},{"source":"antiulcer","target":"companion diagnostic","id":"20971"},{"source":"antiulcer","target":"Halozyme (u)","id":"20972"},{"source":"antiulcer","target":"pembrolizumab","id":"20973"},{"source":"antiulcer","target":"piroxicam","id":"20974"},{"source":"antiulcer","target":"proton pump inhibitors","id":"20975"},{"source":"antiulcer","target":"unspecified","id":"20976"},{"source":"arthritis","target":"PEGPH20","id":"20977"},{"source":"arthritis","target":"Halozyme (u)","id":"20978"},{"source":"arthritis","target":"PEGPH20","id":"20979"},{"source":"arthritis","target":"companion diagnostic","id":"20980"},{"source":"arthritis","target":"Halozyme (u)","id":"20981"},{"source":"arthritis","target":"pembrolizumab","id":"20982"},{"source":"arthritis","target":"piroxicam","id":"20983"},{"source":"arthritis","target":"proton pump inhibitors","id":"20984"},{"source":"arthritis","target":"unspecified","id":"20985"},{"source":"anti-tumor","target":"PEGPH20","id":"20986"},{"source":"anti-tumor","target":"Halozyme (u)","id":"20987"},{"source":"anti-tumor","target":"PEGPH20","id":"20988"},{"source":"anti-tumor","target":"companion diagnostic","id":"20989"},{"source":"anti-tumor","target":"Halozyme (u)","id":"20990"},{"source":"anti-tumor","target":"pembrolizumab","id":"20991"},{"source":"anti-tumor","target":"piroxicam","id":"20992"},{"source":"anti-tumor","target":"proton pump inhibitors","id":"20993"},{"source":"anti-tumor","target":"unspecified","id":"20994"},{"source":"carcinoma","target":"PEGPH20","id":"20995"},{"source":"carcinoma","target":"Halozyme (u)","id":"20996"},{"source":"carcinoma","target":"PEGPH20","id":"20997"},{"source":"carcinoma","target":"companion diagnostic","id":"20998"},{"source":"carcinoma","target":"Halozyme (u)","id":"20999"},{"source":"carcinoma","target":"pembrolizumab","id":"21000"},{"source":"carcinoma","target":"piroxicam","id":"21001"},{"source":"carcinoma","target":"proton pump inhibitors","id":"21002"},{"source":"carcinoma","target":"unspecified","id":"21003"},{"source":"carcinoma","target":"PEGPH20","id":"21004"},{"source":"carcinoma","target":"Halozyme (u)","id":"21005"},{"source":"carcinoma","target":"PEGPH20","id":"21006"},{"source":"carcinoma","target":"companion diagnostic","id":"21007"},{"source":"carcinoma","target":"Halozyme (u)","id":"21008"},{"source":"carcinoma","target":"pembrolizumab","id":"21009"},{"source":"carcinoma","target":"piroxicam","id":"21010"},{"source":"carcinoma","target":"proton pump inhibitors","id":"21011"},{"source":"carcinoma","target":"unspecified","id":"21012"},{"source":"solid tumors","target":"PEGPH20","id":"21013"},{"source":"solid tumors","target":"Halozyme (u)","id":"21014"},{"source":"solid tumors","target":"PEGPH20","id":"21015"},{"source":"solid tumors","target":"companion diagnostic","id":"21016"},{"source":"solid tumors","target":"Halozyme (u)","id":"21017"},{"source":"solid tumors","target":"pembrolizumab","id":"21018"},{"source":"solid tumors","target":"piroxicam","id":"21019"},{"source":"solid tumors","target":"proton pump inhibitors","id":"21020"},{"source":"solid tumors","target":"unspecified","id":"21021"},{"source":"carcinoma","target":"PEGPH20","id":"21022"},{"source":"carcinoma","target":"Halozyme (u)","id":"21023"},{"source":"carcinoma","target":"PEGPH20","id":"21024"},{"source":"carcinoma","target":"companion diagnostic","id":"21025"},{"source":"carcinoma","target":"Halozyme (u)","id":"21026"},{"source":"carcinoma","target":"pembrolizumab","id":"21027"},{"source":"carcinoma","target":"piroxicam","id":"21028"},{"source":"carcinoma","target":"proton pump inhibitors","id":"21029"},{"source":"carcinoma","target":"unspecified","id":"21030"},{"source":"neoplasm metastasis","target":"PEGPH20","id":"21031"},{"source":"neoplasm metastasis","target":"Halozyme (u)","id":"21032"},{"source":"neoplasm metastasis","target":"PEGPH20","id":"21033"},{"source":"neoplasm metastasis","target":"companion diagnostic","id":"21034"},{"source":"neoplasm metastasis","target":"Halozyme (u)","id":"21035"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"21036"},{"source":"neoplasm metastasis","target":"piroxicam","id":"21037"},{"source":"neoplasm metastasis","target":"proton pump inhibitors","id":"21038"},{"source":"neoplasm metastasis","target":"unspecified","id":"21039"},{"source":"lymphoma","target":"PEGPH20","id":"21040"},{"source":"lymphoma","target":"Halozyme (u)","id":"21041"},{"source":"lymphoma","target":"PEGPH20","id":"21042"},{"source":"lymphoma","target":"companion diagnostic","id":"21043"},{"source":"lymphoma","target":"Halozyme (u)","id":"21044"},{"source":"lymphoma","target":"pembrolizumab","id":"21045"},{"source":"lymphoma","target":"piroxicam","id":"21046"},{"source":"lymphoma","target":"proton pump inhibitors","id":"21047"},{"source":"lymphoma","target":"unspecified","id":"21048"},{"source":"carcinoma","target":"PEGPH20","id":"21049"},{"source":"carcinoma","target":"Halozyme (u)","id":"21050"},{"source":"carcinoma","target":"PEGPH20","id":"21051"},{"source":"carcinoma","target":"companion diagnostic","id":"21052"},{"source":"carcinoma","target":"Halozyme (u)","id":"21053"},{"source":"carcinoma","target":"pembrolizumab","id":"21054"},{"source":"carcinoma","target":"piroxicam","id":"21055"},{"source":"carcinoma","target":"proton pump inhibitors","id":"21056"},{"source":"carcinoma","target":"unspecified","id":"21057"},{"source":"stomach neoplasms","target":"PEGPH20","id":"21058"},{"source":"stomach neoplasms","target":"Halozyme (u)","id":"21059"},{"source":"stomach neoplasms","target":"PEGPH20","id":"21060"},{"source":"stomach neoplasms","target":"companion diagnostic","id":"21061"},{"source":"stomach neoplasms","target":"Halozyme (u)","id":"21062"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"21063"},{"source":"stomach neoplasms","target":"piroxicam","id":"21064"},{"source":"stomach neoplasms","target":"proton pump inhibitors","id":"21065"},{"source":"stomach neoplasms","target":"unspecified","id":"21066"},{"source":"residual tumor","target":"PEGPH20","id":"21067"},{"source":"residual tumor","target":"Halozyme (u)","id":"21068"},{"source":"residual tumor","target":"PEGPH20","id":"21069"},{"source":"residual tumor","target":"companion diagnostic","id":"21070"},{"source":"residual tumor","target":"Halozyme (u)","id":"21071"},{"source":"residual tumor","target":"pembrolizumab","id":"21072"},{"source":"residual tumor","target":"piroxicam","id":"21073"},{"source":"residual tumor","target":"proton pump inhibitors","id":"21074"},{"source":"residual tumor","target":"unspecified","id":"21075"},{"source":"residual tumor","target":"PEGPH20","id":"21076"},{"source":"residual tumor","target":"Halozyme (u)","id":"21077"},{"source":"residual tumor","target":"PEGPH20","id":"21078"},{"source":"residual tumor","target":"companion diagnostic","id":"21079"},{"source":"residual tumor","target":"Halozyme (u)","id":"21080"},{"source":"residual tumor","target":"pembrolizumab","id":"21081"},{"source":"residual tumor","target":"piroxicam","id":"21082"},{"source":"residual tumor","target":"proton pump inhibitors","id":"21083"},{"source":"residual tumor","target":"unspecified","id":"21084"},{"source":"metastatic","target":"PEGPH20","id":"21085"},{"source":"metastatic","target":"Halozyme (u)","id":"21086"},{"source":"metastatic","target":"PEGPH20","id":"21087"},{"source":"metastatic","target":"companion diagnostic","id":"21088"},{"source":"metastatic","target":"Halozyme (u)","id":"21089"},{"source":"metastatic","target":"pembrolizumab","id":"21090"},{"source":"metastatic","target":"piroxicam","id":"21091"},{"source":"metastatic","target":"proton pump inhibitors","id":"21092"},{"source":"metastatic","target":"unspecified","id":"21093"},{"source":"anticancer","target":"PEGPH20","id":"21094"},{"source":"anticancer","target":"Halozyme (u)","id":"21095"},{"source":"anticancer","target":"PEGPH20","id":"21096"},{"source":"anticancer","target":"companion diagnostic","id":"21097"},{"source":"anticancer","target":"Halozyme (u)","id":"21098"},{"source":"anticancer","target":"pembrolizumab","id":"21099"},{"source":"anticancer","target":"piroxicam","id":"21100"},{"source":"anticancer","target":"proton pump inhibitors","id":"21101"},{"source":"anticancer","target":"unspecified","id":"21102"},{"source":"antiarthritic","target":"PEGPH20","id":"21103"},{"source":"antiarthritic","target":"Halozyme (u)","id":"21104"},{"source":"antiarthritic","target":"PEGPH20","id":"21105"},{"source":"antiarthritic","target":"companion diagnostic","id":"21106"},{"source":"antiarthritic","target":"Halozyme (u)","id":"21107"},{"source":"antiarthritic","target":"pembrolizumab","id":"21108"},{"source":"antiarthritic","target":"piroxicam","id":"21109"},{"source":"antiarthritic","target":"proton pump inhibitors","id":"21110"},{"source":"antiarthritic","target":"unspecified","id":"21111"},{"source":"solid tumors","target":"PEGPH20","id":"21112"},{"source":"solid tumors","target":"Halozyme (u)","id":"21113"},{"source":"solid tumors","target":"PEGPH20","id":"21114"},{"source":"solid tumors","target":"companion diagnostic","id":"21115"},{"source":"solid tumors","target":"Halozyme (u)","id":"21116"},{"source":"solid tumors","target":"pembrolizumab","id":"21117"},{"source":"solid tumors","target":"piroxicam","id":"21118"},{"source":"solid tumors","target":"proton pump inhibitors","id":"21119"},{"source":"solid tumors","target":"unspecified","id":"21120"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"21121"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"21122"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"21123"},{"source":"Immune checkpoint inhibitor","target":"antiallergic","id":"21124"},{"source":"Immune checkpoint inhibitor","target":"spasm","id":"21125"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"21126"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"21127"},{"source":"Immune checkpoint inhibitor","target":"peptic ulcer","id":"21128"},{"source":"Immune checkpoint inhibitor","target":"spasm","id":"21129"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"21130"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"21131"},{"source":"Immune checkpoint inhibitor","target":"analgesic","id":"21132"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"21133"},{"source":"Immune checkpoint inhibitor","target":"pain","id":"21134"},{"source":"Immune checkpoint inhibitor","target":"antiulcer","id":"21135"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"21136"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"21137"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21138"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21139"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"21140"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21141"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"21142"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"21143"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21144"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"21145"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"21146"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"21147"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"21148"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"21149"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"21150"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"21151"},{"source":"NA","target":"UNK : Indication","id":"21152"},{"source":"NA","target":"anti-inflammatory","id":"21153"},{"source":"NA","target":"non-small-cell lung","id":"21154"},{"source":"NA","target":"antiallergic","id":"21155"},{"source":"NA","target":"spasm","id":"21156"},{"source":"NA","target":"inflammatory bowel diseases","id":"21157"},{"source":"NA","target":"non-small-cell lung","id":"21158"},{"source":"NA","target":"peptic ulcer","id":"21159"},{"source":"NA","target":"spasm","id":"21160"},{"source":"NA","target":"inflammatory bowel diseases","id":"21161"},{"source":"NA","target":"inflammation","id":"21162"},{"source":"NA","target":"analgesic","id":"21163"},{"source":"NA","target":"sclc","id":"21164"},{"source":"NA","target":"pain","id":"21165"},{"source":"NA","target":"antiulcer","id":"21166"},{"source":"NA","target":"arthritis","id":"21167"},{"source":"NA","target":"anti-tumor","id":"21168"},{"source":"NA","target":"carcinoma","id":"21169"},{"source":"NA","target":"carcinoma","id":"21170"},{"source":"NA","target":"solid tumors","id":"21171"},{"source":"NA","target":"carcinoma","id":"21172"},{"source":"NA","target":"neoplasm metastasis","id":"21173"},{"source":"NA","target":"lymphoma","id":"21174"},{"source":"NA","target":"carcinoma","id":"21175"},{"source":"NA","target":"stomach neoplasms","id":"21176"},{"source":"NA","target":"residual tumor","id":"21177"},{"source":"NA","target":"residual tumor","id":"21178"},{"source":"NA","target":"metastatic","id":"21179"},{"source":"NA","target":"anticancer","id":"21180"},{"source":"NA","target":"antiarthritic","id":"21181"},{"source":"NA","target":"solid tumors","id":"21182"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"21183"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"21184"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"21185"},{"source":"Anticancer immunotherapy","target":"antiallergic","id":"21186"},{"source":"Anticancer immunotherapy","target":"spasm","id":"21187"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"21188"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"21189"},{"source":"Anticancer immunotherapy","target":"peptic ulcer","id":"21190"},{"source":"Anticancer immunotherapy","target":"spasm","id":"21191"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"21192"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"21193"},{"source":"Anticancer immunotherapy","target":"analgesic","id":"21194"},{"source":"Anticancer immunotherapy","target":"sclc","id":"21195"},{"source":"Anticancer immunotherapy","target":"pain","id":"21196"},{"source":"Anticancer immunotherapy","target":"antiulcer","id":"21197"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"21198"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"21199"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21200"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21201"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"21202"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21203"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"21204"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"21205"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21206"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"21207"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"21208"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"21209"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"21210"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"21211"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"21212"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"21213"},{"source":"Hyaluronidase stimulant","target":"UNK : Indication","id":"21214"},{"source":"Hyaluronidase stimulant","target":"anti-inflammatory","id":"21215"},{"source":"Hyaluronidase stimulant","target":"non-small-cell lung","id":"21216"},{"source":"Hyaluronidase stimulant","target":"antiallergic","id":"21217"},{"source":"Hyaluronidase stimulant","target":"spasm","id":"21218"},{"source":"Hyaluronidase stimulant","target":"inflammatory bowel diseases","id":"21219"},{"source":"Hyaluronidase stimulant","target":"non-small-cell lung","id":"21220"},{"source":"Hyaluronidase stimulant","target":"peptic ulcer","id":"21221"},{"source":"Hyaluronidase stimulant","target":"spasm","id":"21222"},{"source":"Hyaluronidase stimulant","target":"inflammatory bowel diseases","id":"21223"},{"source":"Hyaluronidase stimulant","target":"inflammation","id":"21224"},{"source":"Hyaluronidase stimulant","target":"analgesic","id":"21225"},{"source":"Hyaluronidase stimulant","target":"sclc","id":"21226"},{"source":"Hyaluronidase stimulant","target":"pain","id":"21227"},{"source":"Hyaluronidase stimulant","target":"antiulcer","id":"21228"},{"source":"Hyaluronidase stimulant","target":"arthritis","id":"21229"},{"source":"Hyaluronidase stimulant","target":"anti-tumor","id":"21230"},{"source":"Hyaluronidase stimulant","target":"carcinoma","id":"21231"},{"source":"Hyaluronidase stimulant","target":"carcinoma","id":"21232"},{"source":"Hyaluronidase stimulant","target":"solid tumors","id":"21233"},{"source":"Hyaluronidase stimulant","target":"carcinoma","id":"21234"},{"source":"Hyaluronidase stimulant","target":"neoplasm metastasis","id":"21235"},{"source":"Hyaluronidase stimulant","target":"lymphoma","id":"21236"},{"source":"Hyaluronidase stimulant","target":"carcinoma","id":"21237"},{"source":"Hyaluronidase stimulant","target":"stomach neoplasms","id":"21238"},{"source":"Hyaluronidase stimulant","target":"residual tumor","id":"21239"},{"source":"Hyaluronidase stimulant","target":"residual tumor","id":"21240"},{"source":"Hyaluronidase stimulant","target":"metastatic","id":"21241"},{"source":"Hyaluronidase stimulant","target":"anticancer","id":"21242"},{"source":"Hyaluronidase stimulant","target":"antiarthritic","id":"21243"},{"source":"Hyaluronidase stimulant","target":"solid tumors","id":"21244"},{"source":"NA","target":"UNK : Indication","id":"21245"},{"source":"NA","target":"anti-inflammatory","id":"21246"},{"source":"NA","target":"non-small-cell lung","id":"21247"},{"source":"NA","target":"antiallergic","id":"21248"},{"source":"NA","target":"spasm","id":"21249"},{"source":"NA","target":"inflammatory bowel diseases","id":"21250"},{"source":"NA","target":"non-small-cell lung","id":"21251"},{"source":"NA","target":"peptic ulcer","id":"21252"},{"source":"NA","target":"spasm","id":"21253"},{"source":"NA","target":"inflammatory bowel diseases","id":"21254"},{"source":"NA","target":"inflammation","id":"21255"},{"source":"NA","target":"analgesic","id":"21256"},{"source":"NA","target":"sclc","id":"21257"},{"source":"NA","target":"pain","id":"21258"},{"source":"NA","target":"antiulcer","id":"21259"},{"source":"NA","target":"arthritis","id":"21260"},{"source":"NA","target":"anti-tumor","id":"21261"},{"source":"NA","target":"carcinoma","id":"21262"},{"source":"NA","target":"carcinoma","id":"21263"},{"source":"NA","target":"solid tumors","id":"21264"},{"source":"NA","target":"carcinoma","id":"21265"},{"source":"NA","target":"neoplasm metastasis","id":"21266"},{"source":"NA","target":"lymphoma","id":"21267"},{"source":"NA","target":"carcinoma","id":"21268"},{"source":"NA","target":"stomach neoplasms","id":"21269"},{"source":"NA","target":"residual tumor","id":"21270"},{"source":"NA","target":"residual tumor","id":"21271"},{"source":"NA","target":"metastatic","id":"21272"},{"source":"NA","target":"anticancer","id":"21273"},{"source":"NA","target":"antiarthritic","id":"21274"},{"source":"NA","target":"solid tumors","id":"21275"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"21276"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"21277"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"21278"},{"source":"CD19 antagonist","target":"antiallergic","id":"21279"},{"source":"CD19 antagonist","target":"spasm","id":"21280"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"21281"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"21282"},{"source":"CD19 antagonist","target":"peptic ulcer","id":"21283"},{"source":"CD19 antagonist","target":"spasm","id":"21284"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"21285"},{"source":"CD19 antagonist","target":"inflammation","id":"21286"},{"source":"CD19 antagonist","target":"analgesic","id":"21287"},{"source":"CD19 antagonist","target":"sclc","id":"21288"},{"source":"CD19 antagonist","target":"pain","id":"21289"},{"source":"CD19 antagonist","target":"antiulcer","id":"21290"},{"source":"CD19 antagonist","target":"arthritis","id":"21291"},{"source":"CD19 antagonist","target":"anti-tumor","id":"21292"},{"source":"CD19 antagonist","target":"carcinoma","id":"21293"},{"source":"CD19 antagonist","target":"carcinoma","id":"21294"},{"source":"CD19 antagonist","target":"solid tumors","id":"21295"},{"source":"CD19 antagonist","target":"carcinoma","id":"21296"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"21297"},{"source":"CD19 antagonist","target":"lymphoma","id":"21298"},{"source":"CD19 antagonist","target":"carcinoma","id":"21299"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"21300"},{"source":"CD19 antagonist","target":"residual tumor","id":"21301"},{"source":"CD19 antagonist","target":"residual tumor","id":"21302"},{"source":"CD19 antagonist","target":"metastatic","id":"21303"},{"source":"CD19 antagonist","target":"anticancer","id":"21304"},{"source":"CD19 antagonist","target":"antiarthritic","id":"21305"},{"source":"CD19 antagonist","target":"solid tumors","id":"21306"},{"source":"NA","target":"UNK : Indication","id":"21307"},{"source":"NA","target":"anti-inflammatory","id":"21308"},{"source":"NA","target":"non-small-cell lung","id":"21309"},{"source":"NA","target":"antiallergic","id":"21310"},{"source":"NA","target":"spasm","id":"21311"},{"source":"NA","target":"inflammatory bowel diseases","id":"21312"},{"source":"NA","target":"non-small-cell lung","id":"21313"},{"source":"NA","target":"peptic ulcer","id":"21314"},{"source":"NA","target":"spasm","id":"21315"},{"source":"NA","target":"inflammatory bowel diseases","id":"21316"},{"source":"NA","target":"inflammation","id":"21317"},{"source":"NA","target":"analgesic","id":"21318"},{"source":"NA","target":"sclc","id":"21319"},{"source":"NA","target":"pain","id":"21320"},{"source":"NA","target":"antiulcer","id":"21321"},{"source":"NA","target":"arthritis","id":"21322"},{"source":"NA","target":"anti-tumor","id":"21323"},{"source":"NA","target":"carcinoma","id":"21324"},{"source":"NA","target":"carcinoma","id":"21325"},{"source":"NA","target":"solid tumors","id":"21326"},{"source":"NA","target":"carcinoma","id":"21327"},{"source":"NA","target":"neoplasm metastasis","id":"21328"},{"source":"NA","target":"lymphoma","id":"21329"},{"source":"NA","target":"carcinoma","id":"21330"},{"source":"NA","target":"stomach neoplasms","id":"21331"},{"source":"NA","target":"residual tumor","id":"21332"},{"source":"NA","target":"residual tumor","id":"21333"},{"source":"NA","target":"metastatic","id":"21334"},{"source":"NA","target":"anticancer","id":"21335"},{"source":"NA","target":"antiarthritic","id":"21336"},{"source":"NA","target":"solid tumors","id":"21337"},{"source":"General pump inhibitor","target":"UNK : Indication","id":"21338"},{"source":"General pump inhibitor","target":"anti-inflammatory","id":"21339"},{"source":"General pump inhibitor","target":"non-small-cell lung","id":"21340"},{"source":"General pump inhibitor","target":"antiallergic","id":"21341"},{"source":"General pump inhibitor","target":"spasm","id":"21342"},{"source":"General pump inhibitor","target":"inflammatory bowel diseases","id":"21343"},{"source":"General pump inhibitor","target":"non-small-cell lung","id":"21344"},{"source":"General pump inhibitor","target":"peptic ulcer","id":"21345"},{"source":"General pump inhibitor","target":"spasm","id":"21346"},{"source":"General pump inhibitor","target":"inflammatory bowel diseases","id":"21347"},{"source":"General pump inhibitor","target":"inflammation","id":"21348"},{"source":"General pump inhibitor","target":"analgesic","id":"21349"},{"source":"General pump inhibitor","target":"sclc","id":"21350"},{"source":"General pump inhibitor","target":"pain","id":"21351"},{"source":"General pump inhibitor","target":"antiulcer","id":"21352"},{"source":"General pump inhibitor","target":"arthritis","id":"21353"},{"source":"General pump inhibitor","target":"anti-tumor","id":"21354"},{"source":"General pump inhibitor","target":"carcinoma","id":"21355"},{"source":"General pump inhibitor","target":"carcinoma","id":"21356"},{"source":"General pump inhibitor","target":"solid tumors","id":"21357"},{"source":"General pump inhibitor","target":"carcinoma","id":"21358"},{"source":"General pump inhibitor","target":"neoplasm metastasis","id":"21359"},{"source":"General pump inhibitor","target":"lymphoma","id":"21360"},{"source":"General pump inhibitor","target":"carcinoma","id":"21361"},{"source":"General pump inhibitor","target":"stomach neoplasms","id":"21362"},{"source":"General pump inhibitor","target":"residual tumor","id":"21363"},{"source":"General pump inhibitor","target":"residual tumor","id":"21364"},{"source":"General pump inhibitor","target":"metastatic","id":"21365"},{"source":"General pump inhibitor","target":"anticancer","id":"21366"},{"source":"General pump inhibitor","target":"antiarthritic","id":"21367"},{"source":"General pump inhibitor","target":"solid tumors","id":"21368"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"21369"},{"source":"Oncology: Gastric","target":"NA","id":"21370"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"21371"},{"source":"Oncology: Gastric","target":"Hyaluronidase stimulant","id":"21372"},{"source":"Oncology: Gastric","target":"NA","id":"21373"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"21374"},{"source":"Oncology: Gastric","target":"NA","id":"21375"},{"source":"Oncology: Gastric","target":"General pump inhibitor","id":"21376"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"21377"},{"source":"Oncology: Lung","target":"NA","id":"21378"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"21379"},{"source":"Oncology: Lung","target":"Hyaluronidase stimulant","id":"21380"},{"source":"Oncology: Lung","target":"NA","id":"21381"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"21382"},{"source":"Oncology: Lung","target":"NA","id":"21383"},{"source":"Oncology: Lung","target":"General pump inhibitor","id":"21384"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"21385"},{"source":"Non-Small Cell","target":"NA","id":"21386"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"21387"},{"source":"Non-Small Cell","target":"Hyaluronidase stimulant","id":"21388"},{"source":"Non-Small Cell","target":"NA","id":"21389"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"21390"},{"source":"Non-Small Cell","target":"NA","id":"21391"},{"source":"Non-Small Cell","target":"General pump inhibitor","id":"21392"},{"source":"vitespen (intradermal) (u)","target":"National Institutes of Health/National Cancer Institute","id":"21393"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"21394"},{"source":"radiation therapy","target":"National Institutes of Health/National Cancer Institute","id":"21395"},{"source":"surgical intervention","target":"National Institutes of Health/National Cancer Institute","id":"21396"},{"source":"temozolomide (IV)","target":"National Institutes of Health/National Cancer Institute","id":"21397"},{"source":"UNK : Indication","target":"vitespen (intradermal) (u)","id":"21398"},{"source":"UNK : Indication","target":"pembrolizumab","id":"21399"},{"source":"UNK : Indication","target":"radiation therapy","id":"21400"},{"source":"UNK : Indication","target":"surgical intervention","id":"21401"},{"source":"UNK : Indication","target":"temozolomide (IV)","id":"21402"},{"source":"gilbert disease","target":"vitespen (intradermal) (u)","id":"21403"},{"source":"gilbert disease","target":"pembrolizumab","id":"21404"},{"source":"gilbert disease","target":"radiation therapy","id":"21405"},{"source":"gilbert disease","target":"surgical intervention","id":"21406"},{"source":"gilbert disease","target":"temozolomide (IV)","id":"21407"},{"source":"astrocytoma","target":"vitespen (intradermal) (u)","id":"21408"},{"source":"astrocytoma","target":"pembrolizumab","id":"21409"},{"source":"astrocytoma","target":"radiation therapy","id":"21410"},{"source":"astrocytoma","target":"surgical intervention","id":"21411"},{"source":"astrocytoma","target":"temozolomide (IV)","id":"21412"},{"source":"gbm","target":"vitespen (intradermal) (u)","id":"21413"},{"source":"gbm","target":"pembrolizumab","id":"21414"},{"source":"gbm","target":"radiation therapy","id":"21415"},{"source":"gbm","target":"surgical intervention","id":"21416"},{"source":"gbm","target":"temozolomide (IV)","id":"21417"},{"source":"glioblastoma","target":"vitespen (intradermal) (u)","id":"21418"},{"source":"glioblastoma","target":"pembrolizumab","id":"21419"},{"source":"glioblastoma","target":"radiation therapy","id":"21420"},{"source":"glioblastoma","target":"surgical intervention","id":"21421"},{"source":"glioblastoma","target":"temozolomide (IV)","id":"21422"},{"source":"residual tumor","target":"vitespen (intradermal) (u)","id":"21423"},{"source":"residual tumor","target":"pembrolizumab","id":"21424"},{"source":"residual tumor","target":"radiation therapy","id":"21425"},{"source":"residual tumor","target":"surgical intervention","id":"21426"},{"source":"residual tumor","target":"temozolomide (IV)","id":"21427"},{"source":"cellulitis","target":"vitespen (intradermal) (u)","id":"21428"},{"source":"cellulitis","target":"pembrolizumab","id":"21429"},{"source":"cellulitis","target":"radiation therapy","id":"21430"},{"source":"cellulitis","target":"surgical intervention","id":"21431"},{"source":"cellulitis","target":"temozolomide (IV)","id":"21432"},{"source":"glioblastoma","target":"vitespen (intradermal) (u)","id":"21433"},{"source":"glioblastoma","target":"pembrolizumab","id":"21434"},{"source":"glioblastoma","target":"radiation therapy","id":"21435"},{"source":"glioblastoma","target":"surgical intervention","id":"21436"},{"source":"glioblastoma","target":"temozolomide (IV)","id":"21437"},{"source":"carcinoma","target":"vitespen (intradermal) (u)","id":"21438"},{"source":"carcinoma","target":"pembrolizumab","id":"21439"},{"source":"carcinoma","target":"radiation therapy","id":"21440"},{"source":"carcinoma","target":"surgical intervention","id":"21441"},{"source":"carcinoma","target":"temozolomide (IV)","id":"21442"},{"source":"gilbert disease","target":"vitespen (intradermal) (u)","id":"21443"},{"source":"gilbert disease","target":"pembrolizumab","id":"21444"},{"source":"gilbert disease","target":"radiation therapy","id":"21445"},{"source":"gilbert disease","target":"surgical intervention","id":"21446"},{"source":"gilbert disease","target":"temozolomide (IV)","id":"21447"},{"source":"anticancer","target":"vitespen (intradermal) (u)","id":"21448"},{"source":"anticancer","target":"pembrolizumab","id":"21449"},{"source":"anticancer","target":"radiation therapy","id":"21450"},{"source":"anticancer","target":"surgical intervention","id":"21451"},{"source":"anticancer","target":"temozolomide (IV)","id":"21452"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"21453"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"21454"},{"source":"Immune checkpoint inhibitor","target":"astrocytoma","id":"21455"},{"source":"Immune checkpoint inhibitor","target":"gbm","id":"21456"},{"source":"Immune checkpoint inhibitor","target":"glioblastoma","id":"21457"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"21458"},{"source":"Immune checkpoint inhibitor","target":"cellulitis","id":"21459"},{"source":"Immune checkpoint inhibitor","target":"glioblastoma","id":"21460"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21461"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"21462"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"21463"},{"source":"NA","target":"UNK : Indication","id":"21464"},{"source":"NA","target":"gilbert disease","id":"21465"},{"source":"NA","target":"astrocytoma","id":"21466"},{"source":"NA","target":"gbm","id":"21467"},{"source":"NA","target":"glioblastoma","id":"21468"},{"source":"NA","target":"residual tumor","id":"21469"},{"source":"NA","target":"cellulitis","id":"21470"},{"source":"NA","target":"glioblastoma","id":"21471"},{"source":"NA","target":"carcinoma","id":"21472"},{"source":"NA","target":"gilbert disease","id":"21473"},{"source":"NA","target":"anticancer","id":"21474"},{"source":"NA","target":"UNK : Indication","id":"21475"},{"source":"NA","target":"gilbert disease","id":"21476"},{"source":"NA","target":"astrocytoma","id":"21477"},{"source":"NA","target":"gbm","id":"21478"},{"source":"NA","target":"glioblastoma","id":"21479"},{"source":"NA","target":"residual tumor","id":"21480"},{"source":"NA","target":"cellulitis","id":"21481"},{"source":"NA","target":"glioblastoma","id":"21482"},{"source":"NA","target":"carcinoma","id":"21483"},{"source":"NA","target":"gilbert disease","id":"21484"},{"source":"NA","target":"anticancer","id":"21485"},{"source":"UPA","target":"UNK : Indication","id":"21486"},{"source":"UPA","target":"gilbert disease","id":"21487"},{"source":"UPA","target":"astrocytoma","id":"21488"},{"source":"UPA","target":"gbm","id":"21489"},{"source":"UPA","target":"glioblastoma","id":"21490"},{"source":"UPA","target":"residual tumor","id":"21491"},{"source":"UPA","target":"cellulitis","id":"21492"},{"source":"UPA","target":"glioblastoma","id":"21493"},{"source":"UPA","target":"carcinoma","id":"21494"},{"source":"UPA","target":"gilbert disease","id":"21495"},{"source":"UPA","target":"anticancer","id":"21496"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"21497"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"21498"},{"source":"Anticancer immunotherapy","target":"astrocytoma","id":"21499"},{"source":"Anticancer immunotherapy","target":"gbm","id":"21500"},{"source":"Anticancer immunotherapy","target":"glioblastoma","id":"21501"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"21502"},{"source":"Anticancer immunotherapy","target":"cellulitis","id":"21503"},{"source":"Anticancer immunotherapy","target":"glioblastoma","id":"21504"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21505"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"21506"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"21507"},{"source":"Immunostimulant","target":"UNK : Indication","id":"21508"},{"source":"Immunostimulant","target":"gilbert disease","id":"21509"},{"source":"Immunostimulant","target":"astrocytoma","id":"21510"},{"source":"Immunostimulant","target":"gbm","id":"21511"},{"source":"Immunostimulant","target":"glioblastoma","id":"21512"},{"source":"Immunostimulant","target":"residual tumor","id":"21513"},{"source":"Immunostimulant","target":"cellulitis","id":"21514"},{"source":"Immunostimulant","target":"glioblastoma","id":"21515"},{"source":"Immunostimulant","target":"carcinoma","id":"21516"},{"source":"Immunostimulant","target":"gilbert disease","id":"21517"},{"source":"Immunostimulant","target":"anticancer","id":"21518"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"21519"},{"source":"CD19 antagonist","target":"gilbert disease","id":"21520"},{"source":"CD19 antagonist","target":"astrocytoma","id":"21521"},{"source":"CD19 antagonist","target":"gbm","id":"21522"},{"source":"CD19 antagonist","target":"glioblastoma","id":"21523"},{"source":"CD19 antagonist","target":"residual tumor","id":"21524"},{"source":"CD19 antagonist","target":"cellulitis","id":"21525"},{"source":"CD19 antagonist","target":"glioblastoma","id":"21526"},{"source":"CD19 antagonist","target":"carcinoma","id":"21527"},{"source":"CD19 antagonist","target":"gilbert disease","id":"21528"},{"source":"CD19 antagonist","target":"anticancer","id":"21529"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"21530"},{"source":"Oncology: CNS","target":"NA","id":"21531"},{"source":"Oncology: CNS","target":"NA","id":"21532"},{"source":"Oncology: CNS","target":"UPA","id":"21533"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"21534"},{"source":"Oncology: CNS","target":"Immunostimulant","id":"21535"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"21536"},{"source":"Glioblastoma","target":"Immune checkpoint inhibitor","id":"21537"},{"source":"Glioblastoma","target":"NA","id":"21538"},{"source":"Glioblastoma","target":"NA","id":"21539"},{"source":"Glioblastoma","target":"UPA","id":"21540"},{"source":"Glioblastoma","target":"Anticancer immunotherapy","id":"21541"},{"source":"Glioblastoma","target":"Immunostimulant","id":"21542"},{"source":"Glioblastoma","target":"CD19 antagonist","id":"21543"},{"source":"pembrolizumab","target":"Merck & Co.","id":"21544"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"21545"},{"source":"UNK : Indication","target":"pembrolizumab","id":"21546"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"21547"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"21548"},{"source":"pharyngeal neoplasms","target":"nab-paclitaxel (IV)","id":"21549"},{"source":"residual tumor","target":"pembrolizumab","id":"21550"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"21551"},{"source":"esophageal cancer","target":"pembrolizumab","id":"21552"},{"source":"esophageal cancer","target":"nab-paclitaxel (IV)","id":"21553"},{"source":"anticancer","target":"pembrolizumab","id":"21554"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"21555"},{"source":"carcinoma","target":"pembrolizumab","id":"21556"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"21557"},{"source":"residual tumor","target":"pembrolizumab","id":"21558"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"21559"},{"source":"gastric cancer","target":"pembrolizumab","id":"21560"},{"source":"gastric cancer","target":"nab-paclitaxel (IV)","id":"21561"},{"source":"metastatic","target":"pembrolizumab","id":"21562"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"21563"},{"source":"carcinoma","target":"pembrolizumab","id":"21564"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"21565"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"21566"},{"source":"stomach neoplasms","target":"nab-paclitaxel (IV)","id":"21567"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"21568"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"21569"},{"source":"carcinoma","target":"pembrolizumab","id":"21570"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"21571"},{"source":"anticancer","target":"pembrolizumab","id":"21572"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"21573"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"21574"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"21575"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"21576"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"21577"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"21578"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21579"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"21580"},{"source":"Immune checkpoint inhibitor","target":"gastric cancer","id":"21581"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"21582"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21583"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"21584"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"21585"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21586"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"21587"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"21588"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"21589"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"21590"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"21591"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"21592"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21593"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"21594"},{"source":"Anticancer immunotherapy","target":"gastric cancer","id":"21595"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"21596"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21597"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"21598"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"21599"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21600"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"21601"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"21602"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"21603"},{"source":"CD19 antagonist","target":"residual tumor","id":"21604"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"21605"},{"source":"CD19 antagonist","target":"anticancer","id":"21606"},{"source":"CD19 antagonist","target":"carcinoma","id":"21607"},{"source":"CD19 antagonist","target":"residual tumor","id":"21608"},{"source":"CD19 antagonist","target":"gastric cancer","id":"21609"},{"source":"CD19 antagonist","target":"metastatic","id":"21610"},{"source":"CD19 antagonist","target":"carcinoma","id":"21611"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"21612"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"21613"},{"source":"CD19 antagonist","target":"carcinoma","id":"21614"},{"source":"CD19 antagonist","target":"anticancer","id":"21615"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"21616"},{"source":"Beta tubulin antagonist","target":"pharyngeal neoplasms","id":"21617"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"21618"},{"source":"Beta tubulin antagonist","target":"esophageal cancer","id":"21619"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"21620"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"21621"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"21622"},{"source":"Beta tubulin antagonist","target":"gastric cancer","id":"21623"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"21624"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"21625"},{"source":"Beta tubulin antagonist","target":"stomach neoplasms","id":"21626"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"21627"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"21628"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"21629"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"21630"},{"source":"Microtubule stimulant","target":"pharyngeal neoplasms","id":"21631"},{"source":"Microtubule stimulant","target":"residual tumor","id":"21632"},{"source":"Microtubule stimulant","target":"esophageal cancer","id":"21633"},{"source":"Microtubule stimulant","target":"anticancer","id":"21634"},{"source":"Microtubule stimulant","target":"carcinoma","id":"21635"},{"source":"Microtubule stimulant","target":"residual tumor","id":"21636"},{"source":"Microtubule stimulant","target":"gastric cancer","id":"21637"},{"source":"Microtubule stimulant","target":"metastatic","id":"21638"},{"source":"Microtubule stimulant","target":"carcinoma","id":"21639"},{"source":"Microtubule stimulant","target":"stomach neoplasms","id":"21640"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"21641"},{"source":"Microtubule stimulant","target":"carcinoma","id":"21642"},{"source":"Microtubule stimulant","target":"anticancer","id":"21643"},{"source":"Taxane","target":"UNK : Indication","id":"21644"},{"source":"Taxane","target":"pharyngeal neoplasms","id":"21645"},{"source":"Taxane","target":"residual tumor","id":"21646"},{"source":"Taxane","target":"esophageal cancer","id":"21647"},{"source":"Taxane","target":"anticancer","id":"21648"},{"source":"Taxane","target":"carcinoma","id":"21649"},{"source":"Taxane","target":"residual tumor","id":"21650"},{"source":"Taxane","target":"gastric cancer","id":"21651"},{"source":"Taxane","target":"metastatic","id":"21652"},{"source":"Taxane","target":"carcinoma","id":"21653"},{"source":"Taxane","target":"stomach neoplasms","id":"21654"},{"source":"Taxane","target":"neoplasm metastasis","id":"21655"},{"source":"Taxane","target":"carcinoma","id":"21656"},{"source":"Taxane","target":"anticancer","id":"21657"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"21658"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"21659"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"21660"},{"source":"Oncology: Esophageal","target":"Beta tubulin antagonist","id":"21661"},{"source":"Oncology: Esophageal","target":"Microtubule stimulant","id":"21662"},{"source":"Oncology: Esophageal","target":"Taxane","id":"21663"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"21664"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"21665"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"21666"},{"source":"Oncology: Gastric","target":"Beta tubulin antagonist","id":"21667"},{"source":"Oncology: Gastric","target":"Microtubule stimulant","id":"21668"},{"source":"Oncology: Gastric","target":"Taxane","id":"21669"},{"source":"pembrolizumab","target":"Amgen","id":"21670"},{"source":"pembrolizumab","target":"Merck & Co.","id":"21671"},{"source":"talimogene laherparepvec (intratumoral) (a)","target":"Amgen","id":"21672"},{"source":"talimogene laherparepvec (intratumoral) (a)","target":"Merck & Co.","id":"21673"},{"source":"UNK : Drug","target":"Amgen","id":"21674"},{"source":"UNK : Drug","target":"Merck & Co.","id":"21675"},{"source":"melanoma","target":"pembrolizumab","id":"21676"},{"source":"melanoma","target":"talimogene laherparepvec (intratumoral) (a)","id":"21677"},{"source":"melanoma","target":"UNK : Drug","id":"21678"},{"source":"melanoma","target":"pembrolizumab","id":"21679"},{"source":"melanoma","target":"talimogene laherparepvec (intratumoral) (a)","id":"21680"},{"source":"melanoma","target":"UNK : Drug","id":"21681"},{"source":"residual tumor","target":"pembrolizumab","id":"21682"},{"source":"residual tumor","target":"talimogene laherparepvec (intratumoral) (a)","id":"21683"},{"source":"residual tumor","target":"UNK : Drug","id":"21684"},{"source":"skin neoplasms","target":"pembrolizumab","id":"21685"},{"source":"skin neoplasms","target":"talimogene laherparepvec (intratumoral) (a)","id":"21686"},{"source":"skin neoplasms","target":"UNK : Drug","id":"21687"},{"source":"residual tumor","target":"pembrolizumab","id":"21688"},{"source":"residual tumor","target":"talimogene laherparepvec (intratumoral) (a)","id":"21689"},{"source":"residual tumor","target":"UNK : Drug","id":"21690"},{"source":"carcinoma","target":"pembrolizumab","id":"21691"},{"source":"carcinoma","target":"talimogene laherparepvec (intratumoral) (a)","id":"21692"},{"source":"carcinoma","target":"UNK : Drug","id":"21693"},{"source":"anticancer","target":"pembrolizumab","id":"21694"},{"source":"anticancer","target":"talimogene laherparepvec (intratumoral) (a)","id":"21695"},{"source":"anticancer","target":"UNK : Drug","id":"21696"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"21697"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"21698"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"21699"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"21700"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"21701"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21702"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"21703"},{"source":"CD19 antagonist","target":"melanoma","id":"21704"},{"source":"CD19 antagonist","target":"melanoma","id":"21705"},{"source":"CD19 antagonist","target":"residual tumor","id":"21706"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"21707"},{"source":"CD19 antagonist","target":"residual tumor","id":"21708"},{"source":"CD19 antagonist","target":"carcinoma","id":"21709"},{"source":"CD19 antagonist","target":"anticancer","id":"21710"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"melanoma","id":"21711"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"melanoma","id":"21712"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"21713"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"skin neoplasms","id":"21714"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"21715"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"21716"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"21717"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"21718"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"21719"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"21720"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"21721"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"21722"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21723"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"21724"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"21725"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"21726"},{"source":"Oncology: Melanoma","target":"Granulocyte macrophage colony stimulating factor agonist","id":"21727"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"21728"},{"source":"pembrolizumab","target":"Merck & Co.","id":"21729"},{"source":"carboplatin","target":"Merck & Co.","id":"21730"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"21731"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"21732"},{"source":"UNK : Indication","target":"pembrolizumab","id":"21733"},{"source":"UNK : Indication","target":"carboplatin","id":"21734"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"21735"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"21736"},{"source":"carcinoma","target":"pembrolizumab","id":"21737"},{"source":"carcinoma","target":"carboplatin","id":"21738"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"21739"},{"source":"carcinoma","target":"pemetrexed disodium","id":"21740"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"21741"},{"source":"squamous cell neoplasms","target":"carboplatin","id":"21742"},{"source":"squamous cell neoplasms","target":"nab-paclitaxel (IV)","id":"21743"},{"source":"squamous cell neoplasms","target":"pemetrexed disodium","id":"21744"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"21745"},{"source":"non-small-cell lung","target":"carboplatin","id":"21746"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"21747"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"21748"},{"source":"psoriasis","target":"pembrolizumab","id":"21749"},{"source":"psoriasis","target":"carboplatin","id":"21750"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"21751"},{"source":"psoriasis","target":"pemetrexed disodium","id":"21752"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"21753"},{"source":"uterine cervical neoplasms","target":"carboplatin","id":"21754"},{"source":"uterine cervical neoplasms","target":"nab-paclitaxel (IV)","id":"21755"},{"source":"uterine cervical neoplasms","target":"pemetrexed disodium","id":"21756"},{"source":"carcinoma","target":"pembrolizumab","id":"21757"},{"source":"carcinoma","target":"carboplatin","id":"21758"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"21759"},{"source":"carcinoma","target":"pemetrexed disodium","id":"21760"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"21761"},{"source":"non-small-cell lung","target":"carboplatin","id":"21762"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"21763"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"21764"},{"source":"bladder cancer","target":"pembrolizumab","id":"21765"},{"source":"bladder cancer","target":"carboplatin","id":"21766"},{"source":"bladder cancer","target":"nab-paclitaxel (IV)","id":"21767"},{"source":"bladder cancer","target":"pemetrexed disodium","id":"21768"},{"source":"amenorrheic","target":"pembrolizumab","id":"21769"},{"source":"amenorrheic","target":"carboplatin","id":"21770"},{"source":"amenorrheic","target":"nab-paclitaxel (IV)","id":"21771"},{"source":"amenorrheic","target":"pemetrexed disodium","id":"21772"},{"source":"sclc","target":"pembrolizumab","id":"21773"},{"source":"sclc","target":"carboplatin","id":"21774"},{"source":"sclc","target":"nab-paclitaxel (IV)","id":"21775"},{"source":"sclc","target":"pemetrexed disodium","id":"21776"},{"source":"cervical cancer","target":"pembrolizumab","id":"21777"},{"source":"cervical cancer","target":"carboplatin","id":"21778"},{"source":"cervical cancer","target":"nab-paclitaxel (IV)","id":"21779"},{"source":"cervical cancer","target":"pemetrexed disodium","id":"21780"},{"source":"psoriasis","target":"pembrolizumab","id":"21781"},{"source":"psoriasis","target":"carboplatin","id":"21782"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"21783"},{"source":"psoriasis","target":"pemetrexed disodium","id":"21784"},{"source":"basal cell neoplasms","target":"pembrolizumab","id":"21785"},{"source":"basal cell neoplasms","target":"carboplatin","id":"21786"},{"source":"basal cell neoplasms","target":"nab-paclitaxel (IV)","id":"21787"},{"source":"basal cell neoplasms","target":"pemetrexed disodium","id":"21788"},{"source":"carcinoma","target":"pembrolizumab","id":"21789"},{"source":"carcinoma","target":"carboplatin","id":"21790"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"21791"},{"source":"carcinoma","target":"pemetrexed disodium","id":"21792"},{"source":"arthritis","target":"pembrolizumab","id":"21793"},{"source":"arthritis","target":"carboplatin","id":"21794"},{"source":"arthritis","target":"nab-paclitaxel (IV)","id":"21795"},{"source":"arthritis","target":"pemetrexed disodium","id":"21796"},{"source":"carcinoma","target":"pembrolizumab","id":"21797"},{"source":"carcinoma","target":"carboplatin","id":"21798"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"21799"},{"source":"carcinoma","target":"pemetrexed disodium","id":"21800"},{"source":"metastatic","target":"pembrolizumab","id":"21801"},{"source":"metastatic","target":"carboplatin","id":"21802"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"21803"},{"source":"metastatic","target":"pemetrexed disodium","id":"21804"},{"source":"carcinoma","target":"pembrolizumab","id":"21805"},{"source":"carcinoma","target":"carboplatin","id":"21806"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"21807"},{"source":"carcinoma","target":"pemetrexed disodium","id":"21808"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"21809"},{"source":"neoplasm metastasis","target":"carboplatin","id":"21810"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"21811"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"21812"},{"source":"antiarthritic","target":"pembrolizumab","id":"21813"},{"source":"antiarthritic","target":"carboplatin","id":"21814"},{"source":"antiarthritic","target":"nab-paclitaxel (IV)","id":"21815"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"21816"},{"source":"lung neoplasms","target":"pembrolizumab","id":"21817"},{"source":"lung neoplasms","target":"carboplatin","id":"21818"},{"source":"lung neoplasms","target":"nab-paclitaxel (IV)","id":"21819"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"21820"},{"source":"solid malignancy","target":"pembrolizumab","id":"21821"},{"source":"solid malignancy","target":"carboplatin","id":"21822"},{"source":"solid malignancy","target":"nab-paclitaxel (IV)","id":"21823"},{"source":"solid malignancy","target":"pemetrexed disodium","id":"21824"},{"source":"skin neoplasms","target":"pembrolizumab","id":"21825"},{"source":"skin neoplasms","target":"carboplatin","id":"21826"},{"source":"skin neoplasms","target":"nab-paclitaxel (IV)","id":"21827"},{"source":"skin neoplasms","target":"pemetrexed disodium","id":"21828"},{"source":"residual tumor","target":"pembrolizumab","id":"21829"},{"source":"residual tumor","target":"carboplatin","id":"21830"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"21831"},{"source":"residual tumor","target":"pemetrexed disodium","id":"21832"},{"source":"amenorrheic","target":"pembrolizumab","id":"21833"},{"source":"amenorrheic","target":"carboplatin","id":"21834"},{"source":"amenorrheic","target":"nab-paclitaxel (IV)","id":"21835"},{"source":"amenorrheic","target":"pemetrexed disodium","id":"21836"},{"source":"anticancer","target":"pembrolizumab","id":"21837"},{"source":"anticancer","target":"carboplatin","id":"21838"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"21839"},{"source":"anticancer","target":"pemetrexed disodium","id":"21840"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"21841"},{"source":"urinary bladder neoplasms","target":"carboplatin","id":"21842"},{"source":"urinary bladder neoplasms","target":"nab-paclitaxel (IV)","id":"21843"},{"source":"urinary bladder neoplasms","target":"pemetrexed disodium","id":"21844"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"21845"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"21846"},{"source":"Dihydrofolate reductase inhibitor","target":"squamous cell neoplasms","id":"21847"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"21848"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"21849"},{"source":"Dihydrofolate reductase inhibitor","target":"uterine cervical neoplasms","id":"21850"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"21851"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"21852"},{"source":"Dihydrofolate reductase inhibitor","target":"bladder cancer","id":"21853"},{"source":"Dihydrofolate reductase inhibitor","target":"amenorrheic","id":"21854"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"21855"},{"source":"Dihydrofolate reductase inhibitor","target":"cervical cancer","id":"21856"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"21857"},{"source":"Dihydrofolate reductase inhibitor","target":"basal cell neoplasms","id":"21858"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"21859"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"21860"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"21861"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"21862"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"21863"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"21864"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"21865"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"21866"},{"source":"Dihydrofolate reductase inhibitor","target":"solid malignancy","id":"21867"},{"source":"Dihydrofolate reductase inhibitor","target":"skin neoplasms","id":"21868"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"21869"},{"source":"Dihydrofolate reductase inhibitor","target":"amenorrheic","id":"21870"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"21871"},{"source":"Dihydrofolate reductase inhibitor","target":"urinary bladder neoplasms","id":"21872"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"21873"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21874"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"21875"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"21876"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"21877"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"21878"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21879"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"21880"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"21881"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"21882"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"21883"},{"source":"Immune checkpoint inhibitor","target":"cervical cancer","id":"21884"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"21885"},{"source":"Immune checkpoint inhibitor","target":"basal cell neoplasms","id":"21886"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21887"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"21888"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21889"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"21890"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"21891"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"21892"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"21893"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"21894"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"21895"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"21896"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"21897"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"21898"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"21899"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"21900"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"21901"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21902"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"21903"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"21904"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"21905"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"21906"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21907"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"21908"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"21909"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"21910"},{"source":"Anticancer immunotherapy","target":"sclc","id":"21911"},{"source":"Anticancer immunotherapy","target":"cervical cancer","id":"21912"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"21913"},{"source":"Anticancer immunotherapy","target":"basal cell neoplasms","id":"21914"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21915"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"21916"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21917"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"21918"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"21919"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"21920"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"21921"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"21922"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"21923"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"21924"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"21925"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"21926"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"21927"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"21928"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"21929"},{"source":"CD19 antagonist","target":"carcinoma","id":"21930"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"21931"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"21932"},{"source":"CD19 antagonist","target":"psoriasis","id":"21933"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"21934"},{"source":"CD19 antagonist","target":"carcinoma","id":"21935"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"21936"},{"source":"CD19 antagonist","target":"bladder cancer","id":"21937"},{"source":"CD19 antagonist","target":"amenorrheic","id":"21938"},{"source":"CD19 antagonist","target":"sclc","id":"21939"},{"source":"CD19 antagonist","target":"cervical cancer","id":"21940"},{"source":"CD19 antagonist","target":"psoriasis","id":"21941"},{"source":"CD19 antagonist","target":"basal cell neoplasms","id":"21942"},{"source":"CD19 antagonist","target":"carcinoma","id":"21943"},{"source":"CD19 antagonist","target":"arthritis","id":"21944"},{"source":"CD19 antagonist","target":"carcinoma","id":"21945"},{"source":"CD19 antagonist","target":"metastatic","id":"21946"},{"source":"CD19 antagonist","target":"carcinoma","id":"21947"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"21948"},{"source":"CD19 antagonist","target":"antiarthritic","id":"21949"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"21950"},{"source":"CD19 antagonist","target":"solid malignancy","id":"21951"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"21952"},{"source":"CD19 antagonist","target":"residual tumor","id":"21953"},{"source":"CD19 antagonist","target":"amenorrheic","id":"21954"},{"source":"CD19 antagonist","target":"anticancer","id":"21955"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"21956"},{"source":"NA","target":"UNK : Indication","id":"21957"},{"source":"NA","target":"carcinoma","id":"21958"},{"source":"NA","target":"squamous cell neoplasms","id":"21959"},{"source":"NA","target":"non-small-cell lung","id":"21960"},{"source":"NA","target":"psoriasis","id":"21961"},{"source":"NA","target":"uterine cervical neoplasms","id":"21962"},{"source":"NA","target":"carcinoma","id":"21963"},{"source":"NA","target":"non-small-cell lung","id":"21964"},{"source":"NA","target":"bladder cancer","id":"21965"},{"source":"NA","target":"amenorrheic","id":"21966"},{"source":"NA","target":"sclc","id":"21967"},{"source":"NA","target":"cervical cancer","id":"21968"},{"source":"NA","target":"psoriasis","id":"21969"},{"source":"NA","target":"basal cell neoplasms","id":"21970"},{"source":"NA","target":"carcinoma","id":"21971"},{"source":"NA","target":"arthritis","id":"21972"},{"source":"NA","target":"carcinoma","id":"21973"},{"source":"NA","target":"metastatic","id":"21974"},{"source":"NA","target":"carcinoma","id":"21975"},{"source":"NA","target":"neoplasm metastasis","id":"21976"},{"source":"NA","target":"antiarthritic","id":"21977"},{"source":"NA","target":"lung neoplasms","id":"21978"},{"source":"NA","target":"solid malignancy","id":"21979"},{"source":"NA","target":"skin neoplasms","id":"21980"},{"source":"NA","target":"residual tumor","id":"21981"},{"source":"NA","target":"amenorrheic","id":"21982"},{"source":"NA","target":"anticancer","id":"21983"},{"source":"NA","target":"urinary bladder neoplasms","id":"21984"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"21985"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"21986"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"21987"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"21988"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"21989"},{"source":"Thymidylate synthase inhibitor","target":"uterine cervical neoplasms","id":"21990"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"21991"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"21992"},{"source":"Thymidylate synthase inhibitor","target":"bladder cancer","id":"21993"},{"source":"Thymidylate synthase inhibitor","target":"amenorrheic","id":"21994"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"21995"},{"source":"Thymidylate synthase inhibitor","target":"cervical cancer","id":"21996"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"21997"},{"source":"Thymidylate synthase inhibitor","target":"basal cell neoplasms","id":"21998"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"21999"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"22000"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"22001"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"22002"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"22003"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"22004"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"22005"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"22006"},{"source":"Thymidylate synthase inhibitor","target":"solid malignancy","id":"22007"},{"source":"Thymidylate synthase inhibitor","target":"skin neoplasms","id":"22008"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"22009"},{"source":"Thymidylate synthase inhibitor","target":"amenorrheic","id":"22010"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"22011"},{"source":"Thymidylate synthase inhibitor","target":"urinary bladder neoplasms","id":"22012"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"22013"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"22014"},{"source":"Beta tubulin antagonist","target":"squamous cell neoplasms","id":"22015"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"22016"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"22017"},{"source":"Beta tubulin antagonist","target":"uterine cervical neoplasms","id":"22018"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"22019"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"22020"},{"source":"Beta tubulin antagonist","target":"bladder cancer","id":"22021"},{"source":"Beta tubulin antagonist","target":"amenorrheic","id":"22022"},{"source":"Beta tubulin antagonist","target":"sclc","id":"22023"},{"source":"Beta tubulin antagonist","target":"cervical cancer","id":"22024"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"22025"},{"source":"Beta tubulin antagonist","target":"basal cell neoplasms","id":"22026"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"22027"},{"source":"Beta tubulin antagonist","target":"arthritis","id":"22028"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"22029"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"22030"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"22031"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"22032"},{"source":"Beta tubulin antagonist","target":"antiarthritic","id":"22033"},{"source":"Beta tubulin antagonist","target":"lung neoplasms","id":"22034"},{"source":"Beta tubulin antagonist","target":"solid malignancy","id":"22035"},{"source":"Beta tubulin antagonist","target":"skin neoplasms","id":"22036"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"22037"},{"source":"Beta tubulin antagonist","target":"amenorrheic","id":"22038"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"22039"},{"source":"Beta tubulin antagonist","target":"urinary bladder neoplasms","id":"22040"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"22041"},{"source":"Microtubule stimulant","target":"carcinoma","id":"22042"},{"source":"Microtubule stimulant","target":"squamous cell neoplasms","id":"22043"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"22044"},{"source":"Microtubule stimulant","target":"psoriasis","id":"22045"},{"source":"Microtubule stimulant","target":"uterine cervical neoplasms","id":"22046"},{"source":"Microtubule stimulant","target":"carcinoma","id":"22047"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"22048"},{"source":"Microtubule stimulant","target":"bladder cancer","id":"22049"},{"source":"Microtubule stimulant","target":"amenorrheic","id":"22050"},{"source":"Microtubule stimulant","target":"sclc","id":"22051"},{"source":"Microtubule stimulant","target":"cervical cancer","id":"22052"},{"source":"Microtubule stimulant","target":"psoriasis","id":"22053"},{"source":"Microtubule stimulant","target":"basal cell neoplasms","id":"22054"},{"source":"Microtubule stimulant","target":"carcinoma","id":"22055"},{"source":"Microtubule stimulant","target":"arthritis","id":"22056"},{"source":"Microtubule stimulant","target":"carcinoma","id":"22057"},{"source":"Microtubule stimulant","target":"metastatic","id":"22058"},{"source":"Microtubule stimulant","target":"carcinoma","id":"22059"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"22060"},{"source":"Microtubule stimulant","target":"antiarthritic","id":"22061"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"22062"},{"source":"Microtubule stimulant","target":"solid malignancy","id":"22063"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"22064"},{"source":"Microtubule stimulant","target":"residual tumor","id":"22065"},{"source":"Microtubule stimulant","target":"amenorrheic","id":"22066"},{"source":"Microtubule stimulant","target":"anticancer","id":"22067"},{"source":"Microtubule stimulant","target":"urinary bladder neoplasms","id":"22068"},{"source":"NA","target":"UNK : Indication","id":"22069"},{"source":"NA","target":"carcinoma","id":"22070"},{"source":"NA","target":"squamous cell neoplasms","id":"22071"},{"source":"NA","target":"non-small-cell lung","id":"22072"},{"source":"NA","target":"psoriasis","id":"22073"},{"source":"NA","target":"uterine cervical neoplasms","id":"22074"},{"source":"NA","target":"carcinoma","id":"22075"},{"source":"NA","target":"non-small-cell lung","id":"22076"},{"source":"NA","target":"bladder cancer","id":"22077"},{"source":"NA","target":"amenorrheic","id":"22078"},{"source":"NA","target":"sclc","id":"22079"},{"source":"NA","target":"cervical cancer","id":"22080"},{"source":"NA","target":"psoriasis","id":"22081"},{"source":"NA","target":"basal cell neoplasms","id":"22082"},{"source":"NA","target":"carcinoma","id":"22083"},{"source":"NA","target":"arthritis","id":"22084"},{"source":"NA","target":"carcinoma","id":"22085"},{"source":"NA","target":"metastatic","id":"22086"},{"source":"NA","target":"carcinoma","id":"22087"},{"source":"NA","target":"neoplasm metastasis","id":"22088"},{"source":"NA","target":"antiarthritic","id":"22089"},{"source":"NA","target":"lung neoplasms","id":"22090"},{"source":"NA","target":"solid malignancy","id":"22091"},{"source":"NA","target":"skin neoplasms","id":"22092"},{"source":"NA","target":"residual tumor","id":"22093"},{"source":"NA","target":"amenorrheic","id":"22094"},{"source":"NA","target":"anticancer","id":"22095"},{"source":"NA","target":"urinary bladder neoplasms","id":"22096"},{"source":"Taxane","target":"UNK : Indication","id":"22097"},{"source":"Taxane","target":"carcinoma","id":"22098"},{"source":"Taxane","target":"squamous cell neoplasms","id":"22099"},{"source":"Taxane","target":"non-small-cell lung","id":"22100"},{"source":"Taxane","target":"psoriasis","id":"22101"},{"source":"Taxane","target":"uterine cervical neoplasms","id":"22102"},{"source":"Taxane","target":"carcinoma","id":"22103"},{"source":"Taxane","target":"non-small-cell lung","id":"22104"},{"source":"Taxane","target":"bladder cancer","id":"22105"},{"source":"Taxane","target":"amenorrheic","id":"22106"},{"source":"Taxane","target":"sclc","id":"22107"},{"source":"Taxane","target":"cervical cancer","id":"22108"},{"source":"Taxane","target":"psoriasis","id":"22109"},{"source":"Taxane","target":"basal cell neoplasms","id":"22110"},{"source":"Taxane","target":"carcinoma","id":"22111"},{"source":"Taxane","target":"arthritis","id":"22112"},{"source":"Taxane","target":"carcinoma","id":"22113"},{"source":"Taxane","target":"metastatic","id":"22114"},{"source":"Taxane","target":"carcinoma","id":"22115"},{"source":"Taxane","target":"neoplasm metastasis","id":"22116"},{"source":"Taxane","target":"antiarthritic","id":"22117"},{"source":"Taxane","target":"lung neoplasms","id":"22118"},{"source":"Taxane","target":"solid malignancy","id":"22119"},{"source":"Taxane","target":"skin neoplasms","id":"22120"},{"source":"Taxane","target":"residual tumor","id":"22121"},{"source":"Taxane","target":"amenorrheic","id":"22122"},{"source":"Taxane","target":"anticancer","id":"22123"},{"source":"Taxane","target":"urinary bladder neoplasms","id":"22124"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"22125"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"22126"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"22127"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"22128"},{"source":"Oncology: Lung","target":"NA","id":"22129"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"22130"},{"source":"Oncology: Lung","target":"Beta tubulin antagonist","id":"22131"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"22132"},{"source":"Oncology: Lung","target":"NA","id":"22133"},{"source":"Oncology: Lung","target":"Taxane","id":"22134"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"22135"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"22136"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"22137"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"22138"},{"source":"Non-Small Cell","target":"NA","id":"22139"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"22140"},{"source":"Non-Small Cell","target":"Beta tubulin antagonist","id":"22141"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"22142"},{"source":"Non-Small Cell","target":"NA","id":"22143"},{"source":"Non-Small Cell","target":"Taxane","id":"22144"},{"source":"epacadostat (u)","target":"Incyte Corporation","id":"22145"},{"source":"epacadostat (u)","target":"Merck & Co.","id":"22146"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"22147"},{"source":"pembrolizumab","target":"Merck & Co.","id":"22148"},{"source":"UNK : Drug","target":"Incyte Corporation","id":"22149"},{"source":"UNK : Drug","target":"Merck & Co.","id":"22150"},{"source":"UNK : Indication","target":"epacadostat (u)","id":"22151"},{"source":"UNK : Indication","target":"pembrolizumab","id":"22152"},{"source":"UNK : Indication","target":"UNK : Drug","id":"22153"},{"source":"anticancer","target":"epacadostat (u)","id":"22154"},{"source":"anticancer","target":"pembrolizumab","id":"22155"},{"source":"anticancer","target":"UNK : Drug","id":"22156"},{"source":"deafness","target":"epacadostat (u)","id":"22157"},{"source":"deafness","target":"pembrolizumab","id":"22158"},{"source":"deafness","target":"UNK : Drug","id":"22159"},{"source":"renal cancer","target":"epacadostat (u)","id":"22160"},{"source":"renal cancer","target":"pembrolizumab","id":"22161"},{"source":"renal cancer","target":"UNK : Drug","id":"22162"},{"source":"neuropathy","target":"epacadostat (u)","id":"22163"},{"source":"neuropathy","target":"pembrolizumab","id":"22164"},{"source":"neuropathy","target":"UNK : Drug","id":"22165"},{"source":"heart failure","target":"epacadostat (u)","id":"22166"},{"source":"heart failure","target":"pembrolizumab","id":"22167"},{"source":"heart failure","target":"UNK : Drug","id":"22168"},{"source":"bladder cancer","target":"epacadostat (u)","id":"22169"},{"source":"bladder cancer","target":"pembrolizumab","id":"22170"},{"source":"bladder cancer","target":"UNK : Drug","id":"22171"},{"source":"non-small-cell lung","target":"epacadostat (u)","id":"22172"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"22173"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"22174"},{"source":"carcinoma","target":"epacadostat (u)","id":"22175"},{"source":"carcinoma","target":"pembrolizumab","id":"22176"},{"source":"carcinoma","target":"UNK : Drug","id":"22177"},{"source":"kidney neoplasms","target":"epacadostat (u)","id":"22178"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"22179"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"22180"},{"source":"urologic neoplasms","target":"epacadostat (u)","id":"22181"},{"source":"urologic neoplasms","target":"pembrolizumab","id":"22182"},{"source":"urologic neoplasms","target":"UNK : Drug","id":"22183"},{"source":"metastatic","target":"epacadostat (u)","id":"22184"},{"source":"metastatic","target":"pembrolizumab","id":"22185"},{"source":"metastatic","target":"UNK : Drug","id":"22186"},{"source":"carcinoma","target":"epacadostat (u)","id":"22187"},{"source":"carcinoma","target":"pembrolizumab","id":"22188"},{"source":"carcinoma","target":"UNK : Drug","id":"22189"},{"source":"neoplasm metastasis","target":"epacadostat (u)","id":"22190"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"22191"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"22192"},{"source":"renal cancer","target":"epacadostat (u)","id":"22193"},{"source":"renal cancer","target":"pembrolizumab","id":"22194"},{"source":"renal cancer","target":"UNK : Drug","id":"22195"},{"source":"transitional","target":"epacadostat (u)","id":"22196"},{"source":"transitional","target":"pembrolizumab","id":"22197"},{"source":"transitional","target":"UNK : Drug","id":"22198"},{"source":"central nervous system diseases","target":"epacadostat (u)","id":"22199"},{"source":"central nervous system diseases","target":"pembrolizumab","id":"22200"},{"source":"central nervous system diseases","target":"UNK : Drug","id":"22201"},{"source":"cancer of the urinary tract","target":"epacadostat (u)","id":"22202"},{"source":"cancer of the urinary tract","target":"pembrolizumab","id":"22203"},{"source":"cancer of the urinary tract","target":"UNK : Drug","id":"22204"},{"source":"residual tumor","target":"epacadostat (u)","id":"22205"},{"source":"residual tumor","target":"pembrolizumab","id":"22206"},{"source":"residual tumor","target":"UNK : Drug","id":"22207"},{"source":"hearing loss","target":"epacadostat (u)","id":"22208"},{"source":"hearing loss","target":"pembrolizumab","id":"22209"},{"source":"hearing loss","target":"UNK : Drug","id":"22210"},{"source":"anticancer","target":"epacadostat (u)","id":"22211"},{"source":"anticancer","target":"pembrolizumab","id":"22212"},{"source":"anticancer","target":"UNK : Drug","id":"22213"},{"source":"urinary bladder neoplasms","target":"epacadostat (u)","id":"22214"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"22215"},{"source":"urinary bladder neoplasms","target":"UNK : Drug","id":"22216"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"22217"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"22218"},{"source":"Anticancer immunotherapy","target":"deafness","id":"22219"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"22220"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"22221"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"22222"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"22223"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"22224"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22225"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"22226"},{"source":"Anticancer immunotherapy","target":"urologic neoplasms","id":"22227"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"22228"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22229"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"22230"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"22231"},{"source":"Anticancer immunotherapy","target":"transitional","id":"22232"},{"source":"Anticancer immunotherapy","target":"central nervous system diseases","id":"22233"},{"source":"Anticancer immunotherapy","target":"cancer of the urinary tract","id":"22234"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"22235"},{"source":"Anticancer immunotherapy","target":"hearing loss","id":"22236"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"22237"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"22238"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"22239"},{"source":"CD19 antagonist","target":"anticancer","id":"22240"},{"source":"CD19 antagonist","target":"deafness","id":"22241"},{"source":"CD19 antagonist","target":"renal cancer","id":"22242"},{"source":"CD19 antagonist","target":"neuropathy","id":"22243"},{"source":"CD19 antagonist","target":"heart failure","id":"22244"},{"source":"CD19 antagonist","target":"bladder cancer","id":"22245"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"22246"},{"source":"CD19 antagonist","target":"carcinoma","id":"22247"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"22248"},{"source":"CD19 antagonist","target":"urologic neoplasms","id":"22249"},{"source":"CD19 antagonist","target":"metastatic","id":"22250"},{"source":"CD19 antagonist","target":"carcinoma","id":"22251"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"22252"},{"source":"CD19 antagonist","target":"renal cancer","id":"22253"},{"source":"CD19 antagonist","target":"transitional","id":"22254"},{"source":"CD19 antagonist","target":"central nervous system diseases","id":"22255"},{"source":"CD19 antagonist","target":"cancer of the urinary tract","id":"22256"},{"source":"CD19 antagonist","target":"residual tumor","id":"22257"},{"source":"CD19 antagonist","target":"hearing loss","id":"22258"},{"source":"CD19 antagonist","target":"anticancer","id":"22259"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"22260"},{"source":"Indoleamine-pyrrole 2","target":"UNK : Indication","id":"22261"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"22262"},{"source":"Indoleamine-pyrrole 2","target":"deafness","id":"22263"},{"source":"Indoleamine-pyrrole 2","target":"renal cancer","id":"22264"},{"source":"Indoleamine-pyrrole 2","target":"neuropathy","id":"22265"},{"source":"Indoleamine-pyrrole 2","target":"heart failure","id":"22266"},{"source":"Indoleamine-pyrrole 2","target":"bladder cancer","id":"22267"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"22268"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"22269"},{"source":"Indoleamine-pyrrole 2","target":"kidney neoplasms","id":"22270"},{"source":"Indoleamine-pyrrole 2","target":"urologic neoplasms","id":"22271"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"22272"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"22273"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"22274"},{"source":"Indoleamine-pyrrole 2","target":"renal cancer","id":"22275"},{"source":"Indoleamine-pyrrole 2","target":"transitional","id":"22276"},{"source":"Indoleamine-pyrrole 2","target":"central nervous system diseases","id":"22277"},{"source":"Indoleamine-pyrrole 2","target":"cancer of the urinary tract","id":"22278"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"22279"},{"source":"Indoleamine-pyrrole 2","target":"hearing loss","id":"22280"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"22281"},{"source":"Indoleamine-pyrrole 2","target":"urinary bladder neoplasms","id":"22282"},{"source":"NA","target":"UNK : Indication","id":"22283"},{"source":"NA","target":"anticancer","id":"22284"},{"source":"NA","target":"deafness","id":"22285"},{"source":"NA","target":"renal cancer","id":"22286"},{"source":"NA","target":"neuropathy","id":"22287"},{"source":"NA","target":"heart failure","id":"22288"},{"source":"NA","target":"bladder cancer","id":"22289"},{"source":"NA","target":"non-small-cell lung","id":"22290"},{"source":"NA","target":"carcinoma","id":"22291"},{"source":"NA","target":"kidney neoplasms","id":"22292"},{"source":"NA","target":"urologic neoplasms","id":"22293"},{"source":"NA","target":"metastatic","id":"22294"},{"source":"NA","target":"carcinoma","id":"22295"},{"source":"NA","target":"neoplasm metastasis","id":"22296"},{"source":"NA","target":"renal cancer","id":"22297"},{"source":"NA","target":"transitional","id":"22298"},{"source":"NA","target":"central nervous system diseases","id":"22299"},{"source":"NA","target":"cancer of the urinary tract","id":"22300"},{"source":"NA","target":"residual tumor","id":"22301"},{"source":"NA","target":"hearing loss","id":"22302"},{"source":"NA","target":"anticancer","id":"22303"},{"source":"NA","target":"urinary bladder neoplasms","id":"22304"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"22305"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"22306"},{"source":"Immune checkpoint inhibitor","target":"deafness","id":"22307"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"22308"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"22309"},{"source":"Immune checkpoint inhibitor","target":"heart failure","id":"22310"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"22311"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"22312"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22313"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"22314"},{"source":"Immune checkpoint inhibitor","target":"urologic neoplasms","id":"22315"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"22316"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22317"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"22318"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"22319"},{"source":"Immune checkpoint inhibitor","target":"transitional","id":"22320"},{"source":"Immune checkpoint inhibitor","target":"central nervous system diseases","id":"22321"},{"source":"Immune checkpoint inhibitor","target":"cancer of the urinary tract","id":"22322"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"22323"},{"source":"Immune checkpoint inhibitor","target":"hearing loss","id":"22324"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"22325"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"22326"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"22327"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"22328"},{"source":"Oncology: Bladder","target":"Indoleamine-pyrrole 2","id":"22329"},{"source":"Oncology: Bladder","target":"NA","id":"22330"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"22331"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"22332"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"22333"},{"source":"Oncology: Renal","target":"Indoleamine-pyrrole 2","id":"22334"},{"source":"Oncology: Renal","target":"NA","id":"22335"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"22336"},{"source":"pembrolizumab","target":"(Other government agency)","id":"22337"},{"source":"pembrolizumab","target":"UK","id":"22338"},{"source":"pembrolizumab","target":"Merck & Co.","id":"22339"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"22340"},{"source":"pembrolizumab","target":"Royal Marsden NHS Trust","id":"22341"},{"source":"radiation therapy","target":"(Other government agency)","id":"22342"},{"source":"radiation therapy","target":"UK","id":"22343"},{"source":"radiation therapy","target":"Merck & Co.","id":"22344"},{"source":"radiation therapy","target":"National Institutes of Health/National Cancer Institute","id":"22345"},{"source":"radiation therapy","target":"Royal Marsden NHS Trust","id":"22346"},{"source":"UNK : Indication","target":"pembrolizumab","id":"22347"},{"source":"UNK : Indication","target":"radiation therapy","id":"22348"},{"source":"carcinoma","target":"pembrolizumab","id":"22349"},{"source":"carcinoma","target":"radiation therapy","id":"22350"},{"source":"residual tumor","target":"pembrolizumab","id":"22351"},{"source":"residual tumor","target":"radiation therapy","id":"22352"},{"source":"thoracic neoplasms","target":"pembrolizumab","id":"22353"},{"source":"thoracic neoplasms","target":"radiation therapy","id":"22354"},{"source":"thoracic tumours","target":"pembrolizumab","id":"22355"},{"source":"thoracic tumours","target":"radiation therapy","id":"22356"},{"source":"carcinoma","target":"pembrolizumab","id":"22357"},{"source":"carcinoma","target":"radiation therapy","id":"22358"},{"source":"skin neoplasms","target":"pembrolizumab","id":"22359"},{"source":"skin neoplasms","target":"radiation therapy","id":"22360"},{"source":"carcinoma","target":"pembrolizumab","id":"22361"},{"source":"carcinoma","target":"radiation therapy","id":"22362"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"22363"},{"source":"non-small-cell lung","target":"radiation therapy","id":"22364"},{"source":"lung cancer","target":"pembrolizumab","id":"22365"},{"source":"lung cancer","target":"radiation therapy","id":"22366"},{"source":"carcinoma","target":"pembrolizumab","id":"22367"},{"source":"carcinoma","target":"radiation therapy","id":"22368"},{"source":"carcinoma","target":"pembrolizumab","id":"22369"},{"source":"carcinoma","target":"radiation therapy","id":"22370"},{"source":"anticancer","target":"pembrolizumab","id":"22371"},{"source":"anticancer","target":"radiation therapy","id":"22372"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"22373"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"22374"},{"source":"lung neoplasms","target":"pembrolizumab","id":"22375"},{"source":"lung neoplasms","target":"radiation therapy","id":"22376"},{"source":"sclc","target":"pembrolizumab","id":"22377"},{"source":"sclc","target":"radiation therapy","id":"22378"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"22379"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22380"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"22381"},{"source":"Anticancer immunotherapy","target":"thoracic neoplasms","id":"22382"},{"source":"Anticancer immunotherapy","target":"thoracic tumours","id":"22383"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22384"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"22385"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22386"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"22387"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"22388"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22389"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22390"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"22391"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"22392"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"22393"},{"source":"Anticancer immunotherapy","target":"sclc","id":"22394"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"22395"},{"source":"CD19 antagonist","target":"carcinoma","id":"22396"},{"source":"CD19 antagonist","target":"residual tumor","id":"22397"},{"source":"CD19 antagonist","target":"thoracic neoplasms","id":"22398"},{"source":"CD19 antagonist","target":"thoracic tumours","id":"22399"},{"source":"CD19 antagonist","target":"carcinoma","id":"22400"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"22401"},{"source":"CD19 antagonist","target":"carcinoma","id":"22402"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"22403"},{"source":"CD19 antagonist","target":"lung cancer","id":"22404"},{"source":"CD19 antagonist","target":"carcinoma","id":"22405"},{"source":"CD19 antagonist","target":"carcinoma","id":"22406"},{"source":"CD19 antagonist","target":"anticancer","id":"22407"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"22408"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"22409"},{"source":"CD19 antagonist","target":"sclc","id":"22410"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"22411"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22412"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"22413"},{"source":"Immune checkpoint inhibitor","target":"thoracic neoplasms","id":"22414"},{"source":"Immune checkpoint inhibitor","target":"thoracic tumours","id":"22415"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22416"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"22417"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22418"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"22419"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"22420"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22421"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22422"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"22423"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"22424"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"22425"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"22426"},{"source":"UPA","target":"UNK : Indication","id":"22427"},{"source":"UPA","target":"carcinoma","id":"22428"},{"source":"UPA","target":"residual tumor","id":"22429"},{"source":"UPA","target":"thoracic neoplasms","id":"22430"},{"source":"UPA","target":"thoracic tumours","id":"22431"},{"source":"UPA","target":"carcinoma","id":"22432"},{"source":"UPA","target":"skin neoplasms","id":"22433"},{"source":"UPA","target":"carcinoma","id":"22434"},{"source":"UPA","target":"non-small-cell lung","id":"22435"},{"source":"UPA","target":"lung cancer","id":"22436"},{"source":"UPA","target":"carcinoma","id":"22437"},{"source":"UPA","target":"carcinoma","id":"22438"},{"source":"UPA","target":"anticancer","id":"22439"},{"source":"UPA","target":"squamous cell neoplasms","id":"22440"},{"source":"UPA","target":"lung neoplasms","id":"22441"},{"source":"UPA","target":"sclc","id":"22442"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"22443"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"22444"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"22445"},{"source":"Oncology: Lung","target":"UPA","id":"22446"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"22447"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"22448"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"22449"},{"source":"Non-Small Cell","target":"UPA","id":"22450"},{"source":"dabrafenib (capsule) (a)","target":"GlaxoSmithKline","id":"22451"},{"source":"dabrafenib (capsule) (a)","target":"Merck & Co.","id":"22452"},{"source":"dabrafenib (capsule) (a)","target":"Novartis","id":"22453"},{"source":"pembrolizumab","target":"GlaxoSmithKline","id":"22454"},{"source":"pembrolizumab","target":"Merck & Co.","id":"22455"},{"source":"pembrolizumab","target":"Novartis","id":"22456"},{"source":"trametinib (tablet) (a)","target":"GlaxoSmithKline","id":"22457"},{"source":"trametinib (tablet) (a)","target":"Merck & Co.","id":"22458"},{"source":"trametinib (tablet) (a)","target":"Novartis","id":"22459"},{"source":"UNK : Drug","target":"GlaxoSmithKline","id":"22460"},{"source":"UNK : Drug","target":"Merck & Co.","id":"22461"},{"source":"UNK : Drug","target":"Novartis","id":"22462"},{"source":"solid tumors","target":"dabrafenib (capsule) (a)","id":"22463"},{"source":"solid tumors","target":"pembrolizumab","id":"22464"},{"source":"solid tumors","target":"trametinib (tablet) (a)","id":"22465"},{"source":"solid tumors","target":"UNK : Drug","id":"22466"},{"source":"melanoma","target":"dabrafenib (capsule) (a)","id":"22467"},{"source":"melanoma","target":"pembrolizumab","id":"22468"},{"source":"melanoma","target":"trametinib (tablet) (a)","id":"22469"},{"source":"melanoma","target":"UNK : Drug","id":"22470"},{"source":"unknown primary","target":"dabrafenib (capsule) (a)","id":"22471"},{"source":"unknown primary","target":"pembrolizumab","id":"22472"},{"source":"unknown primary","target":"trametinib (tablet) (a)","id":"22473"},{"source":"unknown primary","target":"UNK : Drug","id":"22474"},{"source":"melanoma","target":"dabrafenib (capsule) (a)","id":"22475"},{"source":"melanoma","target":"pembrolizumab","id":"22476"},{"source":"melanoma","target":"trametinib (tablet) (a)","id":"22477"},{"source":"melanoma","target":"UNK : Drug","id":"22478"},{"source":"skin neoplasms","target":"dabrafenib (capsule) (a)","id":"22479"},{"source":"skin neoplasms","target":"pembrolizumab","id":"22480"},{"source":"skin neoplasms","target":"trametinib (tablet) (a)","id":"22481"},{"source":"skin neoplasms","target":"UNK : Drug","id":"22482"},{"source":"skin neoplasms","target":"dabrafenib (capsule) (a)","id":"22483"},{"source":"skin neoplasms","target":"pembrolizumab","id":"22484"},{"source":"skin neoplasms","target":"trametinib (tablet) (a)","id":"22485"},{"source":"skin neoplasms","target":"UNK : Drug","id":"22486"},{"source":"residual tumor","target":"dabrafenib (capsule) (a)","id":"22487"},{"source":"residual tumor","target":"pembrolizumab","id":"22488"},{"source":"residual tumor","target":"trametinib (tablet) (a)","id":"22489"},{"source":"residual tumor","target":"UNK : Drug","id":"22490"},{"source":"metastatic","target":"dabrafenib (capsule) (a)","id":"22491"},{"source":"metastatic","target":"pembrolizumab","id":"22492"},{"source":"metastatic","target":"trametinib (tablet) (a)","id":"22493"},{"source":"metastatic","target":"UNK : Drug","id":"22494"},{"source":"carcinoma","target":"dabrafenib (capsule) (a)","id":"22495"},{"source":"carcinoma","target":"pembrolizumab","id":"22496"},{"source":"carcinoma","target":"trametinib (tablet) (a)","id":"22497"},{"source":"carcinoma","target":"UNK : Drug","id":"22498"},{"source":"solid malignancy","target":"dabrafenib (capsule) (a)","id":"22499"},{"source":"solid malignancy","target":"pembrolizumab","id":"22500"},{"source":"solid malignancy","target":"trametinib (tablet) (a)","id":"22501"},{"source":"solid malignancy","target":"UNK : Drug","id":"22502"},{"source":"neoplasm metastasis","target":"dabrafenib (capsule) (a)","id":"22503"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"22504"},{"source":"neoplasm metastasis","target":"trametinib (tablet) (a)","id":"22505"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"22506"},{"source":"sarcoma","target":"dabrafenib (capsule) (a)","id":"22507"},{"source":"sarcoma","target":"pembrolizumab","id":"22508"},{"source":"sarcoma","target":"trametinib (tablet) (a)","id":"22509"},{"source":"sarcoma","target":"UNK : Drug","id":"22510"},{"source":"malabsorption syndromes","target":"dabrafenib (capsule) (a)","id":"22511"},{"source":"malabsorption syndromes","target":"pembrolizumab","id":"22512"},{"source":"malabsorption syndromes","target":"trametinib (tablet) (a)","id":"22513"},{"source":"malabsorption syndromes","target":"UNK : Drug","id":"22514"},{"source":"unknown primary","target":"dabrafenib (capsule) (a)","id":"22515"},{"source":"unknown primary","target":"pembrolizumab","id":"22516"},{"source":"unknown primary","target":"trametinib (tablet) (a)","id":"22517"},{"source":"unknown primary","target":"UNK : Drug","id":"22518"},{"source":"malabsorption syndromes","target":"dabrafenib (capsule) (a)","id":"22519"},{"source":"malabsorption syndromes","target":"pembrolizumab","id":"22520"},{"source":"malabsorption syndromes","target":"trametinib (tablet) (a)","id":"22521"},{"source":"malabsorption syndromes","target":"UNK : Drug","id":"22522"},{"source":"anticancer","target":"dabrafenib (capsule) (a)","id":"22523"},{"source":"anticancer","target":"pembrolizumab","id":"22524"},{"source":"anticancer","target":"trametinib (tablet) (a)","id":"22525"},{"source":"anticancer","target":"UNK : Drug","id":"22526"},{"source":"solid malignancy","target":"dabrafenib (capsule) (a)","id":"22527"},{"source":"solid malignancy","target":"pembrolizumab","id":"22528"},{"source":"solid malignancy","target":"trametinib (tablet) (a)","id":"22529"},{"source":"solid malignancy","target":"UNK : Drug","id":"22530"},{"source":"solid tumors","target":"dabrafenib (capsule) (a)","id":"22531"},{"source":"solid tumors","target":"pembrolizumab","id":"22532"},{"source":"solid tumors","target":"trametinib (tablet) (a)","id":"22533"},{"source":"solid tumors","target":"UNK : Drug","id":"22534"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"22535"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"22536"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"22537"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"22538"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"22539"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"22540"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"22541"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"22542"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22543"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"22544"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"22545"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"22546"},{"source":"Anticancer immunotherapy","target":"malabsorption syndromes","id":"22547"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"22548"},{"source":"Anticancer immunotherapy","target":"malabsorption syndromes","id":"22549"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"22550"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"22551"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"22552"},{"source":"NA","target":"solid tumors","id":"22553"},{"source":"NA","target":"melanoma","id":"22554"},{"source":"NA","target":"unknown primary","id":"22555"},{"source":"NA","target":"melanoma","id":"22556"},{"source":"NA","target":"skin neoplasms","id":"22557"},{"source":"NA","target":"skin neoplasms","id":"22558"},{"source":"NA","target":"residual tumor","id":"22559"},{"source":"NA","target":"metastatic","id":"22560"},{"source":"NA","target":"carcinoma","id":"22561"},{"source":"NA","target":"solid malignancy","id":"22562"},{"source":"NA","target":"neoplasm metastasis","id":"22563"},{"source":"NA","target":"sarcoma","id":"22564"},{"source":"NA","target":"malabsorption syndromes","id":"22565"},{"source":"NA","target":"unknown primary","id":"22566"},{"source":"NA","target":"malabsorption syndromes","id":"22567"},{"source":"NA","target":"anticancer","id":"22568"},{"source":"NA","target":"solid malignancy","id":"22569"},{"source":"NA","target":"solid tumors","id":"22570"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"22571"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"22572"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"22573"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"22574"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"22575"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"22576"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"22577"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"22578"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22579"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"22580"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"22581"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"22582"},{"source":"Immune checkpoint inhibitor","target":"malabsorption syndromes","id":"22583"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"22584"},{"source":"Immune checkpoint inhibitor","target":"malabsorption syndromes","id":"22585"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"22586"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"22587"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"22588"},{"source":"MEK inhibitor","target":"solid tumors","id":"22589"},{"source":"MEK inhibitor","target":"melanoma","id":"22590"},{"source":"MEK inhibitor","target":"unknown primary","id":"22591"},{"source":"MEK inhibitor","target":"melanoma","id":"22592"},{"source":"MEK inhibitor","target":"skin neoplasms","id":"22593"},{"source":"MEK inhibitor","target":"skin neoplasms","id":"22594"},{"source":"MEK inhibitor","target":"residual tumor","id":"22595"},{"source":"MEK inhibitor","target":"metastatic","id":"22596"},{"source":"MEK inhibitor","target":"carcinoma","id":"22597"},{"source":"MEK inhibitor","target":"solid malignancy","id":"22598"},{"source":"MEK inhibitor","target":"neoplasm metastasis","id":"22599"},{"source":"MEK inhibitor","target":"sarcoma","id":"22600"},{"source":"MEK inhibitor","target":"malabsorption syndromes","id":"22601"},{"source":"MEK inhibitor","target":"unknown primary","id":"22602"},{"source":"MEK inhibitor","target":"malabsorption syndromes","id":"22603"},{"source":"MEK inhibitor","target":"anticancer","id":"22604"},{"source":"MEK inhibitor","target":"solid malignancy","id":"22605"},{"source":"MEK inhibitor","target":"solid tumors","id":"22606"},{"source":"CD19 antagonist","target":"solid tumors","id":"22607"},{"source":"CD19 antagonist","target":"melanoma","id":"22608"},{"source":"CD19 antagonist","target":"unknown primary","id":"22609"},{"source":"CD19 antagonist","target":"melanoma","id":"22610"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"22611"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"22612"},{"source":"CD19 antagonist","target":"residual tumor","id":"22613"},{"source":"CD19 antagonist","target":"metastatic","id":"22614"},{"source":"CD19 antagonist","target":"carcinoma","id":"22615"},{"source":"CD19 antagonist","target":"solid malignancy","id":"22616"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"22617"},{"source":"CD19 antagonist","target":"sarcoma","id":"22618"},{"source":"CD19 antagonist","target":"malabsorption syndromes","id":"22619"},{"source":"CD19 antagonist","target":"unknown primary","id":"22620"},{"source":"CD19 antagonist","target":"malabsorption syndromes","id":"22621"},{"source":"CD19 antagonist","target":"anticancer","id":"22622"},{"source":"CD19 antagonist","target":"solid malignancy","id":"22623"},{"source":"CD19 antagonist","target":"solid tumors","id":"22624"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"22625"},{"source":"Oncology: Melanoma","target":"NA","id":"22626"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"22627"},{"source":"Oncology: Melanoma","target":"MEK inhibitor","id":"22628"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"22629"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"22630"},{"source":"Oncology: CNS","target":"NA","id":"22631"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"22632"},{"source":"Oncology: CNS","target":"MEK inhibitor","id":"22633"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"22634"},{"source":"niraparib (a)","target":"(Other Industry Sponsor)","id":"22635"},{"source":"niraparib (a)","target":"Merck & Co.","id":"22636"},{"source":"niraparib (a)","target":"Tesaro","id":"22637"},{"source":"pembrolizumab","target":"(Other Industry Sponsor)","id":"22638"},{"source":"pembrolizumab","target":"Merck & Co.","id":"22639"},{"source":"pembrolizumab","target":"Tesaro","id":"22640"},{"source":"UNK : Drug","target":"(Other Industry Sponsor)","id":"22641"},{"source":"UNK : Drug","target":"Merck & Co.","id":"22642"},{"source":"UNK : Drug","target":"Tesaro","id":"22643"},{"source":"UNK : Indication","target":"niraparib (a)","id":"22644"},{"source":"UNK : Indication","target":"pembrolizumab","id":"22645"},{"source":"UNK : Indication","target":"UNK : Drug","id":"22646"},{"source":"anticancer","target":"niraparib (a)","id":"22647"},{"source":"anticancer","target":"pembrolizumab","id":"22648"},{"source":"anticancer","target":"UNK : Drug","id":"22649"},{"source":"ovarian cancer","target":"niraparib (a)","id":"22650"},{"source":"ovarian cancer","target":"pembrolizumab","id":"22651"},{"source":"ovarian cancer","target":"UNK : Drug","id":"22652"},{"source":"triple-negative breast cancer","target":"niraparib (a)","id":"22653"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"22654"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"22655"},{"source":"primary peritoneal cancer","target":"niraparib (a)","id":"22656"},{"source":"primary peritoneal cancer","target":"pembrolizumab","id":"22657"},{"source":"primary peritoneal cancer","target":"UNK : Drug","id":"22658"},{"source":"peritoneal neoplasms","target":"niraparib (a)","id":"22659"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"22660"},{"source":"peritoneal neoplasms","target":"UNK : Drug","id":"22661"},{"source":"residual tumor","target":"niraparib (a)","id":"22662"},{"source":"residual tumor","target":"pembrolizumab","id":"22663"},{"source":"residual tumor","target":"UNK : Drug","id":"22664"},{"source":"breast neoplasms","target":"niraparib (a)","id":"22665"},{"source":"breast neoplasms","target":"pembrolizumab","id":"22666"},{"source":"breast neoplasms","target":"UNK : Drug","id":"22667"},{"source":"fallopian tube neoplasms","target":"niraparib (a)","id":"22668"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"22669"},{"source":"fallopian tube neoplasms","target":"UNK : Drug","id":"22670"},{"source":"metastatic","target":"niraparib (a)","id":"22671"},{"source":"metastatic","target":"pembrolizumab","id":"22672"},{"source":"metastatic","target":"UNK : Drug","id":"22673"},{"source":"carcinoma","target":"niraparib (a)","id":"22674"},{"source":"carcinoma","target":"pembrolizumab","id":"22675"},{"source":"carcinoma","target":"UNK : Drug","id":"22676"},{"source":"breast neoplasms","target":"niraparib (a)","id":"22677"},{"source":"breast neoplasms","target":"pembrolizumab","id":"22678"},{"source":"breast neoplasms","target":"UNK : Drug","id":"22679"},{"source":"neoplasm metastasis","target":"niraparib (a)","id":"22680"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"22681"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"22682"},{"source":"metastatic","target":"niraparib (a)","id":"22683"},{"source":"metastatic","target":"pembrolizumab","id":"22684"},{"source":"metastatic","target":"UNK : Drug","id":"22685"},{"source":"tnbc","target":"niraparib (a)","id":"22686"},{"source":"tnbc","target":"pembrolizumab","id":"22687"},{"source":"tnbc","target":"UNK : Drug","id":"22688"},{"source":"triple-negative breast cancer","target":"niraparib (a)","id":"22689"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"22690"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"22691"},{"source":"ovarian neoplasms","target":"niraparib (a)","id":"22692"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"22693"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"22694"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"22695"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"22696"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"22697"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"22698"},{"source":"Immune checkpoint inhibitor","target":"primary peritoneal cancer","id":"22699"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"22700"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"22701"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"22702"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"22703"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"22704"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"22705"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"22706"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"22707"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"22708"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"22709"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"22710"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"22711"},{"source":"NA","target":"UNK : Indication","id":"22712"},{"source":"NA","target":"anticancer","id":"22713"},{"source":"NA","target":"ovarian cancer","id":"22714"},{"source":"NA","target":"triple-negative breast cancer","id":"22715"},{"source":"NA","target":"primary peritoneal cancer","id":"22716"},{"source":"NA","target":"peritoneal neoplasms","id":"22717"},{"source":"NA","target":"residual tumor","id":"22718"},{"source":"NA","target":"breast neoplasms","id":"22719"},{"source":"NA","target":"fallopian tube neoplasms","id":"22720"},{"source":"NA","target":"metastatic","id":"22721"},{"source":"NA","target":"carcinoma","id":"22722"},{"source":"NA","target":"breast neoplasms","id":"22723"},{"source":"NA","target":"neoplasm metastasis","id":"22724"},{"source":"NA","target":"metastatic","id":"22725"},{"source":"NA","target":"tnbc","id":"22726"},{"source":"NA","target":"triple-negative breast cancer","id":"22727"},{"source":"NA","target":"ovarian neoplasms","id":"22728"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"22729"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"22730"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"22731"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"22732"},{"source":"Anticancer immunotherapy","target":"primary peritoneal cancer","id":"22733"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"22734"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"22735"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"22736"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"22737"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"22738"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22739"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"22740"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"22741"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"22742"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"22743"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"22744"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"22745"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"22746"},{"source":"CD19 antagonist","target":"anticancer","id":"22747"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"22748"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"22749"},{"source":"CD19 antagonist","target":"primary peritoneal cancer","id":"22750"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"22751"},{"source":"CD19 antagonist","target":"residual tumor","id":"22752"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"22753"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"22754"},{"source":"CD19 antagonist","target":"metastatic","id":"22755"},{"source":"CD19 antagonist","target":"carcinoma","id":"22756"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"22757"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"22758"},{"source":"CD19 antagonist","target":"metastatic","id":"22759"},{"source":"CD19 antagonist","target":"tnbc","id":"22760"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"22761"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"22762"},{"source":"ADP ribose polymerase 1 inhibitor","target":"UNK : Indication","id":"22763"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anticancer","id":"22764"},{"source":"ADP ribose polymerase 1 inhibitor","target":"ovarian cancer","id":"22765"},{"source":"ADP ribose polymerase 1 inhibitor","target":"triple-negative breast cancer","id":"22766"},{"source":"ADP ribose polymerase 1 inhibitor","target":"primary peritoneal cancer","id":"22767"},{"source":"ADP ribose polymerase 1 inhibitor","target":"peritoneal neoplasms","id":"22768"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"22769"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast neoplasms","id":"22770"},{"source":"ADP ribose polymerase 1 inhibitor","target":"fallopian tube neoplasms","id":"22771"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metastatic","id":"22772"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"22773"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast neoplasms","id":"22774"},{"source":"ADP ribose polymerase 1 inhibitor","target":"neoplasm metastasis","id":"22775"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metastatic","id":"22776"},{"source":"ADP ribose polymerase 1 inhibitor","target":"tnbc","id":"22777"},{"source":"ADP ribose polymerase 1 inhibitor","target":"triple-negative breast cancer","id":"22778"},{"source":"ADP ribose polymerase 1 inhibitor","target":"ovarian neoplasms","id":"22779"},{"source":"ADP ribose polymerase 1 inhibitor","target":"UNK : Indication","id":"22780"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anticancer","id":"22781"},{"source":"ADP ribose polymerase 1 inhibitor","target":"ovarian cancer","id":"22782"},{"source":"ADP ribose polymerase 1 inhibitor","target":"triple-negative breast cancer","id":"22783"},{"source":"ADP ribose polymerase 1 inhibitor","target":"primary peritoneal cancer","id":"22784"},{"source":"ADP ribose polymerase 1 inhibitor","target":"peritoneal neoplasms","id":"22785"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"22786"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast neoplasms","id":"22787"},{"source":"ADP ribose polymerase 1 inhibitor","target":"fallopian tube neoplasms","id":"22788"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metastatic","id":"22789"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"22790"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast neoplasms","id":"22791"},{"source":"ADP ribose polymerase 1 inhibitor","target":"neoplasm metastasis","id":"22792"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metastatic","id":"22793"},{"source":"ADP ribose polymerase 1 inhibitor","target":"tnbc","id":"22794"},{"source":"ADP ribose polymerase 1 inhibitor","target":"triple-negative breast cancer","id":"22795"},{"source":"ADP ribose polymerase 1 inhibitor","target":"ovarian neoplasms","id":"22796"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"22797"},{"source":"Oncology: (N/A)","target":"NA","id":"22798"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"22799"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"22800"},{"source":"Oncology: (N/A)","target":"ADP ribose polymerase 1 inhibitor","id":"22801"},{"source":"Oncology: (N/A)","target":"ADP ribose polymerase 1 inhibitor","id":"22802"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"22803"},{"source":"Oncology: Breast","target":"NA","id":"22804"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"22805"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"22806"},{"source":"Oncology: Breast","target":"ADP ribose polymerase 1 inhibitor","id":"22807"},{"source":"Oncology: Breast","target":"ADP ribose polymerase 1 inhibitor","id":"22808"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"22809"},{"source":"Oncology: Ovarian","target":"NA","id":"22810"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"22811"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"22812"},{"source":"Oncology: Ovarian","target":"ADP ribose polymerase 1 inhibitor","id":"22813"},{"source":"Oncology: Ovarian","target":"ADP ribose polymerase 1 inhibitor","id":"22814"},{"source":"CB-1158 (u)","target":"Calithera Biosciences","id":"22815"},{"source":"CB-1158 (u)","target":"Incyte Corporation","id":"22816"},{"source":"nivolumab (a)","target":"Calithera Biosciences","id":"22817"},{"source":"nivolumab (a)","target":"Incyte Corporation","id":"22818"},{"source":"pembrolizumab","target":"Calithera Biosciences","id":"22819"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"22820"},{"source":"colorectal neoplasms","target":"CB-1158 (u)","id":"22821"},{"source":"colorectal neoplasms","target":"nivolumab (a)","id":"22822"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"22823"},{"source":"gilbert syndrome","target":"CB-1158 (u)","id":"22824"},{"source":"gilbert syndrome","target":"nivolumab (a)","id":"22825"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"22826"},{"source":"anticancer","target":"CB-1158 (u)","id":"22827"},{"source":"anticancer","target":"nivolumab (a)","id":"22828"},{"source":"anticancer","target":"pembrolizumab","id":"22829"},{"source":"acute","target":"CB-1158 (u)","id":"22830"},{"source":"acute","target":"nivolumab (a)","id":"22831"},{"source":"acute","target":"pembrolizumab","id":"22832"},{"source":"castration-resistant prostatic neoplasms","target":"CB-1158 (u)","id":"22833"},{"source":"castration-resistant prostatic neoplasms","target":"nivolumab (a)","id":"22834"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"22835"},{"source":"skin neoplasms","target":"CB-1158 (u)","id":"22836"},{"source":"skin neoplasms","target":"nivolumab (a)","id":"22837"},{"source":"skin neoplasms","target":"pembrolizumab","id":"22838"},{"source":"renal cancer","target":"CB-1158 (u)","id":"22839"},{"source":"renal cancer","target":"nivolumab (a)","id":"22840"},{"source":"renal cancer","target":"pembrolizumab","id":"22841"},{"source":"carcinoma","target":"CB-1158 (u)","id":"22842"},{"source":"carcinoma","target":"nivolumab (a)","id":"22843"},{"source":"carcinoma","target":"pembrolizumab","id":"22844"},{"source":"gilbert disease","target":"CB-1158 (u)","id":"22845"},{"source":"gilbert disease","target":"nivolumab (a)","id":"22846"},{"source":"gilbert disease","target":"pembrolizumab","id":"22847"},{"source":"sarcoma","target":"CB-1158 (u)","id":"22848"},{"source":"sarcoma","target":"nivolumab (a)","id":"22849"},{"source":"sarcoma","target":"pembrolizumab","id":"22850"},{"source":"metastatic","target":"CB-1158 (u)","id":"22851"},{"source":"metastatic","target":"nivolumab (a)","id":"22852"},{"source":"metastatic","target":"pembrolizumab","id":"22853"},{"source":"endometrial neoplasms","target":"CB-1158 (u)","id":"22854"},{"source":"endometrial neoplasms","target":"nivolumab (a)","id":"22855"},{"source":"endometrial neoplasms","target":"pembrolizumab","id":"22856"},{"source":"non-small-cell lung","target":"CB-1158 (u)","id":"22857"},{"source":"non-small-cell lung","target":"nivolumab (a)","id":"22858"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"22859"},{"source":"melanoma","target":"CB-1158 (u)","id":"22860"},{"source":"melanoma","target":"nivolumab (a)","id":"22861"},{"source":"melanoma","target":"pembrolizumab","id":"22862"},{"source":"mesothelial","target":"CB-1158 (u)","id":"22863"},{"source":"mesothelial","target":"nivolumab (a)","id":"22864"},{"source":"mesothelial","target":"pembrolizumab","id":"22865"},{"source":"solid tumors","target":"CB-1158 (u)","id":"22866"},{"source":"solid tumors","target":"nivolumab (a)","id":"22867"},{"source":"solid tumors","target":"pembrolizumab","id":"22868"},{"source":"acute","target":"CB-1158 (u)","id":"22869"},{"source":"acute","target":"nivolumab (a)","id":"22870"},{"source":"acute","target":"pembrolizumab","id":"22871"},{"source":"metastatic","target":"CB-1158 (u)","id":"22872"},{"source":"metastatic","target":"nivolumab (a)","id":"22873"},{"source":"metastatic","target":"pembrolizumab","id":"22874"},{"source":"sarcoma","target":"CB-1158 (u)","id":"22875"},{"source":"sarcoma","target":"nivolumab (a)","id":"22876"},{"source":"sarcoma","target":"pembrolizumab","id":"22877"},{"source":"breast neoplasms","target":"CB-1158 (u)","id":"22878"},{"source":"breast neoplasms","target":"nivolumab (a)","id":"22879"},{"source":"breast neoplasms","target":"pembrolizumab","id":"22880"},{"source":"colonic neoplasms","target":"CB-1158 (u)","id":"22881"},{"source":"colonic neoplasms","target":"nivolumab (a)","id":"22882"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"22883"},{"source":"esophageal cancer","target":"CB-1158 (u)","id":"22884"},{"source":"esophageal cancer","target":"nivolumab (a)","id":"22885"},{"source":"esophageal cancer","target":"pembrolizumab","id":"22886"},{"source":"myeloid","target":"CB-1158 (u)","id":"22887"},{"source":"myeloid","target":"nivolumab (a)","id":"22888"},{"source":"myeloid","target":"pembrolizumab","id":"22889"},{"source":"sclc","target":"CB-1158 (u)","id":"22890"},{"source":"sclc","target":"nivolumab (a)","id":"22891"},{"source":"sclc","target":"pembrolizumab","id":"22892"},{"source":"anemia","target":"CB-1158 (u)","id":"22893"},{"source":"anemia","target":"nivolumab (a)","id":"22894"},{"source":"anemia","target":"pembrolizumab","id":"22895"},{"source":"ovarian neoplasms","target":"CB-1158 (u)","id":"22896"},{"source":"ovarian neoplasms","target":"nivolumab (a)","id":"22897"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"22898"},{"source":"renal cell","target":"CB-1158 (u)","id":"22899"},{"source":"renal cell","target":"nivolumab (a)","id":"22900"},{"source":"renal cell","target":"pembrolizumab","id":"22901"},{"source":"rcc","target":"CB-1158 (u)","id":"22902"},{"source":"rcc","target":"nivolumab (a)","id":"22903"},{"source":"rcc","target":"pembrolizumab","id":"22904"},{"source":"pharyngeal neoplasms","target":"CB-1158 (u)","id":"22905"},{"source":"pharyngeal neoplasms","target":"nivolumab (a)","id":"22906"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"22907"},{"source":"mesothelial","target":"CB-1158 (u)","id":"22908"},{"source":"mesothelial","target":"nivolumab (a)","id":"22909"},{"source":"mesothelial","target":"pembrolizumab","id":"22910"},{"source":"endometrioid","target":"CB-1158 (u)","id":"22911"},{"source":"endometrioid","target":"nivolumab (a)","id":"22912"},{"source":"endometrioid","target":"pembrolizumab","id":"22913"},{"source":"carcinoma","target":"CB-1158 (u)","id":"22914"},{"source":"carcinoma","target":"nivolumab (a)","id":"22915"},{"source":"carcinoma","target":"pembrolizumab","id":"22916"},{"source":"alopecia","target":"CB-1158 (u)","id":"22917"},{"source":"alopecia","target":"nivolumab (a)","id":"22918"},{"source":"alopecia","target":"pembrolizumab","id":"22919"},{"source":"mesothelial","target":"CB-1158 (u)","id":"22920"},{"source":"mesothelial","target":"nivolumab (a)","id":"22921"},{"source":"mesothelial","target":"pembrolizumab","id":"22922"},{"source":"kidney neoplasms","target":"CB-1158 (u)","id":"22923"},{"source":"kidney neoplasms","target":"nivolumab (a)","id":"22924"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"22925"},{"source":"leukemia","target":"CB-1158 (u)","id":"22926"},{"source":"leukemia","target":"nivolumab (a)","id":"22927"},{"source":"leukemia","target":"pembrolizumab","id":"22928"},{"source":"unknown primary","target":"CB-1158 (u)","id":"22929"},{"source":"unknown primary","target":"nivolumab (a)","id":"22930"},{"source":"unknown primary","target":"pembrolizumab","id":"22931"},{"source":"carcinoma","target":"CB-1158 (u)","id":"22932"},{"source":"carcinoma","target":"nivolumab (a)","id":"22933"},{"source":"carcinoma","target":"pembrolizumab","id":"22934"},{"source":"gastric cancer","target":"CB-1158 (u)","id":"22935"},{"source":"gastric cancer","target":"nivolumab (a)","id":"22936"},{"source":"gastric cancer","target":"pembrolizumab","id":"22937"},{"source":"metastatic","target":"CB-1158 (u)","id":"22938"},{"source":"metastatic","target":"nivolumab (a)","id":"22939"},{"source":"metastatic","target":"pembrolizumab","id":"22940"},{"source":"carcinoma","target":"CB-1158 (u)","id":"22941"},{"source":"carcinoma","target":"nivolumab (a)","id":"22942"},{"source":"carcinoma","target":"pembrolizumab","id":"22943"},{"source":"soft tissue neoplasms","target":"CB-1158 (u)","id":"22944"},{"source":"soft tissue neoplasms","target":"nivolumab (a)","id":"22945"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"22946"},{"source":"ovarian cancer","target":"CB-1158 (u)","id":"22947"},{"source":"ovarian cancer","target":"nivolumab (a)","id":"22948"},{"source":"ovarian cancer","target":"pembrolizumab","id":"22949"},{"source":"neoplasm metastasis","target":"CB-1158 (u)","id":"22950"},{"source":"neoplasm metastasis","target":"nivolumab (a)","id":"22951"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"22952"},{"source":"carcinoma","target":"CB-1158 (u)","id":"22953"},{"source":"carcinoma","target":"nivolumab (a)","id":"22954"},{"source":"carcinoma","target":"pembrolizumab","id":"22955"},{"source":"colorectal neoplasms","target":"CB-1158 (u)","id":"22956"},{"source":"colorectal neoplasms","target":"nivolumab (a)","id":"22957"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"22958"},{"source":"stomach neoplasms","target":"CB-1158 (u)","id":"22959"},{"source":"stomach neoplasms","target":"nivolumab (a)","id":"22960"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"22961"},{"source":"acute","target":"CB-1158 (u)","id":"22962"},{"source":"acute","target":"nivolumab (a)","id":"22963"},{"source":"acute","target":"pembrolizumab","id":"22964"},{"source":"urinary bladder neoplasms","target":"CB-1158 (u)","id":"22965"},{"source":"urinary bladder neoplasms","target":"nivolumab (a)","id":"22966"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"22967"},{"source":"residual tumor","target":"CB-1158 (u)","id":"22968"},{"source":"residual tumor","target":"nivolumab (a)","id":"22969"},{"source":"residual tumor","target":"pembrolizumab","id":"22970"},{"source":"solid malignancy","target":"CB-1158 (u)","id":"22971"},{"source":"solid malignancy","target":"nivolumab (a)","id":"22972"},{"source":"solid malignancy","target":"pembrolizumab","id":"22973"},{"source":"skin neoplasms","target":"CB-1158 (u)","id":"22974"},{"source":"skin neoplasms","target":"nivolumab (a)","id":"22975"},{"source":"skin neoplasms","target":"pembrolizumab","id":"22976"},{"source":"residual tumor","target":"CB-1158 (u)","id":"22977"},{"source":"residual tumor","target":"nivolumab (a)","id":"22978"},{"source":"residual tumor","target":"pembrolizumab","id":"22979"},{"source":"head and neck neoplasms","target":"CB-1158 (u)","id":"22980"},{"source":"head and neck neoplasms","target":"nivolumab (a)","id":"22981"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"22982"},{"source":"anticancer","target":"CB-1158 (u)","id":"22983"},{"source":"anticancer","target":"nivolumab (a)","id":"22984"},{"source":"anticancer","target":"pembrolizumab","id":"22985"},{"source":"unknown primary","target":"CB-1158 (u)","id":"22986"},{"source":"unknown primary","target":"nivolumab (a)","id":"22987"},{"source":"unknown primary","target":"pembrolizumab","id":"22988"},{"source":"solid tumors","target":"CB-1158 (u)","id":"22989"},{"source":"solid tumors","target":"nivolumab (a)","id":"22990"},{"source":"solid tumors","target":"pembrolizumab","id":"22991"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"22992"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"22993"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"22994"},{"source":"Anticancer immunotherapy","target":"acute","id":"22995"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"22996"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"22997"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"22998"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"22999"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"23000"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"23001"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"23002"},{"source":"Anticancer immunotherapy","target":"endometrial neoplasms","id":"23003"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"23004"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"23005"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"23006"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"23007"},{"source":"Anticancer immunotherapy","target":"acute","id":"23008"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"23009"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"23010"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"23011"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"23012"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"23013"},{"source":"Anticancer immunotherapy","target":"myeloid","id":"23014"},{"source":"Anticancer immunotherapy","target":"sclc","id":"23015"},{"source":"Anticancer immunotherapy","target":"anemia","id":"23016"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"23017"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"23018"},{"source":"Anticancer immunotherapy","target":"rcc","id":"23019"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"23020"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"23021"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"23022"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23023"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"23024"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"23025"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"23026"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"23027"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"23028"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23029"},{"source":"Anticancer immunotherapy","target":"gastric cancer","id":"23030"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"23031"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23032"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"23033"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"23034"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"23035"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23036"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"23037"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"23038"},{"source":"Anticancer immunotherapy","target":"acute","id":"23039"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"23040"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"23041"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"23042"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"23043"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"23044"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"23045"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"23046"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"23047"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"23048"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"23049"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"23050"},{"source":"CD19 antagonist","target":"anticancer","id":"23051"},{"source":"CD19 antagonist","target":"acute","id":"23052"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"23053"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"23054"},{"source":"CD19 antagonist","target":"renal cancer","id":"23055"},{"source":"CD19 antagonist","target":"carcinoma","id":"23056"},{"source":"CD19 antagonist","target":"gilbert disease","id":"23057"},{"source":"CD19 antagonist","target":"sarcoma","id":"23058"},{"source":"CD19 antagonist","target":"metastatic","id":"23059"},{"source":"CD19 antagonist","target":"endometrial neoplasms","id":"23060"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"23061"},{"source":"CD19 antagonist","target":"melanoma","id":"23062"},{"source":"CD19 antagonist","target":"mesothelial","id":"23063"},{"source":"CD19 antagonist","target":"solid tumors","id":"23064"},{"source":"CD19 antagonist","target":"acute","id":"23065"},{"source":"CD19 antagonist","target":"metastatic","id":"23066"},{"source":"CD19 antagonist","target":"sarcoma","id":"23067"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"23068"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"23069"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"23070"},{"source":"CD19 antagonist","target":"myeloid","id":"23071"},{"source":"CD19 antagonist","target":"sclc","id":"23072"},{"source":"CD19 antagonist","target":"anemia","id":"23073"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"23074"},{"source":"CD19 antagonist","target":"renal cell","id":"23075"},{"source":"CD19 antagonist","target":"rcc","id":"23076"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"23077"},{"source":"CD19 antagonist","target":"mesothelial","id":"23078"},{"source":"CD19 antagonist","target":"endometrioid","id":"23079"},{"source":"CD19 antagonist","target":"carcinoma","id":"23080"},{"source":"CD19 antagonist","target":"alopecia","id":"23081"},{"source":"CD19 antagonist","target":"mesothelial","id":"23082"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"23083"},{"source":"CD19 antagonist","target":"leukemia","id":"23084"},{"source":"CD19 antagonist","target":"unknown primary","id":"23085"},{"source":"CD19 antagonist","target":"carcinoma","id":"23086"},{"source":"CD19 antagonist","target":"gastric cancer","id":"23087"},{"source":"CD19 antagonist","target":"metastatic","id":"23088"},{"source":"CD19 antagonist","target":"carcinoma","id":"23089"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"23090"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"23091"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"23092"},{"source":"CD19 antagonist","target":"carcinoma","id":"23093"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"23094"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"23095"},{"source":"CD19 antagonist","target":"acute","id":"23096"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"23097"},{"source":"CD19 antagonist","target":"residual tumor","id":"23098"},{"source":"CD19 antagonist","target":"solid malignancy","id":"23099"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"23100"},{"source":"CD19 antagonist","target":"residual tumor","id":"23101"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"23102"},{"source":"CD19 antagonist","target":"anticancer","id":"23103"},{"source":"CD19 antagonist","target":"unknown primary","id":"23104"},{"source":"CD19 antagonist","target":"solid tumors","id":"23105"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"23106"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"23107"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"23108"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"23109"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"23110"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"23111"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"23112"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23113"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"23114"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"23115"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"23116"},{"source":"Immune checkpoint inhibitor","target":"endometrial neoplasms","id":"23117"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"23118"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"23119"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"23120"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"23121"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"23122"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"23123"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"23124"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"23125"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"23126"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"23127"},{"source":"Immune checkpoint inhibitor","target":"myeloid","id":"23128"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"23129"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"23130"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"23131"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"23132"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"23133"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"23134"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"23135"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"23136"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23137"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"23138"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"23139"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"23140"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"23141"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"23142"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23143"},{"source":"Immune checkpoint inhibitor","target":"gastric cancer","id":"23144"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"23145"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23146"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"23147"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"23148"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"23149"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23150"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"23151"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"23152"},{"source":"Immune checkpoint inhibitor","target":"acute","id":"23153"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"23154"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"23155"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"23156"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"23157"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"23158"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"23159"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"23160"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"23161"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"23162"},{"source":"NA","target":"colorectal neoplasms","id":"23163"},{"source":"NA","target":"gilbert syndrome","id":"23164"},{"source":"NA","target":"anticancer","id":"23165"},{"source":"NA","target":"acute","id":"23166"},{"source":"NA","target":"castration-resistant prostatic neoplasms","id":"23167"},{"source":"NA","target":"skin neoplasms","id":"23168"},{"source":"NA","target":"renal cancer","id":"23169"},{"source":"NA","target":"carcinoma","id":"23170"},{"source":"NA","target":"gilbert disease","id":"23171"},{"source":"NA","target":"sarcoma","id":"23172"},{"source":"NA","target":"metastatic","id":"23173"},{"source":"NA","target":"endometrial neoplasms","id":"23174"},{"source":"NA","target":"non-small-cell lung","id":"23175"},{"source":"NA","target":"melanoma","id":"23176"},{"source":"NA","target":"mesothelial","id":"23177"},{"source":"NA","target":"solid tumors","id":"23178"},{"source":"NA","target":"acute","id":"23179"},{"source":"NA","target":"metastatic","id":"23180"},{"source":"NA","target":"sarcoma","id":"23181"},{"source":"NA","target":"breast neoplasms","id":"23182"},{"source":"NA","target":"colonic neoplasms","id":"23183"},{"source":"NA","target":"esophageal cancer","id":"23184"},{"source":"NA","target":"myeloid","id":"23185"},{"source":"NA","target":"sclc","id":"23186"},{"source":"NA","target":"anemia","id":"23187"},{"source":"NA","target":"ovarian neoplasms","id":"23188"},{"source":"NA","target":"renal cell","id":"23189"},{"source":"NA","target":"rcc","id":"23190"},{"source":"NA","target":"pharyngeal neoplasms","id":"23191"},{"source":"NA","target":"mesothelial","id":"23192"},{"source":"NA","target":"endometrioid","id":"23193"},{"source":"NA","target":"carcinoma","id":"23194"},{"source":"NA","target":"alopecia","id":"23195"},{"source":"NA","target":"mesothelial","id":"23196"},{"source":"NA","target":"kidney neoplasms","id":"23197"},{"source":"NA","target":"leukemia","id":"23198"},{"source":"NA","target":"unknown primary","id":"23199"},{"source":"NA","target":"carcinoma","id":"23200"},{"source":"NA","target":"gastric cancer","id":"23201"},{"source":"NA","target":"metastatic","id":"23202"},{"source":"NA","target":"carcinoma","id":"23203"},{"source":"NA","target":"soft tissue neoplasms","id":"23204"},{"source":"NA","target":"ovarian cancer","id":"23205"},{"source":"NA","target":"neoplasm metastasis","id":"23206"},{"source":"NA","target":"carcinoma","id":"23207"},{"source":"NA","target":"colorectal neoplasms","id":"23208"},{"source":"NA","target":"stomach neoplasms","id":"23209"},{"source":"NA","target":"acute","id":"23210"},{"source":"NA","target":"urinary bladder neoplasms","id":"23211"},{"source":"NA","target":"residual tumor","id":"23212"},{"source":"NA","target":"solid malignancy","id":"23213"},{"source":"NA","target":"skin neoplasms","id":"23214"},{"source":"NA","target":"residual tumor","id":"23215"},{"source":"NA","target":"head and neck neoplasms","id":"23216"},{"source":"NA","target":"anticancer","id":"23217"},{"source":"NA","target":"unknown primary","id":"23218"},{"source":"NA","target":"solid tumors","id":"23219"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"23220"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"23221"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"23222"},{"source":"Oncology: (N/A)","target":"NA","id":"23223"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"23224"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"23225"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"23226"},{"source":"Oncology: Bladder","target":"NA","id":"23227"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"23228"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"23229"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"23230"},{"source":"Oncology: Breast","target":"NA","id":"23231"},{"source":"Oncology: Cervical","target":"Anticancer immunotherapy","id":"23232"},{"source":"Oncology: Cervical","target":"CD19 antagonist","id":"23233"},{"source":"Oncology: Cervical","target":"Immune checkpoint inhibitor","id":"23234"},{"source":"Oncology: Cervical","target":"NA","id":"23235"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"23236"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"23237"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"23238"},{"source":"Oncology: Colorectal","target":"NA","id":"23239"},{"source":"Oncology: Endometrial","target":"Anticancer immunotherapy","id":"23240"},{"source":"Oncology: Endometrial","target":"CD19 antagonist","id":"23241"},{"source":"Oncology: Endometrial","target":"Immune checkpoint inhibitor","id":"23242"},{"source":"Oncology: Endometrial","target":"NA","id":"23243"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"23244"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"23245"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"23246"},{"source":"Oncology: Esophageal","target":"NA","id":"23247"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"23248"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"23249"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"23250"},{"source":"Oncology: Gastric","target":"NA","id":"23251"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"23252"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"23253"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"23254"},{"source":"Oncology: Head/Neck","target":"NA","id":"23255"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"23256"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"23257"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"23258"},{"source":"Oncology: Lung","target":"NA","id":"23259"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"23260"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"23261"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"23262"},{"source":"Non-Small Cell","target":"NA","id":"23263"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"23264"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"23265"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"23266"},{"source":"Oncology: Melanoma","target":"NA","id":"23267"},{"source":"Oncology: Mesothelioma","target":"Anticancer immunotherapy","id":"23268"},{"source":"Oncology: Mesothelioma","target":"CD19 antagonist","id":"23269"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint inhibitor","id":"23270"},{"source":"Oncology: Mesothelioma","target":"NA","id":"23271"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"23272"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"23273"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"23274"},{"source":"Oncology: Ovarian","target":"NA","id":"23275"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"23276"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"23277"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"23278"},{"source":"Oncology: Prostate","target":"NA","id":"23279"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"23280"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"23281"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"23282"},{"source":"Oncology: Renal","target":"NA","id":"23283"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"23284"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"23285"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"23286"},{"source":"Oncology: Soft Tissue Sarcoma","target":"NA","id":"23287"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"23288"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"23289"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"23290"},{"source":"Oncology: CNS","target":"NA","id":"23291"},{"source":"pembrolizumab","target":"H. Lee Moffitt Cancer Center and Research Institute","id":"23292"},{"source":"pembrolizumab","target":"Merck & Co.","id":"23293"},{"source":"vorinostat (a)","target":"H. Lee Moffitt Cancer Center and Research Institute","id":"23294"},{"source":"vorinostat (a)","target":"Merck & Co.","id":"23295"},{"source":"UNK : Drug","target":"H. Lee Moffitt Cancer Center and Research Institute","id":"23296"},{"source":"UNK : Drug","target":"Merck & Co.","id":"23297"},{"source":"UNK : Indication","target":"pembrolizumab","id":"23298"},{"source":"UNK : Indication","target":"vorinostat (a)","id":"23299"},{"source":"UNK : Indication","target":"UNK : Drug","id":"23300"},{"source":"residual tumor","target":"pembrolizumab","id":"23301"},{"source":"residual tumor","target":"vorinostat (a)","id":"23302"},{"source":"residual tumor","target":"UNK : Drug","id":"23303"},{"source":"anti-hiv","target":"pembrolizumab","id":"23304"},{"source":"anti-hiv","target":"vorinostat (a)","id":"23305"},{"source":"anti-hiv","target":"UNK : Drug","id":"23306"},{"source":"solid tumors","target":"pembrolizumab","id":"23307"},{"source":"solid tumors","target":"vorinostat (a)","id":"23308"},{"source":"solid tumors","target":"UNK : Drug","id":"23309"},{"source":"antiparkinsonian","target":"pembrolizumab","id":"23310"},{"source":"antiparkinsonian","target":"vorinostat (a)","id":"23311"},{"source":"antiparkinsonian","target":"UNK : Drug","id":"23312"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"23313"},{"source":"non-small-cell lung","target":"vorinostat (a)","id":"23314"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"23315"},{"source":"sclc","target":"pembrolizumab","id":"23316"},{"source":"sclc","target":"vorinostat (a)","id":"23317"},{"source":"sclc","target":"UNK : Drug","id":"23318"},{"source":"lung cancer","target":"pembrolizumab","id":"23319"},{"source":"lung cancer","target":"vorinostat (a)","id":"23320"},{"source":"lung cancer","target":"UNK : Drug","id":"23321"},{"source":"carcinoma","target":"pembrolizumab","id":"23322"},{"source":"carcinoma","target":"vorinostat (a)","id":"23323"},{"source":"carcinoma","target":"UNK : Drug","id":"23324"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"23325"},{"source":"neoplasm metastasis","target":"vorinostat (a)","id":"23326"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"23327"},{"source":"metastatic","target":"pembrolizumab","id":"23328"},{"source":"metastatic","target":"vorinostat (a)","id":"23329"},{"source":"metastatic","target":"UNK : Drug","id":"23330"},{"source":"carcinoma","target":"pembrolizumab","id":"23331"},{"source":"carcinoma","target":"vorinostat (a)","id":"23332"},{"source":"carcinoma","target":"UNK : Drug","id":"23333"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"23334"},{"source":"non-small-cell lung","target":"vorinostat (a)","id":"23335"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"23336"},{"source":"parkinson disease","target":"pembrolizumab","id":"23337"},{"source":"parkinson disease","target":"vorinostat (a)","id":"23338"},{"source":"parkinson disease","target":"UNK : Drug","id":"23339"},{"source":"anticancer","target":"pembrolizumab","id":"23340"},{"source":"anticancer","target":"vorinostat (a)","id":"23341"},{"source":"anticancer","target":"UNK : Drug","id":"23342"},{"source":"hiv infections","target":"pembrolizumab","id":"23343"},{"source":"hiv infections","target":"vorinostat (a)","id":"23344"},{"source":"hiv infections","target":"UNK : Drug","id":"23345"},{"source":"lung neoplasms","target":"pembrolizumab","id":"23346"},{"source":"lung neoplasms","target":"vorinostat (a)","id":"23347"},{"source":"lung neoplasms","target":"UNK : Drug","id":"23348"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"23349"},{"source":"acquired immunodeficiency syndrome","target":"vorinostat (a)","id":"23350"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"23351"},{"source":"solid tumors","target":"pembrolizumab","id":"23352"},{"source":"solid tumors","target":"vorinostat (a)","id":"23353"},{"source":"solid tumors","target":"UNK : Drug","id":"23354"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"23355"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"23356"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"23357"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"23358"},{"source":"Anticancer immunotherapy","target":"antiparkinsonian","id":"23359"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"23360"},{"source":"Anticancer immunotherapy","target":"sclc","id":"23361"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"23362"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23363"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"23364"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"23365"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23366"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"23367"},{"source":"Anticancer immunotherapy","target":"parkinson disease","id":"23368"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"23369"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"23370"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"23371"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"23372"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"23373"},{"source":"Histone deacetylase inhibitor","target":"UNK : Indication","id":"23374"},{"source":"Histone deacetylase inhibitor","target":"residual tumor","id":"23375"},{"source":"Histone deacetylase inhibitor","target":"anti-hiv","id":"23376"},{"source":"Histone deacetylase inhibitor","target":"solid tumors","id":"23377"},{"source":"Histone deacetylase inhibitor","target":"antiparkinsonian","id":"23378"},{"source":"Histone deacetylase inhibitor","target":"non-small-cell lung","id":"23379"},{"source":"Histone deacetylase inhibitor","target":"sclc","id":"23380"},{"source":"Histone deacetylase inhibitor","target":"lung cancer","id":"23381"},{"source":"Histone deacetylase inhibitor","target":"carcinoma","id":"23382"},{"source":"Histone deacetylase inhibitor","target":"neoplasm metastasis","id":"23383"},{"source":"Histone deacetylase inhibitor","target":"metastatic","id":"23384"},{"source":"Histone deacetylase inhibitor","target":"carcinoma","id":"23385"},{"source":"Histone deacetylase inhibitor","target":"non-small-cell lung","id":"23386"},{"source":"Histone deacetylase inhibitor","target":"parkinson disease","id":"23387"},{"source":"Histone deacetylase inhibitor","target":"anticancer","id":"23388"},{"source":"Histone deacetylase inhibitor","target":"hiv infections","id":"23389"},{"source":"Histone deacetylase inhibitor","target":"lung neoplasms","id":"23390"},{"source":"Histone deacetylase inhibitor","target":"acquired immunodeficiency syndrome","id":"23391"},{"source":"Histone deacetylase inhibitor","target":"solid tumors","id":"23392"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"23393"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"23394"},{"source":"Cell cycle inhibitor","target":"anti-hiv","id":"23395"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"23396"},{"source":"Cell cycle inhibitor","target":"antiparkinsonian","id":"23397"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"23398"},{"source":"Cell cycle inhibitor","target":"sclc","id":"23399"},{"source":"Cell cycle inhibitor","target":"lung cancer","id":"23400"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"23401"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"23402"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"23403"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"23404"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"23405"},{"source":"Cell cycle inhibitor","target":"parkinson disease","id":"23406"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"23407"},{"source":"Cell cycle inhibitor","target":"hiv infections","id":"23408"},{"source":"Cell cycle inhibitor","target":"lung neoplasms","id":"23409"},{"source":"Cell cycle inhibitor","target":"acquired immunodeficiency syndrome","id":"23410"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"23411"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"23412"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"23413"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"23414"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"23415"},{"source":"Immune checkpoint inhibitor","target":"antiparkinsonian","id":"23416"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"23417"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"23418"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"23419"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23420"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"23421"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"23422"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23423"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"23424"},{"source":"Immune checkpoint inhibitor","target":"parkinson disease","id":"23425"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"23426"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"23427"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"23428"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"23429"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"23430"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"23431"},{"source":"CD19 antagonist","target":"residual tumor","id":"23432"},{"source":"CD19 antagonist","target":"anti-hiv","id":"23433"},{"source":"CD19 antagonist","target":"solid tumors","id":"23434"},{"source":"CD19 antagonist","target":"antiparkinsonian","id":"23435"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"23436"},{"source":"CD19 antagonist","target":"sclc","id":"23437"},{"source":"CD19 antagonist","target":"lung cancer","id":"23438"},{"source":"CD19 antagonist","target":"carcinoma","id":"23439"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"23440"},{"source":"CD19 antagonist","target":"metastatic","id":"23441"},{"source":"CD19 antagonist","target":"carcinoma","id":"23442"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"23443"},{"source":"CD19 antagonist","target":"parkinson disease","id":"23444"},{"source":"CD19 antagonist","target":"anticancer","id":"23445"},{"source":"CD19 antagonist","target":"hiv infections","id":"23446"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"23447"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"23448"},{"source":"CD19 antagonist","target":"solid tumors","id":"23449"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"23450"},{"source":"Oncology: Lung","target":"Histone deacetylase inhibitor","id":"23451"},{"source":"Oncology: Lung","target":"Cell cycle inhibitor","id":"23452"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"23453"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"23454"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"23455"},{"source":"Non-Small Cell","target":"Histone deacetylase inhibitor","id":"23456"},{"source":"Non-Small Cell","target":"Cell cycle inhibitor","id":"23457"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"23458"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"23459"},{"source":"epacadostat (u)","target":"Incyte Corporation","id":"23460"},{"source":"epacadostat (u)","target":"Merck & Co.","id":"23461"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"23462"},{"source":"pembrolizumab","target":"Merck & Co.","id":"23463"},{"source":"UNK : Drug","target":"Incyte Corporation","id":"23464"},{"source":"UNK : Drug","target":"Merck & Co.","id":"23465"},{"source":"UNK : Indication","target":"epacadostat (u)","id":"23466"},{"source":"UNK : Indication","target":"pembrolizumab","id":"23467"},{"source":"UNK : Indication","target":"UNK : Drug","id":"23468"},{"source":"melanoma","target":"epacadostat (u)","id":"23469"},{"source":"melanoma","target":"pembrolizumab","id":"23470"},{"source":"melanoma","target":"UNK : Drug","id":"23471"},{"source":"anticancer","target":"epacadostat (u)","id":"23472"},{"source":"anticancer","target":"pembrolizumab","id":"23473"},{"source":"anticancer","target":"UNK : Drug","id":"23474"},{"source":"alopecia","target":"epacadostat (u)","id":"23475"},{"source":"alopecia","target":"pembrolizumab","id":"23476"},{"source":"alopecia","target":"UNK : Drug","id":"23477"},{"source":"skin neoplasms","target":"epacadostat (u)","id":"23478"},{"source":"skin neoplasms","target":"pembrolizumab","id":"23479"},{"source":"skin neoplasms","target":"UNK : Drug","id":"23480"},{"source":"residual tumor","target":"epacadostat (u)","id":"23481"},{"source":"residual tumor","target":"pembrolizumab","id":"23482"},{"source":"residual tumor","target":"UNK : Drug","id":"23483"},{"source":"melanoma","target":"epacadostat (u)","id":"23484"},{"source":"melanoma","target":"pembrolizumab","id":"23485"},{"source":"melanoma","target":"UNK : Drug","id":"23486"},{"source":"metastatic","target":"epacadostat (u)","id":"23487"},{"source":"metastatic","target":"pembrolizumab","id":"23488"},{"source":"metastatic","target":"UNK : Drug","id":"23489"},{"source":"carcinoma","target":"epacadostat (u)","id":"23490"},{"source":"carcinoma","target":"pembrolizumab","id":"23491"},{"source":"carcinoma","target":"UNK : Drug","id":"23492"},{"source":"neoplasm metastasis","target":"epacadostat (u)","id":"23493"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"23494"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"23495"},{"source":"anticancer","target":"epacadostat (u)","id":"23496"},{"source":"anticancer","target":"pembrolizumab","id":"23497"},{"source":"anticancer","target":"UNK : Drug","id":"23498"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"23499"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"23500"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"23501"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"23502"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"23503"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"23504"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"23505"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"23506"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23507"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"23508"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"23509"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"23510"},{"source":"CD19 antagonist","target":"melanoma","id":"23511"},{"source":"CD19 antagonist","target":"anticancer","id":"23512"},{"source":"CD19 antagonist","target":"alopecia","id":"23513"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"23514"},{"source":"CD19 antagonist","target":"residual tumor","id":"23515"},{"source":"CD19 antagonist","target":"melanoma","id":"23516"},{"source":"CD19 antagonist","target":"metastatic","id":"23517"},{"source":"CD19 antagonist","target":"carcinoma","id":"23518"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"23519"},{"source":"CD19 antagonist","target":"anticancer","id":"23520"},{"source":"Indoleamine-pyrrole 2","target":"UNK : Indication","id":"23521"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"23522"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"23523"},{"source":"Indoleamine-pyrrole 2","target":"alopecia","id":"23524"},{"source":"Indoleamine-pyrrole 2","target":"skin neoplasms","id":"23525"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"23526"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"23527"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"23528"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"23529"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"23530"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"23531"},{"source":"NA","target":"UNK : Indication","id":"23532"},{"source":"NA","target":"melanoma","id":"23533"},{"source":"NA","target":"anticancer","id":"23534"},{"source":"NA","target":"alopecia","id":"23535"},{"source":"NA","target":"skin neoplasms","id":"23536"},{"source":"NA","target":"residual tumor","id":"23537"},{"source":"NA","target":"melanoma","id":"23538"},{"source":"NA","target":"metastatic","id":"23539"},{"source":"NA","target":"carcinoma","id":"23540"},{"source":"NA","target":"neoplasm metastasis","id":"23541"},{"source":"NA","target":"anticancer","id":"23542"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"23543"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"23544"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"23545"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"23546"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"23547"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"23548"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"23549"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"23550"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23551"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"23552"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"23553"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"23554"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"23555"},{"source":"Oncology: Melanoma","target":"Indoleamine-pyrrole 2","id":"23556"},{"source":"Oncology: Melanoma","target":"NA","id":"23557"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"23558"},{"source":"NY-ESO-1 T cells","target":"AdaptImmune","id":"23559"},{"source":"NY-ESO-1 T cells","target":"GlaxoSmithKline","id":"23560"},{"source":"NY-ESO-1 T cells","target":"Merck & Co.","id":"23561"},{"source":"Adaptimmune (u)","target":"AdaptImmune","id":"23562"},{"source":"Adaptimmune (u)","target":"GlaxoSmithKline","id":"23563"},{"source":"Adaptimmune (u)","target":"Merck & Co.","id":"23564"},{"source":"cyclophosphamide","target":"AdaptImmune","id":"23565"},{"source":"cyclophosphamide","target":"GlaxoSmithKline","id":"23566"},{"source":"cyclophosphamide","target":"Merck & Co.","id":"23567"},{"source":"unspecified","target":"AdaptImmune","id":"23568"},{"source":"unspecified","target":"GlaxoSmithKline","id":"23569"},{"source":"unspecified","target":"Merck & Co.","id":"23570"},{"source":"fludarabine","target":"AdaptImmune","id":"23571"},{"source":"fludarabine","target":"GlaxoSmithKline","id":"23572"},{"source":"fludarabine","target":"Merck & Co.","id":"23573"},{"source":"pembrolizumab","target":"AdaptImmune","id":"23574"},{"source":"pembrolizumab","target":"GlaxoSmithKline","id":"23575"},{"source":"pembrolizumab","target":"Merck & Co.","id":"23576"},{"source":"UNK : Indication","target":"NY-ESO-1 T cells","id":"23577"},{"source":"UNK : Indication","target":"Adaptimmune (u)","id":"23578"},{"source":"UNK : Indication","target":"cyclophosphamide","id":"23579"},{"source":"UNK : Indication","target":"unspecified","id":"23580"},{"source":"UNK : Indication","target":"fludarabine","id":"23581"},{"source":"UNK : Indication","target":"pembrolizumab","id":"23582"},{"source":"skin neoplasms","target":"NY-ESO-1 T cells","id":"23583"},{"source":"skin neoplasms","target":"Adaptimmune (u)","id":"23584"},{"source":"skin neoplasms","target":"cyclophosphamide","id":"23585"},{"source":"skin neoplasms","target":"unspecified","id":"23586"},{"source":"skin neoplasms","target":"fludarabine","id":"23587"},{"source":"skin neoplasms","target":"pembrolizumab","id":"23588"},{"source":"stem cell transplantation","target":"NY-ESO-1 T cells","id":"23589"},{"source":"stem cell transplantation","target":"Adaptimmune (u)","id":"23590"},{"source":"stem cell transplantation","target":"cyclophosphamide","id":"23591"},{"source":"stem cell transplantation","target":"unspecified","id":"23592"},{"source":"stem cell transplantation","target":"fludarabine","id":"23593"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"23594"},{"source":"plasma cell","target":"NY-ESO-1 T cells","id":"23595"},{"source":"plasma cell","target":"Adaptimmune (u)","id":"23596"},{"source":"plasma cell","target":"cyclophosphamide","id":"23597"},{"source":"plasma cell","target":"unspecified","id":"23598"},{"source":"plasma cell","target":"fludarabine","id":"23599"},{"source":"plasma cell","target":"pembrolizumab","id":"23600"},{"source":"refractory myeloma","target":"NY-ESO-1 T cells","id":"23601"},{"source":"refractory myeloma","target":"Adaptimmune (u)","id":"23602"},{"source":"refractory myeloma","target":"cyclophosphamide","id":"23603"},{"source":"refractory myeloma","target":"unspecified","id":"23604"},{"source":"refractory myeloma","target":"fludarabine","id":"23605"},{"source":"refractory myeloma","target":"pembrolizumab","id":"23606"},{"source":"anti-tumor","target":"NY-ESO-1 T cells","id":"23607"},{"source":"anti-tumor","target":"Adaptimmune (u)","id":"23608"},{"source":"anti-tumor","target":"cyclophosphamide","id":"23609"},{"source":"anti-tumor","target":"unspecified","id":"23610"},{"source":"anti-tumor","target":"fludarabine","id":"23611"},{"source":"anti-tumor","target":"pembrolizumab","id":"23612"},{"source":"plasma cell","target":"NY-ESO-1 T cells","id":"23613"},{"source":"plasma cell","target":"Adaptimmune (u)","id":"23614"},{"source":"plasma cell","target":"cyclophosphamide","id":"23615"},{"source":"plasma cell","target":"unspecified","id":"23616"},{"source":"plasma cell","target":"fludarabine","id":"23617"},{"source":"plasma cell","target":"pembrolizumab","id":"23618"},{"source":"multiple myeloma","target":"NY-ESO-1 T cells","id":"23619"},{"source":"multiple myeloma","target":"Adaptimmune (u)","id":"23620"},{"source":"multiple myeloma","target":"cyclophosphamide","id":"23621"},{"source":"multiple myeloma","target":"unspecified","id":"23622"},{"source":"multiple myeloma","target":"fludarabine","id":"23623"},{"source":"multiple myeloma","target":"pembrolizumab","id":"23624"},{"source":"anti-tumor","target":"NY-ESO-1 T cells","id":"23625"},{"source":"anti-tumor","target":"Adaptimmune (u)","id":"23626"},{"source":"anti-tumor","target":"cyclophosphamide","id":"23627"},{"source":"anti-tumor","target":"unspecified","id":"23628"},{"source":"anti-tumor","target":"fludarabine","id":"23629"},{"source":"anti-tumor","target":"pembrolizumab","id":"23630"},{"source":"carcinoma","target":"NY-ESO-1 T cells","id":"23631"},{"source":"carcinoma","target":"Adaptimmune (u)","id":"23632"},{"source":"carcinoma","target":"cyclophosphamide","id":"23633"},{"source":"carcinoma","target":"unspecified","id":"23634"},{"source":"carcinoma","target":"fludarabine","id":"23635"},{"source":"carcinoma","target":"pembrolizumab","id":"23636"},{"source":"multiple myeloma","target":"NY-ESO-1 T cells","id":"23637"},{"source":"multiple myeloma","target":"Adaptimmune (u)","id":"23638"},{"source":"multiple myeloma","target":"cyclophosphamide","id":"23639"},{"source":"multiple myeloma","target":"unspecified","id":"23640"},{"source":"multiple myeloma","target":"fludarabine","id":"23641"},{"source":"multiple myeloma","target":"pembrolizumab","id":"23642"},{"source":"anticancer","target":"NY-ESO-1 T cells","id":"23643"},{"source":"anticancer","target":"Adaptimmune (u)","id":"23644"},{"source":"anticancer","target":"cyclophosphamide","id":"23645"},{"source":"anticancer","target":"unspecified","id":"23646"},{"source":"anticancer","target":"fludarabine","id":"23647"},{"source":"anticancer","target":"pembrolizumab","id":"23648"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"23649"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"23650"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"23651"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"23652"},{"source":"Immune checkpoint inhibitor","target":"refractory myeloma","id":"23653"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"23654"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"23655"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"23656"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"23657"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23658"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"23659"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"23660"},{"source":"NA","target":"UNK : Indication","id":"23661"},{"source":"NA","target":"skin neoplasms","id":"23662"},{"source":"NA","target":"stem cell transplantation","id":"23663"},{"source":"NA","target":"plasma cell","id":"23664"},{"source":"NA","target":"refractory myeloma","id":"23665"},{"source":"NA","target":"anti-tumor","id":"23666"},{"source":"NA","target":"plasma cell","id":"23667"},{"source":"NA","target":"multiple myeloma","id":"23668"},{"source":"NA","target":"anti-tumor","id":"23669"},{"source":"NA","target":"carcinoma","id":"23670"},{"source":"NA","target":"multiple myeloma","id":"23671"},{"source":"NA","target":"anticancer","id":"23672"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"23673"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"23674"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"23675"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"23676"},{"source":"Anticancer immunotherapy","target":"refractory myeloma","id":"23677"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"23678"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"23679"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"23680"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"23681"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23682"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"23683"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"23684"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"23685"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"23686"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"23687"},{"source":"CD19 antagonist","target":"plasma cell","id":"23688"},{"source":"CD19 antagonist","target":"refractory myeloma","id":"23689"},{"source":"CD19 antagonist","target":"anti-tumor","id":"23690"},{"source":"CD19 antagonist","target":"plasma cell","id":"23691"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"23692"},{"source":"CD19 antagonist","target":"anti-tumor","id":"23693"},{"source":"CD19 antagonist","target":"carcinoma","id":"23694"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"23695"},{"source":"CD19 antagonist","target":"anticancer","id":"23696"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"UNK : Indication","id":"23697"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"skin neoplasms","id":"23698"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"stem cell transplantation","id":"23699"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"plasma cell","id":"23700"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"refractory myeloma","id":"23701"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"anti-tumor","id":"23702"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"plasma cell","id":"23703"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"multiple myeloma","id":"23704"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"anti-tumor","id":"23705"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"carcinoma","id":"23706"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"multiple myeloma","id":"23707"},{"source":"Ribonucleoside diphosphate reductase inhibitor","target":"anticancer","id":"23708"},{"source":"NA","target":"UNK : Indication","id":"23709"},{"source":"NA","target":"skin neoplasms","id":"23710"},{"source":"NA","target":"stem cell transplantation","id":"23711"},{"source":"NA","target":"plasma cell","id":"23712"},{"source":"NA","target":"refractory myeloma","id":"23713"},{"source":"NA","target":"anti-tumor","id":"23714"},{"source":"NA","target":"plasma cell","id":"23715"},{"source":"NA","target":"multiple myeloma","id":"23716"},{"source":"NA","target":"anti-tumor","id":"23717"},{"source":"NA","target":"carcinoma","id":"23718"},{"source":"NA","target":"multiple myeloma","id":"23719"},{"source":"NA","target":"anticancer","id":"23720"},{"source":"Immunostimulant","target":"UNK : Indication","id":"23721"},{"source":"Immunostimulant","target":"skin neoplasms","id":"23722"},{"source":"Immunostimulant","target":"stem cell transplantation","id":"23723"},{"source":"Immunostimulant","target":"plasma cell","id":"23724"},{"source":"Immunostimulant","target":"refractory myeloma","id":"23725"},{"source":"Immunostimulant","target":"anti-tumor","id":"23726"},{"source":"Immunostimulant","target":"plasma cell","id":"23727"},{"source":"Immunostimulant","target":"multiple myeloma","id":"23728"},{"source":"Immunostimulant","target":"anti-tumor","id":"23729"},{"source":"Immunostimulant","target":"carcinoma","id":"23730"},{"source":"Immunostimulant","target":"multiple myeloma","id":"23731"},{"source":"Immunostimulant","target":"anticancer","id":"23732"},{"source":"NA","target":"UNK : Indication","id":"23733"},{"source":"NA","target":"skin neoplasms","id":"23734"},{"source":"NA","target":"stem cell transplantation","id":"23735"},{"source":"NA","target":"plasma cell","id":"23736"},{"source":"NA","target":"refractory myeloma","id":"23737"},{"source":"NA","target":"anti-tumor","id":"23738"},{"source":"NA","target":"plasma cell","id":"23739"},{"source":"NA","target":"multiple myeloma","id":"23740"},{"source":"NA","target":"anti-tumor","id":"23741"},{"source":"NA","target":"carcinoma","id":"23742"},{"source":"NA","target":"multiple myeloma","id":"23743"},{"source":"NA","target":"anticancer","id":"23744"},{"source":"Oncology: Multiple Myeloma","target":"Immune checkpoint inhibitor","id":"23745"},{"source":"Oncology: Multiple Myeloma","target":"NA","id":"23746"},{"source":"Oncology: Multiple Myeloma","target":"Anticancer immunotherapy","id":"23747"},{"source":"Oncology: Multiple Myeloma","target":"CD19 antagonist","id":"23748"},{"source":"Oncology: Multiple Myeloma","target":"Ribonucleoside diphosphate reductase inhibitor","id":"23749"},{"source":"Oncology: Multiple Myeloma","target":"NA","id":"23750"},{"source":"Oncology: Multiple Myeloma","target":"Immunostimulant","id":"23751"},{"source":"Oncology: Multiple Myeloma","target":"NA","id":"23752"},{"source":"ramucirumab (a)","target":"Eli Lilly","id":"23753"},{"source":"ramucirumab (a)","target":"Merck & Co.","id":"23754"},{"source":"pembrolizumab","target":"Eli Lilly","id":"23755"},{"source":"pembrolizumab","target":"Merck & Co.","id":"23756"},{"source":"biliary tract neoplasms","target":"ramucirumab (a)","id":"23757"},{"source":"biliary tract neoplasms","target":"pembrolizumab","id":"23758"},{"source":"renal cancer","target":"ramucirumab (a)","id":"23759"},{"source":"renal cancer","target":"pembrolizumab","id":"23760"},{"source":"non-small-cell lung","target":"ramucirumab (a)","id":"23761"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"23762"},{"source":"non-small-cell lung","target":"ramucirumab (a)","id":"23763"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"23764"},{"source":"non-small-cell lung","target":"ramucirumab (a)","id":"23765"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"23766"},{"source":"esophageal cancer","target":"ramucirumab (a)","id":"23767"},{"source":"esophageal cancer","target":"pembrolizumab","id":"23768"},{"source":"carcinoma","target":"ramucirumab (a)","id":"23769"},{"source":"carcinoma","target":"pembrolizumab","id":"23770"},{"source":"sclc","target":"ramucirumab (a)","id":"23771"},{"source":"sclc","target":"pembrolizumab","id":"23772"},{"source":"carcinoma","target":"ramucirumab (a)","id":"23773"},{"source":"carcinoma","target":"pembrolizumab","id":"23774"},{"source":"pharyngeal neoplasms","target":"ramucirumab (a)","id":"23775"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"23776"},{"source":"kidney neoplasms","target":"ramucirumab (a)","id":"23777"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"23778"},{"source":"carcinoma","target":"ramucirumab (a)","id":"23779"},{"source":"carcinoma","target":"pembrolizumab","id":"23780"},{"source":"carcinoma","target":"ramucirumab (a)","id":"23781"},{"source":"carcinoma","target":"pembrolizumab","id":"23782"},{"source":"metastatic","target":"ramucirumab (a)","id":"23783"},{"source":"metastatic","target":"pembrolizumab","id":"23784"},{"source":"carcinoma","target":"ramucirumab (a)","id":"23785"},{"source":"carcinoma","target":"pembrolizumab","id":"23786"},{"source":"neoplasm metastasis","target":"ramucirumab (a)","id":"23787"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"23788"},{"source":"lung neoplasms","target":"ramucirumab (a)","id":"23789"},{"source":"lung neoplasms","target":"pembrolizumab","id":"23790"},{"source":"stomach neoplasms","target":"ramucirumab (a)","id":"23791"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"23792"},{"source":"transitional","target":"ramucirumab (a)","id":"23793"},{"source":"transitional","target":"pembrolizumab","id":"23794"},{"source":"residual tumor","target":"ramucirumab (a)","id":"23795"},{"source":"residual tumor","target":"pembrolizumab","id":"23796"},{"source":"residual tumor","target":"ramucirumab (a)","id":"23797"},{"source":"residual tumor","target":"pembrolizumab","id":"23798"},{"source":"anticancer","target":"ramucirumab (a)","id":"23799"},{"source":"anticancer","target":"pembrolizumab","id":"23800"},{"source":"urinary bladder neoplasms","target":"ramucirumab (a)","id":"23801"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"23802"},{"source":"Anticancer immunotherapy","target":"biliary tract neoplasms","id":"23803"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"23804"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"23805"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"23806"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"23807"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"23808"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23809"},{"source":"Anticancer immunotherapy","target":"sclc","id":"23810"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23811"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"23812"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"23813"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23814"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23815"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"23816"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23817"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"23818"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"23819"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"23820"},{"source":"Anticancer immunotherapy","target":"transitional","id":"23821"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"23822"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"23823"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"23824"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"23825"},{"source":"CD19 antagonist","target":"biliary tract neoplasms","id":"23826"},{"source":"CD19 antagonist","target":"renal cancer","id":"23827"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"23828"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"23829"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"23830"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"23831"},{"source":"CD19 antagonist","target":"carcinoma","id":"23832"},{"source":"CD19 antagonist","target":"sclc","id":"23833"},{"source":"CD19 antagonist","target":"carcinoma","id":"23834"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"23835"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"23836"},{"source":"CD19 antagonist","target":"carcinoma","id":"23837"},{"source":"CD19 antagonist","target":"carcinoma","id":"23838"},{"source":"CD19 antagonist","target":"metastatic","id":"23839"},{"source":"CD19 antagonist","target":"carcinoma","id":"23840"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"23841"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"23842"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"23843"},{"source":"CD19 antagonist","target":"transitional","id":"23844"},{"source":"CD19 antagonist","target":"residual tumor","id":"23845"},{"source":"CD19 antagonist","target":"residual tumor","id":"23846"},{"source":"CD19 antagonist","target":"anticancer","id":"23847"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"23848"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"biliary tract neoplasms","id":"23849"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cancer","id":"23850"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"non-small-cell lung","id":"23851"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"non-small-cell lung","id":"23852"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"non-small-cell lung","id":"23853"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"esophageal cancer","id":"23854"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"23855"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"sclc","id":"23856"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"23857"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"pharyngeal neoplasms","id":"23858"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"kidney neoplasms","id":"23859"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"23860"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"23861"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"metastatic","id":"23862"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"23863"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"neoplasm metastasis","id":"23864"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"lung neoplasms","id":"23865"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"stomach neoplasms","id":"23866"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"transitional","id":"23867"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"23868"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"23869"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"23870"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"urinary bladder neoplasms","id":"23871"},{"source":"Immune checkpoint inhibitor","target":"biliary tract neoplasms","id":"23872"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"23873"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"23874"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"23875"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"23876"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"23877"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23878"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"23879"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23880"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"23881"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"23882"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23883"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23884"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"23885"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"23886"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"23887"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"23888"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"23889"},{"source":"Immune checkpoint inhibitor","target":"transitional","id":"23890"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"23891"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"23892"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"23893"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"23894"},{"source":"Angiogenesis inhibitor","target":"biliary tract neoplasms","id":"23895"},{"source":"Angiogenesis inhibitor","target":"renal cancer","id":"23896"},{"source":"Angiogenesis inhibitor","target":"non-small-cell lung","id":"23897"},{"source":"Angiogenesis inhibitor","target":"non-small-cell lung","id":"23898"},{"source":"Angiogenesis inhibitor","target":"non-small-cell lung","id":"23899"},{"source":"Angiogenesis inhibitor","target":"esophageal cancer","id":"23900"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"23901"},{"source":"Angiogenesis inhibitor","target":"sclc","id":"23902"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"23903"},{"source":"Angiogenesis inhibitor","target":"pharyngeal neoplasms","id":"23904"},{"source":"Angiogenesis inhibitor","target":"kidney neoplasms","id":"23905"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"23906"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"23907"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"23908"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"23909"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"23910"},{"source":"Angiogenesis inhibitor","target":"lung neoplasms","id":"23911"},{"source":"Angiogenesis inhibitor","target":"stomach neoplasms","id":"23912"},{"source":"Angiogenesis inhibitor","target":"transitional","id":"23913"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"23914"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"23915"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"23916"},{"source":"Angiogenesis inhibitor","target":"urinary bladder neoplasms","id":"23917"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"23918"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"23919"},{"source":"Oncology: Bladder","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"23920"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"23921"},{"source":"Oncology: Bladder","target":"Angiogenesis inhibitor","id":"23922"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"23923"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"23924"},{"source":"Oncology: Esophageal","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"23925"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"23926"},{"source":"Oncology: Esophageal","target":"Angiogenesis inhibitor","id":"23927"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"23928"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"23929"},{"source":"Oncology: Gastric","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"23930"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"23931"},{"source":"Oncology: Gastric","target":"Angiogenesis inhibitor","id":"23932"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"23933"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"23934"},{"source":"Oncology: Lung","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"23935"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"23936"},{"source":"Oncology: Lung","target":"Angiogenesis inhibitor","id":"23937"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"23938"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"23939"},{"source":"Non-Small Cell","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"23940"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"23941"},{"source":"Non-Small Cell","target":"Angiogenesis inhibitor","id":"23942"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"23943"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"23944"},{"source":"Oncology: Renal","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"23945"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"23946"},{"source":"Oncology: Renal","target":"Angiogenesis inhibitor","id":"23947"},{"source":"blinatumomab (IV) (a)","target":"Amgen","id":"23948"},{"source":"blinatumomab (IV) (a)","target":"Merck & Co.","id":"23949"},{"source":"pembrolizumab","target":"Amgen","id":"23950"},{"source":"pembrolizumab","target":"Merck & Co.","id":"23951"},{"source":"UNK : Indication","target":"blinatumomab (IV) (a)","id":"23952"},{"source":"UNK : Indication","target":"pembrolizumab","id":"23953"},{"source":"lymphoma","target":"blinatumomab (IV) (a)","id":"23954"},{"source":"lymphoma","target":"pembrolizumab","id":"23955"},{"source":"b-cell","target":"blinatumomab (IV) (a)","id":"23956"},{"source":"b-cell","target":"pembrolizumab","id":"23957"},{"source":"dlbcl","target":"blinatumomab (IV) (a)","id":"23958"},{"source":"dlbcl","target":"pembrolizumab","id":"23959"},{"source":"lymphoma","target":"blinatumomab (IV) (a)","id":"23960"},{"source":"lymphoma","target":"pembrolizumab","id":"23961"},{"source":"lymphoma","target":"blinatumomab (IV) (a)","id":"23962"},{"source":"lymphoma","target":"pembrolizumab","id":"23963"},{"source":"b-cell","target":"blinatumomab (IV) (a)","id":"23964"},{"source":"b-cell","target":"pembrolizumab","id":"23965"},{"source":"lymphoma","target":"blinatumomab (IV) (a)","id":"23966"},{"source":"lymphoma","target":"pembrolizumab","id":"23967"},{"source":"carcinoma","target":"blinatumomab (IV) (a)","id":"23968"},{"source":"carcinoma","target":"pembrolizumab","id":"23969"},{"source":"non-hodgkin","target":"blinatumomab (IV) (a)","id":"23970"},{"source":"non-hodgkin","target":"pembrolizumab","id":"23971"},{"source":"anticancer","target":"blinatumomab (IV) (a)","id":"23972"},{"source":"anticancer","target":"pembrolizumab","id":"23973"},{"source":"lymphoma","target":"blinatumomab (IV) (a)","id":"23974"},{"source":"lymphoma","target":"pembrolizumab","id":"23975"},{"source":"diffuse","target":"blinatumomab (IV) (a)","id":"23976"},{"source":"diffuse","target":"pembrolizumab","id":"23977"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"23978"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"23979"},{"source":"Anticancer immunotherapy","target":"b-cell","id":"23980"},{"source":"Anticancer immunotherapy","target":"dlbcl","id":"23981"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"23982"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"23983"},{"source":"Anticancer immunotherapy","target":"b-cell","id":"23984"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"23985"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"23986"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"23987"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"23988"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"23989"},{"source":"Anticancer immunotherapy","target":"diffuse","id":"23990"},{"source":"Bispecific T cell engager","target":"UNK : Indication","id":"23991"},{"source":"Bispecific T cell engager","target":"lymphoma","id":"23992"},{"source":"Bispecific T cell engager","target":"b-cell","id":"23993"},{"source":"Bispecific T cell engager","target":"dlbcl","id":"23994"},{"source":"Bispecific T cell engager","target":"lymphoma","id":"23995"},{"source":"Bispecific T cell engager","target":"lymphoma","id":"23996"},{"source":"Bispecific T cell engager","target":"b-cell","id":"23997"},{"source":"Bispecific T cell engager","target":"lymphoma","id":"23998"},{"source":"Bispecific T cell engager","target":"carcinoma","id":"23999"},{"source":"Bispecific T cell engager","target":"non-hodgkin","id":"24000"},{"source":"Bispecific T cell engager","target":"anticancer","id":"24001"},{"source":"Bispecific T cell engager","target":"lymphoma","id":"24002"},{"source":"Bispecific T cell engager","target":"diffuse","id":"24003"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"24004"},{"source":"CD19 antagonist","target":"lymphoma","id":"24005"},{"source":"CD19 antagonist","target":"b-cell","id":"24006"},{"source":"CD19 antagonist","target":"dlbcl","id":"24007"},{"source":"CD19 antagonist","target":"lymphoma","id":"24008"},{"source":"CD19 antagonist","target":"lymphoma","id":"24009"},{"source":"CD19 antagonist","target":"b-cell","id":"24010"},{"source":"CD19 antagonist","target":"lymphoma","id":"24011"},{"source":"CD19 antagonist","target":"carcinoma","id":"24012"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"24013"},{"source":"CD19 antagonist","target":"anticancer","id":"24014"},{"source":"CD19 antagonist","target":"lymphoma","id":"24015"},{"source":"CD19 antagonist","target":"diffuse","id":"24016"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"24017"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"24018"},{"source":"Immune checkpoint inhibitor","target":"b-cell","id":"24019"},{"source":"Immune checkpoint inhibitor","target":"dlbcl","id":"24020"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"24021"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"24022"},{"source":"Immune checkpoint inhibitor","target":"b-cell","id":"24023"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"24024"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24025"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"24026"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"24027"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"24028"},{"source":"Immune checkpoint inhibitor","target":"diffuse","id":"24029"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"24030"},{"source":"CD19 antagonist","target":"lymphoma","id":"24031"},{"source":"CD19 antagonist","target":"b-cell","id":"24032"},{"source":"CD19 antagonist","target":"dlbcl","id":"24033"},{"source":"CD19 antagonist","target":"lymphoma","id":"24034"},{"source":"CD19 antagonist","target":"lymphoma","id":"24035"},{"source":"CD19 antagonist","target":"b-cell","id":"24036"},{"source":"CD19 antagonist","target":"lymphoma","id":"24037"},{"source":"CD19 antagonist","target":"carcinoma","id":"24038"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"24039"},{"source":"CD19 antagonist","target":"anticancer","id":"24040"},{"source":"CD19 antagonist","target":"lymphoma","id":"24041"},{"source":"CD19 antagonist","target":"diffuse","id":"24042"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"24043"},{"source":"Oncology: Lymphoma","target":"Bispecific T cell engager","id":"24044"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"24045"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"24046"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"24047"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"24048"},{"source":"Hodgkin's","target":"Bispecific T cell engager","id":"24049"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"24050"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"24051"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"24052"},{"source":"pembrolizumab","target":"Merck & Co.","id":"24053"},{"source":"dexamethasone","target":"Merck & Co.","id":"24054"},{"source":"lenalidomide (a)","target":"Merck & Co.","id":"24055"},{"source":"UNK : Indication","target":"pembrolizumab","id":"24056"},{"source":"UNK : Indication","target":"dexamethasone","id":"24057"},{"source":"UNK : Indication","target":"lenalidomide (a)","id":"24058"},{"source":"antianaemic","target":"pembrolizumab","id":"24059"},{"source":"antianaemic","target":"dexamethasone","id":"24060"},{"source":"antianaemic","target":"lenalidomide (a)","id":"24061"},{"source":"bone diseases","target":"pembrolizumab","id":"24062"},{"source":"bone diseases","target":"dexamethasone","id":"24063"},{"source":"bone diseases","target":"lenalidomide (a)","id":"24064"},{"source":"skin neoplasms","target":"pembrolizumab","id":"24065"},{"source":"skin neoplasms","target":"dexamethasone","id":"24066"},{"source":"skin neoplasms","target":"lenalidomide (a)","id":"24067"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"24068"},{"source":"anti-inflammatory","target":"dexamethasone","id":"24069"},{"source":"anti-inflammatory","target":"lenalidomide (a)","id":"24070"},{"source":"hypercalcemia","target":"pembrolizumab","id":"24071"},{"source":"hypercalcemia","target":"dexamethasone","id":"24072"},{"source":"hypercalcemia","target":"lenalidomide (a)","id":"24073"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"24074"},{"source":"diabetes mellitus","target":"dexamethasone","id":"24075"},{"source":"diabetes mellitus","target":"lenalidomide (a)","id":"24076"},{"source":"antidiabetic","target":"pembrolizumab","id":"24077"},{"source":"antidiabetic","target":"dexamethasone","id":"24078"},{"source":"antidiabetic","target":"lenalidomide (a)","id":"24079"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"24080"},{"source":"inflammatory bowel diseases","target":"dexamethasone","id":"24081"},{"source":"inflammatory bowel diseases","target":"lenalidomide (a)","id":"24082"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"24083"},{"source":"stem cell transplantation","target":"dexamethasone","id":"24084"},{"source":"stem cell transplantation","target":"lenalidomide (a)","id":"24085"},{"source":"plasma cell","target":"pembrolizumab","id":"24086"},{"source":"plasma cell","target":"dexamethasone","id":"24087"},{"source":"plasma cell","target":"lenalidomide (a)","id":"24088"},{"source":"plasmacytoma","target":"pembrolizumab","id":"24089"},{"source":"plasmacytoma","target":"dexamethasone","id":"24090"},{"source":"plasmacytoma","target":"lenalidomide (a)","id":"24091"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"24092"},{"source":"inflammatory bowel diseases","target":"dexamethasone","id":"24093"},{"source":"inflammatory bowel diseases","target":"lenalidomide (a)","id":"24094"},{"source":"liver diseases","target":"pembrolizumab","id":"24095"},{"source":"liver diseases","target":"dexamethasone","id":"24096"},{"source":"liver diseases","target":"lenalidomide (a)","id":"24097"},{"source":"inflammation","target":"pembrolizumab","id":"24098"},{"source":"inflammation","target":"dexamethasone","id":"24099"},{"source":"inflammation","target":"lenalidomide (a)","id":"24100"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"24101"},{"source":"stem cell transplantation","target":"dexamethasone","id":"24102"},{"source":"stem cell transplantation","target":"lenalidomide (a)","id":"24103"},{"source":"hepatic dysfunction","target":"pembrolizumab","id":"24104"},{"source":"hepatic dysfunction","target":"dexamethasone","id":"24105"},{"source":"hepatic dysfunction","target":"lenalidomide (a)","id":"24106"},{"source":"analgesic","target":"pembrolizumab","id":"24107"},{"source":"analgesic","target":"dexamethasone","id":"24108"},{"source":"analgesic","target":"lenalidomide (a)","id":"24109"},{"source":"pain","target":"pembrolizumab","id":"24110"},{"source":"pain","target":"dexamethasone","id":"24111"},{"source":"pain","target":"lenalidomide (a)","id":"24112"},{"source":"arthritis","target":"pembrolizumab","id":"24113"},{"source":"arthritis","target":"dexamethasone","id":"24114"},{"source":"arthritis","target":"lenalidomide (a)","id":"24115"},{"source":"plasma cell","target":"pembrolizumab","id":"24116"},{"source":"plasma cell","target":"dexamethasone","id":"24117"},{"source":"plasma cell","target":"lenalidomide (a)","id":"24118"},{"source":"multiple myeloma","target":"pembrolizumab","id":"24119"},{"source":"multiple myeloma","target":"dexamethasone","id":"24120"},{"source":"multiple myeloma","target":"lenalidomide (a)","id":"24121"},{"source":"carcinoma","target":"pembrolizumab","id":"24122"},{"source":"carcinoma","target":"dexamethasone","id":"24123"},{"source":"carcinoma","target":"lenalidomide (a)","id":"24124"},{"source":"antiarthritic","target":"pembrolizumab","id":"24125"},{"source":"antiarthritic","target":"dexamethasone","id":"24126"},{"source":"antiarthritic","target":"lenalidomide (a)","id":"24127"},{"source":"anemia","target":"pembrolizumab","id":"24128"},{"source":"anemia","target":"dexamethasone","id":"24129"},{"source":"anemia","target":"lenalidomide (a)","id":"24130"},{"source":"solid malignancy","target":"pembrolizumab","id":"24131"},{"source":"solid malignancy","target":"dexamethasone","id":"24132"},{"source":"solid malignancy","target":"lenalidomide (a)","id":"24133"},{"source":"bone diseases","target":"pembrolizumab","id":"24134"},{"source":"bone diseases","target":"dexamethasone","id":"24135"},{"source":"bone diseases","target":"lenalidomide (a)","id":"24136"},{"source":"plasmacytoma","target":"pembrolizumab","id":"24137"},{"source":"plasmacytoma","target":"dexamethasone","id":"24138"},{"source":"plasmacytoma","target":"lenalidomide (a)","id":"24139"},{"source":"anticancer","target":"pembrolizumab","id":"24140"},{"source":"anticancer","target":"dexamethasone","id":"24141"},{"source":"anticancer","target":"lenalidomide (a)","id":"24142"},{"source":"Immunosuppressant","target":"UNK : Indication","id":"24143"},{"source":"Immunosuppressant","target":"antianaemic","id":"24144"},{"source":"Immunosuppressant","target":"bone diseases","id":"24145"},{"source":"Immunosuppressant","target":"skin neoplasms","id":"24146"},{"source":"Immunosuppressant","target":"anti-inflammatory","id":"24147"},{"source":"Immunosuppressant","target":"hypercalcemia","id":"24148"},{"source":"Immunosuppressant","target":"diabetes mellitus","id":"24149"},{"source":"Immunosuppressant","target":"antidiabetic","id":"24150"},{"source":"Immunosuppressant","target":"inflammatory bowel diseases","id":"24151"},{"source":"Immunosuppressant","target":"stem cell transplantation","id":"24152"},{"source":"Immunosuppressant","target":"plasma cell","id":"24153"},{"source":"Immunosuppressant","target":"plasmacytoma","id":"24154"},{"source":"Immunosuppressant","target":"inflammatory bowel diseases","id":"24155"},{"source":"Immunosuppressant","target":"liver diseases","id":"24156"},{"source":"Immunosuppressant","target":"inflammation","id":"24157"},{"source":"Immunosuppressant","target":"stem cell transplantation","id":"24158"},{"source":"Immunosuppressant","target":"hepatic dysfunction","id":"24159"},{"source":"Immunosuppressant","target":"analgesic","id":"24160"},{"source":"Immunosuppressant","target":"pain","id":"24161"},{"source":"Immunosuppressant","target":"arthritis","id":"24162"},{"source":"Immunosuppressant","target":"plasma cell","id":"24163"},{"source":"Immunosuppressant","target":"multiple myeloma","id":"24164"},{"source":"Immunosuppressant","target":"carcinoma","id":"24165"},{"source":"Immunosuppressant","target":"antiarthritic","id":"24166"},{"source":"Immunosuppressant","target":"anemia","id":"24167"},{"source":"Immunosuppressant","target":"solid malignancy","id":"24168"},{"source":"Immunosuppressant","target":"bone diseases","id":"24169"},{"source":"Immunosuppressant","target":"plasmacytoma","id":"24170"},{"source":"Immunosuppressant","target":"anticancer","id":"24171"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"24172"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"24173"},{"source":"Immune checkpoint inhibitor","target":"bone diseases","id":"24174"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"24175"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"24176"},{"source":"Immune checkpoint inhibitor","target":"hypercalcemia","id":"24177"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"24178"},{"source":"Immune checkpoint inhibitor","target":"antidiabetic","id":"24179"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"24180"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"24181"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"24182"},{"source":"Immune checkpoint inhibitor","target":"plasmacytoma","id":"24183"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"24184"},{"source":"Immune checkpoint inhibitor","target":"liver diseases","id":"24185"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"24186"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"24187"},{"source":"Immune checkpoint inhibitor","target":"hepatic dysfunction","id":"24188"},{"source":"Immune checkpoint inhibitor","target":"analgesic","id":"24189"},{"source":"Immune checkpoint inhibitor","target":"pain","id":"24190"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"24191"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"24192"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"24193"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24194"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"24195"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"24196"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"24197"},{"source":"Immune checkpoint inhibitor","target":"bone diseases","id":"24198"},{"source":"Immune checkpoint inhibitor","target":"plasmacytoma","id":"24199"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"24200"},{"source":"Corticosteroid agonist","target":"UNK : Indication","id":"24201"},{"source":"Corticosteroid agonist","target":"antianaemic","id":"24202"},{"source":"Corticosteroid agonist","target":"bone diseases","id":"24203"},{"source":"Corticosteroid agonist","target":"skin neoplasms","id":"24204"},{"source":"Corticosteroid agonist","target":"anti-inflammatory","id":"24205"},{"source":"Corticosteroid agonist","target":"hypercalcemia","id":"24206"},{"source":"Corticosteroid agonist","target":"diabetes mellitus","id":"24207"},{"source":"Corticosteroid agonist","target":"antidiabetic","id":"24208"},{"source":"Corticosteroid agonist","target":"inflammatory bowel diseases","id":"24209"},{"source":"Corticosteroid agonist","target":"stem cell transplantation","id":"24210"},{"source":"Corticosteroid agonist","target":"plasma cell","id":"24211"},{"source":"Corticosteroid agonist","target":"plasmacytoma","id":"24212"},{"source":"Corticosteroid agonist","target":"inflammatory bowel diseases","id":"24213"},{"source":"Corticosteroid agonist","target":"liver diseases","id":"24214"},{"source":"Corticosteroid agonist","target":"inflammation","id":"24215"},{"source":"Corticosteroid agonist","target":"stem cell transplantation","id":"24216"},{"source":"Corticosteroid agonist","target":"hepatic dysfunction","id":"24217"},{"source":"Corticosteroid agonist","target":"analgesic","id":"24218"},{"source":"Corticosteroid agonist","target":"pain","id":"24219"},{"source":"Corticosteroid agonist","target":"arthritis","id":"24220"},{"source":"Corticosteroid agonist","target":"plasma cell","id":"24221"},{"source":"Corticosteroid agonist","target":"multiple myeloma","id":"24222"},{"source":"Corticosteroid agonist","target":"carcinoma","id":"24223"},{"source":"Corticosteroid agonist","target":"antiarthritic","id":"24224"},{"source":"Corticosteroid agonist","target":"anemia","id":"24225"},{"source":"Corticosteroid agonist","target":"solid malignancy","id":"24226"},{"source":"Corticosteroid agonist","target":"bone diseases","id":"24227"},{"source":"Corticosteroid agonist","target":"plasmacytoma","id":"24228"},{"source":"Corticosteroid agonist","target":"anticancer","id":"24229"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"24230"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"24231"},{"source":"Anticancer immunotherapy","target":"bone diseases","id":"24232"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"24233"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"24234"},{"source":"Anticancer immunotherapy","target":"hypercalcemia","id":"24235"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"24236"},{"source":"Anticancer immunotherapy","target":"antidiabetic","id":"24237"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"24238"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"24239"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"24240"},{"source":"Anticancer immunotherapy","target":"plasmacytoma","id":"24241"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"24242"},{"source":"Anticancer immunotherapy","target":"liver diseases","id":"24243"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"24244"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"24245"},{"source":"Anticancer immunotherapy","target":"hepatic dysfunction","id":"24246"},{"source":"Anticancer immunotherapy","target":"analgesic","id":"24247"},{"source":"Anticancer immunotherapy","target":"pain","id":"24248"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"24249"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"24250"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"24251"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24252"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"24253"},{"source":"Anticancer immunotherapy","target":"anemia","id":"24254"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"24255"},{"source":"Anticancer immunotherapy","target":"bone diseases","id":"24256"},{"source":"Anticancer immunotherapy","target":"plasmacytoma","id":"24257"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"24258"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"24259"},{"source":"CD19 antagonist","target":"antianaemic","id":"24260"},{"source":"CD19 antagonist","target":"bone diseases","id":"24261"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"24262"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"24263"},{"source":"CD19 antagonist","target":"hypercalcemia","id":"24264"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"24265"},{"source":"CD19 antagonist","target":"antidiabetic","id":"24266"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"24267"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"24268"},{"source":"CD19 antagonist","target":"plasma cell","id":"24269"},{"source":"CD19 antagonist","target":"plasmacytoma","id":"24270"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"24271"},{"source":"CD19 antagonist","target":"liver diseases","id":"24272"},{"source":"CD19 antagonist","target":"inflammation","id":"24273"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"24274"},{"source":"CD19 antagonist","target":"hepatic dysfunction","id":"24275"},{"source":"CD19 antagonist","target":"analgesic","id":"24276"},{"source":"CD19 antagonist","target":"pain","id":"24277"},{"source":"CD19 antagonist","target":"arthritis","id":"24278"},{"source":"CD19 antagonist","target":"plasma cell","id":"24279"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"24280"},{"source":"CD19 antagonist","target":"carcinoma","id":"24281"},{"source":"CD19 antagonist","target":"antiarthritic","id":"24282"},{"source":"CD19 antagonist","target":"anemia","id":"24283"},{"source":"CD19 antagonist","target":"solid malignancy","id":"24284"},{"source":"CD19 antagonist","target":"bone diseases","id":"24285"},{"source":"CD19 antagonist","target":"plasmacytoma","id":"24286"},{"source":"CD19 antagonist","target":"anticancer","id":"24287"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"24288"},{"source":"Angiogenesis inhibitor","target":"antianaemic","id":"24289"},{"source":"Angiogenesis inhibitor","target":"bone diseases","id":"24290"},{"source":"Angiogenesis inhibitor","target":"skin neoplasms","id":"24291"},{"source":"Angiogenesis inhibitor","target":"anti-inflammatory","id":"24292"},{"source":"Angiogenesis inhibitor","target":"hypercalcemia","id":"24293"},{"source":"Angiogenesis inhibitor","target":"diabetes mellitus","id":"24294"},{"source":"Angiogenesis inhibitor","target":"antidiabetic","id":"24295"},{"source":"Angiogenesis inhibitor","target":"inflammatory bowel diseases","id":"24296"},{"source":"Angiogenesis inhibitor","target":"stem cell transplantation","id":"24297"},{"source":"Angiogenesis inhibitor","target":"plasma cell","id":"24298"},{"source":"Angiogenesis inhibitor","target":"plasmacytoma","id":"24299"},{"source":"Angiogenesis inhibitor","target":"inflammatory bowel diseases","id":"24300"},{"source":"Angiogenesis inhibitor","target":"liver diseases","id":"24301"},{"source":"Angiogenesis inhibitor","target":"inflammation","id":"24302"},{"source":"Angiogenesis inhibitor","target":"stem cell transplantation","id":"24303"},{"source":"Angiogenesis inhibitor","target":"hepatic dysfunction","id":"24304"},{"source":"Angiogenesis inhibitor","target":"analgesic","id":"24305"},{"source":"Angiogenesis inhibitor","target":"pain","id":"24306"},{"source":"Angiogenesis inhibitor","target":"arthritis","id":"24307"},{"source":"Angiogenesis inhibitor","target":"plasma cell","id":"24308"},{"source":"Angiogenesis inhibitor","target":"multiple myeloma","id":"24309"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"24310"},{"source":"Angiogenesis inhibitor","target":"antiarthritic","id":"24311"},{"source":"Angiogenesis inhibitor","target":"anemia","id":"24312"},{"source":"Angiogenesis inhibitor","target":"solid malignancy","id":"24313"},{"source":"Angiogenesis inhibitor","target":"bone diseases","id":"24314"},{"source":"Angiogenesis inhibitor","target":"plasmacytoma","id":"24315"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"24316"},{"source":"Tumour necrosis factor alpha antagonist","target":"UNK : Indication","id":"24317"},{"source":"Tumour necrosis factor alpha antagonist","target":"antianaemic","id":"24318"},{"source":"Tumour necrosis factor alpha antagonist","target":"bone diseases","id":"24319"},{"source":"Tumour necrosis factor alpha antagonist","target":"skin neoplasms","id":"24320"},{"source":"Tumour necrosis factor alpha antagonist","target":"anti-inflammatory","id":"24321"},{"source":"Tumour necrosis factor alpha antagonist","target":"hypercalcemia","id":"24322"},{"source":"Tumour necrosis factor alpha antagonist","target":"diabetes mellitus","id":"24323"},{"source":"Tumour necrosis factor alpha antagonist","target":"antidiabetic","id":"24324"},{"source":"Tumour necrosis factor alpha antagonist","target":"inflammatory bowel diseases","id":"24325"},{"source":"Tumour necrosis factor alpha antagonist","target":"stem cell transplantation","id":"24326"},{"source":"Tumour necrosis factor alpha antagonist","target":"plasma cell","id":"24327"},{"source":"Tumour necrosis factor alpha antagonist","target":"plasmacytoma","id":"24328"},{"source":"Tumour necrosis factor alpha antagonist","target":"inflammatory bowel diseases","id":"24329"},{"source":"Tumour necrosis factor alpha antagonist","target":"liver diseases","id":"24330"},{"source":"Tumour necrosis factor alpha antagonist","target":"inflammation","id":"24331"},{"source":"Tumour necrosis factor alpha antagonist","target":"stem cell transplantation","id":"24332"},{"source":"Tumour necrosis factor alpha antagonist","target":"hepatic dysfunction","id":"24333"},{"source":"Tumour necrosis factor alpha antagonist","target":"analgesic","id":"24334"},{"source":"Tumour necrosis factor alpha antagonist","target":"pain","id":"24335"},{"source":"Tumour necrosis factor alpha antagonist","target":"arthritis","id":"24336"},{"source":"Tumour necrosis factor alpha antagonist","target":"plasma cell","id":"24337"},{"source":"Tumour necrosis factor alpha antagonist","target":"multiple myeloma","id":"24338"},{"source":"Tumour necrosis factor alpha antagonist","target":"carcinoma","id":"24339"},{"source":"Tumour necrosis factor alpha antagonist","target":"antiarthritic","id":"24340"},{"source":"Tumour necrosis factor alpha antagonist","target":"anemia","id":"24341"},{"source":"Tumour necrosis factor alpha antagonist","target":"solid malignancy","id":"24342"},{"source":"Tumour necrosis factor alpha antagonist","target":"bone diseases","id":"24343"},{"source":"Tumour necrosis factor alpha antagonist","target":"plasmacytoma","id":"24344"},{"source":"Tumour necrosis factor alpha antagonist","target":"anticancer","id":"24345"},{"source":"Oncology: Multiple Myeloma","target":"Immunosuppressant","id":"24346"},{"source":"Oncology: Multiple Myeloma","target":"Immune checkpoint inhibitor","id":"24347"},{"source":"Oncology: Multiple Myeloma","target":"Corticosteroid agonist","id":"24348"},{"source":"Oncology: Multiple Myeloma","target":"Anticancer immunotherapy","id":"24349"},{"source":"Oncology: Multiple Myeloma","target":"CD19 antagonist","id":"24350"},{"source":"Oncology: Multiple Myeloma","target":"Angiogenesis inhibitor","id":"24351"},{"source":"Oncology: Multiple Myeloma","target":"Tumour necrosis factor alpha antagonist","id":"24352"},{"source":"pembrolizumab","target":"Merck & Co.","id":"24353"},{"source":"dexamethasone","target":"Merck & Co.","id":"24354"},{"source":"pomalidomide (capsule)","target":"Merck & Co.","id":"24355"},{"source":"skin neoplasms","target":"pembrolizumab","id":"24356"},{"source":"skin neoplasms","target":"dexamethasone","id":"24357"},{"source":"skin neoplasms","target":"pomalidomide (capsule)","id":"24358"},{"source":"multiple myeloma","target":"pembrolizumab","id":"24359"},{"source":"multiple myeloma","target":"dexamethasone","id":"24360"},{"source":"multiple myeloma","target":"pomalidomide (capsule)","id":"24361"},{"source":"plasma cell","target":"pembrolizumab","id":"24362"},{"source":"plasma cell","target":"dexamethasone","id":"24363"},{"source":"plasma cell","target":"pomalidomide (capsule)","id":"24364"},{"source":"refractory myeloma","target":"pembrolizumab","id":"24365"},{"source":"refractory myeloma","target":"dexamethasone","id":"24366"},{"source":"refractory myeloma","target":"pomalidomide (capsule)","id":"24367"},{"source":"plasma cell","target":"pembrolizumab","id":"24368"},{"source":"plasma cell","target":"dexamethasone","id":"24369"},{"source":"plasma cell","target":"pomalidomide (capsule)","id":"24370"},{"source":"multiple myeloma","target":"pembrolizumab","id":"24371"},{"source":"multiple myeloma","target":"dexamethasone","id":"24372"},{"source":"multiple myeloma","target":"pomalidomide (capsule)","id":"24373"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"24374"},{"source":"anti-inflammatory","target":"dexamethasone","id":"24375"},{"source":"anti-inflammatory","target":"pomalidomide (capsule)","id":"24376"},{"source":"carcinoma","target":"pembrolizumab","id":"24377"},{"source":"carcinoma","target":"dexamethasone","id":"24378"},{"source":"carcinoma","target":"pomalidomide (capsule)","id":"24379"},{"source":"inflammation","target":"pembrolizumab","id":"24380"},{"source":"inflammation","target":"dexamethasone","id":"24381"},{"source":"inflammation","target":"pomalidomide (capsule)","id":"24382"},{"source":"anticancer","target":"pembrolizumab","id":"24383"},{"source":"anticancer","target":"dexamethasone","id":"24384"},{"source":"anticancer","target":"pomalidomide (capsule)","id":"24385"},{"source":"antianaemic","target":"pembrolizumab","id":"24386"},{"source":"antianaemic","target":"dexamethasone","id":"24387"},{"source":"antianaemic","target":"pomalidomide (capsule)","id":"24388"},{"source":"anemia","target":"pembrolizumab","id":"24389"},{"source":"anemia","target":"dexamethasone","id":"24390"},{"source":"anemia","target":"pomalidomide (capsule)","id":"24391"},{"source":"Immunosuppressant","target":"skin neoplasms","id":"24392"},{"source":"Immunosuppressant","target":"multiple myeloma","id":"24393"},{"source":"Immunosuppressant","target":"plasma cell","id":"24394"},{"source":"Immunosuppressant","target":"refractory myeloma","id":"24395"},{"source":"Immunosuppressant","target":"plasma cell","id":"24396"},{"source":"Immunosuppressant","target":"multiple myeloma","id":"24397"},{"source":"Immunosuppressant","target":"anti-inflammatory","id":"24398"},{"source":"Immunosuppressant","target":"carcinoma","id":"24399"},{"source":"Immunosuppressant","target":"inflammation","id":"24400"},{"source":"Immunosuppressant","target":"anticancer","id":"24401"},{"source":"Immunosuppressant","target":"antianaemic","id":"24402"},{"source":"Immunosuppressant","target":"anemia","id":"24403"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"24404"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"24405"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"24406"},{"source":"Immune checkpoint inhibitor","target":"refractory myeloma","id":"24407"},{"source":"Immune checkpoint inhibitor","target":"plasma cell","id":"24408"},{"source":"Immune checkpoint inhibitor","target":"multiple myeloma","id":"24409"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"24410"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24411"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"24412"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"24413"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"24414"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"24415"},{"source":"Corticosteroid agonist","target":"skin neoplasms","id":"24416"},{"source":"Corticosteroid agonist","target":"multiple myeloma","id":"24417"},{"source":"Corticosteroid agonist","target":"plasma cell","id":"24418"},{"source":"Corticosteroid agonist","target":"refractory myeloma","id":"24419"},{"source":"Corticosteroid agonist","target":"plasma cell","id":"24420"},{"source":"Corticosteroid agonist","target":"multiple myeloma","id":"24421"},{"source":"Corticosteroid agonist","target":"anti-inflammatory","id":"24422"},{"source":"Corticosteroid agonist","target":"carcinoma","id":"24423"},{"source":"Corticosteroid agonist","target":"inflammation","id":"24424"},{"source":"Corticosteroid agonist","target":"anticancer","id":"24425"},{"source":"Corticosteroid agonist","target":"antianaemic","id":"24426"},{"source":"Corticosteroid agonist","target":"anemia","id":"24427"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"24428"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"24429"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"24430"},{"source":"Anticancer immunotherapy","target":"refractory myeloma","id":"24431"},{"source":"Anticancer immunotherapy","target":"plasma cell","id":"24432"},{"source":"Anticancer immunotherapy","target":"multiple myeloma","id":"24433"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"24434"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24435"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"24436"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"24437"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"24438"},{"source":"Anticancer immunotherapy","target":"anemia","id":"24439"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"24440"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"24441"},{"source":"CD19 antagonist","target":"plasma cell","id":"24442"},{"source":"CD19 antagonist","target":"refractory myeloma","id":"24443"},{"source":"CD19 antagonist","target":"plasma cell","id":"24444"},{"source":"CD19 antagonist","target":"multiple myeloma","id":"24445"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"24446"},{"source":"CD19 antagonist","target":"carcinoma","id":"24447"},{"source":"CD19 antagonist","target":"inflammation","id":"24448"},{"source":"CD19 antagonist","target":"anticancer","id":"24449"},{"source":"CD19 antagonist","target":"antianaemic","id":"24450"},{"source":"CD19 antagonist","target":"anemia","id":"24451"},{"source":"T helper cell stimulant","target":"skin neoplasms","id":"24452"},{"source":"T helper cell stimulant","target":"multiple myeloma","id":"24453"},{"source":"T helper cell stimulant","target":"plasma cell","id":"24454"},{"source":"T helper cell stimulant","target":"refractory myeloma","id":"24455"},{"source":"T helper cell stimulant","target":"plasma cell","id":"24456"},{"source":"T helper cell stimulant","target":"multiple myeloma","id":"24457"},{"source":"T helper cell stimulant","target":"anti-inflammatory","id":"24458"},{"source":"T helper cell stimulant","target":"carcinoma","id":"24459"},{"source":"T helper cell stimulant","target":"inflammation","id":"24460"},{"source":"T helper cell stimulant","target":"anticancer","id":"24461"},{"source":"T helper cell stimulant","target":"antianaemic","id":"24462"},{"source":"T helper cell stimulant","target":"anemia","id":"24463"},{"source":"Angiogenesis inhibitor","target":"skin neoplasms","id":"24464"},{"source":"Angiogenesis inhibitor","target":"multiple myeloma","id":"24465"},{"source":"Angiogenesis inhibitor","target":"plasma cell","id":"24466"},{"source":"Angiogenesis inhibitor","target":"refractory myeloma","id":"24467"},{"source":"Angiogenesis inhibitor","target":"plasma cell","id":"24468"},{"source":"Angiogenesis inhibitor","target":"multiple myeloma","id":"24469"},{"source":"Angiogenesis inhibitor","target":"anti-inflammatory","id":"24470"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"24471"},{"source":"Angiogenesis inhibitor","target":"inflammation","id":"24472"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"24473"},{"source":"Angiogenesis inhibitor","target":"antianaemic","id":"24474"},{"source":"Angiogenesis inhibitor","target":"anemia","id":"24475"},{"source":"NA","target":"skin neoplasms","id":"24476"},{"source":"NA","target":"multiple myeloma","id":"24477"},{"source":"NA","target":"plasma cell","id":"24478"},{"source":"NA","target":"refractory myeloma","id":"24479"},{"source":"NA","target":"plasma cell","id":"24480"},{"source":"NA","target":"multiple myeloma","id":"24481"},{"source":"NA","target":"anti-inflammatory","id":"24482"},{"source":"NA","target":"carcinoma","id":"24483"},{"source":"NA","target":"inflammation","id":"24484"},{"source":"NA","target":"anticancer","id":"24485"},{"source":"NA","target":"antianaemic","id":"24486"},{"source":"NA","target":"anemia","id":"24487"},{"source":"Oncology: Multiple Myeloma","target":"Immunosuppressant","id":"24488"},{"source":"Oncology: Multiple Myeloma","target":"Immune checkpoint inhibitor","id":"24489"},{"source":"Oncology: Multiple Myeloma","target":"Corticosteroid agonist","id":"24490"},{"source":"Oncology: Multiple Myeloma","target":"Anticancer immunotherapy","id":"24491"},{"source":"Oncology: Multiple Myeloma","target":"CD19 antagonist","id":"24492"},{"source":"Oncology: Multiple Myeloma","target":"T helper cell stimulant","id":"24493"},{"source":"Oncology: Multiple Myeloma","target":"Angiogenesis inhibitor","id":"24494"},{"source":"Oncology: Multiple Myeloma","target":"NA","id":"24495"},{"source":"mRNA-4157 (u)","target":"Merck & Co.","id":"24496"},{"source":"mRNA-4157 (u)","target":"Moderna Therapeutics","id":"24497"},{"source":"pembrolizumab","target":"Merck & Co.","id":"24498"},{"source":"pembrolizumab","target":"Moderna Therapeutics","id":"24499"},{"source":"colorectal neoplasms","target":"mRNA-4157 (u)","id":"24500"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"24501"},{"source":"skin neoplasms","target":"mRNA-4157 (u)","id":"24502"},{"source":"skin neoplasms","target":"pembrolizumab","id":"24503"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24504"},{"source":"carcinoma","target":"pembrolizumab","id":"24505"},{"source":"solid malignancy","target":"mRNA-4157 (u)","id":"24506"},{"source":"solid malignancy","target":"pembrolizumab","id":"24507"},{"source":"papilloma","target":"mRNA-4157 (u)","id":"24508"},{"source":"papilloma","target":"pembrolizumab","id":"24509"},{"source":"non-small-cell lung","target":"mRNA-4157 (u)","id":"24510"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"24511"},{"source":"barrett esophagus","target":"mRNA-4157 (u)","id":"24512"},{"source":"barrett esophagus","target":"pembrolizumab","id":"24513"},{"source":"condylomata acuminata","target":"mRNA-4157 (u)","id":"24514"},{"source":"condylomata acuminata","target":"pembrolizumab","id":"24515"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24516"},{"source":"carcinoma","target":"pembrolizumab","id":"24517"},{"source":"head and neck neoplasms","target":"mRNA-4157 (u)","id":"24518"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"24519"},{"source":"non-small-cell lung","target":"mRNA-4157 (u)","id":"24520"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"24521"},{"source":"melanoma","target":"mRNA-4157 (u)","id":"24522"},{"source":"melanoma","target":"pembrolizumab","id":"24523"},{"source":"solid tumors","target":"mRNA-4157 (u)","id":"24524"},{"source":"solid tumors","target":"pembrolizumab","id":"24525"},{"source":"endometrial neoplasms","target":"mRNA-4157 (u)","id":"24526"},{"source":"endometrial neoplasms","target":"pembrolizumab","id":"24527"},{"source":"papilloma","target":"mRNA-4157 (u)","id":"24528"},{"source":"papilloma","target":"pembrolizumab","id":"24529"},{"source":"colonic neoplasms","target":"mRNA-4157 (u)","id":"24530"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"24531"},{"source":"esophageal cancer","target":"mRNA-4157 (u)","id":"24532"},{"source":"esophageal cancer","target":"pembrolizumab","id":"24533"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24534"},{"source":"carcinoma","target":"pembrolizumab","id":"24535"},{"source":"sclc","target":"mRNA-4157 (u)","id":"24536"},{"source":"sclc","target":"pembrolizumab","id":"24537"},{"source":"papilloma","target":"mRNA-4157 (u)","id":"24538"},{"source":"papilloma","target":"pembrolizumab","id":"24539"},{"source":"pharyngeal neoplasms","target":"mRNA-4157 (u)","id":"24540"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"24541"},{"source":"endometrioid","target":"mRNA-4157 (u)","id":"24542"},{"source":"endometrioid","target":"pembrolizumab","id":"24543"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24544"},{"source":"carcinoma","target":"pembrolizumab","id":"24545"},{"source":"alopecia","target":"mRNA-4157 (u)","id":"24546"},{"source":"alopecia","target":"pembrolizumab","id":"24547"},{"source":"lung cancer","target":"mRNA-4157 (u)","id":"24548"},{"source":"lung cancer","target":"pembrolizumab","id":"24549"},{"source":"unknown primary","target":"mRNA-4157 (u)","id":"24550"},{"source":"unknown primary","target":"pembrolizumab","id":"24551"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24552"},{"source":"carcinoma","target":"pembrolizumab","id":"24553"},{"source":"metastatic","target":"mRNA-4157 (u)","id":"24554"},{"source":"metastatic","target":"pembrolizumab","id":"24555"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24556"},{"source":"carcinoma","target":"pembrolizumab","id":"24557"},{"source":"neoplasm metastasis","target":"mRNA-4157 (u)","id":"24558"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"24559"},{"source":"endometrial cancer","target":"mRNA-4157 (u)","id":"24560"},{"source":"endometrial cancer","target":"pembrolizumab","id":"24561"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24562"},{"source":"carcinoma","target":"pembrolizumab","id":"24563"},{"source":"non-small-cell lung","target":"mRNA-4157 (u)","id":"24564"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"24565"},{"source":"colorectal neoplasms","target":"mRNA-4157 (u)","id":"24566"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"24567"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24568"},{"source":"carcinoma","target":"pembrolizumab","id":"24569"},{"source":"stomach neoplasms","target":"mRNA-4157 (u)","id":"24570"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"24571"},{"source":"non-small-cell lung","target":"mRNA-4157 (u)","id":"24572"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"24573"},{"source":"unknown primary","target":"mRNA-4157 (u)","id":"24574"},{"source":"unknown primary","target":"pembrolizumab","id":"24575"},{"source":"neuropathy","target":"mRNA-4157 (u)","id":"24576"},{"source":"neuropathy","target":"pembrolizumab","id":"24577"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"24578"},{"source":"carcinoma","target":"pembrolizumab","id":"24579"},{"source":"skin neoplasms","target":"mRNA-4157 (u)","id":"24580"},{"source":"skin neoplasms","target":"pembrolizumab","id":"24581"},{"source":"residual tumor","target":"mRNA-4157 (u)","id":"24582"},{"source":"residual tumor","target":"pembrolizumab","id":"24583"},{"source":"solid malignancy","target":"mRNA-4157 (u)","id":"24584"},{"source":"solid malignancy","target":"pembrolizumab","id":"24585"},{"source":"anticancer","target":"mRNA-4157 (u)","id":"24586"},{"source":"anticancer","target":"pembrolizumab","id":"24587"},{"source":"urinary bladder neoplasms","target":"mRNA-4157 (u)","id":"24588"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"24589"},{"source":"solid tumors","target":"mRNA-4157 (u)","id":"24590"},{"source":"solid tumors","target":"pembrolizumab","id":"24591"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"24592"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"24593"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24594"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"24595"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"24596"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"24597"},{"source":"Anticancer immunotherapy","target":"barrett esophagus","id":"24598"},{"source":"Anticancer immunotherapy","target":"condylomata acuminata","id":"24599"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24600"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"24601"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"24602"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"24603"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"24604"},{"source":"Anticancer immunotherapy","target":"endometrial neoplasms","id":"24605"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"24606"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"24607"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"24608"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24609"},{"source":"Anticancer immunotherapy","target":"sclc","id":"24610"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"24611"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"24612"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"24613"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24614"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"24615"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"24616"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"24617"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24618"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"24619"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24620"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"24621"},{"source":"Anticancer immunotherapy","target":"endometrial cancer","id":"24622"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24623"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"24624"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"24625"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24626"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"24627"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"24628"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"24629"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"24630"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24631"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"24632"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"24633"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"24634"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"24635"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"24636"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"24637"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"24638"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"24639"},{"source":"CD19 antagonist","target":"carcinoma","id":"24640"},{"source":"CD19 antagonist","target":"solid malignancy","id":"24641"},{"source":"CD19 antagonist","target":"papilloma","id":"24642"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"24643"},{"source":"CD19 antagonist","target":"barrett esophagus","id":"24644"},{"source":"CD19 antagonist","target":"condylomata acuminata","id":"24645"},{"source":"CD19 antagonist","target":"carcinoma","id":"24646"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"24647"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"24648"},{"source":"CD19 antagonist","target":"melanoma","id":"24649"},{"source":"CD19 antagonist","target":"solid tumors","id":"24650"},{"source":"CD19 antagonist","target":"endometrial neoplasms","id":"24651"},{"source":"CD19 antagonist","target":"papilloma","id":"24652"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"24653"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"24654"},{"source":"CD19 antagonist","target":"carcinoma","id":"24655"},{"source":"CD19 antagonist","target":"sclc","id":"24656"},{"source":"CD19 antagonist","target":"papilloma","id":"24657"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"24658"},{"source":"CD19 antagonist","target":"endometrioid","id":"24659"},{"source":"CD19 antagonist","target":"carcinoma","id":"24660"},{"source":"CD19 antagonist","target":"alopecia","id":"24661"},{"source":"CD19 antagonist","target":"lung cancer","id":"24662"},{"source":"CD19 antagonist","target":"unknown primary","id":"24663"},{"source":"CD19 antagonist","target":"carcinoma","id":"24664"},{"source":"CD19 antagonist","target":"metastatic","id":"24665"},{"source":"CD19 antagonist","target":"carcinoma","id":"24666"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"24667"},{"source":"CD19 antagonist","target":"endometrial cancer","id":"24668"},{"source":"CD19 antagonist","target":"carcinoma","id":"24669"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"24670"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"24671"},{"source":"CD19 antagonist","target":"carcinoma","id":"24672"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"24673"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"24674"},{"source":"CD19 antagonist","target":"unknown primary","id":"24675"},{"source":"CD19 antagonist","target":"neuropathy","id":"24676"},{"source":"CD19 antagonist","target":"carcinoma","id":"24677"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"24678"},{"source":"CD19 antagonist","target":"residual tumor","id":"24679"},{"source":"CD19 antagonist","target":"solid malignancy","id":"24680"},{"source":"CD19 antagonist","target":"anticancer","id":"24681"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"24682"},{"source":"CD19 antagonist","target":"solid tumors","id":"24683"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"24684"},{"source":"Immunostimulant","target":"skin neoplasms","id":"24685"},{"source":"Immunostimulant","target":"carcinoma","id":"24686"},{"source":"Immunostimulant","target":"solid malignancy","id":"24687"},{"source":"Immunostimulant","target":"papilloma","id":"24688"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"24689"},{"source":"Immunostimulant","target":"barrett esophagus","id":"24690"},{"source":"Immunostimulant","target":"condylomata acuminata","id":"24691"},{"source":"Immunostimulant","target":"carcinoma","id":"24692"},{"source":"Immunostimulant","target":"head and neck neoplasms","id":"24693"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"24694"},{"source":"Immunostimulant","target":"melanoma","id":"24695"},{"source":"Immunostimulant","target":"solid tumors","id":"24696"},{"source":"Immunostimulant","target":"endometrial neoplasms","id":"24697"},{"source":"Immunostimulant","target":"papilloma","id":"24698"},{"source":"Immunostimulant","target":"colonic neoplasms","id":"24699"},{"source":"Immunostimulant","target":"esophageal cancer","id":"24700"},{"source":"Immunostimulant","target":"carcinoma","id":"24701"},{"source":"Immunostimulant","target":"sclc","id":"24702"},{"source":"Immunostimulant","target":"papilloma","id":"24703"},{"source":"Immunostimulant","target":"pharyngeal neoplasms","id":"24704"},{"source":"Immunostimulant","target":"endometrioid","id":"24705"},{"source":"Immunostimulant","target":"carcinoma","id":"24706"},{"source":"Immunostimulant","target":"alopecia","id":"24707"},{"source":"Immunostimulant","target":"lung cancer","id":"24708"},{"source":"Immunostimulant","target":"unknown primary","id":"24709"},{"source":"Immunostimulant","target":"carcinoma","id":"24710"},{"source":"Immunostimulant","target":"metastatic","id":"24711"},{"source":"Immunostimulant","target":"carcinoma","id":"24712"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"24713"},{"source":"Immunostimulant","target":"endometrial cancer","id":"24714"},{"source":"Immunostimulant","target":"carcinoma","id":"24715"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"24716"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"24717"},{"source":"Immunostimulant","target":"carcinoma","id":"24718"},{"source":"Immunostimulant","target":"stomach neoplasms","id":"24719"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"24720"},{"source":"Immunostimulant","target":"unknown primary","id":"24721"},{"source":"Immunostimulant","target":"neuropathy","id":"24722"},{"source":"Immunostimulant","target":"carcinoma","id":"24723"},{"source":"Immunostimulant","target":"skin neoplasms","id":"24724"},{"source":"Immunostimulant","target":"residual tumor","id":"24725"},{"source":"Immunostimulant","target":"solid malignancy","id":"24726"},{"source":"Immunostimulant","target":"anticancer","id":"24727"},{"source":"Immunostimulant","target":"urinary bladder neoplasms","id":"24728"},{"source":"Immunostimulant","target":"solid tumors","id":"24729"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"24730"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"24731"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24732"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"24733"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"24734"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"24735"},{"source":"Immune checkpoint inhibitor","target":"barrett esophagus","id":"24736"},{"source":"Immune checkpoint inhibitor","target":"condylomata acuminata","id":"24737"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24738"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"24739"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"24740"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"24741"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"24742"},{"source":"Immune checkpoint inhibitor","target":"endometrial neoplasms","id":"24743"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"24744"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"24745"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"24746"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24747"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"24748"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"24749"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"24750"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"24751"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24752"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"24753"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"24754"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"24755"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24756"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"24757"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24758"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"24759"},{"source":"Immune checkpoint inhibitor","target":"endometrial cancer","id":"24760"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24761"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"24762"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"24763"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24764"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"24765"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"24766"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"24767"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"24768"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24769"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"24770"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"24771"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"24772"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"24773"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"24774"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"24775"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"24776"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"24777"},{"source":"Oncology: Bladder","target":"Immunostimulant","id":"24778"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"24779"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"24780"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"24781"},{"source":"Oncology: Colorectal","target":"Immunostimulant","id":"24782"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"24783"},{"source":"Oncology: Endometrial","target":"Anticancer immunotherapy","id":"24784"},{"source":"Oncology: Endometrial","target":"CD19 antagonist","id":"24785"},{"source":"Oncology: Endometrial","target":"Immunostimulant","id":"24786"},{"source":"Oncology: Endometrial","target":"Immune checkpoint inhibitor","id":"24787"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"24788"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"24789"},{"source":"Oncology: Esophageal","target":"Immunostimulant","id":"24790"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"24791"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"24792"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"24793"},{"source":"Oncology: Gastric","target":"Immunostimulant","id":"24794"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"24795"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"24796"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"24797"},{"source":"Oncology: Head/Neck","target":"Immunostimulant","id":"24798"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"24799"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"24800"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"24801"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"24802"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"24803"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"24804"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"24805"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"24806"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"24807"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"24808"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"24809"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"24810"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"24811"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"24812"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"24813"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"24814"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"24815"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"24816"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"24817"},{"source":"Oncology: Melanoma","target":"Immunostimulant","id":"24818"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"24819"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"24820"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"24821"},{"source":"Oncology: CNS","target":"Immunostimulant","id":"24822"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"24823"},{"source":"LY-2812176 (u)","target":"Leap Therapeutics {HealthCare Pharmaceuticals {Dekkun}}","id":"24824"},{"source":"pembrolizumab","target":"Leap Therapeutics {HealthCare Pharmaceuticals {Dekkun}}","id":"24825"},{"source":"UNK : Indication","target":"LY-2812176 (u)","id":"24826"},{"source":"UNK : Indication","target":"pembrolizumab","id":"24827"},{"source":"pharyngeal neoplasms","target":"LY-2812176 (u)","id":"24828"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"24829"},{"source":"anticancer","target":"LY-2812176 (u)","id":"24830"},{"source":"anticancer","target":"pembrolizumab","id":"24831"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"24832"},{"source":"carcinoma","target":"pembrolizumab","id":"24833"},{"source":"esophageal cancer","target":"LY-2812176 (u)","id":"24834"},{"source":"esophageal cancer","target":"pembrolizumab","id":"24835"},{"source":"stomach neoplasms","target":"LY-2812176 (u)","id":"24836"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"24837"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"24838"},{"source":"carcinoma","target":"pembrolizumab","id":"24839"},{"source":"anticancer","target":"LY-2812176 (u)","id":"24840"},{"source":"anticancer","target":"pembrolizumab","id":"24841"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"24842"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"24843"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"24844"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24845"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"24846"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"24847"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24848"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"24849"},{"source":"DKK-1 inhibitor","target":"UNK : Indication","id":"24850"},{"source":"DKK-1 inhibitor","target":"pharyngeal neoplasms","id":"24851"},{"source":"DKK-1 inhibitor","target":"anticancer","id":"24852"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"24853"},{"source":"DKK-1 inhibitor","target":"esophageal cancer","id":"24854"},{"source":"DKK-1 inhibitor","target":"stomach neoplasms","id":"24855"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"24856"},{"source":"DKK-1 inhibitor","target":"anticancer","id":"24857"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"24858"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"24859"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"24860"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24861"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"24862"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"24863"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24864"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"24865"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"24866"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"24867"},{"source":"CD19 antagonist","target":"anticancer","id":"24868"},{"source":"CD19 antagonist","target":"carcinoma","id":"24869"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"24870"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"24871"},{"source":"CD19 antagonist","target":"carcinoma","id":"24872"},{"source":"CD19 antagonist","target":"anticancer","id":"24873"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"24874"},{"source":"Oncology: Esophageal","target":"DKK-1 inhibitor","id":"24875"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"24876"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"24877"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"24878"},{"source":"Oncology: Gastric","target":"DKK-1 inhibitor","id":"24879"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"24880"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"24881"},{"source":"BNC-105 (u)","target":"(Other government agency)","id":"24882"},{"source":"BNC-105 (u)","target":"Bionomics","id":"24883"},{"source":"pembrolizumab","target":"(Other government agency)","id":"24884"},{"source":"pembrolizumab","target":"Bionomics","id":"24885"},{"source":"ovarian neoplasms","target":"BNC-105 (u)","id":"24886"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"24887"},{"source":"residual tumor","target":"BNC-105 (u)","id":"24888"},{"source":"residual tumor","target":"pembrolizumab","id":"24889"},{"source":"melanoma","target":"BNC-105 (u)","id":"24890"},{"source":"melanoma","target":"pembrolizumab","id":"24891"},{"source":"skin neoplasms","target":"BNC-105 (u)","id":"24892"},{"source":"skin neoplasms","target":"pembrolizumab","id":"24893"},{"source":"cerebellar neoplasms","target":"BNC-105 (u)","id":"24894"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"24895"},{"source":"carcinoma","target":"BNC-105 (u)","id":"24896"},{"source":"carcinoma","target":"pembrolizumab","id":"24897"},{"source":"brain metastases","target":"BNC-105 (u)","id":"24898"},{"source":"brain metastases","target":"pembrolizumab","id":"24899"},{"source":"anticancer","target":"BNC-105 (u)","id":"24900"},{"source":"anticancer","target":"pembrolizumab","id":"24901"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"24902"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"24903"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"24904"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"24905"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"24906"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"24907"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"24908"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"24909"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"24910"},{"source":"CD19 antagonist","target":"residual tumor","id":"24911"},{"source":"CD19 antagonist","target":"melanoma","id":"24912"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"24913"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"24914"},{"source":"CD19 antagonist","target":"carcinoma","id":"24915"},{"source":"CD19 antagonist","target":"brain metastases","id":"24916"},{"source":"CD19 antagonist","target":"anticancer","id":"24917"},{"source":"Tubulin inhibitor","target":"ovarian neoplasms","id":"24918"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"24919"},{"source":"Tubulin inhibitor","target":"melanoma","id":"24920"},{"source":"Tubulin inhibitor","target":"skin neoplasms","id":"24921"},{"source":"Tubulin inhibitor","target":"cerebellar neoplasms","id":"24922"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"24923"},{"source":"Tubulin inhibitor","target":"brain metastases","id":"24924"},{"source":"Tubulin inhibitor","target":"anticancer","id":"24925"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"24926"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"24927"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"24928"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"24929"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"24930"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"24931"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"24932"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"24933"},{"source":"Angiogenesis inhibitor","target":"ovarian neoplasms","id":"24934"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"24935"},{"source":"Angiogenesis inhibitor","target":"melanoma","id":"24936"},{"source":"Angiogenesis inhibitor","target":"skin neoplasms","id":"24937"},{"source":"Angiogenesis inhibitor","target":"cerebellar neoplasms","id":"24938"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"24939"},{"source":"Angiogenesis inhibitor","target":"brain metastases","id":"24940"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"24941"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"24942"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"24943"},{"source":"Oncology: Melanoma","target":"Tubulin inhibitor","id":"24944"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"24945"},{"source":"Oncology: Melanoma","target":"Angiogenesis inhibitor","id":"24946"},{"source":"axitinib (a)","target":"Merck & Co.","id":"24947"},{"source":"axitinib (a)","target":"Pfizer","id":"24948"},{"source":"pembrolizumab","target":"Merck & Co.","id":"24949"},{"source":"pembrolizumab","target":"Pfizer","id":"24950"},{"source":"sunitinib malate","target":"Merck & Co.","id":"24951"},{"source":"sunitinib malate","target":"Pfizer","id":"24952"},{"source":"UNK : Indication","target":"axitinib (a)","id":"24953"},{"source":"UNK : Indication","target":"pembrolizumab","id":"24954"},{"source":"UNK : Indication","target":"sunitinib malate","id":"24955"},{"source":"solid tumors","target":"axitinib (a)","id":"24956"},{"source":"solid tumors","target":"pembrolizumab","id":"24957"},{"source":"solid tumors","target":"sunitinib malate","id":"24958"},{"source":"anticancer","target":"axitinib (a)","id":"24959"},{"source":"anticancer","target":"pembrolizumab","id":"24960"},{"source":"anticancer","target":"sunitinib malate","id":"24961"},{"source":"kidney neoplasms","target":"axitinib (a)","id":"24962"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"24963"},{"source":"kidney neoplasms","target":"sunitinib malate","id":"24964"},{"source":"renal cancer","target":"axitinib (a)","id":"24965"},{"source":"renal cancer","target":"pembrolizumab","id":"24966"},{"source":"renal cancer","target":"sunitinib malate","id":"24967"},{"source":"carcinoma","target":"axitinib (a)","id":"24968"},{"source":"carcinoma","target":"pembrolizumab","id":"24969"},{"source":"carcinoma","target":"sunitinib malate","id":"24970"},{"source":"residual tumor","target":"axitinib (a)","id":"24971"},{"source":"residual tumor","target":"pembrolizumab","id":"24972"},{"source":"residual tumor","target":"sunitinib malate","id":"24973"},{"source":"metastatic","target":"axitinib (a)","id":"24974"},{"source":"metastatic","target":"pembrolizumab","id":"24975"},{"source":"metastatic","target":"sunitinib malate","id":"24976"},{"source":"carcinoma","target":"axitinib (a)","id":"24977"},{"source":"carcinoma","target":"pembrolizumab","id":"24978"},{"source":"carcinoma","target":"sunitinib malate","id":"24979"},{"source":"neoplasm metastasis","target":"axitinib (a)","id":"24980"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"24981"},{"source":"neoplasm metastasis","target":"sunitinib malate","id":"24982"},{"source":"sarcoma","target":"axitinib (a)","id":"24983"},{"source":"sarcoma","target":"pembrolizumab","id":"24984"},{"source":"sarcoma","target":"sunitinib malate","id":"24985"},{"source":"anticancer","target":"axitinib (a)","id":"24986"},{"source":"anticancer","target":"pembrolizumab","id":"24987"},{"source":"anticancer","target":"sunitinib malate","id":"24988"},{"source":"rcc","target":"axitinib (a)","id":"24989"},{"source":"rcc","target":"pembrolizumab","id":"24990"},{"source":"rcc","target":"sunitinib malate","id":"24991"},{"source":"sarcoma","target":"axitinib (a)","id":"24992"},{"source":"sarcoma","target":"pembrolizumab","id":"24993"},{"source":"sarcoma","target":"sunitinib malate","id":"24994"},{"source":"renal cell","target":"axitinib (a)","id":"24995"},{"source":"renal cell","target":"pembrolizumab","id":"24996"},{"source":"renal cell","target":"sunitinib malate","id":"24997"},{"source":"solid tumors","target":"axitinib (a)","id":"24998"},{"source":"solid tumors","target":"pembrolizumab","id":"24999"},{"source":"solid tumors","target":"sunitinib malate","id":"25000"},{"source":"NA","target":"UNK : Indication","id":"25001"},{"source":"NA","target":"solid tumors","id":"25002"},{"source":"NA","target":"anticancer","id":"25003"},{"source":"NA","target":"kidney neoplasms","id":"25004"},{"source":"NA","target":"renal cancer","id":"25005"},{"source":"NA","target":"carcinoma","id":"25006"},{"source":"NA","target":"residual tumor","id":"25007"},{"source":"NA","target":"metastatic","id":"25008"},{"source":"NA","target":"carcinoma","id":"25009"},{"source":"NA","target":"neoplasm metastasis","id":"25010"},{"source":"NA","target":"sarcoma","id":"25011"},{"source":"NA","target":"anticancer","id":"25012"},{"source":"NA","target":"rcc","id":"25013"},{"source":"NA","target":"sarcoma","id":"25014"},{"source":"NA","target":"renal cell","id":"25015"},{"source":"NA","target":"solid tumors","id":"25016"},{"source":"NA","target":"UNK : Indication","id":"25017"},{"source":"NA","target":"solid tumors","id":"25018"},{"source":"NA","target":"anticancer","id":"25019"},{"source":"NA","target":"kidney neoplasms","id":"25020"},{"source":"NA","target":"renal cancer","id":"25021"},{"source":"NA","target":"carcinoma","id":"25022"},{"source":"NA","target":"residual tumor","id":"25023"},{"source":"NA","target":"metastatic","id":"25024"},{"source":"NA","target":"carcinoma","id":"25025"},{"source":"NA","target":"neoplasm metastasis","id":"25026"},{"source":"NA","target":"sarcoma","id":"25027"},{"source":"NA","target":"anticancer","id":"25028"},{"source":"NA","target":"rcc","id":"25029"},{"source":"NA","target":"sarcoma","id":"25030"},{"source":"NA","target":"renal cell","id":"25031"},{"source":"NA","target":"solid tumors","id":"25032"},{"source":"NA","target":"UNK : Indication","id":"25033"},{"source":"NA","target":"solid tumors","id":"25034"},{"source":"NA","target":"anticancer","id":"25035"},{"source":"NA","target":"kidney neoplasms","id":"25036"},{"source":"NA","target":"renal cancer","id":"25037"},{"source":"NA","target":"carcinoma","id":"25038"},{"source":"NA","target":"residual tumor","id":"25039"},{"source":"NA","target":"metastatic","id":"25040"},{"source":"NA","target":"carcinoma","id":"25041"},{"source":"NA","target":"neoplasm metastasis","id":"25042"},{"source":"NA","target":"sarcoma","id":"25043"},{"source":"NA","target":"anticancer","id":"25044"},{"source":"NA","target":"rcc","id":"25045"},{"source":"NA","target":"sarcoma","id":"25046"},{"source":"NA","target":"renal cell","id":"25047"},{"source":"NA","target":"solid tumors","id":"25048"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"25049"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"25050"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25051"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"25052"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"25053"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25054"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"25055"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"25056"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25057"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"25058"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"25059"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25060"},{"source":"Anticancer immunotherapy","target":"rcc","id":"25061"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"25062"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"25063"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"25064"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"25065"},{"source":"CD19 antagonist","target":"solid tumors","id":"25066"},{"source":"CD19 antagonist","target":"anticancer","id":"25067"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"25068"},{"source":"CD19 antagonist","target":"renal cancer","id":"25069"},{"source":"CD19 antagonist","target":"carcinoma","id":"25070"},{"source":"CD19 antagonist","target":"residual tumor","id":"25071"},{"source":"CD19 antagonist","target":"metastatic","id":"25072"},{"source":"CD19 antagonist","target":"carcinoma","id":"25073"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"25074"},{"source":"CD19 antagonist","target":"sarcoma","id":"25075"},{"source":"CD19 antagonist","target":"anticancer","id":"25076"},{"source":"CD19 antagonist","target":"rcc","id":"25077"},{"source":"CD19 antagonist","target":"sarcoma","id":"25078"},{"source":"CD19 antagonist","target":"renal cell","id":"25079"},{"source":"CD19 antagonist","target":"solid tumors","id":"25080"},{"source":"NA","target":"UNK : Indication","id":"25081"},{"source":"NA","target":"solid tumors","id":"25082"},{"source":"NA","target":"anticancer","id":"25083"},{"source":"NA","target":"kidney neoplasms","id":"25084"},{"source":"NA","target":"renal cancer","id":"25085"},{"source":"NA","target":"carcinoma","id":"25086"},{"source":"NA","target":"residual tumor","id":"25087"},{"source":"NA","target":"metastatic","id":"25088"},{"source":"NA","target":"carcinoma","id":"25089"},{"source":"NA","target":"neoplasm metastasis","id":"25090"},{"source":"NA","target":"sarcoma","id":"25091"},{"source":"NA","target":"anticancer","id":"25092"},{"source":"NA","target":"rcc","id":"25093"},{"source":"NA","target":"sarcoma","id":"25094"},{"source":"NA","target":"renal cell","id":"25095"},{"source":"NA","target":"solid tumors","id":"25096"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"UNK : Indication","id":"25097"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"25098"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"25099"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"kidney neoplasms","id":"25100"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"renal cancer","id":"25101"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"25102"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"25103"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"metastatic","id":"25104"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"25105"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"neoplasm metastasis","id":"25106"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"sarcoma","id":"25107"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"25108"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"rcc","id":"25109"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"sarcoma","id":"25110"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"renal cell","id":"25111"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"25112"},{"source":"NA","target":"UNK : Indication","id":"25113"},{"source":"NA","target":"solid tumors","id":"25114"},{"source":"NA","target":"anticancer","id":"25115"},{"source":"NA","target":"kidney neoplasms","id":"25116"},{"source":"NA","target":"renal cancer","id":"25117"},{"source":"NA","target":"carcinoma","id":"25118"},{"source":"NA","target":"residual tumor","id":"25119"},{"source":"NA","target":"metastatic","id":"25120"},{"source":"NA","target":"carcinoma","id":"25121"},{"source":"NA","target":"neoplasm metastasis","id":"25122"},{"source":"NA","target":"sarcoma","id":"25123"},{"source":"NA","target":"anticancer","id":"25124"},{"source":"NA","target":"rcc","id":"25125"},{"source":"NA","target":"sarcoma","id":"25126"},{"source":"NA","target":"renal cell","id":"25127"},{"source":"NA","target":"solid tumors","id":"25128"},{"source":"NA","target":"UNK : Indication","id":"25129"},{"source":"NA","target":"solid tumors","id":"25130"},{"source":"NA","target":"anticancer","id":"25131"},{"source":"NA","target":"kidney neoplasms","id":"25132"},{"source":"NA","target":"renal cancer","id":"25133"},{"source":"NA","target":"carcinoma","id":"25134"},{"source":"NA","target":"residual tumor","id":"25135"},{"source":"NA","target":"metastatic","id":"25136"},{"source":"NA","target":"carcinoma","id":"25137"},{"source":"NA","target":"neoplasm metastasis","id":"25138"},{"source":"NA","target":"sarcoma","id":"25139"},{"source":"NA","target":"anticancer","id":"25140"},{"source":"NA","target":"rcc","id":"25141"},{"source":"NA","target":"sarcoma","id":"25142"},{"source":"NA","target":"renal cell","id":"25143"},{"source":"NA","target":"solid tumors","id":"25144"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"25145"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"25146"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"25147"},{"source":"Angiogenesis inhibitor","target":"kidney neoplasms","id":"25148"},{"source":"Angiogenesis inhibitor","target":"renal cancer","id":"25149"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"25150"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"25151"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"25152"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"25153"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"25154"},{"source":"Angiogenesis inhibitor","target":"sarcoma","id":"25155"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"25156"},{"source":"Angiogenesis inhibitor","target":"rcc","id":"25157"},{"source":"Angiogenesis inhibitor","target":"sarcoma","id":"25158"},{"source":"Angiogenesis inhibitor","target":"renal cell","id":"25159"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"25160"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"25161"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"solid tumors","id":"25162"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"25163"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"kidney neoplasms","id":"25164"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cancer","id":"25165"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"25166"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"25167"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"metastatic","id":"25168"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"25169"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"neoplasm metastasis","id":"25170"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"sarcoma","id":"25171"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"25172"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"rcc","id":"25173"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"sarcoma","id":"25174"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cell","id":"25175"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"solid tumors","id":"25176"},{"source":"NA","target":"UNK : Indication","id":"25177"},{"source":"NA","target":"solid tumors","id":"25178"},{"source":"NA","target":"anticancer","id":"25179"},{"source":"NA","target":"kidney neoplasms","id":"25180"},{"source":"NA","target":"renal cancer","id":"25181"},{"source":"NA","target":"carcinoma","id":"25182"},{"source":"NA","target":"residual tumor","id":"25183"},{"source":"NA","target":"metastatic","id":"25184"},{"source":"NA","target":"carcinoma","id":"25185"},{"source":"NA","target":"neoplasm metastasis","id":"25186"},{"source":"NA","target":"sarcoma","id":"25187"},{"source":"NA","target":"anticancer","id":"25188"},{"source":"NA","target":"rcc","id":"25189"},{"source":"NA","target":"sarcoma","id":"25190"},{"source":"NA","target":"renal cell","id":"25191"},{"source":"NA","target":"solid tumors","id":"25192"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"25193"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"25194"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"25195"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"25196"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"25197"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"25198"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"25199"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"25200"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"25201"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"25202"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"25203"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"25204"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"25205"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"25206"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"25207"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"25208"},{"source":"NA","target":"UNK : Indication","id":"25209"},{"source":"NA","target":"solid tumors","id":"25210"},{"source":"NA","target":"anticancer","id":"25211"},{"source":"NA","target":"kidney neoplasms","id":"25212"},{"source":"NA","target":"renal cancer","id":"25213"},{"source":"NA","target":"carcinoma","id":"25214"},{"source":"NA","target":"residual tumor","id":"25215"},{"source":"NA","target":"metastatic","id":"25216"},{"source":"NA","target":"carcinoma","id":"25217"},{"source":"NA","target":"neoplasm metastasis","id":"25218"},{"source":"NA","target":"sarcoma","id":"25219"},{"source":"NA","target":"anticancer","id":"25220"},{"source":"NA","target":"rcc","id":"25221"},{"source":"NA","target":"sarcoma","id":"25222"},{"source":"NA","target":"renal cell","id":"25223"},{"source":"NA","target":"solid tumors","id":"25224"},{"source":"C-kit inhibitor","target":"UNK : Indication","id":"25225"},{"source":"C-kit inhibitor","target":"solid tumors","id":"25226"},{"source":"C-kit inhibitor","target":"anticancer","id":"25227"},{"source":"C-kit inhibitor","target":"kidney neoplasms","id":"25228"},{"source":"C-kit inhibitor","target":"renal cancer","id":"25229"},{"source":"C-kit inhibitor","target":"carcinoma","id":"25230"},{"source":"C-kit inhibitor","target":"residual tumor","id":"25231"},{"source":"C-kit inhibitor","target":"metastatic","id":"25232"},{"source":"C-kit inhibitor","target":"carcinoma","id":"25233"},{"source":"C-kit inhibitor","target":"neoplasm metastasis","id":"25234"},{"source":"C-kit inhibitor","target":"sarcoma","id":"25235"},{"source":"C-kit inhibitor","target":"anticancer","id":"25236"},{"source":"C-kit inhibitor","target":"rcc","id":"25237"},{"source":"C-kit inhibitor","target":"sarcoma","id":"25238"},{"source":"C-kit inhibitor","target":"renal cell","id":"25239"},{"source":"C-kit inhibitor","target":"solid tumors","id":"25240"},{"source":"Oncology: Renal","target":"NA","id":"25241"},{"source":"Oncology: Renal","target":"NA","id":"25242"},{"source":"Oncology: Renal","target":"NA","id":"25243"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"25244"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"25245"},{"source":"Oncology: Renal","target":"NA","id":"25246"},{"source":"Oncology: Renal","target":"Colony stimulating factor 1 receptor antagonist","id":"25247"},{"source":"Oncology: Renal","target":"NA","id":"25248"},{"source":"Oncology: Renal","target":"NA","id":"25249"},{"source":"Oncology: Renal","target":"Angiogenesis inhibitor","id":"25250"},{"source":"Oncology: Renal","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"25251"},{"source":"Oncology: Renal","target":"NA","id":"25252"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"25253"},{"source":"Oncology: Renal","target":"NA","id":"25254"},{"source":"Oncology: Renal","target":"C-kit inhibitor","id":"25255"},{"source":"pegzilarginase (u)","target":"Biothera","id":"25256"},{"source":"pegzilarginase (u)","target":"Merck & Co.","id":"25257"},{"source":"pembrolizumab","target":"Biothera","id":"25258"},{"source":"pembrolizumab","target":"Merck & Co.","id":"25259"},{"source":"UNK : Drug","target":"Biothera","id":"25260"},{"source":"UNK : Drug","target":"Merck & Co.","id":"25261"},{"source":"UNK : Indication","target":"pegzilarginase (u)","id":"25262"},{"source":"UNK : Indication","target":"pembrolizumab","id":"25263"},{"source":"UNK : Indication","target":"UNK : Drug","id":"25264"},{"source":"sclc","target":"pegzilarginase (u)","id":"25265"},{"source":"sclc","target":"pembrolizumab","id":"25266"},{"source":"sclc","target":"UNK : Drug","id":"25267"},{"source":"anticancer","target":"pegzilarginase (u)","id":"25268"},{"source":"anticancer","target":"pembrolizumab","id":"25269"},{"source":"anticancer","target":"UNK : Drug","id":"25270"},{"source":"carcinoma","target":"pegzilarginase (u)","id":"25271"},{"source":"carcinoma","target":"pembrolizumab","id":"25272"},{"source":"carcinoma","target":"UNK : Drug","id":"25273"},{"source":"lung cancer","target":"pegzilarginase (u)","id":"25274"},{"source":"lung cancer","target":"pembrolizumab","id":"25275"},{"source":"lung cancer","target":"UNK : Drug","id":"25276"},{"source":"residual tumor","target":"pegzilarginase (u)","id":"25277"},{"source":"residual tumor","target":"pembrolizumab","id":"25278"},{"source":"residual tumor","target":"UNK : Drug","id":"25279"},{"source":"carcinoma","target":"pegzilarginase (u)","id":"25280"},{"source":"carcinoma","target":"pembrolizumab","id":"25281"},{"source":"carcinoma","target":"UNK : Drug","id":"25282"},{"source":"anticancer","target":"pegzilarginase (u)","id":"25283"},{"source":"anticancer","target":"pembrolizumab","id":"25284"},{"source":"anticancer","target":"UNK : Drug","id":"25285"},{"source":"lung cancer","target":"pegzilarginase (u)","id":"25286"},{"source":"lung cancer","target":"pembrolizumab","id":"25287"},{"source":"lung cancer","target":"UNK : Drug","id":"25288"},{"source":"lung neoplasms","target":"pegzilarginase (u)","id":"25289"},{"source":"lung neoplasms","target":"pembrolizumab","id":"25290"},{"source":"lung neoplasms","target":"UNK : Drug","id":"25291"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"25292"},{"source":"Anticancer immunotherapy","target":"sclc","id":"25293"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25294"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25295"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"25296"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"25297"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25298"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25299"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"25300"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"25301"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"25302"},{"source":"CD19 antagonist","target":"sclc","id":"25303"},{"source":"CD19 antagonist","target":"anticancer","id":"25304"},{"source":"CD19 antagonist","target":"carcinoma","id":"25305"},{"source":"CD19 antagonist","target":"lung cancer","id":"25306"},{"source":"CD19 antagonist","target":"residual tumor","id":"25307"},{"source":"CD19 antagonist","target":"carcinoma","id":"25308"},{"source":"CD19 antagonist","target":"anticancer","id":"25309"},{"source":"CD19 antagonist","target":"lung cancer","id":"25310"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"25311"},{"source":"NA","target":"UNK : Indication","id":"25312"},{"source":"NA","target":"sclc","id":"25313"},{"source":"NA","target":"anticancer","id":"25314"},{"source":"NA","target":"carcinoma","id":"25315"},{"source":"NA","target":"lung cancer","id":"25316"},{"source":"NA","target":"residual tumor","id":"25317"},{"source":"NA","target":"carcinoma","id":"25318"},{"source":"NA","target":"anticancer","id":"25319"},{"source":"NA","target":"lung cancer","id":"25320"},{"source":"NA","target":"lung neoplasms","id":"25321"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"25322"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"25323"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"25324"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"25325"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"25326"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"25327"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"25328"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"25329"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"25330"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"25331"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"25332"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"25333"},{"source":"Oncology: Lung","target":"NA","id":"25334"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"25335"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"25336"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"25337"},{"source":"Non-Small Cell","target":"NA","id":"25338"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"25339"},{"source":"AFM-13 (u)","target":"Affimed {Affimed Therapeutics AG}","id":"25340"},{"source":"pembrolizumab","target":"Affimed {Affimed Therapeutics AG}","id":"25341"},{"source":"stem cell transplantation","target":"AFM-13 (u)","id":"25342"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"25343"},{"source":"lymphoma","target":"AFM-13 (u)","id":"25344"},{"source":"lymphoma","target":"pembrolizumab","id":"25345"},{"source":"hodgkin disease","target":"AFM-13 (u)","id":"25346"},{"source":"hodgkin disease","target":"pembrolizumab","id":"25347"},{"source":"carcinoma","target":"AFM-13 (u)","id":"25348"},{"source":"carcinoma","target":"pembrolizumab","id":"25349"},{"source":"lymphoma","target":"AFM-13 (u)","id":"25350"},{"source":"lymphoma","target":"pembrolizumab","id":"25351"},{"source":"anticancer","target":"AFM-13 (u)","id":"25352"},{"source":"anticancer","target":"pembrolizumab","id":"25353"},{"source":"lymphoma","target":"AFM-13 (u)","id":"25354"},{"source":"lymphoma","target":"pembrolizumab","id":"25355"},{"source":"lymphoma","target":"AFM-13 (u)","id":"25356"},{"source":"lymphoma","target":"pembrolizumab","id":"25357"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"25358"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"25359"},{"source":"Anticancer immunotherapy","target":"hodgkin disease","id":"25360"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25361"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"25362"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25363"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"25364"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"25365"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"25366"},{"source":"CD19 antagonist","target":"lymphoma","id":"25367"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"25368"},{"source":"CD19 antagonist","target":"carcinoma","id":"25369"},{"source":"CD19 antagonist","target":"lymphoma","id":"25370"},{"source":"CD19 antagonist","target":"anticancer","id":"25371"},{"source":"CD19 antagonist","target":"lymphoma","id":"25372"},{"source":"CD19 antagonist","target":"lymphoma","id":"25373"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"25374"},{"source":"CD19 antagonist","target":"lymphoma","id":"25375"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"25376"},{"source":"CD19 antagonist","target":"carcinoma","id":"25377"},{"source":"CD19 antagonist","target":"lymphoma","id":"25378"},{"source":"CD19 antagonist","target":"anticancer","id":"25379"},{"source":"CD19 antagonist","target":"lymphoma","id":"25380"},{"source":"CD19 antagonist","target":"lymphoma","id":"25381"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"25382"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"25383"},{"source":"Immune checkpoint inhibitor","target":"hodgkin disease","id":"25384"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"25385"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"25386"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"25387"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"25388"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"25389"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"25390"},{"source":"CD19 antagonist","target":"lymphoma","id":"25391"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"25392"},{"source":"CD19 antagonist","target":"carcinoma","id":"25393"},{"source":"CD19 antagonist","target":"lymphoma","id":"25394"},{"source":"CD19 antagonist","target":"anticancer","id":"25395"},{"source":"CD19 antagonist","target":"lymphoma","id":"25396"},{"source":"CD19 antagonist","target":"lymphoma","id":"25397"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"25398"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"25399"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"25400"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"25401"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"25402"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"25403"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"25404"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"25405"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"25406"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"25407"},{"source":"interferon alpha-2b","target":"National Institutes of Health/National Cancer Institute","id":"25408"},{"source":"Genentech (gamma1b) (SC) (a)","target":"National Institutes of Health/National Cancer Institute","id":"25409"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"25410"},{"source":"UNK : Drug","target":"National Institutes of Health/National Cancer Institute","id":"25411"},{"source":"UNK : Indication","target":"interferon alpha-2b","id":"25412"},{"source":"UNK : Indication","target":"Genentech (gamma1b) (SC) (a)","id":"25413"},{"source":"UNK : Indication","target":"pembrolizumab","id":"25414"},{"source":"UNK : Indication","target":"UNK : Drug","id":"25415"},{"source":"sezary syndrome","target":"interferon alpha-2b","id":"25416"},{"source":"sezary syndrome","target":"Genentech (gamma1b) (SC) (a)","id":"25417"},{"source":"sezary syndrome","target":"pembrolizumab","id":"25418"},{"source":"sezary syndrome","target":"UNK : Drug","id":"25419"},{"source":"lymphoma","target":"interferon alpha-2b","id":"25420"},{"source":"lymphoma","target":"Genentech (gamma1b) (SC) (a)","id":"25421"},{"source":"lymphoma","target":"pembrolizumab","id":"25422"},{"source":"lymphoma","target":"UNK : Drug","id":"25423"},{"source":"asthma","target":"interferon alpha-2b","id":"25424"},{"source":"asthma","target":"Genentech (gamma1b) (SC) (a)","id":"25425"},{"source":"asthma","target":"pembrolizumab","id":"25426"},{"source":"asthma","target":"UNK : Drug","id":"25427"},{"source":"antiparkinsonian","target":"interferon alpha-2b","id":"25428"},{"source":"antiparkinsonian","target":"Genentech (gamma1b) (SC) (a)","id":"25429"},{"source":"antiparkinsonian","target":"pembrolizumab","id":"25430"},{"source":"antiparkinsonian","target":"UNK : Drug","id":"25431"},{"source":"mycosis fungoides","target":"interferon alpha-2b","id":"25432"},{"source":"mycosis fungoides","target":"Genentech (gamma1b) (SC) (a)","id":"25433"},{"source":"mycosis fungoides","target":"pembrolizumab","id":"25434"},{"source":"mycosis fungoides","target":"UNK : Drug","id":"25435"},{"source":"residual tumor","target":"interferon alpha-2b","id":"25436"},{"source":"residual tumor","target":"Genentech (gamma1b) (SC) (a)","id":"25437"},{"source":"residual tumor","target":"pembrolizumab","id":"25438"},{"source":"residual tumor","target":"UNK : Drug","id":"25439"},{"source":"asthma","target":"interferon alpha-2b","id":"25440"},{"source":"asthma","target":"Genentech (gamma1b) (SC) (a)","id":"25441"},{"source":"asthma","target":"pembrolizumab","id":"25442"},{"source":"asthma","target":"UNK : Drug","id":"25443"},{"source":"liver metastases","target":"interferon alpha-2b","id":"25444"},{"source":"liver metastases","target":"Genentech (gamma1b) (SC) (a)","id":"25445"},{"source":"liver metastases","target":"pembrolizumab","id":"25446"},{"source":"liver metastases","target":"UNK : Drug","id":"25447"},{"source":"hypersensitivity","target":"interferon alpha-2b","id":"25448"},{"source":"hypersensitivity","target":"Genentech (gamma1b) (SC) (a)","id":"25449"},{"source":"hypersensitivity","target":"pembrolizumab","id":"25450"},{"source":"hypersensitivity","target":"UNK : Drug","id":"25451"},{"source":"carcinoma","target":"interferon alpha-2b","id":"25452"},{"source":"carcinoma","target":"Genentech (gamma1b) (SC) (a)","id":"25453"},{"source":"carcinoma","target":"pembrolizumab","id":"25454"},{"source":"carcinoma","target":"UNK : Drug","id":"25455"},{"source":"cystic fibrosis","target":"interferon alpha-2b","id":"25456"},{"source":"cystic fibrosis","target":"Genentech (gamma1b) (SC) (a)","id":"25457"},{"source":"cystic fibrosis","target":"pembrolizumab","id":"25458"},{"source":"cystic fibrosis","target":"UNK : Drug","id":"25459"},{"source":"non-hodgkin","target":"interferon alpha-2b","id":"25460"},{"source":"non-hodgkin","target":"Genentech (gamma1b) (SC) (a)","id":"25461"},{"source":"non-hodgkin","target":"pembrolizumab","id":"25462"},{"source":"non-hodgkin","target":"UNK : Drug","id":"25463"},{"source":"parkinson disease","target":"interferon alpha-2b","id":"25464"},{"source":"parkinson disease","target":"Genentech (gamma1b) (SC) (a)","id":"25465"},{"source":"parkinson disease","target":"pembrolizumab","id":"25466"},{"source":"parkinson disease","target":"UNK : Drug","id":"25467"},{"source":"anticancer","target":"interferon alpha-2b","id":"25468"},{"source":"anticancer","target":"Genentech (gamma1b) (SC) (a)","id":"25469"},{"source":"anticancer","target":"pembrolizumab","id":"25470"},{"source":"anticancer","target":"UNK : Drug","id":"25471"},{"source":"lymphoma","target":"interferon alpha-2b","id":"25472"},{"source":"lymphoma","target":"Genentech (gamma1b) (SC) (a)","id":"25473"},{"source":"lymphoma","target":"pembrolizumab","id":"25474"},{"source":"lymphoma","target":"UNK : Drug","id":"25475"},{"source":"mycoses","target":"interferon alpha-2b","id":"25476"},{"source":"mycoses","target":"Genentech (gamma1b) (SC) (a)","id":"25477"},{"source":"mycoses","target":"pembrolizumab","id":"25478"},{"source":"mycoses","target":"UNK : Drug","id":"25479"},{"source":"liver neoplasms","target":"interferon alpha-2b","id":"25480"},{"source":"liver neoplasms","target":"Genentech (gamma1b) (SC) (a)","id":"25481"},{"source":"liver neoplasms","target":"pembrolizumab","id":"25482"},{"source":"liver neoplasms","target":"UNK : Drug","id":"25483"},{"source":"antiallergic","target":"interferon alpha-2b","id":"25484"},{"source":"antiallergic","target":"Genentech (gamma1b) (SC) (a)","id":"25485"},{"source":"antiallergic","target":"pembrolizumab","id":"25486"},{"source":"antiallergic","target":"UNK : Drug","id":"25487"},{"source":"Interferon alpha 2b agonist","target":"UNK : Indication","id":"25488"},{"source":"Interferon alpha 2b agonist","target":"sezary syndrome","id":"25489"},{"source":"Interferon alpha 2b agonist","target":"lymphoma","id":"25490"},{"source":"Interferon alpha 2b agonist","target":"asthma","id":"25491"},{"source":"Interferon alpha 2b agonist","target":"antiparkinsonian","id":"25492"},{"source":"Interferon alpha 2b agonist","target":"mycosis fungoides","id":"25493"},{"source":"Interferon alpha 2b agonist","target":"residual tumor","id":"25494"},{"source":"Interferon alpha 2b agonist","target":"asthma","id":"25495"},{"source":"Interferon alpha 2b agonist","target":"liver metastases","id":"25496"},{"source":"Interferon alpha 2b agonist","target":"hypersensitivity","id":"25497"},{"source":"Interferon alpha 2b agonist","target":"carcinoma","id":"25498"},{"source":"Interferon alpha 2b agonist","target":"cystic fibrosis","id":"25499"},{"source":"Interferon alpha 2b agonist","target":"non-hodgkin","id":"25500"},{"source":"Interferon alpha 2b agonist","target":"parkinson disease","id":"25501"},{"source":"Interferon alpha 2b agonist","target":"anticancer","id":"25502"},{"source":"Interferon alpha 2b agonist","target":"lymphoma","id":"25503"},{"source":"Interferon alpha 2b agonist","target":"mycoses","id":"25504"},{"source":"Interferon alpha 2b agonist","target":"liver neoplasms","id":"25505"},{"source":"Interferon alpha 2b agonist","target":"antiallergic","id":"25506"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"25507"},{"source":"Immune checkpoint inhibitor","target":"sezary syndrome","id":"25508"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"25509"},{"source":"Immune checkpoint inhibitor","target":"asthma","id":"25510"},{"source":"Immune checkpoint inhibitor","target":"antiparkinsonian","id":"25511"},{"source":"Immune checkpoint inhibitor","target":"mycosis fungoides","id":"25512"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"25513"},{"source":"Immune checkpoint inhibitor","target":"asthma","id":"25514"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"25515"},{"source":"Immune checkpoint inhibitor","target":"hypersensitivity","id":"25516"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"25517"},{"source":"Immune checkpoint inhibitor","target":"cystic fibrosis","id":"25518"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"25519"},{"source":"Immune checkpoint inhibitor","target":"parkinson disease","id":"25520"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"25521"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"25522"},{"source":"Immune checkpoint inhibitor","target":"mycoses","id":"25523"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"25524"},{"source":"Immune checkpoint inhibitor","target":"antiallergic","id":"25525"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"25526"},{"source":"Anticancer immunotherapy","target":"sezary syndrome","id":"25527"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"25528"},{"source":"Anticancer immunotherapy","target":"asthma","id":"25529"},{"source":"Anticancer immunotherapy","target":"antiparkinsonian","id":"25530"},{"source":"Anticancer immunotherapy","target":"mycosis fungoides","id":"25531"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"25532"},{"source":"Anticancer immunotherapy","target":"asthma","id":"25533"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"25534"},{"source":"Anticancer immunotherapy","target":"hypersensitivity","id":"25535"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25536"},{"source":"Anticancer immunotherapy","target":"cystic fibrosis","id":"25537"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"25538"},{"source":"Anticancer immunotherapy","target":"parkinson disease","id":"25539"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25540"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"25541"},{"source":"Anticancer immunotherapy","target":"mycoses","id":"25542"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"25543"},{"source":"Anticancer immunotherapy","target":"antiallergic","id":"25544"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"25545"},{"source":"CD19 antagonist","target":"sezary syndrome","id":"25546"},{"source":"CD19 antagonist","target":"lymphoma","id":"25547"},{"source":"CD19 antagonist","target":"asthma","id":"25548"},{"source":"CD19 antagonist","target":"antiparkinsonian","id":"25549"},{"source":"CD19 antagonist","target":"mycosis fungoides","id":"25550"},{"source":"CD19 antagonist","target":"residual tumor","id":"25551"},{"source":"CD19 antagonist","target":"asthma","id":"25552"},{"source":"CD19 antagonist","target":"liver metastases","id":"25553"},{"source":"CD19 antagonist","target":"hypersensitivity","id":"25554"},{"source":"CD19 antagonist","target":"carcinoma","id":"25555"},{"source":"CD19 antagonist","target":"cystic fibrosis","id":"25556"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"25557"},{"source":"CD19 antagonist","target":"parkinson disease","id":"25558"},{"source":"CD19 antagonist","target":"anticancer","id":"25559"},{"source":"CD19 antagonist","target":"lymphoma","id":"25560"},{"source":"CD19 antagonist","target":"mycoses","id":"25561"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"25562"},{"source":"CD19 antagonist","target":"antiallergic","id":"25563"},{"source":"T helper cell stimulant","target":"UNK : Indication","id":"25564"},{"source":"T helper cell stimulant","target":"sezary syndrome","id":"25565"},{"source":"T helper cell stimulant","target":"lymphoma","id":"25566"},{"source":"T helper cell stimulant","target":"asthma","id":"25567"},{"source":"T helper cell stimulant","target":"antiparkinsonian","id":"25568"},{"source":"T helper cell stimulant","target":"mycosis fungoides","id":"25569"},{"source":"T helper cell stimulant","target":"residual tumor","id":"25570"},{"source":"T helper cell stimulant","target":"asthma","id":"25571"},{"source":"T helper cell stimulant","target":"liver metastases","id":"25572"},{"source":"T helper cell stimulant","target":"hypersensitivity","id":"25573"},{"source":"T helper cell stimulant","target":"carcinoma","id":"25574"},{"source":"T helper cell stimulant","target":"cystic fibrosis","id":"25575"},{"source":"T helper cell stimulant","target":"non-hodgkin","id":"25576"},{"source":"T helper cell stimulant","target":"parkinson disease","id":"25577"},{"source":"T helper cell stimulant","target":"anticancer","id":"25578"},{"source":"T helper cell stimulant","target":"lymphoma","id":"25579"},{"source":"T helper cell stimulant","target":"mycoses","id":"25580"},{"source":"T helper cell stimulant","target":"liver neoplasms","id":"25581"},{"source":"T helper cell stimulant","target":"antiallergic","id":"25582"},{"source":"Immunostimulant","target":"UNK : Indication","id":"25583"},{"source":"Immunostimulant","target":"sezary syndrome","id":"25584"},{"source":"Immunostimulant","target":"lymphoma","id":"25585"},{"source":"Immunostimulant","target":"asthma","id":"25586"},{"source":"Immunostimulant","target":"antiparkinsonian","id":"25587"},{"source":"Immunostimulant","target":"mycosis fungoides","id":"25588"},{"source":"Immunostimulant","target":"residual tumor","id":"25589"},{"source":"Immunostimulant","target":"asthma","id":"25590"},{"source":"Immunostimulant","target":"liver metastases","id":"25591"},{"source":"Immunostimulant","target":"hypersensitivity","id":"25592"},{"source":"Immunostimulant","target":"carcinoma","id":"25593"},{"source":"Immunostimulant","target":"cystic fibrosis","id":"25594"},{"source":"Immunostimulant","target":"non-hodgkin","id":"25595"},{"source":"Immunostimulant","target":"parkinson disease","id":"25596"},{"source":"Immunostimulant","target":"anticancer","id":"25597"},{"source":"Immunostimulant","target":"lymphoma","id":"25598"},{"source":"Immunostimulant","target":"mycoses","id":"25599"},{"source":"Immunostimulant","target":"liver neoplasms","id":"25600"},{"source":"Immunostimulant","target":"antiallergic","id":"25601"},{"source":"Oncology: Lymphoma","target":"Interferon alpha 2b agonist","id":"25602"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"25603"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"25604"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"25605"},{"source":"Oncology: Lymphoma","target":"T helper cell stimulant","id":"25606"},{"source":"Oncology: Lymphoma","target":"Immunostimulant","id":"25607"},{"source":"Hodgkin's","target":"Interferon alpha 2b agonist","id":"25608"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"25609"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"25610"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"25611"},{"source":"Hodgkin's","target":"T helper cell stimulant","id":"25612"},{"source":"Hodgkin's","target":"Immunostimulant","id":"25613"},{"source":"Provecta (u)","target":"Provectus Biopharmaceuticals","id":"25614"},{"source":"pembrolizumab","target":"Provectus Biopharmaceuticals","id":"25615"},{"source":"UNK : Indication","target":"Provecta (u)","id":"25616"},{"source":"UNK : Indication","target":"pembrolizumab","id":"25617"},{"source":"melanoma","target":"Provecta (u)","id":"25618"},{"source":"melanoma","target":"pembrolizumab","id":"25619"},{"source":"melanoma","target":"Provecta (u)","id":"25620"},{"source":"melanoma","target":"pembrolizumab","id":"25621"},{"source":"skin neoplasms","target":"Provecta (u)","id":"25622"},{"source":"skin neoplasms","target":"pembrolizumab","id":"25623"},{"source":"carcinoma","target":"Provecta (u)","id":"25624"},{"source":"carcinoma","target":"pembrolizumab","id":"25625"},{"source":"anticancer","target":"Provecta (u)","id":"25626"},{"source":"anticancer","target":"pembrolizumab","id":"25627"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"25628"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"25629"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"25630"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"25631"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25632"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25633"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"25634"},{"source":"CD19 antagonist","target":"melanoma","id":"25635"},{"source":"CD19 antagonist","target":"melanoma","id":"25636"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"25637"},{"source":"CD19 antagonist","target":"carcinoma","id":"25638"},{"source":"CD19 antagonist","target":"anticancer","id":"25639"},{"source":"Immunostimulant","target":"UNK : Indication","id":"25640"},{"source":"Immunostimulant","target":"melanoma","id":"25641"},{"source":"Immunostimulant","target":"melanoma","id":"25642"},{"source":"Immunostimulant","target":"skin neoplasms","id":"25643"},{"source":"Immunostimulant","target":"carcinoma","id":"25644"},{"source":"Immunostimulant","target":"anticancer","id":"25645"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"25646"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"25647"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"25648"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"25649"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"25650"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"25651"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"25652"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"25653"},{"source":"Oncology: Melanoma","target":"Immunostimulant","id":"25654"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"25655"},{"source":"pembrolizumab","target":"Merck & Co.","id":"25656"},{"source":"UNK : Drug","target":"Merck & Co.","id":"25657"},{"source":"UNK : Indication","target":"pembrolizumab","id":"25658"},{"source":"UNK : Indication","target":"UNK : Drug","id":"25659"},{"source":"melanoma","target":"pembrolizumab","id":"25660"},{"source":"melanoma","target":"UNK : Drug","id":"25661"},{"source":"anticancer","target":"pembrolizumab","id":"25662"},{"source":"anticancer","target":"UNK : Drug","id":"25663"},{"source":"carcinoma","target":"pembrolizumab","id":"25664"},{"source":"carcinoma","target":"UNK : Drug","id":"25665"},{"source":"skin neoplasms","target":"pembrolizumab","id":"25666"},{"source":"skin neoplasms","target":"UNK : Drug","id":"25667"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"25668"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"25669"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"25670"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25671"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"25672"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"25673"},{"source":"CD19 antagonist","target":"melanoma","id":"25674"},{"source":"CD19 antagonist","target":"anticancer","id":"25675"},{"source":"CD19 antagonist","target":"carcinoma","id":"25676"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"25677"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"25678"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"25679"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"25680"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"25681"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"25682"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"25683"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"25684"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"25685"},{"source":"epacadostat (u)","target":"Incyte Corporation","id":"25686"},{"source":"epacadostat (u)","target":"Merck & Co.","id":"25687"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"25688"},{"source":"pembrolizumab","target":"Merck & Co.","id":"25689"},{"source":"UNK : Drug","target":"Incyte Corporation","id":"25690"},{"source":"UNK : Drug","target":"Merck & Co.","id":"25691"},{"source":"UNK : Indication","target":"epacadostat (u)","id":"25692"},{"source":"UNK : Indication","target":"pembrolizumab","id":"25693"},{"source":"UNK : Indication","target":"UNK : Drug","id":"25694"},{"source":"metastatic","target":"epacadostat (u)","id":"25695"},{"source":"metastatic","target":"pembrolizumab","id":"25696"},{"source":"metastatic","target":"UNK : Drug","id":"25697"},{"source":"colorectal neoplasms","target":"epacadostat (u)","id":"25698"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"25699"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"25700"},{"source":"esophageal cancer","target":"epacadostat (u)","id":"25701"},{"source":"esophageal cancer","target":"pembrolizumab","id":"25702"},{"source":"esophageal cancer","target":"UNK : Drug","id":"25703"},{"source":"ovarian cancer","target":"epacadostat (u)","id":"25704"},{"source":"ovarian cancer","target":"pembrolizumab","id":"25705"},{"source":"ovarian cancer","target":"UNK : Drug","id":"25706"},{"source":"pharyngeal neoplasms","target":"epacadostat (u)","id":"25707"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"25708"},{"source":"pharyngeal neoplasms","target":"UNK : Drug","id":"25709"},{"source":"ovarian cancer","target":"epacadostat (u)","id":"25710"},{"source":"ovarian cancer","target":"pembrolizumab","id":"25711"},{"source":"ovarian cancer","target":"UNK : Drug","id":"25712"},{"source":"castration-resistant prostatic neoplasms","target":"epacadostat (u)","id":"25713"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"25714"},{"source":"castration-resistant prostatic neoplasms","target":"UNK : Drug","id":"25715"},{"source":"carcinoma","target":"epacadostat (u)","id":"25716"},{"source":"carcinoma","target":"pembrolizumab","id":"25717"},{"source":"carcinoma","target":"UNK : Drug","id":"25718"},{"source":"renal cancer","target":"epacadostat (u)","id":"25719"},{"source":"renal cancer","target":"pembrolizumab","id":"25720"},{"source":"renal cancer","target":"UNK : Drug","id":"25721"},{"source":"carcinoma","target":"epacadostat (u)","id":"25722"},{"source":"carcinoma","target":"pembrolizumab","id":"25723"},{"source":"carcinoma","target":"UNK : Drug","id":"25724"},{"source":"squamous cell neoplasms","target":"epacadostat (u)","id":"25725"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"25726"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"25727"},{"source":"glandular and epithelial","target":"epacadostat (u)","id":"25728"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"25729"},{"source":"glandular and epithelial","target":"UNK : Drug","id":"25730"},{"source":"carcinoma","target":"epacadostat (u)","id":"25731"},{"source":"carcinoma","target":"pembrolizumab","id":"25732"},{"source":"carcinoma","target":"UNK : Drug","id":"25733"},{"source":"non-small-cell lung","target":"epacadostat (u)","id":"25734"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"25735"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"25736"},{"source":"breast neoplasms","target":"epacadostat (u)","id":"25737"},{"source":"breast neoplasms","target":"pembrolizumab","id":"25738"},{"source":"breast neoplasms","target":"UNK : Drug","id":"25739"},{"source":"triple-negative breast cancer","target":"epacadostat (u)","id":"25740"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"25741"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"25742"},{"source":"endometrioid","target":"epacadostat (u)","id":"25743"},{"source":"endometrioid","target":"pembrolizumab","id":"25744"},{"source":"endometrioid","target":"UNK : Drug","id":"25745"},{"source":"skin neoplasms","target":"epacadostat (u)","id":"25746"},{"source":"skin neoplasms","target":"pembrolizumab","id":"25747"},{"source":"skin neoplasms","target":"UNK : Drug","id":"25748"},{"source":"liver neoplasms","target":"epacadostat (u)","id":"25749"},{"source":"liver neoplasms","target":"pembrolizumab","id":"25750"},{"source":"liver neoplasms","target":"UNK : Drug","id":"25751"},{"source":"endometrial neoplasms","target":"epacadostat (u)","id":"25752"},{"source":"endometrial neoplasms","target":"pembrolizumab","id":"25753"},{"source":"endometrial neoplasms","target":"UNK : Drug","id":"25754"},{"source":"carcinoma","target":"epacadostat (u)","id":"25755"},{"source":"carcinoma","target":"pembrolizumab","id":"25756"},{"source":"carcinoma","target":"UNK : Drug","id":"25757"},{"source":"residual tumor","target":"epacadostat (u)","id":"25758"},{"source":"residual tumor","target":"pembrolizumab","id":"25759"},{"source":"residual tumor","target":"UNK : Drug","id":"25760"},{"source":"lymphoma","target":"epacadostat (u)","id":"25761"},{"source":"lymphoma","target":"pembrolizumab","id":"25762"},{"source":"lymphoma","target":"UNK : Drug","id":"25763"},{"source":"stem cell transplantation","target":"epacadostat (u)","id":"25764"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"25765"},{"source":"stem cell transplantation","target":"UNK : Drug","id":"25766"},{"source":"carcinoma","target":"epacadostat (u)","id":"25767"},{"source":"carcinoma","target":"pembrolizumab","id":"25768"},{"source":"carcinoma","target":"UNK : Drug","id":"25769"},{"source":"dlbcl","target":"epacadostat (u)","id":"25770"},{"source":"dlbcl","target":"pembrolizumab","id":"25771"},{"source":"dlbcl","target":"UNK : Drug","id":"25772"},{"source":"hcc","target":"epacadostat (u)","id":"25773"},{"source":"hcc","target":"pembrolizumab","id":"25774"},{"source":"hcc","target":"UNK : Drug","id":"25775"},{"source":"lymphoma","target":"epacadostat (u)","id":"25776"},{"source":"lymphoma","target":"pembrolizumab","id":"25777"},{"source":"lymphoma","target":"UNK : Drug","id":"25778"},{"source":"solid tumors","target":"epacadostat (u)","id":"25779"},{"source":"solid tumors","target":"pembrolizumab","id":"25780"},{"source":"solid tumors","target":"UNK : Drug","id":"25781"},{"source":"melanoma","target":"epacadostat (u)","id":"25782"},{"source":"melanoma","target":"pembrolizumab","id":"25783"},{"source":"melanoma","target":"UNK : Drug","id":"25784"},{"source":"liver transplants","target":"epacadostat (u)","id":"25785"},{"source":"liver transplants","target":"pembrolizumab","id":"25786"},{"source":"liver transplants","target":"UNK : Drug","id":"25787"},{"source":"carcinoma","target":"epacadostat (u)","id":"25788"},{"source":"carcinoma","target":"pembrolizumab","id":"25789"},{"source":"carcinoma","target":"UNK : Drug","id":"25790"},{"source":"breast neoplasms","target":"epacadostat (u)","id":"25791"},{"source":"breast neoplasms","target":"pembrolizumab","id":"25792"},{"source":"breast neoplasms","target":"UNK : Drug","id":"25793"},{"source":"colonic neoplasms","target":"epacadostat (u)","id":"25794"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"25795"},{"source":"colonic neoplasms","target":"UNK : Drug","id":"25796"},{"source":"carcinoma","target":"epacadostat (u)","id":"25797"},{"source":"carcinoma","target":"pembrolizumab","id":"25798"},{"source":"carcinoma","target":"UNK : Drug","id":"25799"},{"source":"carcinoma","target":"epacadostat (u)","id":"25800"},{"source":"carcinoma","target":"pembrolizumab","id":"25801"},{"source":"carcinoma","target":"UNK : Drug","id":"25802"},{"source":"liver transplants","target":"epacadostat (u)","id":"25803"},{"source":"liver transplants","target":"pembrolizumab","id":"25804"},{"source":"liver transplants","target":"UNK : Drug","id":"25805"},{"source":"sclc","target":"epacadostat (u)","id":"25806"},{"source":"sclc","target":"pembrolizumab","id":"25807"},{"source":"sclc","target":"UNK : Drug","id":"25808"},{"source":"head and neck neoplasms","target":"epacadostat (u)","id":"25809"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"25810"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"25811"},{"source":"carcinoma","target":"epacadostat (u)","id":"25812"},{"source":"carcinoma","target":"pembrolizumab","id":"25813"},{"source":"carcinoma","target":"UNK : Drug","id":"25814"},{"source":"ovarian neoplasms","target":"epacadostat (u)","id":"25815"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"25816"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"25817"},{"source":"renal cell","target":"epacadostat (u)","id":"25818"},{"source":"renal cell","target":"pembrolizumab","id":"25819"},{"source":"renal cell","target":"UNK : Drug","id":"25820"},{"source":"esophageal neoplasms","target":"epacadostat (u)","id":"25821"},{"source":"esophageal neoplasms","target":"pembrolizumab","id":"25822"},{"source":"esophageal neoplasms","target":"UNK : Drug","id":"25823"},{"source":"carcinoma","target":"epacadostat (u)","id":"25824"},{"source":"carcinoma","target":"pembrolizumab","id":"25825"},{"source":"carcinoma","target":"UNK : Drug","id":"25826"},{"source":"urogenital neoplasms","target":"epacadostat (u)","id":"25827"},{"source":"urogenital neoplasms","target":"pembrolizumab","id":"25828"},{"source":"urogenital neoplasms","target":"UNK : Drug","id":"25829"},{"source":"colorectal cancer","target":"epacadostat (u)","id":"25830"},{"source":"colorectal cancer","target":"pembrolizumab","id":"25831"},{"source":"colorectal cancer","target":"UNK : Drug","id":"25832"},{"source":"carcinoma","target":"epacadostat (u)","id":"25833"},{"source":"carcinoma","target":"pembrolizumab","id":"25834"},{"source":"carcinoma","target":"UNK : Drug","id":"25835"},{"source":"tnbc","target":"epacadostat (u)","id":"25836"},{"source":"tnbc","target":"pembrolizumab","id":"25837"},{"source":"tnbc","target":"UNK : Drug","id":"25838"},{"source":"primary peritoneal cancer","target":"epacadostat (u)","id":"25839"},{"source":"primary peritoneal cancer","target":"pembrolizumab","id":"25840"},{"source":"primary peritoneal cancer","target":"UNK : Drug","id":"25841"},{"source":"kidney neoplasms","target":"epacadostat (u)","id":"25842"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"25843"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"25844"},{"source":"peritoneal neoplasms","target":"epacadostat (u)","id":"25845"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"25846"},{"source":"peritoneal neoplasms","target":"UNK : Drug","id":"25847"},{"source":"carcinoma","target":"epacadostat (u)","id":"25848"},{"source":"carcinoma","target":"pembrolizumab","id":"25849"},{"source":"carcinoma","target":"UNK : Drug","id":"25850"},{"source":"non-small-cell lung","target":"epacadostat (u)","id":"25851"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"25852"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"25853"},{"source":"fallopian tube neoplasms","target":"epacadostat (u)","id":"25854"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"25855"},{"source":"fallopian tube neoplasms","target":"UNK : Drug","id":"25856"},{"source":"clear cell","target":"epacadostat (u)","id":"25857"},{"source":"clear cell","target":"pembrolizumab","id":"25858"},{"source":"clear cell","target":"UNK : Drug","id":"25859"},{"source":"carcinoma","target":"epacadostat (u)","id":"25860"},{"source":"carcinoma","target":"pembrolizumab","id":"25861"},{"source":"carcinoma","target":"UNK : Drug","id":"25862"},{"source":"stem cell transplantation","target":"epacadostat (u)","id":"25863"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"25864"},{"source":"stem cell transplantation","target":"UNK : Drug","id":"25865"},{"source":"neoplasm metastasis","target":"epacadostat (u)","id":"25866"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"25867"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"25868"},{"source":"melanoma","target":"epacadostat (u)","id":"25869"},{"source":"melanoma","target":"pembrolizumab","id":"25870"},{"source":"melanoma","target":"UNK : Drug","id":"25871"},{"source":"lymphoma","target":"epacadostat (u)","id":"25872"},{"source":"lymphoma","target":"pembrolizumab","id":"25873"},{"source":"lymphoma","target":"UNK : Drug","id":"25874"},{"source":"anticancer","target":"epacadostat (u)","id":"25875"},{"source":"anticancer","target":"pembrolizumab","id":"25876"},{"source":"anticancer","target":"UNK : Drug","id":"25877"},{"source":"ovarian cancer","target":"epacadostat (u)","id":"25878"},{"source":"ovarian cancer","target":"pembrolizumab","id":"25879"},{"source":"ovarian cancer","target":"UNK : Drug","id":"25880"},{"source":"colorectal neoplasms","target":"epacadostat (u)","id":"25881"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"25882"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"25883"},{"source":"stomach neoplasms","target":"epacadostat (u)","id":"25884"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"25885"},{"source":"stomach neoplasms","target":"UNK : Drug","id":"25886"},{"source":"rcc","target":"epacadostat (u)","id":"25887"},{"source":"rcc","target":"pembrolizumab","id":"25888"},{"source":"rcc","target":"UNK : Drug","id":"25889"},{"source":"hepatocellular","target":"epacadostat (u)","id":"25890"},{"source":"hepatocellular","target":"pembrolizumab","id":"25891"},{"source":"hepatocellular","target":"UNK : Drug","id":"25892"},{"source":"carcinoma","target":"epacadostat (u)","id":"25893"},{"source":"carcinoma","target":"pembrolizumab","id":"25894"},{"source":"carcinoma","target":"UNK : Drug","id":"25895"},{"source":"gastric cancer","target":"epacadostat (u)","id":"25896"},{"source":"gastric cancer","target":"pembrolizumab","id":"25897"},{"source":"gastric cancer","target":"UNK : Drug","id":"25898"},{"source":"liver cancer","target":"epacadostat (u)","id":"25899"},{"source":"liver cancer","target":"pembrolizumab","id":"25900"},{"source":"liver cancer","target":"UNK : Drug","id":"25901"},{"source":"residual tumor","target":"epacadostat (u)","id":"25902"},{"source":"residual tumor","target":"pembrolizumab","id":"25903"},{"source":"residual tumor","target":"UNK : Drug","id":"25904"},{"source":"stem cell transplantation","target":"epacadostat (u)","id":"25905"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"25906"},{"source":"stem cell transplantation","target":"UNK : Drug","id":"25907"},{"source":"carcinoma","target":"epacadostat (u)","id":"25908"},{"source":"carcinoma","target":"pembrolizumab","id":"25909"},{"source":"carcinoma","target":"UNK : Drug","id":"25910"},{"source":"carcinoma","target":"epacadostat (u)","id":"25911"},{"source":"carcinoma","target":"pembrolizumab","id":"25912"},{"source":"carcinoma","target":"UNK : Drug","id":"25913"},{"source":"stem cell transplantation","target":"epacadostat (u)","id":"25914"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"25915"},{"source":"stem cell transplantation","target":"UNK : Drug","id":"25916"},{"source":"metastatic","target":"epacadostat (u)","id":"25917"},{"source":"metastatic","target":"pembrolizumab","id":"25918"},{"source":"metastatic","target":"UNK : Drug","id":"25919"},{"source":"anticancer","target":"epacadostat (u)","id":"25920"},{"source":"anticancer","target":"pembrolizumab","id":"25921"},{"source":"anticancer","target":"UNK : Drug","id":"25922"},{"source":"non-hodgkin","target":"epacadostat (u)","id":"25923"},{"source":"non-hodgkin","target":"pembrolizumab","id":"25924"},{"source":"non-hodgkin","target":"UNK : Drug","id":"25925"},{"source":"renal cancer","target":"epacadostat (u)","id":"25926"},{"source":"renal cancer","target":"pembrolizumab","id":"25927"},{"source":"renal cancer","target":"UNK : Drug","id":"25928"},{"source":"carcinoma","target":"epacadostat (u)","id":"25929"},{"source":"carcinoma","target":"pembrolizumab","id":"25930"},{"source":"carcinoma","target":"UNK : Drug","id":"25931"},{"source":"hepatorenal syndrome","target":"epacadostat (u)","id":"25932"},{"source":"hepatorenal syndrome","target":"pembrolizumab","id":"25933"},{"source":"hepatorenal syndrome","target":"UNK : Drug","id":"25934"},{"source":"urinary bladder neoplasms","target":"epacadostat (u)","id":"25935"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"25936"},{"source":"urinary bladder neoplasms","target":"UNK : Drug","id":"25937"},{"source":"carcinoma","target":"epacadostat (u)","id":"25938"},{"source":"carcinoma","target":"pembrolizumab","id":"25939"},{"source":"carcinoma","target":"UNK : Drug","id":"25940"},{"source":"solid tumors","target":"epacadostat (u)","id":"25941"},{"source":"solid tumors","target":"pembrolizumab","id":"25942"},{"source":"solid tumors","target":"UNK : Drug","id":"25943"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"25944"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"25945"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"25946"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"25947"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"25948"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"25949"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"25950"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"25951"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25952"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"25953"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25954"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"25955"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"25956"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25957"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"25958"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"25959"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"25960"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"25961"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"25962"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"25963"},{"source":"Anticancer immunotherapy","target":"endometrial neoplasms","id":"25964"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25965"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"25966"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"25967"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"25968"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25969"},{"source":"Anticancer immunotherapy","target":"dlbcl","id":"25970"},{"source":"Anticancer immunotherapy","target":"hcc","id":"25971"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"25972"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"25973"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"25974"},{"source":"Anticancer immunotherapy","target":"liver transplants","id":"25975"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25976"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"25977"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"25978"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25979"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25980"},{"source":"Anticancer immunotherapy","target":"liver transplants","id":"25981"},{"source":"Anticancer immunotherapy","target":"sclc","id":"25982"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"25983"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25984"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"25985"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"25986"},{"source":"Anticancer immunotherapy","target":"esophageal neoplasms","id":"25987"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25988"},{"source":"Anticancer immunotherapy","target":"urogenital neoplasms","id":"25989"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"25990"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25991"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"25992"},{"source":"Anticancer immunotherapy","target":"primary peritoneal cancer","id":"25993"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"25994"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"25995"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"25996"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"25997"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"25998"},{"source":"Anticancer immunotherapy","target":"clear cell","id":"25999"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26000"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"26001"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"26002"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"26003"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"26004"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"26005"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"26006"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"26007"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"26008"},{"source":"Anticancer immunotherapy","target":"rcc","id":"26009"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"26010"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26011"},{"source":"Anticancer immunotherapy","target":"gastric cancer","id":"26012"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"26013"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"26014"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"26015"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26016"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26017"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"26018"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"26019"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"26020"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"26021"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"26022"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26023"},{"source":"Anticancer immunotherapy","target":"hepatorenal syndrome","id":"26024"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"26025"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26026"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"26027"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"26028"},{"source":"CD19 antagonist","target":"metastatic","id":"26029"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"26030"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"26031"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"26032"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"26033"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"26034"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"26035"},{"source":"CD19 antagonist","target":"carcinoma","id":"26036"},{"source":"CD19 antagonist","target":"renal cancer","id":"26037"},{"source":"CD19 antagonist","target":"carcinoma","id":"26038"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"26039"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"26040"},{"source":"CD19 antagonist","target":"carcinoma","id":"26041"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"26042"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"26043"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"26044"},{"source":"CD19 antagonist","target":"endometrioid","id":"26045"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"26046"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"26047"},{"source":"CD19 antagonist","target":"endometrial neoplasms","id":"26048"},{"source":"CD19 antagonist","target":"carcinoma","id":"26049"},{"source":"CD19 antagonist","target":"residual tumor","id":"26050"},{"source":"CD19 antagonist","target":"lymphoma","id":"26051"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"26052"},{"source":"CD19 antagonist","target":"carcinoma","id":"26053"},{"source":"CD19 antagonist","target":"dlbcl","id":"26054"},{"source":"CD19 antagonist","target":"hcc","id":"26055"},{"source":"CD19 antagonist","target":"lymphoma","id":"26056"},{"source":"CD19 antagonist","target":"solid tumors","id":"26057"},{"source":"CD19 antagonist","target":"melanoma","id":"26058"},{"source":"CD19 antagonist","target":"liver transplants","id":"26059"},{"source":"CD19 antagonist","target":"carcinoma","id":"26060"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"26061"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"26062"},{"source":"CD19 antagonist","target":"carcinoma","id":"26063"},{"source":"CD19 antagonist","target":"carcinoma","id":"26064"},{"source":"CD19 antagonist","target":"liver transplants","id":"26065"},{"source":"CD19 antagonist","target":"sclc","id":"26066"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"26067"},{"source":"CD19 antagonist","target":"carcinoma","id":"26068"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"26069"},{"source":"CD19 antagonist","target":"renal cell","id":"26070"},{"source":"CD19 antagonist","target":"esophageal neoplasms","id":"26071"},{"source":"CD19 antagonist","target":"carcinoma","id":"26072"},{"source":"CD19 antagonist","target":"urogenital neoplasms","id":"26073"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"26074"},{"source":"CD19 antagonist","target":"carcinoma","id":"26075"},{"source":"CD19 antagonist","target":"tnbc","id":"26076"},{"source":"CD19 antagonist","target":"primary peritoneal cancer","id":"26077"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"26078"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"26079"},{"source":"CD19 antagonist","target":"carcinoma","id":"26080"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"26081"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"26082"},{"source":"CD19 antagonist","target":"clear cell","id":"26083"},{"source":"CD19 antagonist","target":"carcinoma","id":"26084"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"26085"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"26086"},{"source":"CD19 antagonist","target":"melanoma","id":"26087"},{"source":"CD19 antagonist","target":"lymphoma","id":"26088"},{"source":"CD19 antagonist","target":"anticancer","id":"26089"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"26090"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"26091"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"26092"},{"source":"CD19 antagonist","target":"rcc","id":"26093"},{"source":"CD19 antagonist","target":"hepatocellular","id":"26094"},{"source":"CD19 antagonist","target":"carcinoma","id":"26095"},{"source":"CD19 antagonist","target":"gastric cancer","id":"26096"},{"source":"CD19 antagonist","target":"liver cancer","id":"26097"},{"source":"CD19 antagonist","target":"residual tumor","id":"26098"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"26099"},{"source":"CD19 antagonist","target":"carcinoma","id":"26100"},{"source":"CD19 antagonist","target":"carcinoma","id":"26101"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"26102"},{"source":"CD19 antagonist","target":"metastatic","id":"26103"},{"source":"CD19 antagonist","target":"anticancer","id":"26104"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"26105"},{"source":"CD19 antagonist","target":"renal cancer","id":"26106"},{"source":"CD19 antagonist","target":"carcinoma","id":"26107"},{"source":"CD19 antagonist","target":"hepatorenal syndrome","id":"26108"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"26109"},{"source":"CD19 antagonist","target":"carcinoma","id":"26110"},{"source":"CD19 antagonist","target":"solid tumors","id":"26111"},{"source":"Indoleamine-pyrrole 2","target":"UNK : Indication","id":"26112"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"26113"},{"source":"Indoleamine-pyrrole 2","target":"colorectal neoplasms","id":"26114"},{"source":"Indoleamine-pyrrole 2","target":"esophageal cancer","id":"26115"},{"source":"Indoleamine-pyrrole 2","target":"ovarian cancer","id":"26116"},{"source":"Indoleamine-pyrrole 2","target":"pharyngeal neoplasms","id":"26117"},{"source":"Indoleamine-pyrrole 2","target":"ovarian cancer","id":"26118"},{"source":"Indoleamine-pyrrole 2","target":"castration-resistant prostatic neoplasms","id":"26119"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26120"},{"source":"Indoleamine-pyrrole 2","target":"renal cancer","id":"26121"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26122"},{"source":"Indoleamine-pyrrole 2","target":"squamous cell neoplasms","id":"26123"},{"source":"Indoleamine-pyrrole 2","target":"glandular and epithelial","id":"26124"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26125"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"26126"},{"source":"Indoleamine-pyrrole 2","target":"breast neoplasms","id":"26127"},{"source":"Indoleamine-pyrrole 2","target":"triple-negative breast cancer","id":"26128"},{"source":"Indoleamine-pyrrole 2","target":"endometrioid","id":"26129"},{"source":"Indoleamine-pyrrole 2","target":"skin neoplasms","id":"26130"},{"source":"Indoleamine-pyrrole 2","target":"liver neoplasms","id":"26131"},{"source":"Indoleamine-pyrrole 2","target":"endometrial neoplasms","id":"26132"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26133"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"26134"},{"source":"Indoleamine-pyrrole 2","target":"lymphoma","id":"26135"},{"source":"Indoleamine-pyrrole 2","target":"stem cell transplantation","id":"26136"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26137"},{"source":"Indoleamine-pyrrole 2","target":"dlbcl","id":"26138"},{"source":"Indoleamine-pyrrole 2","target":"hcc","id":"26139"},{"source":"Indoleamine-pyrrole 2","target":"lymphoma","id":"26140"},{"source":"Indoleamine-pyrrole 2","target":"solid tumors","id":"26141"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"26142"},{"source":"Indoleamine-pyrrole 2","target":"liver transplants","id":"26143"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26144"},{"source":"Indoleamine-pyrrole 2","target":"breast neoplasms","id":"26145"},{"source":"Indoleamine-pyrrole 2","target":"colonic neoplasms","id":"26146"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26147"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26148"},{"source":"Indoleamine-pyrrole 2","target":"liver transplants","id":"26149"},{"source":"Indoleamine-pyrrole 2","target":"sclc","id":"26150"},{"source":"Indoleamine-pyrrole 2","target":"head and neck neoplasms","id":"26151"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26152"},{"source":"Indoleamine-pyrrole 2","target":"ovarian neoplasms","id":"26153"},{"source":"Indoleamine-pyrrole 2","target":"renal cell","id":"26154"},{"source":"Indoleamine-pyrrole 2","target":"esophageal neoplasms","id":"26155"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26156"},{"source":"Indoleamine-pyrrole 2","target":"urogenital neoplasms","id":"26157"},{"source":"Indoleamine-pyrrole 2","target":"colorectal cancer","id":"26158"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26159"},{"source":"Indoleamine-pyrrole 2","target":"tnbc","id":"26160"},{"source":"Indoleamine-pyrrole 2","target":"primary peritoneal cancer","id":"26161"},{"source":"Indoleamine-pyrrole 2","target":"kidney neoplasms","id":"26162"},{"source":"Indoleamine-pyrrole 2","target":"peritoneal neoplasms","id":"26163"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26164"},{"source":"Indoleamine-pyrrole 2","target":"non-small-cell lung","id":"26165"},{"source":"Indoleamine-pyrrole 2","target":"fallopian tube neoplasms","id":"26166"},{"source":"Indoleamine-pyrrole 2","target":"clear cell","id":"26167"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26168"},{"source":"Indoleamine-pyrrole 2","target":"stem cell transplantation","id":"26169"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"26170"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"26171"},{"source":"Indoleamine-pyrrole 2","target":"lymphoma","id":"26172"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"26173"},{"source":"Indoleamine-pyrrole 2","target":"ovarian cancer","id":"26174"},{"source":"Indoleamine-pyrrole 2","target":"colorectal neoplasms","id":"26175"},{"source":"Indoleamine-pyrrole 2","target":"stomach neoplasms","id":"26176"},{"source":"Indoleamine-pyrrole 2","target":"rcc","id":"26177"},{"source":"Indoleamine-pyrrole 2","target":"hepatocellular","id":"26178"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26179"},{"source":"Indoleamine-pyrrole 2","target":"gastric cancer","id":"26180"},{"source":"Indoleamine-pyrrole 2","target":"liver cancer","id":"26181"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"26182"},{"source":"Indoleamine-pyrrole 2","target":"stem cell transplantation","id":"26183"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26184"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26185"},{"source":"Indoleamine-pyrrole 2","target":"stem cell transplantation","id":"26186"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"26187"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"26188"},{"source":"Indoleamine-pyrrole 2","target":"non-hodgkin","id":"26189"},{"source":"Indoleamine-pyrrole 2","target":"renal cancer","id":"26190"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26191"},{"source":"Indoleamine-pyrrole 2","target":"hepatorenal syndrome","id":"26192"},{"source":"Indoleamine-pyrrole 2","target":"urinary bladder neoplasms","id":"26193"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"26194"},{"source":"Indoleamine-pyrrole 2","target":"solid tumors","id":"26195"},{"source":"NA","target":"UNK : Indication","id":"26196"},{"source":"NA","target":"metastatic","id":"26197"},{"source":"NA","target":"colorectal neoplasms","id":"26198"},{"source":"NA","target":"esophageal cancer","id":"26199"},{"source":"NA","target":"ovarian cancer","id":"26200"},{"source":"NA","target":"pharyngeal neoplasms","id":"26201"},{"source":"NA","target":"ovarian cancer","id":"26202"},{"source":"NA","target":"castration-resistant prostatic neoplasms","id":"26203"},{"source":"NA","target":"carcinoma","id":"26204"},{"source":"NA","target":"renal cancer","id":"26205"},{"source":"NA","target":"carcinoma","id":"26206"},{"source":"NA","target":"squamous cell neoplasms","id":"26207"},{"source":"NA","target":"glandular and epithelial","id":"26208"},{"source":"NA","target":"carcinoma","id":"26209"},{"source":"NA","target":"non-small-cell lung","id":"26210"},{"source":"NA","target":"breast neoplasms","id":"26211"},{"source":"NA","target":"triple-negative breast cancer","id":"26212"},{"source":"NA","target":"endometrioid","id":"26213"},{"source":"NA","target":"skin neoplasms","id":"26214"},{"source":"NA","target":"liver neoplasms","id":"26215"},{"source":"NA","target":"endometrial neoplasms","id":"26216"},{"source":"NA","target":"carcinoma","id":"26217"},{"source":"NA","target":"residual tumor","id":"26218"},{"source":"NA","target":"lymphoma","id":"26219"},{"source":"NA","target":"stem cell transplantation","id":"26220"},{"source":"NA","target":"carcinoma","id":"26221"},{"source":"NA","target":"dlbcl","id":"26222"},{"source":"NA","target":"hcc","id":"26223"},{"source":"NA","target":"lymphoma","id":"26224"},{"source":"NA","target":"solid tumors","id":"26225"},{"source":"NA","target":"melanoma","id":"26226"},{"source":"NA","target":"liver transplants","id":"26227"},{"source":"NA","target":"carcinoma","id":"26228"},{"source":"NA","target":"breast neoplasms","id":"26229"},{"source":"NA","target":"colonic neoplasms","id":"26230"},{"source":"NA","target":"carcinoma","id":"26231"},{"source":"NA","target":"carcinoma","id":"26232"},{"source":"NA","target":"liver transplants","id":"26233"},{"source":"NA","target":"sclc","id":"26234"},{"source":"NA","target":"head and neck neoplasms","id":"26235"},{"source":"NA","target":"carcinoma","id":"26236"},{"source":"NA","target":"ovarian neoplasms","id":"26237"},{"source":"NA","target":"renal cell","id":"26238"},{"source":"NA","target":"esophageal neoplasms","id":"26239"},{"source":"NA","target":"carcinoma","id":"26240"},{"source":"NA","target":"urogenital neoplasms","id":"26241"},{"source":"NA","target":"colorectal cancer","id":"26242"},{"source":"NA","target":"carcinoma","id":"26243"},{"source":"NA","target":"tnbc","id":"26244"},{"source":"NA","target":"primary peritoneal cancer","id":"26245"},{"source":"NA","target":"kidney neoplasms","id":"26246"},{"source":"NA","target":"peritoneal neoplasms","id":"26247"},{"source":"NA","target":"carcinoma","id":"26248"},{"source":"NA","target":"non-small-cell lung","id":"26249"},{"source":"NA","target":"fallopian tube neoplasms","id":"26250"},{"source":"NA","target":"clear cell","id":"26251"},{"source":"NA","target":"carcinoma","id":"26252"},{"source":"NA","target":"stem cell transplantation","id":"26253"},{"source":"NA","target":"neoplasm metastasis","id":"26254"},{"source":"NA","target":"melanoma","id":"26255"},{"source":"NA","target":"lymphoma","id":"26256"},{"source":"NA","target":"anticancer","id":"26257"},{"source":"NA","target":"ovarian cancer","id":"26258"},{"source":"NA","target":"colorectal neoplasms","id":"26259"},{"source":"NA","target":"stomach neoplasms","id":"26260"},{"source":"NA","target":"rcc","id":"26261"},{"source":"NA","target":"hepatocellular","id":"26262"},{"source":"NA","target":"carcinoma","id":"26263"},{"source":"NA","target":"gastric cancer","id":"26264"},{"source":"NA","target":"liver cancer","id":"26265"},{"source":"NA","target":"residual tumor","id":"26266"},{"source":"NA","target":"stem cell transplantation","id":"26267"},{"source":"NA","target":"carcinoma","id":"26268"},{"source":"NA","target":"carcinoma","id":"26269"},{"source":"NA","target":"stem cell transplantation","id":"26270"},{"source":"NA","target":"metastatic","id":"26271"},{"source":"NA","target":"anticancer","id":"26272"},{"source":"NA","target":"non-hodgkin","id":"26273"},{"source":"NA","target":"renal cancer","id":"26274"},{"source":"NA","target":"carcinoma","id":"26275"},{"source":"NA","target":"hepatorenal syndrome","id":"26276"},{"source":"NA","target":"urinary bladder neoplasms","id":"26277"},{"source":"NA","target":"carcinoma","id":"26278"},{"source":"NA","target":"solid tumors","id":"26279"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"26280"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"26281"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"26282"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"26283"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"26284"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"26285"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"26286"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"26287"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26288"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"26289"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26290"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"26291"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"26292"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26293"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"26294"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"26295"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"26296"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"26297"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"26298"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"26299"},{"source":"Immune checkpoint inhibitor","target":"endometrial neoplasms","id":"26300"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26301"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"26302"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"26303"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"26304"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26305"},{"source":"Immune checkpoint inhibitor","target":"dlbcl","id":"26306"},{"source":"Immune checkpoint inhibitor","target":"hcc","id":"26307"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"26308"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"26309"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"26310"},{"source":"Immune checkpoint inhibitor","target":"liver transplants","id":"26311"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26312"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"26313"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"26314"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26315"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26316"},{"source":"Immune checkpoint inhibitor","target":"liver transplants","id":"26317"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"26318"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"26319"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26320"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"26321"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"26322"},{"source":"Immune checkpoint inhibitor","target":"esophageal neoplasms","id":"26323"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26324"},{"source":"Immune checkpoint inhibitor","target":"urogenital neoplasms","id":"26325"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"26326"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26327"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"26328"},{"source":"Immune checkpoint inhibitor","target":"primary peritoneal cancer","id":"26329"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"26330"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"26331"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26332"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"26333"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"26334"},{"source":"Immune checkpoint inhibitor","target":"clear cell","id":"26335"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26336"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"26337"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"26338"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"26339"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"26340"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"26341"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"26342"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"26343"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"26344"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"26345"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"26346"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26347"},{"source":"Immune checkpoint inhibitor","target":"gastric cancer","id":"26348"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"26349"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"26350"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"26351"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26352"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26353"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"26354"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"26355"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"26356"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"26357"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"26358"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26359"},{"source":"Immune checkpoint inhibitor","target":"hepatorenal syndrome","id":"26360"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"26361"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26362"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"26363"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"26364"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"26365"},{"source":"Oncology: (N/A)","target":"Indoleamine-pyrrole 2","id":"26366"},{"source":"Oncology: (N/A)","target":"NA","id":"26367"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"26368"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"26369"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"26370"},{"source":"Oncology: Bladder","target":"Indoleamine-pyrrole 2","id":"26371"},{"source":"Oncology: Bladder","target":"NA","id":"26372"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"26373"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"26374"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"26375"},{"source":"Oncology: Breast","target":"Indoleamine-pyrrole 2","id":"26376"},{"source":"Oncology: Breast","target":"NA","id":"26377"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"26378"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"26379"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"26380"},{"source":"Oncology: Colorectal","target":"Indoleamine-pyrrole 2","id":"26381"},{"source":"Oncology: Colorectal","target":"NA","id":"26382"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"26383"},{"source":"Oncology: Endometrial","target":"Anticancer immunotherapy","id":"26384"},{"source":"Oncology: Endometrial","target":"CD19 antagonist","id":"26385"},{"source":"Oncology: Endometrial","target":"Indoleamine-pyrrole 2","id":"26386"},{"source":"Oncology: Endometrial","target":"NA","id":"26387"},{"source":"Oncology: Endometrial","target":"Immune checkpoint inhibitor","id":"26388"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"26389"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"26390"},{"source":"Oncology: Esophageal","target":"Indoleamine-pyrrole 2","id":"26391"},{"source":"Oncology: Esophageal","target":"NA","id":"26392"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"26393"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"26394"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"26395"},{"source":"Oncology: Gastric","target":"Indoleamine-pyrrole 2","id":"26396"},{"source":"Oncology: Gastric","target":"NA","id":"26397"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"26398"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"26399"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"26400"},{"source":"Oncology: Head/Neck","target":"Indoleamine-pyrrole 2","id":"26401"},{"source":"Oncology: Head/Neck","target":"NA","id":"26402"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"26403"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"26404"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"26405"},{"source":"Oncology: Liver","target":"Indoleamine-pyrrole 2","id":"26406"},{"source":"Oncology: Liver","target":"NA","id":"26407"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"26408"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"26409"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"26410"},{"source":"Oncology: Lung","target":"Indoleamine-pyrrole 2","id":"26411"},{"source":"Oncology: Lung","target":"NA","id":"26412"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"26413"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"26414"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"26415"},{"source":"Non-Small Cell","target":"Indoleamine-pyrrole 2","id":"26416"},{"source":"Non-Small Cell","target":"NA","id":"26417"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"26418"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"26419"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"26420"},{"source":"Oncology: Lymphoma","target":"Indoleamine-pyrrole 2","id":"26421"},{"source":"Oncology: Lymphoma","target":"NA","id":"26422"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"26423"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"26424"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"26425"},{"source":"Hodgkin's","target":"Indoleamine-pyrrole 2","id":"26426"},{"source":"Hodgkin's","target":"NA","id":"26427"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"26428"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"26429"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"26430"},{"source":"Oncology: Melanoma","target":"Indoleamine-pyrrole 2","id":"26431"},{"source":"Oncology: Melanoma","target":"NA","id":"26432"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"26433"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"26434"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"26435"},{"source":"Oncology: Ovarian","target":"Indoleamine-pyrrole 2","id":"26436"},{"source":"Oncology: Ovarian","target":"NA","id":"26437"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"26438"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"26439"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"26440"},{"source":"Oncology: Prostate","target":"Indoleamine-pyrrole 2","id":"26441"},{"source":"Oncology: Prostate","target":"NA","id":"26442"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"26443"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"26444"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"26445"},{"source":"Oncology: Renal","target":"Indoleamine-pyrrole 2","id":"26446"},{"source":"Oncology: Renal","target":"NA","id":"26447"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"26448"},{"source":"AGEN-1884 (u)","target":"Agenus {Antigenics}","id":"26449"},{"source":"pembrolizumab","target":"Agenus {Antigenics}","id":"26450"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26451"},{"source":"carcinoma","target":"pembrolizumab","id":"26452"},{"source":"squamous cell neoplasms","target":"AGEN-1884 (u)","id":"26453"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"26454"},{"source":"non-small-cell lung","target":"AGEN-1884 (u)","id":"26455"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"26456"},{"source":"uterine cervical neoplasms","target":"AGEN-1884 (u)","id":"26457"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"26458"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26459"},{"source":"carcinoma","target":"pembrolizumab","id":"26460"},{"source":"non-small-cell lung","target":"AGEN-1884 (u)","id":"26461"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"26462"},{"source":"bladder cancer","target":"AGEN-1884 (u)","id":"26463"},{"source":"bladder cancer","target":"pembrolizumab","id":"26464"},{"source":"amenorrheic","target":"AGEN-1884 (u)","id":"26465"},{"source":"amenorrheic","target":"pembrolizumab","id":"26466"},{"source":"sclc","target":"AGEN-1884 (u)","id":"26467"},{"source":"sclc","target":"pembrolizumab","id":"26468"},{"source":"cervical cancer","target":"AGEN-1884 (u)","id":"26469"},{"source":"cervical cancer","target":"pembrolizumab","id":"26470"},{"source":"basal cell neoplasms","target":"AGEN-1884 (u)","id":"26471"},{"source":"basal cell neoplasms","target":"pembrolizumab","id":"26472"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26473"},{"source":"carcinoma","target":"pembrolizumab","id":"26474"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26475"},{"source":"carcinoma","target":"pembrolizumab","id":"26476"},{"source":"metastatic","target":"AGEN-1884 (u)","id":"26477"},{"source":"metastatic","target":"pembrolizumab","id":"26478"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26479"},{"source":"carcinoma","target":"pembrolizumab","id":"26480"},{"source":"neoplasm metastasis","target":"AGEN-1884 (u)","id":"26481"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"26482"},{"source":"solid malignancy","target":"AGEN-1884 (u)","id":"26483"},{"source":"solid malignancy","target":"pembrolizumab","id":"26484"},{"source":"skin neoplasms","target":"AGEN-1884 (u)","id":"26485"},{"source":"skin neoplasms","target":"pembrolizumab","id":"26486"},{"source":"residual tumor","target":"AGEN-1884 (u)","id":"26487"},{"source":"residual tumor","target":"pembrolizumab","id":"26488"},{"source":"amenorrheic","target":"AGEN-1884 (u)","id":"26489"},{"source":"amenorrheic","target":"pembrolizumab","id":"26490"},{"source":"non-small-cell lung","target":"AGEN-1884 (u)","id":"26491"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"26492"},{"source":"anticancer","target":"AGEN-1884 (u)","id":"26493"},{"source":"anticancer","target":"pembrolizumab","id":"26494"},{"source":"urinary bladder neoplasms","target":"AGEN-1884 (u)","id":"26495"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"26496"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26497"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"26498"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"26499"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"26500"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26501"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"26502"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"26503"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"26504"},{"source":"Anticancer immunotherapy","target":"sclc","id":"26505"},{"source":"Anticancer immunotherapy","target":"cervical cancer","id":"26506"},{"source":"Anticancer immunotherapy","target":"basal cell neoplasms","id":"26507"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26508"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26509"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"26510"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26511"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"26512"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"26513"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"26514"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"26515"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"26516"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"26517"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"26518"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"26519"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26520"},{"source":"CTLA4 antagonist","target":"squamous cell neoplasms","id":"26521"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"26522"},{"source":"CTLA4 antagonist","target":"uterine cervical neoplasms","id":"26523"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26524"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"26525"},{"source":"CTLA4 antagonist","target":"bladder cancer","id":"26526"},{"source":"CTLA4 antagonist","target":"amenorrheic","id":"26527"},{"source":"CTLA4 antagonist","target":"sclc","id":"26528"},{"source":"CTLA4 antagonist","target":"cervical cancer","id":"26529"},{"source":"CTLA4 antagonist","target":"basal cell neoplasms","id":"26530"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26531"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26532"},{"source":"CTLA4 antagonist","target":"metastatic","id":"26533"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26534"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"26535"},{"source":"CTLA4 antagonist","target":"solid malignancy","id":"26536"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"26537"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"26538"},{"source":"CTLA4 antagonist","target":"amenorrheic","id":"26539"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"26540"},{"source":"CTLA4 antagonist","target":"anticancer","id":"26541"},{"source":"CTLA4 antagonist","target":"urinary bladder neoplasms","id":"26542"},{"source":"Immunostimulant","target":"carcinoma","id":"26543"},{"source":"Immunostimulant","target":"squamous cell neoplasms","id":"26544"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"26545"},{"source":"Immunostimulant","target":"uterine cervical neoplasms","id":"26546"},{"source":"Immunostimulant","target":"carcinoma","id":"26547"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"26548"},{"source":"Immunostimulant","target":"bladder cancer","id":"26549"},{"source":"Immunostimulant","target":"amenorrheic","id":"26550"},{"source":"Immunostimulant","target":"sclc","id":"26551"},{"source":"Immunostimulant","target":"cervical cancer","id":"26552"},{"source":"Immunostimulant","target":"basal cell neoplasms","id":"26553"},{"source":"Immunostimulant","target":"carcinoma","id":"26554"},{"source":"Immunostimulant","target":"carcinoma","id":"26555"},{"source":"Immunostimulant","target":"metastatic","id":"26556"},{"source":"Immunostimulant","target":"carcinoma","id":"26557"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"26558"},{"source":"Immunostimulant","target":"solid malignancy","id":"26559"},{"source":"Immunostimulant","target":"skin neoplasms","id":"26560"},{"source":"Immunostimulant","target":"residual tumor","id":"26561"},{"source":"Immunostimulant","target":"amenorrheic","id":"26562"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"26563"},{"source":"Immunostimulant","target":"anticancer","id":"26564"},{"source":"Immunostimulant","target":"urinary bladder neoplasms","id":"26565"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26566"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"26567"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"26568"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"26569"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26570"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"26571"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"26572"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"26573"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"26574"},{"source":"Immune checkpoint inhibitor","target":"cervical cancer","id":"26575"},{"source":"Immune checkpoint inhibitor","target":"basal cell neoplasms","id":"26576"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26577"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26578"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"26579"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26580"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"26581"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"26582"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"26583"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"26584"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"26585"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"26586"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"26587"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"26588"},{"source":"CD19 antagonist","target":"carcinoma","id":"26589"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"26590"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"26591"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"26592"},{"source":"CD19 antagonist","target":"carcinoma","id":"26593"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"26594"},{"source":"CD19 antagonist","target":"bladder cancer","id":"26595"},{"source":"CD19 antagonist","target":"amenorrheic","id":"26596"},{"source":"CD19 antagonist","target":"sclc","id":"26597"},{"source":"CD19 antagonist","target":"cervical cancer","id":"26598"},{"source":"CD19 antagonist","target":"basal cell neoplasms","id":"26599"},{"source":"CD19 antagonist","target":"carcinoma","id":"26600"},{"source":"CD19 antagonist","target":"carcinoma","id":"26601"},{"source":"CD19 antagonist","target":"metastatic","id":"26602"},{"source":"CD19 antagonist","target":"carcinoma","id":"26603"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"26604"},{"source":"CD19 antagonist","target":"solid malignancy","id":"26605"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"26606"},{"source":"CD19 antagonist","target":"residual tumor","id":"26607"},{"source":"CD19 antagonist","target":"amenorrheic","id":"26608"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"26609"},{"source":"CD19 antagonist","target":"anticancer","id":"26610"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"26611"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"26612"},{"source":"Oncology: Lung","target":"CTLA4 antagonist","id":"26613"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"26614"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"26615"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"26616"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"26617"},{"source":"Non-Small Cell","target":"CTLA4 antagonist","id":"26618"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"26619"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"26620"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"26621"},{"source":"AGEN-1884 (u)","target":"Agenus {Antigenics}","id":"26622"},{"source":"pembrolizumab","target":"Agenus {Antigenics}","id":"26623"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26624"},{"source":"carcinoma","target":"pembrolizumab","id":"26625"},{"source":"squamous cell neoplasms","target":"AGEN-1884 (u)","id":"26626"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"26627"},{"source":"non-small-cell lung","target":"AGEN-1884 (u)","id":"26628"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"26629"},{"source":"uterine cervical neoplasms","target":"AGEN-1884 (u)","id":"26630"},{"source":"uterine cervical neoplasms","target":"pembrolizumab","id":"26631"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26632"},{"source":"carcinoma","target":"pembrolizumab","id":"26633"},{"source":"non-small-cell lung","target":"AGEN-1884 (u)","id":"26634"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"26635"},{"source":"bladder cancer","target":"AGEN-1884 (u)","id":"26636"},{"source":"bladder cancer","target":"pembrolizumab","id":"26637"},{"source":"amenorrheic","target":"AGEN-1884 (u)","id":"26638"},{"source":"amenorrheic","target":"pembrolizumab","id":"26639"},{"source":"sclc","target":"AGEN-1884 (u)","id":"26640"},{"source":"sclc","target":"pembrolizumab","id":"26641"},{"source":"cervical cancer","target":"AGEN-1884 (u)","id":"26642"},{"source":"cervical cancer","target":"pembrolizumab","id":"26643"},{"source":"basal cell neoplasms","target":"AGEN-1884 (u)","id":"26644"},{"source":"basal cell neoplasms","target":"pembrolizumab","id":"26645"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26646"},{"source":"carcinoma","target":"pembrolizumab","id":"26647"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26648"},{"source":"carcinoma","target":"pembrolizumab","id":"26649"},{"source":"metastatic","target":"AGEN-1884 (u)","id":"26650"},{"source":"metastatic","target":"pembrolizumab","id":"26651"},{"source":"carcinoma","target":"AGEN-1884 (u)","id":"26652"},{"source":"carcinoma","target":"pembrolizumab","id":"26653"},{"source":"neoplasm metastasis","target":"AGEN-1884 (u)","id":"26654"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"26655"},{"source":"solid malignancy","target":"AGEN-1884 (u)","id":"26656"},{"source":"solid malignancy","target":"pembrolizumab","id":"26657"},{"source":"skin neoplasms","target":"AGEN-1884 (u)","id":"26658"},{"source":"skin neoplasms","target":"pembrolizumab","id":"26659"},{"source":"residual tumor","target":"AGEN-1884 (u)","id":"26660"},{"source":"residual tumor","target":"pembrolizumab","id":"26661"},{"source":"amenorrheic","target":"AGEN-1884 (u)","id":"26662"},{"source":"amenorrheic","target":"pembrolizumab","id":"26663"},{"source":"non-small-cell lung","target":"AGEN-1884 (u)","id":"26664"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"26665"},{"source":"anticancer","target":"AGEN-1884 (u)","id":"26666"},{"source":"anticancer","target":"pembrolizumab","id":"26667"},{"source":"urinary bladder neoplasms","target":"AGEN-1884 (u)","id":"26668"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"26669"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26670"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"26671"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"26672"},{"source":"Anticancer immunotherapy","target":"uterine cervical neoplasms","id":"26673"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26674"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"26675"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"26676"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"26677"},{"source":"Anticancer immunotherapy","target":"sclc","id":"26678"},{"source":"Anticancer immunotherapy","target":"cervical cancer","id":"26679"},{"source":"Anticancer immunotherapy","target":"basal cell neoplasms","id":"26680"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26681"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26682"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"26683"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26684"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"26685"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"26686"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"26687"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"26688"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"26689"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"26690"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"26691"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"26692"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26693"},{"source":"CTLA4 antagonist","target":"squamous cell neoplasms","id":"26694"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"26695"},{"source":"CTLA4 antagonist","target":"uterine cervical neoplasms","id":"26696"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26697"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"26698"},{"source":"CTLA4 antagonist","target":"bladder cancer","id":"26699"},{"source":"CTLA4 antagonist","target":"amenorrheic","id":"26700"},{"source":"CTLA4 antagonist","target":"sclc","id":"26701"},{"source":"CTLA4 antagonist","target":"cervical cancer","id":"26702"},{"source":"CTLA4 antagonist","target":"basal cell neoplasms","id":"26703"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26704"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26705"},{"source":"CTLA4 antagonist","target":"metastatic","id":"26706"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"26707"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"26708"},{"source":"CTLA4 antagonist","target":"solid malignancy","id":"26709"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"26710"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"26711"},{"source":"CTLA4 antagonist","target":"amenorrheic","id":"26712"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"26713"},{"source":"CTLA4 antagonist","target":"anticancer","id":"26714"},{"source":"CTLA4 antagonist","target":"urinary bladder neoplasms","id":"26715"},{"source":"Immunostimulant","target":"carcinoma","id":"26716"},{"source":"Immunostimulant","target":"squamous cell neoplasms","id":"26717"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"26718"},{"source":"Immunostimulant","target":"uterine cervical neoplasms","id":"26719"},{"source":"Immunostimulant","target":"carcinoma","id":"26720"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"26721"},{"source":"Immunostimulant","target":"bladder cancer","id":"26722"},{"source":"Immunostimulant","target":"amenorrheic","id":"26723"},{"source":"Immunostimulant","target":"sclc","id":"26724"},{"source":"Immunostimulant","target":"cervical cancer","id":"26725"},{"source":"Immunostimulant","target":"basal cell neoplasms","id":"26726"},{"source":"Immunostimulant","target":"carcinoma","id":"26727"},{"source":"Immunostimulant","target":"carcinoma","id":"26728"},{"source":"Immunostimulant","target":"metastatic","id":"26729"},{"source":"Immunostimulant","target":"carcinoma","id":"26730"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"26731"},{"source":"Immunostimulant","target":"solid malignancy","id":"26732"},{"source":"Immunostimulant","target":"skin neoplasms","id":"26733"},{"source":"Immunostimulant","target":"residual tumor","id":"26734"},{"source":"Immunostimulant","target":"amenorrheic","id":"26735"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"26736"},{"source":"Immunostimulant","target":"anticancer","id":"26737"},{"source":"Immunostimulant","target":"urinary bladder neoplasms","id":"26738"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26739"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"26740"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"26741"},{"source":"Immune checkpoint inhibitor","target":"uterine cervical neoplasms","id":"26742"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26743"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"26744"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"26745"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"26746"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"26747"},{"source":"Immune checkpoint inhibitor","target":"cervical cancer","id":"26748"},{"source":"Immune checkpoint inhibitor","target":"basal cell neoplasms","id":"26749"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26750"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26751"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"26752"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26753"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"26754"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"26755"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"26756"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"26757"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"26758"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"26759"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"26760"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"26761"},{"source":"CD19 antagonist","target":"carcinoma","id":"26762"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"26763"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"26764"},{"source":"CD19 antagonist","target":"uterine cervical neoplasms","id":"26765"},{"source":"CD19 antagonist","target":"carcinoma","id":"26766"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"26767"},{"source":"CD19 antagonist","target":"bladder cancer","id":"26768"},{"source":"CD19 antagonist","target":"amenorrheic","id":"26769"},{"source":"CD19 antagonist","target":"sclc","id":"26770"},{"source":"CD19 antagonist","target":"cervical cancer","id":"26771"},{"source":"CD19 antagonist","target":"basal cell neoplasms","id":"26772"},{"source":"CD19 antagonist","target":"carcinoma","id":"26773"},{"source":"CD19 antagonist","target":"carcinoma","id":"26774"},{"source":"CD19 antagonist","target":"metastatic","id":"26775"},{"source":"CD19 antagonist","target":"carcinoma","id":"26776"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"26777"},{"source":"CD19 antagonist","target":"solid malignancy","id":"26778"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"26779"},{"source":"CD19 antagonist","target":"residual tumor","id":"26780"},{"source":"CD19 antagonist","target":"amenorrheic","id":"26781"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"26782"},{"source":"CD19 antagonist","target":"anticancer","id":"26783"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"26784"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"26785"},{"source":"Oncology: Lung","target":"CTLA4 antagonist","id":"26786"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"26787"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"26788"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"26789"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"26790"},{"source":"Non-Small Cell","target":"CTLA4 antagonist","id":"26791"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"26792"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"26793"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"26794"},{"source":"nivolumab (a)","target":"Teclison/Cheery Pharma","id":"26795"},{"source":"pembrolizumab","target":"Teclison/Cheery Pharma","id":"26796"},{"source":"tirapazamine (intra-arterial) (u)","target":"Teclison/Cheery Pharma","id":"26797"},{"source":"Gelfoam","target":"Teclison/Cheery Pharma","id":"26798"},{"source":"Lipiodol","target":"Teclison/Cheery Pharma","id":"26799"},{"source":"UNK : Indication","target":"nivolumab (a)","id":"26800"},{"source":"UNK : Indication","target":"pembrolizumab","id":"26801"},{"source":"UNK : Indication","target":"tirapazamine (intra-arterial) (u)","id":"26802"},{"source":"UNK : Indication","target":"Gelfoam","id":"26803"},{"source":"UNK : Indication","target":"Lipiodol","id":"26804"},{"source":"colorectal neoplasms","target":"nivolumab (a)","id":"26805"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"26806"},{"source":"colorectal neoplasms","target":"tirapazamine (intra-arterial) (u)","id":"26807"},{"source":"colorectal neoplasms","target":"Gelfoam","id":"26808"},{"source":"colorectal neoplasms","target":"Lipiodol","id":"26809"},{"source":"hepatocellular","target":"nivolumab (a)","id":"26810"},{"source":"hepatocellular","target":"pembrolizumab","id":"26811"},{"source":"hepatocellular","target":"tirapazamine (intra-arterial) (u)","id":"26812"},{"source":"hepatocellular","target":"Gelfoam","id":"26813"},{"source":"hepatocellular","target":"Lipiodol","id":"26814"},{"source":"colorectal cancer","target":"nivolumab (a)","id":"26815"},{"source":"colorectal cancer","target":"pembrolizumab","id":"26816"},{"source":"colorectal cancer","target":"tirapazamine (intra-arterial) (u)","id":"26817"},{"source":"colorectal cancer","target":"Gelfoam","id":"26818"},{"source":"colorectal cancer","target":"Lipiodol","id":"26819"},{"source":"necrosis","target":"nivolumab (a)","id":"26820"},{"source":"necrosis","target":"pembrolizumab","id":"26821"},{"source":"necrosis","target":"tirapazamine (intra-arterial) (u)","id":"26822"},{"source":"necrosis","target":"Gelfoam","id":"26823"},{"source":"necrosis","target":"Lipiodol","id":"26824"},{"source":"liver tumor","target":"nivolumab (a)","id":"26825"},{"source":"liver tumor","target":"pembrolizumab","id":"26826"},{"source":"liver tumor","target":"tirapazamine (intra-arterial) (u)","id":"26827"},{"source":"liver tumor","target":"Gelfoam","id":"26828"},{"source":"liver tumor","target":"Lipiodol","id":"26829"},{"source":"residual tumor","target":"nivolumab (a)","id":"26830"},{"source":"residual tumor","target":"pembrolizumab","id":"26831"},{"source":"residual tumor","target":"tirapazamine (intra-arterial) (u)","id":"26832"},{"source":"residual tumor","target":"Gelfoam","id":"26833"},{"source":"residual tumor","target":"Lipiodol","id":"26834"},{"source":"hcc","target":"nivolumab (a)","id":"26835"},{"source":"hcc","target":"pembrolizumab","id":"26836"},{"source":"hcc","target":"tirapazamine (intra-arterial) (u)","id":"26837"},{"source":"hcc","target":"Gelfoam","id":"26838"},{"source":"hcc","target":"Lipiodol","id":"26839"},{"source":"colonic neoplasms","target":"nivolumab (a)","id":"26840"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"26841"},{"source":"colonic neoplasms","target":"tirapazamine (intra-arterial) (u)","id":"26842"},{"source":"colonic neoplasms","target":"Gelfoam","id":"26843"},{"source":"colonic neoplasms","target":"Lipiodol","id":"26844"},{"source":"liver diseases","target":"nivolumab (a)","id":"26845"},{"source":"liver diseases","target":"pembrolizumab","id":"26846"},{"source":"liver diseases","target":"tirapazamine (intra-arterial) (u)","id":"26847"},{"source":"liver diseases","target":"Gelfoam","id":"26848"},{"source":"liver diseases","target":"Lipiodol","id":"26849"},{"source":"carcinoma","target":"nivolumab (a)","id":"26850"},{"source":"carcinoma","target":"pembrolizumab","id":"26851"},{"source":"carcinoma","target":"tirapazamine (intra-arterial) (u)","id":"26852"},{"source":"carcinoma","target":"Gelfoam","id":"26853"},{"source":"carcinoma","target":"Lipiodol","id":"26854"},{"source":"anti-tumor","target":"nivolumab (a)","id":"26855"},{"source":"anti-tumor","target":"pembrolizumab","id":"26856"},{"source":"anti-tumor","target":"tirapazamine (intra-arterial) (u)","id":"26857"},{"source":"anti-tumor","target":"Gelfoam","id":"26858"},{"source":"anti-tumor","target":"Lipiodol","id":"26859"},{"source":"metastatic","target":"nivolumab (a)","id":"26860"},{"source":"metastatic","target":"pembrolizumab","id":"26861"},{"source":"metastatic","target":"tirapazamine (intra-arterial) (u)","id":"26862"},{"source":"metastatic","target":"Gelfoam","id":"26863"},{"source":"metastatic","target":"Lipiodol","id":"26864"},{"source":"liver diseases","target":"nivolumab (a)","id":"26865"},{"source":"liver diseases","target":"pembrolizumab","id":"26866"},{"source":"liver diseases","target":"tirapazamine (intra-arterial) (u)","id":"26867"},{"source":"liver diseases","target":"Gelfoam","id":"26868"},{"source":"liver diseases","target":"Lipiodol","id":"26869"},{"source":"neoplasm metastasis","target":"nivolumab (a)","id":"26870"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"26871"},{"source":"neoplasm metastasis","target":"tirapazamine (intra-arterial) (u)","id":"26872"},{"source":"neoplasm metastasis","target":"Gelfoam","id":"26873"},{"source":"neoplasm metastasis","target":"Lipiodol","id":"26874"},{"source":"carcinoma","target":"nivolumab (a)","id":"26875"},{"source":"carcinoma","target":"pembrolizumab","id":"26876"},{"source":"carcinoma","target":"tirapazamine (intra-arterial) (u)","id":"26877"},{"source":"carcinoma","target":"Gelfoam","id":"26878"},{"source":"carcinoma","target":"Lipiodol","id":"26879"},{"source":"anticancer","target":"nivolumab (a)","id":"26880"},{"source":"anticancer","target":"pembrolizumab","id":"26881"},{"source":"anticancer","target":"tirapazamine (intra-arterial) (u)","id":"26882"},{"source":"anticancer","target":"Gelfoam","id":"26883"},{"source":"anticancer","target":"Lipiodol","id":"26884"},{"source":"liver cancer","target":"nivolumab (a)","id":"26885"},{"source":"liver cancer","target":"pembrolizumab","id":"26886"},{"source":"liver cancer","target":"tirapazamine (intra-arterial) (u)","id":"26887"},{"source":"liver cancer","target":"Gelfoam","id":"26888"},{"source":"liver cancer","target":"Lipiodol","id":"26889"},{"source":"liver neoplasms","target":"nivolumab (a)","id":"26890"},{"source":"liver neoplasms","target":"pembrolizumab","id":"26891"},{"source":"liver neoplasms","target":"tirapazamine (intra-arterial) (u)","id":"26892"},{"source":"liver neoplasms","target":"Gelfoam","id":"26893"},{"source":"liver neoplasms","target":"Lipiodol","id":"26894"},{"source":"colorectal neoplasms","target":"nivolumab (a)","id":"26895"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"26896"},{"source":"colorectal neoplasms","target":"tirapazamine (intra-arterial) (u)","id":"26897"},{"source":"colorectal neoplasms","target":"Gelfoam","id":"26898"},{"source":"colorectal neoplasms","target":"Lipiodol","id":"26899"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"26900"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"26901"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"26902"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"26903"},{"source":"Immune checkpoint inhibitor","target":"necrosis","id":"26904"},{"source":"Immune checkpoint inhibitor","target":"liver tumor","id":"26905"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"26906"},{"source":"Immune checkpoint inhibitor","target":"hcc","id":"26907"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"26908"},{"source":"Immune checkpoint inhibitor","target":"liver diseases","id":"26909"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26910"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"26911"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"26912"},{"source":"Immune checkpoint inhibitor","target":"liver diseases","id":"26913"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"26914"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"26915"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"26916"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"26917"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"26918"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"26919"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"26920"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"26921"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"26922"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"26923"},{"source":"Anticancer immunotherapy","target":"necrosis","id":"26924"},{"source":"Anticancer immunotherapy","target":"liver tumor","id":"26925"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"26926"},{"source":"Anticancer immunotherapy","target":"hcc","id":"26927"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"26928"},{"source":"Anticancer immunotherapy","target":"liver diseases","id":"26929"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26930"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"26931"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"26932"},{"source":"Anticancer immunotherapy","target":"liver diseases","id":"26933"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"26934"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"26935"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"26936"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"26937"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"26938"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"26939"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"26940"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"26941"},{"source":"CD19 antagonist","target":"hepatocellular","id":"26942"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"26943"},{"source":"CD19 antagonist","target":"necrosis","id":"26944"},{"source":"CD19 antagonist","target":"liver tumor","id":"26945"},{"source":"CD19 antagonist","target":"residual tumor","id":"26946"},{"source":"CD19 antagonist","target":"hcc","id":"26947"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"26948"},{"source":"CD19 antagonist","target":"liver diseases","id":"26949"},{"source":"CD19 antagonist","target":"carcinoma","id":"26950"},{"source":"CD19 antagonist","target":"anti-tumor","id":"26951"},{"source":"CD19 antagonist","target":"metastatic","id":"26952"},{"source":"CD19 antagonist","target":"liver diseases","id":"26953"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"26954"},{"source":"CD19 antagonist","target":"carcinoma","id":"26955"},{"source":"CD19 antagonist","target":"anticancer","id":"26956"},{"source":"CD19 antagonist","target":"liver cancer","id":"26957"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"26958"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"26959"},{"source":"UPA","target":"UNK : Indication","id":"26960"},{"source":"UPA","target":"colorectal neoplasms","id":"26961"},{"source":"UPA","target":"hepatocellular","id":"26962"},{"source":"UPA","target":"colorectal cancer","id":"26963"},{"source":"UPA","target":"necrosis","id":"26964"},{"source":"UPA","target":"liver tumor","id":"26965"},{"source":"UPA","target":"residual tumor","id":"26966"},{"source":"UPA","target":"hcc","id":"26967"},{"source":"UPA","target":"colonic neoplasms","id":"26968"},{"source":"UPA","target":"liver diseases","id":"26969"},{"source":"UPA","target":"carcinoma","id":"26970"},{"source":"UPA","target":"anti-tumor","id":"26971"},{"source":"UPA","target":"metastatic","id":"26972"},{"source":"UPA","target":"liver diseases","id":"26973"},{"source":"UPA","target":"neoplasm metastasis","id":"26974"},{"source":"UPA","target":"carcinoma","id":"26975"},{"source":"UPA","target":"anticancer","id":"26976"},{"source":"UPA","target":"liver cancer","id":"26977"},{"source":"UPA","target":"liver neoplasms","id":"26978"},{"source":"UPA","target":"colorectal neoplasms","id":"26979"},{"source":"NA","target":"UNK : Indication","id":"26980"},{"source":"NA","target":"colorectal neoplasms","id":"26981"},{"source":"NA","target":"hepatocellular","id":"26982"},{"source":"NA","target":"colorectal cancer","id":"26983"},{"source":"NA","target":"necrosis","id":"26984"},{"source":"NA","target":"liver tumor","id":"26985"},{"source":"NA","target":"residual tumor","id":"26986"},{"source":"NA","target":"hcc","id":"26987"},{"source":"NA","target":"colonic neoplasms","id":"26988"},{"source":"NA","target":"liver diseases","id":"26989"},{"source":"NA","target":"carcinoma","id":"26990"},{"source":"NA","target":"anti-tumor","id":"26991"},{"source":"NA","target":"metastatic","id":"26992"},{"source":"NA","target":"liver diseases","id":"26993"},{"source":"NA","target":"neoplasm metastasis","id":"26994"},{"source":"NA","target":"carcinoma","id":"26995"},{"source":"NA","target":"anticancer","id":"26996"},{"source":"NA","target":"liver cancer","id":"26997"},{"source":"NA","target":"liver neoplasms","id":"26998"},{"source":"NA","target":"colorectal neoplasms","id":"26999"},{"source":"Reducing agent","target":"UNK : Indication","id":"27000"},{"source":"Reducing agent","target":"colorectal neoplasms","id":"27001"},{"source":"Reducing agent","target":"hepatocellular","id":"27002"},{"source":"Reducing agent","target":"colorectal cancer","id":"27003"},{"source":"Reducing agent","target":"necrosis","id":"27004"},{"source":"Reducing agent","target":"liver tumor","id":"27005"},{"source":"Reducing agent","target":"residual tumor","id":"27006"},{"source":"Reducing agent","target":"hcc","id":"27007"},{"source":"Reducing agent","target":"colonic neoplasms","id":"27008"},{"source":"Reducing agent","target":"liver diseases","id":"27009"},{"source":"Reducing agent","target":"carcinoma","id":"27010"},{"source":"Reducing agent","target":"anti-tumor","id":"27011"},{"source":"Reducing agent","target":"metastatic","id":"27012"},{"source":"Reducing agent","target":"liver diseases","id":"27013"},{"source":"Reducing agent","target":"neoplasm metastasis","id":"27014"},{"source":"Reducing agent","target":"carcinoma","id":"27015"},{"source":"Reducing agent","target":"anticancer","id":"27016"},{"source":"Reducing agent","target":"liver cancer","id":"27017"},{"source":"Reducing agent","target":"liver neoplasms","id":"27018"},{"source":"Reducing agent","target":"colorectal neoplasms","id":"27019"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"27020"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"27021"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"27022"},{"source":"Oncology: Colorectal","target":"UPA","id":"27023"},{"source":"Oncology: Colorectal","target":"NA","id":"27024"},{"source":"Oncology: Colorectal","target":"Reducing agent","id":"27025"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"27026"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"27027"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"27028"},{"source":"Oncology: Liver","target":"UPA","id":"27029"},{"source":"Oncology: Liver","target":"NA","id":"27030"},{"source":"Oncology: Liver","target":"Reducing agent","id":"27031"},{"source":"Oncology: Metastatic Cancer","target":"Immune checkpoint inhibitor","id":"27032"},{"source":"Oncology: Metastatic Cancer","target":"Anticancer immunotherapy","id":"27033"},{"source":"Oncology: Metastatic Cancer","target":"CD19 antagonist","id":"27034"},{"source":"Oncology: Metastatic Cancer","target":"UPA","id":"27035"},{"source":"Oncology: Metastatic Cancer","target":"NA","id":"27036"},{"source":"Oncology: Metastatic Cancer","target":"Reducing agent","id":"27037"},{"source":"mRNA-4157 (u)","target":"Merck & Co.","id":"27038"},{"source":"mRNA-4157 (u)","target":"Moderna Therapeutics","id":"27039"},{"source":"pembrolizumab","target":"Merck & Co.","id":"27040"},{"source":"pembrolizumab","target":"Moderna Therapeutics","id":"27041"},{"source":"colorectal neoplasms","target":"mRNA-4157 (u)","id":"27042"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"27043"},{"source":"skin neoplasms","target":"mRNA-4157 (u)","id":"27044"},{"source":"skin neoplasms","target":"pembrolizumab","id":"27045"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27046"},{"source":"carcinoma","target":"pembrolizumab","id":"27047"},{"source":"solid malignancy","target":"mRNA-4157 (u)","id":"27048"},{"source":"solid malignancy","target":"pembrolizumab","id":"27049"},{"source":"papilloma","target":"mRNA-4157 (u)","id":"27050"},{"source":"papilloma","target":"pembrolizumab","id":"27051"},{"source":"non-small-cell lung","target":"mRNA-4157 (u)","id":"27052"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"27053"},{"source":"barrett esophagus","target":"mRNA-4157 (u)","id":"27054"},{"source":"barrett esophagus","target":"pembrolizumab","id":"27055"},{"source":"condylomata acuminata","target":"mRNA-4157 (u)","id":"27056"},{"source":"condylomata acuminata","target":"pembrolizumab","id":"27057"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27058"},{"source":"carcinoma","target":"pembrolizumab","id":"27059"},{"source":"head and neck neoplasms","target":"mRNA-4157 (u)","id":"27060"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"27061"},{"source":"non-small-cell lung","target":"mRNA-4157 (u)","id":"27062"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"27063"},{"source":"melanoma","target":"mRNA-4157 (u)","id":"27064"},{"source":"melanoma","target":"pembrolizumab","id":"27065"},{"source":"solid tumors","target":"mRNA-4157 (u)","id":"27066"},{"source":"solid tumors","target":"pembrolizumab","id":"27067"},{"source":"endometrial neoplasms","target":"mRNA-4157 (u)","id":"27068"},{"source":"endometrial neoplasms","target":"pembrolizumab","id":"27069"},{"source":"papilloma","target":"mRNA-4157 (u)","id":"27070"},{"source":"papilloma","target":"pembrolizumab","id":"27071"},{"source":"colonic neoplasms","target":"mRNA-4157 (u)","id":"27072"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"27073"},{"source":"esophageal cancer","target":"mRNA-4157 (u)","id":"27074"},{"source":"esophageal cancer","target":"pembrolizumab","id":"27075"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27076"},{"source":"carcinoma","target":"pembrolizumab","id":"27077"},{"source":"sclc","target":"mRNA-4157 (u)","id":"27078"},{"source":"sclc","target":"pembrolizumab","id":"27079"},{"source":"papilloma","target":"mRNA-4157 (u)","id":"27080"},{"source":"papilloma","target":"pembrolizumab","id":"27081"},{"source":"pharyngeal neoplasms","target":"mRNA-4157 (u)","id":"27082"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"27083"},{"source":"endometrioid","target":"mRNA-4157 (u)","id":"27084"},{"source":"endometrioid","target":"pembrolizumab","id":"27085"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27086"},{"source":"carcinoma","target":"pembrolizumab","id":"27087"},{"source":"alopecia","target":"mRNA-4157 (u)","id":"27088"},{"source":"alopecia","target":"pembrolizumab","id":"27089"},{"source":"lung cancer","target":"mRNA-4157 (u)","id":"27090"},{"source":"lung cancer","target":"pembrolizumab","id":"27091"},{"source":"unknown primary","target":"mRNA-4157 (u)","id":"27092"},{"source":"unknown primary","target":"pembrolizumab","id":"27093"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27094"},{"source":"carcinoma","target":"pembrolizumab","id":"27095"},{"source":"metastatic","target":"mRNA-4157 (u)","id":"27096"},{"source":"metastatic","target":"pembrolizumab","id":"27097"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27098"},{"source":"carcinoma","target":"pembrolizumab","id":"27099"},{"source":"neoplasm metastasis","target":"mRNA-4157 (u)","id":"27100"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"27101"},{"source":"endometrial cancer","target":"mRNA-4157 (u)","id":"27102"},{"source":"endometrial cancer","target":"pembrolizumab","id":"27103"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27104"},{"source":"carcinoma","target":"pembrolizumab","id":"27105"},{"source":"non-small-cell lung","target":"mRNA-4157 (u)","id":"27106"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"27107"},{"source":"colorectal neoplasms","target":"mRNA-4157 (u)","id":"27108"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"27109"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27110"},{"source":"carcinoma","target":"pembrolizumab","id":"27111"},{"source":"stomach neoplasms","target":"mRNA-4157 (u)","id":"27112"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"27113"},{"source":"non-small-cell lung","target":"mRNA-4157 (u)","id":"27114"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"27115"},{"source":"unknown primary","target":"mRNA-4157 (u)","id":"27116"},{"source":"unknown primary","target":"pembrolizumab","id":"27117"},{"source":"neuropathy","target":"mRNA-4157 (u)","id":"27118"},{"source":"neuropathy","target":"pembrolizumab","id":"27119"},{"source":"carcinoma","target":"mRNA-4157 (u)","id":"27120"},{"source":"carcinoma","target":"pembrolizumab","id":"27121"},{"source":"skin neoplasms","target":"mRNA-4157 (u)","id":"27122"},{"source":"skin neoplasms","target":"pembrolizumab","id":"27123"},{"source":"residual tumor","target":"mRNA-4157 (u)","id":"27124"},{"source":"residual tumor","target":"pembrolizumab","id":"27125"},{"source":"solid malignancy","target":"mRNA-4157 (u)","id":"27126"},{"source":"solid malignancy","target":"pembrolizumab","id":"27127"},{"source":"anticancer","target":"mRNA-4157 (u)","id":"27128"},{"source":"anticancer","target":"pembrolizumab","id":"27129"},{"source":"urinary bladder neoplasms","target":"mRNA-4157 (u)","id":"27130"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"27131"},{"source":"solid tumors","target":"mRNA-4157 (u)","id":"27132"},{"source":"solid tumors","target":"pembrolizumab","id":"27133"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"27134"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"27135"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27136"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"27137"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"27138"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27139"},{"source":"Anticancer immunotherapy","target":"barrett esophagus","id":"27140"},{"source":"Anticancer immunotherapy","target":"condylomata acuminata","id":"27141"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27142"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"27143"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27144"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"27145"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"27146"},{"source":"Anticancer immunotherapy","target":"endometrial neoplasms","id":"27147"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"27148"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"27149"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"27150"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27151"},{"source":"Anticancer immunotherapy","target":"sclc","id":"27152"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"27153"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"27154"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"27155"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27156"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"27157"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"27158"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"27159"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27160"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"27161"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27162"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"27163"},{"source":"Anticancer immunotherapy","target":"endometrial cancer","id":"27164"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27165"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27166"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"27167"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27168"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"27169"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27170"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"27171"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"27172"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27173"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"27174"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"27175"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"27176"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"27177"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"27178"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"27179"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"27180"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"27181"},{"source":"CD19 antagonist","target":"carcinoma","id":"27182"},{"source":"CD19 antagonist","target":"solid malignancy","id":"27183"},{"source":"CD19 antagonist","target":"papilloma","id":"27184"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27185"},{"source":"CD19 antagonist","target":"barrett esophagus","id":"27186"},{"source":"CD19 antagonist","target":"condylomata acuminata","id":"27187"},{"source":"CD19 antagonist","target":"carcinoma","id":"27188"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"27189"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27190"},{"source":"CD19 antagonist","target":"melanoma","id":"27191"},{"source":"CD19 antagonist","target":"solid tumors","id":"27192"},{"source":"CD19 antagonist","target":"endometrial neoplasms","id":"27193"},{"source":"CD19 antagonist","target":"papilloma","id":"27194"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"27195"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"27196"},{"source":"CD19 antagonist","target":"carcinoma","id":"27197"},{"source":"CD19 antagonist","target":"sclc","id":"27198"},{"source":"CD19 antagonist","target":"papilloma","id":"27199"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"27200"},{"source":"CD19 antagonist","target":"endometrioid","id":"27201"},{"source":"CD19 antagonist","target":"carcinoma","id":"27202"},{"source":"CD19 antagonist","target":"alopecia","id":"27203"},{"source":"CD19 antagonist","target":"lung cancer","id":"27204"},{"source":"CD19 antagonist","target":"unknown primary","id":"27205"},{"source":"CD19 antagonist","target":"carcinoma","id":"27206"},{"source":"CD19 antagonist","target":"metastatic","id":"27207"},{"source":"CD19 antagonist","target":"carcinoma","id":"27208"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"27209"},{"source":"CD19 antagonist","target":"endometrial cancer","id":"27210"},{"source":"CD19 antagonist","target":"carcinoma","id":"27211"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27212"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"27213"},{"source":"CD19 antagonist","target":"carcinoma","id":"27214"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"27215"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27216"},{"source":"CD19 antagonist","target":"unknown primary","id":"27217"},{"source":"CD19 antagonist","target":"neuropathy","id":"27218"},{"source":"CD19 antagonist","target":"carcinoma","id":"27219"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"27220"},{"source":"CD19 antagonist","target":"residual tumor","id":"27221"},{"source":"CD19 antagonist","target":"solid malignancy","id":"27222"},{"source":"CD19 antagonist","target":"anticancer","id":"27223"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"27224"},{"source":"CD19 antagonist","target":"solid tumors","id":"27225"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"27226"},{"source":"Immunostimulant","target":"skin neoplasms","id":"27227"},{"source":"Immunostimulant","target":"carcinoma","id":"27228"},{"source":"Immunostimulant","target":"solid malignancy","id":"27229"},{"source":"Immunostimulant","target":"papilloma","id":"27230"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"27231"},{"source":"Immunostimulant","target":"barrett esophagus","id":"27232"},{"source":"Immunostimulant","target":"condylomata acuminata","id":"27233"},{"source":"Immunostimulant","target":"carcinoma","id":"27234"},{"source":"Immunostimulant","target":"head and neck neoplasms","id":"27235"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"27236"},{"source":"Immunostimulant","target":"melanoma","id":"27237"},{"source":"Immunostimulant","target":"solid tumors","id":"27238"},{"source":"Immunostimulant","target":"endometrial neoplasms","id":"27239"},{"source":"Immunostimulant","target":"papilloma","id":"27240"},{"source":"Immunostimulant","target":"colonic neoplasms","id":"27241"},{"source":"Immunostimulant","target":"esophageal cancer","id":"27242"},{"source":"Immunostimulant","target":"carcinoma","id":"27243"},{"source":"Immunostimulant","target":"sclc","id":"27244"},{"source":"Immunostimulant","target":"papilloma","id":"27245"},{"source":"Immunostimulant","target":"pharyngeal neoplasms","id":"27246"},{"source":"Immunostimulant","target":"endometrioid","id":"27247"},{"source":"Immunostimulant","target":"carcinoma","id":"27248"},{"source":"Immunostimulant","target":"alopecia","id":"27249"},{"source":"Immunostimulant","target":"lung cancer","id":"27250"},{"source":"Immunostimulant","target":"unknown primary","id":"27251"},{"source":"Immunostimulant","target":"carcinoma","id":"27252"},{"source":"Immunostimulant","target":"metastatic","id":"27253"},{"source":"Immunostimulant","target":"carcinoma","id":"27254"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"27255"},{"source":"Immunostimulant","target":"endometrial cancer","id":"27256"},{"source":"Immunostimulant","target":"carcinoma","id":"27257"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"27258"},{"source":"Immunostimulant","target":"colorectal neoplasms","id":"27259"},{"source":"Immunostimulant","target":"carcinoma","id":"27260"},{"source":"Immunostimulant","target":"stomach neoplasms","id":"27261"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"27262"},{"source":"Immunostimulant","target":"unknown primary","id":"27263"},{"source":"Immunostimulant","target":"neuropathy","id":"27264"},{"source":"Immunostimulant","target":"carcinoma","id":"27265"},{"source":"Immunostimulant","target":"skin neoplasms","id":"27266"},{"source":"Immunostimulant","target":"residual tumor","id":"27267"},{"source":"Immunostimulant","target":"solid malignancy","id":"27268"},{"source":"Immunostimulant","target":"anticancer","id":"27269"},{"source":"Immunostimulant","target":"urinary bladder neoplasms","id":"27270"},{"source":"Immunostimulant","target":"solid tumors","id":"27271"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"27272"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"27273"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27274"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"27275"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"27276"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27277"},{"source":"Immune checkpoint inhibitor","target":"barrett esophagus","id":"27278"},{"source":"Immune checkpoint inhibitor","target":"condylomata acuminata","id":"27279"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27280"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"27281"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27282"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"27283"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"27284"},{"source":"Immune checkpoint inhibitor","target":"endometrial neoplasms","id":"27285"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"27286"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"27287"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"27288"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27289"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"27290"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"27291"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"27292"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"27293"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27294"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"27295"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"27296"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"27297"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27298"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"27299"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27300"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"27301"},{"source":"Immune checkpoint inhibitor","target":"endometrial cancer","id":"27302"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27303"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27304"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"27305"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27306"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"27307"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27308"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"27309"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"27310"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27311"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"27312"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"27313"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"27314"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"27315"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"27316"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"27317"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"27318"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"27319"},{"source":"Oncology: Bladder","target":"Immunostimulant","id":"27320"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"27321"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"27322"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"27323"},{"source":"Oncology: Colorectal","target":"Immunostimulant","id":"27324"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"27325"},{"source":"Oncology: Endometrial","target":"Anticancer immunotherapy","id":"27326"},{"source":"Oncology: Endometrial","target":"CD19 antagonist","id":"27327"},{"source":"Oncology: Endometrial","target":"Immunostimulant","id":"27328"},{"source":"Oncology: Endometrial","target":"Immune checkpoint inhibitor","id":"27329"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"27330"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"27331"},{"source":"Oncology: Esophageal","target":"Immunostimulant","id":"27332"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"27333"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"27334"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"27335"},{"source":"Oncology: Gastric","target":"Immunostimulant","id":"27336"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"27337"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"27338"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"27339"},{"source":"Oncology: Head/Neck","target":"Immunostimulant","id":"27340"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"27341"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"27342"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"27343"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"27344"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"27345"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"27346"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"27347"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"27348"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"27349"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"27350"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"27351"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"27352"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"27353"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"27354"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"27355"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"27356"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"27357"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"27358"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"27359"},{"source":"Oncology: Melanoma","target":"Immunostimulant","id":"27360"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"27361"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"27362"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"27363"},{"source":"Oncology: CNS","target":"Immunostimulant","id":"27364"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"27365"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"27366"},{"source":"Dihydrofolate reductase inhibitor","target":"prostate cancer","id":"27367"},{"source":"Dihydrofolate reductase inhibitor","target":"castration-resistant prostatic neoplasms","id":"27368"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"27369"},{"source":"Dihydrofolate reductase inhibitor","target":"azoospermia","id":"27370"},{"source":"Dihydrofolate reductase inhibitor","target":"gilbert syndrome","id":"27371"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"27372"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"27373"},{"source":"Dihydrofolate reductase inhibitor","target":"gilbert disease","id":"27374"},{"source":"Dihydrofolate reductase inhibitor","target":"pancreatic cancer","id":"27375"},{"source":"Dihydrofolate reductase inhibitor","target":"liver neoplasms","id":"27376"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"27377"},{"source":"Dihydrofolate reductase inhibitor","target":"triple-negative breast cancer","id":"27378"},{"source":"Dihydrofolate reductase inhibitor","target":"breast neoplasms","id":"27379"},{"source":"Dihydrofolate reductase inhibitor","target":"liver metastases","id":"27380"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"27381"},{"source":"Dihydrofolate reductase inhibitor","target":"triple-negative breast cancer","id":"27382"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"27383"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"27384"},{"source":"Dihydrofolate reductase inhibitor","target":"anti-tumor","id":"27385"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"27386"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"27387"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"27388"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"27389"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"27390"},{"source":"Dihydrofolate reductase inhibitor","target":"pancreatic neoplasms","id":"27391"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"27392"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"27393"},{"source":"Dihydrofolate reductase inhibitor","target":"azoospermia","id":"27394"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"27395"},{"source":"Dihydrofolate reductase inhibitor","target":"lung cancer","id":"27396"},{"source":"Dihydrofolate reductase inhibitor","target":"solid tumors","id":"27397"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"27398"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"27399"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"27400"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"27401"},{"source":"Immune checkpoint inhibitor","target":"azoospermia","id":"27402"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"27403"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27404"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"27405"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"27406"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"27407"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"27408"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27409"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"27410"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"27411"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"27412"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"27413"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"27414"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"27415"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"27416"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"27417"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27418"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"27419"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27420"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"27421"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"27422"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"27423"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"27424"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"27425"},{"source":"Immune checkpoint inhibitor","target":"azoospermia","id":"27426"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"27427"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"27428"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"27429"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"27430"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"27431"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"27432"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"27433"},{"source":"Anticancer immunotherapy","target":"azoospermia","id":"27434"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"27435"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27436"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"27437"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"27438"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"27439"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"27440"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27441"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"27442"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"27443"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"27444"},{"source":"Anticancer immunotherapy","target":"sclc","id":"27445"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"27446"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"27447"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"27448"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"27449"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27450"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"27451"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27452"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"27453"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"27454"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"27455"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"27456"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"27457"},{"source":"Anticancer immunotherapy","target":"azoospermia","id":"27458"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"27459"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"27460"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"27461"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"27462"},{"source":"CD19 antagonist","target":"prostate cancer","id":"27463"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"27464"},{"source":"CD19 antagonist","target":"antiarthritic","id":"27465"},{"source":"CD19 antagonist","target":"azoospermia","id":"27466"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"27467"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27468"},{"source":"CD19 antagonist","target":"psoriasis","id":"27469"},{"source":"CD19 antagonist","target":"gilbert disease","id":"27470"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"27471"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"27472"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27473"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"27474"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"27475"},{"source":"CD19 antagonist","target":"liver metastases","id":"27476"},{"source":"CD19 antagonist","target":"sclc","id":"27477"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"27478"},{"source":"CD19 antagonist","target":"psoriasis","id":"27479"},{"source":"CD19 antagonist","target":"arthritis","id":"27480"},{"source":"CD19 antagonist","target":"anti-tumor","id":"27481"},{"source":"CD19 antagonist","target":"carcinoma","id":"27482"},{"source":"CD19 antagonist","target":"metastatic","id":"27483"},{"source":"CD19 antagonist","target":"carcinoma","id":"27484"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"27485"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"27486"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"27487"},{"source":"CD19 antagonist","target":"residual tumor","id":"27488"},{"source":"CD19 antagonist","target":"residual tumor","id":"27489"},{"source":"CD19 antagonist","target":"azoospermia","id":"27490"},{"source":"CD19 antagonist","target":"anticancer","id":"27491"},{"source":"CD19 antagonist","target":"lung cancer","id":"27492"},{"source":"CD19 antagonist","target":"solid tumors","id":"27493"},{"source":"Immunostimulant","target":"UNK : Indication","id":"27494"},{"source":"Immunostimulant","target":"prostate cancer","id":"27495"},{"source":"Immunostimulant","target":"castration-resistant prostatic neoplasms","id":"27496"},{"source":"Immunostimulant","target":"antiarthritic","id":"27497"},{"source":"Immunostimulant","target":"azoospermia","id":"27498"},{"source":"Immunostimulant","target":"gilbert syndrome","id":"27499"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"27500"},{"source":"Immunostimulant","target":"psoriasis","id":"27501"},{"source":"Immunostimulant","target":"gilbert disease","id":"27502"},{"source":"Immunostimulant","target":"pancreatic cancer","id":"27503"},{"source":"Immunostimulant","target":"liver neoplasms","id":"27504"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"27505"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"27506"},{"source":"Immunostimulant","target":"breast neoplasms","id":"27507"},{"source":"Immunostimulant","target":"liver metastases","id":"27508"},{"source":"Immunostimulant","target":"sclc","id":"27509"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"27510"},{"source":"Immunostimulant","target":"psoriasis","id":"27511"},{"source":"Immunostimulant","target":"arthritis","id":"27512"},{"source":"Immunostimulant","target":"anti-tumor","id":"27513"},{"source":"Immunostimulant","target":"carcinoma","id":"27514"},{"source":"Immunostimulant","target":"metastatic","id":"27515"},{"source":"Immunostimulant","target":"carcinoma","id":"27516"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"27517"},{"source":"Immunostimulant","target":"lung neoplasms","id":"27518"},{"source":"Immunostimulant","target":"pancreatic neoplasms","id":"27519"},{"source":"Immunostimulant","target":"residual tumor","id":"27520"},{"source":"Immunostimulant","target":"residual tumor","id":"27521"},{"source":"Immunostimulant","target":"azoospermia","id":"27522"},{"source":"Immunostimulant","target":"anticancer","id":"27523"},{"source":"Immunostimulant","target":"lung cancer","id":"27524"},{"source":"Immunostimulant","target":"solid tumors","id":"27525"},{"source":"Carcinoembryonic antigen inhibitor","target":"UNK : Indication","id":"27526"},{"source":"Carcinoembryonic antigen inhibitor","target":"prostate cancer","id":"27527"},{"source":"Carcinoembryonic antigen inhibitor","target":"castration-resistant prostatic neoplasms","id":"27528"},{"source":"Carcinoembryonic antigen inhibitor","target":"antiarthritic","id":"27529"},{"source":"Carcinoembryonic antigen inhibitor","target":"azoospermia","id":"27530"},{"source":"Carcinoembryonic antigen inhibitor","target":"gilbert syndrome","id":"27531"},{"source":"Carcinoembryonic antigen inhibitor","target":"non-small-cell lung","id":"27532"},{"source":"Carcinoembryonic antigen inhibitor","target":"psoriasis","id":"27533"},{"source":"Carcinoembryonic antigen inhibitor","target":"gilbert disease","id":"27534"},{"source":"Carcinoembryonic antigen inhibitor","target":"pancreatic cancer","id":"27535"},{"source":"Carcinoembryonic antigen inhibitor","target":"liver neoplasms","id":"27536"},{"source":"Carcinoembryonic antigen inhibitor","target":"non-small-cell lung","id":"27537"},{"source":"Carcinoembryonic antigen inhibitor","target":"triple-negative breast cancer","id":"27538"},{"source":"Carcinoembryonic antigen inhibitor","target":"breast neoplasms","id":"27539"},{"source":"Carcinoembryonic antigen inhibitor","target":"liver metastases","id":"27540"},{"source":"Carcinoembryonic antigen inhibitor","target":"sclc","id":"27541"},{"source":"Carcinoembryonic antigen inhibitor","target":"triple-negative breast cancer","id":"27542"},{"source":"Carcinoembryonic antigen inhibitor","target":"psoriasis","id":"27543"},{"source":"Carcinoembryonic antigen inhibitor","target":"arthritis","id":"27544"},{"source":"Carcinoembryonic antigen inhibitor","target":"anti-tumor","id":"27545"},{"source":"Carcinoembryonic antigen inhibitor","target":"carcinoma","id":"27546"},{"source":"Carcinoembryonic antigen inhibitor","target":"metastatic","id":"27547"},{"source":"Carcinoembryonic antigen inhibitor","target":"carcinoma","id":"27548"},{"source":"Carcinoembryonic antigen inhibitor","target":"neoplasm metastasis","id":"27549"},{"source":"Carcinoembryonic antigen inhibitor","target":"lung neoplasms","id":"27550"},{"source":"Carcinoembryonic antigen inhibitor","target":"pancreatic neoplasms","id":"27551"},{"source":"Carcinoembryonic antigen inhibitor","target":"residual tumor","id":"27552"},{"source":"Carcinoembryonic antigen inhibitor","target":"residual tumor","id":"27553"},{"source":"Carcinoembryonic antigen inhibitor","target":"azoospermia","id":"27554"},{"source":"Carcinoembryonic antigen inhibitor","target":"anticancer","id":"27555"},{"source":"Carcinoembryonic antigen inhibitor","target":"lung cancer","id":"27556"},{"source":"Carcinoembryonic antigen inhibitor","target":"solid tumors","id":"27557"},{"source":"NA","target":"UNK : Indication","id":"27558"},{"source":"NA","target":"prostate cancer","id":"27559"},{"source":"NA","target":"castration-resistant prostatic neoplasms","id":"27560"},{"source":"NA","target":"antiarthritic","id":"27561"},{"source":"NA","target":"azoospermia","id":"27562"},{"source":"NA","target":"gilbert syndrome","id":"27563"},{"source":"NA","target":"non-small-cell lung","id":"27564"},{"source":"NA","target":"psoriasis","id":"27565"},{"source":"NA","target":"gilbert disease","id":"27566"},{"source":"NA","target":"pancreatic cancer","id":"27567"},{"source":"NA","target":"liver neoplasms","id":"27568"},{"source":"NA","target":"non-small-cell lung","id":"27569"},{"source":"NA","target":"triple-negative breast cancer","id":"27570"},{"source":"NA","target":"breast neoplasms","id":"27571"},{"source":"NA","target":"liver metastases","id":"27572"},{"source":"NA","target":"sclc","id":"27573"},{"source":"NA","target":"triple-negative breast cancer","id":"27574"},{"source":"NA","target":"psoriasis","id":"27575"},{"source":"NA","target":"arthritis","id":"27576"},{"source":"NA","target":"anti-tumor","id":"27577"},{"source":"NA","target":"carcinoma","id":"27578"},{"source":"NA","target":"metastatic","id":"27579"},{"source":"NA","target":"carcinoma","id":"27580"},{"source":"NA","target":"neoplasm metastasis","id":"27581"},{"source":"NA","target":"lung neoplasms","id":"27582"},{"source":"NA","target":"pancreatic neoplasms","id":"27583"},{"source":"NA","target":"residual tumor","id":"27584"},{"source":"NA","target":"residual tumor","id":"27585"},{"source":"NA","target":"azoospermia","id":"27586"},{"source":"NA","target":"anticancer","id":"27587"},{"source":"NA","target":"lung cancer","id":"27588"},{"source":"NA","target":"solid tumors","id":"27589"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"27590"},{"source":"Thymidylate synthase inhibitor","target":"prostate cancer","id":"27591"},{"source":"Thymidylate synthase inhibitor","target":"castration-resistant prostatic neoplasms","id":"27592"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"27593"},{"source":"Thymidylate synthase inhibitor","target":"azoospermia","id":"27594"},{"source":"Thymidylate synthase inhibitor","target":"gilbert syndrome","id":"27595"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"27596"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"27597"},{"source":"Thymidylate synthase inhibitor","target":"gilbert disease","id":"27598"},{"source":"Thymidylate synthase inhibitor","target":"pancreatic cancer","id":"27599"},{"source":"Thymidylate synthase inhibitor","target":"liver neoplasms","id":"27600"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"27601"},{"source":"Thymidylate synthase inhibitor","target":"triple-negative breast cancer","id":"27602"},{"source":"Thymidylate synthase inhibitor","target":"breast neoplasms","id":"27603"},{"source":"Thymidylate synthase inhibitor","target":"liver metastases","id":"27604"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"27605"},{"source":"Thymidylate synthase inhibitor","target":"triple-negative breast cancer","id":"27606"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"27607"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"27608"},{"source":"Thymidylate synthase inhibitor","target":"anti-tumor","id":"27609"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"27610"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"27611"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"27612"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"27613"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"27614"},{"source":"Thymidylate synthase inhibitor","target":"pancreatic neoplasms","id":"27615"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"27616"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"27617"},{"source":"Thymidylate synthase inhibitor","target":"azoospermia","id":"27618"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"27619"},{"source":"Thymidylate synthase inhibitor","target":"lung cancer","id":"27620"},{"source":"Thymidylate synthase inhibitor","target":"solid tumors","id":"27621"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"27622"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"27623"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"27624"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"27625"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"27626"},{"source":"Oncology: Lung","target":"Carcinoembryonic antigen inhibitor","id":"27627"},{"source":"Oncology: Lung","target":"NA","id":"27628"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"27629"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"27630"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"27631"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"27632"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"27633"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"27634"},{"source":"Non-Small Cell","target":"Carcinoembryonic antigen inhibitor","id":"27635"},{"source":"Non-Small Cell","target":"NA","id":"27636"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"27637"},{"source":"eribulin mesylate (a)","target":"Eisai","id":"27638"},{"source":"eribulin mesylate (a)","target":"Merck & Co.","id":"27639"},{"source":"pembrolizumab","target":"Eisai","id":"27640"},{"source":"pembrolizumab","target":"Merck & Co.","id":"27641"},{"source":"UNK : Drug","target":"Eisai","id":"27642"},{"source":"UNK : Drug","target":"Merck & Co.","id":"27643"},{"source":"UNK : Indication","target":"eribulin mesylate (a)","id":"27644"},{"source":"UNK : Indication","target":"pembrolizumab","id":"27645"},{"source":"UNK : Indication","target":"UNK : Drug","id":"27646"},{"source":"breast neoplasms","target":"eribulin mesylate (a)","id":"27647"},{"source":"breast neoplasms","target":"pembrolizumab","id":"27648"},{"source":"breast neoplasms","target":"UNK : Drug","id":"27649"},{"source":"neuropathy","target":"eribulin mesylate (a)","id":"27650"},{"source":"neuropathy","target":"pembrolizumab","id":"27651"},{"source":"neuropathy","target":"UNK : Drug","id":"27652"},{"source":"alopecia","target":"eribulin mesylate (a)","id":"27653"},{"source":"alopecia","target":"pembrolizumab","id":"27654"},{"source":"alopecia","target":"UNK : Drug","id":"27655"},{"source":"liver metastases","target":"eribulin mesylate (a)","id":"27656"},{"source":"liver metastases","target":"pembrolizumab","id":"27657"},{"source":"liver metastases","target":"UNK : Drug","id":"27658"},{"source":"residual tumor","target":"eribulin mesylate (a)","id":"27659"},{"source":"residual tumor","target":"pembrolizumab","id":"27660"},{"source":"residual tumor","target":"UNK : Drug","id":"27661"},{"source":"azoospermia","target":"eribulin mesylate (a)","id":"27662"},{"source":"azoospermia","target":"pembrolizumab","id":"27663"},{"source":"azoospermia","target":"UNK : Drug","id":"27664"},{"source":"fallopian tube neoplasms","target":"eribulin mesylate (a)","id":"27665"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"27666"},{"source":"fallopian tube neoplasms","target":"UNK : Drug","id":"27667"},{"source":"metastatic","target":"eribulin mesylate (a)","id":"27668"},{"source":"metastatic","target":"pembrolizumab","id":"27669"},{"source":"metastatic","target":"UNK : Drug","id":"27670"},{"source":"carcinoma","target":"eribulin mesylate (a)","id":"27671"},{"source":"carcinoma","target":"pembrolizumab","id":"27672"},{"source":"carcinoma","target":"UNK : Drug","id":"27673"},{"source":"amenorrheic","target":"eribulin mesylate (a)","id":"27674"},{"source":"amenorrheic","target":"pembrolizumab","id":"27675"},{"source":"amenorrheic","target":"UNK : Drug","id":"27676"},{"source":"neoplasm metastasis","target":"eribulin mesylate (a)","id":"27677"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"27678"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"27679"},{"source":"amenorrheic","target":"eribulin mesylate (a)","id":"27680"},{"source":"amenorrheic","target":"pembrolizumab","id":"27681"},{"source":"amenorrheic","target":"UNK : Drug","id":"27682"},{"source":"anticancer","target":"eribulin mesylate (a)","id":"27683"},{"source":"anticancer","target":"pembrolizumab","id":"27684"},{"source":"anticancer","target":"UNK : Drug","id":"27685"},{"source":"bone metastasis","target":"eribulin mesylate (a)","id":"27686"},{"source":"bone metastasis","target":"pembrolizumab","id":"27687"},{"source":"bone metastasis","target":"UNK : Drug","id":"27688"},{"source":"triple-negative breast cancer","target":"eribulin mesylate (a)","id":"27689"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"27690"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"27691"},{"source":"liver neoplasms","target":"eribulin mesylate (a)","id":"27692"},{"source":"liver neoplasms","target":"pembrolizumab","id":"27693"},{"source":"liver neoplasms","target":"UNK : Drug","id":"27694"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"27695"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"27696"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"27697"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"27698"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"27699"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"27700"},{"source":"Anticancer immunotherapy","target":"azoospermia","id":"27701"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"27702"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"27703"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27704"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"27705"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"27706"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"27707"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"27708"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"27709"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"27710"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"27711"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"27712"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"27713"},{"source":"Tubulin inhibitor","target":"neuropathy","id":"27714"},{"source":"Tubulin inhibitor","target":"alopecia","id":"27715"},{"source":"Tubulin inhibitor","target":"liver metastases","id":"27716"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"27717"},{"source":"Tubulin inhibitor","target":"azoospermia","id":"27718"},{"source":"Tubulin inhibitor","target":"fallopian tube neoplasms","id":"27719"},{"source":"Tubulin inhibitor","target":"metastatic","id":"27720"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"27721"},{"source":"Tubulin inhibitor","target":"amenorrheic","id":"27722"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"27723"},{"source":"Tubulin inhibitor","target":"amenorrheic","id":"27724"},{"source":"Tubulin inhibitor","target":"anticancer","id":"27725"},{"source":"Tubulin inhibitor","target":"bone metastasis","id":"27726"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"27727"},{"source":"Tubulin inhibitor","target":"liver neoplasms","id":"27728"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"27729"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"27730"},{"source":"Tubulin inhibitor","target":"neuropathy","id":"27731"},{"source":"Tubulin inhibitor","target":"alopecia","id":"27732"},{"source":"Tubulin inhibitor","target":"liver metastases","id":"27733"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"27734"},{"source":"Tubulin inhibitor","target":"azoospermia","id":"27735"},{"source":"Tubulin inhibitor","target":"fallopian tube neoplasms","id":"27736"},{"source":"Tubulin inhibitor","target":"metastatic","id":"27737"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"27738"},{"source":"Tubulin inhibitor","target":"amenorrheic","id":"27739"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"27740"},{"source":"Tubulin inhibitor","target":"amenorrheic","id":"27741"},{"source":"Tubulin inhibitor","target":"anticancer","id":"27742"},{"source":"Tubulin inhibitor","target":"bone metastasis","id":"27743"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"27744"},{"source":"Tubulin inhibitor","target":"liver neoplasms","id":"27745"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"27746"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"27747"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"27748"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"27749"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"27750"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"27751"},{"source":"Immune checkpoint inhibitor","target":"azoospermia","id":"27752"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"27753"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"27754"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27755"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"27756"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"27757"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"27758"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"27759"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"27760"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"27761"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"27762"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"27763"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"27764"},{"source":"CD19 antagonist","target":"neuropathy","id":"27765"},{"source":"CD19 antagonist","target":"alopecia","id":"27766"},{"source":"CD19 antagonist","target":"liver metastases","id":"27767"},{"source":"CD19 antagonist","target":"residual tumor","id":"27768"},{"source":"CD19 antagonist","target":"azoospermia","id":"27769"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"27770"},{"source":"CD19 antagonist","target":"metastatic","id":"27771"},{"source":"CD19 antagonist","target":"carcinoma","id":"27772"},{"source":"CD19 antagonist","target":"amenorrheic","id":"27773"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"27774"},{"source":"CD19 antagonist","target":"amenorrheic","id":"27775"},{"source":"CD19 antagonist","target":"anticancer","id":"27776"},{"source":"CD19 antagonist","target":"bone metastasis","id":"27777"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"27778"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"27779"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"27780"},{"source":"Oncology: Breast","target":"Tubulin inhibitor","id":"27781"},{"source":"Oncology: Breast","target":"Tubulin inhibitor","id":"27782"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"27783"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"27784"},{"source":"necitumumab (a)","target":"Eli Lilly","id":"27785"},{"source":"necitumumab (a)","target":"Merck & Co.","id":"27786"},{"source":"pembrolizumab","target":"Eli Lilly","id":"27787"},{"source":"pembrolizumab","target":"Merck & Co.","id":"27788"},{"source":"residual tumor","target":"necitumumab (a)","id":"27789"},{"source":"residual tumor","target":"pembrolizumab","id":"27790"},{"source":"solid tumors","target":"necitumumab (a)","id":"27791"},{"source":"solid tumors","target":"pembrolizumab","id":"27792"},{"source":"non-small-cell lung","target":"necitumumab (a)","id":"27793"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"27794"},{"source":"carcinoma","target":"necitumumab (a)","id":"27795"},{"source":"carcinoma","target":"pembrolizumab","id":"27796"},{"source":"non-small-cell lung","target":"necitumumab (a)","id":"27797"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"27798"},{"source":"non-small-cell lung","target":"necitumumab (a)","id":"27799"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"27800"},{"source":"carcinoma","target":"necitumumab (a)","id":"27801"},{"source":"carcinoma","target":"pembrolizumab","id":"27802"},{"source":"anticancer","target":"necitumumab (a)","id":"27803"},{"source":"anticancer","target":"pembrolizumab","id":"27804"},{"source":"lung neoplasms","target":"necitumumab (a)","id":"27805"},{"source":"lung neoplasms","target":"pembrolizumab","id":"27806"},{"source":"sclc","target":"necitumumab (a)","id":"27807"},{"source":"sclc","target":"pembrolizumab","id":"27808"},{"source":"solid tumors","target":"necitumumab (a)","id":"27809"},{"source":"solid tumors","target":"pembrolizumab","id":"27810"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"27811"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"27812"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27813"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27814"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27815"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"27816"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27817"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"27818"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"27819"},{"source":"Anticancer immunotherapy","target":"sclc","id":"27820"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"27821"},{"source":"CD19 antagonist","target":"residual tumor","id":"27822"},{"source":"CD19 antagonist","target":"solid tumors","id":"27823"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27824"},{"source":"CD19 antagonist","target":"carcinoma","id":"27825"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27826"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"27827"},{"source":"CD19 antagonist","target":"carcinoma","id":"27828"},{"source":"CD19 antagonist","target":"anticancer","id":"27829"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"27830"},{"source":"CD19 antagonist","target":"sclc","id":"27831"},{"source":"CD19 antagonist","target":"solid tumors","id":"27832"},{"source":"EGFR antagonist","target":"residual tumor","id":"27833"},{"source":"EGFR antagonist","target":"solid tumors","id":"27834"},{"source":"EGFR antagonist","target":"non-small-cell lung","id":"27835"},{"source":"EGFR antagonist","target":"carcinoma","id":"27836"},{"source":"EGFR antagonist","target":"non-small-cell lung","id":"27837"},{"source":"EGFR antagonist","target":"non-small-cell lung","id":"27838"},{"source":"EGFR antagonist","target":"carcinoma","id":"27839"},{"source":"EGFR antagonist","target":"anticancer","id":"27840"},{"source":"EGFR antagonist","target":"lung neoplasms","id":"27841"},{"source":"EGFR antagonist","target":"sclc","id":"27842"},{"source":"EGFR antagonist","target":"solid tumors","id":"27843"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"27844"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"27845"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27846"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27847"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27848"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"27849"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27850"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"27851"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"27852"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"27853"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"27854"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"27855"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"27856"},{"source":"Oncology: Lung","target":"EGFR antagonist","id":"27857"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"27858"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"27859"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"27860"},{"source":"Non-Small Cell","target":"EGFR antagonist","id":"27861"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"27862"},{"source":"pegzilarginase (u)","target":"Biothera","id":"27863"},{"source":"pegzilarginase (u)","target":"Merck & Co.","id":"27864"},{"source":"pembrolizumab","target":"Biothera","id":"27865"},{"source":"pembrolizumab","target":"Merck & Co.","id":"27866"},{"source":"UNK : Drug","target":"Biothera","id":"27867"},{"source":"UNK : Drug","target":"Merck & Co.","id":"27868"},{"source":"UNK : Indication","target":"pegzilarginase (u)","id":"27869"},{"source":"UNK : Indication","target":"pembrolizumab","id":"27870"},{"source":"UNK : Indication","target":"UNK : Drug","id":"27871"},{"source":"sclc","target":"pegzilarginase (u)","id":"27872"},{"source":"sclc","target":"pembrolizumab","id":"27873"},{"source":"sclc","target":"UNK : Drug","id":"27874"},{"source":"anticancer","target":"pegzilarginase (u)","id":"27875"},{"source":"anticancer","target":"pembrolizumab","id":"27876"},{"source":"anticancer","target":"UNK : Drug","id":"27877"},{"source":"carcinoma","target":"pegzilarginase (u)","id":"27878"},{"source":"carcinoma","target":"pembrolizumab","id":"27879"},{"source":"carcinoma","target":"UNK : Drug","id":"27880"},{"source":"lung cancer","target":"pegzilarginase (u)","id":"27881"},{"source":"lung cancer","target":"pembrolizumab","id":"27882"},{"source":"lung cancer","target":"UNK : Drug","id":"27883"},{"source":"residual tumor","target":"pegzilarginase (u)","id":"27884"},{"source":"residual tumor","target":"pembrolizumab","id":"27885"},{"source":"residual tumor","target":"UNK : Drug","id":"27886"},{"source":"carcinoma","target":"pegzilarginase (u)","id":"27887"},{"source":"carcinoma","target":"pembrolizumab","id":"27888"},{"source":"carcinoma","target":"UNK : Drug","id":"27889"},{"source":"anticancer","target":"pegzilarginase (u)","id":"27890"},{"source":"anticancer","target":"pembrolizumab","id":"27891"},{"source":"anticancer","target":"UNK : Drug","id":"27892"},{"source":"lung cancer","target":"pegzilarginase (u)","id":"27893"},{"source":"lung cancer","target":"pembrolizumab","id":"27894"},{"source":"lung cancer","target":"UNK : Drug","id":"27895"},{"source":"lung neoplasms","target":"pegzilarginase (u)","id":"27896"},{"source":"lung neoplasms","target":"pembrolizumab","id":"27897"},{"source":"lung neoplasms","target":"UNK : Drug","id":"27898"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"27899"},{"source":"Anticancer immunotherapy","target":"sclc","id":"27900"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"27901"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27902"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"27903"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"27904"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"27905"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"27906"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"27907"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"27908"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"27909"},{"source":"CD19 antagonist","target":"sclc","id":"27910"},{"source":"CD19 antagonist","target":"anticancer","id":"27911"},{"source":"CD19 antagonist","target":"carcinoma","id":"27912"},{"source":"CD19 antagonist","target":"lung cancer","id":"27913"},{"source":"CD19 antagonist","target":"residual tumor","id":"27914"},{"source":"CD19 antagonist","target":"carcinoma","id":"27915"},{"source":"CD19 antagonist","target":"anticancer","id":"27916"},{"source":"CD19 antagonist","target":"lung cancer","id":"27917"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"27918"},{"source":"NA","target":"UNK : Indication","id":"27919"},{"source":"NA","target":"sclc","id":"27920"},{"source":"NA","target":"anticancer","id":"27921"},{"source":"NA","target":"carcinoma","id":"27922"},{"source":"NA","target":"lung cancer","id":"27923"},{"source":"NA","target":"residual tumor","id":"27924"},{"source":"NA","target":"carcinoma","id":"27925"},{"source":"NA","target":"anticancer","id":"27926"},{"source":"NA","target":"lung cancer","id":"27927"},{"source":"NA","target":"lung neoplasms","id":"27928"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"27929"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"27930"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"27931"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27932"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"27933"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"27934"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"27935"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"27936"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"27937"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"27938"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"27939"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"27940"},{"source":"Oncology: Lung","target":"NA","id":"27941"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"27942"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"27943"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"27944"},{"source":"Non-Small Cell","target":"NA","id":"27945"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"27946"},{"source":"nivolumab (a)","target":"Teclison/Cheery Pharma","id":"27947"},{"source":"pembrolizumab","target":"Teclison/Cheery Pharma","id":"27948"},{"source":"tirapazamine (intra-arterial) (u)","target":"Teclison/Cheery Pharma","id":"27949"},{"source":"Gelfoam","target":"Teclison/Cheery Pharma","id":"27950"},{"source":"Lipiodol","target":"Teclison/Cheery Pharma","id":"27951"},{"source":"UNK : Indication","target":"nivolumab (a)","id":"27952"},{"source":"UNK : Indication","target":"pembrolizumab","id":"27953"},{"source":"UNK : Indication","target":"tirapazamine (intra-arterial) (u)","id":"27954"},{"source":"UNK : Indication","target":"Gelfoam","id":"27955"},{"source":"UNK : Indication","target":"Lipiodol","id":"27956"},{"source":"colorectal neoplasms","target":"nivolumab (a)","id":"27957"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"27958"},{"source":"colorectal neoplasms","target":"tirapazamine (intra-arterial) (u)","id":"27959"},{"source":"colorectal neoplasms","target":"Gelfoam","id":"27960"},{"source":"colorectal neoplasms","target":"Lipiodol","id":"27961"},{"source":"hepatocellular","target":"nivolumab (a)","id":"27962"},{"source":"hepatocellular","target":"pembrolizumab","id":"27963"},{"source":"hepatocellular","target":"tirapazamine (intra-arterial) (u)","id":"27964"},{"source":"hepatocellular","target":"Gelfoam","id":"27965"},{"source":"hepatocellular","target":"Lipiodol","id":"27966"},{"source":"colorectal cancer","target":"nivolumab (a)","id":"27967"},{"source":"colorectal cancer","target":"pembrolizumab","id":"27968"},{"source":"colorectal cancer","target":"tirapazamine (intra-arterial) (u)","id":"27969"},{"source":"colorectal cancer","target":"Gelfoam","id":"27970"},{"source":"colorectal cancer","target":"Lipiodol","id":"27971"},{"source":"necrosis","target":"nivolumab (a)","id":"27972"},{"source":"necrosis","target":"pembrolizumab","id":"27973"},{"source":"necrosis","target":"tirapazamine (intra-arterial) (u)","id":"27974"},{"source":"necrosis","target":"Gelfoam","id":"27975"},{"source":"necrosis","target":"Lipiodol","id":"27976"},{"source":"liver tumor","target":"nivolumab (a)","id":"27977"},{"source":"liver tumor","target":"pembrolizumab","id":"27978"},{"source":"liver tumor","target":"tirapazamine (intra-arterial) (u)","id":"27979"},{"source":"liver tumor","target":"Gelfoam","id":"27980"},{"source":"liver tumor","target":"Lipiodol","id":"27981"},{"source":"residual tumor","target":"nivolumab (a)","id":"27982"},{"source":"residual tumor","target":"pembrolizumab","id":"27983"},{"source":"residual tumor","target":"tirapazamine (intra-arterial) (u)","id":"27984"},{"source":"residual tumor","target":"Gelfoam","id":"27985"},{"source":"residual tumor","target":"Lipiodol","id":"27986"},{"source":"hcc","target":"nivolumab (a)","id":"27987"},{"source":"hcc","target":"pembrolizumab","id":"27988"},{"source":"hcc","target":"tirapazamine (intra-arterial) (u)","id":"27989"},{"source":"hcc","target":"Gelfoam","id":"27990"},{"source":"hcc","target":"Lipiodol","id":"27991"},{"source":"colonic neoplasms","target":"nivolumab (a)","id":"27992"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"27993"},{"source":"colonic neoplasms","target":"tirapazamine (intra-arterial) (u)","id":"27994"},{"source":"colonic neoplasms","target":"Gelfoam","id":"27995"},{"source":"colonic neoplasms","target":"Lipiodol","id":"27996"},{"source":"liver diseases","target":"nivolumab (a)","id":"27997"},{"source":"liver diseases","target":"pembrolizumab","id":"27998"},{"source":"liver diseases","target":"tirapazamine (intra-arterial) (u)","id":"27999"},{"source":"liver diseases","target":"Gelfoam","id":"28000"},{"source":"liver diseases","target":"Lipiodol","id":"28001"},{"source":"carcinoma","target":"nivolumab (a)","id":"28002"},{"source":"carcinoma","target":"pembrolizumab","id":"28003"},{"source":"carcinoma","target":"tirapazamine (intra-arterial) (u)","id":"28004"},{"source":"carcinoma","target":"Gelfoam","id":"28005"},{"source":"carcinoma","target":"Lipiodol","id":"28006"},{"source":"anti-tumor","target":"nivolumab (a)","id":"28007"},{"source":"anti-tumor","target":"pembrolizumab","id":"28008"},{"source":"anti-tumor","target":"tirapazamine (intra-arterial) (u)","id":"28009"},{"source":"anti-tumor","target":"Gelfoam","id":"28010"},{"source":"anti-tumor","target":"Lipiodol","id":"28011"},{"source":"metastatic","target":"nivolumab (a)","id":"28012"},{"source":"metastatic","target":"pembrolizumab","id":"28013"},{"source":"metastatic","target":"tirapazamine (intra-arterial) (u)","id":"28014"},{"source":"metastatic","target":"Gelfoam","id":"28015"},{"source":"metastatic","target":"Lipiodol","id":"28016"},{"source":"liver diseases","target":"nivolumab (a)","id":"28017"},{"source":"liver diseases","target":"pembrolizumab","id":"28018"},{"source":"liver diseases","target":"tirapazamine (intra-arterial) (u)","id":"28019"},{"source":"liver diseases","target":"Gelfoam","id":"28020"},{"source":"liver diseases","target":"Lipiodol","id":"28021"},{"source":"neoplasm metastasis","target":"nivolumab (a)","id":"28022"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"28023"},{"source":"neoplasm metastasis","target":"tirapazamine (intra-arterial) (u)","id":"28024"},{"source":"neoplasm metastasis","target":"Gelfoam","id":"28025"},{"source":"neoplasm metastasis","target":"Lipiodol","id":"28026"},{"source":"carcinoma","target":"nivolumab (a)","id":"28027"},{"source":"carcinoma","target":"pembrolizumab","id":"28028"},{"source":"carcinoma","target":"tirapazamine (intra-arterial) (u)","id":"28029"},{"source":"carcinoma","target":"Gelfoam","id":"28030"},{"source":"carcinoma","target":"Lipiodol","id":"28031"},{"source":"anticancer","target":"nivolumab (a)","id":"28032"},{"source":"anticancer","target":"pembrolizumab","id":"28033"},{"source":"anticancer","target":"tirapazamine (intra-arterial) (u)","id":"28034"},{"source":"anticancer","target":"Gelfoam","id":"28035"},{"source":"anticancer","target":"Lipiodol","id":"28036"},{"source":"liver cancer","target":"nivolumab (a)","id":"28037"},{"source":"liver cancer","target":"pembrolizumab","id":"28038"},{"source":"liver cancer","target":"tirapazamine (intra-arterial) (u)","id":"28039"},{"source":"liver cancer","target":"Gelfoam","id":"28040"},{"source":"liver cancer","target":"Lipiodol","id":"28041"},{"source":"liver neoplasms","target":"nivolumab (a)","id":"28042"},{"source":"liver neoplasms","target":"pembrolizumab","id":"28043"},{"source":"liver neoplasms","target":"tirapazamine (intra-arterial) (u)","id":"28044"},{"source":"liver neoplasms","target":"Gelfoam","id":"28045"},{"source":"liver neoplasms","target":"Lipiodol","id":"28046"},{"source":"colorectal neoplasms","target":"nivolumab (a)","id":"28047"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"28048"},{"source":"colorectal neoplasms","target":"tirapazamine (intra-arterial) (u)","id":"28049"},{"source":"colorectal neoplasms","target":"Gelfoam","id":"28050"},{"source":"colorectal neoplasms","target":"Lipiodol","id":"28051"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"28052"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"28053"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"28054"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"28055"},{"source":"Immune checkpoint inhibitor","target":"necrosis","id":"28056"},{"source":"Immune checkpoint inhibitor","target":"liver tumor","id":"28057"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"28058"},{"source":"Immune checkpoint inhibitor","target":"hcc","id":"28059"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"28060"},{"source":"Immune checkpoint inhibitor","target":"liver diseases","id":"28061"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28062"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"28063"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"28064"},{"source":"Immune checkpoint inhibitor","target":"liver diseases","id":"28065"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"28066"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28067"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"28068"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"28069"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"28070"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"28071"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"28072"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"28073"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"28074"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"28075"},{"source":"Anticancer immunotherapy","target":"necrosis","id":"28076"},{"source":"Anticancer immunotherapy","target":"liver tumor","id":"28077"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"28078"},{"source":"Anticancer immunotherapy","target":"hcc","id":"28079"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"28080"},{"source":"Anticancer immunotherapy","target":"liver diseases","id":"28081"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28082"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"28083"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"28084"},{"source":"Anticancer immunotherapy","target":"liver diseases","id":"28085"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"28086"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28087"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"28088"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"28089"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"28090"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"28091"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"28092"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"28093"},{"source":"CD19 antagonist","target":"hepatocellular","id":"28094"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"28095"},{"source":"CD19 antagonist","target":"necrosis","id":"28096"},{"source":"CD19 antagonist","target":"liver tumor","id":"28097"},{"source":"CD19 antagonist","target":"residual tumor","id":"28098"},{"source":"CD19 antagonist","target":"hcc","id":"28099"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"28100"},{"source":"CD19 antagonist","target":"liver diseases","id":"28101"},{"source":"CD19 antagonist","target":"carcinoma","id":"28102"},{"source":"CD19 antagonist","target":"anti-tumor","id":"28103"},{"source":"CD19 antagonist","target":"metastatic","id":"28104"},{"source":"CD19 antagonist","target":"liver diseases","id":"28105"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"28106"},{"source":"CD19 antagonist","target":"carcinoma","id":"28107"},{"source":"CD19 antagonist","target":"anticancer","id":"28108"},{"source":"CD19 antagonist","target":"liver cancer","id":"28109"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"28110"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"28111"},{"source":"UPA","target":"UNK : Indication","id":"28112"},{"source":"UPA","target":"colorectal neoplasms","id":"28113"},{"source":"UPA","target":"hepatocellular","id":"28114"},{"source":"UPA","target":"colorectal cancer","id":"28115"},{"source":"UPA","target":"necrosis","id":"28116"},{"source":"UPA","target":"liver tumor","id":"28117"},{"source":"UPA","target":"residual tumor","id":"28118"},{"source":"UPA","target":"hcc","id":"28119"},{"source":"UPA","target":"colonic neoplasms","id":"28120"},{"source":"UPA","target":"liver diseases","id":"28121"},{"source":"UPA","target":"carcinoma","id":"28122"},{"source":"UPA","target":"anti-tumor","id":"28123"},{"source":"UPA","target":"metastatic","id":"28124"},{"source":"UPA","target":"liver diseases","id":"28125"},{"source":"UPA","target":"neoplasm metastasis","id":"28126"},{"source":"UPA","target":"carcinoma","id":"28127"},{"source":"UPA","target":"anticancer","id":"28128"},{"source":"UPA","target":"liver cancer","id":"28129"},{"source":"UPA","target":"liver neoplasms","id":"28130"},{"source":"UPA","target":"colorectal neoplasms","id":"28131"},{"source":"NA","target":"UNK : Indication","id":"28132"},{"source":"NA","target":"colorectal neoplasms","id":"28133"},{"source":"NA","target":"hepatocellular","id":"28134"},{"source":"NA","target":"colorectal cancer","id":"28135"},{"source":"NA","target":"necrosis","id":"28136"},{"source":"NA","target":"liver tumor","id":"28137"},{"source":"NA","target":"residual tumor","id":"28138"},{"source":"NA","target":"hcc","id":"28139"},{"source":"NA","target":"colonic neoplasms","id":"28140"},{"source":"NA","target":"liver diseases","id":"28141"},{"source":"NA","target":"carcinoma","id":"28142"},{"source":"NA","target":"anti-tumor","id":"28143"},{"source":"NA","target":"metastatic","id":"28144"},{"source":"NA","target":"liver diseases","id":"28145"},{"source":"NA","target":"neoplasm metastasis","id":"28146"},{"source":"NA","target":"carcinoma","id":"28147"},{"source":"NA","target":"anticancer","id":"28148"},{"source":"NA","target":"liver cancer","id":"28149"},{"source":"NA","target":"liver neoplasms","id":"28150"},{"source":"NA","target":"colorectal neoplasms","id":"28151"},{"source":"Reducing agent","target":"UNK : Indication","id":"28152"},{"source":"Reducing agent","target":"colorectal neoplasms","id":"28153"},{"source":"Reducing agent","target":"hepatocellular","id":"28154"},{"source":"Reducing agent","target":"colorectal cancer","id":"28155"},{"source":"Reducing agent","target":"necrosis","id":"28156"},{"source":"Reducing agent","target":"liver tumor","id":"28157"},{"source":"Reducing agent","target":"residual tumor","id":"28158"},{"source":"Reducing agent","target":"hcc","id":"28159"},{"source":"Reducing agent","target":"colonic neoplasms","id":"28160"},{"source":"Reducing agent","target":"liver diseases","id":"28161"},{"source":"Reducing agent","target":"carcinoma","id":"28162"},{"source":"Reducing agent","target":"anti-tumor","id":"28163"},{"source":"Reducing agent","target":"metastatic","id":"28164"},{"source":"Reducing agent","target":"liver diseases","id":"28165"},{"source":"Reducing agent","target":"neoplasm metastasis","id":"28166"},{"source":"Reducing agent","target":"carcinoma","id":"28167"},{"source":"Reducing agent","target":"anticancer","id":"28168"},{"source":"Reducing agent","target":"liver cancer","id":"28169"},{"source":"Reducing agent","target":"liver neoplasms","id":"28170"},{"source":"Reducing agent","target":"colorectal neoplasms","id":"28171"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"28172"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"28173"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"28174"},{"source":"Oncology: Colorectal","target":"UPA","id":"28175"},{"source":"Oncology: Colorectal","target":"NA","id":"28176"},{"source":"Oncology: Colorectal","target":"Reducing agent","id":"28177"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"28178"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"28179"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"28180"},{"source":"Oncology: Liver","target":"UPA","id":"28181"},{"source":"Oncology: Liver","target":"NA","id":"28182"},{"source":"Oncology: Liver","target":"Reducing agent","id":"28183"},{"source":"Oncology: Metastatic Cancer","target":"Immune checkpoint inhibitor","id":"28184"},{"source":"Oncology: Metastatic Cancer","target":"Anticancer immunotherapy","id":"28185"},{"source":"Oncology: Metastatic Cancer","target":"CD19 antagonist","id":"28186"},{"source":"Oncology: Metastatic Cancer","target":"UPA","id":"28187"},{"source":"Oncology: Metastatic Cancer","target":"NA","id":"28188"},{"source":"Oncology: Metastatic Cancer","target":"Reducing agent","id":"28189"},{"source":"pembrolizumab","target":"OncoSec","id":"28190"},{"source":"tavokinogene telsaplasmid (u)","target":"OncoSec","id":"28191"},{"source":"electrochemotherapy","target":"OncoSec","id":"28192"},{"source":"UNK : Indication","target":"pembrolizumab","id":"28193"},{"source":"UNK : Indication","target":"tavokinogene telsaplasmid (u)","id":"28194"},{"source":"UNK : Indication","target":"electrochemotherapy","id":"28195"},{"source":"melanoma","target":"pembrolizumab","id":"28196"},{"source":"melanoma","target":"tavokinogene telsaplasmid (u)","id":"28197"},{"source":"melanoma","target":"electrochemotherapy","id":"28198"},{"source":"melanoma","target":"pembrolizumab","id":"28199"},{"source":"melanoma","target":"tavokinogene telsaplasmid (u)","id":"28200"},{"source":"melanoma","target":"electrochemotherapy","id":"28201"},{"source":"pneumonitis","target":"pembrolizumab","id":"28202"},{"source":"pneumonitis","target":"tavokinogene telsaplasmid (u)","id":"28203"},{"source":"pneumonitis","target":"electrochemotherapy","id":"28204"},{"source":"skin neoplasms","target":"pembrolizumab","id":"28205"},{"source":"skin neoplasms","target":"tavokinogene telsaplasmid (u)","id":"28206"},{"source":"skin neoplasms","target":"electrochemotherapy","id":"28207"},{"source":"pneumonia","target":"pembrolizumab","id":"28208"},{"source":"pneumonia","target":"tavokinogene telsaplasmid (u)","id":"28209"},{"source":"pneumonia","target":"electrochemotherapy","id":"28210"},{"source":"liver metastases","target":"pembrolizumab","id":"28211"},{"source":"liver metastases","target":"tavokinogene telsaplasmid (u)","id":"28212"},{"source":"liver metastases","target":"electrochemotherapy","id":"28213"},{"source":"metastatic","target":"pembrolizumab","id":"28214"},{"source":"metastatic","target":"tavokinogene telsaplasmid (u)","id":"28215"},{"source":"metastatic","target":"electrochemotherapy","id":"28216"},{"source":"carcinoma","target":"pembrolizumab","id":"28217"},{"source":"carcinoma","target":"tavokinogene telsaplasmid (u)","id":"28218"},{"source":"carcinoma","target":"electrochemotherapy","id":"28219"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"28220"},{"source":"neoplasm metastasis","target":"tavokinogene telsaplasmid (u)","id":"28221"},{"source":"neoplasm metastasis","target":"electrochemotherapy","id":"28222"},{"source":"anticancer","target":"pembrolizumab","id":"28223"},{"source":"anticancer","target":"tavokinogene telsaplasmid (u)","id":"28224"},{"source":"anticancer","target":"electrochemotherapy","id":"28225"},{"source":"liver neoplasms","target":"pembrolizumab","id":"28226"},{"source":"liver neoplasms","target":"tavokinogene telsaplasmid (u)","id":"28227"},{"source":"liver neoplasms","target":"electrochemotherapy","id":"28228"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"28229"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"28230"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"28231"},{"source":"Anticancer immunotherapy","target":"pneumonitis","id":"28232"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"28233"},{"source":"Anticancer immunotherapy","target":"pneumonia","id":"28234"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"28235"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"28236"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28237"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"28238"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"28239"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"28240"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"28241"},{"source":"CD19 antagonist","target":"melanoma","id":"28242"},{"source":"CD19 antagonist","target":"melanoma","id":"28243"},{"source":"CD19 antagonist","target":"pneumonitis","id":"28244"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"28245"},{"source":"CD19 antagonist","target":"pneumonia","id":"28246"},{"source":"CD19 antagonist","target":"liver metastases","id":"28247"},{"source":"CD19 antagonist","target":"metastatic","id":"28248"},{"source":"CD19 antagonist","target":"carcinoma","id":"28249"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"28250"},{"source":"CD19 antagonist","target":"anticancer","id":"28251"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"28252"},{"source":"Interleukin 12 agonist","target":"UNK : Indication","id":"28253"},{"source":"Interleukin 12 agonist","target":"melanoma","id":"28254"},{"source":"Interleukin 12 agonist","target":"melanoma","id":"28255"},{"source":"Interleukin 12 agonist","target":"pneumonitis","id":"28256"},{"source":"Interleukin 12 agonist","target":"skin neoplasms","id":"28257"},{"source":"Interleukin 12 agonist","target":"pneumonia","id":"28258"},{"source":"Interleukin 12 agonist","target":"liver metastases","id":"28259"},{"source":"Interleukin 12 agonist","target":"metastatic","id":"28260"},{"source":"Interleukin 12 agonist","target":"carcinoma","id":"28261"},{"source":"Interleukin 12 agonist","target":"neoplasm metastasis","id":"28262"},{"source":"Interleukin 12 agonist","target":"anticancer","id":"28263"},{"source":"Interleukin 12 agonist","target":"liver neoplasms","id":"28264"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"28265"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"28266"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"28267"},{"source":"Immune checkpoint inhibitor","target":"pneumonitis","id":"28268"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"28269"},{"source":"Immune checkpoint inhibitor","target":"pneumonia","id":"28270"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"28271"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"28272"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28273"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"28274"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"28275"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"28276"},{"source":"NA","target":"UNK : Indication","id":"28277"},{"source":"NA","target":"melanoma","id":"28278"},{"source":"NA","target":"melanoma","id":"28279"},{"source":"NA","target":"pneumonitis","id":"28280"},{"source":"NA","target":"skin neoplasms","id":"28281"},{"source":"NA","target":"pneumonia","id":"28282"},{"source":"NA","target":"liver metastases","id":"28283"},{"source":"NA","target":"metastatic","id":"28284"},{"source":"NA","target":"carcinoma","id":"28285"},{"source":"NA","target":"neoplasm metastasis","id":"28286"},{"source":"NA","target":"anticancer","id":"28287"},{"source":"NA","target":"liver neoplasms","id":"28288"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"28289"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"28290"},{"source":"Oncology: Melanoma","target":"Interleukin 12 agonist","id":"28291"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"28292"},{"source":"Oncology: Melanoma","target":"NA","id":"28293"},{"source":"tabelecleucel (u)","target":"Biothera","id":"28294"},{"source":"pembrolizumab","target":"Biothera","id":"28295"},{"source":"UNK : Indication","target":"tabelecleucel (u)","id":"28296"},{"source":"UNK : Indication","target":"pembrolizumab","id":"28297"},{"source":"npc","target":"tabelecleucel (u)","id":"28298"},{"source":"npc","target":"pembrolizumab","id":"28299"},{"source":"carcinoma","target":"tabelecleucel (u)","id":"28300"},{"source":"carcinoma","target":"pembrolizumab","id":"28301"},{"source":"esophageal neoplasms","target":"tabelecleucel (u)","id":"28302"},{"source":"esophageal neoplasms","target":"pembrolizumab","id":"28303"},{"source":"carcinoma","target":"tabelecleucel (u)","id":"28304"},{"source":"carcinoma","target":"pembrolizumab","id":"28305"},{"source":"anticancer","target":"tabelecleucel (u)","id":"28306"},{"source":"anticancer","target":"pembrolizumab","id":"28307"},{"source":"head and neck neoplasms","target":"tabelecleucel (u)","id":"28308"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"28309"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"28310"},{"source":"Anticancer immunotherapy","target":"npc","id":"28311"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28312"},{"source":"Anticancer immunotherapy","target":"esophageal neoplasms","id":"28313"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28314"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"28315"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"28316"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"28317"},{"source":"CD19 antagonist","target":"npc","id":"28318"},{"source":"CD19 antagonist","target":"carcinoma","id":"28319"},{"source":"CD19 antagonist","target":"esophageal neoplasms","id":"28320"},{"source":"CD19 antagonist","target":"carcinoma","id":"28321"},{"source":"CD19 antagonist","target":"anticancer","id":"28322"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"28323"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"28324"},{"source":"Immune checkpoint inhibitor","target":"npc","id":"28325"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28326"},{"source":"Immune checkpoint inhibitor","target":"esophageal neoplasms","id":"28327"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28328"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"28329"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"28330"},{"source":"T helper cell stimulant","target":"UNK : Indication","id":"28331"},{"source":"T helper cell stimulant","target":"npc","id":"28332"},{"source":"T helper cell stimulant","target":"carcinoma","id":"28333"},{"source":"T helper cell stimulant","target":"esophageal neoplasms","id":"28334"},{"source":"T helper cell stimulant","target":"carcinoma","id":"28335"},{"source":"T helper cell stimulant","target":"anticancer","id":"28336"},{"source":"T helper cell stimulant","target":"head and neck neoplasms","id":"28337"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"28338"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"28339"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"28340"},{"source":"Oncology: Head/Neck","target":"T helper cell stimulant","id":"28341"},{"source":"mirvetuximab soravtansine (u)","target":"ImmunoGen","id":"28342"},{"source":"bevacizumab","target":"ImmunoGen","id":"28343"},{"source":"carboplatin","target":"ImmunoGen","id":"28344"},{"source":"pegylated liposomal doxorubicin","target":"ImmunoGen","id":"28345"},{"source":"pembrolizumab","target":"ImmunoGen","id":"28346"},{"source":"UNK : Indication","target":"mirvetuximab soravtansine (u)","id":"28347"},{"source":"UNK : Indication","target":"bevacizumab","id":"28348"},{"source":"UNK : Indication","target":"carboplatin","id":"28349"},{"source":"UNK : Indication","target":"pegylated liposomal doxorubicin","id":"28350"},{"source":"UNK : Indication","target":"pembrolizumab","id":"28351"},{"source":"glandular and epithelial","target":"mirvetuximab soravtansine (u)","id":"28352"},{"source":"glandular and epithelial","target":"bevacizumab","id":"28353"},{"source":"glandular and epithelial","target":"carboplatin","id":"28354"},{"source":"glandular and epithelial","target":"pegylated liposomal doxorubicin","id":"28355"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"28356"},{"source":"carcinoma","target":"mirvetuximab soravtansine (u)","id":"28357"},{"source":"carcinoma","target":"bevacizumab","id":"28358"},{"source":"carcinoma","target":"carboplatin","id":"28359"},{"source":"carcinoma","target":"pegylated liposomal doxorubicin","id":"28360"},{"source":"carcinoma","target":"pembrolizumab","id":"28361"},{"source":"ovarian cancer","target":"mirvetuximab soravtansine (u)","id":"28362"},{"source":"ovarian cancer","target":"bevacizumab","id":"28363"},{"source":"ovarian cancer","target":"carboplatin","id":"28364"},{"source":"ovarian cancer","target":"pegylated liposomal doxorubicin","id":"28365"},{"source":"ovarian cancer","target":"pembrolizumab","id":"28366"},{"source":"ovarian cancer","target":"mirvetuximab soravtansine (u)","id":"28367"},{"source":"ovarian cancer","target":"bevacizumab","id":"28368"},{"source":"ovarian cancer","target":"carboplatin","id":"28369"},{"source":"ovarian cancer","target":"pegylated liposomal doxorubicin","id":"28370"},{"source":"ovarian cancer","target":"pembrolizumab","id":"28371"},{"source":"residual tumor","target":"mirvetuximab soravtansine (u)","id":"28372"},{"source":"residual tumor","target":"bevacizumab","id":"28373"},{"source":"residual tumor","target":"carboplatin","id":"28374"},{"source":"residual tumor","target":"pegylated liposomal doxorubicin","id":"28375"},{"source":"residual tumor","target":"pembrolizumab","id":"28376"},{"source":"skin neoplasms","target":"mirvetuximab soravtansine (u)","id":"28377"},{"source":"skin neoplasms","target":"bevacizumab","id":"28378"},{"source":"skin neoplasms","target":"carboplatin","id":"28379"},{"source":"skin neoplasms","target":"pegylated liposomal doxorubicin","id":"28380"},{"source":"skin neoplasms","target":"pembrolizumab","id":"28381"},{"source":"primary peritoneal cancer","target":"mirvetuximab soravtansine (u)","id":"28382"},{"source":"primary peritoneal cancer","target":"bevacizumab","id":"28383"},{"source":"primary peritoneal cancer","target":"carboplatin","id":"28384"},{"source":"primary peritoneal cancer","target":"pegylated liposomal doxorubicin","id":"28385"},{"source":"primary peritoneal cancer","target":"pembrolizumab","id":"28386"},{"source":"peritoneal neoplasms","target":"mirvetuximab soravtansine (u)","id":"28387"},{"source":"peritoneal neoplasms","target":"bevacizumab","id":"28388"},{"source":"peritoneal neoplasms","target":"carboplatin","id":"28389"},{"source":"peritoneal neoplasms","target":"pegylated liposomal doxorubicin","id":"28390"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"28391"},{"source":"fallopian tube cancer","target":"mirvetuximab soravtansine (u)","id":"28392"},{"source":"fallopian tube cancer","target":"bevacizumab","id":"28393"},{"source":"fallopian tube cancer","target":"carboplatin","id":"28394"},{"source":"fallopian tube cancer","target":"pegylated liposomal doxorubicin","id":"28395"},{"source":"fallopian tube cancer","target":"pembrolizumab","id":"28396"},{"source":"anticancer","target":"mirvetuximab soravtansine (u)","id":"28397"},{"source":"anticancer","target":"bevacizumab","id":"28398"},{"source":"anticancer","target":"carboplatin","id":"28399"},{"source":"anticancer","target":"pegylated liposomal doxorubicin","id":"28400"},{"source":"anticancer","target":"pembrolizumab","id":"28401"},{"source":"fallopian tube neoplasms","target":"mirvetuximab soravtansine (u)","id":"28402"},{"source":"fallopian tube neoplasms","target":"bevacizumab","id":"28403"},{"source":"fallopian tube neoplasms","target":"carboplatin","id":"28404"},{"source":"fallopian tube neoplasms","target":"pegylated liposomal doxorubicin","id":"28405"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"28406"},{"source":"carcinoma","target":"mirvetuximab soravtansine (u)","id":"28407"},{"source":"carcinoma","target":"bevacizumab","id":"28408"},{"source":"carcinoma","target":"carboplatin","id":"28409"},{"source":"carcinoma","target":"pegylated liposomal doxorubicin","id":"28410"},{"source":"carcinoma","target":"pembrolizumab","id":"28411"},{"source":"residual tumor","target":"mirvetuximab soravtansine (u)","id":"28412"},{"source":"residual tumor","target":"bevacizumab","id":"28413"},{"source":"residual tumor","target":"carboplatin","id":"28414"},{"source":"residual tumor","target":"pegylated liposomal doxorubicin","id":"28415"},{"source":"residual tumor","target":"pembrolizumab","id":"28416"},{"source":"endometrioid","target":"mirvetuximab soravtansine (u)","id":"28417"},{"source":"endometrioid","target":"bevacizumab","id":"28418"},{"source":"endometrioid","target":"carboplatin","id":"28419"},{"source":"endometrioid","target":"pegylated liposomal doxorubicin","id":"28420"},{"source":"endometrioid","target":"pembrolizumab","id":"28421"},{"source":"glandular and epithelial","target":"mirvetuximab soravtansine (u)","id":"28422"},{"source":"glandular and epithelial","target":"bevacizumab","id":"28423"},{"source":"glandular and epithelial","target":"carboplatin","id":"28424"},{"source":"glandular and epithelial","target":"pegylated liposomal doxorubicin","id":"28425"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"28426"},{"source":"anti-tumor","target":"mirvetuximab soravtansine (u)","id":"28427"},{"source":"anti-tumor","target":"bevacizumab","id":"28428"},{"source":"anti-tumor","target":"carboplatin","id":"28429"},{"source":"anti-tumor","target":"pegylated liposomal doxorubicin","id":"28430"},{"source":"anti-tumor","target":"pembrolizumab","id":"28431"},{"source":"endometrial cancer","target":"mirvetuximab soravtansine (u)","id":"28432"},{"source":"endometrial cancer","target":"bevacizumab","id":"28433"},{"source":"endometrial cancer","target":"carboplatin","id":"28434"},{"source":"endometrial cancer","target":"pegylated liposomal doxorubicin","id":"28435"},{"source":"endometrial cancer","target":"pembrolizumab","id":"28436"},{"source":"ovarian neoplasms","target":"mirvetuximab soravtansine (u)","id":"28437"},{"source":"ovarian neoplasms","target":"bevacizumab","id":"28438"},{"source":"ovarian neoplasms","target":"carboplatin","id":"28439"},{"source":"ovarian neoplasms","target":"pegylated liposomal doxorubicin","id":"28440"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"28441"},{"source":"ovarian cancer","target":"mirvetuximab soravtansine (u)","id":"28442"},{"source":"ovarian cancer","target":"bevacizumab","id":"28443"},{"source":"ovarian cancer","target":"carboplatin","id":"28444"},{"source":"ovarian cancer","target":"pegylated liposomal doxorubicin","id":"28445"},{"source":"ovarian cancer","target":"pembrolizumab","id":"28446"},{"source":"endometrial neoplasms","target":"mirvetuximab soravtansine (u)","id":"28447"},{"source":"endometrial neoplasms","target":"bevacizumab","id":"28448"},{"source":"endometrial neoplasms","target":"carboplatin","id":"28449"},{"source":"endometrial neoplasms","target":"pegylated liposomal doxorubicin","id":"28450"},{"source":"endometrial neoplasms","target":"pembrolizumab","id":"28451"},{"source":"NA","target":"UNK : Indication","id":"28452"},{"source":"NA","target":"glandular and epithelial","id":"28453"},{"source":"NA","target":"carcinoma","id":"28454"},{"source":"NA","target":"ovarian cancer","id":"28455"},{"source":"NA","target":"ovarian cancer","id":"28456"},{"source":"NA","target":"residual tumor","id":"28457"},{"source":"NA","target":"skin neoplasms","id":"28458"},{"source":"NA","target":"primary peritoneal cancer","id":"28459"},{"source":"NA","target":"peritoneal neoplasms","id":"28460"},{"source":"NA","target":"fallopian tube cancer","id":"28461"},{"source":"NA","target":"anticancer","id":"28462"},{"source":"NA","target":"fallopian tube neoplasms","id":"28463"},{"source":"NA","target":"carcinoma","id":"28464"},{"source":"NA","target":"residual tumor","id":"28465"},{"source":"NA","target":"endometrioid","id":"28466"},{"source":"NA","target":"glandular and epithelial","id":"28467"},{"source":"NA","target":"anti-tumor","id":"28468"},{"source":"NA","target":"endometrial cancer","id":"28469"},{"source":"NA","target":"ovarian neoplasms","id":"28470"},{"source":"NA","target":"ovarian cancer","id":"28471"},{"source":"NA","target":"endometrial neoplasms","id":"28472"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"28473"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"28474"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28475"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"28476"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"28477"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"28478"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"28479"},{"source":"Immune checkpoint inhibitor","target":"primary peritoneal cancer","id":"28480"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"28481"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube cancer","id":"28482"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"28483"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"28484"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28485"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"28486"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"28487"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"28488"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"28489"},{"source":"Immune checkpoint inhibitor","target":"endometrial cancer","id":"28490"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"28491"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"28492"},{"source":"Immune checkpoint inhibitor","target":"endometrial neoplasms","id":"28493"},{"source":"NA","target":"UNK : Indication","id":"28494"},{"source":"NA","target":"glandular and epithelial","id":"28495"},{"source":"NA","target":"carcinoma","id":"28496"},{"source":"NA","target":"ovarian cancer","id":"28497"},{"source":"NA","target":"ovarian cancer","id":"28498"},{"source":"NA","target":"residual tumor","id":"28499"},{"source":"NA","target":"skin neoplasms","id":"28500"},{"source":"NA","target":"primary peritoneal cancer","id":"28501"},{"source":"NA","target":"peritoneal neoplasms","id":"28502"},{"source":"NA","target":"fallopian tube cancer","id":"28503"},{"source":"NA","target":"anticancer","id":"28504"},{"source":"NA","target":"fallopian tube neoplasms","id":"28505"},{"source":"NA","target":"carcinoma","id":"28506"},{"source":"NA","target":"residual tumor","id":"28507"},{"source":"NA","target":"endometrioid","id":"28508"},{"source":"NA","target":"glandular and epithelial","id":"28509"},{"source":"NA","target":"anti-tumor","id":"28510"},{"source":"NA","target":"endometrial cancer","id":"28511"},{"source":"NA","target":"ovarian neoplasms","id":"28512"},{"source":"NA","target":"ovarian cancer","id":"28513"},{"source":"NA","target":"endometrial neoplasms","id":"28514"},{"source":"NA","target":"UNK : Indication","id":"28515"},{"source":"NA","target":"glandular and epithelial","id":"28516"},{"source":"NA","target":"carcinoma","id":"28517"},{"source":"NA","target":"ovarian cancer","id":"28518"},{"source":"NA","target":"ovarian cancer","id":"28519"},{"source":"NA","target":"residual tumor","id":"28520"},{"source":"NA","target":"skin neoplasms","id":"28521"},{"source":"NA","target":"primary peritoneal cancer","id":"28522"},{"source":"NA","target":"peritoneal neoplasms","id":"28523"},{"source":"NA","target":"fallopian tube cancer","id":"28524"},{"source":"NA","target":"anticancer","id":"28525"},{"source":"NA","target":"fallopian tube neoplasms","id":"28526"},{"source":"NA","target":"carcinoma","id":"28527"},{"source":"NA","target":"residual tumor","id":"28528"},{"source":"NA","target":"endometrioid","id":"28529"},{"source":"NA","target":"glandular and epithelial","id":"28530"},{"source":"NA","target":"anti-tumor","id":"28531"},{"source":"NA","target":"endometrial cancer","id":"28532"},{"source":"NA","target":"ovarian neoplasms","id":"28533"},{"source":"NA","target":"ovarian cancer","id":"28534"},{"source":"NA","target":"endometrial neoplasms","id":"28535"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"28536"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"28537"},{"source":"CD19 antagonist","target":"carcinoma","id":"28538"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"28539"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"28540"},{"source":"CD19 antagonist","target":"residual tumor","id":"28541"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"28542"},{"source":"CD19 antagonist","target":"primary peritoneal cancer","id":"28543"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"28544"},{"source":"CD19 antagonist","target":"fallopian tube cancer","id":"28545"},{"source":"CD19 antagonist","target":"anticancer","id":"28546"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"28547"},{"source":"CD19 antagonist","target":"carcinoma","id":"28548"},{"source":"CD19 antagonist","target":"residual tumor","id":"28549"},{"source":"CD19 antagonist","target":"endometrioid","id":"28550"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"28551"},{"source":"CD19 antagonist","target":"anti-tumor","id":"28552"},{"source":"CD19 antagonist","target":"endometrial cancer","id":"28553"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"28554"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"28555"},{"source":"CD19 antagonist","target":"endometrial neoplasms","id":"28556"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"28557"},{"source":"Tubulin inhibitor","target":"glandular and epithelial","id":"28558"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"28559"},{"source":"Tubulin inhibitor","target":"ovarian cancer","id":"28560"},{"source":"Tubulin inhibitor","target":"ovarian cancer","id":"28561"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"28562"},{"source":"Tubulin inhibitor","target":"skin neoplasms","id":"28563"},{"source":"Tubulin inhibitor","target":"primary peritoneal cancer","id":"28564"},{"source":"Tubulin inhibitor","target":"peritoneal neoplasms","id":"28565"},{"source":"Tubulin inhibitor","target":"fallopian tube cancer","id":"28566"},{"source":"Tubulin inhibitor","target":"anticancer","id":"28567"},{"source":"Tubulin inhibitor","target":"fallopian tube neoplasms","id":"28568"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"28569"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"28570"},{"source":"Tubulin inhibitor","target":"endometrioid","id":"28571"},{"source":"Tubulin inhibitor","target":"glandular and epithelial","id":"28572"},{"source":"Tubulin inhibitor","target":"anti-tumor","id":"28573"},{"source":"Tubulin inhibitor","target":"endometrial cancer","id":"28574"},{"source":"Tubulin inhibitor","target":"ovarian neoplasms","id":"28575"},{"source":"Tubulin inhibitor","target":"ovarian cancer","id":"28576"},{"source":"Tubulin inhibitor","target":"endometrial neoplasms","id":"28577"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"28578"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"28579"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28580"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"28581"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"28582"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"28583"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"28584"},{"source":"Anticancer immunotherapy","target":"primary peritoneal cancer","id":"28585"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"28586"},{"source":"Anticancer immunotherapy","target":"fallopian tube cancer","id":"28587"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"28588"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"28589"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28590"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"28591"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"28592"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"28593"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"28594"},{"source":"Anticancer immunotherapy","target":"endometrial cancer","id":"28595"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"28596"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"28597"},{"source":"Anticancer immunotherapy","target":"endometrial neoplasms","id":"28598"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"28599"},{"source":"Angiogenesis inhibitor","target":"glandular and epithelial","id":"28600"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"28601"},{"source":"Angiogenesis inhibitor","target":"ovarian cancer","id":"28602"},{"source":"Angiogenesis inhibitor","target":"ovarian cancer","id":"28603"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"28604"},{"source":"Angiogenesis inhibitor","target":"skin neoplasms","id":"28605"},{"source":"Angiogenesis inhibitor","target":"primary peritoneal cancer","id":"28606"},{"source":"Angiogenesis inhibitor","target":"peritoneal neoplasms","id":"28607"},{"source":"Angiogenesis inhibitor","target":"fallopian tube cancer","id":"28608"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"28609"},{"source":"Angiogenesis inhibitor","target":"fallopian tube neoplasms","id":"28610"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"28611"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"28612"},{"source":"Angiogenesis inhibitor","target":"endometrioid","id":"28613"},{"source":"Angiogenesis inhibitor","target":"glandular and epithelial","id":"28614"},{"source":"Angiogenesis inhibitor","target":"anti-tumor","id":"28615"},{"source":"Angiogenesis inhibitor","target":"endometrial cancer","id":"28616"},{"source":"Angiogenesis inhibitor","target":"ovarian neoplasms","id":"28617"},{"source":"Angiogenesis inhibitor","target":"ovarian cancer","id":"28618"},{"source":"Angiogenesis inhibitor","target":"endometrial neoplasms","id":"28619"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"28620"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"glandular and epithelial","id":"28621"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"28622"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian cancer","id":"28623"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian cancer","id":"28624"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"28625"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"skin neoplasms","id":"28626"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"primary peritoneal cancer","id":"28627"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"peritoneal neoplasms","id":"28628"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"fallopian tube cancer","id":"28629"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"28630"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"fallopian tube neoplasms","id":"28631"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"28632"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"residual tumor","id":"28633"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"endometrioid","id":"28634"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"glandular and epithelial","id":"28635"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anti-tumor","id":"28636"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"endometrial cancer","id":"28637"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian neoplasms","id":"28638"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"ovarian cancer","id":"28639"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"endometrial neoplasms","id":"28640"},{"source":"NA","target":"UNK : Indication","id":"28641"},{"source":"NA","target":"glandular and epithelial","id":"28642"},{"source":"NA","target":"carcinoma","id":"28643"},{"source":"NA","target":"ovarian cancer","id":"28644"},{"source":"NA","target":"ovarian cancer","id":"28645"},{"source":"NA","target":"residual tumor","id":"28646"},{"source":"NA","target":"skin neoplasms","id":"28647"},{"source":"NA","target":"primary peritoneal cancer","id":"28648"},{"source":"NA","target":"peritoneal neoplasms","id":"28649"},{"source":"NA","target":"fallopian tube cancer","id":"28650"},{"source":"NA","target":"anticancer","id":"28651"},{"source":"NA","target":"fallopian tube neoplasms","id":"28652"},{"source":"NA","target":"carcinoma","id":"28653"},{"source":"NA","target":"residual tumor","id":"28654"},{"source":"NA","target":"endometrioid","id":"28655"},{"source":"NA","target":"glandular and epithelial","id":"28656"},{"source":"NA","target":"anti-tumor","id":"28657"},{"source":"NA","target":"endometrial cancer","id":"28658"},{"source":"NA","target":"ovarian neoplasms","id":"28659"},{"source":"NA","target":"ovarian cancer","id":"28660"},{"source":"NA","target":"endometrial neoplasms","id":"28661"},{"source":"Oncology: (N/A)","target":"NA","id":"28662"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"28663"},{"source":"Oncology: (N/A)","target":"NA","id":"28664"},{"source":"Oncology: (N/A)","target":"NA","id":"28665"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"28666"},{"source":"Oncology: (N/A)","target":"Tubulin inhibitor","id":"28667"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"28668"},{"source":"Oncology: (N/A)","target":"Angiogenesis inhibitor","id":"28669"},{"source":"Oncology: (N/A)","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"28670"},{"source":"Oncology: (N/A)","target":"NA","id":"28671"},{"source":"Oncology: Endometrial","target":"NA","id":"28672"},{"source":"Oncology: Endometrial","target":"Immune checkpoint inhibitor","id":"28673"},{"source":"Oncology: Endometrial","target":"NA","id":"28674"},{"source":"Oncology: Endometrial","target":"NA","id":"28675"},{"source":"Oncology: Endometrial","target":"CD19 antagonist","id":"28676"},{"source":"Oncology: Endometrial","target":"Tubulin inhibitor","id":"28677"},{"source":"Oncology: Endometrial","target":"Anticancer immunotherapy","id":"28678"},{"source":"Oncology: Endometrial","target":"Angiogenesis inhibitor","id":"28679"},{"source":"Oncology: Endometrial","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"28680"},{"source":"Oncology: Endometrial","target":"NA","id":"28681"},{"source":"Oncology: Ovarian","target":"NA","id":"28682"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"28683"},{"source":"Oncology: Ovarian","target":"NA","id":"28684"},{"source":"Oncology: Ovarian","target":"NA","id":"28685"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"28686"},{"source":"Oncology: Ovarian","target":"Tubulin inhibitor","id":"28687"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"28688"},{"source":"Oncology: Ovarian","target":"Angiogenesis inhibitor","id":"28689"},{"source":"Oncology: Ovarian","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"28690"},{"source":"Oncology: Ovarian","target":"NA","id":"28691"},{"source":"ARRY-382 (u)","target":"Array BioPharma","id":"28692"},{"source":"pembrolizumab","target":"Array BioPharma","id":"28693"},{"source":"UNK : Indication","target":"ARRY-382 (u)","id":"28694"},{"source":"UNK : Indication","target":"pembrolizumab","id":"28695"},{"source":"colorectal neoplasms","target":"ARRY-382 (u)","id":"28696"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"28697"},{"source":"anticancer","target":"ARRY-382 (u)","id":"28698"},{"source":"anticancer","target":"pembrolizumab","id":"28699"},{"source":"melanoma","target":"ARRY-382 (u)","id":"28700"},{"source":"melanoma","target":"pembrolizumab","id":"28701"},{"source":"breast neoplasms","target":"ARRY-382 (u)","id":"28702"},{"source":"breast neoplasms","target":"pembrolizumab","id":"28703"},{"source":"pancreatic cancer","target":"ARRY-382 (u)","id":"28704"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"28705"},{"source":"carcinoma","target":"ARRY-382 (u)","id":"28706"},{"source":"carcinoma","target":"pembrolizumab","id":"28707"},{"source":"head and neck neoplasms","target":"ARRY-382 (u)","id":"28708"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"28709"},{"source":"non-small-cell lung","target":"ARRY-382 (u)","id":"28710"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"28711"},{"source":"melanoma","target":"ARRY-382 (u)","id":"28712"},{"source":"melanoma","target":"pembrolizumab","id":"28713"},{"source":"bladder cancer","target":"ARRY-382 (u)","id":"28714"},{"source":"bladder cancer","target":"pembrolizumab","id":"28715"},{"source":"breast neoplasms","target":"ARRY-382 (u)","id":"28716"},{"source":"breast neoplasms","target":"pembrolizumab","id":"28717"},{"source":"colonic neoplasms","target":"ARRY-382 (u)","id":"28718"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"28719"},{"source":"carcinoma","target":"ARRY-382 (u)","id":"28720"},{"source":"carcinoma","target":"pembrolizumab","id":"28721"},{"source":"head and neck cancer","target":"ARRY-382 (u)","id":"28722"},{"source":"head and neck cancer","target":"pembrolizumab","id":"28723"},{"source":"sclc","target":"ARRY-382 (u)","id":"28724"},{"source":"sclc","target":"pembrolizumab","id":"28725"},{"source":"triple-negative breast cancer","target":"ARRY-382 (u)","id":"28726"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"28727"},{"source":"ovarian neoplasms","target":"ARRY-382 (u)","id":"28728"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"28729"},{"source":"colorectal cancer","target":"ARRY-382 (u)","id":"28730"},{"source":"colorectal cancer","target":"pembrolizumab","id":"28731"},{"source":"anti-tumor","target":"ARRY-382 (u)","id":"28732"},{"source":"anti-tumor","target":"pembrolizumab","id":"28733"},{"source":"carcinoma","target":"ARRY-382 (u)","id":"28734"},{"source":"carcinoma","target":"pembrolizumab","id":"28735"},{"source":"carcinoma","target":"ARRY-382 (u)","id":"28736"},{"source":"carcinoma","target":"pembrolizumab","id":"28737"},{"source":"gastric cancer","target":"ARRY-382 (u)","id":"28738"},{"source":"gastric cancer","target":"pembrolizumab","id":"28739"},{"source":"solid tumors","target":"ARRY-382 (u)","id":"28740"},{"source":"solid tumors","target":"pembrolizumab","id":"28741"},{"source":"carcinoma","target":"ARRY-382 (u)","id":"28742"},{"source":"carcinoma","target":"pembrolizumab","id":"28743"},{"source":"ovarian cancer","target":"ARRY-382 (u)","id":"28744"},{"source":"ovarian cancer","target":"pembrolizumab","id":"28745"},{"source":"neoplasm metastasis","target":"ARRY-382 (u)","id":"28746"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"28747"},{"source":"pancreatic neoplasms","target":"ARRY-382 (u)","id":"28748"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"28749"},{"source":"colorectal neoplasms","target":"ARRY-382 (u)","id":"28750"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"28751"},{"source":"stomach neoplasms","target":"ARRY-382 (u)","id":"28752"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"28753"},{"source":"skin neoplasms","target":"ARRY-382 (u)","id":"28754"},{"source":"skin neoplasms","target":"pembrolizumab","id":"28755"},{"source":"residual tumor","target":"ARRY-382 (u)","id":"28756"},{"source":"residual tumor","target":"pembrolizumab","id":"28757"},{"source":"metastatic","target":"ARRY-382 (u)","id":"28758"},{"source":"metastatic","target":"pembrolizumab","id":"28759"},{"source":"anticancer","target":"ARRY-382 (u)","id":"28760"},{"source":"anticancer","target":"pembrolizumab","id":"28761"},{"source":"urinary bladder neoplasms","target":"ARRY-382 (u)","id":"28762"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"28763"},{"source":"solid tumors","target":"ARRY-382 (u)","id":"28764"},{"source":"solid tumors","target":"pembrolizumab","id":"28765"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"UNK : Indication","id":"28766"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"colorectal neoplasms","id":"28767"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"28768"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"melanoma","id":"28769"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"breast neoplasms","id":"28770"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"pancreatic cancer","id":"28771"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"28772"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"head and neck neoplasms","id":"28773"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"non-small-cell lung","id":"28774"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"melanoma","id":"28775"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"bladder cancer","id":"28776"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"breast neoplasms","id":"28777"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"colonic neoplasms","id":"28778"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"28779"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"head and neck cancer","id":"28780"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"sclc","id":"28781"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"triple-negative breast cancer","id":"28782"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"ovarian neoplasms","id":"28783"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"colorectal cancer","id":"28784"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anti-tumor","id":"28785"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"28786"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"28787"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"gastric cancer","id":"28788"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"solid tumors","id":"28789"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"28790"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"ovarian cancer","id":"28791"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"neoplasm metastasis","id":"28792"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"pancreatic neoplasms","id":"28793"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"colorectal neoplasms","id":"28794"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"stomach neoplasms","id":"28795"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"skin neoplasms","id":"28796"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"28797"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"metastatic","id":"28798"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"28799"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"urinary bladder neoplasms","id":"28800"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"solid tumors","id":"28801"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"UNK : Indication","id":"28802"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colorectal neoplasms","id":"28803"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"28804"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"melanoma","id":"28805"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"breast neoplasms","id":"28806"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"pancreatic cancer","id":"28807"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"28808"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"head and neck neoplasms","id":"28809"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"non-small-cell lung","id":"28810"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"melanoma","id":"28811"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"bladder cancer","id":"28812"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"breast neoplasms","id":"28813"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colonic neoplasms","id":"28814"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"28815"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"head and neck cancer","id":"28816"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"sclc","id":"28817"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"triple-negative breast cancer","id":"28818"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"ovarian neoplasms","id":"28819"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colorectal cancer","id":"28820"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anti-tumor","id":"28821"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"28822"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"28823"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"gastric cancer","id":"28824"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"28825"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"28826"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"ovarian cancer","id":"28827"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"neoplasm metastasis","id":"28828"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"pancreatic neoplasms","id":"28829"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colorectal neoplasms","id":"28830"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"stomach neoplasms","id":"28831"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"skin neoplasms","id":"28832"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"28833"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"metastatic","id":"28834"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"28835"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"urinary bladder neoplasms","id":"28836"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"28837"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"28838"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"28839"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"28840"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"28841"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"28842"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"28843"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28844"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"28845"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"28846"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"28847"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"28848"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"28849"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"28850"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28851"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"28852"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"28853"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"28854"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"28855"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"28856"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"28857"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28858"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28859"},{"source":"Immune checkpoint inhibitor","target":"gastric cancer","id":"28860"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"28861"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"28862"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"28863"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"28864"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"28865"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"28866"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"28867"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"28868"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"28869"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"28870"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"28871"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"28872"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"28873"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"28874"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"28875"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"28876"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"28877"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"28878"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"28879"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28880"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"28881"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"28882"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"28883"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"28884"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"28885"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"28886"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28887"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"28888"},{"source":"Anticancer immunotherapy","target":"sclc","id":"28889"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"28890"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"28891"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"28892"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"28893"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28894"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28895"},{"source":"Anticancer immunotherapy","target":"gastric cancer","id":"28896"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"28897"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"28898"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"28899"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"28900"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"28901"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"28902"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"28903"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"28904"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"28905"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"28906"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"28907"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"28908"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"28909"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"28910"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"28911"},{"source":"CD19 antagonist","target":"anticancer","id":"28912"},{"source":"CD19 antagonist","target":"melanoma","id":"28913"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"28914"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"28915"},{"source":"CD19 antagonist","target":"carcinoma","id":"28916"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"28917"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"28918"},{"source":"CD19 antagonist","target":"melanoma","id":"28919"},{"source":"CD19 antagonist","target":"bladder cancer","id":"28920"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"28921"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"28922"},{"source":"CD19 antagonist","target":"carcinoma","id":"28923"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"28924"},{"source":"CD19 antagonist","target":"sclc","id":"28925"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"28926"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"28927"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"28928"},{"source":"CD19 antagonist","target":"anti-tumor","id":"28929"},{"source":"CD19 antagonist","target":"carcinoma","id":"28930"},{"source":"CD19 antagonist","target":"carcinoma","id":"28931"},{"source":"CD19 antagonist","target":"gastric cancer","id":"28932"},{"source":"CD19 antagonist","target":"solid tumors","id":"28933"},{"source":"CD19 antagonist","target":"carcinoma","id":"28934"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"28935"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"28936"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"28937"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"28938"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"28939"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"28940"},{"source":"CD19 antagonist","target":"residual tumor","id":"28941"},{"source":"CD19 antagonist","target":"metastatic","id":"28942"},{"source":"CD19 antagonist","target":"anticancer","id":"28943"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"28944"},{"source":"CD19 antagonist","target":"solid tumors","id":"28945"},{"source":"NA","target":"UNK : Indication","id":"28946"},{"source":"NA","target":"colorectal neoplasms","id":"28947"},{"source":"NA","target":"anticancer","id":"28948"},{"source":"NA","target":"melanoma","id":"28949"},{"source":"NA","target":"breast neoplasms","id":"28950"},{"source":"NA","target":"pancreatic cancer","id":"28951"},{"source":"NA","target":"carcinoma","id":"28952"},{"source":"NA","target":"head and neck neoplasms","id":"28953"},{"source":"NA","target":"non-small-cell lung","id":"28954"},{"source":"NA","target":"melanoma","id":"28955"},{"source":"NA","target":"bladder cancer","id":"28956"},{"source":"NA","target":"breast neoplasms","id":"28957"},{"source":"NA","target":"colonic neoplasms","id":"28958"},{"source":"NA","target":"carcinoma","id":"28959"},{"source":"NA","target":"head and neck cancer","id":"28960"},{"source":"NA","target":"sclc","id":"28961"},{"source":"NA","target":"triple-negative breast cancer","id":"28962"},{"source":"NA","target":"ovarian neoplasms","id":"28963"},{"source":"NA","target":"colorectal cancer","id":"28964"},{"source":"NA","target":"anti-tumor","id":"28965"},{"source":"NA","target":"carcinoma","id":"28966"},{"source":"NA","target":"carcinoma","id":"28967"},{"source":"NA","target":"gastric cancer","id":"28968"},{"source":"NA","target":"solid tumors","id":"28969"},{"source":"NA","target":"carcinoma","id":"28970"},{"source":"NA","target":"ovarian cancer","id":"28971"},{"source":"NA","target":"neoplasm metastasis","id":"28972"},{"source":"NA","target":"pancreatic neoplasms","id":"28973"},{"source":"NA","target":"colorectal neoplasms","id":"28974"},{"source":"NA","target":"stomach neoplasms","id":"28975"},{"source":"NA","target":"skin neoplasms","id":"28976"},{"source":"NA","target":"residual tumor","id":"28977"},{"source":"NA","target":"metastatic","id":"28978"},{"source":"NA","target":"anticancer","id":"28979"},{"source":"NA","target":"urinary bladder neoplasms","id":"28980"},{"source":"NA","target":"solid tumors","id":"28981"},{"source":"Oncology: Bladder","target":"Granulocyte macrophage colony stimulating factor agonist","id":"28982"},{"source":"Oncology: Bladder","target":"Colony stimulating factor 1 receptor antagonist","id":"28983"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"28984"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"28985"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"28986"},{"source":"Oncology: Bladder","target":"NA","id":"28987"},{"source":"Oncology: Breast","target":"Granulocyte macrophage colony stimulating factor agonist","id":"28988"},{"source":"Oncology: Breast","target":"Colony stimulating factor 1 receptor antagonist","id":"28989"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"28990"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"28991"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"28992"},{"source":"Oncology: Breast","target":"NA","id":"28993"},{"source":"Oncology: Colorectal","target":"Granulocyte macrophage colony stimulating factor agonist","id":"28994"},{"source":"Oncology: Colorectal","target":"Colony stimulating factor 1 receptor antagonist","id":"28995"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"28996"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"28997"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"28998"},{"source":"Oncology: Colorectal","target":"NA","id":"28999"},{"source":"Oncology: Gastric","target":"Granulocyte macrophage colony stimulating factor agonist","id":"29000"},{"source":"Oncology: Gastric","target":"Colony stimulating factor 1 receptor antagonist","id":"29001"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"29002"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"29003"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"29004"},{"source":"Oncology: Gastric","target":"NA","id":"29005"},{"source":"Oncology: Head/Neck","target":"Granulocyte macrophage colony stimulating factor agonist","id":"29006"},{"source":"Oncology: Head/Neck","target":"Colony stimulating factor 1 receptor antagonist","id":"29007"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"29008"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"29009"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"29010"},{"source":"Oncology: Head/Neck","target":"NA","id":"29011"},{"source":"Oncology: Lung","target":"Granulocyte macrophage colony stimulating factor agonist","id":"29012"},{"source":"Oncology: Lung","target":"Colony stimulating factor 1 receptor antagonist","id":"29013"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"29014"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"29015"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"29016"},{"source":"Oncology: Lung","target":"NA","id":"29017"},{"source":"Non-Small Cell","target":"Granulocyte macrophage colony stimulating factor agonist","id":"29018"},{"source":"Non-Small Cell","target":"Colony stimulating factor 1 receptor antagonist","id":"29019"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"29020"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"29021"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"29022"},{"source":"Non-Small Cell","target":"NA","id":"29023"},{"source":"Oncology: Melanoma","target":"Granulocyte macrophage colony stimulating factor agonist","id":"29024"},{"source":"Oncology: Melanoma","target":"Colony stimulating factor 1 receptor antagonist","id":"29025"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"29026"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"29027"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"29028"},{"source":"Oncology: Melanoma","target":"NA","id":"29029"},{"source":"Oncology: Ovarian","target":"Granulocyte macrophage colony stimulating factor agonist","id":"29030"},{"source":"Oncology: Ovarian","target":"Colony stimulating factor 1 receptor antagonist","id":"29031"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"29032"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"29033"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"29034"},{"source":"Oncology: Ovarian","target":"NA","id":"29035"},{"source":"Oncology: Pancreas","target":"Granulocyte macrophage colony stimulating factor agonist","id":"29036"},{"source":"Oncology: Pancreas","target":"Colony stimulating factor 1 receptor antagonist","id":"29037"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"29038"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"29039"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"29040"},{"source":"Oncology: Pancreas","target":"NA","id":"29041"},{"source":"ID-G100 (u)","target":"Immune Design","id":"29042"},{"source":"ID-G100 (u)","target":"Merck & Co.","id":"29043"},{"source":"pembrolizumab","target":"Immune Design","id":"29044"},{"source":"pembrolizumab","target":"Merck & Co.","id":"29045"},{"source":"radiation therapy","target":"Immune Design","id":"29046"},{"source":"radiation therapy","target":"Merck & Co.","id":"29047"},{"source":"UNK : Indication","target":"ID-G100 (u)","id":"29048"},{"source":"UNK : Indication","target":"pembrolizumab","id":"29049"},{"source":"UNK : Indication","target":"radiation therapy","id":"29050"},{"source":"lymphoma","target":"ID-G100 (u)","id":"29051"},{"source":"lymphoma","target":"pembrolizumab","id":"29052"},{"source":"lymphoma","target":"radiation therapy","id":"29053"},{"source":"lymphoma","target":"ID-G100 (u)","id":"29054"},{"source":"lymphoma","target":"pembrolizumab","id":"29055"},{"source":"lymphoma","target":"radiation therapy","id":"29056"},{"source":"follicular","target":"ID-G100 (u)","id":"29057"},{"source":"follicular","target":"pembrolizumab","id":"29058"},{"source":"follicular","target":"radiation therapy","id":"29059"},{"source":"nhl","target":"ID-G100 (u)","id":"29060"},{"source":"nhl","target":"pembrolizumab","id":"29061"},{"source":"nhl","target":"radiation therapy","id":"29062"},{"source":"residual tumor","target":"ID-G100 (u)","id":"29063"},{"source":"residual tumor","target":"pembrolizumab","id":"29064"},{"source":"residual tumor","target":"radiation therapy","id":"29065"},{"source":"non-hodgkin","target":"ID-G100 (u)","id":"29066"},{"source":"non-hodgkin","target":"pembrolizumab","id":"29067"},{"source":"non-hodgkin","target":"radiation therapy","id":"29068"},{"source":"antiarrhythmic","target":"ID-G100 (u)","id":"29069"},{"source":"antiarrhythmic","target":"pembrolizumab","id":"29070"},{"source":"antiarrhythmic","target":"radiation therapy","id":"29071"},{"source":"cardiac arrhythmias","target":"ID-G100 (u)","id":"29072"},{"source":"cardiac arrhythmias","target":"pembrolizumab","id":"29073"},{"source":"cardiac arrhythmias","target":"radiation therapy","id":"29074"},{"source":"residual tumor","target":"ID-G100 (u)","id":"29075"},{"source":"residual tumor","target":"pembrolizumab","id":"29076"},{"source":"residual tumor","target":"radiation therapy","id":"29077"},{"source":"lymphoma","target":"ID-G100 (u)","id":"29078"},{"source":"lymphoma","target":"pembrolizumab","id":"29079"},{"source":"lymphoma","target":"radiation therapy","id":"29080"},{"source":"carcinoma","target":"ID-G100 (u)","id":"29081"},{"source":"carcinoma","target":"pembrolizumab","id":"29082"},{"source":"carcinoma","target":"radiation therapy","id":"29083"},{"source":"anti-tumor","target":"ID-G100 (u)","id":"29084"},{"source":"anti-tumor","target":"pembrolizumab","id":"29085"},{"source":"anti-tumor","target":"radiation therapy","id":"29086"},{"source":"lymphoma","target":"ID-G100 (u)","id":"29087"},{"source":"lymphoma","target":"pembrolizumab","id":"29088"},{"source":"lymphoma","target":"radiation therapy","id":"29089"},{"source":"lymphoma","target":"ID-G100 (u)","id":"29090"},{"source":"lymphoma","target":"pembrolizumab","id":"29091"},{"source":"lymphoma","target":"radiation therapy","id":"29092"},{"source":"anticancer","target":"ID-G100 (u)","id":"29093"},{"source":"anticancer","target":"pembrolizumab","id":"29094"},{"source":"anticancer","target":"radiation therapy","id":"29095"},{"source":"lymphoma","target":"ID-G100 (u)","id":"29096"},{"source":"lymphoma","target":"pembrolizumab","id":"29097"},{"source":"lymphoma","target":"radiation therapy","id":"29098"},{"source":"lymphoma","target":"ID-G100 (u)","id":"29099"},{"source":"lymphoma","target":"pembrolizumab","id":"29100"},{"source":"lymphoma","target":"radiation therapy","id":"29101"},{"source":"ischemia","target":"ID-G100 (u)","id":"29102"},{"source":"ischemia","target":"pembrolizumab","id":"29103"},{"source":"ischemia","target":"radiation therapy","id":"29104"},{"source":"lymphoma","target":"ID-G100 (u)","id":"29105"},{"source":"lymphoma","target":"pembrolizumab","id":"29106"},{"source":"lymphoma","target":"radiation therapy","id":"29107"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"29108"},{"source":"Toll-like receptor 9 agonist","target":"lymphoma","id":"29109"},{"source":"Toll-like receptor 9 agonist","target":"lymphoma","id":"29110"},{"source":"Toll-like receptor 9 agonist","target":"follicular","id":"29111"},{"source":"Toll-like receptor 9 agonist","target":"nhl","id":"29112"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"29113"},{"source":"Toll-like receptor 9 agonist","target":"non-hodgkin","id":"29114"},{"source":"Toll-like receptor 9 agonist","target":"antiarrhythmic","id":"29115"},{"source":"Toll-like receptor 9 agonist","target":"cardiac arrhythmias","id":"29116"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"29117"},{"source":"Toll-like receptor 9 agonist","target":"lymphoma","id":"29118"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"29119"},{"source":"Toll-like receptor 9 agonist","target":"anti-tumor","id":"29120"},{"source":"Toll-like receptor 9 agonist","target":"lymphoma","id":"29121"},{"source":"Toll-like receptor 9 agonist","target":"lymphoma","id":"29122"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"29123"},{"source":"Toll-like receptor 9 agonist","target":"lymphoma","id":"29124"},{"source":"Toll-like receptor 9 agonist","target":"lymphoma","id":"29125"},{"source":"Toll-like receptor 9 agonist","target":"ischemia","id":"29126"},{"source":"Toll-like receptor 9 agonist","target":"lymphoma","id":"29127"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"29128"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"29129"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"29130"},{"source":"Immune checkpoint inhibitor","target":"follicular","id":"29131"},{"source":"Immune checkpoint inhibitor","target":"nhl","id":"29132"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"29133"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"29134"},{"source":"Immune checkpoint inhibitor","target":"antiarrhythmic","id":"29135"},{"source":"Immune checkpoint inhibitor","target":"cardiac arrhythmias","id":"29136"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"29137"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"29138"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29139"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"29140"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"29141"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"29142"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"29143"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"29144"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"29145"},{"source":"Immune checkpoint inhibitor","target":"ischemia","id":"29146"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"29147"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"29148"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"29149"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"29150"},{"source":"Anticancer immunotherapy","target":"follicular","id":"29151"},{"source":"Anticancer immunotherapy","target":"nhl","id":"29152"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"29153"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"29154"},{"source":"Anticancer immunotherapy","target":"antiarrhythmic","id":"29155"},{"source":"Anticancer immunotherapy","target":"cardiac arrhythmias","id":"29156"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"29157"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"29158"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29159"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"29160"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"29161"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"29162"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"29163"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"29164"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"29165"},{"source":"Anticancer immunotherapy","target":"ischemia","id":"29166"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"29167"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"29168"},{"source":"CD19 antagonist","target":"lymphoma","id":"29169"},{"source":"CD19 antagonist","target":"lymphoma","id":"29170"},{"source":"CD19 antagonist","target":"follicular","id":"29171"},{"source":"CD19 antagonist","target":"nhl","id":"29172"},{"source":"CD19 antagonist","target":"residual tumor","id":"29173"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"29174"},{"source":"CD19 antagonist","target":"antiarrhythmic","id":"29175"},{"source":"CD19 antagonist","target":"cardiac arrhythmias","id":"29176"},{"source":"CD19 antagonist","target":"residual tumor","id":"29177"},{"source":"CD19 antagonist","target":"lymphoma","id":"29178"},{"source":"CD19 antagonist","target":"carcinoma","id":"29179"},{"source":"CD19 antagonist","target":"anti-tumor","id":"29180"},{"source":"CD19 antagonist","target":"lymphoma","id":"29181"},{"source":"CD19 antagonist","target":"lymphoma","id":"29182"},{"source":"CD19 antagonist","target":"anticancer","id":"29183"},{"source":"CD19 antagonist","target":"lymphoma","id":"29184"},{"source":"CD19 antagonist","target":"lymphoma","id":"29185"},{"source":"CD19 antagonist","target":"ischemia","id":"29186"},{"source":"CD19 antagonist","target":"lymphoma","id":"29187"},{"source":"UPA","target":"UNK : Indication","id":"29188"},{"source":"UPA","target":"lymphoma","id":"29189"},{"source":"UPA","target":"lymphoma","id":"29190"},{"source":"UPA","target":"follicular","id":"29191"},{"source":"UPA","target":"nhl","id":"29192"},{"source":"UPA","target":"residual tumor","id":"29193"},{"source":"UPA","target":"non-hodgkin","id":"29194"},{"source":"UPA","target":"antiarrhythmic","id":"29195"},{"source":"UPA","target":"cardiac arrhythmias","id":"29196"},{"source":"UPA","target":"residual tumor","id":"29197"},{"source":"UPA","target":"lymphoma","id":"29198"},{"source":"UPA","target":"carcinoma","id":"29199"},{"source":"UPA","target":"anti-tumor","id":"29200"},{"source":"UPA","target":"lymphoma","id":"29201"},{"source":"UPA","target":"lymphoma","id":"29202"},{"source":"UPA","target":"anticancer","id":"29203"},{"source":"UPA","target":"lymphoma","id":"29204"},{"source":"UPA","target":"lymphoma","id":"29205"},{"source":"UPA","target":"ischemia","id":"29206"},{"source":"UPA","target":"lymphoma","id":"29207"},{"source":"Immunostimulant","target":"UNK : Indication","id":"29208"},{"source":"Immunostimulant","target":"lymphoma","id":"29209"},{"source":"Immunostimulant","target":"lymphoma","id":"29210"},{"source":"Immunostimulant","target":"follicular","id":"29211"},{"source":"Immunostimulant","target":"nhl","id":"29212"},{"source":"Immunostimulant","target":"residual tumor","id":"29213"},{"source":"Immunostimulant","target":"non-hodgkin","id":"29214"},{"source":"Immunostimulant","target":"antiarrhythmic","id":"29215"},{"source":"Immunostimulant","target":"cardiac arrhythmias","id":"29216"},{"source":"Immunostimulant","target":"residual tumor","id":"29217"},{"source":"Immunostimulant","target":"lymphoma","id":"29218"},{"source":"Immunostimulant","target":"carcinoma","id":"29219"},{"source":"Immunostimulant","target":"anti-tumor","id":"29220"},{"source":"Immunostimulant","target":"lymphoma","id":"29221"},{"source":"Immunostimulant","target":"lymphoma","id":"29222"},{"source":"Immunostimulant","target":"anticancer","id":"29223"},{"source":"Immunostimulant","target":"lymphoma","id":"29224"},{"source":"Immunostimulant","target":"lymphoma","id":"29225"},{"source":"Immunostimulant","target":"ischemia","id":"29226"},{"source":"Immunostimulant","target":"lymphoma","id":"29227"},{"source":"Oncology: Lymphoma","target":"Toll-like receptor 9 agonist","id":"29228"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"29229"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"29230"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"29231"},{"source":"Oncology: Lymphoma","target":"UPA","id":"29232"},{"source":"Oncology: Lymphoma","target":"Immunostimulant","id":"29233"},{"source":"Hodgkin's","target":"Toll-like receptor 9 agonist","id":"29234"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"29235"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"29236"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"29237"},{"source":"Hodgkin's","target":"UPA","id":"29238"},{"source":"Hodgkin's","target":"Immunostimulant","id":"29239"},{"source":"Lm-LLO-PSA vaccine","target":"Advaxis","id":"29240"},{"source":"Advaxis (u)","target":"Advaxis","id":"29241"},{"source":"radiosurgery","target":"Advaxis","id":"29242"},{"source":"UNK : Indication","target":"Lm-LLO-PSA vaccine","id":"29243"},{"source":"UNK : Indication","target":"Advaxis (u)","id":"29244"},{"source":"UNK : Indication","target":"radiosurgery","id":"29245"},{"source":"prostate cancer","target":"Lm-LLO-PSA vaccine","id":"29246"},{"source":"prostate cancer","target":"Advaxis (u)","id":"29247"},{"source":"prostate cancer","target":"radiosurgery","id":"29248"},{"source":"castration-resistant prostatic neoplasms","target":"Lm-LLO-PSA vaccine","id":"29249"},{"source":"castration-resistant prostatic neoplasms","target":"Advaxis (u)","id":"29250"},{"source":"castration-resistant prostatic neoplasms","target":"radiosurgery","id":"29251"},{"source":"metastatic","target":"Lm-LLO-PSA vaccine","id":"29252"},{"source":"metastatic","target":"Advaxis (u)","id":"29253"},{"source":"metastatic","target":"radiosurgery","id":"29254"},{"source":"carcinoma","target":"Lm-LLO-PSA vaccine","id":"29255"},{"source":"carcinoma","target":"Advaxis (u)","id":"29256"},{"source":"carcinoma","target":"radiosurgery","id":"29257"},{"source":"neoplasm metastasis","target":"Lm-LLO-PSA vaccine","id":"29258"},{"source":"neoplasm metastasis","target":"Advaxis (u)","id":"29259"},{"source":"neoplasm metastasis","target":"radiosurgery","id":"29260"},{"source":"anticancer","target":"Lm-LLO-PSA vaccine","id":"29261"},{"source":"anticancer","target":"Advaxis (u)","id":"29262"},{"source":"anticancer","target":"radiosurgery","id":"29263"},{"source":"NA","target":"UNK : Indication","id":"29264"},{"source":"NA","target":"prostate cancer","id":"29265"},{"source":"NA","target":"castration-resistant prostatic neoplasms","id":"29266"},{"source":"NA","target":"metastatic","id":"29267"},{"source":"NA","target":"carcinoma","id":"29268"},{"source":"NA","target":"neoplasm metastasis","id":"29269"},{"source":"NA","target":"anticancer","id":"29270"},{"source":"Immunostimulant","target":"UNK : Indication","id":"29271"},{"source":"Immunostimulant","target":"prostate cancer","id":"29272"},{"source":"Immunostimulant","target":"castration-resistant prostatic neoplasms","id":"29273"},{"source":"Immunostimulant","target":"metastatic","id":"29274"},{"source":"Immunostimulant","target":"carcinoma","id":"29275"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"29276"},{"source":"Immunostimulant","target":"anticancer","id":"29277"},{"source":"Oncology: Prostate","target":"NA","id":"29278"},{"source":"Oncology: Prostate","target":"Immunostimulant","id":"29279"},{"source":"pazopanib (tablet)","target":"Merck & Co.","id":"29280"},{"source":"pazopanib (tablet)","target":"Novartis","id":"29281"},{"source":"pembrolizumab","target":"Merck & Co.","id":"29282"},{"source":"pembrolizumab","target":"Novartis","id":"29283"},{"source":"UNK : Drug","target":"Merck & Co.","id":"29284"},{"source":"UNK : Drug","target":"Novartis","id":"29285"},{"source":"psoriasis","target":"pazopanib (tablet)","id":"29286"},{"source":"psoriasis","target":"pembrolizumab","id":"29287"},{"source":"psoriasis","target":"UNK : Drug","id":"29288"},{"source":"carcinoma","target":"pazopanib (tablet)","id":"29289"},{"source":"carcinoma","target":"pembrolizumab","id":"29290"},{"source":"carcinoma","target":"UNK : Drug","id":"29291"},{"source":"kidney neoplasms","target":"pazopanib (tablet)","id":"29292"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"29293"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"29294"},{"source":"antianaemic","target":"pazopanib (tablet)","id":"29295"},{"source":"antianaemic","target":"pembrolizumab","id":"29296"},{"source":"antianaemic","target":"UNK : Drug","id":"29297"},{"source":"renal cancer","target":"pazopanib (tablet)","id":"29298"},{"source":"renal cancer","target":"pembrolizumab","id":"29299"},{"source":"renal cancer","target":"UNK : Drug","id":"29300"},{"source":"carcinoma","target":"pazopanib (tablet)","id":"29301"},{"source":"carcinoma","target":"pembrolizumab","id":"29302"},{"source":"carcinoma","target":"UNK : Drug","id":"29303"},{"source":"cessation of menses","target":"pazopanib (tablet)","id":"29304"},{"source":"cessation of menses","target":"pembrolizumab","id":"29305"},{"source":"cessation of menses","target":"UNK : Drug","id":"29306"},{"source":"metastatic","target":"pazopanib (tablet)","id":"29307"},{"source":"metastatic","target":"pembrolizumab","id":"29308"},{"source":"metastatic","target":"UNK : Drug","id":"29309"},{"source":"carcinoma","target":"pazopanib (tablet)","id":"29310"},{"source":"carcinoma","target":"pembrolizumab","id":"29311"},{"source":"carcinoma","target":"UNK : Drug","id":"29312"},{"source":"amenorrheic","target":"pazopanib (tablet)","id":"29313"},{"source":"amenorrheic","target":"pembrolizumab","id":"29314"},{"source":"amenorrheic","target":"UNK : Drug","id":"29315"},{"source":"neoplasm metastasis","target":"pazopanib (tablet)","id":"29316"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"29317"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"29318"},{"source":"psoriasis","target":"pazopanib (tablet)","id":"29319"},{"source":"psoriasis","target":"pembrolizumab","id":"29320"},{"source":"psoriasis","target":"UNK : Drug","id":"29321"},{"source":"clear cell","target":"pazopanib (tablet)","id":"29322"},{"source":"clear cell","target":"pembrolizumab","id":"29323"},{"source":"clear cell","target":"UNK : Drug","id":"29324"},{"source":"rcc","target":"pazopanib (tablet)","id":"29325"},{"source":"rcc","target":"pembrolizumab","id":"29326"},{"source":"rcc","target":"UNK : Drug","id":"29327"},{"source":"anticancer","target":"pazopanib (tablet)","id":"29328"},{"source":"anticancer","target":"pembrolizumab","id":"29329"},{"source":"anticancer","target":"UNK : Drug","id":"29330"},{"source":"renal cell","target":"pazopanib (tablet)","id":"29331"},{"source":"renal cell","target":"pembrolizumab","id":"29332"},{"source":"renal cell","target":"UNK : Drug","id":"29333"},{"source":"anemia","target":"pazopanib (tablet)","id":"29334"},{"source":"anemia","target":"pembrolizumab","id":"29335"},{"source":"anemia","target":"UNK : Drug","id":"29336"},{"source":"NA","target":"psoriasis","id":"29337"},{"source":"NA","target":"carcinoma","id":"29338"},{"source":"NA","target":"kidney neoplasms","id":"29339"},{"source":"NA","target":"antianaemic","id":"29340"},{"source":"NA","target":"renal cancer","id":"29341"},{"source":"NA","target":"carcinoma","id":"29342"},{"source":"NA","target":"cessation of menses","id":"29343"},{"source":"NA","target":"metastatic","id":"29344"},{"source":"NA","target":"carcinoma","id":"29345"},{"source":"NA","target":"amenorrheic","id":"29346"},{"source":"NA","target":"neoplasm metastasis","id":"29347"},{"source":"NA","target":"psoriasis","id":"29348"},{"source":"NA","target":"clear cell","id":"29349"},{"source":"NA","target":"rcc","id":"29350"},{"source":"NA","target":"anticancer","id":"29351"},{"source":"NA","target":"renal cell","id":"29352"},{"source":"NA","target":"anemia","id":"29353"},{"source":"NA","target":"psoriasis","id":"29354"},{"source":"NA","target":"carcinoma","id":"29355"},{"source":"NA","target":"kidney neoplasms","id":"29356"},{"source":"NA","target":"antianaemic","id":"29357"},{"source":"NA","target":"renal cancer","id":"29358"},{"source":"NA","target":"carcinoma","id":"29359"},{"source":"NA","target":"cessation of menses","id":"29360"},{"source":"NA","target":"metastatic","id":"29361"},{"source":"NA","target":"carcinoma","id":"29362"},{"source":"NA","target":"amenorrheic","id":"29363"},{"source":"NA","target":"neoplasm metastasis","id":"29364"},{"source":"NA","target":"psoriasis","id":"29365"},{"source":"NA","target":"clear cell","id":"29366"},{"source":"NA","target":"rcc","id":"29367"},{"source":"NA","target":"anticancer","id":"29368"},{"source":"NA","target":"renal cell","id":"29369"},{"source":"NA","target":"anemia","id":"29370"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"29371"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29372"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"29373"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"29374"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"29375"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29376"},{"source":"Immune checkpoint inhibitor","target":"cessation of menses","id":"29377"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"29378"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29379"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"29380"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"29381"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"29382"},{"source":"Immune checkpoint inhibitor","target":"clear cell","id":"29383"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"29384"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"29385"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"29386"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"29387"},{"source":"NA","target":"psoriasis","id":"29388"},{"source":"NA","target":"carcinoma","id":"29389"},{"source":"NA","target":"kidney neoplasms","id":"29390"},{"source":"NA","target":"antianaemic","id":"29391"},{"source":"NA","target":"renal cancer","id":"29392"},{"source":"NA","target":"carcinoma","id":"29393"},{"source":"NA","target":"cessation of menses","id":"29394"},{"source":"NA","target":"metastatic","id":"29395"},{"source":"NA","target":"carcinoma","id":"29396"},{"source":"NA","target":"amenorrheic","id":"29397"},{"source":"NA","target":"neoplasm metastasis","id":"29398"},{"source":"NA","target":"psoriasis","id":"29399"},{"source":"NA","target":"clear cell","id":"29400"},{"source":"NA","target":"rcc","id":"29401"},{"source":"NA","target":"anticancer","id":"29402"},{"source":"NA","target":"renal cell","id":"29403"},{"source":"NA","target":"anemia","id":"29404"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"29405"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29406"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"29407"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"29408"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"29409"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29410"},{"source":"Anticancer immunotherapy","target":"cessation of menses","id":"29411"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"29412"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29413"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"29414"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"29415"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"29416"},{"source":"Anticancer immunotherapy","target":"clear cell","id":"29417"},{"source":"Anticancer immunotherapy","target":"rcc","id":"29418"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"29419"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"29420"},{"source":"Anticancer immunotherapy","target":"anemia","id":"29421"},{"source":"CD19 antagonist","target":"psoriasis","id":"29422"},{"source":"CD19 antagonist","target":"carcinoma","id":"29423"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"29424"},{"source":"CD19 antagonist","target":"antianaemic","id":"29425"},{"source":"CD19 antagonist","target":"renal cancer","id":"29426"},{"source":"CD19 antagonist","target":"carcinoma","id":"29427"},{"source":"CD19 antagonist","target":"cessation of menses","id":"29428"},{"source":"CD19 antagonist","target":"metastatic","id":"29429"},{"source":"CD19 antagonist","target":"carcinoma","id":"29430"},{"source":"CD19 antagonist","target":"amenorrheic","id":"29431"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"29432"},{"source":"CD19 antagonist","target":"psoriasis","id":"29433"},{"source":"CD19 antagonist","target":"clear cell","id":"29434"},{"source":"CD19 antagonist","target":"rcc","id":"29435"},{"source":"CD19 antagonist","target":"anticancer","id":"29436"},{"source":"CD19 antagonist","target":"renal cell","id":"29437"},{"source":"CD19 antagonist","target":"anemia","id":"29438"},{"source":"NA","target":"psoriasis","id":"29439"},{"source":"NA","target":"carcinoma","id":"29440"},{"source":"NA","target":"kidney neoplasms","id":"29441"},{"source":"NA","target":"antianaemic","id":"29442"},{"source":"NA","target":"renal cancer","id":"29443"},{"source":"NA","target":"carcinoma","id":"29444"},{"source":"NA","target":"cessation of menses","id":"29445"},{"source":"NA","target":"metastatic","id":"29446"},{"source":"NA","target":"carcinoma","id":"29447"},{"source":"NA","target":"amenorrheic","id":"29448"},{"source":"NA","target":"neoplasm metastasis","id":"29449"},{"source":"NA","target":"psoriasis","id":"29450"},{"source":"NA","target":"clear cell","id":"29451"},{"source":"NA","target":"rcc","id":"29452"},{"source":"NA","target":"anticancer","id":"29453"},{"source":"NA","target":"renal cell","id":"29454"},{"source":"NA","target":"anemia","id":"29455"},{"source":"NA","target":"psoriasis","id":"29456"},{"source":"NA","target":"carcinoma","id":"29457"},{"source":"NA","target":"kidney neoplasms","id":"29458"},{"source":"NA","target":"antianaemic","id":"29459"},{"source":"NA","target":"renal cancer","id":"29460"},{"source":"NA","target":"carcinoma","id":"29461"},{"source":"NA","target":"cessation of menses","id":"29462"},{"source":"NA","target":"metastatic","id":"29463"},{"source":"NA","target":"carcinoma","id":"29464"},{"source":"NA","target":"amenorrheic","id":"29465"},{"source":"NA","target":"neoplasm metastasis","id":"29466"},{"source":"NA","target":"psoriasis","id":"29467"},{"source":"NA","target":"clear cell","id":"29468"},{"source":"NA","target":"rcc","id":"29469"},{"source":"NA","target":"anticancer","id":"29470"},{"source":"NA","target":"renal cell","id":"29471"},{"source":"NA","target":"anemia","id":"29472"},{"source":"NA","target":"psoriasis","id":"29473"},{"source":"NA","target":"carcinoma","id":"29474"},{"source":"NA","target":"kidney neoplasms","id":"29475"},{"source":"NA","target":"antianaemic","id":"29476"},{"source":"NA","target":"renal cancer","id":"29477"},{"source":"NA","target":"carcinoma","id":"29478"},{"source":"NA","target":"cessation of menses","id":"29479"},{"source":"NA","target":"metastatic","id":"29480"},{"source":"NA","target":"carcinoma","id":"29481"},{"source":"NA","target":"amenorrheic","id":"29482"},{"source":"NA","target":"neoplasm metastasis","id":"29483"},{"source":"NA","target":"psoriasis","id":"29484"},{"source":"NA","target":"clear cell","id":"29485"},{"source":"NA","target":"rcc","id":"29486"},{"source":"NA","target":"anticancer","id":"29487"},{"source":"NA","target":"renal cell","id":"29488"},{"source":"NA","target":"anemia","id":"29489"},{"source":"NA","target":"psoriasis","id":"29490"},{"source":"NA","target":"carcinoma","id":"29491"},{"source":"NA","target":"kidney neoplasms","id":"29492"},{"source":"NA","target":"antianaemic","id":"29493"},{"source":"NA","target":"renal cancer","id":"29494"},{"source":"NA","target":"carcinoma","id":"29495"},{"source":"NA","target":"cessation of menses","id":"29496"},{"source":"NA","target":"metastatic","id":"29497"},{"source":"NA","target":"carcinoma","id":"29498"},{"source":"NA","target":"amenorrheic","id":"29499"},{"source":"NA","target":"neoplasm metastasis","id":"29500"},{"source":"NA","target":"psoriasis","id":"29501"},{"source":"NA","target":"clear cell","id":"29502"},{"source":"NA","target":"rcc","id":"29503"},{"source":"NA","target":"anticancer","id":"29504"},{"source":"NA","target":"renal cell","id":"29505"},{"source":"NA","target":"anemia","id":"29506"},{"source":"Angiogenesis inhibitor","target":"psoriasis","id":"29507"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"29508"},{"source":"Angiogenesis inhibitor","target":"kidney neoplasms","id":"29509"},{"source":"Angiogenesis inhibitor","target":"antianaemic","id":"29510"},{"source":"Angiogenesis inhibitor","target":"renal cancer","id":"29511"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"29512"},{"source":"Angiogenesis inhibitor","target":"cessation of menses","id":"29513"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"29514"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"29515"},{"source":"Angiogenesis inhibitor","target":"amenorrheic","id":"29516"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"29517"},{"source":"Angiogenesis inhibitor","target":"psoriasis","id":"29518"},{"source":"Angiogenesis inhibitor","target":"clear cell","id":"29519"},{"source":"Angiogenesis inhibitor","target":"rcc","id":"29520"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"29521"},{"source":"Angiogenesis inhibitor","target":"renal cell","id":"29522"},{"source":"Angiogenesis inhibitor","target":"anemia","id":"29523"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"psoriasis","id":"29524"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"29525"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"kidney neoplasms","id":"29526"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"antianaemic","id":"29527"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cancer","id":"29528"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"29529"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"cessation of menses","id":"29530"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"metastatic","id":"29531"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"29532"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"amenorrheic","id":"29533"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"neoplasm metastasis","id":"29534"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"psoriasis","id":"29535"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"clear cell","id":"29536"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"rcc","id":"29537"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"29538"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cell","id":"29539"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anemia","id":"29540"},{"source":"NA","target":"psoriasis","id":"29541"},{"source":"NA","target":"carcinoma","id":"29542"},{"source":"NA","target":"kidney neoplasms","id":"29543"},{"source":"NA","target":"antianaemic","id":"29544"},{"source":"NA","target":"renal cancer","id":"29545"},{"source":"NA","target":"carcinoma","id":"29546"},{"source":"NA","target":"cessation of menses","id":"29547"},{"source":"NA","target":"metastatic","id":"29548"},{"source":"NA","target":"carcinoma","id":"29549"},{"source":"NA","target":"amenorrheic","id":"29550"},{"source":"NA","target":"neoplasm metastasis","id":"29551"},{"source":"NA","target":"psoriasis","id":"29552"},{"source":"NA","target":"clear cell","id":"29553"},{"source":"NA","target":"rcc","id":"29554"},{"source":"NA","target":"anticancer","id":"29555"},{"source":"NA","target":"renal cell","id":"29556"},{"source":"NA","target":"anemia","id":"29557"},{"source":"C-kit inhibitor","target":"psoriasis","id":"29558"},{"source":"C-kit inhibitor","target":"carcinoma","id":"29559"},{"source":"C-kit inhibitor","target":"kidney neoplasms","id":"29560"},{"source":"C-kit inhibitor","target":"antianaemic","id":"29561"},{"source":"C-kit inhibitor","target":"renal cancer","id":"29562"},{"source":"C-kit inhibitor","target":"carcinoma","id":"29563"},{"source":"C-kit inhibitor","target":"cessation of menses","id":"29564"},{"source":"C-kit inhibitor","target":"metastatic","id":"29565"},{"source":"C-kit inhibitor","target":"carcinoma","id":"29566"},{"source":"C-kit inhibitor","target":"amenorrheic","id":"29567"},{"source":"C-kit inhibitor","target":"neoplasm metastasis","id":"29568"},{"source":"C-kit inhibitor","target":"psoriasis","id":"29569"},{"source":"C-kit inhibitor","target":"clear cell","id":"29570"},{"source":"C-kit inhibitor","target":"rcc","id":"29571"},{"source":"C-kit inhibitor","target":"anticancer","id":"29572"},{"source":"C-kit inhibitor","target":"renal cell","id":"29573"},{"source":"C-kit inhibitor","target":"anemia","id":"29574"},{"source":"Oncology: Renal","target":"NA","id":"29575"},{"source":"Oncology: Renal","target":"NA","id":"29576"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"29577"},{"source":"Oncology: Renal","target":"NA","id":"29578"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"29579"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"29580"},{"source":"Oncology: Renal","target":"NA","id":"29581"},{"source":"Oncology: Renal","target":"NA","id":"29582"},{"source":"Oncology: Renal","target":"NA","id":"29583"},{"source":"Oncology: Renal","target":"NA","id":"29584"},{"source":"Oncology: Renal","target":"Angiogenesis inhibitor","id":"29585"},{"source":"Oncology: Renal","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"29586"},{"source":"Oncology: Renal","target":"NA","id":"29587"},{"source":"Oncology: Renal","target":"C-kit inhibitor","id":"29588"},{"source":"talimogene laherparepvec (intratumoral) (a)","target":"Amgen","id":"29589"},{"source":"talimogene laherparepvec (intratumoral) (a)","target":"Merck & Co.","id":"29590"},{"source":"pembrolizumab","target":"Amgen","id":"29591"},{"source":"pembrolizumab","target":"Merck & Co.","id":"29592"},{"source":"UNK : Indication","target":"talimogene laherparepvec (intratumoral) (a)","id":"29593"},{"source":"UNK : Indication","target":"pembrolizumab","id":"29594"},{"source":"carcinoma","target":"talimogene laherparepvec (intratumoral) (a)","id":"29595"},{"source":"carcinoma","target":"pembrolizumab","id":"29596"},{"source":"squamous cell neoplasms","target":"talimogene laherparepvec (intratumoral) (a)","id":"29597"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"29598"},{"source":"hpv type","target":"talimogene laherparepvec (intratumoral) (a)","id":"29599"},{"source":"hpv type","target":"pembrolizumab","id":"29600"},{"source":"residual tumor","target":"talimogene laherparepvec (intratumoral) (a)","id":"29601"},{"source":"residual tumor","target":"pembrolizumab","id":"29602"},{"source":"carcinoma","target":"talimogene laherparepvec (intratumoral) (a)","id":"29603"},{"source":"carcinoma","target":"pembrolizumab","id":"29604"},{"source":"squamous cell neoplasms","target":"talimogene laherparepvec (intratumoral) (a)","id":"29605"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"29606"},{"source":"residual tumor","target":"talimogene laherparepvec (intratumoral) (a)","id":"29607"},{"source":"residual tumor","target":"pembrolizumab","id":"29608"},{"source":"liver metastases","target":"talimogene laherparepvec (intratumoral) (a)","id":"29609"},{"source":"liver metastases","target":"pembrolizumab","id":"29610"},{"source":"hpv testing","target":"talimogene laherparepvec (intratumoral) (a)","id":"29611"},{"source":"hpv testing","target":"pembrolizumab","id":"29612"},{"source":"metastatic","target":"talimogene laherparepvec (intratumoral) (a)","id":"29613"},{"source":"metastatic","target":"pembrolizumab","id":"29614"},{"source":"carcinoma","target":"talimogene laherparepvec (intratumoral) (a)","id":"29615"},{"source":"carcinoma","target":"pembrolizumab","id":"29616"},{"source":"oropharyngeal cancer","target":"talimogene laherparepvec (intratumoral) (a)","id":"29617"},{"source":"oropharyngeal cancer","target":"pembrolizumab","id":"29618"},{"source":"neoplasm metastasis","target":"talimogene laherparepvec (intratumoral) (a)","id":"29619"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"29620"},{"source":"anticancer","target":"talimogene laherparepvec (intratumoral) (a)","id":"29621"},{"source":"anticancer","target":"pembrolizumab","id":"29622"},{"source":"papilloma","target":"talimogene laherparepvec (intratumoral) (a)","id":"29623"},{"source":"papilloma","target":"pembrolizumab","id":"29624"},{"source":"pharyngeal neoplasms","target":"talimogene laherparepvec (intratumoral) (a)","id":"29625"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"29626"},{"source":"carcinoma","target":"talimogene laherparepvec (intratumoral) (a)","id":"29627"},{"source":"carcinoma","target":"pembrolizumab","id":"29628"},{"source":"head and neck neoplasms","target":"talimogene laherparepvec (intratumoral) (a)","id":"29629"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"29630"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"29631"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29632"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"29633"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"29634"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"29635"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29636"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"29637"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"29638"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"29639"},{"source":"Anticancer immunotherapy","target":"hpv testing","id":"29640"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"29641"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29642"},{"source":"Anticancer immunotherapy","target":"oropharyngeal cancer","id":"29643"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"29644"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"29645"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"29646"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"29647"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29648"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"29649"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"29650"},{"source":"CD19 antagonist","target":"carcinoma","id":"29651"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"29652"},{"source":"CD19 antagonist","target":"hpv type","id":"29653"},{"source":"CD19 antagonist","target":"residual tumor","id":"29654"},{"source":"CD19 antagonist","target":"carcinoma","id":"29655"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"29656"},{"source":"CD19 antagonist","target":"residual tumor","id":"29657"},{"source":"CD19 antagonist","target":"liver metastases","id":"29658"},{"source":"CD19 antagonist","target":"hpv testing","id":"29659"},{"source":"CD19 antagonist","target":"metastatic","id":"29660"},{"source":"CD19 antagonist","target":"carcinoma","id":"29661"},{"source":"CD19 antagonist","target":"oropharyngeal cancer","id":"29662"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"29663"},{"source":"CD19 antagonist","target":"anticancer","id":"29664"},{"source":"CD19 antagonist","target":"papilloma","id":"29665"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"29666"},{"source":"CD19 antagonist","target":"carcinoma","id":"29667"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"29668"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"UNK : Indication","id":"29669"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"29670"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"squamous cell neoplasms","id":"29671"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"hpv type","id":"29672"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"29673"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"29674"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"squamous cell neoplasms","id":"29675"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"29676"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"liver metastases","id":"29677"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"hpv testing","id":"29678"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"metastatic","id":"29679"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"29680"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"oropharyngeal cancer","id":"29681"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"neoplasm metastasis","id":"29682"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"29683"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"papilloma","id":"29684"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"pharyngeal neoplasms","id":"29685"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"29686"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"head and neck neoplasms","id":"29687"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"29688"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29689"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"29690"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"29691"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"29692"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29693"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"29694"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"29695"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"29696"},{"source":"Immune checkpoint inhibitor","target":"hpv testing","id":"29697"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"29698"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29699"},{"source":"Immune checkpoint inhibitor","target":"oropharyngeal cancer","id":"29700"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"29701"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"29702"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"29703"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"29704"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29705"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"29706"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"29707"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"29708"},{"source":"Oncology: Head/Neck","target":"Granulocyte macrophage colony stimulating factor agonist","id":"29709"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"29710"},{"source":"TRX-518 (u)","target":"Leap Therapeutics/Macrocure","id":"29711"},{"source":"gemcitabine hydrochloride","target":"Leap Therapeutics/Macrocure","id":"29712"},{"source":"nivolumab (a)","target":"Leap Therapeutics/Macrocure","id":"29713"},{"source":"pembrolizumab","target":"Leap Therapeutics/Macrocure","id":"29714"},{"source":"UNK : Indication","target":"TRX-518 (u)","id":"29715"},{"source":"UNK : Indication","target":"gemcitabine hydrochloride","id":"29716"},{"source":"UNK : Indication","target":"nivolumab (a)","id":"29717"},{"source":"UNK : Indication","target":"pembrolizumab","id":"29718"},{"source":"solid tumors","target":"TRX-518 (u)","id":"29719"},{"source":"solid tumors","target":"gemcitabine hydrochloride","id":"29720"},{"source":"solid tumors","target":"nivolumab (a)","id":"29721"},{"source":"solid tumors","target":"pembrolizumab","id":"29722"},{"source":"skin neoplasms","target":"TRX-518 (u)","id":"29723"},{"source":"skin neoplasms","target":"gemcitabine hydrochloride","id":"29724"},{"source":"skin neoplasms","target":"nivolumab (a)","id":"29725"},{"source":"skin neoplasms","target":"pembrolizumab","id":"29726"},{"source":"unknown primary","target":"TRX-518 (u)","id":"29727"},{"source":"unknown primary","target":"gemcitabine hydrochloride","id":"29728"},{"source":"unknown primary","target":"nivolumab (a)","id":"29729"},{"source":"unknown primary","target":"pembrolizumab","id":"29730"},{"source":"carcinoma","target":"TRX-518 (u)","id":"29731"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"29732"},{"source":"carcinoma","target":"nivolumab (a)","id":"29733"},{"source":"carcinoma","target":"pembrolizumab","id":"29734"},{"source":"anticancer","target":"TRX-518 (u)","id":"29735"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"29736"},{"source":"anticancer","target":"nivolumab (a)","id":"29737"},{"source":"anticancer","target":"pembrolizumab","id":"29738"},{"source":"unknown primary","target":"TRX-518 (u)","id":"29739"},{"source":"unknown primary","target":"gemcitabine hydrochloride","id":"29740"},{"source":"unknown primary","target":"nivolumab (a)","id":"29741"},{"source":"unknown primary","target":"pembrolizumab","id":"29742"},{"source":"solid tumors","target":"TRX-518 (u)","id":"29743"},{"source":"solid tumors","target":"gemcitabine hydrochloride","id":"29744"},{"source":"solid tumors","target":"nivolumab (a)","id":"29745"},{"source":"solid tumors","target":"pembrolizumab","id":"29746"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"UNK : Indication","id":"29747"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"solid tumors","id":"29748"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"skin neoplasms","id":"29749"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"unknown primary","id":"29750"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"carcinoma","id":"29751"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"anticancer","id":"29752"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"unknown primary","id":"29753"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"solid tumors","id":"29754"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"29755"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"29756"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"29757"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"29758"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29759"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"29760"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"29761"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"29762"},{"source":"Immune checkpoint stimulant","target":"UNK : Indication","id":"29763"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"29764"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"29765"},{"source":"Immune checkpoint stimulant","target":"unknown primary","id":"29766"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"29767"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"29768"},{"source":"Immune checkpoint stimulant","target":"unknown primary","id":"29769"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"29770"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"29771"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"29772"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"29773"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"29774"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29775"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"29776"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"29777"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"29778"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"29779"},{"source":"CD19 antagonist","target":"solid tumors","id":"29780"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"29781"},{"source":"CD19 antagonist","target":"unknown primary","id":"29782"},{"source":"CD19 antagonist","target":"carcinoma","id":"29783"},{"source":"CD19 antagonist","target":"anticancer","id":"29784"},{"source":"CD19 antagonist","target":"unknown primary","id":"29785"},{"source":"CD19 antagonist","target":"solid tumors","id":"29786"},{"source":"NA","target":"UNK : Indication","id":"29787"},{"source":"NA","target":"solid tumors","id":"29788"},{"source":"NA","target":"skin neoplasms","id":"29789"},{"source":"NA","target":"unknown primary","id":"29790"},{"source":"NA","target":"carcinoma","id":"29791"},{"source":"NA","target":"anticancer","id":"29792"},{"source":"NA","target":"unknown primary","id":"29793"},{"source":"NA","target":"solid tumors","id":"29794"},{"source":"NA","target":"UNK : Indication","id":"29795"},{"source":"NA","target":"solid tumors","id":"29796"},{"source":"NA","target":"skin neoplasms","id":"29797"},{"source":"NA","target":"unknown primary","id":"29798"},{"source":"NA","target":"carcinoma","id":"29799"},{"source":"NA","target":"anticancer","id":"29800"},{"source":"NA","target":"unknown primary","id":"29801"},{"source":"NA","target":"solid tumors","id":"29802"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"29803"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"29804"},{"source":"Cell cycle inhibitor","target":"skin neoplasms","id":"29805"},{"source":"Cell cycle inhibitor","target":"unknown primary","id":"29806"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"29807"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"29808"},{"source":"Cell cycle inhibitor","target":"unknown primary","id":"29809"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"29810"},{"source":"Oncology: CNS","target":"Glucocorticoid-induced TNFR-related protein agonist","id":"29811"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"29812"},{"source":"Oncology: CNS","target":"Immune checkpoint stimulant","id":"29813"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"29814"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"29815"},{"source":"Oncology: CNS","target":"NA","id":"29816"},{"source":"Oncology: CNS","target":"NA","id":"29817"},{"source":"Oncology: CNS","target":"Cell cycle inhibitor","id":"29818"},{"source":"pembrolizumab","target":"Merck & Co.","id":"29819"},{"source":"cisplatin","target":"Merck & Co.","id":"29820"},{"source":"radiation therapy","target":"Merck & Co.","id":"29821"},{"source":"UNK : Indication","target":"pembrolizumab","id":"29822"},{"source":"UNK : Indication","target":"cisplatin","id":"29823"},{"source":"UNK : Indication","target":"radiation therapy","id":"29824"},{"source":"carcinoma","target":"pembrolizumab","id":"29825"},{"source":"carcinoma","target":"cisplatin","id":"29826"},{"source":"carcinoma","target":"radiation therapy","id":"29827"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"29828"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"29829"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"29830"},{"source":"head and neck cancer","target":"pembrolizumab","id":"29831"},{"source":"head and neck cancer","target":"cisplatin","id":"29832"},{"source":"head and neck cancer","target":"radiation therapy","id":"29833"},{"source":"anticancer","target":"pembrolizumab","id":"29834"},{"source":"anticancer","target":"cisplatin","id":"29835"},{"source":"anticancer","target":"radiation therapy","id":"29836"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"29837"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"29838"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"29839"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"29840"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"29841"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"29842"},{"source":"residual tumor","target":"pembrolizumab","id":"29843"},{"source":"residual tumor","target":"cisplatin","id":"29844"},{"source":"residual tumor","target":"radiation therapy","id":"29845"},{"source":"carcinoma","target":"pembrolizumab","id":"29846"},{"source":"carcinoma","target":"cisplatin","id":"29847"},{"source":"carcinoma","target":"radiation therapy","id":"29848"},{"source":"carcinoma","target":"pembrolizumab","id":"29849"},{"source":"carcinoma","target":"cisplatin","id":"29850"},{"source":"carcinoma","target":"radiation therapy","id":"29851"},{"source":"anticancer","target":"pembrolizumab","id":"29852"},{"source":"anticancer","target":"cisplatin","id":"29853"},{"source":"anticancer","target":"radiation therapy","id":"29854"},{"source":"skin neoplasms","target":"pembrolizumab","id":"29855"},{"source":"skin neoplasms","target":"cisplatin","id":"29856"},{"source":"skin neoplasms","target":"radiation therapy","id":"29857"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"29858"},{"source":"head and neck neoplasms","target":"cisplatin","id":"29859"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"29860"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"29861"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29862"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"29863"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"29864"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"29865"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"29866"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"29867"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"29868"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29869"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"29870"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"29871"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"29872"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"29873"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"29874"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29875"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"29876"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"29877"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"29878"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"29879"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"29880"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"29881"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29882"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"29883"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"29884"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"29885"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"29886"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"29887"},{"source":"CD19 antagonist","target":"carcinoma","id":"29888"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"29889"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"29890"},{"source":"CD19 antagonist","target":"anticancer","id":"29891"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"29892"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"29893"},{"source":"CD19 antagonist","target":"residual tumor","id":"29894"},{"source":"CD19 antagonist","target":"carcinoma","id":"29895"},{"source":"CD19 antagonist","target":"carcinoma","id":"29896"},{"source":"CD19 antagonist","target":"anticancer","id":"29897"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"29898"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"29899"},{"source":"UPA","target":"UNK : Indication","id":"29900"},{"source":"UPA","target":"carcinoma","id":"29901"},{"source":"UPA","target":"squamous cell neoplasms","id":"29902"},{"source":"UPA","target":"head and neck cancer","id":"29903"},{"source":"UPA","target":"anticancer","id":"29904"},{"source":"UPA","target":"pharyngeal neoplasms","id":"29905"},{"source":"UPA","target":"squamous cell neoplasms","id":"29906"},{"source":"UPA","target":"residual tumor","id":"29907"},{"source":"UPA","target":"carcinoma","id":"29908"},{"source":"UPA","target":"carcinoma","id":"29909"},{"source":"UPA","target":"anticancer","id":"29910"},{"source":"UPA","target":"skin neoplasms","id":"29911"},{"source":"UPA","target":"head and neck neoplasms","id":"29912"},{"source":"NA","target":"UNK : Indication","id":"29913"},{"source":"NA","target":"carcinoma","id":"29914"},{"source":"NA","target":"squamous cell neoplasms","id":"29915"},{"source":"NA","target":"head and neck cancer","id":"29916"},{"source":"NA","target":"anticancer","id":"29917"},{"source":"NA","target":"pharyngeal neoplasms","id":"29918"},{"source":"NA","target":"squamous cell neoplasms","id":"29919"},{"source":"NA","target":"residual tumor","id":"29920"},{"source":"NA","target":"carcinoma","id":"29921"},{"source":"NA","target":"carcinoma","id":"29922"},{"source":"NA","target":"anticancer","id":"29923"},{"source":"NA","target":"skin neoplasms","id":"29924"},{"source":"NA","target":"head and neck neoplasms","id":"29925"},{"source":"NA","target":"UNK : Indication","id":"29926"},{"source":"NA","target":"carcinoma","id":"29927"},{"source":"NA","target":"squamous cell neoplasms","id":"29928"},{"source":"NA","target":"head and neck cancer","id":"29929"},{"source":"NA","target":"anticancer","id":"29930"},{"source":"NA","target":"pharyngeal neoplasms","id":"29931"},{"source":"NA","target":"squamous cell neoplasms","id":"29932"},{"source":"NA","target":"residual tumor","id":"29933"},{"source":"NA","target":"carcinoma","id":"29934"},{"source":"NA","target":"carcinoma","id":"29935"},{"source":"NA","target":"anticancer","id":"29936"},{"source":"NA","target":"skin neoplasms","id":"29937"},{"source":"NA","target":"head and neck neoplasms","id":"29938"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"29939"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"29940"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"29941"},{"source":"Oncology: Head/Neck","target":"UPA","id":"29942"},{"source":"Oncology: Head/Neck","target":"NA","id":"29943"},{"source":"Oncology: Head/Neck","target":"NA","id":"29944"},{"source":"ipilimumab","target":"(Other Hospital/Academic/Medical Center)","id":"29945"},{"source":"ipilimumab","target":"Medical Health Research Infrastructure Council (MHRIC - Australia","id":"29946"},{"source":"nivolumab (a)","target":"(Other Hospital/Academic/Medical Center)","id":"29947"},{"source":"nivolumab (a)","target":"Medical Health Research Infrastructure Council (MHRIC - Australia","id":"29948"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"29949"},{"source":"pembrolizumab","target":"Medical Health Research Infrastructure Council (MHRIC - Australia","id":"29950"},{"source":"radiosurgery","target":"(Other Hospital/Academic/Medical Center)","id":"29951"},{"source":"radiosurgery","target":"Medical Health Research Infrastructure Council (MHRIC - Australia","id":"29952"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"29953"},{"source":"UNK : Drug","target":"Medical Health Research Infrastructure Council (MHRIC - Australia","id":"29954"},{"source":"UNK : Indication","target":"ipilimumab","id":"29955"},{"source":"UNK : Indication","target":"nivolumab (a)","id":"29956"},{"source":"UNK : Indication","target":"pembrolizumab","id":"29957"},{"source":"UNK : Indication","target":"radiosurgery","id":"29958"},{"source":"UNK : Indication","target":"UNK : Drug","id":"29959"},{"source":"anti-hiv","target":"ipilimumab","id":"29960"},{"source":"anti-hiv","target":"nivolumab (a)","id":"29961"},{"source":"anti-hiv","target":"pembrolizumab","id":"29962"},{"source":"anti-hiv","target":"radiosurgery","id":"29963"},{"source":"anti-hiv","target":"UNK : Drug","id":"29964"},{"source":"melanoma","target":"ipilimumab","id":"29965"},{"source":"melanoma","target":"nivolumab (a)","id":"29966"},{"source":"melanoma","target":"pembrolizumab","id":"29967"},{"source":"melanoma","target":"radiosurgery","id":"29968"},{"source":"melanoma","target":"UNK : Drug","id":"29969"},{"source":"melanoma","target":"ipilimumab","id":"29970"},{"source":"melanoma","target":"nivolumab (a)","id":"29971"},{"source":"melanoma","target":"pembrolizumab","id":"29972"},{"source":"melanoma","target":"radiosurgery","id":"29973"},{"source":"melanoma","target":"UNK : Drug","id":"29974"},{"source":"liver metastases","target":"ipilimumab","id":"29975"},{"source":"liver metastases","target":"nivolumab (a)","id":"29976"},{"source":"liver metastases","target":"pembrolizumab","id":"29977"},{"source":"liver metastases","target":"radiosurgery","id":"29978"},{"source":"liver metastases","target":"UNK : Drug","id":"29979"},{"source":"skin neoplasms","target":"ipilimumab","id":"29980"},{"source":"skin neoplasms","target":"nivolumab (a)","id":"29981"},{"source":"skin neoplasms","target":"pembrolizumab","id":"29982"},{"source":"skin neoplasms","target":"radiosurgery","id":"29983"},{"source":"skin neoplasms","target":"UNK : Drug","id":"29984"},{"source":"carcinoma","target":"ipilimumab","id":"29985"},{"source":"carcinoma","target":"nivolumab (a)","id":"29986"},{"source":"carcinoma","target":"pembrolizumab","id":"29987"},{"source":"carcinoma","target":"radiosurgery","id":"29988"},{"source":"carcinoma","target":"UNK : Drug","id":"29989"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"29990"},{"source":"neoplasm metastasis","target":"nivolumab (a)","id":"29991"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"29992"},{"source":"neoplasm metastasis","target":"radiosurgery","id":"29993"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"29994"},{"source":"anticancer","target":"ipilimumab","id":"29995"},{"source":"anticancer","target":"nivolumab (a)","id":"29996"},{"source":"anticancer","target":"pembrolizumab","id":"29997"},{"source":"anticancer","target":"radiosurgery","id":"29998"},{"source":"anticancer","target":"UNK : Drug","id":"29999"},{"source":"hiv infections","target":"ipilimumab","id":"30000"},{"source":"hiv infections","target":"nivolumab (a)","id":"30001"},{"source":"hiv infections","target":"pembrolizumab","id":"30002"},{"source":"hiv infections","target":"radiosurgery","id":"30003"},{"source":"hiv infections","target":"UNK : Drug","id":"30004"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"30005"},{"source":"acquired immunodeficiency syndrome","target":"nivolumab (a)","id":"30006"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"30007"},{"source":"acquired immunodeficiency syndrome","target":"radiosurgery","id":"30008"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"30009"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"30010"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"30011"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"30012"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"30013"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"30014"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"30015"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30016"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"30017"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"30018"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"30019"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"30020"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"30021"},{"source":"CD19 antagonist","target":"anti-hiv","id":"30022"},{"source":"CD19 antagonist","target":"melanoma","id":"30023"},{"source":"CD19 antagonist","target":"melanoma","id":"30024"},{"source":"CD19 antagonist","target":"liver metastases","id":"30025"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"30026"},{"source":"CD19 antagonist","target":"carcinoma","id":"30027"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"30028"},{"source":"CD19 antagonist","target":"anticancer","id":"30029"},{"source":"CD19 antagonist","target":"hiv infections","id":"30030"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"30031"},{"source":"NA","target":"UNK : Indication","id":"30032"},{"source":"NA","target":"anti-hiv","id":"30033"},{"source":"NA","target":"melanoma","id":"30034"},{"source":"NA","target":"melanoma","id":"30035"},{"source":"NA","target":"liver metastases","id":"30036"},{"source":"NA","target":"skin neoplasms","id":"30037"},{"source":"NA","target":"carcinoma","id":"30038"},{"source":"NA","target":"neoplasm metastasis","id":"30039"},{"source":"NA","target":"anticancer","id":"30040"},{"source":"NA","target":"hiv infections","id":"30041"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"30042"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"30043"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"30044"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"30045"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"30046"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"30047"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"30048"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30049"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"30050"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"30051"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"30052"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"30053"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"30054"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"30055"},{"source":"CTLA4 antagonist","target":"melanoma","id":"30056"},{"source":"CTLA4 antagonist","target":"melanoma","id":"30057"},{"source":"CTLA4 antagonist","target":"liver metastases","id":"30058"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"30059"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"30060"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"30061"},{"source":"CTLA4 antagonist","target":"anticancer","id":"30062"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"30063"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"30064"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"30065"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"30066"},{"source":"Oncology: Melanoma","target":"NA","id":"30067"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"30068"},{"source":"Oncology: Melanoma","target":"CTLA4 antagonist","id":"30069"},{"source":"pembrolizumab","target":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","id":"30070"},{"source":"pembrolizumab","target":"Merck & Co.","id":"30071"},{"source":"doxorubicin HCL","target":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","id":"30072"},{"source":"doxorubicin HCL","target":"Merck & Co.","id":"30073"},{"source":"pegylated liposomal doxorubicin","target":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","id":"30074"},{"source":"pegylated liposomal doxorubicin","target":"Merck & Co.","id":"30075"},{"source":"unspecified","target":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","id":"30076"},{"source":"unspecified","target":"Merck & Co.","id":"30077"},{"source":"UNK : Indication","target":"pembrolizumab","id":"30078"},{"source":"UNK : Indication","target":"doxorubicin HCL","id":"30079"},{"source":"UNK : Indication","target":"pegylated liposomal doxorubicin","id":"30080"},{"source":"UNK : Indication","target":"unspecified","id":"30081"},{"source":"anticancer","target":"pembrolizumab","id":"30082"},{"source":"anticancer","target":"doxorubicin HCL","id":"30083"},{"source":"anticancer","target":"pegylated liposomal doxorubicin","id":"30084"},{"source":"anticancer","target":"unspecified","id":"30085"},{"source":"ovarian cancer","target":"pembrolizumab","id":"30086"},{"source":"ovarian cancer","target":"doxorubicin HCL","id":"30087"},{"source":"ovarian cancer","target":"pegylated liposomal doxorubicin","id":"30088"},{"source":"ovarian cancer","target":"unspecified","id":"30089"},{"source":"ovarian cancer","target":"pembrolizumab","id":"30090"},{"source":"ovarian cancer","target":"doxorubicin HCL","id":"30091"},{"source":"ovarian cancer","target":"pegylated liposomal doxorubicin","id":"30092"},{"source":"ovarian cancer","target":"unspecified","id":"30093"},{"source":"sarcoma","target":"pembrolizumab","id":"30094"},{"source":"sarcoma","target":"doxorubicin HCL","id":"30095"},{"source":"sarcoma","target":"pegylated liposomal doxorubicin","id":"30096"},{"source":"sarcoma","target":"unspecified","id":"30097"},{"source":"liver metastases","target":"pembrolizumab","id":"30098"},{"source":"liver metastases","target":"doxorubicin HCL","id":"30099"},{"source":"liver metastases","target":"pegylated liposomal doxorubicin","id":"30100"},{"source":"liver metastases","target":"unspecified","id":"30101"},{"source":"primary peritoneal cancer","target":"pembrolizumab","id":"30102"},{"source":"primary peritoneal cancer","target":"doxorubicin HCL","id":"30103"},{"source":"primary peritoneal cancer","target":"pegylated liposomal doxorubicin","id":"30104"},{"source":"primary peritoneal cancer","target":"unspecified","id":"30105"},{"source":"liver neoplasms","target":"pembrolizumab","id":"30106"},{"source":"liver neoplasms","target":"doxorubicin HCL","id":"30107"},{"source":"liver neoplasms","target":"pegylated liposomal doxorubicin","id":"30108"},{"source":"liver neoplasms","target":"unspecified","id":"30109"},{"source":"residual tumor","target":"pembrolizumab","id":"30110"},{"source":"residual tumor","target":"doxorubicin HCL","id":"30111"},{"source":"residual tumor","target":"pegylated liposomal doxorubicin","id":"30112"},{"source":"residual tumor","target":"unspecified","id":"30113"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"30114"},{"source":"fallopian tube neoplasms","target":"doxorubicin HCL","id":"30115"},{"source":"fallopian tube neoplasms","target":"pegylated liposomal doxorubicin","id":"30116"},{"source":"fallopian tube neoplasms","target":"unspecified","id":"30117"},{"source":"carcinoma","target":"pembrolizumab","id":"30118"},{"source":"carcinoma","target":"doxorubicin HCL","id":"30119"},{"source":"carcinoma","target":"pegylated liposomal doxorubicin","id":"30120"},{"source":"carcinoma","target":"unspecified","id":"30121"},{"source":"sarcoma","target":"pembrolizumab","id":"30122"},{"source":"sarcoma","target":"doxorubicin HCL","id":"30123"},{"source":"sarcoma","target":"pegylated liposomal doxorubicin","id":"30124"},{"source":"sarcoma","target":"unspecified","id":"30125"},{"source":"anticancer","target":"pembrolizumab","id":"30126"},{"source":"anticancer","target":"doxorubicin HCL","id":"30127"},{"source":"anticancer","target":"pegylated liposomal doxorubicin","id":"30128"},{"source":"anticancer","target":"unspecified","id":"30129"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"30130"},{"source":"peritoneal neoplasms","target":"doxorubicin HCL","id":"30131"},{"source":"peritoneal neoplasms","target":"pegylated liposomal doxorubicin","id":"30132"},{"source":"peritoneal neoplasms","target":"unspecified","id":"30133"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"30134"},{"source":"ovarian neoplasms","target":"doxorubicin HCL","id":"30135"},{"source":"ovarian neoplasms","target":"pegylated liposomal doxorubicin","id":"30136"},{"source":"ovarian neoplasms","target":"unspecified","id":"30137"},{"source":"ovarian cancer","target":"pembrolizumab","id":"30138"},{"source":"ovarian cancer","target":"doxorubicin HCL","id":"30139"},{"source":"ovarian cancer","target":"pegylated liposomal doxorubicin","id":"30140"},{"source":"ovarian cancer","target":"unspecified","id":"30141"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"30142"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"30143"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"30144"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"30145"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"30146"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"30147"},{"source":"Immune checkpoint inhibitor","target":"primary peritoneal cancer","id":"30148"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"30149"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"30150"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"30151"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30152"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"30153"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"30154"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"30155"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"30156"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"30157"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"30158"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"30159"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"30160"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"30161"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"30162"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"30163"},{"source":"Anticancer immunotherapy","target":"primary peritoneal cancer","id":"30164"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"30165"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"30166"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"30167"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30168"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"30169"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"30170"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"30171"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"30172"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"30173"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"30174"},{"source":"CD19 antagonist","target":"anticancer","id":"30175"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"30176"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"30177"},{"source":"CD19 antagonist","target":"sarcoma","id":"30178"},{"source":"CD19 antagonist","target":"liver metastases","id":"30179"},{"source":"CD19 antagonist","target":"primary peritoneal cancer","id":"30180"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"30181"},{"source":"CD19 antagonist","target":"residual tumor","id":"30182"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"30183"},{"source":"CD19 antagonist","target":"carcinoma","id":"30184"},{"source":"CD19 antagonist","target":"sarcoma","id":"30185"},{"source":"CD19 antagonist","target":"anticancer","id":"30186"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"30187"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"30188"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"30189"},{"source":"NA","target":"UNK : Indication","id":"30190"},{"source":"NA","target":"anticancer","id":"30191"},{"source":"NA","target":"ovarian cancer","id":"30192"},{"source":"NA","target":"ovarian cancer","id":"30193"},{"source":"NA","target":"sarcoma","id":"30194"},{"source":"NA","target":"liver metastases","id":"30195"},{"source":"NA","target":"primary peritoneal cancer","id":"30196"},{"source":"NA","target":"liver neoplasms","id":"30197"},{"source":"NA","target":"residual tumor","id":"30198"},{"source":"NA","target":"fallopian tube neoplasms","id":"30199"},{"source":"NA","target":"carcinoma","id":"30200"},{"source":"NA","target":"sarcoma","id":"30201"},{"source":"NA","target":"anticancer","id":"30202"},{"source":"NA","target":"peritoneal neoplasms","id":"30203"},{"source":"NA","target":"ovarian neoplasms","id":"30204"},{"source":"NA","target":"ovarian cancer","id":"30205"},{"source":"NA","target":"UNK : Indication","id":"30206"},{"source":"NA","target":"anticancer","id":"30207"},{"source":"NA","target":"ovarian cancer","id":"30208"},{"source":"NA","target":"ovarian cancer","id":"30209"},{"source":"NA","target":"sarcoma","id":"30210"},{"source":"NA","target":"liver metastases","id":"30211"},{"source":"NA","target":"primary peritoneal cancer","id":"30212"},{"source":"NA","target":"liver neoplasms","id":"30213"},{"source":"NA","target":"residual tumor","id":"30214"},{"source":"NA","target":"fallopian tube neoplasms","id":"30215"},{"source":"NA","target":"carcinoma","id":"30216"},{"source":"NA","target":"sarcoma","id":"30217"},{"source":"NA","target":"anticancer","id":"30218"},{"source":"NA","target":"peritoneal neoplasms","id":"30219"},{"source":"NA","target":"ovarian neoplasms","id":"30220"},{"source":"NA","target":"ovarian cancer","id":"30221"},{"source":"NA","target":"UNK : Indication","id":"30222"},{"source":"NA","target":"anticancer","id":"30223"},{"source":"NA","target":"ovarian cancer","id":"30224"},{"source":"NA","target":"ovarian cancer","id":"30225"},{"source":"NA","target":"sarcoma","id":"30226"},{"source":"NA","target":"liver metastases","id":"30227"},{"source":"NA","target":"primary peritoneal cancer","id":"30228"},{"source":"NA","target":"liver neoplasms","id":"30229"},{"source":"NA","target":"residual tumor","id":"30230"},{"source":"NA","target":"fallopian tube neoplasms","id":"30231"},{"source":"NA","target":"carcinoma","id":"30232"},{"source":"NA","target":"sarcoma","id":"30233"},{"source":"NA","target":"anticancer","id":"30234"},{"source":"NA","target":"peritoneal neoplasms","id":"30235"},{"source":"NA","target":"ovarian neoplasms","id":"30236"},{"source":"NA","target":"ovarian cancer","id":"30237"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"30238"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"30239"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"30240"},{"source":"Oncology: (N/A)","target":"NA","id":"30241"},{"source":"Oncology: (N/A)","target":"NA","id":"30242"},{"source":"Oncology: (N/A)","target":"NA","id":"30243"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"30244"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"30245"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"30246"},{"source":"Oncology: Ovarian","target":"NA","id":"30247"},{"source":"Oncology: Ovarian","target":"NA","id":"30248"},{"source":"Oncology: Ovarian","target":"NA","id":"30249"},{"source":"MK-1966 (u)","target":"Merck & Co.","id":"30250"},{"source":"SD-101 (intratumoral) (u)","target":"Merck & Co.","id":"30251"},{"source":"UNK : Drug","target":"Merck & Co.","id":"30252"},{"source":"UNK : Indication","target":"MK-1966 (u)","id":"30253"},{"source":"UNK : Indication","target":"SD-101 (intratumoral) (u)","id":"30254"},{"source":"UNK : Indication","target":"UNK : Drug","id":"30255"},{"source":"solid malignancy","target":"MK-1966 (u)","id":"30256"},{"source":"solid malignancy","target":"SD-101 (intratumoral) (u)","id":"30257"},{"source":"solid malignancy","target":"UNK : Drug","id":"30258"},{"source":"malignancies","target":"MK-1966 (u)","id":"30259"},{"source":"malignancies","target":"SD-101 (intratumoral) (u)","id":"30260"},{"source":"malignancies","target":"UNK : Drug","id":"30261"},{"source":"hematologic neoplasms","target":"MK-1966 (u)","id":"30262"},{"source":"hematologic neoplasms","target":"SD-101 (intratumoral) (u)","id":"30263"},{"source":"hematologic neoplasms","target":"UNK : Drug","id":"30264"},{"source":"skin neoplasms","target":"MK-1966 (u)","id":"30265"},{"source":"skin neoplasms","target":"SD-101 (intratumoral) (u)","id":"30266"},{"source":"skin neoplasms","target":"UNK : Drug","id":"30267"},{"source":"unknown primary","target":"MK-1966 (u)","id":"30268"},{"source":"unknown primary","target":"SD-101 (intratumoral) (u)","id":"30269"},{"source":"unknown primary","target":"UNK : Drug","id":"30270"},{"source":"residual tumor","target":"MK-1966 (u)","id":"30271"},{"source":"residual tumor","target":"SD-101 (intratumoral) (u)","id":"30272"},{"source":"residual tumor","target":"UNK : Drug","id":"30273"},{"source":"carcinoma","target":"MK-1966 (u)","id":"30274"},{"source":"carcinoma","target":"SD-101 (intratumoral) (u)","id":"30275"},{"source":"carcinoma","target":"UNK : Drug","id":"30276"},{"source":"anticancer","target":"MK-1966 (u)","id":"30277"},{"source":"anticancer","target":"SD-101 (intratumoral) (u)","id":"30278"},{"source":"anticancer","target":"UNK : Drug","id":"30279"},{"source":"unknown primary","target":"MK-1966 (u)","id":"30280"},{"source":"unknown primary","target":"SD-101 (intratumoral) (u)","id":"30281"},{"source":"unknown primary","target":"UNK : Drug","id":"30282"},{"source":"malignancies","target":"MK-1966 (u)","id":"30283"},{"source":"malignancies","target":"SD-101 (intratumoral) (u)","id":"30284"},{"source":"malignancies","target":"UNK : Drug","id":"30285"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"30286"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"30287"},{"source":"Anticancer immunotherapy","target":"malignancies","id":"30288"},{"source":"Anticancer immunotherapy","target":"hematologic neoplasms","id":"30289"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"30290"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"30291"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"30292"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30293"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"30294"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"30295"},{"source":"Anticancer immunotherapy","target":"malignancies","id":"30296"},{"source":"Interleukin 12 agonist","target":"UNK : Indication","id":"30297"},{"source":"Interleukin 12 agonist","target":"solid malignancy","id":"30298"},{"source":"Interleukin 12 agonist","target":"malignancies","id":"30299"},{"source":"Interleukin 12 agonist","target":"hematologic neoplasms","id":"30300"},{"source":"Interleukin 12 agonist","target":"skin neoplasms","id":"30301"},{"source":"Interleukin 12 agonist","target":"unknown primary","id":"30302"},{"source":"Interleukin 12 agonist","target":"residual tumor","id":"30303"},{"source":"Interleukin 12 agonist","target":"carcinoma","id":"30304"},{"source":"Interleukin 12 agonist","target":"anticancer","id":"30305"},{"source":"Interleukin 12 agonist","target":"unknown primary","id":"30306"},{"source":"Interleukin 12 agonist","target":"malignancies","id":"30307"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"30308"},{"source":"Toll-like receptor 9 agonist","target":"solid malignancy","id":"30309"},{"source":"Toll-like receptor 9 agonist","target":"malignancies","id":"30310"},{"source":"Toll-like receptor 9 agonist","target":"hematologic neoplasms","id":"30311"},{"source":"Toll-like receptor 9 agonist","target":"skin neoplasms","id":"30312"},{"source":"Toll-like receptor 9 agonist","target":"unknown primary","id":"30313"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"30314"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"30315"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"30316"},{"source":"Toll-like receptor 9 agonist","target":"unknown primary","id":"30317"},{"source":"Toll-like receptor 9 agonist","target":"malignancies","id":"30318"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"30319"},{"source":"Oncology: CNS","target":"Interleukin 12 agonist","id":"30320"},{"source":"Oncology: CNS","target":"Toll-like receptor 9 agonist","id":"30321"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"30322"},{"source":"Oncology: CNS","target":"Interleukin 12 agonist","id":"30323"},{"source":"Oncology: CNS","target":"Toll-like receptor 9 agonist","id":"30324"},{"source":"GSK-3174998 (u)","target":"GlaxoSmithKline","id":"30325"},{"source":"GSK-3174998 (u)","target":"Merck & Co.","id":"30326"},{"source":"pembrolizumab","target":"GlaxoSmithKline","id":"30327"},{"source":"pembrolizumab","target":"Merck & Co.","id":"30328"},{"source":"UNK : Indication","target":"GSK-3174998 (u)","id":"30329"},{"source":"UNK : Indication","target":"pembrolizumab","id":"30330"},{"source":"colorectal neoplasms","target":"GSK-3174998 (u)","id":"30331"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"30332"},{"source":"renal cancer","target":"GSK-3174998 (u)","id":"30333"},{"source":"renal cancer","target":"pembrolizumab","id":"30334"},{"source":"carcinoma","target":"GSK-3174998 (u)","id":"30335"},{"source":"carcinoma","target":"pembrolizumab","id":"30336"},{"source":"gilbert syndrome","target":"GSK-3174998 (u)","id":"30337"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"30338"},{"source":"non-small-cell lung","target":"GSK-3174998 (u)","id":"30339"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"30340"},{"source":"carcinoma","target":"GSK-3174998 (u)","id":"30341"},{"source":"carcinoma","target":"pembrolizumab","id":"30342"},{"source":"breast neoplasms","target":"GSK-3174998 (u)","id":"30343"},{"source":"breast neoplasms","target":"pembrolizumab","id":"30344"},{"source":"gilbert disease","target":"GSK-3174998 (u)","id":"30345"},{"source":"gilbert disease","target":"pembrolizumab","id":"30346"},{"source":"sarcoma","target":"GSK-3174998 (u)","id":"30347"},{"source":"sarcoma","target":"pembrolizumab","id":"30348"},{"source":"carcinoma","target":"GSK-3174998 (u)","id":"30349"},{"source":"carcinoma","target":"pembrolizumab","id":"30350"},{"source":"head and neck neoplasms","target":"GSK-3174998 (u)","id":"30351"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"30352"},{"source":"non-small-cell lung","target":"GSK-3174998 (u)","id":"30353"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"30354"},{"source":"melanoma","target":"GSK-3174998 (u)","id":"30355"},{"source":"melanoma","target":"pembrolizumab","id":"30356"},{"source":"microsatellite instability","target":"GSK-3174998 (u)","id":"30357"},{"source":"microsatellite instability","target":"pembrolizumab","id":"30358"},{"source":"sarcoma","target":"GSK-3174998 (u)","id":"30359"},{"source":"sarcoma","target":"pembrolizumab","id":"30360"},{"source":"breast neoplasms","target":"GSK-3174998 (u)","id":"30361"},{"source":"breast neoplasms","target":"pembrolizumab","id":"30362"},{"source":"colonic neoplasms","target":"GSK-3174998 (u)","id":"30363"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"30364"},{"source":"sclc","target":"GSK-3174998 (u)","id":"30365"},{"source":"sclc","target":"pembrolizumab","id":"30366"},{"source":"tnbc","target":"GSK-3174998 (u)","id":"30367"},{"source":"tnbc","target":"pembrolizumab","id":"30368"},{"source":"triple-negative breast cancer","target":"GSK-3174998 (u)","id":"30369"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"30370"},{"source":"renal cell","target":"GSK-3174998 (u)","id":"30371"},{"source":"renal cell","target":"pembrolizumab","id":"30372"},{"source":"rcc","target":"GSK-3174998 (u)","id":"30373"},{"source":"rcc","target":"pembrolizumab","id":"30374"},{"source":"kidney neoplasms","target":"GSK-3174998 (u)","id":"30375"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"30376"},{"source":"anti-tumor","target":"GSK-3174998 (u)","id":"30377"},{"source":"anti-tumor","target":"pembrolizumab","id":"30378"},{"source":"carcinoma","target":"GSK-3174998 (u)","id":"30379"},{"source":"carcinoma","target":"pembrolizumab","id":"30380"},{"source":"solid tumors","target":"GSK-3174998 (u)","id":"30381"},{"source":"solid tumors","target":"pembrolizumab","id":"30382"},{"source":"carcinoma","target":"GSK-3174998 (u)","id":"30383"},{"source":"carcinoma","target":"pembrolizumab","id":"30384"},{"source":"soft tissue neoplasms","target":"GSK-3174998 (u)","id":"30385"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"30386"},{"source":"neoplasm metastasis","target":"GSK-3174998 (u)","id":"30387"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"30388"},{"source":"carcinoma","target":"GSK-3174998 (u)","id":"30389"},{"source":"carcinoma","target":"pembrolizumab","id":"30390"},{"source":"colorectal neoplasms","target":"GSK-3174998 (u)","id":"30391"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"30392"},{"source":"bundle branch block","target":"GSK-3174998 (u)","id":"30393"},{"source":"bundle branch block","target":"pembrolizumab","id":"30394"},{"source":"bundle branch block","target":"GSK-3174998 (u)","id":"30395"},{"source":"bundle branch block","target":"pembrolizumab","id":"30396"},{"source":"skin neoplasms","target":"GSK-3174998 (u)","id":"30397"},{"source":"skin neoplasms","target":"pembrolizumab","id":"30398"},{"source":"residual tumor","target":"GSK-3174998 (u)","id":"30399"},{"source":"residual tumor","target":"pembrolizumab","id":"30400"},{"source":"metastatic","target":"GSK-3174998 (u)","id":"30401"},{"source":"metastatic","target":"pembrolizumab","id":"30402"},{"source":"anticancer","target":"GSK-3174998 (u)","id":"30403"},{"source":"anticancer","target":"pembrolizumab","id":"30404"},{"source":"solid malignancy","target":"GSK-3174998 (u)","id":"30405"},{"source":"solid malignancy","target":"pembrolizumab","id":"30406"},{"source":"anticancer","target":"GSK-3174998 (u)","id":"30407"},{"source":"anticancer","target":"pembrolizumab","id":"30408"},{"source":"urinary bladder neoplasms","target":"GSK-3174998 (u)","id":"30409"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"30410"},{"source":"solid tumors","target":"GSK-3174998 (u)","id":"30411"},{"source":"solid tumors","target":"pembrolizumab","id":"30412"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"30413"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"30414"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"30415"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30416"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"30417"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"30418"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30419"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"30420"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"30421"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"30422"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30423"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"30424"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"30425"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"30426"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"30427"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"30428"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"30429"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"30430"},{"source":"Anticancer immunotherapy","target":"sclc","id":"30431"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"30432"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"30433"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"30434"},{"source":"Anticancer immunotherapy","target":"rcc","id":"30435"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"30436"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"30437"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30438"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"30439"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30440"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"30441"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"30442"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30443"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"30444"},{"source":"Anticancer immunotherapy","target":"bundle branch block","id":"30445"},{"source":"Anticancer immunotherapy","target":"bundle branch block","id":"30446"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"30447"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"30448"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"30449"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"30450"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"30451"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"30452"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"30453"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"30454"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"30455"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"30456"},{"source":"CD19 antagonist","target":"renal cancer","id":"30457"},{"source":"CD19 antagonist","target":"carcinoma","id":"30458"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"30459"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"30460"},{"source":"CD19 antagonist","target":"carcinoma","id":"30461"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"30462"},{"source":"CD19 antagonist","target":"gilbert disease","id":"30463"},{"source":"CD19 antagonist","target":"sarcoma","id":"30464"},{"source":"CD19 antagonist","target":"carcinoma","id":"30465"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"30466"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"30467"},{"source":"CD19 antagonist","target":"melanoma","id":"30468"},{"source":"CD19 antagonist","target":"microsatellite instability","id":"30469"},{"source":"CD19 antagonist","target":"sarcoma","id":"30470"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"30471"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"30472"},{"source":"CD19 antagonist","target":"sclc","id":"30473"},{"source":"CD19 antagonist","target":"tnbc","id":"30474"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"30475"},{"source":"CD19 antagonist","target":"renal cell","id":"30476"},{"source":"CD19 antagonist","target":"rcc","id":"30477"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"30478"},{"source":"CD19 antagonist","target":"anti-tumor","id":"30479"},{"source":"CD19 antagonist","target":"carcinoma","id":"30480"},{"source":"CD19 antagonist","target":"solid tumors","id":"30481"},{"source":"CD19 antagonist","target":"carcinoma","id":"30482"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"30483"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"30484"},{"source":"CD19 antagonist","target":"carcinoma","id":"30485"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"30486"},{"source":"CD19 antagonist","target":"bundle branch block","id":"30487"},{"source":"CD19 antagonist","target":"bundle branch block","id":"30488"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"30489"},{"source":"CD19 antagonist","target":"residual tumor","id":"30490"},{"source":"CD19 antagonist","target":"metastatic","id":"30491"},{"source":"CD19 antagonist","target":"anticancer","id":"30492"},{"source":"CD19 antagonist","target":"solid malignancy","id":"30493"},{"source":"CD19 antagonist","target":"anticancer","id":"30494"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"30495"},{"source":"CD19 antagonist","target":"solid tumors","id":"30496"},{"source":"Immune checkpoint stimulant","target":"UNK : Indication","id":"30497"},{"source":"Immune checkpoint stimulant","target":"colorectal neoplasms","id":"30498"},{"source":"Immune checkpoint stimulant","target":"renal cancer","id":"30499"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"30500"},{"source":"Immune checkpoint stimulant","target":"gilbert syndrome","id":"30501"},{"source":"Immune checkpoint stimulant","target":"non-small-cell lung","id":"30502"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"30503"},{"source":"Immune checkpoint stimulant","target":"breast neoplasms","id":"30504"},{"source":"Immune checkpoint stimulant","target":"gilbert disease","id":"30505"},{"source":"Immune checkpoint stimulant","target":"sarcoma","id":"30506"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"30507"},{"source":"Immune checkpoint stimulant","target":"head and neck neoplasms","id":"30508"},{"source":"Immune checkpoint stimulant","target":"non-small-cell lung","id":"30509"},{"source":"Immune checkpoint stimulant","target":"melanoma","id":"30510"},{"source":"Immune checkpoint stimulant","target":"microsatellite instability","id":"30511"},{"source":"Immune checkpoint stimulant","target":"sarcoma","id":"30512"},{"source":"Immune checkpoint stimulant","target":"breast neoplasms","id":"30513"},{"source":"Immune checkpoint stimulant","target":"colonic neoplasms","id":"30514"},{"source":"Immune checkpoint stimulant","target":"sclc","id":"30515"},{"source":"Immune checkpoint stimulant","target":"tnbc","id":"30516"},{"source":"Immune checkpoint stimulant","target":"triple-negative breast cancer","id":"30517"},{"source":"Immune checkpoint stimulant","target":"renal cell","id":"30518"},{"source":"Immune checkpoint stimulant","target":"rcc","id":"30519"},{"source":"Immune checkpoint stimulant","target":"kidney neoplasms","id":"30520"},{"source":"Immune checkpoint stimulant","target":"anti-tumor","id":"30521"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"30522"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"30523"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"30524"},{"source":"Immune checkpoint stimulant","target":"soft tissue neoplasms","id":"30525"},{"source":"Immune checkpoint stimulant","target":"neoplasm metastasis","id":"30526"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"30527"},{"source":"Immune checkpoint stimulant","target":"colorectal neoplasms","id":"30528"},{"source":"Immune checkpoint stimulant","target":"bundle branch block","id":"30529"},{"source":"Immune checkpoint stimulant","target":"bundle branch block","id":"30530"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"30531"},{"source":"Immune checkpoint stimulant","target":"residual tumor","id":"30532"},{"source":"Immune checkpoint stimulant","target":"metastatic","id":"30533"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"30534"},{"source":"Immune checkpoint stimulant","target":"solid malignancy","id":"30535"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"30536"},{"source":"Immune checkpoint stimulant","target":"urinary bladder neoplasms","id":"30537"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"30538"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"30539"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"30540"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"30541"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30542"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"30543"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"30544"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30545"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"30546"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"30547"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"30548"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30549"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"30550"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"30551"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"30552"},{"source":"Immune checkpoint inhibitor","target":"microsatellite instability","id":"30553"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"30554"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"30555"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"30556"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"30557"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"30558"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"30559"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"30560"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"30561"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"30562"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"30563"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30564"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"30565"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30566"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"30567"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"30568"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30569"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"30570"},{"source":"Immune checkpoint inhibitor","target":"bundle branch block","id":"30571"},{"source":"Immune checkpoint inhibitor","target":"bundle branch block","id":"30572"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"30573"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"30574"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"30575"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"30576"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"30577"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"30578"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"30579"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"30580"},{"source":"CD40 agonist","target":"UNK : Indication","id":"30581"},{"source":"CD40 agonist","target":"colorectal neoplasms","id":"30582"},{"source":"CD40 agonist","target":"renal cancer","id":"30583"},{"source":"CD40 agonist","target":"carcinoma","id":"30584"},{"source":"CD40 agonist","target":"gilbert syndrome","id":"30585"},{"source":"CD40 agonist","target":"non-small-cell lung","id":"30586"},{"source":"CD40 agonist","target":"carcinoma","id":"30587"},{"source":"CD40 agonist","target":"breast neoplasms","id":"30588"},{"source":"CD40 agonist","target":"gilbert disease","id":"30589"},{"source":"CD40 agonist","target":"sarcoma","id":"30590"},{"source":"CD40 agonist","target":"carcinoma","id":"30591"},{"source":"CD40 agonist","target":"head and neck neoplasms","id":"30592"},{"source":"CD40 agonist","target":"non-small-cell lung","id":"30593"},{"source":"CD40 agonist","target":"melanoma","id":"30594"},{"source":"CD40 agonist","target":"microsatellite instability","id":"30595"},{"source":"CD40 agonist","target":"sarcoma","id":"30596"},{"source":"CD40 agonist","target":"breast neoplasms","id":"30597"},{"source":"CD40 agonist","target":"colonic neoplasms","id":"30598"},{"source":"CD40 agonist","target":"sclc","id":"30599"},{"source":"CD40 agonist","target":"tnbc","id":"30600"},{"source":"CD40 agonist","target":"triple-negative breast cancer","id":"30601"},{"source":"CD40 agonist","target":"renal cell","id":"30602"},{"source":"CD40 agonist","target":"rcc","id":"30603"},{"source":"CD40 agonist","target":"kidney neoplasms","id":"30604"},{"source":"CD40 agonist","target":"anti-tumor","id":"30605"},{"source":"CD40 agonist","target":"carcinoma","id":"30606"},{"source":"CD40 agonist","target":"solid tumors","id":"30607"},{"source":"CD40 agonist","target":"carcinoma","id":"30608"},{"source":"CD40 agonist","target":"soft tissue neoplasms","id":"30609"},{"source":"CD40 agonist","target":"neoplasm metastasis","id":"30610"},{"source":"CD40 agonist","target":"carcinoma","id":"30611"},{"source":"CD40 agonist","target":"colorectal neoplasms","id":"30612"},{"source":"CD40 agonist","target":"bundle branch block","id":"30613"},{"source":"CD40 agonist","target":"bundle branch block","id":"30614"},{"source":"CD40 agonist","target":"skin neoplasms","id":"30615"},{"source":"CD40 agonist","target":"residual tumor","id":"30616"},{"source":"CD40 agonist","target":"metastatic","id":"30617"},{"source":"CD40 agonist","target":"anticancer","id":"30618"},{"source":"CD40 agonist","target":"solid malignancy","id":"30619"},{"source":"CD40 agonist","target":"anticancer","id":"30620"},{"source":"CD40 agonist","target":"urinary bladder neoplasms","id":"30621"},{"source":"CD40 agonist","target":"solid tumors","id":"30622"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"30623"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"30624"},{"source":"Oncology: Bladder","target":"Immune checkpoint stimulant","id":"30625"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"30626"},{"source":"Oncology: Bladder","target":"CD40 agonist","id":"30627"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"30628"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"30629"},{"source":"Oncology: Breast","target":"Immune checkpoint stimulant","id":"30630"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"30631"},{"source":"Oncology: Breast","target":"CD40 agonist","id":"30632"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"30633"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"30634"},{"source":"Oncology: Colorectal","target":"Immune checkpoint stimulant","id":"30635"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"30636"},{"source":"Oncology: Colorectal","target":"CD40 agonist","id":"30637"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"30638"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"30639"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint stimulant","id":"30640"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"30641"},{"source":"Oncology: Head/Neck","target":"CD40 agonist","id":"30642"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"30643"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"30644"},{"source":"Oncology: Lung","target":"Immune checkpoint stimulant","id":"30645"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"30646"},{"source":"Oncology: Lung","target":"CD40 agonist","id":"30647"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"30648"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"30649"},{"source":"Non-Small Cell","target":"Immune checkpoint stimulant","id":"30650"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"30651"},{"source":"Non-Small Cell","target":"CD40 agonist","id":"30652"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"30653"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"30654"},{"source":"Oncology: Melanoma","target":"Immune checkpoint stimulant","id":"30655"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"30656"},{"source":"Oncology: Melanoma","target":"CD40 agonist","id":"30657"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"30658"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"30659"},{"source":"Oncology: Renal","target":"Immune checkpoint stimulant","id":"30660"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"30661"},{"source":"Oncology: Renal","target":"CD40 agonist","id":"30662"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"30663"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"30664"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint stimulant","id":"30665"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"30666"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD40 agonist","id":"30667"},{"source":"TRX-518 (u)","target":"Leap Therapeutics/Macrocure","id":"30668"},{"source":"gemcitabine hydrochloride","target":"Leap Therapeutics/Macrocure","id":"30669"},{"source":"nivolumab (a)","target":"Leap Therapeutics/Macrocure","id":"30670"},{"source":"pembrolizumab","target":"Leap Therapeutics/Macrocure","id":"30671"},{"source":"UNK : Indication","target":"TRX-518 (u)","id":"30672"},{"source":"UNK : Indication","target":"gemcitabine hydrochloride","id":"30673"},{"source":"UNK : Indication","target":"nivolumab (a)","id":"30674"},{"source":"UNK : Indication","target":"pembrolizumab","id":"30675"},{"source":"solid tumors","target":"TRX-518 (u)","id":"30676"},{"source":"solid tumors","target":"gemcitabine hydrochloride","id":"30677"},{"source":"solid tumors","target":"nivolumab (a)","id":"30678"},{"source":"solid tumors","target":"pembrolizumab","id":"30679"},{"source":"skin neoplasms","target":"TRX-518 (u)","id":"30680"},{"source":"skin neoplasms","target":"gemcitabine hydrochloride","id":"30681"},{"source":"skin neoplasms","target":"nivolumab (a)","id":"30682"},{"source":"skin neoplasms","target":"pembrolizumab","id":"30683"},{"source":"unknown primary","target":"TRX-518 (u)","id":"30684"},{"source":"unknown primary","target":"gemcitabine hydrochloride","id":"30685"},{"source":"unknown primary","target":"nivolumab (a)","id":"30686"},{"source":"unknown primary","target":"pembrolizumab","id":"30687"},{"source":"carcinoma","target":"TRX-518 (u)","id":"30688"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"30689"},{"source":"carcinoma","target":"nivolumab (a)","id":"30690"},{"source":"carcinoma","target":"pembrolizumab","id":"30691"},{"source":"anticancer","target":"TRX-518 (u)","id":"30692"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"30693"},{"source":"anticancer","target":"nivolumab (a)","id":"30694"},{"source":"anticancer","target":"pembrolizumab","id":"30695"},{"source":"unknown primary","target":"TRX-518 (u)","id":"30696"},{"source":"unknown primary","target":"gemcitabine hydrochloride","id":"30697"},{"source":"unknown primary","target":"nivolumab (a)","id":"30698"},{"source":"unknown primary","target":"pembrolizumab","id":"30699"},{"source":"solid tumors","target":"TRX-518 (u)","id":"30700"},{"source":"solid tumors","target":"gemcitabine hydrochloride","id":"30701"},{"source":"solid tumors","target":"nivolumab (a)","id":"30702"},{"source":"solid tumors","target":"pembrolizumab","id":"30703"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"UNK : Indication","id":"30704"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"solid tumors","id":"30705"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"skin neoplasms","id":"30706"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"unknown primary","id":"30707"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"carcinoma","id":"30708"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"anticancer","id":"30709"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"unknown primary","id":"30710"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"solid tumors","id":"30711"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"30712"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"30713"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"30714"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"30715"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"30716"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"30717"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"30718"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"30719"},{"source":"Immune checkpoint stimulant","target":"UNK : Indication","id":"30720"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"30721"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"30722"},{"source":"Immune checkpoint stimulant","target":"unknown primary","id":"30723"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"30724"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"30725"},{"source":"Immune checkpoint stimulant","target":"unknown primary","id":"30726"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"30727"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"30728"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"30729"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"30730"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"30731"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30732"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"30733"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"30734"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"30735"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"30736"},{"source":"CD19 antagonist","target":"solid tumors","id":"30737"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"30738"},{"source":"CD19 antagonist","target":"unknown primary","id":"30739"},{"source":"CD19 antagonist","target":"carcinoma","id":"30740"},{"source":"CD19 antagonist","target":"anticancer","id":"30741"},{"source":"CD19 antagonist","target":"unknown primary","id":"30742"},{"source":"CD19 antagonist","target":"solid tumors","id":"30743"},{"source":"NA","target":"UNK : Indication","id":"30744"},{"source":"NA","target":"solid tumors","id":"30745"},{"source":"NA","target":"skin neoplasms","id":"30746"},{"source":"NA","target":"unknown primary","id":"30747"},{"source":"NA","target":"carcinoma","id":"30748"},{"source":"NA","target":"anticancer","id":"30749"},{"source":"NA","target":"unknown primary","id":"30750"},{"source":"NA","target":"solid tumors","id":"30751"},{"source":"NA","target":"UNK : Indication","id":"30752"},{"source":"NA","target":"solid tumors","id":"30753"},{"source":"NA","target":"skin neoplasms","id":"30754"},{"source":"NA","target":"unknown primary","id":"30755"},{"source":"NA","target":"carcinoma","id":"30756"},{"source":"NA","target":"anticancer","id":"30757"},{"source":"NA","target":"unknown primary","id":"30758"},{"source":"NA","target":"solid tumors","id":"30759"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"30760"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"30761"},{"source":"Cell cycle inhibitor","target":"skin neoplasms","id":"30762"},{"source":"Cell cycle inhibitor","target":"unknown primary","id":"30763"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"30764"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"30765"},{"source":"Cell cycle inhibitor","target":"unknown primary","id":"30766"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"30767"},{"source":"Oncology: CNS","target":"Glucocorticoid-induced TNFR-related protein agonist","id":"30768"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"30769"},{"source":"Oncology: CNS","target":"Immune checkpoint stimulant","id":"30770"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"30771"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"30772"},{"source":"Oncology: CNS","target":"NA","id":"30773"},{"source":"Oncology: CNS","target":"NA","id":"30774"},{"source":"Oncology: CNS","target":"Cell cycle inhibitor","id":"30775"},{"source":"utomilumab (u)","target":"MD Anderson Cancer Center","id":"30776"},{"source":"utomilumab (u)","target":"University of Texas","id":"30777"},{"source":"utomilumab (u)","target":"Pfizer","id":"30778"},{"source":"cetuximab","target":"MD Anderson Cancer Center","id":"30779"},{"source":"cetuximab","target":"University of Texas","id":"30780"},{"source":"cetuximab","target":"Pfizer","id":"30781"},{"source":"irinotecan (IV)","target":"MD Anderson Cancer Center","id":"30782"},{"source":"irinotecan (IV)","target":"University of Texas","id":"30783"},{"source":"irinotecan (IV)","target":"Pfizer","id":"30784"},{"source":"colorectal neoplasms","target":"utomilumab (u)","id":"30785"},{"source":"colorectal neoplasms","target":"cetuximab","id":"30786"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"30787"},{"source":"colorectal cancer","target":"utomilumab (u)","id":"30788"},{"source":"colorectal cancer","target":"cetuximab","id":"30789"},{"source":"colorectal cancer","target":"irinotecan (IV)","id":"30790"},{"source":"heart failure","target":"utomilumab (u)","id":"30791"},{"source":"heart failure","target":"cetuximab","id":"30792"},{"source":"heart failure","target":"irinotecan (IV)","id":"30793"},{"source":"skin neoplasms","target":"utomilumab (u)","id":"30794"},{"source":"skin neoplasms","target":"cetuximab","id":"30795"},{"source":"skin neoplasms","target":"irinotecan (IV)","id":"30796"},{"source":"microsatellite instability","target":"utomilumab (u)","id":"30797"},{"source":"microsatellite instability","target":"cetuximab","id":"30798"},{"source":"microsatellite instability","target":"irinotecan (IV)","id":"30799"},{"source":"residual tumor","target":"utomilumab (u)","id":"30800"},{"source":"residual tumor","target":"cetuximab","id":"30801"},{"source":"residual tumor","target":"irinotecan (IV)","id":"30802"},{"source":"gilbert disease","target":"utomilumab (u)","id":"30803"},{"source":"gilbert disease","target":"cetuximab","id":"30804"},{"source":"gilbert disease","target":"irinotecan (IV)","id":"30805"},{"source":"colonic neoplasms","target":"utomilumab (u)","id":"30806"},{"source":"colonic neoplasms","target":"cetuximab","id":"30807"},{"source":"colonic neoplasms","target":"irinotecan (IV)","id":"30808"},{"source":"metastatic","target":"utomilumab (u)","id":"30809"},{"source":"metastatic","target":"cetuximab","id":"30810"},{"source":"metastatic","target":"irinotecan (IV)","id":"30811"},{"source":"carcinoma","target":"utomilumab (u)","id":"30812"},{"source":"carcinoma","target":"cetuximab","id":"30813"},{"source":"carcinoma","target":"irinotecan (IV)","id":"30814"},{"source":"gilbert syndrome","target":"utomilumab (u)","id":"30815"},{"source":"gilbert syndrome","target":"cetuximab","id":"30816"},{"source":"gilbert syndrome","target":"irinotecan (IV)","id":"30817"},{"source":"heart failure","target":"utomilumab (u)","id":"30818"},{"source":"heart failure","target":"cetuximab","id":"30819"},{"source":"heart failure","target":"irinotecan (IV)","id":"30820"},{"source":"neoplasm metastasis","target":"utomilumab (u)","id":"30821"},{"source":"neoplasm metastasis","target":"cetuximab","id":"30822"},{"source":"neoplasm metastasis","target":"irinotecan (IV)","id":"30823"},{"source":"anticancer","target":"utomilumab (u)","id":"30824"},{"source":"anticancer","target":"cetuximab","id":"30825"},{"source":"anticancer","target":"irinotecan (IV)","id":"30826"},{"source":"colorectal neoplasms","target":"utomilumab (u)","id":"30827"},{"source":"colorectal neoplasms","target":"cetuximab","id":"30828"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"30829"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"30830"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"30831"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"30832"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"30833"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"30834"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"30835"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"30836"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"30837"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"30838"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"30839"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"30840"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"30841"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"30842"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"30843"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"30844"},{"source":"CD137 agonist","target":"colorectal neoplasms","id":"30845"},{"source":"CD137 agonist","target":"colorectal cancer","id":"30846"},{"source":"CD137 agonist","target":"heart failure","id":"30847"},{"source":"CD137 agonist","target":"skin neoplasms","id":"30848"},{"source":"CD137 agonist","target":"microsatellite instability","id":"30849"},{"source":"CD137 agonist","target":"residual tumor","id":"30850"},{"source":"CD137 agonist","target":"gilbert disease","id":"30851"},{"source":"CD137 agonist","target":"colonic neoplasms","id":"30852"},{"source":"CD137 agonist","target":"metastatic","id":"30853"},{"source":"CD137 agonist","target":"carcinoma","id":"30854"},{"source":"CD137 agonist","target":"gilbert syndrome","id":"30855"},{"source":"CD137 agonist","target":"heart failure","id":"30856"},{"source":"CD137 agonist","target":"neoplasm metastasis","id":"30857"},{"source":"CD137 agonist","target":"anticancer","id":"30858"},{"source":"CD137 agonist","target":"colorectal neoplasms","id":"30859"},{"source":"EGFR antagonist","target":"colorectal neoplasms","id":"30860"},{"source":"EGFR antagonist","target":"colorectal cancer","id":"30861"},{"source":"EGFR antagonist","target":"heart failure","id":"30862"},{"source":"EGFR antagonist","target":"skin neoplasms","id":"30863"},{"source":"EGFR antagonist","target":"microsatellite instability","id":"30864"},{"source":"EGFR antagonist","target":"residual tumor","id":"30865"},{"source":"EGFR antagonist","target":"gilbert disease","id":"30866"},{"source":"EGFR antagonist","target":"colonic neoplasms","id":"30867"},{"source":"EGFR antagonist","target":"metastatic","id":"30868"},{"source":"EGFR antagonist","target":"carcinoma","id":"30869"},{"source":"EGFR antagonist","target":"gilbert syndrome","id":"30870"},{"source":"EGFR antagonist","target":"heart failure","id":"30871"},{"source":"EGFR antagonist","target":"neoplasm metastasis","id":"30872"},{"source":"EGFR antagonist","target":"anticancer","id":"30873"},{"source":"EGFR antagonist","target":"colorectal neoplasms","id":"30874"},{"source":"NA","target":"colorectal neoplasms","id":"30875"},{"source":"NA","target":"colorectal cancer","id":"30876"},{"source":"NA","target":"heart failure","id":"30877"},{"source":"NA","target":"skin neoplasms","id":"30878"},{"source":"NA","target":"microsatellite instability","id":"30879"},{"source":"NA","target":"residual tumor","id":"30880"},{"source":"NA","target":"gilbert disease","id":"30881"},{"source":"NA","target":"colonic neoplasms","id":"30882"},{"source":"NA","target":"metastatic","id":"30883"},{"source":"NA","target":"carcinoma","id":"30884"},{"source":"NA","target":"gilbert syndrome","id":"30885"},{"source":"NA","target":"heart failure","id":"30886"},{"source":"NA","target":"neoplasm metastasis","id":"30887"},{"source":"NA","target":"anticancer","id":"30888"},{"source":"NA","target":"colorectal neoplasms","id":"30889"},{"source":"Immune checkpoint stimulant","target":"colorectal neoplasms","id":"30890"},{"source":"Immune checkpoint stimulant","target":"colorectal cancer","id":"30891"},{"source":"Immune checkpoint stimulant","target":"heart failure","id":"30892"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"30893"},{"source":"Immune checkpoint stimulant","target":"microsatellite instability","id":"30894"},{"source":"Immune checkpoint stimulant","target":"residual tumor","id":"30895"},{"source":"Immune checkpoint stimulant","target":"gilbert disease","id":"30896"},{"source":"Immune checkpoint stimulant","target":"colonic neoplasms","id":"30897"},{"source":"Immune checkpoint stimulant","target":"metastatic","id":"30898"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"30899"},{"source":"Immune checkpoint stimulant","target":"gilbert syndrome","id":"30900"},{"source":"Immune checkpoint stimulant","target":"heart failure","id":"30901"},{"source":"Immune checkpoint stimulant","target":"neoplasm metastasis","id":"30902"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"30903"},{"source":"Immune checkpoint stimulant","target":"colorectal neoplasms","id":"30904"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"30905"},{"source":"Oncology: Colorectal","target":"CD137 agonist","id":"30906"},{"source":"Oncology: Colorectal","target":"EGFR antagonist","id":"30907"},{"source":"Oncology: Colorectal","target":"NA","id":"30908"},{"source":"Oncology: Colorectal","target":"Immune checkpoint stimulant","id":"30909"},{"source":"cisplatin","target":"Merck & Co.","id":"30910"},{"source":"cisplatin","target":"University of Pittsburgh","id":"30911"},{"source":"radiation therapy","target":"Merck & Co.","id":"30912"},{"source":"radiation therapy","target":"University of Pittsburgh","id":"30913"},{"source":"pembrolizumab","target":"Merck & Co.","id":"30914"},{"source":"pembrolizumab","target":"University of Pittsburgh","id":"30915"},{"source":"UNK : Drug","target":"Merck & Co.","id":"30916"},{"source":"UNK : Drug","target":"University of Pittsburgh","id":"30917"},{"source":"UNK : Indication","target":"cisplatin","id":"30918"},{"source":"UNK : Indication","target":"radiation therapy","id":"30919"},{"source":"UNK : Indication","target":"pembrolizumab","id":"30920"},{"source":"UNK : Indication","target":"UNK : Drug","id":"30921"},{"source":"anticancer","target":"cisplatin","id":"30922"},{"source":"anticancer","target":"radiation therapy","id":"30923"},{"source":"anticancer","target":"pembrolizumab","id":"30924"},{"source":"anticancer","target":"UNK : Drug","id":"30925"},{"source":"liver metastases","target":"cisplatin","id":"30926"},{"source":"liver metastases","target":"radiation therapy","id":"30927"},{"source":"liver metastases","target":"pembrolizumab","id":"30928"},{"source":"liver metastases","target":"UNK : Drug","id":"30929"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"30930"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"30931"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"30932"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"30933"},{"source":"skin neoplasms","target":"cisplatin","id":"30934"},{"source":"skin neoplasms","target":"radiation therapy","id":"30935"},{"source":"skin neoplasms","target":"pembrolizumab","id":"30936"},{"source":"skin neoplasms","target":"UNK : Drug","id":"30937"},{"source":"head and neck neoplasms","target":"cisplatin","id":"30938"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"30939"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"30940"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"30941"},{"source":"carcinoma","target":"cisplatin","id":"30942"},{"source":"carcinoma","target":"radiation therapy","id":"30943"},{"source":"carcinoma","target":"pembrolizumab","id":"30944"},{"source":"carcinoma","target":"UNK : Drug","id":"30945"},{"source":"head and neck cancer","target":"cisplatin","id":"30946"},{"source":"head and neck cancer","target":"radiation therapy","id":"30947"},{"source":"head and neck cancer","target":"pembrolizumab","id":"30948"},{"source":"head and neck cancer","target":"UNK : Drug","id":"30949"},{"source":"tonsillar neoplasms","target":"cisplatin","id":"30950"},{"source":"tonsillar neoplasms","target":"radiation therapy","id":"30951"},{"source":"tonsillar neoplasms","target":"pembrolizumab","id":"30952"},{"source":"tonsillar neoplasms","target":"UNK : Drug","id":"30953"},{"source":"carcinoma","target":"cisplatin","id":"30954"},{"source":"carcinoma","target":"radiation therapy","id":"30955"},{"source":"carcinoma","target":"pembrolizumab","id":"30956"},{"source":"carcinoma","target":"UNK : Drug","id":"30957"},{"source":"carcinoma","target":"cisplatin","id":"30958"},{"source":"carcinoma","target":"radiation therapy","id":"30959"},{"source":"carcinoma","target":"pembrolizumab","id":"30960"},{"source":"carcinoma","target":"UNK : Drug","id":"30961"},{"source":"tonsil cancers","target":"cisplatin","id":"30962"},{"source":"tonsil cancers","target":"radiation therapy","id":"30963"},{"source":"tonsil cancers","target":"pembrolizumab","id":"30964"},{"source":"tonsil cancers","target":"UNK : Drug","id":"30965"},{"source":"thyroid neoplasms","target":"cisplatin","id":"30966"},{"source":"thyroid neoplasms","target":"radiation therapy","id":"30967"},{"source":"thyroid neoplasms","target":"pembrolizumab","id":"30968"},{"source":"thyroid neoplasms","target":"UNK : Drug","id":"30969"},{"source":"metastatic","target":"cisplatin","id":"30970"},{"source":"metastatic","target":"radiation therapy","id":"30971"},{"source":"metastatic","target":"pembrolizumab","id":"30972"},{"source":"metastatic","target":"UNK : Drug","id":"30973"},{"source":"carcinoma","target":"cisplatin","id":"30974"},{"source":"carcinoma","target":"radiation therapy","id":"30975"},{"source":"carcinoma","target":"pembrolizumab","id":"30976"},{"source":"carcinoma","target":"UNK : Drug","id":"30977"},{"source":"neoplasm metastasis","target":"cisplatin","id":"30978"},{"source":"neoplasm metastasis","target":"radiation therapy","id":"30979"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"30980"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"30981"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"30982"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"30983"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"30984"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"30985"},{"source":"residual tumor","target":"cisplatin","id":"30986"},{"source":"residual tumor","target":"radiation therapy","id":"30987"},{"source":"residual tumor","target":"pembrolizumab","id":"30988"},{"source":"residual tumor","target":"UNK : Drug","id":"30989"},{"source":"solid malignancy","target":"cisplatin","id":"30990"},{"source":"solid malignancy","target":"radiation therapy","id":"30991"},{"source":"solid malignancy","target":"pembrolizumab","id":"30992"},{"source":"solid malignancy","target":"UNK : Drug","id":"30993"},{"source":"carcinoma","target":"cisplatin","id":"30994"},{"source":"carcinoma","target":"radiation therapy","id":"30995"},{"source":"carcinoma","target":"pembrolizumab","id":"30996"},{"source":"carcinoma","target":"UNK : Drug","id":"30997"},{"source":"residual tumor","target":"cisplatin","id":"30998"},{"source":"residual tumor","target":"radiation therapy","id":"30999"},{"source":"residual tumor","target":"pembrolizumab","id":"31000"},{"source":"residual tumor","target":"UNK : Drug","id":"31001"},{"source":"anticancer","target":"cisplatin","id":"31002"},{"source":"anticancer","target":"radiation therapy","id":"31003"},{"source":"anticancer","target":"pembrolizumab","id":"31004"},{"source":"anticancer","target":"UNK : Drug","id":"31005"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"31006"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31007"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"31008"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"31009"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"31010"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"31011"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31012"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"31013"},{"source":"Immune checkpoint inhibitor","target":"tonsillar neoplasms","id":"31014"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31015"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31016"},{"source":"Immune checkpoint inhibitor","target":"tonsil cancers","id":"31017"},{"source":"Immune checkpoint inhibitor","target":"thyroid neoplasms","id":"31018"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"31019"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31020"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"31021"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"31022"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"31023"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"31024"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31025"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"31026"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31027"},{"source":"NA","target":"UNK : Indication","id":"31028"},{"source":"NA","target":"anticancer","id":"31029"},{"source":"NA","target":"liver metastases","id":"31030"},{"source":"NA","target":"squamous cell neoplasms","id":"31031"},{"source":"NA","target":"skin neoplasms","id":"31032"},{"source":"NA","target":"head and neck neoplasms","id":"31033"},{"source":"NA","target":"carcinoma","id":"31034"},{"source":"NA","target":"head and neck cancer","id":"31035"},{"source":"NA","target":"tonsillar neoplasms","id":"31036"},{"source":"NA","target":"carcinoma","id":"31037"},{"source":"NA","target":"carcinoma","id":"31038"},{"source":"NA","target":"tonsil cancers","id":"31039"},{"source":"NA","target":"thyroid neoplasms","id":"31040"},{"source":"NA","target":"metastatic","id":"31041"},{"source":"NA","target":"carcinoma","id":"31042"},{"source":"NA","target":"neoplasm metastasis","id":"31043"},{"source":"NA","target":"squamous cell neoplasms","id":"31044"},{"source":"NA","target":"residual tumor","id":"31045"},{"source":"NA","target":"solid malignancy","id":"31046"},{"source":"NA","target":"carcinoma","id":"31047"},{"source":"NA","target":"residual tumor","id":"31048"},{"source":"NA","target":"anticancer","id":"31049"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"31050"},{"source":"CD19 antagonist","target":"anticancer","id":"31051"},{"source":"CD19 antagonist","target":"liver metastases","id":"31052"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"31053"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"31054"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"31055"},{"source":"CD19 antagonist","target":"carcinoma","id":"31056"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"31057"},{"source":"CD19 antagonist","target":"tonsillar neoplasms","id":"31058"},{"source":"CD19 antagonist","target":"carcinoma","id":"31059"},{"source":"CD19 antagonist","target":"carcinoma","id":"31060"},{"source":"CD19 antagonist","target":"tonsil cancers","id":"31061"},{"source":"CD19 antagonist","target":"thyroid neoplasms","id":"31062"},{"source":"CD19 antagonist","target":"metastatic","id":"31063"},{"source":"CD19 antagonist","target":"carcinoma","id":"31064"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"31065"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"31066"},{"source":"CD19 antagonist","target":"residual tumor","id":"31067"},{"source":"CD19 antagonist","target":"solid malignancy","id":"31068"},{"source":"CD19 antagonist","target":"carcinoma","id":"31069"},{"source":"CD19 antagonist","target":"residual tumor","id":"31070"},{"source":"CD19 antagonist","target":"anticancer","id":"31071"},{"source":"UPA","target":"UNK : Indication","id":"31072"},{"source":"UPA","target":"anticancer","id":"31073"},{"source":"UPA","target":"liver metastases","id":"31074"},{"source":"UPA","target":"squamous cell neoplasms","id":"31075"},{"source":"UPA","target":"skin neoplasms","id":"31076"},{"source":"UPA","target":"head and neck neoplasms","id":"31077"},{"source":"UPA","target":"carcinoma","id":"31078"},{"source":"UPA","target":"head and neck cancer","id":"31079"},{"source":"UPA","target":"tonsillar neoplasms","id":"31080"},{"source":"UPA","target":"carcinoma","id":"31081"},{"source":"UPA","target":"carcinoma","id":"31082"},{"source":"UPA","target":"tonsil cancers","id":"31083"},{"source":"UPA","target":"thyroid neoplasms","id":"31084"},{"source":"UPA","target":"metastatic","id":"31085"},{"source":"UPA","target":"carcinoma","id":"31086"},{"source":"UPA","target":"neoplasm metastasis","id":"31087"},{"source":"UPA","target":"squamous cell neoplasms","id":"31088"},{"source":"UPA","target":"residual tumor","id":"31089"},{"source":"UPA","target":"solid malignancy","id":"31090"},{"source":"UPA","target":"carcinoma","id":"31091"},{"source":"UPA","target":"residual tumor","id":"31092"},{"source":"UPA","target":"anticancer","id":"31093"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"31094"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31095"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"31096"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"31097"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"31098"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"31099"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31100"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"31101"},{"source":"Anticancer immunotherapy","target":"tonsillar neoplasms","id":"31102"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31103"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31104"},{"source":"Anticancer immunotherapy","target":"tonsil cancers","id":"31105"},{"source":"Anticancer immunotherapy","target":"thyroid neoplasms","id":"31106"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"31107"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31108"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"31109"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"31110"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"31111"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"31112"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31113"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"31114"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31115"},{"source":"NA","target":"UNK : Indication","id":"31116"},{"source":"NA","target":"anticancer","id":"31117"},{"source":"NA","target":"liver metastases","id":"31118"},{"source":"NA","target":"squamous cell neoplasms","id":"31119"},{"source":"NA","target":"skin neoplasms","id":"31120"},{"source":"NA","target":"head and neck neoplasms","id":"31121"},{"source":"NA","target":"carcinoma","id":"31122"},{"source":"NA","target":"head and neck cancer","id":"31123"},{"source":"NA","target":"tonsillar neoplasms","id":"31124"},{"source":"NA","target":"carcinoma","id":"31125"},{"source":"NA","target":"carcinoma","id":"31126"},{"source":"NA","target":"tonsil cancers","id":"31127"},{"source":"NA","target":"thyroid neoplasms","id":"31128"},{"source":"NA","target":"metastatic","id":"31129"},{"source":"NA","target":"carcinoma","id":"31130"},{"source":"NA","target":"neoplasm metastasis","id":"31131"},{"source":"NA","target":"squamous cell neoplasms","id":"31132"},{"source":"NA","target":"residual tumor","id":"31133"},{"source":"NA","target":"solid malignancy","id":"31134"},{"source":"NA","target":"carcinoma","id":"31135"},{"source":"NA","target":"residual tumor","id":"31136"},{"source":"NA","target":"anticancer","id":"31137"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"31138"},{"source":"Oncology: Head/Neck","target":"NA","id":"31139"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"31140"},{"source":"Oncology: Head/Neck","target":"UPA","id":"31141"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"31142"},{"source":"Oncology: Head/Neck","target":"NA","id":"31143"},{"source":"pembrolizumab","target":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","id":"31144"},{"source":"pembrolizumab","target":"Merck & Co.","id":"31145"},{"source":"radiation therapy","target":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","id":"31146"},{"source":"radiation therapy","target":"Merck & Co.","id":"31147"},{"source":"UNK : Drug","target":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","id":"31148"},{"source":"UNK : Drug","target":"Merck & Co.","id":"31149"},{"source":"UNK : Indication","target":"pembrolizumab","id":"31150"},{"source":"UNK : Indication","target":"radiation therapy","id":"31151"},{"source":"UNK : Indication","target":"UNK : Drug","id":"31152"},{"source":"anticancer","target":"pembrolizumab","id":"31153"},{"source":"anticancer","target":"radiation therapy","id":"31154"},{"source":"anticancer","target":"UNK : Drug","id":"31155"},{"source":"carcinoma","target":"pembrolizumab","id":"31156"},{"source":"carcinoma","target":"radiation therapy","id":"31157"},{"source":"carcinoma","target":"UNK : Drug","id":"31158"},{"source":"liver metastases","target":"pembrolizumab","id":"31159"},{"source":"liver metastases","target":"radiation therapy","id":"31160"},{"source":"liver metastases","target":"UNK : Drug","id":"31161"},{"source":"carcinoma","target":"pembrolizumab","id":"31162"},{"source":"carcinoma","target":"radiation therapy","id":"31163"},{"source":"carcinoma","target":"UNK : Drug","id":"31164"},{"source":"residual tumor","target":"pembrolizumab","id":"31165"},{"source":"residual tumor","target":"radiation therapy","id":"31166"},{"source":"residual tumor","target":"UNK : Drug","id":"31167"},{"source":"head and neck cancer","target":"pembrolizumab","id":"31168"},{"source":"head and neck cancer","target":"radiation therapy","id":"31169"},{"source":"head and neck cancer","target":"UNK : Drug","id":"31170"},{"source":"liver metastases","target":"pembrolizumab","id":"31171"},{"source":"liver metastases","target":"radiation therapy","id":"31172"},{"source":"liver metastases","target":"UNK : Drug","id":"31173"},{"source":"metastatic","target":"pembrolizumab","id":"31174"},{"source":"metastatic","target":"radiation therapy","id":"31175"},{"source":"metastatic","target":"UNK : Drug","id":"31176"},{"source":"carcinoma","target":"pembrolizumab","id":"31177"},{"source":"carcinoma","target":"radiation therapy","id":"31178"},{"source":"carcinoma","target":"UNK : Drug","id":"31179"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"31180"},{"source":"neoplasm metastasis","target":"radiation therapy","id":"31181"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"31182"},{"source":"anticancer","target":"pembrolizumab","id":"31183"},{"source":"anticancer","target":"radiation therapy","id":"31184"},{"source":"anticancer","target":"UNK : Drug","id":"31185"},{"source":"liver neoplasms","target":"pembrolizumab","id":"31186"},{"source":"liver neoplasms","target":"radiation therapy","id":"31187"},{"source":"liver neoplasms","target":"UNK : Drug","id":"31188"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"31189"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"31190"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"31191"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"31192"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31193"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31194"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"31195"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31196"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"31197"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"31198"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"31199"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"31200"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31201"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"31202"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31203"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"31204"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"31205"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"31206"},{"source":"CD19 antagonist","target":"anticancer","id":"31207"},{"source":"CD19 antagonist","target":"carcinoma","id":"31208"},{"source":"CD19 antagonist","target":"liver metastases","id":"31209"},{"source":"CD19 antagonist","target":"carcinoma","id":"31210"},{"source":"CD19 antagonist","target":"residual tumor","id":"31211"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"31212"},{"source":"CD19 antagonist","target":"liver metastases","id":"31213"},{"source":"CD19 antagonist","target":"metastatic","id":"31214"},{"source":"CD19 antagonist","target":"carcinoma","id":"31215"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"31216"},{"source":"CD19 antagonist","target":"anticancer","id":"31217"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"31218"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"31219"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"31220"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31221"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31222"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"31223"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31224"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"31225"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"31226"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"31227"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"31228"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31229"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"31230"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31231"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"31232"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"31233"},{"source":"UPA","target":"UNK : Indication","id":"31234"},{"source":"UPA","target":"anticancer","id":"31235"},{"source":"UPA","target":"carcinoma","id":"31236"},{"source":"UPA","target":"liver metastases","id":"31237"},{"source":"UPA","target":"carcinoma","id":"31238"},{"source":"UPA","target":"residual tumor","id":"31239"},{"source":"UPA","target":"head and neck cancer","id":"31240"},{"source":"UPA","target":"liver metastases","id":"31241"},{"source":"UPA","target":"metastatic","id":"31242"},{"source":"UPA","target":"carcinoma","id":"31243"},{"source":"UPA","target":"neoplasm metastasis","id":"31244"},{"source":"UPA","target":"anticancer","id":"31245"},{"source":"UPA","target":"liver neoplasms","id":"31246"},{"source":"UPA","target":"head and neck neoplasms","id":"31247"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"31248"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"31249"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"31250"},{"source":"Oncology: Head/Neck","target":"UPA","id":"31251"},{"source":"demcizumab (u)","target":"Celgene","id":"31252"},{"source":"demcizumab (u)","target":"OncoMed","id":"31253"},{"source":"pembrolizumab","target":"Celgene","id":"31254"},{"source":"pembrolizumab","target":"OncoMed","id":"31255"},{"source":"UNK : Indication","target":"demcizumab (u)","id":"31256"},{"source":"UNK : Indication","target":"pembrolizumab","id":"31257"},{"source":"residual tumor","target":"demcizumab (u)","id":"31258"},{"source":"residual tumor","target":"pembrolizumab","id":"31259"},{"source":"solid tumors","target":"demcizumab (u)","id":"31260"},{"source":"solid tumors","target":"pembrolizumab","id":"31261"},{"source":"anticancer","target":"demcizumab (u)","id":"31262"},{"source":"anticancer","target":"pembrolizumab","id":"31263"},{"source":"castration-resistant prostatic neoplasms","target":"demcizumab (u)","id":"31264"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"31265"},{"source":"carcinoma","target":"demcizumab (u)","id":"31266"},{"source":"carcinoma","target":"pembrolizumab","id":"31267"},{"source":"non-small-cell lung","target":"demcizumab (u)","id":"31268"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"31269"},{"source":"metastatic","target":"demcizumab (u)","id":"31270"},{"source":"metastatic","target":"pembrolizumab","id":"31271"},{"source":"carcinoma","target":"demcizumab (u)","id":"31272"},{"source":"carcinoma","target":"pembrolizumab","id":"31273"},{"source":"neoplasm metastasis","target":"demcizumab (u)","id":"31274"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"31275"},{"source":"anti-tumor","target":"demcizumab (u)","id":"31276"},{"source":"anti-tumor","target":"pembrolizumab","id":"31277"},{"source":"anticancer","target":"demcizumab (u)","id":"31278"},{"source":"anticancer","target":"pembrolizumab","id":"31279"},{"source":"prostate cancer","target":"demcizumab (u)","id":"31280"},{"source":"prostate cancer","target":"pembrolizumab","id":"31281"},{"source":"solid tumors","target":"demcizumab (u)","id":"31282"},{"source":"solid tumors","target":"pembrolizumab","id":"31283"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"31284"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"31285"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"31286"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31287"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"31288"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31289"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"31290"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"31291"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31292"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"31293"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"31294"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31295"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"31296"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"31297"},{"source":"Delta-like 4 antagonist","target":"UNK : Indication","id":"31298"},{"source":"Delta-like 4 antagonist","target":"residual tumor","id":"31299"},{"source":"Delta-like 4 antagonist","target":"solid tumors","id":"31300"},{"source":"Delta-like 4 antagonist","target":"anticancer","id":"31301"},{"source":"Delta-like 4 antagonist","target":"castration-resistant prostatic neoplasms","id":"31302"},{"source":"Delta-like 4 antagonist","target":"carcinoma","id":"31303"},{"source":"Delta-like 4 antagonist","target":"non-small-cell lung","id":"31304"},{"source":"Delta-like 4 antagonist","target":"metastatic","id":"31305"},{"source":"Delta-like 4 antagonist","target":"carcinoma","id":"31306"},{"source":"Delta-like 4 antagonist","target":"neoplasm metastasis","id":"31307"},{"source":"Delta-like 4 antagonist","target":"anti-tumor","id":"31308"},{"source":"Delta-like 4 antagonist","target":"anticancer","id":"31309"},{"source":"Delta-like 4 antagonist","target":"prostate cancer","id":"31310"},{"source":"Delta-like 4 antagonist","target":"solid tumors","id":"31311"},{"source":"Immunostimulant","target":"UNK : Indication","id":"31312"},{"source":"Immunostimulant","target":"residual tumor","id":"31313"},{"source":"Immunostimulant","target":"solid tumors","id":"31314"},{"source":"Immunostimulant","target":"anticancer","id":"31315"},{"source":"Immunostimulant","target":"castration-resistant prostatic neoplasms","id":"31316"},{"source":"Immunostimulant","target":"carcinoma","id":"31317"},{"source":"Immunostimulant","target":"non-small-cell lung","id":"31318"},{"source":"Immunostimulant","target":"metastatic","id":"31319"},{"source":"Immunostimulant","target":"carcinoma","id":"31320"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"31321"},{"source":"Immunostimulant","target":"anti-tumor","id":"31322"},{"source":"Immunostimulant","target":"anticancer","id":"31323"},{"source":"Immunostimulant","target":"prostate cancer","id":"31324"},{"source":"Immunostimulant","target":"solid tumors","id":"31325"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"31326"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"31327"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"31328"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31329"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"31330"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31331"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"31332"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"31333"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31334"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"31335"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"31336"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31337"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"31338"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"31339"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"31340"},{"source":"CD19 antagonist","target":"residual tumor","id":"31341"},{"source":"CD19 antagonist","target":"solid tumors","id":"31342"},{"source":"CD19 antagonist","target":"anticancer","id":"31343"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"31344"},{"source":"CD19 antagonist","target":"carcinoma","id":"31345"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"31346"},{"source":"CD19 antagonist","target":"metastatic","id":"31347"},{"source":"CD19 antagonist","target":"carcinoma","id":"31348"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"31349"},{"source":"CD19 antagonist","target":"anti-tumor","id":"31350"},{"source":"CD19 antagonist","target":"anticancer","id":"31351"},{"source":"CD19 antagonist","target":"prostate cancer","id":"31352"},{"source":"CD19 antagonist","target":"solid tumors","id":"31353"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"31354"},{"source":"Oncology: Lung","target":"Delta-like 4 antagonist","id":"31355"},{"source":"Oncology: Lung","target":"Immunostimulant","id":"31356"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"31357"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"31358"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"31359"},{"source":"Non-Small Cell","target":"Delta-like 4 antagonist","id":"31360"},{"source":"Non-Small Cell","target":"Immunostimulant","id":"31361"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"31362"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"31363"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"31364"},{"source":"Oncology: Prostate","target":"Delta-like 4 antagonist","id":"31365"},{"source":"Oncology: Prostate","target":"Immunostimulant","id":"31366"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"31367"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"31368"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"31369"},{"source":"UNK : Drug","target":"National Institutes of Health/National Cancer Institute","id":"31370"},{"source":"UNK : Indication","target":"pembrolizumab","id":"31371"},{"source":"UNK : Indication","target":"UNK : Drug","id":"31372"},{"source":"anticancer","target":"pembrolizumab","id":"31373"},{"source":"anticancer","target":"UNK : Drug","id":"31374"},{"source":"human immunodeficiency virus","target":"pembrolizumab","id":"31375"},{"source":"human immunodeficiency virus","target":"UNK : Drug","id":"31376"},{"source":"deafness","target":"pembrolizumab","id":"31377"},{"source":"deafness","target":"UNK : Drug","id":"31378"},{"source":"renal cancer","target":"pembrolizumab","id":"31379"},{"source":"renal cancer","target":"UNK : Drug","id":"31380"},{"source":"sjogren's syndrome","target":"pembrolizumab","id":"31381"},{"source":"sjogren's syndrome","target":"UNK : Drug","id":"31382"},{"source":"joint diseases","target":"pembrolizumab","id":"31383"},{"source":"joint diseases","target":"UNK : Drug","id":"31384"},{"source":"carcinoma","target":"pembrolizumab","id":"31385"},{"source":"carcinoma","target":"UNK : Drug","id":"31386"},{"source":"hepatitis c virus","target":"pembrolizumab","id":"31387"},{"source":"hepatitis c virus","target":"UNK : Drug","id":"31388"},{"source":"guillain-barre syndrome","target":"pembrolizumab","id":"31389"},{"source":"guillain-barre syndrome","target":"UNK : Drug","id":"31390"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"31391"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"31392"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"31393"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"31394"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"31395"},{"source":"diabetes mellitus","target":"UNK : Drug","id":"31396"},{"source":"hiv infections","target":"pembrolizumab","id":"31397"},{"source":"hiv infections","target":"UNK : Drug","id":"31398"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"31399"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"31400"},{"source":"carcinoma","target":"pembrolizumab","id":"31401"},{"source":"carcinoma","target":"UNK : Drug","id":"31402"},{"source":"crohn disease","target":"pembrolizumab","id":"31403"},{"source":"crohn disease","target":"UNK : Drug","id":"31404"},{"source":"systemic lupus erythematosus","target":"pembrolizumab","id":"31405"},{"source":"systemic lupus erythematosus","target":"UNK : Drug","id":"31406"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"31407"},{"source":"inflammatory bowel diseases","target":"UNK : Drug","id":"31408"},{"source":"stevens-johnson syndrome","target":"pembrolizumab","id":"31409"},{"source":"stevens-johnson syndrome","target":"UNK : Drug","id":"31410"},{"source":"hcv","target":"pembrolizumab","id":"31411"},{"source":"hcv","target":"UNK : Drug","id":"31412"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"31413"},{"source":"diabetes mellitus","target":"UNK : Drug","id":"31414"},{"source":"hearing loss","target":"pembrolizumab","id":"31415"},{"source":"hearing loss","target":"UNK : Drug","id":"31416"},{"source":"bladder cancer","target":"pembrolizumab","id":"31417"},{"source":"bladder cancer","target":"UNK : Drug","id":"31418"},{"source":"residual neoplasm","target":"pembrolizumab","id":"31419"},{"source":"residual neoplasm","target":"UNK : Drug","id":"31420"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"31421"},{"source":"autoimmune diseases","target":"UNK : Drug","id":"31422"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"31423"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"31424"},{"source":"demyelinating","target":"pembrolizumab","id":"31425"},{"source":"demyelinating","target":"UNK : Drug","id":"31426"},{"source":"residual cancer","target":"pembrolizumab","id":"31427"},{"source":"residual cancer","target":"UNK : Drug","id":"31428"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"31429"},{"source":"autoimmune diseases","target":"UNK : Drug","id":"31430"},{"source":"pneumonitis","target":"pembrolizumab","id":"31431"},{"source":"pneumonitis","target":"UNK : Drug","id":"31432"},{"source":"solid tumors","target":"pembrolizumab","id":"31433"},{"source":"solid tumors","target":"UNK : Drug","id":"31434"},{"source":"crohn's","target":"pembrolizumab","id":"31435"},{"source":"crohn's","target":"UNK : Drug","id":"31436"},{"source":"multiple sclerosis","target":"pembrolizumab","id":"31437"},{"source":"multiple sclerosis","target":"UNK : Drug","id":"31438"},{"source":"carcinoma","target":"pembrolizumab","id":"31439"},{"source":"carcinoma","target":"UNK : Drug","id":"31440"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"31441"},{"source":"diabetes mellitus","target":"UNK : Drug","id":"31442"},{"source":"solid tumors","target":"pembrolizumab","id":"31443"},{"source":"solid tumors","target":"UNK : Drug","id":"31444"},{"source":"psoriasis","target":"pembrolizumab","id":"31445"},{"source":"psoriasis","target":"UNK : Drug","id":"31446"},{"source":"bladder tumor","target":"pembrolizumab","id":"31447"},{"source":"bladder tumor","target":"UNK : Drug","id":"31448"},{"source":"arthropathies","target":"pembrolizumab","id":"31449"},{"source":"arthropathies","target":"UNK : Drug","id":"31450"},{"source":"anti-hiv","target":"pembrolizumab","id":"31451"},{"source":"anti-hiv","target":"UNK : Drug","id":"31452"},{"source":"toxic epidermal necrolysis","target":"pembrolizumab","id":"31453"},{"source":"toxic epidermal necrolysis","target":"UNK : Drug","id":"31454"},{"source":"connective tissue diseases","target":"pembrolizumab","id":"31455"},{"source":"connective tissue diseases","target":"UNK : Drug","id":"31456"},{"source":"liver metastases","target":"pembrolizumab","id":"31457"},{"source":"liver metastases","target":"UNK : Drug","id":"31458"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"31459"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"31460"},{"source":"vitiligo","target":"pembrolizumab","id":"31461"},{"source":"vitiligo","target":"UNK : Drug","id":"31462"},{"source":"systemic scleroderma","target":"pembrolizumab","id":"31463"},{"source":"systemic scleroderma","target":"UNK : Drug","id":"31464"},{"source":"metastatic","target":"pembrolizumab","id":"31465"},{"source":"metastatic","target":"UNK : Drug","id":"31466"},{"source":"carcinoma","target":"pembrolizumab","id":"31467"},{"source":"carcinoma","target":"UNK : Drug","id":"31468"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"31469"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"31470"},{"source":"demyelinating","target":"pembrolizumab","id":"31471"},{"source":"demyelinating","target":"UNK : Drug","id":"31472"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"31473"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"31474"},{"source":"ulcerative colitis","target":"pembrolizumab","id":"31475"},{"source":"ulcerative colitis","target":"UNK : Drug","id":"31476"},{"source":"thyroiditis","target":"pembrolizumab","id":"31477"},{"source":"thyroiditis","target":"UNK : Drug","id":"31478"},{"source":"transitional","target":"pembrolizumab","id":"31479"},{"source":"transitional","target":"UNK : Drug","id":"31480"},{"source":"neuropathy","target":"pembrolizumab","id":"31481"},{"source":"neuropathy","target":"UNK : Drug","id":"31482"},{"source":"systemic scleroderma","target":"pembrolizumab","id":"31483"},{"source":"systemic scleroderma","target":"UNK : Drug","id":"31484"},{"source":"heart failure","target":"pembrolizumab","id":"31485"},{"source":"heart failure","target":"UNK : Drug","id":"31486"},{"source":"pneumonia","target":"pembrolizumab","id":"31487"},{"source":"pneumonia","target":"UNK : Drug","id":"31488"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"31489"},{"source":"inflammatory bowel diseases","target":"UNK : Drug","id":"31490"},{"source":"arthritis","target":"pembrolizumab","id":"31491"},{"source":"arthritis","target":"UNK : Drug","id":"31492"},{"source":"carcinoma","target":"pembrolizumab","id":"31493"},{"source":"carcinoma","target":"UNK : Drug","id":"31494"},{"source":"myasthenia gravis","target":"pembrolizumab","id":"31495"},{"source":"myasthenia gravis","target":"UNK : Drug","id":"31496"},{"source":"measles","target":"pembrolizumab","id":"31497"},{"source":"measles","target":"UNK : Drug","id":"31498"},{"source":"anticancer","target":"pembrolizumab","id":"31499"},{"source":"anticancer","target":"UNK : Drug","id":"31500"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"31501"},{"source":"urinary bladder neoplasms","target":"UNK : Drug","id":"31502"},{"source":"hypopigmentation","target":"pembrolizumab","id":"31503"},{"source":"hypopigmentation","target":"UNK : Drug","id":"31504"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"31505"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31506"},{"source":"Anticancer immunotherapy","target":"human immunodeficiency virus","id":"31507"},{"source":"Anticancer immunotherapy","target":"deafness","id":"31508"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"31509"},{"source":"Anticancer immunotherapy","target":"sjogren's syndrome","id":"31510"},{"source":"Anticancer immunotherapy","target":"joint diseases","id":"31511"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31512"},{"source":"Anticancer immunotherapy","target":"hepatitis c virus","id":"31513"},{"source":"Anticancer immunotherapy","target":"guillain-barre syndrome","id":"31514"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"31515"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"31516"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"31517"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"31518"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"31519"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31520"},{"source":"Anticancer immunotherapy","target":"crohn disease","id":"31521"},{"source":"Anticancer immunotherapy","target":"systemic lupus erythematosus","id":"31522"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"31523"},{"source":"Anticancer immunotherapy","target":"stevens-johnson syndrome","id":"31524"},{"source":"Anticancer immunotherapy","target":"hcv","id":"31525"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"31526"},{"source":"Anticancer immunotherapy","target":"hearing loss","id":"31527"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"31528"},{"source":"Anticancer immunotherapy","target":"residual neoplasm","id":"31529"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"31530"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"31531"},{"source":"Anticancer immunotherapy","target":"demyelinating","id":"31532"},{"source":"Anticancer immunotherapy","target":"residual cancer","id":"31533"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"31534"},{"source":"Anticancer immunotherapy","target":"pneumonitis","id":"31535"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"31536"},{"source":"Anticancer immunotherapy","target":"crohn's","id":"31537"},{"source":"Anticancer immunotherapy","target":"multiple sclerosis","id":"31538"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31539"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"31540"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"31541"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"31542"},{"source":"Anticancer immunotherapy","target":"bladder tumor","id":"31543"},{"source":"Anticancer immunotherapy","target":"arthropathies","id":"31544"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"31545"},{"source":"Anticancer immunotherapy","target":"toxic epidermal necrolysis","id":"31546"},{"source":"Anticancer immunotherapy","target":"connective tissue diseases","id":"31547"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"31548"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"31549"},{"source":"Anticancer immunotherapy","target":"vitiligo","id":"31550"},{"source":"Anticancer immunotherapy","target":"systemic scleroderma","id":"31551"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"31552"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31553"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"31554"},{"source":"Anticancer immunotherapy","target":"demyelinating","id":"31555"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"31556"},{"source":"Anticancer immunotherapy","target":"ulcerative colitis","id":"31557"},{"source":"Anticancer immunotherapy","target":"thyroiditis","id":"31558"},{"source":"Anticancer immunotherapy","target":"transitional","id":"31559"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"31560"},{"source":"Anticancer immunotherapy","target":"systemic scleroderma","id":"31561"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"31562"},{"source":"Anticancer immunotherapy","target":"pneumonia","id":"31563"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"31564"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"31565"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31566"},{"source":"Anticancer immunotherapy","target":"myasthenia gravis","id":"31567"},{"source":"Anticancer immunotherapy","target":"measles","id":"31568"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31569"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"31570"},{"source":"Anticancer immunotherapy","target":"hypopigmentation","id":"31571"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"31572"},{"source":"CD19 antagonist","target":"anticancer","id":"31573"},{"source":"CD19 antagonist","target":"human immunodeficiency virus","id":"31574"},{"source":"CD19 antagonist","target":"deafness","id":"31575"},{"source":"CD19 antagonist","target":"renal cancer","id":"31576"},{"source":"CD19 antagonist","target":"sjogren's syndrome","id":"31577"},{"source":"CD19 antagonist","target":"joint diseases","id":"31578"},{"source":"CD19 antagonist","target":"carcinoma","id":"31579"},{"source":"CD19 antagonist","target":"hepatitis c virus","id":"31580"},{"source":"CD19 antagonist","target":"guillain-barre syndrome","id":"31581"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"31582"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"31583"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"31584"},{"source":"CD19 antagonist","target":"hiv infections","id":"31585"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"31586"},{"source":"CD19 antagonist","target":"carcinoma","id":"31587"},{"source":"CD19 antagonist","target":"crohn disease","id":"31588"},{"source":"CD19 antagonist","target":"systemic lupus erythematosus","id":"31589"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"31590"},{"source":"CD19 antagonist","target":"stevens-johnson syndrome","id":"31591"},{"source":"CD19 antagonist","target":"hcv","id":"31592"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"31593"},{"source":"CD19 antagonist","target":"hearing loss","id":"31594"},{"source":"CD19 antagonist","target":"bladder cancer","id":"31595"},{"source":"CD19 antagonist","target":"residual neoplasm","id":"31596"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"31597"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"31598"},{"source":"CD19 antagonist","target":"demyelinating","id":"31599"},{"source":"CD19 antagonist","target":"residual cancer","id":"31600"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"31601"},{"source":"CD19 antagonist","target":"pneumonitis","id":"31602"},{"source":"CD19 antagonist","target":"solid tumors","id":"31603"},{"source":"CD19 antagonist","target":"crohn's","id":"31604"},{"source":"CD19 antagonist","target":"multiple sclerosis","id":"31605"},{"source":"CD19 antagonist","target":"carcinoma","id":"31606"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"31607"},{"source":"CD19 antagonist","target":"solid tumors","id":"31608"},{"source":"CD19 antagonist","target":"psoriasis","id":"31609"},{"source":"CD19 antagonist","target":"bladder tumor","id":"31610"},{"source":"CD19 antagonist","target":"arthropathies","id":"31611"},{"source":"CD19 antagonist","target":"anti-hiv","id":"31612"},{"source":"CD19 antagonist","target":"toxic epidermal necrolysis","id":"31613"},{"source":"CD19 antagonist","target":"connective tissue diseases","id":"31614"},{"source":"CD19 antagonist","target":"liver metastases","id":"31615"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"31616"},{"source":"CD19 antagonist","target":"vitiligo","id":"31617"},{"source":"CD19 antagonist","target":"systemic scleroderma","id":"31618"},{"source":"CD19 antagonist","target":"metastatic","id":"31619"},{"source":"CD19 antagonist","target":"carcinoma","id":"31620"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"31621"},{"source":"CD19 antagonist","target":"demyelinating","id":"31622"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"31623"},{"source":"CD19 antagonist","target":"ulcerative colitis","id":"31624"},{"source":"CD19 antagonist","target":"thyroiditis","id":"31625"},{"source":"CD19 antagonist","target":"transitional","id":"31626"},{"source":"CD19 antagonist","target":"neuropathy","id":"31627"},{"source":"CD19 antagonist","target":"systemic scleroderma","id":"31628"},{"source":"CD19 antagonist","target":"heart failure","id":"31629"},{"source":"CD19 antagonist","target":"pneumonia","id":"31630"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"31631"},{"source":"CD19 antagonist","target":"arthritis","id":"31632"},{"source":"CD19 antagonist","target":"carcinoma","id":"31633"},{"source":"CD19 antagonist","target":"myasthenia gravis","id":"31634"},{"source":"CD19 antagonist","target":"measles","id":"31635"},{"source":"CD19 antagonist","target":"anticancer","id":"31636"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"31637"},{"source":"CD19 antagonist","target":"hypopigmentation","id":"31638"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"31639"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31640"},{"source":"Immune checkpoint inhibitor","target":"human immunodeficiency virus","id":"31641"},{"source":"Immune checkpoint inhibitor","target":"deafness","id":"31642"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"31643"},{"source":"Immune checkpoint inhibitor","target":"sjogren's syndrome","id":"31644"},{"source":"Immune checkpoint inhibitor","target":"joint diseases","id":"31645"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31646"},{"source":"Immune checkpoint inhibitor","target":"hepatitis c virus","id":"31647"},{"source":"Immune checkpoint inhibitor","target":"guillain-barre syndrome","id":"31648"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"31649"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"31650"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"31651"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"31652"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"31653"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31654"},{"source":"Immune checkpoint inhibitor","target":"crohn disease","id":"31655"},{"source":"Immune checkpoint inhibitor","target":"systemic lupus erythematosus","id":"31656"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"31657"},{"source":"Immune checkpoint inhibitor","target":"stevens-johnson syndrome","id":"31658"},{"source":"Immune checkpoint inhibitor","target":"hcv","id":"31659"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"31660"},{"source":"Immune checkpoint inhibitor","target":"hearing loss","id":"31661"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"31662"},{"source":"Immune checkpoint inhibitor","target":"residual neoplasm","id":"31663"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"31664"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"31665"},{"source":"Immune checkpoint inhibitor","target":"demyelinating","id":"31666"},{"source":"Immune checkpoint inhibitor","target":"residual cancer","id":"31667"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"31668"},{"source":"Immune checkpoint inhibitor","target":"pneumonitis","id":"31669"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"31670"},{"source":"Immune checkpoint inhibitor","target":"crohn's","id":"31671"},{"source":"Immune checkpoint inhibitor","target":"multiple sclerosis","id":"31672"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31673"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"31674"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"31675"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"31676"},{"source":"Immune checkpoint inhibitor","target":"bladder tumor","id":"31677"},{"source":"Immune checkpoint inhibitor","target":"arthropathies","id":"31678"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"31679"},{"source":"Immune checkpoint inhibitor","target":"toxic epidermal necrolysis","id":"31680"},{"source":"Immune checkpoint inhibitor","target":"connective tissue diseases","id":"31681"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"31682"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"31683"},{"source":"Immune checkpoint inhibitor","target":"vitiligo","id":"31684"},{"source":"Immune checkpoint inhibitor","target":"systemic scleroderma","id":"31685"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"31686"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31687"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"31688"},{"source":"Immune checkpoint inhibitor","target":"demyelinating","id":"31689"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"31690"},{"source":"Immune checkpoint inhibitor","target":"ulcerative colitis","id":"31691"},{"source":"Immune checkpoint inhibitor","target":"thyroiditis","id":"31692"},{"source":"Immune checkpoint inhibitor","target":"transitional","id":"31693"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"31694"},{"source":"Immune checkpoint inhibitor","target":"systemic scleroderma","id":"31695"},{"source":"Immune checkpoint inhibitor","target":"heart failure","id":"31696"},{"source":"Immune checkpoint inhibitor","target":"pneumonia","id":"31697"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"31698"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"31699"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31700"},{"source":"Immune checkpoint inhibitor","target":"myasthenia gravis","id":"31701"},{"source":"Immune checkpoint inhibitor","target":"measles","id":"31702"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31703"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"31704"},{"source":"Immune checkpoint inhibitor","target":"hypopigmentation","id":"31705"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"31706"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"31707"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"31708"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"31709"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"31710"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"31711"},{"source":"CIN vaccine","target":"IO Biotech","id":"31712"},{"source":"CIN vaccine","target":"Merck & Co.","id":"31713"},{"source":"Aduro (u)","target":"IO Biotech","id":"31714"},{"source":"Aduro (u)","target":"Merck & Co.","id":"31715"},{"source":"pembrolizumab","target":"IO Biotech","id":"31716"},{"source":"pembrolizumab","target":"Merck & Co.","id":"31717"},{"source":"stomach neoplasms","target":"CIN vaccine","id":"31718"},{"source":"stomach neoplasms","target":"Aduro (u)","id":"31719"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"31720"},{"source":"pharyngeal neoplasms","target":"CIN vaccine","id":"31721"},{"source":"pharyngeal neoplasms","target":"Aduro (u)","id":"31722"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"31723"},{"source":"carcinoma","target":"CIN vaccine","id":"31724"},{"source":"carcinoma","target":"Aduro (u)","id":"31725"},{"source":"carcinoma","target":"pembrolizumab","id":"31726"},{"source":"UNK : Indication","target":"CIN vaccine","id":"31727"},{"source":"UNK : Indication","target":"Aduro (u)","id":"31728"},{"source":"UNK : Indication","target":"pembrolizumab","id":"31729"},{"source":"esophageal cancer","target":"CIN vaccine","id":"31730"},{"source":"esophageal cancer","target":"Aduro (u)","id":"31731"},{"source":"esophageal cancer","target":"pembrolizumab","id":"31732"},{"source":"carcinoma","target":"CIN vaccine","id":"31733"},{"source":"carcinoma","target":"Aduro (u)","id":"31734"},{"source":"carcinoma","target":"pembrolizumab","id":"31735"},{"source":"carcinoma","target":"CIN vaccine","id":"31736"},{"source":"carcinoma","target":"Aduro (u)","id":"31737"},{"source":"carcinoma","target":"pembrolizumab","id":"31738"},{"source":"metastatic","target":"CIN vaccine","id":"31739"},{"source":"metastatic","target":"Aduro (u)","id":"31740"},{"source":"metastatic","target":"pembrolizumab","id":"31741"},{"source":"carcinoma","target":"CIN vaccine","id":"31742"},{"source":"carcinoma","target":"Aduro (u)","id":"31743"},{"source":"carcinoma","target":"pembrolizumab","id":"31744"},{"source":"neoplasm metastasis","target":"CIN vaccine","id":"31745"},{"source":"neoplasm metastasis","target":"Aduro (u)","id":"31746"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"31747"},{"source":"carcinoma","target":"CIN vaccine","id":"31748"},{"source":"carcinoma","target":"Aduro (u)","id":"31749"},{"source":"carcinoma","target":"pembrolizumab","id":"31750"},{"source":"barrett esophagus","target":"CIN vaccine","id":"31751"},{"source":"barrett esophagus","target":"Aduro (u)","id":"31752"},{"source":"barrett esophagus","target":"pembrolizumab","id":"31753"},{"source":"anticancer","target":"CIN vaccine","id":"31754"},{"source":"anticancer","target":"Aduro (u)","id":"31755"},{"source":"anticancer","target":"pembrolizumab","id":"31756"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"31757"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"31758"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31759"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"31760"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"31761"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31762"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31763"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"31764"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31765"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"31766"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31767"},{"source":"Anticancer immunotherapy","target":"barrett esophagus","id":"31768"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31769"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"31770"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"31771"},{"source":"CD19 antagonist","target":"carcinoma","id":"31772"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"31773"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"31774"},{"source":"CD19 antagonist","target":"carcinoma","id":"31775"},{"source":"CD19 antagonist","target":"carcinoma","id":"31776"},{"source":"CD19 antagonist","target":"metastatic","id":"31777"},{"source":"CD19 antagonist","target":"carcinoma","id":"31778"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"31779"},{"source":"CD19 antagonist","target":"carcinoma","id":"31780"},{"source":"CD19 antagonist","target":"barrett esophagus","id":"31781"},{"source":"CD19 antagonist","target":"anticancer","id":"31782"},{"source":"Immunostimulant","target":"stomach neoplasms","id":"31783"},{"source":"Immunostimulant","target":"pharyngeal neoplasms","id":"31784"},{"source":"Immunostimulant","target":"carcinoma","id":"31785"},{"source":"Immunostimulant","target":"UNK : Indication","id":"31786"},{"source":"Immunostimulant","target":"esophageal cancer","id":"31787"},{"source":"Immunostimulant","target":"carcinoma","id":"31788"},{"source":"Immunostimulant","target":"carcinoma","id":"31789"},{"source":"Immunostimulant","target":"metastatic","id":"31790"},{"source":"Immunostimulant","target":"carcinoma","id":"31791"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"31792"},{"source":"Immunostimulant","target":"carcinoma","id":"31793"},{"source":"Immunostimulant","target":"barrett esophagus","id":"31794"},{"source":"Immunostimulant","target":"anticancer","id":"31795"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"31796"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"31797"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31798"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"31799"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"31800"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31801"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31802"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"31803"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31804"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"31805"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31806"},{"source":"Immune checkpoint inhibitor","target":"barrett esophagus","id":"31807"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31808"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"31809"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"31810"},{"source":"Oncology: Esophageal","target":"Immunostimulant","id":"31811"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"31812"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"31813"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"31814"},{"source":"Oncology: Gastric","target":"Immunostimulant","id":"31815"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"31816"},{"source":"cetuximab","target":"Merck & Co.","id":"31817"},{"source":"pembrolizumab","target":"Merck & Co.","id":"31818"},{"source":"UNK : Drug","target":"Merck & Co.","id":"31819"},{"source":"carcinoma","target":"cetuximab","id":"31820"},{"source":"carcinoma","target":"pembrolizumab","id":"31821"},{"source":"carcinoma","target":"UNK : Drug","id":"31822"},{"source":"UNK : Indication","target":"cetuximab","id":"31823"},{"source":"UNK : Indication","target":"pembrolizumab","id":"31824"},{"source":"UNK : Indication","target":"UNK : Drug","id":"31825"},{"source":"squamous cell neoplasms","target":"cetuximab","id":"31826"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"31827"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"31828"},{"source":"pharyngeal neoplasms","target":"cetuximab","id":"31829"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"31830"},{"source":"pharyngeal neoplasms","target":"UNK : Drug","id":"31831"},{"source":"carcinoma","target":"cetuximab","id":"31832"},{"source":"carcinoma","target":"pembrolizumab","id":"31833"},{"source":"carcinoma","target":"UNK : Drug","id":"31834"},{"source":"carcinoma","target":"cetuximab","id":"31835"},{"source":"carcinoma","target":"pembrolizumab","id":"31836"},{"source":"carcinoma","target":"UNK : Drug","id":"31837"},{"source":"mouth neoplasms","target":"cetuximab","id":"31838"},{"source":"mouth neoplasms","target":"pembrolizumab","id":"31839"},{"source":"mouth neoplasms","target":"UNK : Drug","id":"31840"},{"source":"carcinoma","target":"cetuximab","id":"31841"},{"source":"carcinoma","target":"pembrolizumab","id":"31842"},{"source":"carcinoma","target":"UNK : Drug","id":"31843"},{"source":"carcinoma","target":"cetuximab","id":"31844"},{"source":"carcinoma","target":"pembrolizumab","id":"31845"},{"source":"carcinoma","target":"UNK : Drug","id":"31846"},{"source":"metastatic","target":"cetuximab","id":"31847"},{"source":"metastatic","target":"pembrolizumab","id":"31848"},{"source":"metastatic","target":"UNK : Drug","id":"31849"},{"source":"neoplasm metastasis","target":"cetuximab","id":"31850"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"31851"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"31852"},{"source":"esophageal neoplasms","target":"cetuximab","id":"31853"},{"source":"esophageal neoplasms","target":"pembrolizumab","id":"31854"},{"source":"esophageal neoplasms","target":"UNK : Drug","id":"31855"},{"source":"anticancer","target":"cetuximab","id":"31856"},{"source":"anticancer","target":"pembrolizumab","id":"31857"},{"source":"anticancer","target":"UNK : Drug","id":"31858"},{"source":"squamous cell neoplasms","target":"cetuximab","id":"31859"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"31860"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"31861"},{"source":"pharyngeal neoplasms","target":"cetuximab","id":"31862"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"31863"},{"source":"pharyngeal neoplasms","target":"UNK : Drug","id":"31864"},{"source":"carcinoma","target":"cetuximab","id":"31865"},{"source":"carcinoma","target":"pembrolizumab","id":"31866"},{"source":"carcinoma","target":"UNK : Drug","id":"31867"},{"source":"head and neck neoplasms","target":"cetuximab","id":"31868"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"31869"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"31870"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31871"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"31872"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"31873"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"31874"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31875"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31876"},{"source":"Anticancer immunotherapy","target":"mouth neoplasms","id":"31877"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31878"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31879"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"31880"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"31881"},{"source":"Anticancer immunotherapy","target":"esophageal neoplasms","id":"31882"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31883"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"31884"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"31885"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31886"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"31887"},{"source":"CD19 antagonist","target":"carcinoma","id":"31888"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"31889"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"31890"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"31891"},{"source":"CD19 antagonist","target":"carcinoma","id":"31892"},{"source":"CD19 antagonist","target":"carcinoma","id":"31893"},{"source":"CD19 antagonist","target":"mouth neoplasms","id":"31894"},{"source":"CD19 antagonist","target":"carcinoma","id":"31895"},{"source":"CD19 antagonist","target":"carcinoma","id":"31896"},{"source":"CD19 antagonist","target":"metastatic","id":"31897"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"31898"},{"source":"CD19 antagonist","target":"esophageal neoplasms","id":"31899"},{"source":"CD19 antagonist","target":"anticancer","id":"31900"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"31901"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"31902"},{"source":"CD19 antagonist","target":"carcinoma","id":"31903"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"31904"},{"source":"EGFR antagonist","target":"carcinoma","id":"31905"},{"source":"EGFR antagonist","target":"UNK : Indication","id":"31906"},{"source":"EGFR antagonist","target":"squamous cell neoplasms","id":"31907"},{"source":"EGFR antagonist","target":"pharyngeal neoplasms","id":"31908"},{"source":"EGFR antagonist","target":"carcinoma","id":"31909"},{"source":"EGFR antagonist","target":"carcinoma","id":"31910"},{"source":"EGFR antagonist","target":"mouth neoplasms","id":"31911"},{"source":"EGFR antagonist","target":"carcinoma","id":"31912"},{"source":"EGFR antagonist","target":"carcinoma","id":"31913"},{"source":"EGFR antagonist","target":"metastatic","id":"31914"},{"source":"EGFR antagonist","target":"neoplasm metastasis","id":"31915"},{"source":"EGFR antagonist","target":"esophageal neoplasms","id":"31916"},{"source":"EGFR antagonist","target":"anticancer","id":"31917"},{"source":"EGFR antagonist","target":"squamous cell neoplasms","id":"31918"},{"source":"EGFR antagonist","target":"pharyngeal neoplasms","id":"31919"},{"source":"EGFR antagonist","target":"carcinoma","id":"31920"},{"source":"EGFR antagonist","target":"head and neck neoplasms","id":"31921"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31922"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"31923"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"31924"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"31925"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31926"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31927"},{"source":"Immune checkpoint inhibitor","target":"mouth neoplasms","id":"31928"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31929"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31930"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"31931"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"31932"},{"source":"Immune checkpoint inhibitor","target":"esophageal neoplasms","id":"31933"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31934"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"31935"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"31936"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31937"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"31938"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"31939"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"31940"},{"source":"Oncology: Head/Neck","target":"EGFR antagonist","id":"31941"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"31942"},{"source":"pembrolizumab","target":"Merck & Co.","id":"31943"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"31944"},{"source":"UNK : Indication","target":"pembrolizumab","id":"31945"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"31946"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"31947"},{"source":"pharyngeal neoplasms","target":"nab-paclitaxel (IV)","id":"31948"},{"source":"pleural effusion","target":"pembrolizumab","id":"31949"},{"source":"pleural effusion","target":"nab-paclitaxel (IV)","id":"31950"},{"source":"esophageal cancer","target":"pembrolizumab","id":"31951"},{"source":"esophageal cancer","target":"nab-paclitaxel (IV)","id":"31952"},{"source":"carcinoma","target":"pembrolizumab","id":"31953"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"31954"},{"source":"residual tumor","target":"pembrolizumab","id":"31955"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"31956"},{"source":"metastatic","target":"pembrolizumab","id":"31957"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"31958"},{"source":"carcinoma","target":"pembrolizumab","id":"31959"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"31960"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"31961"},{"source":"stomach neoplasms","target":"nab-paclitaxel (IV)","id":"31962"},{"source":"hydrothorax","target":"pembrolizumab","id":"31963"},{"source":"hydrothorax","target":"nab-paclitaxel (IV)","id":"31964"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"31965"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"31966"},{"source":"carcinoma","target":"pembrolizumab","id":"31967"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"31968"},{"source":"anticancer","target":"pembrolizumab","id":"31969"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"31970"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"31971"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"31972"},{"source":"Immune checkpoint inhibitor","target":"pleural effusion","id":"31973"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"31974"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31975"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"31976"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"31977"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31978"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"31979"},{"source":"Immune checkpoint inhibitor","target":"hydrothorax","id":"31980"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"31981"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"31982"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"31983"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"31984"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"31985"},{"source":"Anticancer immunotherapy","target":"pleural effusion","id":"31986"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"31987"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31988"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"31989"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"31990"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31991"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"31992"},{"source":"Anticancer immunotherapy","target":"hydrothorax","id":"31993"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"31994"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"31995"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"31996"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"31997"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"31998"},{"source":"CD19 antagonist","target":"pleural effusion","id":"31999"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"32000"},{"source":"CD19 antagonist","target":"carcinoma","id":"32001"},{"source":"CD19 antagonist","target":"residual tumor","id":"32002"},{"source":"CD19 antagonist","target":"metastatic","id":"32003"},{"source":"CD19 antagonist","target":"carcinoma","id":"32004"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"32005"},{"source":"CD19 antagonist","target":"hydrothorax","id":"32006"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"32007"},{"source":"CD19 antagonist","target":"carcinoma","id":"32008"},{"source":"CD19 antagonist","target":"anticancer","id":"32009"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"32010"},{"source":"Beta tubulin antagonist","target":"pharyngeal neoplasms","id":"32011"},{"source":"Beta tubulin antagonist","target":"pleural effusion","id":"32012"},{"source":"Beta tubulin antagonist","target":"esophageal cancer","id":"32013"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"32014"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"32015"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"32016"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"32017"},{"source":"Beta tubulin antagonist","target":"stomach neoplasms","id":"32018"},{"source":"Beta tubulin antagonist","target":"hydrothorax","id":"32019"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"32020"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"32021"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"32022"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"32023"},{"source":"Microtubule stimulant","target":"pharyngeal neoplasms","id":"32024"},{"source":"Microtubule stimulant","target":"pleural effusion","id":"32025"},{"source":"Microtubule stimulant","target":"esophageal cancer","id":"32026"},{"source":"Microtubule stimulant","target":"carcinoma","id":"32027"},{"source":"Microtubule stimulant","target":"residual tumor","id":"32028"},{"source":"Microtubule stimulant","target":"metastatic","id":"32029"},{"source":"Microtubule stimulant","target":"carcinoma","id":"32030"},{"source":"Microtubule stimulant","target":"stomach neoplasms","id":"32031"},{"source":"Microtubule stimulant","target":"hydrothorax","id":"32032"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"32033"},{"source":"Microtubule stimulant","target":"carcinoma","id":"32034"},{"source":"Microtubule stimulant","target":"anticancer","id":"32035"},{"source":"Taxane","target":"UNK : Indication","id":"32036"},{"source":"Taxane","target":"pharyngeal neoplasms","id":"32037"},{"source":"Taxane","target":"pleural effusion","id":"32038"},{"source":"Taxane","target":"esophageal cancer","id":"32039"},{"source":"Taxane","target":"carcinoma","id":"32040"},{"source":"Taxane","target":"residual tumor","id":"32041"},{"source":"Taxane","target":"metastatic","id":"32042"},{"source":"Taxane","target":"carcinoma","id":"32043"},{"source":"Taxane","target":"stomach neoplasms","id":"32044"},{"source":"Taxane","target":"hydrothorax","id":"32045"},{"source":"Taxane","target":"neoplasm metastasis","id":"32046"},{"source":"Taxane","target":"carcinoma","id":"32047"},{"source":"Taxane","target":"anticancer","id":"32048"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"32049"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"32050"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"32051"},{"source":"Oncology: Esophageal","target":"Beta tubulin antagonist","id":"32052"},{"source":"Oncology: Esophageal","target":"Microtubule stimulant","id":"32053"},{"source":"Oncology: Esophageal","target":"Taxane","id":"32054"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"32055"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"32056"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"32057"},{"source":"Oncology: Gastric","target":"Beta tubulin antagonist","id":"32058"},{"source":"Oncology: Gastric","target":"Microtubule stimulant","id":"32059"},{"source":"Oncology: Gastric","target":"Taxane","id":"32060"},{"source":"bemcentinib (u)","target":"(Other Hospital/Academic/Medical Center)","id":"32061"},{"source":"bemcentinib (u)","target":"BerGenBio","id":"32062"},{"source":"dabrafenib (capsule) (a)","target":"(Other Hospital/Academic/Medical Center)","id":"32063"},{"source":"dabrafenib (capsule) (a)","target":"BerGenBio","id":"32064"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"32065"},{"source":"pembrolizumab","target":"BerGenBio","id":"32066"},{"source":"trametinib (tablet) (a)","target":"(Other Hospital/Academic/Medical Center)","id":"32067"},{"source":"trametinib (tablet) (a)","target":"BerGenBio","id":"32068"},{"source":"residual tumor","target":"bemcentinib (u)","id":"32069"},{"source":"residual tumor","target":"dabrafenib (capsule) (a)","id":"32070"},{"source":"residual tumor","target":"pembrolizumab","id":"32071"},{"source":"residual tumor","target":"trametinib (tablet) (a)","id":"32072"},{"source":"melanoma","target":"bemcentinib (u)","id":"32073"},{"source":"melanoma","target":"dabrafenib (capsule) (a)","id":"32074"},{"source":"melanoma","target":"pembrolizumab","id":"32075"},{"source":"melanoma","target":"trametinib (tablet) (a)","id":"32076"},{"source":"skin neoplasms","target":"bemcentinib (u)","id":"32077"},{"source":"skin neoplasms","target":"dabrafenib (capsule) (a)","id":"32078"},{"source":"skin neoplasms","target":"pembrolizumab","id":"32079"},{"source":"skin neoplasms","target":"trametinib (tablet) (a)","id":"32080"},{"source":"metastatic","target":"bemcentinib (u)","id":"32081"},{"source":"metastatic","target":"dabrafenib (capsule) (a)","id":"32082"},{"source":"metastatic","target":"pembrolizumab","id":"32083"},{"source":"metastatic","target":"trametinib (tablet) (a)","id":"32084"},{"source":"carcinoma","target":"bemcentinib (u)","id":"32085"},{"source":"carcinoma","target":"dabrafenib (capsule) (a)","id":"32086"},{"source":"carcinoma","target":"pembrolizumab","id":"32087"},{"source":"carcinoma","target":"trametinib (tablet) (a)","id":"32088"},{"source":"neoplasm metastasis","target":"bemcentinib (u)","id":"32089"},{"source":"neoplasm metastasis","target":"dabrafenib (capsule) (a)","id":"32090"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"32091"},{"source":"neoplasm metastasis","target":"trametinib (tablet) (a)","id":"32092"},{"source":"anticancer","target":"bemcentinib (u)","id":"32093"},{"source":"anticancer","target":"dabrafenib (capsule) (a)","id":"32094"},{"source":"anticancer","target":"pembrolizumab","id":"32095"},{"source":"anticancer","target":"trametinib (tablet) (a)","id":"32096"},{"source":"NA","target":"residual tumor","id":"32097"},{"source":"NA","target":"melanoma","id":"32098"},{"source":"NA","target":"skin neoplasms","id":"32099"},{"source":"NA","target":"metastatic","id":"32100"},{"source":"NA","target":"carcinoma","id":"32101"},{"source":"NA","target":"neoplasm metastasis","id":"32102"},{"source":"NA","target":"anticancer","id":"32103"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"32104"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"32105"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"32106"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"32107"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"32108"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"32109"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"32110"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"32111"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"32112"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"32113"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"32114"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32115"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"32116"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"32117"},{"source":"CD19 antagonist","target":"residual tumor","id":"32118"},{"source":"CD19 antagonist","target":"melanoma","id":"32119"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"32120"},{"source":"CD19 antagonist","target":"metastatic","id":"32121"},{"source":"CD19 antagonist","target":"carcinoma","id":"32122"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"32123"},{"source":"CD19 antagonist","target":"anticancer","id":"32124"},{"source":"NA","target":"residual tumor","id":"32125"},{"source":"NA","target":"melanoma","id":"32126"},{"source":"NA","target":"skin neoplasms","id":"32127"},{"source":"NA","target":"metastatic","id":"32128"},{"source":"NA","target":"carcinoma","id":"32129"},{"source":"NA","target":"neoplasm metastasis","id":"32130"},{"source":"NA","target":"anticancer","id":"32131"},{"source":"MEK inhibitor","target":"residual tumor","id":"32132"},{"source":"MEK inhibitor","target":"melanoma","id":"32133"},{"source":"MEK inhibitor","target":"skin neoplasms","id":"32134"},{"source":"MEK inhibitor","target":"metastatic","id":"32135"},{"source":"MEK inhibitor","target":"carcinoma","id":"32136"},{"source":"MEK inhibitor","target":"neoplasm metastasis","id":"32137"},{"source":"MEK inhibitor","target":"anticancer","id":"32138"},{"source":"Oncology: Melanoma","target":"NA","id":"32139"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"32140"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"32141"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"32142"},{"source":"Oncology: Melanoma","target":"NA","id":"32143"},{"source":"Oncology: Melanoma","target":"MEK inhibitor","id":"32144"},{"source":"utomilumab (u)","target":"MD Anderson Cancer Center","id":"32145"},{"source":"utomilumab (u)","target":"University of Texas","id":"32146"},{"source":"utomilumab (u)","target":"Pfizer","id":"32147"},{"source":"cetuximab","target":"MD Anderson Cancer Center","id":"32148"},{"source":"cetuximab","target":"University of Texas","id":"32149"},{"source":"cetuximab","target":"Pfizer","id":"32150"},{"source":"irinotecan (IV)","target":"MD Anderson Cancer Center","id":"32151"},{"source":"irinotecan (IV)","target":"University of Texas","id":"32152"},{"source":"irinotecan (IV)","target":"Pfizer","id":"32153"},{"source":"colorectal neoplasms","target":"utomilumab (u)","id":"32154"},{"source":"colorectal neoplasms","target":"cetuximab","id":"32155"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"32156"},{"source":"colorectal cancer","target":"utomilumab (u)","id":"32157"},{"source":"colorectal cancer","target":"cetuximab","id":"32158"},{"source":"colorectal cancer","target":"irinotecan (IV)","id":"32159"},{"source":"heart failure","target":"utomilumab (u)","id":"32160"},{"source":"heart failure","target":"cetuximab","id":"32161"},{"source":"heart failure","target":"irinotecan (IV)","id":"32162"},{"source":"skin neoplasms","target":"utomilumab (u)","id":"32163"},{"source":"skin neoplasms","target":"cetuximab","id":"32164"},{"source":"skin neoplasms","target":"irinotecan (IV)","id":"32165"},{"source":"microsatellite instability","target":"utomilumab (u)","id":"32166"},{"source":"microsatellite instability","target":"cetuximab","id":"32167"},{"source":"microsatellite instability","target":"irinotecan (IV)","id":"32168"},{"source":"residual tumor","target":"utomilumab (u)","id":"32169"},{"source":"residual tumor","target":"cetuximab","id":"32170"},{"source":"residual tumor","target":"irinotecan (IV)","id":"32171"},{"source":"gilbert disease","target":"utomilumab (u)","id":"32172"},{"source":"gilbert disease","target":"cetuximab","id":"32173"},{"source":"gilbert disease","target":"irinotecan (IV)","id":"32174"},{"source":"colonic neoplasms","target":"utomilumab (u)","id":"32175"},{"source":"colonic neoplasms","target":"cetuximab","id":"32176"},{"source":"colonic neoplasms","target":"irinotecan (IV)","id":"32177"},{"source":"metastatic","target":"utomilumab (u)","id":"32178"},{"source":"metastatic","target":"cetuximab","id":"32179"},{"source":"metastatic","target":"irinotecan (IV)","id":"32180"},{"source":"carcinoma","target":"utomilumab (u)","id":"32181"},{"source":"carcinoma","target":"cetuximab","id":"32182"},{"source":"carcinoma","target":"irinotecan (IV)","id":"32183"},{"source":"gilbert syndrome","target":"utomilumab (u)","id":"32184"},{"source":"gilbert syndrome","target":"cetuximab","id":"32185"},{"source":"gilbert syndrome","target":"irinotecan (IV)","id":"32186"},{"source":"heart failure","target":"utomilumab (u)","id":"32187"},{"source":"heart failure","target":"cetuximab","id":"32188"},{"source":"heart failure","target":"irinotecan (IV)","id":"32189"},{"source":"neoplasm metastasis","target":"utomilumab (u)","id":"32190"},{"source":"neoplasm metastasis","target":"cetuximab","id":"32191"},{"source":"neoplasm metastasis","target":"irinotecan (IV)","id":"32192"},{"source":"anticancer","target":"utomilumab (u)","id":"32193"},{"source":"anticancer","target":"cetuximab","id":"32194"},{"source":"anticancer","target":"irinotecan (IV)","id":"32195"},{"source":"colorectal neoplasms","target":"utomilumab (u)","id":"32196"},{"source":"colorectal neoplasms","target":"cetuximab","id":"32197"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"32198"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"32199"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"32200"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"32201"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"32202"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"32203"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"32204"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"32205"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"32206"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"32207"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32208"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"32209"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"32210"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"32211"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"32212"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"32213"},{"source":"CD137 agonist","target":"colorectal neoplasms","id":"32214"},{"source":"CD137 agonist","target":"colorectal cancer","id":"32215"},{"source":"CD137 agonist","target":"heart failure","id":"32216"},{"source":"CD137 agonist","target":"skin neoplasms","id":"32217"},{"source":"CD137 agonist","target":"microsatellite instability","id":"32218"},{"source":"CD137 agonist","target":"residual tumor","id":"32219"},{"source":"CD137 agonist","target":"gilbert disease","id":"32220"},{"source":"CD137 agonist","target":"colonic neoplasms","id":"32221"},{"source":"CD137 agonist","target":"metastatic","id":"32222"},{"source":"CD137 agonist","target":"carcinoma","id":"32223"},{"source":"CD137 agonist","target":"gilbert syndrome","id":"32224"},{"source":"CD137 agonist","target":"heart failure","id":"32225"},{"source":"CD137 agonist","target":"neoplasm metastasis","id":"32226"},{"source":"CD137 agonist","target":"anticancer","id":"32227"},{"source":"CD137 agonist","target":"colorectal neoplasms","id":"32228"},{"source":"EGFR antagonist","target":"colorectal neoplasms","id":"32229"},{"source":"EGFR antagonist","target":"colorectal cancer","id":"32230"},{"source":"EGFR antagonist","target":"heart failure","id":"32231"},{"source":"EGFR antagonist","target":"skin neoplasms","id":"32232"},{"source":"EGFR antagonist","target":"microsatellite instability","id":"32233"},{"source":"EGFR antagonist","target":"residual tumor","id":"32234"},{"source":"EGFR antagonist","target":"gilbert disease","id":"32235"},{"source":"EGFR antagonist","target":"colonic neoplasms","id":"32236"},{"source":"EGFR antagonist","target":"metastatic","id":"32237"},{"source":"EGFR antagonist","target":"carcinoma","id":"32238"},{"source":"EGFR antagonist","target":"gilbert syndrome","id":"32239"},{"source":"EGFR antagonist","target":"heart failure","id":"32240"},{"source":"EGFR antagonist","target":"neoplasm metastasis","id":"32241"},{"source":"EGFR antagonist","target":"anticancer","id":"32242"},{"source":"EGFR antagonist","target":"colorectal neoplasms","id":"32243"},{"source":"NA","target":"colorectal neoplasms","id":"32244"},{"source":"NA","target":"colorectal cancer","id":"32245"},{"source":"NA","target":"heart failure","id":"32246"},{"source":"NA","target":"skin neoplasms","id":"32247"},{"source":"NA","target":"microsatellite instability","id":"32248"},{"source":"NA","target":"residual tumor","id":"32249"},{"source":"NA","target":"gilbert disease","id":"32250"},{"source":"NA","target":"colonic neoplasms","id":"32251"},{"source":"NA","target":"metastatic","id":"32252"},{"source":"NA","target":"carcinoma","id":"32253"},{"source":"NA","target":"gilbert syndrome","id":"32254"},{"source":"NA","target":"heart failure","id":"32255"},{"source":"NA","target":"neoplasm metastasis","id":"32256"},{"source":"NA","target":"anticancer","id":"32257"},{"source":"NA","target":"colorectal neoplasms","id":"32258"},{"source":"Immune checkpoint stimulant","target":"colorectal neoplasms","id":"32259"},{"source":"Immune checkpoint stimulant","target":"colorectal cancer","id":"32260"},{"source":"Immune checkpoint stimulant","target":"heart failure","id":"32261"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"32262"},{"source":"Immune checkpoint stimulant","target":"microsatellite instability","id":"32263"},{"source":"Immune checkpoint stimulant","target":"residual tumor","id":"32264"},{"source":"Immune checkpoint stimulant","target":"gilbert disease","id":"32265"},{"source":"Immune checkpoint stimulant","target":"colonic neoplasms","id":"32266"},{"source":"Immune checkpoint stimulant","target":"metastatic","id":"32267"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"32268"},{"source":"Immune checkpoint stimulant","target":"gilbert syndrome","id":"32269"},{"source":"Immune checkpoint stimulant","target":"heart failure","id":"32270"},{"source":"Immune checkpoint stimulant","target":"neoplasm metastasis","id":"32271"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"32272"},{"source":"Immune checkpoint stimulant","target":"colorectal neoplasms","id":"32273"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"32274"},{"source":"Oncology: Colorectal","target":"CD137 agonist","id":"32275"},{"source":"Oncology: Colorectal","target":"EGFR antagonist","id":"32276"},{"source":"Oncology: Colorectal","target":"NA","id":"32277"},{"source":"Oncology: Colorectal","target":"Immune checkpoint stimulant","id":"32278"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"32279"},{"source":"pembrolizumab","target":"Merck & Co.","id":"32280"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"32281"},{"source":"UNK : Drug","target":"Merck & Co.","id":"32282"},{"source":"anemia","target":"pembrolizumab","id":"32283"},{"source":"anemia","target":"UNK : Drug","id":"32284"},{"source":"residual tumor","target":"pembrolizumab","id":"32285"},{"source":"residual tumor","target":"UNK : Drug","id":"32286"},{"source":"skin neoplasms","target":"pembrolizumab","id":"32287"},{"source":"skin neoplasms","target":"UNK : Drug","id":"32288"},{"source":"unknown primary","target":"pembrolizumab","id":"32289"},{"source":"unknown primary","target":"UNK : Drug","id":"32290"},{"source":"residual tumor","target":"pembrolizumab","id":"32291"},{"source":"residual tumor","target":"UNK : Drug","id":"32292"},{"source":"carcinoma","target":"pembrolizumab","id":"32293"},{"source":"carcinoma","target":"UNK : Drug","id":"32294"},{"source":"anticancer","target":"pembrolizumab","id":"32295"},{"source":"anticancer","target":"UNK : Drug","id":"32296"},{"source":"unknown primary","target":"pembrolizumab","id":"32297"},{"source":"unknown primary","target":"UNK : Drug","id":"32298"},{"source":"solid tumors","target":"pembrolizumab","id":"32299"},{"source":"solid tumors","target":"UNK : Drug","id":"32300"},{"source":"Anticancer immunotherapy","target":"anemia","id":"32301"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"32302"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"32303"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"32304"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"32305"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32306"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"32307"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"32308"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"32309"},{"source":"CD19 antagonist","target":"anemia","id":"32310"},{"source":"CD19 antagonist","target":"residual tumor","id":"32311"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"32312"},{"source":"CD19 antagonist","target":"unknown primary","id":"32313"},{"source":"CD19 antagonist","target":"residual tumor","id":"32314"},{"source":"CD19 antagonist","target":"carcinoma","id":"32315"},{"source":"CD19 antagonist","target":"anticancer","id":"32316"},{"source":"CD19 antagonist","target":"unknown primary","id":"32317"},{"source":"CD19 antagonist","target":"solid tumors","id":"32318"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"32319"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"32320"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"32321"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"32322"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"32323"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"32324"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"32325"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"32326"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"32327"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"32328"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"32329"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"32330"},{"source":"pembrolizumab","target":"Merck & Co.","id":"32331"},{"source":"sodium chloride 0.9%","target":"Merck & Co.","id":"32332"},{"source":"UNK : Indication","target":"pembrolizumab","id":"32333"},{"source":"UNK : Indication","target":"sodium chloride 0.9%","id":"32334"},{"source":"hepatocellular","target":"pembrolizumab","id":"32335"},{"source":"hepatocellular","target":"sodium chloride 0.9%","id":"32336"},{"source":"carcinoma","target":"pembrolizumab","id":"32337"},{"source":"carcinoma","target":"sodium chloride 0.9%","id":"32338"},{"source":"myelofibrosis","target":"pembrolizumab","id":"32339"},{"source":"myelofibrosis","target":"sodium chloride 0.9%","id":"32340"},{"source":"hcc","target":"pembrolizumab","id":"32341"},{"source":"hcc","target":"sodium chloride 0.9%","id":"32342"},{"source":"carcinoma","target":"pembrolizumab","id":"32343"},{"source":"carcinoma","target":"sodium chloride 0.9%","id":"32344"},{"source":"liver cirrhosis","target":"pembrolizumab","id":"32345"},{"source":"liver cirrhosis","target":"sodium chloride 0.9%","id":"32346"},{"source":"carcinoma","target":"pembrolizumab","id":"32347"},{"source":"carcinoma","target":"sodium chloride 0.9%","id":"32348"},{"source":"anticancer","target":"pembrolizumab","id":"32349"},{"source":"anticancer","target":"sodium chloride 0.9%","id":"32350"},{"source":"liver cirrhosis","target":"pembrolizumab","id":"32351"},{"source":"liver cirrhosis","target":"sodium chloride 0.9%","id":"32352"},{"source":"liver cancer","target":"pembrolizumab","id":"32353"},{"source":"liver cancer","target":"sodium chloride 0.9%","id":"32354"},{"source":"liver neoplasms","target":"pembrolizumab","id":"32355"},{"source":"liver neoplasms","target":"sodium chloride 0.9%","id":"32356"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"32357"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"32358"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32359"},{"source":"Anticancer immunotherapy","target":"myelofibrosis","id":"32360"},{"source":"Anticancer immunotherapy","target":"hcc","id":"32361"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32362"},{"source":"Anticancer immunotherapy","target":"liver cirrhosis","id":"32363"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32364"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"32365"},{"source":"Anticancer immunotherapy","target":"liver cirrhosis","id":"32366"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"32367"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"32368"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"32369"},{"source":"CD19 antagonist","target":"hepatocellular","id":"32370"},{"source":"CD19 antagonist","target":"carcinoma","id":"32371"},{"source":"CD19 antagonist","target":"myelofibrosis","id":"32372"},{"source":"CD19 antagonist","target":"hcc","id":"32373"},{"source":"CD19 antagonist","target":"carcinoma","id":"32374"},{"source":"CD19 antagonist","target":"liver cirrhosis","id":"32375"},{"source":"CD19 antagonist","target":"carcinoma","id":"32376"},{"source":"CD19 antagonist","target":"anticancer","id":"32377"},{"source":"CD19 antagonist","target":"liver cirrhosis","id":"32378"},{"source":"CD19 antagonist","target":"liver cancer","id":"32379"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"32380"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"32381"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"32382"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"32383"},{"source":"Immune checkpoint inhibitor","target":"myelofibrosis","id":"32384"},{"source":"Immune checkpoint inhibitor","target":"hcc","id":"32385"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"32386"},{"source":"Immune checkpoint inhibitor","target":"liver cirrhosis","id":"32387"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"32388"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"32389"},{"source":"Immune checkpoint inhibitor","target":"liver cirrhosis","id":"32390"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"32391"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"32392"},{"source":"UPA","target":"UNK : Indication","id":"32393"},{"source":"UPA","target":"hepatocellular","id":"32394"},{"source":"UPA","target":"carcinoma","id":"32395"},{"source":"UPA","target":"myelofibrosis","id":"32396"},{"source":"UPA","target":"hcc","id":"32397"},{"source":"UPA","target":"carcinoma","id":"32398"},{"source":"UPA","target":"liver cirrhosis","id":"32399"},{"source":"UPA","target":"carcinoma","id":"32400"},{"source":"UPA","target":"anticancer","id":"32401"},{"source":"UPA","target":"liver cirrhosis","id":"32402"},{"source":"UPA","target":"liver cancer","id":"32403"},{"source":"UPA","target":"liver neoplasms","id":"32404"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"32405"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"32406"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"32407"},{"source":"Oncology: Liver","target":"UPA","id":"32408"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"32409"},{"source":"pembrolizumab","target":"Merck & Co.","id":"32410"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"32411"},{"source":"UNK : Drug","target":"Merck & Co.","id":"32412"},{"source":"anemia","target":"pembrolizumab","id":"32413"},{"source":"anemia","target":"UNK : Drug","id":"32414"},{"source":"residual tumor","target":"pembrolizumab","id":"32415"},{"source":"residual tumor","target":"UNK : Drug","id":"32416"},{"source":"skin neoplasms","target":"pembrolizumab","id":"32417"},{"source":"skin neoplasms","target":"UNK : Drug","id":"32418"},{"source":"unknown primary","target":"pembrolizumab","id":"32419"},{"source":"unknown primary","target":"UNK : Drug","id":"32420"},{"source":"residual tumor","target":"pembrolizumab","id":"32421"},{"source":"residual tumor","target":"UNK : Drug","id":"32422"},{"source":"carcinoma","target":"pembrolizumab","id":"32423"},{"source":"carcinoma","target":"UNK : Drug","id":"32424"},{"source":"anticancer","target":"pembrolizumab","id":"32425"},{"source":"anticancer","target":"UNK : Drug","id":"32426"},{"source":"unknown primary","target":"pembrolizumab","id":"32427"},{"source":"unknown primary","target":"UNK : Drug","id":"32428"},{"source":"solid tumors","target":"pembrolizumab","id":"32429"},{"source":"solid tumors","target":"UNK : Drug","id":"32430"},{"source":"Anticancer immunotherapy","target":"anemia","id":"32431"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"32432"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"32433"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"32434"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"32435"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32436"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"32437"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"32438"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"32439"},{"source":"CD19 antagonist","target":"anemia","id":"32440"},{"source":"CD19 antagonist","target":"residual tumor","id":"32441"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"32442"},{"source":"CD19 antagonist","target":"unknown primary","id":"32443"},{"source":"CD19 antagonist","target":"residual tumor","id":"32444"},{"source":"CD19 antagonist","target":"carcinoma","id":"32445"},{"source":"CD19 antagonist","target":"anticancer","id":"32446"},{"source":"CD19 antagonist","target":"unknown primary","id":"32447"},{"source":"CD19 antagonist","target":"solid tumors","id":"32448"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"32449"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"32450"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"32451"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"32452"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"32453"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"32454"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"32455"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"32456"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"32457"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"32458"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"32459"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"32460"},{"source":"13-valent pneumococcal conjugate vaccine","target":"Mayo Clinic","id":"32461"},{"source":"13-valent pneumococcal conjugate vaccine","target":"National Cancer Research Institute","id":"32462"},{"source":"undisclosed - analgesic","target":"Mayo Clinic","id":"32463"},{"source":"undisclosed - analgesic","target":"National Cancer Research Institute","id":"32464"},{"source":"autologous dendritic cells (u)","target":"Mayo Clinic","id":"32465"},{"source":"autologous dendritic cells (u)","target":"National Cancer Research Institute","id":"32466"},{"source":"pembrolizumab","target":"Mayo Clinic","id":"32467"},{"source":"pembrolizumab","target":"National Cancer Research Institute","id":"32468"},{"source":"surgical intervention","target":"Mayo Clinic","id":"32469"},{"source":"surgical intervention","target":"National Cancer Research Institute","id":"32470"},{"source":"UNK : Indication","target":"13-valent pneumococcal conjugate vaccine","id":"32471"},{"source":"UNK : Indication","target":"undisclosed - analgesic","id":"32472"},{"source":"UNK : Indication","target":"autologous dendritic cells (u)","id":"32473"},{"source":"UNK : Indication","target":"pembrolizumab","id":"32474"},{"source":"UNK : Indication","target":"surgical intervention","id":"32475"},{"source":"mantle-cell","target":"13-valent pneumococcal conjugate vaccine","id":"32476"},{"source":"mantle-cell","target":"undisclosed - analgesic","id":"32477"},{"source":"mantle-cell","target":"autologous dendritic cells (u)","id":"32478"},{"source":"mantle-cell","target":"pembrolizumab","id":"32479"},{"source":"mantle-cell","target":"surgical intervention","id":"32480"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32481"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32482"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32483"},{"source":"lymphoma","target":"pembrolizumab","id":"32484"},{"source":"lymphoma","target":"surgical intervention","id":"32485"},{"source":"human immunodeficiency virus","target":"13-valent pneumococcal conjugate vaccine","id":"32486"},{"source":"human immunodeficiency virus","target":"undisclosed - analgesic","id":"32487"},{"source":"human immunodeficiency virus","target":"autologous dendritic cells (u)","id":"32488"},{"source":"human immunodeficiency virus","target":"pembrolizumab","id":"32489"},{"source":"human immunodeficiency virus","target":"surgical intervention","id":"32490"},{"source":"nhl","target":"13-valent pneumococcal conjugate vaccine","id":"32491"},{"source":"nhl","target":"undisclosed - analgesic","id":"32492"},{"source":"nhl","target":"autologous dendritic cells (u)","id":"32493"},{"source":"nhl","target":"pembrolizumab","id":"32494"},{"source":"nhl","target":"surgical intervention","id":"32495"},{"source":"lymphocytic","target":"13-valent pneumococcal conjugate vaccine","id":"32496"},{"source":"lymphocytic","target":"undisclosed - analgesic","id":"32497"},{"source":"lymphocytic","target":"autologous dendritic cells (u)","id":"32498"},{"source":"lymphocytic","target":"pembrolizumab","id":"32499"},{"source":"lymphocytic","target":"surgical intervention","id":"32500"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32501"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32502"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32503"},{"source":"lymphoma","target":"pembrolizumab","id":"32504"},{"source":"lymphoma","target":"surgical intervention","id":"32505"},{"source":"chronic obstructive pulmonary disease","target":"13-valent pneumococcal conjugate vaccine","id":"32506"},{"source":"chronic obstructive pulmonary disease","target":"undisclosed - analgesic","id":"32507"},{"source":"chronic obstructive pulmonary disease","target":"autologous dendritic cells (u)","id":"32508"},{"source":"chronic obstructive pulmonary disease","target":"pembrolizumab","id":"32509"},{"source":"chronic obstructive pulmonary disease","target":"surgical intervention","id":"32510"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32511"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32512"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32513"},{"source":"lymphoma","target":"pembrolizumab","id":"32514"},{"source":"lymphoma","target":"surgical intervention","id":"32515"},{"source":"chronic hepatitis b","target":"13-valent pneumococcal conjugate vaccine","id":"32516"},{"source":"chronic hepatitis b","target":"undisclosed - analgesic","id":"32517"},{"source":"chronic hepatitis b","target":"autologous dendritic cells (u)","id":"32518"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"32519"},{"source":"chronic hepatitis b","target":"surgical intervention","id":"32520"},{"source":"gilbert disease","target":"13-valent pneumococcal conjugate vaccine","id":"32521"},{"source":"gilbert disease","target":"undisclosed - analgesic","id":"32522"},{"source":"gilbert disease","target":"autologous dendritic cells (u)","id":"32523"},{"source":"gilbert disease","target":"pembrolizumab","id":"32524"},{"source":"gilbert disease","target":"surgical intervention","id":"32525"},{"source":"hiv infections","target":"13-valent pneumococcal conjugate vaccine","id":"32526"},{"source":"hiv infections","target":"undisclosed - analgesic","id":"32527"},{"source":"hiv infections","target":"autologous dendritic cells (u)","id":"32528"},{"source":"hiv infections","target":"pembrolizumab","id":"32529"},{"source":"hiv infections","target":"surgical intervention","id":"32530"},{"source":"mycobacterium infections","target":"13-valent pneumococcal conjugate vaccine","id":"32531"},{"source":"mycobacterium infections","target":"undisclosed - analgesic","id":"32532"},{"source":"mycobacterium infections","target":"autologous dendritic cells (u)","id":"32533"},{"source":"mycobacterium infections","target":"pembrolizumab","id":"32534"},{"source":"mycobacterium infections","target":"surgical intervention","id":"32535"},{"source":"acquired immunodeficiency syndrome","target":"13-valent pneumococcal conjugate vaccine","id":"32536"},{"source":"acquired immunodeficiency syndrome","target":"undisclosed - analgesic","id":"32537"},{"source":"acquired immunodeficiency syndrome","target":"autologous dendritic cells (u)","id":"32538"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"32539"},{"source":"acquired immunodeficiency syndrome","target":"surgical intervention","id":"32540"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32541"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32542"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32543"},{"source":"lymphoma","target":"pembrolizumab","id":"32544"},{"source":"lymphoma","target":"surgical intervention","id":"32545"},{"source":"stem cell transplantation","target":"13-valent pneumococcal conjugate vaccine","id":"32546"},{"source":"stem cell transplantation","target":"undisclosed - analgesic","id":"32547"},{"source":"stem cell transplantation","target":"autologous dendritic cells (u)","id":"32548"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"32549"},{"source":"stem cell transplantation","target":"surgical intervention","id":"32550"},{"source":"b-cell","target":"13-valent pneumococcal conjugate vaccine","id":"32551"},{"source":"b-cell","target":"undisclosed - analgesic","id":"32552"},{"source":"b-cell","target":"autologous dendritic cells (u)","id":"32553"},{"source":"b-cell","target":"pembrolizumab","id":"32554"},{"source":"b-cell","target":"surgical intervention","id":"32555"},{"source":"dlbcl","target":"13-valent pneumococcal conjugate vaccine","id":"32556"},{"source":"dlbcl","target":"undisclosed - analgesic","id":"32557"},{"source":"dlbcl","target":"autologous dendritic cells (u)","id":"32558"},{"source":"dlbcl","target":"pembrolizumab","id":"32559"},{"source":"dlbcl","target":"surgical intervention","id":"32560"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32561"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32562"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32563"},{"source":"lymphoma","target":"pembrolizumab","id":"32564"},{"source":"lymphoma","target":"surgical intervention","id":"32565"},{"source":"gilbert disease","target":"13-valent pneumococcal conjugate vaccine","id":"32566"},{"source":"gilbert disease","target":"undisclosed - analgesic","id":"32567"},{"source":"gilbert disease","target":"autologous dendritic cells (u)","id":"32568"},{"source":"gilbert disease","target":"pembrolizumab","id":"32569"},{"source":"gilbert disease","target":"surgical intervention","id":"32570"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32571"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32572"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32573"},{"source":"lymphoma","target":"pembrolizumab","id":"32574"},{"source":"lymphoma","target":"surgical intervention","id":"32575"},{"source":"t-cell","target":"13-valent pneumococcal conjugate vaccine","id":"32576"},{"source":"t-cell","target":"undisclosed - analgesic","id":"32577"},{"source":"t-cell","target":"autologous dendritic cells (u)","id":"32578"},{"source":"t-cell","target":"pembrolizumab","id":"32579"},{"source":"t-cell","target":"surgical intervention","id":"32580"},{"source":"hsct","target":"13-valent pneumococcal conjugate vaccine","id":"32581"},{"source":"hsct","target":"undisclosed - analgesic","id":"32582"},{"source":"hsct","target":"autologous dendritic cells (u)","id":"32583"},{"source":"hsct","target":"pembrolizumab","id":"32584"},{"source":"hsct","target":"surgical intervention","id":"32585"},{"source":"stem cell transplantation","target":"13-valent pneumococcal conjugate vaccine","id":"32586"},{"source":"stem cell transplantation","target":"undisclosed - analgesic","id":"32587"},{"source":"stem cell transplantation","target":"autologous dendritic cells (u)","id":"32588"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"32589"},{"source":"stem cell transplantation","target":"surgical intervention","id":"32590"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32591"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32592"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32593"},{"source":"lymphoma","target":"pembrolizumab","id":"32594"},{"source":"lymphoma","target":"surgical intervention","id":"32595"},{"source":"anti-hiv","target":"13-valent pneumococcal conjugate vaccine","id":"32596"},{"source":"anti-hiv","target":"undisclosed - analgesic","id":"32597"},{"source":"anti-hiv","target":"autologous dendritic cells (u)","id":"32598"},{"source":"anti-hiv","target":"pembrolizumab","id":"32599"},{"source":"anti-hiv","target":"surgical intervention","id":"32600"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32601"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32602"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32603"},{"source":"lymphoma","target":"pembrolizumab","id":"32604"},{"source":"lymphoma","target":"surgical intervention","id":"32605"},{"source":"leukemia","target":"13-valent pneumococcal conjugate vaccine","id":"32606"},{"source":"leukemia","target":"undisclosed - analgesic","id":"32607"},{"source":"leukemia","target":"autologous dendritic cells (u)","id":"32608"},{"source":"leukemia","target":"pembrolizumab","id":"32609"},{"source":"leukemia","target":"surgical intervention","id":"32610"},{"source":"follicular","target":"13-valent pneumococcal conjugate vaccine","id":"32611"},{"source":"follicular","target":"undisclosed - analgesic","id":"32612"},{"source":"follicular","target":"autologous dendritic cells (u)","id":"32613"},{"source":"follicular","target":"pembrolizumab","id":"32614"},{"source":"follicular","target":"surgical intervention","id":"32615"},{"source":"carcinoma","target":"13-valent pneumococcal conjugate vaccine","id":"32616"},{"source":"carcinoma","target":"undisclosed - analgesic","id":"32617"},{"source":"carcinoma","target":"autologous dendritic cells (u)","id":"32618"},{"source":"carcinoma","target":"pembrolizumab","id":"32619"},{"source":"carcinoma","target":"surgical intervention","id":"32620"},{"source":"tuberculosis","target":"13-valent pneumococcal conjugate vaccine","id":"32621"},{"source":"tuberculosis","target":"undisclosed - analgesic","id":"32622"},{"source":"tuberculosis","target":"autologous dendritic cells (u)","id":"32623"},{"source":"tuberculosis","target":"pembrolizumab","id":"32624"},{"source":"tuberculosis","target":"surgical intervention","id":"32625"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32626"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32627"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32628"},{"source":"lymphoma","target":"pembrolizumab","id":"32629"},{"source":"lymphoma","target":"surgical intervention","id":"32630"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32631"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32632"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32633"},{"source":"lymphoma","target":"pembrolizumab","id":"32634"},{"source":"lymphoma","target":"surgical intervention","id":"32635"},{"source":"diffuse","target":"13-valent pneumococcal conjugate vaccine","id":"32636"},{"source":"diffuse","target":"undisclosed - analgesic","id":"32637"},{"source":"diffuse","target":"autologous dendritic cells (u)","id":"32638"},{"source":"diffuse","target":"pembrolizumab","id":"32639"},{"source":"diffuse","target":"surgical intervention","id":"32640"},{"source":"lymphoma","target":"13-valent pneumococcal conjugate vaccine","id":"32641"},{"source":"lymphoma","target":"undisclosed - analgesic","id":"32642"},{"source":"lymphoma","target":"autologous dendritic cells (u)","id":"32643"},{"source":"lymphoma","target":"pembrolizumab","id":"32644"},{"source":"lymphoma","target":"surgical intervention","id":"32645"},{"source":"leukemia","target":"13-valent pneumococcal conjugate vaccine","id":"32646"},{"source":"leukemia","target":"undisclosed - analgesic","id":"32647"},{"source":"leukemia","target":"autologous dendritic cells (u)","id":"32648"},{"source":"leukemia","target":"pembrolizumab","id":"32649"},{"source":"leukemia","target":"surgical intervention","id":"32650"},{"source":"residual tumor","target":"13-valent pneumococcal conjugate vaccine","id":"32651"},{"source":"residual tumor","target":"undisclosed - analgesic","id":"32652"},{"source":"residual tumor","target":"autologous dendritic cells (u)","id":"32653"},{"source":"residual tumor","target":"pembrolizumab","id":"32654"},{"source":"residual tumor","target":"surgical intervention","id":"32655"},{"source":"marginal zone","target":"13-valent pneumococcal conjugate vaccine","id":"32656"},{"source":"marginal zone","target":"undisclosed - analgesic","id":"32657"},{"source":"marginal zone","target":"autologous dendritic cells (u)","id":"32658"},{"source":"marginal zone","target":"pembrolizumab","id":"32659"},{"source":"marginal zone","target":"surgical intervention","id":"32660"},{"source":"residual tumor","target":"13-valent pneumococcal conjugate vaccine","id":"32661"},{"source":"residual tumor","target":"undisclosed - analgesic","id":"32662"},{"source":"residual tumor","target":"autologous dendritic cells (u)","id":"32663"},{"source":"residual tumor","target":"pembrolizumab","id":"32664"},{"source":"residual tumor","target":"surgical intervention","id":"32665"},{"source":"b-cell","target":"13-valent pneumococcal conjugate vaccine","id":"32666"},{"source":"b-cell","target":"undisclosed - analgesic","id":"32667"},{"source":"b-cell","target":"autologous dendritic cells (u)","id":"32668"},{"source":"b-cell","target":"pembrolizumab","id":"32669"},{"source":"b-cell","target":"surgical intervention","id":"32670"},{"source":"leukemia","target":"13-valent pneumococcal conjugate vaccine","id":"32671"},{"source":"leukemia","target":"undisclosed - analgesic","id":"32672"},{"source":"leukemia","target":"autologous dendritic cells (u)","id":"32673"},{"source":"leukemia","target":"pembrolizumab","id":"32674"},{"source":"leukemia","target":"surgical intervention","id":"32675"},{"source":"non-hodgkin","target":"13-valent pneumococcal conjugate vaccine","id":"32676"},{"source":"non-hodgkin","target":"undisclosed - analgesic","id":"32677"},{"source":"non-hodgkin","target":"autologous dendritic cells (u)","id":"32678"},{"source":"non-hodgkin","target":"pembrolizumab","id":"32679"},{"source":"non-hodgkin","target":"surgical intervention","id":"32680"},{"source":"anticancer","target":"13-valent pneumococcal conjugate vaccine","id":"32681"},{"source":"anticancer","target":"undisclosed - analgesic","id":"32682"},{"source":"anticancer","target":"autologous dendritic cells (u)","id":"32683"},{"source":"anticancer","target":"pembrolizumab","id":"32684"},{"source":"anticancer","target":"surgical intervention","id":"32685"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"32686"},{"source":"Anticancer immunotherapy","target":"mantle-cell","id":"32687"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32688"},{"source":"Anticancer immunotherapy","target":"human immunodeficiency virus","id":"32689"},{"source":"Anticancer immunotherapy","target":"nhl","id":"32690"},{"source":"Anticancer immunotherapy","target":"lymphocytic","id":"32691"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32692"},{"source":"Anticancer immunotherapy","target":"chronic obstructive pulmonary disease","id":"32693"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32694"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"32695"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"32696"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"32697"},{"source":"Anticancer immunotherapy","target":"mycobacterium infections","id":"32698"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"32699"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32700"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"32701"},{"source":"Anticancer immunotherapy","target":"b-cell","id":"32702"},{"source":"Anticancer immunotherapy","target":"dlbcl","id":"32703"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32704"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"32705"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32706"},{"source":"Anticancer immunotherapy","target":"t-cell","id":"32707"},{"source":"Anticancer immunotherapy","target":"hsct","id":"32708"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"32709"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32710"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"32711"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32712"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"32713"},{"source":"Anticancer immunotherapy","target":"follicular","id":"32714"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32715"},{"source":"Anticancer immunotherapy","target":"tuberculosis","id":"32716"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32717"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32718"},{"source":"Anticancer immunotherapy","target":"diffuse","id":"32719"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"32720"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"32721"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"32722"},{"source":"Anticancer immunotherapy","target":"marginal zone","id":"32723"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"32724"},{"source":"Anticancer immunotherapy","target":"b-cell","id":"32725"},{"source":"Anticancer immunotherapy","target":"leukemia","id":"32726"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"32727"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"32728"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"32729"},{"source":"CD19 antagonist","target":"mantle-cell","id":"32730"},{"source":"CD19 antagonist","target":"lymphoma","id":"32731"},{"source":"CD19 antagonist","target":"human immunodeficiency virus","id":"32732"},{"source":"CD19 antagonist","target":"nhl","id":"32733"},{"source":"CD19 antagonist","target":"lymphocytic","id":"32734"},{"source":"CD19 antagonist","target":"lymphoma","id":"32735"},{"source":"CD19 antagonist","target":"chronic obstructive pulmonary disease","id":"32736"},{"source":"CD19 antagonist","target":"lymphoma","id":"32737"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"32738"},{"source":"CD19 antagonist","target":"gilbert disease","id":"32739"},{"source":"CD19 antagonist","target":"hiv infections","id":"32740"},{"source":"CD19 antagonist","target":"mycobacterium infections","id":"32741"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"32742"},{"source":"CD19 antagonist","target":"lymphoma","id":"32743"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"32744"},{"source":"CD19 antagonist","target":"b-cell","id":"32745"},{"source":"CD19 antagonist","target":"dlbcl","id":"32746"},{"source":"CD19 antagonist","target":"lymphoma","id":"32747"},{"source":"CD19 antagonist","target":"gilbert disease","id":"32748"},{"source":"CD19 antagonist","target":"lymphoma","id":"32749"},{"source":"CD19 antagonist","target":"t-cell","id":"32750"},{"source":"CD19 antagonist","target":"hsct","id":"32751"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"32752"},{"source":"CD19 antagonist","target":"lymphoma","id":"32753"},{"source":"CD19 antagonist","target":"anti-hiv","id":"32754"},{"source":"CD19 antagonist","target":"lymphoma","id":"32755"},{"source":"CD19 antagonist","target":"leukemia","id":"32756"},{"source":"CD19 antagonist","target":"follicular","id":"32757"},{"source":"CD19 antagonist","target":"carcinoma","id":"32758"},{"source":"CD19 antagonist","target":"tuberculosis","id":"32759"},{"source":"CD19 antagonist","target":"lymphoma","id":"32760"},{"source":"CD19 antagonist","target":"lymphoma","id":"32761"},{"source":"CD19 antagonist","target":"diffuse","id":"32762"},{"source":"CD19 antagonist","target":"lymphoma","id":"32763"},{"source":"CD19 antagonist","target":"leukemia","id":"32764"},{"source":"CD19 antagonist","target":"residual tumor","id":"32765"},{"source":"CD19 antagonist","target":"marginal zone","id":"32766"},{"source":"CD19 antagonist","target":"residual tumor","id":"32767"},{"source":"CD19 antagonist","target":"b-cell","id":"32768"},{"source":"CD19 antagonist","target":"leukemia","id":"32769"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"32770"},{"source":"CD19 antagonist","target":"anticancer","id":"32771"},{"source":"Immunostimulant","target":"UNK : Indication","id":"32772"},{"source":"Immunostimulant","target":"mantle-cell","id":"32773"},{"source":"Immunostimulant","target":"lymphoma","id":"32774"},{"source":"Immunostimulant","target":"human immunodeficiency virus","id":"32775"},{"source":"Immunostimulant","target":"nhl","id":"32776"},{"source":"Immunostimulant","target":"lymphocytic","id":"32777"},{"source":"Immunostimulant","target":"lymphoma","id":"32778"},{"source":"Immunostimulant","target":"chronic obstructive pulmonary disease","id":"32779"},{"source":"Immunostimulant","target":"lymphoma","id":"32780"},{"source":"Immunostimulant","target":"chronic hepatitis b","id":"32781"},{"source":"Immunostimulant","target":"gilbert disease","id":"32782"},{"source":"Immunostimulant","target":"hiv infections","id":"32783"},{"source":"Immunostimulant","target":"mycobacterium infections","id":"32784"},{"source":"Immunostimulant","target":"acquired immunodeficiency syndrome","id":"32785"},{"source":"Immunostimulant","target":"lymphoma","id":"32786"},{"source":"Immunostimulant","target":"stem cell transplantation","id":"32787"},{"source":"Immunostimulant","target":"b-cell","id":"32788"},{"source":"Immunostimulant","target":"dlbcl","id":"32789"},{"source":"Immunostimulant","target":"lymphoma","id":"32790"},{"source":"Immunostimulant","target":"gilbert disease","id":"32791"},{"source":"Immunostimulant","target":"lymphoma","id":"32792"},{"source":"Immunostimulant","target":"t-cell","id":"32793"},{"source":"Immunostimulant","target":"hsct","id":"32794"},{"source":"Immunostimulant","target":"stem cell transplantation","id":"32795"},{"source":"Immunostimulant","target":"lymphoma","id":"32796"},{"source":"Immunostimulant","target":"anti-hiv","id":"32797"},{"source":"Immunostimulant","target":"lymphoma","id":"32798"},{"source":"Immunostimulant","target":"leukemia","id":"32799"},{"source":"Immunostimulant","target":"follicular","id":"32800"},{"source":"Immunostimulant","target":"carcinoma","id":"32801"},{"source":"Immunostimulant","target":"tuberculosis","id":"32802"},{"source":"Immunostimulant","target":"lymphoma","id":"32803"},{"source":"Immunostimulant","target":"lymphoma","id":"32804"},{"source":"Immunostimulant","target":"diffuse","id":"32805"},{"source":"Immunostimulant","target":"lymphoma","id":"32806"},{"source":"Immunostimulant","target":"leukemia","id":"32807"},{"source":"Immunostimulant","target":"residual tumor","id":"32808"},{"source":"Immunostimulant","target":"marginal zone","id":"32809"},{"source":"Immunostimulant","target":"residual tumor","id":"32810"},{"source":"Immunostimulant","target":"b-cell","id":"32811"},{"source":"Immunostimulant","target":"leukemia","id":"32812"},{"source":"Immunostimulant","target":"non-hodgkin","id":"32813"},{"source":"Immunostimulant","target":"anticancer","id":"32814"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"32815"},{"source":"Immune checkpoint inhibitor","target":"mantle-cell","id":"32816"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32817"},{"source":"Immune checkpoint inhibitor","target":"human immunodeficiency virus","id":"32818"},{"source":"Immune checkpoint inhibitor","target":"nhl","id":"32819"},{"source":"Immune checkpoint inhibitor","target":"lymphocytic","id":"32820"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32821"},{"source":"Immune checkpoint inhibitor","target":"chronic obstructive pulmonary disease","id":"32822"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32823"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"32824"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"32825"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"32826"},{"source":"Immune checkpoint inhibitor","target":"mycobacterium infections","id":"32827"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"32828"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32829"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"32830"},{"source":"Immune checkpoint inhibitor","target":"b-cell","id":"32831"},{"source":"Immune checkpoint inhibitor","target":"dlbcl","id":"32832"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32833"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"32834"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32835"},{"source":"Immune checkpoint inhibitor","target":"t-cell","id":"32836"},{"source":"Immune checkpoint inhibitor","target":"hsct","id":"32837"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"32838"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32839"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"32840"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32841"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"32842"},{"source":"Immune checkpoint inhibitor","target":"follicular","id":"32843"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"32844"},{"source":"Immune checkpoint inhibitor","target":"tuberculosis","id":"32845"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32846"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32847"},{"source":"Immune checkpoint inhibitor","target":"diffuse","id":"32848"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"32849"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"32850"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"32851"},{"source":"Immune checkpoint inhibitor","target":"marginal zone","id":"32852"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"32853"},{"source":"Immune checkpoint inhibitor","target":"b-cell","id":"32854"},{"source":"Immune checkpoint inhibitor","target":"leukemia","id":"32855"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"32856"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"32857"},{"source":"NA","target":"UNK : Indication","id":"32858"},{"source":"NA","target":"mantle-cell","id":"32859"},{"source":"NA","target":"lymphoma","id":"32860"},{"source":"NA","target":"human immunodeficiency virus","id":"32861"},{"source":"NA","target":"nhl","id":"32862"},{"source":"NA","target":"lymphocytic","id":"32863"},{"source":"NA","target":"lymphoma","id":"32864"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"32865"},{"source":"NA","target":"lymphoma","id":"32866"},{"source":"NA","target":"chronic hepatitis b","id":"32867"},{"source":"NA","target":"gilbert disease","id":"32868"},{"source":"NA","target":"hiv infections","id":"32869"},{"source":"NA","target":"mycobacterium infections","id":"32870"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"32871"},{"source":"NA","target":"lymphoma","id":"32872"},{"source":"NA","target":"stem cell transplantation","id":"32873"},{"source":"NA","target":"b-cell","id":"32874"},{"source":"NA","target":"dlbcl","id":"32875"},{"source":"NA","target":"lymphoma","id":"32876"},{"source":"NA","target":"gilbert disease","id":"32877"},{"source":"NA","target":"lymphoma","id":"32878"},{"source":"NA","target":"t-cell","id":"32879"},{"source":"NA","target":"hsct","id":"32880"},{"source":"NA","target":"stem cell transplantation","id":"32881"},{"source":"NA","target":"lymphoma","id":"32882"},{"source":"NA","target":"anti-hiv","id":"32883"},{"source":"NA","target":"lymphoma","id":"32884"},{"source":"NA","target":"leukemia","id":"32885"},{"source":"NA","target":"follicular","id":"32886"},{"source":"NA","target":"carcinoma","id":"32887"},{"source":"NA","target":"tuberculosis","id":"32888"},{"source":"NA","target":"lymphoma","id":"32889"},{"source":"NA","target":"lymphoma","id":"32890"},{"source":"NA","target":"diffuse","id":"32891"},{"source":"NA","target":"lymphoma","id":"32892"},{"source":"NA","target":"leukemia","id":"32893"},{"source":"NA","target":"residual tumor","id":"32894"},{"source":"NA","target":"marginal zone","id":"32895"},{"source":"NA","target":"residual tumor","id":"32896"},{"source":"NA","target":"b-cell","id":"32897"},{"source":"NA","target":"leukemia","id":"32898"},{"source":"NA","target":"non-hodgkin","id":"32899"},{"source":"NA","target":"anticancer","id":"32900"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"32901"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"32902"},{"source":"Oncology: Lymphoma","target":"Immunostimulant","id":"32903"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"32904"},{"source":"Oncology: Lymphoma","target":"NA","id":"32905"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"32906"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"32907"},{"source":"Hodgkin's","target":"Immunostimulant","id":"32908"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"32909"},{"source":"Hodgkin's","target":"NA","id":"32910"},{"source":"Lm-LLO-PSA vaccine","target":"(Other Hospital/Academic/Medical Center)","id":"32911"},{"source":"Advaxis (u)","target":"(Other Hospital/Academic/Medical Center)","id":"32912"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"32913"},{"source":"UNK : Indication","target":"Lm-LLO-PSA vaccine","id":"32914"},{"source":"UNK : Indication","target":"Advaxis (u)","id":"32915"},{"source":"UNK : Indication","target":"UNK : Drug","id":"32916"},{"source":"castration-resistant prostatic neoplasms","target":"Lm-LLO-PSA vaccine","id":"32917"},{"source":"castration-resistant prostatic neoplasms","target":"Advaxis (u)","id":"32918"},{"source":"castration-resistant prostatic neoplasms","target":"UNK : Drug","id":"32919"},{"source":"prostate cancer","target":"Lm-LLO-PSA vaccine","id":"32920"},{"source":"prostate cancer","target":"Advaxis (u)","id":"32921"},{"source":"prostate cancer","target":"UNK : Drug","id":"32922"},{"source":"carcinoma","target":"Lm-LLO-PSA vaccine","id":"32923"},{"source":"carcinoma","target":"Advaxis (u)","id":"32924"},{"source":"carcinoma","target":"UNK : Drug","id":"32925"},{"source":"anticancer","target":"Lm-LLO-PSA vaccine","id":"32926"},{"source":"anticancer","target":"Advaxis (u)","id":"32927"},{"source":"anticancer","target":"UNK : Drug","id":"32928"},{"source":"Immunostimulant","target":"UNK : Indication","id":"32929"},{"source":"Immunostimulant","target":"castration-resistant prostatic neoplasms","id":"32930"},{"source":"Immunostimulant","target":"prostate cancer","id":"32931"},{"source":"Immunostimulant","target":"carcinoma","id":"32932"},{"source":"Immunostimulant","target":"anticancer","id":"32933"},{"source":"Oncology: Prostate","target":"Immunostimulant","id":"32934"},{"source":"lenvatinib (capsule) (a)","target":"Eisai","id":"32935"},{"source":"pembrolizumab","target":"Eisai","id":"32936"},{"source":"hepatocellular","target":"lenvatinib (capsule) (a)","id":"32937"},{"source":"hepatocellular","target":"pembrolizumab","id":"32938"},{"source":"hcc","target":"lenvatinib (capsule) (a)","id":"32939"},{"source":"hcc","target":"pembrolizumab","id":"32940"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"32941"},{"source":"solid tumors","target":"pembrolizumab","id":"32942"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"32943"},{"source":"carcinoma","target":"pembrolizumab","id":"32944"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"32945"},{"source":"carcinoma","target":"pembrolizumab","id":"32946"},{"source":"anticancer","target":"lenvatinib (capsule) (a)","id":"32947"},{"source":"anticancer","target":"pembrolizumab","id":"32948"},{"source":"liver cancer","target":"lenvatinib (capsule) (a)","id":"32949"},{"source":"liver cancer","target":"pembrolizumab","id":"32950"},{"source":"liver neoplasms","target":"lenvatinib (capsule) (a)","id":"32951"},{"source":"liver neoplasms","target":"pembrolizumab","id":"32952"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"32953"},{"source":"solid tumors","target":"pembrolizumab","id":"32954"},{"source":"NA","target":"hepatocellular","id":"32955"},{"source":"NA","target":"hcc","id":"32956"},{"source":"NA","target":"solid tumors","id":"32957"},{"source":"NA","target":"carcinoma","id":"32958"},{"source":"NA","target":"carcinoma","id":"32959"},{"source":"NA","target":"anticancer","id":"32960"},{"source":"NA","target":"liver cancer","id":"32961"},{"source":"NA","target":"liver neoplasms","id":"32962"},{"source":"NA","target":"solid tumors","id":"32963"},{"source":"NA","target":"hepatocellular","id":"32964"},{"source":"NA","target":"hcc","id":"32965"},{"source":"NA","target":"solid tumors","id":"32966"},{"source":"NA","target":"carcinoma","id":"32967"},{"source":"NA","target":"carcinoma","id":"32968"},{"source":"NA","target":"anticancer","id":"32969"},{"source":"NA","target":"liver cancer","id":"32970"},{"source":"NA","target":"liver neoplasms","id":"32971"},{"source":"NA","target":"solid tumors","id":"32972"},{"source":"NA","target":"hepatocellular","id":"32973"},{"source":"NA","target":"hcc","id":"32974"},{"source":"NA","target":"solid tumors","id":"32975"},{"source":"NA","target":"carcinoma","id":"32976"},{"source":"NA","target":"carcinoma","id":"32977"},{"source":"NA","target":"anticancer","id":"32978"},{"source":"NA","target":"liver cancer","id":"32979"},{"source":"NA","target":"liver neoplasms","id":"32980"},{"source":"NA","target":"solid tumors","id":"32981"},{"source":"NA","target":"hepatocellular","id":"32982"},{"source":"NA","target":"hcc","id":"32983"},{"source":"NA","target":"solid tumors","id":"32984"},{"source":"NA","target":"carcinoma","id":"32985"},{"source":"NA","target":"carcinoma","id":"32986"},{"source":"NA","target":"anticancer","id":"32987"},{"source":"NA","target":"liver cancer","id":"32988"},{"source":"NA","target":"liver neoplasms","id":"32989"},{"source":"NA","target":"solid tumors","id":"32990"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"32991"},{"source":"Anticancer immunotherapy","target":"hcc","id":"32992"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"32993"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32994"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"32995"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"32996"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"32997"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"32998"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"32999"},{"source":"CD19 antagonist","target":"hepatocellular","id":"33000"},{"source":"CD19 antagonist","target":"hcc","id":"33001"},{"source":"CD19 antagonist","target":"solid tumors","id":"33002"},{"source":"CD19 antagonist","target":"carcinoma","id":"33003"},{"source":"CD19 antagonist","target":"carcinoma","id":"33004"},{"source":"CD19 antagonist","target":"anticancer","id":"33005"},{"source":"CD19 antagonist","target":"liver cancer","id":"33006"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"33007"},{"source":"CD19 antagonist","target":"solid tumors","id":"33008"},{"source":"NA","target":"hepatocellular","id":"33009"},{"source":"NA","target":"hcc","id":"33010"},{"source":"NA","target":"solid tumors","id":"33011"},{"source":"NA","target":"carcinoma","id":"33012"},{"source":"NA","target":"carcinoma","id":"33013"},{"source":"NA","target":"anticancer","id":"33014"},{"source":"NA","target":"liver cancer","id":"33015"},{"source":"NA","target":"liver neoplasms","id":"33016"},{"source":"NA","target":"solid tumors","id":"33017"},{"source":"NA","target":"hepatocellular","id":"33018"},{"source":"NA","target":"hcc","id":"33019"},{"source":"NA","target":"solid tumors","id":"33020"},{"source":"NA","target":"carcinoma","id":"33021"},{"source":"NA","target":"carcinoma","id":"33022"},{"source":"NA","target":"anticancer","id":"33023"},{"source":"NA","target":"liver cancer","id":"33024"},{"source":"NA","target":"liver neoplasms","id":"33025"},{"source":"NA","target":"solid tumors","id":"33026"},{"source":"Angiopoietin inhibitor","target":"hepatocellular","id":"33027"},{"source":"Angiopoietin inhibitor","target":"hcc","id":"33028"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"33029"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"33030"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"33031"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"33032"},{"source":"Angiopoietin inhibitor","target":"liver cancer","id":"33033"},{"source":"Angiopoietin inhibitor","target":"liver neoplasms","id":"33034"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"33035"},{"source":"NA","target":"hepatocellular","id":"33036"},{"source":"NA","target":"hcc","id":"33037"},{"source":"NA","target":"solid tumors","id":"33038"},{"source":"NA","target":"carcinoma","id":"33039"},{"source":"NA","target":"carcinoma","id":"33040"},{"source":"NA","target":"anticancer","id":"33041"},{"source":"NA","target":"liver cancer","id":"33042"},{"source":"NA","target":"liver neoplasms","id":"33043"},{"source":"NA","target":"solid tumors","id":"33044"},{"source":"NA","target":"hepatocellular","id":"33045"},{"source":"NA","target":"hcc","id":"33046"},{"source":"NA","target":"solid tumors","id":"33047"},{"source":"NA","target":"carcinoma","id":"33048"},{"source":"NA","target":"carcinoma","id":"33049"},{"source":"NA","target":"anticancer","id":"33050"},{"source":"NA","target":"liver cancer","id":"33051"},{"source":"NA","target":"liver neoplasms","id":"33052"},{"source":"NA","target":"solid tumors","id":"33053"},{"source":"NA","target":"hepatocellular","id":"33054"},{"source":"NA","target":"hcc","id":"33055"},{"source":"NA","target":"solid tumors","id":"33056"},{"source":"NA","target":"carcinoma","id":"33057"},{"source":"NA","target":"carcinoma","id":"33058"},{"source":"NA","target":"anticancer","id":"33059"},{"source":"NA","target":"liver cancer","id":"33060"},{"source":"NA","target":"liver neoplasms","id":"33061"},{"source":"NA","target":"solid tumors","id":"33062"},{"source":"Angiogenesis inhibitor","target":"hepatocellular","id":"33063"},{"source":"Angiogenesis inhibitor","target":"hcc","id":"33064"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"33065"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"33066"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"33067"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"33068"},{"source":"Angiogenesis inhibitor","target":"liver cancer","id":"33069"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"33070"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"33071"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"33072"},{"source":"Immune checkpoint inhibitor","target":"hcc","id":"33073"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"33074"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33075"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33076"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33077"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"33078"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"33079"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"33080"},{"source":"C-kit inhibitor","target":"hepatocellular","id":"33081"},{"source":"C-kit inhibitor","target":"hcc","id":"33082"},{"source":"C-kit inhibitor","target":"solid tumors","id":"33083"},{"source":"C-kit inhibitor","target":"carcinoma","id":"33084"},{"source":"C-kit inhibitor","target":"carcinoma","id":"33085"},{"source":"C-kit inhibitor","target":"anticancer","id":"33086"},{"source":"C-kit inhibitor","target":"liver cancer","id":"33087"},{"source":"C-kit inhibitor","target":"liver neoplasms","id":"33088"},{"source":"C-kit inhibitor","target":"solid tumors","id":"33089"},{"source":"Oncology: Liver","target":"NA","id":"33090"},{"source":"Oncology: Liver","target":"NA","id":"33091"},{"source":"Oncology: Liver","target":"NA","id":"33092"},{"source":"Oncology: Liver","target":"NA","id":"33093"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"33094"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"33095"},{"source":"Oncology: Liver","target":"NA","id":"33096"},{"source":"Oncology: Liver","target":"NA","id":"33097"},{"source":"Oncology: Liver","target":"Angiopoietin inhibitor","id":"33098"},{"source":"Oncology: Liver","target":"NA","id":"33099"},{"source":"Oncology: Liver","target":"NA","id":"33100"},{"source":"Oncology: Liver","target":"NA","id":"33101"},{"source":"Oncology: Liver","target":"Angiogenesis inhibitor","id":"33102"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"33103"},{"source":"Oncology: Liver","target":"C-kit inhibitor","id":"33104"},{"source":"pembrolizumab","target":"Merck & Co.","id":"33105"},{"source":"carboplatin","target":"Merck & Co.","id":"33106"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"33107"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"33108"},{"source":"UNK : Indication","target":"pembrolizumab","id":"33109"},{"source":"UNK : Indication","target":"carboplatin","id":"33110"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"33111"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"33112"},{"source":"residual tumor","target":"pembrolizumab","id":"33113"},{"source":"residual tumor","target":"carboplatin","id":"33114"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"33115"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"33116"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33117"},{"source":"non-small-cell lung","target":"carboplatin","id":"33118"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"33119"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"33120"},{"source":"anticancer","target":"pembrolizumab","id":"33121"},{"source":"anticancer","target":"carboplatin","id":"33122"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"33123"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"33124"},{"source":"carcinoma","target":"pembrolizumab","id":"33125"},{"source":"carcinoma","target":"carboplatin","id":"33126"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"33127"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"33128"},{"source":"metastatic","target":"pembrolizumab","id":"33129"},{"source":"metastatic","target":"carboplatin","id":"33130"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"33131"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"33132"},{"source":"carcinoma","target":"pembrolizumab","id":"33133"},{"source":"carcinoma","target":"carboplatin","id":"33134"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"33135"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"33136"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33137"},{"source":"non-small-cell lung","target":"carboplatin","id":"33138"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"33139"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"33140"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"33141"},{"source":"neoplasm metastasis","target":"carboplatin","id":"33142"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"33143"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"33144"},{"source":"anticancer","target":"pembrolizumab","id":"33145"},{"source":"anticancer","target":"carboplatin","id":"33146"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"33147"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"33148"},{"source":"lung neoplasms","target":"pembrolizumab","id":"33149"},{"source":"lung neoplasms","target":"carboplatin","id":"33150"},{"source":"lung neoplasms","target":"nab-paclitaxel (IV)","id":"33151"},{"source":"lung neoplasms","target":"nab-paclitaxel (IV)","id":"33152"},{"source":"sclc","target":"pembrolizumab","id":"33153"},{"source":"sclc","target":"carboplatin","id":"33154"},{"source":"sclc","target":"nab-paclitaxel (IV)","id":"33155"},{"source":"sclc","target":"nab-paclitaxel (IV)","id":"33156"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"33157"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"33158"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"33159"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33160"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33161"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"33162"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33163"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"33164"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"33165"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33166"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"33167"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"33168"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"33169"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"33170"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33171"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33172"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33173"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"33174"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33175"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33176"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"33177"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33178"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"33179"},{"source":"Anticancer immunotherapy","target":"sclc","id":"33180"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"33181"},{"source":"CD19 antagonist","target":"residual tumor","id":"33182"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33183"},{"source":"CD19 antagonist","target":"anticancer","id":"33184"},{"source":"CD19 antagonist","target":"carcinoma","id":"33185"},{"source":"CD19 antagonist","target":"metastatic","id":"33186"},{"source":"CD19 antagonist","target":"carcinoma","id":"33187"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33188"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"33189"},{"source":"CD19 antagonist","target":"anticancer","id":"33190"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"33191"},{"source":"CD19 antagonist","target":"sclc","id":"33192"},{"source":"NA","target":"UNK : Indication","id":"33193"},{"source":"NA","target":"residual tumor","id":"33194"},{"source":"NA","target":"non-small-cell lung","id":"33195"},{"source":"NA","target":"anticancer","id":"33196"},{"source":"NA","target":"carcinoma","id":"33197"},{"source":"NA","target":"metastatic","id":"33198"},{"source":"NA","target":"carcinoma","id":"33199"},{"source":"NA","target":"non-small-cell lung","id":"33200"},{"source":"NA","target":"neoplasm metastasis","id":"33201"},{"source":"NA","target":"anticancer","id":"33202"},{"source":"NA","target":"lung neoplasms","id":"33203"},{"source":"NA","target":"sclc","id":"33204"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"33205"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"33206"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"33207"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"33208"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"33209"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"33210"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"33211"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"33212"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"33213"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"33214"},{"source":"Beta tubulin antagonist","target":"lung neoplasms","id":"33215"},{"source":"Beta tubulin antagonist","target":"sclc","id":"33216"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"33217"},{"source":"Microtubule stimulant","target":"residual tumor","id":"33218"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"33219"},{"source":"Microtubule stimulant","target":"anticancer","id":"33220"},{"source":"Microtubule stimulant","target":"carcinoma","id":"33221"},{"source":"Microtubule stimulant","target":"metastatic","id":"33222"},{"source":"Microtubule stimulant","target":"carcinoma","id":"33223"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"33224"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"33225"},{"source":"Microtubule stimulant","target":"anticancer","id":"33226"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"33227"},{"source":"Microtubule stimulant","target":"sclc","id":"33228"},{"source":"Taxane","target":"UNK : Indication","id":"33229"},{"source":"Taxane","target":"residual tumor","id":"33230"},{"source":"Taxane","target":"non-small-cell lung","id":"33231"},{"source":"Taxane","target":"anticancer","id":"33232"},{"source":"Taxane","target":"carcinoma","id":"33233"},{"source":"Taxane","target":"metastatic","id":"33234"},{"source":"Taxane","target":"carcinoma","id":"33235"},{"source":"Taxane","target":"non-small-cell lung","id":"33236"},{"source":"Taxane","target":"neoplasm metastasis","id":"33237"},{"source":"Taxane","target":"anticancer","id":"33238"},{"source":"Taxane","target":"lung neoplasms","id":"33239"},{"source":"Taxane","target":"sclc","id":"33240"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"33241"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"33242"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"33243"},{"source":"Oncology: Lung","target":"NA","id":"33244"},{"source":"Oncology: Lung","target":"Beta tubulin antagonist","id":"33245"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"33246"},{"source":"Oncology: Lung","target":"Taxane","id":"33247"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"33248"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"33249"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"33250"},{"source":"Non-Small Cell","target":"NA","id":"33251"},{"source":"Non-Small Cell","target":"Beta tubulin antagonist","id":"33252"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"33253"},{"source":"Non-Small Cell","target":"Taxane","id":"33254"},{"source":"pembrolizumab","target":"Merck & Co.","id":"33255"},{"source":"UNK : Drug","target":"Merck & Co.","id":"33256"},{"source":"residual tumor","target":"pembrolizumab","id":"33257"},{"source":"residual tumor","target":"UNK : Drug","id":"33258"},{"source":"carcinoma","target":"pembrolizumab","id":"33259"},{"source":"carcinoma","target":"UNK : Drug","id":"33260"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33261"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"33262"},{"source":"anticancer","target":"pembrolizumab","id":"33263"},{"source":"anticancer","target":"UNK : Drug","id":"33264"},{"source":"carcinoma","target":"pembrolizumab","id":"33265"},{"source":"carcinoma","target":"UNK : Drug","id":"33266"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33267"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"33268"},{"source":"carcinoma","target":"pembrolizumab","id":"33269"},{"source":"carcinoma","target":"UNK : Drug","id":"33270"},{"source":"anticancer","target":"pembrolizumab","id":"33271"},{"source":"anticancer","target":"UNK : Drug","id":"33272"},{"source":"lung neoplasms","target":"pembrolizumab","id":"33273"},{"source":"lung neoplasms","target":"UNK : Drug","id":"33274"},{"source":"sclc","target":"pembrolizumab","id":"33275"},{"source":"sclc","target":"UNK : Drug","id":"33276"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"33277"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33278"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33279"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33280"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33281"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33282"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33283"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33284"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"33285"},{"source":"Anticancer immunotherapy","target":"sclc","id":"33286"},{"source":"CD19 antagonist","target":"residual tumor","id":"33287"},{"source":"CD19 antagonist","target":"carcinoma","id":"33288"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33289"},{"source":"CD19 antagonist","target":"anticancer","id":"33290"},{"source":"CD19 antagonist","target":"carcinoma","id":"33291"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33292"},{"source":"CD19 antagonist","target":"carcinoma","id":"33293"},{"source":"CD19 antagonist","target":"anticancer","id":"33294"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"33295"},{"source":"CD19 antagonist","target":"sclc","id":"33296"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"33297"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33298"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"33299"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33300"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33301"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"33302"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33303"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33304"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"33305"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"33306"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"33307"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"33308"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"33309"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"33310"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"33311"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"33312"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"33313"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"33314"},{"source":"UNK : Indication","target":"pembrolizumab","id":"33315"},{"source":"UNK : Indication","target":"UNK : Drug","id":"33316"},{"source":"residual tumor","target":"pembrolizumab","id":"33317"},{"source":"residual tumor","target":"UNK : Drug","id":"33318"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33319"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"33320"},{"source":"anti-tumor","target":"pembrolizumab","id":"33321"},{"source":"anti-tumor","target":"UNK : Drug","id":"33322"},{"source":"carcinoma","target":"pembrolizumab","id":"33323"},{"source":"carcinoma","target":"UNK : Drug","id":"33324"},{"source":"metastatic","target":"pembrolizumab","id":"33325"},{"source":"metastatic","target":"UNK : Drug","id":"33326"},{"source":"carcinoma","target":"pembrolizumab","id":"33327"},{"source":"carcinoma","target":"UNK : Drug","id":"33328"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33329"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"33330"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"33331"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"33332"},{"source":"anticancer","target":"pembrolizumab","id":"33333"},{"source":"anticancer","target":"UNK : Drug","id":"33334"},{"source":"lung neoplasms","target":"pembrolizumab","id":"33335"},{"source":"lung neoplasms","target":"UNK : Drug","id":"33336"},{"source":"sclc","target":"pembrolizumab","id":"33337"},{"source":"sclc","target":"UNK : Drug","id":"33338"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"33339"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"33340"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33341"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"33342"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33343"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"33344"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33345"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33346"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"33347"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33348"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"33349"},{"source":"Anticancer immunotherapy","target":"sclc","id":"33350"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"33351"},{"source":"CD19 antagonist","target":"residual tumor","id":"33352"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33353"},{"source":"CD19 antagonist","target":"anti-tumor","id":"33354"},{"source":"CD19 antagonist","target":"carcinoma","id":"33355"},{"source":"CD19 antagonist","target":"metastatic","id":"33356"},{"source":"CD19 antagonist","target":"carcinoma","id":"33357"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33358"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"33359"},{"source":"CD19 antagonist","target":"anticancer","id":"33360"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"33361"},{"source":"CD19 antagonist","target":"sclc","id":"33362"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"33363"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"33364"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"33365"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"33366"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33367"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"33368"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33369"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"33370"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"33371"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33372"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"33373"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"33374"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"33375"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"33376"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"33377"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"33378"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"33379"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"33380"},{"source":"6 melanoma helper peptide vaccine (u)","target":"University of Virginia","id":"33381"},{"source":"pembrolizumab","target":"University of Virginia","id":"33382"},{"source":"UNK : Drug","target":"University of Virginia","id":"33383"},{"source":"UNK : Indication","target":"6 melanoma helper peptide vaccine (u)","id":"33384"},{"source":"UNK : Indication","target":"pembrolizumab","id":"33385"},{"source":"UNK : Indication","target":"UNK : Drug","id":"33386"},{"source":"ovarian neoplasms","target":"6 melanoma helper peptide vaccine (u)","id":"33387"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"33388"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"33389"},{"source":"brain metastases","target":"6 melanoma helper peptide vaccine (u)","id":"33390"},{"source":"brain metastases","target":"pembrolizumab","id":"33391"},{"source":"brain metastases","target":"UNK : Drug","id":"33392"},{"source":"melanoma","target":"6 melanoma helper peptide vaccine (u)","id":"33393"},{"source":"melanoma","target":"pembrolizumab","id":"33394"},{"source":"melanoma","target":"UNK : Drug","id":"33395"},{"source":"anticancer","target":"6 melanoma helper peptide vaccine (u)","id":"33396"},{"source":"anticancer","target":"pembrolizumab","id":"33397"},{"source":"anticancer","target":"UNK : Drug","id":"33398"},{"source":"melanoma","target":"6 melanoma helper peptide vaccine (u)","id":"33399"},{"source":"melanoma","target":"pembrolizumab","id":"33400"},{"source":"melanoma","target":"UNK : Drug","id":"33401"},{"source":"melanoma","target":"6 melanoma helper peptide vaccine (u)","id":"33402"},{"source":"melanoma","target":"pembrolizumab","id":"33403"},{"source":"melanoma","target":"UNK : Drug","id":"33404"},{"source":"skin neoplasms","target":"6 melanoma helper peptide vaccine (u)","id":"33405"},{"source":"skin neoplasms","target":"pembrolizumab","id":"33406"},{"source":"skin neoplasms","target":"UNK : Drug","id":"33407"},{"source":"cerebellar neoplasms","target":"6 melanoma helper peptide vaccine (u)","id":"33408"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"33409"},{"source":"cerebellar neoplasms","target":"UNK : Drug","id":"33410"},{"source":"carcinoma","target":"6 melanoma helper peptide vaccine (u)","id":"33411"},{"source":"carcinoma","target":"pembrolizumab","id":"33412"},{"source":"carcinoma","target":"UNK : Drug","id":"33413"},{"source":"brain metastases","target":"6 melanoma helper peptide vaccine (u)","id":"33414"},{"source":"brain metastases","target":"pembrolizumab","id":"33415"},{"source":"brain metastases","target":"UNK : Drug","id":"33416"},{"source":"anticancer","target":"6 melanoma helper peptide vaccine (u)","id":"33417"},{"source":"anticancer","target":"pembrolizumab","id":"33418"},{"source":"anticancer","target":"UNK : Drug","id":"33419"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"33420"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"33421"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"33422"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"33423"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33424"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"33425"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"33426"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"33427"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"33428"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33429"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"33430"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33431"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"33432"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"33433"},{"source":"CD19 antagonist","target":"brain metastases","id":"33434"},{"source":"CD19 antagonist","target":"melanoma","id":"33435"},{"source":"CD19 antagonist","target":"anticancer","id":"33436"},{"source":"CD19 antagonist","target":"melanoma","id":"33437"},{"source":"CD19 antagonist","target":"melanoma","id":"33438"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"33439"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"33440"},{"source":"CD19 antagonist","target":"carcinoma","id":"33441"},{"source":"CD19 antagonist","target":"brain metastases","id":"33442"},{"source":"CD19 antagonist","target":"anticancer","id":"33443"},{"source":"Immunostimulant","target":"UNK : Indication","id":"33444"},{"source":"Immunostimulant","target":"ovarian neoplasms","id":"33445"},{"source":"Immunostimulant","target":"brain metastases","id":"33446"},{"source":"Immunostimulant","target":"melanoma","id":"33447"},{"source":"Immunostimulant","target":"anticancer","id":"33448"},{"source":"Immunostimulant","target":"melanoma","id":"33449"},{"source":"Immunostimulant","target":"melanoma","id":"33450"},{"source":"Immunostimulant","target":"skin neoplasms","id":"33451"},{"source":"Immunostimulant","target":"cerebellar neoplasms","id":"33452"},{"source":"Immunostimulant","target":"carcinoma","id":"33453"},{"source":"Immunostimulant","target":"brain metastases","id":"33454"},{"source":"Immunostimulant","target":"anticancer","id":"33455"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"33456"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"33457"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"33458"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"33459"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33460"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"33461"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"33462"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"33463"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"33464"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33465"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"33466"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33467"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"33468"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"33469"},{"source":"Oncology: Melanoma","target":"Immunostimulant","id":"33470"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"33471"},{"source":"AMG-820 (u)","target":"Amgen","id":"33472"},{"source":"AMG-820 (u)","target":"Merck & Co.","id":"33473"},{"source":"pembrolizumab","target":"Amgen","id":"33474"},{"source":"pembrolizumab","target":"Merck & Co.","id":"33475"},{"source":"UNK : Drug","target":"Amgen","id":"33476"},{"source":"UNK : Drug","target":"Merck & Co.","id":"33477"},{"source":"UNK : Indication","target":"AMG-820 (u)","id":"33478"},{"source":"UNK : Indication","target":"pembrolizumab","id":"33479"},{"source":"UNK : Indication","target":"UNK : Drug","id":"33480"},{"source":"residual tumor","target":"AMG-820 (u)","id":"33481"},{"source":"residual tumor","target":"pembrolizumab","id":"33482"},{"source":"residual tumor","target":"UNK : Drug","id":"33483"},{"source":"colorectal neoplasms","target":"AMG-820 (u)","id":"33484"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"33485"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"33486"},{"source":"solid tumors","target":"AMG-820 (u)","id":"33487"},{"source":"solid tumors","target":"pembrolizumab","id":"33488"},{"source":"solid tumors","target":"UNK : Drug","id":"33489"},{"source":"colorectal neoplasms","target":"AMG-820 (u)","id":"33490"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"33491"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"33492"},{"source":"skin neoplasms","target":"AMG-820 (u)","id":"33493"},{"source":"skin neoplasms","target":"pembrolizumab","id":"33494"},{"source":"skin neoplasms","target":"UNK : Drug","id":"33495"},{"source":"unknown primary","target":"AMG-820 (u)","id":"33496"},{"source":"unknown primary","target":"pembrolizumab","id":"33497"},{"source":"unknown primary","target":"UNK : Drug","id":"33498"},{"source":"carcinoma","target":"AMG-820 (u)","id":"33499"},{"source":"carcinoma","target":"pembrolizumab","id":"33500"},{"source":"carcinoma","target":"UNK : Drug","id":"33501"},{"source":"colonic neoplasms","target":"AMG-820 (u)","id":"33502"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"33503"},{"source":"colonic neoplasms","target":"UNK : Drug","id":"33504"},{"source":"non-small-cell lung","target":"AMG-820 (u)","id":"33505"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33506"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"33507"},{"source":"carcinoma","target":"AMG-820 (u)","id":"33508"},{"source":"carcinoma","target":"pembrolizumab","id":"33509"},{"source":"carcinoma","target":"UNK : Drug","id":"33510"},{"source":"anti-tumor","target":"AMG-820 (u)","id":"33511"},{"source":"anti-tumor","target":"pembrolizumab","id":"33512"},{"source":"anti-tumor","target":"UNK : Drug","id":"33513"},{"source":"non-small-cell lung","target":"AMG-820 (u)","id":"33514"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33515"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"33516"},{"source":"pancreatic cancer","target":"AMG-820 (u)","id":"33517"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"33518"},{"source":"pancreatic cancer","target":"UNK : Drug","id":"33519"},{"source":"anticancer","target":"AMG-820 (u)","id":"33520"},{"source":"anticancer","target":"pembrolizumab","id":"33521"},{"source":"anticancer","target":"UNK : Drug","id":"33522"},{"source":"unknown primary","target":"AMG-820 (u)","id":"33523"},{"source":"unknown primary","target":"pembrolizumab","id":"33524"},{"source":"unknown primary","target":"UNK : Drug","id":"33525"},{"source":"pancreatic neoplasms","target":"AMG-820 (u)","id":"33526"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"33527"},{"source":"pancreatic neoplasms","target":"UNK : Drug","id":"33528"},{"source":"solid tumors","target":"AMG-820 (u)","id":"33529"},{"source":"solid tumors","target":"pembrolizumab","id":"33530"},{"source":"solid tumors","target":"UNK : Drug","id":"33531"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"33532"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"33533"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"33534"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"33535"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"33536"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"33537"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"33538"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33539"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"33540"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33541"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33542"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"33543"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33544"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"33545"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33546"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"33547"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"33548"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"33549"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"33550"},{"source":"CD19 antagonist","target":"residual tumor","id":"33551"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"33552"},{"source":"CD19 antagonist","target":"solid tumors","id":"33553"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"33554"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"33555"},{"source":"CD19 antagonist","target":"unknown primary","id":"33556"},{"source":"CD19 antagonist","target":"carcinoma","id":"33557"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"33558"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33559"},{"source":"CD19 antagonist","target":"carcinoma","id":"33560"},{"source":"CD19 antagonist","target":"anti-tumor","id":"33561"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33562"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"33563"},{"source":"CD19 antagonist","target":"anticancer","id":"33564"},{"source":"CD19 antagonist","target":"unknown primary","id":"33565"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"33566"},{"source":"CD19 antagonist","target":"solid tumors","id":"33567"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"UNK : Indication","id":"33568"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"33569"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colorectal neoplasms","id":"33570"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"33571"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colorectal neoplasms","id":"33572"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"skin neoplasms","id":"33573"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"unknown primary","id":"33574"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"33575"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"colonic neoplasms","id":"33576"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"non-small-cell lung","id":"33577"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"33578"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anti-tumor","id":"33579"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"non-small-cell lung","id":"33580"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"pancreatic cancer","id":"33581"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"33582"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"unknown primary","id":"33583"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"pancreatic neoplasms","id":"33584"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"33585"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"33586"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"33587"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"33588"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"33589"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"33590"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"33591"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"33592"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33593"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"33594"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"33595"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33596"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"33597"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"33598"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"33599"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33600"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"33601"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"33602"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"33603"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"33604"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"33605"},{"source":"Oncology: Colorectal","target":"Colony stimulating factor 1 receptor antagonist","id":"33606"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"33607"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"33608"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"33609"},{"source":"Oncology: Lung","target":"Colony stimulating factor 1 receptor antagonist","id":"33610"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"33611"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"33612"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"33613"},{"source":"Non-Small Cell","target":"Colony stimulating factor 1 receptor antagonist","id":"33614"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"33615"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"33616"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"33617"},{"source":"Oncology: Pancreas","target":"Colony stimulating factor 1 receptor antagonist","id":"33618"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"33619"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"33620"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"33621"},{"source":"Oncology: CNS","target":"Colony stimulating factor 1 receptor antagonist","id":"33622"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"33623"},{"source":"pelareorep (u)","target":"Oncolytics Biotech","id":"33624"},{"source":"bevacizumab","target":"Oncolytics Biotech","id":"33625"},{"source":"5-fluorouracil","target":"Oncolytics Biotech","id":"33626"},{"source":"leucovorin","target":"Oncolytics Biotech","id":"33627"},{"source":"Spectrum","target":"Oncolytics Biotech","id":"33628"},{"source":"oxaliplatin (IV)","target":"Oncolytics Biotech","id":"33629"},{"source":"pembrolizumab","target":"Oncolytics Biotech","id":"33630"},{"source":"colorectal neoplasms","target":"pelareorep (u)","id":"33631"},{"source":"colorectal neoplasms","target":"bevacizumab","id":"33632"},{"source":"colorectal neoplasms","target":"5-fluorouracil","id":"33633"},{"source":"colorectal neoplasms","target":"leucovorin","id":"33634"},{"source":"colorectal neoplasms","target":"Spectrum","id":"33635"},{"source":"colorectal neoplasms","target":"oxaliplatin (IV)","id":"33636"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"33637"},{"source":"colorectal cancer","target":"pelareorep (u)","id":"33638"},{"source":"colorectal cancer","target":"bevacizumab","id":"33639"},{"source":"colorectal cancer","target":"5-fluorouracil","id":"33640"},{"source":"colorectal cancer","target":"leucovorin","id":"33641"},{"source":"colorectal cancer","target":"Spectrum","id":"33642"},{"source":"colorectal cancer","target":"oxaliplatin (IV)","id":"33643"},{"source":"colorectal cancer","target":"pembrolizumab","id":"33644"},{"source":"metastatic","target":"pelareorep (u)","id":"33645"},{"source":"metastatic","target":"bevacizumab","id":"33646"},{"source":"metastatic","target":"5-fluorouracil","id":"33647"},{"source":"metastatic","target":"leucovorin","id":"33648"},{"source":"metastatic","target":"Spectrum","id":"33649"},{"source":"metastatic","target":"oxaliplatin (IV)","id":"33650"},{"source":"metastatic","target":"pembrolizumab","id":"33651"},{"source":"colonic neoplasms","target":"pelareorep (u)","id":"33652"},{"source":"colonic neoplasms","target":"bevacizumab","id":"33653"},{"source":"colonic neoplasms","target":"5-fluorouracil","id":"33654"},{"source":"colonic neoplasms","target":"leucovorin","id":"33655"},{"source":"colonic neoplasms","target":"Spectrum","id":"33656"},{"source":"colonic neoplasms","target":"oxaliplatin (IV)","id":"33657"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"33658"},{"source":"metastatic","target":"pelareorep (u)","id":"33659"},{"source":"metastatic","target":"bevacizumab","id":"33660"},{"source":"metastatic","target":"5-fluorouracil","id":"33661"},{"source":"metastatic","target":"leucovorin","id":"33662"},{"source":"metastatic","target":"Spectrum","id":"33663"},{"source":"metastatic","target":"oxaliplatin (IV)","id":"33664"},{"source":"metastatic","target":"pembrolizumab","id":"33665"},{"source":"carcinoma","target":"pelareorep (u)","id":"33666"},{"source":"carcinoma","target":"bevacizumab","id":"33667"},{"source":"carcinoma","target":"5-fluorouracil","id":"33668"},{"source":"carcinoma","target":"leucovorin","id":"33669"},{"source":"carcinoma","target":"Spectrum","id":"33670"},{"source":"carcinoma","target":"oxaliplatin (IV)","id":"33671"},{"source":"carcinoma","target":"pembrolizumab","id":"33672"},{"source":"neoplasm metastasis","target":"pelareorep (u)","id":"33673"},{"source":"neoplasm metastasis","target":"bevacizumab","id":"33674"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"33675"},{"source":"neoplasm metastasis","target":"leucovorin","id":"33676"},{"source":"neoplasm metastasis","target":"Spectrum","id":"33677"},{"source":"neoplasm metastasis","target":"oxaliplatin (IV)","id":"33678"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"33679"},{"source":"anticancer","target":"pelareorep (u)","id":"33680"},{"source":"anticancer","target":"bevacizumab","id":"33681"},{"source":"anticancer","target":"5-fluorouracil","id":"33682"},{"source":"anticancer","target":"leucovorin","id":"33683"},{"source":"anticancer","target":"Spectrum","id":"33684"},{"source":"anticancer","target":"oxaliplatin (IV)","id":"33685"},{"source":"anticancer","target":"pembrolizumab","id":"33686"},{"source":"colorectal neoplasms","target":"pelareorep (u)","id":"33687"},{"source":"colorectal neoplasms","target":"bevacizumab","id":"33688"},{"source":"colorectal neoplasms","target":"5-fluorouracil","id":"33689"},{"source":"colorectal neoplasms","target":"leucovorin","id":"33690"},{"source":"colorectal neoplasms","target":"Spectrum","id":"33691"},{"source":"colorectal neoplasms","target":"oxaliplatin (IV)","id":"33692"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"33693"},{"source":"NA","target":"colorectal neoplasms","id":"33694"},{"source":"NA","target":"colorectal cancer","id":"33695"},{"source":"NA","target":"metastatic","id":"33696"},{"source":"NA","target":"colonic neoplasms","id":"33697"},{"source":"NA","target":"metastatic","id":"33698"},{"source":"NA","target":"carcinoma","id":"33699"},{"source":"NA","target":"neoplasm metastasis","id":"33700"},{"source":"NA","target":"anticancer","id":"33701"},{"source":"NA","target":"colorectal neoplasms","id":"33702"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"33703"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"33704"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"33705"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"33706"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"33707"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33708"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"33709"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33710"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"33711"},{"source":"NA","target":"colorectal neoplasms","id":"33712"},{"source":"NA","target":"colorectal cancer","id":"33713"},{"source":"NA","target":"metastatic","id":"33714"},{"source":"NA","target":"colonic neoplasms","id":"33715"},{"source":"NA","target":"metastatic","id":"33716"},{"source":"NA","target":"carcinoma","id":"33717"},{"source":"NA","target":"neoplasm metastasis","id":"33718"},{"source":"NA","target":"anticancer","id":"33719"},{"source":"NA","target":"colorectal neoplasms","id":"33720"},{"source":"NA","target":"colorectal neoplasms","id":"33721"},{"source":"NA","target":"colorectal cancer","id":"33722"},{"source":"NA","target":"metastatic","id":"33723"},{"source":"NA","target":"colonic neoplasms","id":"33724"},{"source":"NA","target":"metastatic","id":"33725"},{"source":"NA","target":"carcinoma","id":"33726"},{"source":"NA","target":"neoplasm metastasis","id":"33727"},{"source":"NA","target":"anticancer","id":"33728"},{"source":"NA","target":"colorectal neoplasms","id":"33729"},{"source":"UPA","target":"colorectal neoplasms","id":"33730"},{"source":"UPA","target":"colorectal cancer","id":"33731"},{"source":"UPA","target":"metastatic","id":"33732"},{"source":"UPA","target":"colonic neoplasms","id":"33733"},{"source":"UPA","target":"metastatic","id":"33734"},{"source":"UPA","target":"carcinoma","id":"33735"},{"source":"UPA","target":"neoplasm metastasis","id":"33736"},{"source":"UPA","target":"anticancer","id":"33737"},{"source":"UPA","target":"colorectal neoplasms","id":"33738"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"33739"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"33740"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"33741"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"33742"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"33743"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33744"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"33745"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33746"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"33747"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"33748"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"33749"},{"source":"CD19 antagonist","target":"metastatic","id":"33750"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"33751"},{"source":"CD19 antagonist","target":"metastatic","id":"33752"},{"source":"CD19 antagonist","target":"carcinoma","id":"33753"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"33754"},{"source":"CD19 antagonist","target":"anticancer","id":"33755"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"33756"},{"source":"Angiogenesis inhibitor","target":"colorectal neoplasms","id":"33757"},{"source":"Angiogenesis inhibitor","target":"colorectal cancer","id":"33758"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"33759"},{"source":"Angiogenesis inhibitor","target":"colonic neoplasms","id":"33760"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"33761"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"33762"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"33763"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"33764"},{"source":"Angiogenesis inhibitor","target":"colorectal neoplasms","id":"33765"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"colorectal neoplasms","id":"33766"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"colorectal cancer","id":"33767"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"metastatic","id":"33768"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"colonic neoplasms","id":"33769"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"metastatic","id":"33770"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"33771"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"neoplasm metastasis","id":"33772"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"33773"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"colorectal neoplasms","id":"33774"},{"source":"NA","target":"colorectal neoplasms","id":"33775"},{"source":"NA","target":"colorectal cancer","id":"33776"},{"source":"NA","target":"metastatic","id":"33777"},{"source":"NA","target":"colonic neoplasms","id":"33778"},{"source":"NA","target":"metastatic","id":"33779"},{"source":"NA","target":"carcinoma","id":"33780"},{"source":"NA","target":"neoplasm metastasis","id":"33781"},{"source":"NA","target":"anticancer","id":"33782"},{"source":"NA","target":"colorectal neoplasms","id":"33783"},{"source":"Thymidylate synthase inhibitor","target":"colorectal neoplasms","id":"33784"},{"source":"Thymidylate synthase inhibitor","target":"colorectal cancer","id":"33785"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"33786"},{"source":"Thymidylate synthase inhibitor","target":"colonic neoplasms","id":"33787"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"33788"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"33789"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"33790"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"33791"},{"source":"Thymidylate synthase inhibitor","target":"colorectal neoplasms","id":"33792"},{"source":"Oncology: Colorectal","target":"NA","id":"33793"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"33794"},{"source":"Oncology: Colorectal","target":"NA","id":"33795"},{"source":"Oncology: Colorectal","target":"NA","id":"33796"},{"source":"Oncology: Colorectal","target":"UPA","id":"33797"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"33798"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"33799"},{"source":"Oncology: Colorectal","target":"Angiogenesis inhibitor","id":"33800"},{"source":"Oncology: Colorectal","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"33801"},{"source":"Oncology: Colorectal","target":"NA","id":"33802"},{"source":"Oncology: Colorectal","target":"Thymidylate synthase inhibitor","id":"33803"},{"source":"Oncology: Metastatic Cancer","target":"NA","id":"33804"},{"source":"Oncology: Metastatic Cancer","target":"Immune checkpoint inhibitor","id":"33805"},{"source":"Oncology: Metastatic Cancer","target":"NA","id":"33806"},{"source":"Oncology: Metastatic Cancer","target":"NA","id":"33807"},{"source":"Oncology: Metastatic Cancer","target":"UPA","id":"33808"},{"source":"Oncology: Metastatic Cancer","target":"Anticancer immunotherapy","id":"33809"},{"source":"Oncology: Metastatic Cancer","target":"CD19 antagonist","id":"33810"},{"source":"Oncology: Metastatic Cancer","target":"Angiogenesis inhibitor","id":"33811"},{"source":"Oncology: Metastatic Cancer","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"33812"},{"source":"Oncology: Metastatic Cancer","target":"NA","id":"33813"},{"source":"Oncology: Metastatic Cancer","target":"Thymidylate synthase inhibitor","id":"33814"},{"source":"pembrolizumab","target":"Merck & Co.","id":"33815"},{"source":"capecitabine","target":"Merck & Co.","id":"33816"},{"source":"cisplatin","target":"Merck & Co.","id":"33817"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"33818"},{"source":"UNK : Indication","target":"pembrolizumab","id":"33819"},{"source":"UNK : Indication","target":"capecitabine","id":"33820"},{"source":"UNK : Indication","target":"cisplatin","id":"33821"},{"source":"UNK : Indication","target":"5-fluorouracil","id":"33822"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"33823"},{"source":"pharyngeal neoplasms","target":"capecitabine","id":"33824"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"33825"},{"source":"pharyngeal neoplasms","target":"5-fluorouracil","id":"33826"},{"source":"esophageal cancer","target":"pembrolizumab","id":"33827"},{"source":"esophageal cancer","target":"capecitabine","id":"33828"},{"source":"esophageal cancer","target":"cisplatin","id":"33829"},{"source":"esophageal cancer","target":"5-fluorouracil","id":"33830"},{"source":"carcinoma","target":"pembrolizumab","id":"33831"},{"source":"carcinoma","target":"capecitabine","id":"33832"},{"source":"carcinoma","target":"cisplatin","id":"33833"},{"source":"carcinoma","target":"5-fluorouracil","id":"33834"},{"source":"metastatic","target":"pembrolizumab","id":"33835"},{"source":"metastatic","target":"capecitabine","id":"33836"},{"source":"metastatic","target":"cisplatin","id":"33837"},{"source":"metastatic","target":"5-fluorouracil","id":"33838"},{"source":"carcinoma","target":"pembrolizumab","id":"33839"},{"source":"carcinoma","target":"capecitabine","id":"33840"},{"source":"carcinoma","target":"cisplatin","id":"33841"},{"source":"carcinoma","target":"5-fluorouracil","id":"33842"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"33843"},{"source":"stomach neoplasms","target":"capecitabine","id":"33844"},{"source":"stomach neoplasms","target":"cisplatin","id":"33845"},{"source":"stomach neoplasms","target":"5-fluorouracil","id":"33846"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"33847"},{"source":"neoplasm metastasis","target":"capecitabine","id":"33848"},{"source":"neoplasm metastasis","target":"cisplatin","id":"33849"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"33850"},{"source":"carcinoma","target":"pembrolizumab","id":"33851"},{"source":"carcinoma","target":"capecitabine","id":"33852"},{"source":"carcinoma","target":"cisplatin","id":"33853"},{"source":"carcinoma","target":"5-fluorouracil","id":"33854"},{"source":"anticancer","target":"pembrolizumab","id":"33855"},{"source":"anticancer","target":"capecitabine","id":"33856"},{"source":"anticancer","target":"cisplatin","id":"33857"},{"source":"anticancer","target":"5-fluorouracil","id":"33858"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"33859"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"33860"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"33861"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33862"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"33863"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33864"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"33865"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"33866"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"33867"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"33868"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"33869"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"33870"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"33871"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33872"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"33873"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33874"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"33875"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"33876"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33877"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33878"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"33879"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"33880"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"33881"},{"source":"CD19 antagonist","target":"carcinoma","id":"33882"},{"source":"CD19 antagonist","target":"metastatic","id":"33883"},{"source":"CD19 antagonist","target":"carcinoma","id":"33884"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"33885"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"33886"},{"source":"CD19 antagonist","target":"carcinoma","id":"33887"},{"source":"CD19 antagonist","target":"anticancer","id":"33888"},{"source":"NA","target":"UNK : Indication","id":"33889"},{"source":"NA","target":"pharyngeal neoplasms","id":"33890"},{"source":"NA","target":"esophageal cancer","id":"33891"},{"source":"NA","target":"carcinoma","id":"33892"},{"source":"NA","target":"metastatic","id":"33893"},{"source":"NA","target":"carcinoma","id":"33894"},{"source":"NA","target":"stomach neoplasms","id":"33895"},{"source":"NA","target":"neoplasm metastasis","id":"33896"},{"source":"NA","target":"carcinoma","id":"33897"},{"source":"NA","target":"anticancer","id":"33898"},{"source":"NA","target":"UNK : Indication","id":"33899"},{"source":"NA","target":"pharyngeal neoplasms","id":"33900"},{"source":"NA","target":"esophageal cancer","id":"33901"},{"source":"NA","target":"carcinoma","id":"33902"},{"source":"NA","target":"metastatic","id":"33903"},{"source":"NA","target":"carcinoma","id":"33904"},{"source":"NA","target":"stomach neoplasms","id":"33905"},{"source":"NA","target":"neoplasm metastasis","id":"33906"},{"source":"NA","target":"carcinoma","id":"33907"},{"source":"NA","target":"anticancer","id":"33908"},{"source":"NA","target":"UNK : Indication","id":"33909"},{"source":"NA","target":"pharyngeal neoplasms","id":"33910"},{"source":"NA","target":"esophageal cancer","id":"33911"},{"source":"NA","target":"carcinoma","id":"33912"},{"source":"NA","target":"metastatic","id":"33913"},{"source":"NA","target":"carcinoma","id":"33914"},{"source":"NA","target":"stomach neoplasms","id":"33915"},{"source":"NA","target":"neoplasm metastasis","id":"33916"},{"source":"NA","target":"carcinoma","id":"33917"},{"source":"NA","target":"anticancer","id":"33918"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"33919"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"33920"},{"source":"Thymidylate synthase inhibitor","target":"esophageal cancer","id":"33921"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"33922"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"33923"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"33924"},{"source":"Thymidylate synthase inhibitor","target":"stomach neoplasms","id":"33925"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"33926"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"33927"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"33928"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"33929"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"33930"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"33931"},{"source":"Oncology: Esophageal","target":"NA","id":"33932"},{"source":"Oncology: Esophageal","target":"NA","id":"33933"},{"source":"Oncology: Esophageal","target":"NA","id":"33934"},{"source":"Oncology: Esophageal","target":"Thymidylate synthase inhibitor","id":"33935"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"33936"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"33937"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"33938"},{"source":"Oncology: Gastric","target":"NA","id":"33939"},{"source":"Oncology: Gastric","target":"NA","id":"33940"},{"source":"Oncology: Gastric","target":"NA","id":"33941"},{"source":"Oncology: Gastric","target":"Thymidylate synthase inhibitor","id":"33942"},{"source":"LYC-55716 (u)","target":"Lycera","id":"33943"},{"source":"pembrolizumab","target":"Lycera","id":"33944"},{"source":"UNK : Indication","target":"LYC-55716 (u)","id":"33945"},{"source":"UNK : Indication","target":"pembrolizumab","id":"33946"},{"source":"residual tumor","target":"LYC-55716 (u)","id":"33947"},{"source":"residual tumor","target":"pembrolizumab","id":"33948"},{"source":"non-small-cell lung","target":"LYC-55716 (u)","id":"33949"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33950"},{"source":"sclc","target":"LYC-55716 (u)","id":"33951"},{"source":"sclc","target":"pembrolizumab","id":"33952"},{"source":"gilbert syndrome","target":"LYC-55716 (u)","id":"33953"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"33954"},{"source":"carcinoma","target":"LYC-55716 (u)","id":"33955"},{"source":"carcinoma","target":"pembrolizumab","id":"33956"},{"source":"gilbert disease","target":"LYC-55716 (u)","id":"33957"},{"source":"gilbert disease","target":"pembrolizumab","id":"33958"},{"source":"liver metastases","target":"LYC-55716 (u)","id":"33959"},{"source":"liver metastases","target":"pembrolizumab","id":"33960"},{"source":"metastatic","target":"LYC-55716 (u)","id":"33961"},{"source":"metastatic","target":"pembrolizumab","id":"33962"},{"source":"carcinoma","target":"LYC-55716 (u)","id":"33963"},{"source":"carcinoma","target":"pembrolizumab","id":"33964"},{"source":"non-small-cell lung","target":"LYC-55716 (u)","id":"33965"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"33966"},{"source":"neoplasm metastasis","target":"LYC-55716 (u)","id":"33967"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"33968"},{"source":"anticancer","target":"LYC-55716 (u)","id":"33969"},{"source":"anticancer","target":"pembrolizumab","id":"33970"},{"source":"lung neoplasms","target":"LYC-55716 (u)","id":"33971"},{"source":"lung neoplasms","target":"pembrolizumab","id":"33972"},{"source":"liver neoplasms","target":"LYC-55716 (u)","id":"33973"},{"source":"liver neoplasms","target":"pembrolizumab","id":"33974"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"33975"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"33976"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33977"},{"source":"Anticancer immunotherapy","target":"sclc","id":"33978"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"33979"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33980"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"33981"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"33982"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"33983"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"33984"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"33985"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"33986"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"33987"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"33988"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"33989"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"33990"},{"source":"CD19 antagonist","target":"residual tumor","id":"33991"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"33992"},{"source":"CD19 antagonist","target":"sclc","id":"33993"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"33994"},{"source":"CD19 antagonist","target":"carcinoma","id":"33995"},{"source":"CD19 antagonist","target":"gilbert disease","id":"33996"},{"source":"CD19 antagonist","target":"liver metastases","id":"33997"},{"source":"CD19 antagonist","target":"metastatic","id":"33998"},{"source":"CD19 antagonist","target":"carcinoma","id":"33999"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"34000"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"34001"},{"source":"CD19 antagonist","target":"anticancer","id":"34002"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"34003"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"34004"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"UNK : Indication","id":"34005"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"residual tumor","id":"34006"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"non-small-cell lung","id":"34007"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"sclc","id":"34008"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"gilbert syndrome","id":"34009"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"carcinoma","id":"34010"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"gilbert disease","id":"34011"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"liver metastases","id":"34012"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"metastatic","id":"34013"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"carcinoma","id":"34014"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"non-small-cell lung","id":"34015"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"neoplasm metastasis","id":"34016"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"anticancer","id":"34017"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"lung neoplasms","id":"34018"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"liver neoplasms","id":"34019"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"34020"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"34021"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"34022"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"34023"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"34024"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34025"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"34026"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"34027"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"34028"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34029"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"34030"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"34031"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34032"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"34033"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"34034"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"34035"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"34036"},{"source":"Oncology: Lung","target":"RORC RAR-related orphan receptor C gamma-t inhibitor","id":"34037"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"34038"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"34039"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"34040"},{"source":"Non-Small Cell","target":"RORC RAR-related orphan receptor C gamma-t inhibitor","id":"34041"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"34042"},{"source":"LYC-55716 (u)","target":"Lycera","id":"34043"},{"source":"pembrolizumab","target":"Lycera","id":"34044"},{"source":"UNK : Indication","target":"LYC-55716 (u)","id":"34045"},{"source":"UNK : Indication","target":"pembrolizumab","id":"34046"},{"source":"residual tumor","target":"LYC-55716 (u)","id":"34047"},{"source":"residual tumor","target":"pembrolizumab","id":"34048"},{"source":"non-small-cell lung","target":"LYC-55716 (u)","id":"34049"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"34050"},{"source":"sclc","target":"LYC-55716 (u)","id":"34051"},{"source":"sclc","target":"pembrolizumab","id":"34052"},{"source":"gilbert syndrome","target":"LYC-55716 (u)","id":"34053"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"34054"},{"source":"carcinoma","target":"LYC-55716 (u)","id":"34055"},{"source":"carcinoma","target":"pembrolizumab","id":"34056"},{"source":"gilbert disease","target":"LYC-55716 (u)","id":"34057"},{"source":"gilbert disease","target":"pembrolizumab","id":"34058"},{"source":"liver metastases","target":"LYC-55716 (u)","id":"34059"},{"source":"liver metastases","target":"pembrolizumab","id":"34060"},{"source":"metastatic","target":"LYC-55716 (u)","id":"34061"},{"source":"metastatic","target":"pembrolizumab","id":"34062"},{"source":"carcinoma","target":"LYC-55716 (u)","id":"34063"},{"source":"carcinoma","target":"pembrolizumab","id":"34064"},{"source":"non-small-cell lung","target":"LYC-55716 (u)","id":"34065"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"34066"},{"source":"neoplasm metastasis","target":"LYC-55716 (u)","id":"34067"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"34068"},{"source":"anticancer","target":"LYC-55716 (u)","id":"34069"},{"source":"anticancer","target":"pembrolizumab","id":"34070"},{"source":"lung neoplasms","target":"LYC-55716 (u)","id":"34071"},{"source":"lung neoplasms","target":"pembrolizumab","id":"34072"},{"source":"liver neoplasms","target":"LYC-55716 (u)","id":"34073"},{"source":"liver neoplasms","target":"pembrolizumab","id":"34074"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"34075"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"34076"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"34077"},{"source":"Anticancer immunotherapy","target":"sclc","id":"34078"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"34079"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34080"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"34081"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"34082"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"34083"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34084"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"34085"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"34086"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"34087"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"34088"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"34089"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"34090"},{"source":"CD19 antagonist","target":"residual tumor","id":"34091"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"34092"},{"source":"CD19 antagonist","target":"sclc","id":"34093"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"34094"},{"source":"CD19 antagonist","target":"carcinoma","id":"34095"},{"source":"CD19 antagonist","target":"gilbert disease","id":"34096"},{"source":"CD19 antagonist","target":"liver metastases","id":"34097"},{"source":"CD19 antagonist","target":"metastatic","id":"34098"},{"source":"CD19 antagonist","target":"carcinoma","id":"34099"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"34100"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"34101"},{"source":"CD19 antagonist","target":"anticancer","id":"34102"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"34103"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"34104"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"UNK : Indication","id":"34105"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"residual tumor","id":"34106"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"non-small-cell lung","id":"34107"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"sclc","id":"34108"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"gilbert syndrome","id":"34109"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"carcinoma","id":"34110"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"gilbert disease","id":"34111"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"liver metastases","id":"34112"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"metastatic","id":"34113"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"carcinoma","id":"34114"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"non-small-cell lung","id":"34115"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"neoplasm metastasis","id":"34116"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"anticancer","id":"34117"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"lung neoplasms","id":"34118"},{"source":"RORC RAR-related orphan receptor C gamma-t inhibitor","target":"liver neoplasms","id":"34119"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"34120"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"34121"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"34122"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"34123"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"34124"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34125"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"34126"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"34127"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"34128"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34129"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"34130"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"34131"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34132"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"34133"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"34134"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"34135"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"34136"},{"source":"Oncology: Lung","target":"RORC RAR-related orphan receptor C gamma-t inhibitor","id":"34137"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"34138"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"34139"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"34140"},{"source":"Non-Small Cell","target":"RORC RAR-related orphan receptor C gamma-t inhibitor","id":"34141"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"34142"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"34143"},{"source":"UNK : Drug","target":"National Institutes of Health/National Cancer Institute","id":"34144"},{"source":"UNK : Indication","target":"pembrolizumab","id":"34145"},{"source":"UNK : Indication","target":"UNK : Drug","id":"34146"},{"source":"anticancer","target":"pembrolizumab","id":"34147"},{"source":"anticancer","target":"UNK : Drug","id":"34148"},{"source":"human immunodeficiency virus","target":"pembrolizumab","id":"34149"},{"source":"human immunodeficiency virus","target":"UNK : Drug","id":"34150"},{"source":"deafness","target":"pembrolizumab","id":"34151"},{"source":"deafness","target":"UNK : Drug","id":"34152"},{"source":"renal cancer","target":"pembrolizumab","id":"34153"},{"source":"renal cancer","target":"UNK : Drug","id":"34154"},{"source":"sjogren's syndrome","target":"pembrolizumab","id":"34155"},{"source":"sjogren's syndrome","target":"UNK : Drug","id":"34156"},{"source":"joint diseases","target":"pembrolizumab","id":"34157"},{"source":"joint diseases","target":"UNK : Drug","id":"34158"},{"source":"carcinoma","target":"pembrolizumab","id":"34159"},{"source":"carcinoma","target":"UNK : Drug","id":"34160"},{"source":"hepatitis c virus","target":"pembrolizumab","id":"34161"},{"source":"hepatitis c virus","target":"UNK : Drug","id":"34162"},{"source":"guillain-barre syndrome","target":"pembrolizumab","id":"34163"},{"source":"guillain-barre syndrome","target":"UNK : Drug","id":"34164"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"34165"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"34166"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"34167"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"34168"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"34169"},{"source":"diabetes mellitus","target":"UNK : Drug","id":"34170"},{"source":"hiv infections","target":"pembrolizumab","id":"34171"},{"source":"hiv infections","target":"UNK : Drug","id":"34172"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"34173"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"34174"},{"source":"carcinoma","target":"pembrolizumab","id":"34175"},{"source":"carcinoma","target":"UNK : Drug","id":"34176"},{"source":"crohn disease","target":"pembrolizumab","id":"34177"},{"source":"crohn disease","target":"UNK : Drug","id":"34178"},{"source":"systemic lupus erythematosus","target":"pembrolizumab","id":"34179"},{"source":"systemic lupus erythematosus","target":"UNK : Drug","id":"34180"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"34181"},{"source":"inflammatory bowel diseases","target":"UNK : Drug","id":"34182"},{"source":"stevens-johnson syndrome","target":"pembrolizumab","id":"34183"},{"source":"stevens-johnson syndrome","target":"UNK : Drug","id":"34184"},{"source":"hcv","target":"pembrolizumab","id":"34185"},{"source":"hcv","target":"UNK : Drug","id":"34186"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"34187"},{"source":"diabetes mellitus","target":"UNK : Drug","id":"34188"},{"source":"hearing loss","target":"pembrolizumab","id":"34189"},{"source":"hearing loss","target":"UNK : Drug","id":"34190"},{"source":"bladder cancer","target":"pembrolizumab","id":"34191"},{"source":"bladder cancer","target":"UNK : Drug","id":"34192"},{"source":"residual neoplasm","target":"pembrolizumab","id":"34193"},{"source":"residual neoplasm","target":"UNK : Drug","id":"34194"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"34195"},{"source":"autoimmune diseases","target":"UNK : Drug","id":"34196"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"34197"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"34198"},{"source":"demyelinating","target":"pembrolizumab","id":"34199"},{"source":"demyelinating","target":"UNK : Drug","id":"34200"},{"source":"residual cancer","target":"pembrolizumab","id":"34201"},{"source":"residual cancer","target":"UNK : Drug","id":"34202"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"34203"},{"source":"autoimmune diseases","target":"UNK : Drug","id":"34204"},{"source":"pneumonitis","target":"pembrolizumab","id":"34205"},{"source":"pneumonitis","target":"UNK : Drug","id":"34206"},{"source":"solid tumors","target":"pembrolizumab","id":"34207"},{"source":"solid tumors","target":"UNK : Drug","id":"34208"},{"source":"crohn's","target":"pembrolizumab","id":"34209"},{"source":"crohn's","target":"UNK : Drug","id":"34210"},{"source":"multiple sclerosis","target":"pembrolizumab","id":"34211"},{"source":"multiple sclerosis","target":"UNK : Drug","id":"34212"},{"source":"carcinoma","target":"pembrolizumab","id":"34213"},{"source":"carcinoma","target":"UNK : Drug","id":"34214"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"34215"},{"source":"diabetes mellitus","target":"UNK : Drug","id":"34216"},{"source":"solid tumors","target":"pembrolizumab","id":"34217"},{"source":"solid tumors","target":"UNK : Drug","id":"34218"},{"source":"psoriasis","target":"pembrolizumab","id":"34219"},{"source":"psoriasis","target":"UNK : Drug","id":"34220"},{"source":"bladder tumor","target":"pembrolizumab","id":"34221"},{"source":"bladder tumor","target":"UNK : Drug","id":"34222"},{"source":"arthropathies","target":"pembrolizumab","id":"34223"},{"source":"arthropathies","target":"UNK : Drug","id":"34224"},{"source":"anti-hiv","target":"pembrolizumab","id":"34225"},{"source":"anti-hiv","target":"UNK : Drug","id":"34226"},{"source":"toxic epidermal necrolysis","target":"pembrolizumab","id":"34227"},{"source":"toxic epidermal necrolysis","target":"UNK : Drug","id":"34228"},{"source":"connective tissue diseases","target":"pembrolizumab","id":"34229"},{"source":"connective tissue diseases","target":"UNK : Drug","id":"34230"},{"source":"liver metastases","target":"pembrolizumab","id":"34231"},{"source":"liver metastases","target":"UNK : Drug","id":"34232"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"34233"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"34234"},{"source":"vitiligo","target":"pembrolizumab","id":"34235"},{"source":"vitiligo","target":"UNK : Drug","id":"34236"},{"source":"systemic scleroderma","target":"pembrolizumab","id":"34237"},{"source":"systemic scleroderma","target":"UNK : Drug","id":"34238"},{"source":"metastatic","target":"pembrolizumab","id":"34239"},{"source":"metastatic","target":"UNK : Drug","id":"34240"},{"source":"carcinoma","target":"pembrolizumab","id":"34241"},{"source":"carcinoma","target":"UNK : Drug","id":"34242"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"34243"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"34244"},{"source":"demyelinating","target":"pembrolizumab","id":"34245"},{"source":"demyelinating","target":"UNK : Drug","id":"34246"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"34247"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"34248"},{"source":"ulcerative colitis","target":"pembrolizumab","id":"34249"},{"source":"ulcerative colitis","target":"UNK : Drug","id":"34250"},{"source":"thyroiditis","target":"pembrolizumab","id":"34251"},{"source":"thyroiditis","target":"UNK : Drug","id":"34252"},{"source":"transitional","target":"pembrolizumab","id":"34253"},{"source":"transitional","target":"UNK : Drug","id":"34254"},{"source":"neuropathy","target":"pembrolizumab","id":"34255"},{"source":"neuropathy","target":"UNK : Drug","id":"34256"},{"source":"systemic scleroderma","target":"pembrolizumab","id":"34257"},{"source":"systemic scleroderma","target":"UNK : Drug","id":"34258"},{"source":"heart failure","target":"pembrolizumab","id":"34259"},{"source":"heart failure","target":"UNK : Drug","id":"34260"},{"source":"pneumonia","target":"pembrolizumab","id":"34261"},{"source":"pneumonia","target":"UNK : Drug","id":"34262"},{"source":"inflammatory bowel diseases","target":"pembrolizumab","id":"34263"},{"source":"inflammatory bowel diseases","target":"UNK : Drug","id":"34264"},{"source":"arthritis","target":"pembrolizumab","id":"34265"},{"source":"arthritis","target":"UNK : Drug","id":"34266"},{"source":"carcinoma","target":"pembrolizumab","id":"34267"},{"source":"carcinoma","target":"UNK : Drug","id":"34268"},{"source":"myasthenia gravis","target":"pembrolizumab","id":"34269"},{"source":"myasthenia gravis","target":"UNK : Drug","id":"34270"},{"source":"measles","target":"pembrolizumab","id":"34271"},{"source":"measles","target":"UNK : Drug","id":"34272"},{"source":"anticancer","target":"pembrolizumab","id":"34273"},{"source":"anticancer","target":"UNK : Drug","id":"34274"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"34275"},{"source":"urinary bladder neoplasms","target":"UNK : Drug","id":"34276"},{"source":"hypopigmentation","target":"pembrolizumab","id":"34277"},{"source":"hypopigmentation","target":"UNK : Drug","id":"34278"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"34279"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"34280"},{"source":"Anticancer immunotherapy","target":"human immunodeficiency virus","id":"34281"},{"source":"Anticancer immunotherapy","target":"deafness","id":"34282"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"34283"},{"source":"Anticancer immunotherapy","target":"sjogren's syndrome","id":"34284"},{"source":"Anticancer immunotherapy","target":"joint diseases","id":"34285"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34286"},{"source":"Anticancer immunotherapy","target":"hepatitis c virus","id":"34287"},{"source":"Anticancer immunotherapy","target":"guillain-barre syndrome","id":"34288"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"34289"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"34290"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"34291"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"34292"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"34293"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34294"},{"source":"Anticancer immunotherapy","target":"crohn disease","id":"34295"},{"source":"Anticancer immunotherapy","target":"systemic lupus erythematosus","id":"34296"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"34297"},{"source":"Anticancer immunotherapy","target":"stevens-johnson syndrome","id":"34298"},{"source":"Anticancer immunotherapy","target":"hcv","id":"34299"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"34300"},{"source":"Anticancer immunotherapy","target":"hearing loss","id":"34301"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"34302"},{"source":"Anticancer immunotherapy","target":"residual neoplasm","id":"34303"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"34304"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"34305"},{"source":"Anticancer immunotherapy","target":"demyelinating","id":"34306"},{"source":"Anticancer immunotherapy","target":"residual cancer","id":"34307"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"34308"},{"source":"Anticancer immunotherapy","target":"pneumonitis","id":"34309"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"34310"},{"source":"Anticancer immunotherapy","target":"crohn's","id":"34311"},{"source":"Anticancer immunotherapy","target":"multiple sclerosis","id":"34312"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34313"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"34314"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"34315"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"34316"},{"source":"Anticancer immunotherapy","target":"bladder tumor","id":"34317"},{"source":"Anticancer immunotherapy","target":"arthropathies","id":"34318"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"34319"},{"source":"Anticancer immunotherapy","target":"toxic epidermal necrolysis","id":"34320"},{"source":"Anticancer immunotherapy","target":"connective tissue diseases","id":"34321"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"34322"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"34323"},{"source":"Anticancer immunotherapy","target":"vitiligo","id":"34324"},{"source":"Anticancer immunotherapy","target":"systemic scleroderma","id":"34325"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"34326"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34327"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"34328"},{"source":"Anticancer immunotherapy","target":"demyelinating","id":"34329"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"34330"},{"source":"Anticancer immunotherapy","target":"ulcerative colitis","id":"34331"},{"source":"Anticancer immunotherapy","target":"thyroiditis","id":"34332"},{"source":"Anticancer immunotherapy","target":"transitional","id":"34333"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"34334"},{"source":"Anticancer immunotherapy","target":"systemic scleroderma","id":"34335"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"34336"},{"source":"Anticancer immunotherapy","target":"pneumonia","id":"34337"},{"source":"Anticancer immunotherapy","target":"inflammatory bowel diseases","id":"34338"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"34339"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34340"},{"source":"Anticancer immunotherapy","target":"myasthenia gravis","id":"34341"},{"source":"Anticancer immunotherapy","target":"measles","id":"34342"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"34343"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"34344"},{"source":"Anticancer immunotherapy","target":"hypopigmentation","id":"34345"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"34346"},{"source":"CD19 antagonist","target":"anticancer","id":"34347"},{"source":"CD19 antagonist","target":"human immunodeficiency virus","id":"34348"},{"source":"CD19 antagonist","target":"deafness","id":"34349"},{"source":"CD19 antagonist","target":"renal cancer","id":"34350"},{"source":"CD19 antagonist","target":"sjogren's syndrome","id":"34351"},{"source":"CD19 antagonist","target":"joint diseases","id":"34352"},{"source":"CD19 antagonist","target":"carcinoma","id":"34353"},{"source":"CD19 antagonist","target":"hepatitis c virus","id":"34354"},{"source":"CD19 antagonist","target":"guillain-barre syndrome","id":"34355"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"34356"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"34357"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"34358"},{"source":"CD19 antagonist","target":"hiv infections","id":"34359"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"34360"},{"source":"CD19 antagonist","target":"carcinoma","id":"34361"},{"source":"CD19 antagonist","target":"crohn disease","id":"34362"},{"source":"CD19 antagonist","target":"systemic lupus erythematosus","id":"34363"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"34364"},{"source":"CD19 antagonist","target":"stevens-johnson syndrome","id":"34365"},{"source":"CD19 antagonist","target":"hcv","id":"34366"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"34367"},{"source":"CD19 antagonist","target":"hearing loss","id":"34368"},{"source":"CD19 antagonist","target":"bladder cancer","id":"34369"},{"source":"CD19 antagonist","target":"residual neoplasm","id":"34370"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"34371"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"34372"},{"source":"CD19 antagonist","target":"demyelinating","id":"34373"},{"source":"CD19 antagonist","target":"residual cancer","id":"34374"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"34375"},{"source":"CD19 antagonist","target":"pneumonitis","id":"34376"},{"source":"CD19 antagonist","target":"solid tumors","id":"34377"},{"source":"CD19 antagonist","target":"crohn's","id":"34378"},{"source":"CD19 antagonist","target":"multiple sclerosis","id":"34379"},{"source":"CD19 antagonist","target":"carcinoma","id":"34380"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"34381"},{"source":"CD19 antagonist","target":"solid tumors","id":"34382"},{"source":"CD19 antagonist","target":"psoriasis","id":"34383"},{"source":"CD19 antagonist","target":"bladder tumor","id":"34384"},{"source":"CD19 antagonist","target":"arthropathies","id":"34385"},{"source":"CD19 antagonist","target":"anti-hiv","id":"34386"},{"source":"CD19 antagonist","target":"toxic epidermal necrolysis","id":"34387"},{"source":"CD19 antagonist","target":"connective tissue diseases","id":"34388"},{"source":"CD19 antagonist","target":"liver metastases","id":"34389"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"34390"},{"source":"CD19 antagonist","target":"vitiligo","id":"34391"},{"source":"CD19 antagonist","target":"systemic scleroderma","id":"34392"},{"source":"CD19 antagonist","target":"metastatic","id":"34393"},{"source":"CD19 antagonist","target":"carcinoma","id":"34394"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"34395"},{"source":"CD19 antagonist","target":"demyelinating","id":"34396"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"34397"},{"source":"CD19 antagonist","target":"ulcerative colitis","id":"34398"},{"source":"CD19 antagonist","target":"thyroiditis","id":"34399"},{"source":"CD19 antagonist","target":"transitional","id":"34400"},{"source":"CD19 antagonist","target":"neuropathy","id":"34401"},{"source":"CD19 antagonist","target":"systemic scleroderma","id":"34402"},{"source":"CD19 antagonist","target":"heart failure","id":"34403"},{"source":"CD19 antagonist","target":"pneumonia","id":"34404"},{"source":"CD19 antagonist","target":"inflammatory bowel diseases","id":"34405"},{"source":"CD19 antagonist","target":"arthritis","id":"34406"},{"source":"CD19 antagonist","target":"carcinoma","id":"34407"},{"source":"CD19 antagonist","target":"myasthenia gravis","id":"34408"},{"source":"CD19 antagonist","target":"measles","id":"34409"},{"source":"CD19 antagonist","target":"anticancer","id":"34410"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"34411"},{"source":"CD19 antagonist","target":"hypopigmentation","id":"34412"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"34413"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34414"},{"source":"Immune checkpoint inhibitor","target":"human immunodeficiency virus","id":"34415"},{"source":"Immune checkpoint inhibitor","target":"deafness","id":"34416"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"34417"},{"source":"Immune checkpoint inhibitor","target":"sjogren's syndrome","id":"34418"},{"source":"Immune checkpoint inhibitor","target":"joint diseases","id":"34419"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34420"},{"source":"Immune checkpoint inhibitor","target":"hepatitis c virus","id":"34421"},{"source":"Immune checkpoint inhibitor","target":"guillain-barre syndrome","id":"34422"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"34423"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"34424"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"34425"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"34426"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"34427"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34428"},{"source":"Immune checkpoint inhibitor","target":"crohn disease","id":"34429"},{"source":"Immune checkpoint inhibitor","target":"systemic lupus erythematosus","id":"34430"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"34431"},{"source":"Immune checkpoint inhibitor","target":"stevens-johnson syndrome","id":"34432"},{"source":"Immune checkpoint inhibitor","target":"hcv","id":"34433"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"34434"},{"source":"Immune checkpoint inhibitor","target":"hearing loss","id":"34435"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"34436"},{"source":"Immune checkpoint inhibitor","target":"residual neoplasm","id":"34437"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"34438"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"34439"},{"source":"Immune checkpoint inhibitor","target":"demyelinating","id":"34440"},{"source":"Immune checkpoint inhibitor","target":"residual cancer","id":"34441"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"34442"},{"source":"Immune checkpoint inhibitor","target":"pneumonitis","id":"34443"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"34444"},{"source":"Immune checkpoint inhibitor","target":"crohn's","id":"34445"},{"source":"Immune checkpoint inhibitor","target":"multiple sclerosis","id":"34446"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34447"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"34448"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"34449"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"34450"},{"source":"Immune checkpoint inhibitor","target":"bladder tumor","id":"34451"},{"source":"Immune checkpoint inhibitor","target":"arthropathies","id":"34452"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"34453"},{"source":"Immune checkpoint inhibitor","target":"toxic epidermal necrolysis","id":"34454"},{"source":"Immune checkpoint inhibitor","target":"connective tissue diseases","id":"34455"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"34456"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"34457"},{"source":"Immune checkpoint inhibitor","target":"vitiligo","id":"34458"},{"source":"Immune checkpoint inhibitor","target":"systemic scleroderma","id":"34459"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"34460"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34461"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"34462"},{"source":"Immune checkpoint inhibitor","target":"demyelinating","id":"34463"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"34464"},{"source":"Immune checkpoint inhibitor","target":"ulcerative colitis","id":"34465"},{"source":"Immune checkpoint inhibitor","target":"thyroiditis","id":"34466"},{"source":"Immune checkpoint inhibitor","target":"transitional","id":"34467"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"34468"},{"source":"Immune checkpoint inhibitor","target":"systemic scleroderma","id":"34469"},{"source":"Immune checkpoint inhibitor","target":"heart failure","id":"34470"},{"source":"Immune checkpoint inhibitor","target":"pneumonia","id":"34471"},{"source":"Immune checkpoint inhibitor","target":"inflammatory bowel diseases","id":"34472"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"34473"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34474"},{"source":"Immune checkpoint inhibitor","target":"myasthenia gravis","id":"34475"},{"source":"Immune checkpoint inhibitor","target":"measles","id":"34476"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34477"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"34478"},{"source":"Immune checkpoint inhibitor","target":"hypopigmentation","id":"34479"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"34480"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"34481"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"34482"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"34483"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"34484"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"34485"},{"source":"CVA-21 (intratumoral) (u)","target":"(Other Cooperative Group)","id":"34486"},{"source":"CVA-21 (intratumoral) (u)","target":"Viralytics {Psiron}","id":"34487"},{"source":"ipilimumab","target":"(Other Cooperative Group)","id":"34488"},{"source":"ipilimumab","target":"Viralytics {Psiron}","id":"34489"},{"source":"UNK : Indication","target":"CVA-21 (intratumoral) (u)","id":"34490"},{"source":"UNK : Indication","target":"ipilimumab","id":"34491"},{"source":"anti-hiv","target":"CVA-21 (intratumoral) (u)","id":"34492"},{"source":"anti-hiv","target":"ipilimumab","id":"34493"},{"source":"melanoma","target":"CVA-21 (intratumoral) (u)","id":"34494"},{"source":"melanoma","target":"ipilimumab","id":"34495"},{"source":"anticancer","target":"CVA-21 (intratumoral) (u)","id":"34496"},{"source":"anticancer","target":"ipilimumab","id":"34497"},{"source":"bleeding","target":"CVA-21 (intratumoral) (u)","id":"34498"},{"source":"bleeding","target":"ipilimumab","id":"34499"},{"source":"anticancer","target":"CVA-21 (intratumoral) (u)","id":"34500"},{"source":"anticancer","target":"ipilimumab","id":"34501"},{"source":"skin neoplasms","target":"CVA-21 (intratumoral) (u)","id":"34502"},{"source":"skin neoplasms","target":"ipilimumab","id":"34503"},{"source":"residual tumor","target":"CVA-21 (intratumoral) (u)","id":"34504"},{"source":"residual tumor","target":"ipilimumab","id":"34505"},{"source":"liver metastases","target":"CVA-21 (intratumoral) (u)","id":"34506"},{"source":"liver metastases","target":"ipilimumab","id":"34507"},{"source":"anti-tumor","target":"CVA-21 (intratumoral) (u)","id":"34508"},{"source":"anti-tumor","target":"ipilimumab","id":"34509"},{"source":"metastatic","target":"CVA-21 (intratumoral) (u)","id":"34510"},{"source":"metastatic","target":"ipilimumab","id":"34511"},{"source":"carcinoma","target":"CVA-21 (intratumoral) (u)","id":"34512"},{"source":"carcinoma","target":"ipilimumab","id":"34513"},{"source":"melanoma","target":"CVA-21 (intratumoral) (u)","id":"34514"},{"source":"melanoma","target":"ipilimumab","id":"34515"},{"source":"neoplasm metastasis","target":"CVA-21 (intratumoral) (u)","id":"34516"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"34517"},{"source":"hemorrhage","target":"CVA-21 (intratumoral) (u)","id":"34518"},{"source":"hemorrhage","target":"ipilimumab","id":"34519"},{"source":"hiv infections","target":"CVA-21 (intratumoral) (u)","id":"34520"},{"source":"hiv infections","target":"ipilimumab","id":"34521"},{"source":"acquired immunodeficiency syndrome","target":"CVA-21 (intratumoral) (u)","id":"34522"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"34523"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"34524"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"34525"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"34526"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"34527"},{"source":"Anticancer immunotherapy","target":"bleeding","id":"34528"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"34529"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"34530"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"34531"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"34532"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"34533"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"34534"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34535"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"34536"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"34537"},{"source":"Anticancer immunotherapy","target":"hemorrhage","id":"34538"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"34539"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"34540"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"34541"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"34542"},{"source":"CTLA4 antagonist","target":"melanoma","id":"34543"},{"source":"CTLA4 antagonist","target":"anticancer","id":"34544"},{"source":"CTLA4 antagonist","target":"bleeding","id":"34545"},{"source":"CTLA4 antagonist","target":"anticancer","id":"34546"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"34547"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"34548"},{"source":"CTLA4 antagonist","target":"liver metastases","id":"34549"},{"source":"CTLA4 antagonist","target":"anti-tumor","id":"34550"},{"source":"CTLA4 antagonist","target":"metastatic","id":"34551"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"34552"},{"source":"CTLA4 antagonist","target":"melanoma","id":"34553"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"34554"},{"source":"CTLA4 antagonist","target":"hemorrhage","id":"34555"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"34556"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"34557"},{"source":"Apoptosis stimulant","target":"UNK : Indication","id":"34558"},{"source":"Apoptosis stimulant","target":"anti-hiv","id":"34559"},{"source":"Apoptosis stimulant","target":"melanoma","id":"34560"},{"source":"Apoptosis stimulant","target":"anticancer","id":"34561"},{"source":"Apoptosis stimulant","target":"bleeding","id":"34562"},{"source":"Apoptosis stimulant","target":"anticancer","id":"34563"},{"source":"Apoptosis stimulant","target":"skin neoplasms","id":"34564"},{"source":"Apoptosis stimulant","target":"residual tumor","id":"34565"},{"source":"Apoptosis stimulant","target":"liver metastases","id":"34566"},{"source":"Apoptosis stimulant","target":"anti-tumor","id":"34567"},{"source":"Apoptosis stimulant","target":"metastatic","id":"34568"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"34569"},{"source":"Apoptosis stimulant","target":"melanoma","id":"34570"},{"source":"Apoptosis stimulant","target":"neoplasm metastasis","id":"34571"},{"source":"Apoptosis stimulant","target":"hemorrhage","id":"34572"},{"source":"Apoptosis stimulant","target":"hiv infections","id":"34573"},{"source":"Apoptosis stimulant","target":"acquired immunodeficiency syndrome","id":"34574"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"34575"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"34576"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"34577"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34578"},{"source":"Immune checkpoint inhibitor","target":"bleeding","id":"34579"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34580"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"34581"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"34582"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"34583"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"34584"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"34585"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34586"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"34587"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"34588"},{"source":"Immune checkpoint inhibitor","target":"hemorrhage","id":"34589"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"34590"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"34591"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"34592"},{"source":"Oncology: Melanoma","target":"CTLA4 antagonist","id":"34593"},{"source":"Oncology: Melanoma","target":"Apoptosis stimulant","id":"34594"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"34595"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"34596"},{"source":"undisclosed - antiretroviral (ARV) agent (a)","target":"National Institutes of Health/National Cancer Institute","id":"34597"},{"source":"UNK : Drug","target":"National Institutes of Health/National Cancer Institute","id":"34598"},{"source":"UNK : Indication","target":"pembrolizumab","id":"34599"},{"source":"UNK : Indication","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34600"},{"source":"UNK : Indication","target":"UNK : Drug","id":"34601"},{"source":"anti-hiv","target":"pembrolizumab","id":"34602"},{"source":"anti-hiv","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34603"},{"source":"anti-hiv","target":"UNK : Drug","id":"34604"},{"source":"anticancer","target":"pembrolizumab","id":"34605"},{"source":"anticancer","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34606"},{"source":"anticancer","target":"UNK : Drug","id":"34607"},{"source":"human immunodeficiency virus","target":"pembrolizumab","id":"34608"},{"source":"human immunodeficiency virus","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34609"},{"source":"human immunodeficiency virus","target":"UNK : Drug","id":"34610"},{"source":"skin neoplasms","target":"pembrolizumab","id":"34611"},{"source":"skin neoplasms","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34612"},{"source":"skin neoplasms","target":"UNK : Drug","id":"34613"},{"source":"skin neoplasms","target":"pembrolizumab","id":"34614"},{"source":"skin neoplasms","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34615"},{"source":"skin neoplasms","target":"UNK : Drug","id":"34616"},{"source":"unknown primary","target":"pembrolizumab","id":"34617"},{"source":"unknown primary","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34618"},{"source":"unknown primary","target":"UNK : Drug","id":"34619"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"34620"},{"source":"gilbert syndrome","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34621"},{"source":"gilbert syndrome","target":"UNK : Drug","id":"34622"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"34623"},{"source":"non-small-cell lung","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34624"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"34625"},{"source":"liver transplants","target":"pembrolizumab","id":"34626"},{"source":"liver transplants","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34627"},{"source":"liver transplants","target":"UNK : Drug","id":"34628"},{"source":"aids","target":"pembrolizumab","id":"34629"},{"source":"aids","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34630"},{"source":"aids","target":"UNK : Drug","id":"34631"},{"source":"gilbert disease","target":"pembrolizumab","id":"34632"},{"source":"gilbert disease","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34633"},{"source":"gilbert disease","target":"UNK : Drug","id":"34634"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"34635"},{"source":"pancreatic cancer","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34636"},{"source":"pancreatic cancer","target":"UNK : Drug","id":"34637"},{"source":"hiv infections","target":"pembrolizumab","id":"34638"},{"source":"hiv infections","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34639"},{"source":"hiv infections","target":"UNK : Drug","id":"34640"},{"source":"hiv seropositivity","target":"pembrolizumab","id":"34641"},{"source":"hiv seropositivity","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34642"},{"source":"hiv seropositivity","target":"UNK : Drug","id":"34643"},{"source":"liver neoplasms","target":"pembrolizumab","id":"34644"},{"source":"liver neoplasms","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34645"},{"source":"liver neoplasms","target":"UNK : Drug","id":"34646"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"34647"},{"source":"head and neck neoplasms","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34648"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"34649"},{"source":"ks","target":"pembrolizumab","id":"34650"},{"source":"ks","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34651"},{"source":"ks","target":"UNK : Drug","id":"34652"},{"source":"lymphoma","target":"pembrolizumab","id":"34653"},{"source":"lymphoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34654"},{"source":"lymphoma","target":"UNK : Drug","id":"34655"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"34656"},{"source":"stem cell transplantation","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34657"},{"source":"stem cell transplantation","target":"UNK : Drug","id":"34658"},{"source":"kaposi","target":"pembrolizumab","id":"34659"},{"source":"kaposi","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34660"},{"source":"kaposi","target":"UNK : Drug","id":"34661"},{"source":"lymphoma","target":"pembrolizumab","id":"34662"},{"source":"lymphoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34663"},{"source":"lymphoma","target":"UNK : Drug","id":"34664"},{"source":"unknown primary","target":"pembrolizumab","id":"34665"},{"source":"unknown primary","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34666"},{"source":"unknown primary","target":"UNK : Drug","id":"34667"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"34668"},{"source":"acquired immunodeficiency syndrome","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34669"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"34670"},{"source":"hcc","target":"pembrolizumab","id":"34671"},{"source":"hcc","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34672"},{"source":"hcc","target":"UNK : Drug","id":"34673"},{"source":"neutropenia","target":"pembrolizumab","id":"34674"},{"source":"neutropenia","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34675"},{"source":"neutropenia","target":"UNK : Drug","id":"34676"},{"source":"carcinoma","target":"pembrolizumab","id":"34677"},{"source":"carcinoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34678"},{"source":"carcinoma","target":"UNK : Drug","id":"34679"},{"source":"stem cell transplantation","target":"pembrolizumab","id":"34680"},{"source":"stem cell transplantation","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34681"},{"source":"stem cell transplantation","target":"UNK : Drug","id":"34682"},{"source":"liver transplants","target":"pembrolizumab","id":"34683"},{"source":"liver transplants","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34684"},{"source":"liver transplants","target":"UNK : Drug","id":"34685"},{"source":"sclc","target":"pembrolizumab","id":"34686"},{"source":"sclc","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34687"},{"source":"sclc","target":"UNK : Drug","id":"34688"},{"source":"infectious disease","target":"pembrolizumab","id":"34689"},{"source":"infectious disease","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34690"},{"source":"infectious disease","target":"UNK : Drug","id":"34691"},{"source":"liver cancer","target":"pembrolizumab","id":"34692"},{"source":"liver cancer","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34693"},{"source":"liver cancer","target":"UNK : Drug","id":"34694"},{"source":"solid tumors","target":"pembrolizumab","id":"34695"},{"source":"solid tumors","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34696"},{"source":"solid tumors","target":"UNK : Drug","id":"34697"},{"source":"anti-hiv","target":"pembrolizumab","id":"34698"},{"source":"anti-hiv","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34699"},{"source":"anti-hiv","target":"UNK : Drug","id":"34700"},{"source":"alopecia","target":"pembrolizumab","id":"34701"},{"source":"alopecia","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34702"},{"source":"alopecia","target":"UNK : Drug","id":"34703"},{"source":"solid tumors","target":"pembrolizumab","id":"34704"},{"source":"solid tumors","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34705"},{"source":"solid tumors","target":"UNK : Drug","id":"34706"},{"source":"non-hodgkin","target":"pembrolizumab","id":"34707"},{"source":"non-hodgkin","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34708"},{"source":"non-hodgkin","target":"UNK : Drug","id":"34709"},{"source":"carcinoma","target":"pembrolizumab","id":"34710"},{"source":"carcinoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34711"},{"source":"carcinoma","target":"UNK : Drug","id":"34712"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"34713"},{"source":"non-small-cell lung","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34714"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"34715"},{"source":"hepatocellular","target":"pembrolizumab","id":"34716"},{"source":"hepatocellular","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34717"},{"source":"hepatocellular","target":"UNK : Drug","id":"34718"},{"source":"carcinoma","target":"pembrolizumab","id":"34719"},{"source":"carcinoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34720"},{"source":"carcinoma","target":"UNK : Drug","id":"34721"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"34722"},{"source":"neoplasm metastasis","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34723"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"34724"},{"source":"melanoma","target":"pembrolizumab","id":"34725"},{"source":"melanoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34726"},{"source":"melanoma","target":"UNK : Drug","id":"34727"},{"source":"lymphoma","target":"pembrolizumab","id":"34728"},{"source":"lymphoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34729"},{"source":"lymphoma","target":"UNK : Drug","id":"34730"},{"source":"lung neoplasms","target":"pembrolizumab","id":"34731"},{"source":"lung neoplasms","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34732"},{"source":"lung neoplasms","target":"UNK : Drug","id":"34733"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"34734"},{"source":"pancreatic neoplasms","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34735"},{"source":"pancreatic neoplasms","target":"UNK : Drug","id":"34736"},{"source":"sarcoma","target":"pembrolizumab","id":"34737"},{"source":"sarcoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34738"},{"source":"sarcoma","target":"UNK : Drug","id":"34739"},{"source":"unknown primary","target":"pembrolizumab","id":"34740"},{"source":"unknown primary","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34741"},{"source":"unknown primary","target":"UNK : Drug","id":"34742"},{"source":"neuropathy","target":"pembrolizumab","id":"34743"},{"source":"neuropathy","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34744"},{"source":"neuropathy","target":"UNK : Drug","id":"34745"},{"source":"residual tumor","target":"pembrolizumab","id":"34746"},{"source":"residual tumor","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34747"},{"source":"residual tumor","target":"UNK : Drug","id":"34748"},{"source":"lymphoma","target":"pembrolizumab","id":"34749"},{"source":"lymphoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34750"},{"source":"lymphoma","target":"UNK : Drug","id":"34751"},{"source":"skin neoplasms","target":"pembrolizumab","id":"34752"},{"source":"skin neoplasms","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34753"},{"source":"skin neoplasms","target":"UNK : Drug","id":"34754"},{"source":"residual tumor","target":"pembrolizumab","id":"34755"},{"source":"residual tumor","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34756"},{"source":"residual tumor","target":"UNK : Drug","id":"34757"},{"source":"hodgkin disease","target":"pembrolizumab","id":"34758"},{"source":"hodgkin disease","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34759"},{"source":"hodgkin disease","target":"UNK : Drug","id":"34760"},{"source":"anticancer","target":"pembrolizumab","id":"34761"},{"source":"anticancer","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34762"},{"source":"anticancer","target":"UNK : Drug","id":"34763"},{"source":"metastatic","target":"pembrolizumab","id":"34764"},{"source":"metastatic","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34765"},{"source":"metastatic","target":"UNK : Drug","id":"34766"},{"source":"sarcoma","target":"pembrolizumab","id":"34767"},{"source":"sarcoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34768"},{"source":"sarcoma","target":"UNK : Drug","id":"34769"},{"source":"anticancer","target":"pembrolizumab","id":"34770"},{"source":"anticancer","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34771"},{"source":"anticancer","target":"UNK : Drug","id":"34772"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"34773"},{"source":"urinary bladder neoplasms","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34774"},{"source":"urinary bladder neoplasms","target":"UNK : Drug","id":"34775"},{"source":"lymphoma","target":"pembrolizumab","id":"34776"},{"source":"lymphoma","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34777"},{"source":"lymphoma","target":"UNK : Drug","id":"34778"},{"source":"communicable diseases","target":"pembrolizumab","id":"34779"},{"source":"communicable diseases","target":"undisclosed - antiretroviral (ARV) agent (a)","id":"34780"},{"source":"communicable diseases","target":"UNK : Drug","id":"34781"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"34782"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"34783"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"34784"},{"source":"Anticancer immunotherapy","target":"human immunodeficiency virus","id":"34785"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"34786"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"34787"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"34788"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"34789"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"34790"},{"source":"Anticancer immunotherapy","target":"liver transplants","id":"34791"},{"source":"Anticancer immunotherapy","target":"aids","id":"34792"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"34793"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"34794"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"34795"},{"source":"Anticancer immunotherapy","target":"hiv seropositivity","id":"34796"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"34797"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"34798"},{"source":"Anticancer immunotherapy","target":"ks","id":"34799"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"34800"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"34801"},{"source":"Anticancer immunotherapy","target":"kaposi","id":"34802"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"34803"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"34804"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"34805"},{"source":"Anticancer immunotherapy","target":"hcc","id":"34806"},{"source":"Anticancer immunotherapy","target":"neutropenia","id":"34807"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34808"},{"source":"Anticancer immunotherapy","target":"stem cell transplantation","id":"34809"},{"source":"Anticancer immunotherapy","target":"liver transplants","id":"34810"},{"source":"Anticancer immunotherapy","target":"sclc","id":"34811"},{"source":"Anticancer immunotherapy","target":"infectious disease","id":"34812"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"34813"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"34814"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"34815"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"34816"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"34817"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"34818"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34819"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"34820"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"34821"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"34822"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"34823"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"34824"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"34825"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"34826"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"34827"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"34828"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"34829"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"34830"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"34831"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"34832"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"34833"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"34834"},{"source":"Anticancer immunotherapy","target":"hodgkin disease","id":"34835"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"34836"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"34837"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"34838"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"34839"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"34840"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"34841"},{"source":"Anticancer immunotherapy","target":"communicable diseases","id":"34842"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"34843"},{"source":"CD19 antagonist","target":"anti-hiv","id":"34844"},{"source":"CD19 antagonist","target":"anticancer","id":"34845"},{"source":"CD19 antagonist","target":"human immunodeficiency virus","id":"34846"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"34847"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"34848"},{"source":"CD19 antagonist","target":"unknown primary","id":"34849"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"34850"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"34851"},{"source":"CD19 antagonist","target":"liver transplants","id":"34852"},{"source":"CD19 antagonist","target":"aids","id":"34853"},{"source":"CD19 antagonist","target":"gilbert disease","id":"34854"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"34855"},{"source":"CD19 antagonist","target":"hiv infections","id":"34856"},{"source":"CD19 antagonist","target":"hiv seropositivity","id":"34857"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"34858"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"34859"},{"source":"CD19 antagonist","target":"ks","id":"34860"},{"source":"CD19 antagonist","target":"lymphoma","id":"34861"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"34862"},{"source":"CD19 antagonist","target":"kaposi","id":"34863"},{"source":"CD19 antagonist","target":"lymphoma","id":"34864"},{"source":"CD19 antagonist","target":"unknown primary","id":"34865"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"34866"},{"source":"CD19 antagonist","target":"hcc","id":"34867"},{"source":"CD19 antagonist","target":"neutropenia","id":"34868"},{"source":"CD19 antagonist","target":"carcinoma","id":"34869"},{"source":"CD19 antagonist","target":"stem cell transplantation","id":"34870"},{"source":"CD19 antagonist","target":"liver transplants","id":"34871"},{"source":"CD19 antagonist","target":"sclc","id":"34872"},{"source":"CD19 antagonist","target":"infectious disease","id":"34873"},{"source":"CD19 antagonist","target":"liver cancer","id":"34874"},{"source":"CD19 antagonist","target":"solid tumors","id":"34875"},{"source":"CD19 antagonist","target":"anti-hiv","id":"34876"},{"source":"CD19 antagonist","target":"alopecia","id":"34877"},{"source":"CD19 antagonist","target":"solid tumors","id":"34878"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"34879"},{"source":"CD19 antagonist","target":"carcinoma","id":"34880"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"34881"},{"source":"CD19 antagonist","target":"hepatocellular","id":"34882"},{"source":"CD19 antagonist","target":"carcinoma","id":"34883"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"34884"},{"source":"CD19 antagonist","target":"melanoma","id":"34885"},{"source":"CD19 antagonist","target":"lymphoma","id":"34886"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"34887"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"34888"},{"source":"CD19 antagonist","target":"sarcoma","id":"34889"},{"source":"CD19 antagonist","target":"unknown primary","id":"34890"},{"source":"CD19 antagonist","target":"neuropathy","id":"34891"},{"source":"CD19 antagonist","target":"residual tumor","id":"34892"},{"source":"CD19 antagonist","target":"lymphoma","id":"34893"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"34894"},{"source":"CD19 antagonist","target":"residual tumor","id":"34895"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"34896"},{"source":"CD19 antagonist","target":"anticancer","id":"34897"},{"source":"CD19 antagonist","target":"metastatic","id":"34898"},{"source":"CD19 antagonist","target":"sarcoma","id":"34899"},{"source":"CD19 antagonist","target":"anticancer","id":"34900"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"34901"},{"source":"CD19 antagonist","target":"lymphoma","id":"34902"},{"source":"CD19 antagonist","target":"communicable diseases","id":"34903"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"34904"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"34905"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34906"},{"source":"Immune checkpoint inhibitor","target":"human immunodeficiency virus","id":"34907"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"34908"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"34909"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"34910"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"34911"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"34912"},{"source":"Immune checkpoint inhibitor","target":"liver transplants","id":"34913"},{"source":"Immune checkpoint inhibitor","target":"aids","id":"34914"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"34915"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"34916"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"34917"},{"source":"Immune checkpoint inhibitor","target":"hiv seropositivity","id":"34918"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"34919"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"34920"},{"source":"Immune checkpoint inhibitor","target":"ks","id":"34921"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"34922"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"34923"},{"source":"Immune checkpoint inhibitor","target":"kaposi","id":"34924"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"34925"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"34926"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"34927"},{"source":"Immune checkpoint inhibitor","target":"hcc","id":"34928"},{"source":"Immune checkpoint inhibitor","target":"neutropenia","id":"34929"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34930"},{"source":"Immune checkpoint inhibitor","target":"stem cell transplantation","id":"34931"},{"source":"Immune checkpoint inhibitor","target":"liver transplants","id":"34932"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"34933"},{"source":"Immune checkpoint inhibitor","target":"infectious disease","id":"34934"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"34935"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"34936"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"34937"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"34938"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"34939"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"34940"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34941"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"34942"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"34943"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"34944"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"34945"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"34946"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"34947"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"34948"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"34949"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"34950"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"34951"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"34952"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"34953"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"34954"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"34955"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"34956"},{"source":"Immune checkpoint inhibitor","target":"hodgkin disease","id":"34957"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34958"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"34959"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"34960"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"34961"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"34962"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"34963"},{"source":"Immune checkpoint inhibitor","target":"communicable diseases","id":"34964"},{"source":"UPA","target":"UNK : Indication","id":"34965"},{"source":"UPA","target":"anti-hiv","id":"34966"},{"source":"UPA","target":"anticancer","id":"34967"},{"source":"UPA","target":"human immunodeficiency virus","id":"34968"},{"source":"UPA","target":"skin neoplasms","id":"34969"},{"source":"UPA","target":"skin neoplasms","id":"34970"},{"source":"UPA","target":"unknown primary","id":"34971"},{"source":"UPA","target":"gilbert syndrome","id":"34972"},{"source":"UPA","target":"non-small-cell lung","id":"34973"},{"source":"UPA","target":"liver transplants","id":"34974"},{"source":"UPA","target":"aids","id":"34975"},{"source":"UPA","target":"gilbert disease","id":"34976"},{"source":"UPA","target":"pancreatic cancer","id":"34977"},{"source":"UPA","target":"hiv infections","id":"34978"},{"source":"UPA","target":"hiv seropositivity","id":"34979"},{"source":"UPA","target":"liver neoplasms","id":"34980"},{"source":"UPA","target":"head and neck neoplasms","id":"34981"},{"source":"UPA","target":"ks","id":"34982"},{"source":"UPA","target":"lymphoma","id":"34983"},{"source":"UPA","target":"stem cell transplantation","id":"34984"},{"source":"UPA","target":"kaposi","id":"34985"},{"source":"UPA","target":"lymphoma","id":"34986"},{"source":"UPA","target":"unknown primary","id":"34987"},{"source":"UPA","target":"acquired immunodeficiency syndrome","id":"34988"},{"source":"UPA","target":"hcc","id":"34989"},{"source":"UPA","target":"neutropenia","id":"34990"},{"source":"UPA","target":"carcinoma","id":"34991"},{"source":"UPA","target":"stem cell transplantation","id":"34992"},{"source":"UPA","target":"liver transplants","id":"34993"},{"source":"UPA","target":"sclc","id":"34994"},{"source":"UPA","target":"infectious disease","id":"34995"},{"source":"UPA","target":"liver cancer","id":"34996"},{"source":"UPA","target":"solid tumors","id":"34997"},{"source":"UPA","target":"anti-hiv","id":"34998"},{"source":"UPA","target":"alopecia","id":"34999"},{"source":"UPA","target":"solid tumors","id":"35000"},{"source":"UPA","target":"non-hodgkin","id":"35001"},{"source":"UPA","target":"carcinoma","id":"35002"},{"source":"UPA","target":"non-small-cell lung","id":"35003"},{"source":"UPA","target":"hepatocellular","id":"35004"},{"source":"UPA","target":"carcinoma","id":"35005"},{"source":"UPA","target":"neoplasm metastasis","id":"35006"},{"source":"UPA","target":"melanoma","id":"35007"},{"source":"UPA","target":"lymphoma","id":"35008"},{"source":"UPA","target":"lung neoplasms","id":"35009"},{"source":"UPA","target":"pancreatic neoplasms","id":"35010"},{"source":"UPA","target":"sarcoma","id":"35011"},{"source":"UPA","target":"unknown primary","id":"35012"},{"source":"UPA","target":"neuropathy","id":"35013"},{"source":"UPA","target":"residual tumor","id":"35014"},{"source":"UPA","target":"lymphoma","id":"35015"},{"source":"UPA","target":"skin neoplasms","id":"35016"},{"source":"UPA","target":"residual tumor","id":"35017"},{"source":"UPA","target":"hodgkin disease","id":"35018"},{"source":"UPA","target":"anticancer","id":"35019"},{"source":"UPA","target":"metastatic","id":"35020"},{"source":"UPA","target":"sarcoma","id":"35021"},{"source":"UPA","target":"anticancer","id":"35022"},{"source":"UPA","target":"urinary bladder neoplasms","id":"35023"},{"source":"UPA","target":"lymphoma","id":"35024"},{"source":"UPA","target":"communicable diseases","id":"35025"},{"source":"Infectious Disease: HPV","target":"Anticancer immunotherapy","id":"35026"},{"source":"Infectious Disease: HPV","target":"CD19 antagonist","id":"35027"},{"source":"Infectious Disease: HPV","target":"Immune checkpoint inhibitor","id":"35028"},{"source":"Infectious Disease: HPV","target":"UPA","id":"35029"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"35030"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"35031"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"35032"},{"source":"Oncology: (N/A)","target":"UPA","id":"35033"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"35034"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"35035"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"35036"},{"source":"Oncology: Bladder","target":"UPA","id":"35037"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"35038"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"35039"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"35040"},{"source":"Oncology: Head/Neck","target":"UPA","id":"35041"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"35042"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"35043"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"35044"},{"source":"Oncology: Liver","target":"UPA","id":"35045"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"35046"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"35047"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"35048"},{"source":"Oncology: Lung","target":"UPA","id":"35049"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"35050"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"35051"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"35052"},{"source":"Non-Small Cell","target":"UPA","id":"35053"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"35054"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"35055"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"35056"},{"source":"Oncology: Lymphoma","target":"UPA","id":"35057"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"35058"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"35059"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"35060"},{"source":"Hodgkin's","target":"UPA","id":"35061"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"35062"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"35063"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"35064"},{"source":"Oncology: Lymphoma","target":"UPA","id":"35065"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"35066"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"35067"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"35068"},{"source":"Hodgkin's","target":"UPA","id":"35069"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"35070"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"35071"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"35072"},{"source":"Oncology: Melanoma","target":"UPA","id":"35073"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"35074"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"35075"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"35076"},{"source":"Oncology: Pancreas","target":"UPA","id":"35077"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"35078"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"35079"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"35080"},{"source":"Oncology: CNS","target":"UPA","id":"35081"},{"source":"guadecitabine (u)","target":"Merck & Co.","id":"35082"},{"source":"guadecitabine (u)","target":"National Institutes of Health/National Cancer Institute","id":"35083"},{"source":"guadecitabine (u)","target":"Northwestern University","id":"35084"},{"source":"guadecitabine (u)","target":"X4 Pharmaceuticals","id":"35085"},{"source":"pembrolizumab","target":"Merck & Co.","id":"35086"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"35087"},{"source":"pembrolizumab","target":"Northwestern University","id":"35088"},{"source":"pembrolizumab","target":"X4 Pharmaceuticals","id":"35089"},{"source":"UNK : Indication","target":"guadecitabine (u)","id":"35090"},{"source":"UNK : Indication","target":"pembrolizumab","id":"35091"},{"source":"residual tumor","target":"guadecitabine (u)","id":"35092"},{"source":"residual tumor","target":"pembrolizumab","id":"35093"},{"source":"solid tumors","target":"guadecitabine (u)","id":"35094"},{"source":"solid tumors","target":"pembrolizumab","id":"35095"},{"source":"pleural effusion","target":"guadecitabine (u)","id":"35096"},{"source":"pleural effusion","target":"pembrolizumab","id":"35097"},{"source":"anticancer","target":"guadecitabine (u)","id":"35098"},{"source":"anticancer","target":"pembrolizumab","id":"35099"},{"source":"ovarian cancer","target":"guadecitabine (u)","id":"35100"},{"source":"ovarian cancer","target":"pembrolizumab","id":"35101"},{"source":"ovarian cancer","target":"guadecitabine (u)","id":"35102"},{"source":"ovarian cancer","target":"pembrolizumab","id":"35103"},{"source":"liver metastases","target":"guadecitabine (u)","id":"35104"},{"source":"liver metastases","target":"pembrolizumab","id":"35105"},{"source":"liver neoplasms","target":"guadecitabine (u)","id":"35106"},{"source":"liver neoplasms","target":"pembrolizumab","id":"35107"},{"source":"fallopian tube cancer","target":"guadecitabine (u)","id":"35108"},{"source":"fallopian tube cancer","target":"pembrolizumab","id":"35109"},{"source":"carcinoma","target":"guadecitabine (u)","id":"35110"},{"source":"carcinoma","target":"pembrolizumab","id":"35111"},{"source":"fallopian tube neoplasms","target":"guadecitabine (u)","id":"35112"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"35113"},{"source":"thoracentesis","target":"guadecitabine (u)","id":"35114"},{"source":"thoracentesis","target":"pembrolizumab","id":"35115"},{"source":"carcinoma","target":"guadecitabine (u)","id":"35116"},{"source":"carcinoma","target":"pembrolizumab","id":"35117"},{"source":"metastatic","target":"guadecitabine (u)","id":"35118"},{"source":"metastatic","target":"pembrolizumab","id":"35119"},{"source":"anticancer","target":"guadecitabine (u)","id":"35120"},{"source":"anticancer","target":"pembrolizumab","id":"35121"},{"source":"ovarian neoplasms","target":"guadecitabine (u)","id":"35122"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"35123"},{"source":"ovarian cancer","target":"guadecitabine (u)","id":"35124"},{"source":"ovarian cancer","target":"pembrolizumab","id":"35125"},{"source":"solid tumors","target":"guadecitabine (u)","id":"35126"},{"source":"solid tumors","target":"pembrolizumab","id":"35127"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"35128"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"35129"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"35130"},{"source":"Anticancer immunotherapy","target":"pleural effusion","id":"35131"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"35132"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"35133"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"35134"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"35135"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"35136"},{"source":"Anticancer immunotherapy","target":"fallopian tube cancer","id":"35137"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"35138"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"35139"},{"source":"Anticancer immunotherapy","target":"thoracentesis","id":"35140"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"35141"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"35142"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"35143"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"35144"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"35145"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"35146"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"35147"},{"source":"CD19 antagonist","target":"residual tumor","id":"35148"},{"source":"CD19 antagonist","target":"solid tumors","id":"35149"},{"source":"CD19 antagonist","target":"pleural effusion","id":"35150"},{"source":"CD19 antagonist","target":"anticancer","id":"35151"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"35152"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"35153"},{"source":"CD19 antagonist","target":"liver metastases","id":"35154"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"35155"},{"source":"CD19 antagonist","target":"fallopian tube cancer","id":"35156"},{"source":"CD19 antagonist","target":"carcinoma","id":"35157"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"35158"},{"source":"CD19 antagonist","target":"thoracentesis","id":"35159"},{"source":"CD19 antagonist","target":"carcinoma","id":"35160"},{"source":"CD19 antagonist","target":"metastatic","id":"35161"},{"source":"CD19 antagonist","target":"anticancer","id":"35162"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"35163"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"35164"},{"source":"CD19 antagonist","target":"solid tumors","id":"35165"},{"source":"NA","target":"UNK : Indication","id":"35166"},{"source":"NA","target":"residual tumor","id":"35167"},{"source":"NA","target":"solid tumors","id":"35168"},{"source":"NA","target":"pleural effusion","id":"35169"},{"source":"NA","target":"anticancer","id":"35170"},{"source":"NA","target":"ovarian cancer","id":"35171"},{"source":"NA","target":"ovarian cancer","id":"35172"},{"source":"NA","target":"liver metastases","id":"35173"},{"source":"NA","target":"liver neoplasms","id":"35174"},{"source":"NA","target":"fallopian tube cancer","id":"35175"},{"source":"NA","target":"carcinoma","id":"35176"},{"source":"NA","target":"fallopian tube neoplasms","id":"35177"},{"source":"NA","target":"thoracentesis","id":"35178"},{"source":"NA","target":"carcinoma","id":"35179"},{"source":"NA","target":"metastatic","id":"35180"},{"source":"NA","target":"anticancer","id":"35181"},{"source":"NA","target":"ovarian neoplasms","id":"35182"},{"source":"NA","target":"ovarian cancer","id":"35183"},{"source":"NA","target":"solid tumors","id":"35184"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"35185"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"35186"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"35187"},{"source":"Immune checkpoint inhibitor","target":"pleural effusion","id":"35188"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"35189"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"35190"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"35191"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"35192"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"35193"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube cancer","id":"35194"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"35195"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"35196"},{"source":"Immune checkpoint inhibitor","target":"thoracentesis","id":"35197"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"35198"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"35199"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"35200"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"35201"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"35202"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"35203"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"35204"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"35205"},{"source":"Oncology: (N/A)","target":"NA","id":"35206"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"35207"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"35208"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"35209"},{"source":"Oncology: Ovarian","target":"NA","id":"35210"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"35211"},{"source":"4SC-202 (u)","target":"4SC","id":"35212"},{"source":"pembrolizumab","target":"4SC","id":"35213"},{"source":"UNK : Indication","target":"4SC-202 (u)","id":"35214"},{"source":"UNK : Indication","target":"pembrolizumab","id":"35215"},{"source":"metastatic","target":"4SC-202 (u)","id":"35216"},{"source":"metastatic","target":"pembrolizumab","id":"35217"},{"source":"solid tumors","target":"4SC-202 (u)","id":"35218"},{"source":"solid tumors","target":"pembrolizumab","id":"35219"},{"source":"melanoma","target":"4SC-202 (u)","id":"35220"},{"source":"melanoma","target":"pembrolizumab","id":"35221"},{"source":"anticancer","target":"4SC-202 (u)","id":"35222"},{"source":"anticancer","target":"pembrolizumab","id":"35223"},{"source":"liver metastases","target":"4SC-202 (u)","id":"35224"},{"source":"liver metastases","target":"pembrolizumab","id":"35225"},{"source":"inflamed","target":"4SC-202 (u)","id":"35226"},{"source":"inflamed","target":"pembrolizumab","id":"35227"},{"source":"skin neoplasms","target":"4SC-202 (u)","id":"35228"},{"source":"skin neoplasms","target":"pembrolizumab","id":"35229"},{"source":"residual tumor","target":"4SC-202 (u)","id":"35230"},{"source":"residual tumor","target":"pembrolizumab","id":"35231"},{"source":"metastatic","target":"4SC-202 (u)","id":"35232"},{"source":"metastatic","target":"pembrolizumab","id":"35233"},{"source":"carcinoma","target":"4SC-202 (u)","id":"35234"},{"source":"carcinoma","target":"pembrolizumab","id":"35235"},{"source":"inflammation","target":"4SC-202 (u)","id":"35236"},{"source":"inflammation","target":"pembrolizumab","id":"35237"},{"source":"neoplasm metastasis","target":"4SC-202 (u)","id":"35238"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"35239"},{"source":"anticancer","target":"4SC-202 (u)","id":"35240"},{"source":"anticancer","target":"pembrolizumab","id":"35241"},{"source":"solid tumors","target":"4SC-202 (u)","id":"35242"},{"source":"solid tumors","target":"pembrolizumab","id":"35243"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"35244"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"35245"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"35246"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"35247"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"35248"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"35249"},{"source":"Anticancer immunotherapy","target":"inflamed","id":"35250"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"35251"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"35252"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"35253"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"35254"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"35255"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"35256"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"35257"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"35258"},{"source":"Histone deacetylase inhibitor","target":"UNK : Indication","id":"35259"},{"source":"Histone deacetylase inhibitor","target":"metastatic","id":"35260"},{"source":"Histone deacetylase inhibitor","target":"solid tumors","id":"35261"},{"source":"Histone deacetylase inhibitor","target":"melanoma","id":"35262"},{"source":"Histone deacetylase inhibitor","target":"anticancer","id":"35263"},{"source":"Histone deacetylase inhibitor","target":"liver metastases","id":"35264"},{"source":"Histone deacetylase inhibitor","target":"inflamed","id":"35265"},{"source":"Histone deacetylase inhibitor","target":"skin neoplasms","id":"35266"},{"source":"Histone deacetylase inhibitor","target":"residual tumor","id":"35267"},{"source":"Histone deacetylase inhibitor","target":"metastatic","id":"35268"},{"source":"Histone deacetylase inhibitor","target":"carcinoma","id":"35269"},{"source":"Histone deacetylase inhibitor","target":"inflammation","id":"35270"},{"source":"Histone deacetylase inhibitor","target":"neoplasm metastasis","id":"35271"},{"source":"Histone deacetylase inhibitor","target":"anticancer","id":"35272"},{"source":"Histone deacetylase inhibitor","target":"solid tumors","id":"35273"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"35274"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"35275"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"35276"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"35277"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"35278"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"35279"},{"source":"Immune checkpoint inhibitor","target":"inflamed","id":"35280"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"35281"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"35282"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"35283"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"35284"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"35285"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"35286"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"35287"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"35288"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"UNK : Indication","id":"35289"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"metastatic","id":"35290"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"solid tumors","id":"35291"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"melanoma","id":"35292"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"anticancer","id":"35293"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"liver metastases","id":"35294"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"inflamed","id":"35295"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"skin neoplasms","id":"35296"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"residual tumor","id":"35297"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"metastatic","id":"35298"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"carcinoma","id":"35299"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"inflammation","id":"35300"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"neoplasm metastasis","id":"35301"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"anticancer","id":"35302"},{"source":"Lysine (K)-specific demethylase 1A inhibitor","target":"solid tumors","id":"35303"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"35304"},{"source":"CD19 antagonist","target":"metastatic","id":"35305"},{"source":"CD19 antagonist","target":"solid tumors","id":"35306"},{"source":"CD19 antagonist","target":"melanoma","id":"35307"},{"source":"CD19 antagonist","target":"anticancer","id":"35308"},{"source":"CD19 antagonist","target":"liver metastases","id":"35309"},{"source":"CD19 antagonist","target":"inflamed","id":"35310"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"35311"},{"source":"CD19 antagonist","target":"residual tumor","id":"35312"},{"source":"CD19 antagonist","target":"metastatic","id":"35313"},{"source":"CD19 antagonist","target":"carcinoma","id":"35314"},{"source":"CD19 antagonist","target":"inflammation","id":"35315"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"35316"},{"source":"CD19 antagonist","target":"anticancer","id":"35317"},{"source":"CD19 antagonist","target":"solid tumors","id":"35318"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"35319"},{"source":"Oncology: Melanoma","target":"Histone deacetylase inhibitor","id":"35320"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"35321"},{"source":"Oncology: Melanoma","target":"Lysine (K)-specific demethylase 1A inhibitor","id":"35322"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"35323"},{"source":"abemaciclib (capsule) (a)","target":"Eli Lilly","id":"35324"},{"source":"abemaciclib (capsule) (a)","target":"Merck & Co.","id":"35325"},{"source":"pembrolizumab","target":"Eli Lilly","id":"35326"},{"source":"pembrolizumab","target":"Merck & Co.","id":"35327"},{"source":"UNK : Drug","target":"Eli Lilly","id":"35328"},{"source":"UNK : Drug","target":"Merck & Co.","id":"35329"},{"source":"UNK : Indication","target":"abemaciclib (capsule) (a)","id":"35330"},{"source":"UNK : Indication","target":"pembrolizumab","id":"35331"},{"source":"UNK : Indication","target":"UNK : Drug","id":"35332"},{"source":"residual tumor","target":"abemaciclib (capsule) (a)","id":"35333"},{"source":"residual tumor","target":"pembrolizumab","id":"35334"},{"source":"residual tumor","target":"UNK : Drug","id":"35335"},{"source":"solid tumors","target":"abemaciclib (capsule) (a)","id":"35336"},{"source":"solid tumors","target":"pembrolizumab","id":"35337"},{"source":"solid tumors","target":"UNK : Drug","id":"35338"},{"source":"anticancer","target":"abemaciclib (capsule) (a)","id":"35339"},{"source":"anticancer","target":"pembrolizumab","id":"35340"},{"source":"anticancer","target":"UNK : Drug","id":"35341"},{"source":"triple-negative breast cancer","target":"abemaciclib (capsule) (a)","id":"35342"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"35343"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"35344"},{"source":"non-small-cell lung","target":"abemaciclib (capsule) (a)","id":"35345"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"35346"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"35347"},{"source":"carcinoma","target":"abemaciclib (capsule) (a)","id":"35348"},{"source":"carcinoma","target":"pembrolizumab","id":"35349"},{"source":"carcinoma","target":"UNK : Drug","id":"35350"},{"source":"breast neoplasms","target":"abemaciclib (capsule) (a)","id":"35351"},{"source":"breast neoplasms","target":"pembrolizumab","id":"35352"},{"source":"breast neoplasms","target":"UNK : Drug","id":"35353"},{"source":"metastatic","target":"abemaciclib (capsule) (a)","id":"35354"},{"source":"metastatic","target":"pembrolizumab","id":"35355"},{"source":"metastatic","target":"UNK : Drug","id":"35356"},{"source":"carcinoma","target":"abemaciclib (capsule) (a)","id":"35357"},{"source":"carcinoma","target":"pembrolizumab","id":"35358"},{"source":"carcinoma","target":"UNK : Drug","id":"35359"},{"source":"non-small-cell lung","target":"abemaciclib (capsule) (a)","id":"35360"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"35361"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"35362"},{"source":"neoplasm metastasis","target":"abemaciclib (capsule) (a)","id":"35363"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"35364"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"35365"},{"source":"sarcoma","target":"abemaciclib (capsule) (a)","id":"35366"},{"source":"sarcoma","target":"pembrolizumab","id":"35367"},{"source":"sarcoma","target":"UNK : Drug","id":"35368"},{"source":"anticancer","target":"abemaciclib (capsule) (a)","id":"35369"},{"source":"anticancer","target":"pembrolizumab","id":"35370"},{"source":"anticancer","target":"UNK : Drug","id":"35371"},{"source":"lung neoplasms","target":"abemaciclib (capsule) (a)","id":"35372"},{"source":"lung neoplasms","target":"pembrolizumab","id":"35373"},{"source":"lung neoplasms","target":"UNK : Drug","id":"35374"},{"source":"sclc","target":"abemaciclib (capsule) (a)","id":"35375"},{"source":"sclc","target":"pembrolizumab","id":"35376"},{"source":"sclc","target":"UNK : Drug","id":"35377"},{"source":"solid tumors","target":"abemaciclib (capsule) (a)","id":"35378"},{"source":"solid tumors","target":"pembrolizumab","id":"35379"},{"source":"solid tumors","target":"UNK : Drug","id":"35380"},{"source":"NA","target":"UNK : Indication","id":"35381"},{"source":"NA","target":"residual tumor","id":"35382"},{"source":"NA","target":"solid tumors","id":"35383"},{"source":"NA","target":"anticancer","id":"35384"},{"source":"NA","target":"triple-negative breast cancer","id":"35385"},{"source":"NA","target":"non-small-cell lung","id":"35386"},{"source":"NA","target":"carcinoma","id":"35387"},{"source":"NA","target":"breast neoplasms","id":"35388"},{"source":"NA","target":"metastatic","id":"35389"},{"source":"NA","target":"carcinoma","id":"35390"},{"source":"NA","target":"non-small-cell lung","id":"35391"},{"source":"NA","target":"neoplasm metastasis","id":"35392"},{"source":"NA","target":"sarcoma","id":"35393"},{"source":"NA","target":"anticancer","id":"35394"},{"source":"NA","target":"lung neoplasms","id":"35395"},{"source":"NA","target":"sclc","id":"35396"},{"source":"NA","target":"solid tumors","id":"35397"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"35398"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"35399"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"35400"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"35401"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"35402"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"35403"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"35404"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"35405"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"35406"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"35407"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"35408"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"35409"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"35410"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"35411"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"35412"},{"source":"Anticancer immunotherapy","target":"sclc","id":"35413"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"35414"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"35415"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"35416"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"35417"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"35418"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"35419"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"35420"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"35421"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"35422"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"35423"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"35424"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"35425"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"35426"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"35427"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"35428"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"35429"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"35430"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"35431"},{"source":"NA","target":"UNK : Indication","id":"35432"},{"source":"NA","target":"residual tumor","id":"35433"},{"source":"NA","target":"solid tumors","id":"35434"},{"source":"NA","target":"anticancer","id":"35435"},{"source":"NA","target":"triple-negative breast cancer","id":"35436"},{"source":"NA","target":"non-small-cell lung","id":"35437"},{"source":"NA","target":"carcinoma","id":"35438"},{"source":"NA","target":"breast neoplasms","id":"35439"},{"source":"NA","target":"metastatic","id":"35440"},{"source":"NA","target":"carcinoma","id":"35441"},{"source":"NA","target":"non-small-cell lung","id":"35442"},{"source":"NA","target":"neoplasm metastasis","id":"35443"},{"source":"NA","target":"sarcoma","id":"35444"},{"source":"NA","target":"anticancer","id":"35445"},{"source":"NA","target":"lung neoplasms","id":"35446"},{"source":"NA","target":"sclc","id":"35447"},{"source":"NA","target":"solid tumors","id":"35448"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"35449"},{"source":"CD19 antagonist","target":"residual tumor","id":"35450"},{"source":"CD19 antagonist","target":"solid tumors","id":"35451"},{"source":"CD19 antagonist","target":"anticancer","id":"35452"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"35453"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"35454"},{"source":"CD19 antagonist","target":"carcinoma","id":"35455"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"35456"},{"source":"CD19 antagonist","target":"metastatic","id":"35457"},{"source":"CD19 antagonist","target":"carcinoma","id":"35458"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"35459"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"35460"},{"source":"CD19 antagonist","target":"sarcoma","id":"35461"},{"source":"CD19 antagonist","target":"anticancer","id":"35462"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"35463"},{"source":"CD19 antagonist","target":"sclc","id":"35464"},{"source":"CD19 antagonist","target":"solid tumors","id":"35465"},{"source":"Oncology: Breast","target":"NA","id":"35466"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"35467"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"35468"},{"source":"Oncology: Breast","target":"NA","id":"35469"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"35470"},{"source":"Oncology: Lung","target":"NA","id":"35471"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"35472"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"35473"},{"source":"Oncology: Lung","target":"NA","id":"35474"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"35475"},{"source":"Non-Small Cell","target":"NA","id":"35476"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"35477"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"35478"},{"source":"Non-Small Cell","target":"NA","id":"35479"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"35480"},{"source":"cetuximab","target":"National Institutes of Health/National Cancer Institute","id":"35481"},{"source":"cetuximab","target":"Roswell Park Cancer Institute","id":"35482"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"35483"},{"source":"pembrolizumab","target":"Roswell Park Cancer Institute","id":"35484"},{"source":"UNK : Drug","target":"National Institutes of Health/National Cancer Institute","id":"35485"},{"source":"UNK : Drug","target":"Roswell Park Cancer Institute","id":"35486"},{"source":"UNK : Indication","target":"cetuximab","id":"35487"},{"source":"UNK : Indication","target":"pembrolizumab","id":"35488"},{"source":"UNK : Indication","target":"UNK : Drug","id":"35489"},{"source":"metastatic","target":"cetuximab","id":"35490"},{"source":"metastatic","target":"pembrolizumab","id":"35491"},{"source":"metastatic","target":"UNK : Drug","id":"35492"},{"source":"colorectal neoplasms","target":"cetuximab","id":"35493"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"35494"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"35495"},{"source":"solid tumors","target":"cetuximab","id":"35496"},{"source":"solid tumors","target":"pembrolizumab","id":"35497"},{"source":"solid tumors","target":"UNK : Drug","id":"35498"},{"source":"colorectal cancer","target":"cetuximab","id":"35499"},{"source":"colorectal cancer","target":"pembrolizumab","id":"35500"},{"source":"colorectal cancer","target":"UNK : Drug","id":"35501"},{"source":"neuroblastoma","target":"cetuximab","id":"35502"},{"source":"neuroblastoma","target":"pembrolizumab","id":"35503"},{"source":"neuroblastoma","target":"UNK : Drug","id":"35504"},{"source":"liver metastases","target":"cetuximab","id":"35505"},{"source":"liver metastases","target":"pembrolizumab","id":"35506"},{"source":"liver metastases","target":"UNK : Drug","id":"35507"},{"source":"residual tumor","target":"cetuximab","id":"35508"},{"source":"residual tumor","target":"pembrolizumab","id":"35509"},{"source":"residual tumor","target":"UNK : Drug","id":"35510"},{"source":"colonic neoplasms","target":"cetuximab","id":"35511"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"35512"},{"source":"colonic neoplasms","target":"UNK : Drug","id":"35513"},{"source":"metastatic","target":"cetuximab","id":"35514"},{"source":"metastatic","target":"pembrolizumab","id":"35515"},{"source":"metastatic","target":"UNK : Drug","id":"35516"},{"source":"carcinoma","target":"cetuximab","id":"35517"},{"source":"carcinoma","target":"pembrolizumab","id":"35518"},{"source":"carcinoma","target":"UNK : Drug","id":"35519"},{"source":"neoplasm metastasis","target":"cetuximab","id":"35520"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"35521"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"35522"},{"source":"sarcoma","target":"cetuximab","id":"35523"},{"source":"sarcoma","target":"pembrolizumab","id":"35524"},{"source":"sarcoma","target":"UNK : Drug","id":"35525"},{"source":"anticancer","target":"cetuximab","id":"35526"},{"source":"anticancer","target":"pembrolizumab","id":"35527"},{"source":"anticancer","target":"UNK : Drug","id":"35528"},{"source":"colorectal neoplasms","target":"cetuximab","id":"35529"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"35530"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"35531"},{"source":"liver neoplasms","target":"cetuximab","id":"35532"},{"source":"liver neoplasms","target":"pembrolizumab","id":"35533"},{"source":"liver neoplasms","target":"UNK : Drug","id":"35534"},{"source":"solid tumors","target":"cetuximab","id":"35535"},{"source":"solid tumors","target":"pembrolizumab","id":"35536"},{"source":"solid tumors","target":"UNK : Drug","id":"35537"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"35538"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"35539"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"35540"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"35541"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"35542"},{"source":"Anticancer immunotherapy","target":"neuroblastoma","id":"35543"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"35544"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"35545"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"35546"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"35547"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"35548"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"35549"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"35550"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"35551"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"35552"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"35553"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"35554"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"35555"},{"source":"CD19 antagonist","target":"metastatic","id":"35556"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"35557"},{"source":"CD19 antagonist","target":"solid tumors","id":"35558"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"35559"},{"source":"CD19 antagonist","target":"neuroblastoma","id":"35560"},{"source":"CD19 antagonist","target":"liver metastases","id":"35561"},{"source":"CD19 antagonist","target":"residual tumor","id":"35562"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"35563"},{"source":"CD19 antagonist","target":"metastatic","id":"35564"},{"source":"CD19 antagonist","target":"carcinoma","id":"35565"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"35566"},{"source":"CD19 antagonist","target":"sarcoma","id":"35567"},{"source":"CD19 antagonist","target":"anticancer","id":"35568"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"35569"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"35570"},{"source":"CD19 antagonist","target":"solid tumors","id":"35571"},{"source":"EGFR antagonist","target":"UNK : Indication","id":"35572"},{"source":"EGFR antagonist","target":"metastatic","id":"35573"},{"source":"EGFR antagonist","target":"colorectal neoplasms","id":"35574"},{"source":"EGFR antagonist","target":"solid tumors","id":"35575"},{"source":"EGFR antagonist","target":"colorectal cancer","id":"35576"},{"source":"EGFR antagonist","target":"neuroblastoma","id":"35577"},{"source":"EGFR antagonist","target":"liver metastases","id":"35578"},{"source":"EGFR antagonist","target":"residual tumor","id":"35579"},{"source":"EGFR antagonist","target":"colonic neoplasms","id":"35580"},{"source":"EGFR antagonist","target":"metastatic","id":"35581"},{"source":"EGFR antagonist","target":"carcinoma","id":"35582"},{"source":"EGFR antagonist","target":"neoplasm metastasis","id":"35583"},{"source":"EGFR antagonist","target":"sarcoma","id":"35584"},{"source":"EGFR antagonist","target":"anticancer","id":"35585"},{"source":"EGFR antagonist","target":"colorectal neoplasms","id":"35586"},{"source":"EGFR antagonist","target":"liver neoplasms","id":"35587"},{"source":"EGFR antagonist","target":"solid tumors","id":"35588"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"35589"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"35590"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"35591"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"35592"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"35593"},{"source":"Immune checkpoint inhibitor","target":"neuroblastoma","id":"35594"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"35595"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"35596"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"35597"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"35598"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"35599"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"35600"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"35601"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"35602"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"35603"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"35604"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"35605"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"35606"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"35607"},{"source":"Oncology: Colorectal","target":"EGFR antagonist","id":"35608"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"35609"},{"source":"PVX-410 (u)","target":"Massachusetts General Hospital","id":"35610"},{"source":"PVX-410 (u)","target":"Merck & Co.","id":"35611"},{"source":"Montanide","target":"Massachusetts General Hospital","id":"35612"},{"source":"Montanide","target":"Merck & Co.","id":"35613"},{"source":"pembrolizumab","target":"Massachusetts General Hospital","id":"35614"},{"source":"pembrolizumab","target":"Merck & Co.","id":"35615"},{"source":"poly-ICLC","target":"Massachusetts General Hospital","id":"35616"},{"source":"poly-ICLC","target":"Merck & Co.","id":"35617"},{"source":"Oncovir","target":"Massachusetts General Hospital","id":"35618"},{"source":"Oncovir","target":"Merck & Co.","id":"35619"},{"source":"UNK : Indication","target":"PVX-410 (u)","id":"35620"},{"source":"UNK : Indication","target":"Montanide","id":"35621"},{"source":"UNK : Indication","target":"pembrolizumab","id":"35622"},{"source":"UNK : Indication","target":"poly-ICLC","id":"35623"},{"source":"UNK : Indication","target":"Oncovir","id":"35624"},{"source":"metaplasia","target":"PVX-410 (u)","id":"35625"},{"source":"metaplasia","target":"Montanide","id":"35626"},{"source":"metaplasia","target":"pembrolizumab","id":"35627"},{"source":"metaplasia","target":"poly-ICLC","id":"35628"},{"source":"metaplasia","target":"Oncovir","id":"35629"},{"source":"chronic hepatitis b","target":"PVX-410 (u)","id":"35630"},{"source":"chronic hepatitis b","target":"Montanide","id":"35631"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"35632"},{"source":"chronic hepatitis b","target":"poly-ICLC","id":"35633"},{"source":"chronic hepatitis b","target":"Oncovir","id":"35634"},{"source":"human immunodeficiency virus","target":"PVX-410 (u)","id":"35635"},{"source":"human immunodeficiency virus","target":"Montanide","id":"35636"},{"source":"human immunodeficiency virus","target":"pembrolizumab","id":"35637"},{"source":"human immunodeficiency virus","target":"poly-ICLC","id":"35638"},{"source":"human immunodeficiency virus","target":"Oncovir","id":"35639"},{"source":"hepatitis c virus","target":"PVX-410 (u)","id":"35640"},{"source":"hepatitis c virus","target":"Montanide","id":"35641"},{"source":"hepatitis c virus","target":"pembrolizumab","id":"35642"},{"source":"hepatitis c virus","target":"poly-ICLC","id":"35643"},{"source":"hepatitis c virus","target":"Oncovir","id":"35644"},{"source":"breast neoplasms","target":"PVX-410 (u)","id":"35645"},{"source":"breast neoplasms","target":"Montanide","id":"35646"},{"source":"breast neoplasms","target":"pembrolizumab","id":"35647"},{"source":"breast neoplasms","target":"poly-ICLC","id":"35648"},{"source":"breast neoplasms","target":"Oncovir","id":"35649"},{"source":"chronic hepatitis b","target":"PVX-410 (u)","id":"35650"},{"source":"chronic hepatitis b","target":"Montanide","id":"35651"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"35652"},{"source":"chronic hepatitis b","target":"poly-ICLC","id":"35653"},{"source":"chronic hepatitis b","target":"Oncovir","id":"35654"},{"source":"hiv infections","target":"PVX-410 (u)","id":"35655"},{"source":"hiv infections","target":"Montanide","id":"35656"},{"source":"hiv infections","target":"pembrolizumab","id":"35657"},{"source":"hiv infections","target":"poly-ICLC","id":"35658"},{"source":"hiv infections","target":"Oncovir","id":"35659"},{"source":"acquired immunodeficiency syndrome","target":"PVX-410 (u)","id":"35660"},{"source":"acquired immunodeficiency syndrome","target":"Montanide","id":"35661"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"35662"},{"source":"acquired immunodeficiency syndrome","target":"poly-ICLC","id":"35663"},{"source":"acquired immunodeficiency syndrome","target":"Oncovir","id":"35664"},{"source":"hcv","target":"PVX-410 (u)","id":"35665"},{"source":"hcv","target":"Montanide","id":"35666"},{"source":"hcv","target":"pembrolizumab","id":"35667"},{"source":"hcv","target":"poly-ICLC","id":"35668"},{"source":"hcv","target":"Oncovir","id":"35669"},{"source":"liver neoplasms","target":"PVX-410 (u)","id":"35670"},{"source":"liver neoplasms","target":"Montanide","id":"35671"},{"source":"liver neoplasms","target":"pembrolizumab","id":"35672"},{"source":"liver neoplasms","target":"poly-ICLC","id":"35673"},{"source":"liver neoplasms","target":"Oncovir","id":"35674"},{"source":"breast neoplasms","target":"PVX-410 (u)","id":"35675"},{"source":"breast neoplasms","target":"Montanide","id":"35676"},{"source":"breast neoplasms","target":"pembrolizumab","id":"35677"},{"source":"breast neoplasms","target":"poly-ICLC","id":"35678"},{"source":"breast neoplasms","target":"Oncovir","id":"35679"},{"source":"liver metastases","target":"PVX-410 (u)","id":"35680"},{"source":"liver metastases","target":"Montanide","id":"35681"},{"source":"liver metastases","target":"pembrolizumab","id":"35682"},{"source":"liver metastases","target":"poly-ICLC","id":"35683"},{"source":"liver metastases","target":"Oncovir","id":"35684"},{"source":"tnbc","target":"PVX-410 (u)","id":"35685"},{"source":"tnbc","target":"Montanide","id":"35686"},{"source":"tnbc","target":"pembrolizumab","id":"35687"},{"source":"tnbc","target":"poly-ICLC","id":"35688"},{"source":"tnbc","target":"Oncovir","id":"35689"},{"source":"triple-negative breast cancer","target":"PVX-410 (u)","id":"35690"},{"source":"triple-negative breast cancer","target":"Montanide","id":"35691"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"35692"},{"source":"triple-negative breast cancer","target":"poly-ICLC","id":"35693"},{"source":"triple-negative breast cancer","target":"Oncovir","id":"35694"},{"source":"anti-hiv","target":"PVX-410 (u)","id":"35695"},{"source":"anti-hiv","target":"Montanide","id":"35696"},{"source":"anti-hiv","target":"pembrolizumab","id":"35697"},{"source":"anti-hiv","target":"poly-ICLC","id":"35698"},{"source":"anti-hiv","target":"Oncovir","id":"35699"},{"source":"metastatic","target":"PVX-410 (u)","id":"35700"},{"source":"metastatic","target":"Montanide","id":"35701"},{"source":"metastatic","target":"pembrolizumab","id":"35702"},{"source":"metastatic","target":"poly-ICLC","id":"35703"},{"source":"metastatic","target":"Oncovir","id":"35704"},{"source":"carcinoma","target":"PVX-410 (u)","id":"35705"},{"source":"carcinoma","target":"Montanide","id":"35706"},{"source":"carcinoma","target":"pembrolizumab","id":"35707"},{"source":"carcinoma","target":"poly-ICLC","id":"35708"},{"source":"carcinoma","target":"Oncovir","id":"35709"},{"source":"neoplasm metastasis","target":"PVX-410 (u)","id":"35710"},{"source":"neoplasm metastasis","target":"Montanide","id":"35711"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"35712"},{"source":"neoplasm metastasis","target":"poly-ICLC","id":"35713"},{"source":"neoplasm metastasis","target":"Oncovir","id":"35714"},{"source":"metaplasia","target":"PVX-410 (u)","id":"35715"},{"source":"metaplasia","target":"Montanide","id":"35716"},{"source":"metaplasia","target":"pembrolizumab","id":"35717"},{"source":"metaplasia","target":"poly-ICLC","id":"35718"},{"source":"metaplasia","target":"Oncovir","id":"35719"},{"source":"triple-negative breast cancer","target":"PVX-410 (u)","id":"35720"},{"source":"triple-negative breast cancer","target":"Montanide","id":"35721"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"35722"},{"source":"triple-negative breast cancer","target":"poly-ICLC","id":"35723"},{"source":"triple-negative breast cancer","target":"Oncovir","id":"35724"},{"source":"hiv) 1","target":"PVX-410 (u)","id":"35725"},{"source":"hiv) 1","target":"Montanide","id":"35726"},{"source":"hiv) 1","target":"pembrolizumab","id":"35727"},{"source":"hiv) 1","target":"poly-ICLC","id":"35728"},{"source":"hiv) 1","target":"Oncovir","id":"35729"},{"source":"residual tumor","target":"PVX-410 (u)","id":"35730"},{"source":"residual tumor","target":"Montanide","id":"35731"},{"source":"residual tumor","target":"pembrolizumab","id":"35732"},{"source":"residual tumor","target":"poly-ICLC","id":"35733"},{"source":"residual tumor","target":"Oncovir","id":"35734"},{"source":"anticancer","target":"PVX-410 (u)","id":"35735"},{"source":"anticancer","target":"Montanide","id":"35736"},{"source":"anticancer","target":"pembrolizumab","id":"35737"},{"source":"anticancer","target":"poly-ICLC","id":"35738"},{"source":"anticancer","target":"Oncovir","id":"35739"},{"source":"residual tumor","target":"PVX-410 (u)","id":"35740"},{"source":"residual tumor","target":"Montanide","id":"35741"},{"source":"residual tumor","target":"pembrolizumab","id":"35742"},{"source":"residual tumor","target":"poly-ICLC","id":"35743"},{"source":"residual tumor","target":"Oncovir","id":"35744"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"35745"},{"source":"Anticancer immunotherapy","target":"metaplasia","id":"35746"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"35747"},{"source":"Anticancer immunotherapy","target":"human immunodeficiency virus","id":"35748"},{"source":"Anticancer immunotherapy","target":"hepatitis c virus","id":"35749"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"35750"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"35751"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"35752"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"35753"},{"source":"Anticancer immunotherapy","target":"hcv","id":"35754"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"35755"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"35756"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"35757"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"35758"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"35759"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"35760"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"35761"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"35762"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"35763"},{"source":"Anticancer immunotherapy","target":"metaplasia","id":"35764"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"35765"},{"source":"Anticancer immunotherapy","target":"hiv) 1","id":"35766"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"35767"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"35768"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"35769"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"35770"},{"source":"CD19 antagonist","target":"metaplasia","id":"35771"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"35772"},{"source":"CD19 antagonist","target":"human immunodeficiency virus","id":"35773"},{"source":"CD19 antagonist","target":"hepatitis c virus","id":"35774"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"35775"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"35776"},{"source":"CD19 antagonist","target":"hiv infections","id":"35777"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"35778"},{"source":"CD19 antagonist","target":"hcv","id":"35779"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"35780"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"35781"},{"source":"CD19 antagonist","target":"liver metastases","id":"35782"},{"source":"CD19 antagonist","target":"tnbc","id":"35783"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"35784"},{"source":"CD19 antagonist","target":"anti-hiv","id":"35785"},{"source":"CD19 antagonist","target":"metastatic","id":"35786"},{"source":"CD19 antagonist","target":"carcinoma","id":"35787"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"35788"},{"source":"CD19 antagonist","target":"metaplasia","id":"35789"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"35790"},{"source":"CD19 antagonist","target":"hiv) 1","id":"35791"},{"source":"CD19 antagonist","target":"residual tumor","id":"35792"},{"source":"CD19 antagonist","target":"anticancer","id":"35793"},{"source":"CD19 antagonist","target":"residual tumor","id":"35794"},{"source":"Immunostimulant","target":"UNK : Indication","id":"35795"},{"source":"Immunostimulant","target":"metaplasia","id":"35796"},{"source":"Immunostimulant","target":"chronic hepatitis b","id":"35797"},{"source":"Immunostimulant","target":"human immunodeficiency virus","id":"35798"},{"source":"Immunostimulant","target":"hepatitis c virus","id":"35799"},{"source":"Immunostimulant","target":"breast neoplasms","id":"35800"},{"source":"Immunostimulant","target":"chronic hepatitis b","id":"35801"},{"source":"Immunostimulant","target":"hiv infections","id":"35802"},{"source":"Immunostimulant","target":"acquired immunodeficiency syndrome","id":"35803"},{"source":"Immunostimulant","target":"hcv","id":"35804"},{"source":"Immunostimulant","target":"liver neoplasms","id":"35805"},{"source":"Immunostimulant","target":"breast neoplasms","id":"35806"},{"source":"Immunostimulant","target":"liver metastases","id":"35807"},{"source":"Immunostimulant","target":"tnbc","id":"35808"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"35809"},{"source":"Immunostimulant","target":"anti-hiv","id":"35810"},{"source":"Immunostimulant","target":"metastatic","id":"35811"},{"source":"Immunostimulant","target":"carcinoma","id":"35812"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"35813"},{"source":"Immunostimulant","target":"metaplasia","id":"35814"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"35815"},{"source":"Immunostimulant","target":"hiv) 1","id":"35816"},{"source":"Immunostimulant","target":"residual tumor","id":"35817"},{"source":"Immunostimulant","target":"anticancer","id":"35818"},{"source":"Immunostimulant","target":"residual tumor","id":"35819"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"35820"},{"source":"Immune checkpoint inhibitor","target":"metaplasia","id":"35821"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"35822"},{"source":"Immune checkpoint inhibitor","target":"human immunodeficiency virus","id":"35823"},{"source":"Immune checkpoint inhibitor","target":"hepatitis c virus","id":"35824"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"35825"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"35826"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"35827"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"35828"},{"source":"Immune checkpoint inhibitor","target":"hcv","id":"35829"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"35830"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"35831"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"35832"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"35833"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"35834"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"35835"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"35836"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"35837"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"35838"},{"source":"Immune checkpoint inhibitor","target":"metaplasia","id":"35839"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"35840"},{"source":"Immune checkpoint inhibitor","target":"hiv) 1","id":"35841"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"35842"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"35843"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"35844"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"35845"},{"source":"Toll-like receptor 9 agonist","target":"metaplasia","id":"35846"},{"source":"Toll-like receptor 9 agonist","target":"chronic hepatitis b","id":"35847"},{"source":"Toll-like receptor 9 agonist","target":"human immunodeficiency virus","id":"35848"},{"source":"Toll-like receptor 9 agonist","target":"hepatitis c virus","id":"35849"},{"source":"Toll-like receptor 9 agonist","target":"breast neoplasms","id":"35850"},{"source":"Toll-like receptor 9 agonist","target":"chronic hepatitis b","id":"35851"},{"source":"Toll-like receptor 9 agonist","target":"hiv infections","id":"35852"},{"source":"Toll-like receptor 9 agonist","target":"acquired immunodeficiency syndrome","id":"35853"},{"source":"Toll-like receptor 9 agonist","target":"hcv","id":"35854"},{"source":"Toll-like receptor 9 agonist","target":"liver neoplasms","id":"35855"},{"source":"Toll-like receptor 9 agonist","target":"breast neoplasms","id":"35856"},{"source":"Toll-like receptor 9 agonist","target":"liver metastases","id":"35857"},{"source":"Toll-like receptor 9 agonist","target":"tnbc","id":"35858"},{"source":"Toll-like receptor 9 agonist","target":"triple-negative breast cancer","id":"35859"},{"source":"Toll-like receptor 9 agonist","target":"anti-hiv","id":"35860"},{"source":"Toll-like receptor 9 agonist","target":"metastatic","id":"35861"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"35862"},{"source":"Toll-like receptor 9 agonist","target":"neoplasm metastasis","id":"35863"},{"source":"Toll-like receptor 9 agonist","target":"metaplasia","id":"35864"},{"source":"Toll-like receptor 9 agonist","target":"triple-negative breast cancer","id":"35865"},{"source":"Toll-like receptor 9 agonist","target":"hiv) 1","id":"35866"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"35867"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"35868"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"35869"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"35870"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"35871"},{"source":"Oncology: Breast","target":"Immunostimulant","id":"35872"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"35873"},{"source":"Oncology: Breast","target":"Toll-like receptor 9 agonist","id":"35874"},{"source":"PVX-410 (u)","target":"Massachusetts General Hospital","id":"35875"},{"source":"PVX-410 (u)","target":"Merck & Co.","id":"35876"},{"source":"Montanide","target":"Massachusetts General Hospital","id":"35877"},{"source":"Montanide","target":"Merck & Co.","id":"35878"},{"source":"pembrolizumab","target":"Massachusetts General Hospital","id":"35879"},{"source":"pembrolizumab","target":"Merck & Co.","id":"35880"},{"source":"poly-ICLC","target":"Massachusetts General Hospital","id":"35881"},{"source":"poly-ICLC","target":"Merck & Co.","id":"35882"},{"source":"Oncovir","target":"Massachusetts General Hospital","id":"35883"},{"source":"Oncovir","target":"Merck & Co.","id":"35884"},{"source":"UNK : Indication","target":"PVX-410 (u)","id":"35885"},{"source":"UNK : Indication","target":"Montanide","id":"35886"},{"source":"UNK : Indication","target":"pembrolizumab","id":"35887"},{"source":"UNK : Indication","target":"poly-ICLC","id":"35888"},{"source":"UNK : Indication","target":"Oncovir","id":"35889"},{"source":"metaplasia","target":"PVX-410 (u)","id":"35890"},{"source":"metaplasia","target":"Montanide","id":"35891"},{"source":"metaplasia","target":"pembrolizumab","id":"35892"},{"source":"metaplasia","target":"poly-ICLC","id":"35893"},{"source":"metaplasia","target":"Oncovir","id":"35894"},{"source":"chronic hepatitis b","target":"PVX-410 (u)","id":"35895"},{"source":"chronic hepatitis b","target":"Montanide","id":"35896"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"35897"},{"source":"chronic hepatitis b","target":"poly-ICLC","id":"35898"},{"source":"chronic hepatitis b","target":"Oncovir","id":"35899"},{"source":"human immunodeficiency virus","target":"PVX-410 (u)","id":"35900"},{"source":"human immunodeficiency virus","target":"Montanide","id":"35901"},{"source":"human immunodeficiency virus","target":"pembrolizumab","id":"35902"},{"source":"human immunodeficiency virus","target":"poly-ICLC","id":"35903"},{"source":"human immunodeficiency virus","target":"Oncovir","id":"35904"},{"source":"hepatitis c virus","target":"PVX-410 (u)","id":"35905"},{"source":"hepatitis c virus","target":"Montanide","id":"35906"},{"source":"hepatitis c virus","target":"pembrolizumab","id":"35907"},{"source":"hepatitis c virus","target":"poly-ICLC","id":"35908"},{"source":"hepatitis c virus","target":"Oncovir","id":"35909"},{"source":"breast neoplasms","target":"PVX-410 (u)","id":"35910"},{"source":"breast neoplasms","target":"Montanide","id":"35911"},{"source":"breast neoplasms","target":"pembrolizumab","id":"35912"},{"source":"breast neoplasms","target":"poly-ICLC","id":"35913"},{"source":"breast neoplasms","target":"Oncovir","id":"35914"},{"source":"chronic hepatitis b","target":"PVX-410 (u)","id":"35915"},{"source":"chronic hepatitis b","target":"Montanide","id":"35916"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"35917"},{"source":"chronic hepatitis b","target":"poly-ICLC","id":"35918"},{"source":"chronic hepatitis b","target":"Oncovir","id":"35919"},{"source":"hiv infections","target":"PVX-410 (u)","id":"35920"},{"source":"hiv infections","target":"Montanide","id":"35921"},{"source":"hiv infections","target":"pembrolizumab","id":"35922"},{"source":"hiv infections","target":"poly-ICLC","id":"35923"},{"source":"hiv infections","target":"Oncovir","id":"35924"},{"source":"acquired immunodeficiency syndrome","target":"PVX-410 (u)","id":"35925"},{"source":"acquired immunodeficiency syndrome","target":"Montanide","id":"35926"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"35927"},{"source":"acquired immunodeficiency syndrome","target":"poly-ICLC","id":"35928"},{"source":"acquired immunodeficiency syndrome","target":"Oncovir","id":"35929"},{"source":"hcv","target":"PVX-410 (u)","id":"35930"},{"source":"hcv","target":"Montanide","id":"35931"},{"source":"hcv","target":"pembrolizumab","id":"35932"},{"source":"hcv","target":"poly-ICLC","id":"35933"},{"source":"hcv","target":"Oncovir","id":"35934"},{"source":"liver neoplasms","target":"PVX-410 (u)","id":"35935"},{"source":"liver neoplasms","target":"Montanide","id":"35936"},{"source":"liver neoplasms","target":"pembrolizumab","id":"35937"},{"source":"liver neoplasms","target":"poly-ICLC","id":"35938"},{"source":"liver neoplasms","target":"Oncovir","id":"35939"},{"source":"breast neoplasms","target":"PVX-410 (u)","id":"35940"},{"source":"breast neoplasms","target":"Montanide","id":"35941"},{"source":"breast neoplasms","target":"pembrolizumab","id":"35942"},{"source":"breast neoplasms","target":"poly-ICLC","id":"35943"},{"source":"breast neoplasms","target":"Oncovir","id":"35944"},{"source":"liver metastases","target":"PVX-410 (u)","id":"35945"},{"source":"liver metastases","target":"Montanide","id":"35946"},{"source":"liver metastases","target":"pembrolizumab","id":"35947"},{"source":"liver metastases","target":"poly-ICLC","id":"35948"},{"source":"liver metastases","target":"Oncovir","id":"35949"},{"source":"tnbc","target":"PVX-410 (u)","id":"35950"},{"source":"tnbc","target":"Montanide","id":"35951"},{"source":"tnbc","target":"pembrolizumab","id":"35952"},{"source":"tnbc","target":"poly-ICLC","id":"35953"},{"source":"tnbc","target":"Oncovir","id":"35954"},{"source":"triple-negative breast cancer","target":"PVX-410 (u)","id":"35955"},{"source":"triple-negative breast cancer","target":"Montanide","id":"35956"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"35957"},{"source":"triple-negative breast cancer","target":"poly-ICLC","id":"35958"},{"source":"triple-negative breast cancer","target":"Oncovir","id":"35959"},{"source":"anti-hiv","target":"PVX-410 (u)","id":"35960"},{"source":"anti-hiv","target":"Montanide","id":"35961"},{"source":"anti-hiv","target":"pembrolizumab","id":"35962"},{"source":"anti-hiv","target":"poly-ICLC","id":"35963"},{"source":"anti-hiv","target":"Oncovir","id":"35964"},{"source":"metastatic","target":"PVX-410 (u)","id":"35965"},{"source":"metastatic","target":"Montanide","id":"35966"},{"source":"metastatic","target":"pembrolizumab","id":"35967"},{"source":"metastatic","target":"poly-ICLC","id":"35968"},{"source":"metastatic","target":"Oncovir","id":"35969"},{"source":"carcinoma","target":"PVX-410 (u)","id":"35970"},{"source":"carcinoma","target":"Montanide","id":"35971"},{"source":"carcinoma","target":"pembrolizumab","id":"35972"},{"source":"carcinoma","target":"poly-ICLC","id":"35973"},{"source":"carcinoma","target":"Oncovir","id":"35974"},{"source":"neoplasm metastasis","target":"PVX-410 (u)","id":"35975"},{"source":"neoplasm metastasis","target":"Montanide","id":"35976"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"35977"},{"source":"neoplasm metastasis","target":"poly-ICLC","id":"35978"},{"source":"neoplasm metastasis","target":"Oncovir","id":"35979"},{"source":"metaplasia","target":"PVX-410 (u)","id":"35980"},{"source":"metaplasia","target":"Montanide","id":"35981"},{"source":"metaplasia","target":"pembrolizumab","id":"35982"},{"source":"metaplasia","target":"poly-ICLC","id":"35983"},{"source":"metaplasia","target":"Oncovir","id":"35984"},{"source":"triple-negative breast cancer","target":"PVX-410 (u)","id":"35985"},{"source":"triple-negative breast cancer","target":"Montanide","id":"35986"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"35987"},{"source":"triple-negative breast cancer","target":"poly-ICLC","id":"35988"},{"source":"triple-negative breast cancer","target":"Oncovir","id":"35989"},{"source":"hiv) 1","target":"PVX-410 (u)","id":"35990"},{"source":"hiv) 1","target":"Montanide","id":"35991"},{"source":"hiv) 1","target":"pembrolizumab","id":"35992"},{"source":"hiv) 1","target":"poly-ICLC","id":"35993"},{"source":"hiv) 1","target":"Oncovir","id":"35994"},{"source":"residual tumor","target":"PVX-410 (u)","id":"35995"},{"source":"residual tumor","target":"Montanide","id":"35996"},{"source":"residual tumor","target":"pembrolizumab","id":"35997"},{"source":"residual tumor","target":"poly-ICLC","id":"35998"},{"source":"residual tumor","target":"Oncovir","id":"35999"},{"source":"anticancer","target":"PVX-410 (u)","id":"36000"},{"source":"anticancer","target":"Montanide","id":"36001"},{"source":"anticancer","target":"pembrolizumab","id":"36002"},{"source":"anticancer","target":"poly-ICLC","id":"36003"},{"source":"anticancer","target":"Oncovir","id":"36004"},{"source":"residual tumor","target":"PVX-410 (u)","id":"36005"},{"source":"residual tumor","target":"Montanide","id":"36006"},{"source":"residual tumor","target":"pembrolizumab","id":"36007"},{"source":"residual tumor","target":"poly-ICLC","id":"36008"},{"source":"residual tumor","target":"Oncovir","id":"36009"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"36010"},{"source":"Anticancer immunotherapy","target":"metaplasia","id":"36011"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"36012"},{"source":"Anticancer immunotherapy","target":"human immunodeficiency virus","id":"36013"},{"source":"Anticancer immunotherapy","target":"hepatitis c virus","id":"36014"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"36015"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"36016"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"36017"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"36018"},{"source":"Anticancer immunotherapy","target":"hcv","id":"36019"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"36020"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"36021"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"36022"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"36023"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"36024"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"36025"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"36026"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36027"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"36028"},{"source":"Anticancer immunotherapy","target":"metaplasia","id":"36029"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"36030"},{"source":"Anticancer immunotherapy","target":"hiv) 1","id":"36031"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"36032"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36033"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"36034"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"36035"},{"source":"CD19 antagonist","target":"metaplasia","id":"36036"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"36037"},{"source":"CD19 antagonist","target":"human immunodeficiency virus","id":"36038"},{"source":"CD19 antagonist","target":"hepatitis c virus","id":"36039"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"36040"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"36041"},{"source":"CD19 antagonist","target":"hiv infections","id":"36042"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"36043"},{"source":"CD19 antagonist","target":"hcv","id":"36044"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"36045"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"36046"},{"source":"CD19 antagonist","target":"liver metastases","id":"36047"},{"source":"CD19 antagonist","target":"tnbc","id":"36048"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"36049"},{"source":"CD19 antagonist","target":"anti-hiv","id":"36050"},{"source":"CD19 antagonist","target":"metastatic","id":"36051"},{"source":"CD19 antagonist","target":"carcinoma","id":"36052"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"36053"},{"source":"CD19 antagonist","target":"metaplasia","id":"36054"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"36055"},{"source":"CD19 antagonist","target":"hiv) 1","id":"36056"},{"source":"CD19 antagonist","target":"residual tumor","id":"36057"},{"source":"CD19 antagonist","target":"anticancer","id":"36058"},{"source":"CD19 antagonist","target":"residual tumor","id":"36059"},{"source":"Immunostimulant","target":"UNK : Indication","id":"36060"},{"source":"Immunostimulant","target":"metaplasia","id":"36061"},{"source":"Immunostimulant","target":"chronic hepatitis b","id":"36062"},{"source":"Immunostimulant","target":"human immunodeficiency virus","id":"36063"},{"source":"Immunostimulant","target":"hepatitis c virus","id":"36064"},{"source":"Immunostimulant","target":"breast neoplasms","id":"36065"},{"source":"Immunostimulant","target":"chronic hepatitis b","id":"36066"},{"source":"Immunostimulant","target":"hiv infections","id":"36067"},{"source":"Immunostimulant","target":"acquired immunodeficiency syndrome","id":"36068"},{"source":"Immunostimulant","target":"hcv","id":"36069"},{"source":"Immunostimulant","target":"liver neoplasms","id":"36070"},{"source":"Immunostimulant","target":"breast neoplasms","id":"36071"},{"source":"Immunostimulant","target":"liver metastases","id":"36072"},{"source":"Immunostimulant","target":"tnbc","id":"36073"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"36074"},{"source":"Immunostimulant","target":"anti-hiv","id":"36075"},{"source":"Immunostimulant","target":"metastatic","id":"36076"},{"source":"Immunostimulant","target":"carcinoma","id":"36077"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"36078"},{"source":"Immunostimulant","target":"metaplasia","id":"36079"},{"source":"Immunostimulant","target":"triple-negative breast cancer","id":"36080"},{"source":"Immunostimulant","target":"hiv) 1","id":"36081"},{"source":"Immunostimulant","target":"residual tumor","id":"36082"},{"source":"Immunostimulant","target":"anticancer","id":"36083"},{"source":"Immunostimulant","target":"residual tumor","id":"36084"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"36085"},{"source":"Immune checkpoint inhibitor","target":"metaplasia","id":"36086"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"36087"},{"source":"Immune checkpoint inhibitor","target":"human immunodeficiency virus","id":"36088"},{"source":"Immune checkpoint inhibitor","target":"hepatitis c virus","id":"36089"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"36090"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"36091"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"36092"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"36093"},{"source":"Immune checkpoint inhibitor","target":"hcv","id":"36094"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"36095"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"36096"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"36097"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"36098"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"36099"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"36100"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"36101"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36102"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"36103"},{"source":"Immune checkpoint inhibitor","target":"metaplasia","id":"36104"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"36105"},{"source":"Immune checkpoint inhibitor","target":"hiv) 1","id":"36106"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"36107"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36108"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"36109"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"36110"},{"source":"Toll-like receptor 9 agonist","target":"metaplasia","id":"36111"},{"source":"Toll-like receptor 9 agonist","target":"chronic hepatitis b","id":"36112"},{"source":"Toll-like receptor 9 agonist","target":"human immunodeficiency virus","id":"36113"},{"source":"Toll-like receptor 9 agonist","target":"hepatitis c virus","id":"36114"},{"source":"Toll-like receptor 9 agonist","target":"breast neoplasms","id":"36115"},{"source":"Toll-like receptor 9 agonist","target":"chronic hepatitis b","id":"36116"},{"source":"Toll-like receptor 9 agonist","target":"hiv infections","id":"36117"},{"source":"Toll-like receptor 9 agonist","target":"acquired immunodeficiency syndrome","id":"36118"},{"source":"Toll-like receptor 9 agonist","target":"hcv","id":"36119"},{"source":"Toll-like receptor 9 agonist","target":"liver neoplasms","id":"36120"},{"source":"Toll-like receptor 9 agonist","target":"breast neoplasms","id":"36121"},{"source":"Toll-like receptor 9 agonist","target":"liver metastases","id":"36122"},{"source":"Toll-like receptor 9 agonist","target":"tnbc","id":"36123"},{"source":"Toll-like receptor 9 agonist","target":"triple-negative breast cancer","id":"36124"},{"source":"Toll-like receptor 9 agonist","target":"anti-hiv","id":"36125"},{"source":"Toll-like receptor 9 agonist","target":"metastatic","id":"36126"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"36127"},{"source":"Toll-like receptor 9 agonist","target":"neoplasm metastasis","id":"36128"},{"source":"Toll-like receptor 9 agonist","target":"metaplasia","id":"36129"},{"source":"Toll-like receptor 9 agonist","target":"triple-negative breast cancer","id":"36130"},{"source":"Toll-like receptor 9 agonist","target":"hiv) 1","id":"36131"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"36132"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"36133"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"36134"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"36135"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"36136"},{"source":"Oncology: Breast","target":"Immunostimulant","id":"36137"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"36138"},{"source":"Oncology: Breast","target":"Toll-like receptor 9 agonist","id":"36139"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"36140"},{"source":"pembrolizumab","target":"Merck & Co.","id":"36141"},{"source":"docetaxel","target":"(Other Hospital/Academic/Medical Center)","id":"36142"},{"source":"docetaxel","target":"Merck & Co.","id":"36143"},{"source":"gemcitabine hydrochloride","target":"(Other Hospital/Academic/Medical Center)","id":"36144"},{"source":"gemcitabine hydrochloride","target":"Merck & Co.","id":"36145"},{"source":"pemetrexed disodium","target":"(Other Hospital/Academic/Medical Center)","id":"36146"},{"source":"pemetrexed disodium","target":"Merck & Co.","id":"36147"},{"source":"psoriasis","target":"pembrolizumab","id":"36148"},{"source":"psoriasis","target":"docetaxel","id":"36149"},{"source":"psoriasis","target":"gemcitabine hydrochloride","id":"36150"},{"source":"psoriasis","target":"pemetrexed disodium","id":"36151"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"36152"},{"source":"non-small-cell lung","target":"docetaxel","id":"36153"},{"source":"non-small-cell lung","target":"gemcitabine hydrochloride","id":"36154"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"36155"},{"source":"anticancer","target":"pembrolizumab","id":"36156"},{"source":"anticancer","target":"docetaxel","id":"36157"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"36158"},{"source":"anticancer","target":"pemetrexed disodium","id":"36159"},{"source":"malaria","target":"pembrolizumab","id":"36160"},{"source":"malaria","target":"docetaxel","id":"36161"},{"source":"malaria","target":"gemcitabine hydrochloride","id":"36162"},{"source":"malaria","target":"pemetrexed disodium","id":"36163"},{"source":"residual tumor","target":"pembrolizumab","id":"36164"},{"source":"residual tumor","target":"docetaxel","id":"36165"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"36166"},{"source":"residual tumor","target":"pemetrexed disodium","id":"36167"},{"source":"arthritis","target":"pembrolizumab","id":"36168"},{"source":"arthritis","target":"docetaxel","id":"36169"},{"source":"arthritis","target":"gemcitabine hydrochloride","id":"36170"},{"source":"arthritis","target":"pemetrexed disodium","id":"36171"},{"source":"antiarthritic","target":"pembrolizumab","id":"36172"},{"source":"antiarthritic","target":"docetaxel","id":"36173"},{"source":"antiarthritic","target":"gemcitabine hydrochloride","id":"36174"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"36175"},{"source":"carcinoma","target":"pembrolizumab","id":"36176"},{"source":"carcinoma","target":"docetaxel","id":"36177"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"36178"},{"source":"carcinoma","target":"pemetrexed disodium","id":"36179"},{"source":"malaria","target":"pembrolizumab","id":"36180"},{"source":"malaria","target":"docetaxel","id":"36181"},{"source":"malaria","target":"gemcitabine hydrochloride","id":"36182"},{"source":"malaria","target":"pemetrexed disodium","id":"36183"},{"source":"carcinoma","target":"pembrolizumab","id":"36184"},{"source":"carcinoma","target":"docetaxel","id":"36185"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"36186"},{"source":"carcinoma","target":"pemetrexed disodium","id":"36187"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"36188"},{"source":"non-small-cell lung","target":"docetaxel","id":"36189"},{"source":"non-small-cell lung","target":"gemcitabine hydrochloride","id":"36190"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"36191"},{"source":"psoriasis","target":"pembrolizumab","id":"36192"},{"source":"psoriasis","target":"docetaxel","id":"36193"},{"source":"psoriasis","target":"gemcitabine hydrochloride","id":"36194"},{"source":"psoriasis","target":"pemetrexed disodium","id":"36195"},{"source":"anticancer","target":"pembrolizumab","id":"36196"},{"source":"anticancer","target":"docetaxel","id":"36197"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"36198"},{"source":"anticancer","target":"pemetrexed disodium","id":"36199"},{"source":"lung neoplasms","target":"pembrolizumab","id":"36200"},{"source":"lung neoplasms","target":"docetaxel","id":"36201"},{"source":"lung neoplasms","target":"gemcitabine hydrochloride","id":"36202"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"36203"},{"source":"sclc","target":"pembrolizumab","id":"36204"},{"source":"sclc","target":"docetaxel","id":"36205"},{"source":"sclc","target":"gemcitabine hydrochloride","id":"36206"},{"source":"sclc","target":"pemetrexed disodium","id":"36207"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"36208"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"36209"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"36210"},{"source":"Dihydrofolate reductase inhibitor","target":"malaria","id":"36211"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"36212"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"36213"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"36214"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"36215"},{"source":"Dihydrofolate reductase inhibitor","target":"malaria","id":"36216"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"36217"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"36218"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"36219"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"36220"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"36221"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"36222"},{"source":"Cell cycle inhibitor","target":"psoriasis","id":"36223"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"36224"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"36225"},{"source":"Cell cycle inhibitor","target":"malaria","id":"36226"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"36227"},{"source":"Cell cycle inhibitor","target":"arthritis","id":"36228"},{"source":"Cell cycle inhibitor","target":"antiarthritic","id":"36229"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"36230"},{"source":"Cell cycle inhibitor","target":"malaria","id":"36231"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"36232"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"36233"},{"source":"Cell cycle inhibitor","target":"psoriasis","id":"36234"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"36235"},{"source":"Cell cycle inhibitor","target":"lung neoplasms","id":"36236"},{"source":"Cell cycle inhibitor","target":"sclc","id":"36237"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"36238"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"36239"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36240"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"36241"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"36242"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"36243"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"36244"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36245"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"36246"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36247"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"36248"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"36249"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36250"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"36251"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"36252"},{"source":"NA","target":"psoriasis","id":"36253"},{"source":"NA","target":"non-small-cell lung","id":"36254"},{"source":"NA","target":"anticancer","id":"36255"},{"source":"NA","target":"malaria","id":"36256"},{"source":"NA","target":"residual tumor","id":"36257"},{"source":"NA","target":"arthritis","id":"36258"},{"source":"NA","target":"antiarthritic","id":"36259"},{"source":"NA","target":"carcinoma","id":"36260"},{"source":"NA","target":"malaria","id":"36261"},{"source":"NA","target":"carcinoma","id":"36262"},{"source":"NA","target":"non-small-cell lung","id":"36263"},{"source":"NA","target":"psoriasis","id":"36264"},{"source":"NA","target":"anticancer","id":"36265"},{"source":"NA","target":"lung neoplasms","id":"36266"},{"source":"NA","target":"sclc","id":"36267"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"36268"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"36269"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36270"},{"source":"Anticancer immunotherapy","target":"malaria","id":"36271"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"36272"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"36273"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"36274"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36275"},{"source":"Anticancer immunotherapy","target":"malaria","id":"36276"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36277"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"36278"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"36279"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36280"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"36281"},{"source":"Anticancer immunotherapy","target":"sclc","id":"36282"},{"source":"CD19 antagonist","target":"psoriasis","id":"36283"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"36284"},{"source":"CD19 antagonist","target":"anticancer","id":"36285"},{"source":"CD19 antagonist","target":"malaria","id":"36286"},{"source":"CD19 antagonist","target":"residual tumor","id":"36287"},{"source":"CD19 antagonist","target":"arthritis","id":"36288"},{"source":"CD19 antagonist","target":"antiarthritic","id":"36289"},{"source":"CD19 antagonist","target":"carcinoma","id":"36290"},{"source":"CD19 antagonist","target":"malaria","id":"36291"},{"source":"CD19 antagonist","target":"carcinoma","id":"36292"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"36293"},{"source":"CD19 antagonist","target":"psoriasis","id":"36294"},{"source":"CD19 antagonist","target":"anticancer","id":"36295"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"36296"},{"source":"CD19 antagonist","target":"sclc","id":"36297"},{"source":"Taxane","target":"psoriasis","id":"36298"},{"source":"Taxane","target":"non-small-cell lung","id":"36299"},{"source":"Taxane","target":"anticancer","id":"36300"},{"source":"Taxane","target":"malaria","id":"36301"},{"source":"Taxane","target":"residual tumor","id":"36302"},{"source":"Taxane","target":"arthritis","id":"36303"},{"source":"Taxane","target":"antiarthritic","id":"36304"},{"source":"Taxane","target":"carcinoma","id":"36305"},{"source":"Taxane","target":"malaria","id":"36306"},{"source":"Taxane","target":"carcinoma","id":"36307"},{"source":"Taxane","target":"non-small-cell lung","id":"36308"},{"source":"Taxane","target":"psoriasis","id":"36309"},{"source":"Taxane","target":"anticancer","id":"36310"},{"source":"Taxane","target":"lung neoplasms","id":"36311"},{"source":"Taxane","target":"sclc","id":"36312"},{"source":"Microtubule stimulant","target":"psoriasis","id":"36313"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"36314"},{"source":"Microtubule stimulant","target":"anticancer","id":"36315"},{"source":"Microtubule stimulant","target":"malaria","id":"36316"},{"source":"Microtubule stimulant","target":"residual tumor","id":"36317"},{"source":"Microtubule stimulant","target":"arthritis","id":"36318"},{"source":"Microtubule stimulant","target":"antiarthritic","id":"36319"},{"source":"Microtubule stimulant","target":"carcinoma","id":"36320"},{"source":"Microtubule stimulant","target":"malaria","id":"36321"},{"source":"Microtubule stimulant","target":"carcinoma","id":"36322"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"36323"},{"source":"Microtubule stimulant","target":"psoriasis","id":"36324"},{"source":"Microtubule stimulant","target":"anticancer","id":"36325"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"36326"},{"source":"Microtubule stimulant","target":"sclc","id":"36327"},{"source":"NA","target":"psoriasis","id":"36328"},{"source":"NA","target":"non-small-cell lung","id":"36329"},{"source":"NA","target":"anticancer","id":"36330"},{"source":"NA","target":"malaria","id":"36331"},{"source":"NA","target":"residual tumor","id":"36332"},{"source":"NA","target":"arthritis","id":"36333"},{"source":"NA","target":"antiarthritic","id":"36334"},{"source":"NA","target":"carcinoma","id":"36335"},{"source":"NA","target":"malaria","id":"36336"},{"source":"NA","target":"carcinoma","id":"36337"},{"source":"NA","target":"non-small-cell lung","id":"36338"},{"source":"NA","target":"psoriasis","id":"36339"},{"source":"NA","target":"anticancer","id":"36340"},{"source":"NA","target":"lung neoplasms","id":"36341"},{"source":"NA","target":"sclc","id":"36342"},{"source":"NA","target":"psoriasis","id":"36343"},{"source":"NA","target":"non-small-cell lung","id":"36344"},{"source":"NA","target":"anticancer","id":"36345"},{"source":"NA","target":"malaria","id":"36346"},{"source":"NA","target":"residual tumor","id":"36347"},{"source":"NA","target":"arthritis","id":"36348"},{"source":"NA","target":"antiarthritic","id":"36349"},{"source":"NA","target":"carcinoma","id":"36350"},{"source":"NA","target":"malaria","id":"36351"},{"source":"NA","target":"carcinoma","id":"36352"},{"source":"NA","target":"non-small-cell lung","id":"36353"},{"source":"NA","target":"psoriasis","id":"36354"},{"source":"NA","target":"anticancer","id":"36355"},{"source":"NA","target":"lung neoplasms","id":"36356"},{"source":"NA","target":"sclc","id":"36357"},{"source":"Tubulin inhibitor","target":"psoriasis","id":"36358"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"36359"},{"source":"Tubulin inhibitor","target":"anticancer","id":"36360"},{"source":"Tubulin inhibitor","target":"malaria","id":"36361"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"36362"},{"source":"Tubulin inhibitor","target":"arthritis","id":"36363"},{"source":"Tubulin inhibitor","target":"antiarthritic","id":"36364"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"36365"},{"source":"Tubulin inhibitor","target":"malaria","id":"36366"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"36367"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"36368"},{"source":"Tubulin inhibitor","target":"psoriasis","id":"36369"},{"source":"Tubulin inhibitor","target":"anticancer","id":"36370"},{"source":"Tubulin inhibitor","target":"lung neoplasms","id":"36371"},{"source":"Tubulin inhibitor","target":"sclc","id":"36372"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"36373"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"36374"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"36375"},{"source":"Thymidylate synthase inhibitor","target":"malaria","id":"36376"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"36377"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"36378"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"36379"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"36380"},{"source":"Thymidylate synthase inhibitor","target":"malaria","id":"36381"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"36382"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"36383"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"36384"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"36385"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"36386"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"36387"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"36388"},{"source":"Oncology: Lung","target":"Cell cycle inhibitor","id":"36389"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"36390"},{"source":"Oncology: Lung","target":"NA","id":"36391"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"36392"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"36393"},{"source":"Oncology: Lung","target":"Taxane","id":"36394"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"36395"},{"source":"Oncology: Lung","target":"NA","id":"36396"},{"source":"Oncology: Lung","target":"NA","id":"36397"},{"source":"Oncology: Lung","target":"Tubulin inhibitor","id":"36398"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"36399"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"36400"},{"source":"Non-Small Cell","target":"Cell cycle inhibitor","id":"36401"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"36402"},{"source":"Non-Small Cell","target":"NA","id":"36403"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"36404"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"36405"},{"source":"Non-Small Cell","target":"Taxane","id":"36406"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"36407"},{"source":"Non-Small Cell","target":"NA","id":"36408"},{"source":"Non-Small Cell","target":"NA","id":"36409"},{"source":"Non-Small Cell","target":"Tubulin inhibitor","id":"36410"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"36411"},{"source":"afatinib (a)","target":"National Institutes of Health/National Cancer Institute","id":"36412"},{"source":"afatinib (a)","target":"University of California Davis","id":"36413"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"36414"},{"source":"pembrolizumab","target":"University of California Davis","id":"36415"},{"source":"UNK : Drug","target":"National Institutes of Health/National Cancer Institute","id":"36416"},{"source":"UNK : Drug","target":"University of California Davis","id":"36417"},{"source":"UNK : Indication","target":"afatinib (a)","id":"36418"},{"source":"UNK : Indication","target":"pembrolizumab","id":"36419"},{"source":"UNK : Indication","target":"UNK : Drug","id":"36420"},{"source":"residual tumor","target":"afatinib (a)","id":"36421"},{"source":"residual tumor","target":"pembrolizumab","id":"36422"},{"source":"residual tumor","target":"UNK : Drug","id":"36423"},{"source":"solid tumors","target":"afatinib (a)","id":"36424"},{"source":"solid tumors","target":"pembrolizumab","id":"36425"},{"source":"solid tumors","target":"UNK : Drug","id":"36426"},{"source":"copd","target":"afatinib (a)","id":"36427"},{"source":"copd","target":"pembrolizumab","id":"36428"},{"source":"copd","target":"UNK : Drug","id":"36429"},{"source":"anticancer","target":"afatinib (a)","id":"36430"},{"source":"anticancer","target":"pembrolizumab","id":"36431"},{"source":"anticancer","target":"UNK : Drug","id":"36432"},{"source":"non-small-cell lung","target":"afatinib (a)","id":"36433"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"36434"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"36435"},{"source":"carcinoma","target":"afatinib (a)","id":"36436"},{"source":"carcinoma","target":"pembrolizumab","id":"36437"},{"source":"carcinoma","target":"UNK : Drug","id":"36438"},{"source":"chronic obstructive pulmonary disease","target":"afatinib (a)","id":"36439"},{"source":"chronic obstructive pulmonary disease","target":"pembrolizumab","id":"36440"},{"source":"chronic obstructive pulmonary disease","target":"UNK : Drug","id":"36441"},{"source":"liver metastases","target":"afatinib (a)","id":"36442"},{"source":"liver metastases","target":"pembrolizumab","id":"36443"},{"source":"liver metastases","target":"UNK : Drug","id":"36444"},{"source":"metastatic","target":"afatinib (a)","id":"36445"},{"source":"metastatic","target":"pembrolizumab","id":"36446"},{"source":"metastatic","target":"UNK : Drug","id":"36447"},{"source":"carcinoma","target":"afatinib (a)","id":"36448"},{"source":"carcinoma","target":"pembrolizumab","id":"36449"},{"source":"carcinoma","target":"UNK : Drug","id":"36450"},{"source":"non-small-cell lung","target":"afatinib (a)","id":"36451"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"36452"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"36453"},{"source":"neoplasm metastasis","target":"afatinib (a)","id":"36454"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"36455"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"36456"},{"source":"neoplastic","target":"afatinib (a)","id":"36457"},{"source":"neoplastic","target":"pembrolizumab","id":"36458"},{"source":"neoplastic","target":"UNK : Drug","id":"36459"},{"source":"anticancer","target":"afatinib (a)","id":"36460"},{"source":"anticancer","target":"pembrolizumab","id":"36461"},{"source":"anticancer","target":"UNK : Drug","id":"36462"},{"source":"lung neoplasms","target":"afatinib (a)","id":"36463"},{"source":"lung neoplasms","target":"pembrolizumab","id":"36464"},{"source":"lung neoplasms","target":"UNK : Drug","id":"36465"},{"source":"liver neoplasms","target":"afatinib (a)","id":"36466"},{"source":"liver neoplasms","target":"pembrolizumab","id":"36467"},{"source":"liver neoplasms","target":"UNK : Drug","id":"36468"},{"source":"solid tumors","target":"afatinib (a)","id":"36469"},{"source":"solid tumors","target":"pembrolizumab","id":"36470"},{"source":"solid tumors","target":"UNK : Drug","id":"36471"},{"source":"NA","target":"UNK : Indication","id":"36472"},{"source":"NA","target":"residual tumor","id":"36473"},{"source":"NA","target":"solid tumors","id":"36474"},{"source":"NA","target":"copd","id":"36475"},{"source":"NA","target":"anticancer","id":"36476"},{"source":"NA","target":"non-small-cell lung","id":"36477"},{"source":"NA","target":"carcinoma","id":"36478"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"36479"},{"source":"NA","target":"liver metastases","id":"36480"},{"source":"NA","target":"metastatic","id":"36481"},{"source":"NA","target":"carcinoma","id":"36482"},{"source":"NA","target":"non-small-cell lung","id":"36483"},{"source":"NA","target":"neoplasm metastasis","id":"36484"},{"source":"NA","target":"neoplastic","id":"36485"},{"source":"NA","target":"anticancer","id":"36486"},{"source":"NA","target":"lung neoplasms","id":"36487"},{"source":"NA","target":"liver neoplasms","id":"36488"},{"source":"NA","target":"solid tumors","id":"36489"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"36490"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"36491"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"36492"},{"source":"Immune checkpoint inhibitor","target":"copd","id":"36493"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36494"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"36495"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36496"},{"source":"Immune checkpoint inhibitor","target":"chronic obstructive pulmonary disease","id":"36497"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"36498"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"36499"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36500"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"36501"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"36502"},{"source":"Immune checkpoint inhibitor","target":"neoplastic","id":"36503"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36504"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"36505"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"36506"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"36507"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"36508"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"36509"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"36510"},{"source":"Anticancer immunotherapy","target":"copd","id":"36511"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36512"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"36513"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36514"},{"source":"Anticancer immunotherapy","target":"chronic obstructive pulmonary disease","id":"36515"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"36516"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"36517"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36518"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"36519"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"36520"},{"source":"Anticancer immunotherapy","target":"neoplastic","id":"36521"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36522"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"36523"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"36524"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"36525"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"36526"},{"source":"CD19 antagonist","target":"residual tumor","id":"36527"},{"source":"CD19 antagonist","target":"solid tumors","id":"36528"},{"source":"CD19 antagonist","target":"copd","id":"36529"},{"source":"CD19 antagonist","target":"anticancer","id":"36530"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"36531"},{"source":"CD19 antagonist","target":"carcinoma","id":"36532"},{"source":"CD19 antagonist","target":"chronic obstructive pulmonary disease","id":"36533"},{"source":"CD19 antagonist","target":"liver metastases","id":"36534"},{"source":"CD19 antagonist","target":"metastatic","id":"36535"},{"source":"CD19 antagonist","target":"carcinoma","id":"36536"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"36537"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"36538"},{"source":"CD19 antagonist","target":"neoplastic","id":"36539"},{"source":"CD19 antagonist","target":"anticancer","id":"36540"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"36541"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"36542"},{"source":"CD19 antagonist","target":"solid tumors","id":"36543"},{"source":"NA","target":"UNK : Indication","id":"36544"},{"source":"NA","target":"residual tumor","id":"36545"},{"source":"NA","target":"solid tumors","id":"36546"},{"source":"NA","target":"copd","id":"36547"},{"source":"NA","target":"anticancer","id":"36548"},{"source":"NA","target":"non-small-cell lung","id":"36549"},{"source":"NA","target":"carcinoma","id":"36550"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"36551"},{"source":"NA","target":"liver metastases","id":"36552"},{"source":"NA","target":"metastatic","id":"36553"},{"source":"NA","target":"carcinoma","id":"36554"},{"source":"NA","target":"non-small-cell lung","id":"36555"},{"source":"NA","target":"neoplasm metastasis","id":"36556"},{"source":"NA","target":"neoplastic","id":"36557"},{"source":"NA","target":"anticancer","id":"36558"},{"source":"NA","target":"lung neoplasms","id":"36559"},{"source":"NA","target":"liver neoplasms","id":"36560"},{"source":"NA","target":"solid tumors","id":"36561"},{"source":"NA","target":"UNK : Indication","id":"36562"},{"source":"NA","target":"residual tumor","id":"36563"},{"source":"NA","target":"solid tumors","id":"36564"},{"source":"NA","target":"copd","id":"36565"},{"source":"NA","target":"anticancer","id":"36566"},{"source":"NA","target":"non-small-cell lung","id":"36567"},{"source":"NA","target":"carcinoma","id":"36568"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"36569"},{"source":"NA","target":"liver metastases","id":"36570"},{"source":"NA","target":"metastatic","id":"36571"},{"source":"NA","target":"carcinoma","id":"36572"},{"source":"NA","target":"non-small-cell lung","id":"36573"},{"source":"NA","target":"neoplasm metastasis","id":"36574"},{"source":"NA","target":"neoplastic","id":"36575"},{"source":"NA","target":"anticancer","id":"36576"},{"source":"NA","target":"lung neoplasms","id":"36577"},{"source":"NA","target":"liver neoplasms","id":"36578"},{"source":"NA","target":"solid tumors","id":"36579"},{"source":"Oncology: Lung","target":"NA","id":"36580"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"36581"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"36582"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"36583"},{"source":"Oncology: Lung","target":"NA","id":"36584"},{"source":"Oncology: Lung","target":"NA","id":"36585"},{"source":"Non-Small Cell","target":"NA","id":"36586"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"36587"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"36588"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"36589"},{"source":"Non-Small Cell","target":"NA","id":"36590"},{"source":"Non-Small Cell","target":"NA","id":"36591"},{"source":"pembrolizumab","target":"(Other Cooperative Group)","id":"36592"},{"source":"pembrolizumab","target":"(Other Industry Sponsor)","id":"36593"},{"source":"pembrolizumab","target":"AbbVie","id":"36594"},{"source":"pembrolizumab","target":"Merck & Co.","id":"36595"},{"source":"paricalcitol","target":"(Other Cooperative Group)","id":"36596"},{"source":"paricalcitol","target":"(Other Industry Sponsor)","id":"36597"},{"source":"paricalcitol","target":"AbbVie","id":"36598"},{"source":"paricalcitol","target":"Merck & Co.","id":"36599"},{"source":"injectable","target":"(Other Cooperative Group)","id":"36600"},{"source":"injectable","target":"(Other Industry Sponsor)","id":"36601"},{"source":"injectable","target":"AbbVie","id":"36602"},{"source":"injectable","target":"Merck & Co.","id":"36603"},{"source":"AbbVie","target":"(Other Cooperative Group)","id":"36604"},{"source":"AbbVie","target":"(Other Industry Sponsor)","id":"36605"},{"source":"AbbVie","target":"AbbVie","id":"36606"},{"source":"AbbVie","target":"Merck & Co.","id":"36607"},{"source":"UNK : Indication","target":"pembrolizumab","id":"36608"},{"source":"UNK : Indication","target":"paricalcitol","id":"36609"},{"source":"UNK : Indication","target":"injectable","id":"36610"},{"source":"UNK : Indication","target":"AbbVie","id":"36611"},{"source":"residual tumor","target":"pembrolizumab","id":"36612"},{"source":"residual tumor","target":"paricalcitol","id":"36613"},{"source":"residual tumor","target":"injectable","id":"36614"},{"source":"residual tumor","target":"AbbVie","id":"36615"},{"source":"metastatic","target":"pembrolizumab","id":"36616"},{"source":"metastatic","target":"paricalcitol","id":"36617"},{"source":"metastatic","target":"injectable","id":"36618"},{"source":"metastatic","target":"AbbVie","id":"36619"},{"source":"carcinoma","target":"pembrolizumab","id":"36620"},{"source":"carcinoma","target":"paricalcitol","id":"36621"},{"source":"carcinoma","target":"injectable","id":"36622"},{"source":"carcinoma","target":"AbbVie","id":"36623"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"36624"},{"source":"pancreatic cancer","target":"paricalcitol","id":"36625"},{"source":"pancreatic cancer","target":"injectable","id":"36626"},{"source":"pancreatic cancer","target":"AbbVie","id":"36627"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"36628"},{"source":"neoplasm metastasis","target":"paricalcitol","id":"36629"},{"source":"neoplasm metastasis","target":"injectable","id":"36630"},{"source":"neoplasm metastasis","target":"AbbVie","id":"36631"},{"source":"carcinoma","target":"pembrolizumab","id":"36632"},{"source":"carcinoma","target":"paricalcitol","id":"36633"},{"source":"carcinoma","target":"injectable","id":"36634"},{"source":"carcinoma","target":"AbbVie","id":"36635"},{"source":"anticancer","target":"pembrolizumab","id":"36636"},{"source":"anticancer","target":"paricalcitol","id":"36637"},{"source":"anticancer","target":"injectable","id":"36638"},{"source":"anticancer","target":"AbbVie","id":"36639"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"36640"},{"source":"pancreatic neoplasms","target":"paricalcitol","id":"36641"},{"source":"pancreatic neoplasms","target":"injectable","id":"36642"},{"source":"pancreatic neoplasms","target":"AbbVie","id":"36643"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"36644"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"36645"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"36646"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36647"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"36648"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"36649"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36650"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36651"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"36652"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"36653"},{"source":"CD19 antagonist","target":"residual tumor","id":"36654"},{"source":"CD19 antagonist","target":"metastatic","id":"36655"},{"source":"CD19 antagonist","target":"carcinoma","id":"36656"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"36657"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"36658"},{"source":"CD19 antagonist","target":"carcinoma","id":"36659"},{"source":"CD19 antagonist","target":"anticancer","id":"36660"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"36661"},{"source":"Vitamin D agonist","target":"UNK : Indication","id":"36662"},{"source":"Vitamin D agonist","target":"residual tumor","id":"36663"},{"source":"Vitamin D agonist","target":"metastatic","id":"36664"},{"source":"Vitamin D agonist","target":"carcinoma","id":"36665"},{"source":"Vitamin D agonist","target":"pancreatic cancer","id":"36666"},{"source":"Vitamin D agonist","target":"neoplasm metastasis","id":"36667"},{"source":"Vitamin D agonist","target":"carcinoma","id":"36668"},{"source":"Vitamin D agonist","target":"anticancer","id":"36669"},{"source":"Vitamin D agonist","target":"pancreatic neoplasms","id":"36670"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"36671"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"36672"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"36673"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36674"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"36675"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"36676"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36677"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36678"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"36679"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"36680"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"36681"},{"source":"Oncology: Pancreas","target":"Vitamin D agonist","id":"36682"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"36683"},{"source":"birinapant (u)","target":"TetraLogic Pharmaceuticals","id":"36684"},{"source":"UNK : Drug","target":"TetraLogic Pharmaceuticals","id":"36685"},{"source":"UNK : Indication","target":"birinapant (u)","id":"36686"},{"source":"UNK : Indication","target":"UNK : Drug","id":"36687"},{"source":"colorectal neoplasms","target":"birinapant (u)","id":"36688"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"36689"},{"source":"colorectal cancer","target":"birinapant (u)","id":"36690"},{"source":"colorectal cancer","target":"UNK : Drug","id":"36691"},{"source":"anti-hiv","target":"birinapant (u)","id":"36692"},{"source":"anti-hiv","target":"UNK : Drug","id":"36693"},{"source":"colonic neoplasms","target":"birinapant (u)","id":"36694"},{"source":"colonic neoplasms","target":"UNK : Drug","id":"36695"},{"source":"carcinoma","target":"birinapant (u)","id":"36696"},{"source":"carcinoma","target":"UNK : Drug","id":"36697"},{"source":"anticancer","target":"birinapant (u)","id":"36698"},{"source":"anticancer","target":"UNK : Drug","id":"36699"},{"source":"hiv infections","target":"birinapant (u)","id":"36700"},{"source":"hiv infections","target":"UNK : Drug","id":"36701"},{"source":"acquired immunodeficiency syndrome","target":"birinapant (u)","id":"36702"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"36703"},{"source":"colorectal neoplasms","target":"birinapant (u)","id":"36704"},{"source":"colorectal neoplasms","target":"UNK : Drug","id":"36705"},{"source":"IAP antagonist","target":"UNK : Indication","id":"36706"},{"source":"IAP antagonist","target":"colorectal neoplasms","id":"36707"},{"source":"IAP antagonist","target":"colorectal cancer","id":"36708"},{"source":"IAP antagonist","target":"anti-hiv","id":"36709"},{"source":"IAP antagonist","target":"colonic neoplasms","id":"36710"},{"source":"IAP antagonist","target":"carcinoma","id":"36711"},{"source":"IAP antagonist","target":"anticancer","id":"36712"},{"source":"IAP antagonist","target":"hiv infections","id":"36713"},{"source":"IAP antagonist","target":"acquired immunodeficiency syndrome","id":"36714"},{"source":"IAP antagonist","target":"colorectal neoplasms","id":"36715"},{"source":"Oncology: Colorectal","target":"IAP antagonist","id":"36716"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"36717"},{"source":"cisplatin","target":"(Other Hospital/Academic/Medical Center)","id":"36718"},{"source":"radiation therapy","target":"(Other Hospital/Academic/Medical Center)","id":"36719"},{"source":"surgical intervention","target":"(Other Hospital/Academic/Medical Center)","id":"36720"},{"source":"UNK : Indication","target":"pembrolizumab","id":"36721"},{"source":"UNK : Indication","target":"cisplatin","id":"36722"},{"source":"UNK : Indication","target":"radiation therapy","id":"36723"},{"source":"UNK : Indication","target":"surgical intervention","id":"36724"},{"source":"carcinoma","target":"pembrolizumab","id":"36725"},{"source":"carcinoma","target":"cisplatin","id":"36726"},{"source":"carcinoma","target":"radiation therapy","id":"36727"},{"source":"carcinoma","target":"surgical intervention","id":"36728"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"36729"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"36730"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"36731"},{"source":"squamous cell neoplasms","target":"surgical intervention","id":"36732"},{"source":"anticancer","target":"pembrolizumab","id":"36733"},{"source":"anticancer","target":"cisplatin","id":"36734"},{"source":"anticancer","target":"radiation therapy","id":"36735"},{"source":"anticancer","target":"surgical intervention","id":"36736"},{"source":"carcinoma","target":"pembrolizumab","id":"36737"},{"source":"carcinoma","target":"cisplatin","id":"36738"},{"source":"carcinoma","target":"radiation therapy","id":"36739"},{"source":"carcinoma","target":"surgical intervention","id":"36740"},{"source":"carcinoma","target":"pembrolizumab","id":"36741"},{"source":"carcinoma","target":"cisplatin","id":"36742"},{"source":"carcinoma","target":"radiation therapy","id":"36743"},{"source":"carcinoma","target":"surgical intervention","id":"36744"},{"source":"carcinoma","target":"pembrolizumab","id":"36745"},{"source":"carcinoma","target":"cisplatin","id":"36746"},{"source":"carcinoma","target":"radiation therapy","id":"36747"},{"source":"carcinoma","target":"surgical intervention","id":"36748"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"36749"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"36750"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"36751"},{"source":"squamous cell neoplasms","target":"surgical intervention","id":"36752"},{"source":"carcinoma","target":"pembrolizumab","id":"36753"},{"source":"carcinoma","target":"cisplatin","id":"36754"},{"source":"carcinoma","target":"radiation therapy","id":"36755"},{"source":"carcinoma","target":"surgical intervention","id":"36756"},{"source":"carcinoma","target":"pembrolizumab","id":"36757"},{"source":"carcinoma","target":"cisplatin","id":"36758"},{"source":"carcinoma","target":"radiation therapy","id":"36759"},{"source":"carcinoma","target":"surgical intervention","id":"36760"},{"source":"anticancer","target":"pembrolizumab","id":"36761"},{"source":"anticancer","target":"cisplatin","id":"36762"},{"source":"anticancer","target":"radiation therapy","id":"36763"},{"source":"anticancer","target":"surgical intervention","id":"36764"},{"source":"skin neoplasms","target":"pembrolizumab","id":"36765"},{"source":"skin neoplasms","target":"cisplatin","id":"36766"},{"source":"skin neoplasms","target":"radiation therapy","id":"36767"},{"source":"skin neoplasms","target":"surgical intervention","id":"36768"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"36769"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"36770"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"36771"},{"source":"pharyngeal neoplasms","target":"surgical intervention","id":"36772"},{"source":"carcinoma","target":"pembrolizumab","id":"36773"},{"source":"carcinoma","target":"cisplatin","id":"36774"},{"source":"carcinoma","target":"radiation therapy","id":"36775"},{"source":"carcinoma","target":"surgical intervention","id":"36776"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"36777"},{"source":"head and neck neoplasms","target":"cisplatin","id":"36778"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"36779"},{"source":"head and neck neoplasms","target":"surgical intervention","id":"36780"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"36781"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36782"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"36783"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36784"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36785"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36786"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36787"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"36788"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36789"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36790"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36791"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"36792"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"36793"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36794"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"36795"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"36796"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36797"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"36798"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36799"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36800"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36801"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36802"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"36803"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36804"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36805"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36806"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"36807"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"36808"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36809"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"36810"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"36811"},{"source":"CD19 antagonist","target":"carcinoma","id":"36812"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"36813"},{"source":"CD19 antagonist","target":"anticancer","id":"36814"},{"source":"CD19 antagonist","target":"carcinoma","id":"36815"},{"source":"CD19 antagonist","target":"carcinoma","id":"36816"},{"source":"CD19 antagonist","target":"carcinoma","id":"36817"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"36818"},{"source":"CD19 antagonist","target":"carcinoma","id":"36819"},{"source":"CD19 antagonist","target":"carcinoma","id":"36820"},{"source":"CD19 antagonist","target":"anticancer","id":"36821"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"36822"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"36823"},{"source":"CD19 antagonist","target":"carcinoma","id":"36824"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"36825"},{"source":"UPA","target":"UNK : Indication","id":"36826"},{"source":"UPA","target":"carcinoma","id":"36827"},{"source":"UPA","target":"squamous cell neoplasms","id":"36828"},{"source":"UPA","target":"anticancer","id":"36829"},{"source":"UPA","target":"carcinoma","id":"36830"},{"source":"UPA","target":"carcinoma","id":"36831"},{"source":"UPA","target":"carcinoma","id":"36832"},{"source":"UPA","target":"squamous cell neoplasms","id":"36833"},{"source":"UPA","target":"carcinoma","id":"36834"},{"source":"UPA","target":"carcinoma","id":"36835"},{"source":"UPA","target":"anticancer","id":"36836"},{"source":"UPA","target":"skin neoplasms","id":"36837"},{"source":"UPA","target":"pharyngeal neoplasms","id":"36838"},{"source":"UPA","target":"carcinoma","id":"36839"},{"source":"UPA","target":"head and neck neoplasms","id":"36840"},{"source":"NA","target":"UNK : Indication","id":"36841"},{"source":"NA","target":"carcinoma","id":"36842"},{"source":"NA","target":"squamous cell neoplasms","id":"36843"},{"source":"NA","target":"anticancer","id":"36844"},{"source":"NA","target":"carcinoma","id":"36845"},{"source":"NA","target":"carcinoma","id":"36846"},{"source":"NA","target":"carcinoma","id":"36847"},{"source":"NA","target":"squamous cell neoplasms","id":"36848"},{"source":"NA","target":"carcinoma","id":"36849"},{"source":"NA","target":"carcinoma","id":"36850"},{"source":"NA","target":"anticancer","id":"36851"},{"source":"NA","target":"skin neoplasms","id":"36852"},{"source":"NA","target":"pharyngeal neoplasms","id":"36853"},{"source":"NA","target":"carcinoma","id":"36854"},{"source":"NA","target":"head and neck neoplasms","id":"36855"},{"source":"NA","target":"UNK : Indication","id":"36856"},{"source":"NA","target":"carcinoma","id":"36857"},{"source":"NA","target":"squamous cell neoplasms","id":"36858"},{"source":"NA","target":"anticancer","id":"36859"},{"source":"NA","target":"carcinoma","id":"36860"},{"source":"NA","target":"carcinoma","id":"36861"},{"source":"NA","target":"carcinoma","id":"36862"},{"source":"NA","target":"squamous cell neoplasms","id":"36863"},{"source":"NA","target":"carcinoma","id":"36864"},{"source":"NA","target":"carcinoma","id":"36865"},{"source":"NA","target":"anticancer","id":"36866"},{"source":"NA","target":"skin neoplasms","id":"36867"},{"source":"NA","target":"pharyngeal neoplasms","id":"36868"},{"source":"NA","target":"carcinoma","id":"36869"},{"source":"NA","target":"head and neck neoplasms","id":"36870"},{"source":"NA","target":"UNK : Indication","id":"36871"},{"source":"NA","target":"carcinoma","id":"36872"},{"source":"NA","target":"squamous cell neoplasms","id":"36873"},{"source":"NA","target":"anticancer","id":"36874"},{"source":"NA","target":"carcinoma","id":"36875"},{"source":"NA","target":"carcinoma","id":"36876"},{"source":"NA","target":"carcinoma","id":"36877"},{"source":"NA","target":"squamous cell neoplasms","id":"36878"},{"source":"NA","target":"carcinoma","id":"36879"},{"source":"NA","target":"carcinoma","id":"36880"},{"source":"NA","target":"anticancer","id":"36881"},{"source":"NA","target":"skin neoplasms","id":"36882"},{"source":"NA","target":"pharyngeal neoplasms","id":"36883"},{"source":"NA","target":"carcinoma","id":"36884"},{"source":"NA","target":"head and neck neoplasms","id":"36885"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"36886"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"36887"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"36888"},{"source":"Oncology: Head/Neck","target":"UPA","id":"36889"},{"source":"Oncology: Head/Neck","target":"NA","id":"36890"},{"source":"Oncology: Head/Neck","target":"NA","id":"36891"},{"source":"Oncology: Head/Neck","target":"NA","id":"36892"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"36893"},{"source":"cisplatin","target":"(Other Hospital/Academic/Medical Center)","id":"36894"},{"source":"radiation therapy","target":"(Other Hospital/Academic/Medical Center)","id":"36895"},{"source":"surgical intervention","target":"(Other Hospital/Academic/Medical Center)","id":"36896"},{"source":"UNK : Indication","target":"pembrolizumab","id":"36897"},{"source":"UNK : Indication","target":"cisplatin","id":"36898"},{"source":"UNK : Indication","target":"radiation therapy","id":"36899"},{"source":"UNK : Indication","target":"surgical intervention","id":"36900"},{"source":"carcinoma","target":"pembrolizumab","id":"36901"},{"source":"carcinoma","target":"cisplatin","id":"36902"},{"source":"carcinoma","target":"radiation therapy","id":"36903"},{"source":"carcinoma","target":"surgical intervention","id":"36904"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"36905"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"36906"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"36907"},{"source":"squamous cell neoplasms","target":"surgical intervention","id":"36908"},{"source":"anticancer","target":"pembrolizumab","id":"36909"},{"source":"anticancer","target":"cisplatin","id":"36910"},{"source":"anticancer","target":"radiation therapy","id":"36911"},{"source":"anticancer","target":"surgical intervention","id":"36912"},{"source":"carcinoma","target":"pembrolizumab","id":"36913"},{"source":"carcinoma","target":"cisplatin","id":"36914"},{"source":"carcinoma","target":"radiation therapy","id":"36915"},{"source":"carcinoma","target":"surgical intervention","id":"36916"},{"source":"carcinoma","target":"pembrolizumab","id":"36917"},{"source":"carcinoma","target":"cisplatin","id":"36918"},{"source":"carcinoma","target":"radiation therapy","id":"36919"},{"source":"carcinoma","target":"surgical intervention","id":"36920"},{"source":"carcinoma","target":"pembrolizumab","id":"36921"},{"source":"carcinoma","target":"cisplatin","id":"36922"},{"source":"carcinoma","target":"radiation therapy","id":"36923"},{"source":"carcinoma","target":"surgical intervention","id":"36924"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"36925"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"36926"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"36927"},{"source":"squamous cell neoplasms","target":"surgical intervention","id":"36928"},{"source":"carcinoma","target":"pembrolizumab","id":"36929"},{"source":"carcinoma","target":"cisplatin","id":"36930"},{"source":"carcinoma","target":"radiation therapy","id":"36931"},{"source":"carcinoma","target":"surgical intervention","id":"36932"},{"source":"carcinoma","target":"pembrolizumab","id":"36933"},{"source":"carcinoma","target":"cisplatin","id":"36934"},{"source":"carcinoma","target":"radiation therapy","id":"36935"},{"source":"carcinoma","target":"surgical intervention","id":"36936"},{"source":"anticancer","target":"pembrolizumab","id":"36937"},{"source":"anticancer","target":"cisplatin","id":"36938"},{"source":"anticancer","target":"radiation therapy","id":"36939"},{"source":"anticancer","target":"surgical intervention","id":"36940"},{"source":"skin neoplasms","target":"pembrolizumab","id":"36941"},{"source":"skin neoplasms","target":"cisplatin","id":"36942"},{"source":"skin neoplasms","target":"radiation therapy","id":"36943"},{"source":"skin neoplasms","target":"surgical intervention","id":"36944"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"36945"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"36946"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"36947"},{"source":"pharyngeal neoplasms","target":"surgical intervention","id":"36948"},{"source":"carcinoma","target":"pembrolizumab","id":"36949"},{"source":"carcinoma","target":"cisplatin","id":"36950"},{"source":"carcinoma","target":"radiation therapy","id":"36951"},{"source":"carcinoma","target":"surgical intervention","id":"36952"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"36953"},{"source":"head and neck neoplasms","target":"cisplatin","id":"36954"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"36955"},{"source":"head and neck neoplasms","target":"surgical intervention","id":"36956"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"36957"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36958"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"36959"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36960"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36961"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36962"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36963"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"36964"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36965"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36966"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"36967"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"36968"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"36969"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"36970"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"36971"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"36972"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36973"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"36974"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36975"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36976"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36977"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36978"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"36979"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36980"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36981"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"36982"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"36983"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"36984"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"36985"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"36986"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"36987"},{"source":"CD19 antagonist","target":"carcinoma","id":"36988"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"36989"},{"source":"CD19 antagonist","target":"anticancer","id":"36990"},{"source":"CD19 antagonist","target":"carcinoma","id":"36991"},{"source":"CD19 antagonist","target":"carcinoma","id":"36992"},{"source":"CD19 antagonist","target":"carcinoma","id":"36993"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"36994"},{"source":"CD19 antagonist","target":"carcinoma","id":"36995"},{"source":"CD19 antagonist","target":"carcinoma","id":"36996"},{"source":"CD19 antagonist","target":"anticancer","id":"36997"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"36998"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"36999"},{"source":"CD19 antagonist","target":"carcinoma","id":"37000"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"37001"},{"source":"UPA","target":"UNK : Indication","id":"37002"},{"source":"UPA","target":"carcinoma","id":"37003"},{"source":"UPA","target":"squamous cell neoplasms","id":"37004"},{"source":"UPA","target":"anticancer","id":"37005"},{"source":"UPA","target":"carcinoma","id":"37006"},{"source":"UPA","target":"carcinoma","id":"37007"},{"source":"UPA","target":"carcinoma","id":"37008"},{"source":"UPA","target":"squamous cell neoplasms","id":"37009"},{"source":"UPA","target":"carcinoma","id":"37010"},{"source":"UPA","target":"carcinoma","id":"37011"},{"source":"UPA","target":"anticancer","id":"37012"},{"source":"UPA","target":"skin neoplasms","id":"37013"},{"source":"UPA","target":"pharyngeal neoplasms","id":"37014"},{"source":"UPA","target":"carcinoma","id":"37015"},{"source":"UPA","target":"head and neck neoplasms","id":"37016"},{"source":"NA","target":"UNK : Indication","id":"37017"},{"source":"NA","target":"carcinoma","id":"37018"},{"source":"NA","target":"squamous cell neoplasms","id":"37019"},{"source":"NA","target":"anticancer","id":"37020"},{"source":"NA","target":"carcinoma","id":"37021"},{"source":"NA","target":"carcinoma","id":"37022"},{"source":"NA","target":"carcinoma","id":"37023"},{"source":"NA","target":"squamous cell neoplasms","id":"37024"},{"source":"NA","target":"carcinoma","id":"37025"},{"source":"NA","target":"carcinoma","id":"37026"},{"source":"NA","target":"anticancer","id":"37027"},{"source":"NA","target":"skin neoplasms","id":"37028"},{"source":"NA","target":"pharyngeal neoplasms","id":"37029"},{"source":"NA","target":"carcinoma","id":"37030"},{"source":"NA","target":"head and neck neoplasms","id":"37031"},{"source":"NA","target":"UNK : Indication","id":"37032"},{"source":"NA","target":"carcinoma","id":"37033"},{"source":"NA","target":"squamous cell neoplasms","id":"37034"},{"source":"NA","target":"anticancer","id":"37035"},{"source":"NA","target":"carcinoma","id":"37036"},{"source":"NA","target":"carcinoma","id":"37037"},{"source":"NA","target":"carcinoma","id":"37038"},{"source":"NA","target":"squamous cell neoplasms","id":"37039"},{"source":"NA","target":"carcinoma","id":"37040"},{"source":"NA","target":"carcinoma","id":"37041"},{"source":"NA","target":"anticancer","id":"37042"},{"source":"NA","target":"skin neoplasms","id":"37043"},{"source":"NA","target":"pharyngeal neoplasms","id":"37044"},{"source":"NA","target":"carcinoma","id":"37045"},{"source":"NA","target":"head and neck neoplasms","id":"37046"},{"source":"NA","target":"UNK : Indication","id":"37047"},{"source":"NA","target":"carcinoma","id":"37048"},{"source":"NA","target":"squamous cell neoplasms","id":"37049"},{"source":"NA","target":"anticancer","id":"37050"},{"source":"NA","target":"carcinoma","id":"37051"},{"source":"NA","target":"carcinoma","id":"37052"},{"source":"NA","target":"carcinoma","id":"37053"},{"source":"NA","target":"squamous cell neoplasms","id":"37054"},{"source":"NA","target":"carcinoma","id":"37055"},{"source":"NA","target":"carcinoma","id":"37056"},{"source":"NA","target":"anticancer","id":"37057"},{"source":"NA","target":"skin neoplasms","id":"37058"},{"source":"NA","target":"pharyngeal neoplasms","id":"37059"},{"source":"NA","target":"carcinoma","id":"37060"},{"source":"NA","target":"head and neck neoplasms","id":"37061"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"37062"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"37063"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"37064"},{"source":"Oncology: Head/Neck","target":"UPA","id":"37065"},{"source":"Oncology: Head/Neck","target":"NA","id":"37066"},{"source":"Oncology: Head/Neck","target":"NA","id":"37067"},{"source":"Oncology: Head/Neck","target":"NA","id":"37068"},{"source":"epacadostat (u)","target":"Incyte Corporation","id":"37069"},{"source":"epacadostat (u)","target":"Merck & Co.","id":"37070"},{"source":"pembrolizumab","target":"Incyte Corporation","id":"37071"},{"source":"pembrolizumab","target":"Merck & Co.","id":"37072"},{"source":"UNK : Drug","target":"Incyte Corporation","id":"37073"},{"source":"UNK : Drug","target":"Merck & Co.","id":"37074"},{"source":"UNK : Indication","target":"epacadostat (u)","id":"37075"},{"source":"UNK : Indication","target":"pembrolizumab","id":"37076"},{"source":"UNK : Indication","target":"UNK : Drug","id":"37077"},{"source":"neuropathy","target":"epacadostat (u)","id":"37078"},{"source":"neuropathy","target":"pembrolizumab","id":"37079"},{"source":"neuropathy","target":"UNK : Drug","id":"37080"},{"source":"alopecia","target":"epacadostat (u)","id":"37081"},{"source":"alopecia","target":"pembrolizumab","id":"37082"},{"source":"alopecia","target":"UNK : Drug","id":"37083"},{"source":"kidney neoplasms","target":"epacadostat (u)","id":"37084"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"37085"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"37086"},{"source":"transitional","target":"epacadostat (u)","id":"37087"},{"source":"transitional","target":"pembrolizumab","id":"37088"},{"source":"transitional","target":"UNK : Drug","id":"37089"},{"source":"residual tumor","target":"epacadostat (u)","id":"37090"},{"source":"residual tumor","target":"pembrolizumab","id":"37091"},{"source":"residual tumor","target":"UNK : Drug","id":"37092"},{"source":"bladder cancer","target":"epacadostat (u)","id":"37093"},{"source":"bladder cancer","target":"pembrolizumab","id":"37094"},{"source":"bladder cancer","target":"UNK : Drug","id":"37095"},{"source":"metastatic","target":"epacadostat (u)","id":"37096"},{"source":"metastatic","target":"pembrolizumab","id":"37097"},{"source":"metastatic","target":"UNK : Drug","id":"37098"},{"source":"carcinoma","target":"epacadostat (u)","id":"37099"},{"source":"carcinoma","target":"pembrolizumab","id":"37100"},{"source":"carcinoma","target":"UNK : Drug","id":"37101"},{"source":"neoplasm metastasis","target":"epacadostat (u)","id":"37102"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"37103"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"37104"},{"source":"anticancer","target":"epacadostat (u)","id":"37105"},{"source":"anticancer","target":"pembrolizumab","id":"37106"},{"source":"anticancer","target":"UNK : Drug","id":"37107"},{"source":"urinary bladder neoplasms","target":"epacadostat (u)","id":"37108"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"37109"},{"source":"urinary bladder neoplasms","target":"UNK : Drug","id":"37110"},{"source":"carcinoma","target":"epacadostat (u)","id":"37111"},{"source":"carcinoma","target":"pembrolizumab","id":"37112"},{"source":"carcinoma","target":"UNK : Drug","id":"37113"},{"source":"carcinoma","target":"epacadostat (u)","id":"37114"},{"source":"carcinoma","target":"pembrolizumab","id":"37115"},{"source":"carcinoma","target":"UNK : Drug","id":"37116"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"37117"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"37118"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"37119"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"37120"},{"source":"Anticancer immunotherapy","target":"transitional","id":"37121"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"37122"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"37123"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"37124"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37125"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"37126"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"37127"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"37128"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37129"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37130"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"37131"},{"source":"CD19 antagonist","target":"neuropathy","id":"37132"},{"source":"CD19 antagonist","target":"alopecia","id":"37133"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"37134"},{"source":"CD19 antagonist","target":"transitional","id":"37135"},{"source":"CD19 antagonist","target":"residual tumor","id":"37136"},{"source":"CD19 antagonist","target":"bladder cancer","id":"37137"},{"source":"CD19 antagonist","target":"metastatic","id":"37138"},{"source":"CD19 antagonist","target":"carcinoma","id":"37139"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"37140"},{"source":"CD19 antagonist","target":"anticancer","id":"37141"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"37142"},{"source":"CD19 antagonist","target":"carcinoma","id":"37143"},{"source":"CD19 antagonist","target":"carcinoma","id":"37144"},{"source":"Indoleamine-pyrrole 2","target":"UNK : Indication","id":"37145"},{"source":"Indoleamine-pyrrole 2","target":"neuropathy","id":"37146"},{"source":"Indoleamine-pyrrole 2","target":"alopecia","id":"37147"},{"source":"Indoleamine-pyrrole 2","target":"kidney neoplasms","id":"37148"},{"source":"Indoleamine-pyrrole 2","target":"transitional","id":"37149"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"37150"},{"source":"Indoleamine-pyrrole 2","target":"bladder cancer","id":"37151"},{"source":"Indoleamine-pyrrole 2","target":"metastatic","id":"37152"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"37153"},{"source":"Indoleamine-pyrrole 2","target":"neoplasm metastasis","id":"37154"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"37155"},{"source":"Indoleamine-pyrrole 2","target":"urinary bladder neoplasms","id":"37156"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"37157"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"37158"},{"source":"NA","target":"UNK : Indication","id":"37159"},{"source":"NA","target":"neuropathy","id":"37160"},{"source":"NA","target":"alopecia","id":"37161"},{"source":"NA","target":"kidney neoplasms","id":"37162"},{"source":"NA","target":"transitional","id":"37163"},{"source":"NA","target":"residual tumor","id":"37164"},{"source":"NA","target":"bladder cancer","id":"37165"},{"source":"NA","target":"metastatic","id":"37166"},{"source":"NA","target":"carcinoma","id":"37167"},{"source":"NA","target":"neoplasm metastasis","id":"37168"},{"source":"NA","target":"anticancer","id":"37169"},{"source":"NA","target":"urinary bladder neoplasms","id":"37170"},{"source":"NA","target":"carcinoma","id":"37171"},{"source":"NA","target":"carcinoma","id":"37172"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"37173"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"37174"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"37175"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"37176"},{"source":"Immune checkpoint inhibitor","target":"transitional","id":"37177"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"37178"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"37179"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"37180"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37181"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"37182"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"37183"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"37184"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37185"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37186"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"37187"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"37188"},{"source":"Oncology: Bladder","target":"Indoleamine-pyrrole 2","id":"37189"},{"source":"Oncology: Bladder","target":"NA","id":"37190"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"37191"},{"source":"pembrolizumab","target":"Merck & Co.","id":"37192"},{"source":"b-vedotin","target":"Merck & Co.","id":"37193"},{"source":"lymphoma","target":"pembrolizumab","id":"37194"},{"source":"lymphoma","target":"b-vedotin","id":"37195"},{"source":"hodgkin disease","target":"pembrolizumab","id":"37196"},{"source":"hodgkin disease","target":"b-vedotin","id":"37197"},{"source":"carcinoma","target":"pembrolizumab","id":"37198"},{"source":"carcinoma","target":"b-vedotin","id":"37199"},{"source":"anticancer","target":"pembrolizumab","id":"37200"},{"source":"anticancer","target":"b-vedotin","id":"37201"},{"source":"lymphoma","target":"pembrolizumab","id":"37202"},{"source":"lymphoma","target":"b-vedotin","id":"37203"},{"source":"lymphoma","target":"pembrolizumab","id":"37204"},{"source":"lymphoma","target":"b-vedotin","id":"37205"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"37206"},{"source":"Anticancer immunotherapy","target":"hodgkin disease","id":"37207"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37208"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"37209"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"37210"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"37211"},{"source":"CD19 antagonist","target":"lymphoma","id":"37212"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"37213"},{"source":"CD19 antagonist","target":"carcinoma","id":"37214"},{"source":"CD19 antagonist","target":"anticancer","id":"37215"},{"source":"CD19 antagonist","target":"lymphoma","id":"37216"},{"source":"CD19 antagonist","target":"lymphoma","id":"37217"},{"source":"Tubulin inhibitor","target":"lymphoma","id":"37218"},{"source":"Tubulin inhibitor","target":"hodgkin disease","id":"37219"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"37220"},{"source":"Tubulin inhibitor","target":"anticancer","id":"37221"},{"source":"Tubulin inhibitor","target":"lymphoma","id":"37222"},{"source":"Tubulin inhibitor","target":"lymphoma","id":"37223"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"37224"},{"source":"Immune checkpoint inhibitor","target":"hodgkin disease","id":"37225"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37226"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"37227"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"37228"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"37229"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"37230"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"37231"},{"source":"Oncology: Lymphoma","target":"Tubulin inhibitor","id":"37232"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"37233"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"37234"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"37235"},{"source":"Hodgkin's","target":"Tubulin inhibitor","id":"37236"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"37237"},{"source":"pembrolizumab","target":"Merck & Co.","id":"37238"},{"source":"docetaxel","target":"Merck & Co.","id":"37239"},{"source":"irinotecan (IV)","target":"Merck & Co.","id":"37240"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"37241"},{"source":"carcinoma","target":"pembrolizumab","id":"37242"},{"source":"carcinoma","target":"docetaxel","id":"37243"},{"source":"carcinoma","target":"irinotecan (IV)","id":"37244"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"37245"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"37246"},{"source":"pharyngeal neoplasms","target":"docetaxel","id":"37247"},{"source":"pharyngeal neoplasms","target":"irinotecan (IV)","id":"37248"},{"source":"pharyngeal neoplasms","target":"nab-paclitaxel (IV)","id":"37249"},{"source":"carcinoma","target":"pembrolizumab","id":"37250"},{"source":"carcinoma","target":"docetaxel","id":"37251"},{"source":"carcinoma","target":"irinotecan (IV)","id":"37252"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"37253"},{"source":"solid tumors","target":"pembrolizumab","id":"37254"},{"source":"solid tumors","target":"docetaxel","id":"37255"},{"source":"solid tumors","target":"irinotecan (IV)","id":"37256"},{"source":"solid tumors","target":"nab-paclitaxel (IV)","id":"37257"},{"source":"malaria","target":"pembrolizumab","id":"37258"},{"source":"malaria","target":"docetaxel","id":"37259"},{"source":"malaria","target":"irinotecan (IV)","id":"37260"},{"source":"malaria","target":"nab-paclitaxel (IV)","id":"37261"},{"source":"esophageal cancer","target":"pembrolizumab","id":"37262"},{"source":"esophageal cancer","target":"docetaxel","id":"37263"},{"source":"esophageal cancer","target":"irinotecan (IV)","id":"37264"},{"source":"esophageal cancer","target":"nab-paclitaxel (IV)","id":"37265"},{"source":"carcinoma","target":"pembrolizumab","id":"37266"},{"source":"carcinoma","target":"docetaxel","id":"37267"},{"source":"carcinoma","target":"irinotecan (IV)","id":"37268"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"37269"},{"source":"skin neoplasms","target":"pembrolizumab","id":"37270"},{"source":"skin neoplasms","target":"docetaxel","id":"37271"},{"source":"skin neoplasms","target":"irinotecan (IV)","id":"37272"},{"source":"skin neoplasms","target":"nab-paclitaxel (IV)","id":"37273"},{"source":"residual tumor","target":"pembrolizumab","id":"37274"},{"source":"residual tumor","target":"docetaxel","id":"37275"},{"source":"residual tumor","target":"irinotecan (IV)","id":"37276"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"37277"},{"source":"malaria","target":"pembrolizumab","id":"37278"},{"source":"malaria","target":"docetaxel","id":"37279"},{"source":"malaria","target":"irinotecan (IV)","id":"37280"},{"source":"malaria","target":"nab-paclitaxel (IV)","id":"37281"},{"source":"carcinoma","target":"pembrolizumab","id":"37282"},{"source":"carcinoma","target":"docetaxel","id":"37283"},{"source":"carcinoma","target":"irinotecan (IV)","id":"37284"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"37285"},{"source":"metastatic","target":"pembrolizumab","id":"37286"},{"source":"metastatic","target":"docetaxel","id":"37287"},{"source":"metastatic","target":"irinotecan (IV)","id":"37288"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"37289"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"37290"},{"source":"neoplasm metastasis","target":"docetaxel","id":"37291"},{"source":"neoplasm metastasis","target":"irinotecan (IV)","id":"37292"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"37293"},{"source":"carcinoma","target":"pembrolizumab","id":"37294"},{"source":"carcinoma","target":"docetaxel","id":"37295"},{"source":"carcinoma","target":"irinotecan (IV)","id":"37296"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"37297"},{"source":"barrett esophagus","target":"pembrolizumab","id":"37298"},{"source":"barrett esophagus","target":"docetaxel","id":"37299"},{"source":"barrett esophagus","target":"irinotecan (IV)","id":"37300"},{"source":"barrett esophagus","target":"nab-paclitaxel (IV)","id":"37301"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"37302"},{"source":"squamous cell neoplasms","target":"docetaxel","id":"37303"},{"source":"squamous cell neoplasms","target":"irinotecan (IV)","id":"37304"},{"source":"squamous cell neoplasms","target":"nab-paclitaxel (IV)","id":"37305"},{"source":"UNK : Indication","target":"pembrolizumab","id":"37306"},{"source":"UNK : Indication","target":"docetaxel","id":"37307"},{"source":"UNK : Indication","target":"irinotecan (IV)","id":"37308"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"37309"},{"source":"anticancer","target":"pembrolizumab","id":"37310"},{"source":"anticancer","target":"docetaxel","id":"37311"},{"source":"anticancer","target":"irinotecan (IV)","id":"37312"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"37313"},{"source":"solid tumors","target":"pembrolizumab","id":"37314"},{"source":"solid tumors","target":"docetaxel","id":"37315"},{"source":"solid tumors","target":"irinotecan (IV)","id":"37316"},{"source":"solid tumors","target":"nab-paclitaxel (IV)","id":"37317"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37318"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"37319"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37320"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"37321"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"37322"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"37323"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37324"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"37325"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"37326"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"37327"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37328"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"37329"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"37330"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37331"},{"source":"Immune checkpoint inhibitor","target":"barrett esophagus","id":"37332"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"37333"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"37334"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"37335"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"37336"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37337"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"37338"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37339"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"37340"},{"source":"Anticancer immunotherapy","target":"malaria","id":"37341"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"37342"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37343"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"37344"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"37345"},{"source":"Anticancer immunotherapy","target":"malaria","id":"37346"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37347"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"37348"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"37349"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37350"},{"source":"Anticancer immunotherapy","target":"barrett esophagus","id":"37351"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"37352"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"37353"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"37354"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"37355"},{"source":"CD19 antagonist","target":"carcinoma","id":"37356"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"37357"},{"source":"CD19 antagonist","target":"carcinoma","id":"37358"},{"source":"CD19 antagonist","target":"solid tumors","id":"37359"},{"source":"CD19 antagonist","target":"malaria","id":"37360"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"37361"},{"source":"CD19 antagonist","target":"carcinoma","id":"37362"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"37363"},{"source":"CD19 antagonist","target":"residual tumor","id":"37364"},{"source":"CD19 antagonist","target":"malaria","id":"37365"},{"source":"CD19 antagonist","target":"carcinoma","id":"37366"},{"source":"CD19 antagonist","target":"metastatic","id":"37367"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"37368"},{"source":"CD19 antagonist","target":"carcinoma","id":"37369"},{"source":"CD19 antagonist","target":"barrett esophagus","id":"37370"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"37371"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"37372"},{"source":"CD19 antagonist","target":"anticancer","id":"37373"},{"source":"CD19 antagonist","target":"solid tumors","id":"37374"},{"source":"NA","target":"carcinoma","id":"37375"},{"source":"NA","target":"pharyngeal neoplasms","id":"37376"},{"source":"NA","target":"carcinoma","id":"37377"},{"source":"NA","target":"solid tumors","id":"37378"},{"source":"NA","target":"malaria","id":"37379"},{"source":"NA","target":"esophageal cancer","id":"37380"},{"source":"NA","target":"carcinoma","id":"37381"},{"source":"NA","target":"skin neoplasms","id":"37382"},{"source":"NA","target":"residual tumor","id":"37383"},{"source":"NA","target":"malaria","id":"37384"},{"source":"NA","target":"carcinoma","id":"37385"},{"source":"NA","target":"metastatic","id":"37386"},{"source":"NA","target":"neoplasm metastasis","id":"37387"},{"source":"NA","target":"carcinoma","id":"37388"},{"source":"NA","target":"barrett esophagus","id":"37389"},{"source":"NA","target":"squamous cell neoplasms","id":"37390"},{"source":"NA","target":"UNK : Indication","id":"37391"},{"source":"NA","target":"anticancer","id":"37392"},{"source":"NA","target":"solid tumors","id":"37393"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"37394"},{"source":"Beta tubulin antagonist","target":"pharyngeal neoplasms","id":"37395"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"37396"},{"source":"Beta tubulin antagonist","target":"solid tumors","id":"37397"},{"source":"Beta tubulin antagonist","target":"malaria","id":"37398"},{"source":"Beta tubulin antagonist","target":"esophageal cancer","id":"37399"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"37400"},{"source":"Beta tubulin antagonist","target":"skin neoplasms","id":"37401"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"37402"},{"source":"Beta tubulin antagonist","target":"malaria","id":"37403"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"37404"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"37405"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"37406"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"37407"},{"source":"Beta tubulin antagonist","target":"barrett esophagus","id":"37408"},{"source":"Beta tubulin antagonist","target":"squamous cell neoplasms","id":"37409"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"37410"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"37411"},{"source":"Beta tubulin antagonist","target":"solid tumors","id":"37412"},{"source":"Microtubule stimulant","target":"carcinoma","id":"37413"},{"source":"Microtubule stimulant","target":"pharyngeal neoplasms","id":"37414"},{"source":"Microtubule stimulant","target":"carcinoma","id":"37415"},{"source":"Microtubule stimulant","target":"solid tumors","id":"37416"},{"source":"Microtubule stimulant","target":"malaria","id":"37417"},{"source":"Microtubule stimulant","target":"esophageal cancer","id":"37418"},{"source":"Microtubule stimulant","target":"carcinoma","id":"37419"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"37420"},{"source":"Microtubule stimulant","target":"residual tumor","id":"37421"},{"source":"Microtubule stimulant","target":"malaria","id":"37422"},{"source":"Microtubule stimulant","target":"carcinoma","id":"37423"},{"source":"Microtubule stimulant","target":"metastatic","id":"37424"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"37425"},{"source":"Microtubule stimulant","target":"carcinoma","id":"37426"},{"source":"Microtubule stimulant","target":"barrett esophagus","id":"37427"},{"source":"Microtubule stimulant","target":"squamous cell neoplasms","id":"37428"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"37429"},{"source":"Microtubule stimulant","target":"anticancer","id":"37430"},{"source":"Microtubule stimulant","target":"solid tumors","id":"37431"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"37432"},{"source":"Tubulin inhibitor","target":"pharyngeal neoplasms","id":"37433"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"37434"},{"source":"Tubulin inhibitor","target":"solid tumors","id":"37435"},{"source":"Tubulin inhibitor","target":"malaria","id":"37436"},{"source":"Tubulin inhibitor","target":"esophageal cancer","id":"37437"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"37438"},{"source":"Tubulin inhibitor","target":"skin neoplasms","id":"37439"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"37440"},{"source":"Tubulin inhibitor","target":"malaria","id":"37441"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"37442"},{"source":"Tubulin inhibitor","target":"metastatic","id":"37443"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"37444"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"37445"},{"source":"Tubulin inhibitor","target":"barrett esophagus","id":"37446"},{"source":"Tubulin inhibitor","target":"squamous cell neoplasms","id":"37447"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"37448"},{"source":"Tubulin inhibitor","target":"anticancer","id":"37449"},{"source":"Tubulin inhibitor","target":"solid tumors","id":"37450"},{"source":"Taxane","target":"carcinoma","id":"37451"},{"source":"Taxane","target":"pharyngeal neoplasms","id":"37452"},{"source":"Taxane","target":"carcinoma","id":"37453"},{"source":"Taxane","target":"solid tumors","id":"37454"},{"source":"Taxane","target":"malaria","id":"37455"},{"source":"Taxane","target":"esophageal cancer","id":"37456"},{"source":"Taxane","target":"carcinoma","id":"37457"},{"source":"Taxane","target":"skin neoplasms","id":"37458"},{"source":"Taxane","target":"residual tumor","id":"37459"},{"source":"Taxane","target":"malaria","id":"37460"},{"source":"Taxane","target":"carcinoma","id":"37461"},{"source":"Taxane","target":"metastatic","id":"37462"},{"source":"Taxane","target":"neoplasm metastasis","id":"37463"},{"source":"Taxane","target":"carcinoma","id":"37464"},{"source":"Taxane","target":"barrett esophagus","id":"37465"},{"source":"Taxane","target":"squamous cell neoplasms","id":"37466"},{"source":"Taxane","target":"UNK : Indication","id":"37467"},{"source":"Taxane","target":"anticancer","id":"37468"},{"source":"Taxane","target":"solid tumors","id":"37469"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"37470"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"37471"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"37472"},{"source":"Oncology: Esophageal","target":"NA","id":"37473"},{"source":"Oncology: Esophageal","target":"Beta tubulin antagonist","id":"37474"},{"source":"Oncology: Esophageal","target":"Microtubule stimulant","id":"37475"},{"source":"Oncology: Esophageal","target":"Tubulin inhibitor","id":"37476"},{"source":"Oncology: Esophageal","target":"Taxane","id":"37477"},{"source":"ARB-1598 (intratumoral) (u)","target":"Checkmate Pharmaceuticals","id":"37478"},{"source":"ARB-1598 (SC) (u)","target":"Checkmate Pharmaceuticals","id":"37479"},{"source":"pembrolizumab","target":"Checkmate Pharmaceuticals","id":"37480"},{"source":"UNK : Indication","target":"ARB-1598 (intratumoral) (u)","id":"37481"},{"source":"UNK : Indication","target":"ARB-1598 (SC) (u)","id":"37482"},{"source":"UNK : Indication","target":"pembrolizumab","id":"37483"},{"source":"melanoma","target":"ARB-1598 (intratumoral) (u)","id":"37484"},{"source":"melanoma","target":"ARB-1598 (SC) (u)","id":"37485"},{"source":"melanoma","target":"pembrolizumab","id":"37486"},{"source":"melanoma","target":"ARB-1598 (intratumoral) (u)","id":"37487"},{"source":"melanoma","target":"ARB-1598 (SC) (u)","id":"37488"},{"source":"melanoma","target":"pembrolizumab","id":"37489"},{"source":"melanoma","target":"ARB-1598 (intratumoral) (u)","id":"37490"},{"source":"melanoma","target":"ARB-1598 (SC) (u)","id":"37491"},{"source":"melanoma","target":"pembrolizumab","id":"37492"},{"source":"anti-tumor","target":"ARB-1598 (intratumoral) (u)","id":"37493"},{"source":"anti-tumor","target":"ARB-1598 (SC) (u)","id":"37494"},{"source":"anti-tumor","target":"pembrolizumab","id":"37495"},{"source":"skin neoplasms","target":"ARB-1598 (intratumoral) (u)","id":"37496"},{"source":"skin neoplasms","target":"ARB-1598 (SC) (u)","id":"37497"},{"source":"skin neoplasms","target":"pembrolizumab","id":"37498"},{"source":"metastatic","target":"ARB-1598 (intratumoral) (u)","id":"37499"},{"source":"metastatic","target":"ARB-1598 (SC) (u)","id":"37500"},{"source":"metastatic","target":"pembrolizumab","id":"37501"},{"source":"carcinoma","target":"ARB-1598 (intratumoral) (u)","id":"37502"},{"source":"carcinoma","target":"ARB-1598 (SC) (u)","id":"37503"},{"source":"carcinoma","target":"pembrolizumab","id":"37504"},{"source":"neoplasm metastasis","target":"ARB-1598 (intratumoral) (u)","id":"37505"},{"source":"neoplasm metastasis","target":"ARB-1598 (SC) (u)","id":"37506"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"37507"},{"source":"anticancer","target":"ARB-1598 (intratumoral) (u)","id":"37508"},{"source":"anticancer","target":"ARB-1598 (SC) (u)","id":"37509"},{"source":"anticancer","target":"pembrolizumab","id":"37510"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"37511"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"37512"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"37513"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"37514"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"37515"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"37516"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"37517"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37518"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"37519"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"37520"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"37521"},{"source":"CD19 antagonist","target":"melanoma","id":"37522"},{"source":"CD19 antagonist","target":"melanoma","id":"37523"},{"source":"CD19 antagonist","target":"melanoma","id":"37524"},{"source":"CD19 antagonist","target":"anti-tumor","id":"37525"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"37526"},{"source":"CD19 antagonist","target":"metastatic","id":"37527"},{"source":"CD19 antagonist","target":"carcinoma","id":"37528"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"37529"},{"source":"CD19 antagonist","target":"anticancer","id":"37530"},{"source":"Immunostimulant","target":"UNK : Indication","id":"37531"},{"source":"Immunostimulant","target":"melanoma","id":"37532"},{"source":"Immunostimulant","target":"melanoma","id":"37533"},{"source":"Immunostimulant","target":"melanoma","id":"37534"},{"source":"Immunostimulant","target":"anti-tumor","id":"37535"},{"source":"Immunostimulant","target":"skin neoplasms","id":"37536"},{"source":"Immunostimulant","target":"metastatic","id":"37537"},{"source":"Immunostimulant","target":"carcinoma","id":"37538"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"37539"},{"source":"Immunostimulant","target":"anticancer","id":"37540"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"37541"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"37542"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"37543"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"37544"},{"source":"Toll-like receptor 9 agonist","target":"anti-tumor","id":"37545"},{"source":"Toll-like receptor 9 agonist","target":"skin neoplasms","id":"37546"},{"source":"Toll-like receptor 9 agonist","target":"metastatic","id":"37547"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"37548"},{"source":"Toll-like receptor 9 agonist","target":"neoplasm metastasis","id":"37549"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"37550"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"37551"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"37552"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"37553"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"37554"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"37555"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"37556"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"37557"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"37558"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"37559"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"37560"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"37561"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"37562"},{"source":"Oncology: Melanoma","target":"Immunostimulant","id":"37563"},{"source":"Oncology: Melanoma","target":"Toll-like receptor 9 agonist","id":"37564"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"37565"},{"source":"lenvatinib (capsule) (a)","target":"Eisai","id":"37566"},{"source":"lenvatinib (capsule) (a)","target":"Merck & Co.","id":"37567"},{"source":"pembrolizumab","target":"Eisai","id":"37568"},{"source":"pembrolizumab","target":"Merck & Co.","id":"37569"},{"source":"UNK : Indication","target":"lenvatinib (capsule) (a)","id":"37570"},{"source":"UNK : Indication","target":"pembrolizumab","id":"37571"},{"source":"renal cancer","target":"lenvatinib (capsule) (a)","id":"37572"},{"source":"renal cancer","target":"pembrolizumab","id":"37573"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"37574"},{"source":"carcinoma","target":"pembrolizumab","id":"37575"},{"source":"azoospermia","target":"lenvatinib (capsule) (a)","id":"37576"},{"source":"azoospermia","target":"pembrolizumab","id":"37577"},{"source":"fallopian tube neoplasms","target":"lenvatinib (capsule) (a)","id":"37578"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"37579"},{"source":"non-small-cell lung","target":"lenvatinib (capsule) (a)","id":"37580"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"37581"},{"source":"hypertension","target":"lenvatinib (capsule) (a)","id":"37582"},{"source":"hypertension","target":"pembrolizumab","id":"37583"},{"source":"brain metastases","target":"lenvatinib (capsule) (a)","id":"37584"},{"source":"brain metastases","target":"pembrolizumab","id":"37585"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"37586"},{"source":"carcinoma","target":"pembrolizumab","id":"37587"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"37588"},{"source":"carcinoma","target":"pembrolizumab","id":"37589"},{"source":"liver neoplasms","target":"lenvatinib (capsule) (a)","id":"37590"},{"source":"liver neoplasms","target":"pembrolizumab","id":"37591"},{"source":"endometrial neoplasms","target":"lenvatinib (capsule) (a)","id":"37592"},{"source":"endometrial neoplasms","target":"pembrolizumab","id":"37593"},{"source":"non-small-cell lung","target":"lenvatinib (capsule) (a)","id":"37594"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"37595"},{"source":"melanoma","target":"lenvatinib (capsule) (a)","id":"37596"},{"source":"melanoma","target":"pembrolizumab","id":"37597"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"37598"},{"source":"solid tumors","target":"pembrolizumab","id":"37599"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"37600"},{"source":"carcinoma","target":"pembrolizumab","id":"37601"},{"source":"liver metastases","target":"lenvatinib (capsule) (a)","id":"37602"},{"source":"liver metastases","target":"pembrolizumab","id":"37603"},{"source":"amenorrheic","target":"lenvatinib (capsule) (a)","id":"37604"},{"source":"amenorrheic","target":"pembrolizumab","id":"37605"},{"source":"sclc","target":"lenvatinib (capsule) (a)","id":"37606"},{"source":"sclc","target":"pembrolizumab","id":"37607"},{"source":"head and neck neoplasms","target":"lenvatinib (capsule) (a)","id":"37608"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"37609"},{"source":"renal cell","target":"lenvatinib (capsule) (a)","id":"37610"},{"source":"renal cell","target":"pembrolizumab","id":"37611"},{"source":"antihypertensive","target":"lenvatinib (capsule) (a)","id":"37612"},{"source":"antihypertensive","target":"pembrolizumab","id":"37613"},{"source":"endometrioid","target":"lenvatinib (capsule) (a)","id":"37614"},{"source":"endometrioid","target":"pembrolizumab","id":"37615"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"37616"},{"source":"carcinoma","target":"pembrolizumab","id":"37617"},{"source":"kidney neoplasms","target":"lenvatinib (capsule) (a)","id":"37618"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"37619"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"37620"},{"source":"carcinoma","target":"pembrolizumab","id":"37621"},{"source":"cerebellar neoplasms","target":"lenvatinib (capsule) (a)","id":"37622"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"37623"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"37624"},{"source":"carcinoma","target":"pembrolizumab","id":"37625"},{"source":"neoplasm metastasis","target":"lenvatinib (capsule) (a)","id":"37626"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"37627"},{"source":"melanoma","target":"lenvatinib (capsule) (a)","id":"37628"},{"source":"melanoma","target":"pembrolizumab","id":"37629"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"37630"},{"source":"carcinoma","target":"pembrolizumab","id":"37631"},{"source":"ovarian neoplasms","target":"lenvatinib (capsule) (a)","id":"37632"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"37633"},{"source":"bone metastasis","target":"lenvatinib (capsule) (a)","id":"37634"},{"source":"bone metastasis","target":"pembrolizumab","id":"37635"},{"source":"residual tumor","target":"lenvatinib (capsule) (a)","id":"37636"},{"source":"residual tumor","target":"pembrolizumab","id":"37637"},{"source":"skin neoplasms","target":"lenvatinib (capsule) (a)","id":"37638"},{"source":"skin neoplasms","target":"pembrolizumab","id":"37639"},{"source":"residual tumor","target":"lenvatinib (capsule) (a)","id":"37640"},{"source":"residual tumor","target":"pembrolizumab","id":"37641"},{"source":"metastatic","target":"lenvatinib (capsule) (a)","id":"37642"},{"source":"metastatic","target":"pembrolizumab","id":"37643"},{"source":"amenorrheic","target":"lenvatinib (capsule) (a)","id":"37644"},{"source":"amenorrheic","target":"pembrolizumab","id":"37645"},{"source":"anticancer","target":"lenvatinib (capsule) (a)","id":"37646"},{"source":"anticancer","target":"pembrolizumab","id":"37647"},{"source":"urinary bladder neoplasms","target":"lenvatinib (capsule) (a)","id":"37648"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"37649"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"37650"},{"source":"solid tumors","target":"pembrolizumab","id":"37651"},{"source":"NA","target":"UNK : Indication","id":"37652"},{"source":"NA","target":"renal cancer","id":"37653"},{"source":"NA","target":"carcinoma","id":"37654"},{"source":"NA","target":"azoospermia","id":"37655"},{"source":"NA","target":"fallopian tube neoplasms","id":"37656"},{"source":"NA","target":"non-small-cell lung","id":"37657"},{"source":"NA","target":"hypertension","id":"37658"},{"source":"NA","target":"brain metastases","id":"37659"},{"source":"NA","target":"carcinoma","id":"37660"},{"source":"NA","target":"carcinoma","id":"37661"},{"source":"NA","target":"liver neoplasms","id":"37662"},{"source":"NA","target":"endometrial neoplasms","id":"37663"},{"source":"NA","target":"non-small-cell lung","id":"37664"},{"source":"NA","target":"melanoma","id":"37665"},{"source":"NA","target":"solid tumors","id":"37666"},{"source":"NA","target":"carcinoma","id":"37667"},{"source":"NA","target":"liver metastases","id":"37668"},{"source":"NA","target":"amenorrheic","id":"37669"},{"source":"NA","target":"sclc","id":"37670"},{"source":"NA","target":"head and neck neoplasms","id":"37671"},{"source":"NA","target":"renal cell","id":"37672"},{"source":"NA","target":"antihypertensive","id":"37673"},{"source":"NA","target":"endometrioid","id":"37674"},{"source":"NA","target":"carcinoma","id":"37675"},{"source":"NA","target":"kidney neoplasms","id":"37676"},{"source":"NA","target":"carcinoma","id":"37677"},{"source":"NA","target":"cerebellar neoplasms","id":"37678"},{"source":"NA","target":"carcinoma","id":"37679"},{"source":"NA","target":"neoplasm metastasis","id":"37680"},{"source":"NA","target":"melanoma","id":"37681"},{"source":"NA","target":"carcinoma","id":"37682"},{"source":"NA","target":"ovarian neoplasms","id":"37683"},{"source":"NA","target":"bone metastasis","id":"37684"},{"source":"NA","target":"residual tumor","id":"37685"},{"source":"NA","target":"skin neoplasms","id":"37686"},{"source":"NA","target":"residual tumor","id":"37687"},{"source":"NA","target":"metastatic","id":"37688"},{"source":"NA","target":"amenorrheic","id":"37689"},{"source":"NA","target":"anticancer","id":"37690"},{"source":"NA","target":"urinary bladder neoplasms","id":"37691"},{"source":"NA","target":"solid tumors","id":"37692"},{"source":"NA","target":"UNK : Indication","id":"37693"},{"source":"NA","target":"renal cancer","id":"37694"},{"source":"NA","target":"carcinoma","id":"37695"},{"source":"NA","target":"azoospermia","id":"37696"},{"source":"NA","target":"fallopian tube neoplasms","id":"37697"},{"source":"NA","target":"non-small-cell lung","id":"37698"},{"source":"NA","target":"hypertension","id":"37699"},{"source":"NA","target":"brain metastases","id":"37700"},{"source":"NA","target":"carcinoma","id":"37701"},{"source":"NA","target":"carcinoma","id":"37702"},{"source":"NA","target":"liver neoplasms","id":"37703"},{"source":"NA","target":"endometrial neoplasms","id":"37704"},{"source":"NA","target":"non-small-cell lung","id":"37705"},{"source":"NA","target":"melanoma","id":"37706"},{"source":"NA","target":"solid tumors","id":"37707"},{"source":"NA","target":"carcinoma","id":"37708"},{"source":"NA","target":"liver metastases","id":"37709"},{"source":"NA","target":"amenorrheic","id":"37710"},{"source":"NA","target":"sclc","id":"37711"},{"source":"NA","target":"head and neck neoplasms","id":"37712"},{"source":"NA","target":"renal cell","id":"37713"},{"source":"NA","target":"antihypertensive","id":"37714"},{"source":"NA","target":"endometrioid","id":"37715"},{"source":"NA","target":"carcinoma","id":"37716"},{"source":"NA","target":"kidney neoplasms","id":"37717"},{"source":"NA","target":"carcinoma","id":"37718"},{"source":"NA","target":"cerebellar neoplasms","id":"37719"},{"source":"NA","target":"carcinoma","id":"37720"},{"source":"NA","target":"neoplasm metastasis","id":"37721"},{"source":"NA","target":"melanoma","id":"37722"},{"source":"NA","target":"carcinoma","id":"37723"},{"source":"NA","target":"ovarian neoplasms","id":"37724"},{"source":"NA","target":"bone metastasis","id":"37725"},{"source":"NA","target":"residual tumor","id":"37726"},{"source":"NA","target":"skin neoplasms","id":"37727"},{"source":"NA","target":"residual tumor","id":"37728"},{"source":"NA","target":"metastatic","id":"37729"},{"source":"NA","target":"amenorrheic","id":"37730"},{"source":"NA","target":"anticancer","id":"37731"},{"source":"NA","target":"urinary bladder neoplasms","id":"37732"},{"source":"NA","target":"solid tumors","id":"37733"},{"source":"NA","target":"UNK : Indication","id":"37734"},{"source":"NA","target":"renal cancer","id":"37735"},{"source":"NA","target":"carcinoma","id":"37736"},{"source":"NA","target":"azoospermia","id":"37737"},{"source":"NA","target":"fallopian tube neoplasms","id":"37738"},{"source":"NA","target":"non-small-cell lung","id":"37739"},{"source":"NA","target":"hypertension","id":"37740"},{"source":"NA","target":"brain metastases","id":"37741"},{"source":"NA","target":"carcinoma","id":"37742"},{"source":"NA","target":"carcinoma","id":"37743"},{"source":"NA","target":"liver neoplasms","id":"37744"},{"source":"NA","target":"endometrial neoplasms","id":"37745"},{"source":"NA","target":"non-small-cell lung","id":"37746"},{"source":"NA","target":"melanoma","id":"37747"},{"source":"NA","target":"solid tumors","id":"37748"},{"source":"NA","target":"carcinoma","id":"37749"},{"source":"NA","target":"liver metastases","id":"37750"},{"source":"NA","target":"amenorrheic","id":"37751"},{"source":"NA","target":"sclc","id":"37752"},{"source":"NA","target":"head and neck neoplasms","id":"37753"},{"source":"NA","target":"renal cell","id":"37754"},{"source":"NA","target":"antihypertensive","id":"37755"},{"source":"NA","target":"endometrioid","id":"37756"},{"source":"NA","target":"carcinoma","id":"37757"},{"source":"NA","target":"kidney neoplasms","id":"37758"},{"source":"NA","target":"carcinoma","id":"37759"},{"source":"NA","target":"cerebellar neoplasms","id":"37760"},{"source":"NA","target":"carcinoma","id":"37761"},{"source":"NA","target":"neoplasm metastasis","id":"37762"},{"source":"NA","target":"melanoma","id":"37763"},{"source":"NA","target":"carcinoma","id":"37764"},{"source":"NA","target":"ovarian neoplasms","id":"37765"},{"source":"NA","target":"bone metastasis","id":"37766"},{"source":"NA","target":"residual tumor","id":"37767"},{"source":"NA","target":"skin neoplasms","id":"37768"},{"source":"NA","target":"residual tumor","id":"37769"},{"source":"NA","target":"metastatic","id":"37770"},{"source":"NA","target":"amenorrheic","id":"37771"},{"source":"NA","target":"anticancer","id":"37772"},{"source":"NA","target":"urinary bladder neoplasms","id":"37773"},{"source":"NA","target":"solid tumors","id":"37774"},{"source":"NA","target":"UNK : Indication","id":"37775"},{"source":"NA","target":"renal cancer","id":"37776"},{"source":"NA","target":"carcinoma","id":"37777"},{"source":"NA","target":"azoospermia","id":"37778"},{"source":"NA","target":"fallopian tube neoplasms","id":"37779"},{"source":"NA","target":"non-small-cell lung","id":"37780"},{"source":"NA","target":"hypertension","id":"37781"},{"source":"NA","target":"brain metastases","id":"37782"},{"source":"NA","target":"carcinoma","id":"37783"},{"source":"NA","target":"carcinoma","id":"37784"},{"source":"NA","target":"liver neoplasms","id":"37785"},{"source":"NA","target":"endometrial neoplasms","id":"37786"},{"source":"NA","target":"non-small-cell lung","id":"37787"},{"source":"NA","target":"melanoma","id":"37788"},{"source":"NA","target":"solid tumors","id":"37789"},{"source":"NA","target":"carcinoma","id":"37790"},{"source":"NA","target":"liver metastases","id":"37791"},{"source":"NA","target":"amenorrheic","id":"37792"},{"source":"NA","target":"sclc","id":"37793"},{"source":"NA","target":"head and neck neoplasms","id":"37794"},{"source":"NA","target":"renal cell","id":"37795"},{"source":"NA","target":"antihypertensive","id":"37796"},{"source":"NA","target":"endometrioid","id":"37797"},{"source":"NA","target":"carcinoma","id":"37798"},{"source":"NA","target":"kidney neoplasms","id":"37799"},{"source":"NA","target":"carcinoma","id":"37800"},{"source":"NA","target":"cerebellar neoplasms","id":"37801"},{"source":"NA","target":"carcinoma","id":"37802"},{"source":"NA","target":"neoplasm metastasis","id":"37803"},{"source":"NA","target":"melanoma","id":"37804"},{"source":"NA","target":"carcinoma","id":"37805"},{"source":"NA","target":"ovarian neoplasms","id":"37806"},{"source":"NA","target":"bone metastasis","id":"37807"},{"source":"NA","target":"residual tumor","id":"37808"},{"source":"NA","target":"skin neoplasms","id":"37809"},{"source":"NA","target":"residual tumor","id":"37810"},{"source":"NA","target":"metastatic","id":"37811"},{"source":"NA","target":"amenorrheic","id":"37812"},{"source":"NA","target":"anticancer","id":"37813"},{"source":"NA","target":"urinary bladder neoplasms","id":"37814"},{"source":"NA","target":"solid tumors","id":"37815"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"37816"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"37817"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37818"},{"source":"Anticancer immunotherapy","target":"azoospermia","id":"37819"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"37820"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"37821"},{"source":"Anticancer immunotherapy","target":"hypertension","id":"37822"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"37823"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37824"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37825"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"37826"},{"source":"Anticancer immunotherapy","target":"endometrial neoplasms","id":"37827"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"37828"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"37829"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"37830"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37831"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"37832"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"37833"},{"source":"Anticancer immunotherapy","target":"sclc","id":"37834"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"37835"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"37836"},{"source":"Anticancer immunotherapy","target":"antihypertensive","id":"37837"},{"source":"Anticancer immunotherapy","target":"endometrioid","id":"37838"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37839"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"37840"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37841"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"37842"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37843"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"37844"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"37845"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"37846"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"37847"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"37848"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"37849"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"37850"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"37851"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"37852"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"37853"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"37854"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"37855"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"37856"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"37857"},{"source":"CD19 antagonist","target":"renal cancer","id":"37858"},{"source":"CD19 antagonist","target":"carcinoma","id":"37859"},{"source":"CD19 antagonist","target":"azoospermia","id":"37860"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"37861"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"37862"},{"source":"CD19 antagonist","target":"hypertension","id":"37863"},{"source":"CD19 antagonist","target":"brain metastases","id":"37864"},{"source":"CD19 antagonist","target":"carcinoma","id":"37865"},{"source":"CD19 antagonist","target":"carcinoma","id":"37866"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"37867"},{"source":"CD19 antagonist","target":"endometrial neoplasms","id":"37868"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"37869"},{"source":"CD19 antagonist","target":"melanoma","id":"37870"},{"source":"CD19 antagonist","target":"solid tumors","id":"37871"},{"source":"CD19 antagonist","target":"carcinoma","id":"37872"},{"source":"CD19 antagonist","target":"liver metastases","id":"37873"},{"source":"CD19 antagonist","target":"amenorrheic","id":"37874"},{"source":"CD19 antagonist","target":"sclc","id":"37875"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"37876"},{"source":"CD19 antagonist","target":"renal cell","id":"37877"},{"source":"CD19 antagonist","target":"antihypertensive","id":"37878"},{"source":"CD19 antagonist","target":"endometrioid","id":"37879"},{"source":"CD19 antagonist","target":"carcinoma","id":"37880"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"37881"},{"source":"CD19 antagonist","target":"carcinoma","id":"37882"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"37883"},{"source":"CD19 antagonist","target":"carcinoma","id":"37884"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"37885"},{"source":"CD19 antagonist","target":"melanoma","id":"37886"},{"source":"CD19 antagonist","target":"carcinoma","id":"37887"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"37888"},{"source":"CD19 antagonist","target":"bone metastasis","id":"37889"},{"source":"CD19 antagonist","target":"residual tumor","id":"37890"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"37891"},{"source":"CD19 antagonist","target":"residual tumor","id":"37892"},{"source":"CD19 antagonist","target":"metastatic","id":"37893"},{"source":"CD19 antagonist","target":"amenorrheic","id":"37894"},{"source":"CD19 antagonist","target":"anticancer","id":"37895"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"37896"},{"source":"CD19 antagonist","target":"solid tumors","id":"37897"},{"source":"NA","target":"UNK : Indication","id":"37898"},{"source":"NA","target":"renal cancer","id":"37899"},{"source":"NA","target":"carcinoma","id":"37900"},{"source":"NA","target":"azoospermia","id":"37901"},{"source":"NA","target":"fallopian tube neoplasms","id":"37902"},{"source":"NA","target":"non-small-cell lung","id":"37903"},{"source":"NA","target":"hypertension","id":"37904"},{"source":"NA","target":"brain metastases","id":"37905"},{"source":"NA","target":"carcinoma","id":"37906"},{"source":"NA","target":"carcinoma","id":"37907"},{"source":"NA","target":"liver neoplasms","id":"37908"},{"source":"NA","target":"endometrial neoplasms","id":"37909"},{"source":"NA","target":"non-small-cell lung","id":"37910"},{"source":"NA","target":"melanoma","id":"37911"},{"source":"NA","target":"solid tumors","id":"37912"},{"source":"NA","target":"carcinoma","id":"37913"},{"source":"NA","target":"liver metastases","id":"37914"},{"source":"NA","target":"amenorrheic","id":"37915"},{"source":"NA","target":"sclc","id":"37916"},{"source":"NA","target":"head and neck neoplasms","id":"37917"},{"source":"NA","target":"renal cell","id":"37918"},{"source":"NA","target":"antihypertensive","id":"37919"},{"source":"NA","target":"endometrioid","id":"37920"},{"source":"NA","target":"carcinoma","id":"37921"},{"source":"NA","target":"kidney neoplasms","id":"37922"},{"source":"NA","target":"carcinoma","id":"37923"},{"source":"NA","target":"cerebellar neoplasms","id":"37924"},{"source":"NA","target":"carcinoma","id":"37925"},{"source":"NA","target":"neoplasm metastasis","id":"37926"},{"source":"NA","target":"melanoma","id":"37927"},{"source":"NA","target":"carcinoma","id":"37928"},{"source":"NA","target":"ovarian neoplasms","id":"37929"},{"source":"NA","target":"bone metastasis","id":"37930"},{"source":"NA","target":"residual tumor","id":"37931"},{"source":"NA","target":"skin neoplasms","id":"37932"},{"source":"NA","target":"residual tumor","id":"37933"},{"source":"NA","target":"metastatic","id":"37934"},{"source":"NA","target":"amenorrheic","id":"37935"},{"source":"NA","target":"anticancer","id":"37936"},{"source":"NA","target":"urinary bladder neoplasms","id":"37937"},{"source":"NA","target":"solid tumors","id":"37938"},{"source":"NA","target":"UNK : Indication","id":"37939"},{"source":"NA","target":"renal cancer","id":"37940"},{"source":"NA","target":"carcinoma","id":"37941"},{"source":"NA","target":"azoospermia","id":"37942"},{"source":"NA","target":"fallopian tube neoplasms","id":"37943"},{"source":"NA","target":"non-small-cell lung","id":"37944"},{"source":"NA","target":"hypertension","id":"37945"},{"source":"NA","target":"brain metastases","id":"37946"},{"source":"NA","target":"carcinoma","id":"37947"},{"source":"NA","target":"carcinoma","id":"37948"},{"source":"NA","target":"liver neoplasms","id":"37949"},{"source":"NA","target":"endometrial neoplasms","id":"37950"},{"source":"NA","target":"non-small-cell lung","id":"37951"},{"source":"NA","target":"melanoma","id":"37952"},{"source":"NA","target":"solid tumors","id":"37953"},{"source":"NA","target":"carcinoma","id":"37954"},{"source":"NA","target":"liver metastases","id":"37955"},{"source":"NA","target":"amenorrheic","id":"37956"},{"source":"NA","target":"sclc","id":"37957"},{"source":"NA","target":"head and neck neoplasms","id":"37958"},{"source":"NA","target":"renal cell","id":"37959"},{"source":"NA","target":"antihypertensive","id":"37960"},{"source":"NA","target":"endometrioid","id":"37961"},{"source":"NA","target":"carcinoma","id":"37962"},{"source":"NA","target":"kidney neoplasms","id":"37963"},{"source":"NA","target":"carcinoma","id":"37964"},{"source":"NA","target":"cerebellar neoplasms","id":"37965"},{"source":"NA","target":"carcinoma","id":"37966"},{"source":"NA","target":"neoplasm metastasis","id":"37967"},{"source":"NA","target":"melanoma","id":"37968"},{"source":"NA","target":"carcinoma","id":"37969"},{"source":"NA","target":"ovarian neoplasms","id":"37970"},{"source":"NA","target":"bone metastasis","id":"37971"},{"source":"NA","target":"residual tumor","id":"37972"},{"source":"NA","target":"skin neoplasms","id":"37973"},{"source":"NA","target":"residual tumor","id":"37974"},{"source":"NA","target":"metastatic","id":"37975"},{"source":"NA","target":"amenorrheic","id":"37976"},{"source":"NA","target":"anticancer","id":"37977"},{"source":"NA","target":"urinary bladder neoplasms","id":"37978"},{"source":"NA","target":"solid tumors","id":"37979"},{"source":"Angiopoietin inhibitor","target":"UNK : Indication","id":"37980"},{"source":"Angiopoietin inhibitor","target":"renal cancer","id":"37981"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"37982"},{"source":"Angiopoietin inhibitor","target":"azoospermia","id":"37983"},{"source":"Angiopoietin inhibitor","target":"fallopian tube neoplasms","id":"37984"},{"source":"Angiopoietin inhibitor","target":"non-small-cell lung","id":"37985"},{"source":"Angiopoietin inhibitor","target":"hypertension","id":"37986"},{"source":"Angiopoietin inhibitor","target":"brain metastases","id":"37987"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"37988"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"37989"},{"source":"Angiopoietin inhibitor","target":"liver neoplasms","id":"37990"},{"source":"Angiopoietin inhibitor","target":"endometrial neoplasms","id":"37991"},{"source":"Angiopoietin inhibitor","target":"non-small-cell lung","id":"37992"},{"source":"Angiopoietin inhibitor","target":"melanoma","id":"37993"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"37994"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"37995"},{"source":"Angiopoietin inhibitor","target":"liver metastases","id":"37996"},{"source":"Angiopoietin inhibitor","target":"amenorrheic","id":"37997"},{"source":"Angiopoietin inhibitor","target":"sclc","id":"37998"},{"source":"Angiopoietin inhibitor","target":"head and neck neoplasms","id":"37999"},{"source":"Angiopoietin inhibitor","target":"renal cell","id":"38000"},{"source":"Angiopoietin inhibitor","target":"antihypertensive","id":"38001"},{"source":"Angiopoietin inhibitor","target":"endometrioid","id":"38002"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"38003"},{"source":"Angiopoietin inhibitor","target":"kidney neoplasms","id":"38004"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"38005"},{"source":"Angiopoietin inhibitor","target":"cerebellar neoplasms","id":"38006"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"38007"},{"source":"Angiopoietin inhibitor","target":"neoplasm metastasis","id":"38008"},{"source":"Angiopoietin inhibitor","target":"melanoma","id":"38009"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"38010"},{"source":"Angiopoietin inhibitor","target":"ovarian neoplasms","id":"38011"},{"source":"Angiopoietin inhibitor","target":"bone metastasis","id":"38012"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"38013"},{"source":"Angiopoietin inhibitor","target":"skin neoplasms","id":"38014"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"38015"},{"source":"Angiopoietin inhibitor","target":"metastatic","id":"38016"},{"source":"Angiopoietin inhibitor","target":"amenorrheic","id":"38017"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"38018"},{"source":"Angiopoietin inhibitor","target":"urinary bladder neoplasms","id":"38019"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"38020"},{"source":"NA","target":"UNK : Indication","id":"38021"},{"source":"NA","target":"renal cancer","id":"38022"},{"source":"NA","target":"carcinoma","id":"38023"},{"source":"NA","target":"azoospermia","id":"38024"},{"source":"NA","target":"fallopian tube neoplasms","id":"38025"},{"source":"NA","target":"non-small-cell lung","id":"38026"},{"source":"NA","target":"hypertension","id":"38027"},{"source":"NA","target":"brain metastases","id":"38028"},{"source":"NA","target":"carcinoma","id":"38029"},{"source":"NA","target":"carcinoma","id":"38030"},{"source":"NA","target":"liver neoplasms","id":"38031"},{"source":"NA","target":"endometrial neoplasms","id":"38032"},{"source":"NA","target":"non-small-cell lung","id":"38033"},{"source":"NA","target":"melanoma","id":"38034"},{"source":"NA","target":"solid tumors","id":"38035"},{"source":"NA","target":"carcinoma","id":"38036"},{"source":"NA","target":"liver metastases","id":"38037"},{"source":"NA","target":"amenorrheic","id":"38038"},{"source":"NA","target":"sclc","id":"38039"},{"source":"NA","target":"head and neck neoplasms","id":"38040"},{"source":"NA","target":"renal cell","id":"38041"},{"source":"NA","target":"antihypertensive","id":"38042"},{"source":"NA","target":"endometrioid","id":"38043"},{"source":"NA","target":"carcinoma","id":"38044"},{"source":"NA","target":"kidney neoplasms","id":"38045"},{"source":"NA","target":"carcinoma","id":"38046"},{"source":"NA","target":"cerebellar neoplasms","id":"38047"},{"source":"NA","target":"carcinoma","id":"38048"},{"source":"NA","target":"neoplasm metastasis","id":"38049"},{"source":"NA","target":"melanoma","id":"38050"},{"source":"NA","target":"carcinoma","id":"38051"},{"source":"NA","target":"ovarian neoplasms","id":"38052"},{"source":"NA","target":"bone metastasis","id":"38053"},{"source":"NA","target":"residual tumor","id":"38054"},{"source":"NA","target":"skin neoplasms","id":"38055"},{"source":"NA","target":"residual tumor","id":"38056"},{"source":"NA","target":"metastatic","id":"38057"},{"source":"NA","target":"amenorrheic","id":"38058"},{"source":"NA","target":"anticancer","id":"38059"},{"source":"NA","target":"urinary bladder neoplasms","id":"38060"},{"source":"NA","target":"solid tumors","id":"38061"},{"source":"NA","target":"UNK : Indication","id":"38062"},{"source":"NA","target":"renal cancer","id":"38063"},{"source":"NA","target":"carcinoma","id":"38064"},{"source":"NA","target":"azoospermia","id":"38065"},{"source":"NA","target":"fallopian tube neoplasms","id":"38066"},{"source":"NA","target":"non-small-cell lung","id":"38067"},{"source":"NA","target":"hypertension","id":"38068"},{"source":"NA","target":"brain metastases","id":"38069"},{"source":"NA","target":"carcinoma","id":"38070"},{"source":"NA","target":"carcinoma","id":"38071"},{"source":"NA","target":"liver neoplasms","id":"38072"},{"source":"NA","target":"endometrial neoplasms","id":"38073"},{"source":"NA","target":"non-small-cell lung","id":"38074"},{"source":"NA","target":"melanoma","id":"38075"},{"source":"NA","target":"solid tumors","id":"38076"},{"source":"NA","target":"carcinoma","id":"38077"},{"source":"NA","target":"liver metastases","id":"38078"},{"source":"NA","target":"amenorrheic","id":"38079"},{"source":"NA","target":"sclc","id":"38080"},{"source":"NA","target":"head and neck neoplasms","id":"38081"},{"source":"NA","target":"renal cell","id":"38082"},{"source":"NA","target":"antihypertensive","id":"38083"},{"source":"NA","target":"endometrioid","id":"38084"},{"source":"NA","target":"carcinoma","id":"38085"},{"source":"NA","target":"kidney neoplasms","id":"38086"},{"source":"NA","target":"carcinoma","id":"38087"},{"source":"NA","target":"cerebellar neoplasms","id":"38088"},{"source":"NA","target":"carcinoma","id":"38089"},{"source":"NA","target":"neoplasm metastasis","id":"38090"},{"source":"NA","target":"melanoma","id":"38091"},{"source":"NA","target":"carcinoma","id":"38092"},{"source":"NA","target":"ovarian neoplasms","id":"38093"},{"source":"NA","target":"bone metastasis","id":"38094"},{"source":"NA","target":"residual tumor","id":"38095"},{"source":"NA","target":"skin neoplasms","id":"38096"},{"source":"NA","target":"residual tumor","id":"38097"},{"source":"NA","target":"metastatic","id":"38098"},{"source":"NA","target":"amenorrheic","id":"38099"},{"source":"NA","target":"anticancer","id":"38100"},{"source":"NA","target":"urinary bladder neoplasms","id":"38101"},{"source":"NA","target":"solid tumors","id":"38102"},{"source":"NA","target":"UNK : Indication","id":"38103"},{"source":"NA","target":"renal cancer","id":"38104"},{"source":"NA","target":"carcinoma","id":"38105"},{"source":"NA","target":"azoospermia","id":"38106"},{"source":"NA","target":"fallopian tube neoplasms","id":"38107"},{"source":"NA","target":"non-small-cell lung","id":"38108"},{"source":"NA","target":"hypertension","id":"38109"},{"source":"NA","target":"brain metastases","id":"38110"},{"source":"NA","target":"carcinoma","id":"38111"},{"source":"NA","target":"carcinoma","id":"38112"},{"source":"NA","target":"liver neoplasms","id":"38113"},{"source":"NA","target":"endometrial neoplasms","id":"38114"},{"source":"NA","target":"non-small-cell lung","id":"38115"},{"source":"NA","target":"melanoma","id":"38116"},{"source":"NA","target":"solid tumors","id":"38117"},{"source":"NA","target":"carcinoma","id":"38118"},{"source":"NA","target":"liver metastases","id":"38119"},{"source":"NA","target":"amenorrheic","id":"38120"},{"source":"NA","target":"sclc","id":"38121"},{"source":"NA","target":"head and neck neoplasms","id":"38122"},{"source":"NA","target":"renal cell","id":"38123"},{"source":"NA","target":"antihypertensive","id":"38124"},{"source":"NA","target":"endometrioid","id":"38125"},{"source":"NA","target":"carcinoma","id":"38126"},{"source":"NA","target":"kidney neoplasms","id":"38127"},{"source":"NA","target":"carcinoma","id":"38128"},{"source":"NA","target":"cerebellar neoplasms","id":"38129"},{"source":"NA","target":"carcinoma","id":"38130"},{"source":"NA","target":"neoplasm metastasis","id":"38131"},{"source":"NA","target":"melanoma","id":"38132"},{"source":"NA","target":"carcinoma","id":"38133"},{"source":"NA","target":"ovarian neoplasms","id":"38134"},{"source":"NA","target":"bone metastasis","id":"38135"},{"source":"NA","target":"residual tumor","id":"38136"},{"source":"NA","target":"skin neoplasms","id":"38137"},{"source":"NA","target":"residual tumor","id":"38138"},{"source":"NA","target":"metastatic","id":"38139"},{"source":"NA","target":"amenorrheic","id":"38140"},{"source":"NA","target":"anticancer","id":"38141"},{"source":"NA","target":"urinary bladder neoplasms","id":"38142"},{"source":"NA","target":"solid tumors","id":"38143"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"38144"},{"source":"Angiogenesis inhibitor","target":"renal cancer","id":"38145"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38146"},{"source":"Angiogenesis inhibitor","target":"azoospermia","id":"38147"},{"source":"Angiogenesis inhibitor","target":"fallopian tube neoplasms","id":"38148"},{"source":"Angiogenesis inhibitor","target":"non-small-cell lung","id":"38149"},{"source":"Angiogenesis inhibitor","target":"hypertension","id":"38150"},{"source":"Angiogenesis inhibitor","target":"brain metastases","id":"38151"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38152"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38153"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"38154"},{"source":"Angiogenesis inhibitor","target":"endometrial neoplasms","id":"38155"},{"source":"Angiogenesis inhibitor","target":"non-small-cell lung","id":"38156"},{"source":"Angiogenesis inhibitor","target":"melanoma","id":"38157"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"38158"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38159"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"38160"},{"source":"Angiogenesis inhibitor","target":"amenorrheic","id":"38161"},{"source":"Angiogenesis inhibitor","target":"sclc","id":"38162"},{"source":"Angiogenesis inhibitor","target":"head and neck neoplasms","id":"38163"},{"source":"Angiogenesis inhibitor","target":"renal cell","id":"38164"},{"source":"Angiogenesis inhibitor","target":"antihypertensive","id":"38165"},{"source":"Angiogenesis inhibitor","target":"endometrioid","id":"38166"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38167"},{"source":"Angiogenesis inhibitor","target":"kidney neoplasms","id":"38168"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38169"},{"source":"Angiogenesis inhibitor","target":"cerebellar neoplasms","id":"38170"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38171"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"38172"},{"source":"Angiogenesis inhibitor","target":"melanoma","id":"38173"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"38174"},{"source":"Angiogenesis inhibitor","target":"ovarian neoplasms","id":"38175"},{"source":"Angiogenesis inhibitor","target":"bone metastasis","id":"38176"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"38177"},{"source":"Angiogenesis inhibitor","target":"skin neoplasms","id":"38178"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"38179"},{"source":"Angiogenesis inhibitor","target":"metastatic","id":"38180"},{"source":"Angiogenesis inhibitor","target":"amenorrheic","id":"38181"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"38182"},{"source":"Angiogenesis inhibitor","target":"urinary bladder neoplasms","id":"38183"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"38184"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"38185"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"38186"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38187"},{"source":"Immune checkpoint inhibitor","target":"azoospermia","id":"38188"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"38189"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"38190"},{"source":"Immune checkpoint inhibitor","target":"hypertension","id":"38191"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"38192"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38193"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38194"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"38195"},{"source":"Immune checkpoint inhibitor","target":"endometrial neoplasms","id":"38196"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"38197"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"38198"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"38199"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38200"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"38201"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"38202"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"38203"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"38204"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"38205"},{"source":"Immune checkpoint inhibitor","target":"antihypertensive","id":"38206"},{"source":"Immune checkpoint inhibitor","target":"endometrioid","id":"38207"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38208"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"38209"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38210"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"38211"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38212"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"38213"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"38214"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38215"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"38216"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"38217"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"38218"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"38219"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"38220"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"38221"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"38222"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"38223"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"38224"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"38225"},{"source":"C-kit inhibitor","target":"UNK : Indication","id":"38226"},{"source":"C-kit inhibitor","target":"renal cancer","id":"38227"},{"source":"C-kit inhibitor","target":"carcinoma","id":"38228"},{"source":"C-kit inhibitor","target":"azoospermia","id":"38229"},{"source":"C-kit inhibitor","target":"fallopian tube neoplasms","id":"38230"},{"source":"C-kit inhibitor","target":"non-small-cell lung","id":"38231"},{"source":"C-kit inhibitor","target":"hypertension","id":"38232"},{"source":"C-kit inhibitor","target":"brain metastases","id":"38233"},{"source":"C-kit inhibitor","target":"carcinoma","id":"38234"},{"source":"C-kit inhibitor","target":"carcinoma","id":"38235"},{"source":"C-kit inhibitor","target":"liver neoplasms","id":"38236"},{"source":"C-kit inhibitor","target":"endometrial neoplasms","id":"38237"},{"source":"C-kit inhibitor","target":"non-small-cell lung","id":"38238"},{"source":"C-kit inhibitor","target":"melanoma","id":"38239"},{"source":"C-kit inhibitor","target":"solid tumors","id":"38240"},{"source":"C-kit inhibitor","target":"carcinoma","id":"38241"},{"source":"C-kit inhibitor","target":"liver metastases","id":"38242"},{"source":"C-kit inhibitor","target":"amenorrheic","id":"38243"},{"source":"C-kit inhibitor","target":"sclc","id":"38244"},{"source":"C-kit inhibitor","target":"head and neck neoplasms","id":"38245"},{"source":"C-kit inhibitor","target":"renal cell","id":"38246"},{"source":"C-kit inhibitor","target":"antihypertensive","id":"38247"},{"source":"C-kit inhibitor","target":"endometrioid","id":"38248"},{"source":"C-kit inhibitor","target":"carcinoma","id":"38249"},{"source":"C-kit inhibitor","target":"kidney neoplasms","id":"38250"},{"source":"C-kit inhibitor","target":"carcinoma","id":"38251"},{"source":"C-kit inhibitor","target":"cerebellar neoplasms","id":"38252"},{"source":"C-kit inhibitor","target":"carcinoma","id":"38253"},{"source":"C-kit inhibitor","target":"neoplasm metastasis","id":"38254"},{"source":"C-kit inhibitor","target":"melanoma","id":"38255"},{"source":"C-kit inhibitor","target":"carcinoma","id":"38256"},{"source":"C-kit inhibitor","target":"ovarian neoplasms","id":"38257"},{"source":"C-kit inhibitor","target":"bone metastasis","id":"38258"},{"source":"C-kit inhibitor","target":"residual tumor","id":"38259"},{"source":"C-kit inhibitor","target":"skin neoplasms","id":"38260"},{"source":"C-kit inhibitor","target":"residual tumor","id":"38261"},{"source":"C-kit inhibitor","target":"metastatic","id":"38262"},{"source":"C-kit inhibitor","target":"amenorrheic","id":"38263"},{"source":"C-kit inhibitor","target":"anticancer","id":"38264"},{"source":"C-kit inhibitor","target":"urinary bladder neoplasms","id":"38265"},{"source":"C-kit inhibitor","target":"solid tumors","id":"38266"},{"source":"Oncology: Bladder","target":"NA","id":"38267"},{"source":"Oncology: Bladder","target":"NA","id":"38268"},{"source":"Oncology: Bladder","target":"NA","id":"38269"},{"source":"Oncology: Bladder","target":"NA","id":"38270"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"38271"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"38272"},{"source":"Oncology: Bladder","target":"NA","id":"38273"},{"source":"Oncology: Bladder","target":"NA","id":"38274"},{"source":"Oncology: Bladder","target":"Angiopoietin inhibitor","id":"38275"},{"source":"Oncology: Bladder","target":"NA","id":"38276"},{"source":"Oncology: Bladder","target":"NA","id":"38277"},{"source":"Oncology: Bladder","target":"NA","id":"38278"},{"source":"Oncology: Bladder","target":"Angiogenesis inhibitor","id":"38279"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"38280"},{"source":"Oncology: Bladder","target":"C-kit inhibitor","id":"38281"},{"source":"Oncology: Endometrial","target":"NA","id":"38282"},{"source":"Oncology: Endometrial","target":"NA","id":"38283"},{"source":"Oncology: Endometrial","target":"NA","id":"38284"},{"source":"Oncology: Endometrial","target":"NA","id":"38285"},{"source":"Oncology: Endometrial","target":"Anticancer immunotherapy","id":"38286"},{"source":"Oncology: Endometrial","target":"CD19 antagonist","id":"38287"},{"source":"Oncology: Endometrial","target":"NA","id":"38288"},{"source":"Oncology: Endometrial","target":"NA","id":"38289"},{"source":"Oncology: Endometrial","target":"Angiopoietin inhibitor","id":"38290"},{"source":"Oncology: Endometrial","target":"NA","id":"38291"},{"source":"Oncology: Endometrial","target":"NA","id":"38292"},{"source":"Oncology: Endometrial","target":"NA","id":"38293"},{"source":"Oncology: Endometrial","target":"Angiogenesis inhibitor","id":"38294"},{"source":"Oncology: Endometrial","target":"Immune checkpoint inhibitor","id":"38295"},{"source":"Oncology: Endometrial","target":"C-kit inhibitor","id":"38296"},{"source":"Oncology: Head/Neck","target":"NA","id":"38297"},{"source":"Oncology: Head/Neck","target":"NA","id":"38298"},{"source":"Oncology: Head/Neck","target":"NA","id":"38299"},{"source":"Oncology: Head/Neck","target":"NA","id":"38300"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"38301"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"38302"},{"source":"Oncology: Head/Neck","target":"NA","id":"38303"},{"source":"Oncology: Head/Neck","target":"NA","id":"38304"},{"source":"Oncology: Head/Neck","target":"Angiopoietin inhibitor","id":"38305"},{"source":"Oncology: Head/Neck","target":"NA","id":"38306"},{"source":"Oncology: Head/Neck","target":"NA","id":"38307"},{"source":"Oncology: Head/Neck","target":"NA","id":"38308"},{"source":"Oncology: Head/Neck","target":"Angiogenesis inhibitor","id":"38309"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"38310"},{"source":"Oncology: Head/Neck","target":"C-kit inhibitor","id":"38311"},{"source":"Oncology: Lung","target":"NA","id":"38312"},{"source":"Oncology: Lung","target":"NA","id":"38313"},{"source":"Oncology: Lung","target":"NA","id":"38314"},{"source":"Oncology: Lung","target":"NA","id":"38315"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"38316"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"38317"},{"source":"Oncology: Lung","target":"NA","id":"38318"},{"source":"Oncology: Lung","target":"NA","id":"38319"},{"source":"Oncology: Lung","target":"Angiopoietin inhibitor","id":"38320"},{"source":"Oncology: Lung","target":"NA","id":"38321"},{"source":"Oncology: Lung","target":"NA","id":"38322"},{"source":"Oncology: Lung","target":"NA","id":"38323"},{"source":"Oncology: Lung","target":"Angiogenesis inhibitor","id":"38324"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"38325"},{"source":"Oncology: Lung","target":"C-kit inhibitor","id":"38326"},{"source":"Non-Small Cell","target":"NA","id":"38327"},{"source":"Non-Small Cell","target":"NA","id":"38328"},{"source":"Non-Small Cell","target":"NA","id":"38329"},{"source":"Non-Small Cell","target":"NA","id":"38330"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"38331"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"38332"},{"source":"Non-Small Cell","target":"NA","id":"38333"},{"source":"Non-Small Cell","target":"NA","id":"38334"},{"source":"Non-Small Cell","target":"Angiopoietin inhibitor","id":"38335"},{"source":"Non-Small Cell","target":"NA","id":"38336"},{"source":"Non-Small Cell","target":"NA","id":"38337"},{"source":"Non-Small Cell","target":"NA","id":"38338"},{"source":"Non-Small Cell","target":"Angiogenesis inhibitor","id":"38339"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"38340"},{"source":"Non-Small Cell","target":"C-kit inhibitor","id":"38341"},{"source":"Oncology: Melanoma","target":"NA","id":"38342"},{"source":"Oncology: Melanoma","target":"NA","id":"38343"},{"source":"Oncology: Melanoma","target":"NA","id":"38344"},{"source":"Oncology: Melanoma","target":"NA","id":"38345"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"38346"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"38347"},{"source":"Oncology: Melanoma","target":"NA","id":"38348"},{"source":"Oncology: Melanoma","target":"NA","id":"38349"},{"source":"Oncology: Melanoma","target":"Angiopoietin inhibitor","id":"38350"},{"source":"Oncology: Melanoma","target":"NA","id":"38351"},{"source":"Oncology: Melanoma","target":"NA","id":"38352"},{"source":"Oncology: Melanoma","target":"NA","id":"38353"},{"source":"Oncology: Melanoma","target":"Angiogenesis inhibitor","id":"38354"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"38355"},{"source":"Oncology: Melanoma","target":"C-kit inhibitor","id":"38356"},{"source":"Oncology: Renal","target":"NA","id":"38357"},{"source":"Oncology: Renal","target":"NA","id":"38358"},{"source":"Oncology: Renal","target":"NA","id":"38359"},{"source":"Oncology: Renal","target":"NA","id":"38360"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"38361"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"38362"},{"source":"Oncology: Renal","target":"NA","id":"38363"},{"source":"Oncology: Renal","target":"NA","id":"38364"},{"source":"Oncology: Renal","target":"Angiopoietin inhibitor","id":"38365"},{"source":"Oncology: Renal","target":"NA","id":"38366"},{"source":"Oncology: Renal","target":"NA","id":"38367"},{"source":"Oncology: Renal","target":"NA","id":"38368"},{"source":"Oncology: Renal","target":"Angiogenesis inhibitor","id":"38369"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"38370"},{"source":"Oncology: Renal","target":"C-kit inhibitor","id":"38371"},{"source":"AFM-13 (u)","target":"Affimed {Affimed Therapeutics AG}","id":"38372"},{"source":"AFM-13 (u)","target":"Columbia University Medical Center","id":"38373"},{"source":"UNK : Drug","target":"Affimed {Affimed Therapeutics AG}","id":"38374"},{"source":"UNK : Drug","target":"Columbia University Medical Center","id":"38375"},{"source":"cutaneous","target":"AFM-13 (u)","id":"38376"},{"source":"cutaneous","target":"UNK : Drug","id":"38377"},{"source":"lymphoma","target":"AFM-13 (u)","id":"38378"},{"source":"lymphoma","target":"UNK : Drug","id":"38379"},{"source":"t-cell","target":"AFM-13 (u)","id":"38380"},{"source":"t-cell","target":"UNK : Drug","id":"38381"},{"source":"lymphoma","target":"AFM-13 (u)","id":"38382"},{"source":"lymphoma","target":"UNK : Drug","id":"38383"},{"source":"hodgkin disease","target":"AFM-13 (u)","id":"38384"},{"source":"hodgkin disease","target":"UNK : Drug","id":"38385"},{"source":"carcinoma","target":"AFM-13 (u)","id":"38386"},{"source":"carcinoma","target":"UNK : Drug","id":"38387"},{"source":"lymphoma","target":"AFM-13 (u)","id":"38388"},{"source":"lymphoma","target":"UNK : Drug","id":"38389"},{"source":"non-hodgkin","target":"AFM-13 (u)","id":"38390"},{"source":"non-hodgkin","target":"UNK : Drug","id":"38391"},{"source":"gilbert disease","target":"AFM-13 (u)","id":"38392"},{"source":"gilbert disease","target":"UNK : Drug","id":"38393"},{"source":"lymphoma","target":"AFM-13 (u)","id":"38394"},{"source":"lymphoma","target":"UNK : Drug","id":"38395"},{"source":"anticancer","target":"AFM-13 (u)","id":"38396"},{"source":"anticancer","target":"UNK : Drug","id":"38397"},{"source":"lymphoma","target":"AFM-13 (u)","id":"38398"},{"source":"lymphoma","target":"UNK : Drug","id":"38399"},{"source":"gilbert disease","target":"AFM-13 (u)","id":"38400"},{"source":"gilbert disease","target":"UNK : Drug","id":"38401"},{"source":"Anticancer immunotherapy","target":"cutaneous","id":"38402"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"38403"},{"source":"Anticancer immunotherapy","target":"t-cell","id":"38404"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"38405"},{"source":"Anticancer immunotherapy","target":"hodgkin disease","id":"38406"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"38407"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"38408"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"38409"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"38410"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"38411"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"38412"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"38413"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"38414"},{"source":"CD19 antagonist","target":"cutaneous","id":"38415"},{"source":"CD19 antagonist","target":"lymphoma","id":"38416"},{"source":"CD19 antagonist","target":"t-cell","id":"38417"},{"source":"CD19 antagonist","target":"lymphoma","id":"38418"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"38419"},{"source":"CD19 antagonist","target":"carcinoma","id":"38420"},{"source":"CD19 antagonist","target":"lymphoma","id":"38421"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"38422"},{"source":"CD19 antagonist","target":"gilbert disease","id":"38423"},{"source":"CD19 antagonist","target":"lymphoma","id":"38424"},{"source":"CD19 antagonist","target":"anticancer","id":"38425"},{"source":"CD19 antagonist","target":"lymphoma","id":"38426"},{"source":"CD19 antagonist","target":"gilbert disease","id":"38427"},{"source":"CD19 antagonist","target":"cutaneous","id":"38428"},{"source":"CD19 antagonist","target":"lymphoma","id":"38429"},{"source":"CD19 antagonist","target":"t-cell","id":"38430"},{"source":"CD19 antagonist","target":"lymphoma","id":"38431"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"38432"},{"source":"CD19 antagonist","target":"carcinoma","id":"38433"},{"source":"CD19 antagonist","target":"lymphoma","id":"38434"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"38435"},{"source":"CD19 antagonist","target":"gilbert disease","id":"38436"},{"source":"CD19 antagonist","target":"lymphoma","id":"38437"},{"source":"CD19 antagonist","target":"anticancer","id":"38438"},{"source":"CD19 antagonist","target":"lymphoma","id":"38439"},{"source":"CD19 antagonist","target":"gilbert disease","id":"38440"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"38441"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"38442"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"38443"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"38444"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"38445"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"38446"},{"source":"pembrolizumab","target":"Merck & Co.","id":"38447"},{"source":"carboplatin","target":"Merck & Co.","id":"38448"},{"source":"cyclophosphamide","target":"Merck & Co.","id":"38449"},{"source":"pegylated liposomal doxorubicin","target":"Merck & Co.","id":"38450"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"38451"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"38452"},{"source":"UNK : Indication","target":"pembrolizumab","id":"38453"},{"source":"UNK : Indication","target":"carboplatin","id":"38454"},{"source":"UNK : Indication","target":"cyclophosphamide","id":"38455"},{"source":"UNK : Indication","target":"pegylated liposomal doxorubicin","id":"38456"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"38457"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"38458"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"38459"},{"source":"triple-negative breast cancer","target":"carboplatin","id":"38460"},{"source":"triple-negative breast cancer","target":"cyclophosphamide","id":"38461"},{"source":"triple-negative breast cancer","target":"pegylated liposomal doxorubicin","id":"38462"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"38463"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"38464"},{"source":"residual tumor","target":"pembrolizumab","id":"38465"},{"source":"residual tumor","target":"carboplatin","id":"38466"},{"source":"residual tumor","target":"cyclophosphamide","id":"38467"},{"source":"residual tumor","target":"pegylated liposomal doxorubicin","id":"38468"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"38469"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"38470"},{"source":"breast neoplasms","target":"pembrolizumab","id":"38471"},{"source":"breast neoplasms","target":"carboplatin","id":"38472"},{"source":"breast neoplasms","target":"cyclophosphamide","id":"38473"},{"source":"breast neoplasms","target":"pegylated liposomal doxorubicin","id":"38474"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"38475"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"38476"},{"source":"metastatic","target":"pembrolizumab","id":"38477"},{"source":"metastatic","target":"carboplatin","id":"38478"},{"source":"metastatic","target":"cyclophosphamide","id":"38479"},{"source":"metastatic","target":"pegylated liposomal doxorubicin","id":"38480"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"38481"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"38482"},{"source":"carcinoma","target":"pembrolizumab","id":"38483"},{"source":"carcinoma","target":"carboplatin","id":"38484"},{"source":"carcinoma","target":"cyclophosphamide","id":"38485"},{"source":"carcinoma","target":"pegylated liposomal doxorubicin","id":"38486"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"38487"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"38488"},{"source":"breast neoplasms","target":"pembrolizumab","id":"38489"},{"source":"breast neoplasms","target":"carboplatin","id":"38490"},{"source":"breast neoplasms","target":"cyclophosphamide","id":"38491"},{"source":"breast neoplasms","target":"pegylated liposomal doxorubicin","id":"38492"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"38493"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"38494"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"38495"},{"source":"neoplasm metastasis","target":"carboplatin","id":"38496"},{"source":"neoplasm metastasis","target":"cyclophosphamide","id":"38497"},{"source":"neoplasm metastasis","target":"pegylated liposomal doxorubicin","id":"38498"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"38499"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"38500"},{"source":"anticancer","target":"pembrolizumab","id":"38501"},{"source":"anticancer","target":"carboplatin","id":"38502"},{"source":"anticancer","target":"cyclophosphamide","id":"38503"},{"source":"anticancer","target":"pegylated liposomal doxorubicin","id":"38504"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"38505"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"38506"},{"source":"tnbc","target":"pembrolizumab","id":"38507"},{"source":"tnbc","target":"carboplatin","id":"38508"},{"source":"tnbc","target":"cyclophosphamide","id":"38509"},{"source":"tnbc","target":"pegylated liposomal doxorubicin","id":"38510"},{"source":"tnbc","target":"nab-paclitaxel (IV)","id":"38511"},{"source":"tnbc","target":"nab-paclitaxel (IV)","id":"38512"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"38513"},{"source":"triple-negative breast cancer","target":"carboplatin","id":"38514"},{"source":"triple-negative breast cancer","target":"cyclophosphamide","id":"38515"},{"source":"triple-negative breast cancer","target":"pegylated liposomal doxorubicin","id":"38516"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"38517"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"38518"},{"source":"Immunosuppressant","target":"UNK : Indication","id":"38519"},{"source":"Immunosuppressant","target":"triple-negative breast cancer","id":"38520"},{"source":"Immunosuppressant","target":"residual tumor","id":"38521"},{"source":"Immunosuppressant","target":"breast neoplasms","id":"38522"},{"source":"Immunosuppressant","target":"metastatic","id":"38523"},{"source":"Immunosuppressant","target":"carcinoma","id":"38524"},{"source":"Immunosuppressant","target":"breast neoplasms","id":"38525"},{"source":"Immunosuppressant","target":"neoplasm metastasis","id":"38526"},{"source":"Immunosuppressant","target":"anticancer","id":"38527"},{"source":"Immunosuppressant","target":"tnbc","id":"38528"},{"source":"Immunosuppressant","target":"triple-negative breast cancer","id":"38529"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"38530"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"38531"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"38532"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"38533"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"38534"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38535"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"38536"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"38537"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"38538"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"38539"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"38540"},{"source":"NA","target":"UNK : Indication","id":"38541"},{"source":"NA","target":"triple-negative breast cancer","id":"38542"},{"source":"NA","target":"residual tumor","id":"38543"},{"source":"NA","target":"breast neoplasms","id":"38544"},{"source":"NA","target":"metastatic","id":"38545"},{"source":"NA","target":"carcinoma","id":"38546"},{"source":"NA","target":"breast neoplasms","id":"38547"},{"source":"NA","target":"neoplasm metastasis","id":"38548"},{"source":"NA","target":"anticancer","id":"38549"},{"source":"NA","target":"tnbc","id":"38550"},{"source":"NA","target":"triple-negative breast cancer","id":"38551"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"38552"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"38553"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"38554"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"38555"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"38556"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"38557"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"38558"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"38559"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"38560"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"38561"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"38562"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"38563"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"38564"},{"source":"CD19 antagonist","target":"residual tumor","id":"38565"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"38566"},{"source":"CD19 antagonist","target":"metastatic","id":"38567"},{"source":"CD19 antagonist","target":"carcinoma","id":"38568"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"38569"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"38570"},{"source":"CD19 antagonist","target":"anticancer","id":"38571"},{"source":"CD19 antagonist","target":"tnbc","id":"38572"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"38573"},{"source":"NA","target":"UNK : Indication","id":"38574"},{"source":"NA","target":"triple-negative breast cancer","id":"38575"},{"source":"NA","target":"residual tumor","id":"38576"},{"source":"NA","target":"breast neoplasms","id":"38577"},{"source":"NA","target":"metastatic","id":"38578"},{"source":"NA","target":"carcinoma","id":"38579"},{"source":"NA","target":"breast neoplasms","id":"38580"},{"source":"NA","target":"neoplasm metastasis","id":"38581"},{"source":"NA","target":"anticancer","id":"38582"},{"source":"NA","target":"tnbc","id":"38583"},{"source":"NA","target":"triple-negative breast cancer","id":"38584"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"38585"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"38586"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"38587"},{"source":"Beta tubulin antagonist","target":"breast neoplasms","id":"38588"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"38589"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"38590"},{"source":"Beta tubulin antagonist","target":"breast neoplasms","id":"38591"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"38592"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"38593"},{"source":"Beta tubulin antagonist","target":"tnbc","id":"38594"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"38595"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"38596"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"38597"},{"source":"Microtubule stimulant","target":"residual tumor","id":"38598"},{"source":"Microtubule stimulant","target":"breast neoplasms","id":"38599"},{"source":"Microtubule stimulant","target":"metastatic","id":"38600"},{"source":"Microtubule stimulant","target":"carcinoma","id":"38601"},{"source":"Microtubule stimulant","target":"breast neoplasms","id":"38602"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"38603"},{"source":"Microtubule stimulant","target":"anticancer","id":"38604"},{"source":"Microtubule stimulant","target":"tnbc","id":"38605"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"38606"},{"source":"NA","target":"UNK : Indication","id":"38607"},{"source":"NA","target":"triple-negative breast cancer","id":"38608"},{"source":"NA","target":"residual tumor","id":"38609"},{"source":"NA","target":"breast neoplasms","id":"38610"},{"source":"NA","target":"metastatic","id":"38611"},{"source":"NA","target":"carcinoma","id":"38612"},{"source":"NA","target":"breast neoplasms","id":"38613"},{"source":"NA","target":"neoplasm metastasis","id":"38614"},{"source":"NA","target":"anticancer","id":"38615"},{"source":"NA","target":"tnbc","id":"38616"},{"source":"NA","target":"triple-negative breast cancer","id":"38617"},{"source":"NA","target":"UNK : Indication","id":"38618"},{"source":"NA","target":"triple-negative breast cancer","id":"38619"},{"source":"NA","target":"residual tumor","id":"38620"},{"source":"NA","target":"breast neoplasms","id":"38621"},{"source":"NA","target":"metastatic","id":"38622"},{"source":"NA","target":"carcinoma","id":"38623"},{"source":"NA","target":"breast neoplasms","id":"38624"},{"source":"NA","target":"neoplasm metastasis","id":"38625"},{"source":"NA","target":"anticancer","id":"38626"},{"source":"NA","target":"tnbc","id":"38627"},{"source":"NA","target":"triple-negative breast cancer","id":"38628"},{"source":"Taxane","target":"UNK : Indication","id":"38629"},{"source":"Taxane","target":"triple-negative breast cancer","id":"38630"},{"source":"Taxane","target":"residual tumor","id":"38631"},{"source":"Taxane","target":"breast neoplasms","id":"38632"},{"source":"Taxane","target":"metastatic","id":"38633"},{"source":"Taxane","target":"carcinoma","id":"38634"},{"source":"Taxane","target":"breast neoplasms","id":"38635"},{"source":"Taxane","target":"neoplasm metastasis","id":"38636"},{"source":"Taxane","target":"anticancer","id":"38637"},{"source":"Taxane","target":"tnbc","id":"38638"},{"source":"Taxane","target":"triple-negative breast cancer","id":"38639"},{"source":"Oncology: Breast","target":"Immunosuppressant","id":"38640"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"38641"},{"source":"Oncology: Breast","target":"NA","id":"38642"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"38643"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"38644"},{"source":"Oncology: Breast","target":"NA","id":"38645"},{"source":"Oncology: Breast","target":"Beta tubulin antagonist","id":"38646"},{"source":"Oncology: Breast","target":"Microtubule stimulant","id":"38647"},{"source":"Oncology: Breast","target":"NA","id":"38648"},{"source":"Oncology: Breast","target":"NA","id":"38649"},{"source":"Oncology: Breast","target":"Taxane","id":"38650"},{"source":"b-vedotin","target":"Merck & Co.","id":"38651"},{"source":"b-vedotin","target":"Seattle Genetics","id":"38652"},{"source":"pembrolizumab","target":"Merck & Co.","id":"38653"},{"source":"pembrolizumab","target":"Seattle Genetics","id":"38654"},{"source":"UNK : Indication","target":"b-vedotin","id":"38655"},{"source":"UNK : Indication","target":"pembrolizumab","id":"38656"},{"source":"triple-negative breast cancer","target":"b-vedotin","id":"38657"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"38658"},{"source":"residual tumor","target":"b-vedotin","id":"38659"},{"source":"residual tumor","target":"pembrolizumab","id":"38660"},{"source":"breast neoplasms","target":"b-vedotin","id":"38661"},{"source":"breast neoplasms","target":"pembrolizumab","id":"38662"},{"source":"metastatic","target":"b-vedotin","id":"38663"},{"source":"metastatic","target":"pembrolizumab","id":"38664"},{"source":"carcinoma","target":"b-vedotin","id":"38665"},{"source":"carcinoma","target":"pembrolizumab","id":"38666"},{"source":"breast neoplasms","target":"b-vedotin","id":"38667"},{"source":"breast neoplasms","target":"pembrolizumab","id":"38668"},{"source":"neoplasm metastasis","target":"b-vedotin","id":"38669"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"38670"},{"source":"anticancer","target":"b-vedotin","id":"38671"},{"source":"anticancer","target":"pembrolizumab","id":"38672"},{"source":"tnbc","target":"b-vedotin","id":"38673"},{"source":"tnbc","target":"pembrolizumab","id":"38674"},{"source":"triple-negative breast cancer","target":"b-vedotin","id":"38675"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"38676"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"38677"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"38678"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"38679"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"38680"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"38681"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"38682"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"38683"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"38684"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"38685"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"38686"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"38687"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"38688"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"38689"},{"source":"CD19 antagonist","target":"residual tumor","id":"38690"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"38691"},{"source":"CD19 antagonist","target":"metastatic","id":"38692"},{"source":"CD19 antagonist","target":"carcinoma","id":"38693"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"38694"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"38695"},{"source":"CD19 antagonist","target":"anticancer","id":"38696"},{"source":"CD19 antagonist","target":"tnbc","id":"38697"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"38698"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"38699"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"38700"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"38701"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"38702"},{"source":"Tubulin inhibitor","target":"metastatic","id":"38703"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"38704"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"38705"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"38706"},{"source":"Tubulin inhibitor","target":"anticancer","id":"38707"},{"source":"Tubulin inhibitor","target":"tnbc","id":"38708"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"38709"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"38710"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"38711"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"38712"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"38713"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"38714"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38715"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"38716"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"38717"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"38718"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"38719"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"38720"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"38721"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"38722"},{"source":"Oncology: Breast","target":"Tubulin inhibitor","id":"38723"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"38724"},{"source":"PEGPH20","target":"Halozyme Therapeutics","id":"38725"},{"source":"Halozyme (u)","target":"Halozyme Therapeutics","id":"38726"},{"source":"docetaxel","target":"Halozyme Therapeutics","id":"38727"},{"source":"non-small-cell lung","target":"PEGPH20","id":"38728"},{"source":"non-small-cell lung","target":"Halozyme (u)","id":"38729"},{"source":"non-small-cell lung","target":"docetaxel","id":"38730"},{"source":"residual tumor","target":"PEGPH20","id":"38731"},{"source":"residual tumor","target":"Halozyme (u)","id":"38732"},{"source":"residual tumor","target":"docetaxel","id":"38733"},{"source":"non-small-cell lung","target":"PEGPH20","id":"38734"},{"source":"non-small-cell lung","target":"Halozyme (u)","id":"38735"},{"source":"non-small-cell lung","target":"docetaxel","id":"38736"},{"source":"malaria","target":"PEGPH20","id":"38737"},{"source":"malaria","target":"Halozyme (u)","id":"38738"},{"source":"malaria","target":"docetaxel","id":"38739"},{"source":"residual tumor","target":"PEGPH20","id":"38740"},{"source":"residual tumor","target":"Halozyme (u)","id":"38741"},{"source":"residual tumor","target":"docetaxel","id":"38742"},{"source":"carcinoma","target":"PEGPH20","id":"38743"},{"source":"carcinoma","target":"Halozyme (u)","id":"38744"},{"source":"carcinoma","target":"docetaxel","id":"38745"},{"source":"malaria","target":"PEGPH20","id":"38746"},{"source":"malaria","target":"Halozyme (u)","id":"38747"},{"source":"malaria","target":"docetaxel","id":"38748"},{"source":"carcinoma","target":"PEGPH20","id":"38749"},{"source":"carcinoma","target":"Halozyme (u)","id":"38750"},{"source":"carcinoma","target":"docetaxel","id":"38751"},{"source":"metastatic","target":"PEGPH20","id":"38752"},{"source":"metastatic","target":"Halozyme (u)","id":"38753"},{"source":"metastatic","target":"docetaxel","id":"38754"},{"source":"neoplasm metastasis","target":"PEGPH20","id":"38755"},{"source":"neoplasm metastasis","target":"Halozyme (u)","id":"38756"},{"source":"neoplasm metastasis","target":"docetaxel","id":"38757"},{"source":"anticancer","target":"PEGPH20","id":"38758"},{"source":"anticancer","target":"Halozyme (u)","id":"38759"},{"source":"anticancer","target":"docetaxel","id":"38760"},{"source":"lymphoma","target":"PEGPH20","id":"38761"},{"source":"lymphoma","target":"Halozyme (u)","id":"38762"},{"source":"lymphoma","target":"docetaxel","id":"38763"},{"source":"lung neoplasms","target":"PEGPH20","id":"38764"},{"source":"lung neoplasms","target":"Halozyme (u)","id":"38765"},{"source":"lung neoplasms","target":"docetaxel","id":"38766"},{"source":"sclc","target":"PEGPH20","id":"38767"},{"source":"sclc","target":"Halozyme (u)","id":"38768"},{"source":"sclc","target":"docetaxel","id":"38769"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"38770"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"38771"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"38772"},{"source":"Tubulin inhibitor","target":"malaria","id":"38773"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"38774"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"38775"},{"source":"Tubulin inhibitor","target":"malaria","id":"38776"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"38777"},{"source":"Tubulin inhibitor","target":"metastatic","id":"38778"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"38779"},{"source":"Tubulin inhibitor","target":"anticancer","id":"38780"},{"source":"Tubulin inhibitor","target":"lymphoma","id":"38781"},{"source":"Tubulin inhibitor","target":"lung neoplasms","id":"38782"},{"source":"Tubulin inhibitor","target":"sclc","id":"38783"},{"source":"Hyaluronidase stimulant","target":"non-small-cell lung","id":"38784"},{"source":"Hyaluronidase stimulant","target":"residual tumor","id":"38785"},{"source":"Hyaluronidase stimulant","target":"non-small-cell lung","id":"38786"},{"source":"Hyaluronidase stimulant","target":"malaria","id":"38787"},{"source":"Hyaluronidase stimulant","target":"residual tumor","id":"38788"},{"source":"Hyaluronidase stimulant","target":"carcinoma","id":"38789"},{"source":"Hyaluronidase stimulant","target":"malaria","id":"38790"},{"source":"Hyaluronidase stimulant","target":"carcinoma","id":"38791"},{"source":"Hyaluronidase stimulant","target":"metastatic","id":"38792"},{"source":"Hyaluronidase stimulant","target":"neoplasm metastasis","id":"38793"},{"source":"Hyaluronidase stimulant","target":"anticancer","id":"38794"},{"source":"Hyaluronidase stimulant","target":"lymphoma","id":"38795"},{"source":"Hyaluronidase stimulant","target":"lung neoplasms","id":"38796"},{"source":"Hyaluronidase stimulant","target":"sclc","id":"38797"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"38798"},{"source":"Microtubule stimulant","target":"residual tumor","id":"38799"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"38800"},{"source":"Microtubule stimulant","target":"malaria","id":"38801"},{"source":"Microtubule stimulant","target":"residual tumor","id":"38802"},{"source":"Microtubule stimulant","target":"carcinoma","id":"38803"},{"source":"Microtubule stimulant","target":"malaria","id":"38804"},{"source":"Microtubule stimulant","target":"carcinoma","id":"38805"},{"source":"Microtubule stimulant","target":"metastatic","id":"38806"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"38807"},{"source":"Microtubule stimulant","target":"anticancer","id":"38808"},{"source":"Microtubule stimulant","target":"lymphoma","id":"38809"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"38810"},{"source":"Microtubule stimulant","target":"sclc","id":"38811"},{"source":"Taxane","target":"non-small-cell lung","id":"38812"},{"source":"Taxane","target":"residual tumor","id":"38813"},{"source":"Taxane","target":"non-small-cell lung","id":"38814"},{"source":"Taxane","target":"malaria","id":"38815"},{"source":"Taxane","target":"residual tumor","id":"38816"},{"source":"Taxane","target":"carcinoma","id":"38817"},{"source":"Taxane","target":"malaria","id":"38818"},{"source":"Taxane","target":"carcinoma","id":"38819"},{"source":"Taxane","target":"metastatic","id":"38820"},{"source":"Taxane","target":"neoplasm metastasis","id":"38821"},{"source":"Taxane","target":"anticancer","id":"38822"},{"source":"Taxane","target":"lymphoma","id":"38823"},{"source":"Taxane","target":"lung neoplasms","id":"38824"},{"source":"Taxane","target":"sclc","id":"38825"},{"source":"Oncology: Lung","target":"Tubulin inhibitor","id":"38826"},{"source":"Oncology: Lung","target":"Hyaluronidase stimulant","id":"38827"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"38828"},{"source":"Oncology: Lung","target":"Taxane","id":"38829"},{"source":"Non-Small Cell","target":"Tubulin inhibitor","id":"38830"},{"source":"Non-Small Cell","target":"Hyaluronidase stimulant","id":"38831"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"38832"},{"source":"Non-Small Cell","target":"Taxane","id":"38833"},{"source":"pembrolizumab","target":"(Other Cooperative Group)","id":"38834"},{"source":"pembrolizumab","target":"(Other Industry Sponsor)","id":"38835"},{"source":"pembrolizumab","target":"AbbVie","id":"38836"},{"source":"pembrolizumab","target":"Merck & Co.","id":"38837"},{"source":"paricalcitol","target":"(Other Cooperative Group)","id":"38838"},{"source":"paricalcitol","target":"(Other Industry Sponsor)","id":"38839"},{"source":"paricalcitol","target":"AbbVie","id":"38840"},{"source":"paricalcitol","target":"Merck & Co.","id":"38841"},{"source":"injectable","target":"(Other Cooperative Group)","id":"38842"},{"source":"injectable","target":"(Other Industry Sponsor)","id":"38843"},{"source":"injectable","target":"AbbVie","id":"38844"},{"source":"injectable","target":"Merck & Co.","id":"38845"},{"source":"AbbVie","target":"(Other Cooperative Group)","id":"38846"},{"source":"AbbVie","target":"(Other Industry Sponsor)","id":"38847"},{"source":"AbbVie","target":"AbbVie","id":"38848"},{"source":"AbbVie","target":"Merck & Co.","id":"38849"},{"source":"UNK : Indication","target":"pembrolizumab","id":"38850"},{"source":"UNK : Indication","target":"paricalcitol","id":"38851"},{"source":"UNK : Indication","target":"injectable","id":"38852"},{"source":"UNK : Indication","target":"AbbVie","id":"38853"},{"source":"residual tumor","target":"pembrolizumab","id":"38854"},{"source":"residual tumor","target":"paricalcitol","id":"38855"},{"source":"residual tumor","target":"injectable","id":"38856"},{"source":"residual tumor","target":"AbbVie","id":"38857"},{"source":"metastatic","target":"pembrolizumab","id":"38858"},{"source":"metastatic","target":"paricalcitol","id":"38859"},{"source":"metastatic","target":"injectable","id":"38860"},{"source":"metastatic","target":"AbbVie","id":"38861"},{"source":"carcinoma","target":"pembrolizumab","id":"38862"},{"source":"carcinoma","target":"paricalcitol","id":"38863"},{"source":"carcinoma","target":"injectable","id":"38864"},{"source":"carcinoma","target":"AbbVie","id":"38865"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"38866"},{"source":"pancreatic cancer","target":"paricalcitol","id":"38867"},{"source":"pancreatic cancer","target":"injectable","id":"38868"},{"source":"pancreatic cancer","target":"AbbVie","id":"38869"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"38870"},{"source":"neoplasm metastasis","target":"paricalcitol","id":"38871"},{"source":"neoplasm metastasis","target":"injectable","id":"38872"},{"source":"neoplasm metastasis","target":"AbbVie","id":"38873"},{"source":"carcinoma","target":"pembrolizumab","id":"38874"},{"source":"carcinoma","target":"paricalcitol","id":"38875"},{"source":"carcinoma","target":"injectable","id":"38876"},{"source":"carcinoma","target":"AbbVie","id":"38877"},{"source":"anticancer","target":"pembrolizumab","id":"38878"},{"source":"anticancer","target":"paricalcitol","id":"38879"},{"source":"anticancer","target":"injectable","id":"38880"},{"source":"anticancer","target":"AbbVie","id":"38881"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"38882"},{"source":"pancreatic neoplasms","target":"paricalcitol","id":"38883"},{"source":"pancreatic neoplasms","target":"injectable","id":"38884"},{"source":"pancreatic neoplasms","target":"AbbVie","id":"38885"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"38886"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"38887"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"38888"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"38889"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"38890"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"38891"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"38892"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"38893"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"38894"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"38895"},{"source":"CD19 antagonist","target":"residual tumor","id":"38896"},{"source":"CD19 antagonist","target":"metastatic","id":"38897"},{"source":"CD19 antagonist","target":"carcinoma","id":"38898"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"38899"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"38900"},{"source":"CD19 antagonist","target":"carcinoma","id":"38901"},{"source":"CD19 antagonist","target":"anticancer","id":"38902"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"38903"},{"source":"Vitamin D agonist","target":"UNK : Indication","id":"38904"},{"source":"Vitamin D agonist","target":"residual tumor","id":"38905"},{"source":"Vitamin D agonist","target":"metastatic","id":"38906"},{"source":"Vitamin D agonist","target":"carcinoma","id":"38907"},{"source":"Vitamin D agonist","target":"pancreatic cancer","id":"38908"},{"source":"Vitamin D agonist","target":"neoplasm metastasis","id":"38909"},{"source":"Vitamin D agonist","target":"carcinoma","id":"38910"},{"source":"Vitamin D agonist","target":"anticancer","id":"38911"},{"source":"Vitamin D agonist","target":"pancreatic neoplasms","id":"38912"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"38913"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"38914"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"38915"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38916"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"38917"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"38918"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"38919"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"38920"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"38921"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"38922"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"38923"},{"source":"Oncology: Pancreas","target":"Vitamin D agonist","id":"38924"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"38925"},{"source":"TG-02","target":"Targovax {Oncos Therapeutics}","id":"38926"},{"source":"Targovax (u)","target":"Targovax {Oncos Therapeutics}","id":"38927"},{"source":"GM-CSF","target":"Targovax {Oncos Therapeutics}","id":"38928"},{"source":"unspecified","target":"Targovax {Oncos Therapeutics}","id":"38929"},{"source":"pembrolizumab","target":"Targovax {Oncos Therapeutics}","id":"38930"},{"source":"UNK : Indication","target":"TG-02","id":"38931"},{"source":"UNK : Indication","target":"Targovax (u)","id":"38932"},{"source":"UNK : Indication","target":"GM-CSF","id":"38933"},{"source":"UNK : Indication","target":"unspecified","id":"38934"},{"source":"UNK : Indication","target":"pembrolizumab","id":"38935"},{"source":"colorectal neoplasms","target":"TG-02","id":"38936"},{"source":"colorectal neoplasms","target":"Targovax (u)","id":"38937"},{"source":"colorectal neoplasms","target":"GM-CSF","id":"38938"},{"source":"colorectal neoplasms","target":"unspecified","id":"38939"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"38940"},{"source":"carcinoma","target":"TG-02","id":"38941"},{"source":"carcinoma","target":"Targovax (u)","id":"38942"},{"source":"carcinoma","target":"GM-CSF","id":"38943"},{"source":"carcinoma","target":"unspecified","id":"38944"},{"source":"carcinoma","target":"pembrolizumab","id":"38945"},{"source":"anti-tumor","target":"TG-02","id":"38946"},{"source":"anti-tumor","target":"Targovax (u)","id":"38947"},{"source":"anti-tumor","target":"GM-CSF","id":"38948"},{"source":"anti-tumor","target":"unspecified","id":"38949"},{"source":"anti-tumor","target":"pembrolizumab","id":"38950"},{"source":"residual tumor","target":"TG-02","id":"38951"},{"source":"residual tumor","target":"Targovax (u)","id":"38952"},{"source":"residual tumor","target":"GM-CSF","id":"38953"},{"source":"residual tumor","target":"unspecified","id":"38954"},{"source":"residual tumor","target":"pembrolizumab","id":"38955"},{"source":"residual tumor","target":"TG-02","id":"38956"},{"source":"residual tumor","target":"Targovax (u)","id":"38957"},{"source":"residual tumor","target":"GM-CSF","id":"38958"},{"source":"residual tumor","target":"unspecified","id":"38959"},{"source":"residual tumor","target":"pembrolizumab","id":"38960"},{"source":"colonic neoplasms","target":"TG-02","id":"38961"},{"source":"colonic neoplasms","target":"Targovax (u)","id":"38962"},{"source":"colonic neoplasms","target":"GM-CSF","id":"38963"},{"source":"colonic neoplasms","target":"unspecified","id":"38964"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"38965"},{"source":"carcinoma","target":"TG-02","id":"38966"},{"source":"carcinoma","target":"Targovax (u)","id":"38967"},{"source":"carcinoma","target":"GM-CSF","id":"38968"},{"source":"carcinoma","target":"unspecified","id":"38969"},{"source":"carcinoma","target":"pembrolizumab","id":"38970"},{"source":"anti-tumor","target":"TG-02","id":"38971"},{"source":"anti-tumor","target":"Targovax (u)","id":"38972"},{"source":"anti-tumor","target":"GM-CSF","id":"38973"},{"source":"anti-tumor","target":"unspecified","id":"38974"},{"source":"anti-tumor","target":"pembrolizumab","id":"38975"},{"source":"carcinoma","target":"TG-02","id":"38976"},{"source":"carcinoma","target":"Targovax (u)","id":"38977"},{"source":"carcinoma","target":"GM-CSF","id":"38978"},{"source":"carcinoma","target":"unspecified","id":"38979"},{"source":"carcinoma","target":"pembrolizumab","id":"38980"},{"source":"anticancer","target":"TG-02","id":"38981"},{"source":"anticancer","target":"Targovax (u)","id":"38982"},{"source":"anticancer","target":"GM-CSF","id":"38983"},{"source":"anticancer","target":"unspecified","id":"38984"},{"source":"anticancer","target":"pembrolizumab","id":"38985"},{"source":"colorectal cancer","target":"TG-02","id":"38986"},{"source":"colorectal cancer","target":"Targovax (u)","id":"38987"},{"source":"colorectal cancer","target":"GM-CSF","id":"38988"},{"source":"colorectal cancer","target":"unspecified","id":"38989"},{"source":"colorectal cancer","target":"pembrolizumab","id":"38990"},{"source":"non-small-cell lung","target":"TG-02","id":"38991"},{"source":"non-small-cell lung","target":"Targovax (u)","id":"38992"},{"source":"non-small-cell lung","target":"GM-CSF","id":"38993"},{"source":"non-small-cell lung","target":"unspecified","id":"38994"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"38995"},{"source":"carcinoma","target":"TG-02","id":"38996"},{"source":"carcinoma","target":"Targovax (u)","id":"38997"},{"source":"carcinoma","target":"GM-CSF","id":"38998"},{"source":"carcinoma","target":"unspecified","id":"38999"},{"source":"carcinoma","target":"pembrolizumab","id":"39000"},{"source":"colorectal neoplasms","target":"TG-02","id":"39001"},{"source":"colorectal neoplasms","target":"Targovax (u)","id":"39002"},{"source":"colorectal neoplasms","target":"GM-CSF","id":"39003"},{"source":"colorectal neoplasms","target":"unspecified","id":"39004"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"39005"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"39006"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"39007"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39008"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"39009"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"39010"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"39011"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"39012"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39013"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"39014"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39015"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"39016"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"39017"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"39018"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39019"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"39020"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"39021"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"39022"},{"source":"CD19 antagonist","target":"carcinoma","id":"39023"},{"source":"CD19 antagonist","target":"anti-tumor","id":"39024"},{"source":"CD19 antagonist","target":"residual tumor","id":"39025"},{"source":"CD19 antagonist","target":"residual tumor","id":"39026"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"39027"},{"source":"CD19 antagonist","target":"carcinoma","id":"39028"},{"source":"CD19 antagonist","target":"anti-tumor","id":"39029"},{"source":"CD19 antagonist","target":"carcinoma","id":"39030"},{"source":"CD19 antagonist","target":"anticancer","id":"39031"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"39032"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"39033"},{"source":"CD19 antagonist","target":"carcinoma","id":"39034"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"39035"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"UNK : Indication","id":"39036"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"colorectal neoplasms","id":"39037"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"39038"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anti-tumor","id":"39039"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"39040"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"39041"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"colonic neoplasms","id":"39042"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"39043"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anti-tumor","id":"39044"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"39045"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"39046"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"colorectal cancer","id":"39047"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"non-small-cell lung","id":"39048"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"39049"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"colorectal neoplasms","id":"39050"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"39051"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"39052"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39053"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"39054"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"39055"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"39056"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"39057"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39058"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"39059"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39060"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"39061"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"39062"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"39063"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39064"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"39065"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"39066"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"39067"},{"source":"Oncology: Colorectal","target":"Granulocyte macrophage colony stimulating factor agonist","id":"39068"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"39069"},{"source":"carboplatin","target":"Medical College of Wisconsin Cancer Center","id":"39070"},{"source":"carboplatin","target":"The Cleveland Clinic Foundation","id":"39071"},{"source":"nab-paclitaxel (IV)","target":"Medical College of Wisconsin Cancer Center","id":"39072"},{"source":"nab-paclitaxel (IV)","target":"The Cleveland Clinic Foundation","id":"39073"},{"source":"pembrolizumab","target":"Medical College of Wisconsin Cancer Center","id":"39074"},{"source":"pembrolizumab","target":"The Cleveland Clinic Foundation","id":"39075"},{"source":"UNK : Drug","target":"Medical College of Wisconsin Cancer Center","id":"39076"},{"source":"UNK : Drug","target":"The Cleveland Clinic Foundation","id":"39077"},{"source":"ovarian cancer","target":"carboplatin","id":"39078"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"39079"},{"source":"ovarian cancer","target":"pembrolizumab","id":"39080"},{"source":"ovarian cancer","target":"UNK : Drug","id":"39081"},{"source":"ovarian cancer","target":"carboplatin","id":"39082"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"39083"},{"source":"ovarian cancer","target":"pembrolizumab","id":"39084"},{"source":"ovarian cancer","target":"UNK : Drug","id":"39085"},{"source":"primary peritoneal cancer","target":"carboplatin","id":"39086"},{"source":"primary peritoneal cancer","target":"nab-paclitaxel (IV)","id":"39087"},{"source":"primary peritoneal cancer","target":"pembrolizumab","id":"39088"},{"source":"primary peritoneal cancer","target":"UNK : Drug","id":"39089"},{"source":"ovarian neoplasms","target":"carboplatin","id":"39090"},{"source":"ovarian neoplasms","target":"nab-paclitaxel (IV)","id":"39091"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"39092"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"39093"},{"source":"residual tumor","target":"carboplatin","id":"39094"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"39095"},{"source":"residual tumor","target":"pembrolizumab","id":"39096"},{"source":"residual tumor","target":"UNK : Drug","id":"39097"},{"source":"fallopian tube neoplasms","target":"carboplatin","id":"39098"},{"source":"fallopian tube neoplasms","target":"nab-paclitaxel (IV)","id":"39099"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"39100"},{"source":"fallopian tube neoplasms","target":"UNK : Drug","id":"39101"},{"source":"carcinoma","target":"carboplatin","id":"39102"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"39103"},{"source":"carcinoma","target":"pembrolizumab","id":"39104"},{"source":"carcinoma","target":"UNK : Drug","id":"39105"},{"source":"anticancer","target":"carboplatin","id":"39106"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"39107"},{"source":"anticancer","target":"pembrolizumab","id":"39108"},{"source":"anticancer","target":"UNK : Drug","id":"39109"},{"source":"peritoneal neoplasms","target":"carboplatin","id":"39110"},{"source":"peritoneal neoplasms","target":"nab-paclitaxel (IV)","id":"39111"},{"source":"peritoneal neoplasms","target":"pembrolizumab","id":"39112"},{"source":"peritoneal neoplasms","target":"UNK : Drug","id":"39113"},{"source":"fallopian tube cancer","target":"carboplatin","id":"39114"},{"source":"fallopian tube cancer","target":"nab-paclitaxel (IV)","id":"39115"},{"source":"fallopian tube cancer","target":"pembrolizumab","id":"39116"},{"source":"fallopian tube cancer","target":"UNK : Drug","id":"39117"},{"source":"ovarian cancer","target":"carboplatin","id":"39118"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"39119"},{"source":"ovarian cancer","target":"pembrolizumab","id":"39120"},{"source":"ovarian cancer","target":"UNK : Drug","id":"39121"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"39122"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"39123"},{"source":"Immune checkpoint inhibitor","target":"primary peritoneal cancer","id":"39124"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"39125"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"39126"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"39127"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39128"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"39129"},{"source":"Immune checkpoint inhibitor","target":"peritoneal neoplasms","id":"39130"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube cancer","id":"39131"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"39132"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"39133"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"39134"},{"source":"Beta tubulin antagonist","target":"primary peritoneal cancer","id":"39135"},{"source":"Beta tubulin antagonist","target":"ovarian neoplasms","id":"39136"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"39137"},{"source":"Beta tubulin antagonist","target":"fallopian tube neoplasms","id":"39138"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"39139"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"39140"},{"source":"Beta tubulin antagonist","target":"peritoneal neoplasms","id":"39141"},{"source":"Beta tubulin antagonist","target":"fallopian tube cancer","id":"39142"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"39143"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"39144"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"39145"},{"source":"CD19 antagonist","target":"primary peritoneal cancer","id":"39146"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"39147"},{"source":"CD19 antagonist","target":"residual tumor","id":"39148"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"39149"},{"source":"CD19 antagonist","target":"carcinoma","id":"39150"},{"source":"CD19 antagonist","target":"anticancer","id":"39151"},{"source":"CD19 antagonist","target":"peritoneal neoplasms","id":"39152"},{"source":"CD19 antagonist","target":"fallopian tube cancer","id":"39153"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"39154"},{"source":"NA","target":"ovarian cancer","id":"39155"},{"source":"NA","target":"ovarian cancer","id":"39156"},{"source":"NA","target":"primary peritoneal cancer","id":"39157"},{"source":"NA","target":"ovarian neoplasms","id":"39158"},{"source":"NA","target":"residual tumor","id":"39159"},{"source":"NA","target":"fallopian tube neoplasms","id":"39160"},{"source":"NA","target":"carcinoma","id":"39161"},{"source":"NA","target":"anticancer","id":"39162"},{"source":"NA","target":"peritoneal neoplasms","id":"39163"},{"source":"NA","target":"fallopian tube cancer","id":"39164"},{"source":"NA","target":"ovarian cancer","id":"39165"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"39166"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"39167"},{"source":"Microtubule stimulant","target":"primary peritoneal cancer","id":"39168"},{"source":"Microtubule stimulant","target":"ovarian neoplasms","id":"39169"},{"source":"Microtubule stimulant","target":"residual tumor","id":"39170"},{"source":"Microtubule stimulant","target":"fallopian tube neoplasms","id":"39171"},{"source":"Microtubule stimulant","target":"carcinoma","id":"39172"},{"source":"Microtubule stimulant","target":"anticancer","id":"39173"},{"source":"Microtubule stimulant","target":"peritoneal neoplasms","id":"39174"},{"source":"Microtubule stimulant","target":"fallopian tube cancer","id":"39175"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"39176"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"39177"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"39178"},{"source":"Anticancer immunotherapy","target":"primary peritoneal cancer","id":"39179"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"39180"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"39181"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"39182"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39183"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"39184"},{"source":"Anticancer immunotherapy","target":"peritoneal neoplasms","id":"39185"},{"source":"Anticancer immunotherapy","target":"fallopian tube cancer","id":"39186"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"39187"},{"source":"Taxane","target":"ovarian cancer","id":"39188"},{"source":"Taxane","target":"ovarian cancer","id":"39189"},{"source":"Taxane","target":"primary peritoneal cancer","id":"39190"},{"source":"Taxane","target":"ovarian neoplasms","id":"39191"},{"source":"Taxane","target":"residual tumor","id":"39192"},{"source":"Taxane","target":"fallopian tube neoplasms","id":"39193"},{"source":"Taxane","target":"carcinoma","id":"39194"},{"source":"Taxane","target":"anticancer","id":"39195"},{"source":"Taxane","target":"peritoneal neoplasms","id":"39196"},{"source":"Taxane","target":"fallopian tube cancer","id":"39197"},{"source":"Taxane","target":"ovarian cancer","id":"39198"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"39199"},{"source":"Oncology: (N/A)","target":"Beta tubulin antagonist","id":"39200"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"39201"},{"source":"Oncology: (N/A)","target":"NA","id":"39202"},{"source":"Oncology: (N/A)","target":"Microtubule stimulant","id":"39203"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"39204"},{"source":"Oncology: (N/A)","target":"Taxane","id":"39205"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"39206"},{"source":"Oncology: Ovarian","target":"Beta tubulin antagonist","id":"39207"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"39208"},{"source":"Oncology: Ovarian","target":"NA","id":"39209"},{"source":"Oncology: Ovarian","target":"Microtubule stimulant","id":"39210"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"39211"},{"source":"Oncology: Ovarian","target":"Taxane","id":"39212"},{"source":"birinapant (u)","target":"Jonsson Comprehensive Cancer Center","id":"39213"},{"source":"birinapant (u)","target":"UCLA","id":"39214"},{"source":"birinapant (u)","target":"Medivir","id":"39215"},{"source":"birinapant (u)","target":"National Institutes of Health/National Cancer Institute","id":"39216"},{"source":"carboplatin","target":"Jonsson Comprehensive Cancer Center","id":"39217"},{"source":"carboplatin","target":"UCLA","id":"39218"},{"source":"carboplatin","target":"Medivir","id":"39219"},{"source":"carboplatin","target":"National Institutes of Health/National Cancer Institute","id":"39220"},{"source":"nab-paclitaxel (IV)","target":"Jonsson Comprehensive Cancer Center","id":"39221"},{"source":"nab-paclitaxel (IV)","target":"UCLA","id":"39222"},{"source":"nab-paclitaxel (IV)","target":"Medivir","id":"39223"},{"source":"nab-paclitaxel (IV)","target":"National Institutes of Health/National Cancer Institute","id":"39224"},{"source":"surgical intervention","target":"Jonsson Comprehensive Cancer Center","id":"39225"},{"source":"surgical intervention","target":"UCLA","id":"39226"},{"source":"surgical intervention","target":"Medivir","id":"39227"},{"source":"surgical intervention","target":"National Institutes of Health/National Cancer Institute","id":"39228"},{"source":"UNK : Indication","target":"birinapant (u)","id":"39229"},{"source":"UNK : Indication","target":"carboplatin","id":"39230"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"39231"},{"source":"UNK : Indication","target":"surgical intervention","id":"39232"},{"source":"anti-hiv","target":"birinapant (u)","id":"39233"},{"source":"anti-hiv","target":"carboplatin","id":"39234"},{"source":"anti-hiv","target":"nab-paclitaxel (IV)","id":"39235"},{"source":"anti-hiv","target":"surgical intervention","id":"39236"},{"source":"ovarian cancer","target":"birinapant (u)","id":"39237"},{"source":"ovarian cancer","target":"carboplatin","id":"39238"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"39239"},{"source":"ovarian cancer","target":"surgical intervention","id":"39240"},{"source":"skin neoplasms","target":"birinapant (u)","id":"39241"},{"source":"skin neoplasms","target":"carboplatin","id":"39242"},{"source":"skin neoplasms","target":"nab-paclitaxel (IV)","id":"39243"},{"source":"skin neoplasms","target":"surgical intervention","id":"39244"},{"source":"gilbert disease","target":"birinapant (u)","id":"39245"},{"source":"gilbert disease","target":"carboplatin","id":"39246"},{"source":"gilbert disease","target":"nab-paclitaxel (IV)","id":"39247"},{"source":"gilbert disease","target":"surgical intervention","id":"39248"},{"source":"hiv infections","target":"birinapant (u)","id":"39249"},{"source":"hiv infections","target":"carboplatin","id":"39250"},{"source":"hiv infections","target":"nab-paclitaxel (IV)","id":"39251"},{"source":"hiv infections","target":"surgical intervention","id":"39252"},{"source":"liver neoplasms","target":"birinapant (u)","id":"39253"},{"source":"liver neoplasms","target":"carboplatin","id":"39254"},{"source":"liver neoplasms","target":"nab-paclitaxel (IV)","id":"39255"},{"source":"liver neoplasms","target":"surgical intervention","id":"39256"},{"source":"endometrial neoplasms","target":"birinapant (u)","id":"39257"},{"source":"endometrial neoplasms","target":"carboplatin","id":"39258"},{"source":"endometrial neoplasms","target":"nab-paclitaxel (IV)","id":"39259"},{"source":"endometrial neoplasms","target":"surgical intervention","id":"39260"},{"source":"glandular and epithelial","target":"birinapant (u)","id":"39261"},{"source":"glandular and epithelial","target":"carboplatin","id":"39262"},{"source":"glandular and epithelial","target":"nab-paclitaxel (IV)","id":"39263"},{"source":"glandular and epithelial","target":"surgical intervention","id":"39264"},{"source":"carcinoma","target":"birinapant (u)","id":"39265"},{"source":"carcinoma","target":"carboplatin","id":"39266"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"39267"},{"source":"carcinoma","target":"surgical intervention","id":"39268"},{"source":"liver metastases","target":"birinapant (u)","id":"39269"},{"source":"liver metastases","target":"carboplatin","id":"39270"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"39271"},{"source":"liver metastases","target":"surgical intervention","id":"39272"},{"source":"gilbert syndrome","target":"birinapant (u)","id":"39273"},{"source":"gilbert syndrome","target":"carboplatin","id":"39274"},{"source":"gilbert syndrome","target":"nab-paclitaxel (IV)","id":"39275"},{"source":"gilbert syndrome","target":"surgical intervention","id":"39276"},{"source":"carcinoma","target":"birinapant (u)","id":"39277"},{"source":"carcinoma","target":"carboplatin","id":"39278"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"39279"},{"source":"carcinoma","target":"surgical intervention","id":"39280"},{"source":"acquired immunodeficiency syndrome","target":"birinapant (u)","id":"39281"},{"source":"acquired immunodeficiency syndrome","target":"carboplatin","id":"39282"},{"source":"acquired immunodeficiency syndrome","target":"nab-paclitaxel (IV)","id":"39283"},{"source":"acquired immunodeficiency syndrome","target":"surgical intervention","id":"39284"},{"source":"serous","target":"birinapant (u)","id":"39285"},{"source":"serous","target":"carboplatin","id":"39286"},{"source":"serous","target":"nab-paclitaxel (IV)","id":"39287"},{"source":"serous","target":"surgical intervention","id":"39288"},{"source":"carcinoma","target":"birinapant (u)","id":"39289"},{"source":"carcinoma","target":"carboplatin","id":"39290"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"39291"},{"source":"carcinoma","target":"surgical intervention","id":"39292"},{"source":"ovarian neoplasms","target":"birinapant (u)","id":"39293"},{"source":"ovarian neoplasms","target":"carboplatin","id":"39294"},{"source":"ovarian neoplasms","target":"nab-paclitaxel (IV)","id":"39295"},{"source":"ovarian neoplasms","target":"surgical intervention","id":"39296"},{"source":"endometrioid","target":"birinapant (u)","id":"39297"},{"source":"endometrioid","target":"carboplatin","id":"39298"},{"source":"endometrioid","target":"nab-paclitaxel (IV)","id":"39299"},{"source":"endometrioid","target":"surgical intervention","id":"39300"},{"source":"carcinoma","target":"birinapant (u)","id":"39301"},{"source":"carcinoma","target":"carboplatin","id":"39302"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"39303"},{"source":"carcinoma","target":"surgical intervention","id":"39304"},{"source":"fallopian tube neoplasms","target":"birinapant (u)","id":"39305"},{"source":"fallopian tube neoplasms","target":"carboplatin","id":"39306"},{"source":"fallopian tube neoplasms","target":"nab-paclitaxel (IV)","id":"39307"},{"source":"fallopian tube neoplasms","target":"surgical intervention","id":"39308"},{"source":"carcinoma","target":"birinapant (u)","id":"39309"},{"source":"carcinoma","target":"carboplatin","id":"39310"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"39311"},{"source":"carcinoma","target":"surgical intervention","id":"39312"},{"source":"glandular and epithelial","target":"birinapant (u)","id":"39313"},{"source":"glandular and epithelial","target":"carboplatin","id":"39314"},{"source":"glandular and epithelial","target":"nab-paclitaxel (IV)","id":"39315"},{"source":"glandular and epithelial","target":"surgical intervention","id":"39316"},{"source":"neuropathy","target":"birinapant (u)","id":"39317"},{"source":"neuropathy","target":"carboplatin","id":"39318"},{"source":"neuropathy","target":"nab-paclitaxel (IV)","id":"39319"},{"source":"neuropathy","target":"surgical intervention","id":"39320"},{"source":"carcinoma","target":"birinapant (u)","id":"39321"},{"source":"carcinoma","target":"carboplatin","id":"39322"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"39323"},{"source":"carcinoma","target":"surgical intervention","id":"39324"},{"source":"residual tumor","target":"birinapant (u)","id":"39325"},{"source":"residual tumor","target":"carboplatin","id":"39326"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"39327"},{"source":"residual tumor","target":"surgical intervention","id":"39328"},{"source":"residual tumor","target":"birinapant (u)","id":"39329"},{"source":"residual tumor","target":"carboplatin","id":"39330"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"39331"},{"source":"residual tumor","target":"surgical intervention","id":"39332"},{"source":"anticancer","target":"birinapant (u)","id":"39333"},{"source":"anticancer","target":"carboplatin","id":"39334"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"39335"},{"source":"anticancer","target":"surgical intervention","id":"39336"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"39337"},{"source":"Beta tubulin antagonist","target":"anti-hiv","id":"39338"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"39339"},{"source":"Beta tubulin antagonist","target":"skin neoplasms","id":"39340"},{"source":"Beta tubulin antagonist","target":"gilbert disease","id":"39341"},{"source":"Beta tubulin antagonist","target":"hiv infections","id":"39342"},{"source":"Beta tubulin antagonist","target":"liver neoplasms","id":"39343"},{"source":"Beta tubulin antagonist","target":"endometrial neoplasms","id":"39344"},{"source":"Beta tubulin antagonist","target":"glandular and epithelial","id":"39345"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"39346"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"39347"},{"source":"Beta tubulin antagonist","target":"gilbert syndrome","id":"39348"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"39349"},{"source":"Beta tubulin antagonist","target":"acquired immunodeficiency syndrome","id":"39350"},{"source":"Beta tubulin antagonist","target":"serous","id":"39351"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"39352"},{"source":"Beta tubulin antagonist","target":"ovarian neoplasms","id":"39353"},{"source":"Beta tubulin antagonist","target":"endometrioid","id":"39354"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"39355"},{"source":"Beta tubulin antagonist","target":"fallopian tube neoplasms","id":"39356"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"39357"},{"source":"Beta tubulin antagonist","target":"glandular and epithelial","id":"39358"},{"source":"Beta tubulin antagonist","target":"neuropathy","id":"39359"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"39360"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"39361"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"39362"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"39363"},{"source":"NA","target":"UNK : Indication","id":"39364"},{"source":"NA","target":"anti-hiv","id":"39365"},{"source":"NA","target":"ovarian cancer","id":"39366"},{"source":"NA","target":"skin neoplasms","id":"39367"},{"source":"NA","target":"gilbert disease","id":"39368"},{"source":"NA","target":"hiv infections","id":"39369"},{"source":"NA","target":"liver neoplasms","id":"39370"},{"source":"NA","target":"endometrial neoplasms","id":"39371"},{"source":"NA","target":"glandular and epithelial","id":"39372"},{"source":"NA","target":"carcinoma","id":"39373"},{"source":"NA","target":"liver metastases","id":"39374"},{"source":"NA","target":"gilbert syndrome","id":"39375"},{"source":"NA","target":"carcinoma","id":"39376"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"39377"},{"source":"NA","target":"serous","id":"39378"},{"source":"NA","target":"carcinoma","id":"39379"},{"source":"NA","target":"ovarian neoplasms","id":"39380"},{"source":"NA","target":"endometrioid","id":"39381"},{"source":"NA","target":"carcinoma","id":"39382"},{"source":"NA","target":"fallopian tube neoplasms","id":"39383"},{"source":"NA","target":"carcinoma","id":"39384"},{"source":"NA","target":"glandular and epithelial","id":"39385"},{"source":"NA","target":"neuropathy","id":"39386"},{"source":"NA","target":"carcinoma","id":"39387"},{"source":"NA","target":"residual tumor","id":"39388"},{"source":"NA","target":"residual tumor","id":"39389"},{"source":"NA","target":"anticancer","id":"39390"},{"source":"NA","target":"UNK : Indication","id":"39391"},{"source":"NA","target":"anti-hiv","id":"39392"},{"source":"NA","target":"ovarian cancer","id":"39393"},{"source":"NA","target":"skin neoplasms","id":"39394"},{"source":"NA","target":"gilbert disease","id":"39395"},{"source":"NA","target":"hiv infections","id":"39396"},{"source":"NA","target":"liver neoplasms","id":"39397"},{"source":"NA","target":"endometrial neoplasms","id":"39398"},{"source":"NA","target":"glandular and epithelial","id":"39399"},{"source":"NA","target":"carcinoma","id":"39400"},{"source":"NA","target":"liver metastases","id":"39401"},{"source":"NA","target":"gilbert syndrome","id":"39402"},{"source":"NA","target":"carcinoma","id":"39403"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"39404"},{"source":"NA","target":"serous","id":"39405"},{"source":"NA","target":"carcinoma","id":"39406"},{"source":"NA","target":"ovarian neoplasms","id":"39407"},{"source":"NA","target":"endometrioid","id":"39408"},{"source":"NA","target":"carcinoma","id":"39409"},{"source":"NA","target":"fallopian tube neoplasms","id":"39410"},{"source":"NA","target":"carcinoma","id":"39411"},{"source":"NA","target":"glandular and epithelial","id":"39412"},{"source":"NA","target":"neuropathy","id":"39413"},{"source":"NA","target":"carcinoma","id":"39414"},{"source":"NA","target":"residual tumor","id":"39415"},{"source":"NA","target":"residual tumor","id":"39416"},{"source":"NA","target":"anticancer","id":"39417"},{"source":"IAP antagonist","target":"UNK : Indication","id":"39418"},{"source":"IAP antagonist","target":"anti-hiv","id":"39419"},{"source":"IAP antagonist","target":"ovarian cancer","id":"39420"},{"source":"IAP antagonist","target":"skin neoplasms","id":"39421"},{"source":"IAP antagonist","target":"gilbert disease","id":"39422"},{"source":"IAP antagonist","target":"hiv infections","id":"39423"},{"source":"IAP antagonist","target":"liver neoplasms","id":"39424"},{"source":"IAP antagonist","target":"endometrial neoplasms","id":"39425"},{"source":"IAP antagonist","target":"glandular and epithelial","id":"39426"},{"source":"IAP antagonist","target":"carcinoma","id":"39427"},{"source":"IAP antagonist","target":"liver metastases","id":"39428"},{"source":"IAP antagonist","target":"gilbert syndrome","id":"39429"},{"source":"IAP antagonist","target":"carcinoma","id":"39430"},{"source":"IAP antagonist","target":"acquired immunodeficiency syndrome","id":"39431"},{"source":"IAP antagonist","target":"serous","id":"39432"},{"source":"IAP antagonist","target":"carcinoma","id":"39433"},{"source":"IAP antagonist","target":"ovarian neoplasms","id":"39434"},{"source":"IAP antagonist","target":"endometrioid","id":"39435"},{"source":"IAP antagonist","target":"carcinoma","id":"39436"},{"source":"IAP antagonist","target":"fallopian tube neoplasms","id":"39437"},{"source":"IAP antagonist","target":"carcinoma","id":"39438"},{"source":"IAP antagonist","target":"glandular and epithelial","id":"39439"},{"source":"IAP antagonist","target":"neuropathy","id":"39440"},{"source":"IAP antagonist","target":"carcinoma","id":"39441"},{"source":"IAP antagonist","target":"residual tumor","id":"39442"},{"source":"IAP antagonist","target":"residual tumor","id":"39443"},{"source":"IAP antagonist","target":"anticancer","id":"39444"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"39445"},{"source":"Microtubule stimulant","target":"anti-hiv","id":"39446"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"39447"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"39448"},{"source":"Microtubule stimulant","target":"gilbert disease","id":"39449"},{"source":"Microtubule stimulant","target":"hiv infections","id":"39450"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"39451"},{"source":"Microtubule stimulant","target":"endometrial neoplasms","id":"39452"},{"source":"Microtubule stimulant","target":"glandular and epithelial","id":"39453"},{"source":"Microtubule stimulant","target":"carcinoma","id":"39454"},{"source":"Microtubule stimulant","target":"liver metastases","id":"39455"},{"source":"Microtubule stimulant","target":"gilbert syndrome","id":"39456"},{"source":"Microtubule stimulant","target":"carcinoma","id":"39457"},{"source":"Microtubule stimulant","target":"acquired immunodeficiency syndrome","id":"39458"},{"source":"Microtubule stimulant","target":"serous","id":"39459"},{"source":"Microtubule stimulant","target":"carcinoma","id":"39460"},{"source":"Microtubule stimulant","target":"ovarian neoplasms","id":"39461"},{"source":"Microtubule stimulant","target":"endometrioid","id":"39462"},{"source":"Microtubule stimulant","target":"carcinoma","id":"39463"},{"source":"Microtubule stimulant","target":"fallopian tube neoplasms","id":"39464"},{"source":"Microtubule stimulant","target":"carcinoma","id":"39465"},{"source":"Microtubule stimulant","target":"glandular and epithelial","id":"39466"},{"source":"Microtubule stimulant","target":"neuropathy","id":"39467"},{"source":"Microtubule stimulant","target":"carcinoma","id":"39468"},{"source":"Microtubule stimulant","target":"residual tumor","id":"39469"},{"source":"Microtubule stimulant","target":"residual tumor","id":"39470"},{"source":"Microtubule stimulant","target":"anticancer","id":"39471"},{"source":"Taxane","target":"UNK : Indication","id":"39472"},{"source":"Taxane","target":"anti-hiv","id":"39473"},{"source":"Taxane","target":"ovarian cancer","id":"39474"},{"source":"Taxane","target":"skin neoplasms","id":"39475"},{"source":"Taxane","target":"gilbert disease","id":"39476"},{"source":"Taxane","target":"hiv infections","id":"39477"},{"source":"Taxane","target":"liver neoplasms","id":"39478"},{"source":"Taxane","target":"endometrial neoplasms","id":"39479"},{"source":"Taxane","target":"glandular and epithelial","id":"39480"},{"source":"Taxane","target":"carcinoma","id":"39481"},{"source":"Taxane","target":"liver metastases","id":"39482"},{"source":"Taxane","target":"gilbert syndrome","id":"39483"},{"source":"Taxane","target":"carcinoma","id":"39484"},{"source":"Taxane","target":"acquired immunodeficiency syndrome","id":"39485"},{"source":"Taxane","target":"serous","id":"39486"},{"source":"Taxane","target":"carcinoma","id":"39487"},{"source":"Taxane","target":"ovarian neoplasms","id":"39488"},{"source":"Taxane","target":"endometrioid","id":"39489"},{"source":"Taxane","target":"carcinoma","id":"39490"},{"source":"Taxane","target":"fallopian tube neoplasms","id":"39491"},{"source":"Taxane","target":"carcinoma","id":"39492"},{"source":"Taxane","target":"glandular and epithelial","id":"39493"},{"source":"Taxane","target":"neuropathy","id":"39494"},{"source":"Taxane","target":"carcinoma","id":"39495"},{"source":"Taxane","target":"residual tumor","id":"39496"},{"source":"Taxane","target":"residual tumor","id":"39497"},{"source":"Taxane","target":"anticancer","id":"39498"},{"source":"Oncology: (N/A)","target":"Beta tubulin antagonist","id":"39499"},{"source":"Oncology: (N/A)","target":"NA","id":"39500"},{"source":"Oncology: (N/A)","target":"NA","id":"39501"},{"source":"Oncology: (N/A)","target":"IAP antagonist","id":"39502"},{"source":"Oncology: (N/A)","target":"Microtubule stimulant","id":"39503"},{"source":"Oncology: (N/A)","target":"Taxane","id":"39504"},{"source":"Oncology: Endometrial","target":"Beta tubulin antagonist","id":"39505"},{"source":"Oncology: Endometrial","target":"NA","id":"39506"},{"source":"Oncology: Endometrial","target":"NA","id":"39507"},{"source":"Oncology: Endometrial","target":"IAP antagonist","id":"39508"},{"source":"Oncology: Endometrial","target":"Microtubule stimulant","id":"39509"},{"source":"Oncology: Endometrial","target":"Taxane","id":"39510"},{"source":"Oncology: Ovarian","target":"Beta tubulin antagonist","id":"39511"},{"source":"Oncology: Ovarian","target":"NA","id":"39512"},{"source":"Oncology: Ovarian","target":"NA","id":"39513"},{"source":"Oncology: Ovarian","target":"IAP antagonist","id":"39514"},{"source":"Oncology: Ovarian","target":"Microtubule stimulant","id":"39515"},{"source":"Oncology: Ovarian","target":"Taxane","id":"39516"},{"source":"indoximod (u)","target":"NewLink Genetics","id":"39517"},{"source":"ipilimumab","target":"NewLink Genetics","id":"39518"},{"source":"nivolumab (a)","target":"NewLink Genetics","id":"39519"},{"source":"pembrolizumab","target":"NewLink Genetics","id":"39520"},{"source":"ovarian neoplasms","target":"indoximod (u)","id":"39521"},{"source":"ovarian neoplasms","target":"ipilimumab","id":"39522"},{"source":"ovarian neoplasms","target":"nivolumab (a)","id":"39523"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"39524"},{"source":"anti-hiv","target":"indoximod (u)","id":"39525"},{"source":"anti-hiv","target":"ipilimumab","id":"39526"},{"source":"anti-hiv","target":"nivolumab (a)","id":"39527"},{"source":"anti-hiv","target":"pembrolizumab","id":"39528"},{"source":"acquired immunodeficiency syndrome","target":"indoximod (u)","id":"39529"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"39530"},{"source":"acquired immunodeficiency syndrome","target":"nivolumab (a)","id":"39531"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"39532"},{"source":"gilbert syndrome","target":"indoximod (u)","id":"39533"},{"source":"gilbert syndrome","target":"ipilimumab","id":"39534"},{"source":"gilbert syndrome","target":"nivolumab (a)","id":"39535"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"39536"},{"source":"melanoma","target":"indoximod (u)","id":"39537"},{"source":"melanoma","target":"ipilimumab","id":"39538"},{"source":"melanoma","target":"nivolumab (a)","id":"39539"},{"source":"melanoma","target":"pembrolizumab","id":"39540"},{"source":"residual tumor","target":"indoximod (u)","id":"39541"},{"source":"residual tumor","target":"ipilimumab","id":"39542"},{"source":"residual tumor","target":"nivolumab (a)","id":"39543"},{"source":"residual tumor","target":"pembrolizumab","id":"39544"},{"source":"skin neoplasms","target":"indoximod (u)","id":"39545"},{"source":"skin neoplasms","target":"ipilimumab","id":"39546"},{"source":"skin neoplasms","target":"nivolumab (a)","id":"39547"},{"source":"skin neoplasms","target":"pembrolizumab","id":"39548"},{"source":"hepatic metastases","target":"indoximod (u)","id":"39549"},{"source":"hepatic metastases","target":"ipilimumab","id":"39550"},{"source":"hepatic metastases","target":"nivolumab (a)","id":"39551"},{"source":"hepatic metastases","target":"pembrolizumab","id":"39552"},{"source":"cerebellar neoplasms","target":"indoximod (u)","id":"39553"},{"source":"cerebellar neoplasms","target":"ipilimumab","id":"39554"},{"source":"cerebellar neoplasms","target":"nivolumab (a)","id":"39555"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"39556"},{"source":"carcinoma","target":"indoximod (u)","id":"39557"},{"source":"carcinoma","target":"ipilimumab","id":"39558"},{"source":"carcinoma","target":"nivolumab (a)","id":"39559"},{"source":"carcinoma","target":"pembrolizumab","id":"39560"},{"source":"brain metastases","target":"indoximod (u)","id":"39561"},{"source":"brain metastases","target":"ipilimumab","id":"39562"},{"source":"brain metastases","target":"nivolumab (a)","id":"39563"},{"source":"brain metastases","target":"pembrolizumab","id":"39564"},{"source":"gilbert disease","target":"indoximod (u)","id":"39565"},{"source":"gilbert disease","target":"ipilimumab","id":"39566"},{"source":"gilbert disease","target":"nivolumab (a)","id":"39567"},{"source":"gilbert disease","target":"pembrolizumab","id":"39568"},{"source":"melanoma","target":"indoximod (u)","id":"39569"},{"source":"melanoma","target":"ipilimumab","id":"39570"},{"source":"melanoma","target":"nivolumab (a)","id":"39571"},{"source":"melanoma","target":"pembrolizumab","id":"39572"},{"source":"anticancer","target":"indoximod (u)","id":"39573"},{"source":"anticancer","target":"ipilimumab","id":"39574"},{"source":"anticancer","target":"nivolumab (a)","id":"39575"},{"source":"anticancer","target":"pembrolizumab","id":"39576"},{"source":"hiv infections","target":"indoximod (u)","id":"39577"},{"source":"hiv infections","target":"ipilimumab","id":"39578"},{"source":"hiv infections","target":"nivolumab (a)","id":"39579"},{"source":"hiv infections","target":"pembrolizumab","id":"39580"},{"source":"liver neoplasms","target":"indoximod (u)","id":"39581"},{"source":"liver neoplasms","target":"ipilimumab","id":"39582"},{"source":"liver neoplasms","target":"nivolumab (a)","id":"39583"},{"source":"liver neoplasms","target":"pembrolizumab","id":"39584"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"39585"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"39586"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"39587"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"39588"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"39589"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"39590"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"39591"},{"source":"Immune checkpoint inhibitor","target":"hepatic metastases","id":"39592"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"39593"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39594"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"39595"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"39596"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"39597"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"39598"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"39599"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"39600"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"39601"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"39602"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"39603"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"39604"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"39605"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"39606"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"39607"},{"source":"Anticancer immunotherapy","target":"hepatic metastases","id":"39608"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"39609"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39610"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"39611"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"39612"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"39613"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"39614"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"39615"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"39616"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"39617"},{"source":"CD19 antagonist","target":"anti-hiv","id":"39618"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"39619"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"39620"},{"source":"CD19 antagonist","target":"melanoma","id":"39621"},{"source":"CD19 antagonist","target":"residual tumor","id":"39622"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"39623"},{"source":"CD19 antagonist","target":"hepatic metastases","id":"39624"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"39625"},{"source":"CD19 antagonist","target":"carcinoma","id":"39626"},{"source":"CD19 antagonist","target":"brain metastases","id":"39627"},{"source":"CD19 antagonist","target":"gilbert disease","id":"39628"},{"source":"CD19 antagonist","target":"melanoma","id":"39629"},{"source":"CD19 antagonist","target":"anticancer","id":"39630"},{"source":"CD19 antagonist","target":"hiv infections","id":"39631"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"39632"},{"source":"CTLA4 antagonist","target":"ovarian neoplasms","id":"39633"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"39634"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"39635"},{"source":"CTLA4 antagonist","target":"gilbert syndrome","id":"39636"},{"source":"CTLA4 antagonist","target":"melanoma","id":"39637"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"39638"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"39639"},{"source":"CTLA4 antagonist","target":"hepatic metastases","id":"39640"},{"source":"CTLA4 antagonist","target":"cerebellar neoplasms","id":"39641"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"39642"},{"source":"CTLA4 antagonist","target":"brain metastases","id":"39643"},{"source":"CTLA4 antagonist","target":"gilbert disease","id":"39644"},{"source":"CTLA4 antagonist","target":"melanoma","id":"39645"},{"source":"CTLA4 antagonist","target":"anticancer","id":"39646"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"39647"},{"source":"CTLA4 antagonist","target":"liver neoplasms","id":"39648"},{"source":"NA","target":"ovarian neoplasms","id":"39649"},{"source":"NA","target":"anti-hiv","id":"39650"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"39651"},{"source":"NA","target":"gilbert syndrome","id":"39652"},{"source":"NA","target":"melanoma","id":"39653"},{"source":"NA","target":"residual tumor","id":"39654"},{"source":"NA","target":"skin neoplasms","id":"39655"},{"source":"NA","target":"hepatic metastases","id":"39656"},{"source":"NA","target":"cerebellar neoplasms","id":"39657"},{"source":"NA","target":"carcinoma","id":"39658"},{"source":"NA","target":"brain metastases","id":"39659"},{"source":"NA","target":"gilbert disease","id":"39660"},{"source":"NA","target":"melanoma","id":"39661"},{"source":"NA","target":"anticancer","id":"39662"},{"source":"NA","target":"hiv infections","id":"39663"},{"source":"NA","target":"liver neoplasms","id":"39664"},{"source":"Indoleamine-pyrrole 2","target":"ovarian neoplasms","id":"39665"},{"source":"Indoleamine-pyrrole 2","target":"anti-hiv","id":"39666"},{"source":"Indoleamine-pyrrole 2","target":"acquired immunodeficiency syndrome","id":"39667"},{"source":"Indoleamine-pyrrole 2","target":"gilbert syndrome","id":"39668"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"39669"},{"source":"Indoleamine-pyrrole 2","target":"residual tumor","id":"39670"},{"source":"Indoleamine-pyrrole 2","target":"skin neoplasms","id":"39671"},{"source":"Indoleamine-pyrrole 2","target":"hepatic metastases","id":"39672"},{"source":"Indoleamine-pyrrole 2","target":"cerebellar neoplasms","id":"39673"},{"source":"Indoleamine-pyrrole 2","target":"carcinoma","id":"39674"},{"source":"Indoleamine-pyrrole 2","target":"brain metastases","id":"39675"},{"source":"Indoleamine-pyrrole 2","target":"gilbert disease","id":"39676"},{"source":"Indoleamine-pyrrole 2","target":"melanoma","id":"39677"},{"source":"Indoleamine-pyrrole 2","target":"anticancer","id":"39678"},{"source":"Indoleamine-pyrrole 2","target":"hiv infections","id":"39679"},{"source":"Indoleamine-pyrrole 2","target":"liver neoplasms","id":"39680"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"39681"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"39682"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"39683"},{"source":"Oncology: Melanoma","target":"CTLA4 antagonist","id":"39684"},{"source":"Oncology: Melanoma","target":"NA","id":"39685"},{"source":"Oncology: Melanoma","target":"Indoleamine-pyrrole 2","id":"39686"},{"source":"b-vedotin","target":"Merck & Co.","id":"39687"},{"source":"b-vedotin","target":"Seattle Genetics","id":"39688"},{"source":"pembrolizumab","target":"Merck & Co.","id":"39689"},{"source":"pembrolizumab","target":"Seattle Genetics","id":"39690"},{"source":"UNK : Indication","target":"b-vedotin","id":"39691"},{"source":"UNK : Indication","target":"pembrolizumab","id":"39692"},{"source":"triple-negative breast cancer","target":"b-vedotin","id":"39693"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"39694"},{"source":"residual tumor","target":"b-vedotin","id":"39695"},{"source":"residual tumor","target":"pembrolizumab","id":"39696"},{"source":"breast neoplasms","target":"b-vedotin","id":"39697"},{"source":"breast neoplasms","target":"pembrolizumab","id":"39698"},{"source":"metastatic","target":"b-vedotin","id":"39699"},{"source":"metastatic","target":"pembrolizumab","id":"39700"},{"source":"carcinoma","target":"b-vedotin","id":"39701"},{"source":"carcinoma","target":"pembrolizumab","id":"39702"},{"source":"breast neoplasms","target":"b-vedotin","id":"39703"},{"source":"breast neoplasms","target":"pembrolizumab","id":"39704"},{"source":"neoplasm metastasis","target":"b-vedotin","id":"39705"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"39706"},{"source":"anticancer","target":"b-vedotin","id":"39707"},{"source":"anticancer","target":"pembrolizumab","id":"39708"},{"source":"tnbc","target":"b-vedotin","id":"39709"},{"source":"tnbc","target":"pembrolizumab","id":"39710"},{"source":"triple-negative breast cancer","target":"b-vedotin","id":"39711"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"39712"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"39713"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"39714"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"39715"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"39716"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"39717"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39718"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"39719"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"39720"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"39721"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"39722"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"39723"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"39724"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"39725"},{"source":"CD19 antagonist","target":"residual tumor","id":"39726"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"39727"},{"source":"CD19 antagonist","target":"metastatic","id":"39728"},{"source":"CD19 antagonist","target":"carcinoma","id":"39729"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"39730"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"39731"},{"source":"CD19 antagonist","target":"anticancer","id":"39732"},{"source":"CD19 antagonist","target":"tnbc","id":"39733"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"39734"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"39735"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"39736"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"39737"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"39738"},{"source":"Tubulin inhibitor","target":"metastatic","id":"39739"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"39740"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"39741"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"39742"},{"source":"Tubulin inhibitor","target":"anticancer","id":"39743"},{"source":"Tubulin inhibitor","target":"tnbc","id":"39744"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"39745"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"39746"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"39747"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"39748"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"39749"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"39750"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39751"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"39752"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"39753"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"39754"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"39755"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"39756"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"39757"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"39758"},{"source":"Oncology: Breast","target":"Tubulin inhibitor","id":"39759"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"39760"},{"source":"crizotinib (IV) (u)","target":"Merck & Co.","id":"39761"},{"source":"crizotinib (IV) (u)","target":"Pfizer","id":"39762"},{"source":"pembrolizumab","target":"Merck & Co.","id":"39763"},{"source":"pembrolizumab","target":"Pfizer","id":"39764"},{"source":"UNK : Drug","target":"Merck & Co.","id":"39765"},{"source":"UNK : Drug","target":"Pfizer","id":"39766"},{"source":"UNK : Indication","target":"crizotinib (IV) (u)","id":"39767"},{"source":"UNK : Indication","target":"pembrolizumab","id":"39768"},{"source":"UNK : Indication","target":"UNK : Drug","id":"39769"},{"source":"ovarian neoplasms","target":"crizotinib (IV) (u)","id":"39770"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"39771"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"39772"},{"source":"non-small-cell lung","target":"crizotinib (IV) (u)","id":"39773"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"39774"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"39775"},{"source":"non-small-cell lung","target":"crizotinib (IV) (u)","id":"39776"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"39777"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"39778"},{"source":"sclc","target":"crizotinib (IV) (u)","id":"39779"},{"source":"sclc","target":"pembrolizumab","id":"39780"},{"source":"sclc","target":"UNK : Drug","id":"39781"},{"source":"non-small-cell lung","target":"crizotinib (IV) (u)","id":"39782"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"39783"},{"source":"non-small-cell lung","target":"UNK : Drug","id":"39784"},{"source":"carcinoma","target":"crizotinib (IV) (u)","id":"39785"},{"source":"carcinoma","target":"pembrolizumab","id":"39786"},{"source":"carcinoma","target":"UNK : Drug","id":"39787"},{"source":"cerebellar neoplasms","target":"crizotinib (IV) (u)","id":"39788"},{"source":"cerebellar neoplasms","target":"pembrolizumab","id":"39789"},{"source":"cerebellar neoplasms","target":"UNK : Drug","id":"39790"},{"source":"carcinoma","target":"crizotinib (IV) (u)","id":"39791"},{"source":"carcinoma","target":"pembrolizumab","id":"39792"},{"source":"carcinoma","target":"UNK : Drug","id":"39793"},{"source":"brain metastases","target":"crizotinib (IV) (u)","id":"39794"},{"source":"brain metastases","target":"pembrolizumab","id":"39795"},{"source":"brain metastases","target":"UNK : Drug","id":"39796"},{"source":"metastatic","target":"crizotinib (IV) (u)","id":"39797"},{"source":"metastatic","target":"pembrolizumab","id":"39798"},{"source":"metastatic","target":"UNK : Drug","id":"39799"},{"source":"neoplasm metastasis","target":"crizotinib (IV) (u)","id":"39800"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"39801"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"39802"},{"source":"anticancer","target":"crizotinib (IV) (u)","id":"39803"},{"source":"anticancer","target":"pembrolizumab","id":"39804"},{"source":"anticancer","target":"UNK : Drug","id":"39805"},{"source":"lung neoplasms","target":"crizotinib (IV) (u)","id":"39806"},{"source":"lung neoplasms","target":"pembrolizumab","id":"39807"},{"source":"lung neoplasms","target":"UNK : Drug","id":"39808"},{"source":"residual tumor","target":"crizotinib (IV) (u)","id":"39809"},{"source":"residual tumor","target":"pembrolizumab","id":"39810"},{"source":"residual tumor","target":"UNK : Drug","id":"39811"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"39812"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"39813"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"39814"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"39815"},{"source":"Anticancer immunotherapy","target":"sclc","id":"39816"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"39817"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39818"},{"source":"Anticancer immunotherapy","target":"cerebellar neoplasms","id":"39819"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39820"},{"source":"Anticancer immunotherapy","target":"brain metastases","id":"39821"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"39822"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"39823"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"39824"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"39825"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"39826"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"39827"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"39828"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"39829"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"39830"},{"source":"CD19 antagonist","target":"sclc","id":"39831"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"39832"},{"source":"CD19 antagonist","target":"carcinoma","id":"39833"},{"source":"CD19 antagonist","target":"cerebellar neoplasms","id":"39834"},{"source":"CD19 antagonist","target":"carcinoma","id":"39835"},{"source":"CD19 antagonist","target":"brain metastases","id":"39836"},{"source":"CD19 antagonist","target":"metastatic","id":"39837"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"39838"},{"source":"CD19 antagonist","target":"anticancer","id":"39839"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"39840"},{"source":"CD19 antagonist","target":"residual tumor","id":"39841"},{"source":"NA","target":"UNK : Indication","id":"39842"},{"source":"NA","target":"ovarian neoplasms","id":"39843"},{"source":"NA","target":"non-small-cell lung","id":"39844"},{"source":"NA","target":"non-small-cell lung","id":"39845"},{"source":"NA","target":"sclc","id":"39846"},{"source":"NA","target":"non-small-cell lung","id":"39847"},{"source":"NA","target":"carcinoma","id":"39848"},{"source":"NA","target":"cerebellar neoplasms","id":"39849"},{"source":"NA","target":"carcinoma","id":"39850"},{"source":"NA","target":"brain metastases","id":"39851"},{"source":"NA","target":"metastatic","id":"39852"},{"source":"NA","target":"neoplasm metastasis","id":"39853"},{"source":"NA","target":"anticancer","id":"39854"},{"source":"NA","target":"lung neoplasms","id":"39855"},{"source":"NA","target":"residual tumor","id":"39856"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"39857"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"39858"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"39859"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"39860"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"39861"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"39862"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39863"},{"source":"Immune checkpoint inhibitor","target":"cerebellar neoplasms","id":"39864"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"39865"},{"source":"Immune checkpoint inhibitor","target":"brain metastases","id":"39866"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"39867"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"39868"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"39869"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"39870"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"39871"},{"source":"NA","target":"UNK : Indication","id":"39872"},{"source":"NA","target":"ovarian neoplasms","id":"39873"},{"source":"NA","target":"non-small-cell lung","id":"39874"},{"source":"NA","target":"non-small-cell lung","id":"39875"},{"source":"NA","target":"sclc","id":"39876"},{"source":"NA","target":"non-small-cell lung","id":"39877"},{"source":"NA","target":"carcinoma","id":"39878"},{"source":"NA","target":"cerebellar neoplasms","id":"39879"},{"source":"NA","target":"carcinoma","id":"39880"},{"source":"NA","target":"brain metastases","id":"39881"},{"source":"NA","target":"metastatic","id":"39882"},{"source":"NA","target":"neoplasm metastasis","id":"39883"},{"source":"NA","target":"anticancer","id":"39884"},{"source":"NA","target":"lung neoplasms","id":"39885"},{"source":"NA","target":"residual tumor","id":"39886"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"39887"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"39888"},{"source":"Oncology: Lung","target":"NA","id":"39889"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"39890"},{"source":"Oncology: Lung","target":"NA","id":"39891"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"39892"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"39893"},{"source":"Non-Small Cell","target":"NA","id":"39894"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"39895"},{"source":"Non-Small Cell","target":"NA","id":"39896"},{"source":"pembrolizumab","target":"Merck & Co.","id":"39897"},{"source":"pembrolizumab","target":"University Health Network","id":"39898"},{"source":"pembrolizumab","target":"Toronto/Princess Margaret Cancer Centre {Princess Margaret Hospital}","id":"39899"},{"source":"UNK : Drug","target":"Merck & Co.","id":"39900"},{"source":"UNK : Drug","target":"University Health Network","id":"39901"},{"source":"UNK : Drug","target":"Toronto/Princess Margaret Cancer Centre {Princess Margaret Hospital}","id":"39902"},{"source":"UNK : Indication","target":"pembrolizumab","id":"39903"},{"source":"UNK : Indication","target":"UNK : Drug","id":"39904"},{"source":"ovarian cancer","target":"pembrolizumab","id":"39905"},{"source":"ovarian cancer","target":"UNK : Drug","id":"39906"},{"source":"ovarian cancer","target":"pembrolizumab","id":"39907"},{"source":"ovarian cancer","target":"UNK : Drug","id":"39908"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"39909"},{"source":"castration-resistant prostatic neoplasms","target":"UNK : Drug","id":"39910"},{"source":"skin neoplasms","target":"pembrolizumab","id":"39911"},{"source":"skin neoplasms","target":"UNK : Drug","id":"39912"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"39913"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"39914"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"39915"},{"source":"glandular and epithelial","target":"UNK : Drug","id":"39916"},{"source":"breast neoplasms","target":"pembrolizumab","id":"39917"},{"source":"breast neoplasms","target":"UNK : Drug","id":"39918"},{"source":"carcinoma","target":"pembrolizumab","id":"39919"},{"source":"carcinoma","target":"UNK : Drug","id":"39920"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"39921"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"39922"},{"source":"carcinoma","target":"pembrolizumab","id":"39923"},{"source":"carcinoma","target":"UNK : Drug","id":"39924"},{"source":"lymphoma","target":"pembrolizumab","id":"39925"},{"source":"lymphoma","target":"UNK : Drug","id":"39926"},{"source":"melanoma","target":"pembrolizumab","id":"39927"},{"source":"melanoma","target":"UNK : Drug","id":"39928"},{"source":"melanoma","target":"pembrolizumab","id":"39929"},{"source":"melanoma","target":"UNK : Drug","id":"39930"},{"source":"head and neck cancer","target":"pembrolizumab","id":"39931"},{"source":"head and neck cancer","target":"UNK : Drug","id":"39932"},{"source":"breast neoplasms","target":"pembrolizumab","id":"39933"},{"source":"breast neoplasms","target":"UNK : Drug","id":"39934"},{"source":"ovarian neoplasms","target":"pembrolizumab","id":"39935"},{"source":"ovarian neoplasms","target":"UNK : Drug","id":"39936"},{"source":"glandular and epithelial","target":"pembrolizumab","id":"39937"},{"source":"glandular and epithelial","target":"UNK : Drug","id":"39938"},{"source":"unknown primary","target":"pembrolizumab","id":"39939"},{"source":"unknown primary","target":"UNK : Drug","id":"39940"},{"source":"solid tumors","target":"pembrolizumab","id":"39941"},{"source":"solid tumors","target":"UNK : Drug","id":"39942"},{"source":"carcinoma","target":"pembrolizumab","id":"39943"},{"source":"carcinoma","target":"UNK : Drug","id":"39944"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"39945"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"39946"},{"source":"lymphoma","target":"pembrolizumab","id":"39947"},{"source":"lymphoma","target":"UNK : Drug","id":"39948"},{"source":"ovarian cancer","target":"pembrolizumab","id":"39949"},{"source":"ovarian cancer","target":"UNK : Drug","id":"39950"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"39951"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"39952"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"39953"},{"source":"triple-negative breast cancer","target":"UNK : Drug","id":"39954"},{"source":"skin neoplasms","target":"pembrolizumab","id":"39955"},{"source":"skin neoplasms","target":"UNK : Drug","id":"39956"},{"source":"residual tumor","target":"pembrolizumab","id":"39957"},{"source":"residual tumor","target":"UNK : Drug","id":"39958"},{"source":"metastatic","target":"pembrolizumab","id":"39959"},{"source":"metastatic","target":"UNK : Drug","id":"39960"},{"source":"ovarian cancer","target":"pembrolizumab","id":"39961"},{"source":"ovarian cancer","target":"UNK : Drug","id":"39962"},{"source":"solid malignancy","target":"pembrolizumab","id":"39963"},{"source":"solid malignancy","target":"UNK : Drug","id":"39964"},{"source":"non-hodgkin","target":"pembrolizumab","id":"39965"},{"source":"non-hodgkin","target":"UNK : Drug","id":"39966"},{"source":"anticancer","target":"pembrolizumab","id":"39967"},{"source":"anticancer","target":"UNK : Drug","id":"39968"},{"source":"unknown primary","target":"pembrolizumab","id":"39969"},{"source":"unknown primary","target":"UNK : Drug","id":"39970"},{"source":"solid tumors","target":"pembrolizumab","id":"39971"},{"source":"solid tumors","target":"UNK : Drug","id":"39972"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"39973"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"39974"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"39975"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"39976"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"39977"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"39978"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"39979"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"39980"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39981"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"39982"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39983"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"39984"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"39985"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"39986"},{"source":"Anticancer immunotherapy","target":"head and neck cancer","id":"39987"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"39988"},{"source":"Anticancer immunotherapy","target":"ovarian neoplasms","id":"39989"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"39990"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"39991"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"39992"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"39993"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"39994"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"39995"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"39996"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"39997"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"39998"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"39999"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"40000"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"40001"},{"source":"Anticancer immunotherapy","target":"ovarian cancer","id":"40002"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"40003"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"40004"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40005"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"40006"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"40007"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"40008"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"40009"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"40010"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"40011"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"40012"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"40013"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"40014"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"40015"},{"source":"CD19 antagonist","target":"carcinoma","id":"40016"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"40017"},{"source":"CD19 antagonist","target":"carcinoma","id":"40018"},{"source":"CD19 antagonist","target":"lymphoma","id":"40019"},{"source":"CD19 antagonist","target":"melanoma","id":"40020"},{"source":"CD19 antagonist","target":"melanoma","id":"40021"},{"source":"CD19 antagonist","target":"head and neck cancer","id":"40022"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"40023"},{"source":"CD19 antagonist","target":"ovarian neoplasms","id":"40024"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"40025"},{"source":"CD19 antagonist","target":"unknown primary","id":"40026"},{"source":"CD19 antagonist","target":"solid tumors","id":"40027"},{"source":"CD19 antagonist","target":"carcinoma","id":"40028"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"40029"},{"source":"CD19 antagonist","target":"lymphoma","id":"40030"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"40031"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"40032"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"40033"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"40034"},{"source":"CD19 antagonist","target":"residual tumor","id":"40035"},{"source":"CD19 antagonist","target":"metastatic","id":"40036"},{"source":"CD19 antagonist","target":"ovarian cancer","id":"40037"},{"source":"CD19 antagonist","target":"solid malignancy","id":"40038"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"40039"},{"source":"CD19 antagonist","target":"anticancer","id":"40040"},{"source":"CD19 antagonist","target":"unknown primary","id":"40041"},{"source":"CD19 antagonist","target":"solid tumors","id":"40042"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"40043"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"40044"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"40045"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"40046"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"40047"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"40048"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"40049"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"40050"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40051"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"40052"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40053"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"40054"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"40055"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"40056"},{"source":"Immune checkpoint inhibitor","target":"head and neck cancer","id":"40057"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"40058"},{"source":"Immune checkpoint inhibitor","target":"ovarian neoplasms","id":"40059"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"40060"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"40061"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"40062"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40063"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"40064"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"40065"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"40066"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"40067"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"40068"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"40069"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"40070"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"40071"},{"source":"Immune checkpoint inhibitor","target":"ovarian cancer","id":"40072"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"40073"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"40074"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"40075"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"40076"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"40077"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"40078"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"40079"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"40080"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"40081"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"40082"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"40083"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"40084"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"40085"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"40086"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"40087"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"40088"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"40089"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"40090"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"40091"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"40092"},{"source":"Oncology: Ovarian","target":"Anticancer immunotherapy","id":"40093"},{"source":"Oncology: Ovarian","target":"CD19 antagonist","id":"40094"},{"source":"Oncology: Ovarian","target":"Immune checkpoint inhibitor","id":"40095"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"40096"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"40097"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"40098"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"40099"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"40100"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"40101"},{"source":"birinapant (u)","target":"TetraLogic Pharmaceuticals","id":"40102"},{"source":"UNK : Drug","target":"TetraLogic Pharmaceuticals","id":"40103"},{"source":"UNK : Indication","target":"birinapant (u)","id":"40104"},{"source":"UNK : Indication","target":"UNK : Drug","id":"40105"},{"source":"anti-hiv","target":"birinapant (u)","id":"40106"},{"source":"anti-hiv","target":"UNK : Drug","id":"40107"},{"source":"myelodysplastic syndromes","target":"birinapant (u)","id":"40108"},{"source":"myelodysplastic syndromes","target":"UNK : Drug","id":"40109"},{"source":"acquired immunodeficiency syndrome","target":"birinapant (u)","id":"40110"},{"source":"acquired immunodeficiency syndrome","target":"UNK : Drug","id":"40111"},{"source":"carcinoma","target":"birinapant (u)","id":"40112"},{"source":"carcinoma","target":"UNK : Drug","id":"40113"},{"source":"myelodysplastic syndromes","target":"birinapant (u)","id":"40114"},{"source":"myelodysplastic syndromes","target":"UNK : Drug","id":"40115"},{"source":"anticancer","target":"birinapant (u)","id":"40116"},{"source":"anticancer","target":"UNK : Drug","id":"40117"},{"source":"hiv infections","target":"birinapant (u)","id":"40118"},{"source":"hiv infections","target":"UNK : Drug","id":"40119"},{"source":"leukemia","target":"birinapant (u)","id":"40120"},{"source":"leukemia","target":"UNK : Drug","id":"40121"},{"source":"IAP antagonist","target":"UNK : Indication","id":"40122"},{"source":"IAP antagonist","target":"anti-hiv","id":"40123"},{"source":"IAP antagonist","target":"myelodysplastic syndromes","id":"40124"},{"source":"IAP antagonist","target":"acquired immunodeficiency syndrome","id":"40125"},{"source":"IAP antagonist","target":"carcinoma","id":"40126"},{"source":"IAP antagonist","target":"myelodysplastic syndromes","id":"40127"},{"source":"IAP antagonist","target":"anticancer","id":"40128"},{"source":"IAP antagonist","target":"hiv infections","id":"40129"},{"source":"IAP antagonist","target":"leukemia","id":"40130"},{"source":"Oncology: Myelodysplastic Syndrome","target":"IAP antagonist","id":"40131"},{"source":"pembrolizumab","target":"Breast International Group","id":"40132"},{"source":"pembrolizumab","target":"Breast International Group","id":"40133"},{"source":"trastuzumab (IV)","target":"Breast International Group","id":"40134"},{"source":"trastuzumab (IV)","target":"Breast International Group","id":"40135"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"40136"},{"source":"gilbert syndrome","target":"trastuzumab (IV)","id":"40137"},{"source":"residual tumor","target":"pembrolizumab","id":"40138"},{"source":"residual tumor","target":"trastuzumab (IV)","id":"40139"},{"source":"liver metastases","target":"pembrolizumab","id":"40140"},{"source":"liver metastases","target":"trastuzumab (IV)","id":"40141"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"40142"},{"source":"triple-negative breast cancer","target":"trastuzumab (IV)","id":"40143"},{"source":"residual tumor","target":"pembrolizumab","id":"40144"},{"source":"residual tumor","target":"trastuzumab (IV)","id":"40145"},{"source":"breast neoplasms","target":"pembrolizumab","id":"40146"},{"source":"breast neoplasms","target":"trastuzumab (IV)","id":"40147"},{"source":"gilbert disease","target":"pembrolizumab","id":"40148"},{"source":"gilbert disease","target":"trastuzumab (IV)","id":"40149"},{"source":"metastatic","target":"pembrolizumab","id":"40150"},{"source":"metastatic","target":"trastuzumab (IV)","id":"40151"},{"source":"carcinoma","target":"pembrolizumab","id":"40152"},{"source":"carcinoma","target":"trastuzumab (IV)","id":"40153"},{"source":"proteinuria","target":"pembrolizumab","id":"40154"},{"source":"proteinuria","target":"trastuzumab (IV)","id":"40155"},{"source":"anticancer","target":"pembrolizumab","id":"40156"},{"source":"anticancer","target":"trastuzumab (IV)","id":"40157"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"40158"},{"source":"neoplasm metastasis","target":"trastuzumab (IV)","id":"40159"},{"source":"carcinoma","target":"pembrolizumab","id":"40160"},{"source":"carcinoma","target":"trastuzumab (IV)","id":"40161"},{"source":"anticancer","target":"pembrolizumab","id":"40162"},{"source":"anticancer","target":"trastuzumab (IV)","id":"40163"},{"source":"liver neoplasms","target":"pembrolizumab","id":"40164"},{"source":"liver neoplasms","target":"trastuzumab (IV)","id":"40165"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"40166"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"40167"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"40168"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"40169"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"40170"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"40171"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"40172"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"40173"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40174"},{"source":"Anticancer immunotherapy","target":"proteinuria","id":"40175"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40176"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"40177"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40178"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40179"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"40180"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"40181"},{"source":"CD19 antagonist","target":"residual tumor","id":"40182"},{"source":"CD19 antagonist","target":"liver metastases","id":"40183"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"40184"},{"source":"CD19 antagonist","target":"residual tumor","id":"40185"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"40186"},{"source":"CD19 antagonist","target":"gilbert disease","id":"40187"},{"source":"CD19 antagonist","target":"metastatic","id":"40188"},{"source":"CD19 antagonist","target":"carcinoma","id":"40189"},{"source":"CD19 antagonist","target":"proteinuria","id":"40190"},{"source":"CD19 antagonist","target":"anticancer","id":"40191"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"40192"},{"source":"CD19 antagonist","target":"carcinoma","id":"40193"},{"source":"CD19 antagonist","target":"anticancer","id":"40194"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"40195"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"40196"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"40197"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"40198"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"40199"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"40200"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"40201"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"40202"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"40203"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40204"},{"source":"Immune checkpoint inhibitor","target":"proteinuria","id":"40205"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"40206"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"40207"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40208"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"40209"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"40210"},{"source":"ErbB-2 antagonist","target":"gilbert syndrome","id":"40211"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"40212"},{"source":"ErbB-2 antagonist","target":"liver metastases","id":"40213"},{"source":"ErbB-2 antagonist","target":"triple-negative breast cancer","id":"40214"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"40215"},{"source":"ErbB-2 antagonist","target":"breast neoplasms","id":"40216"},{"source":"ErbB-2 antagonist","target":"gilbert disease","id":"40217"},{"source":"ErbB-2 antagonist","target":"metastatic","id":"40218"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"40219"},{"source":"ErbB-2 antagonist","target":"proteinuria","id":"40220"},{"source":"ErbB-2 antagonist","target":"anticancer","id":"40221"},{"source":"ErbB-2 antagonist","target":"neoplasm metastasis","id":"40222"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"40223"},{"source":"ErbB-2 antagonist","target":"anticancer","id":"40224"},{"source":"ErbB-2 antagonist","target":"liver neoplasms","id":"40225"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"40226"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"40227"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"40228"},{"source":"Oncology: Breast","target":"ErbB-2 antagonist","id":"40229"},{"source":"defactinib (u)","target":"(Other Hospital/Academic/Medical Center)","id":"40230"},{"source":"defactinib (u)","target":"UK","id":"40231"},{"source":"defactinib (u)","target":"Merck & Co.","id":"40232"},{"source":"defactinib (u)","target":"UK","id":"40233"},{"source":"defactinib (u)","target":"University of Edinburgh","id":"40234"},{"source":"defactinib (u)","target":"University of Glasgow","id":"40235"},{"source":"defactinib (u)","target":"University of Leeds","id":"40236"},{"source":"defactinib (u)","target":"Leicester","id":"40237"},{"source":"defactinib (u)","target":"United Kingdom","id":"40238"},{"source":"defactinib (u)","target":"University of Southampton","id":"40239"},{"source":"defactinib (u)","target":"Verastem","id":"40240"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"40241"},{"source":"pembrolizumab","target":"UK","id":"40242"},{"source":"pembrolizumab","target":"Merck & Co.","id":"40243"},{"source":"pembrolizumab","target":"UK","id":"40244"},{"source":"pembrolizumab","target":"University of Edinburgh","id":"40245"},{"source":"pembrolizumab","target":"University of Glasgow","id":"40246"},{"source":"pembrolizumab","target":"University of Leeds","id":"40247"},{"source":"pembrolizumab","target":"Leicester","id":"40248"},{"source":"pembrolizumab","target":"United Kingdom","id":"40249"},{"source":"pembrolizumab","target":"University of Southampton","id":"40250"},{"source":"pembrolizumab","target":"Verastem","id":"40251"},{"source":"non-small-cell lung","target":"defactinib (u)","id":"40252"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"40253"},{"source":"residual tumor","target":"defactinib (u)","id":"40254"},{"source":"residual tumor","target":"pembrolizumab","id":"40255"},{"source":"solid malignancy","target":"defactinib (u)","id":"40256"},{"source":"solid malignancy","target":"pembrolizumab","id":"40257"},{"source":"mesothelial","target":"defactinib (u)","id":"40258"},{"source":"mesothelial","target":"pembrolizumab","id":"40259"},{"source":"solid tumors","target":"defactinib (u)","id":"40260"},{"source":"solid tumors","target":"pembrolizumab","id":"40261"},{"source":"mesothelial","target":"defactinib (u)","id":"40262"},{"source":"mesothelial","target":"pembrolizumab","id":"40263"},{"source":"mesothelial","target":"defactinib (u)","id":"40264"},{"source":"mesothelial","target":"pembrolizumab","id":"40265"},{"source":"skin neoplasms","target":"defactinib (u)","id":"40266"},{"source":"skin neoplasms","target":"pembrolizumab","id":"40267"},{"source":"unknown primary","target":"defactinib (u)","id":"40268"},{"source":"unknown primary","target":"pembrolizumab","id":"40269"},{"source":"carcinoma","target":"defactinib (u)","id":"40270"},{"source":"carcinoma","target":"pembrolizumab","id":"40271"},{"source":"non-small-cell lung","target":"defactinib (u)","id":"40272"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"40273"},{"source":"carcinoma","target":"defactinib (u)","id":"40274"},{"source":"carcinoma","target":"pembrolizumab","id":"40275"},{"source":"pancreatic cancer","target":"defactinib (u)","id":"40276"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"40277"},{"source":"carcinoma","target":"defactinib (u)","id":"40278"},{"source":"carcinoma","target":"pembrolizumab","id":"40279"},{"source":"anticancer","target":"defactinib (u)","id":"40280"},{"source":"anticancer","target":"pembrolizumab","id":"40281"},{"source":"unknown primary","target":"defactinib (u)","id":"40282"},{"source":"unknown primary","target":"pembrolizumab","id":"40283"},{"source":"sclc","target":"defactinib (u)","id":"40284"},{"source":"sclc","target":"pembrolizumab","id":"40285"},{"source":"pancreatic neoplasms","target":"defactinib (u)","id":"40286"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"40287"},{"source":"solid tumors","target":"defactinib (u)","id":"40288"},{"source":"solid tumors","target":"pembrolizumab","id":"40289"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"40290"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"40291"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"40292"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"40293"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"40294"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"40295"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"40296"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"40297"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"40298"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40299"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"40300"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40301"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"40302"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40303"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40304"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"40305"},{"source":"Anticancer immunotherapy","target":"sclc","id":"40306"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"40307"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"40308"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"40309"},{"source":"CD19 antagonist","target":"residual tumor","id":"40310"},{"source":"CD19 antagonist","target":"solid malignancy","id":"40311"},{"source":"CD19 antagonist","target":"mesothelial","id":"40312"},{"source":"CD19 antagonist","target":"solid tumors","id":"40313"},{"source":"CD19 antagonist","target":"mesothelial","id":"40314"},{"source":"CD19 antagonist","target":"mesothelial","id":"40315"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"40316"},{"source":"CD19 antagonist","target":"unknown primary","id":"40317"},{"source":"CD19 antagonist","target":"carcinoma","id":"40318"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"40319"},{"source":"CD19 antagonist","target":"carcinoma","id":"40320"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"40321"},{"source":"CD19 antagonist","target":"carcinoma","id":"40322"},{"source":"CD19 antagonist","target":"anticancer","id":"40323"},{"source":"CD19 antagonist","target":"unknown primary","id":"40324"},{"source":"CD19 antagonist","target":"sclc","id":"40325"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"40326"},{"source":"CD19 antagonist","target":"solid tumors","id":"40327"},{"source":"NA","target":"non-small-cell lung","id":"40328"},{"source":"NA","target":"residual tumor","id":"40329"},{"source":"NA","target":"solid malignancy","id":"40330"},{"source":"NA","target":"mesothelial","id":"40331"},{"source":"NA","target":"solid tumors","id":"40332"},{"source":"NA","target":"mesothelial","id":"40333"},{"source":"NA","target":"mesothelial","id":"40334"},{"source":"NA","target":"skin neoplasms","id":"40335"},{"source":"NA","target":"unknown primary","id":"40336"},{"source":"NA","target":"carcinoma","id":"40337"},{"source":"NA","target":"non-small-cell lung","id":"40338"},{"source":"NA","target":"carcinoma","id":"40339"},{"source":"NA","target":"pancreatic cancer","id":"40340"},{"source":"NA","target":"carcinoma","id":"40341"},{"source":"NA","target":"anticancer","id":"40342"},{"source":"NA","target":"unknown primary","id":"40343"},{"source":"NA","target":"sclc","id":"40344"},{"source":"NA","target":"pancreatic neoplasms","id":"40345"},{"source":"NA","target":"solid tumors","id":"40346"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"40347"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"40348"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"40349"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"40350"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"40351"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"40352"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"40353"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"40354"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"40355"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40356"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"40357"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40358"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"40359"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40360"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"40361"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"40362"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"40363"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"40364"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"40365"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"40366"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"40367"},{"source":"Oncology: Lung","target":"NA","id":"40368"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"40369"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"40370"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"40371"},{"source":"Non-Small Cell","target":"NA","id":"40372"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"40373"},{"source":"Oncology: Mesothelioma","target":"Anticancer immunotherapy","id":"40374"},{"source":"Oncology: Mesothelioma","target":"CD19 antagonist","id":"40375"},{"source":"Oncology: Mesothelioma","target":"NA","id":"40376"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint inhibitor","id":"40377"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"40378"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"40379"},{"source":"Oncology: Pancreas","target":"NA","id":"40380"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"40381"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"40382"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"40383"},{"source":"Oncology: CNS","target":"NA","id":"40384"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"40385"},{"source":"TRX-518 (u)","target":"Leap Therapeutics {HealthCare Pharmaceuticals {Dekkun}}","id":"40386"},{"source":"UNK : Drug","target":"Leap Therapeutics {HealthCare Pharmaceuticals {Dekkun}}","id":"40387"},{"source":"UNK : Indication","target":"TRX-518 (u)","id":"40388"},{"source":"UNK : Indication","target":"UNK : Drug","id":"40389"},{"source":"solid tumors","target":"TRX-518 (u)","id":"40390"},{"source":"solid tumors","target":"UNK : Drug","id":"40391"},{"source":"skin neoplasms","target":"TRX-518 (u)","id":"40392"},{"source":"skin neoplasms","target":"UNK : Drug","id":"40393"},{"source":"unknown primary","target":"TRX-518 (u)","id":"40394"},{"source":"unknown primary","target":"UNK : Drug","id":"40395"},{"source":"carcinoma","target":"TRX-518 (u)","id":"40396"},{"source":"carcinoma","target":"UNK : Drug","id":"40397"},{"source":"solid malignancy","target":"TRX-518 (u)","id":"40398"},{"source":"solid malignancy","target":"UNK : Drug","id":"40399"},{"source":"anticancer","target":"TRX-518 (u)","id":"40400"},{"source":"anticancer","target":"UNK : Drug","id":"40401"},{"source":"unknown primary","target":"TRX-518 (u)","id":"40402"},{"source":"unknown primary","target":"UNK : Drug","id":"40403"},{"source":"solid tumors","target":"TRX-518 (u)","id":"40404"},{"source":"solid tumors","target":"UNK : Drug","id":"40405"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"40406"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"40407"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"40408"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"40409"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40410"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"40411"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40412"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"40413"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"40414"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"UNK : Indication","id":"40415"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"solid tumors","id":"40416"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"skin neoplasms","id":"40417"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"unknown primary","id":"40418"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"carcinoma","id":"40419"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"solid malignancy","id":"40420"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"anticancer","id":"40421"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"unknown primary","id":"40422"},{"source":"Glucocorticoid-induced TNFR-related protein agonist","target":"solid tumors","id":"40423"},{"source":"Immune checkpoint stimulant","target":"UNK : Indication","id":"40424"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"40425"},{"source":"Immune checkpoint stimulant","target":"skin neoplasms","id":"40426"},{"source":"Immune checkpoint stimulant","target":"unknown primary","id":"40427"},{"source":"Immune checkpoint stimulant","target":"carcinoma","id":"40428"},{"source":"Immune checkpoint stimulant","target":"solid malignancy","id":"40429"},{"source":"Immune checkpoint stimulant","target":"anticancer","id":"40430"},{"source":"Immune checkpoint stimulant","target":"unknown primary","id":"40431"},{"source":"Immune checkpoint stimulant","target":"solid tumors","id":"40432"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"40433"},{"source":"Oncology: CNS","target":"Glucocorticoid-induced TNFR-related protein agonist","id":"40434"},{"source":"Oncology: CNS","target":"Immune checkpoint stimulant","id":"40435"},{"source":"enadenotucirev (u)","target":"Bristol-Myers Squibb","id":"40436"},{"source":"enadenotucirev (u)","target":"PsiOxus","id":"40437"},{"source":"nivolumab (a)","target":"Bristol-Myers Squibb","id":"40438"},{"source":"nivolumab (a)","target":"PsiOxus","id":"40439"},{"source":"colorectal neoplasms","target":"enadenotucirev (u)","id":"40440"},{"source":"colorectal neoplasms","target":"nivolumab (a)","id":"40441"},{"source":"pancreatitis","target":"enadenotucirev (u)","id":"40442"},{"source":"pancreatitis","target":"nivolumab (a)","id":"40443"},{"source":"squamous cell neoplasms","target":"enadenotucirev (u)","id":"40444"},{"source":"squamous cell neoplasms","target":"nivolumab (a)","id":"40445"},{"source":"glandular and epithelial","target":"enadenotucirev (u)","id":"40446"},{"source":"glandular and epithelial","target":"nivolumab (a)","id":"40447"},{"source":"gilbert syndrome","target":"enadenotucirev (u)","id":"40448"},{"source":"gilbert syndrome","target":"nivolumab (a)","id":"40449"},{"source":"proteinuria","target":"enadenotucirev (u)","id":"40450"},{"source":"proteinuria","target":"nivolumab (a)","id":"40451"},{"source":"gilbert disease","target":"enadenotucirev (u)","id":"40452"},{"source":"gilbert disease","target":"nivolumab (a)","id":"40453"},{"source":"malignancies","target":"enadenotucirev (u)","id":"40454"},{"source":"malignancies","target":"nivolumab (a)","id":"40455"},{"source":"head and neck neoplasms","target":"enadenotucirev (u)","id":"40456"},{"source":"head and neck neoplasms","target":"nivolumab (a)","id":"40457"},{"source":"carcinoma","target":"enadenotucirev (u)","id":"40458"},{"source":"carcinoma","target":"nivolumab (a)","id":"40459"},{"source":"residual tumor","target":"enadenotucirev (u)","id":"40460"},{"source":"residual tumor","target":"nivolumab (a)","id":"40461"},{"source":"non-small-cell lung","target":"enadenotucirev (u)","id":"40462"},{"source":"non-small-cell lung","target":"nivolumab (a)","id":"40463"},{"source":"colonic neoplasms","target":"enadenotucirev (u)","id":"40464"},{"source":"colonic neoplasms","target":"nivolumab (a)","id":"40465"},{"source":"epithelial tumors","target":"enadenotucirev (u)","id":"40466"},{"source":"epithelial tumors","target":"nivolumab (a)","id":"40467"},{"source":"sclc","target":"enadenotucirev (u)","id":"40468"},{"source":"sclc","target":"nivolumab (a)","id":"40469"},{"source":"colorectal cancer","target":"enadenotucirev (u)","id":"40470"},{"source":"colorectal cancer","target":"nivolumab (a)","id":"40471"},{"source":"alopecia","target":"enadenotucirev (u)","id":"40472"},{"source":"alopecia","target":"nivolumab (a)","id":"40473"},{"source":"salivary gland neoplasms","target":"enadenotucirev (u)","id":"40474"},{"source":"salivary gland neoplasms","target":"nivolumab (a)","id":"40475"},{"source":"salivary gland cancer","target":"enadenotucirev (u)","id":"40476"},{"source":"salivary gland cancer","target":"nivolumab (a)","id":"40477"},{"source":"carcinoma","target":"enadenotucirev (u)","id":"40478"},{"source":"carcinoma","target":"nivolumab (a)","id":"40479"},{"source":"solid tumors","target":"enadenotucirev (u)","id":"40480"},{"source":"solid tumors","target":"nivolumab (a)","id":"40481"},{"source":"carcinoma","target":"enadenotucirev (u)","id":"40482"},{"source":"carcinoma","target":"nivolumab (a)","id":"40483"},{"source":"neoplasm metastasis","target":"enadenotucirev (u)","id":"40484"},{"source":"neoplasm metastasis","target":"nivolumab (a)","id":"40485"},{"source":"colorectal neoplasms","target":"enadenotucirev (u)","id":"40486"},{"source":"colorectal neoplasms","target":"nivolumab (a)","id":"40487"},{"source":"squamous cell neoplasms","target":"enadenotucirev (u)","id":"40488"},{"source":"squamous cell neoplasms","target":"nivolumab (a)","id":"40489"},{"source":"residual tumor","target":"enadenotucirev (u)","id":"40490"},{"source":"residual tumor","target":"nivolumab (a)","id":"40491"},{"source":"metastatic","target":"enadenotucirev (u)","id":"40492"},{"source":"metastatic","target":"nivolumab (a)","id":"40493"},{"source":"parotid neoplasms","target":"enadenotucirev (u)","id":"40494"},{"source":"parotid neoplasms","target":"nivolumab (a)","id":"40495"},{"source":"amenorrheic","target":"enadenotucirev (u)","id":"40496"},{"source":"amenorrheic","target":"nivolumab (a)","id":"40497"},{"source":"anticancer","target":"enadenotucirev (u)","id":"40498"},{"source":"anticancer","target":"nivolumab (a)","id":"40499"},{"source":"urinary bladder neoplasms","target":"enadenotucirev (u)","id":"40500"},{"source":"urinary bladder neoplasms","target":"nivolumab (a)","id":"40501"},{"source":"solid tumors","target":"enadenotucirev (u)","id":"40502"},{"source":"solid tumors","target":"nivolumab (a)","id":"40503"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"40504"},{"source":"Anticancer immunotherapy","target":"pancreatitis","id":"40505"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"40506"},{"source":"Anticancer immunotherapy","target":"glandular and epithelial","id":"40507"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"40508"},{"source":"Anticancer immunotherapy","target":"proteinuria","id":"40509"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"40510"},{"source":"Anticancer immunotherapy","target":"malignancies","id":"40511"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"40512"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40513"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"40514"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"40515"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"40516"},{"source":"Anticancer immunotherapy","target":"epithelial tumors","id":"40517"},{"source":"Anticancer immunotherapy","target":"sclc","id":"40518"},{"source":"Anticancer immunotherapy","target":"colorectal cancer","id":"40519"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"40520"},{"source":"Anticancer immunotherapy","target":"salivary gland neoplasms","id":"40521"},{"source":"Anticancer immunotherapy","target":"salivary gland cancer","id":"40522"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40523"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"40524"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40525"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"40526"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"40527"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"40528"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"40529"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"40530"},{"source":"Anticancer immunotherapy","target":"parotid neoplasms","id":"40531"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"40532"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40533"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"40534"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"40535"},{"source":"NA","target":"colorectal neoplasms","id":"40536"},{"source":"NA","target":"pancreatitis","id":"40537"},{"source":"NA","target":"squamous cell neoplasms","id":"40538"},{"source":"NA","target":"glandular and epithelial","id":"40539"},{"source":"NA","target":"gilbert syndrome","id":"40540"},{"source":"NA","target":"proteinuria","id":"40541"},{"source":"NA","target":"gilbert disease","id":"40542"},{"source":"NA","target":"malignancies","id":"40543"},{"source":"NA","target":"head and neck neoplasms","id":"40544"},{"source":"NA","target":"carcinoma","id":"40545"},{"source":"NA","target":"residual tumor","id":"40546"},{"source":"NA","target":"non-small-cell lung","id":"40547"},{"source":"NA","target":"colonic neoplasms","id":"40548"},{"source":"NA","target":"epithelial tumors","id":"40549"},{"source":"NA","target":"sclc","id":"40550"},{"source":"NA","target":"colorectal cancer","id":"40551"},{"source":"NA","target":"alopecia","id":"40552"},{"source":"NA","target":"salivary gland neoplasms","id":"40553"},{"source":"NA","target":"salivary gland cancer","id":"40554"},{"source":"NA","target":"carcinoma","id":"40555"},{"source":"NA","target":"solid tumors","id":"40556"},{"source":"NA","target":"carcinoma","id":"40557"},{"source":"NA","target":"neoplasm metastasis","id":"40558"},{"source":"NA","target":"colorectal neoplasms","id":"40559"},{"source":"NA","target":"squamous cell neoplasms","id":"40560"},{"source":"NA","target":"residual tumor","id":"40561"},{"source":"NA","target":"metastatic","id":"40562"},{"source":"NA","target":"parotid neoplasms","id":"40563"},{"source":"NA","target":"amenorrheic","id":"40564"},{"source":"NA","target":"anticancer","id":"40565"},{"source":"NA","target":"urinary bladder neoplasms","id":"40566"},{"source":"NA","target":"solid tumors","id":"40567"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"40568"},{"source":"Immune checkpoint inhibitor","target":"pancreatitis","id":"40569"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"40570"},{"source":"Immune checkpoint inhibitor","target":"glandular and epithelial","id":"40571"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"40572"},{"source":"Immune checkpoint inhibitor","target":"proteinuria","id":"40573"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"40574"},{"source":"Immune checkpoint inhibitor","target":"malignancies","id":"40575"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"40576"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40577"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"40578"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"40579"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"40580"},{"source":"Immune checkpoint inhibitor","target":"epithelial tumors","id":"40581"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"40582"},{"source":"Immune checkpoint inhibitor","target":"colorectal cancer","id":"40583"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"40584"},{"source":"Immune checkpoint inhibitor","target":"salivary gland neoplasms","id":"40585"},{"source":"Immune checkpoint inhibitor","target":"salivary gland cancer","id":"40586"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40587"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"40588"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40589"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"40590"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"40591"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"40592"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"40593"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"40594"},{"source":"Immune checkpoint inhibitor","target":"parotid neoplasms","id":"40595"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"40596"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"40597"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"40598"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"40599"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"40600"},{"source":"CD19 antagonist","target":"pancreatitis","id":"40601"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"40602"},{"source":"CD19 antagonist","target":"glandular and epithelial","id":"40603"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"40604"},{"source":"CD19 antagonist","target":"proteinuria","id":"40605"},{"source":"CD19 antagonist","target":"gilbert disease","id":"40606"},{"source":"CD19 antagonist","target":"malignancies","id":"40607"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"40608"},{"source":"CD19 antagonist","target":"carcinoma","id":"40609"},{"source":"CD19 antagonist","target":"residual tumor","id":"40610"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"40611"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"40612"},{"source":"CD19 antagonist","target":"epithelial tumors","id":"40613"},{"source":"CD19 antagonist","target":"sclc","id":"40614"},{"source":"CD19 antagonist","target":"colorectal cancer","id":"40615"},{"source":"CD19 antagonist","target":"alopecia","id":"40616"},{"source":"CD19 antagonist","target":"salivary gland neoplasms","id":"40617"},{"source":"CD19 antagonist","target":"salivary gland cancer","id":"40618"},{"source":"CD19 antagonist","target":"carcinoma","id":"40619"},{"source":"CD19 antagonist","target":"solid tumors","id":"40620"},{"source":"CD19 antagonist","target":"carcinoma","id":"40621"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"40622"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"40623"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"40624"},{"source":"CD19 antagonist","target":"residual tumor","id":"40625"},{"source":"CD19 antagonist","target":"metastatic","id":"40626"},{"source":"CD19 antagonist","target":"parotid neoplasms","id":"40627"},{"source":"CD19 antagonist","target":"amenorrheic","id":"40628"},{"source":"CD19 antagonist","target":"anticancer","id":"40629"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"40630"},{"source":"CD19 antagonist","target":"solid tumors","id":"40631"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"40632"},{"source":"Oncology: (N/A)","target":"NA","id":"40633"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"40634"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"40635"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"40636"},{"source":"Oncology: Bladder","target":"NA","id":"40637"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"40638"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"40639"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"40640"},{"source":"Oncology: Colorectal","target":"NA","id":"40641"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"40642"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"40643"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"40644"},{"source":"Oncology: Head/Neck","target":"NA","id":"40645"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"40646"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"40647"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"40648"},{"source":"Oncology: Lung","target":"NA","id":"40649"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"40650"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"40651"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"40652"},{"source":"Non-Small Cell","target":"NA","id":"40653"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"40654"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"40655"},{"source":"melphalan hydrochloride","target":"Delcath Systems","id":"40656"},{"source":"melphalan hydrochloride","target":"Medco Health Solutions","id":"40657"},{"source":"Delcath Systems (u)","target":"Delcath Systems","id":"40658"},{"source":"Delcath Systems (u)","target":"Medco Health Solutions","id":"40659"},{"source":"dacarbazine","target":"Delcath Systems","id":"40660"},{"source":"dacarbazine","target":"Medco Health Solutions","id":"40661"},{"source":"ipilimumab","target":"Delcath Systems","id":"40662"},{"source":"ipilimumab","target":"Medco Health Solutions","id":"40663"},{"source":"pembrolizumab","target":"Delcath Systems","id":"40664"},{"source":"pembrolizumab","target":"Medco Health Solutions","id":"40665"},{"source":"UNK : Indication","target":"melphalan hydrochloride","id":"40666"},{"source":"UNK : Indication","target":"Delcath Systems (u)","id":"40667"},{"source":"UNK : Indication","target":"dacarbazine","id":"40668"},{"source":"UNK : Indication","target":"ipilimumab","id":"40669"},{"source":"UNK : Indication","target":"pembrolizumab","id":"40670"},{"source":"anti-hiv","target":"melphalan hydrochloride","id":"40671"},{"source":"anti-hiv","target":"Delcath Systems (u)","id":"40672"},{"source":"anti-hiv","target":"dacarbazine","id":"40673"},{"source":"anti-hiv","target":"ipilimumab","id":"40674"},{"source":"anti-hiv","target":"pembrolizumab","id":"40675"},{"source":"solid malignancy","target":"melphalan hydrochloride","id":"40676"},{"source":"solid malignancy","target":"Delcath Systems (u)","id":"40677"},{"source":"solid malignancy","target":"dacarbazine","id":"40678"},{"source":"solid malignancy","target":"ipilimumab","id":"40679"},{"source":"solid malignancy","target":"pembrolizumab","id":"40680"},{"source":"melanoma","target":"melphalan hydrochloride","id":"40681"},{"source":"melanoma","target":"Delcath Systems (u)","id":"40682"},{"source":"melanoma","target":"dacarbazine","id":"40683"},{"source":"melanoma","target":"ipilimumab","id":"40684"},{"source":"melanoma","target":"pembrolizumab","id":"40685"},{"source":"melanoma","target":"melphalan hydrochloride","id":"40686"},{"source":"melanoma","target":"Delcath Systems (u)","id":"40687"},{"source":"melanoma","target":"dacarbazine","id":"40688"},{"source":"melanoma","target":"ipilimumab","id":"40689"},{"source":"melanoma","target":"pembrolizumab","id":"40690"},{"source":"anti-tumor","target":"melphalan hydrochloride","id":"40691"},{"source":"anti-tumor","target":"Delcath Systems (u)","id":"40692"},{"source":"anti-tumor","target":"dacarbazine","id":"40693"},{"source":"anti-tumor","target":"ipilimumab","id":"40694"},{"source":"anti-tumor","target":"pembrolizumab","id":"40695"},{"source":"skin neoplasms","target":"melphalan hydrochloride","id":"40696"},{"source":"skin neoplasms","target":"Delcath Systems (u)","id":"40697"},{"source":"skin neoplasms","target":"dacarbazine","id":"40698"},{"source":"skin neoplasms","target":"ipilimumab","id":"40699"},{"source":"skin neoplasms","target":"pembrolizumab","id":"40700"},{"source":"liver metastases","target":"melphalan hydrochloride","id":"40701"},{"source":"liver metastases","target":"Delcath Systems (u)","id":"40702"},{"source":"liver metastases","target":"dacarbazine","id":"40703"},{"source":"liver metastases","target":"ipilimumab","id":"40704"},{"source":"liver metastases","target":"pembrolizumab","id":"40705"},{"source":"liver neoplasms","target":"melphalan hydrochloride","id":"40706"},{"source":"liver neoplasms","target":"Delcath Systems (u)","id":"40707"},{"source":"liver neoplasms","target":"dacarbazine","id":"40708"},{"source":"liver neoplasms","target":"ipilimumab","id":"40709"},{"source":"liver neoplasms","target":"pembrolizumab","id":"40710"},{"source":"hepatic metastases","target":"melphalan hydrochloride","id":"40711"},{"source":"hepatic metastases","target":"Delcath Systems (u)","id":"40712"},{"source":"hepatic metastases","target":"dacarbazine","id":"40713"},{"source":"hepatic metastases","target":"ipilimumab","id":"40714"},{"source":"hepatic metastases","target":"pembrolizumab","id":"40715"},{"source":"liver metastases","target":"melphalan hydrochloride","id":"40716"},{"source":"liver metastases","target":"Delcath Systems (u)","id":"40717"},{"source":"liver metastases","target":"dacarbazine","id":"40718"},{"source":"liver metastases","target":"ipilimumab","id":"40719"},{"source":"liver metastases","target":"pembrolizumab","id":"40720"},{"source":"liver diseases","target":"melphalan hydrochloride","id":"40721"},{"source":"liver diseases","target":"Delcath Systems (u)","id":"40722"},{"source":"liver diseases","target":"dacarbazine","id":"40723"},{"source":"liver diseases","target":"ipilimumab","id":"40724"},{"source":"liver diseases","target":"pembrolizumab","id":"40725"},{"source":"carcinoma","target":"melphalan hydrochloride","id":"40726"},{"source":"carcinoma","target":"Delcath Systems (u)","id":"40727"},{"source":"carcinoma","target":"dacarbazine","id":"40728"},{"source":"carcinoma","target":"ipilimumab","id":"40729"},{"source":"carcinoma","target":"pembrolizumab","id":"40730"},{"source":"lymphatic diseases","target":"melphalan hydrochloride","id":"40731"},{"source":"lymphatic diseases","target":"Delcath Systems (u)","id":"40732"},{"source":"lymphatic diseases","target":"dacarbazine","id":"40733"},{"source":"lymphatic diseases","target":"ipilimumab","id":"40734"},{"source":"lymphatic diseases","target":"pembrolizumab","id":"40735"},{"source":"neoplasm metastasis","target":"melphalan hydrochloride","id":"40736"},{"source":"neoplasm metastasis","target":"Delcath Systems (u)","id":"40737"},{"source":"neoplasm metastasis","target":"dacarbazine","id":"40738"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"40739"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"40740"},{"source":"anticancer","target":"melphalan hydrochloride","id":"40741"},{"source":"anticancer","target":"Delcath Systems (u)","id":"40742"},{"source":"anticancer","target":"dacarbazine","id":"40743"},{"source":"anticancer","target":"ipilimumab","id":"40744"},{"source":"anticancer","target":"pembrolizumab","id":"40745"},{"source":"hiv infections","target":"melphalan hydrochloride","id":"40746"},{"source":"hiv infections","target":"Delcath Systems (u)","id":"40747"},{"source":"hiv infections","target":"dacarbazine","id":"40748"},{"source":"hiv infections","target":"ipilimumab","id":"40749"},{"source":"hiv infections","target":"pembrolizumab","id":"40750"},{"source":"acquired immunodeficiency syndrome","target":"melphalan hydrochloride","id":"40751"},{"source":"acquired immunodeficiency syndrome","target":"Delcath Systems (u)","id":"40752"},{"source":"acquired immunodeficiency syndrome","target":"dacarbazine","id":"40753"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"40754"},{"source":"acquired immunodeficiency syndrome","target":"pembrolizumab","id":"40755"},{"source":"NA","target":"UNK : Indication","id":"40756"},{"source":"NA","target":"anti-hiv","id":"40757"},{"source":"NA","target":"solid malignancy","id":"40758"},{"source":"NA","target":"melanoma","id":"40759"},{"source":"NA","target":"melanoma","id":"40760"},{"source":"NA","target":"anti-tumor","id":"40761"},{"source":"NA","target":"skin neoplasms","id":"40762"},{"source":"NA","target":"liver metastases","id":"40763"},{"source":"NA","target":"liver neoplasms","id":"40764"},{"source":"NA","target":"hepatic metastases","id":"40765"},{"source":"NA","target":"liver metastases","id":"40766"},{"source":"NA","target":"liver diseases","id":"40767"},{"source":"NA","target":"carcinoma","id":"40768"},{"source":"NA","target":"lymphatic diseases","id":"40769"},{"source":"NA","target":"neoplasm metastasis","id":"40770"},{"source":"NA","target":"anticancer","id":"40771"},{"source":"NA","target":"hiv infections","id":"40772"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"40773"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"40774"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"40775"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"40776"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"40777"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"40778"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"40779"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"40780"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"40781"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"40782"},{"source":"Anticancer immunotherapy","target":"hepatic metastases","id":"40783"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"40784"},{"source":"Anticancer immunotherapy","target":"liver diseases","id":"40785"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40786"},{"source":"Anticancer immunotherapy","target":"lymphatic diseases","id":"40787"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"40788"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40789"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"40790"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"40791"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"40792"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"40793"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"40794"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"40795"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"40796"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"40797"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"40798"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"40799"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"40800"},{"source":"Immune checkpoint inhibitor","target":"hepatic metastases","id":"40801"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"40802"},{"source":"Immune checkpoint inhibitor","target":"liver diseases","id":"40803"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40804"},{"source":"Immune checkpoint inhibitor","target":"lymphatic diseases","id":"40805"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"40806"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"40807"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"40808"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"40809"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"40810"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"40811"},{"source":"CTLA4 antagonist","target":"solid malignancy","id":"40812"},{"source":"CTLA4 antagonist","target":"melanoma","id":"40813"},{"source":"CTLA4 antagonist","target":"melanoma","id":"40814"},{"source":"CTLA4 antagonist","target":"anti-tumor","id":"40815"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"40816"},{"source":"CTLA4 antagonist","target":"liver metastases","id":"40817"},{"source":"CTLA4 antagonist","target":"liver neoplasms","id":"40818"},{"source":"CTLA4 antagonist","target":"hepatic metastases","id":"40819"},{"source":"CTLA4 antagonist","target":"liver metastases","id":"40820"},{"source":"CTLA4 antagonist","target":"liver diseases","id":"40821"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"40822"},{"source":"CTLA4 antagonist","target":"lymphatic diseases","id":"40823"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"40824"},{"source":"CTLA4 antagonist","target":"anticancer","id":"40825"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"40826"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"40827"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"40828"},{"source":"CD19 antagonist","target":"anti-hiv","id":"40829"},{"source":"CD19 antagonist","target":"solid malignancy","id":"40830"},{"source":"CD19 antagonist","target":"melanoma","id":"40831"},{"source":"CD19 antagonist","target":"melanoma","id":"40832"},{"source":"CD19 antagonist","target":"anti-tumor","id":"40833"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"40834"},{"source":"CD19 antagonist","target":"liver metastases","id":"40835"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"40836"},{"source":"CD19 antagonist","target":"hepatic metastases","id":"40837"},{"source":"CD19 antagonist","target":"liver metastases","id":"40838"},{"source":"CD19 antagonist","target":"liver diseases","id":"40839"},{"source":"CD19 antagonist","target":"carcinoma","id":"40840"},{"source":"CD19 antagonist","target":"lymphatic diseases","id":"40841"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"40842"},{"source":"CD19 antagonist","target":"anticancer","id":"40843"},{"source":"CD19 antagonist","target":"hiv infections","id":"40844"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"40845"},{"source":"Oncology: Melanoma","target":"NA","id":"40846"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"40847"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"40848"},{"source":"Oncology: Melanoma","target":"CTLA4 antagonist","id":"40849"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"40850"},{"source":"Oncology: Metastatic Cancer","target":"NA","id":"40851"},{"source":"Oncology: Metastatic Cancer","target":"Anticancer immunotherapy","id":"40852"},{"source":"Oncology: Metastatic Cancer","target":"Immune checkpoint inhibitor","id":"40853"},{"source":"Oncology: Metastatic Cancer","target":"CTLA4 antagonist","id":"40854"},{"source":"Oncology: Metastatic Cancer","target":"CD19 antagonist","id":"40855"},{"source":"defactinib (u)","target":"(Other Hospital/Academic/Medical Center)","id":"40856"},{"source":"defactinib (u)","target":"Washington University School of Medicine","id":"40857"},{"source":"gemcitabine hydrochloride","target":"(Other Hospital/Academic/Medical Center)","id":"40858"},{"source":"gemcitabine hydrochloride","target":"Washington University School of Medicine","id":"40859"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"40860"},{"source":"pembrolizumab","target":"Washington University School of Medicine","id":"40861"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"40862"},{"source":"UNK : Drug","target":"Washington University School of Medicine","id":"40863"},{"source":"anticancer","target":"defactinib (u)","id":"40864"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"40865"},{"source":"anticancer","target":"pembrolizumab","id":"40866"},{"source":"anticancer","target":"UNK : Drug","id":"40867"},{"source":"skin neoplasms","target":"defactinib (u)","id":"40868"},{"source":"skin neoplasms","target":"gemcitabine hydrochloride","id":"40869"},{"source":"skin neoplasms","target":"pembrolizumab","id":"40870"},{"source":"skin neoplasms","target":"UNK : Drug","id":"40871"},{"source":"unknown primary","target":"defactinib (u)","id":"40872"},{"source":"unknown primary","target":"gemcitabine hydrochloride","id":"40873"},{"source":"unknown primary","target":"pembrolizumab","id":"40874"},{"source":"unknown primary","target":"UNK : Drug","id":"40875"},{"source":"residual tumor","target":"defactinib (u)","id":"40876"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"40877"},{"source":"residual tumor","target":"pembrolizumab","id":"40878"},{"source":"residual tumor","target":"UNK : Drug","id":"40879"},{"source":"carcinoma","target":"defactinib (u)","id":"40880"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"40881"},{"source":"carcinoma","target":"pembrolizumab","id":"40882"},{"source":"carcinoma","target":"UNK : Drug","id":"40883"},{"source":"pancreatic cancer","target":"defactinib (u)","id":"40884"},{"source":"pancreatic cancer","target":"gemcitabine hydrochloride","id":"40885"},{"source":"pancreatic cancer","target":"pembrolizumab","id":"40886"},{"source":"pancreatic cancer","target":"UNK : Drug","id":"40887"},{"source":"anticancer","target":"defactinib (u)","id":"40888"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"40889"},{"source":"anticancer","target":"pembrolizumab","id":"40890"},{"source":"anticancer","target":"UNK : Drug","id":"40891"},{"source":"unknown primary","target":"defactinib (u)","id":"40892"},{"source":"unknown primary","target":"gemcitabine hydrochloride","id":"40893"},{"source":"unknown primary","target":"pembrolizumab","id":"40894"},{"source":"unknown primary","target":"UNK : Drug","id":"40895"},{"source":"carcinoma","target":"defactinib (u)","id":"40896"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"40897"},{"source":"carcinoma","target":"pembrolizumab","id":"40898"},{"source":"carcinoma","target":"UNK : Drug","id":"40899"},{"source":"pancreatic neoplasms","target":"defactinib (u)","id":"40900"},{"source":"pancreatic neoplasms","target":"gemcitabine hydrochloride","id":"40901"},{"source":"pancreatic neoplasms","target":"pembrolizumab","id":"40902"},{"source":"pancreatic neoplasms","target":"UNK : Drug","id":"40903"},{"source":"solid tumors","target":"defactinib (u)","id":"40904"},{"source":"solid tumors","target":"gemcitabine hydrochloride","id":"40905"},{"source":"solid tumors","target":"pembrolizumab","id":"40906"},{"source":"solid tumors","target":"UNK : Drug","id":"40907"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"40908"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"40909"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"40910"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"40911"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40912"},{"source":"Immune checkpoint inhibitor","target":"pancreatic cancer","id":"40913"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"40914"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"40915"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"40916"},{"source":"Immune checkpoint inhibitor","target":"pancreatic neoplasms","id":"40917"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"40918"},{"source":"NA","target":"anticancer","id":"40919"},{"source":"NA","target":"skin neoplasms","id":"40920"},{"source":"NA","target":"unknown primary","id":"40921"},{"source":"NA","target":"residual tumor","id":"40922"},{"source":"NA","target":"carcinoma","id":"40923"},{"source":"NA","target":"pancreatic cancer","id":"40924"},{"source":"NA","target":"anticancer","id":"40925"},{"source":"NA","target":"unknown primary","id":"40926"},{"source":"NA","target":"carcinoma","id":"40927"},{"source":"NA","target":"pancreatic neoplasms","id":"40928"},{"source":"NA","target":"solid tumors","id":"40929"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40930"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"40931"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"40932"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"40933"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40934"},{"source":"Anticancer immunotherapy","target":"pancreatic cancer","id":"40935"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"40936"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"40937"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"40938"},{"source":"Anticancer immunotherapy","target":"pancreatic neoplasms","id":"40939"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"40940"},{"source":"CD19 antagonist","target":"anticancer","id":"40941"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"40942"},{"source":"CD19 antagonist","target":"unknown primary","id":"40943"},{"source":"CD19 antagonist","target":"residual tumor","id":"40944"},{"source":"CD19 antagonist","target":"carcinoma","id":"40945"},{"source":"CD19 antagonist","target":"pancreatic cancer","id":"40946"},{"source":"CD19 antagonist","target":"anticancer","id":"40947"},{"source":"CD19 antagonist","target":"unknown primary","id":"40948"},{"source":"CD19 antagonist","target":"carcinoma","id":"40949"},{"source":"CD19 antagonist","target":"pancreatic neoplasms","id":"40950"},{"source":"CD19 antagonist","target":"solid tumors","id":"40951"},{"source":"NA","target":"anticancer","id":"40952"},{"source":"NA","target":"skin neoplasms","id":"40953"},{"source":"NA","target":"unknown primary","id":"40954"},{"source":"NA","target":"residual tumor","id":"40955"},{"source":"NA","target":"carcinoma","id":"40956"},{"source":"NA","target":"pancreatic cancer","id":"40957"},{"source":"NA","target":"anticancer","id":"40958"},{"source":"NA","target":"unknown primary","id":"40959"},{"source":"NA","target":"carcinoma","id":"40960"},{"source":"NA","target":"pancreatic neoplasms","id":"40961"},{"source":"NA","target":"solid tumors","id":"40962"},{"source":"NA","target":"anticancer","id":"40963"},{"source":"NA","target":"skin neoplasms","id":"40964"},{"source":"NA","target":"unknown primary","id":"40965"},{"source":"NA","target":"residual tumor","id":"40966"},{"source":"NA","target":"carcinoma","id":"40967"},{"source":"NA","target":"pancreatic cancer","id":"40968"},{"source":"NA","target":"anticancer","id":"40969"},{"source":"NA","target":"unknown primary","id":"40970"},{"source":"NA","target":"carcinoma","id":"40971"},{"source":"NA","target":"pancreatic neoplasms","id":"40972"},{"source":"NA","target":"solid tumors","id":"40973"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"40974"},{"source":"Cell cycle inhibitor","target":"skin neoplasms","id":"40975"},{"source":"Cell cycle inhibitor","target":"unknown primary","id":"40976"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"40977"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"40978"},{"source":"Cell cycle inhibitor","target":"pancreatic cancer","id":"40979"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"40980"},{"source":"Cell cycle inhibitor","target":"unknown primary","id":"40981"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"40982"},{"source":"Cell cycle inhibitor","target":"pancreatic neoplasms","id":"40983"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"40984"},{"source":"Oncology: Pancreas","target":"Immune checkpoint inhibitor","id":"40985"},{"source":"Oncology: Pancreas","target":"NA","id":"40986"},{"source":"Oncology: Pancreas","target":"Anticancer immunotherapy","id":"40987"},{"source":"Oncology: Pancreas","target":"CD19 antagonist","id":"40988"},{"source":"Oncology: Pancreas","target":"NA","id":"40989"},{"source":"Oncology: Pancreas","target":"NA","id":"40990"},{"source":"Oncology: Pancreas","target":"Cell cycle inhibitor","id":"40991"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"40992"},{"source":"Oncology: CNS","target":"NA","id":"40993"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"40994"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"40995"},{"source":"Oncology: CNS","target":"NA","id":"40996"},{"source":"Oncology: CNS","target":"NA","id":"40997"},{"source":"Oncology: CNS","target":"Cell cycle inhibitor","id":"40998"},{"source":"pembrolizumab","target":"Merck & Co.","id":"40999"},{"source":"UNK : Drug","target":"Merck & Co.","id":"41000"},{"source":"sarcoma","target":"pembrolizumab","id":"41001"},{"source":"sarcoma","target":"UNK : Drug","id":"41002"},{"source":"skin neoplasms","target":"pembrolizumab","id":"41003"},{"source":"skin neoplasms","target":"UNK : Drug","id":"41004"},{"source":"renal cancer","target":"pembrolizumab","id":"41005"},{"source":"renal cancer","target":"UNK : Drug","id":"41006"},{"source":"carcinoma","target":"pembrolizumab","id":"41007"},{"source":"carcinoma","target":"UNK : Drug","id":"41008"},{"source":"glioblastoma","target":"pembrolizumab","id":"41009"},{"source":"glioblastoma","target":"UNK : Drug","id":"41010"},{"source":"sarcoma","target":"pembrolizumab","id":"41011"},{"source":"sarcoma","target":"UNK : Drug","id":"41012"},{"source":"liver neoplasms","target":"pembrolizumab","id":"41013"},{"source":"liver neoplasms","target":"UNK : Drug","id":"41014"},{"source":"lymphoma","target":"pembrolizumab","id":"41015"},{"source":"lymphoma","target":"UNK : Drug","id":"41016"},{"source":"melanoma","target":"pembrolizumab","id":"41017"},{"source":"melanoma","target":"UNK : Drug","id":"41018"},{"source":"mesothelial","target":"pembrolizumab","id":"41019"},{"source":"mesothelial","target":"UNK : Drug","id":"41020"},{"source":"microsatellite instability","target":"pembrolizumab","id":"41021"},{"source":"microsatellite instability","target":"UNK : Drug","id":"41022"},{"source":"sarcoma","target":"pembrolizumab","id":"41023"},{"source":"sarcoma","target":"UNK : Drug","id":"41024"},{"source":"carcinoma","target":"pembrolizumab","id":"41025"},{"source":"carcinoma","target":"UNK : Drug","id":"41026"},{"source":"liver cancer","target":"pembrolizumab","id":"41027"},{"source":"liver cancer","target":"UNK : Drug","id":"41028"},{"source":"renal cell","target":"pembrolizumab","id":"41029"},{"source":"renal cell","target":"UNK : Drug","id":"41030"},{"source":"mesothelial","target":"pembrolizumab","id":"41031"},{"source":"mesothelial","target":"UNK : Drug","id":"41032"},{"source":"neuroblastoma","target":"pembrolizumab","id":"41033"},{"source":"neuroblastoma","target":"UNK : Drug","id":"41034"},{"source":"mesothelial","target":"pembrolizumab","id":"41035"},{"source":"mesothelial","target":"UNK : Drug","id":"41036"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"41037"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"41038"},{"source":"unknown primary","target":"pembrolizumab","id":"41039"},{"source":"unknown primary","target":"UNK : Drug","id":"41040"},{"source":"metastatic","target":"pembrolizumab","id":"41041"},{"source":"metastatic","target":"UNK : Drug","id":"41042"},{"source":"carcinoma","target":"pembrolizumab","id":"41043"},{"source":"carcinoma","target":"UNK : Drug","id":"41044"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"41045"},{"source":"soft tissue neoplasms","target":"UNK : Drug","id":"41046"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"41047"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"41048"},{"source":"lymphoma","target":"pembrolizumab","id":"41049"},{"source":"lymphoma","target":"UNK : Drug","id":"41050"},{"source":"hepatocellular","target":"pembrolizumab","id":"41051"},{"source":"hepatocellular","target":"UNK : Drug","id":"41052"},{"source":"lymphoma","target":"pembrolizumab","id":"41053"},{"source":"lymphoma","target":"UNK : Drug","id":"41054"},{"source":"medulloblastoma","target":"pembrolizumab","id":"41055"},{"source":"medulloblastoma","target":"UNK : Drug","id":"41056"},{"source":"skin neoplasms","target":"pembrolizumab","id":"41057"},{"source":"skin neoplasms","target":"UNK : Drug","id":"41058"},{"source":"residual tumor","target":"pembrolizumab","id":"41059"},{"source":"residual tumor","target":"UNK : Drug","id":"41060"},{"source":"hodgkin disease","target":"pembrolizumab","id":"41061"},{"source":"hodgkin disease","target":"UNK : Drug","id":"41062"},{"source":"solid malignancy","target":"pembrolizumab","id":"41063"},{"source":"solid malignancy","target":"UNK : Drug","id":"41064"},{"source":"non-hodgkin","target":"pembrolizumab","id":"41065"},{"source":"non-hodgkin","target":"UNK : Drug","id":"41066"},{"source":"anticancer","target":"pembrolizumab","id":"41067"},{"source":"anticancer","target":"UNK : Drug","id":"41068"},{"source":"unknown primary","target":"pembrolizumab","id":"41069"},{"source":"unknown primary","target":"UNK : Drug","id":"41070"},{"source":"lymphoma","target":"pembrolizumab","id":"41071"},{"source":"lymphoma","target":"UNK : Drug","id":"41072"},{"source":"solid tumors","target":"pembrolizumab","id":"41073"},{"source":"solid tumors","target":"UNK : Drug","id":"41074"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"41075"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"41076"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"41077"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"41078"},{"source":"Anticancer immunotherapy","target":"glioblastoma","id":"41079"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"41080"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"41081"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"41082"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"41083"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"41084"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"41085"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"41086"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"41087"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"41088"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"41089"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"41090"},{"source":"Anticancer immunotherapy","target":"neuroblastoma","id":"41091"},{"source":"Anticancer immunotherapy","target":"mesothelial","id":"41092"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"41093"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"41094"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"41095"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"41096"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"41097"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"41098"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"41099"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"41100"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"41101"},{"source":"Anticancer immunotherapy","target":"medulloblastoma","id":"41102"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"41103"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"41104"},{"source":"Anticancer immunotherapy","target":"hodgkin disease","id":"41105"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"41106"},{"source":"Anticancer immunotherapy","target":"non-hodgkin","id":"41107"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"41108"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"41109"},{"source":"Anticancer immunotherapy","target":"lymphoma","id":"41110"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"41111"},{"source":"CD19 antagonist","target":"sarcoma","id":"41112"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"41113"},{"source":"CD19 antagonist","target":"renal cancer","id":"41114"},{"source":"CD19 antagonist","target":"carcinoma","id":"41115"},{"source":"CD19 antagonist","target":"glioblastoma","id":"41116"},{"source":"CD19 antagonist","target":"sarcoma","id":"41117"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"41118"},{"source":"CD19 antagonist","target":"lymphoma","id":"41119"},{"source":"CD19 antagonist","target":"melanoma","id":"41120"},{"source":"CD19 antagonist","target":"mesothelial","id":"41121"},{"source":"CD19 antagonist","target":"microsatellite instability","id":"41122"},{"source":"CD19 antagonist","target":"sarcoma","id":"41123"},{"source":"CD19 antagonist","target":"carcinoma","id":"41124"},{"source":"CD19 antagonist","target":"liver cancer","id":"41125"},{"source":"CD19 antagonist","target":"renal cell","id":"41126"},{"source":"CD19 antagonist","target":"mesothelial","id":"41127"},{"source":"CD19 antagonist","target":"neuroblastoma","id":"41128"},{"source":"CD19 antagonist","target":"mesothelial","id":"41129"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"41130"},{"source":"CD19 antagonist","target":"unknown primary","id":"41131"},{"source":"CD19 antagonist","target":"metastatic","id":"41132"},{"source":"CD19 antagonist","target":"carcinoma","id":"41133"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"41134"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"41135"},{"source":"CD19 antagonist","target":"lymphoma","id":"41136"},{"source":"CD19 antagonist","target":"hepatocellular","id":"41137"},{"source":"CD19 antagonist","target":"lymphoma","id":"41138"},{"source":"CD19 antagonist","target":"medulloblastoma","id":"41139"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"41140"},{"source":"CD19 antagonist","target":"residual tumor","id":"41141"},{"source":"CD19 antagonist","target":"hodgkin disease","id":"41142"},{"source":"CD19 antagonist","target":"solid malignancy","id":"41143"},{"source":"CD19 antagonist","target":"non-hodgkin","id":"41144"},{"source":"CD19 antagonist","target":"anticancer","id":"41145"},{"source":"CD19 antagonist","target":"unknown primary","id":"41146"},{"source":"CD19 antagonist","target":"lymphoma","id":"41147"},{"source":"CD19 antagonist","target":"solid tumors","id":"41148"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"41149"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"41150"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"41151"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"41152"},{"source":"Immune checkpoint inhibitor","target":"glioblastoma","id":"41153"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"41154"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"41155"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"41156"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"41157"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"41158"},{"source":"Immune checkpoint inhibitor","target":"microsatellite instability","id":"41159"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"41160"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"41161"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"41162"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"41163"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"41164"},{"source":"Immune checkpoint inhibitor","target":"neuroblastoma","id":"41165"},{"source":"Immune checkpoint inhibitor","target":"mesothelial","id":"41166"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"41167"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"41168"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"41169"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"41170"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"41171"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"41172"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"41173"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"41174"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"41175"},{"source":"Immune checkpoint inhibitor","target":"medulloblastoma","id":"41176"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"41177"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"41178"},{"source":"Immune checkpoint inhibitor","target":"hodgkin disease","id":"41179"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"41180"},{"source":"Immune checkpoint inhibitor","target":"non-hodgkin","id":"41181"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"41182"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"41183"},{"source":"Immune checkpoint inhibitor","target":"lymphoma","id":"41184"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"41185"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"41186"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"41187"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"41188"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"41189"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"41190"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"41191"},{"source":"Glioblastoma","target":"Anticancer immunotherapy","id":"41192"},{"source":"Glioblastoma","target":"CD19 antagonist","id":"41193"},{"source":"Glioblastoma","target":"Immune checkpoint inhibitor","id":"41194"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"41195"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"41196"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"41197"},{"source":"Medulloblastoma","target":"Anticancer immunotherapy","id":"41198"},{"source":"Medulloblastoma","target":"CD19 antagonist","id":"41199"},{"source":"Medulloblastoma","target":"Immune checkpoint inhibitor","id":"41200"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"41201"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"41202"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"41203"},{"source":"Other","target":"Anticancer immunotherapy","id":"41204"},{"source":"Other","target":"CD19 antagonist","id":"41205"},{"source":"Other","target":"Immune checkpoint inhibitor","id":"41206"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"41207"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"41208"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"41209"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"41210"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"41211"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"41212"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"41213"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"41214"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"41215"},{"source":"Oncology: Lymphoma","target":"Anticancer immunotherapy","id":"41216"},{"source":"Oncology: Lymphoma","target":"CD19 antagonist","id":"41217"},{"source":"Oncology: Lymphoma","target":"Immune checkpoint inhibitor","id":"41218"},{"source":"Hodgkin's","target":"Anticancer immunotherapy","id":"41219"},{"source":"Hodgkin's","target":"CD19 antagonist","id":"41220"},{"source":"Hodgkin's","target":"Immune checkpoint inhibitor","id":"41221"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"41222"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"41223"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"41224"},{"source":"Oncology: Mesothelioma","target":"Anticancer immunotherapy","id":"41225"},{"source":"Oncology: Mesothelioma","target":"CD19 antagonist","id":"41226"},{"source":"Oncology: Mesothelioma","target":"Immune checkpoint inhibitor","id":"41227"},{"source":"Oncology: Osteosarcoma","target":"Anticancer immunotherapy","id":"41228"},{"source":"Oncology: Osteosarcoma","target":"CD19 antagonist","id":"41229"},{"source":"Oncology: Osteosarcoma","target":"Immune checkpoint inhibitor","id":"41230"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"41231"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"41232"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"41233"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"41234"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"41235"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"41236"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"41237"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"41238"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"41239"},{"source":"LY-2812176 (u)","target":"Leap Therapeutics/Macrocure","id":"41240"},{"source":"nab-paclitaxel (IV)","target":"Leap Therapeutics/Macrocure","id":"41241"},{"source":"UNK : Indication","target":"LY-2812176 (u)","id":"41242"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"41243"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"41244"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"41245"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"41246"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"41247"},{"source":"malignancies","target":"LY-2812176 (u)","id":"41248"},{"source":"malignancies","target":"nab-paclitaxel (IV)","id":"41249"},{"source":"endometrioid","target":"LY-2812176 (u)","id":"41250"},{"source":"endometrioid","target":"nab-paclitaxel (IV)","id":"41251"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"41252"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"41253"},{"source":"ovarian cancer","target":"LY-2812176 (u)","id":"41254"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"41255"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"41256"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"41257"},{"source":"residual tumor","target":"LY-2812176 (u)","id":"41258"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"41259"},{"source":"skin neoplasms","target":"LY-2812176 (u)","id":"41260"},{"source":"skin neoplasms","target":"nab-paclitaxel (IV)","id":"41261"},{"source":"residual tumor","target":"LY-2812176 (u)","id":"41262"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"41263"},{"source":"anticancer","target":"LY-2812176 (u)","id":"41264"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"41265"},{"source":"uterine cervical neoplasms","target":"LY-2812176 (u)","id":"41266"},{"source":"uterine cervical neoplasms","target":"nab-paclitaxel (IV)","id":"41267"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"41268"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"41269"},{"source":"metastatic","target":"LY-2812176 (u)","id":"41270"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"41271"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"41272"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"41273"},{"source":"neoplasm metastasis","target":"LY-2812176 (u)","id":"41274"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"41275"},{"source":"endometrial cancer","target":"LY-2812176 (u)","id":"41276"},{"source":"endometrial cancer","target":"nab-paclitaxel (IV)","id":"41277"},{"source":"squamous cell neoplasms","target":"LY-2812176 (u)","id":"41278"},{"source":"squamous cell neoplasms","target":"nab-paclitaxel (IV)","id":"41279"},{"source":"ovarian neoplasms","target":"LY-2812176 (u)","id":"41280"},{"source":"ovarian neoplasms","target":"nab-paclitaxel (IV)","id":"41281"},{"source":"endometrial neoplasms","target":"LY-2812176 (u)","id":"41282"},{"source":"endometrial neoplasms","target":"nab-paclitaxel (IV)","id":"41283"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"41284"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"41285"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"41286"},{"source":"Beta tubulin antagonist","target":"malignancies","id":"41287"},{"source":"Beta tubulin antagonist","target":"endometrioid","id":"41288"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"41289"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"41290"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"41291"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"41292"},{"source":"Beta tubulin antagonist","target":"skin neoplasms","id":"41293"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"41294"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"41295"},{"source":"Beta tubulin antagonist","target":"uterine cervical neoplasms","id":"41296"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"41297"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"41298"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"41299"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"41300"},{"source":"Beta tubulin antagonist","target":"endometrial cancer","id":"41301"},{"source":"Beta tubulin antagonist","target":"squamous cell neoplasms","id":"41302"},{"source":"Beta tubulin antagonist","target":"ovarian neoplasms","id":"41303"},{"source":"Beta tubulin antagonist","target":"endometrial neoplasms","id":"41304"},{"source":"DKK-1 inhibitor","target":"UNK : Indication","id":"41305"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"41306"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"41307"},{"source":"DKK-1 inhibitor","target":"malignancies","id":"41308"},{"source":"DKK-1 inhibitor","target":"endometrioid","id":"41309"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"41310"},{"source":"DKK-1 inhibitor","target":"ovarian cancer","id":"41311"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"41312"},{"source":"DKK-1 inhibitor","target":"residual tumor","id":"41313"},{"source":"DKK-1 inhibitor","target":"skin neoplasms","id":"41314"},{"source":"DKK-1 inhibitor","target":"residual tumor","id":"41315"},{"source":"DKK-1 inhibitor","target":"anticancer","id":"41316"},{"source":"DKK-1 inhibitor","target":"uterine cervical neoplasms","id":"41317"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"41318"},{"source":"DKK-1 inhibitor","target":"metastatic","id":"41319"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"41320"},{"source":"DKK-1 inhibitor","target":"neoplasm metastasis","id":"41321"},{"source":"DKK-1 inhibitor","target":"endometrial cancer","id":"41322"},{"source":"DKK-1 inhibitor","target":"squamous cell neoplasms","id":"41323"},{"source":"DKK-1 inhibitor","target":"ovarian neoplasms","id":"41324"},{"source":"DKK-1 inhibitor","target":"endometrial neoplasms","id":"41325"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"41326"},{"source":"Microtubule stimulant","target":"carcinoma","id":"41327"},{"source":"Microtubule stimulant","target":"carcinoma","id":"41328"},{"source":"Microtubule stimulant","target":"malignancies","id":"41329"},{"source":"Microtubule stimulant","target":"endometrioid","id":"41330"},{"source":"Microtubule stimulant","target":"carcinoma","id":"41331"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"41332"},{"source":"Microtubule stimulant","target":"carcinoma","id":"41333"},{"source":"Microtubule stimulant","target":"residual tumor","id":"41334"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"41335"},{"source":"Microtubule stimulant","target":"residual tumor","id":"41336"},{"source":"Microtubule stimulant","target":"anticancer","id":"41337"},{"source":"Microtubule stimulant","target":"uterine cervical neoplasms","id":"41338"},{"source":"Microtubule stimulant","target":"carcinoma","id":"41339"},{"source":"Microtubule stimulant","target":"metastatic","id":"41340"},{"source":"Microtubule stimulant","target":"carcinoma","id":"41341"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"41342"},{"source":"Microtubule stimulant","target":"endometrial cancer","id":"41343"},{"source":"Microtubule stimulant","target":"squamous cell neoplasms","id":"41344"},{"source":"Microtubule stimulant","target":"ovarian neoplasms","id":"41345"},{"source":"Microtubule stimulant","target":"endometrial neoplasms","id":"41346"},{"source":"Taxane","target":"UNK : Indication","id":"41347"},{"source":"Taxane","target":"carcinoma","id":"41348"},{"source":"Taxane","target":"carcinoma","id":"41349"},{"source":"Taxane","target":"malignancies","id":"41350"},{"source":"Taxane","target":"endometrioid","id":"41351"},{"source":"Taxane","target":"carcinoma","id":"41352"},{"source":"Taxane","target":"ovarian cancer","id":"41353"},{"source":"Taxane","target":"carcinoma","id":"41354"},{"source":"Taxane","target":"residual tumor","id":"41355"},{"source":"Taxane","target":"skin neoplasms","id":"41356"},{"source":"Taxane","target":"residual tumor","id":"41357"},{"source":"Taxane","target":"anticancer","id":"41358"},{"source":"Taxane","target":"uterine cervical neoplasms","id":"41359"},{"source":"Taxane","target":"carcinoma","id":"41360"},{"source":"Taxane","target":"metastatic","id":"41361"},{"source":"Taxane","target":"carcinoma","id":"41362"},{"source":"Taxane","target":"neoplasm metastasis","id":"41363"},{"source":"Taxane","target":"endometrial cancer","id":"41364"},{"source":"Taxane","target":"squamous cell neoplasms","id":"41365"},{"source":"Taxane","target":"ovarian neoplasms","id":"41366"},{"source":"Taxane","target":"endometrial neoplasms","id":"41367"},{"source":"Oncology: (N/A)","target":"Beta tubulin antagonist","id":"41368"},{"source":"Oncology: (N/A)","target":"DKK-1 inhibitor","id":"41369"},{"source":"Oncology: (N/A)","target":"Microtubule stimulant","id":"41370"},{"source":"Oncology: (N/A)","target":"Taxane","id":"41371"},{"source":"Oncology: Endometrial","target":"Beta tubulin antagonist","id":"41372"},{"source":"Oncology: Endometrial","target":"DKK-1 inhibitor","id":"41373"},{"source":"Oncology: Endometrial","target":"Microtubule stimulant","id":"41374"},{"source":"Oncology: Endometrial","target":"Taxane","id":"41375"},{"source":"Oncology: Ovarian","target":"Beta tubulin antagonist","id":"41376"},{"source":"Oncology: Ovarian","target":"DKK-1 inhibitor","id":"41377"},{"source":"Oncology: Ovarian","target":"Microtubule stimulant","id":"41378"},{"source":"Oncology: Ovarian","target":"Taxane","id":"41379"},{"source":"radiation therapy","target":"Angimmune","id":"41380"},{"source":"radiation therapy","target":"University of Louisville","id":"41381"},{"source":"Resimmune (u)","target":"Angimmune","id":"41382"},{"source":"Resimmune (u)","target":"University of Louisville","id":"41383"},{"source":"UNK : Drug","target":"Angimmune","id":"41384"},{"source":"UNK : Drug","target":"University of Louisville","id":"41385"},{"source":"UNK : Indication","target":"radiation therapy","id":"41386"},{"source":"UNK : Indication","target":"Resimmune (u)","id":"41387"},{"source":"UNK : Indication","target":"UNK : Drug","id":"41388"},{"source":"melanoma","target":"radiation therapy","id":"41389"},{"source":"melanoma","target":"Resimmune (u)","id":"41390"},{"source":"melanoma","target":"UNK : Drug","id":"41391"},{"source":"melanoma","target":"radiation therapy","id":"41392"},{"source":"melanoma","target":"Resimmune (u)","id":"41393"},{"source":"melanoma","target":"UNK : Drug","id":"41394"},{"source":"hypertrophy","target":"radiation therapy","id":"41395"},{"source":"hypertrophy","target":"Resimmune (u)","id":"41396"},{"source":"hypertrophy","target":"UNK : Drug","id":"41397"},{"source":"residual tumor","target":"radiation therapy","id":"41398"},{"source":"residual tumor","target":"Resimmune (u)","id":"41399"},{"source":"residual tumor","target":"UNK : Drug","id":"41400"},{"source":"carcinoma","target":"radiation therapy","id":"41401"},{"source":"carcinoma","target":"Resimmune (u)","id":"41402"},{"source":"carcinoma","target":"UNK : Drug","id":"41403"},{"source":"anticancer","target":"radiation therapy","id":"41404"},{"source":"anticancer","target":"Resimmune (u)","id":"41405"},{"source":"anticancer","target":"UNK : Drug","id":"41406"},{"source":"skin neoplasms","target":"radiation therapy","id":"41407"},{"source":"skin neoplasms","target":"Resimmune (u)","id":"41408"},{"source":"skin neoplasms","target":"UNK : Drug","id":"41409"},{"source":"UPA","target":"UNK : Indication","id":"41410"},{"source":"UPA","target":"melanoma","id":"41411"},{"source":"UPA","target":"melanoma","id":"41412"},{"source":"UPA","target":"hypertrophy","id":"41413"},{"source":"UPA","target":"residual tumor","id":"41414"},{"source":"UPA","target":"carcinoma","id":"41415"},{"source":"UPA","target":"anticancer","id":"41416"},{"source":"UPA","target":"skin neoplasms","id":"41417"},{"source":"Oncology: Melanoma","target":"UPA","id":"41418"},{"source":"lenvatinib (capsule) (a)","target":"Eisai","id":"41419"},{"source":"everolimus","target":"Eisai","id":"41420"},{"source":"pembrolizumab","target":"Eisai","id":"41421"},{"source":"sunitinib malate","target":"Eisai","id":"41422"},{"source":"UNK : Indication","target":"lenvatinib (capsule) (a)","id":"41423"},{"source":"UNK : Indication","target":"everolimus","id":"41424"},{"source":"UNK : Indication","target":"pembrolizumab","id":"41425"},{"source":"UNK : Indication","target":"sunitinib malate","id":"41426"},{"source":"liver metastases","target":"lenvatinib (capsule) (a)","id":"41427"},{"source":"liver metastases","target":"everolimus","id":"41428"},{"source":"liver metastases","target":"pembrolizumab","id":"41429"},{"source":"liver metastases","target":"sunitinib malate","id":"41430"},{"source":"antihypertensive","target":"lenvatinib (capsule) (a)","id":"41431"},{"source":"antihypertensive","target":"everolimus","id":"41432"},{"source":"antihypertensive","target":"pembrolizumab","id":"41433"},{"source":"antihypertensive","target":"sunitinib malate","id":"41434"},{"source":"gilbert syndrome","target":"lenvatinib (capsule) (a)","id":"41435"},{"source":"gilbert syndrome","target":"everolimus","id":"41436"},{"source":"gilbert syndrome","target":"pembrolizumab","id":"41437"},{"source":"gilbert syndrome","target":"sunitinib malate","id":"41438"},{"source":"kidney neoplasms","target":"lenvatinib (capsule) (a)","id":"41439"},{"source":"kidney neoplasms","target":"everolimus","id":"41440"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"41441"},{"source":"kidney neoplasms","target":"sunitinib malate","id":"41442"},{"source":"arthritis","target":"lenvatinib (capsule) (a)","id":"41443"},{"source":"arthritis","target":"everolimus","id":"41444"},{"source":"arthritis","target":"pembrolizumab","id":"41445"},{"source":"arthritis","target":"sunitinib malate","id":"41446"},{"source":"renal cancer","target":"lenvatinib (capsule) (a)","id":"41447"},{"source":"renal cancer","target":"everolimus","id":"41448"},{"source":"renal cancer","target":"pembrolizumab","id":"41449"},{"source":"renal cancer","target":"sunitinib malate","id":"41450"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"41451"},{"source":"carcinoma","target":"everolimus","id":"41452"},{"source":"carcinoma","target":"pembrolizumab","id":"41453"},{"source":"carcinoma","target":"sunitinib malate","id":"41454"},{"source":"antiarthritic","target":"lenvatinib (capsule) (a)","id":"41455"},{"source":"antiarthritic","target":"everolimus","id":"41456"},{"source":"antiarthritic","target":"pembrolizumab","id":"41457"},{"source":"antiarthritic","target":"sunitinib malate","id":"41458"},{"source":"unconjugated hyperbilirubinemia","target":"lenvatinib (capsule) (a)","id":"41459"},{"source":"unconjugated hyperbilirubinemia","target":"everolimus","id":"41460"},{"source":"unconjugated hyperbilirubinemia","target":"pembrolizumab","id":"41461"},{"source":"unconjugated hyperbilirubinemia","target":"sunitinib malate","id":"41462"},{"source":"fallopian tube neoplasms","target":"lenvatinib (capsule) (a)","id":"41463"},{"source":"fallopian tube neoplasms","target":"everolimus","id":"41464"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"41465"},{"source":"fallopian tube neoplasms","target":"sunitinib malate","id":"41466"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"41467"},{"source":"solid tumors","target":"everolimus","id":"41468"},{"source":"solid tumors","target":"pembrolizumab","id":"41469"},{"source":"solid tumors","target":"sunitinib malate","id":"41470"},{"source":"carcinoma","target":"lenvatinib (capsule) (a)","id":"41471"},{"source":"carcinoma","target":"everolimus","id":"41472"},{"source":"carcinoma","target":"pembrolizumab","id":"41473"},{"source":"carcinoma","target":"sunitinib malate","id":"41474"},{"source":"bone metastasis","target":"lenvatinib (capsule) (a)","id":"41475"},{"source":"bone metastasis","target":"everolimus","id":"41476"},{"source":"bone metastasis","target":"pembrolizumab","id":"41477"},{"source":"bone metastasis","target":"sunitinib malate","id":"41478"},{"source":"gilbert disease","target":"lenvatinib (capsule) (a)","id":"41479"},{"source":"gilbert disease","target":"everolimus","id":"41480"},{"source":"gilbert disease","target":"pembrolizumab","id":"41481"},{"source":"gilbert disease","target":"sunitinib malate","id":"41482"},{"source":"hypertension","target":"lenvatinib (capsule) (a)","id":"41483"},{"source":"hypertension","target":"everolimus","id":"41484"},{"source":"hypertension","target":"pembrolizumab","id":"41485"},{"source":"hypertension","target":"sunitinib malate","id":"41486"},{"source":"anticancer","target":"lenvatinib (capsule) (a)","id":"41487"},{"source":"anticancer","target":"everolimus","id":"41488"},{"source":"anticancer","target":"pembrolizumab","id":"41489"},{"source":"anticancer","target":"sunitinib malate","id":"41490"},{"source":"rcc","target":"lenvatinib (capsule) (a)","id":"41491"},{"source":"rcc","target":"everolimus","id":"41492"},{"source":"rcc","target":"pembrolizumab","id":"41493"},{"source":"rcc","target":"sunitinib malate","id":"41494"},{"source":"liver neoplasms","target":"lenvatinib (capsule) (a)","id":"41495"},{"source":"liver neoplasms","target":"everolimus","id":"41496"},{"source":"liver neoplasms","target":"pembrolizumab","id":"41497"},{"source":"liver neoplasms","target":"sunitinib malate","id":"41498"},{"source":"renal cell","target":"lenvatinib (capsule) (a)","id":"41499"},{"source":"renal cell","target":"everolimus","id":"41500"},{"source":"renal cell","target":"pembrolizumab","id":"41501"},{"source":"renal cell","target":"sunitinib malate","id":"41502"},{"source":"solid tumors","target":"lenvatinib (capsule) (a)","id":"41503"},{"source":"solid tumors","target":"everolimus","id":"41504"},{"source":"solid tumors","target":"pembrolizumab","id":"41505"},{"source":"solid tumors","target":"sunitinib malate","id":"41506"},{"source":"NA","target":"UNK : Indication","id":"41507"},{"source":"NA","target":"liver metastases","id":"41508"},{"source":"NA","target":"antihypertensive","id":"41509"},{"source":"NA","target":"gilbert syndrome","id":"41510"},{"source":"NA","target":"kidney neoplasms","id":"41511"},{"source":"NA","target":"arthritis","id":"41512"},{"source":"NA","target":"renal cancer","id":"41513"},{"source":"NA","target":"carcinoma","id":"41514"},{"source":"NA","target":"antiarthritic","id":"41515"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41516"},{"source":"NA","target":"fallopian tube neoplasms","id":"41517"},{"source":"NA","target":"solid tumors","id":"41518"},{"source":"NA","target":"carcinoma","id":"41519"},{"source":"NA","target":"bone metastasis","id":"41520"},{"source":"NA","target":"gilbert disease","id":"41521"},{"source":"NA","target":"hypertension","id":"41522"},{"source":"NA","target":"anticancer","id":"41523"},{"source":"NA","target":"rcc","id":"41524"},{"source":"NA","target":"liver neoplasms","id":"41525"},{"source":"NA","target":"renal cell","id":"41526"},{"source":"NA","target":"solid tumors","id":"41527"},{"source":"NA","target":"UNK : Indication","id":"41528"},{"source":"NA","target":"liver metastases","id":"41529"},{"source":"NA","target":"antihypertensive","id":"41530"},{"source":"NA","target":"gilbert syndrome","id":"41531"},{"source":"NA","target":"kidney neoplasms","id":"41532"},{"source":"NA","target":"arthritis","id":"41533"},{"source":"NA","target":"renal cancer","id":"41534"},{"source":"NA","target":"carcinoma","id":"41535"},{"source":"NA","target":"antiarthritic","id":"41536"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41537"},{"source":"NA","target":"fallopian tube neoplasms","id":"41538"},{"source":"NA","target":"solid tumors","id":"41539"},{"source":"NA","target":"carcinoma","id":"41540"},{"source":"NA","target":"bone metastasis","id":"41541"},{"source":"NA","target":"gilbert disease","id":"41542"},{"source":"NA","target":"hypertension","id":"41543"},{"source":"NA","target":"anticancer","id":"41544"},{"source":"NA","target":"rcc","id":"41545"},{"source":"NA","target":"liver neoplasms","id":"41546"},{"source":"NA","target":"renal cell","id":"41547"},{"source":"NA","target":"solid tumors","id":"41548"},{"source":"NA","target":"UNK : Indication","id":"41549"},{"source":"NA","target":"liver metastases","id":"41550"},{"source":"NA","target":"antihypertensive","id":"41551"},{"source":"NA","target":"gilbert syndrome","id":"41552"},{"source":"NA","target":"kidney neoplasms","id":"41553"},{"source":"NA","target":"arthritis","id":"41554"},{"source":"NA","target":"renal cancer","id":"41555"},{"source":"NA","target":"carcinoma","id":"41556"},{"source":"NA","target":"antiarthritic","id":"41557"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41558"},{"source":"NA","target":"fallopian tube neoplasms","id":"41559"},{"source":"NA","target":"solid tumors","id":"41560"},{"source":"NA","target":"carcinoma","id":"41561"},{"source":"NA","target":"bone metastasis","id":"41562"},{"source":"NA","target":"gilbert disease","id":"41563"},{"source":"NA","target":"hypertension","id":"41564"},{"source":"NA","target":"anticancer","id":"41565"},{"source":"NA","target":"rcc","id":"41566"},{"source":"NA","target":"liver neoplasms","id":"41567"},{"source":"NA","target":"renal cell","id":"41568"},{"source":"NA","target":"solid tumors","id":"41569"},{"source":"NA","target":"UNK : Indication","id":"41570"},{"source":"NA","target":"liver metastases","id":"41571"},{"source":"NA","target":"antihypertensive","id":"41572"},{"source":"NA","target":"gilbert syndrome","id":"41573"},{"source":"NA","target":"kidney neoplasms","id":"41574"},{"source":"NA","target":"arthritis","id":"41575"},{"source":"NA","target":"renal cancer","id":"41576"},{"source":"NA","target":"carcinoma","id":"41577"},{"source":"NA","target":"antiarthritic","id":"41578"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41579"},{"source":"NA","target":"fallopian tube neoplasms","id":"41580"},{"source":"NA","target":"solid tumors","id":"41581"},{"source":"NA","target":"carcinoma","id":"41582"},{"source":"NA","target":"bone metastasis","id":"41583"},{"source":"NA","target":"gilbert disease","id":"41584"},{"source":"NA","target":"hypertension","id":"41585"},{"source":"NA","target":"anticancer","id":"41586"},{"source":"NA","target":"rcc","id":"41587"},{"source":"NA","target":"liver neoplasms","id":"41588"},{"source":"NA","target":"renal cell","id":"41589"},{"source":"NA","target":"solid tumors","id":"41590"},{"source":"NA","target":"UNK : Indication","id":"41591"},{"source":"NA","target":"liver metastases","id":"41592"},{"source":"NA","target":"antihypertensive","id":"41593"},{"source":"NA","target":"gilbert syndrome","id":"41594"},{"source":"NA","target":"kidney neoplasms","id":"41595"},{"source":"NA","target":"arthritis","id":"41596"},{"source":"NA","target":"renal cancer","id":"41597"},{"source":"NA","target":"carcinoma","id":"41598"},{"source":"NA","target":"antiarthritic","id":"41599"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41600"},{"source":"NA","target":"fallopian tube neoplasms","id":"41601"},{"source":"NA","target":"solid tumors","id":"41602"},{"source":"NA","target":"carcinoma","id":"41603"},{"source":"NA","target":"bone metastasis","id":"41604"},{"source":"NA","target":"gilbert disease","id":"41605"},{"source":"NA","target":"hypertension","id":"41606"},{"source":"NA","target":"anticancer","id":"41607"},{"source":"NA","target":"rcc","id":"41608"},{"source":"NA","target":"liver neoplasms","id":"41609"},{"source":"NA","target":"renal cell","id":"41610"},{"source":"NA","target":"solid tumors","id":"41611"},{"source":"NA","target":"UNK : Indication","id":"41612"},{"source":"NA","target":"liver metastases","id":"41613"},{"source":"NA","target":"antihypertensive","id":"41614"},{"source":"NA","target":"gilbert syndrome","id":"41615"},{"source":"NA","target":"kidney neoplasms","id":"41616"},{"source":"NA","target":"arthritis","id":"41617"},{"source":"NA","target":"renal cancer","id":"41618"},{"source":"NA","target":"carcinoma","id":"41619"},{"source":"NA","target":"antiarthritic","id":"41620"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41621"},{"source":"NA","target":"fallopian tube neoplasms","id":"41622"},{"source":"NA","target":"solid tumors","id":"41623"},{"source":"NA","target":"carcinoma","id":"41624"},{"source":"NA","target":"bone metastasis","id":"41625"},{"source":"NA","target":"gilbert disease","id":"41626"},{"source":"NA","target":"hypertension","id":"41627"},{"source":"NA","target":"anticancer","id":"41628"},{"source":"NA","target":"rcc","id":"41629"},{"source":"NA","target":"liver neoplasms","id":"41630"},{"source":"NA","target":"renal cell","id":"41631"},{"source":"NA","target":"solid tumors","id":"41632"},{"source":"NA","target":"UNK : Indication","id":"41633"},{"source":"NA","target":"liver metastases","id":"41634"},{"source":"NA","target":"antihypertensive","id":"41635"},{"source":"NA","target":"gilbert syndrome","id":"41636"},{"source":"NA","target":"kidney neoplasms","id":"41637"},{"source":"NA","target":"arthritis","id":"41638"},{"source":"NA","target":"renal cancer","id":"41639"},{"source":"NA","target":"carcinoma","id":"41640"},{"source":"NA","target":"antiarthritic","id":"41641"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41642"},{"source":"NA","target":"fallopian tube neoplasms","id":"41643"},{"source":"NA","target":"solid tumors","id":"41644"},{"source":"NA","target":"carcinoma","id":"41645"},{"source":"NA","target":"bone metastasis","id":"41646"},{"source":"NA","target":"gilbert disease","id":"41647"},{"source":"NA","target":"hypertension","id":"41648"},{"source":"NA","target":"anticancer","id":"41649"},{"source":"NA","target":"rcc","id":"41650"},{"source":"NA","target":"liver neoplasms","id":"41651"},{"source":"NA","target":"renal cell","id":"41652"},{"source":"NA","target":"solid tumors","id":"41653"},{"source":"NA","target":"UNK : Indication","id":"41654"},{"source":"NA","target":"liver metastases","id":"41655"},{"source":"NA","target":"antihypertensive","id":"41656"},{"source":"NA","target":"gilbert syndrome","id":"41657"},{"source":"NA","target":"kidney neoplasms","id":"41658"},{"source":"NA","target":"arthritis","id":"41659"},{"source":"NA","target":"renal cancer","id":"41660"},{"source":"NA","target":"carcinoma","id":"41661"},{"source":"NA","target":"antiarthritic","id":"41662"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41663"},{"source":"NA","target":"fallopian tube neoplasms","id":"41664"},{"source":"NA","target":"solid tumors","id":"41665"},{"source":"NA","target":"carcinoma","id":"41666"},{"source":"NA","target":"bone metastasis","id":"41667"},{"source":"NA","target":"gilbert disease","id":"41668"},{"source":"NA","target":"hypertension","id":"41669"},{"source":"NA","target":"anticancer","id":"41670"},{"source":"NA","target":"rcc","id":"41671"},{"source":"NA","target":"liver neoplasms","id":"41672"},{"source":"NA","target":"renal cell","id":"41673"},{"source":"NA","target":"solid tumors","id":"41674"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"41675"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"41676"},{"source":"Anticancer immunotherapy","target":"antihypertensive","id":"41677"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"41678"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"41679"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"41680"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"41681"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"41682"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"41683"},{"source":"Anticancer immunotherapy","target":"unconjugated hyperbilirubinemia","id":"41684"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"41685"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"41686"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"41687"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"41688"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"41689"},{"source":"Anticancer immunotherapy","target":"hypertension","id":"41690"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"41691"},{"source":"Anticancer immunotherapy","target":"rcc","id":"41692"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"41693"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"41694"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"41695"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"41696"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"41697"},{"source":"Angiogenesis inhibitor","target":"antihypertensive","id":"41698"},{"source":"Angiogenesis inhibitor","target":"gilbert syndrome","id":"41699"},{"source":"Angiogenesis inhibitor","target":"kidney neoplasms","id":"41700"},{"source":"Angiogenesis inhibitor","target":"arthritis","id":"41701"},{"source":"Angiogenesis inhibitor","target":"renal cancer","id":"41702"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"41703"},{"source":"Angiogenesis inhibitor","target":"antiarthritic","id":"41704"},{"source":"Angiogenesis inhibitor","target":"unconjugated hyperbilirubinemia","id":"41705"},{"source":"Angiogenesis inhibitor","target":"fallopian tube neoplasms","id":"41706"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"41707"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"41708"},{"source":"Angiogenesis inhibitor","target":"bone metastasis","id":"41709"},{"source":"Angiogenesis inhibitor","target":"gilbert disease","id":"41710"},{"source":"Angiogenesis inhibitor","target":"hypertension","id":"41711"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"41712"},{"source":"Angiogenesis inhibitor","target":"rcc","id":"41713"},{"source":"Angiogenesis inhibitor","target":"liver neoplasms","id":"41714"},{"source":"Angiogenesis inhibitor","target":"renal cell","id":"41715"},{"source":"Angiogenesis inhibitor","target":"solid tumors","id":"41716"},{"source":"Immunosuppressant","target":"UNK : Indication","id":"41717"},{"source":"Immunosuppressant","target":"liver metastases","id":"41718"},{"source":"Immunosuppressant","target":"antihypertensive","id":"41719"},{"source":"Immunosuppressant","target":"gilbert syndrome","id":"41720"},{"source":"Immunosuppressant","target":"kidney neoplasms","id":"41721"},{"source":"Immunosuppressant","target":"arthritis","id":"41722"},{"source":"Immunosuppressant","target":"renal cancer","id":"41723"},{"source":"Immunosuppressant","target":"carcinoma","id":"41724"},{"source":"Immunosuppressant","target":"antiarthritic","id":"41725"},{"source":"Immunosuppressant","target":"unconjugated hyperbilirubinemia","id":"41726"},{"source":"Immunosuppressant","target":"fallopian tube neoplasms","id":"41727"},{"source":"Immunosuppressant","target":"solid tumors","id":"41728"},{"source":"Immunosuppressant","target":"carcinoma","id":"41729"},{"source":"Immunosuppressant","target":"bone metastasis","id":"41730"},{"source":"Immunosuppressant","target":"gilbert disease","id":"41731"},{"source":"Immunosuppressant","target":"hypertension","id":"41732"},{"source":"Immunosuppressant","target":"anticancer","id":"41733"},{"source":"Immunosuppressant","target":"rcc","id":"41734"},{"source":"Immunosuppressant","target":"liver neoplasms","id":"41735"},{"source":"Immunosuppressant","target":"renal cell","id":"41736"},{"source":"Immunosuppressant","target":"solid tumors","id":"41737"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"41738"},{"source":"CD19 antagonist","target":"liver metastases","id":"41739"},{"source":"CD19 antagonist","target":"antihypertensive","id":"41740"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"41741"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"41742"},{"source":"CD19 antagonist","target":"arthritis","id":"41743"},{"source":"CD19 antagonist","target":"renal cancer","id":"41744"},{"source":"CD19 antagonist","target":"carcinoma","id":"41745"},{"source":"CD19 antagonist","target":"antiarthritic","id":"41746"},{"source":"CD19 antagonist","target":"unconjugated hyperbilirubinemia","id":"41747"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"41748"},{"source":"CD19 antagonist","target":"solid tumors","id":"41749"},{"source":"CD19 antagonist","target":"carcinoma","id":"41750"},{"source":"CD19 antagonist","target":"bone metastasis","id":"41751"},{"source":"CD19 antagonist","target":"gilbert disease","id":"41752"},{"source":"CD19 antagonist","target":"hypertension","id":"41753"},{"source":"CD19 antagonist","target":"anticancer","id":"41754"},{"source":"CD19 antagonist","target":"rcc","id":"41755"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"41756"},{"source":"CD19 antagonist","target":"renal cell","id":"41757"},{"source":"CD19 antagonist","target":"solid tumors","id":"41758"},{"source":"NA","target":"UNK : Indication","id":"41759"},{"source":"NA","target":"liver metastases","id":"41760"},{"source":"NA","target":"antihypertensive","id":"41761"},{"source":"NA","target":"gilbert syndrome","id":"41762"},{"source":"NA","target":"kidney neoplasms","id":"41763"},{"source":"NA","target":"arthritis","id":"41764"},{"source":"NA","target":"renal cancer","id":"41765"},{"source":"NA","target":"carcinoma","id":"41766"},{"source":"NA","target":"antiarthritic","id":"41767"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41768"},{"source":"NA","target":"fallopian tube neoplasms","id":"41769"},{"source":"NA","target":"solid tumors","id":"41770"},{"source":"NA","target":"carcinoma","id":"41771"},{"source":"NA","target":"bone metastasis","id":"41772"},{"source":"NA","target":"gilbert disease","id":"41773"},{"source":"NA","target":"hypertension","id":"41774"},{"source":"NA","target":"anticancer","id":"41775"},{"source":"NA","target":"rcc","id":"41776"},{"source":"NA","target":"liver neoplasms","id":"41777"},{"source":"NA","target":"renal cell","id":"41778"},{"source":"NA","target":"solid tumors","id":"41779"},{"source":"Angiopoietin inhibitor","target":"UNK : Indication","id":"41780"},{"source":"Angiopoietin inhibitor","target":"liver metastases","id":"41781"},{"source":"Angiopoietin inhibitor","target":"antihypertensive","id":"41782"},{"source":"Angiopoietin inhibitor","target":"gilbert syndrome","id":"41783"},{"source":"Angiopoietin inhibitor","target":"kidney neoplasms","id":"41784"},{"source":"Angiopoietin inhibitor","target":"arthritis","id":"41785"},{"source":"Angiopoietin inhibitor","target":"renal cancer","id":"41786"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"41787"},{"source":"Angiopoietin inhibitor","target":"antiarthritic","id":"41788"},{"source":"Angiopoietin inhibitor","target":"unconjugated hyperbilirubinemia","id":"41789"},{"source":"Angiopoietin inhibitor","target":"fallopian tube neoplasms","id":"41790"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"41791"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"41792"},{"source":"Angiopoietin inhibitor","target":"bone metastasis","id":"41793"},{"source":"Angiopoietin inhibitor","target":"gilbert disease","id":"41794"},{"source":"Angiopoietin inhibitor","target":"hypertension","id":"41795"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"41796"},{"source":"Angiopoietin inhibitor","target":"rcc","id":"41797"},{"source":"Angiopoietin inhibitor","target":"liver neoplasms","id":"41798"},{"source":"Angiopoietin inhibitor","target":"renal cell","id":"41799"},{"source":"Angiopoietin inhibitor","target":"solid tumors","id":"41800"},{"source":"NA","target":"UNK : Indication","id":"41801"},{"source":"NA","target":"liver metastases","id":"41802"},{"source":"NA","target":"antihypertensive","id":"41803"},{"source":"NA","target":"gilbert syndrome","id":"41804"},{"source":"NA","target":"kidney neoplasms","id":"41805"},{"source":"NA","target":"arthritis","id":"41806"},{"source":"NA","target":"renal cancer","id":"41807"},{"source":"NA","target":"carcinoma","id":"41808"},{"source":"NA","target":"antiarthritic","id":"41809"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41810"},{"source":"NA","target":"fallopian tube neoplasms","id":"41811"},{"source":"NA","target":"solid tumors","id":"41812"},{"source":"NA","target":"carcinoma","id":"41813"},{"source":"NA","target":"bone metastasis","id":"41814"},{"source":"NA","target":"gilbert disease","id":"41815"},{"source":"NA","target":"hypertension","id":"41816"},{"source":"NA","target":"anticancer","id":"41817"},{"source":"NA","target":"rcc","id":"41818"},{"source":"NA","target":"liver neoplasms","id":"41819"},{"source":"NA","target":"renal cell","id":"41820"},{"source":"NA","target":"solid tumors","id":"41821"},{"source":"NA","target":"UNK : Indication","id":"41822"},{"source":"NA","target":"liver metastases","id":"41823"},{"source":"NA","target":"antihypertensive","id":"41824"},{"source":"NA","target":"gilbert syndrome","id":"41825"},{"source":"NA","target":"kidney neoplasms","id":"41826"},{"source":"NA","target":"arthritis","id":"41827"},{"source":"NA","target":"renal cancer","id":"41828"},{"source":"NA","target":"carcinoma","id":"41829"},{"source":"NA","target":"antiarthritic","id":"41830"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41831"},{"source":"NA","target":"fallopian tube neoplasms","id":"41832"},{"source":"NA","target":"solid tumors","id":"41833"},{"source":"NA","target":"carcinoma","id":"41834"},{"source":"NA","target":"bone metastasis","id":"41835"},{"source":"NA","target":"gilbert disease","id":"41836"},{"source":"NA","target":"hypertension","id":"41837"},{"source":"NA","target":"anticancer","id":"41838"},{"source":"NA","target":"rcc","id":"41839"},{"source":"NA","target":"liver neoplasms","id":"41840"},{"source":"NA","target":"renal cell","id":"41841"},{"source":"NA","target":"solid tumors","id":"41842"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"UNK : Indication","id":"41843"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"liver metastases","id":"41844"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antihypertensive","id":"41845"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"gilbert syndrome","id":"41846"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"kidney neoplasms","id":"41847"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"arthritis","id":"41848"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"renal cancer","id":"41849"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"41850"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antiarthritic","id":"41851"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"unconjugated hyperbilirubinemia","id":"41852"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"fallopian tube neoplasms","id":"41853"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"41854"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"41855"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"bone metastasis","id":"41856"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"gilbert disease","id":"41857"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"hypertension","id":"41858"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"41859"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"rcc","id":"41860"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"liver neoplasms","id":"41861"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"renal cell","id":"41862"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid tumors","id":"41863"},{"source":"NA","target":"UNK : Indication","id":"41864"},{"source":"NA","target":"liver metastases","id":"41865"},{"source":"NA","target":"antihypertensive","id":"41866"},{"source":"NA","target":"gilbert syndrome","id":"41867"},{"source":"NA","target":"kidney neoplasms","id":"41868"},{"source":"NA","target":"arthritis","id":"41869"},{"source":"NA","target":"renal cancer","id":"41870"},{"source":"NA","target":"carcinoma","id":"41871"},{"source":"NA","target":"antiarthritic","id":"41872"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41873"},{"source":"NA","target":"fallopian tube neoplasms","id":"41874"},{"source":"NA","target":"solid tumors","id":"41875"},{"source":"NA","target":"carcinoma","id":"41876"},{"source":"NA","target":"bone metastasis","id":"41877"},{"source":"NA","target":"gilbert disease","id":"41878"},{"source":"NA","target":"hypertension","id":"41879"},{"source":"NA","target":"anticancer","id":"41880"},{"source":"NA","target":"rcc","id":"41881"},{"source":"NA","target":"liver neoplasms","id":"41882"},{"source":"NA","target":"renal cell","id":"41883"},{"source":"NA","target":"solid tumors","id":"41884"},{"source":"C-kit inhibitor","target":"UNK : Indication","id":"41885"},{"source":"C-kit inhibitor","target":"liver metastases","id":"41886"},{"source":"C-kit inhibitor","target":"antihypertensive","id":"41887"},{"source":"C-kit inhibitor","target":"gilbert syndrome","id":"41888"},{"source":"C-kit inhibitor","target":"kidney neoplasms","id":"41889"},{"source":"C-kit inhibitor","target":"arthritis","id":"41890"},{"source":"C-kit inhibitor","target":"renal cancer","id":"41891"},{"source":"C-kit inhibitor","target":"carcinoma","id":"41892"},{"source":"C-kit inhibitor","target":"antiarthritic","id":"41893"},{"source":"C-kit inhibitor","target":"unconjugated hyperbilirubinemia","id":"41894"},{"source":"C-kit inhibitor","target":"fallopian tube neoplasms","id":"41895"},{"source":"C-kit inhibitor","target":"solid tumors","id":"41896"},{"source":"C-kit inhibitor","target":"carcinoma","id":"41897"},{"source":"C-kit inhibitor","target":"bone metastasis","id":"41898"},{"source":"C-kit inhibitor","target":"gilbert disease","id":"41899"},{"source":"C-kit inhibitor","target":"hypertension","id":"41900"},{"source":"C-kit inhibitor","target":"anticancer","id":"41901"},{"source":"C-kit inhibitor","target":"rcc","id":"41902"},{"source":"C-kit inhibitor","target":"liver neoplasms","id":"41903"},{"source":"C-kit inhibitor","target":"renal cell","id":"41904"},{"source":"C-kit inhibitor","target":"solid tumors","id":"41905"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"41906"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"41907"},{"source":"Immune checkpoint inhibitor","target":"antihypertensive","id":"41908"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"41909"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"41910"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"41911"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"41912"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"41913"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"41914"},{"source":"Immune checkpoint inhibitor","target":"unconjugated hyperbilirubinemia","id":"41915"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"41916"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"41917"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"41918"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"41919"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"41920"},{"source":"Immune checkpoint inhibitor","target":"hypertension","id":"41921"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"41922"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"41923"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"41924"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"41925"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"41926"},{"source":"NA","target":"UNK : Indication","id":"41927"},{"source":"NA","target":"liver metastases","id":"41928"},{"source":"NA","target":"antihypertensive","id":"41929"},{"source":"NA","target":"gilbert syndrome","id":"41930"},{"source":"NA","target":"kidney neoplasms","id":"41931"},{"source":"NA","target":"arthritis","id":"41932"},{"source":"NA","target":"renal cancer","id":"41933"},{"source":"NA","target":"carcinoma","id":"41934"},{"source":"NA","target":"antiarthritic","id":"41935"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41936"},{"source":"NA","target":"fallopian tube neoplasms","id":"41937"},{"source":"NA","target":"solid tumors","id":"41938"},{"source":"NA","target":"carcinoma","id":"41939"},{"source":"NA","target":"bone metastasis","id":"41940"},{"source":"NA","target":"gilbert disease","id":"41941"},{"source":"NA","target":"hypertension","id":"41942"},{"source":"NA","target":"anticancer","id":"41943"},{"source":"NA","target":"rcc","id":"41944"},{"source":"NA","target":"liver neoplasms","id":"41945"},{"source":"NA","target":"renal cell","id":"41946"},{"source":"NA","target":"solid tumors","id":"41947"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"41948"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver metastases","id":"41949"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"antihypertensive","id":"41950"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"gilbert syndrome","id":"41951"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"kidney neoplasms","id":"41952"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"arthritis","id":"41953"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cancer","id":"41954"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"41955"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"antiarthritic","id":"41956"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"unconjugated hyperbilirubinemia","id":"41957"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"fallopian tube neoplasms","id":"41958"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"solid tumors","id":"41959"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"41960"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"bone metastasis","id":"41961"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"gilbert disease","id":"41962"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"hypertension","id":"41963"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"41964"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"rcc","id":"41965"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"liver neoplasms","id":"41966"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"renal cell","id":"41967"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"solid tumors","id":"41968"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"41969"},{"source":"Cell cycle inhibitor","target":"liver metastases","id":"41970"},{"source":"Cell cycle inhibitor","target":"antihypertensive","id":"41971"},{"source":"Cell cycle inhibitor","target":"gilbert syndrome","id":"41972"},{"source":"Cell cycle inhibitor","target":"kidney neoplasms","id":"41973"},{"source":"Cell cycle inhibitor","target":"arthritis","id":"41974"},{"source":"Cell cycle inhibitor","target":"renal cancer","id":"41975"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"41976"},{"source":"Cell cycle inhibitor","target":"antiarthritic","id":"41977"},{"source":"Cell cycle inhibitor","target":"unconjugated hyperbilirubinemia","id":"41978"},{"source":"Cell cycle inhibitor","target":"fallopian tube neoplasms","id":"41979"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"41980"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"41981"},{"source":"Cell cycle inhibitor","target":"bone metastasis","id":"41982"},{"source":"Cell cycle inhibitor","target":"gilbert disease","id":"41983"},{"source":"Cell cycle inhibitor","target":"hypertension","id":"41984"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"41985"},{"source":"Cell cycle inhibitor","target":"rcc","id":"41986"},{"source":"Cell cycle inhibitor","target":"liver neoplasms","id":"41987"},{"source":"Cell cycle inhibitor","target":"renal cell","id":"41988"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"41989"},{"source":"NA","target":"UNK : Indication","id":"41990"},{"source":"NA","target":"liver metastases","id":"41991"},{"source":"NA","target":"antihypertensive","id":"41992"},{"source":"NA","target":"gilbert syndrome","id":"41993"},{"source":"NA","target":"kidney neoplasms","id":"41994"},{"source":"NA","target":"arthritis","id":"41995"},{"source":"NA","target":"renal cancer","id":"41996"},{"source":"NA","target":"carcinoma","id":"41997"},{"source":"NA","target":"antiarthritic","id":"41998"},{"source":"NA","target":"unconjugated hyperbilirubinemia","id":"41999"},{"source":"NA","target":"fallopian tube neoplasms","id":"42000"},{"source":"NA","target":"solid tumors","id":"42001"},{"source":"NA","target":"carcinoma","id":"42002"},{"source":"NA","target":"bone metastasis","id":"42003"},{"source":"NA","target":"gilbert disease","id":"42004"},{"source":"NA","target":"hypertension","id":"42005"},{"source":"NA","target":"anticancer","id":"42006"},{"source":"NA","target":"rcc","id":"42007"},{"source":"NA","target":"liver neoplasms","id":"42008"},{"source":"NA","target":"renal cell","id":"42009"},{"source":"NA","target":"solid tumors","id":"42010"},{"source":"Oncology: Renal","target":"NA","id":"42011"},{"source":"Oncology: Renal","target":"NA","id":"42012"},{"source":"Oncology: Renal","target":"NA","id":"42013"},{"source":"Oncology: Renal","target":"NA","id":"42014"},{"source":"Oncology: Renal","target":"NA","id":"42015"},{"source":"Oncology: Renal","target":"NA","id":"42016"},{"source":"Oncology: Renal","target":"NA","id":"42017"},{"source":"Oncology: Renal","target":"NA","id":"42018"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"42019"},{"source":"Oncology: Renal","target":"Angiogenesis inhibitor","id":"42020"},{"source":"Oncology: Renal","target":"Immunosuppressant","id":"42021"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"42022"},{"source":"Oncology: Renal","target":"NA","id":"42023"},{"source":"Oncology: Renal","target":"Angiopoietin inhibitor","id":"42024"},{"source":"Oncology: Renal","target":"NA","id":"42025"},{"source":"Oncology: Renal","target":"NA","id":"42026"},{"source":"Oncology: Renal","target":"Colony stimulating factor 1 receptor antagonist","id":"42027"},{"source":"Oncology: Renal","target":"NA","id":"42028"},{"source":"Oncology: Renal","target":"C-kit inhibitor","id":"42029"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"42030"},{"source":"Oncology: Renal","target":"NA","id":"42031"},{"source":"Oncology: Renal","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"42032"},{"source":"Oncology: Renal","target":"Cell cycle inhibitor","id":"42033"},{"source":"Oncology: Renal","target":"NA","id":"42034"},{"source":"afatinib (a)","target":"Boehringer Ingelheim","id":"42035"},{"source":"afatinib (a)","target":"Merck & Co.","id":"42036"},{"source":"pembrolizumab","target":"Boehringer Ingelheim","id":"42037"},{"source":"pembrolizumab","target":"Merck & Co.","id":"42038"},{"source":"UNK : Indication","target":"afatinib (a)","id":"42039"},{"source":"UNK : Indication","target":"pembrolizumab","id":"42040"},{"source":"sclc","target":"afatinib (a)","id":"42041"},{"source":"sclc","target":"pembrolizumab","id":"42042"},{"source":"squamous cell neoplasms","target":"afatinib (a)","id":"42043"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"42044"},{"source":"carcinoma","target":"afatinib (a)","id":"42045"},{"source":"carcinoma","target":"pembrolizumab","id":"42046"},{"source":"carcinoma","target":"afatinib (a)","id":"42047"},{"source":"carcinoma","target":"pembrolizumab","id":"42048"},{"source":"residual tumor","target":"afatinib (a)","id":"42049"},{"source":"residual tumor","target":"pembrolizumab","id":"42050"},{"source":"non-small-cell lung","target":"afatinib (a)","id":"42051"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"42052"},{"source":"anticancer","target":"afatinib (a)","id":"42053"},{"source":"anticancer","target":"pembrolizumab","id":"42054"},{"source":"sclc","target":"afatinib (a)","id":"42055"},{"source":"sclc","target":"pembrolizumab","id":"42056"},{"source":"copd","target":"afatinib (a)","id":"42057"},{"source":"copd","target":"pembrolizumab","id":"42058"},{"source":"alopecia","target":"afatinib (a)","id":"42059"},{"source":"alopecia","target":"pembrolizumab","id":"42060"},{"source":"carcinoma","target":"afatinib (a)","id":"42061"},{"source":"carcinoma","target":"pembrolizumab","id":"42062"},{"source":"metastatic","target":"afatinib (a)","id":"42063"},{"source":"metastatic","target":"pembrolizumab","id":"42064"},{"source":"carcinoma","target":"afatinib (a)","id":"42065"},{"source":"carcinoma","target":"pembrolizumab","id":"42066"},{"source":"neoplasm metastasis","target":"afatinib (a)","id":"42067"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"42068"},{"source":"lung neoplasms","target":"afatinib (a)","id":"42069"},{"source":"lung neoplasms","target":"pembrolizumab","id":"42070"},{"source":"squamous cell neoplasms","target":"afatinib (a)","id":"42071"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"42072"},{"source":"neuropathy","target":"afatinib (a)","id":"42073"},{"source":"neuropathy","target":"pembrolizumab","id":"42074"},{"source":"skin neoplasms","target":"afatinib (a)","id":"42075"},{"source":"skin neoplasms","target":"pembrolizumab","id":"42076"},{"source":"chronic obstructive pulmonary disease","target":"afatinib (a)","id":"42077"},{"source":"chronic obstructive pulmonary disease","target":"pembrolizumab","id":"42078"},{"source":"anticancer","target":"afatinib (a)","id":"42079"},{"source":"anticancer","target":"pembrolizumab","id":"42080"},{"source":"solid tumors","target":"afatinib (a)","id":"42081"},{"source":"solid tumors","target":"pembrolizumab","id":"42082"},{"source":"solid tumors","target":"afatinib (a)","id":"42083"},{"source":"solid tumors","target":"pembrolizumab","id":"42084"},{"source":"NA","target":"UNK : Indication","id":"42085"},{"source":"NA","target":"sclc","id":"42086"},{"source":"NA","target":"squamous cell neoplasms","id":"42087"},{"source":"NA","target":"carcinoma","id":"42088"},{"source":"NA","target":"carcinoma","id":"42089"},{"source":"NA","target":"residual tumor","id":"42090"},{"source":"NA","target":"non-small-cell lung","id":"42091"},{"source":"NA","target":"anticancer","id":"42092"},{"source":"NA","target":"sclc","id":"42093"},{"source":"NA","target":"copd","id":"42094"},{"source":"NA","target":"alopecia","id":"42095"},{"source":"NA","target":"carcinoma","id":"42096"},{"source":"NA","target":"metastatic","id":"42097"},{"source":"NA","target":"carcinoma","id":"42098"},{"source":"NA","target":"neoplasm metastasis","id":"42099"},{"source":"NA","target":"lung neoplasms","id":"42100"},{"source":"NA","target":"squamous cell neoplasms","id":"42101"},{"source":"NA","target":"neuropathy","id":"42102"},{"source":"NA","target":"skin neoplasms","id":"42103"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"42104"},{"source":"NA","target":"anticancer","id":"42105"},{"source":"NA","target":"solid tumors","id":"42106"},{"source":"NA","target":"solid tumors","id":"42107"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"42108"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"42109"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"42110"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42111"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42112"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"42113"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"42114"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"42115"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"42116"},{"source":"Immune checkpoint inhibitor","target":"copd","id":"42117"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"42118"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42119"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"42120"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42121"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"42122"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"42123"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"42124"},{"source":"Immune checkpoint inhibitor","target":"neuropathy","id":"42125"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"42126"},{"source":"Immune checkpoint inhibitor","target":"chronic obstructive pulmonary disease","id":"42127"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"42128"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"42129"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"42130"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"42131"},{"source":"Anticancer immunotherapy","target":"sclc","id":"42132"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"42133"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42134"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42135"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"42136"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"42137"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"42138"},{"source":"Anticancer immunotherapy","target":"sclc","id":"42139"},{"source":"Anticancer immunotherapy","target":"copd","id":"42140"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"42141"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42142"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"42143"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42144"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"42145"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"42146"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"42147"},{"source":"Anticancer immunotherapy","target":"neuropathy","id":"42148"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"42149"},{"source":"Anticancer immunotherapy","target":"chronic obstructive pulmonary disease","id":"42150"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"42151"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"42152"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"42153"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"42154"},{"source":"CD19 antagonist","target":"sclc","id":"42155"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"42156"},{"source":"CD19 antagonist","target":"carcinoma","id":"42157"},{"source":"CD19 antagonist","target":"carcinoma","id":"42158"},{"source":"CD19 antagonist","target":"residual tumor","id":"42159"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"42160"},{"source":"CD19 antagonist","target":"anticancer","id":"42161"},{"source":"CD19 antagonist","target":"sclc","id":"42162"},{"source":"CD19 antagonist","target":"copd","id":"42163"},{"source":"CD19 antagonist","target":"alopecia","id":"42164"},{"source":"CD19 antagonist","target":"carcinoma","id":"42165"},{"source":"CD19 antagonist","target":"metastatic","id":"42166"},{"source":"CD19 antagonist","target":"carcinoma","id":"42167"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"42168"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"42169"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"42170"},{"source":"CD19 antagonist","target":"neuropathy","id":"42171"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"42172"},{"source":"CD19 antagonist","target":"chronic obstructive pulmonary disease","id":"42173"},{"source":"CD19 antagonist","target":"anticancer","id":"42174"},{"source":"CD19 antagonist","target":"solid tumors","id":"42175"},{"source":"CD19 antagonist","target":"solid tumors","id":"42176"},{"source":"NA","target":"UNK : Indication","id":"42177"},{"source":"NA","target":"sclc","id":"42178"},{"source":"NA","target":"squamous cell neoplasms","id":"42179"},{"source":"NA","target":"carcinoma","id":"42180"},{"source":"NA","target":"carcinoma","id":"42181"},{"source":"NA","target":"residual tumor","id":"42182"},{"source":"NA","target":"non-small-cell lung","id":"42183"},{"source":"NA","target":"anticancer","id":"42184"},{"source":"NA","target":"sclc","id":"42185"},{"source":"NA","target":"copd","id":"42186"},{"source":"NA","target":"alopecia","id":"42187"},{"source":"NA","target":"carcinoma","id":"42188"},{"source":"NA","target":"metastatic","id":"42189"},{"source":"NA","target":"carcinoma","id":"42190"},{"source":"NA","target":"neoplasm metastasis","id":"42191"},{"source":"NA","target":"lung neoplasms","id":"42192"},{"source":"NA","target":"squamous cell neoplasms","id":"42193"},{"source":"NA","target":"neuropathy","id":"42194"},{"source":"NA","target":"skin neoplasms","id":"42195"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"42196"},{"source":"NA","target":"anticancer","id":"42197"},{"source":"NA","target":"solid tumors","id":"42198"},{"source":"NA","target":"solid tumors","id":"42199"},{"source":"NA","target":"UNK : Indication","id":"42200"},{"source":"NA","target":"sclc","id":"42201"},{"source":"NA","target":"squamous cell neoplasms","id":"42202"},{"source":"NA","target":"carcinoma","id":"42203"},{"source":"NA","target":"carcinoma","id":"42204"},{"source":"NA","target":"residual tumor","id":"42205"},{"source":"NA","target":"non-small-cell lung","id":"42206"},{"source":"NA","target":"anticancer","id":"42207"},{"source":"NA","target":"sclc","id":"42208"},{"source":"NA","target":"copd","id":"42209"},{"source":"NA","target":"alopecia","id":"42210"},{"source":"NA","target":"carcinoma","id":"42211"},{"source":"NA","target":"metastatic","id":"42212"},{"source":"NA","target":"carcinoma","id":"42213"},{"source":"NA","target":"neoplasm metastasis","id":"42214"},{"source":"NA","target":"lung neoplasms","id":"42215"},{"source":"NA","target":"squamous cell neoplasms","id":"42216"},{"source":"NA","target":"neuropathy","id":"42217"},{"source":"NA","target":"skin neoplasms","id":"42218"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"42219"},{"source":"NA","target":"anticancer","id":"42220"},{"source":"NA","target":"solid tumors","id":"42221"},{"source":"NA","target":"solid tumors","id":"42222"},{"source":"Oncology: Lung","target":"NA","id":"42223"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"42224"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"42225"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"42226"},{"source":"Oncology: Lung","target":"NA","id":"42227"},{"source":"Oncology: Lung","target":"NA","id":"42228"},{"source":"Non-Small Cell","target":"NA","id":"42229"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"42230"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"42231"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"42232"},{"source":"Non-Small Cell","target":"NA","id":"42233"},{"source":"Non-Small Cell","target":"NA","id":"42234"},{"source":"pembrolizumab","target":"Merck & Co.","id":"42235"},{"source":"capecitabine","target":"Merck & Co.","id":"42236"},{"source":"docetaxel","target":"Merck & Co.","id":"42237"},{"source":"gemcitabine hydrochloride","target":"Merck & Co.","id":"42238"},{"source":"malaria","target":"pembrolizumab","id":"42239"},{"source":"malaria","target":"capecitabine","id":"42240"},{"source":"malaria","target":"docetaxel","id":"42241"},{"source":"malaria","target":"gemcitabine hydrochloride","id":"42242"},{"source":"malaria","target":"pembrolizumab","id":"42243"},{"source":"malaria","target":"capecitabine","id":"42244"},{"source":"malaria","target":"docetaxel","id":"42245"},{"source":"malaria","target":"gemcitabine hydrochloride","id":"42246"},{"source":"oropharyngeal cancer","target":"pembrolizumab","id":"42247"},{"source":"oropharyngeal cancer","target":"capecitabine","id":"42248"},{"source":"oropharyngeal cancer","target":"docetaxel","id":"42249"},{"source":"oropharyngeal cancer","target":"gemcitabine hydrochloride","id":"42250"},{"source":"npc","target":"pembrolizumab","id":"42251"},{"source":"npc","target":"capecitabine","id":"42252"},{"source":"npc","target":"docetaxel","id":"42253"},{"source":"npc","target":"gemcitabine hydrochloride","id":"42254"},{"source":"residual tumor","target":"pembrolizumab","id":"42255"},{"source":"residual tumor","target":"capecitabine","id":"42256"},{"source":"residual tumor","target":"docetaxel","id":"42257"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"42258"},{"source":"liver metastases","target":"pembrolizumab","id":"42259"},{"source":"liver metastases","target":"capecitabine","id":"42260"},{"source":"liver metastases","target":"docetaxel","id":"42261"},{"source":"liver metastases","target":"gemcitabine hydrochloride","id":"42262"},{"source":"carcinoma","target":"pembrolizumab","id":"42263"},{"source":"carcinoma","target":"capecitabine","id":"42264"},{"source":"carcinoma","target":"docetaxel","id":"42265"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"42266"},{"source":"carcinoma","target":"pembrolizumab","id":"42267"},{"source":"carcinoma","target":"capecitabine","id":"42268"},{"source":"carcinoma","target":"docetaxel","id":"42269"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"42270"},{"source":"anti-tumor","target":"pembrolizumab","id":"42271"},{"source":"anti-tumor","target":"capecitabine","id":"42272"},{"source":"anti-tumor","target":"docetaxel","id":"42273"},{"source":"anti-tumor","target":"gemcitabine hydrochloride","id":"42274"},{"source":"metastatic","target":"pembrolizumab","id":"42275"},{"source":"metastatic","target":"capecitabine","id":"42276"},{"source":"metastatic","target":"docetaxel","id":"42277"},{"source":"metastatic","target":"gemcitabine hydrochloride","id":"42278"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"42279"},{"source":"neoplasm metastasis","target":"capecitabine","id":"42280"},{"source":"neoplasm metastasis","target":"docetaxel","id":"42281"},{"source":"neoplasm metastasis","target":"gemcitabine hydrochloride","id":"42282"},{"source":"esophageal neoplasms","target":"pembrolizumab","id":"42283"},{"source":"esophageal neoplasms","target":"capecitabine","id":"42284"},{"source":"esophageal neoplasms","target":"docetaxel","id":"42285"},{"source":"esophageal neoplasms","target":"gemcitabine hydrochloride","id":"42286"},{"source":"anticancer","target":"pembrolizumab","id":"42287"},{"source":"anticancer","target":"capecitabine","id":"42288"},{"source":"anticancer","target":"docetaxel","id":"42289"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"42290"},{"source":"liver neoplasms","target":"pembrolizumab","id":"42291"},{"source":"liver neoplasms","target":"capecitabine","id":"42292"},{"source":"liver neoplasms","target":"docetaxel","id":"42293"},{"source":"liver neoplasms","target":"gemcitabine hydrochloride","id":"42294"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"42295"},{"source":"head and neck neoplasms","target":"capecitabine","id":"42296"},{"source":"head and neck neoplasms","target":"docetaxel","id":"42297"},{"source":"head and neck neoplasms","target":"gemcitabine hydrochloride","id":"42298"},{"source":"Cell cycle inhibitor","target":"malaria","id":"42299"},{"source":"Cell cycle inhibitor","target":"malaria","id":"42300"},{"source":"Cell cycle inhibitor","target":"oropharyngeal cancer","id":"42301"},{"source":"Cell cycle inhibitor","target":"npc","id":"42302"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"42303"},{"source":"Cell cycle inhibitor","target":"liver metastases","id":"42304"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"42305"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"42306"},{"source":"Cell cycle inhibitor","target":"anti-tumor","id":"42307"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"42308"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"42309"},{"source":"Cell cycle inhibitor","target":"esophageal neoplasms","id":"42310"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"42311"},{"source":"Cell cycle inhibitor","target":"liver neoplasms","id":"42312"},{"source":"Cell cycle inhibitor","target":"head and neck neoplasms","id":"42313"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"42314"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"42315"},{"source":"Immune checkpoint inhibitor","target":"oropharyngeal cancer","id":"42316"},{"source":"Immune checkpoint inhibitor","target":"npc","id":"42317"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"42318"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"42319"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42320"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42321"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"42322"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"42323"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"42324"},{"source":"Immune checkpoint inhibitor","target":"esophageal neoplasms","id":"42325"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"42326"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"42327"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"42328"},{"source":"NA","target":"malaria","id":"42329"},{"source":"NA","target":"malaria","id":"42330"},{"source":"NA","target":"oropharyngeal cancer","id":"42331"},{"source":"NA","target":"npc","id":"42332"},{"source":"NA","target":"residual tumor","id":"42333"},{"source":"NA","target":"liver metastases","id":"42334"},{"source":"NA","target":"carcinoma","id":"42335"},{"source":"NA","target":"carcinoma","id":"42336"},{"source":"NA","target":"anti-tumor","id":"42337"},{"source":"NA","target":"metastatic","id":"42338"},{"source":"NA","target":"neoplasm metastasis","id":"42339"},{"source":"NA","target":"esophageal neoplasms","id":"42340"},{"source":"NA","target":"anticancer","id":"42341"},{"source":"NA","target":"liver neoplasms","id":"42342"},{"source":"NA","target":"head and neck neoplasms","id":"42343"},{"source":"Anticancer immunotherapy","target":"malaria","id":"42344"},{"source":"Anticancer immunotherapy","target":"malaria","id":"42345"},{"source":"Anticancer immunotherapy","target":"oropharyngeal cancer","id":"42346"},{"source":"Anticancer immunotherapy","target":"npc","id":"42347"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"42348"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"42349"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42350"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42351"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"42352"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"42353"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"42354"},{"source":"Anticancer immunotherapy","target":"esophageal neoplasms","id":"42355"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"42356"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"42357"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"42358"},{"source":"CD19 antagonist","target":"malaria","id":"42359"},{"source":"CD19 antagonist","target":"malaria","id":"42360"},{"source":"CD19 antagonist","target":"oropharyngeal cancer","id":"42361"},{"source":"CD19 antagonist","target":"npc","id":"42362"},{"source":"CD19 antagonist","target":"residual tumor","id":"42363"},{"source":"CD19 antagonist","target":"liver metastases","id":"42364"},{"source":"CD19 antagonist","target":"carcinoma","id":"42365"},{"source":"CD19 antagonist","target":"carcinoma","id":"42366"},{"source":"CD19 antagonist","target":"anti-tumor","id":"42367"},{"source":"CD19 antagonist","target":"metastatic","id":"42368"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"42369"},{"source":"CD19 antagonist","target":"esophageal neoplasms","id":"42370"},{"source":"CD19 antagonist","target":"anticancer","id":"42371"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"42372"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"42373"},{"source":"Taxane","target":"malaria","id":"42374"},{"source":"Taxane","target":"malaria","id":"42375"},{"source":"Taxane","target":"oropharyngeal cancer","id":"42376"},{"source":"Taxane","target":"npc","id":"42377"},{"source":"Taxane","target":"residual tumor","id":"42378"},{"source":"Taxane","target":"liver metastases","id":"42379"},{"source":"Taxane","target":"carcinoma","id":"42380"},{"source":"Taxane","target":"carcinoma","id":"42381"},{"source":"Taxane","target":"anti-tumor","id":"42382"},{"source":"Taxane","target":"metastatic","id":"42383"},{"source":"Taxane","target":"neoplasm metastasis","id":"42384"},{"source":"Taxane","target":"esophageal neoplasms","id":"42385"},{"source":"Taxane","target":"anticancer","id":"42386"},{"source":"Taxane","target":"liver neoplasms","id":"42387"},{"source":"Taxane","target":"head and neck neoplasms","id":"42388"},{"source":"Microtubule stimulant","target":"malaria","id":"42389"},{"source":"Microtubule stimulant","target":"malaria","id":"42390"},{"source":"Microtubule stimulant","target":"oropharyngeal cancer","id":"42391"},{"source":"Microtubule stimulant","target":"npc","id":"42392"},{"source":"Microtubule stimulant","target":"residual tumor","id":"42393"},{"source":"Microtubule stimulant","target":"liver metastases","id":"42394"},{"source":"Microtubule stimulant","target":"carcinoma","id":"42395"},{"source":"Microtubule stimulant","target":"carcinoma","id":"42396"},{"source":"Microtubule stimulant","target":"anti-tumor","id":"42397"},{"source":"Microtubule stimulant","target":"metastatic","id":"42398"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"42399"},{"source":"Microtubule stimulant","target":"esophageal neoplasms","id":"42400"},{"source":"Microtubule stimulant","target":"anticancer","id":"42401"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"42402"},{"source":"Microtubule stimulant","target":"head and neck neoplasms","id":"42403"},{"source":"NA","target":"malaria","id":"42404"},{"source":"NA","target":"malaria","id":"42405"},{"source":"NA","target":"oropharyngeal cancer","id":"42406"},{"source":"NA","target":"npc","id":"42407"},{"source":"NA","target":"residual tumor","id":"42408"},{"source":"NA","target":"liver metastases","id":"42409"},{"source":"NA","target":"carcinoma","id":"42410"},{"source":"NA","target":"carcinoma","id":"42411"},{"source":"NA","target":"anti-tumor","id":"42412"},{"source":"NA","target":"metastatic","id":"42413"},{"source":"NA","target":"neoplasm metastasis","id":"42414"},{"source":"NA","target":"esophageal neoplasms","id":"42415"},{"source":"NA","target":"anticancer","id":"42416"},{"source":"NA","target":"liver neoplasms","id":"42417"},{"source":"NA","target":"head and neck neoplasms","id":"42418"},{"source":"NA","target":"malaria","id":"42419"},{"source":"NA","target":"malaria","id":"42420"},{"source":"NA","target":"oropharyngeal cancer","id":"42421"},{"source":"NA","target":"npc","id":"42422"},{"source":"NA","target":"residual tumor","id":"42423"},{"source":"NA","target":"liver metastases","id":"42424"},{"source":"NA","target":"carcinoma","id":"42425"},{"source":"NA","target":"carcinoma","id":"42426"},{"source":"NA","target":"anti-tumor","id":"42427"},{"source":"NA","target":"metastatic","id":"42428"},{"source":"NA","target":"neoplasm metastasis","id":"42429"},{"source":"NA","target":"esophageal neoplasms","id":"42430"},{"source":"NA","target":"anticancer","id":"42431"},{"source":"NA","target":"liver neoplasms","id":"42432"},{"source":"NA","target":"head and neck neoplasms","id":"42433"},{"source":"Tubulin inhibitor","target":"malaria","id":"42434"},{"source":"Tubulin inhibitor","target":"malaria","id":"42435"},{"source":"Tubulin inhibitor","target":"oropharyngeal cancer","id":"42436"},{"source":"Tubulin inhibitor","target":"npc","id":"42437"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"42438"},{"source":"Tubulin inhibitor","target":"liver metastases","id":"42439"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"42440"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"42441"},{"source":"Tubulin inhibitor","target":"anti-tumor","id":"42442"},{"source":"Tubulin inhibitor","target":"metastatic","id":"42443"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"42444"},{"source":"Tubulin inhibitor","target":"esophageal neoplasms","id":"42445"},{"source":"Tubulin inhibitor","target":"anticancer","id":"42446"},{"source":"Tubulin inhibitor","target":"liver neoplasms","id":"42447"},{"source":"Tubulin inhibitor","target":"head and neck neoplasms","id":"42448"},{"source":"Thymidylate synthase inhibitor","target":"malaria","id":"42449"},{"source":"Thymidylate synthase inhibitor","target":"malaria","id":"42450"},{"source":"Thymidylate synthase inhibitor","target":"oropharyngeal cancer","id":"42451"},{"source":"Thymidylate synthase inhibitor","target":"npc","id":"42452"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"42453"},{"source":"Thymidylate synthase inhibitor","target":"liver metastases","id":"42454"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"42455"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"42456"},{"source":"Thymidylate synthase inhibitor","target":"anti-tumor","id":"42457"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"42458"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"42459"},{"source":"Thymidylate synthase inhibitor","target":"esophageal neoplasms","id":"42460"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"42461"},{"source":"Thymidylate synthase inhibitor","target":"liver neoplasms","id":"42462"},{"source":"Thymidylate synthase inhibitor","target":"head and neck neoplasms","id":"42463"},{"source":"Oncology: Head/Neck","target":"Cell cycle inhibitor","id":"42464"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"42465"},{"source":"Oncology: Head/Neck","target":"NA","id":"42466"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"42467"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"42468"},{"source":"Oncology: Head/Neck","target":"Taxane","id":"42469"},{"source":"Oncology: Head/Neck","target":"Microtubule stimulant","id":"42470"},{"source":"Oncology: Head/Neck","target":"NA","id":"42471"},{"source":"Oncology: Head/Neck","target":"NA","id":"42472"},{"source":"Oncology: Head/Neck","target":"Tubulin inhibitor","id":"42473"},{"source":"Oncology: Head/Neck","target":"Thymidylate synthase inhibitor","id":"42474"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"42475"},{"source":"pembrolizumab","target":"(Other Industry Sponsor)","id":"42476"},{"source":"pembrolizumab","target":"Merck & Co.","id":"42477"},{"source":"pembrolizumab","target":"Sarcoma Alliance for Research through Collaboration","id":"42478"},{"source":"radiation therapy","target":"(Other Hospital/Academic/Medical Center)","id":"42479"},{"source":"radiation therapy","target":"(Other Industry Sponsor)","id":"42480"},{"source":"radiation therapy","target":"Merck & Co.","id":"42481"},{"source":"radiation therapy","target":"Sarcoma Alliance for Research through Collaboration","id":"42482"},{"source":"surgical intervention","target":"(Other Hospital/Academic/Medical Center)","id":"42483"},{"source":"surgical intervention","target":"(Other Industry Sponsor)","id":"42484"},{"source":"surgical intervention","target":"Merck & Co.","id":"42485"},{"source":"surgical intervention","target":"Sarcoma Alliance for Research through Collaboration","id":"42486"},{"source":"UNK : Indication","target":"pembrolizumab","id":"42487"},{"source":"UNK : Indication","target":"radiation therapy","id":"42488"},{"source":"UNK : Indication","target":"surgical intervention","id":"42489"},{"source":"sarcoma","target":"pembrolizumab","id":"42490"},{"source":"sarcoma","target":"radiation therapy","id":"42491"},{"source":"sarcoma","target":"surgical intervention","id":"42492"},{"source":"prostate cancer","target":"pembrolizumab","id":"42493"},{"source":"prostate cancer","target":"radiation therapy","id":"42494"},{"source":"prostate cancer","target":"surgical intervention","id":"42495"},{"source":"melanoma","target":"pembrolizumab","id":"42496"},{"source":"melanoma","target":"radiation therapy","id":"42497"},{"source":"melanoma","target":"surgical intervention","id":"42498"},{"source":"melanoma","target":"pembrolizumab","id":"42499"},{"source":"melanoma","target":"radiation therapy","id":"42500"},{"source":"melanoma","target":"surgical intervention","id":"42501"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"42502"},{"source":"castration-resistant prostatic neoplasms","target":"radiation therapy","id":"42503"},{"source":"castration-resistant prostatic neoplasms","target":"surgical intervention","id":"42504"},{"source":"skin neoplasms","target":"pembrolizumab","id":"42505"},{"source":"skin neoplasms","target":"radiation therapy","id":"42506"},{"source":"skin neoplasms","target":"surgical intervention","id":"42507"},{"source":"residual tumor","target":"pembrolizumab","id":"42508"},{"source":"residual tumor","target":"radiation therapy","id":"42509"},{"source":"residual tumor","target":"surgical intervention","id":"42510"},{"source":"metastatic","target":"pembrolizumab","id":"42511"},{"source":"metastatic","target":"radiation therapy","id":"42512"},{"source":"metastatic","target":"surgical intervention","id":"42513"},{"source":"carcinoma","target":"pembrolizumab","id":"42514"},{"source":"carcinoma","target":"radiation therapy","id":"42515"},{"source":"carcinoma","target":"surgical intervention","id":"42516"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"42517"},{"source":"soft tissue neoplasms","target":"radiation therapy","id":"42518"},{"source":"soft tissue neoplasms","target":"surgical intervention","id":"42519"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"42520"},{"source":"neoplasm metastasis","target":"radiation therapy","id":"42521"},{"source":"neoplasm metastasis","target":"surgical intervention","id":"42522"},{"source":"sarcoma","target":"pembrolizumab","id":"42523"},{"source":"sarcoma","target":"radiation therapy","id":"42524"},{"source":"sarcoma","target":"surgical intervention","id":"42525"},{"source":"skin cancer","target":"pembrolizumab","id":"42526"},{"source":"skin cancer","target":"radiation therapy","id":"42527"},{"source":"skin cancer","target":"surgical intervention","id":"42528"},{"source":"anticancer","target":"pembrolizumab","id":"42529"},{"source":"anticancer","target":"radiation therapy","id":"42530"},{"source":"anticancer","target":"surgical intervention","id":"42531"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"42532"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"42533"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"42534"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"42535"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"42536"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"42537"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"42538"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"42539"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"42540"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42541"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"42542"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"42543"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"42544"},{"source":"Anticancer immunotherapy","target":"skin cancer","id":"42545"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"42546"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"42547"},{"source":"CD19 antagonist","target":"sarcoma","id":"42548"},{"source":"CD19 antagonist","target":"prostate cancer","id":"42549"},{"source":"CD19 antagonist","target":"melanoma","id":"42550"},{"source":"CD19 antagonist","target":"melanoma","id":"42551"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"42552"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"42553"},{"source":"CD19 antagonist","target":"residual tumor","id":"42554"},{"source":"CD19 antagonist","target":"metastatic","id":"42555"},{"source":"CD19 antagonist","target":"carcinoma","id":"42556"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"42557"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"42558"},{"source":"CD19 antagonist","target":"sarcoma","id":"42559"},{"source":"CD19 antagonist","target":"skin cancer","id":"42560"},{"source":"CD19 antagonist","target":"anticancer","id":"42561"},{"source":"NA","target":"UNK : Indication","id":"42562"},{"source":"NA","target":"sarcoma","id":"42563"},{"source":"NA","target":"prostate cancer","id":"42564"},{"source":"NA","target":"melanoma","id":"42565"},{"source":"NA","target":"melanoma","id":"42566"},{"source":"NA","target":"castration-resistant prostatic neoplasms","id":"42567"},{"source":"NA","target":"skin neoplasms","id":"42568"},{"source":"NA","target":"residual tumor","id":"42569"},{"source":"NA","target":"metastatic","id":"42570"},{"source":"NA","target":"carcinoma","id":"42571"},{"source":"NA","target":"soft tissue neoplasms","id":"42572"},{"source":"NA","target":"neoplasm metastasis","id":"42573"},{"source":"NA","target":"sarcoma","id":"42574"},{"source":"NA","target":"skin cancer","id":"42575"},{"source":"NA","target":"anticancer","id":"42576"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"42577"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"42578"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"42579"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"42580"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"42581"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"42582"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"42583"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"42584"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"42585"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42586"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"42587"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"42588"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"42589"},{"source":"Immune checkpoint inhibitor","target":"skin cancer","id":"42590"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"42591"},{"source":"UPA","target":"UNK : Indication","id":"42592"},{"source":"UPA","target":"sarcoma","id":"42593"},{"source":"UPA","target":"prostate cancer","id":"42594"},{"source":"UPA","target":"melanoma","id":"42595"},{"source":"UPA","target":"melanoma","id":"42596"},{"source":"UPA","target":"castration-resistant prostatic neoplasms","id":"42597"},{"source":"UPA","target":"skin neoplasms","id":"42598"},{"source":"UPA","target":"residual tumor","id":"42599"},{"source":"UPA","target":"metastatic","id":"42600"},{"source":"UPA","target":"carcinoma","id":"42601"},{"source":"UPA","target":"soft tissue neoplasms","id":"42602"},{"source":"UPA","target":"neoplasm metastasis","id":"42603"},{"source":"UPA","target":"sarcoma","id":"42604"},{"source":"UPA","target":"skin cancer","id":"42605"},{"source":"UPA","target":"anticancer","id":"42606"},{"source":"Oncology: (N/A)","target":"Anticancer immunotherapy","id":"42607"},{"source":"Oncology: (N/A)","target":"CD19 antagonist","id":"42608"},{"source":"Oncology: (N/A)","target":"NA","id":"42609"},{"source":"Oncology: (N/A)","target":"Immune checkpoint inhibitor","id":"42610"},{"source":"Oncology: (N/A)","target":"UPA","id":"42611"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"42612"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"42613"},{"source":"Oncology: Prostate","target":"NA","id":"42614"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"42615"},{"source":"Oncology: Prostate","target":"UPA","id":"42616"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Anticancer immunotherapy","id":"42617"},{"source":"Oncology: Soft Tissue Sarcoma","target":"CD19 antagonist","id":"42618"},{"source":"Oncology: Soft Tissue Sarcoma","target":"NA","id":"42619"},{"source":"Oncology: Soft Tissue Sarcoma","target":"Immune checkpoint inhibitor","id":"42620"},{"source":"Oncology: Soft Tissue Sarcoma","target":"UPA","id":"42621"},{"source":"pembrolizumab","target":"Merck & Co.","id":"42622"},{"source":"cisplatin","target":"Merck & Co.","id":"42623"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"42624"},{"source":"carcinoma","target":"pembrolizumab","id":"42625"},{"source":"carcinoma","target":"cisplatin","id":"42626"},{"source":"carcinoma","target":"5-fluorouracil","id":"42627"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"42628"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"42629"},{"source":"pharyngeal neoplasms","target":"5-fluorouracil","id":"42630"},{"source":"carcinoma","target":"pembrolizumab","id":"42631"},{"source":"carcinoma","target":"cisplatin","id":"42632"},{"source":"carcinoma","target":"5-fluorouracil","id":"42633"},{"source":"carcinoma","target":"pembrolizumab","id":"42634"},{"source":"carcinoma","target":"cisplatin","id":"42635"},{"source":"carcinoma","target":"5-fluorouracil","id":"42636"},{"source":"UNK : Indication","target":"pembrolizumab","id":"42637"},{"source":"UNK : Indication","target":"cisplatin","id":"42638"},{"source":"UNK : Indication","target":"5-fluorouracil","id":"42639"},{"source":"bleeding","target":"pembrolizumab","id":"42640"},{"source":"bleeding","target":"cisplatin","id":"42641"},{"source":"bleeding","target":"5-fluorouracil","id":"42642"},{"source":"residual tumor","target":"pembrolizumab","id":"42643"},{"source":"residual tumor","target":"cisplatin","id":"42644"},{"source":"residual tumor","target":"5-fluorouracil","id":"42645"},{"source":"esophageal cancer","target":"pembrolizumab","id":"42646"},{"source":"esophageal cancer","target":"cisplatin","id":"42647"},{"source":"esophageal cancer","target":"5-fluorouracil","id":"42648"},{"source":"skin neoplasms","target":"pembrolizumab","id":"42649"},{"source":"skin neoplasms","target":"cisplatin","id":"42650"},{"source":"skin neoplasms","target":"5-fluorouracil","id":"42651"},{"source":"residual tumor","target":"pembrolizumab","id":"42652"},{"source":"residual tumor","target":"cisplatin","id":"42653"},{"source":"residual tumor","target":"5-fluorouracil","id":"42654"},{"source":"metastatic","target":"pembrolizumab","id":"42655"},{"source":"metastatic","target":"cisplatin","id":"42656"},{"source":"metastatic","target":"5-fluorouracil","id":"42657"},{"source":"carcinoma","target":"pembrolizumab","id":"42658"},{"source":"carcinoma","target":"cisplatin","id":"42659"},{"source":"carcinoma","target":"5-fluorouracil","id":"42660"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"42661"},{"source":"neoplasm metastasis","target":"cisplatin","id":"42662"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"42663"},{"source":"carcinoma","target":"pembrolizumab","id":"42664"},{"source":"carcinoma","target":"cisplatin","id":"42665"},{"source":"carcinoma","target":"5-fluorouracil","id":"42666"},{"source":"hemorrhage","target":"pembrolizumab","id":"42667"},{"source":"hemorrhage","target":"cisplatin","id":"42668"},{"source":"hemorrhage","target":"5-fluorouracil","id":"42669"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"42670"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"42671"},{"source":"squamous cell neoplasms","target":"5-fluorouracil","id":"42672"},{"source":"anticancer","target":"pembrolizumab","id":"42673"},{"source":"anticancer","target":"cisplatin","id":"42674"},{"source":"anticancer","target":"5-fluorouracil","id":"42675"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42676"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"42677"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42678"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42679"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"42680"},{"source":"Immune checkpoint inhibitor","target":"bleeding","id":"42681"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"42682"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"42683"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"42684"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"42685"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"42686"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42687"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"42688"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"42689"},{"source":"Immune checkpoint inhibitor","target":"hemorrhage","id":"42690"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"42691"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"42692"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42693"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"42694"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42695"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42696"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"42697"},{"source":"Anticancer immunotherapy","target":"bleeding","id":"42698"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"42699"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"42700"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"42701"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"42702"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"42703"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42704"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"42705"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42706"},{"source":"Anticancer immunotherapy","target":"hemorrhage","id":"42707"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"42708"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"42709"},{"source":"CD19 antagonist","target":"carcinoma","id":"42710"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"42711"},{"source":"CD19 antagonist","target":"carcinoma","id":"42712"},{"source":"CD19 antagonist","target":"carcinoma","id":"42713"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"42714"},{"source":"CD19 antagonist","target":"bleeding","id":"42715"},{"source":"CD19 antagonist","target":"residual tumor","id":"42716"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"42717"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"42718"},{"source":"CD19 antagonist","target":"residual tumor","id":"42719"},{"source":"CD19 antagonist","target":"metastatic","id":"42720"},{"source":"CD19 antagonist","target":"carcinoma","id":"42721"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"42722"},{"source":"CD19 antagonist","target":"carcinoma","id":"42723"},{"source":"CD19 antagonist","target":"hemorrhage","id":"42724"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"42725"},{"source":"CD19 antagonist","target":"anticancer","id":"42726"},{"source":"NA","target":"carcinoma","id":"42727"},{"source":"NA","target":"pharyngeal neoplasms","id":"42728"},{"source":"NA","target":"carcinoma","id":"42729"},{"source":"NA","target":"carcinoma","id":"42730"},{"source":"NA","target":"UNK : Indication","id":"42731"},{"source":"NA","target":"bleeding","id":"42732"},{"source":"NA","target":"residual tumor","id":"42733"},{"source":"NA","target":"esophageal cancer","id":"42734"},{"source":"NA","target":"skin neoplasms","id":"42735"},{"source":"NA","target":"residual tumor","id":"42736"},{"source":"NA","target":"metastatic","id":"42737"},{"source":"NA","target":"carcinoma","id":"42738"},{"source":"NA","target":"neoplasm metastasis","id":"42739"},{"source":"NA","target":"carcinoma","id":"42740"},{"source":"NA","target":"hemorrhage","id":"42741"},{"source":"NA","target":"squamous cell neoplasms","id":"42742"},{"source":"NA","target":"anticancer","id":"42743"},{"source":"NA","target":"carcinoma","id":"42744"},{"source":"NA","target":"pharyngeal neoplasms","id":"42745"},{"source":"NA","target":"carcinoma","id":"42746"},{"source":"NA","target":"carcinoma","id":"42747"},{"source":"NA","target":"UNK : Indication","id":"42748"},{"source":"NA","target":"bleeding","id":"42749"},{"source":"NA","target":"residual tumor","id":"42750"},{"source":"NA","target":"esophageal cancer","id":"42751"},{"source":"NA","target":"skin neoplasms","id":"42752"},{"source":"NA","target":"residual tumor","id":"42753"},{"source":"NA","target":"metastatic","id":"42754"},{"source":"NA","target":"carcinoma","id":"42755"},{"source":"NA","target":"neoplasm metastasis","id":"42756"},{"source":"NA","target":"carcinoma","id":"42757"},{"source":"NA","target":"hemorrhage","id":"42758"},{"source":"NA","target":"squamous cell neoplasms","id":"42759"},{"source":"NA","target":"anticancer","id":"42760"},{"source":"NA","target":"carcinoma","id":"42761"},{"source":"NA","target":"pharyngeal neoplasms","id":"42762"},{"source":"NA","target":"carcinoma","id":"42763"},{"source":"NA","target":"carcinoma","id":"42764"},{"source":"NA","target":"UNK : Indication","id":"42765"},{"source":"NA","target":"bleeding","id":"42766"},{"source":"NA","target":"residual tumor","id":"42767"},{"source":"NA","target":"esophageal cancer","id":"42768"},{"source":"NA","target":"skin neoplasms","id":"42769"},{"source":"NA","target":"residual tumor","id":"42770"},{"source":"NA","target":"metastatic","id":"42771"},{"source":"NA","target":"carcinoma","id":"42772"},{"source":"NA","target":"neoplasm metastasis","id":"42773"},{"source":"NA","target":"carcinoma","id":"42774"},{"source":"NA","target":"hemorrhage","id":"42775"},{"source":"NA","target":"squamous cell neoplasms","id":"42776"},{"source":"NA","target":"anticancer","id":"42777"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"42778"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"42779"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"42780"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"42781"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"42782"},{"source":"Thymidylate synthase inhibitor","target":"bleeding","id":"42783"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"42784"},{"source":"Thymidylate synthase inhibitor","target":"esophageal cancer","id":"42785"},{"source":"Thymidylate synthase inhibitor","target":"skin neoplasms","id":"42786"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"42787"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"42788"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"42789"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"42790"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"42791"},{"source":"Thymidylate synthase inhibitor","target":"hemorrhage","id":"42792"},{"source":"Thymidylate synthase inhibitor","target":"squamous cell neoplasms","id":"42793"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"42794"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"42795"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"42796"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"42797"},{"source":"Oncology: Esophageal","target":"NA","id":"42798"},{"source":"Oncology: Esophageal","target":"NA","id":"42799"},{"source":"Oncology: Esophageal","target":"NA","id":"42800"},{"source":"Oncology: Esophageal","target":"Thymidylate synthase inhibitor","id":"42801"},{"source":"LY-2812176 (u)","target":"Leap Therapeutics/Macrocure","id":"42802"},{"source":"nab-paclitaxel (IV)","target":"Leap Therapeutics/Macrocure","id":"42803"},{"source":"UNK : Indication","target":"LY-2812176 (u)","id":"42804"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"42805"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"42806"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"42807"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"42808"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"42809"},{"source":"malignancies","target":"LY-2812176 (u)","id":"42810"},{"source":"malignancies","target":"nab-paclitaxel (IV)","id":"42811"},{"source":"endometrioid","target":"LY-2812176 (u)","id":"42812"},{"source":"endometrioid","target":"nab-paclitaxel (IV)","id":"42813"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"42814"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"42815"},{"source":"ovarian cancer","target":"LY-2812176 (u)","id":"42816"},{"source":"ovarian cancer","target":"nab-paclitaxel (IV)","id":"42817"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"42818"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"42819"},{"source":"residual tumor","target":"LY-2812176 (u)","id":"42820"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"42821"},{"source":"skin neoplasms","target":"LY-2812176 (u)","id":"42822"},{"source":"skin neoplasms","target":"nab-paclitaxel (IV)","id":"42823"},{"source":"residual tumor","target":"LY-2812176 (u)","id":"42824"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"42825"},{"source":"anticancer","target":"LY-2812176 (u)","id":"42826"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"42827"},{"source":"uterine cervical neoplasms","target":"LY-2812176 (u)","id":"42828"},{"source":"uterine cervical neoplasms","target":"nab-paclitaxel (IV)","id":"42829"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"42830"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"42831"},{"source":"metastatic","target":"LY-2812176 (u)","id":"42832"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"42833"},{"source":"carcinoma","target":"LY-2812176 (u)","id":"42834"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"42835"},{"source":"neoplasm metastasis","target":"LY-2812176 (u)","id":"42836"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"42837"},{"source":"endometrial cancer","target":"LY-2812176 (u)","id":"42838"},{"source":"endometrial cancer","target":"nab-paclitaxel (IV)","id":"42839"},{"source":"squamous cell neoplasms","target":"LY-2812176 (u)","id":"42840"},{"source":"squamous cell neoplasms","target":"nab-paclitaxel (IV)","id":"42841"},{"source":"ovarian neoplasms","target":"LY-2812176 (u)","id":"42842"},{"source":"ovarian neoplasms","target":"nab-paclitaxel (IV)","id":"42843"},{"source":"endometrial neoplasms","target":"LY-2812176 (u)","id":"42844"},{"source":"endometrial neoplasms","target":"nab-paclitaxel (IV)","id":"42845"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"42846"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"42847"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"42848"},{"source":"Beta tubulin antagonist","target":"malignancies","id":"42849"},{"source":"Beta tubulin antagonist","target":"endometrioid","id":"42850"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"42851"},{"source":"Beta tubulin antagonist","target":"ovarian cancer","id":"42852"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"42853"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"42854"},{"source":"Beta tubulin antagonist","target":"skin neoplasms","id":"42855"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"42856"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"42857"},{"source":"Beta tubulin antagonist","target":"uterine cervical neoplasms","id":"42858"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"42859"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"42860"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"42861"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"42862"},{"source":"Beta tubulin antagonist","target":"endometrial cancer","id":"42863"},{"source":"Beta tubulin antagonist","target":"squamous cell neoplasms","id":"42864"},{"source":"Beta tubulin antagonist","target":"ovarian neoplasms","id":"42865"},{"source":"Beta tubulin antagonist","target":"endometrial neoplasms","id":"42866"},{"source":"DKK-1 inhibitor","target":"UNK : Indication","id":"42867"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"42868"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"42869"},{"source":"DKK-1 inhibitor","target":"malignancies","id":"42870"},{"source":"DKK-1 inhibitor","target":"endometrioid","id":"42871"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"42872"},{"source":"DKK-1 inhibitor","target":"ovarian cancer","id":"42873"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"42874"},{"source":"DKK-1 inhibitor","target":"residual tumor","id":"42875"},{"source":"DKK-1 inhibitor","target":"skin neoplasms","id":"42876"},{"source":"DKK-1 inhibitor","target":"residual tumor","id":"42877"},{"source":"DKK-1 inhibitor","target":"anticancer","id":"42878"},{"source":"DKK-1 inhibitor","target":"uterine cervical neoplasms","id":"42879"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"42880"},{"source":"DKK-1 inhibitor","target":"metastatic","id":"42881"},{"source":"DKK-1 inhibitor","target":"carcinoma","id":"42882"},{"source":"DKK-1 inhibitor","target":"neoplasm metastasis","id":"42883"},{"source":"DKK-1 inhibitor","target":"endometrial cancer","id":"42884"},{"source":"DKK-1 inhibitor","target":"squamous cell neoplasms","id":"42885"},{"source":"DKK-1 inhibitor","target":"ovarian neoplasms","id":"42886"},{"source":"DKK-1 inhibitor","target":"endometrial neoplasms","id":"42887"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"42888"},{"source":"Microtubule stimulant","target":"carcinoma","id":"42889"},{"source":"Microtubule stimulant","target":"carcinoma","id":"42890"},{"source":"Microtubule stimulant","target":"malignancies","id":"42891"},{"source":"Microtubule stimulant","target":"endometrioid","id":"42892"},{"source":"Microtubule stimulant","target":"carcinoma","id":"42893"},{"source":"Microtubule stimulant","target":"ovarian cancer","id":"42894"},{"source":"Microtubule stimulant","target":"carcinoma","id":"42895"},{"source":"Microtubule stimulant","target":"residual tumor","id":"42896"},{"source":"Microtubule stimulant","target":"skin neoplasms","id":"42897"},{"source":"Microtubule stimulant","target":"residual tumor","id":"42898"},{"source":"Microtubule stimulant","target":"anticancer","id":"42899"},{"source":"Microtubule stimulant","target":"uterine cervical neoplasms","id":"42900"},{"source":"Microtubule stimulant","target":"carcinoma","id":"42901"},{"source":"Microtubule stimulant","target":"metastatic","id":"42902"},{"source":"Microtubule stimulant","target":"carcinoma","id":"42903"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"42904"},{"source":"Microtubule stimulant","target":"endometrial cancer","id":"42905"},{"source":"Microtubule stimulant","target":"squamous cell neoplasms","id":"42906"},{"source":"Microtubule stimulant","target":"ovarian neoplasms","id":"42907"},{"source":"Microtubule stimulant","target":"endometrial neoplasms","id":"42908"},{"source":"Taxane","target":"UNK : Indication","id":"42909"},{"source":"Taxane","target":"carcinoma","id":"42910"},{"source":"Taxane","target":"carcinoma","id":"42911"},{"source":"Taxane","target":"malignancies","id":"42912"},{"source":"Taxane","target":"endometrioid","id":"42913"},{"source":"Taxane","target":"carcinoma","id":"42914"},{"source":"Taxane","target":"ovarian cancer","id":"42915"},{"source":"Taxane","target":"carcinoma","id":"42916"},{"source":"Taxane","target":"residual tumor","id":"42917"},{"source":"Taxane","target":"skin neoplasms","id":"42918"},{"source":"Taxane","target":"residual tumor","id":"42919"},{"source":"Taxane","target":"anticancer","id":"42920"},{"source":"Taxane","target":"uterine cervical neoplasms","id":"42921"},{"source":"Taxane","target":"carcinoma","id":"42922"},{"source":"Taxane","target":"metastatic","id":"42923"},{"source":"Taxane","target":"carcinoma","id":"42924"},{"source":"Taxane","target":"neoplasm metastasis","id":"42925"},{"source":"Taxane","target":"endometrial cancer","id":"42926"},{"source":"Taxane","target":"squamous cell neoplasms","id":"42927"},{"source":"Taxane","target":"ovarian neoplasms","id":"42928"},{"source":"Taxane","target":"endometrial neoplasms","id":"42929"},{"source":"Oncology: (N/A)","target":"Beta tubulin antagonist","id":"42930"},{"source":"Oncology: (N/A)","target":"DKK-1 inhibitor","id":"42931"},{"source":"Oncology: (N/A)","target":"Microtubule stimulant","id":"42932"},{"source":"Oncology: (N/A)","target":"Taxane","id":"42933"},{"source":"Oncology: Endometrial","target":"Beta tubulin antagonist","id":"42934"},{"source":"Oncology: Endometrial","target":"DKK-1 inhibitor","id":"42935"},{"source":"Oncology: Endometrial","target":"Microtubule stimulant","id":"42936"},{"source":"Oncology: Endometrial","target":"Taxane","id":"42937"},{"source":"Oncology: Ovarian","target":"Beta tubulin antagonist","id":"42938"},{"source":"Oncology: Ovarian","target":"DKK-1 inhibitor","id":"42939"},{"source":"Oncology: Ovarian","target":"Microtubule stimulant","id":"42940"},{"source":"Oncology: Ovarian","target":"Taxane","id":"42941"},{"source":"pegzilarginase (u)","target":"Biothera","id":"42942"},{"source":"pembrolizumab","target":"Biothera","id":"42943"},{"source":"UNK : Indication","target":"pegzilarginase (u)","id":"42944"},{"source":"UNK : Indication","target":"pembrolizumab","id":"42945"},{"source":"sclc","target":"pegzilarginase (u)","id":"42946"},{"source":"sclc","target":"pembrolizumab","id":"42947"},{"source":"solid tumors","target":"pegzilarginase (u)","id":"42948"},{"source":"solid tumors","target":"pembrolizumab","id":"42949"},{"source":"melanoma","target":"pegzilarginase (u)","id":"42950"},{"source":"melanoma","target":"pembrolizumab","id":"42951"},{"source":"anticancer","target":"pegzilarginase (u)","id":"42952"},{"source":"anticancer","target":"pembrolizumab","id":"42953"},{"source":"unknown primary","target":"pegzilarginase (u)","id":"42954"},{"source":"unknown primary","target":"pembrolizumab","id":"42955"},{"source":"carcinoma","target":"pegzilarginase (u)","id":"42956"},{"source":"carcinoma","target":"pembrolizumab","id":"42957"},{"source":"skin neoplasms","target":"pegzilarginase (u)","id":"42958"},{"source":"skin neoplasms","target":"pembrolizumab","id":"42959"},{"source":"skin neoplasms","target":"pegzilarginase (u)","id":"42960"},{"source":"skin neoplasms","target":"pembrolizumab","id":"42961"},{"source":"residual tumor","target":"pegzilarginase (u)","id":"42962"},{"source":"residual tumor","target":"pembrolizumab","id":"42963"},{"source":"metastatic","target":"pegzilarginase (u)","id":"42964"},{"source":"metastatic","target":"pembrolizumab","id":"42965"},{"source":"carcinoma","target":"pegzilarginase (u)","id":"42966"},{"source":"carcinoma","target":"pembrolizumab","id":"42967"},{"source":"neoplasm metastasis","target":"pegzilarginase (u)","id":"42968"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"42969"},{"source":"anti-tumor","target":"pegzilarginase (u)","id":"42970"},{"source":"anti-tumor","target":"pembrolizumab","id":"42971"},{"source":"anticancer","target":"pegzilarginase (u)","id":"42972"},{"source":"anticancer","target":"pembrolizumab","id":"42973"},{"source":"unknown primary","target":"pegzilarginase (u)","id":"42974"},{"source":"unknown primary","target":"pembrolizumab","id":"42975"},{"source":"non-small-cell lung","target":"pegzilarginase (u)","id":"42976"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"42977"},{"source":"carcinoma","target":"pegzilarginase (u)","id":"42978"},{"source":"carcinoma","target":"pembrolizumab","id":"42979"},{"source":"solid tumors","target":"pegzilarginase (u)","id":"42980"},{"source":"solid tumors","target":"pembrolizumab","id":"42981"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"42982"},{"source":"Anticancer immunotherapy","target":"sclc","id":"42983"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"42984"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"42985"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"42986"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"42987"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42988"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"42989"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"42990"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"42991"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"42992"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42993"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"42994"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"42995"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"42996"},{"source":"Anticancer immunotherapy","target":"unknown primary","id":"42997"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"42998"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"42999"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"43000"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"43001"},{"source":"CD19 antagonist","target":"sclc","id":"43002"},{"source":"CD19 antagonist","target":"solid tumors","id":"43003"},{"source":"CD19 antagonist","target":"melanoma","id":"43004"},{"source":"CD19 antagonist","target":"anticancer","id":"43005"},{"source":"CD19 antagonist","target":"unknown primary","id":"43006"},{"source":"CD19 antagonist","target":"carcinoma","id":"43007"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"43008"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"43009"},{"source":"CD19 antagonist","target":"residual tumor","id":"43010"},{"source":"CD19 antagonist","target":"metastatic","id":"43011"},{"source":"CD19 antagonist","target":"carcinoma","id":"43012"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"43013"},{"source":"CD19 antagonist","target":"anti-tumor","id":"43014"},{"source":"CD19 antagonist","target":"anticancer","id":"43015"},{"source":"CD19 antagonist","target":"unknown primary","id":"43016"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"43017"},{"source":"CD19 antagonist","target":"carcinoma","id":"43018"},{"source":"CD19 antagonist","target":"solid tumors","id":"43019"},{"source":"NA","target":"UNK : Indication","id":"43020"},{"source":"NA","target":"sclc","id":"43021"},{"source":"NA","target":"solid tumors","id":"43022"},{"source":"NA","target":"melanoma","id":"43023"},{"source":"NA","target":"anticancer","id":"43024"},{"source":"NA","target":"unknown primary","id":"43025"},{"source":"NA","target":"carcinoma","id":"43026"},{"source":"NA","target":"skin neoplasms","id":"43027"},{"source":"NA","target":"skin neoplasms","id":"43028"},{"source":"NA","target":"residual tumor","id":"43029"},{"source":"NA","target":"metastatic","id":"43030"},{"source":"NA","target":"carcinoma","id":"43031"},{"source":"NA","target":"neoplasm metastasis","id":"43032"},{"source":"NA","target":"anti-tumor","id":"43033"},{"source":"NA","target":"anticancer","id":"43034"},{"source":"NA","target":"unknown primary","id":"43035"},{"source":"NA","target":"non-small-cell lung","id":"43036"},{"source":"NA","target":"carcinoma","id":"43037"},{"source":"NA","target":"solid tumors","id":"43038"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"43039"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"43040"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"43041"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"43042"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"43043"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"43044"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43045"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"43046"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"43047"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"43048"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"43049"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43050"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"43051"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"43052"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"43053"},{"source":"Immune checkpoint inhibitor","target":"unknown primary","id":"43054"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"43055"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43056"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"43057"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"43058"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"43059"},{"source":"Oncology: Lung","target":"NA","id":"43060"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"43061"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"43062"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"43063"},{"source":"Non-Small Cell","target":"NA","id":"43064"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"43065"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"43066"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"43067"},{"source":"Oncology: Melanoma","target":"NA","id":"43068"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"43069"},{"source":"Oncology: CNS","target":"Anticancer immunotherapy","id":"43070"},{"source":"Oncology: CNS","target":"CD19 antagonist","id":"43071"},{"source":"Oncology: CNS","target":"NA","id":"43072"},{"source":"Oncology: CNS","target":"Immune checkpoint inhibitor","id":"43073"},{"source":"pembrolizumab","target":"Merck & Co.","id":"43074"},{"source":"capecitabine","target":"Merck & Co.","id":"43075"},{"source":"cisplatin","target":"Merck & Co.","id":"43076"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"43077"},{"source":"surgical intervention","target":"Merck & Co.","id":"43078"},{"source":"UNK : Indication","target":"pembrolizumab","id":"43079"},{"source":"UNK : Indication","target":"capecitabine","id":"43080"},{"source":"UNK : Indication","target":"cisplatin","id":"43081"},{"source":"UNK : Indication","target":"5-fluorouracil","id":"43082"},{"source":"UNK : Indication","target":"surgical intervention","id":"43083"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"43084"},{"source":"pharyngeal neoplasms","target":"capecitabine","id":"43085"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"43086"},{"source":"pharyngeal neoplasms","target":"5-fluorouracil","id":"43087"},{"source":"pharyngeal neoplasms","target":"surgical intervention","id":"43088"},{"source":"anticancer","target":"pembrolizumab","id":"43089"},{"source":"anticancer","target":"capecitabine","id":"43090"},{"source":"anticancer","target":"cisplatin","id":"43091"},{"source":"anticancer","target":"5-fluorouracil","id":"43092"},{"source":"anticancer","target":"surgical intervention","id":"43093"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"43094"},{"source":"autoimmune diseases","target":"capecitabine","id":"43095"},{"source":"autoimmune diseases","target":"cisplatin","id":"43096"},{"source":"autoimmune diseases","target":"5-fluorouracil","id":"43097"},{"source":"autoimmune diseases","target":"surgical intervention","id":"43098"},{"source":"autoimmune diseases","target":"pembrolizumab","id":"43099"},{"source":"autoimmune diseases","target":"capecitabine","id":"43100"},{"source":"autoimmune diseases","target":"cisplatin","id":"43101"},{"source":"autoimmune diseases","target":"5-fluorouracil","id":"43102"},{"source":"autoimmune diseases","target":"surgical intervention","id":"43103"},{"source":"esophageal cancer","target":"pembrolizumab","id":"43104"},{"source":"esophageal cancer","target":"capecitabine","id":"43105"},{"source":"esophageal cancer","target":"cisplatin","id":"43106"},{"source":"esophageal cancer","target":"5-fluorouracil","id":"43107"},{"source":"esophageal cancer","target":"surgical intervention","id":"43108"},{"source":"carcinoma","target":"pembrolizumab","id":"43109"},{"source":"carcinoma","target":"capecitabine","id":"43110"},{"source":"carcinoma","target":"cisplatin","id":"43111"},{"source":"carcinoma","target":"5-fluorouracil","id":"43112"},{"source":"carcinoma","target":"surgical intervention","id":"43113"},{"source":"residual tumor","target":"pembrolizumab","id":"43114"},{"source":"residual tumor","target":"capecitabine","id":"43115"},{"source":"residual tumor","target":"cisplatin","id":"43116"},{"source":"residual tumor","target":"5-fluorouracil","id":"43117"},{"source":"residual tumor","target":"surgical intervention","id":"43118"},{"source":"metastatic","target":"pembrolizumab","id":"43119"},{"source":"metastatic","target":"capecitabine","id":"43120"},{"source":"metastatic","target":"cisplatin","id":"43121"},{"source":"metastatic","target":"5-fluorouracil","id":"43122"},{"source":"metastatic","target":"surgical intervention","id":"43123"},{"source":"carcinoma","target":"pembrolizumab","id":"43124"},{"source":"carcinoma","target":"capecitabine","id":"43125"},{"source":"carcinoma","target":"cisplatin","id":"43126"},{"source":"carcinoma","target":"5-fluorouracil","id":"43127"},{"source":"carcinoma","target":"surgical intervention","id":"43128"},{"source":"stomach neoplasms","target":"pembrolizumab","id":"43129"},{"source":"stomach neoplasms","target":"capecitabine","id":"43130"},{"source":"stomach neoplasms","target":"cisplatin","id":"43131"},{"source":"stomach neoplasms","target":"5-fluorouracil","id":"43132"},{"source":"stomach neoplasms","target":"surgical intervention","id":"43133"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"43134"},{"source":"neoplasm metastasis","target":"capecitabine","id":"43135"},{"source":"neoplasm metastasis","target":"cisplatin","id":"43136"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"43137"},{"source":"neoplasm metastasis","target":"surgical intervention","id":"43138"},{"source":"carcinoma","target":"pembrolizumab","id":"43139"},{"source":"carcinoma","target":"capecitabine","id":"43140"},{"source":"carcinoma","target":"cisplatin","id":"43141"},{"source":"carcinoma","target":"5-fluorouracil","id":"43142"},{"source":"carcinoma","target":"surgical intervention","id":"43143"},{"source":"anticancer","target":"pembrolizumab","id":"43144"},{"source":"anticancer","target":"capecitabine","id":"43145"},{"source":"anticancer","target":"cisplatin","id":"43146"},{"source":"anticancer","target":"5-fluorouracil","id":"43147"},{"source":"anticancer","target":"surgical intervention","id":"43148"},{"source":"residual tumor","target":"pembrolizumab","id":"43149"},{"source":"residual tumor","target":"capecitabine","id":"43150"},{"source":"residual tumor","target":"cisplatin","id":"43151"},{"source":"residual tumor","target":"5-fluorouracil","id":"43152"},{"source":"residual tumor","target":"surgical intervention","id":"43153"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"43154"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"43155"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"43156"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"43157"},{"source":"Immune checkpoint inhibitor","target":"autoimmune diseases","id":"43158"},{"source":"Immune checkpoint inhibitor","target":"esophageal cancer","id":"43159"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43160"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"43161"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"43162"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43163"},{"source":"Immune checkpoint inhibitor","target":"stomach neoplasms","id":"43164"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"43165"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43166"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"43167"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"43168"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"43169"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"43170"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"43171"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"43172"},{"source":"Anticancer immunotherapy","target":"autoimmune diseases","id":"43173"},{"source":"Anticancer immunotherapy","target":"esophageal cancer","id":"43174"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43175"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"43176"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"43177"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43178"},{"source":"Anticancer immunotherapy","target":"stomach neoplasms","id":"43179"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"43180"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43181"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"43182"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"43183"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"43184"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"43185"},{"source":"CD19 antagonist","target":"anticancer","id":"43186"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"43187"},{"source":"CD19 antagonist","target":"autoimmune diseases","id":"43188"},{"source":"CD19 antagonist","target":"esophageal cancer","id":"43189"},{"source":"CD19 antagonist","target":"carcinoma","id":"43190"},{"source":"CD19 antagonist","target":"residual tumor","id":"43191"},{"source":"CD19 antagonist","target":"metastatic","id":"43192"},{"source":"CD19 antagonist","target":"carcinoma","id":"43193"},{"source":"CD19 antagonist","target":"stomach neoplasms","id":"43194"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"43195"},{"source":"CD19 antagonist","target":"carcinoma","id":"43196"},{"source":"CD19 antagonist","target":"anticancer","id":"43197"},{"source":"CD19 antagonist","target":"residual tumor","id":"43198"},{"source":"NA","target":"UNK : Indication","id":"43199"},{"source":"NA","target":"pharyngeal neoplasms","id":"43200"},{"source":"NA","target":"anticancer","id":"43201"},{"source":"NA","target":"autoimmune diseases","id":"43202"},{"source":"NA","target":"autoimmune diseases","id":"43203"},{"source":"NA","target":"esophageal cancer","id":"43204"},{"source":"NA","target":"carcinoma","id":"43205"},{"source":"NA","target":"residual tumor","id":"43206"},{"source":"NA","target":"metastatic","id":"43207"},{"source":"NA","target":"carcinoma","id":"43208"},{"source":"NA","target":"stomach neoplasms","id":"43209"},{"source":"NA","target":"neoplasm metastasis","id":"43210"},{"source":"NA","target":"carcinoma","id":"43211"},{"source":"NA","target":"anticancer","id":"43212"},{"source":"NA","target":"residual tumor","id":"43213"},{"source":"NA","target":"UNK : Indication","id":"43214"},{"source":"NA","target":"pharyngeal neoplasms","id":"43215"},{"source":"NA","target":"anticancer","id":"43216"},{"source":"NA","target":"autoimmune diseases","id":"43217"},{"source":"NA","target":"autoimmune diseases","id":"43218"},{"source":"NA","target":"esophageal cancer","id":"43219"},{"source":"NA","target":"carcinoma","id":"43220"},{"source":"NA","target":"residual tumor","id":"43221"},{"source":"NA","target":"metastatic","id":"43222"},{"source":"NA","target":"carcinoma","id":"43223"},{"source":"NA","target":"stomach neoplasms","id":"43224"},{"source":"NA","target":"neoplasm metastasis","id":"43225"},{"source":"NA","target":"carcinoma","id":"43226"},{"source":"NA","target":"anticancer","id":"43227"},{"source":"NA","target":"residual tumor","id":"43228"},{"source":"NA","target":"UNK : Indication","id":"43229"},{"source":"NA","target":"pharyngeal neoplasms","id":"43230"},{"source":"NA","target":"anticancer","id":"43231"},{"source":"NA","target":"autoimmune diseases","id":"43232"},{"source":"NA","target":"autoimmune diseases","id":"43233"},{"source":"NA","target":"esophageal cancer","id":"43234"},{"source":"NA","target":"carcinoma","id":"43235"},{"source":"NA","target":"residual tumor","id":"43236"},{"source":"NA","target":"metastatic","id":"43237"},{"source":"NA","target":"carcinoma","id":"43238"},{"source":"NA","target":"stomach neoplasms","id":"43239"},{"source":"NA","target":"neoplasm metastasis","id":"43240"},{"source":"NA","target":"carcinoma","id":"43241"},{"source":"NA","target":"anticancer","id":"43242"},{"source":"NA","target":"residual tumor","id":"43243"},{"source":"NA","target":"UNK : Indication","id":"43244"},{"source":"NA","target":"pharyngeal neoplasms","id":"43245"},{"source":"NA","target":"anticancer","id":"43246"},{"source":"NA","target":"autoimmune diseases","id":"43247"},{"source":"NA","target":"autoimmune diseases","id":"43248"},{"source":"NA","target":"esophageal cancer","id":"43249"},{"source":"NA","target":"carcinoma","id":"43250"},{"source":"NA","target":"residual tumor","id":"43251"},{"source":"NA","target":"metastatic","id":"43252"},{"source":"NA","target":"carcinoma","id":"43253"},{"source":"NA","target":"stomach neoplasms","id":"43254"},{"source":"NA","target":"neoplasm metastasis","id":"43255"},{"source":"NA","target":"carcinoma","id":"43256"},{"source":"NA","target":"anticancer","id":"43257"},{"source":"NA","target":"residual tumor","id":"43258"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"43259"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"43260"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"43261"},{"source":"Thymidylate synthase inhibitor","target":"autoimmune diseases","id":"43262"},{"source":"Thymidylate synthase inhibitor","target":"autoimmune diseases","id":"43263"},{"source":"Thymidylate synthase inhibitor","target":"esophageal cancer","id":"43264"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"43265"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"43266"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"43267"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"43268"},{"source":"Thymidylate synthase inhibitor","target":"stomach neoplasms","id":"43269"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"43270"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"43271"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"43272"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"43273"},{"source":"Oncology: Esophageal","target":"Immune checkpoint inhibitor","id":"43274"},{"source":"Oncology: Esophageal","target":"Anticancer immunotherapy","id":"43275"},{"source":"Oncology: Esophageal","target":"CD19 antagonist","id":"43276"},{"source":"Oncology: Esophageal","target":"NA","id":"43277"},{"source":"Oncology: Esophageal","target":"NA","id":"43278"},{"source":"Oncology: Esophageal","target":"NA","id":"43279"},{"source":"Oncology: Esophageal","target":"NA","id":"43280"},{"source":"Oncology: Esophageal","target":"Thymidylate synthase inhibitor","id":"43281"},{"source":"Oncology: Gastric","target":"Immune checkpoint inhibitor","id":"43282"},{"source":"Oncology: Gastric","target":"Anticancer immunotherapy","id":"43283"},{"source":"Oncology: Gastric","target":"CD19 antagonist","id":"43284"},{"source":"Oncology: Gastric","target":"NA","id":"43285"},{"source":"Oncology: Gastric","target":"NA","id":"43286"},{"source":"Oncology: Gastric","target":"NA","id":"43287"},{"source":"Oncology: Gastric","target":"NA","id":"43288"},{"source":"Oncology: Gastric","target":"Thymidylate synthase inhibitor","id":"43289"},{"source":"ARB-1598 (intratumoral) (u)","target":"Checkmate Pharmaceuticals","id":"43290"},{"source":"pembrolizumab","target":"Checkmate Pharmaceuticals","id":"43291"},{"source":"UNK : Indication","target":"ARB-1598 (intratumoral) (u)","id":"43292"},{"source":"UNK : Indication","target":"pembrolizumab","id":"43293"},{"source":"melanoma","target":"ARB-1598 (intratumoral) (u)","id":"43294"},{"source":"melanoma","target":"pembrolizumab","id":"43295"},{"source":"melanoma","target":"ARB-1598 (intratumoral) (u)","id":"43296"},{"source":"melanoma","target":"pembrolizumab","id":"43297"},{"source":"melanoma","target":"ARB-1598 (intratumoral) (u)","id":"43298"},{"source":"melanoma","target":"pembrolizumab","id":"43299"},{"source":"anti-tumor","target":"ARB-1598 (intratumoral) (u)","id":"43300"},{"source":"anti-tumor","target":"pembrolizumab","id":"43301"},{"source":"skin neoplasms","target":"ARB-1598 (intratumoral) (u)","id":"43302"},{"source":"skin neoplasms","target":"pembrolizumab","id":"43303"},{"source":"residual tumor","target":"ARB-1598 (intratumoral) (u)","id":"43304"},{"source":"residual tumor","target":"pembrolizumab","id":"43305"},{"source":"metastatic","target":"ARB-1598 (intratumoral) (u)","id":"43306"},{"source":"metastatic","target":"pembrolizumab","id":"43307"},{"source":"carcinoma","target":"ARB-1598 (intratumoral) (u)","id":"43308"},{"source":"carcinoma","target":"pembrolizumab","id":"43309"},{"source":"neoplasm metastasis","target":"ARB-1598 (intratumoral) (u)","id":"43310"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"43311"},{"source":"anticancer","target":"ARB-1598 (intratumoral) (u)","id":"43312"},{"source":"anticancer","target":"pembrolizumab","id":"43313"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"43314"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"43315"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"43316"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"43317"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"43318"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"43319"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"43320"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"43321"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43322"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"43323"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"43324"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"43325"},{"source":"CD19 antagonist","target":"melanoma","id":"43326"},{"source":"CD19 antagonist","target":"melanoma","id":"43327"},{"source":"CD19 antagonist","target":"melanoma","id":"43328"},{"source":"CD19 antagonist","target":"anti-tumor","id":"43329"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"43330"},{"source":"CD19 antagonist","target":"residual tumor","id":"43331"},{"source":"CD19 antagonist","target":"metastatic","id":"43332"},{"source":"CD19 antagonist","target":"carcinoma","id":"43333"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"43334"},{"source":"CD19 antagonist","target":"anticancer","id":"43335"},{"source":"Immunostimulant","target":"UNK : Indication","id":"43336"},{"source":"Immunostimulant","target":"melanoma","id":"43337"},{"source":"Immunostimulant","target":"melanoma","id":"43338"},{"source":"Immunostimulant","target":"melanoma","id":"43339"},{"source":"Immunostimulant","target":"anti-tumor","id":"43340"},{"source":"Immunostimulant","target":"skin neoplasms","id":"43341"},{"source":"Immunostimulant","target":"residual tumor","id":"43342"},{"source":"Immunostimulant","target":"metastatic","id":"43343"},{"source":"Immunostimulant","target":"carcinoma","id":"43344"},{"source":"Immunostimulant","target":"neoplasm metastasis","id":"43345"},{"source":"Immunostimulant","target":"anticancer","id":"43346"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"43347"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"43348"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"43349"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"43350"},{"source":"Toll-like receptor 9 agonist","target":"anti-tumor","id":"43351"},{"source":"Toll-like receptor 9 agonist","target":"skin neoplasms","id":"43352"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"43353"},{"source":"Toll-like receptor 9 agonist","target":"metastatic","id":"43354"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"43355"},{"source":"Toll-like receptor 9 agonist","target":"neoplasm metastasis","id":"43356"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"43357"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"43358"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"43359"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"43360"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"43361"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"43362"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"43363"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"43364"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"43365"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43366"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"43367"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"43368"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"43369"},{"source":"Oncology: Melanoma","target":"CD19 antagonist","id":"43370"},{"source":"Oncology: Melanoma","target":"Immunostimulant","id":"43371"},{"source":"Oncology: Melanoma","target":"Toll-like receptor 9 agonist","id":"43372"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"43373"},{"source":"pembrolizumab","target":"Merck & Co.","id":"43374"},{"source":"dexamethasone","target":"Merck & Co.","id":"43375"},{"source":"docetaxel","target":"Merck & Co.","id":"43376"},{"source":"enzalutamide (capsule)","target":"Merck & Co.","id":"43377"},{"source":"olaparib (capsule)","target":"Merck & Co.","id":"43378"},{"source":"prednisone","target":"Merck & Co.","id":"43379"},{"source":"UNK : Indication","target":"pembrolizumab","id":"43380"},{"source":"UNK : Indication","target":"dexamethasone","id":"43381"},{"source":"UNK : Indication","target":"docetaxel","id":"43382"},{"source":"UNK : Indication","target":"enzalutamide (capsule)","id":"43383"},{"source":"UNK : Indication","target":"olaparib (capsule)","id":"43384"},{"source":"UNK : Indication","target":"prednisone","id":"43385"},{"source":"prostate cancer","target":"pembrolizumab","id":"43386"},{"source":"prostate cancer","target":"dexamethasone","id":"43387"},{"source":"prostate cancer","target":"docetaxel","id":"43388"},{"source":"prostate cancer","target":"enzalutamide (capsule)","id":"43389"},{"source":"prostate cancer","target":"olaparib (capsule)","id":"43390"},{"source":"prostate cancer","target":"prednisone","id":"43391"},{"source":"malaria","target":"pembrolizumab","id":"43392"},{"source":"malaria","target":"dexamethasone","id":"43393"},{"source":"malaria","target":"docetaxel","id":"43394"},{"source":"malaria","target":"enzalutamide (capsule)","id":"43395"},{"source":"malaria","target":"olaparib (capsule)","id":"43396"},{"source":"malaria","target":"prednisone","id":"43397"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"43398"},{"source":"castration-resistant prostatic neoplasms","target":"dexamethasone","id":"43399"},{"source":"castration-resistant prostatic neoplasms","target":"docetaxel","id":"43400"},{"source":"castration-resistant prostatic neoplasms","target":"enzalutamide (capsule)","id":"43401"},{"source":"castration-resistant prostatic neoplasms","target":"olaparib (capsule)","id":"43402"},{"source":"castration-resistant prostatic neoplasms","target":"prednisone","id":"43403"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"43404"},{"source":"castration-resistant prostatic neoplasms","target":"dexamethasone","id":"43405"},{"source":"castration-resistant prostatic neoplasms","target":"docetaxel","id":"43406"},{"source":"castration-resistant prostatic neoplasms","target":"enzalutamide (capsule)","id":"43407"},{"source":"castration-resistant prostatic neoplasms","target":"olaparib (capsule)","id":"43408"},{"source":"castration-resistant prostatic neoplasms","target":"prednisone","id":"43409"},{"source":"prostate cancer","target":"pembrolizumab","id":"43410"},{"source":"prostate cancer","target":"dexamethasone","id":"43411"},{"source":"prostate cancer","target":"docetaxel","id":"43412"},{"source":"prostate cancer","target":"enzalutamide (capsule)","id":"43413"},{"source":"prostate cancer","target":"olaparib (capsule)","id":"43414"},{"source":"prostate cancer","target":"prednisone","id":"43415"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"43416"},{"source":"anti-inflammatory","target":"dexamethasone","id":"43417"},{"source":"anti-inflammatory","target":"docetaxel","id":"43418"},{"source":"anti-inflammatory","target":"enzalutamide (capsule)","id":"43419"},{"source":"anti-inflammatory","target":"olaparib (capsule)","id":"43420"},{"source":"anti-inflammatory","target":"prednisone","id":"43421"},{"source":"residual tumor","target":"pembrolizumab","id":"43422"},{"source":"residual tumor","target":"dexamethasone","id":"43423"},{"source":"residual tumor","target":"docetaxel","id":"43424"},{"source":"residual tumor","target":"enzalutamide (capsule)","id":"43425"},{"source":"residual tumor","target":"olaparib (capsule)","id":"43426"},{"source":"residual tumor","target":"prednisone","id":"43427"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"43428"},{"source":"fallopian tube neoplasms","target":"dexamethasone","id":"43429"},{"source":"fallopian tube neoplasms","target":"docetaxel","id":"43430"},{"source":"fallopian tube neoplasms","target":"enzalutamide (capsule)","id":"43431"},{"source":"fallopian tube neoplasms","target":"olaparib (capsule)","id":"43432"},{"source":"fallopian tube neoplasms","target":"prednisone","id":"43433"},{"source":"malaria","target":"pembrolizumab","id":"43434"},{"source":"malaria","target":"dexamethasone","id":"43435"},{"source":"malaria","target":"docetaxel","id":"43436"},{"source":"malaria","target":"enzalutamide (capsule)","id":"43437"},{"source":"malaria","target":"olaparib (capsule)","id":"43438"},{"source":"malaria","target":"prednisone","id":"43439"},{"source":"carcinoma","target":"pembrolizumab","id":"43440"},{"source":"carcinoma","target":"dexamethasone","id":"43441"},{"source":"carcinoma","target":"docetaxel","id":"43442"},{"source":"carcinoma","target":"enzalutamide (capsule)","id":"43443"},{"source":"carcinoma","target":"olaparib (capsule)","id":"43444"},{"source":"carcinoma","target":"prednisone","id":"43445"},{"source":"inflammation","target":"pembrolizumab","id":"43446"},{"source":"inflammation","target":"dexamethasone","id":"43447"},{"source":"inflammation","target":"docetaxel","id":"43448"},{"source":"inflammation","target":"enzalutamide (capsule)","id":"43449"},{"source":"inflammation","target":"olaparib (capsule)","id":"43450"},{"source":"inflammation","target":"prednisone","id":"43451"},{"source":"metastatic","target":"pembrolizumab","id":"43452"},{"source":"metastatic","target":"dexamethasone","id":"43453"},{"source":"metastatic","target":"docetaxel","id":"43454"},{"source":"metastatic","target":"enzalutamide (capsule)","id":"43455"},{"source":"metastatic","target":"olaparib (capsule)","id":"43456"},{"source":"metastatic","target":"prednisone","id":"43457"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"43458"},{"source":"neoplasm metastasis","target":"dexamethasone","id":"43459"},{"source":"neoplasm metastasis","target":"docetaxel","id":"43460"},{"source":"neoplasm metastasis","target":"enzalutamide (capsule)","id":"43461"},{"source":"neoplasm metastasis","target":"olaparib (capsule)","id":"43462"},{"source":"neoplasm metastasis","target":"prednisone","id":"43463"},{"source":"carcinoma","target":"pembrolizumab","id":"43464"},{"source":"carcinoma","target":"dexamethasone","id":"43465"},{"source":"carcinoma","target":"docetaxel","id":"43466"},{"source":"carcinoma","target":"enzalutamide (capsule)","id":"43467"},{"source":"carcinoma","target":"olaparib (capsule)","id":"43468"},{"source":"carcinoma","target":"prednisone","id":"43469"},{"source":"anticancer","target":"pembrolizumab","id":"43470"},{"source":"anticancer","target":"dexamethasone","id":"43471"},{"source":"anticancer","target":"docetaxel","id":"43472"},{"source":"anticancer","target":"enzalutamide (capsule)","id":"43473"},{"source":"anticancer","target":"olaparib (capsule)","id":"43474"},{"source":"anticancer","target":"prednisone","id":"43475"},{"source":"residual tumor","target":"pembrolizumab","id":"43476"},{"source":"residual tumor","target":"dexamethasone","id":"43477"},{"source":"residual tumor","target":"docetaxel","id":"43478"},{"source":"residual tumor","target":"enzalutamide (capsule)","id":"43479"},{"source":"residual tumor","target":"olaparib (capsule)","id":"43480"},{"source":"residual tumor","target":"prednisone","id":"43481"},{"source":"bone metastasis","target":"pembrolizumab","id":"43482"},{"source":"bone metastasis","target":"dexamethasone","id":"43483"},{"source":"bone metastasis","target":"docetaxel","id":"43484"},{"source":"bone metastasis","target":"enzalutamide (capsule)","id":"43485"},{"source":"bone metastasis","target":"olaparib (capsule)","id":"43486"},{"source":"bone metastasis","target":"prednisone","id":"43487"},{"source":"Immunosuppressant","target":"UNK : Indication","id":"43488"},{"source":"Immunosuppressant","target":"prostate cancer","id":"43489"},{"source":"Immunosuppressant","target":"malaria","id":"43490"},{"source":"Immunosuppressant","target":"castration-resistant prostatic neoplasms","id":"43491"},{"source":"Immunosuppressant","target":"castration-resistant prostatic neoplasms","id":"43492"},{"source":"Immunosuppressant","target":"prostate cancer","id":"43493"},{"source":"Immunosuppressant","target":"anti-inflammatory","id":"43494"},{"source":"Immunosuppressant","target":"residual tumor","id":"43495"},{"source":"Immunosuppressant","target":"fallopian tube neoplasms","id":"43496"},{"source":"Immunosuppressant","target":"malaria","id":"43497"},{"source":"Immunosuppressant","target":"carcinoma","id":"43498"},{"source":"Immunosuppressant","target":"inflammation","id":"43499"},{"source":"Immunosuppressant","target":"metastatic","id":"43500"},{"source":"Immunosuppressant","target":"neoplasm metastasis","id":"43501"},{"source":"Immunosuppressant","target":"carcinoma","id":"43502"},{"source":"Immunosuppressant","target":"anticancer","id":"43503"},{"source":"Immunosuppressant","target":"residual tumor","id":"43504"},{"source":"Immunosuppressant","target":"bone metastasis","id":"43505"},{"source":"Corticosteroid agonist","target":"UNK : Indication","id":"43506"},{"source":"Corticosteroid agonist","target":"prostate cancer","id":"43507"},{"source":"Corticosteroid agonist","target":"malaria","id":"43508"},{"source":"Corticosteroid agonist","target":"castration-resistant prostatic neoplasms","id":"43509"},{"source":"Corticosteroid agonist","target":"castration-resistant prostatic neoplasms","id":"43510"},{"source":"Corticosteroid agonist","target":"prostate cancer","id":"43511"},{"source":"Corticosteroid agonist","target":"anti-inflammatory","id":"43512"},{"source":"Corticosteroid agonist","target":"residual tumor","id":"43513"},{"source":"Corticosteroid agonist","target":"fallopian tube neoplasms","id":"43514"},{"source":"Corticosteroid agonist","target":"malaria","id":"43515"},{"source":"Corticosteroid agonist","target":"carcinoma","id":"43516"},{"source":"Corticosteroid agonist","target":"inflammation","id":"43517"},{"source":"Corticosteroid agonist","target":"metastatic","id":"43518"},{"source":"Corticosteroid agonist","target":"neoplasm metastasis","id":"43519"},{"source":"Corticosteroid agonist","target":"carcinoma","id":"43520"},{"source":"Corticosteroid agonist","target":"anticancer","id":"43521"},{"source":"Corticosteroid agonist","target":"residual tumor","id":"43522"},{"source":"Corticosteroid agonist","target":"bone metastasis","id":"43523"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"43524"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"43525"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"43526"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"43527"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"43528"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"43529"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"43530"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"43531"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"43532"},{"source":"Immune checkpoint inhibitor","target":"malaria","id":"43533"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43534"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"43535"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"43536"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"43537"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43538"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"43539"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"43540"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"43541"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"43542"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"43543"},{"source":"Anticancer immunotherapy","target":"malaria","id":"43544"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"43545"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"43546"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"43547"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"43548"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"43549"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"43550"},{"source":"Anticancer immunotherapy","target":"malaria","id":"43551"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43552"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"43553"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"43554"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"43555"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43556"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"43557"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"43558"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"43559"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"43560"},{"source":"CD19 antagonist","target":"prostate cancer","id":"43561"},{"source":"CD19 antagonist","target":"malaria","id":"43562"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"43563"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"43564"},{"source":"CD19 antagonist","target":"prostate cancer","id":"43565"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"43566"},{"source":"CD19 antagonist","target":"residual tumor","id":"43567"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"43568"},{"source":"CD19 antagonist","target":"malaria","id":"43569"},{"source":"CD19 antagonist","target":"carcinoma","id":"43570"},{"source":"CD19 antagonist","target":"inflammation","id":"43571"},{"source":"CD19 antagonist","target":"metastatic","id":"43572"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"43573"},{"source":"CD19 antagonist","target":"carcinoma","id":"43574"},{"source":"CD19 antagonist","target":"anticancer","id":"43575"},{"source":"CD19 antagonist","target":"residual tumor","id":"43576"},{"source":"CD19 antagonist","target":"bone metastasis","id":"43577"},{"source":"Androgen receptor antagonist","target":"UNK : Indication","id":"43578"},{"source":"Androgen receptor antagonist","target":"prostate cancer","id":"43579"},{"source":"Androgen receptor antagonist","target":"malaria","id":"43580"},{"source":"Androgen receptor antagonist","target":"castration-resistant prostatic neoplasms","id":"43581"},{"source":"Androgen receptor antagonist","target":"castration-resistant prostatic neoplasms","id":"43582"},{"source":"Androgen receptor antagonist","target":"prostate cancer","id":"43583"},{"source":"Androgen receptor antagonist","target":"anti-inflammatory","id":"43584"},{"source":"Androgen receptor antagonist","target":"residual tumor","id":"43585"},{"source":"Androgen receptor antagonist","target":"fallopian tube neoplasms","id":"43586"},{"source":"Androgen receptor antagonist","target":"malaria","id":"43587"},{"source":"Androgen receptor antagonist","target":"carcinoma","id":"43588"},{"source":"Androgen receptor antagonist","target":"inflammation","id":"43589"},{"source":"Androgen receptor antagonist","target":"metastatic","id":"43590"},{"source":"Androgen receptor antagonist","target":"neoplasm metastasis","id":"43591"},{"source":"Androgen receptor antagonist","target":"carcinoma","id":"43592"},{"source":"Androgen receptor antagonist","target":"anticancer","id":"43593"},{"source":"Androgen receptor antagonist","target":"residual tumor","id":"43594"},{"source":"Androgen receptor antagonist","target":"bone metastasis","id":"43595"},{"source":"ADP ribose polymerase 1 inhibitor","target":"UNK : Indication","id":"43596"},{"source":"ADP ribose polymerase 1 inhibitor","target":"prostate cancer","id":"43597"},{"source":"ADP ribose polymerase 1 inhibitor","target":"malaria","id":"43598"},{"source":"ADP ribose polymerase 1 inhibitor","target":"castration-resistant prostatic neoplasms","id":"43599"},{"source":"ADP ribose polymerase 1 inhibitor","target":"castration-resistant prostatic neoplasms","id":"43600"},{"source":"ADP ribose polymerase 1 inhibitor","target":"prostate cancer","id":"43601"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anti-inflammatory","id":"43602"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"43603"},{"source":"ADP ribose polymerase 1 inhibitor","target":"fallopian tube neoplasms","id":"43604"},{"source":"ADP ribose polymerase 1 inhibitor","target":"malaria","id":"43605"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"43606"},{"source":"ADP ribose polymerase 1 inhibitor","target":"inflammation","id":"43607"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metastatic","id":"43608"},{"source":"ADP ribose polymerase 1 inhibitor","target":"neoplasm metastasis","id":"43609"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"43610"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anticancer","id":"43611"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"43612"},{"source":"ADP ribose polymerase 1 inhibitor","target":"bone metastasis","id":"43613"},{"source":"Taxane","target":"UNK : Indication","id":"43614"},{"source":"Taxane","target":"prostate cancer","id":"43615"},{"source":"Taxane","target":"malaria","id":"43616"},{"source":"Taxane","target":"castration-resistant prostatic neoplasms","id":"43617"},{"source":"Taxane","target":"castration-resistant prostatic neoplasms","id":"43618"},{"source":"Taxane","target":"prostate cancer","id":"43619"},{"source":"Taxane","target":"anti-inflammatory","id":"43620"},{"source":"Taxane","target":"residual tumor","id":"43621"},{"source":"Taxane","target":"fallopian tube neoplasms","id":"43622"},{"source":"Taxane","target":"malaria","id":"43623"},{"source":"Taxane","target":"carcinoma","id":"43624"},{"source":"Taxane","target":"inflammation","id":"43625"},{"source":"Taxane","target":"metastatic","id":"43626"},{"source":"Taxane","target":"neoplasm metastasis","id":"43627"},{"source":"Taxane","target":"carcinoma","id":"43628"},{"source":"Taxane","target":"anticancer","id":"43629"},{"source":"Taxane","target":"residual tumor","id":"43630"},{"source":"Taxane","target":"bone metastasis","id":"43631"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"43632"},{"source":"Microtubule stimulant","target":"prostate cancer","id":"43633"},{"source":"Microtubule stimulant","target":"malaria","id":"43634"},{"source":"Microtubule stimulant","target":"castration-resistant prostatic neoplasms","id":"43635"},{"source":"Microtubule stimulant","target":"castration-resistant prostatic neoplasms","id":"43636"},{"source":"Microtubule stimulant","target":"prostate cancer","id":"43637"},{"source":"Microtubule stimulant","target":"anti-inflammatory","id":"43638"},{"source":"Microtubule stimulant","target":"residual tumor","id":"43639"},{"source":"Microtubule stimulant","target":"fallopian tube neoplasms","id":"43640"},{"source":"Microtubule stimulant","target":"malaria","id":"43641"},{"source":"Microtubule stimulant","target":"carcinoma","id":"43642"},{"source":"Microtubule stimulant","target":"inflammation","id":"43643"},{"source":"Microtubule stimulant","target":"metastatic","id":"43644"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"43645"},{"source":"Microtubule stimulant","target":"carcinoma","id":"43646"},{"source":"Microtubule stimulant","target":"anticancer","id":"43647"},{"source":"Microtubule stimulant","target":"residual tumor","id":"43648"},{"source":"Microtubule stimulant","target":"bone metastasis","id":"43649"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"43650"},{"source":"Tubulin inhibitor","target":"prostate cancer","id":"43651"},{"source":"Tubulin inhibitor","target":"malaria","id":"43652"},{"source":"Tubulin inhibitor","target":"castration-resistant prostatic neoplasms","id":"43653"},{"source":"Tubulin inhibitor","target":"castration-resistant prostatic neoplasms","id":"43654"},{"source":"Tubulin inhibitor","target":"prostate cancer","id":"43655"},{"source":"Tubulin inhibitor","target":"anti-inflammatory","id":"43656"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"43657"},{"source":"Tubulin inhibitor","target":"fallopian tube neoplasms","id":"43658"},{"source":"Tubulin inhibitor","target":"malaria","id":"43659"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"43660"},{"source":"Tubulin inhibitor","target":"inflammation","id":"43661"},{"source":"Tubulin inhibitor","target":"metastatic","id":"43662"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"43663"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"43664"},{"source":"Tubulin inhibitor","target":"anticancer","id":"43665"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"43666"},{"source":"Tubulin inhibitor","target":"bone metastasis","id":"43667"},{"source":"ADP ribose polymerase 1 inhibitor","target":"UNK : Indication","id":"43668"},{"source":"ADP ribose polymerase 1 inhibitor","target":"prostate cancer","id":"43669"},{"source":"ADP ribose polymerase 1 inhibitor","target":"malaria","id":"43670"},{"source":"ADP ribose polymerase 1 inhibitor","target":"castration-resistant prostatic neoplasms","id":"43671"},{"source":"ADP ribose polymerase 1 inhibitor","target":"castration-resistant prostatic neoplasms","id":"43672"},{"source":"ADP ribose polymerase 1 inhibitor","target":"prostate cancer","id":"43673"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anti-inflammatory","id":"43674"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"43675"},{"source":"ADP ribose polymerase 1 inhibitor","target":"fallopian tube neoplasms","id":"43676"},{"source":"ADP ribose polymerase 1 inhibitor","target":"malaria","id":"43677"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"43678"},{"source":"ADP ribose polymerase 1 inhibitor","target":"inflammation","id":"43679"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metastatic","id":"43680"},{"source":"ADP ribose polymerase 1 inhibitor","target":"neoplasm metastasis","id":"43681"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"43682"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anticancer","id":"43683"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"43684"},{"source":"ADP ribose polymerase 1 inhibitor","target":"bone metastasis","id":"43685"},{"source":"Oncology: Prostate","target":"Immunosuppressant","id":"43686"},{"source":"Oncology: Prostate","target":"Corticosteroid agonist","id":"43687"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"43688"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"43689"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"43690"},{"source":"Oncology: Prostate","target":"Androgen receptor antagonist","id":"43691"},{"source":"Oncology: Prostate","target":"ADP ribose polymerase 1 inhibitor","id":"43692"},{"source":"Oncology: Prostate","target":"Taxane","id":"43693"},{"source":"Oncology: Prostate","target":"Microtubule stimulant","id":"43694"},{"source":"Oncology: Prostate","target":"Tubulin inhibitor","id":"43695"},{"source":"Oncology: Prostate","target":"ADP ribose polymerase 1 inhibitor","id":"43696"},{"source":"pembrolizumab","target":"Merck & Co.","id":"43697"},{"source":"UNK : Drug","target":"Merck & Co.","id":"43698"},{"source":"kidney tumor","target":"pembrolizumab","id":"43699"},{"source":"kidney tumor","target":"UNK : Drug","id":"43700"},{"source":"liver metastases","target":"pembrolizumab","id":"43701"},{"source":"liver metastases","target":"UNK : Drug","id":"43702"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"43703"},{"source":"kidney neoplasms","target":"UNK : Drug","id":"43704"},{"source":"renal cancer","target":"pembrolizumab","id":"43705"},{"source":"renal cancer","target":"UNK : Drug","id":"43706"},{"source":"carcinoma","target":"pembrolizumab","id":"43707"},{"source":"carcinoma","target":"UNK : Drug","id":"43708"},{"source":"soft tissue metastases","target":"pembrolizumab","id":"43709"},{"source":"soft tissue metastases","target":"UNK : Drug","id":"43710"},{"source":"residual tumor","target":"pembrolizumab","id":"43711"},{"source":"residual tumor","target":"UNK : Drug","id":"43712"},{"source":"metastatic","target":"pembrolizumab","id":"43713"},{"source":"metastatic","target":"UNK : Drug","id":"43714"},{"source":"carcinoma","target":"pembrolizumab","id":"43715"},{"source":"carcinoma","target":"UNK : Drug","id":"43716"},{"source":"soft tissue neoplasms","target":"pembrolizumab","id":"43717"},{"source":"soft tissue neoplasms","target":"UNK : Drug","id":"43718"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"43719"},{"source":"neoplasm metastasis","target":"UNK : Drug","id":"43720"},{"source":"sarcoma","target":"pembrolizumab","id":"43721"},{"source":"sarcoma","target":"UNK : Drug","id":"43722"},{"source":"anticancer","target":"pembrolizumab","id":"43723"},{"source":"anticancer","target":"UNK : Drug","id":"43724"},{"source":"sarcoma","target":"pembrolizumab","id":"43725"},{"source":"sarcoma","target":"UNK : Drug","id":"43726"},{"source":"renal cell","target":"pembrolizumab","id":"43727"},{"source":"renal cell","target":"UNK : Drug","id":"43728"},{"source":"rcc","target":"pembrolizumab","id":"43729"},{"source":"rcc","target":"UNK : Drug","id":"43730"},{"source":"Anticancer immunotherapy","target":"kidney tumor","id":"43731"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"43732"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"43733"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"43734"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43735"},{"source":"Anticancer immunotherapy","target":"soft tissue metastases","id":"43736"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"43737"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"43738"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43739"},{"source":"Anticancer immunotherapy","target":"soft tissue neoplasms","id":"43740"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"43741"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"43742"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"43743"},{"source":"Anticancer immunotherapy","target":"sarcoma","id":"43744"},{"source":"Anticancer immunotherapy","target":"renal cell","id":"43745"},{"source":"Anticancer immunotherapy","target":"rcc","id":"43746"},{"source":"CD19 antagonist","target":"kidney tumor","id":"43747"},{"source":"CD19 antagonist","target":"liver metastases","id":"43748"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"43749"},{"source":"CD19 antagonist","target":"renal cancer","id":"43750"},{"source":"CD19 antagonist","target":"carcinoma","id":"43751"},{"source":"CD19 antagonist","target":"soft tissue metastases","id":"43752"},{"source":"CD19 antagonist","target":"residual tumor","id":"43753"},{"source":"CD19 antagonist","target":"metastatic","id":"43754"},{"source":"CD19 antagonist","target":"carcinoma","id":"43755"},{"source":"CD19 antagonist","target":"soft tissue neoplasms","id":"43756"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"43757"},{"source":"CD19 antagonist","target":"sarcoma","id":"43758"},{"source":"CD19 antagonist","target":"anticancer","id":"43759"},{"source":"CD19 antagonist","target":"sarcoma","id":"43760"},{"source":"CD19 antagonist","target":"renal cell","id":"43761"},{"source":"CD19 antagonist","target":"rcc","id":"43762"},{"source":"Immune checkpoint inhibitor","target":"kidney tumor","id":"43763"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"43764"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"43765"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"43766"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43767"},{"source":"Immune checkpoint inhibitor","target":"soft tissue metastases","id":"43768"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"43769"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"43770"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43771"},{"source":"Immune checkpoint inhibitor","target":"soft tissue neoplasms","id":"43772"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"43773"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"43774"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"43775"},{"source":"Immune checkpoint inhibitor","target":"sarcoma","id":"43776"},{"source":"Immune checkpoint inhibitor","target":"renal cell","id":"43777"},{"source":"Immune checkpoint inhibitor","target":"rcc","id":"43778"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"43779"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"43780"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"43781"},{"source":"cisplatin","target":"(Other Hospital/Academic/Medical Center)","id":"43782"},{"source":"cisplatin","target":"Merck & Co.","id":"43783"},{"source":"pembrolizumab","target":"(Other Hospital/Academic/Medical Center)","id":"43784"},{"source":"pembrolizumab","target":"Merck & Co.","id":"43785"},{"source":"radiation therapy","target":"(Other Hospital/Academic/Medical Center)","id":"43786"},{"source":"radiation therapy","target":"Merck & Co.","id":"43787"},{"source":"undisclosed - chemotherapy","target":"(Other Hospital/Academic/Medical Center)","id":"43788"},{"source":"undisclosed - chemotherapy","target":"Merck & Co.","id":"43789"},{"source":"UNK : Drug","target":"(Other Hospital/Academic/Medical Center)","id":"43790"},{"source":"UNK : Drug","target":"Merck & Co.","id":"43791"},{"source":"carcinoma","target":"cisplatin","id":"43792"},{"source":"carcinoma","target":"pembrolizumab","id":"43793"},{"source":"carcinoma","target":"radiation therapy","id":"43794"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"43795"},{"source":"carcinoma","target":"UNK : Drug","id":"43796"},{"source":"UNK : Indication","target":"cisplatin","id":"43797"},{"source":"UNK : Indication","target":"pembrolizumab","id":"43798"},{"source":"UNK : Indication","target":"radiation therapy","id":"43799"},{"source":"UNK : Indication","target":"undisclosed - chemotherapy","id":"43800"},{"source":"UNK : Indication","target":"UNK : Drug","id":"43801"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"43802"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"43803"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"43804"},{"source":"squamous cell neoplasms","target":"undisclosed - chemotherapy","id":"43805"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"43806"},{"source":"carcinoma","target":"cisplatin","id":"43807"},{"source":"carcinoma","target":"pembrolizumab","id":"43808"},{"source":"carcinoma","target":"radiation therapy","id":"43809"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"43810"},{"source":"carcinoma","target":"UNK : Drug","id":"43811"},{"source":"carcinoma","target":"cisplatin","id":"43812"},{"source":"carcinoma","target":"pembrolizumab","id":"43813"},{"source":"carcinoma","target":"radiation therapy","id":"43814"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"43815"},{"source":"carcinoma","target":"UNK : Drug","id":"43816"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"43817"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"43818"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"43819"},{"source":"pharyngeal neoplasms","target":"undisclosed - chemotherapy","id":"43820"},{"source":"pharyngeal neoplasms","target":"UNK : Drug","id":"43821"},{"source":"carcinoma","target":"cisplatin","id":"43822"},{"source":"carcinoma","target":"pembrolizumab","id":"43823"},{"source":"carcinoma","target":"radiation therapy","id":"43824"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"43825"},{"source":"carcinoma","target":"UNK : Drug","id":"43826"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"43827"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"43828"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"43829"},{"source":"squamous cell neoplasms","target":"undisclosed - chemotherapy","id":"43830"},{"source":"squamous cell neoplasms","target":"UNK : Drug","id":"43831"},{"source":"mouth neoplasms","target":"cisplatin","id":"43832"},{"source":"mouth neoplasms","target":"pembrolizumab","id":"43833"},{"source":"mouth neoplasms","target":"radiation therapy","id":"43834"},{"source":"mouth neoplasms","target":"undisclosed - chemotherapy","id":"43835"},{"source":"mouth neoplasms","target":"UNK : Drug","id":"43836"},{"source":"liver metastases","target":"cisplatin","id":"43837"},{"source":"liver metastases","target":"pembrolizumab","id":"43838"},{"source":"liver metastases","target":"radiation therapy","id":"43839"},{"source":"liver metastases","target":"undisclosed - chemotherapy","id":"43840"},{"source":"liver metastases","target":"UNK : Drug","id":"43841"},{"source":"carcinoma","target":"cisplatin","id":"43842"},{"source":"carcinoma","target":"pembrolizumab","id":"43843"},{"source":"carcinoma","target":"radiation therapy","id":"43844"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"43845"},{"source":"carcinoma","target":"UNK : Drug","id":"43846"},{"source":"residual tumor","target":"cisplatin","id":"43847"},{"source":"residual tumor","target":"pembrolizumab","id":"43848"},{"source":"residual tumor","target":"radiation therapy","id":"43849"},{"source":"residual tumor","target":"undisclosed - chemotherapy","id":"43850"},{"source":"residual tumor","target":"UNK : Drug","id":"43851"},{"source":"anticancer","target":"cisplatin","id":"43852"},{"source":"anticancer","target":"pembrolizumab","id":"43853"},{"source":"anticancer","target":"radiation therapy","id":"43854"},{"source":"anticancer","target":"undisclosed - chemotherapy","id":"43855"},{"source":"anticancer","target":"UNK : Drug","id":"43856"},{"source":"carcinoma","target":"cisplatin","id":"43857"},{"source":"carcinoma","target":"pembrolizumab","id":"43858"},{"source":"carcinoma","target":"radiation therapy","id":"43859"},{"source":"carcinoma","target":"undisclosed - chemotherapy","id":"43860"},{"source":"carcinoma","target":"UNK : Drug","id":"43861"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"43862"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"43863"},{"source":"pharyngeal neoplasms","target":"radiation therapy","id":"43864"},{"source":"pharyngeal neoplasms","target":"undisclosed - chemotherapy","id":"43865"},{"source":"pharyngeal neoplasms","target":"UNK : Drug","id":"43866"},{"source":"liver neoplasms","target":"cisplatin","id":"43867"},{"source":"liver neoplasms","target":"pembrolizumab","id":"43868"},{"source":"liver neoplasms","target":"radiation therapy","id":"43869"},{"source":"liver neoplasms","target":"undisclosed - chemotherapy","id":"43870"},{"source":"liver neoplasms","target":"UNK : Drug","id":"43871"},{"source":"head and neck neoplasms","target":"cisplatin","id":"43872"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"43873"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"43874"},{"source":"head and neck neoplasms","target":"undisclosed - chemotherapy","id":"43875"},{"source":"head and neck neoplasms","target":"UNK : Drug","id":"43876"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43877"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"43878"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"43879"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43880"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43881"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"43882"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43883"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"43884"},{"source":"Immune checkpoint inhibitor","target":"mouth neoplasms","id":"43885"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"43886"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43887"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"43888"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"43889"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"43890"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"43891"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"43892"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"43893"},{"source":"NA","target":"carcinoma","id":"43894"},{"source":"NA","target":"UNK : Indication","id":"43895"},{"source":"NA","target":"squamous cell neoplasms","id":"43896"},{"source":"NA","target":"carcinoma","id":"43897"},{"source":"NA","target":"carcinoma","id":"43898"},{"source":"NA","target":"pharyngeal neoplasms","id":"43899"},{"source":"NA","target":"carcinoma","id":"43900"},{"source":"NA","target":"squamous cell neoplasms","id":"43901"},{"source":"NA","target":"mouth neoplasms","id":"43902"},{"source":"NA","target":"liver metastases","id":"43903"},{"source":"NA","target":"carcinoma","id":"43904"},{"source":"NA","target":"residual tumor","id":"43905"},{"source":"NA","target":"anticancer","id":"43906"},{"source":"NA","target":"carcinoma","id":"43907"},{"source":"NA","target":"pharyngeal neoplasms","id":"43908"},{"source":"NA","target":"liver neoplasms","id":"43909"},{"source":"NA","target":"head and neck neoplasms","id":"43910"},{"source":"CD19 antagonist","target":"carcinoma","id":"43911"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"43912"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"43913"},{"source":"CD19 antagonist","target":"carcinoma","id":"43914"},{"source":"CD19 antagonist","target":"carcinoma","id":"43915"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"43916"},{"source":"CD19 antagonist","target":"carcinoma","id":"43917"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"43918"},{"source":"CD19 antagonist","target":"mouth neoplasms","id":"43919"},{"source":"CD19 antagonist","target":"liver metastases","id":"43920"},{"source":"CD19 antagonist","target":"carcinoma","id":"43921"},{"source":"CD19 antagonist","target":"residual tumor","id":"43922"},{"source":"CD19 antagonist","target":"anticancer","id":"43923"},{"source":"CD19 antagonist","target":"carcinoma","id":"43924"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"43925"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"43926"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"43927"},{"source":"UPA","target":"carcinoma","id":"43928"},{"source":"UPA","target":"UNK : Indication","id":"43929"},{"source":"UPA","target":"squamous cell neoplasms","id":"43930"},{"source":"UPA","target":"carcinoma","id":"43931"},{"source":"UPA","target":"carcinoma","id":"43932"},{"source":"UPA","target":"pharyngeal neoplasms","id":"43933"},{"source":"UPA","target":"carcinoma","id":"43934"},{"source":"UPA","target":"squamous cell neoplasms","id":"43935"},{"source":"UPA","target":"mouth neoplasms","id":"43936"},{"source":"UPA","target":"liver metastases","id":"43937"},{"source":"UPA","target":"carcinoma","id":"43938"},{"source":"UPA","target":"residual tumor","id":"43939"},{"source":"UPA","target":"anticancer","id":"43940"},{"source":"UPA","target":"carcinoma","id":"43941"},{"source":"UPA","target":"pharyngeal neoplasms","id":"43942"},{"source":"UPA","target":"liver neoplasms","id":"43943"},{"source":"UPA","target":"head and neck neoplasms","id":"43944"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43945"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"43946"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"43947"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43948"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43949"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"43950"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43951"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"43952"},{"source":"Anticancer immunotherapy","target":"mouth neoplasms","id":"43953"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"43954"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43955"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"43956"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"43957"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"43958"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"43959"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"43960"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"43961"},{"source":"NA","target":"carcinoma","id":"43962"},{"source":"NA","target":"UNK : Indication","id":"43963"},{"source":"NA","target":"squamous cell neoplasms","id":"43964"},{"source":"NA","target":"carcinoma","id":"43965"},{"source":"NA","target":"carcinoma","id":"43966"},{"source":"NA","target":"pharyngeal neoplasms","id":"43967"},{"source":"NA","target":"carcinoma","id":"43968"},{"source":"NA","target":"squamous cell neoplasms","id":"43969"},{"source":"NA","target":"mouth neoplasms","id":"43970"},{"source":"NA","target":"liver metastases","id":"43971"},{"source":"NA","target":"carcinoma","id":"43972"},{"source":"NA","target":"residual tumor","id":"43973"},{"source":"NA","target":"anticancer","id":"43974"},{"source":"NA","target":"carcinoma","id":"43975"},{"source":"NA","target":"pharyngeal neoplasms","id":"43976"},{"source":"NA","target":"liver neoplasms","id":"43977"},{"source":"NA","target":"head and neck neoplasms","id":"43978"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"43979"},{"source":"Oncology: Head/Neck","target":"NA","id":"43980"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"43981"},{"source":"Oncology: Head/Neck","target":"UPA","id":"43982"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"43983"},{"source":"Oncology: Head/Neck","target":"NA","id":"43984"},{"source":"IMO-2125 (intratumoral) (u)","target":"Idera Pharmaceuticals {Hybridon}","id":"43985"},{"source":"ipilimumab","target":"Idera Pharmaceuticals {Hybridon}","id":"43986"},{"source":"UNK : Indication","target":"IMO-2125 (intratumoral) (u)","id":"43987"},{"source":"UNK : Indication","target":"ipilimumab","id":"43988"},{"source":"anti-hiv","target":"IMO-2125 (intratumoral) (u)","id":"43989"},{"source":"anti-hiv","target":"ipilimumab","id":"43990"},{"source":"melanoma","target":"IMO-2125 (intratumoral) (u)","id":"43991"},{"source":"melanoma","target":"ipilimumab","id":"43992"},{"source":"melanoma","target":"IMO-2125 (intratumoral) (u)","id":"43993"},{"source":"melanoma","target":"ipilimumab","id":"43994"},{"source":"anticancer","target":"IMO-2125 (intratumoral) (u)","id":"43995"},{"source":"anticancer","target":"ipilimumab","id":"43996"},{"source":"skin neoplasms","target":"IMO-2125 (intratumoral) (u)","id":"43997"},{"source":"skin neoplasms","target":"ipilimumab","id":"43998"},{"source":"residual tumor","target":"IMO-2125 (intratumoral) (u)","id":"43999"},{"source":"residual tumor","target":"ipilimumab","id":"44000"},{"source":"gilbert syndrome","target":"IMO-2125 (intratumoral) (u)","id":"44001"},{"source":"gilbert syndrome","target":"ipilimumab","id":"44002"},{"source":"carcinoma","target":"IMO-2125 (intratumoral) (u)","id":"44003"},{"source":"carcinoma","target":"ipilimumab","id":"44004"},{"source":"gilbert disease","target":"IMO-2125 (intratumoral) (u)","id":"44005"},{"source":"gilbert disease","target":"ipilimumab","id":"44006"},{"source":"anticancer","target":"IMO-2125 (intratumoral) (u)","id":"44007"},{"source":"anticancer","target":"ipilimumab","id":"44008"},{"source":"hiv infections","target":"IMO-2125 (intratumoral) (u)","id":"44009"},{"source":"hiv infections","target":"ipilimumab","id":"44010"},{"source":"acquired immunodeficiency syndrome","target":"IMO-2125 (intratumoral) (u)","id":"44011"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"44012"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"44013"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"44014"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"44015"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"44016"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"44017"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"44018"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"44019"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"44020"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44021"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"44022"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"44023"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"44024"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"44025"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"44026"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"44027"},{"source":"CTLA4 antagonist","target":"melanoma","id":"44028"},{"source":"CTLA4 antagonist","target":"melanoma","id":"44029"},{"source":"CTLA4 antagonist","target":"anticancer","id":"44030"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"44031"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"44032"},{"source":"CTLA4 antagonist","target":"gilbert syndrome","id":"44033"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"44034"},{"source":"CTLA4 antagonist","target":"gilbert disease","id":"44035"},{"source":"CTLA4 antagonist","target":"anticancer","id":"44036"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"44037"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"44038"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"44039"},{"source":"Toll-like receptor 9 agonist","target":"anti-hiv","id":"44040"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"44041"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"44042"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"44043"},{"source":"Toll-like receptor 9 agonist","target":"skin neoplasms","id":"44044"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"44045"},{"source":"Toll-like receptor 9 agonist","target":"gilbert syndrome","id":"44046"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"44047"},{"source":"Toll-like receptor 9 agonist","target":"gilbert disease","id":"44048"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"44049"},{"source":"Toll-like receptor 9 agonist","target":"hiv infections","id":"44050"},{"source":"Toll-like receptor 9 agonist","target":"acquired immunodeficiency syndrome","id":"44051"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"44052"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"44053"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"44054"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"44055"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"44056"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"44057"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"44058"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"44059"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44060"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"44061"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"44062"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"44063"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"44064"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"44065"},{"source":"Oncology: Melanoma","target":"CTLA4 antagonist","id":"44066"},{"source":"Oncology: Melanoma","target":"Toll-like receptor 9 agonist","id":"44067"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"44068"},{"source":"pembrolizumab","target":"Merck & Co.","id":"44069"},{"source":"carboplatin","target":"Merck & Co.","id":"44070"},{"source":"cisplatin","target":"Merck & Co.","id":"44071"},{"source":"unspecified","target":"Merck & Co.","id":"44072"},{"source":"gemcitabine hydrochloride","target":"Merck & Co.","id":"44073"},{"source":"UNK : Indication","target":"pembrolizumab","id":"44074"},{"source":"UNK : Indication","target":"carboplatin","id":"44075"},{"source":"UNK : Indication","target":"cisplatin","id":"44076"},{"source":"UNK : Indication","target":"unspecified","id":"44077"},{"source":"UNK : Indication","target":"gemcitabine hydrochloride","id":"44078"},{"source":"non-small-cell lung","target":"pembrolizumab","id":"44079"},{"source":"non-small-cell lung","target":"carboplatin","id":"44080"},{"source":"non-small-cell lung","target":"cisplatin","id":"44081"},{"source":"non-small-cell lung","target":"unspecified","id":"44082"},{"source":"non-small-cell lung","target":"gemcitabine hydrochloride","id":"44083"},{"source":"transitional","target":"pembrolizumab","id":"44084"},{"source":"transitional","target":"carboplatin","id":"44085"},{"source":"transitional","target":"cisplatin","id":"44086"},{"source":"transitional","target":"unspecified","id":"44087"},{"source":"transitional","target":"gemcitabine hydrochloride","id":"44088"},{"source":"bladder cancer","target":"pembrolizumab","id":"44089"},{"source":"bladder cancer","target":"carboplatin","id":"44090"},{"source":"bladder cancer","target":"cisplatin","id":"44091"},{"source":"bladder cancer","target":"unspecified","id":"44092"},{"source":"bladder cancer","target":"gemcitabine hydrochloride","id":"44093"},{"source":"kidney neoplasms","target":"pembrolizumab","id":"44094"},{"source":"kidney neoplasms","target":"carboplatin","id":"44095"},{"source":"kidney neoplasms","target":"cisplatin","id":"44096"},{"source":"kidney neoplasms","target":"unspecified","id":"44097"},{"source":"kidney neoplasms","target":"gemcitabine hydrochloride","id":"44098"},{"source":"renal cancer","target":"pembrolizumab","id":"44099"},{"source":"renal cancer","target":"carboplatin","id":"44100"},{"source":"renal cancer","target":"cisplatin","id":"44101"},{"source":"renal cancer","target":"unspecified","id":"44102"},{"source":"renal cancer","target":"gemcitabine hydrochloride","id":"44103"},{"source":"residual tumor","target":"pembrolizumab","id":"44104"},{"source":"residual tumor","target":"carboplatin","id":"44105"},{"source":"residual tumor","target":"cisplatin","id":"44106"},{"source":"residual tumor","target":"unspecified","id":"44107"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"44108"},{"source":"metastatic","target":"pembrolizumab","id":"44109"},{"source":"metastatic","target":"carboplatin","id":"44110"},{"source":"metastatic","target":"cisplatin","id":"44111"},{"source":"metastatic","target":"unspecified","id":"44112"},{"source":"metastatic","target":"gemcitabine hydrochloride","id":"44113"},{"source":"carcinoma","target":"pembrolizumab","id":"44114"},{"source":"carcinoma","target":"carboplatin","id":"44115"},{"source":"carcinoma","target":"cisplatin","id":"44116"},{"source":"carcinoma","target":"unspecified","id":"44117"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"44118"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"44119"},{"source":"neoplasm metastasis","target":"carboplatin","id":"44120"},{"source":"neoplasm metastasis","target":"cisplatin","id":"44121"},{"source":"neoplasm metastasis","target":"unspecified","id":"44122"},{"source":"neoplasm metastasis","target":"gemcitabine hydrochloride","id":"44123"},{"source":"anticancer","target":"pembrolizumab","id":"44124"},{"source":"anticancer","target":"carboplatin","id":"44125"},{"source":"anticancer","target":"cisplatin","id":"44126"},{"source":"anticancer","target":"unspecified","id":"44127"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"44128"},{"source":"urinary bladder neoplasms","target":"pembrolizumab","id":"44129"},{"source":"urinary bladder neoplasms","target":"carboplatin","id":"44130"},{"source":"urinary bladder neoplasms","target":"cisplatin","id":"44131"},{"source":"urinary bladder neoplasms","target":"unspecified","id":"44132"},{"source":"urinary bladder neoplasms","target":"gemcitabine hydrochloride","id":"44133"},{"source":"carcinoma","target":"pembrolizumab","id":"44134"},{"source":"carcinoma","target":"carboplatin","id":"44135"},{"source":"carcinoma","target":"cisplatin","id":"44136"},{"source":"carcinoma","target":"unspecified","id":"44137"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"44138"},{"source":"residual tumor","target":"pembrolizumab","id":"44139"},{"source":"residual tumor","target":"carboplatin","id":"44140"},{"source":"residual tumor","target":"cisplatin","id":"44141"},{"source":"residual tumor","target":"unspecified","id":"44142"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"44143"},{"source":"carcinoma","target":"pembrolizumab","id":"44144"},{"source":"carcinoma","target":"carboplatin","id":"44145"},{"source":"carcinoma","target":"cisplatin","id":"44146"},{"source":"carcinoma","target":"unspecified","id":"44147"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"44148"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"44149"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"44150"},{"source":"Immune checkpoint inhibitor","target":"transitional","id":"44151"},{"source":"Immune checkpoint inhibitor","target":"bladder cancer","id":"44152"},{"source":"Immune checkpoint inhibitor","target":"kidney neoplasms","id":"44153"},{"source":"Immune checkpoint inhibitor","target":"renal cancer","id":"44154"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"44155"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"44156"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44157"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"44158"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"44159"},{"source":"Immune checkpoint inhibitor","target":"urinary bladder neoplasms","id":"44160"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44161"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"44162"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44163"},{"source":"NA","target":"UNK : Indication","id":"44164"},{"source":"NA","target":"non-small-cell lung","id":"44165"},{"source":"NA","target":"transitional","id":"44166"},{"source":"NA","target":"bladder cancer","id":"44167"},{"source":"NA","target":"kidney neoplasms","id":"44168"},{"source":"NA","target":"renal cancer","id":"44169"},{"source":"NA","target":"residual tumor","id":"44170"},{"source":"NA","target":"metastatic","id":"44171"},{"source":"NA","target":"carcinoma","id":"44172"},{"source":"NA","target":"neoplasm metastasis","id":"44173"},{"source":"NA","target":"anticancer","id":"44174"},{"source":"NA","target":"urinary bladder neoplasms","id":"44175"},{"source":"NA","target":"carcinoma","id":"44176"},{"source":"NA","target":"residual tumor","id":"44177"},{"source":"NA","target":"carcinoma","id":"44178"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"44179"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"44180"},{"source":"Anticancer immunotherapy","target":"transitional","id":"44181"},{"source":"Anticancer immunotherapy","target":"bladder cancer","id":"44182"},{"source":"Anticancer immunotherapy","target":"kidney neoplasms","id":"44183"},{"source":"Anticancer immunotherapy","target":"renal cancer","id":"44184"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"44185"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"44186"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44187"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"44188"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"44189"},{"source":"Anticancer immunotherapy","target":"urinary bladder neoplasms","id":"44190"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44191"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"44192"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44193"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"44194"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"44195"},{"source":"CD19 antagonist","target":"transitional","id":"44196"},{"source":"CD19 antagonist","target":"bladder cancer","id":"44197"},{"source":"CD19 antagonist","target":"kidney neoplasms","id":"44198"},{"source":"CD19 antagonist","target":"renal cancer","id":"44199"},{"source":"CD19 antagonist","target":"residual tumor","id":"44200"},{"source":"CD19 antagonist","target":"metastatic","id":"44201"},{"source":"CD19 antagonist","target":"carcinoma","id":"44202"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"44203"},{"source":"CD19 antagonist","target":"anticancer","id":"44204"},{"source":"CD19 antagonist","target":"urinary bladder neoplasms","id":"44205"},{"source":"CD19 antagonist","target":"carcinoma","id":"44206"},{"source":"CD19 antagonist","target":"residual tumor","id":"44207"},{"source":"CD19 antagonist","target":"carcinoma","id":"44208"},{"source":"NA","target":"UNK : Indication","id":"44209"},{"source":"NA","target":"non-small-cell lung","id":"44210"},{"source":"NA","target":"transitional","id":"44211"},{"source":"NA","target":"bladder cancer","id":"44212"},{"source":"NA","target":"kidney neoplasms","id":"44213"},{"source":"NA","target":"renal cancer","id":"44214"},{"source":"NA","target":"residual tumor","id":"44215"},{"source":"NA","target":"metastatic","id":"44216"},{"source":"NA","target":"carcinoma","id":"44217"},{"source":"NA","target":"neoplasm metastasis","id":"44218"},{"source":"NA","target":"anticancer","id":"44219"},{"source":"NA","target":"urinary bladder neoplasms","id":"44220"},{"source":"NA","target":"carcinoma","id":"44221"},{"source":"NA","target":"residual tumor","id":"44222"},{"source":"NA","target":"carcinoma","id":"44223"},{"source":"NA","target":"UNK : Indication","id":"44224"},{"source":"NA","target":"non-small-cell lung","id":"44225"},{"source":"NA","target":"transitional","id":"44226"},{"source":"NA","target":"bladder cancer","id":"44227"},{"source":"NA","target":"kidney neoplasms","id":"44228"},{"source":"NA","target":"renal cancer","id":"44229"},{"source":"NA","target":"residual tumor","id":"44230"},{"source":"NA","target":"metastatic","id":"44231"},{"source":"NA","target":"carcinoma","id":"44232"},{"source":"NA","target":"neoplasm metastasis","id":"44233"},{"source":"NA","target":"anticancer","id":"44234"},{"source":"NA","target":"urinary bladder neoplasms","id":"44235"},{"source":"NA","target":"carcinoma","id":"44236"},{"source":"NA","target":"residual tumor","id":"44237"},{"source":"NA","target":"carcinoma","id":"44238"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"44239"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"44240"},{"source":"Cell cycle inhibitor","target":"transitional","id":"44241"},{"source":"Cell cycle inhibitor","target":"bladder cancer","id":"44242"},{"source":"Cell cycle inhibitor","target":"kidney neoplasms","id":"44243"},{"source":"Cell cycle inhibitor","target":"renal cancer","id":"44244"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"44245"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"44246"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"44247"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"44248"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"44249"},{"source":"Cell cycle inhibitor","target":"urinary bladder neoplasms","id":"44250"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"44251"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"44252"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"44253"},{"source":"Oncology: Bladder","target":"Immune checkpoint inhibitor","id":"44254"},{"source":"Oncology: Bladder","target":"NA","id":"44255"},{"source":"Oncology: Bladder","target":"Anticancer immunotherapy","id":"44256"},{"source":"Oncology: Bladder","target":"CD19 antagonist","id":"44257"},{"source":"Oncology: Bladder","target":"NA","id":"44258"},{"source":"Oncology: Bladder","target":"NA","id":"44259"},{"source":"Oncology: Bladder","target":"Cell cycle inhibitor","id":"44260"},{"source":"Oncology: Renal","target":"Immune checkpoint inhibitor","id":"44261"},{"source":"Oncology: Renal","target":"NA","id":"44262"},{"source":"Oncology: Renal","target":"Anticancer immunotherapy","id":"44263"},{"source":"Oncology: Renal","target":"CD19 antagonist","id":"44264"},{"source":"Oncology: Renal","target":"NA","id":"44265"},{"source":"Oncology: Renal","target":"NA","id":"44266"},{"source":"Oncology: Renal","target":"Cell cycle inhibitor","id":"44267"},{"source":"abemaciclib (capsule) (a)","target":"(Other Cooperative Group)","id":"44268"},{"source":"abemaciclib (capsule) (a)","target":"Eli Lilly","id":"44269"},{"source":"anastrozole (tablet)","target":"(Other Cooperative Group)","id":"44270"},{"source":"anastrozole (tablet)","target":"Eli Lilly","id":"44271"},{"source":"exemestane","target":"(Other Cooperative Group)","id":"44272"},{"source":"exemestane","target":"Eli Lilly","id":"44273"},{"source":"goserelin","target":"(Other Cooperative Group)","id":"44274"},{"source":"goserelin","target":"Eli Lilly","id":"44275"},{"source":"letrozole","target":"(Other Cooperative Group)","id":"44276"},{"source":"letrozole","target":"Eli Lilly","id":"44277"},{"source":"leuprorelin","target":"(Other Cooperative Group)","id":"44278"},{"source":"leuprorelin","target":"Eli Lilly","id":"44279"},{"source":"Abbott","target":"(Other Cooperative Group)","id":"44280"},{"source":"Abbott","target":"Eli Lilly","id":"44281"},{"source":"tamoxifen citrate (tablet)","target":"(Other Cooperative Group)","id":"44282"},{"source":"tamoxifen citrate (tablet)","target":"Eli Lilly","id":"44283"},{"source":"unspecified","target":"(Other Cooperative Group)","id":"44284"},{"source":"unspecified","target":"Eli Lilly","id":"44285"},{"source":"UNK : Indication","target":"abemaciclib (capsule) (a)","id":"44286"},{"source":"UNK : Indication","target":"anastrozole (tablet)","id":"44287"},{"source":"UNK : Indication","target":"exemestane","id":"44288"},{"source":"UNK : Indication","target":"goserelin","id":"44289"},{"source":"UNK : Indication","target":"letrozole","id":"44290"},{"source":"UNK : Indication","target":"leuprorelin","id":"44291"},{"source":"UNK : Indication","target":"Abbott","id":"44292"},{"source":"UNK : Indication","target":"tamoxifen citrate (tablet)","id":"44293"},{"source":"UNK : Indication","target":"unspecified","id":"44294"},{"source":"menstruation disturbances","target":"abemaciclib (capsule) (a)","id":"44295"},{"source":"menstruation disturbances","target":"anastrozole (tablet)","id":"44296"},{"source":"menstruation disturbances","target":"exemestane","id":"44297"},{"source":"menstruation disturbances","target":"goserelin","id":"44298"},{"source":"menstruation disturbances","target":"letrozole","id":"44299"},{"source":"menstruation disturbances","target":"leuprorelin","id":"44300"},{"source":"menstruation disturbances","target":"Abbott","id":"44301"},{"source":"menstruation disturbances","target":"tamoxifen citrate (tablet)","id":"44302"},{"source":"menstruation disturbances","target":"unspecified","id":"44303"},{"source":"anti-hiv","target":"abemaciclib (capsule) (a)","id":"44304"},{"source":"anti-hiv","target":"anastrozole (tablet)","id":"44305"},{"source":"anti-hiv","target":"exemestane","id":"44306"},{"source":"anti-hiv","target":"goserelin","id":"44307"},{"source":"anti-hiv","target":"letrozole","id":"44308"},{"source":"anti-hiv","target":"leuprorelin","id":"44309"},{"source":"anti-hiv","target":"Abbott","id":"44310"},{"source":"anti-hiv","target":"tamoxifen citrate (tablet)","id":"44311"},{"source":"anti-hiv","target":"unspecified","id":"44312"},{"source":"liver metastases","target":"abemaciclib (capsule) (a)","id":"44313"},{"source":"liver metastases","target":"anastrozole (tablet)","id":"44314"},{"source":"liver metastases","target":"exemestane","id":"44315"},{"source":"liver metastases","target":"goserelin","id":"44316"},{"source":"liver metastases","target":"letrozole","id":"44317"},{"source":"liver metastases","target":"leuprorelin","id":"44318"},{"source":"liver metastases","target":"Abbott","id":"44319"},{"source":"liver metastases","target":"tamoxifen citrate (tablet)","id":"44320"},{"source":"liver metastases","target":"unspecified","id":"44321"},{"source":"anticancer","target":"abemaciclib (capsule) (a)","id":"44322"},{"source":"anticancer","target":"anastrozole (tablet)","id":"44323"},{"source":"anticancer","target":"exemestane","id":"44324"},{"source":"anticancer","target":"goserelin","id":"44325"},{"source":"anticancer","target":"letrozole","id":"44326"},{"source":"anticancer","target":"leuprorelin","id":"44327"},{"source":"anticancer","target":"Abbott","id":"44328"},{"source":"anticancer","target":"tamoxifen citrate (tablet)","id":"44329"},{"source":"anticancer","target":"unspecified","id":"44330"},{"source":"prostate disorders","target":"abemaciclib (capsule) (a)","id":"44331"},{"source":"prostate disorders","target":"anastrozole (tablet)","id":"44332"},{"source":"prostate disorders","target":"exemestane","id":"44333"},{"source":"prostate disorders","target":"goserelin","id":"44334"},{"source":"prostate disorders","target":"letrozole","id":"44335"},{"source":"prostate disorders","target":"leuprorelin","id":"44336"},{"source":"prostate disorders","target":"Abbott","id":"44337"},{"source":"prostate disorders","target":"tamoxifen citrate (tablet)","id":"44338"},{"source":"prostate disorders","target":"unspecified","id":"44339"},{"source":"solid malignancy","target":"abemaciclib (capsule) (a)","id":"44340"},{"source":"solid malignancy","target":"anastrozole (tablet)","id":"44341"},{"source":"solid malignancy","target":"exemestane","id":"44342"},{"source":"solid malignancy","target":"goserelin","id":"44343"},{"source":"solid malignancy","target":"letrozole","id":"44344"},{"source":"solid malignancy","target":"leuprorelin","id":"44345"},{"source":"solid malignancy","target":"Abbott","id":"44346"},{"source":"solid malignancy","target":"tamoxifen citrate (tablet)","id":"44347"},{"source":"solid malignancy","target":"unspecified","id":"44348"},{"source":"menstruation disorders","target":"abemaciclib (capsule) (a)","id":"44349"},{"source":"menstruation disorders","target":"anastrozole (tablet)","id":"44350"},{"source":"menstruation disorders","target":"exemestane","id":"44351"},{"source":"menstruation disorders","target":"goserelin","id":"44352"},{"source":"menstruation disorders","target":"letrozole","id":"44353"},{"source":"menstruation disorders","target":"leuprorelin","id":"44354"},{"source":"menstruation disorders","target":"Abbott","id":"44355"},{"source":"menstruation disorders","target":"tamoxifen citrate (tablet)","id":"44356"},{"source":"menstruation disorders","target":"unspecified","id":"44357"},{"source":"prostatic diseases","target":"abemaciclib (capsule) (a)","id":"44358"},{"source":"prostatic diseases","target":"anastrozole (tablet)","id":"44359"},{"source":"prostatic diseases","target":"exemestane","id":"44360"},{"source":"prostatic diseases","target":"goserelin","id":"44361"},{"source":"prostatic diseases","target":"letrozole","id":"44362"},{"source":"prostatic diseases","target":"leuprorelin","id":"44363"},{"source":"prostatic diseases","target":"Abbott","id":"44364"},{"source":"prostatic diseases","target":"tamoxifen citrate (tablet)","id":"44365"},{"source":"prostatic diseases","target":"unspecified","id":"44366"},{"source":"residual tumor","target":"abemaciclib (capsule) (a)","id":"44367"},{"source":"residual tumor","target":"anastrozole (tablet)","id":"44368"},{"source":"residual tumor","target":"exemestane","id":"44369"},{"source":"residual tumor","target":"goserelin","id":"44370"},{"source":"residual tumor","target":"letrozole","id":"44371"},{"source":"residual tumor","target":"leuprorelin","id":"44372"},{"source":"residual tumor","target":"Abbott","id":"44373"},{"source":"residual tumor","target":"tamoxifen citrate (tablet)","id":"44374"},{"source":"residual tumor","target":"unspecified","id":"44375"},{"source":"breast neoplasms","target":"abemaciclib (capsule) (a)","id":"44376"},{"source":"breast neoplasms","target":"anastrozole (tablet)","id":"44377"},{"source":"breast neoplasms","target":"exemestane","id":"44378"},{"source":"breast neoplasms","target":"goserelin","id":"44379"},{"source":"breast neoplasms","target":"letrozole","id":"44380"},{"source":"breast neoplasms","target":"leuprorelin","id":"44381"},{"source":"breast neoplasms","target":"Abbott","id":"44382"},{"source":"breast neoplasms","target":"tamoxifen citrate (tablet)","id":"44383"},{"source":"breast neoplasms","target":"unspecified","id":"44384"},{"source":"carcinoma","target":"abemaciclib (capsule) (a)","id":"44385"},{"source":"carcinoma","target":"anastrozole (tablet)","id":"44386"},{"source":"carcinoma","target":"exemestane","id":"44387"},{"source":"carcinoma","target":"goserelin","id":"44388"},{"source":"carcinoma","target":"letrozole","id":"44389"},{"source":"carcinoma","target":"leuprorelin","id":"44390"},{"source":"carcinoma","target":"Abbott","id":"44391"},{"source":"carcinoma","target":"tamoxifen citrate (tablet)","id":"44392"},{"source":"carcinoma","target":"unspecified","id":"44393"},{"source":"neoplasm metastasis","target":"abemaciclib (capsule) (a)","id":"44394"},{"source":"neoplasm metastasis","target":"anastrozole (tablet)","id":"44395"},{"source":"neoplasm metastasis","target":"exemestane","id":"44396"},{"source":"neoplasm metastasis","target":"goserelin","id":"44397"},{"source":"neoplasm metastasis","target":"letrozole","id":"44398"},{"source":"neoplasm metastasis","target":"leuprorelin","id":"44399"},{"source":"neoplasm metastasis","target":"Abbott","id":"44400"},{"source":"neoplasm metastasis","target":"tamoxifen citrate (tablet)","id":"44401"},{"source":"neoplasm metastasis","target":"unspecified","id":"44402"},{"source":"anticancer","target":"abemaciclib (capsule) (a)","id":"44403"},{"source":"anticancer","target":"anastrozole (tablet)","id":"44404"},{"source":"anticancer","target":"exemestane","id":"44405"},{"source":"anticancer","target":"goserelin","id":"44406"},{"source":"anticancer","target":"letrozole","id":"44407"},{"source":"anticancer","target":"leuprorelin","id":"44408"},{"source":"anticancer","target":"Abbott","id":"44409"},{"source":"anticancer","target":"tamoxifen citrate (tablet)","id":"44410"},{"source":"anticancer","target":"unspecified","id":"44411"},{"source":"hiv infections","target":"abemaciclib (capsule) (a)","id":"44412"},{"source":"hiv infections","target":"anastrozole (tablet)","id":"44413"},{"source":"hiv infections","target":"exemestane","id":"44414"},{"source":"hiv infections","target":"goserelin","id":"44415"},{"source":"hiv infections","target":"letrozole","id":"44416"},{"source":"hiv infections","target":"leuprorelin","id":"44417"},{"source":"hiv infections","target":"Abbott","id":"44418"},{"source":"hiv infections","target":"tamoxifen citrate (tablet)","id":"44419"},{"source":"hiv infections","target":"unspecified","id":"44420"},{"source":"triple-negative breast cancer","target":"abemaciclib (capsule) (a)","id":"44421"},{"source":"triple-negative breast cancer","target":"anastrozole (tablet)","id":"44422"},{"source":"triple-negative breast cancer","target":"exemestane","id":"44423"},{"source":"triple-negative breast cancer","target":"goserelin","id":"44424"},{"source":"triple-negative breast cancer","target":"letrozole","id":"44425"},{"source":"triple-negative breast cancer","target":"leuprorelin","id":"44426"},{"source":"triple-negative breast cancer","target":"Abbott","id":"44427"},{"source":"triple-negative breast cancer","target":"tamoxifen citrate (tablet)","id":"44428"},{"source":"triple-negative breast cancer","target":"unspecified","id":"44429"},{"source":"acquired immunodeficiency syndrome","target":"abemaciclib (capsule) (a)","id":"44430"},{"source":"acquired immunodeficiency syndrome","target":"anastrozole (tablet)","id":"44431"},{"source":"acquired immunodeficiency syndrome","target":"exemestane","id":"44432"},{"source":"acquired immunodeficiency syndrome","target":"goserelin","id":"44433"},{"source":"acquired immunodeficiency syndrome","target":"letrozole","id":"44434"},{"source":"acquired immunodeficiency syndrome","target":"leuprorelin","id":"44435"},{"source":"acquired immunodeficiency syndrome","target":"Abbott","id":"44436"},{"source":"acquired immunodeficiency syndrome","target":"tamoxifen citrate (tablet)","id":"44437"},{"source":"acquired immunodeficiency syndrome","target":"unspecified","id":"44438"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"UNK : Indication","id":"44439"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"menstruation disturbances","id":"44440"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"anti-hiv","id":"44441"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"liver metastases","id":"44442"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"anticancer","id":"44443"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"prostate disorders","id":"44444"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"solid malignancy","id":"44445"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"menstruation disorders","id":"44446"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"prostatic diseases","id":"44447"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"residual tumor","id":"44448"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"breast neoplasms","id":"44449"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"carcinoma","id":"44450"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"neoplasm metastasis","id":"44451"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"anticancer","id":"44452"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"hiv infections","id":"44453"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"triple-negative breast cancer","id":"44454"},{"source":"Luteinizing hormone releasing hormone (LHRH) agonist","target":"acquired immunodeficiency syndrome","id":"44455"},{"source":"NA","target":"UNK : Indication","id":"44456"},{"source":"NA","target":"menstruation disturbances","id":"44457"},{"source":"NA","target":"anti-hiv","id":"44458"},{"source":"NA","target":"liver metastases","id":"44459"},{"source":"NA","target":"anticancer","id":"44460"},{"source":"NA","target":"prostate disorders","id":"44461"},{"source":"NA","target":"solid malignancy","id":"44462"},{"source":"NA","target":"menstruation disorders","id":"44463"},{"source":"NA","target":"prostatic diseases","id":"44464"},{"source":"NA","target":"residual tumor","id":"44465"},{"source":"NA","target":"breast neoplasms","id":"44466"},{"source":"NA","target":"carcinoma","id":"44467"},{"source":"NA","target":"neoplasm metastasis","id":"44468"},{"source":"NA","target":"anticancer","id":"44469"},{"source":"NA","target":"hiv infections","id":"44470"},{"source":"NA","target":"triple-negative breast cancer","id":"44471"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"44472"},{"source":"Selective estrogen receptor modulator","target":"UNK : Indication","id":"44473"},{"source":"Selective estrogen receptor modulator","target":"menstruation disturbances","id":"44474"},{"source":"Selective estrogen receptor modulator","target":"anti-hiv","id":"44475"},{"source":"Selective estrogen receptor modulator","target":"liver metastases","id":"44476"},{"source":"Selective estrogen receptor modulator","target":"anticancer","id":"44477"},{"source":"Selective estrogen receptor modulator","target":"prostate disorders","id":"44478"},{"source":"Selective estrogen receptor modulator","target":"solid malignancy","id":"44479"},{"source":"Selective estrogen receptor modulator","target":"menstruation disorders","id":"44480"},{"source":"Selective estrogen receptor modulator","target":"prostatic diseases","id":"44481"},{"source":"Selective estrogen receptor modulator","target":"residual tumor","id":"44482"},{"source":"Selective estrogen receptor modulator","target":"breast neoplasms","id":"44483"},{"source":"Selective estrogen receptor modulator","target":"carcinoma","id":"44484"},{"source":"Selective estrogen receptor modulator","target":"neoplasm metastasis","id":"44485"},{"source":"Selective estrogen receptor modulator","target":"anticancer","id":"44486"},{"source":"Selective estrogen receptor modulator","target":"hiv infections","id":"44487"},{"source":"Selective estrogen receptor modulator","target":"triple-negative breast cancer","id":"44488"},{"source":"Selective estrogen receptor modulator","target":"acquired immunodeficiency syndrome","id":"44489"},{"source":"NA","target":"UNK : Indication","id":"44490"},{"source":"NA","target":"menstruation disturbances","id":"44491"},{"source":"NA","target":"anti-hiv","id":"44492"},{"source":"NA","target":"liver metastases","id":"44493"},{"source":"NA","target":"anticancer","id":"44494"},{"source":"NA","target":"prostate disorders","id":"44495"},{"source":"NA","target":"solid malignancy","id":"44496"},{"source":"NA","target":"menstruation disorders","id":"44497"},{"source":"NA","target":"prostatic diseases","id":"44498"},{"source":"NA","target":"residual tumor","id":"44499"},{"source":"NA","target":"breast neoplasms","id":"44500"},{"source":"NA","target":"carcinoma","id":"44501"},{"source":"NA","target":"neoplasm metastasis","id":"44502"},{"source":"NA","target":"anticancer","id":"44503"},{"source":"NA","target":"hiv infections","id":"44504"},{"source":"NA","target":"triple-negative breast cancer","id":"44505"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"44506"},{"source":"Estrogen receptor antagonist","target":"UNK : Indication","id":"44507"},{"source":"Estrogen receptor antagonist","target":"menstruation disturbances","id":"44508"},{"source":"Estrogen receptor antagonist","target":"anti-hiv","id":"44509"},{"source":"Estrogen receptor antagonist","target":"liver metastases","id":"44510"},{"source":"Estrogen receptor antagonist","target":"anticancer","id":"44511"},{"source":"Estrogen receptor antagonist","target":"prostate disorders","id":"44512"},{"source":"Estrogen receptor antagonist","target":"solid malignancy","id":"44513"},{"source":"Estrogen receptor antagonist","target":"menstruation disorders","id":"44514"},{"source":"Estrogen receptor antagonist","target":"prostatic diseases","id":"44515"},{"source":"Estrogen receptor antagonist","target":"residual tumor","id":"44516"},{"source":"Estrogen receptor antagonist","target":"breast neoplasms","id":"44517"},{"source":"Estrogen receptor antagonist","target":"carcinoma","id":"44518"},{"source":"Estrogen receptor antagonist","target":"neoplasm metastasis","id":"44519"},{"source":"Estrogen receptor antagonist","target":"anticancer","id":"44520"},{"source":"Estrogen receptor antagonist","target":"hiv infections","id":"44521"},{"source":"Estrogen receptor antagonist","target":"triple-negative breast cancer","id":"44522"},{"source":"Estrogen receptor antagonist","target":"acquired immunodeficiency syndrome","id":"44523"},{"source":"Aromatase inhibitor","target":"UNK : Indication","id":"44524"},{"source":"Aromatase inhibitor","target":"menstruation disturbances","id":"44525"},{"source":"Aromatase inhibitor","target":"anti-hiv","id":"44526"},{"source":"Aromatase inhibitor","target":"liver metastases","id":"44527"},{"source":"Aromatase inhibitor","target":"anticancer","id":"44528"},{"source":"Aromatase inhibitor","target":"prostate disorders","id":"44529"},{"source":"Aromatase inhibitor","target":"solid malignancy","id":"44530"},{"source":"Aromatase inhibitor","target":"menstruation disorders","id":"44531"},{"source":"Aromatase inhibitor","target":"prostatic diseases","id":"44532"},{"source":"Aromatase inhibitor","target":"residual tumor","id":"44533"},{"source":"Aromatase inhibitor","target":"breast neoplasms","id":"44534"},{"source":"Aromatase inhibitor","target":"carcinoma","id":"44535"},{"source":"Aromatase inhibitor","target":"neoplasm metastasis","id":"44536"},{"source":"Aromatase inhibitor","target":"anticancer","id":"44537"},{"source":"Aromatase inhibitor","target":"hiv infections","id":"44538"},{"source":"Aromatase inhibitor","target":"triple-negative breast cancer","id":"44539"},{"source":"Aromatase inhibitor","target":"acquired immunodeficiency syndrome","id":"44540"},{"source":"Oncology: Breast","target":"Luteinizing hormone releasing hormone (LHRH) agonist","id":"44541"},{"source":"Oncology: Breast","target":"NA","id":"44542"},{"source":"Oncology: Breast","target":"Selective estrogen receptor modulator","id":"44543"},{"source":"Oncology: Breast","target":"NA","id":"44544"},{"source":"Oncology: Breast","target":"Estrogen receptor antagonist","id":"44545"},{"source":"Oncology: Breast","target":"Aromatase inhibitor","id":"44546"},{"source":"bemcentinib (u)","target":"(Other Hospital/Academic/Medical Center)","id":"44547"},{"source":"bemcentinib (u)","target":"BerGenBio","id":"44548"},{"source":"bemcentinib (u)","target":"University of Texas","id":"44549"},{"source":"docetaxel","target":"(Other Hospital/Academic/Medical Center)","id":"44550"},{"source":"docetaxel","target":"BerGenBio","id":"44551"},{"source":"docetaxel","target":"University of Texas","id":"44552"},{"source":"non-small-cell lung","target":"bemcentinib (u)","id":"44553"},{"source":"non-small-cell lung","target":"docetaxel","id":"44554"},{"source":"ovarian neoplasms","target":"bemcentinib (u)","id":"44555"},{"source":"ovarian neoplasms","target":"docetaxel","id":"44556"},{"source":"malaria","target":"bemcentinib (u)","id":"44557"},{"source":"malaria","target":"docetaxel","id":"44558"},{"source":"non-small-cell lung","target":"bemcentinib (u)","id":"44559"},{"source":"non-small-cell lung","target":"docetaxel","id":"44560"},{"source":"infertility","target":"bemcentinib (u)","id":"44561"},{"source":"infertility","target":"docetaxel","id":"44562"},{"source":"malaria","target":"bemcentinib (u)","id":"44563"},{"source":"malaria","target":"docetaxel","id":"44564"},{"source":"alopecia","target":"bemcentinib (u)","id":"44565"},{"source":"alopecia","target":"docetaxel","id":"44566"},{"source":"sterility","target":"bemcentinib (u)","id":"44567"},{"source":"sterility","target":"docetaxel","id":"44568"},{"source":"sclc","target":"bemcentinib (u)","id":"44569"},{"source":"sclc","target":"docetaxel","id":"44570"},{"source":"non-small-cell lung","target":"bemcentinib (u)","id":"44571"},{"source":"non-small-cell lung","target":"docetaxel","id":"44572"},{"source":"carcinoma","target":"bemcentinib (u)","id":"44573"},{"source":"carcinoma","target":"docetaxel","id":"44574"},{"source":"liver metastases","target":"bemcentinib (u)","id":"44575"},{"source":"liver metastases","target":"docetaxel","id":"44576"},{"source":"cerebellar neoplasms","target":"bemcentinib (u)","id":"44577"},{"source":"cerebellar neoplasms","target":"docetaxel","id":"44578"},{"source":"carcinoma","target":"bemcentinib (u)","id":"44579"},{"source":"carcinoma","target":"docetaxel","id":"44580"},{"source":"brain metastases","target":"bemcentinib (u)","id":"44581"},{"source":"brain metastases","target":"docetaxel","id":"44582"},{"source":"anticancer","target":"bemcentinib (u)","id":"44583"},{"source":"anticancer","target":"docetaxel","id":"44584"},{"source":"lung neoplasms","target":"bemcentinib (u)","id":"44585"},{"source":"lung neoplasms","target":"docetaxel","id":"44586"},{"source":"liver neoplasms","target":"bemcentinib (u)","id":"44587"},{"source":"liver neoplasms","target":"docetaxel","id":"44588"},{"source":"anticancer","target":"bemcentinib (u)","id":"44589"},{"source":"anticancer","target":"docetaxel","id":"44590"},{"source":"Taxane","target":"non-small-cell lung","id":"44591"},{"source":"Taxane","target":"ovarian neoplasms","id":"44592"},{"source":"Taxane","target":"malaria","id":"44593"},{"source":"Taxane","target":"non-small-cell lung","id":"44594"},{"source":"Taxane","target":"infertility","id":"44595"},{"source":"Taxane","target":"malaria","id":"44596"},{"source":"Taxane","target":"alopecia","id":"44597"},{"source":"Taxane","target":"sterility","id":"44598"},{"source":"Taxane","target":"sclc","id":"44599"},{"source":"Taxane","target":"non-small-cell lung","id":"44600"},{"source":"Taxane","target":"carcinoma","id":"44601"},{"source":"Taxane","target":"liver metastases","id":"44602"},{"source":"Taxane","target":"cerebellar neoplasms","id":"44603"},{"source":"Taxane","target":"carcinoma","id":"44604"},{"source":"Taxane","target":"brain metastases","id":"44605"},{"source":"Taxane","target":"anticancer","id":"44606"},{"source":"Taxane","target":"lung neoplasms","id":"44607"},{"source":"Taxane","target":"liver neoplasms","id":"44608"},{"source":"Taxane","target":"anticancer","id":"44609"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"44610"},{"source":"Tubulin inhibitor","target":"ovarian neoplasms","id":"44611"},{"source":"Tubulin inhibitor","target":"malaria","id":"44612"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"44613"},{"source":"Tubulin inhibitor","target":"infertility","id":"44614"},{"source":"Tubulin inhibitor","target":"malaria","id":"44615"},{"source":"Tubulin inhibitor","target":"alopecia","id":"44616"},{"source":"Tubulin inhibitor","target":"sterility","id":"44617"},{"source":"Tubulin inhibitor","target":"sclc","id":"44618"},{"source":"Tubulin inhibitor","target":"non-small-cell lung","id":"44619"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"44620"},{"source":"Tubulin inhibitor","target":"liver metastases","id":"44621"},{"source":"Tubulin inhibitor","target":"cerebellar neoplasms","id":"44622"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"44623"},{"source":"Tubulin inhibitor","target":"brain metastases","id":"44624"},{"source":"Tubulin inhibitor","target":"anticancer","id":"44625"},{"source":"Tubulin inhibitor","target":"lung neoplasms","id":"44626"},{"source":"Tubulin inhibitor","target":"liver neoplasms","id":"44627"},{"source":"Tubulin inhibitor","target":"anticancer","id":"44628"},{"source":"NA","target":"non-small-cell lung","id":"44629"},{"source":"NA","target":"ovarian neoplasms","id":"44630"},{"source":"NA","target":"malaria","id":"44631"},{"source":"NA","target":"non-small-cell lung","id":"44632"},{"source":"NA","target":"infertility","id":"44633"},{"source":"NA","target":"malaria","id":"44634"},{"source":"NA","target":"alopecia","id":"44635"},{"source":"NA","target":"sterility","id":"44636"},{"source":"NA","target":"sclc","id":"44637"},{"source":"NA","target":"non-small-cell lung","id":"44638"},{"source":"NA","target":"carcinoma","id":"44639"},{"source":"NA","target":"liver metastases","id":"44640"},{"source":"NA","target":"cerebellar neoplasms","id":"44641"},{"source":"NA","target":"carcinoma","id":"44642"},{"source":"NA","target":"brain metastases","id":"44643"},{"source":"NA","target":"anticancer","id":"44644"},{"source":"NA","target":"lung neoplasms","id":"44645"},{"source":"NA","target":"liver neoplasms","id":"44646"},{"source":"NA","target":"anticancer","id":"44647"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"44648"},{"source":"Microtubule stimulant","target":"ovarian neoplasms","id":"44649"},{"source":"Microtubule stimulant","target":"malaria","id":"44650"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"44651"},{"source":"Microtubule stimulant","target":"infertility","id":"44652"},{"source":"Microtubule stimulant","target":"malaria","id":"44653"},{"source":"Microtubule stimulant","target":"alopecia","id":"44654"},{"source":"Microtubule stimulant","target":"sterility","id":"44655"},{"source":"Microtubule stimulant","target":"sclc","id":"44656"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"44657"},{"source":"Microtubule stimulant","target":"carcinoma","id":"44658"},{"source":"Microtubule stimulant","target":"liver metastases","id":"44659"},{"source":"Microtubule stimulant","target":"cerebellar neoplasms","id":"44660"},{"source":"Microtubule stimulant","target":"carcinoma","id":"44661"},{"source":"Microtubule stimulant","target":"brain metastases","id":"44662"},{"source":"Microtubule stimulant","target":"anticancer","id":"44663"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"44664"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"44665"},{"source":"Microtubule stimulant","target":"anticancer","id":"44666"},{"source":"Oncology: Lung","target":"Taxane","id":"44667"},{"source":"Oncology: Lung","target":"Tubulin inhibitor","id":"44668"},{"source":"Oncology: Lung","target":"NA","id":"44669"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"44670"},{"source":"Non-Small Cell","target":"Taxane","id":"44671"},{"source":"Non-Small Cell","target":"Tubulin inhibitor","id":"44672"},{"source":"Non-Small Cell","target":"NA","id":"44673"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"44674"},{"source":"pembrolizumab","target":"Merck & Co.","id":"44675"},{"source":"carboplatin","target":"Merck & Co.","id":"44676"},{"source":"cetuximab","target":"Merck & Co.","id":"44677"},{"source":"cisplatin","target":"Merck & Co.","id":"44678"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"44679"},{"source":"larynx cancer","target":"pembrolizumab","id":"44680"},{"source":"larynx cancer","target":"carboplatin","id":"44681"},{"source":"larynx cancer","target":"cetuximab","id":"44682"},{"source":"larynx cancer","target":"cisplatin","id":"44683"},{"source":"larynx cancer","target":"5-fluorouracil","id":"44684"},{"source":"oropharyngeal cancer","target":"pembrolizumab","id":"44685"},{"source":"oropharyngeal cancer","target":"carboplatin","id":"44686"},{"source":"oropharyngeal cancer","target":"cetuximab","id":"44687"},{"source":"oropharyngeal cancer","target":"cisplatin","id":"44688"},{"source":"oropharyngeal cancer","target":"5-fluorouracil","id":"44689"},{"source":"sclc","target":"pembrolizumab","id":"44690"},{"source":"sclc","target":"carboplatin","id":"44691"},{"source":"sclc","target":"cetuximab","id":"44692"},{"source":"sclc","target":"cisplatin","id":"44693"},{"source":"sclc","target":"5-fluorouracil","id":"44694"},{"source":"carcinoma","target":"pembrolizumab","id":"44695"},{"source":"carcinoma","target":"carboplatin","id":"44696"},{"source":"carcinoma","target":"cetuximab","id":"44697"},{"source":"carcinoma","target":"cisplatin","id":"44698"},{"source":"carcinoma","target":"5-fluorouracil","id":"44699"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"44700"},{"source":"pharyngeal neoplasms","target":"carboplatin","id":"44701"},{"source":"pharyngeal neoplasms","target":"cetuximab","id":"44702"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"44703"},{"source":"pharyngeal neoplasms","target":"5-fluorouracil","id":"44704"},{"source":"carcinoma","target":"pembrolizumab","id":"44705"},{"source":"carcinoma","target":"carboplatin","id":"44706"},{"source":"carcinoma","target":"cetuximab","id":"44707"},{"source":"carcinoma","target":"cisplatin","id":"44708"},{"source":"carcinoma","target":"5-fluorouracil","id":"44709"},{"source":"hpv type","target":"pembrolizumab","id":"44710"},{"source":"hpv type","target":"carboplatin","id":"44711"},{"source":"hpv type","target":"cetuximab","id":"44712"},{"source":"hpv type","target":"cisplatin","id":"44713"},{"source":"hpv type","target":"5-fluorouracil","id":"44714"},{"source":"carcinoma","target":"pembrolizumab","id":"44715"},{"source":"carcinoma","target":"carboplatin","id":"44716"},{"source":"carcinoma","target":"cetuximab","id":"44717"},{"source":"carcinoma","target":"cisplatin","id":"44718"},{"source":"carcinoma","target":"5-fluorouracil","id":"44719"},{"source":"residual tumor","target":"pembrolizumab","id":"44720"},{"source":"residual tumor","target":"carboplatin","id":"44721"},{"source":"residual tumor","target":"cetuximab","id":"44722"},{"source":"residual tumor","target":"cisplatin","id":"44723"},{"source":"residual tumor","target":"5-fluorouracil","id":"44724"},{"source":"metastatic","target":"pembrolizumab","id":"44725"},{"source":"metastatic","target":"carboplatin","id":"44726"},{"source":"metastatic","target":"cetuximab","id":"44727"},{"source":"metastatic","target":"cisplatin","id":"44728"},{"source":"metastatic","target":"5-fluorouracil","id":"44729"},{"source":"carcinoma","target":"pembrolizumab","id":"44730"},{"source":"carcinoma","target":"carboplatin","id":"44731"},{"source":"carcinoma","target":"cetuximab","id":"44732"},{"source":"carcinoma","target":"cisplatin","id":"44733"},{"source":"carcinoma","target":"5-fluorouracil","id":"44734"},{"source":"hpv testing","target":"pembrolizumab","id":"44735"},{"source":"hpv testing","target":"carboplatin","id":"44736"},{"source":"hpv testing","target":"cetuximab","id":"44737"},{"source":"hpv testing","target":"cisplatin","id":"44738"},{"source":"hpv testing","target":"5-fluorouracil","id":"44739"},{"source":"larynx cancer","target":"pembrolizumab","id":"44740"},{"source":"larynx cancer","target":"carboplatin","id":"44741"},{"source":"larynx cancer","target":"cetuximab","id":"44742"},{"source":"larynx cancer","target":"cisplatin","id":"44743"},{"source":"larynx cancer","target":"5-fluorouracil","id":"44744"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"44745"},{"source":"neoplasm metastasis","target":"carboplatin","id":"44746"},{"source":"neoplasm metastasis","target":"cetuximab","id":"44747"},{"source":"neoplasm metastasis","target":"cisplatin","id":"44748"},{"source":"neoplasm metastasis","target":"5-fluorouracil","id":"44749"},{"source":"anticancer","target":"pembrolizumab","id":"44750"},{"source":"anticancer","target":"carboplatin","id":"44751"},{"source":"anticancer","target":"cetuximab","id":"44752"},{"source":"anticancer","target":"cisplatin","id":"44753"},{"source":"anticancer","target":"5-fluorouracil","id":"44754"},{"source":"papilloma","target":"pembrolizumab","id":"44755"},{"source":"papilloma","target":"carboplatin","id":"44756"},{"source":"papilloma","target":"cetuximab","id":"44757"},{"source":"papilloma","target":"cisplatin","id":"44758"},{"source":"papilloma","target":"5-fluorouracil","id":"44759"},{"source":"pharyngeal neoplasms","target":"pembrolizumab","id":"44760"},{"source":"pharyngeal neoplasms","target":"carboplatin","id":"44761"},{"source":"pharyngeal neoplasms","target":"cetuximab","id":"44762"},{"source":"pharyngeal neoplasms","target":"cisplatin","id":"44763"},{"source":"pharyngeal neoplasms","target":"5-fluorouracil","id":"44764"},{"source":"carcinoma","target":"pembrolizumab","id":"44765"},{"source":"carcinoma","target":"carboplatin","id":"44766"},{"source":"carcinoma","target":"cetuximab","id":"44767"},{"source":"carcinoma","target":"cisplatin","id":"44768"},{"source":"carcinoma","target":"5-fluorouracil","id":"44769"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"44770"},{"source":"head and neck neoplasms","target":"carboplatin","id":"44771"},{"source":"head and neck neoplasms","target":"cetuximab","id":"44772"},{"source":"head and neck neoplasms","target":"cisplatin","id":"44773"},{"source":"head and neck neoplasms","target":"5-fluorouracil","id":"44774"},{"source":"EGFR antagonist","target":"larynx cancer","id":"44775"},{"source":"EGFR antagonist","target":"oropharyngeal cancer","id":"44776"},{"source":"EGFR antagonist","target":"sclc","id":"44777"},{"source":"EGFR antagonist","target":"carcinoma","id":"44778"},{"source":"EGFR antagonist","target":"pharyngeal neoplasms","id":"44779"},{"source":"EGFR antagonist","target":"carcinoma","id":"44780"},{"source":"EGFR antagonist","target":"hpv type","id":"44781"},{"source":"EGFR antagonist","target":"carcinoma","id":"44782"},{"source":"EGFR antagonist","target":"residual tumor","id":"44783"},{"source":"EGFR antagonist","target":"metastatic","id":"44784"},{"source":"EGFR antagonist","target":"carcinoma","id":"44785"},{"source":"EGFR antagonist","target":"hpv testing","id":"44786"},{"source":"EGFR antagonist","target":"larynx cancer","id":"44787"},{"source":"EGFR antagonist","target":"neoplasm metastasis","id":"44788"},{"source":"EGFR antagonist","target":"anticancer","id":"44789"},{"source":"EGFR antagonist","target":"papilloma","id":"44790"},{"source":"EGFR antagonist","target":"pharyngeal neoplasms","id":"44791"},{"source":"EGFR antagonist","target":"carcinoma","id":"44792"},{"source":"EGFR antagonist","target":"head and neck neoplasms","id":"44793"},{"source":"Immune checkpoint inhibitor","target":"larynx cancer","id":"44794"},{"source":"Immune checkpoint inhibitor","target":"oropharyngeal cancer","id":"44795"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"44796"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44797"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"44798"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44799"},{"source":"Immune checkpoint inhibitor","target":"hpv type","id":"44800"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44801"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"44802"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"44803"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44804"},{"source":"Immune checkpoint inhibitor","target":"hpv testing","id":"44805"},{"source":"Immune checkpoint inhibitor","target":"larynx cancer","id":"44806"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"44807"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"44808"},{"source":"Immune checkpoint inhibitor","target":"papilloma","id":"44809"},{"source":"Immune checkpoint inhibitor","target":"pharyngeal neoplasms","id":"44810"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"44811"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"44812"},{"source":"Anticancer immunotherapy","target":"larynx cancer","id":"44813"},{"source":"Anticancer immunotherapy","target":"oropharyngeal cancer","id":"44814"},{"source":"Anticancer immunotherapy","target":"sclc","id":"44815"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44816"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"44817"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44818"},{"source":"Anticancer immunotherapy","target":"hpv type","id":"44819"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44820"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"44821"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"44822"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44823"},{"source":"Anticancer immunotherapy","target":"hpv testing","id":"44824"},{"source":"Anticancer immunotherapy","target":"larynx cancer","id":"44825"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"44826"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"44827"},{"source":"Anticancer immunotherapy","target":"papilloma","id":"44828"},{"source":"Anticancer immunotherapy","target":"pharyngeal neoplasms","id":"44829"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44830"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"44831"},{"source":"CD19 antagonist","target":"larynx cancer","id":"44832"},{"source":"CD19 antagonist","target":"oropharyngeal cancer","id":"44833"},{"source":"CD19 antagonist","target":"sclc","id":"44834"},{"source":"CD19 antagonist","target":"carcinoma","id":"44835"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"44836"},{"source":"CD19 antagonist","target":"carcinoma","id":"44837"},{"source":"CD19 antagonist","target":"hpv type","id":"44838"},{"source":"CD19 antagonist","target":"carcinoma","id":"44839"},{"source":"CD19 antagonist","target":"residual tumor","id":"44840"},{"source":"CD19 antagonist","target":"metastatic","id":"44841"},{"source":"CD19 antagonist","target":"carcinoma","id":"44842"},{"source":"CD19 antagonist","target":"hpv testing","id":"44843"},{"source":"CD19 antagonist","target":"larynx cancer","id":"44844"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"44845"},{"source":"CD19 antagonist","target":"anticancer","id":"44846"},{"source":"CD19 antagonist","target":"papilloma","id":"44847"},{"source":"CD19 antagonist","target":"pharyngeal neoplasms","id":"44848"},{"source":"CD19 antagonist","target":"carcinoma","id":"44849"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"44850"},{"source":"NA","target":"larynx cancer","id":"44851"},{"source":"NA","target":"oropharyngeal cancer","id":"44852"},{"source":"NA","target":"sclc","id":"44853"},{"source":"NA","target":"carcinoma","id":"44854"},{"source":"NA","target":"pharyngeal neoplasms","id":"44855"},{"source":"NA","target":"carcinoma","id":"44856"},{"source":"NA","target":"hpv type","id":"44857"},{"source":"NA","target":"carcinoma","id":"44858"},{"source":"NA","target":"residual tumor","id":"44859"},{"source":"NA","target":"metastatic","id":"44860"},{"source":"NA","target":"carcinoma","id":"44861"},{"source":"NA","target":"hpv testing","id":"44862"},{"source":"NA","target":"larynx cancer","id":"44863"},{"source":"NA","target":"neoplasm metastasis","id":"44864"},{"source":"NA","target":"anticancer","id":"44865"},{"source":"NA","target":"papilloma","id":"44866"},{"source":"NA","target":"pharyngeal neoplasms","id":"44867"},{"source":"NA","target":"carcinoma","id":"44868"},{"source":"NA","target":"head and neck neoplasms","id":"44869"},{"source":"NA","target":"larynx cancer","id":"44870"},{"source":"NA","target":"oropharyngeal cancer","id":"44871"},{"source":"NA","target":"sclc","id":"44872"},{"source":"NA","target":"carcinoma","id":"44873"},{"source":"NA","target":"pharyngeal neoplasms","id":"44874"},{"source":"NA","target":"carcinoma","id":"44875"},{"source":"NA","target":"hpv type","id":"44876"},{"source":"NA","target":"carcinoma","id":"44877"},{"source":"NA","target":"residual tumor","id":"44878"},{"source":"NA","target":"metastatic","id":"44879"},{"source":"NA","target":"carcinoma","id":"44880"},{"source":"NA","target":"hpv testing","id":"44881"},{"source":"NA","target":"larynx cancer","id":"44882"},{"source":"NA","target":"neoplasm metastasis","id":"44883"},{"source":"NA","target":"anticancer","id":"44884"},{"source":"NA","target":"papilloma","id":"44885"},{"source":"NA","target":"pharyngeal neoplasms","id":"44886"},{"source":"NA","target":"carcinoma","id":"44887"},{"source":"NA","target":"head and neck neoplasms","id":"44888"},{"source":"NA","target":"larynx cancer","id":"44889"},{"source":"NA","target":"oropharyngeal cancer","id":"44890"},{"source":"NA","target":"sclc","id":"44891"},{"source":"NA","target":"carcinoma","id":"44892"},{"source":"NA","target":"pharyngeal neoplasms","id":"44893"},{"source":"NA","target":"carcinoma","id":"44894"},{"source":"NA","target":"hpv type","id":"44895"},{"source":"NA","target":"carcinoma","id":"44896"},{"source":"NA","target":"residual tumor","id":"44897"},{"source":"NA","target":"metastatic","id":"44898"},{"source":"NA","target":"carcinoma","id":"44899"},{"source":"NA","target":"hpv testing","id":"44900"},{"source":"NA","target":"larynx cancer","id":"44901"},{"source":"NA","target":"neoplasm metastasis","id":"44902"},{"source":"NA","target":"anticancer","id":"44903"},{"source":"NA","target":"papilloma","id":"44904"},{"source":"NA","target":"pharyngeal neoplasms","id":"44905"},{"source":"NA","target":"carcinoma","id":"44906"},{"source":"NA","target":"head and neck neoplasms","id":"44907"},{"source":"Thymidylate synthase inhibitor","target":"larynx cancer","id":"44908"},{"source":"Thymidylate synthase inhibitor","target":"oropharyngeal cancer","id":"44909"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"44910"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"44911"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"44912"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"44913"},{"source":"Thymidylate synthase inhibitor","target":"hpv type","id":"44914"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"44915"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"44916"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"44917"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"44918"},{"source":"Thymidylate synthase inhibitor","target":"hpv testing","id":"44919"},{"source":"Thymidylate synthase inhibitor","target":"larynx cancer","id":"44920"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"44921"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"44922"},{"source":"Thymidylate synthase inhibitor","target":"papilloma","id":"44923"},{"source":"Thymidylate synthase inhibitor","target":"pharyngeal neoplasms","id":"44924"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"44925"},{"source":"Thymidylate synthase inhibitor","target":"head and neck neoplasms","id":"44926"},{"source":"Oncology: Head/Neck","target":"EGFR antagonist","id":"44927"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"44928"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"44929"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"44930"},{"source":"Oncology: Head/Neck","target":"NA","id":"44931"},{"source":"Oncology: Head/Neck","target":"NA","id":"44932"},{"source":"Oncology: Head/Neck","target":"NA","id":"44933"},{"source":"Oncology: Head/Neck","target":"Thymidylate synthase inhibitor","id":"44934"},{"source":"IMO-2125 (intratumoral) (u)","target":"Idera Pharmaceuticals {Hybridon}","id":"44935"},{"source":"ipilimumab","target":"Idera Pharmaceuticals {Hybridon}","id":"44936"},{"source":"UNK : Indication","target":"IMO-2125 (intratumoral) (u)","id":"44937"},{"source":"UNK : Indication","target":"ipilimumab","id":"44938"},{"source":"anti-hiv","target":"IMO-2125 (intratumoral) (u)","id":"44939"},{"source":"anti-hiv","target":"ipilimumab","id":"44940"},{"source":"melanoma","target":"IMO-2125 (intratumoral) (u)","id":"44941"},{"source":"melanoma","target":"ipilimumab","id":"44942"},{"source":"melanoma","target":"IMO-2125 (intratumoral) (u)","id":"44943"},{"source":"melanoma","target":"ipilimumab","id":"44944"},{"source":"anticancer","target":"IMO-2125 (intratumoral) (u)","id":"44945"},{"source":"anticancer","target":"ipilimumab","id":"44946"},{"source":"skin neoplasms","target":"IMO-2125 (intratumoral) (u)","id":"44947"},{"source":"skin neoplasms","target":"ipilimumab","id":"44948"},{"source":"residual tumor","target":"IMO-2125 (intratumoral) (u)","id":"44949"},{"source":"residual tumor","target":"ipilimumab","id":"44950"},{"source":"gilbert syndrome","target":"IMO-2125 (intratumoral) (u)","id":"44951"},{"source":"gilbert syndrome","target":"ipilimumab","id":"44952"},{"source":"carcinoma","target":"IMO-2125 (intratumoral) (u)","id":"44953"},{"source":"carcinoma","target":"ipilimumab","id":"44954"},{"source":"gilbert disease","target":"IMO-2125 (intratumoral) (u)","id":"44955"},{"source":"gilbert disease","target":"ipilimumab","id":"44956"},{"source":"anticancer","target":"IMO-2125 (intratumoral) (u)","id":"44957"},{"source":"anticancer","target":"ipilimumab","id":"44958"},{"source":"hiv infections","target":"IMO-2125 (intratumoral) (u)","id":"44959"},{"source":"hiv infections","target":"ipilimumab","id":"44960"},{"source":"acquired immunodeficiency syndrome","target":"IMO-2125 (intratumoral) (u)","id":"44961"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"44962"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"44963"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"44964"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"44965"},{"source":"Anticancer immunotherapy","target":"melanoma","id":"44966"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"44967"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"44968"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"44969"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"44970"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"44971"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"44972"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"44973"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"44974"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"44975"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"44976"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"44977"},{"source":"CTLA4 antagonist","target":"melanoma","id":"44978"},{"source":"CTLA4 antagonist","target":"melanoma","id":"44979"},{"source":"CTLA4 antagonist","target":"anticancer","id":"44980"},{"source":"CTLA4 antagonist","target":"skin neoplasms","id":"44981"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"44982"},{"source":"CTLA4 antagonist","target":"gilbert syndrome","id":"44983"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"44984"},{"source":"CTLA4 antagonist","target":"gilbert disease","id":"44985"},{"source":"CTLA4 antagonist","target":"anticancer","id":"44986"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"44987"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"44988"},{"source":"Toll-like receptor 9 agonist","target":"UNK : Indication","id":"44989"},{"source":"Toll-like receptor 9 agonist","target":"anti-hiv","id":"44990"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"44991"},{"source":"Toll-like receptor 9 agonist","target":"melanoma","id":"44992"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"44993"},{"source":"Toll-like receptor 9 agonist","target":"skin neoplasms","id":"44994"},{"source":"Toll-like receptor 9 agonist","target":"residual tumor","id":"44995"},{"source":"Toll-like receptor 9 agonist","target":"gilbert syndrome","id":"44996"},{"source":"Toll-like receptor 9 agonist","target":"carcinoma","id":"44997"},{"source":"Toll-like receptor 9 agonist","target":"gilbert disease","id":"44998"},{"source":"Toll-like receptor 9 agonist","target":"anticancer","id":"44999"},{"source":"Toll-like receptor 9 agonist","target":"hiv infections","id":"45000"},{"source":"Toll-like receptor 9 agonist","target":"acquired immunodeficiency syndrome","id":"45001"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"45002"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"45003"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"45004"},{"source":"Immune checkpoint inhibitor","target":"melanoma","id":"45005"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"45006"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"45007"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"45008"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"45009"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"45010"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"45011"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"45012"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"45013"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"45014"},{"source":"Oncology: Melanoma","target":"Anticancer immunotherapy","id":"45015"},{"source":"Oncology: Melanoma","target":"CTLA4 antagonist","id":"45016"},{"source":"Oncology: Melanoma","target":"Toll-like receptor 9 agonist","id":"45017"},{"source":"Oncology: Melanoma","target":"Immune checkpoint inhibitor","id":"45018"},{"source":"abemaciclib (capsule) (a)","target":"Eli Lilly","id":"45019"},{"source":"fulvestrant (IM)","target":"Eli Lilly","id":"45020"},{"source":"UNK : Indication","target":"abemaciclib (capsule) (a)","id":"45021"},{"source":"UNK : Indication","target":"fulvestrant (IM)","id":"45022"},{"source":"colorectal neoplasms","target":"abemaciclib (capsule) (a)","id":"45023"},{"source":"colorectal neoplasms","target":"fulvestrant (IM)","id":"45024"},{"source":"anticancer","target":"abemaciclib (capsule) (a)","id":"45025"},{"source":"anticancer","target":"fulvestrant (IM)","id":"45026"},{"source":"astrocytoma","target":"abemaciclib (capsule) (a)","id":"45027"},{"source":"astrocytoma","target":"fulvestrant (IM)","id":"45028"},{"source":"ovarian cancer","target":"abemaciclib (capsule) (a)","id":"45029"},{"source":"ovarian cancer","target":"fulvestrant (IM)","id":"45030"},{"source":"menstruation disorders","target":"abemaciclib (capsule) (a)","id":"45031"},{"source":"menstruation disorders","target":"fulvestrant (IM)","id":"45032"},{"source":"glioblastoma","target":"abemaciclib (capsule) (a)","id":"45033"},{"source":"glioblastoma","target":"fulvestrant (IM)","id":"45034"},{"source":"non-small-cell lung","target":"abemaciclib (capsule) (a)","id":"45035"},{"source":"non-small-cell lung","target":"fulvestrant (IM)","id":"45036"},{"source":"lymphoma","target":"abemaciclib (capsule) (a)","id":"45037"},{"source":"lymphoma","target":"fulvestrant (IM)","id":"45038"},{"source":"melanoma","target":"abemaciclib (capsule) (a)","id":"45039"},{"source":"melanoma","target":"fulvestrant (IM)","id":"45040"},{"source":"solid tumors","target":"abemaciclib (capsule) (a)","id":"45041"},{"source":"solid tumors","target":"fulvestrant (IM)","id":"45042"},{"source":"glioblastoma","target":"abemaciclib (capsule) (a)","id":"45043"},{"source":"glioblastoma","target":"fulvestrant (IM)","id":"45044"},{"source":"breast neoplasms","target":"abemaciclib (capsule) (a)","id":"45045"},{"source":"breast neoplasms","target":"fulvestrant (IM)","id":"45046"},{"source":"colonic neoplasms","target":"abemaciclib (capsule) (a)","id":"45047"},{"source":"colonic neoplasms","target":"fulvestrant (IM)","id":"45048"},{"source":"triple-negative breast cancer","target":"abemaciclib (capsule) (a)","id":"45049"},{"source":"triple-negative breast cancer","target":"fulvestrant (IM)","id":"45050"},{"source":"ovarian neoplasms","target":"abemaciclib (capsule) (a)","id":"45051"},{"source":"ovarian neoplasms","target":"fulvestrant (IM)","id":"45052"},{"source":"menstruation disturbances","target":"abemaciclib (capsule) (a)","id":"45053"},{"source":"menstruation disturbances","target":"fulvestrant (IM)","id":"45054"},{"source":"colorectal cancer","target":"abemaciclib (capsule) (a)","id":"45055"},{"source":"colorectal cancer","target":"fulvestrant (IM)","id":"45056"},{"source":"alopecia","target":"abemaciclib (capsule) (a)","id":"45057"},{"source":"alopecia","target":"fulvestrant (IM)","id":"45058"},{"source":"carcinoma","target":"abemaciclib (capsule) (a)","id":"45059"},{"source":"carcinoma","target":"fulvestrant (IM)","id":"45060"},{"source":"non-small-cell lung","target":"abemaciclib (capsule) (a)","id":"45061"},{"source":"non-small-cell lung","target":"fulvestrant (IM)","id":"45062"},{"source":"carcinoma","target":"abemaciclib (capsule) (a)","id":"45063"},{"source":"carcinoma","target":"fulvestrant (IM)","id":"45064"},{"source":"neoplasm metastasis","target":"abemaciclib (capsule) (a)","id":"45065"},{"source":"neoplasm metastasis","target":"fulvestrant (IM)","id":"45066"},{"source":"lymphoma","target":"abemaciclib (capsule) (a)","id":"45067"},{"source":"lymphoma","target":"fulvestrant (IM)","id":"45068"},{"source":"colorectal neoplasms","target":"abemaciclib (capsule) (a)","id":"45069"},{"source":"colorectal neoplasms","target":"fulvestrant (IM)","id":"45070"},{"source":"lymphoma","target":"abemaciclib (capsule) (a)","id":"45071"},{"source":"lymphoma","target":"fulvestrant (IM)","id":"45072"},{"source":"skin neoplasms","target":"abemaciclib (capsule) (a)","id":"45073"},{"source":"skin neoplasms","target":"fulvestrant (IM)","id":"45074"},{"source":"hodgkin disease","target":"abemaciclib (capsule) (a)","id":"45075"},{"source":"hodgkin disease","target":"fulvestrant (IM)","id":"45076"},{"source":"anticancer","target":"abemaciclib (capsule) (a)","id":"45077"},{"source":"anticancer","target":"fulvestrant (IM)","id":"45078"},{"source":"metastatic","target":"abemaciclib (capsule) (a)","id":"45079"},{"source":"metastatic","target":"fulvestrant (IM)","id":"45080"},{"source":"non-hodgkin","target":"abemaciclib (capsule) (a)","id":"45081"},{"source":"non-hodgkin","target":"fulvestrant (IM)","id":"45082"},{"source":"lymphoma","target":"abemaciclib (capsule) (a)","id":"45083"},{"source":"lymphoma","target":"fulvestrant (IM)","id":"45084"},{"source":"anticancer","target":"abemaciclib (capsule) (a)","id":"45085"},{"source":"anticancer","target":"fulvestrant (IM)","id":"45086"},{"source":"solid tumors","target":"abemaciclib (capsule) (a)","id":"45087"},{"source":"solid tumors","target":"fulvestrant (IM)","id":"45088"},{"source":"NA","target":"UNK : Indication","id":"45089"},{"source":"NA","target":"colorectal neoplasms","id":"45090"},{"source":"NA","target":"anticancer","id":"45091"},{"source":"NA","target":"astrocytoma","id":"45092"},{"source":"NA","target":"ovarian cancer","id":"45093"},{"source":"NA","target":"menstruation disorders","id":"45094"},{"source":"NA","target":"glioblastoma","id":"45095"},{"source":"NA","target":"non-small-cell lung","id":"45096"},{"source":"NA","target":"lymphoma","id":"45097"},{"source":"NA","target":"melanoma","id":"45098"},{"source":"NA","target":"solid tumors","id":"45099"},{"source":"NA","target":"glioblastoma","id":"45100"},{"source":"NA","target":"breast neoplasms","id":"45101"},{"source":"NA","target":"colonic neoplasms","id":"45102"},{"source":"NA","target":"triple-negative breast cancer","id":"45103"},{"source":"NA","target":"ovarian neoplasms","id":"45104"},{"source":"NA","target":"menstruation disturbances","id":"45105"},{"source":"NA","target":"colorectal cancer","id":"45106"},{"source":"NA","target":"alopecia","id":"45107"},{"source":"NA","target":"carcinoma","id":"45108"},{"source":"NA","target":"non-small-cell lung","id":"45109"},{"source":"NA","target":"carcinoma","id":"45110"},{"source":"NA","target":"neoplasm metastasis","id":"45111"},{"source":"NA","target":"lymphoma","id":"45112"},{"source":"NA","target":"colorectal neoplasms","id":"45113"},{"source":"NA","target":"lymphoma","id":"45114"},{"source":"NA","target":"skin neoplasms","id":"45115"},{"source":"NA","target":"hodgkin disease","id":"45116"},{"source":"NA","target":"anticancer","id":"45117"},{"source":"NA","target":"metastatic","id":"45118"},{"source":"NA","target":"non-hodgkin","id":"45119"},{"source":"NA","target":"lymphoma","id":"45120"},{"source":"NA","target":"anticancer","id":"45121"},{"source":"NA","target":"solid tumors","id":"45122"},{"source":"Selective estrogen receptor modulator","target":"UNK : Indication","id":"45123"},{"source":"Selective estrogen receptor modulator","target":"colorectal neoplasms","id":"45124"},{"source":"Selective estrogen receptor modulator","target":"anticancer","id":"45125"},{"source":"Selective estrogen receptor modulator","target":"astrocytoma","id":"45126"},{"source":"Selective estrogen receptor modulator","target":"ovarian cancer","id":"45127"},{"source":"Selective estrogen receptor modulator","target":"menstruation disorders","id":"45128"},{"source":"Selective estrogen receptor modulator","target":"glioblastoma","id":"45129"},{"source":"Selective estrogen receptor modulator","target":"non-small-cell lung","id":"45130"},{"source":"Selective estrogen receptor modulator","target":"lymphoma","id":"45131"},{"source":"Selective estrogen receptor modulator","target":"melanoma","id":"45132"},{"source":"Selective estrogen receptor modulator","target":"solid tumors","id":"45133"},{"source":"Selective estrogen receptor modulator","target":"glioblastoma","id":"45134"},{"source":"Selective estrogen receptor modulator","target":"breast neoplasms","id":"45135"},{"source":"Selective estrogen receptor modulator","target":"colonic neoplasms","id":"45136"},{"source":"Selective estrogen receptor modulator","target":"triple-negative breast cancer","id":"45137"},{"source":"Selective estrogen receptor modulator","target":"ovarian neoplasms","id":"45138"},{"source":"Selective estrogen receptor modulator","target":"menstruation disturbances","id":"45139"},{"source":"Selective estrogen receptor modulator","target":"colorectal cancer","id":"45140"},{"source":"Selective estrogen receptor modulator","target":"alopecia","id":"45141"},{"source":"Selective estrogen receptor modulator","target":"carcinoma","id":"45142"},{"source":"Selective estrogen receptor modulator","target":"non-small-cell lung","id":"45143"},{"source":"Selective estrogen receptor modulator","target":"carcinoma","id":"45144"},{"source":"Selective estrogen receptor modulator","target":"neoplasm metastasis","id":"45145"},{"source":"Selective estrogen receptor modulator","target":"lymphoma","id":"45146"},{"source":"Selective estrogen receptor modulator","target":"colorectal neoplasms","id":"45147"},{"source":"Selective estrogen receptor modulator","target":"lymphoma","id":"45148"},{"source":"Selective estrogen receptor modulator","target":"skin neoplasms","id":"45149"},{"source":"Selective estrogen receptor modulator","target":"hodgkin disease","id":"45150"},{"source":"Selective estrogen receptor modulator","target":"anticancer","id":"45151"},{"source":"Selective estrogen receptor modulator","target":"metastatic","id":"45152"},{"source":"Selective estrogen receptor modulator","target":"non-hodgkin","id":"45153"},{"source":"Selective estrogen receptor modulator","target":"lymphoma","id":"45154"},{"source":"Selective estrogen receptor modulator","target":"anticancer","id":"45155"},{"source":"Selective estrogen receptor modulator","target":"solid tumors","id":"45156"},{"source":"NA","target":"UNK : Indication","id":"45157"},{"source":"NA","target":"colorectal neoplasms","id":"45158"},{"source":"NA","target":"anticancer","id":"45159"},{"source":"NA","target":"astrocytoma","id":"45160"},{"source":"NA","target":"ovarian cancer","id":"45161"},{"source":"NA","target":"menstruation disorders","id":"45162"},{"source":"NA","target":"glioblastoma","id":"45163"},{"source":"NA","target":"non-small-cell lung","id":"45164"},{"source":"NA","target":"lymphoma","id":"45165"},{"source":"NA","target":"melanoma","id":"45166"},{"source":"NA","target":"solid tumors","id":"45167"},{"source":"NA","target":"glioblastoma","id":"45168"},{"source":"NA","target":"breast neoplasms","id":"45169"},{"source":"NA","target":"colonic neoplasms","id":"45170"},{"source":"NA","target":"triple-negative breast cancer","id":"45171"},{"source":"NA","target":"ovarian neoplasms","id":"45172"},{"source":"NA","target":"menstruation disturbances","id":"45173"},{"source":"NA","target":"colorectal cancer","id":"45174"},{"source":"NA","target":"alopecia","id":"45175"},{"source":"NA","target":"carcinoma","id":"45176"},{"source":"NA","target":"non-small-cell lung","id":"45177"},{"source":"NA","target":"carcinoma","id":"45178"},{"source":"NA","target":"neoplasm metastasis","id":"45179"},{"source":"NA","target":"lymphoma","id":"45180"},{"source":"NA","target":"colorectal neoplasms","id":"45181"},{"source":"NA","target":"lymphoma","id":"45182"},{"source":"NA","target":"skin neoplasms","id":"45183"},{"source":"NA","target":"hodgkin disease","id":"45184"},{"source":"NA","target":"anticancer","id":"45185"},{"source":"NA","target":"metastatic","id":"45186"},{"source":"NA","target":"non-hodgkin","id":"45187"},{"source":"NA","target":"lymphoma","id":"45188"},{"source":"NA","target":"anticancer","id":"45189"},{"source":"NA","target":"solid tumors","id":"45190"},{"source":"Estrogen receptor antagonist","target":"UNK : Indication","id":"45191"},{"source":"Estrogen receptor antagonist","target":"colorectal neoplasms","id":"45192"},{"source":"Estrogen receptor antagonist","target":"anticancer","id":"45193"},{"source":"Estrogen receptor antagonist","target":"astrocytoma","id":"45194"},{"source":"Estrogen receptor antagonist","target":"ovarian cancer","id":"45195"},{"source":"Estrogen receptor antagonist","target":"menstruation disorders","id":"45196"},{"source":"Estrogen receptor antagonist","target":"glioblastoma","id":"45197"},{"source":"Estrogen receptor antagonist","target":"non-small-cell lung","id":"45198"},{"source":"Estrogen receptor antagonist","target":"lymphoma","id":"45199"},{"source":"Estrogen receptor antagonist","target":"melanoma","id":"45200"},{"source":"Estrogen receptor antagonist","target":"solid tumors","id":"45201"},{"source":"Estrogen receptor antagonist","target":"glioblastoma","id":"45202"},{"source":"Estrogen receptor antagonist","target":"breast neoplasms","id":"45203"},{"source":"Estrogen receptor antagonist","target":"colonic neoplasms","id":"45204"},{"source":"Estrogen receptor antagonist","target":"triple-negative breast cancer","id":"45205"},{"source":"Estrogen receptor antagonist","target":"ovarian neoplasms","id":"45206"},{"source":"Estrogen receptor antagonist","target":"menstruation disturbances","id":"45207"},{"source":"Estrogen receptor antagonist","target":"colorectal cancer","id":"45208"},{"source":"Estrogen receptor antagonist","target":"alopecia","id":"45209"},{"source":"Estrogen receptor antagonist","target":"carcinoma","id":"45210"},{"source":"Estrogen receptor antagonist","target":"non-small-cell lung","id":"45211"},{"source":"Estrogen receptor antagonist","target":"carcinoma","id":"45212"},{"source":"Estrogen receptor antagonist","target":"neoplasm metastasis","id":"45213"},{"source":"Estrogen receptor antagonist","target":"lymphoma","id":"45214"},{"source":"Estrogen receptor antagonist","target":"colorectal neoplasms","id":"45215"},{"source":"Estrogen receptor antagonist","target":"lymphoma","id":"45216"},{"source":"Estrogen receptor antagonist","target":"skin neoplasms","id":"45217"},{"source":"Estrogen receptor antagonist","target":"hodgkin disease","id":"45218"},{"source":"Estrogen receptor antagonist","target":"anticancer","id":"45219"},{"source":"Estrogen receptor antagonist","target":"metastatic","id":"45220"},{"source":"Estrogen receptor antagonist","target":"non-hodgkin","id":"45221"},{"source":"Estrogen receptor antagonist","target":"lymphoma","id":"45222"},{"source":"Estrogen receptor antagonist","target":"anticancer","id":"45223"},{"source":"Estrogen receptor antagonist","target":"solid tumors","id":"45224"},{"source":"NA","target":"UNK : Indication","id":"45225"},{"source":"NA","target":"colorectal neoplasms","id":"45226"},{"source":"NA","target":"anticancer","id":"45227"},{"source":"NA","target":"astrocytoma","id":"45228"},{"source":"NA","target":"ovarian cancer","id":"45229"},{"source":"NA","target":"menstruation disorders","id":"45230"},{"source":"NA","target":"glioblastoma","id":"45231"},{"source":"NA","target":"non-small-cell lung","id":"45232"},{"source":"NA","target":"lymphoma","id":"45233"},{"source":"NA","target":"melanoma","id":"45234"},{"source":"NA","target":"solid tumors","id":"45235"},{"source":"NA","target":"glioblastoma","id":"45236"},{"source":"NA","target":"breast neoplasms","id":"45237"},{"source":"NA","target":"colonic neoplasms","id":"45238"},{"source":"NA","target":"triple-negative breast cancer","id":"45239"},{"source":"NA","target":"ovarian neoplasms","id":"45240"},{"source":"NA","target":"menstruation disturbances","id":"45241"},{"source":"NA","target":"colorectal cancer","id":"45242"},{"source":"NA","target":"alopecia","id":"45243"},{"source":"NA","target":"carcinoma","id":"45244"},{"source":"NA","target":"non-small-cell lung","id":"45245"},{"source":"NA","target":"carcinoma","id":"45246"},{"source":"NA","target":"neoplasm metastasis","id":"45247"},{"source":"NA","target":"lymphoma","id":"45248"},{"source":"NA","target":"colorectal neoplasms","id":"45249"},{"source":"NA","target":"lymphoma","id":"45250"},{"source":"NA","target":"skin neoplasms","id":"45251"},{"source":"NA","target":"hodgkin disease","id":"45252"},{"source":"NA","target":"anticancer","id":"45253"},{"source":"NA","target":"metastatic","id":"45254"},{"source":"NA","target":"non-hodgkin","id":"45255"},{"source":"NA","target":"lymphoma","id":"45256"},{"source":"NA","target":"anticancer","id":"45257"},{"source":"NA","target":"solid tumors","id":"45258"},{"source":"Oncology: Breast","target":"NA","id":"45259"},{"source":"Oncology: Breast","target":"Selective estrogen receptor modulator","id":"45260"},{"source":"Oncology: Breast","target":"NA","id":"45261"},{"source":"Oncology: Breast","target":"Estrogen receptor antagonist","id":"45262"},{"source":"Oncology: Breast","target":"NA","id":"45263"},{"source":"Oncology: CNS","target":"NA","id":"45264"},{"source":"Oncology: CNS","target":"Selective estrogen receptor modulator","id":"45265"},{"source":"Oncology: CNS","target":"NA","id":"45266"},{"source":"Oncology: CNS","target":"Estrogen receptor antagonist","id":"45267"},{"source":"Oncology: CNS","target":"NA","id":"45268"},{"source":"Glioblastoma","target":"NA","id":"45269"},{"source":"Glioblastoma","target":"Selective estrogen receptor modulator","id":"45270"},{"source":"Glioblastoma","target":"NA","id":"45271"},{"source":"Glioblastoma","target":"Estrogen receptor antagonist","id":"45272"},{"source":"Glioblastoma","target":"NA","id":"45273"},{"source":"Oncology: Colorectal","target":"NA","id":"45274"},{"source":"Oncology: Colorectal","target":"Selective estrogen receptor modulator","id":"45275"},{"source":"Oncology: Colorectal","target":"NA","id":"45276"},{"source":"Oncology: Colorectal","target":"Estrogen receptor antagonist","id":"45277"},{"source":"Oncology: Colorectal","target":"NA","id":"45278"},{"source":"Oncology: Lung","target":"NA","id":"45279"},{"source":"Oncology: Lung","target":"Selective estrogen receptor modulator","id":"45280"},{"source":"Oncology: Lung","target":"NA","id":"45281"},{"source":"Oncology: Lung","target":"Estrogen receptor antagonist","id":"45282"},{"source":"Oncology: Lung","target":"NA","id":"45283"},{"source":"Non-Small Cell","target":"NA","id":"45284"},{"source":"Non-Small Cell","target":"Selective estrogen receptor modulator","id":"45285"},{"source":"Non-Small Cell","target":"NA","id":"45286"},{"source":"Non-Small Cell","target":"Estrogen receptor antagonist","id":"45287"},{"source":"Non-Small Cell","target":"NA","id":"45288"},{"source":"Oncology: Lymphoma","target":"NA","id":"45289"},{"source":"Oncology: Lymphoma","target":"Selective estrogen receptor modulator","id":"45290"},{"source":"Oncology: Lymphoma","target":"NA","id":"45291"},{"source":"Oncology: Lymphoma","target":"Estrogen receptor antagonist","id":"45292"},{"source":"Oncology: Lymphoma","target":"NA","id":"45293"},{"source":"Hodgkin's","target":"NA","id":"45294"},{"source":"Hodgkin's","target":"Selective estrogen receptor modulator","id":"45295"},{"source":"Hodgkin's","target":"NA","id":"45296"},{"source":"Hodgkin's","target":"Estrogen receptor antagonist","id":"45297"},{"source":"Hodgkin's","target":"NA","id":"45298"},{"source":"Oncology: Lymphoma","target":"NA","id":"45299"},{"source":"Oncology: Lymphoma","target":"Selective estrogen receptor modulator","id":"45300"},{"source":"Oncology: Lymphoma","target":"NA","id":"45301"},{"source":"Oncology: Lymphoma","target":"Estrogen receptor antagonist","id":"45302"},{"source":"Oncology: Lymphoma","target":"NA","id":"45303"},{"source":"Hodgkin's","target":"NA","id":"45304"},{"source":"Hodgkin's","target":"Selective estrogen receptor modulator","id":"45305"},{"source":"Hodgkin's","target":"NA","id":"45306"},{"source":"Hodgkin's","target":"Estrogen receptor antagonist","id":"45307"},{"source":"Hodgkin's","target":"NA","id":"45308"},{"source":"Oncology: Melanoma","target":"NA","id":"45309"},{"source":"Oncology: Melanoma","target":"Selective estrogen receptor modulator","id":"45310"},{"source":"Oncology: Melanoma","target":"NA","id":"45311"},{"source":"Oncology: Melanoma","target":"Estrogen receptor antagonist","id":"45312"},{"source":"Oncology: Melanoma","target":"NA","id":"45313"},{"source":"Oncology: Ovarian","target":"NA","id":"45314"},{"source":"Oncology: Ovarian","target":"Selective estrogen receptor modulator","id":"45315"},{"source":"Oncology: Ovarian","target":"NA","id":"45316"},{"source":"Oncology: Ovarian","target":"Estrogen receptor antagonist","id":"45317"},{"source":"Oncology: Ovarian","target":"NA","id":"45318"},{"source":"pembrolizumab","target":"Merck & Co.","id":"45319"},{"source":"capecitabine","target":"Merck & Co.","id":"45320"},{"source":"eribulin mesylate (a)","target":"Merck & Co.","id":"45321"},{"source":"gemcitabine hydrochloride","target":"Merck & Co.","id":"45322"},{"source":"vinorelbine","target":"Merck & Co.","id":"45323"},{"source":"UNK : Indication","target":"pembrolizumab","id":"45324"},{"source":"UNK : Indication","target":"capecitabine","id":"45325"},{"source":"UNK : Indication","target":"eribulin mesylate (a)","id":"45326"},{"source":"UNK : Indication","target":"gemcitabine hydrochloride","id":"45327"},{"source":"UNK : Indication","target":"vinorelbine","id":"45328"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"45329"},{"source":"triple-negative breast cancer","target":"capecitabine","id":"45330"},{"source":"triple-negative breast cancer","target":"eribulin mesylate (a)","id":"45331"},{"source":"triple-negative breast cancer","target":"gemcitabine hydrochloride","id":"45332"},{"source":"triple-negative breast cancer","target":"vinorelbine","id":"45333"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"45334"},{"source":"triple-negative breast cancer","target":"capecitabine","id":"45335"},{"source":"triple-negative breast cancer","target":"eribulin mesylate (a)","id":"45336"},{"source":"triple-negative breast cancer","target":"gemcitabine hydrochloride","id":"45337"},{"source":"triple-negative breast cancer","target":"vinorelbine","id":"45338"},{"source":"residual tumor","target":"pembrolizumab","id":"45339"},{"source":"residual tumor","target":"capecitabine","id":"45340"},{"source":"residual tumor","target":"eribulin mesylate (a)","id":"45341"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"45342"},{"source":"residual tumor","target":"vinorelbine","id":"45343"},{"source":"breast neoplasms","target":"pembrolizumab","id":"45344"},{"source":"breast neoplasms","target":"capecitabine","id":"45345"},{"source":"breast neoplasms","target":"eribulin mesylate (a)","id":"45346"},{"source":"breast neoplasms","target":"gemcitabine hydrochloride","id":"45347"},{"source":"breast neoplasms","target":"vinorelbine","id":"45348"},{"source":"metastatic","target":"pembrolizumab","id":"45349"},{"source":"metastatic","target":"capecitabine","id":"45350"},{"source":"metastatic","target":"eribulin mesylate (a)","id":"45351"},{"source":"metastatic","target":"gemcitabine hydrochloride","id":"45352"},{"source":"metastatic","target":"vinorelbine","id":"45353"},{"source":"carcinoma","target":"pembrolizumab","id":"45354"},{"source":"carcinoma","target":"capecitabine","id":"45355"},{"source":"carcinoma","target":"eribulin mesylate (a)","id":"45356"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"45357"},{"source":"carcinoma","target":"vinorelbine","id":"45358"},{"source":"breast neoplasms","target":"pembrolizumab","id":"45359"},{"source":"breast neoplasms","target":"capecitabine","id":"45360"},{"source":"breast neoplasms","target":"eribulin mesylate (a)","id":"45361"},{"source":"breast neoplasms","target":"gemcitabine hydrochloride","id":"45362"},{"source":"breast neoplasms","target":"vinorelbine","id":"45363"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"45364"},{"source":"neoplasm metastasis","target":"capecitabine","id":"45365"},{"source":"neoplasm metastasis","target":"eribulin mesylate (a)","id":"45366"},{"source":"neoplasm metastasis","target":"gemcitabine hydrochloride","id":"45367"},{"source":"neoplasm metastasis","target":"vinorelbine","id":"45368"},{"source":"anticancer","target":"pembrolizumab","id":"45369"},{"source":"anticancer","target":"capecitabine","id":"45370"},{"source":"anticancer","target":"eribulin mesylate (a)","id":"45371"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"45372"},{"source":"anticancer","target":"vinorelbine","id":"45373"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"45374"},{"source":"triple-negative breast cancer","target":"capecitabine","id":"45375"},{"source":"triple-negative breast cancer","target":"eribulin mesylate (a)","id":"45376"},{"source":"triple-negative breast cancer","target":"gemcitabine hydrochloride","id":"45377"},{"source":"triple-negative breast cancer","target":"vinorelbine","id":"45378"},{"source":"Vinca alkaloid","target":"UNK : Indication","id":"45379"},{"source":"Vinca alkaloid","target":"triple-negative breast cancer","id":"45380"},{"source":"Vinca alkaloid","target":"triple-negative breast cancer","id":"45381"},{"source":"Vinca alkaloid","target":"residual tumor","id":"45382"},{"source":"Vinca alkaloid","target":"breast neoplasms","id":"45383"},{"source":"Vinca alkaloid","target":"metastatic","id":"45384"},{"source":"Vinca alkaloid","target":"carcinoma","id":"45385"},{"source":"Vinca alkaloid","target":"breast neoplasms","id":"45386"},{"source":"Vinca alkaloid","target":"neoplasm metastasis","id":"45387"},{"source":"Vinca alkaloid","target":"anticancer","id":"45388"},{"source":"Vinca alkaloid","target":"triple-negative breast cancer","id":"45389"},{"source":"Apoptosis stimulant","target":"UNK : Indication","id":"45390"},{"source":"Apoptosis stimulant","target":"triple-negative breast cancer","id":"45391"},{"source":"Apoptosis stimulant","target":"triple-negative breast cancer","id":"45392"},{"source":"Apoptosis stimulant","target":"residual tumor","id":"45393"},{"source":"Apoptosis stimulant","target":"breast neoplasms","id":"45394"},{"source":"Apoptosis stimulant","target":"metastatic","id":"45395"},{"source":"Apoptosis stimulant","target":"carcinoma","id":"45396"},{"source":"Apoptosis stimulant","target":"breast neoplasms","id":"45397"},{"source":"Apoptosis stimulant","target":"neoplasm metastasis","id":"45398"},{"source":"Apoptosis stimulant","target":"anticancer","id":"45399"},{"source":"Apoptosis stimulant","target":"triple-negative breast cancer","id":"45400"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"45401"},{"source":"Cell cycle inhibitor","target":"triple-negative breast cancer","id":"45402"},{"source":"Cell cycle inhibitor","target":"triple-negative breast cancer","id":"45403"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"45404"},{"source":"Cell cycle inhibitor","target":"breast neoplasms","id":"45405"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"45406"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"45407"},{"source":"Cell cycle inhibitor","target":"breast neoplasms","id":"45408"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"45409"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"45410"},{"source":"Cell cycle inhibitor","target":"triple-negative breast cancer","id":"45411"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"45412"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"45413"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"45414"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"45415"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"45416"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"45417"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"45418"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"45419"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"45420"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"45421"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"45422"},{"source":"NA","target":"UNK : Indication","id":"45423"},{"source":"NA","target":"triple-negative breast cancer","id":"45424"},{"source":"NA","target":"triple-negative breast cancer","id":"45425"},{"source":"NA","target":"residual tumor","id":"45426"},{"source":"NA","target":"breast neoplasms","id":"45427"},{"source":"NA","target":"metastatic","id":"45428"},{"source":"NA","target":"carcinoma","id":"45429"},{"source":"NA","target":"breast neoplasms","id":"45430"},{"source":"NA","target":"neoplasm metastasis","id":"45431"},{"source":"NA","target":"anticancer","id":"45432"},{"source":"NA","target":"triple-negative breast cancer","id":"45433"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"45434"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"45435"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"45436"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"45437"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"45438"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"45439"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"45440"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"45441"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"45442"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"45443"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"45444"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"45445"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"45446"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"45447"},{"source":"CD19 antagonist","target":"residual tumor","id":"45448"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"45449"},{"source":"CD19 antagonist","target":"metastatic","id":"45450"},{"source":"CD19 antagonist","target":"carcinoma","id":"45451"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"45452"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"45453"},{"source":"CD19 antagonist","target":"anticancer","id":"45454"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"45455"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"45456"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"45457"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"45458"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"45459"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"45460"},{"source":"Tubulin inhibitor","target":"metastatic","id":"45461"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"45462"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"45463"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"45464"},{"source":"Tubulin inhibitor","target":"anticancer","id":"45465"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"45466"},{"source":"NA","target":"UNK : Indication","id":"45467"},{"source":"NA","target":"triple-negative breast cancer","id":"45468"},{"source":"NA","target":"triple-negative breast cancer","id":"45469"},{"source":"NA","target":"residual tumor","id":"45470"},{"source":"NA","target":"breast neoplasms","id":"45471"},{"source":"NA","target":"metastatic","id":"45472"},{"source":"NA","target":"carcinoma","id":"45473"},{"source":"NA","target":"breast neoplasms","id":"45474"},{"source":"NA","target":"neoplasm metastasis","id":"45475"},{"source":"NA","target":"anticancer","id":"45476"},{"source":"NA","target":"triple-negative breast cancer","id":"45477"},{"source":"NA","target":"UNK : Indication","id":"45478"},{"source":"NA","target":"triple-negative breast cancer","id":"45479"},{"source":"NA","target":"triple-negative breast cancer","id":"45480"},{"source":"NA","target":"residual tumor","id":"45481"},{"source":"NA","target":"breast neoplasms","id":"45482"},{"source":"NA","target":"metastatic","id":"45483"},{"source":"NA","target":"carcinoma","id":"45484"},{"source":"NA","target":"breast neoplasms","id":"45485"},{"source":"NA","target":"neoplasm metastasis","id":"45486"},{"source":"NA","target":"anticancer","id":"45487"},{"source":"NA","target":"triple-negative breast cancer","id":"45488"},{"source":"Tubulin inhibitor","target":"UNK : Indication","id":"45489"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"45490"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"45491"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"45492"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"45493"},{"source":"Tubulin inhibitor","target":"metastatic","id":"45494"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"45495"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"45496"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"45497"},{"source":"Tubulin inhibitor","target":"anticancer","id":"45498"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"45499"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"45500"},{"source":"Thymidylate synthase inhibitor","target":"triple-negative breast cancer","id":"45501"},{"source":"Thymidylate synthase inhibitor","target":"triple-negative breast cancer","id":"45502"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"45503"},{"source":"Thymidylate synthase inhibitor","target":"breast neoplasms","id":"45504"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"45505"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"45506"},{"source":"Thymidylate synthase inhibitor","target":"breast neoplasms","id":"45507"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"45508"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"45509"},{"source":"Thymidylate synthase inhibitor","target":"triple-negative breast cancer","id":"45510"},{"source":"Oncology: Breast","target":"Vinca alkaloid","id":"45511"},{"source":"Oncology: Breast","target":"Apoptosis stimulant","id":"45512"},{"source":"Oncology: Breast","target":"Cell cycle inhibitor","id":"45513"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"45514"},{"source":"Oncology: Breast","target":"NA","id":"45515"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"45516"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"45517"},{"source":"Oncology: Breast","target":"Tubulin inhibitor","id":"45518"},{"source":"Oncology: Breast","target":"NA","id":"45519"},{"source":"Oncology: Breast","target":"NA","id":"45520"},{"source":"Oncology: Breast","target":"Tubulin inhibitor","id":"45521"},{"source":"Oncology: Breast","target":"Thymidylate synthase inhibitor","id":"45522"},{"source":"pembrolizumab","target":"Merck & Co.","id":"45523"},{"source":"enzalutamide (capsule)","target":"Merck & Co.","id":"45524"},{"source":"UNK : Indication","target":"pembrolizumab","id":"45525"},{"source":"UNK : Indication","target":"enzalutamide (capsule)","id":"45526"},{"source":"prostate cancer","target":"pembrolizumab","id":"45527"},{"source":"prostate cancer","target":"enzalutamide (capsule)","id":"45528"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"45529"},{"source":"castration-resistant prostatic neoplasms","target":"enzalutamide (capsule)","id":"45530"},{"source":"castration-resistant prostatic neoplasms","target":"pembrolizumab","id":"45531"},{"source":"castration-resistant prostatic neoplasms","target":"enzalutamide (capsule)","id":"45532"},{"source":"prostate cancer","target":"pembrolizumab","id":"45533"},{"source":"prostate cancer","target":"enzalutamide (capsule)","id":"45534"},{"source":"residual tumor","target":"pembrolizumab","id":"45535"},{"source":"residual tumor","target":"enzalutamide (capsule)","id":"45536"},{"source":"fallopian tube neoplasms","target":"pembrolizumab","id":"45537"},{"source":"fallopian tube neoplasms","target":"enzalutamide (capsule)","id":"45538"},{"source":"metastatic","target":"pembrolizumab","id":"45539"},{"source":"metastatic","target":"enzalutamide (capsule)","id":"45540"},{"source":"carcinoma","target":"pembrolizumab","id":"45541"},{"source":"carcinoma","target":"enzalutamide (capsule)","id":"45542"},{"source":"carcinoma","target":"pembrolizumab","id":"45543"},{"source":"carcinoma","target":"enzalutamide (capsule)","id":"45544"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"45545"},{"source":"neoplasm metastasis","target":"enzalutamide (capsule)","id":"45546"},{"source":"carcinoma","target":"pembrolizumab","id":"45547"},{"source":"carcinoma","target":"enzalutamide (capsule)","id":"45548"},{"source":"anticancer","target":"pembrolizumab","id":"45549"},{"source":"anticancer","target":"enzalutamide (capsule)","id":"45550"},{"source":"bone metastasis","target":"pembrolizumab","id":"45551"},{"source":"bone metastasis","target":"enzalutamide (capsule)","id":"45552"},{"source":"residual tumor","target":"pembrolizumab","id":"45553"},{"source":"residual tumor","target":"enzalutamide (capsule)","id":"45554"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"45555"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"45556"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"45557"},{"source":"Anticancer immunotherapy","target":"castration-resistant prostatic neoplasms","id":"45558"},{"source":"Anticancer immunotherapy","target":"prostate cancer","id":"45559"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"45560"},{"source":"Anticancer immunotherapy","target":"fallopian tube neoplasms","id":"45561"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"45562"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"45563"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"45564"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"45565"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"45566"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"45567"},{"source":"Anticancer immunotherapy","target":"bone metastasis","id":"45568"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"45569"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"45570"},{"source":"CD19 antagonist","target":"prostate cancer","id":"45571"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"45572"},{"source":"CD19 antagonist","target":"castration-resistant prostatic neoplasms","id":"45573"},{"source":"CD19 antagonist","target":"prostate cancer","id":"45574"},{"source":"CD19 antagonist","target":"residual tumor","id":"45575"},{"source":"CD19 antagonist","target":"fallopian tube neoplasms","id":"45576"},{"source":"CD19 antagonist","target":"metastatic","id":"45577"},{"source":"CD19 antagonist","target":"carcinoma","id":"45578"},{"source":"CD19 antagonist","target":"carcinoma","id":"45579"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"45580"},{"source":"CD19 antagonist","target":"carcinoma","id":"45581"},{"source":"CD19 antagonist","target":"anticancer","id":"45582"},{"source":"CD19 antagonist","target":"bone metastasis","id":"45583"},{"source":"CD19 antagonist","target":"residual tumor","id":"45584"},{"source":"Androgen receptor antagonist","target":"UNK : Indication","id":"45585"},{"source":"Androgen receptor antagonist","target":"prostate cancer","id":"45586"},{"source":"Androgen receptor antagonist","target":"castration-resistant prostatic neoplasms","id":"45587"},{"source":"Androgen receptor antagonist","target":"castration-resistant prostatic neoplasms","id":"45588"},{"source":"Androgen receptor antagonist","target":"prostate cancer","id":"45589"},{"source":"Androgen receptor antagonist","target":"residual tumor","id":"45590"},{"source":"Androgen receptor antagonist","target":"fallopian tube neoplasms","id":"45591"},{"source":"Androgen receptor antagonist","target":"metastatic","id":"45592"},{"source":"Androgen receptor antagonist","target":"carcinoma","id":"45593"},{"source":"Androgen receptor antagonist","target":"carcinoma","id":"45594"},{"source":"Androgen receptor antagonist","target":"neoplasm metastasis","id":"45595"},{"source":"Androgen receptor antagonist","target":"carcinoma","id":"45596"},{"source":"Androgen receptor antagonist","target":"anticancer","id":"45597"},{"source":"Androgen receptor antagonist","target":"bone metastasis","id":"45598"},{"source":"Androgen receptor antagonist","target":"residual tumor","id":"45599"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"45600"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"45601"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"45602"},{"source":"Immune checkpoint inhibitor","target":"castration-resistant prostatic neoplasms","id":"45603"},{"source":"Immune checkpoint inhibitor","target":"prostate cancer","id":"45604"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"45605"},{"source":"Immune checkpoint inhibitor","target":"fallopian tube neoplasms","id":"45606"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"45607"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"45608"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"45609"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"45610"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"45611"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"45612"},{"source":"Immune checkpoint inhibitor","target":"bone metastasis","id":"45613"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"45614"},{"source":"Oncology: Prostate","target":"Anticancer immunotherapy","id":"45615"},{"source":"Oncology: Prostate","target":"CD19 antagonist","id":"45616"},{"source":"Oncology: Prostate","target":"Androgen receptor antagonist","id":"45617"},{"source":"Oncology: Prostate","target":"Immune checkpoint inhibitor","id":"45618"},{"source":"pembrolizumab","target":"Merck & Co.","id":"45619"},{"source":"carboplatin","target":"Merck & Co.","id":"45620"},{"source":"gemcitabine hydrochloride","target":"Merck & Co.","id":"45621"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"45622"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"45623"},{"source":"sodium chloride 0.9%","target":"Merck & Co.","id":"45624"},{"source":"UNK : Indication","target":"pembrolizumab","id":"45625"},{"source":"UNK : Indication","target":"carboplatin","id":"45626"},{"source":"UNK : Indication","target":"gemcitabine hydrochloride","id":"45627"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"45628"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"45629"},{"source":"UNK : Indication","target":"sodium chloride 0.9%","id":"45630"},{"source":"metastatic","target":"pembrolizumab","id":"45631"},{"source":"metastatic","target":"carboplatin","id":"45632"},{"source":"metastatic","target":"gemcitabine hydrochloride","id":"45633"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"45634"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"45635"},{"source":"metastatic","target":"sodium chloride 0.9%","id":"45636"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"45637"},{"source":"triple-negative breast cancer","target":"carboplatin","id":"45638"},{"source":"triple-negative breast cancer","target":"gemcitabine hydrochloride","id":"45639"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"45640"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"45641"},{"source":"triple-negative breast cancer","target":"sodium chloride 0.9%","id":"45642"},{"source":"anti-tumor","target":"pembrolizumab","id":"45643"},{"source":"anti-tumor","target":"carboplatin","id":"45644"},{"source":"anti-tumor","target":"gemcitabine hydrochloride","id":"45645"},{"source":"anti-tumor","target":"nab-paclitaxel (IV)","id":"45646"},{"source":"anti-tumor","target":"nab-paclitaxel (IV)","id":"45647"},{"source":"anti-tumor","target":"sodium chloride 0.9%","id":"45648"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"45649"},{"source":"triple-negative breast cancer","target":"carboplatin","id":"45650"},{"source":"triple-negative breast cancer","target":"gemcitabine hydrochloride","id":"45651"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"45652"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"45653"},{"source":"triple-negative breast cancer","target":"sodium chloride 0.9%","id":"45654"},{"source":"residual tumor","target":"pembrolizumab","id":"45655"},{"source":"residual tumor","target":"carboplatin","id":"45656"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"45657"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"45658"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"45659"},{"source":"residual tumor","target":"sodium chloride 0.9%","id":"45660"},{"source":"liver metastases","target":"pembrolizumab","id":"45661"},{"source":"liver metastases","target":"carboplatin","id":"45662"},{"source":"liver metastases","target":"gemcitabine hydrochloride","id":"45663"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"45664"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"45665"},{"source":"liver metastases","target":"sodium chloride 0.9%","id":"45666"},{"source":"breast tumor","target":"pembrolizumab","id":"45667"},{"source":"breast tumor","target":"carboplatin","id":"45668"},{"source":"breast tumor","target":"gemcitabine hydrochloride","id":"45669"},{"source":"breast tumor","target":"nab-paclitaxel (IV)","id":"45670"},{"source":"breast tumor","target":"nab-paclitaxel (IV)","id":"45671"},{"source":"breast tumor","target":"sodium chloride 0.9%","id":"45672"},{"source":"residual tumor","target":"pembrolizumab","id":"45673"},{"source":"residual tumor","target":"carboplatin","id":"45674"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"45675"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"45676"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"45677"},{"source":"residual tumor","target":"sodium chloride 0.9%","id":"45678"},{"source":"breast neoplasms","target":"pembrolizumab","id":"45679"},{"source":"breast neoplasms","target":"carboplatin","id":"45680"},{"source":"breast neoplasms","target":"gemcitabine hydrochloride","id":"45681"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"45682"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"45683"},{"source":"breast neoplasms","target":"sodium chloride 0.9%","id":"45684"},{"source":"liver metastases","target":"pembrolizumab","id":"45685"},{"source":"liver metastases","target":"carboplatin","id":"45686"},{"source":"liver metastases","target":"gemcitabine hydrochloride","id":"45687"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"45688"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"45689"},{"source":"liver metastases","target":"sodium chloride 0.9%","id":"45690"},{"source":"metastatic","target":"pembrolizumab","id":"45691"},{"source":"metastatic","target":"carboplatin","id":"45692"},{"source":"metastatic","target":"gemcitabine hydrochloride","id":"45693"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"45694"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"45695"},{"source":"metastatic","target":"sodium chloride 0.9%","id":"45696"},{"source":"carcinoma","target":"pembrolizumab","id":"45697"},{"source":"carcinoma","target":"carboplatin","id":"45698"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"45699"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"45700"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"45701"},{"source":"carcinoma","target":"sodium chloride 0.9%","id":"45702"},{"source":"breast neoplasms","target":"pembrolizumab","id":"45703"},{"source":"breast neoplasms","target":"carboplatin","id":"45704"},{"source":"breast neoplasms","target":"gemcitabine hydrochloride","id":"45705"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"45706"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"45707"},{"source":"breast neoplasms","target":"sodium chloride 0.9%","id":"45708"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"45709"},{"source":"neoplasm metastasis","target":"carboplatin","id":"45710"},{"source":"neoplasm metastasis","target":"gemcitabine hydrochloride","id":"45711"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"45712"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"45713"},{"source":"neoplasm metastasis","target":"sodium chloride 0.9%","id":"45714"},{"source":"anticancer","target":"pembrolizumab","id":"45715"},{"source":"anticancer","target":"carboplatin","id":"45716"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"45717"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"45718"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"45719"},{"source":"anticancer","target":"sodium chloride 0.9%","id":"45720"},{"source":"tnbc","target":"pembrolizumab","id":"45721"},{"source":"tnbc","target":"carboplatin","id":"45722"},{"source":"tnbc","target":"gemcitabine hydrochloride","id":"45723"},{"source":"tnbc","target":"nab-paclitaxel (IV)","id":"45724"},{"source":"tnbc","target":"nab-paclitaxel (IV)","id":"45725"},{"source":"tnbc","target":"sodium chloride 0.9%","id":"45726"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"45727"},{"source":"triple-negative breast cancer","target":"carboplatin","id":"45728"},{"source":"triple-negative breast cancer","target":"gemcitabine hydrochloride","id":"45729"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"45730"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"45731"},{"source":"triple-negative breast cancer","target":"sodium chloride 0.9%","id":"45732"},{"source":"liver neoplasms","target":"pembrolizumab","id":"45733"},{"source":"liver neoplasms","target":"carboplatin","id":"45734"},{"source":"liver neoplasms","target":"gemcitabine hydrochloride","id":"45735"},{"source":"liver neoplasms","target":"nab-paclitaxel (IV)","id":"45736"},{"source":"liver neoplasms","target":"nab-paclitaxel (IV)","id":"45737"},{"source":"liver neoplasms","target":"sodium chloride 0.9%","id":"45738"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"45739"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"45740"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"45741"},{"source":"Immune checkpoint inhibitor","target":"anti-tumor","id":"45742"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"45743"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"45744"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"45745"},{"source":"Immune checkpoint inhibitor","target":"breast tumor","id":"45746"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"45747"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"45748"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"45749"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"45750"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"45751"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"45752"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"45753"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"45754"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"45755"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"45756"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"45757"},{"source":"NA","target":"UNK : Indication","id":"45758"},{"source":"NA","target":"metastatic","id":"45759"},{"source":"NA","target":"triple-negative breast cancer","id":"45760"},{"source":"NA","target":"anti-tumor","id":"45761"},{"source":"NA","target":"triple-negative breast cancer","id":"45762"},{"source":"NA","target":"residual tumor","id":"45763"},{"source":"NA","target":"liver metastases","id":"45764"},{"source":"NA","target":"breast tumor","id":"45765"},{"source":"NA","target":"residual tumor","id":"45766"},{"source":"NA","target":"breast neoplasms","id":"45767"},{"source":"NA","target":"liver metastases","id":"45768"},{"source":"NA","target":"metastatic","id":"45769"},{"source":"NA","target":"carcinoma","id":"45770"},{"source":"NA","target":"breast neoplasms","id":"45771"},{"source":"NA","target":"neoplasm metastasis","id":"45772"},{"source":"NA","target":"anticancer","id":"45773"},{"source":"NA","target":"tnbc","id":"45774"},{"source":"NA","target":"triple-negative breast cancer","id":"45775"},{"source":"NA","target":"liver neoplasms","id":"45776"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"45777"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"45778"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"45779"},{"source":"Anticancer immunotherapy","target":"anti-tumor","id":"45780"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"45781"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"45782"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"45783"},{"source":"Anticancer immunotherapy","target":"breast tumor","id":"45784"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"45785"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"45786"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"45787"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"45788"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"45789"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"45790"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"45791"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"45792"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"45793"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"45794"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"45795"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"45796"},{"source":"CD19 antagonist","target":"metastatic","id":"45797"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"45798"},{"source":"CD19 antagonist","target":"anti-tumor","id":"45799"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"45800"},{"source":"CD19 antagonist","target":"residual tumor","id":"45801"},{"source":"CD19 antagonist","target":"liver metastases","id":"45802"},{"source":"CD19 antagonist","target":"breast tumor","id":"45803"},{"source":"CD19 antagonist","target":"residual tumor","id":"45804"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"45805"},{"source":"CD19 antagonist","target":"liver metastases","id":"45806"},{"source":"CD19 antagonist","target":"metastatic","id":"45807"},{"source":"CD19 antagonist","target":"carcinoma","id":"45808"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"45809"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"45810"},{"source":"CD19 antagonist","target":"anticancer","id":"45811"},{"source":"CD19 antagonist","target":"tnbc","id":"45812"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"45813"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"45814"},{"source":"NA","target":"UNK : Indication","id":"45815"},{"source":"NA","target":"metastatic","id":"45816"},{"source":"NA","target":"triple-negative breast cancer","id":"45817"},{"source":"NA","target":"anti-tumor","id":"45818"},{"source":"NA","target":"triple-negative breast cancer","id":"45819"},{"source":"NA","target":"residual tumor","id":"45820"},{"source":"NA","target":"liver metastases","id":"45821"},{"source":"NA","target":"breast tumor","id":"45822"},{"source":"NA","target":"residual tumor","id":"45823"},{"source":"NA","target":"breast neoplasms","id":"45824"},{"source":"NA","target":"liver metastases","id":"45825"},{"source":"NA","target":"metastatic","id":"45826"},{"source":"NA","target":"carcinoma","id":"45827"},{"source":"NA","target":"breast neoplasms","id":"45828"},{"source":"NA","target":"neoplasm metastasis","id":"45829"},{"source":"NA","target":"anticancer","id":"45830"},{"source":"NA","target":"tnbc","id":"45831"},{"source":"NA","target":"triple-negative breast cancer","id":"45832"},{"source":"NA","target":"liver neoplasms","id":"45833"},{"source":"UPA","target":"UNK : Indication","id":"45834"},{"source":"UPA","target":"metastatic","id":"45835"},{"source":"UPA","target":"triple-negative breast cancer","id":"45836"},{"source":"UPA","target":"anti-tumor","id":"45837"},{"source":"UPA","target":"triple-negative breast cancer","id":"45838"},{"source":"UPA","target":"residual tumor","id":"45839"},{"source":"UPA","target":"liver metastases","id":"45840"},{"source":"UPA","target":"breast tumor","id":"45841"},{"source":"UPA","target":"residual tumor","id":"45842"},{"source":"UPA","target":"breast neoplasms","id":"45843"},{"source":"UPA","target":"liver metastases","id":"45844"},{"source":"UPA","target":"metastatic","id":"45845"},{"source":"UPA","target":"carcinoma","id":"45846"},{"source":"UPA","target":"breast neoplasms","id":"45847"},{"source":"UPA","target":"neoplasm metastasis","id":"45848"},{"source":"UPA","target":"anticancer","id":"45849"},{"source":"UPA","target":"tnbc","id":"45850"},{"source":"UPA","target":"triple-negative breast cancer","id":"45851"},{"source":"UPA","target":"liver neoplasms","id":"45852"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"45853"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"45854"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"45855"},{"source":"Beta tubulin antagonist","target":"anti-tumor","id":"45856"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"45857"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"45858"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"45859"},{"source":"Beta tubulin antagonist","target":"breast tumor","id":"45860"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"45861"},{"source":"Beta tubulin antagonist","target":"breast neoplasms","id":"45862"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"45863"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"45864"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"45865"},{"source":"Beta tubulin antagonist","target":"breast neoplasms","id":"45866"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"45867"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"45868"},{"source":"Beta tubulin antagonist","target":"tnbc","id":"45869"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"45870"},{"source":"Beta tubulin antagonist","target":"liver neoplasms","id":"45871"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"45872"},{"source":"Microtubule stimulant","target":"metastatic","id":"45873"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"45874"},{"source":"Microtubule stimulant","target":"anti-tumor","id":"45875"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"45876"},{"source":"Microtubule stimulant","target":"residual tumor","id":"45877"},{"source":"Microtubule stimulant","target":"liver metastases","id":"45878"},{"source":"Microtubule stimulant","target":"breast tumor","id":"45879"},{"source":"Microtubule stimulant","target":"residual tumor","id":"45880"},{"source":"Microtubule stimulant","target":"breast neoplasms","id":"45881"},{"source":"Microtubule stimulant","target":"liver metastases","id":"45882"},{"source":"Microtubule stimulant","target":"metastatic","id":"45883"},{"source":"Microtubule stimulant","target":"carcinoma","id":"45884"},{"source":"Microtubule stimulant","target":"breast neoplasms","id":"45885"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"45886"},{"source":"Microtubule stimulant","target":"anticancer","id":"45887"},{"source":"Microtubule stimulant","target":"tnbc","id":"45888"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"45889"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"45890"},{"source":"NA","target":"UNK : Indication","id":"45891"},{"source":"NA","target":"metastatic","id":"45892"},{"source":"NA","target":"triple-negative breast cancer","id":"45893"},{"source":"NA","target":"anti-tumor","id":"45894"},{"source":"NA","target":"triple-negative breast cancer","id":"45895"},{"source":"NA","target":"residual tumor","id":"45896"},{"source":"NA","target":"liver metastases","id":"45897"},{"source":"NA","target":"breast tumor","id":"45898"},{"source":"NA","target":"residual tumor","id":"45899"},{"source":"NA","target":"breast neoplasms","id":"45900"},{"source":"NA","target":"liver metastases","id":"45901"},{"source":"NA","target":"metastatic","id":"45902"},{"source":"NA","target":"carcinoma","id":"45903"},{"source":"NA","target":"breast neoplasms","id":"45904"},{"source":"NA","target":"neoplasm metastasis","id":"45905"},{"source":"NA","target":"anticancer","id":"45906"},{"source":"NA","target":"tnbc","id":"45907"},{"source":"NA","target":"triple-negative breast cancer","id":"45908"},{"source":"NA","target":"liver neoplasms","id":"45909"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"45910"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"45911"},{"source":"Cell cycle inhibitor","target":"triple-negative breast cancer","id":"45912"},{"source":"Cell cycle inhibitor","target":"anti-tumor","id":"45913"},{"source":"Cell cycle inhibitor","target":"triple-negative breast cancer","id":"45914"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"45915"},{"source":"Cell cycle inhibitor","target":"liver metastases","id":"45916"},{"source":"Cell cycle inhibitor","target":"breast tumor","id":"45917"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"45918"},{"source":"Cell cycle inhibitor","target":"breast neoplasms","id":"45919"},{"source":"Cell cycle inhibitor","target":"liver metastases","id":"45920"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"45921"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"45922"},{"source":"Cell cycle inhibitor","target":"breast neoplasms","id":"45923"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"45924"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"45925"},{"source":"Cell cycle inhibitor","target":"tnbc","id":"45926"},{"source":"Cell cycle inhibitor","target":"triple-negative breast cancer","id":"45927"},{"source":"Cell cycle inhibitor","target":"liver neoplasms","id":"45928"},{"source":"Taxane","target":"UNK : Indication","id":"45929"},{"source":"Taxane","target":"metastatic","id":"45930"},{"source":"Taxane","target":"triple-negative breast cancer","id":"45931"},{"source":"Taxane","target":"anti-tumor","id":"45932"},{"source":"Taxane","target":"triple-negative breast cancer","id":"45933"},{"source":"Taxane","target":"residual tumor","id":"45934"},{"source":"Taxane","target":"liver metastases","id":"45935"},{"source":"Taxane","target":"breast tumor","id":"45936"},{"source":"Taxane","target":"residual tumor","id":"45937"},{"source":"Taxane","target":"breast neoplasms","id":"45938"},{"source":"Taxane","target":"liver metastases","id":"45939"},{"source":"Taxane","target":"metastatic","id":"45940"},{"source":"Taxane","target":"carcinoma","id":"45941"},{"source":"Taxane","target":"breast neoplasms","id":"45942"},{"source":"Taxane","target":"neoplasm metastasis","id":"45943"},{"source":"Taxane","target":"anticancer","id":"45944"},{"source":"Taxane","target":"tnbc","id":"45945"},{"source":"Taxane","target":"triple-negative breast cancer","id":"45946"},{"source":"Taxane","target":"liver neoplasms","id":"45947"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"45948"},{"source":"Oncology: Breast","target":"NA","id":"45949"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"45950"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"45951"},{"source":"Oncology: Breast","target":"NA","id":"45952"},{"source":"Oncology: Breast","target":"UPA","id":"45953"},{"source":"Oncology: Breast","target":"Beta tubulin antagonist","id":"45954"},{"source":"Oncology: Breast","target":"Microtubule stimulant","id":"45955"},{"source":"Oncology: Breast","target":"NA","id":"45956"},{"source":"Oncology: Breast","target":"Cell cycle inhibitor","id":"45957"},{"source":"Oncology: Breast","target":"Taxane","id":"45958"},{"source":"pembrolizumab","target":"Merck & Co.","id":"45959"},{"source":"UNK : Drug","target":"Merck & Co.","id":"45960"},{"source":"anti-hepatitis b","target":"pembrolizumab","id":"45961"},{"source":"anti-hepatitis b","target":"UNK : Drug","id":"45962"},{"source":"hepatocellular","target":"pembrolizumab","id":"45963"},{"source":"hepatocellular","target":"UNK : Drug","id":"45964"},{"source":"hcv","target":"pembrolizumab","id":"45965"},{"source":"hcv","target":"UNK : Drug","id":"45966"},{"source":"solid tumors","target":"pembrolizumab","id":"45967"},{"source":"solid tumors","target":"UNK : Drug","id":"45968"},{"source":"carcinoma","target":"pembrolizumab","id":"45969"},{"source":"carcinoma","target":"UNK : Drug","id":"45970"},{"source":"hcc","target":"pembrolizumab","id":"45971"},{"source":"hcc","target":"UNK : Drug","id":"45972"},{"source":"liver cirrhosis","target":"pembrolizumab","id":"45973"},{"source":"liver cirrhosis","target":"UNK : Drug","id":"45974"},{"source":"carcinoma","target":"pembrolizumab","id":"45975"},{"source":"carcinoma","target":"UNK : Drug","id":"45976"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"45977"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"45978"},{"source":"chronic hepatitis b","target":"pembrolizumab","id":"45979"},{"source":"chronic hepatitis b","target":"UNK : Drug","id":"45980"},{"source":"carcinoma","target":"pembrolizumab","id":"45981"},{"source":"carcinoma","target":"UNK : Drug","id":"45982"},{"source":"anticancer","target":"pembrolizumab","id":"45983"},{"source":"anticancer","target":"UNK : Drug","id":"45984"},{"source":"hbv","target":"pembrolizumab","id":"45985"},{"source":"hbv","target":"UNK : Drug","id":"45986"},{"source":"liver cancer","target":"pembrolizumab","id":"45987"},{"source":"liver cancer","target":"UNK : Drug","id":"45988"},{"source":"liver neoplasms","target":"pembrolizumab","id":"45989"},{"source":"liver neoplasms","target":"UNK : Drug","id":"45990"},{"source":"hcv","target":"pembrolizumab","id":"45991"},{"source":"hcv","target":"UNK : Drug","id":"45992"},{"source":"solid tumors","target":"pembrolizumab","id":"45993"},{"source":"solid tumors","target":"UNK : Drug","id":"45994"},{"source":"Anticancer immunotherapy","target":"anti-hepatitis b","id":"45995"},{"source":"Anticancer immunotherapy","target":"hepatocellular","id":"45996"},{"source":"Anticancer immunotherapy","target":"hcv","id":"45997"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"45998"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"45999"},{"source":"Anticancer immunotherapy","target":"hcc","id":"46000"},{"source":"Anticancer immunotherapy","target":"liver cirrhosis","id":"46001"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"46002"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"46003"},{"source":"Anticancer immunotherapy","target":"chronic hepatitis b","id":"46004"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"46005"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"46006"},{"source":"Anticancer immunotherapy","target":"hbv","id":"46007"},{"source":"Anticancer immunotherapy","target":"liver cancer","id":"46008"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"46009"},{"source":"Anticancer immunotherapy","target":"hcv","id":"46010"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"46011"},{"source":"CD19 antagonist","target":"anti-hepatitis b","id":"46012"},{"source":"CD19 antagonist","target":"hepatocellular","id":"46013"},{"source":"CD19 antagonist","target":"hcv","id":"46014"},{"source":"CD19 antagonist","target":"solid tumors","id":"46015"},{"source":"CD19 antagonist","target":"carcinoma","id":"46016"},{"source":"CD19 antagonist","target":"hcc","id":"46017"},{"source":"CD19 antagonist","target":"liver cirrhosis","id":"46018"},{"source":"CD19 antagonist","target":"carcinoma","id":"46019"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"46020"},{"source":"CD19 antagonist","target":"chronic hepatitis b","id":"46021"},{"source":"CD19 antagonist","target":"carcinoma","id":"46022"},{"source":"CD19 antagonist","target":"anticancer","id":"46023"},{"source":"CD19 antagonist","target":"hbv","id":"46024"},{"source":"CD19 antagonist","target":"liver cancer","id":"46025"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"46026"},{"source":"CD19 antagonist","target":"hcv","id":"46027"},{"source":"CD19 antagonist","target":"solid tumors","id":"46028"},{"source":"Immune checkpoint inhibitor","target":"anti-hepatitis b","id":"46029"},{"source":"Immune checkpoint inhibitor","target":"hepatocellular","id":"46030"},{"source":"Immune checkpoint inhibitor","target":"hcv","id":"46031"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"46032"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"46033"},{"source":"Immune checkpoint inhibitor","target":"hcc","id":"46034"},{"source":"Immune checkpoint inhibitor","target":"liver cirrhosis","id":"46035"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"46036"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"46037"},{"source":"Immune checkpoint inhibitor","target":"chronic hepatitis b","id":"46038"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"46039"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"46040"},{"source":"Immune checkpoint inhibitor","target":"hbv","id":"46041"},{"source":"Immune checkpoint inhibitor","target":"liver cancer","id":"46042"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"46043"},{"source":"Immune checkpoint inhibitor","target":"hcv","id":"46044"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"46045"},{"source":"Oncology: Liver","target":"Anticancer immunotherapy","id":"46046"},{"source":"Oncology: Liver","target":"CD19 antagonist","id":"46047"},{"source":"Oncology: Liver","target":"Immune checkpoint inhibitor","id":"46048"},{"source":"ganetespib (u)","target":"(Other Cooperative Group)","id":"46049"},{"source":"ganetespib (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46050"},{"source":"ganetespib (u)","target":"National Institutes of Health/National Cancer Institute","id":"46051"},{"source":"ganitumab (u)","target":"(Other Cooperative Group)","id":"46052"},{"source":"ganitumab (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46053"},{"source":"ganitumab (u)","target":"National Institutes of Health/National Cancer Institute","id":"46054"},{"source":"irinotecan (IV)","target":"(Other Cooperative Group)","id":"46055"},{"source":"irinotecan (IV)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46056"},{"source":"irinotecan (IV)","target":"National Institutes of Health/National Cancer Institute","id":"46057"},{"source":"unspecified","target":"(Other Cooperative Group)","id":"46058"},{"source":"unspecified","target":"American College of Radiology Imaging Network (ACRIN)","id":"46059"},{"source":"unspecified","target":"National Institutes of Health/National Cancer Institute","id":"46060"},{"source":"metformin 500mg (u)","target":"(Other Cooperative Group)","id":"46061"},{"source":"metformin 500mg (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46062"},{"source":"metformin 500mg (u)","target":"National Institutes of Health/National Cancer Institute","id":"46063"},{"source":"unspecified","target":"(Other Cooperative Group)","id":"46064"},{"source":"unspecified","target":"American College of Radiology Imaging Network (ACRIN)","id":"46065"},{"source":"unspecified","target":"National Institutes of Health/National Cancer Institute","id":"46066"},{"source":"MK-2206 (u)","target":"(Other Cooperative Group)","id":"46067"},{"source":"MK-2206 (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46068"},{"source":"MK-2206 (u)","target":"National Institutes of Health/National Cancer Institute","id":"46069"},{"source":"neratinib (a)","target":"(Other Cooperative Group)","id":"46070"},{"source":"neratinib (a)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46071"},{"source":"neratinib (a)","target":"National Institutes of Health/National Cancer Institute","id":"46072"},{"source":"patritumab (u)","target":"(Other Cooperative Group)","id":"46073"},{"source":"patritumab (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46074"},{"source":"patritumab (u)","target":"National Institutes of Health/National Cancer Institute","id":"46075"},{"source":"pembrolizumab","target":"(Other Cooperative Group)","id":"46076"},{"source":"pembrolizumab","target":"American College of Radiology Imaging Network (ACRIN)","id":"46077"},{"source":"pembrolizumab","target":"National Institutes of Health/National Cancer Institute","id":"46078"},{"source":"pertuzumab (a)","target":"(Other Cooperative Group)","id":"46079"},{"source":"pertuzumab (a)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46080"},{"source":"pertuzumab (a)","target":"National Institutes of Health/National Cancer Institute","id":"46081"},{"source":"pexidartinib (u)","target":"(Other Cooperative Group)","id":"46082"},{"source":"pexidartinib (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46083"},{"source":"pexidartinib (u)","target":"National Institutes of Health/National Cancer Institute","id":"46084"},{"source":"talazoparib (u)","target":"(Other Cooperative Group)","id":"46085"},{"source":"talazoparib (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46086"},{"source":"talazoparib (u)","target":"National Institutes of Health/National Cancer Institute","id":"46087"},{"source":"trastuzumab (IV)","target":"(Other Cooperative Group)","id":"46088"},{"source":"trastuzumab (IV)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46089"},{"source":"trastuzumab (IV)","target":"National Institutes of Health/National Cancer Institute","id":"46090"},{"source":"trastuzumab emtansine (a)","target":"(Other Cooperative Group)","id":"46091"},{"source":"trastuzumab emtansine (a)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46092"},{"source":"trastuzumab emtansine (a)","target":"National Institutes of Health/National Cancer Institute","id":"46093"},{"source":"trebananib (u)","target":"(Other Cooperative Group)","id":"46094"},{"source":"trebananib (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46095"},{"source":"trebananib (u)","target":"National Institutes of Health/National Cancer Institute","id":"46096"},{"source":"veliparib (u)","target":"(Other Cooperative Group)","id":"46097"},{"source":"veliparib (u)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46098"},{"source":"veliparib (u)","target":"National Institutes of Health/National Cancer Institute","id":"46099"},{"source":"cyclophosphamide","target":"(Other Cooperative Group)","id":"46100"},{"source":"cyclophosphamide","target":"American College of Radiology Imaging Network (ACRIN)","id":"46101"},{"source":"cyclophosphamide","target":"National Institutes of Health/National Cancer Institute","id":"46102"},{"source":"unspecified","target":"(Other Cooperative Group)","id":"46103"},{"source":"unspecified","target":"American College of Radiology Imaging Network (ACRIN)","id":"46104"},{"source":"unspecified","target":"National Institutes of Health/National Cancer Institute","id":"46105"},{"source":"pegylated liposomal doxorubicin","target":"(Other Cooperative Group)","id":"46106"},{"source":"pegylated liposomal doxorubicin","target":"American College of Radiology Imaging Network (ACRIN)","id":"46107"},{"source":"pegylated liposomal doxorubicin","target":"National Institutes of Health/National Cancer Institute","id":"46108"},{"source":"nab-paclitaxel (IV)","target":"(Other Cooperative Group)","id":"46109"},{"source":"nab-paclitaxel (IV)","target":"American College of Radiology Imaging Network (ACRIN)","id":"46110"},{"source":"nab-paclitaxel (IV)","target":"National Institutes of Health/National Cancer Institute","id":"46111"},{"source":"surgical intervention","target":"(Other Cooperative Group)","id":"46112"},{"source":"surgical intervention","target":"American College of Radiology Imaging Network (ACRIN)","id":"46113"},{"source":"surgical intervention","target":"National Institutes of Health/National Cancer Institute","id":"46114"},{"source":"metaplasia","target":"ganetespib (u)","id":"46115"},{"source":"metaplasia","target":"ganitumab (u)","id":"46116"},{"source":"metaplasia","target":"irinotecan (IV)","id":"46117"},{"source":"metaplasia","target":"unspecified","id":"46118"},{"source":"metaplasia","target":"metformin 500mg (u)","id":"46119"},{"source":"metaplasia","target":"unspecified","id":"46120"},{"source":"metaplasia","target":"MK-2206 (u)","id":"46121"},{"source":"metaplasia","target":"neratinib (a)","id":"46122"},{"source":"metaplasia","target":"patritumab (u)","id":"46123"},{"source":"metaplasia","target":"pembrolizumab","id":"46124"},{"source":"metaplasia","target":"pertuzumab (a)","id":"46125"},{"source":"metaplasia","target":"pexidartinib (u)","id":"46126"},{"source":"metaplasia","target":"talazoparib (u)","id":"46127"},{"source":"metaplasia","target":"trastuzumab (IV)","id":"46128"},{"source":"metaplasia","target":"trastuzumab emtansine (a)","id":"46129"},{"source":"metaplasia","target":"trebananib (u)","id":"46130"},{"source":"metaplasia","target":"veliparib (u)","id":"46131"},{"source":"metaplasia","target":"cyclophosphamide","id":"46132"},{"source":"metaplasia","target":"unspecified","id":"46133"},{"source":"metaplasia","target":"pegylated liposomal doxorubicin","id":"46134"},{"source":"metaplasia","target":"nab-paclitaxel (IV)","id":"46135"},{"source":"metaplasia","target":"surgical intervention","id":"46136"},{"source":"anticancer","target":"ganetespib (u)","id":"46137"},{"source":"anticancer","target":"ganitumab (u)","id":"46138"},{"source":"anticancer","target":"irinotecan (IV)","id":"46139"},{"source":"anticancer","target":"unspecified","id":"46140"},{"source":"anticancer","target":"metformin 500mg (u)","id":"46141"},{"source":"anticancer","target":"unspecified","id":"46142"},{"source":"anticancer","target":"MK-2206 (u)","id":"46143"},{"source":"anticancer","target":"neratinib (a)","id":"46144"},{"source":"anticancer","target":"patritumab (u)","id":"46145"},{"source":"anticancer","target":"pembrolizumab","id":"46146"},{"source":"anticancer","target":"pertuzumab (a)","id":"46147"},{"source":"anticancer","target":"pexidartinib (u)","id":"46148"},{"source":"anticancer","target":"talazoparib (u)","id":"46149"},{"source":"anticancer","target":"trastuzumab (IV)","id":"46150"},{"source":"anticancer","target":"trastuzumab emtansine (a)","id":"46151"},{"source":"anticancer","target":"trebananib (u)","id":"46152"},{"source":"anticancer","target":"veliparib (u)","id":"46153"},{"source":"anticancer","target":"cyclophosphamide","id":"46154"},{"source":"anticancer","target":"unspecified","id":"46155"},{"source":"anticancer","target":"pegylated liposomal doxorubicin","id":"46156"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"46157"},{"source":"anticancer","target":"surgical intervention","id":"46158"},{"source":"liver metastases","target":"ganetespib (u)","id":"46159"},{"source":"liver metastases","target":"ganitumab (u)","id":"46160"},{"source":"liver metastases","target":"irinotecan (IV)","id":"46161"},{"source":"liver metastases","target":"unspecified","id":"46162"},{"source":"liver metastases","target":"metformin 500mg (u)","id":"46163"},{"source":"liver metastases","target":"unspecified","id":"46164"},{"source":"liver metastases","target":"MK-2206 (u)","id":"46165"},{"source":"liver metastases","target":"neratinib (a)","id":"46166"},{"source":"liver metastases","target":"patritumab (u)","id":"46167"},{"source":"liver metastases","target":"pembrolizumab","id":"46168"},{"source":"liver metastases","target":"pertuzumab (a)","id":"46169"},{"source":"liver metastases","target":"pexidartinib (u)","id":"46170"},{"source":"liver metastases","target":"talazoparib (u)","id":"46171"},{"source":"liver metastases","target":"trastuzumab (IV)","id":"46172"},{"source":"liver metastases","target":"trastuzumab emtansine (a)","id":"46173"},{"source":"liver metastases","target":"trebananib (u)","id":"46174"},{"source":"liver metastases","target":"veliparib (u)","id":"46175"},{"source":"liver metastases","target":"cyclophosphamide","id":"46176"},{"source":"liver metastases","target":"unspecified","id":"46177"},{"source":"liver metastases","target":"pegylated liposomal doxorubicin","id":"46178"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"46179"},{"source":"liver metastases","target":"surgical intervention","id":"46180"},{"source":"atrial flutter","target":"ganetespib (u)","id":"46181"},{"source":"atrial flutter","target":"ganitumab (u)","id":"46182"},{"source":"atrial flutter","target":"irinotecan (IV)","id":"46183"},{"source":"atrial flutter","target":"unspecified","id":"46184"},{"source":"atrial flutter","target":"metformin 500mg (u)","id":"46185"},{"source":"atrial flutter","target":"unspecified","id":"46186"},{"source":"atrial flutter","target":"MK-2206 (u)","id":"46187"},{"source":"atrial flutter","target":"neratinib (a)","id":"46188"},{"source":"atrial flutter","target":"patritumab (u)","id":"46189"},{"source":"atrial flutter","target":"pembrolizumab","id":"46190"},{"source":"atrial flutter","target":"pertuzumab (a)","id":"46191"},{"source":"atrial flutter","target":"pexidartinib (u)","id":"46192"},{"source":"atrial flutter","target":"talazoparib (u)","id":"46193"},{"source":"atrial flutter","target":"trastuzumab (IV)","id":"46194"},{"source":"atrial flutter","target":"trastuzumab emtansine (a)","id":"46195"},{"source":"atrial flutter","target":"trebananib (u)","id":"46196"},{"source":"atrial flutter","target":"veliparib (u)","id":"46197"},{"source":"atrial flutter","target":"cyclophosphamide","id":"46198"},{"source":"atrial flutter","target":"unspecified","id":"46199"},{"source":"atrial flutter","target":"pegylated liposomal doxorubicin","id":"46200"},{"source":"atrial flutter","target":"nab-paclitaxel (IV)","id":"46201"},{"source":"atrial flutter","target":"surgical intervention","id":"46202"},{"source":"breast tumor","target":"ganetespib (u)","id":"46203"},{"source":"breast tumor","target":"ganitumab (u)","id":"46204"},{"source":"breast tumor","target":"irinotecan (IV)","id":"46205"},{"source":"breast tumor","target":"unspecified","id":"46206"},{"source":"breast tumor","target":"metformin 500mg (u)","id":"46207"},{"source":"breast tumor","target":"unspecified","id":"46208"},{"source":"breast tumor","target":"MK-2206 (u)","id":"46209"},{"source":"breast tumor","target":"neratinib (a)","id":"46210"},{"source":"breast tumor","target":"patritumab (u)","id":"46211"},{"source":"breast tumor","target":"pembrolizumab","id":"46212"},{"source":"breast tumor","target":"pertuzumab (a)","id":"46213"},{"source":"breast tumor","target":"pexidartinib (u)","id":"46214"},{"source":"breast tumor","target":"talazoparib (u)","id":"46215"},{"source":"breast tumor","target":"trastuzumab (IV)","id":"46216"},{"source":"breast tumor","target":"trastuzumab emtansine (a)","id":"46217"},{"source":"breast tumor","target":"trebananib (u)","id":"46218"},{"source":"breast tumor","target":"veliparib (u)","id":"46219"},{"source":"breast tumor","target":"cyclophosphamide","id":"46220"},{"source":"breast tumor","target":"unspecified","id":"46221"},{"source":"breast tumor","target":"pegylated liposomal doxorubicin","id":"46222"},{"source":"breast tumor","target":"nab-paclitaxel (IV)","id":"46223"},{"source":"breast tumor","target":"surgical intervention","id":"46224"},{"source":"antidiabetic","target":"ganetespib (u)","id":"46225"},{"source":"antidiabetic","target":"ganitumab (u)","id":"46226"},{"source":"antidiabetic","target":"irinotecan (IV)","id":"46227"},{"source":"antidiabetic","target":"unspecified","id":"46228"},{"source":"antidiabetic","target":"metformin 500mg (u)","id":"46229"},{"source":"antidiabetic","target":"unspecified","id":"46230"},{"source":"antidiabetic","target":"MK-2206 (u)","id":"46231"},{"source":"antidiabetic","target":"neratinib (a)","id":"46232"},{"source":"antidiabetic","target":"patritumab (u)","id":"46233"},{"source":"antidiabetic","target":"pembrolizumab","id":"46234"},{"source":"antidiabetic","target":"pertuzumab (a)","id":"46235"},{"source":"antidiabetic","target":"pexidartinib (u)","id":"46236"},{"source":"antidiabetic","target":"talazoparib (u)","id":"46237"},{"source":"antidiabetic","target":"trastuzumab (IV)","id":"46238"},{"source":"antidiabetic","target":"trastuzumab emtansine (a)","id":"46239"},{"source":"antidiabetic","target":"trebananib (u)","id":"46240"},{"source":"antidiabetic","target":"veliparib (u)","id":"46241"},{"source":"antidiabetic","target":"cyclophosphamide","id":"46242"},{"source":"antidiabetic","target":"unspecified","id":"46243"},{"source":"antidiabetic","target":"pegylated liposomal doxorubicin","id":"46244"},{"source":"antidiabetic","target":"nab-paclitaxel (IV)","id":"46245"},{"source":"antidiabetic","target":"surgical intervention","id":"46246"},{"source":"teratogenesis","target":"ganetespib (u)","id":"46247"},{"source":"teratogenesis","target":"ganitumab (u)","id":"46248"},{"source":"teratogenesis","target":"irinotecan (IV)","id":"46249"},{"source":"teratogenesis","target":"unspecified","id":"46250"},{"source":"teratogenesis","target":"metformin 500mg (u)","id":"46251"},{"source":"teratogenesis","target":"unspecified","id":"46252"},{"source":"teratogenesis","target":"MK-2206 (u)","id":"46253"},{"source":"teratogenesis","target":"neratinib (a)","id":"46254"},{"source":"teratogenesis","target":"patritumab (u)","id":"46255"},{"source":"teratogenesis","target":"pembrolizumab","id":"46256"},{"source":"teratogenesis","target":"pertuzumab (a)","id":"46257"},{"source":"teratogenesis","target":"pexidartinib (u)","id":"46258"},{"source":"teratogenesis","target":"talazoparib (u)","id":"46259"},{"source":"teratogenesis","target":"trastuzumab (IV)","id":"46260"},{"source":"teratogenesis","target":"trastuzumab emtansine (a)","id":"46261"},{"source":"teratogenesis","target":"trebananib (u)","id":"46262"},{"source":"teratogenesis","target":"veliparib (u)","id":"46263"},{"source":"teratogenesis","target":"cyclophosphamide","id":"46264"},{"source":"teratogenesis","target":"unspecified","id":"46265"},{"source":"teratogenesis","target":"pegylated liposomal doxorubicin","id":"46266"},{"source":"teratogenesis","target":"nab-paclitaxel (IV)","id":"46267"},{"source":"teratogenesis","target":"surgical intervention","id":"46268"},{"source":"breast tumor","target":"ganetespib (u)","id":"46269"},{"source":"breast tumor","target":"ganitumab (u)","id":"46270"},{"source":"breast tumor","target":"irinotecan (IV)","id":"46271"},{"source":"breast tumor","target":"unspecified","id":"46272"},{"source":"breast tumor","target":"metformin 500mg (u)","id":"46273"},{"source":"breast tumor","target":"unspecified","id":"46274"},{"source":"breast tumor","target":"MK-2206 (u)","id":"46275"},{"source":"breast tumor","target":"neratinib (a)","id":"46276"},{"source":"breast tumor","target":"patritumab (u)","id":"46277"},{"source":"breast tumor","target":"pembrolizumab","id":"46278"},{"source":"breast tumor","target":"pertuzumab (a)","id":"46279"},{"source":"breast tumor","target":"pexidartinib (u)","id":"46280"},{"source":"breast tumor","target":"talazoparib (u)","id":"46281"},{"source":"breast tumor","target":"trastuzumab (IV)","id":"46282"},{"source":"breast tumor","target":"trastuzumab emtansine (a)","id":"46283"},{"source":"breast tumor","target":"trebananib (u)","id":"46284"},{"source":"breast tumor","target":"veliparib (u)","id":"46285"},{"source":"breast tumor","target":"cyclophosphamide","id":"46286"},{"source":"breast tumor","target":"unspecified","id":"46287"},{"source":"breast tumor","target":"pegylated liposomal doxorubicin","id":"46288"},{"source":"breast tumor","target":"nab-paclitaxel (IV)","id":"46289"},{"source":"breast tumor","target":"surgical intervention","id":"46290"},{"source":"heart failure","target":"ganetespib (u)","id":"46291"},{"source":"heart failure","target":"ganitumab (u)","id":"46292"},{"source":"heart failure","target":"irinotecan (IV)","id":"46293"},{"source":"heart failure","target":"unspecified","id":"46294"},{"source":"heart failure","target":"metformin 500mg (u)","id":"46295"},{"source":"heart failure","target":"unspecified","id":"46296"},{"source":"heart failure","target":"MK-2206 (u)","id":"46297"},{"source":"heart failure","target":"neratinib (a)","id":"46298"},{"source":"heart failure","target":"patritumab (u)","id":"46299"},{"source":"heart failure","target":"pembrolizumab","id":"46300"},{"source":"heart failure","target":"pertuzumab (a)","id":"46301"},{"source":"heart failure","target":"pexidartinib (u)","id":"46302"},{"source":"heart failure","target":"talazoparib (u)","id":"46303"},{"source":"heart failure","target":"trastuzumab (IV)","id":"46304"},{"source":"heart failure","target":"trastuzumab emtansine (a)","id":"46305"},{"source":"heart failure","target":"trebananib (u)","id":"46306"},{"source":"heart failure","target":"veliparib (u)","id":"46307"},{"source":"heart failure","target":"cyclophosphamide","id":"46308"},{"source":"heart failure","target":"unspecified","id":"46309"},{"source":"heart failure","target":"pegylated liposomal doxorubicin","id":"46310"},{"source":"heart failure","target":"nab-paclitaxel (IV)","id":"46311"},{"source":"heart failure","target":"surgical intervention","id":"46312"},{"source":"gilbert disease","target":"ganetespib (u)","id":"46313"},{"source":"gilbert disease","target":"ganitumab (u)","id":"46314"},{"source":"gilbert disease","target":"irinotecan (IV)","id":"46315"},{"source":"gilbert disease","target":"unspecified","id":"46316"},{"source":"gilbert disease","target":"metformin 500mg (u)","id":"46317"},{"source":"gilbert disease","target":"unspecified","id":"46318"},{"source":"gilbert disease","target":"MK-2206 (u)","id":"46319"},{"source":"gilbert disease","target":"neratinib (a)","id":"46320"},{"source":"gilbert disease","target":"patritumab (u)","id":"46321"},{"source":"gilbert disease","target":"pembrolizumab","id":"46322"},{"source":"gilbert disease","target":"pertuzumab (a)","id":"46323"},{"source":"gilbert disease","target":"pexidartinib (u)","id":"46324"},{"source":"gilbert disease","target":"talazoparib (u)","id":"46325"},{"source":"gilbert disease","target":"trastuzumab (IV)","id":"46326"},{"source":"gilbert disease","target":"trastuzumab emtansine (a)","id":"46327"},{"source":"gilbert disease","target":"trebananib (u)","id":"46328"},{"source":"gilbert disease","target":"veliparib (u)","id":"46329"},{"source":"gilbert disease","target":"cyclophosphamide","id":"46330"},{"source":"gilbert disease","target":"unspecified","id":"46331"},{"source":"gilbert disease","target":"pegylated liposomal doxorubicin","id":"46332"},{"source":"gilbert disease","target":"nab-paclitaxel (IV)","id":"46333"},{"source":"gilbert disease","target":"surgical intervention","id":"46334"},{"source":"diabetes mellitus","target":"ganetespib (u)","id":"46335"},{"source":"diabetes mellitus","target":"ganitumab (u)","id":"46336"},{"source":"diabetes mellitus","target":"irinotecan (IV)","id":"46337"},{"source":"diabetes mellitus","target":"unspecified","id":"46338"},{"source":"diabetes mellitus","target":"metformin 500mg (u)","id":"46339"},{"source":"diabetes mellitus","target":"unspecified","id":"46340"},{"source":"diabetes mellitus","target":"MK-2206 (u)","id":"46341"},{"source":"diabetes mellitus","target":"neratinib (a)","id":"46342"},{"source":"diabetes mellitus","target":"patritumab (u)","id":"46343"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"46344"},{"source":"diabetes mellitus","target":"pertuzumab (a)","id":"46345"},{"source":"diabetes mellitus","target":"pexidartinib (u)","id":"46346"},{"source":"diabetes mellitus","target":"talazoparib (u)","id":"46347"},{"source":"diabetes mellitus","target":"trastuzumab (IV)","id":"46348"},{"source":"diabetes mellitus","target":"trastuzumab emtansine (a)","id":"46349"},{"source":"diabetes mellitus","target":"trebananib (u)","id":"46350"},{"source":"diabetes mellitus","target":"veliparib (u)","id":"46351"},{"source":"diabetes mellitus","target":"cyclophosphamide","id":"46352"},{"source":"diabetes mellitus","target":"unspecified","id":"46353"},{"source":"diabetes mellitus","target":"pegylated liposomal doxorubicin","id":"46354"},{"source":"diabetes mellitus","target":"nab-paclitaxel (IV)","id":"46355"},{"source":"diabetes mellitus","target":"surgical intervention","id":"46356"},{"source":"antidiabetic","target":"ganetespib (u)","id":"46357"},{"source":"antidiabetic","target":"ganitumab (u)","id":"46358"},{"source":"antidiabetic","target":"irinotecan (IV)","id":"46359"},{"source":"antidiabetic","target":"unspecified","id":"46360"},{"source":"antidiabetic","target":"metformin 500mg (u)","id":"46361"},{"source":"antidiabetic","target":"unspecified","id":"46362"},{"source":"antidiabetic","target":"MK-2206 (u)","id":"46363"},{"source":"antidiabetic","target":"neratinib (a)","id":"46364"},{"source":"antidiabetic","target":"patritumab (u)","id":"46365"},{"source":"antidiabetic","target":"pembrolizumab","id":"46366"},{"source":"antidiabetic","target":"pertuzumab (a)","id":"46367"},{"source":"antidiabetic","target":"pexidartinib (u)","id":"46368"},{"source":"antidiabetic","target":"talazoparib (u)","id":"46369"},{"source":"antidiabetic","target":"trastuzumab (IV)","id":"46370"},{"source":"antidiabetic","target":"trastuzumab emtansine (a)","id":"46371"},{"source":"antidiabetic","target":"trebananib (u)","id":"46372"},{"source":"antidiabetic","target":"veliparib (u)","id":"46373"},{"source":"antidiabetic","target":"cyclophosphamide","id":"46374"},{"source":"antidiabetic","target":"unspecified","id":"46375"},{"source":"antidiabetic","target":"pegylated liposomal doxorubicin","id":"46376"},{"source":"antidiabetic","target":"nab-paclitaxel (IV)","id":"46377"},{"source":"antidiabetic","target":"surgical intervention","id":"46378"},{"source":"asthma","target":"ganetespib (u)","id":"46379"},{"source":"asthma","target":"ganitumab (u)","id":"46380"},{"source":"asthma","target":"irinotecan (IV)","id":"46381"},{"source":"asthma","target":"unspecified","id":"46382"},{"source":"asthma","target":"metformin 500mg (u)","id":"46383"},{"source":"asthma","target":"unspecified","id":"46384"},{"source":"asthma","target":"MK-2206 (u)","id":"46385"},{"source":"asthma","target":"neratinib (a)","id":"46386"},{"source":"asthma","target":"patritumab (u)","id":"46387"},{"source":"asthma","target":"pembrolizumab","id":"46388"},{"source":"asthma","target":"pertuzumab (a)","id":"46389"},{"source":"asthma","target":"pexidartinib (u)","id":"46390"},{"source":"asthma","target":"talazoparib (u)","id":"46391"},{"source":"asthma","target":"trastuzumab (IV)","id":"46392"},{"source":"asthma","target":"trastuzumab emtansine (a)","id":"46393"},{"source":"asthma","target":"trebananib (u)","id":"46394"},{"source":"asthma","target":"veliparib (u)","id":"46395"},{"source":"asthma","target":"cyclophosphamide","id":"46396"},{"source":"asthma","target":"unspecified","id":"46397"},{"source":"asthma","target":"pegylated liposomal doxorubicin","id":"46398"},{"source":"asthma","target":"nab-paclitaxel (IV)","id":"46399"},{"source":"asthma","target":"surgical intervention","id":"46400"},{"source":"copd","target":"ganetespib (u)","id":"46401"},{"source":"copd","target":"ganitumab (u)","id":"46402"},{"source":"copd","target":"irinotecan (IV)","id":"46403"},{"source":"copd","target":"unspecified","id":"46404"},{"source":"copd","target":"metformin 500mg (u)","id":"46405"},{"source":"copd","target":"unspecified","id":"46406"},{"source":"copd","target":"MK-2206 (u)","id":"46407"},{"source":"copd","target":"neratinib (a)","id":"46408"},{"source":"copd","target":"patritumab (u)","id":"46409"},{"source":"copd","target":"pembrolizumab","id":"46410"},{"source":"copd","target":"pertuzumab (a)","id":"46411"},{"source":"copd","target":"pexidartinib (u)","id":"46412"},{"source":"copd","target":"talazoparib (u)","id":"46413"},{"source":"copd","target":"trastuzumab (IV)","id":"46414"},{"source":"copd","target":"trastuzumab emtansine (a)","id":"46415"},{"source":"copd","target":"trebananib (u)","id":"46416"},{"source":"copd","target":"veliparib (u)","id":"46417"},{"source":"copd","target":"cyclophosphamide","id":"46418"},{"source":"copd","target":"unspecified","id":"46419"},{"source":"copd","target":"pegylated liposomal doxorubicin","id":"46420"},{"source":"copd","target":"nab-paclitaxel (IV)","id":"46421"},{"source":"copd","target":"surgical intervention","id":"46422"},{"source":"heart failure","target":"ganetespib (u)","id":"46423"},{"source":"heart failure","target":"ganitumab (u)","id":"46424"},{"source":"heart failure","target":"irinotecan (IV)","id":"46425"},{"source":"heart failure","target":"unspecified","id":"46426"},{"source":"heart failure","target":"metformin 500mg (u)","id":"46427"},{"source":"heart failure","target":"unspecified","id":"46428"},{"source":"heart failure","target":"MK-2206 (u)","id":"46429"},{"source":"heart failure","target":"neratinib (a)","id":"46430"},{"source":"heart failure","target":"patritumab (u)","id":"46431"},{"source":"heart failure","target":"pembrolizumab","id":"46432"},{"source":"heart failure","target":"pertuzumab (a)","id":"46433"},{"source":"heart failure","target":"pexidartinib (u)","id":"46434"},{"source":"heart failure","target":"talazoparib (u)","id":"46435"},{"source":"heart failure","target":"trastuzumab (IV)","id":"46436"},{"source":"heart failure","target":"trastuzumab emtansine (a)","id":"46437"},{"source":"heart failure","target":"trebananib (u)","id":"46438"},{"source":"heart failure","target":"veliparib (u)","id":"46439"},{"source":"heart failure","target":"cyclophosphamide","id":"46440"},{"source":"heart failure","target":"unspecified","id":"46441"},{"source":"heart failure","target":"pegylated liposomal doxorubicin","id":"46442"},{"source":"heart failure","target":"nab-paclitaxel (IV)","id":"46443"},{"source":"heart failure","target":"surgical intervention","id":"46444"},{"source":"residual neoplasm","target":"ganetespib (u)","id":"46445"},{"source":"residual neoplasm","target":"ganitumab (u)","id":"46446"},{"source":"residual neoplasm","target":"irinotecan (IV)","id":"46447"},{"source":"residual neoplasm","target":"unspecified","id":"46448"},{"source":"residual neoplasm","target":"metformin 500mg (u)","id":"46449"},{"source":"residual neoplasm","target":"unspecified","id":"46450"},{"source":"residual neoplasm","target":"MK-2206 (u)","id":"46451"},{"source":"residual neoplasm","target":"neratinib (a)","id":"46452"},{"source":"residual neoplasm","target":"patritumab (u)","id":"46453"},{"source":"residual neoplasm","target":"pembrolizumab","id":"46454"},{"source":"residual neoplasm","target":"pertuzumab (a)","id":"46455"},{"source":"residual neoplasm","target":"pexidartinib (u)","id":"46456"},{"source":"residual neoplasm","target":"talazoparib (u)","id":"46457"},{"source":"residual neoplasm","target":"trastuzumab (IV)","id":"46458"},{"source":"residual neoplasm","target":"trastuzumab emtansine (a)","id":"46459"},{"source":"residual neoplasm","target":"trebananib (u)","id":"46460"},{"source":"residual neoplasm","target":"veliparib (u)","id":"46461"},{"source":"residual neoplasm","target":"cyclophosphamide","id":"46462"},{"source":"residual neoplasm","target":"unspecified","id":"46463"},{"source":"residual neoplasm","target":"pegylated liposomal doxorubicin","id":"46464"},{"source":"residual neoplasm","target":"nab-paclitaxel (IV)","id":"46465"},{"source":"residual neoplasm","target":"surgical intervention","id":"46466"},{"source":"antiallergic","target":"ganetespib (u)","id":"46467"},{"source":"antiallergic","target":"ganitumab (u)","id":"46468"},{"source":"antiallergic","target":"irinotecan (IV)","id":"46469"},{"source":"antiallergic","target":"unspecified","id":"46470"},{"source":"antiallergic","target":"metformin 500mg (u)","id":"46471"},{"source":"antiallergic","target":"unspecified","id":"46472"},{"source":"antiallergic","target":"MK-2206 (u)","id":"46473"},{"source":"antiallergic","target":"neratinib (a)","id":"46474"},{"source":"antiallergic","target":"patritumab (u)","id":"46475"},{"source":"antiallergic","target":"pembrolizumab","id":"46476"},{"source":"antiallergic","target":"pertuzumab (a)","id":"46477"},{"source":"antiallergic","target":"pexidartinib (u)","id":"46478"},{"source":"antiallergic","target":"talazoparib (u)","id":"46479"},{"source":"antiallergic","target":"trastuzumab (IV)","id":"46480"},{"source":"antiallergic","target":"trastuzumab emtansine (a)","id":"46481"},{"source":"antiallergic","target":"trebananib (u)","id":"46482"},{"source":"antiallergic","target":"veliparib (u)","id":"46483"},{"source":"antiallergic","target":"cyclophosphamide","id":"46484"},{"source":"antiallergic","target":"unspecified","id":"46485"},{"source":"antiallergic","target":"pegylated liposomal doxorubicin","id":"46486"},{"source":"antiallergic","target":"nab-paclitaxel (IV)","id":"46487"},{"source":"antiallergic","target":"surgical intervention","id":"46488"},{"source":"carcinoma","target":"ganetespib (u)","id":"46489"},{"source":"carcinoma","target":"ganitumab (u)","id":"46490"},{"source":"carcinoma","target":"irinotecan (IV)","id":"46491"},{"source":"carcinoma","target":"unspecified","id":"46492"},{"source":"carcinoma","target":"metformin 500mg (u)","id":"46493"},{"source":"carcinoma","target":"unspecified","id":"46494"},{"source":"carcinoma","target":"MK-2206 (u)","id":"46495"},{"source":"carcinoma","target":"neratinib (a)","id":"46496"},{"source":"carcinoma","target":"patritumab (u)","id":"46497"},{"source":"carcinoma","target":"pembrolizumab","id":"46498"},{"source":"carcinoma","target":"pertuzumab (a)","id":"46499"},{"source":"carcinoma","target":"pexidartinib (u)","id":"46500"},{"source":"carcinoma","target":"talazoparib (u)","id":"46501"},{"source":"carcinoma","target":"trastuzumab (IV)","id":"46502"},{"source":"carcinoma","target":"trastuzumab emtansine (a)","id":"46503"},{"source":"carcinoma","target":"trebananib (u)","id":"46504"},{"source":"carcinoma","target":"veliparib (u)","id":"46505"},{"source":"carcinoma","target":"cyclophosphamide","id":"46506"},{"source":"carcinoma","target":"unspecified","id":"46507"},{"source":"carcinoma","target":"pegylated liposomal doxorubicin","id":"46508"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"46509"},{"source":"carcinoma","target":"surgical intervention","id":"46510"},{"source":"breast neoplasms","target":"ganetespib (u)","id":"46511"},{"source":"breast neoplasms","target":"ganitumab (u)","id":"46512"},{"source":"breast neoplasms","target":"irinotecan (IV)","id":"46513"},{"source":"breast neoplasms","target":"unspecified","id":"46514"},{"source":"breast neoplasms","target":"metformin 500mg (u)","id":"46515"},{"source":"breast neoplasms","target":"unspecified","id":"46516"},{"source":"breast neoplasms","target":"MK-2206 (u)","id":"46517"},{"source":"breast neoplasms","target":"neratinib (a)","id":"46518"},{"source":"breast neoplasms","target":"patritumab (u)","id":"46519"},{"source":"breast neoplasms","target":"pembrolizumab","id":"46520"},{"source":"breast neoplasms","target":"pertuzumab (a)","id":"46521"},{"source":"breast neoplasms","target":"pexidartinib (u)","id":"46522"},{"source":"breast neoplasms","target":"talazoparib (u)","id":"46523"},{"source":"breast neoplasms","target":"trastuzumab (IV)","id":"46524"},{"source":"breast neoplasms","target":"trastuzumab emtansine (a)","id":"46525"},{"source":"breast neoplasms","target":"trebananib (u)","id":"46526"},{"source":"breast neoplasms","target":"veliparib (u)","id":"46527"},{"source":"breast neoplasms","target":"cyclophosphamide","id":"46528"},{"source":"breast neoplasms","target":"unspecified","id":"46529"},{"source":"breast neoplasms","target":"pegylated liposomal doxorubicin","id":"46530"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"46531"},{"source":"breast neoplasms","target":"surgical intervention","id":"46532"},{"source":"hypersensitivity","target":"ganetespib (u)","id":"46533"},{"source":"hypersensitivity","target":"ganitumab (u)","id":"46534"},{"source":"hypersensitivity","target":"irinotecan (IV)","id":"46535"},{"source":"hypersensitivity","target":"unspecified","id":"46536"},{"source":"hypersensitivity","target":"metformin 500mg (u)","id":"46537"},{"source":"hypersensitivity","target":"unspecified","id":"46538"},{"source":"hypersensitivity","target":"MK-2206 (u)","id":"46539"},{"source":"hypersensitivity","target":"neratinib (a)","id":"46540"},{"source":"hypersensitivity","target":"patritumab (u)","id":"46541"},{"source":"hypersensitivity","target":"pembrolizumab","id":"46542"},{"source":"hypersensitivity","target":"pertuzumab (a)","id":"46543"},{"source":"hypersensitivity","target":"pexidartinib (u)","id":"46544"},{"source":"hypersensitivity","target":"talazoparib (u)","id":"46545"},{"source":"hypersensitivity","target":"trastuzumab (IV)","id":"46546"},{"source":"hypersensitivity","target":"trastuzumab emtansine (a)","id":"46547"},{"source":"hypersensitivity","target":"trebananib (u)","id":"46548"},{"source":"hypersensitivity","target":"veliparib (u)","id":"46549"},{"source":"hypersensitivity","target":"cyclophosphamide","id":"46550"},{"source":"hypersensitivity","target":"unspecified","id":"46551"},{"source":"hypersensitivity","target":"pegylated liposomal doxorubicin","id":"46552"},{"source":"hypersensitivity","target":"nab-paclitaxel (IV)","id":"46553"},{"source":"hypersensitivity","target":"surgical intervention","id":"46554"},{"source":"inflammation","target":"ganetespib (u)","id":"46555"},{"source":"inflammation","target":"ganitumab (u)","id":"46556"},{"source":"inflammation","target":"irinotecan (IV)","id":"46557"},{"source":"inflammation","target":"unspecified","id":"46558"},{"source":"inflammation","target":"metformin 500mg (u)","id":"46559"},{"source":"inflammation","target":"unspecified","id":"46560"},{"source":"inflammation","target":"MK-2206 (u)","id":"46561"},{"source":"inflammation","target":"neratinib (a)","id":"46562"},{"source":"inflammation","target":"patritumab (u)","id":"46563"},{"source":"inflammation","target":"pembrolizumab","id":"46564"},{"source":"inflammation","target":"pertuzumab (a)","id":"46565"},{"source":"inflammation","target":"pexidartinib (u)","id":"46566"},{"source":"inflammation","target":"talazoparib (u)","id":"46567"},{"source":"inflammation","target":"trastuzumab (IV)","id":"46568"},{"source":"inflammation","target":"trastuzumab emtansine (a)","id":"46569"},{"source":"inflammation","target":"trebananib (u)","id":"46570"},{"source":"inflammation","target":"veliparib (u)","id":"46571"},{"source":"inflammation","target":"cyclophosphamide","id":"46572"},{"source":"inflammation","target":"unspecified","id":"46573"},{"source":"inflammation","target":"pegylated liposomal doxorubicin","id":"46574"},{"source":"inflammation","target":"nab-paclitaxel (IV)","id":"46575"},{"source":"inflammation","target":"surgical intervention","id":"46576"},{"source":"multiple sclerosis","target":"ganetespib (u)","id":"46577"},{"source":"multiple sclerosis","target":"ganitumab (u)","id":"46578"},{"source":"multiple sclerosis","target":"irinotecan (IV)","id":"46579"},{"source":"multiple sclerosis","target":"unspecified","id":"46580"},{"source":"multiple sclerosis","target":"metformin 500mg (u)","id":"46581"},{"source":"multiple sclerosis","target":"unspecified","id":"46582"},{"source":"multiple sclerosis","target":"MK-2206 (u)","id":"46583"},{"source":"multiple sclerosis","target":"neratinib (a)","id":"46584"},{"source":"multiple sclerosis","target":"patritumab (u)","id":"46585"},{"source":"multiple sclerosis","target":"pembrolizumab","id":"46586"},{"source":"multiple sclerosis","target":"pertuzumab (a)","id":"46587"},{"source":"multiple sclerosis","target":"pexidartinib (u)","id":"46588"},{"source":"multiple sclerosis","target":"talazoparib (u)","id":"46589"},{"source":"multiple sclerosis","target":"trastuzumab (IV)","id":"46590"},{"source":"multiple sclerosis","target":"trastuzumab emtansine (a)","id":"46591"},{"source":"multiple sclerosis","target":"trebananib (u)","id":"46592"},{"source":"multiple sclerosis","target":"veliparib (u)","id":"46593"},{"source":"multiple sclerosis","target":"cyclophosphamide","id":"46594"},{"source":"multiple sclerosis","target":"unspecified","id":"46595"},{"source":"multiple sclerosis","target":"pegylated liposomal doxorubicin","id":"46596"},{"source":"multiple sclerosis","target":"nab-paclitaxel (IV)","id":"46597"},{"source":"multiple sclerosis","target":"surgical intervention","id":"46598"},{"source":"triple-negative breast cancer","target":"ganetespib (u)","id":"46599"},{"source":"triple-negative breast cancer","target":"ganitumab (u)","id":"46600"},{"source":"triple-negative breast cancer","target":"irinotecan (IV)","id":"46601"},{"source":"triple-negative breast cancer","target":"unspecified","id":"46602"},{"source":"triple-negative breast cancer","target":"metformin 500mg (u)","id":"46603"},{"source":"triple-negative breast cancer","target":"unspecified","id":"46604"},{"source":"triple-negative breast cancer","target":"MK-2206 (u)","id":"46605"},{"source":"triple-negative breast cancer","target":"neratinib (a)","id":"46606"},{"source":"triple-negative breast cancer","target":"patritumab (u)","id":"46607"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"46608"},{"source":"triple-negative breast cancer","target":"pertuzumab (a)","id":"46609"},{"source":"triple-negative breast cancer","target":"pexidartinib (u)","id":"46610"},{"source":"triple-negative breast cancer","target":"talazoparib (u)","id":"46611"},{"source":"triple-negative breast cancer","target":"trastuzumab (IV)","id":"46612"},{"source":"triple-negative breast cancer","target":"trastuzumab emtansine (a)","id":"46613"},{"source":"triple-negative breast cancer","target":"trebananib (u)","id":"46614"},{"source":"triple-negative breast cancer","target":"veliparib (u)","id":"46615"},{"source":"triple-negative breast cancer","target":"cyclophosphamide","id":"46616"},{"source":"triple-negative breast cancer","target":"unspecified","id":"46617"},{"source":"triple-negative breast cancer","target":"pegylated liposomal doxorubicin","id":"46618"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"46619"},{"source":"triple-negative breast cancer","target":"surgical intervention","id":"46620"},{"source":"diabetes mellitus","target":"ganetespib (u)","id":"46621"},{"source":"diabetes mellitus","target":"ganitumab (u)","id":"46622"},{"source":"diabetes mellitus","target":"irinotecan (IV)","id":"46623"},{"source":"diabetes mellitus","target":"unspecified","id":"46624"},{"source":"diabetes mellitus","target":"metformin 500mg (u)","id":"46625"},{"source":"diabetes mellitus","target":"unspecified","id":"46626"},{"source":"diabetes mellitus","target":"MK-2206 (u)","id":"46627"},{"source":"diabetes mellitus","target":"neratinib (a)","id":"46628"},{"source":"diabetes mellitus","target":"patritumab (u)","id":"46629"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"46630"},{"source":"diabetes mellitus","target":"pertuzumab (a)","id":"46631"},{"source":"diabetes mellitus","target":"pexidartinib (u)","id":"46632"},{"source":"diabetes mellitus","target":"talazoparib (u)","id":"46633"},{"source":"diabetes mellitus","target":"trastuzumab (IV)","id":"46634"},{"source":"diabetes mellitus","target":"trastuzumab emtansine (a)","id":"46635"},{"source":"diabetes mellitus","target":"trebananib (u)","id":"46636"},{"source":"diabetes mellitus","target":"veliparib (u)","id":"46637"},{"source":"diabetes mellitus","target":"cyclophosphamide","id":"46638"},{"source":"diabetes mellitus","target":"unspecified","id":"46639"},{"source":"diabetes mellitus","target":"pegylated liposomal doxorubicin","id":"46640"},{"source":"diabetes mellitus","target":"nab-paclitaxel (IV)","id":"46641"},{"source":"diabetes mellitus","target":"surgical intervention","id":"46642"},{"source":"cardiac disease","target":"ganetespib (u)","id":"46643"},{"source":"cardiac disease","target":"ganitumab (u)","id":"46644"},{"source":"cardiac disease","target":"irinotecan (IV)","id":"46645"},{"source":"cardiac disease","target":"unspecified","id":"46646"},{"source":"cardiac disease","target":"metformin 500mg (u)","id":"46647"},{"source":"cardiac disease","target":"unspecified","id":"46648"},{"source":"cardiac disease","target":"MK-2206 (u)","id":"46649"},{"source":"cardiac disease","target":"neratinib (a)","id":"46650"},{"source":"cardiac disease","target":"patritumab (u)","id":"46651"},{"source":"cardiac disease","target":"pembrolizumab","id":"46652"},{"source":"cardiac disease","target":"pertuzumab (a)","id":"46653"},{"source":"cardiac disease","target":"pexidartinib (u)","id":"46654"},{"source":"cardiac disease","target":"talazoparib (u)","id":"46655"},{"source":"cardiac disease","target":"trastuzumab (IV)","id":"46656"},{"source":"cardiac disease","target":"trastuzumab emtansine (a)","id":"46657"},{"source":"cardiac disease","target":"trebananib (u)","id":"46658"},{"source":"cardiac disease","target":"veliparib (u)","id":"46659"},{"source":"cardiac disease","target":"cyclophosphamide","id":"46660"},{"source":"cardiac disease","target":"unspecified","id":"46661"},{"source":"cardiac disease","target":"pegylated liposomal doxorubicin","id":"46662"},{"source":"cardiac disease","target":"nab-paclitaxel (IV)","id":"46663"},{"source":"cardiac disease","target":"surgical intervention","id":"46664"},{"source":"unstable angina","target":"ganetespib (u)","id":"46665"},{"source":"unstable angina","target":"ganitumab (u)","id":"46666"},{"source":"unstable angina","target":"irinotecan (IV)","id":"46667"},{"source":"unstable angina","target":"unspecified","id":"46668"},{"source":"unstable angina","target":"metformin 500mg (u)","id":"46669"},{"source":"unstable angina","target":"unspecified","id":"46670"},{"source":"unstable angina","target":"MK-2206 (u)","id":"46671"},{"source":"unstable angina","target":"neratinib (a)","id":"46672"},{"source":"unstable angina","target":"patritumab (u)","id":"46673"},{"source":"unstable angina","target":"pembrolizumab","id":"46674"},{"source":"unstable angina","target":"pertuzumab (a)","id":"46675"},{"source":"unstable angina","target":"pexidartinib (u)","id":"46676"},{"source":"unstable angina","target":"talazoparib (u)","id":"46677"},{"source":"unstable angina","target":"trastuzumab (IV)","id":"46678"},{"source":"unstable angina","target":"trastuzumab emtansine (a)","id":"46679"},{"source":"unstable angina","target":"trebananib (u)","id":"46680"},{"source":"unstable angina","target":"veliparib (u)","id":"46681"},{"source":"unstable angina","target":"cyclophosphamide","id":"46682"},{"source":"unstable angina","target":"unspecified","id":"46683"},{"source":"unstable angina","target":"pegylated liposomal doxorubicin","id":"46684"},{"source":"unstable angina","target":"nab-paclitaxel (IV)","id":"46685"},{"source":"unstable angina","target":"surgical intervention","id":"46686"},{"source":"diabetes mellitus","target":"ganetespib (u)","id":"46687"},{"source":"diabetes mellitus","target":"ganitumab (u)","id":"46688"},{"source":"diabetes mellitus","target":"irinotecan (IV)","id":"46689"},{"source":"diabetes mellitus","target":"unspecified","id":"46690"},{"source":"diabetes mellitus","target":"metformin 500mg (u)","id":"46691"},{"source":"diabetes mellitus","target":"unspecified","id":"46692"},{"source":"diabetes mellitus","target":"MK-2206 (u)","id":"46693"},{"source":"diabetes mellitus","target":"neratinib (a)","id":"46694"},{"source":"diabetes mellitus","target":"patritumab (u)","id":"46695"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"46696"},{"source":"diabetes mellitus","target":"pertuzumab (a)","id":"46697"},{"source":"diabetes mellitus","target":"pexidartinib (u)","id":"46698"},{"source":"diabetes mellitus","target":"talazoparib (u)","id":"46699"},{"source":"diabetes mellitus","target":"trastuzumab (IV)","id":"46700"},{"source":"diabetes mellitus","target":"trastuzumab emtansine (a)","id":"46701"},{"source":"diabetes mellitus","target":"trebananib (u)","id":"46702"},{"source":"diabetes mellitus","target":"veliparib (u)","id":"46703"},{"source":"diabetes mellitus","target":"cyclophosphamide","id":"46704"},{"source":"diabetes mellitus","target":"unspecified","id":"46705"},{"source":"diabetes mellitus","target":"pegylated liposomal doxorubicin","id":"46706"},{"source":"diabetes mellitus","target":"nab-paclitaxel (IV)","id":"46707"},{"source":"diabetes mellitus","target":"surgical intervention","id":"46708"},{"source":"anti-inflammatory","target":"ganetespib (u)","id":"46709"},{"source":"anti-inflammatory","target":"ganitumab (u)","id":"46710"},{"source":"anti-inflammatory","target":"irinotecan (IV)","id":"46711"},{"source":"anti-inflammatory","target":"unspecified","id":"46712"},{"source":"anti-inflammatory","target":"metformin 500mg (u)","id":"46713"},{"source":"anti-inflammatory","target":"unspecified","id":"46714"},{"source":"anti-inflammatory","target":"MK-2206 (u)","id":"46715"},{"source":"anti-inflammatory","target":"neratinib (a)","id":"46716"},{"source":"anti-inflammatory","target":"patritumab (u)","id":"46717"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"46718"},{"source":"anti-inflammatory","target":"pertuzumab (a)","id":"46719"},{"source":"anti-inflammatory","target":"pexidartinib (u)","id":"46720"},{"source":"anti-inflammatory","target":"talazoparib (u)","id":"46721"},{"source":"anti-inflammatory","target":"trastuzumab (IV)","id":"46722"},{"source":"anti-inflammatory","target":"trastuzumab emtansine (a)","id":"46723"},{"source":"anti-inflammatory","target":"trebananib (u)","id":"46724"},{"source":"anti-inflammatory","target":"veliparib (u)","id":"46725"},{"source":"anti-inflammatory","target":"cyclophosphamide","id":"46726"},{"source":"anti-inflammatory","target":"unspecified","id":"46727"},{"source":"anti-inflammatory","target":"pegylated liposomal doxorubicin","id":"46728"},{"source":"anti-inflammatory","target":"nab-paclitaxel (IV)","id":"46729"},{"source":"anti-inflammatory","target":"surgical intervention","id":"46730"},{"source":"arthritis","target":"ganetespib (u)","id":"46731"},{"source":"arthritis","target":"ganitumab (u)","id":"46732"},{"source":"arthritis","target":"irinotecan (IV)","id":"46733"},{"source":"arthritis","target":"unspecified","id":"46734"},{"source":"arthritis","target":"metformin 500mg (u)","id":"46735"},{"source":"arthritis","target":"unspecified","id":"46736"},{"source":"arthritis","target":"MK-2206 (u)","id":"46737"},{"source":"arthritis","target":"neratinib (a)","id":"46738"},{"source":"arthritis","target":"patritumab (u)","id":"46739"},{"source":"arthritis","target":"pembrolizumab","id":"46740"},{"source":"arthritis","target":"pertuzumab (a)","id":"46741"},{"source":"arthritis","target":"pexidartinib (u)","id":"46742"},{"source":"arthritis","target":"talazoparib (u)","id":"46743"},{"source":"arthritis","target":"trastuzumab (IV)","id":"46744"},{"source":"arthritis","target":"trastuzumab emtansine (a)","id":"46745"},{"source":"arthritis","target":"trebananib (u)","id":"46746"},{"source":"arthritis","target":"veliparib (u)","id":"46747"},{"source":"arthritis","target":"cyclophosphamide","id":"46748"},{"source":"arthritis","target":"unspecified","id":"46749"},{"source":"arthritis","target":"pegylated liposomal doxorubicin","id":"46750"},{"source":"arthritis","target":"nab-paclitaxel (IV)","id":"46751"},{"source":"arthritis","target":"surgical intervention","id":"46752"},{"source":"residual tumor","target":"ganetespib (u)","id":"46753"},{"source":"residual tumor","target":"ganitumab (u)","id":"46754"},{"source":"residual tumor","target":"irinotecan (IV)","id":"46755"},{"source":"residual tumor","target":"unspecified","id":"46756"},{"source":"residual tumor","target":"metformin 500mg (u)","id":"46757"},{"source":"residual tumor","target":"unspecified","id":"46758"},{"source":"residual tumor","target":"MK-2206 (u)","id":"46759"},{"source":"residual tumor","target":"neratinib (a)","id":"46760"},{"source":"residual tumor","target":"patritumab (u)","id":"46761"},{"source":"residual tumor","target":"pembrolizumab","id":"46762"},{"source":"residual tumor","target":"pertuzumab (a)","id":"46763"},{"source":"residual tumor","target":"pexidartinib (u)","id":"46764"},{"source":"residual tumor","target":"talazoparib (u)","id":"46765"},{"source":"residual tumor","target":"trastuzumab (IV)","id":"46766"},{"source":"residual tumor","target":"trastuzumab emtansine (a)","id":"46767"},{"source":"residual tumor","target":"trebananib (u)","id":"46768"},{"source":"residual tumor","target":"veliparib (u)","id":"46769"},{"source":"residual tumor","target":"cyclophosphamide","id":"46770"},{"source":"residual tumor","target":"unspecified","id":"46771"},{"source":"residual tumor","target":"pegylated liposomal doxorubicin","id":"46772"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"46773"},{"source":"residual tumor","target":"surgical intervention","id":"46774"},{"source":"cardiac conditions","target":"ganetespib (u)","id":"46775"},{"source":"cardiac conditions","target":"ganitumab (u)","id":"46776"},{"source":"cardiac conditions","target":"irinotecan (IV)","id":"46777"},{"source":"cardiac conditions","target":"unspecified","id":"46778"},{"source":"cardiac conditions","target":"metformin 500mg (u)","id":"46779"},{"source":"cardiac conditions","target":"unspecified","id":"46780"},{"source":"cardiac conditions","target":"MK-2206 (u)","id":"46781"},{"source":"cardiac conditions","target":"neratinib (a)","id":"46782"},{"source":"cardiac conditions","target":"patritumab (u)","id":"46783"},{"source":"cardiac conditions","target":"pembrolizumab","id":"46784"},{"source":"cardiac conditions","target":"pertuzumab (a)","id":"46785"},{"source":"cardiac conditions","target":"pexidartinib (u)","id":"46786"},{"source":"cardiac conditions","target":"talazoparib (u)","id":"46787"},{"source":"cardiac conditions","target":"trastuzumab (IV)","id":"46788"},{"source":"cardiac conditions","target":"trastuzumab emtansine (a)","id":"46789"},{"source":"cardiac conditions","target":"trebananib (u)","id":"46790"},{"source":"cardiac conditions","target":"veliparib (u)","id":"46791"},{"source":"cardiac conditions","target":"cyclophosphamide","id":"46792"},{"source":"cardiac conditions","target":"unspecified","id":"46793"},{"source":"cardiac conditions","target":"pegylated liposomal doxorubicin","id":"46794"},{"source":"cardiac conditions","target":"nab-paclitaxel (IV)","id":"46795"},{"source":"cardiac conditions","target":"surgical intervention","id":"46796"},{"source":"solid malignancy","target":"ganetespib (u)","id":"46797"},{"source":"solid malignancy","target":"ganitumab (u)","id":"46798"},{"source":"solid malignancy","target":"irinotecan (IV)","id":"46799"},{"source":"solid malignancy","target":"unspecified","id":"46800"},{"source":"solid malignancy","target":"metformin 500mg (u)","id":"46801"},{"source":"solid malignancy","target":"unspecified","id":"46802"},{"source":"solid malignancy","target":"MK-2206 (u)","id":"46803"},{"source":"solid malignancy","target":"neratinib (a)","id":"46804"},{"source":"solid malignancy","target":"patritumab (u)","id":"46805"},{"source":"solid malignancy","target":"pembrolizumab","id":"46806"},{"source":"solid malignancy","target":"pertuzumab (a)","id":"46807"},{"source":"solid malignancy","target":"pexidartinib (u)","id":"46808"},{"source":"solid malignancy","target":"talazoparib (u)","id":"46809"},{"source":"solid malignancy","target":"trastuzumab (IV)","id":"46810"},{"source":"solid malignancy","target":"trastuzumab emtansine (a)","id":"46811"},{"source":"solid malignancy","target":"trebananib (u)","id":"46812"},{"source":"solid malignancy","target":"veliparib (u)","id":"46813"},{"source":"solid malignancy","target":"cyclophosphamide","id":"46814"},{"source":"solid malignancy","target":"unspecified","id":"46815"},{"source":"solid malignancy","target":"pegylated liposomal doxorubicin","id":"46816"},{"source":"solid malignancy","target":"nab-paclitaxel (IV)","id":"46817"},{"source":"solid malignancy","target":"surgical intervention","id":"46818"},{"source":"carcinoma","target":"ganetespib (u)","id":"46819"},{"source":"carcinoma","target":"ganitumab (u)","id":"46820"},{"source":"carcinoma","target":"irinotecan (IV)","id":"46821"},{"source":"carcinoma","target":"unspecified","id":"46822"},{"source":"carcinoma","target":"metformin 500mg (u)","id":"46823"},{"source":"carcinoma","target":"unspecified","id":"46824"},{"source":"carcinoma","target":"MK-2206 (u)","id":"46825"},{"source":"carcinoma","target":"neratinib (a)","id":"46826"},{"source":"carcinoma","target":"patritumab (u)","id":"46827"},{"source":"carcinoma","target":"pembrolizumab","id":"46828"},{"source":"carcinoma","target":"pertuzumab (a)","id":"46829"},{"source":"carcinoma","target":"pexidartinib (u)","id":"46830"},{"source":"carcinoma","target":"talazoparib (u)","id":"46831"},{"source":"carcinoma","target":"trastuzumab (IV)","id":"46832"},{"source":"carcinoma","target":"trastuzumab emtansine (a)","id":"46833"},{"source":"carcinoma","target":"trebananib (u)","id":"46834"},{"source":"carcinoma","target":"veliparib (u)","id":"46835"},{"source":"carcinoma","target":"cyclophosphamide","id":"46836"},{"source":"carcinoma","target":"unspecified","id":"46837"},{"source":"carcinoma","target":"pegylated liposomal doxorubicin","id":"46838"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"46839"},{"source":"carcinoma","target":"surgical intervention","id":"46840"},{"source":"myocardial infarction","target":"ganetespib (u)","id":"46841"},{"source":"myocardial infarction","target":"ganitumab (u)","id":"46842"},{"source":"myocardial infarction","target":"irinotecan (IV)","id":"46843"},{"source":"myocardial infarction","target":"unspecified","id":"46844"},{"source":"myocardial infarction","target":"metformin 500mg (u)","id":"46845"},{"source":"myocardial infarction","target":"unspecified","id":"46846"},{"source":"myocardial infarction","target":"MK-2206 (u)","id":"46847"},{"source":"myocardial infarction","target":"neratinib (a)","id":"46848"},{"source":"myocardial infarction","target":"patritumab (u)","id":"46849"},{"source":"myocardial infarction","target":"pembrolizumab","id":"46850"},{"source":"myocardial infarction","target":"pertuzumab (a)","id":"46851"},{"source":"myocardial infarction","target":"pexidartinib (u)","id":"46852"},{"source":"myocardial infarction","target":"talazoparib (u)","id":"46853"},{"source":"myocardial infarction","target":"trastuzumab (IV)","id":"46854"},{"source":"myocardial infarction","target":"trastuzumab emtansine (a)","id":"46855"},{"source":"myocardial infarction","target":"trebananib (u)","id":"46856"},{"source":"myocardial infarction","target":"veliparib (u)","id":"46857"},{"source":"myocardial infarction","target":"cyclophosphamide","id":"46858"},{"source":"myocardial infarction","target":"unspecified","id":"46859"},{"source":"myocardial infarction","target":"pegylated liposomal doxorubicin","id":"46860"},{"source":"myocardial infarction","target":"nab-paclitaxel (IV)","id":"46861"},{"source":"myocardial infarction","target":"surgical intervention","id":"46862"},{"source":"neoplasm metastasis","target":"ganetespib (u)","id":"46863"},{"source":"neoplasm metastasis","target":"ganitumab (u)","id":"46864"},{"source":"neoplasm metastasis","target":"irinotecan (IV)","id":"46865"},{"source":"neoplasm metastasis","target":"unspecified","id":"46866"},{"source":"neoplasm metastasis","target":"metformin 500mg (u)","id":"46867"},{"source":"neoplasm metastasis","target":"unspecified","id":"46868"},{"source":"neoplasm metastasis","target":"MK-2206 (u)","id":"46869"},{"source":"neoplasm metastasis","target":"neratinib (a)","id":"46870"},{"source":"neoplasm metastasis","target":"patritumab (u)","id":"46871"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"46872"},{"source":"neoplasm metastasis","target":"pertuzumab (a)","id":"46873"},{"source":"neoplasm metastasis","target":"pexidartinib (u)","id":"46874"},{"source":"neoplasm metastasis","target":"talazoparib (u)","id":"46875"},{"source":"neoplasm metastasis","target":"trastuzumab (IV)","id":"46876"},{"source":"neoplasm metastasis","target":"trastuzumab emtansine (a)","id":"46877"},{"source":"neoplasm metastasis","target":"trebananib (u)","id":"46878"},{"source":"neoplasm metastasis","target":"veliparib (u)","id":"46879"},{"source":"neoplasm metastasis","target":"cyclophosphamide","id":"46880"},{"source":"neoplasm metastasis","target":"unspecified","id":"46881"},{"source":"neoplasm metastasis","target":"pegylated liposomal doxorubicin","id":"46882"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"46883"},{"source":"neoplasm metastasis","target":"surgical intervention","id":"46884"},{"source":"teratogenic","target":"ganetespib (u)","id":"46885"},{"source":"teratogenic","target":"ganitumab (u)","id":"46886"},{"source":"teratogenic","target":"irinotecan (IV)","id":"46887"},{"source":"teratogenic","target":"unspecified","id":"46888"},{"source":"teratogenic","target":"metformin 500mg (u)","id":"46889"},{"source":"teratogenic","target":"unspecified","id":"46890"},{"source":"teratogenic","target":"MK-2206 (u)","id":"46891"},{"source":"teratogenic","target":"neratinib (a)","id":"46892"},{"source":"teratogenic","target":"patritumab (u)","id":"46893"},{"source":"teratogenic","target":"pembrolizumab","id":"46894"},{"source":"teratogenic","target":"pertuzumab (a)","id":"46895"},{"source":"teratogenic","target":"pexidartinib (u)","id":"46896"},{"source":"teratogenic","target":"talazoparib (u)","id":"46897"},{"source":"teratogenic","target":"trastuzumab (IV)","id":"46898"},{"source":"teratogenic","target":"trastuzumab emtansine (a)","id":"46899"},{"source":"teratogenic","target":"trebananib (u)","id":"46900"},{"source":"teratogenic","target":"veliparib (u)","id":"46901"},{"source":"teratogenic","target":"cyclophosphamide","id":"46902"},{"source":"teratogenic","target":"unspecified","id":"46903"},{"source":"teratogenic","target":"pegylated liposomal doxorubicin","id":"46904"},{"source":"teratogenic","target":"nab-paclitaxel (IV)","id":"46905"},{"source":"teratogenic","target":"surgical intervention","id":"46906"},{"source":"anti-inflammatory","target":"ganetespib (u)","id":"46907"},{"source":"anti-inflammatory","target":"ganitumab (u)","id":"46908"},{"source":"anti-inflammatory","target":"irinotecan (IV)","id":"46909"},{"source":"anti-inflammatory","target":"unspecified","id":"46910"},{"source":"anti-inflammatory","target":"metformin 500mg (u)","id":"46911"},{"source":"anti-inflammatory","target":"unspecified","id":"46912"},{"source":"anti-inflammatory","target":"MK-2206 (u)","id":"46913"},{"source":"anti-inflammatory","target":"neratinib (a)","id":"46914"},{"source":"anti-inflammatory","target":"patritumab (u)","id":"46915"},{"source":"anti-inflammatory","target":"pembrolizumab","id":"46916"},{"source":"anti-inflammatory","target":"pertuzumab (a)","id":"46917"},{"source":"anti-inflammatory","target":"pexidartinib (u)","id":"46918"},{"source":"anti-inflammatory","target":"talazoparib (u)","id":"46919"},{"source":"anti-inflammatory","target":"trastuzumab (IV)","id":"46920"},{"source":"anti-inflammatory","target":"trastuzumab emtansine (a)","id":"46921"},{"source":"anti-inflammatory","target":"trebananib (u)","id":"46922"},{"source":"anti-inflammatory","target":"veliparib (u)","id":"46923"},{"source":"anti-inflammatory","target":"cyclophosphamide","id":"46924"},{"source":"anti-inflammatory","target":"unspecified","id":"46925"},{"source":"anti-inflammatory","target":"pegylated liposomal doxorubicin","id":"46926"},{"source":"anti-inflammatory","target":"nab-paclitaxel (IV)","id":"46927"},{"source":"anti-inflammatory","target":"surgical intervention","id":"46928"},{"source":"metaplasia","target":"ganetespib (u)","id":"46929"},{"source":"metaplasia","target":"ganitumab (u)","id":"46930"},{"source":"metaplasia","target":"irinotecan (IV)","id":"46931"},{"source":"metaplasia","target":"unspecified","id":"46932"},{"source":"metaplasia","target":"metformin 500mg (u)","id":"46933"},{"source":"metaplasia","target":"unspecified","id":"46934"},{"source":"metaplasia","target":"MK-2206 (u)","id":"46935"},{"source":"metaplasia","target":"neratinib (a)","id":"46936"},{"source":"metaplasia","target":"patritumab (u)","id":"46937"},{"source":"metaplasia","target":"pembrolizumab","id":"46938"},{"source":"metaplasia","target":"pertuzumab (a)","id":"46939"},{"source":"metaplasia","target":"pexidartinib (u)","id":"46940"},{"source":"metaplasia","target":"talazoparib (u)","id":"46941"},{"source":"metaplasia","target":"trastuzumab (IV)","id":"46942"},{"source":"metaplasia","target":"trastuzumab emtansine (a)","id":"46943"},{"source":"metaplasia","target":"trebananib (u)","id":"46944"},{"source":"metaplasia","target":"veliparib (u)","id":"46945"},{"source":"metaplasia","target":"cyclophosphamide","id":"46946"},{"source":"metaplasia","target":"unspecified","id":"46947"},{"source":"metaplasia","target":"pegylated liposomal doxorubicin","id":"46948"},{"source":"metaplasia","target":"nab-paclitaxel (IV)","id":"46949"},{"source":"metaplasia","target":"surgical intervention","id":"46950"},{"source":"diabetes mellitus","target":"ganetespib (u)","id":"46951"},{"source":"diabetes mellitus","target":"ganitumab (u)","id":"46952"},{"source":"diabetes mellitus","target":"irinotecan (IV)","id":"46953"},{"source":"diabetes mellitus","target":"unspecified","id":"46954"},{"source":"diabetes mellitus","target":"metformin 500mg (u)","id":"46955"},{"source":"diabetes mellitus","target":"unspecified","id":"46956"},{"source":"diabetes mellitus","target":"MK-2206 (u)","id":"46957"},{"source":"diabetes mellitus","target":"neratinib (a)","id":"46958"},{"source":"diabetes mellitus","target":"patritumab (u)","id":"46959"},{"source":"diabetes mellitus","target":"pembrolizumab","id":"46960"},{"source":"diabetes mellitus","target":"pertuzumab (a)","id":"46961"},{"source":"diabetes mellitus","target":"pexidartinib (u)","id":"46962"},{"source":"diabetes mellitus","target":"talazoparib (u)","id":"46963"},{"source":"diabetes mellitus","target":"trastuzumab (IV)","id":"46964"},{"source":"diabetes mellitus","target":"trastuzumab emtansine (a)","id":"46965"},{"source":"diabetes mellitus","target":"trebananib (u)","id":"46966"},{"source":"diabetes mellitus","target":"veliparib (u)","id":"46967"},{"source":"diabetes mellitus","target":"cyclophosphamide","id":"46968"},{"source":"diabetes mellitus","target":"unspecified","id":"46969"},{"source":"diabetes mellitus","target":"pegylated liposomal doxorubicin","id":"46970"},{"source":"diabetes mellitus","target":"nab-paclitaxel (IV)","id":"46971"},{"source":"diabetes mellitus","target":"surgical intervention","id":"46972"},{"source":"cardiac arrhythmias","target":"ganetespib (u)","id":"46973"},{"source":"cardiac arrhythmias","target":"ganitumab (u)","id":"46974"},{"source":"cardiac arrhythmias","target":"irinotecan (IV)","id":"46975"},{"source":"cardiac arrhythmias","target":"unspecified","id":"46976"},{"source":"cardiac arrhythmias","target":"metformin 500mg (u)","id":"46977"},{"source":"cardiac arrhythmias","target":"unspecified","id":"46978"},{"source":"cardiac arrhythmias","target":"MK-2206 (u)","id":"46979"},{"source":"cardiac arrhythmias","target":"neratinib (a)","id":"46980"},{"source":"cardiac arrhythmias","target":"patritumab (u)","id":"46981"},{"source":"cardiac arrhythmias","target":"pembrolizumab","id":"46982"},{"source":"cardiac arrhythmias","target":"pertuzumab (a)","id":"46983"},{"source":"cardiac arrhythmias","target":"pexidartinib (u)","id":"46984"},{"source":"cardiac arrhythmias","target":"talazoparib (u)","id":"46985"},{"source":"cardiac arrhythmias","target":"trastuzumab (IV)","id":"46986"},{"source":"cardiac arrhythmias","target":"trastuzumab emtansine (a)","id":"46987"},{"source":"cardiac arrhythmias","target":"trebananib (u)","id":"46988"},{"source":"cardiac arrhythmias","target":"veliparib (u)","id":"46989"},{"source":"cardiac arrhythmias","target":"cyclophosphamide","id":"46990"},{"source":"cardiac arrhythmias","target":"unspecified","id":"46991"},{"source":"cardiac arrhythmias","target":"pegylated liposomal doxorubicin","id":"46992"},{"source":"cardiac arrhythmias","target":"nab-paclitaxel (IV)","id":"46993"},{"source":"cardiac arrhythmias","target":"surgical intervention","id":"46994"},{"source":"liver metastases","target":"ganetespib (u)","id":"46995"},{"source":"liver metastases","target":"ganitumab (u)","id":"46996"},{"source":"liver metastases","target":"irinotecan (IV)","id":"46997"},{"source":"liver metastases","target":"unspecified","id":"46998"},{"source":"liver metastases","target":"metformin 500mg (u)","id":"46999"},{"source":"liver metastases","target":"unspecified","id":"47000"},{"source":"liver metastases","target":"MK-2206 (u)","id":"47001"},{"source":"liver metastases","target":"neratinib (a)","id":"47002"},{"source":"liver metastases","target":"patritumab (u)","id":"47003"},{"source":"liver metastases","target":"pembrolizumab","id":"47004"},{"source":"liver metastases","target":"pertuzumab (a)","id":"47005"},{"source":"liver metastases","target":"pexidartinib (u)","id":"47006"},{"source":"liver metastases","target":"talazoparib (u)","id":"47007"},{"source":"liver metastases","target":"trastuzumab (IV)","id":"47008"},{"source":"liver metastases","target":"trastuzumab emtansine (a)","id":"47009"},{"source":"liver metastases","target":"trebananib (u)","id":"47010"},{"source":"liver metastases","target":"veliparib (u)","id":"47011"},{"source":"liver metastases","target":"cyclophosphamide","id":"47012"},{"source":"liver metastases","target":"unspecified","id":"47013"},{"source":"liver metastases","target":"pegylated liposomal doxorubicin","id":"47014"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"47015"},{"source":"liver metastases","target":"surgical intervention","id":"47016"},{"source":"gilbert disease","target":"ganetespib (u)","id":"47017"},{"source":"gilbert disease","target":"ganitumab (u)","id":"47018"},{"source":"gilbert disease","target":"irinotecan (IV)","id":"47019"},{"source":"gilbert disease","target":"unspecified","id":"47020"},{"source":"gilbert disease","target":"metformin 500mg (u)","id":"47021"},{"source":"gilbert disease","target":"unspecified","id":"47022"},{"source":"gilbert disease","target":"MK-2206 (u)","id":"47023"},{"source":"gilbert disease","target":"neratinib (a)","id":"47024"},{"source":"gilbert disease","target":"patritumab (u)","id":"47025"},{"source":"gilbert disease","target":"pembrolizumab","id":"47026"},{"source":"gilbert disease","target":"pertuzumab (a)","id":"47027"},{"source":"gilbert disease","target":"pexidartinib (u)","id":"47028"},{"source":"gilbert disease","target":"talazoparib (u)","id":"47029"},{"source":"gilbert disease","target":"trastuzumab (IV)","id":"47030"},{"source":"gilbert disease","target":"trastuzumab emtansine (a)","id":"47031"},{"source":"gilbert disease","target":"trebananib (u)","id":"47032"},{"source":"gilbert disease","target":"veliparib (u)","id":"47033"},{"source":"gilbert disease","target":"cyclophosphamide","id":"47034"},{"source":"gilbert disease","target":"unspecified","id":"47035"},{"source":"gilbert disease","target":"pegylated liposomal doxorubicin","id":"47036"},{"source":"gilbert disease","target":"nab-paclitaxel (IV)","id":"47037"},{"source":"gilbert disease","target":"surgical intervention","id":"47038"},{"source":"hypoglycemic","target":"ganetespib (u)","id":"47039"},{"source":"hypoglycemic","target":"ganitumab (u)","id":"47040"},{"source":"hypoglycemic","target":"irinotecan (IV)","id":"47041"},{"source":"hypoglycemic","target":"unspecified","id":"47042"},{"source":"hypoglycemic","target":"metformin 500mg (u)","id":"47043"},{"source":"hypoglycemic","target":"unspecified","id":"47044"},{"source":"hypoglycemic","target":"MK-2206 (u)","id":"47045"},{"source":"hypoglycemic","target":"neratinib (a)","id":"47046"},{"source":"hypoglycemic","target":"patritumab (u)","id":"47047"},{"source":"hypoglycemic","target":"pembrolizumab","id":"47048"},{"source":"hypoglycemic","target":"pertuzumab (a)","id":"47049"},{"source":"hypoglycemic","target":"pexidartinib (u)","id":"47050"},{"source":"hypoglycemic","target":"talazoparib (u)","id":"47051"},{"source":"hypoglycemic","target":"trastuzumab (IV)","id":"47052"},{"source":"hypoglycemic","target":"trastuzumab emtansine (a)","id":"47053"},{"source":"hypoglycemic","target":"trebananib (u)","id":"47054"},{"source":"hypoglycemic","target":"veliparib (u)","id":"47055"},{"source":"hypoglycemic","target":"cyclophosphamide","id":"47056"},{"source":"hypoglycemic","target":"unspecified","id":"47057"},{"source":"hypoglycemic","target":"pegylated liposomal doxorubicin","id":"47058"},{"source":"hypoglycemic","target":"nab-paclitaxel (IV)","id":"47059"},{"source":"hypoglycemic","target":"surgical intervention","id":"47060"},{"source":"residual tumor","target":"ganetespib (u)","id":"47061"},{"source":"residual tumor","target":"ganitumab (u)","id":"47062"},{"source":"residual tumor","target":"irinotecan (IV)","id":"47063"},{"source":"residual tumor","target":"unspecified","id":"47064"},{"source":"residual tumor","target":"metformin 500mg (u)","id":"47065"},{"source":"residual tumor","target":"unspecified","id":"47066"},{"source":"residual tumor","target":"MK-2206 (u)","id":"47067"},{"source":"residual tumor","target":"neratinib (a)","id":"47068"},{"source":"residual tumor","target":"patritumab (u)","id":"47069"},{"source":"residual tumor","target":"pembrolizumab","id":"47070"},{"source":"residual tumor","target":"pertuzumab (a)","id":"47071"},{"source":"residual tumor","target":"pexidartinib (u)","id":"47072"},{"source":"residual tumor","target":"talazoparib (u)","id":"47073"},{"source":"residual tumor","target":"trastuzumab (IV)","id":"47074"},{"source":"residual tumor","target":"trastuzumab emtansine (a)","id":"47075"},{"source":"residual tumor","target":"trebananib (u)","id":"47076"},{"source":"residual tumor","target":"veliparib (u)","id":"47077"},{"source":"residual tumor","target":"cyclophosphamide","id":"47078"},{"source":"residual tumor","target":"unspecified","id":"47079"},{"source":"residual tumor","target":"pegylated liposomal doxorubicin","id":"47080"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"47081"},{"source":"residual tumor","target":"surgical intervention","id":"47082"},{"source":"hypoglycemic","target":"ganetespib (u)","id":"47083"},{"source":"hypoglycemic","target":"ganitumab (u)","id":"47084"},{"source":"hypoglycemic","target":"irinotecan (IV)","id":"47085"},{"source":"hypoglycemic","target":"unspecified","id":"47086"},{"source":"hypoglycemic","target":"metformin 500mg (u)","id":"47087"},{"source":"hypoglycemic","target":"unspecified","id":"47088"},{"source":"hypoglycemic","target":"MK-2206 (u)","id":"47089"},{"source":"hypoglycemic","target":"neratinib (a)","id":"47090"},{"source":"hypoglycemic","target":"patritumab (u)","id":"47091"},{"source":"hypoglycemic","target":"pembrolizumab","id":"47092"},{"source":"hypoglycemic","target":"pertuzumab (a)","id":"47093"},{"source":"hypoglycemic","target":"pexidartinib (u)","id":"47094"},{"source":"hypoglycemic","target":"talazoparib (u)","id":"47095"},{"source":"hypoglycemic","target":"trastuzumab (IV)","id":"47096"},{"source":"hypoglycemic","target":"trastuzumab emtansine (a)","id":"47097"},{"source":"hypoglycemic","target":"trebananib (u)","id":"47098"},{"source":"hypoglycemic","target":"veliparib (u)","id":"47099"},{"source":"hypoglycemic","target":"cyclophosphamide","id":"47100"},{"source":"hypoglycemic","target":"unspecified","id":"47101"},{"source":"hypoglycemic","target":"pegylated liposomal doxorubicin","id":"47102"},{"source":"hypoglycemic","target":"nab-paclitaxel (IV)","id":"47103"},{"source":"hypoglycemic","target":"surgical intervention","id":"47104"},{"source":"cardiac arrhythmias","target":"ganetespib (u)","id":"47105"},{"source":"cardiac arrhythmias","target":"ganitumab (u)","id":"47106"},{"source":"cardiac arrhythmias","target":"irinotecan (IV)","id":"47107"},{"source":"cardiac arrhythmias","target":"unspecified","id":"47108"},{"source":"cardiac arrhythmias","target":"metformin 500mg (u)","id":"47109"},{"source":"cardiac arrhythmias","target":"unspecified","id":"47110"},{"source":"cardiac arrhythmias","target":"MK-2206 (u)","id":"47111"},{"source":"cardiac arrhythmias","target":"neratinib (a)","id":"47112"},{"source":"cardiac arrhythmias","target":"patritumab (u)","id":"47113"},{"source":"cardiac arrhythmias","target":"pembrolizumab","id":"47114"},{"source":"cardiac arrhythmias","target":"pertuzumab (a)","id":"47115"},{"source":"cardiac arrhythmias","target":"pexidartinib (u)","id":"47116"},{"source":"cardiac arrhythmias","target":"talazoparib (u)","id":"47117"},{"source":"cardiac arrhythmias","target":"trastuzumab (IV)","id":"47118"},{"source":"cardiac arrhythmias","target":"trastuzumab emtansine (a)","id":"47119"},{"source":"cardiac arrhythmias","target":"trebananib (u)","id":"47120"},{"source":"cardiac arrhythmias","target":"veliparib (u)","id":"47121"},{"source":"cardiac arrhythmias","target":"cyclophosphamide","id":"47122"},{"source":"cardiac arrhythmias","target":"unspecified","id":"47123"},{"source":"cardiac arrhythmias","target":"pegylated liposomal doxorubicin","id":"47124"},{"source":"cardiac arrhythmias","target":"nab-paclitaxel (IV)","id":"47125"},{"source":"cardiac arrhythmias","target":"surgical intervention","id":"47126"},{"source":"residual tumor","target":"ganetespib (u)","id":"47127"},{"source":"residual tumor","target":"ganitumab (u)","id":"47128"},{"source":"residual tumor","target":"irinotecan (IV)","id":"47129"},{"source":"residual tumor","target":"unspecified","id":"47130"},{"source":"residual tumor","target":"metformin 500mg (u)","id":"47131"},{"source":"residual tumor","target":"unspecified","id":"47132"},{"source":"residual tumor","target":"MK-2206 (u)","id":"47133"},{"source":"residual tumor","target":"neratinib (a)","id":"47134"},{"source":"residual tumor","target":"patritumab (u)","id":"47135"},{"source":"residual tumor","target":"pembrolizumab","id":"47136"},{"source":"residual tumor","target":"pertuzumab (a)","id":"47137"},{"source":"residual tumor","target":"pexidartinib (u)","id":"47138"},{"source":"residual tumor","target":"talazoparib (u)","id":"47139"},{"source":"residual tumor","target":"trastuzumab (IV)","id":"47140"},{"source":"residual tumor","target":"trastuzumab emtansine (a)","id":"47141"},{"source":"residual tumor","target":"trebananib (u)","id":"47142"},{"source":"residual tumor","target":"veliparib (u)","id":"47143"},{"source":"residual tumor","target":"cyclophosphamide","id":"47144"},{"source":"residual tumor","target":"unspecified","id":"47145"},{"source":"residual tumor","target":"pegylated liposomal doxorubicin","id":"47146"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"47147"},{"source":"residual tumor","target":"surgical intervention","id":"47148"},{"source":"insulin resistance","target":"ganetespib (u)","id":"47149"},{"source":"insulin resistance","target":"ganitumab (u)","id":"47150"},{"source":"insulin resistance","target":"irinotecan (IV)","id":"47151"},{"source":"insulin resistance","target":"unspecified","id":"47152"},{"source":"insulin resistance","target":"metformin 500mg (u)","id":"47153"},{"source":"insulin resistance","target":"unspecified","id":"47154"},{"source":"insulin resistance","target":"MK-2206 (u)","id":"47155"},{"source":"insulin resistance","target":"neratinib (a)","id":"47156"},{"source":"insulin resistance","target":"patritumab (u)","id":"47157"},{"source":"insulin resistance","target":"pembrolizumab","id":"47158"},{"source":"insulin resistance","target":"pertuzumab (a)","id":"47159"},{"source":"insulin resistance","target":"pexidartinib (u)","id":"47160"},{"source":"insulin resistance","target":"talazoparib (u)","id":"47161"},{"source":"insulin resistance","target":"trastuzumab (IV)","id":"47162"},{"source":"insulin resistance","target":"trastuzumab emtansine (a)","id":"47163"},{"source":"insulin resistance","target":"trebananib (u)","id":"47164"},{"source":"insulin resistance","target":"veliparib (u)","id":"47165"},{"source":"insulin resistance","target":"cyclophosphamide","id":"47166"},{"source":"insulin resistance","target":"unspecified","id":"47167"},{"source":"insulin resistance","target":"pegylated liposomal doxorubicin","id":"47168"},{"source":"insulin resistance","target":"nab-paclitaxel (IV)","id":"47169"},{"source":"insulin resistance","target":"surgical intervention","id":"47170"},{"source":"aneurysm","target":"ganetespib (u)","id":"47171"},{"source":"aneurysm","target":"ganitumab (u)","id":"47172"},{"source":"aneurysm","target":"irinotecan (IV)","id":"47173"},{"source":"aneurysm","target":"unspecified","id":"47174"},{"source":"aneurysm","target":"metformin 500mg (u)","id":"47175"},{"source":"aneurysm","target":"unspecified","id":"47176"},{"source":"aneurysm","target":"MK-2206 (u)","id":"47177"},{"source":"aneurysm","target":"neratinib (a)","id":"47178"},{"source":"aneurysm","target":"patritumab (u)","id":"47179"},{"source":"aneurysm","target":"pembrolizumab","id":"47180"},{"source":"aneurysm","target":"pertuzumab (a)","id":"47181"},{"source":"aneurysm","target":"pexidartinib (u)","id":"47182"},{"source":"aneurysm","target":"talazoparib (u)","id":"47183"},{"source":"aneurysm","target":"trastuzumab (IV)","id":"47184"},{"source":"aneurysm","target":"trastuzumab emtansine (a)","id":"47185"},{"source":"aneurysm","target":"trebananib (u)","id":"47186"},{"source":"aneurysm","target":"veliparib (u)","id":"47187"},{"source":"aneurysm","target":"cyclophosphamide","id":"47188"},{"source":"aneurysm","target":"unspecified","id":"47189"},{"source":"aneurysm","target":"pegylated liposomal doxorubicin","id":"47190"},{"source":"aneurysm","target":"nab-paclitaxel (IV)","id":"47191"},{"source":"aneurysm","target":"surgical intervention","id":"47192"},{"source":"chronic obstructive pulmonary disease","target":"ganetespib (u)","id":"47193"},{"source":"chronic obstructive pulmonary disease","target":"ganitumab (u)","id":"47194"},{"source":"chronic obstructive pulmonary disease","target":"irinotecan (IV)","id":"47195"},{"source":"chronic obstructive pulmonary disease","target":"unspecified","id":"47196"},{"source":"chronic obstructive pulmonary disease","target":"metformin 500mg (u)","id":"47197"},{"source":"chronic obstructive pulmonary disease","target":"unspecified","id":"47198"},{"source":"chronic obstructive pulmonary disease","target":"MK-2206 (u)","id":"47199"},{"source":"chronic obstructive pulmonary disease","target":"neratinib (a)","id":"47200"},{"source":"chronic obstructive pulmonary disease","target":"patritumab (u)","id":"47201"},{"source":"chronic obstructive pulmonary disease","target":"pembrolizumab","id":"47202"},{"source":"chronic obstructive pulmonary disease","target":"pertuzumab (a)","id":"47203"},{"source":"chronic obstructive pulmonary disease","target":"pexidartinib (u)","id":"47204"},{"source":"chronic obstructive pulmonary disease","target":"talazoparib (u)","id":"47205"},{"source":"chronic obstructive pulmonary disease","target":"trastuzumab (IV)","id":"47206"},{"source":"chronic obstructive pulmonary disease","target":"trastuzumab emtansine (a)","id":"47207"},{"source":"chronic obstructive pulmonary disease","target":"trebananib (u)","id":"47208"},{"source":"chronic obstructive pulmonary disease","target":"veliparib (u)","id":"47209"},{"source":"chronic obstructive pulmonary disease","target":"cyclophosphamide","id":"47210"},{"source":"chronic obstructive pulmonary disease","target":"unspecified","id":"47211"},{"source":"chronic obstructive pulmonary disease","target":"pegylated liposomal doxorubicin","id":"47212"},{"source":"chronic obstructive pulmonary disease","target":"nab-paclitaxel (IV)","id":"47213"},{"source":"chronic obstructive pulmonary disease","target":"surgical intervention","id":"47214"},{"source":"hypertension","target":"ganetespib (u)","id":"47215"},{"source":"hypertension","target":"ganitumab (u)","id":"47216"},{"source":"hypertension","target":"irinotecan (IV)","id":"47217"},{"source":"hypertension","target":"unspecified","id":"47218"},{"source":"hypertension","target":"metformin 500mg (u)","id":"47219"},{"source":"hypertension","target":"unspecified","id":"47220"},{"source":"hypertension","target":"MK-2206 (u)","id":"47221"},{"source":"hypertension","target":"neratinib (a)","id":"47222"},{"source":"hypertension","target":"patritumab (u)","id":"47223"},{"source":"hypertension","target":"pembrolizumab","id":"47224"},{"source":"hypertension","target":"pertuzumab (a)","id":"47225"},{"source":"hypertension","target":"pexidartinib (u)","id":"47226"},{"source":"hypertension","target":"talazoparib (u)","id":"47227"},{"source":"hypertension","target":"trastuzumab (IV)","id":"47228"},{"source":"hypertension","target":"trastuzumab emtansine (a)","id":"47229"},{"source":"hypertension","target":"trebananib (u)","id":"47230"},{"source":"hypertension","target":"veliparib (u)","id":"47231"},{"source":"hypertension","target":"cyclophosphamide","id":"47232"},{"source":"hypertension","target":"unspecified","id":"47233"},{"source":"hypertension","target":"pegylated liposomal doxorubicin","id":"47234"},{"source":"hypertension","target":"nab-paclitaxel (IV)","id":"47235"},{"source":"hypertension","target":"surgical intervention","id":"47236"},{"source":"anticancer","target":"ganetespib (u)","id":"47237"},{"source":"anticancer","target":"ganitumab (u)","id":"47238"},{"source":"anticancer","target":"irinotecan (IV)","id":"47239"},{"source":"anticancer","target":"unspecified","id":"47240"},{"source":"anticancer","target":"metformin 500mg (u)","id":"47241"},{"source":"anticancer","target":"unspecified","id":"47242"},{"source":"anticancer","target":"MK-2206 (u)","id":"47243"},{"source":"anticancer","target":"neratinib (a)","id":"47244"},{"source":"anticancer","target":"patritumab (u)","id":"47245"},{"source":"anticancer","target":"pembrolizumab","id":"47246"},{"source":"anticancer","target":"pertuzumab (a)","id":"47247"},{"source":"anticancer","target":"pexidartinib (u)","id":"47248"},{"source":"anticancer","target":"talazoparib (u)","id":"47249"},{"source":"anticancer","target":"trastuzumab (IV)","id":"47250"},{"source":"anticancer","target":"trastuzumab emtansine (a)","id":"47251"},{"source":"anticancer","target":"trebananib (u)","id":"47252"},{"source":"anticancer","target":"veliparib (u)","id":"47253"},{"source":"anticancer","target":"cyclophosphamide","id":"47254"},{"source":"anticancer","target":"unspecified","id":"47255"},{"source":"anticancer","target":"pegylated liposomal doxorubicin","id":"47256"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"47257"},{"source":"anticancer","target":"surgical intervention","id":"47258"},{"source":"antiarthritic","target":"ganetespib (u)","id":"47259"},{"source":"antiarthritic","target":"ganitumab (u)","id":"47260"},{"source":"antiarthritic","target":"irinotecan (IV)","id":"47261"},{"source":"antiarthritic","target":"unspecified","id":"47262"},{"source":"antiarthritic","target":"metformin 500mg (u)","id":"47263"},{"source":"antiarthritic","target":"unspecified","id":"47264"},{"source":"antiarthritic","target":"MK-2206 (u)","id":"47265"},{"source":"antiarthritic","target":"neratinib (a)","id":"47266"},{"source":"antiarthritic","target":"patritumab (u)","id":"47267"},{"source":"antiarthritic","target":"pembrolizumab","id":"47268"},{"source":"antiarthritic","target":"pertuzumab (a)","id":"47269"},{"source":"antiarthritic","target":"pexidartinib (u)","id":"47270"},{"source":"antiarthritic","target":"talazoparib (u)","id":"47271"},{"source":"antiarthritic","target":"trastuzumab (IV)","id":"47272"},{"source":"antiarthritic","target":"trastuzumab emtansine (a)","id":"47273"},{"source":"antiarthritic","target":"trebananib (u)","id":"47274"},{"source":"antiarthritic","target":"veliparib (u)","id":"47275"},{"source":"antiarthritic","target":"cyclophosphamide","id":"47276"},{"source":"antiarthritic","target":"unspecified","id":"47277"},{"source":"antiarthritic","target":"pegylated liposomal doxorubicin","id":"47278"},{"source":"antiarthritic","target":"nab-paclitaxel (IV)","id":"47279"},{"source":"antiarthritic","target":"surgical intervention","id":"47280"},{"source":"heart diseases","target":"ganetespib (u)","id":"47281"},{"source":"heart diseases","target":"ganitumab (u)","id":"47282"},{"source":"heart diseases","target":"irinotecan (IV)","id":"47283"},{"source":"heart diseases","target":"unspecified","id":"47284"},{"source":"heart diseases","target":"metformin 500mg (u)","id":"47285"},{"source":"heart diseases","target":"unspecified","id":"47286"},{"source":"heart diseases","target":"MK-2206 (u)","id":"47287"},{"source":"heart diseases","target":"neratinib (a)","id":"47288"},{"source":"heart diseases","target":"patritumab (u)","id":"47289"},{"source":"heart diseases","target":"pembrolizumab","id":"47290"},{"source":"heart diseases","target":"pertuzumab (a)","id":"47291"},{"source":"heart diseases","target":"pexidartinib (u)","id":"47292"},{"source":"heart diseases","target":"talazoparib (u)","id":"47293"},{"source":"heart diseases","target":"trastuzumab (IV)","id":"47294"},{"source":"heart diseases","target":"trastuzumab emtansine (a)","id":"47295"},{"source":"heart diseases","target":"trebananib (u)","id":"47296"},{"source":"heart diseases","target":"veliparib (u)","id":"47297"},{"source":"heart diseases","target":"cyclophosphamide","id":"47298"},{"source":"heart diseases","target":"unspecified","id":"47299"},{"source":"heart diseases","target":"pegylated liposomal doxorubicin","id":"47300"},{"source":"heart diseases","target":"nab-paclitaxel (IV)","id":"47301"},{"source":"heart diseases","target":"surgical intervention","id":"47302"},{"source":"NA","target":"metaplasia","id":"47303"},{"source":"NA","target":"anticancer","id":"47304"},{"source":"NA","target":"liver metastases","id":"47305"},{"source":"NA","target":"atrial flutter","id":"47306"},{"source":"NA","target":"breast tumor","id":"47307"},{"source":"NA","target":"antidiabetic","id":"47308"},{"source":"NA","target":"teratogenesis","id":"47309"},{"source":"NA","target":"breast tumor","id":"47310"},{"source":"NA","target":"heart failure","id":"47311"},{"source":"NA","target":"gilbert disease","id":"47312"},{"source":"NA","target":"diabetes mellitus","id":"47313"},{"source":"NA","target":"antidiabetic","id":"47314"},{"source":"NA","target":"asthma","id":"47315"},{"source":"NA","target":"copd","id":"47316"},{"source":"NA","target":"heart failure","id":"47317"},{"source":"NA","target":"residual neoplasm","id":"47318"},{"source":"NA","target":"antiallergic","id":"47319"},{"source":"NA","target":"carcinoma","id":"47320"},{"source":"NA","target":"breast neoplasms","id":"47321"},{"source":"NA","target":"hypersensitivity","id":"47322"},{"source":"NA","target":"inflammation","id":"47323"},{"source":"NA","target":"multiple sclerosis","id":"47324"},{"source":"NA","target":"triple-negative breast cancer","id":"47325"},{"source":"NA","target":"diabetes mellitus","id":"47326"},{"source":"NA","target":"cardiac disease","id":"47327"},{"source":"NA","target":"unstable angina","id":"47328"},{"source":"NA","target":"diabetes mellitus","id":"47329"},{"source":"NA","target":"anti-inflammatory","id":"47330"},{"source":"NA","target":"arthritis","id":"47331"},{"source":"NA","target":"residual tumor","id":"47332"},{"source":"NA","target":"cardiac conditions","id":"47333"},{"source":"NA","target":"solid malignancy","id":"47334"},{"source":"NA","target":"carcinoma","id":"47335"},{"source":"NA","target":"myocardial infarction","id":"47336"},{"source":"NA","target":"neoplasm metastasis","id":"47337"},{"source":"NA","target":"teratogenic","id":"47338"},{"source":"NA","target":"anti-inflammatory","id":"47339"},{"source":"NA","target":"metaplasia","id":"47340"},{"source":"NA","target":"diabetes mellitus","id":"47341"},{"source":"NA","target":"cardiac arrhythmias","id":"47342"},{"source":"NA","target":"liver metastases","id":"47343"},{"source":"NA","target":"gilbert disease","id":"47344"},{"source":"NA","target":"hypoglycemic","id":"47345"},{"source":"NA","target":"residual tumor","id":"47346"},{"source":"NA","target":"hypoglycemic","id":"47347"},{"source":"NA","target":"cardiac arrhythmias","id":"47348"},{"source":"NA","target":"residual tumor","id":"47349"},{"source":"NA","target":"insulin resistance","id":"47350"},{"source":"NA","target":"aneurysm","id":"47351"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"47352"},{"source":"NA","target":"hypertension","id":"47353"},{"source":"NA","target":"anticancer","id":"47354"},{"source":"NA","target":"antiarthritic","id":"47355"},{"source":"NA","target":"heart diseases","id":"47356"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"metaplasia","id":"47357"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"47358"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"liver metastases","id":"47359"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"atrial flutter","id":"47360"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"breast tumor","id":"47361"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antidiabetic","id":"47362"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"teratogenesis","id":"47363"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"breast tumor","id":"47364"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"heart failure","id":"47365"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"gilbert disease","id":"47366"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"diabetes mellitus","id":"47367"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antidiabetic","id":"47368"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"asthma","id":"47369"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"copd","id":"47370"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"heart failure","id":"47371"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual neoplasm","id":"47372"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antiallergic","id":"47373"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"47374"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"breast neoplasms","id":"47375"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"hypersensitivity","id":"47376"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"inflammation","id":"47377"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"multiple sclerosis","id":"47378"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"triple-negative breast cancer","id":"47379"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"diabetes mellitus","id":"47380"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"cardiac disease","id":"47381"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"unstable angina","id":"47382"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"diabetes mellitus","id":"47383"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anti-inflammatory","id":"47384"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"arthritis","id":"47385"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"47386"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"cardiac conditions","id":"47387"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"solid malignancy","id":"47388"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"carcinoma","id":"47389"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"myocardial infarction","id":"47390"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"neoplasm metastasis","id":"47391"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"teratogenic","id":"47392"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anti-inflammatory","id":"47393"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"metaplasia","id":"47394"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"diabetes mellitus","id":"47395"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"cardiac arrhythmias","id":"47396"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"liver metastases","id":"47397"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"gilbert disease","id":"47398"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"hypoglycemic","id":"47399"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"47400"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"hypoglycemic","id":"47401"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"cardiac arrhythmias","id":"47402"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"residual tumor","id":"47403"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"insulin resistance","id":"47404"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"aneurysm","id":"47405"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"chronic obstructive pulmonary disease","id":"47406"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"hypertension","id":"47407"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"anticancer","id":"47408"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"antiarthritic","id":"47409"},{"source":"Colony stimulating factor 1 receptor antagonist","target":"heart diseases","id":"47410"},{"source":"NA","target":"metaplasia","id":"47411"},{"source":"NA","target":"anticancer","id":"47412"},{"source":"NA","target":"liver metastases","id":"47413"},{"source":"NA","target":"atrial flutter","id":"47414"},{"source":"NA","target":"breast tumor","id":"47415"},{"source":"NA","target":"antidiabetic","id":"47416"},{"source":"NA","target":"teratogenesis","id":"47417"},{"source":"NA","target":"breast tumor","id":"47418"},{"source":"NA","target":"heart failure","id":"47419"},{"source":"NA","target":"gilbert disease","id":"47420"},{"source":"NA","target":"diabetes mellitus","id":"47421"},{"source":"NA","target":"antidiabetic","id":"47422"},{"source":"NA","target":"asthma","id":"47423"},{"source":"NA","target":"copd","id":"47424"},{"source":"NA","target":"heart failure","id":"47425"},{"source":"NA","target":"residual neoplasm","id":"47426"},{"source":"NA","target":"antiallergic","id":"47427"},{"source":"NA","target":"carcinoma","id":"47428"},{"source":"NA","target":"breast neoplasms","id":"47429"},{"source":"NA","target":"hypersensitivity","id":"47430"},{"source":"NA","target":"inflammation","id":"47431"},{"source":"NA","target":"multiple sclerosis","id":"47432"},{"source":"NA","target":"triple-negative breast cancer","id":"47433"},{"source":"NA","target":"diabetes mellitus","id":"47434"},{"source":"NA","target":"cardiac disease","id":"47435"},{"source":"NA","target":"unstable angina","id":"47436"},{"source":"NA","target":"diabetes mellitus","id":"47437"},{"source":"NA","target":"anti-inflammatory","id":"47438"},{"source":"NA","target":"arthritis","id":"47439"},{"source":"NA","target":"residual tumor","id":"47440"},{"source":"NA","target":"cardiac conditions","id":"47441"},{"source":"NA","target":"solid malignancy","id":"47442"},{"source":"NA","target":"carcinoma","id":"47443"},{"source":"NA","target":"myocardial infarction","id":"47444"},{"source":"NA","target":"neoplasm metastasis","id":"47445"},{"source":"NA","target":"teratogenic","id":"47446"},{"source":"NA","target":"anti-inflammatory","id":"47447"},{"source":"NA","target":"metaplasia","id":"47448"},{"source":"NA","target":"diabetes mellitus","id":"47449"},{"source":"NA","target":"cardiac arrhythmias","id":"47450"},{"source":"NA","target":"liver metastases","id":"47451"},{"source":"NA","target":"gilbert disease","id":"47452"},{"source":"NA","target":"hypoglycemic","id":"47453"},{"source":"NA","target":"residual tumor","id":"47454"},{"source":"NA","target":"hypoglycemic","id":"47455"},{"source":"NA","target":"cardiac arrhythmias","id":"47456"},{"source":"NA","target":"residual tumor","id":"47457"},{"source":"NA","target":"insulin resistance","id":"47458"},{"source":"NA","target":"aneurysm","id":"47459"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"47460"},{"source":"NA","target":"hypertension","id":"47461"},{"source":"NA","target":"anticancer","id":"47462"},{"source":"NA","target":"antiarthritic","id":"47463"},{"source":"NA","target":"heart diseases","id":"47464"},{"source":"NA","target":"metaplasia","id":"47465"},{"source":"NA","target":"anticancer","id":"47466"},{"source":"NA","target":"liver metastases","id":"47467"},{"source":"NA","target":"atrial flutter","id":"47468"},{"source":"NA","target":"breast tumor","id":"47469"},{"source":"NA","target":"antidiabetic","id":"47470"},{"source":"NA","target":"teratogenesis","id":"47471"},{"source":"NA","target":"breast tumor","id":"47472"},{"source":"NA","target":"heart failure","id":"47473"},{"source":"NA","target":"gilbert disease","id":"47474"},{"source":"NA","target":"diabetes mellitus","id":"47475"},{"source":"NA","target":"antidiabetic","id":"47476"},{"source":"NA","target":"asthma","id":"47477"},{"source":"NA","target":"copd","id":"47478"},{"source":"NA","target":"heart failure","id":"47479"},{"source":"NA","target":"residual neoplasm","id":"47480"},{"source":"NA","target":"antiallergic","id":"47481"},{"source":"NA","target":"carcinoma","id":"47482"},{"source":"NA","target":"breast neoplasms","id":"47483"},{"source":"NA","target":"hypersensitivity","id":"47484"},{"source":"NA","target":"inflammation","id":"47485"},{"source":"NA","target":"multiple sclerosis","id":"47486"},{"source":"NA","target":"triple-negative breast cancer","id":"47487"},{"source":"NA","target":"diabetes mellitus","id":"47488"},{"source":"NA","target":"cardiac disease","id":"47489"},{"source":"NA","target":"unstable angina","id":"47490"},{"source":"NA","target":"diabetes mellitus","id":"47491"},{"source":"NA","target":"anti-inflammatory","id":"47492"},{"source":"NA","target":"arthritis","id":"47493"},{"source":"NA","target":"residual tumor","id":"47494"},{"source":"NA","target":"cardiac conditions","id":"47495"},{"source":"NA","target":"solid malignancy","id":"47496"},{"source":"NA","target":"carcinoma","id":"47497"},{"source":"NA","target":"myocardial infarction","id":"47498"},{"source":"NA","target":"neoplasm metastasis","id":"47499"},{"source":"NA","target":"teratogenic","id":"47500"},{"source":"NA","target":"anti-inflammatory","id":"47501"},{"source":"NA","target":"metaplasia","id":"47502"},{"source":"NA","target":"diabetes mellitus","id":"47503"},{"source":"NA","target":"cardiac arrhythmias","id":"47504"},{"source":"NA","target":"liver metastases","id":"47505"},{"source":"NA","target":"gilbert disease","id":"47506"},{"source":"NA","target":"hypoglycemic","id":"47507"},{"source":"NA","target":"residual tumor","id":"47508"},{"source":"NA","target":"hypoglycemic","id":"47509"},{"source":"NA","target":"cardiac arrhythmias","id":"47510"},{"source":"NA","target":"residual tumor","id":"47511"},{"source":"NA","target":"insulin resistance","id":"47512"},{"source":"NA","target":"aneurysm","id":"47513"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"47514"},{"source":"NA","target":"hypertension","id":"47515"},{"source":"NA","target":"anticancer","id":"47516"},{"source":"NA","target":"antiarthritic","id":"47517"},{"source":"NA","target":"heart diseases","id":"47518"},{"source":"NA","target":"metaplasia","id":"47519"},{"source":"NA","target":"anticancer","id":"47520"},{"source":"NA","target":"liver metastases","id":"47521"},{"source":"NA","target":"atrial flutter","id":"47522"},{"source":"NA","target":"breast tumor","id":"47523"},{"source":"NA","target":"antidiabetic","id":"47524"},{"source":"NA","target":"teratogenesis","id":"47525"},{"source":"NA","target":"breast tumor","id":"47526"},{"source":"NA","target":"heart failure","id":"47527"},{"source":"NA","target":"gilbert disease","id":"47528"},{"source":"NA","target":"diabetes mellitus","id":"47529"},{"source":"NA","target":"antidiabetic","id":"47530"},{"source":"NA","target":"asthma","id":"47531"},{"source":"NA","target":"copd","id":"47532"},{"source":"NA","target":"heart failure","id":"47533"},{"source":"NA","target":"residual neoplasm","id":"47534"},{"source":"NA","target":"antiallergic","id":"47535"},{"source":"NA","target":"carcinoma","id":"47536"},{"source":"NA","target":"breast neoplasms","id":"47537"},{"source":"NA","target":"hypersensitivity","id":"47538"},{"source":"NA","target":"inflammation","id":"47539"},{"source":"NA","target":"multiple sclerosis","id":"47540"},{"source":"NA","target":"triple-negative breast cancer","id":"47541"},{"source":"NA","target":"diabetes mellitus","id":"47542"},{"source":"NA","target":"cardiac disease","id":"47543"},{"source":"NA","target":"unstable angina","id":"47544"},{"source":"NA","target":"diabetes mellitus","id":"47545"},{"source":"NA","target":"anti-inflammatory","id":"47546"},{"source":"NA","target":"arthritis","id":"47547"},{"source":"NA","target":"residual tumor","id":"47548"},{"source":"NA","target":"cardiac conditions","id":"47549"},{"source":"NA","target":"solid malignancy","id":"47550"},{"source":"NA","target":"carcinoma","id":"47551"},{"source":"NA","target":"myocardial infarction","id":"47552"},{"source":"NA","target":"neoplasm metastasis","id":"47553"},{"source":"NA","target":"teratogenic","id":"47554"},{"source":"NA","target":"anti-inflammatory","id":"47555"},{"source":"NA","target":"metaplasia","id":"47556"},{"source":"NA","target":"diabetes mellitus","id":"47557"},{"source":"NA","target":"cardiac arrhythmias","id":"47558"},{"source":"NA","target":"liver metastases","id":"47559"},{"source":"NA","target":"gilbert disease","id":"47560"},{"source":"NA","target":"hypoglycemic","id":"47561"},{"source":"NA","target":"residual tumor","id":"47562"},{"source":"NA","target":"hypoglycemic","id":"47563"},{"source":"NA","target":"cardiac arrhythmias","id":"47564"},{"source":"NA","target":"residual tumor","id":"47565"},{"source":"NA","target":"insulin resistance","id":"47566"},{"source":"NA","target":"aneurysm","id":"47567"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"47568"},{"source":"NA","target":"hypertension","id":"47569"},{"source":"NA","target":"anticancer","id":"47570"},{"source":"NA","target":"antiarthritic","id":"47571"},{"source":"NA","target":"heart diseases","id":"47572"},{"source":"Microtubule stimulant","target":"metaplasia","id":"47573"},{"source":"Microtubule stimulant","target":"anticancer","id":"47574"},{"source":"Microtubule stimulant","target":"liver metastases","id":"47575"},{"source":"Microtubule stimulant","target":"atrial flutter","id":"47576"},{"source":"Microtubule stimulant","target":"breast tumor","id":"47577"},{"source":"Microtubule stimulant","target":"antidiabetic","id":"47578"},{"source":"Microtubule stimulant","target":"teratogenesis","id":"47579"},{"source":"Microtubule stimulant","target":"breast tumor","id":"47580"},{"source":"Microtubule stimulant","target":"heart failure","id":"47581"},{"source":"Microtubule stimulant","target":"gilbert disease","id":"47582"},{"source":"Microtubule stimulant","target":"diabetes mellitus","id":"47583"},{"source":"Microtubule stimulant","target":"antidiabetic","id":"47584"},{"source":"Microtubule stimulant","target":"asthma","id":"47585"},{"source":"Microtubule stimulant","target":"copd","id":"47586"},{"source":"Microtubule stimulant","target":"heart failure","id":"47587"},{"source":"Microtubule stimulant","target":"residual neoplasm","id":"47588"},{"source":"Microtubule stimulant","target":"antiallergic","id":"47589"},{"source":"Microtubule stimulant","target":"carcinoma","id":"47590"},{"source":"Microtubule stimulant","target":"breast neoplasms","id":"47591"},{"source":"Microtubule stimulant","target":"hypersensitivity","id":"47592"},{"source":"Microtubule stimulant","target":"inflammation","id":"47593"},{"source":"Microtubule stimulant","target":"multiple sclerosis","id":"47594"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"47595"},{"source":"Microtubule stimulant","target":"diabetes mellitus","id":"47596"},{"source":"Microtubule stimulant","target":"cardiac disease","id":"47597"},{"source":"Microtubule stimulant","target":"unstable angina","id":"47598"},{"source":"Microtubule stimulant","target":"diabetes mellitus","id":"47599"},{"source":"Microtubule stimulant","target":"anti-inflammatory","id":"47600"},{"source":"Microtubule stimulant","target":"arthritis","id":"47601"},{"source":"Microtubule stimulant","target":"residual tumor","id":"47602"},{"source":"Microtubule stimulant","target":"cardiac conditions","id":"47603"},{"source":"Microtubule stimulant","target":"solid malignancy","id":"47604"},{"source":"Microtubule stimulant","target":"carcinoma","id":"47605"},{"source":"Microtubule stimulant","target":"myocardial infarction","id":"47606"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"47607"},{"source":"Microtubule stimulant","target":"teratogenic","id":"47608"},{"source":"Microtubule stimulant","target":"anti-inflammatory","id":"47609"},{"source":"Microtubule stimulant","target":"metaplasia","id":"47610"},{"source":"Microtubule stimulant","target":"diabetes mellitus","id":"47611"},{"source":"Microtubule stimulant","target":"cardiac arrhythmias","id":"47612"},{"source":"Microtubule stimulant","target":"liver metastases","id":"47613"},{"source":"Microtubule stimulant","target":"gilbert disease","id":"47614"},{"source":"Microtubule stimulant","target":"hypoglycemic","id":"47615"},{"source":"Microtubule stimulant","target":"residual tumor","id":"47616"},{"source":"Microtubule stimulant","target":"hypoglycemic","id":"47617"},{"source":"Microtubule stimulant","target":"cardiac arrhythmias","id":"47618"},{"source":"Microtubule stimulant","target":"residual tumor","id":"47619"},{"source":"Microtubule stimulant","target":"insulin resistance","id":"47620"},{"source":"Microtubule stimulant","target":"aneurysm","id":"47621"},{"source":"Microtubule stimulant","target":"chronic obstructive pulmonary disease","id":"47622"},{"source":"Microtubule stimulant","target":"hypertension","id":"47623"},{"source":"Microtubule stimulant","target":"anticancer","id":"47624"},{"source":"Microtubule stimulant","target":"antiarthritic","id":"47625"},{"source":"Microtubule stimulant","target":"heart diseases","id":"47626"},{"source":"Heat shock protein 90 antagonist","target":"metaplasia","id":"47627"},{"source":"Heat shock protein 90 antagonist","target":"anticancer","id":"47628"},{"source":"Heat shock protein 90 antagonist","target":"liver metastases","id":"47629"},{"source":"Heat shock protein 90 antagonist","target":"atrial flutter","id":"47630"},{"source":"Heat shock protein 90 antagonist","target":"breast tumor","id":"47631"},{"source":"Heat shock protein 90 antagonist","target":"antidiabetic","id":"47632"},{"source":"Heat shock protein 90 antagonist","target":"teratogenesis","id":"47633"},{"source":"Heat shock protein 90 antagonist","target":"breast tumor","id":"47634"},{"source":"Heat shock protein 90 antagonist","target":"heart failure","id":"47635"},{"source":"Heat shock protein 90 antagonist","target":"gilbert disease","id":"47636"},{"source":"Heat shock protein 90 antagonist","target":"diabetes mellitus","id":"47637"},{"source":"Heat shock protein 90 antagonist","target":"antidiabetic","id":"47638"},{"source":"Heat shock protein 90 antagonist","target":"asthma","id":"47639"},{"source":"Heat shock protein 90 antagonist","target":"copd","id":"47640"},{"source":"Heat shock protein 90 antagonist","target":"heart failure","id":"47641"},{"source":"Heat shock protein 90 antagonist","target":"residual neoplasm","id":"47642"},{"source":"Heat shock protein 90 antagonist","target":"antiallergic","id":"47643"},{"source":"Heat shock protein 90 antagonist","target":"carcinoma","id":"47644"},{"source":"Heat shock protein 90 antagonist","target":"breast neoplasms","id":"47645"},{"source":"Heat shock protein 90 antagonist","target":"hypersensitivity","id":"47646"},{"source":"Heat shock protein 90 antagonist","target":"inflammation","id":"47647"},{"source":"Heat shock protein 90 antagonist","target":"multiple sclerosis","id":"47648"},{"source":"Heat shock protein 90 antagonist","target":"triple-negative breast cancer","id":"47649"},{"source":"Heat shock protein 90 antagonist","target":"diabetes mellitus","id":"47650"},{"source":"Heat shock protein 90 antagonist","target":"cardiac disease","id":"47651"},{"source":"Heat shock protein 90 antagonist","target":"unstable angina","id":"47652"},{"source":"Heat shock protein 90 antagonist","target":"diabetes mellitus","id":"47653"},{"source":"Heat shock protein 90 antagonist","target":"anti-inflammatory","id":"47654"},{"source":"Heat shock protein 90 antagonist","target":"arthritis","id":"47655"},{"source":"Heat shock protein 90 antagonist","target":"residual tumor","id":"47656"},{"source":"Heat shock protein 90 antagonist","target":"cardiac conditions","id":"47657"},{"source":"Heat shock protein 90 antagonist","target":"solid malignancy","id":"47658"},{"source":"Heat shock protein 90 antagonist","target":"carcinoma","id":"47659"},{"source":"Heat shock protein 90 antagonist","target":"myocardial infarction","id":"47660"},{"source":"Heat shock protein 90 antagonist","target":"neoplasm metastasis","id":"47661"},{"source":"Heat shock protein 90 antagonist","target":"teratogenic","id":"47662"},{"source":"Heat shock protein 90 antagonist","target":"anti-inflammatory","id":"47663"},{"source":"Heat shock protein 90 antagonist","target":"metaplasia","id":"47664"},{"source":"Heat shock protein 90 antagonist","target":"diabetes mellitus","id":"47665"},{"source":"Heat shock protein 90 antagonist","target":"cardiac arrhythmias","id":"47666"},{"source":"Heat shock protein 90 antagonist","target":"liver metastases","id":"47667"},{"source":"Heat shock protein 90 antagonist","target":"gilbert disease","id":"47668"},{"source":"Heat shock protein 90 antagonist","target":"hypoglycemic","id":"47669"},{"source":"Heat shock protein 90 antagonist","target":"residual tumor","id":"47670"},{"source":"Heat shock protein 90 antagonist","target":"hypoglycemic","id":"47671"},{"source":"Heat shock protein 90 antagonist","target":"cardiac arrhythmias","id":"47672"},{"source":"Heat shock protein 90 antagonist","target":"residual tumor","id":"47673"},{"source":"Heat shock protein 90 antagonist","target":"insulin resistance","id":"47674"},{"source":"Heat shock protein 90 antagonist","target":"aneurysm","id":"47675"},{"source":"Heat shock protein 90 antagonist","target":"chronic obstructive pulmonary disease","id":"47676"},{"source":"Heat shock protein 90 antagonist","target":"hypertension","id":"47677"},{"source":"Heat shock protein 90 antagonist","target":"anticancer","id":"47678"},{"source":"Heat shock protein 90 antagonist","target":"antiarthritic","id":"47679"},{"source":"Heat shock protein 90 antagonist","target":"heart diseases","id":"47680"},{"source":"Taxane","target":"metaplasia","id":"47681"},{"source":"Taxane","target":"anticancer","id":"47682"},{"source":"Taxane","target":"liver metastases","id":"47683"},{"source":"Taxane","target":"atrial flutter","id":"47684"},{"source":"Taxane","target":"breast tumor","id":"47685"},{"source":"Taxane","target":"antidiabetic","id":"47686"},{"source":"Taxane","target":"teratogenesis","id":"47687"},{"source":"Taxane","target":"breast tumor","id":"47688"},{"source":"Taxane","target":"heart failure","id":"47689"},{"source":"Taxane","target":"gilbert disease","id":"47690"},{"source":"Taxane","target":"diabetes mellitus","id":"47691"},{"source":"Taxane","target":"antidiabetic","id":"47692"},{"source":"Taxane","target":"asthma","id":"47693"},{"source":"Taxane","target":"copd","id":"47694"},{"source":"Taxane","target":"heart failure","id":"47695"},{"source":"Taxane","target":"residual neoplasm","id":"47696"},{"source":"Taxane","target":"antiallergic","id":"47697"},{"source":"Taxane","target":"carcinoma","id":"47698"},{"source":"Taxane","target":"breast neoplasms","id":"47699"},{"source":"Taxane","target":"hypersensitivity","id":"47700"},{"source":"Taxane","target":"inflammation","id":"47701"},{"source":"Taxane","target":"multiple sclerosis","id":"47702"},{"source":"Taxane","target":"triple-negative breast cancer","id":"47703"},{"source":"Taxane","target":"diabetes mellitus","id":"47704"},{"source":"Taxane","target":"cardiac disease","id":"47705"},{"source":"Taxane","target":"unstable angina","id":"47706"},{"source":"Taxane","target":"diabetes mellitus","id":"47707"},{"source":"Taxane","target":"anti-inflammatory","id":"47708"},{"source":"Taxane","target":"arthritis","id":"47709"},{"source":"Taxane","target":"residual tumor","id":"47710"},{"source":"Taxane","target":"cardiac conditions","id":"47711"},{"source":"Taxane","target":"solid malignancy","id":"47712"},{"source":"Taxane","target":"carcinoma","id":"47713"},{"source":"Taxane","target":"myocardial infarction","id":"47714"},{"source":"Taxane","target":"neoplasm metastasis","id":"47715"},{"source":"Taxane","target":"teratogenic","id":"47716"},{"source":"Taxane","target":"anti-inflammatory","id":"47717"},{"source":"Taxane","target":"metaplasia","id":"47718"},{"source":"Taxane","target":"diabetes mellitus","id":"47719"},{"source":"Taxane","target":"cardiac arrhythmias","id":"47720"},{"source":"Taxane","target":"liver metastases","id":"47721"},{"source":"Taxane","target":"gilbert disease","id":"47722"},{"source":"Taxane","target":"hypoglycemic","id":"47723"},{"source":"Taxane","target":"residual tumor","id":"47724"},{"source":"Taxane","target":"hypoglycemic","id":"47725"},{"source":"Taxane","target":"cardiac arrhythmias","id":"47726"},{"source":"Taxane","target":"residual tumor","id":"47727"},{"source":"Taxane","target":"insulin resistance","id":"47728"},{"source":"Taxane","target":"aneurysm","id":"47729"},{"source":"Taxane","target":"chronic obstructive pulmonary disease","id":"47730"},{"source":"Taxane","target":"hypertension","id":"47731"},{"source":"Taxane","target":"anticancer","id":"47732"},{"source":"Taxane","target":"antiarthritic","id":"47733"},{"source":"Taxane","target":"heart diseases","id":"47734"},{"source":"Immune checkpoint inhibitor","target":"metaplasia","id":"47735"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"47736"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"47737"},{"source":"Immune checkpoint inhibitor","target":"atrial flutter","id":"47738"},{"source":"Immune checkpoint inhibitor","target":"breast tumor","id":"47739"},{"source":"Immune checkpoint inhibitor","target":"antidiabetic","id":"47740"},{"source":"Immune checkpoint inhibitor","target":"teratogenesis","id":"47741"},{"source":"Immune checkpoint inhibitor","target":"breast tumor","id":"47742"},{"source":"Immune checkpoint inhibitor","target":"heart failure","id":"47743"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"47744"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"47745"},{"source":"Immune checkpoint inhibitor","target":"antidiabetic","id":"47746"},{"source":"Immune checkpoint inhibitor","target":"asthma","id":"47747"},{"source":"Immune checkpoint inhibitor","target":"copd","id":"47748"},{"source":"Immune checkpoint inhibitor","target":"heart failure","id":"47749"},{"source":"Immune checkpoint inhibitor","target":"residual neoplasm","id":"47750"},{"source":"Immune checkpoint inhibitor","target":"antiallergic","id":"47751"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"47752"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"47753"},{"source":"Immune checkpoint inhibitor","target":"hypersensitivity","id":"47754"},{"source":"Immune checkpoint inhibitor","target":"inflammation","id":"47755"},{"source":"Immune checkpoint inhibitor","target":"multiple sclerosis","id":"47756"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"47757"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"47758"},{"source":"Immune checkpoint inhibitor","target":"cardiac disease","id":"47759"},{"source":"Immune checkpoint inhibitor","target":"unstable angina","id":"47760"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"47761"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"47762"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"47763"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"47764"},{"source":"Immune checkpoint inhibitor","target":"cardiac conditions","id":"47765"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"47766"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"47767"},{"source":"Immune checkpoint inhibitor","target":"myocardial infarction","id":"47768"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"47769"},{"source":"Immune checkpoint inhibitor","target":"teratogenic","id":"47770"},{"source":"Immune checkpoint inhibitor","target":"anti-inflammatory","id":"47771"},{"source":"Immune checkpoint inhibitor","target":"metaplasia","id":"47772"},{"source":"Immune checkpoint inhibitor","target":"diabetes mellitus","id":"47773"},{"source":"Immune checkpoint inhibitor","target":"cardiac arrhythmias","id":"47774"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"47775"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"47776"},{"source":"Immune checkpoint inhibitor","target":"hypoglycemic","id":"47777"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"47778"},{"source":"Immune checkpoint inhibitor","target":"hypoglycemic","id":"47779"},{"source":"Immune checkpoint inhibitor","target":"cardiac arrhythmias","id":"47780"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"47781"},{"source":"Immune checkpoint inhibitor","target":"insulin resistance","id":"47782"},{"source":"Immune checkpoint inhibitor","target":"aneurysm","id":"47783"},{"source":"Immune checkpoint inhibitor","target":"chronic obstructive pulmonary disease","id":"47784"},{"source":"Immune checkpoint inhibitor","target":"hypertension","id":"47785"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"47786"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"47787"},{"source":"Immune checkpoint inhibitor","target":"heart diseases","id":"47788"},{"source":"Anticancer immunotherapy","target":"metaplasia","id":"47789"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"47790"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"47791"},{"source":"Anticancer immunotherapy","target":"atrial flutter","id":"47792"},{"source":"Anticancer immunotherapy","target":"breast tumor","id":"47793"},{"source":"Anticancer immunotherapy","target":"antidiabetic","id":"47794"},{"source":"Anticancer immunotherapy","target":"teratogenesis","id":"47795"},{"source":"Anticancer immunotherapy","target":"breast tumor","id":"47796"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"47797"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"47798"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"47799"},{"source":"Anticancer immunotherapy","target":"antidiabetic","id":"47800"},{"source":"Anticancer immunotherapy","target":"asthma","id":"47801"},{"source":"Anticancer immunotherapy","target":"copd","id":"47802"},{"source":"Anticancer immunotherapy","target":"heart failure","id":"47803"},{"source":"Anticancer immunotherapy","target":"residual neoplasm","id":"47804"},{"source":"Anticancer immunotherapy","target":"antiallergic","id":"47805"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"47806"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"47807"},{"source":"Anticancer immunotherapy","target":"hypersensitivity","id":"47808"},{"source":"Anticancer immunotherapy","target":"inflammation","id":"47809"},{"source":"Anticancer immunotherapy","target":"multiple sclerosis","id":"47810"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"47811"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"47812"},{"source":"Anticancer immunotherapy","target":"cardiac disease","id":"47813"},{"source":"Anticancer immunotherapy","target":"unstable angina","id":"47814"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"47815"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"47816"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"47817"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"47818"},{"source":"Anticancer immunotherapy","target":"cardiac conditions","id":"47819"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"47820"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"47821"},{"source":"Anticancer immunotherapy","target":"myocardial infarction","id":"47822"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"47823"},{"source":"Anticancer immunotherapy","target":"teratogenic","id":"47824"},{"source":"Anticancer immunotherapy","target":"anti-inflammatory","id":"47825"},{"source":"Anticancer immunotherapy","target":"metaplasia","id":"47826"},{"source":"Anticancer immunotherapy","target":"diabetes mellitus","id":"47827"},{"source":"Anticancer immunotherapy","target":"cardiac arrhythmias","id":"47828"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"47829"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"47830"},{"source":"Anticancer immunotherapy","target":"hypoglycemic","id":"47831"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"47832"},{"source":"Anticancer immunotherapy","target":"hypoglycemic","id":"47833"},{"source":"Anticancer immunotherapy","target":"cardiac arrhythmias","id":"47834"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"47835"},{"source":"Anticancer immunotherapy","target":"insulin resistance","id":"47836"},{"source":"Anticancer immunotherapy","target":"aneurysm","id":"47837"},{"source":"Anticancer immunotherapy","target":"chronic obstructive pulmonary disease","id":"47838"},{"source":"Anticancer immunotherapy","target":"hypertension","id":"47839"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"47840"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"47841"},{"source":"Anticancer immunotherapy","target":"heart diseases","id":"47842"},{"source":"NA","target":"metaplasia","id":"47843"},{"source":"NA","target":"anticancer","id":"47844"},{"source":"NA","target":"liver metastases","id":"47845"},{"source":"NA","target":"atrial flutter","id":"47846"},{"source":"NA","target":"breast tumor","id":"47847"},{"source":"NA","target":"antidiabetic","id":"47848"},{"source":"NA","target":"teratogenesis","id":"47849"},{"source":"NA","target":"breast tumor","id":"47850"},{"source":"NA","target":"heart failure","id":"47851"},{"source":"NA","target":"gilbert disease","id":"47852"},{"source":"NA","target":"diabetes mellitus","id":"47853"},{"source":"NA","target":"antidiabetic","id":"47854"},{"source":"NA","target":"asthma","id":"47855"},{"source":"NA","target":"copd","id":"47856"},{"source":"NA","target":"heart failure","id":"47857"},{"source":"NA","target":"residual neoplasm","id":"47858"},{"source":"NA","target":"antiallergic","id":"47859"},{"source":"NA","target":"carcinoma","id":"47860"},{"source":"NA","target":"breast neoplasms","id":"47861"},{"source":"NA","target":"hypersensitivity","id":"47862"},{"source":"NA","target":"inflammation","id":"47863"},{"source":"NA","target":"multiple sclerosis","id":"47864"},{"source":"NA","target":"triple-negative breast cancer","id":"47865"},{"source":"NA","target":"diabetes mellitus","id":"47866"},{"source":"NA","target":"cardiac disease","id":"47867"},{"source":"NA","target":"unstable angina","id":"47868"},{"source":"NA","target":"diabetes mellitus","id":"47869"},{"source":"NA","target":"anti-inflammatory","id":"47870"},{"source":"NA","target":"arthritis","id":"47871"},{"source":"NA","target":"residual tumor","id":"47872"},{"source":"NA","target":"cardiac conditions","id":"47873"},{"source":"NA","target":"solid malignancy","id":"47874"},{"source":"NA","target":"carcinoma","id":"47875"},{"source":"NA","target":"myocardial infarction","id":"47876"},{"source":"NA","target":"neoplasm metastasis","id":"47877"},{"source":"NA","target":"teratogenic","id":"47878"},{"source":"NA","target":"anti-inflammatory","id":"47879"},{"source":"NA","target":"metaplasia","id":"47880"},{"source":"NA","target":"diabetes mellitus","id":"47881"},{"source":"NA","target":"cardiac arrhythmias","id":"47882"},{"source":"NA","target":"liver metastases","id":"47883"},{"source":"NA","target":"gilbert disease","id":"47884"},{"source":"NA","target":"hypoglycemic","id":"47885"},{"source":"NA","target":"residual tumor","id":"47886"},{"source":"NA","target":"hypoglycemic","id":"47887"},{"source":"NA","target":"cardiac arrhythmias","id":"47888"},{"source":"NA","target":"residual tumor","id":"47889"},{"source":"NA","target":"insulin resistance","id":"47890"},{"source":"NA","target":"aneurysm","id":"47891"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"47892"},{"source":"NA","target":"hypertension","id":"47893"},{"source":"NA","target":"anticancer","id":"47894"},{"source":"NA","target":"antiarthritic","id":"47895"},{"source":"NA","target":"heart diseases","id":"47896"},{"source":"Insulin-like growth factor 1 antagonist","target":"metaplasia","id":"47897"},{"source":"Insulin-like growth factor 1 antagonist","target":"anticancer","id":"47898"},{"source":"Insulin-like growth factor 1 antagonist","target":"liver metastases","id":"47899"},{"source":"Insulin-like growth factor 1 antagonist","target":"atrial flutter","id":"47900"},{"source":"Insulin-like growth factor 1 antagonist","target":"breast tumor","id":"47901"},{"source":"Insulin-like growth factor 1 antagonist","target":"antidiabetic","id":"47902"},{"source":"Insulin-like growth factor 1 antagonist","target":"teratogenesis","id":"47903"},{"source":"Insulin-like growth factor 1 antagonist","target":"breast tumor","id":"47904"},{"source":"Insulin-like growth factor 1 antagonist","target":"heart failure","id":"47905"},{"source":"Insulin-like growth factor 1 antagonist","target":"gilbert disease","id":"47906"},{"source":"Insulin-like growth factor 1 antagonist","target":"diabetes mellitus","id":"47907"},{"source":"Insulin-like growth factor 1 antagonist","target":"antidiabetic","id":"47908"},{"source":"Insulin-like growth factor 1 antagonist","target":"asthma","id":"47909"},{"source":"Insulin-like growth factor 1 antagonist","target":"copd","id":"47910"},{"source":"Insulin-like growth factor 1 antagonist","target":"heart failure","id":"47911"},{"source":"Insulin-like growth factor 1 antagonist","target":"residual neoplasm","id":"47912"},{"source":"Insulin-like growth factor 1 antagonist","target":"antiallergic","id":"47913"},{"source":"Insulin-like growth factor 1 antagonist","target":"carcinoma","id":"47914"},{"source":"Insulin-like growth factor 1 antagonist","target":"breast neoplasms","id":"47915"},{"source":"Insulin-like growth factor 1 antagonist","target":"hypersensitivity","id":"47916"},{"source":"Insulin-like growth factor 1 antagonist","target":"inflammation","id":"47917"},{"source":"Insulin-like growth factor 1 antagonist","target":"multiple sclerosis","id":"47918"},{"source":"Insulin-like growth factor 1 antagonist","target":"triple-negative breast cancer","id":"47919"},{"source":"Insulin-like growth factor 1 antagonist","target":"diabetes mellitus","id":"47920"},{"source":"Insulin-like growth factor 1 antagonist","target":"cardiac disease","id":"47921"},{"source":"Insulin-like growth factor 1 antagonist","target":"unstable angina","id":"47922"},{"source":"Insulin-like growth factor 1 antagonist","target":"diabetes mellitus","id":"47923"},{"source":"Insulin-like growth factor 1 antagonist","target":"anti-inflammatory","id":"47924"},{"source":"Insulin-like growth factor 1 antagonist","target":"arthritis","id":"47925"},{"source":"Insulin-like growth factor 1 antagonist","target":"residual tumor","id":"47926"},{"source":"Insulin-like growth factor 1 antagonist","target":"cardiac conditions","id":"47927"},{"source":"Insulin-like growth factor 1 antagonist","target":"solid malignancy","id":"47928"},{"source":"Insulin-like growth factor 1 antagonist","target":"carcinoma","id":"47929"},{"source":"Insulin-like growth factor 1 antagonist","target":"myocardial infarction","id":"47930"},{"source":"Insulin-like growth factor 1 antagonist","target":"neoplasm metastasis","id":"47931"},{"source":"Insulin-like growth factor 1 antagonist","target":"teratogenic","id":"47932"},{"source":"Insulin-like growth factor 1 antagonist","target":"anti-inflammatory","id":"47933"},{"source":"Insulin-like growth factor 1 antagonist","target":"metaplasia","id":"47934"},{"source":"Insulin-like growth factor 1 antagonist","target":"diabetes mellitus","id":"47935"},{"source":"Insulin-like growth factor 1 antagonist","target":"cardiac arrhythmias","id":"47936"},{"source":"Insulin-like growth factor 1 antagonist","target":"liver metastases","id":"47937"},{"source":"Insulin-like growth factor 1 antagonist","target":"gilbert disease","id":"47938"},{"source":"Insulin-like growth factor 1 antagonist","target":"hypoglycemic","id":"47939"},{"source":"Insulin-like growth factor 1 antagonist","target":"residual tumor","id":"47940"},{"source":"Insulin-like growth factor 1 antagonist","target":"hypoglycemic","id":"47941"},{"source":"Insulin-like growth factor 1 antagonist","target":"cardiac arrhythmias","id":"47942"},{"source":"Insulin-like growth factor 1 antagonist","target":"residual tumor","id":"47943"},{"source":"Insulin-like growth factor 1 antagonist","target":"insulin resistance","id":"47944"},{"source":"Insulin-like growth factor 1 antagonist","target":"aneurysm","id":"47945"},{"source":"Insulin-like growth factor 1 antagonist","target":"chronic obstructive pulmonary disease","id":"47946"},{"source":"Insulin-like growth factor 1 antagonist","target":"hypertension","id":"47947"},{"source":"Insulin-like growth factor 1 antagonist","target":"anticancer","id":"47948"},{"source":"Insulin-like growth factor 1 antagonist","target":"antiarthritic","id":"47949"},{"source":"Insulin-like growth factor 1 antagonist","target":"heart diseases","id":"47950"},{"source":"C-kit inhibitor","target":"metaplasia","id":"47951"},{"source":"C-kit inhibitor","target":"anticancer","id":"47952"},{"source":"C-kit inhibitor","target":"liver metastases","id":"47953"},{"source":"C-kit inhibitor","target":"atrial flutter","id":"47954"},{"source":"C-kit inhibitor","target":"breast tumor","id":"47955"},{"source":"C-kit inhibitor","target":"antidiabetic","id":"47956"},{"source":"C-kit inhibitor","target":"teratogenesis","id":"47957"},{"source":"C-kit inhibitor","target":"breast tumor","id":"47958"},{"source":"C-kit inhibitor","target":"heart failure","id":"47959"},{"source":"C-kit inhibitor","target":"gilbert disease","id":"47960"},{"source":"C-kit inhibitor","target":"diabetes mellitus","id":"47961"},{"source":"C-kit inhibitor","target":"antidiabetic","id":"47962"},{"source":"C-kit inhibitor","target":"asthma","id":"47963"},{"source":"C-kit inhibitor","target":"copd","id":"47964"},{"source":"C-kit inhibitor","target":"heart failure","id":"47965"},{"source":"C-kit inhibitor","target":"residual neoplasm","id":"47966"},{"source":"C-kit inhibitor","target":"antiallergic","id":"47967"},{"source":"C-kit inhibitor","target":"carcinoma","id":"47968"},{"source":"C-kit inhibitor","target":"breast neoplasms","id":"47969"},{"source":"C-kit inhibitor","target":"hypersensitivity","id":"47970"},{"source":"C-kit inhibitor","target":"inflammation","id":"47971"},{"source":"C-kit inhibitor","target":"multiple sclerosis","id":"47972"},{"source":"C-kit inhibitor","target":"triple-negative breast cancer","id":"47973"},{"source":"C-kit inhibitor","target":"diabetes mellitus","id":"47974"},{"source":"C-kit inhibitor","target":"cardiac disease","id":"47975"},{"source":"C-kit inhibitor","target":"unstable angina","id":"47976"},{"source":"C-kit inhibitor","target":"diabetes mellitus","id":"47977"},{"source":"C-kit inhibitor","target":"anti-inflammatory","id":"47978"},{"source":"C-kit inhibitor","target":"arthritis","id":"47979"},{"source":"C-kit inhibitor","target":"residual tumor","id":"47980"},{"source":"C-kit inhibitor","target":"cardiac conditions","id":"47981"},{"source":"C-kit inhibitor","target":"solid malignancy","id":"47982"},{"source":"C-kit inhibitor","target":"carcinoma","id":"47983"},{"source":"C-kit inhibitor","target":"myocardial infarction","id":"47984"},{"source":"C-kit inhibitor","target":"neoplasm metastasis","id":"47985"},{"source":"C-kit inhibitor","target":"teratogenic","id":"47986"},{"source":"C-kit inhibitor","target":"anti-inflammatory","id":"47987"},{"source":"C-kit inhibitor","target":"metaplasia","id":"47988"},{"source":"C-kit inhibitor","target":"diabetes mellitus","id":"47989"},{"source":"C-kit inhibitor","target":"cardiac arrhythmias","id":"47990"},{"source":"C-kit inhibitor","target":"liver metastases","id":"47991"},{"source":"C-kit inhibitor","target":"gilbert disease","id":"47992"},{"source":"C-kit inhibitor","target":"hypoglycemic","id":"47993"},{"source":"C-kit inhibitor","target":"residual tumor","id":"47994"},{"source":"C-kit inhibitor","target":"hypoglycemic","id":"47995"},{"source":"C-kit inhibitor","target":"cardiac arrhythmias","id":"47996"},{"source":"C-kit inhibitor","target":"residual tumor","id":"47997"},{"source":"C-kit inhibitor","target":"insulin resistance","id":"47998"},{"source":"C-kit inhibitor","target":"aneurysm","id":"47999"},{"source":"C-kit inhibitor","target":"chronic obstructive pulmonary disease","id":"48000"},{"source":"C-kit inhibitor","target":"hypertension","id":"48001"},{"source":"C-kit inhibitor","target":"anticancer","id":"48002"},{"source":"C-kit inhibitor","target":"antiarthritic","id":"48003"},{"source":"C-kit inhibitor","target":"heart diseases","id":"48004"},{"source":"NA","target":"metaplasia","id":"48005"},{"source":"NA","target":"anticancer","id":"48006"},{"source":"NA","target":"liver metastases","id":"48007"},{"source":"NA","target":"atrial flutter","id":"48008"},{"source":"NA","target":"breast tumor","id":"48009"},{"source":"NA","target":"antidiabetic","id":"48010"},{"source":"NA","target":"teratogenesis","id":"48011"},{"source":"NA","target":"breast tumor","id":"48012"},{"source":"NA","target":"heart failure","id":"48013"},{"source":"NA","target":"gilbert disease","id":"48014"},{"source":"NA","target":"diabetes mellitus","id":"48015"},{"source":"NA","target":"antidiabetic","id":"48016"},{"source":"NA","target":"asthma","id":"48017"},{"source":"NA","target":"copd","id":"48018"},{"source":"NA","target":"heart failure","id":"48019"},{"source":"NA","target":"residual neoplasm","id":"48020"},{"source":"NA","target":"antiallergic","id":"48021"},{"source":"NA","target":"carcinoma","id":"48022"},{"source":"NA","target":"breast neoplasms","id":"48023"},{"source":"NA","target":"hypersensitivity","id":"48024"},{"source":"NA","target":"inflammation","id":"48025"},{"source":"NA","target":"multiple sclerosis","id":"48026"},{"source":"NA","target":"triple-negative breast cancer","id":"48027"},{"source":"NA","target":"diabetes mellitus","id":"48028"},{"source":"NA","target":"cardiac disease","id":"48029"},{"source":"NA","target":"unstable angina","id":"48030"},{"source":"NA","target":"diabetes mellitus","id":"48031"},{"source":"NA","target":"anti-inflammatory","id":"48032"},{"source":"NA","target":"arthritis","id":"48033"},{"source":"NA","target":"residual tumor","id":"48034"},{"source":"NA","target":"cardiac conditions","id":"48035"},{"source":"NA","target":"solid malignancy","id":"48036"},{"source":"NA","target":"carcinoma","id":"48037"},{"source":"NA","target":"myocardial infarction","id":"48038"},{"source":"NA","target":"neoplasm metastasis","id":"48039"},{"source":"NA","target":"teratogenic","id":"48040"},{"source":"NA","target":"anti-inflammatory","id":"48041"},{"source":"NA","target":"metaplasia","id":"48042"},{"source":"NA","target":"diabetes mellitus","id":"48043"},{"source":"NA","target":"cardiac arrhythmias","id":"48044"},{"source":"NA","target":"liver metastases","id":"48045"},{"source":"NA","target":"gilbert disease","id":"48046"},{"source":"NA","target":"hypoglycemic","id":"48047"},{"source":"NA","target":"residual tumor","id":"48048"},{"source":"NA","target":"hypoglycemic","id":"48049"},{"source":"NA","target":"cardiac arrhythmias","id":"48050"},{"source":"NA","target":"residual tumor","id":"48051"},{"source":"NA","target":"insulin resistance","id":"48052"},{"source":"NA","target":"aneurysm","id":"48053"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"48054"},{"source":"NA","target":"hypertension","id":"48055"},{"source":"NA","target":"anticancer","id":"48056"},{"source":"NA","target":"antiarthritic","id":"48057"},{"source":"NA","target":"heart diseases","id":"48058"},{"source":"NA","target":"metaplasia","id":"48059"},{"source":"NA","target":"anticancer","id":"48060"},{"source":"NA","target":"liver metastases","id":"48061"},{"source":"NA","target":"atrial flutter","id":"48062"},{"source":"NA","target":"breast tumor","id":"48063"},{"source":"NA","target":"antidiabetic","id":"48064"},{"source":"NA","target":"teratogenesis","id":"48065"},{"source":"NA","target":"breast tumor","id":"48066"},{"source":"NA","target":"heart failure","id":"48067"},{"source":"NA","target":"gilbert disease","id":"48068"},{"source":"NA","target":"diabetes mellitus","id":"48069"},{"source":"NA","target":"antidiabetic","id":"48070"},{"source":"NA","target":"asthma","id":"48071"},{"source":"NA","target":"copd","id":"48072"},{"source":"NA","target":"heart failure","id":"48073"},{"source":"NA","target":"residual neoplasm","id":"48074"},{"source":"NA","target":"antiallergic","id":"48075"},{"source":"NA","target":"carcinoma","id":"48076"},{"source":"NA","target":"breast neoplasms","id":"48077"},{"source":"NA","target":"hypersensitivity","id":"48078"},{"source":"NA","target":"inflammation","id":"48079"},{"source":"NA","target":"multiple sclerosis","id":"48080"},{"source":"NA","target":"triple-negative breast cancer","id":"48081"},{"source":"NA","target":"diabetes mellitus","id":"48082"},{"source":"NA","target":"cardiac disease","id":"48083"},{"source":"NA","target":"unstable angina","id":"48084"},{"source":"NA","target":"diabetes mellitus","id":"48085"},{"source":"NA","target":"anti-inflammatory","id":"48086"},{"source":"NA","target":"arthritis","id":"48087"},{"source":"NA","target":"residual tumor","id":"48088"},{"source":"NA","target":"cardiac conditions","id":"48089"},{"source":"NA","target":"solid malignancy","id":"48090"},{"source":"NA","target":"carcinoma","id":"48091"},{"source":"NA","target":"myocardial infarction","id":"48092"},{"source":"NA","target":"neoplasm metastasis","id":"48093"},{"source":"NA","target":"teratogenic","id":"48094"},{"source":"NA","target":"anti-inflammatory","id":"48095"},{"source":"NA","target":"metaplasia","id":"48096"},{"source":"NA","target":"diabetes mellitus","id":"48097"},{"source":"NA","target":"cardiac arrhythmias","id":"48098"},{"source":"NA","target":"liver metastases","id":"48099"},{"source":"NA","target":"gilbert disease","id":"48100"},{"source":"NA","target":"hypoglycemic","id":"48101"},{"source":"NA","target":"residual tumor","id":"48102"},{"source":"NA","target":"hypoglycemic","id":"48103"},{"source":"NA","target":"cardiac arrhythmias","id":"48104"},{"source":"NA","target":"residual tumor","id":"48105"},{"source":"NA","target":"insulin resistance","id":"48106"},{"source":"NA","target":"aneurysm","id":"48107"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"48108"},{"source":"NA","target":"hypertension","id":"48109"},{"source":"NA","target":"anticancer","id":"48110"},{"source":"NA","target":"antiarthritic","id":"48111"},{"source":"NA","target":"heart diseases","id":"48112"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metaplasia","id":"48113"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anticancer","id":"48114"},{"source":"ADP ribose polymerase 1 inhibitor","target":"liver metastases","id":"48115"},{"source":"ADP ribose polymerase 1 inhibitor","target":"atrial flutter","id":"48116"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast tumor","id":"48117"},{"source":"ADP ribose polymerase 1 inhibitor","target":"antidiabetic","id":"48118"},{"source":"ADP ribose polymerase 1 inhibitor","target":"teratogenesis","id":"48119"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast tumor","id":"48120"},{"source":"ADP ribose polymerase 1 inhibitor","target":"heart failure","id":"48121"},{"source":"ADP ribose polymerase 1 inhibitor","target":"gilbert disease","id":"48122"},{"source":"ADP ribose polymerase 1 inhibitor","target":"diabetes mellitus","id":"48123"},{"source":"ADP ribose polymerase 1 inhibitor","target":"antidiabetic","id":"48124"},{"source":"ADP ribose polymerase 1 inhibitor","target":"asthma","id":"48125"},{"source":"ADP ribose polymerase 1 inhibitor","target":"copd","id":"48126"},{"source":"ADP ribose polymerase 1 inhibitor","target":"heart failure","id":"48127"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual neoplasm","id":"48128"},{"source":"ADP ribose polymerase 1 inhibitor","target":"antiallergic","id":"48129"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"48130"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast neoplasms","id":"48131"},{"source":"ADP ribose polymerase 1 inhibitor","target":"hypersensitivity","id":"48132"},{"source":"ADP ribose polymerase 1 inhibitor","target":"inflammation","id":"48133"},{"source":"ADP ribose polymerase 1 inhibitor","target":"multiple sclerosis","id":"48134"},{"source":"ADP ribose polymerase 1 inhibitor","target":"triple-negative breast cancer","id":"48135"},{"source":"ADP ribose polymerase 1 inhibitor","target":"diabetes mellitus","id":"48136"},{"source":"ADP ribose polymerase 1 inhibitor","target":"cardiac disease","id":"48137"},{"source":"ADP ribose polymerase 1 inhibitor","target":"unstable angina","id":"48138"},{"source":"ADP ribose polymerase 1 inhibitor","target":"diabetes mellitus","id":"48139"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anti-inflammatory","id":"48140"},{"source":"ADP ribose polymerase 1 inhibitor","target":"arthritis","id":"48141"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"48142"},{"source":"ADP ribose polymerase 1 inhibitor","target":"cardiac conditions","id":"48143"},{"source":"ADP ribose polymerase 1 inhibitor","target":"solid malignancy","id":"48144"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"48145"},{"source":"ADP ribose polymerase 1 inhibitor","target":"myocardial infarction","id":"48146"},{"source":"ADP ribose polymerase 1 inhibitor","target":"neoplasm metastasis","id":"48147"},{"source":"ADP ribose polymerase 1 inhibitor","target":"teratogenic","id":"48148"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anti-inflammatory","id":"48149"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metaplasia","id":"48150"},{"source":"ADP ribose polymerase 1 inhibitor","target":"diabetes mellitus","id":"48151"},{"source":"ADP ribose polymerase 1 inhibitor","target":"cardiac arrhythmias","id":"48152"},{"source":"ADP ribose polymerase 1 inhibitor","target":"liver metastases","id":"48153"},{"source":"ADP ribose polymerase 1 inhibitor","target":"gilbert disease","id":"48154"},{"source":"ADP ribose polymerase 1 inhibitor","target":"hypoglycemic","id":"48155"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"48156"},{"source":"ADP ribose polymerase 1 inhibitor","target":"hypoglycemic","id":"48157"},{"source":"ADP ribose polymerase 1 inhibitor","target":"cardiac arrhythmias","id":"48158"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"48159"},{"source":"ADP ribose polymerase 1 inhibitor","target":"insulin resistance","id":"48160"},{"source":"ADP ribose polymerase 1 inhibitor","target":"aneurysm","id":"48161"},{"source":"ADP ribose polymerase 1 inhibitor","target":"chronic obstructive pulmonary disease","id":"48162"},{"source":"ADP ribose polymerase 1 inhibitor","target":"hypertension","id":"48163"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anticancer","id":"48164"},{"source":"ADP ribose polymerase 1 inhibitor","target":"antiarthritic","id":"48165"},{"source":"ADP ribose polymerase 1 inhibitor","target":"heart diseases","id":"48166"},{"source":"NA","target":"metaplasia","id":"48167"},{"source":"NA","target":"anticancer","id":"48168"},{"source":"NA","target":"liver metastases","id":"48169"},{"source":"NA","target":"atrial flutter","id":"48170"},{"source":"NA","target":"breast tumor","id":"48171"},{"source":"NA","target":"antidiabetic","id":"48172"},{"source":"NA","target":"teratogenesis","id":"48173"},{"source":"NA","target":"breast tumor","id":"48174"},{"source":"NA","target":"heart failure","id":"48175"},{"source":"NA","target":"gilbert disease","id":"48176"},{"source":"NA","target":"diabetes mellitus","id":"48177"},{"source":"NA","target":"antidiabetic","id":"48178"},{"source":"NA","target":"asthma","id":"48179"},{"source":"NA","target":"copd","id":"48180"},{"source":"NA","target":"heart failure","id":"48181"},{"source":"NA","target":"residual neoplasm","id":"48182"},{"source":"NA","target":"antiallergic","id":"48183"},{"source":"NA","target":"carcinoma","id":"48184"},{"source":"NA","target":"breast neoplasms","id":"48185"},{"source":"NA","target":"hypersensitivity","id":"48186"},{"source":"NA","target":"inflammation","id":"48187"},{"source":"NA","target":"multiple sclerosis","id":"48188"},{"source":"NA","target":"triple-negative breast cancer","id":"48189"},{"source":"NA","target":"diabetes mellitus","id":"48190"},{"source":"NA","target":"cardiac disease","id":"48191"},{"source":"NA","target":"unstable angina","id":"48192"},{"source":"NA","target":"diabetes mellitus","id":"48193"},{"source":"NA","target":"anti-inflammatory","id":"48194"},{"source":"NA","target":"arthritis","id":"48195"},{"source":"NA","target":"residual tumor","id":"48196"},{"source":"NA","target":"cardiac conditions","id":"48197"},{"source":"NA","target":"solid malignancy","id":"48198"},{"source":"NA","target":"carcinoma","id":"48199"},{"source":"NA","target":"myocardial infarction","id":"48200"},{"source":"NA","target":"neoplasm metastasis","id":"48201"},{"source":"NA","target":"teratogenic","id":"48202"},{"source":"NA","target":"anti-inflammatory","id":"48203"},{"source":"NA","target":"metaplasia","id":"48204"},{"source":"NA","target":"diabetes mellitus","id":"48205"},{"source":"NA","target":"cardiac arrhythmias","id":"48206"},{"source":"NA","target":"liver metastases","id":"48207"},{"source":"NA","target":"gilbert disease","id":"48208"},{"source":"NA","target":"hypoglycemic","id":"48209"},{"source":"NA","target":"residual tumor","id":"48210"},{"source":"NA","target":"hypoglycemic","id":"48211"},{"source":"NA","target":"cardiac arrhythmias","id":"48212"},{"source":"NA","target":"residual tumor","id":"48213"},{"source":"NA","target":"insulin resistance","id":"48214"},{"source":"NA","target":"aneurysm","id":"48215"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"48216"},{"source":"NA","target":"hypertension","id":"48217"},{"source":"NA","target":"anticancer","id":"48218"},{"source":"NA","target":"antiarthritic","id":"48219"},{"source":"NA","target":"heart diseases","id":"48220"},{"source":"Angiogenesis inhibitor","target":"metaplasia","id":"48221"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"48222"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"48223"},{"source":"Angiogenesis inhibitor","target":"atrial flutter","id":"48224"},{"source":"Angiogenesis inhibitor","target":"breast tumor","id":"48225"},{"source":"Angiogenesis inhibitor","target":"antidiabetic","id":"48226"},{"source":"Angiogenesis inhibitor","target":"teratogenesis","id":"48227"},{"source":"Angiogenesis inhibitor","target":"breast tumor","id":"48228"},{"source":"Angiogenesis inhibitor","target":"heart failure","id":"48229"},{"source":"Angiogenesis inhibitor","target":"gilbert disease","id":"48230"},{"source":"Angiogenesis inhibitor","target":"diabetes mellitus","id":"48231"},{"source":"Angiogenesis inhibitor","target":"antidiabetic","id":"48232"},{"source":"Angiogenesis inhibitor","target":"asthma","id":"48233"},{"source":"Angiogenesis inhibitor","target":"copd","id":"48234"},{"source":"Angiogenesis inhibitor","target":"heart failure","id":"48235"},{"source":"Angiogenesis inhibitor","target":"residual neoplasm","id":"48236"},{"source":"Angiogenesis inhibitor","target":"antiallergic","id":"48237"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"48238"},{"source":"Angiogenesis inhibitor","target":"breast neoplasms","id":"48239"},{"source":"Angiogenesis inhibitor","target":"hypersensitivity","id":"48240"},{"source":"Angiogenesis inhibitor","target":"inflammation","id":"48241"},{"source":"Angiogenesis inhibitor","target":"multiple sclerosis","id":"48242"},{"source":"Angiogenesis inhibitor","target":"triple-negative breast cancer","id":"48243"},{"source":"Angiogenesis inhibitor","target":"diabetes mellitus","id":"48244"},{"source":"Angiogenesis inhibitor","target":"cardiac disease","id":"48245"},{"source":"Angiogenesis inhibitor","target":"unstable angina","id":"48246"},{"source":"Angiogenesis inhibitor","target":"diabetes mellitus","id":"48247"},{"source":"Angiogenesis inhibitor","target":"anti-inflammatory","id":"48248"},{"source":"Angiogenesis inhibitor","target":"arthritis","id":"48249"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"48250"},{"source":"Angiogenesis inhibitor","target":"cardiac conditions","id":"48251"},{"source":"Angiogenesis inhibitor","target":"solid malignancy","id":"48252"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"48253"},{"source":"Angiogenesis inhibitor","target":"myocardial infarction","id":"48254"},{"source":"Angiogenesis inhibitor","target":"neoplasm metastasis","id":"48255"},{"source":"Angiogenesis inhibitor","target":"teratogenic","id":"48256"},{"source":"Angiogenesis inhibitor","target":"anti-inflammatory","id":"48257"},{"source":"Angiogenesis inhibitor","target":"metaplasia","id":"48258"},{"source":"Angiogenesis inhibitor","target":"diabetes mellitus","id":"48259"},{"source":"Angiogenesis inhibitor","target":"cardiac arrhythmias","id":"48260"},{"source":"Angiogenesis inhibitor","target":"liver metastases","id":"48261"},{"source":"Angiogenesis inhibitor","target":"gilbert disease","id":"48262"},{"source":"Angiogenesis inhibitor","target":"hypoglycemic","id":"48263"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"48264"},{"source":"Angiogenesis inhibitor","target":"hypoglycemic","id":"48265"},{"source":"Angiogenesis inhibitor","target":"cardiac arrhythmias","id":"48266"},{"source":"Angiogenesis inhibitor","target":"residual tumor","id":"48267"},{"source":"Angiogenesis inhibitor","target":"insulin resistance","id":"48268"},{"source":"Angiogenesis inhibitor","target":"aneurysm","id":"48269"},{"source":"Angiogenesis inhibitor","target":"chronic obstructive pulmonary disease","id":"48270"},{"source":"Angiogenesis inhibitor","target":"hypertension","id":"48271"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"48272"},{"source":"Angiogenesis inhibitor","target":"antiarthritic","id":"48273"},{"source":"Angiogenesis inhibitor","target":"heart diseases","id":"48274"},{"source":"NA","target":"metaplasia","id":"48275"},{"source":"NA","target":"anticancer","id":"48276"},{"source":"NA","target":"liver metastases","id":"48277"},{"source":"NA","target":"atrial flutter","id":"48278"},{"source":"NA","target":"breast tumor","id":"48279"},{"source":"NA","target":"antidiabetic","id":"48280"},{"source":"NA","target":"teratogenesis","id":"48281"},{"source":"NA","target":"breast tumor","id":"48282"},{"source":"NA","target":"heart failure","id":"48283"},{"source":"NA","target":"gilbert disease","id":"48284"},{"source":"NA","target":"diabetes mellitus","id":"48285"},{"source":"NA","target":"antidiabetic","id":"48286"},{"source":"NA","target":"asthma","id":"48287"},{"source":"NA","target":"copd","id":"48288"},{"source":"NA","target":"heart failure","id":"48289"},{"source":"NA","target":"residual neoplasm","id":"48290"},{"source":"NA","target":"antiallergic","id":"48291"},{"source":"NA","target":"carcinoma","id":"48292"},{"source":"NA","target":"breast neoplasms","id":"48293"},{"source":"NA","target":"hypersensitivity","id":"48294"},{"source":"NA","target":"inflammation","id":"48295"},{"source":"NA","target":"multiple sclerosis","id":"48296"},{"source":"NA","target":"triple-negative breast cancer","id":"48297"},{"source":"NA","target":"diabetes mellitus","id":"48298"},{"source":"NA","target":"cardiac disease","id":"48299"},{"source":"NA","target":"unstable angina","id":"48300"},{"source":"NA","target":"diabetes mellitus","id":"48301"},{"source":"NA","target":"anti-inflammatory","id":"48302"},{"source":"NA","target":"arthritis","id":"48303"},{"source":"NA","target":"residual tumor","id":"48304"},{"source":"NA","target":"cardiac conditions","id":"48305"},{"source":"NA","target":"solid malignancy","id":"48306"},{"source":"NA","target":"carcinoma","id":"48307"},{"source":"NA","target":"myocardial infarction","id":"48308"},{"source":"NA","target":"neoplasm metastasis","id":"48309"},{"source":"NA","target":"teratogenic","id":"48310"},{"source":"NA","target":"anti-inflammatory","id":"48311"},{"source":"NA","target":"metaplasia","id":"48312"},{"source":"NA","target":"diabetes mellitus","id":"48313"},{"source":"NA","target":"cardiac arrhythmias","id":"48314"},{"source":"NA","target":"liver metastases","id":"48315"},{"source":"NA","target":"gilbert disease","id":"48316"},{"source":"NA","target":"hypoglycemic","id":"48317"},{"source":"NA","target":"residual tumor","id":"48318"},{"source":"NA","target":"hypoglycemic","id":"48319"},{"source":"NA","target":"cardiac arrhythmias","id":"48320"},{"source":"NA","target":"residual tumor","id":"48321"},{"source":"NA","target":"insulin resistance","id":"48322"},{"source":"NA","target":"aneurysm","id":"48323"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"48324"},{"source":"NA","target":"hypertension","id":"48325"},{"source":"NA","target":"anticancer","id":"48326"},{"source":"NA","target":"antiarthritic","id":"48327"},{"source":"NA","target":"heart diseases","id":"48328"},{"source":"Beta tubulin antagonist","target":"metaplasia","id":"48329"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"48330"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"48331"},{"source":"Beta tubulin antagonist","target":"atrial flutter","id":"48332"},{"source":"Beta tubulin antagonist","target":"breast tumor","id":"48333"},{"source":"Beta tubulin antagonist","target":"antidiabetic","id":"48334"},{"source":"Beta tubulin antagonist","target":"teratogenesis","id":"48335"},{"source":"Beta tubulin antagonist","target":"breast tumor","id":"48336"},{"source":"Beta tubulin antagonist","target":"heart failure","id":"48337"},{"source":"Beta tubulin antagonist","target":"gilbert disease","id":"48338"},{"source":"Beta tubulin antagonist","target":"diabetes mellitus","id":"48339"},{"source":"Beta tubulin antagonist","target":"antidiabetic","id":"48340"},{"source":"Beta tubulin antagonist","target":"asthma","id":"48341"},{"source":"Beta tubulin antagonist","target":"copd","id":"48342"},{"source":"Beta tubulin antagonist","target":"heart failure","id":"48343"},{"source":"Beta tubulin antagonist","target":"residual neoplasm","id":"48344"},{"source":"Beta tubulin antagonist","target":"antiallergic","id":"48345"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"48346"},{"source":"Beta tubulin antagonist","target":"breast neoplasms","id":"48347"},{"source":"Beta tubulin antagonist","target":"hypersensitivity","id":"48348"},{"source":"Beta tubulin antagonist","target":"inflammation","id":"48349"},{"source":"Beta tubulin antagonist","target":"multiple sclerosis","id":"48350"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"48351"},{"source":"Beta tubulin antagonist","target":"diabetes mellitus","id":"48352"},{"source":"Beta tubulin antagonist","target":"cardiac disease","id":"48353"},{"source":"Beta tubulin antagonist","target":"unstable angina","id":"48354"},{"source":"Beta tubulin antagonist","target":"diabetes mellitus","id":"48355"},{"source":"Beta tubulin antagonist","target":"anti-inflammatory","id":"48356"},{"source":"Beta tubulin antagonist","target":"arthritis","id":"48357"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"48358"},{"source":"Beta tubulin antagonist","target":"cardiac conditions","id":"48359"},{"source":"Beta tubulin antagonist","target":"solid malignancy","id":"48360"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"48361"},{"source":"Beta tubulin antagonist","target":"myocardial infarction","id":"48362"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"48363"},{"source":"Beta tubulin antagonist","target":"teratogenic","id":"48364"},{"source":"Beta tubulin antagonist","target":"anti-inflammatory","id":"48365"},{"source":"Beta tubulin antagonist","target":"metaplasia","id":"48366"},{"source":"Beta tubulin antagonist","target":"diabetes mellitus","id":"48367"},{"source":"Beta tubulin antagonist","target":"cardiac arrhythmias","id":"48368"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"48369"},{"source":"Beta tubulin antagonist","target":"gilbert disease","id":"48370"},{"source":"Beta tubulin antagonist","target":"hypoglycemic","id":"48371"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"48372"},{"source":"Beta tubulin antagonist","target":"hypoglycemic","id":"48373"},{"source":"Beta tubulin antagonist","target":"cardiac arrhythmias","id":"48374"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"48375"},{"source":"Beta tubulin antagonist","target":"insulin resistance","id":"48376"},{"source":"Beta tubulin antagonist","target":"aneurysm","id":"48377"},{"source":"Beta tubulin antagonist","target":"chronic obstructive pulmonary disease","id":"48378"},{"source":"Beta tubulin antagonist","target":"hypertension","id":"48379"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"48380"},{"source":"Beta tubulin antagonist","target":"antiarthritic","id":"48381"},{"source":"Beta tubulin antagonist","target":"heart diseases","id":"48382"},{"source":"CD19 antagonist","target":"metaplasia","id":"48383"},{"source":"CD19 antagonist","target":"anticancer","id":"48384"},{"source":"CD19 antagonist","target":"liver metastases","id":"48385"},{"source":"CD19 antagonist","target":"atrial flutter","id":"48386"},{"source":"CD19 antagonist","target":"breast tumor","id":"48387"},{"source":"CD19 antagonist","target":"antidiabetic","id":"48388"},{"source":"CD19 antagonist","target":"teratogenesis","id":"48389"},{"source":"CD19 antagonist","target":"breast tumor","id":"48390"},{"source":"CD19 antagonist","target":"heart failure","id":"48391"},{"source":"CD19 antagonist","target":"gilbert disease","id":"48392"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"48393"},{"source":"CD19 antagonist","target":"antidiabetic","id":"48394"},{"source":"CD19 antagonist","target":"asthma","id":"48395"},{"source":"CD19 antagonist","target":"copd","id":"48396"},{"source":"CD19 antagonist","target":"heart failure","id":"48397"},{"source":"CD19 antagonist","target":"residual neoplasm","id":"48398"},{"source":"CD19 antagonist","target":"antiallergic","id":"48399"},{"source":"CD19 antagonist","target":"carcinoma","id":"48400"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"48401"},{"source":"CD19 antagonist","target":"hypersensitivity","id":"48402"},{"source":"CD19 antagonist","target":"inflammation","id":"48403"},{"source":"CD19 antagonist","target":"multiple sclerosis","id":"48404"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"48405"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"48406"},{"source":"CD19 antagonist","target":"cardiac disease","id":"48407"},{"source":"CD19 antagonist","target":"unstable angina","id":"48408"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"48409"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"48410"},{"source":"CD19 antagonist","target":"arthritis","id":"48411"},{"source":"CD19 antagonist","target":"residual tumor","id":"48412"},{"source":"CD19 antagonist","target":"cardiac conditions","id":"48413"},{"source":"CD19 antagonist","target":"solid malignancy","id":"48414"},{"source":"CD19 antagonist","target":"carcinoma","id":"48415"},{"source":"CD19 antagonist","target":"myocardial infarction","id":"48416"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"48417"},{"source":"CD19 antagonist","target":"teratogenic","id":"48418"},{"source":"CD19 antagonist","target":"anti-inflammatory","id":"48419"},{"source":"CD19 antagonist","target":"metaplasia","id":"48420"},{"source":"CD19 antagonist","target":"diabetes mellitus","id":"48421"},{"source":"CD19 antagonist","target":"cardiac arrhythmias","id":"48422"},{"source":"CD19 antagonist","target":"liver metastases","id":"48423"},{"source":"CD19 antagonist","target":"gilbert disease","id":"48424"},{"source":"CD19 antagonist","target":"hypoglycemic","id":"48425"},{"source":"CD19 antagonist","target":"residual tumor","id":"48426"},{"source":"CD19 antagonist","target":"hypoglycemic","id":"48427"},{"source":"CD19 antagonist","target":"cardiac arrhythmias","id":"48428"},{"source":"CD19 antagonist","target":"residual tumor","id":"48429"},{"source":"CD19 antagonist","target":"insulin resistance","id":"48430"},{"source":"CD19 antagonist","target":"aneurysm","id":"48431"},{"source":"CD19 antagonist","target":"chronic obstructive pulmonary disease","id":"48432"},{"source":"CD19 antagonist","target":"hypertension","id":"48433"},{"source":"CD19 antagonist","target":"anticancer","id":"48434"},{"source":"CD19 antagonist","target":"antiarthritic","id":"48435"},{"source":"CD19 antagonist","target":"heart diseases","id":"48436"},{"source":"Biguanide","target":"metaplasia","id":"48437"},{"source":"Biguanide","target":"anticancer","id":"48438"},{"source":"Biguanide","target":"liver metastases","id":"48439"},{"source":"Biguanide","target":"atrial flutter","id":"48440"},{"source":"Biguanide","target":"breast tumor","id":"48441"},{"source":"Biguanide","target":"antidiabetic","id":"48442"},{"source":"Biguanide","target":"teratogenesis","id":"48443"},{"source":"Biguanide","target":"breast tumor","id":"48444"},{"source":"Biguanide","target":"heart failure","id":"48445"},{"source":"Biguanide","target":"gilbert disease","id":"48446"},{"source":"Biguanide","target":"diabetes mellitus","id":"48447"},{"source":"Biguanide","target":"antidiabetic","id":"48448"},{"source":"Biguanide","target":"asthma","id":"48449"},{"source":"Biguanide","target":"copd","id":"48450"},{"source":"Biguanide","target":"heart failure","id":"48451"},{"source":"Biguanide","target":"residual neoplasm","id":"48452"},{"source":"Biguanide","target":"antiallergic","id":"48453"},{"source":"Biguanide","target":"carcinoma","id":"48454"},{"source":"Biguanide","target":"breast neoplasms","id":"48455"},{"source":"Biguanide","target":"hypersensitivity","id":"48456"},{"source":"Biguanide","target":"inflammation","id":"48457"},{"source":"Biguanide","target":"multiple sclerosis","id":"48458"},{"source":"Biguanide","target":"triple-negative breast cancer","id":"48459"},{"source":"Biguanide","target":"diabetes mellitus","id":"48460"},{"source":"Biguanide","target":"cardiac disease","id":"48461"},{"source":"Biguanide","target":"unstable angina","id":"48462"},{"source":"Biguanide","target":"diabetes mellitus","id":"48463"},{"source":"Biguanide","target":"anti-inflammatory","id":"48464"},{"source":"Biguanide","target":"arthritis","id":"48465"},{"source":"Biguanide","target":"residual tumor","id":"48466"},{"source":"Biguanide","target":"cardiac conditions","id":"48467"},{"source":"Biguanide","target":"solid malignancy","id":"48468"},{"source":"Biguanide","target":"carcinoma","id":"48469"},{"source":"Biguanide","target":"myocardial infarction","id":"48470"},{"source":"Biguanide","target":"neoplasm metastasis","id":"48471"},{"source":"Biguanide","target":"teratogenic","id":"48472"},{"source":"Biguanide","target":"anti-inflammatory","id":"48473"},{"source":"Biguanide","target":"metaplasia","id":"48474"},{"source":"Biguanide","target":"diabetes mellitus","id":"48475"},{"source":"Biguanide","target":"cardiac arrhythmias","id":"48476"},{"source":"Biguanide","target":"liver metastases","id":"48477"},{"source":"Biguanide","target":"gilbert disease","id":"48478"},{"source":"Biguanide","target":"hypoglycemic","id":"48479"},{"source":"Biguanide","target":"residual tumor","id":"48480"},{"source":"Biguanide","target":"hypoglycemic","id":"48481"},{"source":"Biguanide","target":"cardiac arrhythmias","id":"48482"},{"source":"Biguanide","target":"residual tumor","id":"48483"},{"source":"Biguanide","target":"insulin resistance","id":"48484"},{"source":"Biguanide","target":"aneurysm","id":"48485"},{"source":"Biguanide","target":"chronic obstructive pulmonary disease","id":"48486"},{"source":"Biguanide","target":"hypertension","id":"48487"},{"source":"Biguanide","target":"anticancer","id":"48488"},{"source":"Biguanide","target":"antiarthritic","id":"48489"},{"source":"Biguanide","target":"heart diseases","id":"48490"},{"source":"Tubulin inhibitor","target":"metaplasia","id":"48491"},{"source":"Tubulin inhibitor","target":"anticancer","id":"48492"},{"source":"Tubulin inhibitor","target":"liver metastases","id":"48493"},{"source":"Tubulin inhibitor","target":"atrial flutter","id":"48494"},{"source":"Tubulin inhibitor","target":"breast tumor","id":"48495"},{"source":"Tubulin inhibitor","target":"antidiabetic","id":"48496"},{"source":"Tubulin inhibitor","target":"teratogenesis","id":"48497"},{"source":"Tubulin inhibitor","target":"breast tumor","id":"48498"},{"source":"Tubulin inhibitor","target":"heart failure","id":"48499"},{"source":"Tubulin inhibitor","target":"gilbert disease","id":"48500"},{"source":"Tubulin inhibitor","target":"diabetes mellitus","id":"48501"},{"source":"Tubulin inhibitor","target":"antidiabetic","id":"48502"},{"source":"Tubulin inhibitor","target":"asthma","id":"48503"},{"source":"Tubulin inhibitor","target":"copd","id":"48504"},{"source":"Tubulin inhibitor","target":"heart failure","id":"48505"},{"source":"Tubulin inhibitor","target":"residual neoplasm","id":"48506"},{"source":"Tubulin inhibitor","target":"antiallergic","id":"48507"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"48508"},{"source":"Tubulin inhibitor","target":"breast neoplasms","id":"48509"},{"source":"Tubulin inhibitor","target":"hypersensitivity","id":"48510"},{"source":"Tubulin inhibitor","target":"inflammation","id":"48511"},{"source":"Tubulin inhibitor","target":"multiple sclerosis","id":"48512"},{"source":"Tubulin inhibitor","target":"triple-negative breast cancer","id":"48513"},{"source":"Tubulin inhibitor","target":"diabetes mellitus","id":"48514"},{"source":"Tubulin inhibitor","target":"cardiac disease","id":"48515"},{"source":"Tubulin inhibitor","target":"unstable angina","id":"48516"},{"source":"Tubulin inhibitor","target":"diabetes mellitus","id":"48517"},{"source":"Tubulin inhibitor","target":"anti-inflammatory","id":"48518"},{"source":"Tubulin inhibitor","target":"arthritis","id":"48519"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"48520"},{"source":"Tubulin inhibitor","target":"cardiac conditions","id":"48521"},{"source":"Tubulin inhibitor","target":"solid malignancy","id":"48522"},{"source":"Tubulin inhibitor","target":"carcinoma","id":"48523"},{"source":"Tubulin inhibitor","target":"myocardial infarction","id":"48524"},{"source":"Tubulin inhibitor","target":"neoplasm metastasis","id":"48525"},{"source":"Tubulin inhibitor","target":"teratogenic","id":"48526"},{"source":"Tubulin inhibitor","target":"anti-inflammatory","id":"48527"},{"source":"Tubulin inhibitor","target":"metaplasia","id":"48528"},{"source":"Tubulin inhibitor","target":"diabetes mellitus","id":"48529"},{"source":"Tubulin inhibitor","target":"cardiac arrhythmias","id":"48530"},{"source":"Tubulin inhibitor","target":"liver metastases","id":"48531"},{"source":"Tubulin inhibitor","target":"gilbert disease","id":"48532"},{"source":"Tubulin inhibitor","target":"hypoglycemic","id":"48533"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"48534"},{"source":"Tubulin inhibitor","target":"hypoglycemic","id":"48535"},{"source":"Tubulin inhibitor","target":"cardiac arrhythmias","id":"48536"},{"source":"Tubulin inhibitor","target":"residual tumor","id":"48537"},{"source":"Tubulin inhibitor","target":"insulin resistance","id":"48538"},{"source":"Tubulin inhibitor","target":"aneurysm","id":"48539"},{"source":"Tubulin inhibitor","target":"chronic obstructive pulmonary disease","id":"48540"},{"source":"Tubulin inhibitor","target":"hypertension","id":"48541"},{"source":"Tubulin inhibitor","target":"anticancer","id":"48542"},{"source":"Tubulin inhibitor","target":"antiarthritic","id":"48543"},{"source":"Tubulin inhibitor","target":"heart diseases","id":"48544"},{"source":"NA","target":"metaplasia","id":"48545"},{"source":"NA","target":"anticancer","id":"48546"},{"source":"NA","target":"liver metastases","id":"48547"},{"source":"NA","target":"atrial flutter","id":"48548"},{"source":"NA","target":"breast tumor","id":"48549"},{"source":"NA","target":"antidiabetic","id":"48550"},{"source":"NA","target":"teratogenesis","id":"48551"},{"source":"NA","target":"breast tumor","id":"48552"},{"source":"NA","target":"heart failure","id":"48553"},{"source":"NA","target":"gilbert disease","id":"48554"},{"source":"NA","target":"diabetes mellitus","id":"48555"},{"source":"NA","target":"antidiabetic","id":"48556"},{"source":"NA","target":"asthma","id":"48557"},{"source":"NA","target":"copd","id":"48558"},{"source":"NA","target":"heart failure","id":"48559"},{"source":"NA","target":"residual neoplasm","id":"48560"},{"source":"NA","target":"antiallergic","id":"48561"},{"source":"NA","target":"carcinoma","id":"48562"},{"source":"NA","target":"breast neoplasms","id":"48563"},{"source":"NA","target":"hypersensitivity","id":"48564"},{"source":"NA","target":"inflammation","id":"48565"},{"source":"NA","target":"multiple sclerosis","id":"48566"},{"source":"NA","target":"triple-negative breast cancer","id":"48567"},{"source":"NA","target":"diabetes mellitus","id":"48568"},{"source":"NA","target":"cardiac disease","id":"48569"},{"source":"NA","target":"unstable angina","id":"48570"},{"source":"NA","target":"diabetes mellitus","id":"48571"},{"source":"NA","target":"anti-inflammatory","id":"48572"},{"source":"NA","target":"arthritis","id":"48573"},{"source":"NA","target":"residual tumor","id":"48574"},{"source":"NA","target":"cardiac conditions","id":"48575"},{"source":"NA","target":"solid malignancy","id":"48576"},{"source":"NA","target":"carcinoma","id":"48577"},{"source":"NA","target":"myocardial infarction","id":"48578"},{"source":"NA","target":"neoplasm metastasis","id":"48579"},{"source":"NA","target":"teratogenic","id":"48580"},{"source":"NA","target":"anti-inflammatory","id":"48581"},{"source":"NA","target":"metaplasia","id":"48582"},{"source":"NA","target":"diabetes mellitus","id":"48583"},{"source":"NA","target":"cardiac arrhythmias","id":"48584"},{"source":"NA","target":"liver metastases","id":"48585"},{"source":"NA","target":"gilbert disease","id":"48586"},{"source":"NA","target":"hypoglycemic","id":"48587"},{"source":"NA","target":"residual tumor","id":"48588"},{"source":"NA","target":"hypoglycemic","id":"48589"},{"source":"NA","target":"cardiac arrhythmias","id":"48590"},{"source":"NA","target":"residual tumor","id":"48591"},{"source":"NA","target":"insulin resistance","id":"48592"},{"source":"NA","target":"aneurysm","id":"48593"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"48594"},{"source":"NA","target":"hypertension","id":"48595"},{"source":"NA","target":"anticancer","id":"48596"},{"source":"NA","target":"antiarthritic","id":"48597"},{"source":"NA","target":"heart diseases","id":"48598"},{"source":"NA","target":"metaplasia","id":"48599"},{"source":"NA","target":"anticancer","id":"48600"},{"source":"NA","target":"liver metastases","id":"48601"},{"source":"NA","target":"atrial flutter","id":"48602"},{"source":"NA","target":"breast tumor","id":"48603"},{"source":"NA","target":"antidiabetic","id":"48604"},{"source":"NA","target":"teratogenesis","id":"48605"},{"source":"NA","target":"breast tumor","id":"48606"},{"source":"NA","target":"heart failure","id":"48607"},{"source":"NA","target":"gilbert disease","id":"48608"},{"source":"NA","target":"diabetes mellitus","id":"48609"},{"source":"NA","target":"antidiabetic","id":"48610"},{"source":"NA","target":"asthma","id":"48611"},{"source":"NA","target":"copd","id":"48612"},{"source":"NA","target":"heart failure","id":"48613"},{"source":"NA","target":"residual neoplasm","id":"48614"},{"source":"NA","target":"antiallergic","id":"48615"},{"source":"NA","target":"carcinoma","id":"48616"},{"source":"NA","target":"breast neoplasms","id":"48617"},{"source":"NA","target":"hypersensitivity","id":"48618"},{"source":"NA","target":"inflammation","id":"48619"},{"source":"NA","target":"multiple sclerosis","id":"48620"},{"source":"NA","target":"triple-negative breast cancer","id":"48621"},{"source":"NA","target":"diabetes mellitus","id":"48622"},{"source":"NA","target":"cardiac disease","id":"48623"},{"source":"NA","target":"unstable angina","id":"48624"},{"source":"NA","target":"diabetes mellitus","id":"48625"},{"source":"NA","target":"anti-inflammatory","id":"48626"},{"source":"NA","target":"arthritis","id":"48627"},{"source":"NA","target":"residual tumor","id":"48628"},{"source":"NA","target":"cardiac conditions","id":"48629"},{"source":"NA","target":"solid malignancy","id":"48630"},{"source":"NA","target":"carcinoma","id":"48631"},{"source":"NA","target":"myocardial infarction","id":"48632"},{"source":"NA","target":"neoplasm metastasis","id":"48633"},{"source":"NA","target":"teratogenic","id":"48634"},{"source":"NA","target":"anti-inflammatory","id":"48635"},{"source":"NA","target":"metaplasia","id":"48636"},{"source":"NA","target":"diabetes mellitus","id":"48637"},{"source":"NA","target":"cardiac arrhythmias","id":"48638"},{"source":"NA","target":"liver metastases","id":"48639"},{"source":"NA","target":"gilbert disease","id":"48640"},{"source":"NA","target":"hypoglycemic","id":"48641"},{"source":"NA","target":"residual tumor","id":"48642"},{"source":"NA","target":"hypoglycemic","id":"48643"},{"source":"NA","target":"cardiac arrhythmias","id":"48644"},{"source":"NA","target":"residual tumor","id":"48645"},{"source":"NA","target":"insulin resistance","id":"48646"},{"source":"NA","target":"aneurysm","id":"48647"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"48648"},{"source":"NA","target":"hypertension","id":"48649"},{"source":"NA","target":"anticancer","id":"48650"},{"source":"NA","target":"antiarthritic","id":"48651"},{"source":"NA","target":"heart diseases","id":"48652"},{"source":"Angiopoietin inhibitor","target":"metaplasia","id":"48653"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"48654"},{"source":"Angiopoietin inhibitor","target":"liver metastases","id":"48655"},{"source":"Angiopoietin inhibitor","target":"atrial flutter","id":"48656"},{"source":"Angiopoietin inhibitor","target":"breast tumor","id":"48657"},{"source":"Angiopoietin inhibitor","target":"antidiabetic","id":"48658"},{"source":"Angiopoietin inhibitor","target":"teratogenesis","id":"48659"},{"source":"Angiopoietin inhibitor","target":"breast tumor","id":"48660"},{"source":"Angiopoietin inhibitor","target":"heart failure","id":"48661"},{"source":"Angiopoietin inhibitor","target":"gilbert disease","id":"48662"},{"source":"Angiopoietin inhibitor","target":"diabetes mellitus","id":"48663"},{"source":"Angiopoietin inhibitor","target":"antidiabetic","id":"48664"},{"source":"Angiopoietin inhibitor","target":"asthma","id":"48665"},{"source":"Angiopoietin inhibitor","target":"copd","id":"48666"},{"source":"Angiopoietin inhibitor","target":"heart failure","id":"48667"},{"source":"Angiopoietin inhibitor","target":"residual neoplasm","id":"48668"},{"source":"Angiopoietin inhibitor","target":"antiallergic","id":"48669"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"48670"},{"source":"Angiopoietin inhibitor","target":"breast neoplasms","id":"48671"},{"source":"Angiopoietin inhibitor","target":"hypersensitivity","id":"48672"},{"source":"Angiopoietin inhibitor","target":"inflammation","id":"48673"},{"source":"Angiopoietin inhibitor","target":"multiple sclerosis","id":"48674"},{"source":"Angiopoietin inhibitor","target":"triple-negative breast cancer","id":"48675"},{"source":"Angiopoietin inhibitor","target":"diabetes mellitus","id":"48676"},{"source":"Angiopoietin inhibitor","target":"cardiac disease","id":"48677"},{"source":"Angiopoietin inhibitor","target":"unstable angina","id":"48678"},{"source":"Angiopoietin inhibitor","target":"diabetes mellitus","id":"48679"},{"source":"Angiopoietin inhibitor","target":"anti-inflammatory","id":"48680"},{"source":"Angiopoietin inhibitor","target":"arthritis","id":"48681"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"48682"},{"source":"Angiopoietin inhibitor","target":"cardiac conditions","id":"48683"},{"source":"Angiopoietin inhibitor","target":"solid malignancy","id":"48684"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"48685"},{"source":"Angiopoietin inhibitor","target":"myocardial infarction","id":"48686"},{"source":"Angiopoietin inhibitor","target":"neoplasm metastasis","id":"48687"},{"source":"Angiopoietin inhibitor","target":"teratogenic","id":"48688"},{"source":"Angiopoietin inhibitor","target":"anti-inflammatory","id":"48689"},{"source":"Angiopoietin inhibitor","target":"metaplasia","id":"48690"},{"source":"Angiopoietin inhibitor","target":"diabetes mellitus","id":"48691"},{"source":"Angiopoietin inhibitor","target":"cardiac arrhythmias","id":"48692"},{"source":"Angiopoietin inhibitor","target":"liver metastases","id":"48693"},{"source":"Angiopoietin inhibitor","target":"gilbert disease","id":"48694"},{"source":"Angiopoietin inhibitor","target":"hypoglycemic","id":"48695"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"48696"},{"source":"Angiopoietin inhibitor","target":"hypoglycemic","id":"48697"},{"source":"Angiopoietin inhibitor","target":"cardiac arrhythmias","id":"48698"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"48699"},{"source":"Angiopoietin inhibitor","target":"insulin resistance","id":"48700"},{"source":"Angiopoietin inhibitor","target":"aneurysm","id":"48701"},{"source":"Angiopoietin inhibitor","target":"chronic obstructive pulmonary disease","id":"48702"},{"source":"Angiopoietin inhibitor","target":"hypertension","id":"48703"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"48704"},{"source":"Angiopoietin inhibitor","target":"antiarthritic","id":"48705"},{"source":"Angiopoietin inhibitor","target":"heart diseases","id":"48706"},{"source":"NA","target":"metaplasia","id":"48707"},{"source":"NA","target":"anticancer","id":"48708"},{"source":"NA","target":"liver metastases","id":"48709"},{"source":"NA","target":"atrial flutter","id":"48710"},{"source":"NA","target":"breast tumor","id":"48711"},{"source":"NA","target":"antidiabetic","id":"48712"},{"source":"NA","target":"teratogenesis","id":"48713"},{"source":"NA","target":"breast tumor","id":"48714"},{"source":"NA","target":"heart failure","id":"48715"},{"source":"NA","target":"gilbert disease","id":"48716"},{"source":"NA","target":"diabetes mellitus","id":"48717"},{"source":"NA","target":"antidiabetic","id":"48718"},{"source":"NA","target":"asthma","id":"48719"},{"source":"NA","target":"copd","id":"48720"},{"source":"NA","target":"heart failure","id":"48721"},{"source":"NA","target":"residual neoplasm","id":"48722"},{"source":"NA","target":"antiallergic","id":"48723"},{"source":"NA","target":"carcinoma","id":"48724"},{"source":"NA","target":"breast neoplasms","id":"48725"},{"source":"NA","target":"hypersensitivity","id":"48726"},{"source":"NA","target":"inflammation","id":"48727"},{"source":"NA","target":"multiple sclerosis","id":"48728"},{"source":"NA","target":"triple-negative breast cancer","id":"48729"},{"source":"NA","target":"diabetes mellitus","id":"48730"},{"source":"NA","target":"cardiac disease","id":"48731"},{"source":"NA","target":"unstable angina","id":"48732"},{"source":"NA","target":"diabetes mellitus","id":"48733"},{"source":"NA","target":"anti-inflammatory","id":"48734"},{"source":"NA","target":"arthritis","id":"48735"},{"source":"NA","target":"residual tumor","id":"48736"},{"source":"NA","target":"cardiac conditions","id":"48737"},{"source":"NA","target":"solid malignancy","id":"48738"},{"source":"NA","target":"carcinoma","id":"48739"},{"source":"NA","target":"myocardial infarction","id":"48740"},{"source":"NA","target":"neoplasm metastasis","id":"48741"},{"source":"NA","target":"teratogenic","id":"48742"},{"source":"NA","target":"anti-inflammatory","id":"48743"},{"source":"NA","target":"metaplasia","id":"48744"},{"source":"NA","target":"diabetes mellitus","id":"48745"},{"source":"NA","target":"cardiac arrhythmias","id":"48746"},{"source":"NA","target":"liver metastases","id":"48747"},{"source":"NA","target":"gilbert disease","id":"48748"},{"source":"NA","target":"hypoglycemic","id":"48749"},{"source":"NA","target":"residual tumor","id":"48750"},{"source":"NA","target":"hypoglycemic","id":"48751"},{"source":"NA","target":"cardiac arrhythmias","id":"48752"},{"source":"NA","target":"residual tumor","id":"48753"},{"source":"NA","target":"insulin resistance","id":"48754"},{"source":"NA","target":"aneurysm","id":"48755"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"48756"},{"source":"NA","target":"hypertension","id":"48757"},{"source":"NA","target":"anticancer","id":"48758"},{"source":"NA","target":"antiarthritic","id":"48759"},{"source":"NA","target":"heart diseases","id":"48760"},{"source":"Angiopoietin inhibitor","target":"metaplasia","id":"48761"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"48762"},{"source":"Angiopoietin inhibitor","target":"liver metastases","id":"48763"},{"source":"Angiopoietin inhibitor","target":"atrial flutter","id":"48764"},{"source":"Angiopoietin inhibitor","target":"breast tumor","id":"48765"},{"source":"Angiopoietin inhibitor","target":"antidiabetic","id":"48766"},{"source":"Angiopoietin inhibitor","target":"teratogenesis","id":"48767"},{"source":"Angiopoietin inhibitor","target":"breast tumor","id":"48768"},{"source":"Angiopoietin inhibitor","target":"heart failure","id":"48769"},{"source":"Angiopoietin inhibitor","target":"gilbert disease","id":"48770"},{"source":"Angiopoietin inhibitor","target":"diabetes mellitus","id":"48771"},{"source":"Angiopoietin inhibitor","target":"antidiabetic","id":"48772"},{"source":"Angiopoietin inhibitor","target":"asthma","id":"48773"},{"source":"Angiopoietin inhibitor","target":"copd","id":"48774"},{"source":"Angiopoietin inhibitor","target":"heart failure","id":"48775"},{"source":"Angiopoietin inhibitor","target":"residual neoplasm","id":"48776"},{"source":"Angiopoietin inhibitor","target":"antiallergic","id":"48777"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"48778"},{"source":"Angiopoietin inhibitor","target":"breast neoplasms","id":"48779"},{"source":"Angiopoietin inhibitor","target":"hypersensitivity","id":"48780"},{"source":"Angiopoietin inhibitor","target":"inflammation","id":"48781"},{"source":"Angiopoietin inhibitor","target":"multiple sclerosis","id":"48782"},{"source":"Angiopoietin inhibitor","target":"triple-negative breast cancer","id":"48783"},{"source":"Angiopoietin inhibitor","target":"diabetes mellitus","id":"48784"},{"source":"Angiopoietin inhibitor","target":"cardiac disease","id":"48785"},{"source":"Angiopoietin inhibitor","target":"unstable angina","id":"48786"},{"source":"Angiopoietin inhibitor","target":"diabetes mellitus","id":"48787"},{"source":"Angiopoietin inhibitor","target":"anti-inflammatory","id":"48788"},{"source":"Angiopoietin inhibitor","target":"arthritis","id":"48789"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"48790"},{"source":"Angiopoietin inhibitor","target":"cardiac conditions","id":"48791"},{"source":"Angiopoietin inhibitor","target":"solid malignancy","id":"48792"},{"source":"Angiopoietin inhibitor","target":"carcinoma","id":"48793"},{"source":"Angiopoietin inhibitor","target":"myocardial infarction","id":"48794"},{"source":"Angiopoietin inhibitor","target":"neoplasm metastasis","id":"48795"},{"source":"Angiopoietin inhibitor","target":"teratogenic","id":"48796"},{"source":"Angiopoietin inhibitor","target":"anti-inflammatory","id":"48797"},{"source":"Angiopoietin inhibitor","target":"metaplasia","id":"48798"},{"source":"Angiopoietin inhibitor","target":"diabetes mellitus","id":"48799"},{"source":"Angiopoietin inhibitor","target":"cardiac arrhythmias","id":"48800"},{"source":"Angiopoietin inhibitor","target":"liver metastases","id":"48801"},{"source":"Angiopoietin inhibitor","target":"gilbert disease","id":"48802"},{"source":"Angiopoietin inhibitor","target":"hypoglycemic","id":"48803"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"48804"},{"source":"Angiopoietin inhibitor","target":"hypoglycemic","id":"48805"},{"source":"Angiopoietin inhibitor","target":"cardiac arrhythmias","id":"48806"},{"source":"Angiopoietin inhibitor","target":"residual tumor","id":"48807"},{"source":"Angiopoietin inhibitor","target":"insulin resistance","id":"48808"},{"source":"Angiopoietin inhibitor","target":"aneurysm","id":"48809"},{"source":"Angiopoietin inhibitor","target":"chronic obstructive pulmonary disease","id":"48810"},{"source":"Angiopoietin inhibitor","target":"hypertension","id":"48811"},{"source":"Angiopoietin inhibitor","target":"anticancer","id":"48812"},{"source":"Angiopoietin inhibitor","target":"antiarthritic","id":"48813"},{"source":"Angiopoietin inhibitor","target":"heart diseases","id":"48814"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metaplasia","id":"48815"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anticancer","id":"48816"},{"source":"ADP ribose polymerase 1 inhibitor","target":"liver metastases","id":"48817"},{"source":"ADP ribose polymerase 1 inhibitor","target":"atrial flutter","id":"48818"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast tumor","id":"48819"},{"source":"ADP ribose polymerase 1 inhibitor","target":"antidiabetic","id":"48820"},{"source":"ADP ribose polymerase 1 inhibitor","target":"teratogenesis","id":"48821"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast tumor","id":"48822"},{"source":"ADP ribose polymerase 1 inhibitor","target":"heart failure","id":"48823"},{"source":"ADP ribose polymerase 1 inhibitor","target":"gilbert disease","id":"48824"},{"source":"ADP ribose polymerase 1 inhibitor","target":"diabetes mellitus","id":"48825"},{"source":"ADP ribose polymerase 1 inhibitor","target":"antidiabetic","id":"48826"},{"source":"ADP ribose polymerase 1 inhibitor","target":"asthma","id":"48827"},{"source":"ADP ribose polymerase 1 inhibitor","target":"copd","id":"48828"},{"source":"ADP ribose polymerase 1 inhibitor","target":"heart failure","id":"48829"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual neoplasm","id":"48830"},{"source":"ADP ribose polymerase 1 inhibitor","target":"antiallergic","id":"48831"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"48832"},{"source":"ADP ribose polymerase 1 inhibitor","target":"breast neoplasms","id":"48833"},{"source":"ADP ribose polymerase 1 inhibitor","target":"hypersensitivity","id":"48834"},{"source":"ADP ribose polymerase 1 inhibitor","target":"inflammation","id":"48835"},{"source":"ADP ribose polymerase 1 inhibitor","target":"multiple sclerosis","id":"48836"},{"source":"ADP ribose polymerase 1 inhibitor","target":"triple-negative breast cancer","id":"48837"},{"source":"ADP ribose polymerase 1 inhibitor","target":"diabetes mellitus","id":"48838"},{"source":"ADP ribose polymerase 1 inhibitor","target":"cardiac disease","id":"48839"},{"source":"ADP ribose polymerase 1 inhibitor","target":"unstable angina","id":"48840"},{"source":"ADP ribose polymerase 1 inhibitor","target":"diabetes mellitus","id":"48841"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anti-inflammatory","id":"48842"},{"source":"ADP ribose polymerase 1 inhibitor","target":"arthritis","id":"48843"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"48844"},{"source":"ADP ribose polymerase 1 inhibitor","target":"cardiac conditions","id":"48845"},{"source":"ADP ribose polymerase 1 inhibitor","target":"solid malignancy","id":"48846"},{"source":"ADP ribose polymerase 1 inhibitor","target":"carcinoma","id":"48847"},{"source":"ADP ribose polymerase 1 inhibitor","target":"myocardial infarction","id":"48848"},{"source":"ADP ribose polymerase 1 inhibitor","target":"neoplasm metastasis","id":"48849"},{"source":"ADP ribose polymerase 1 inhibitor","target":"teratogenic","id":"48850"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anti-inflammatory","id":"48851"},{"source":"ADP ribose polymerase 1 inhibitor","target":"metaplasia","id":"48852"},{"source":"ADP ribose polymerase 1 inhibitor","target":"diabetes mellitus","id":"48853"},{"source":"ADP ribose polymerase 1 inhibitor","target":"cardiac arrhythmias","id":"48854"},{"source":"ADP ribose polymerase 1 inhibitor","target":"liver metastases","id":"48855"},{"source":"ADP ribose polymerase 1 inhibitor","target":"gilbert disease","id":"48856"},{"source":"ADP ribose polymerase 1 inhibitor","target":"hypoglycemic","id":"48857"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"48858"},{"source":"ADP ribose polymerase 1 inhibitor","target":"hypoglycemic","id":"48859"},{"source":"ADP ribose polymerase 1 inhibitor","target":"cardiac arrhythmias","id":"48860"},{"source":"ADP ribose polymerase 1 inhibitor","target":"residual tumor","id":"48861"},{"source":"ADP ribose polymerase 1 inhibitor","target":"insulin resistance","id":"48862"},{"source":"ADP ribose polymerase 1 inhibitor","target":"aneurysm","id":"48863"},{"source":"ADP ribose polymerase 1 inhibitor","target":"chronic obstructive pulmonary disease","id":"48864"},{"source":"ADP ribose polymerase 1 inhibitor","target":"hypertension","id":"48865"},{"source":"ADP ribose polymerase 1 inhibitor","target":"anticancer","id":"48866"},{"source":"ADP ribose polymerase 1 inhibitor","target":"antiarthritic","id":"48867"},{"source":"ADP ribose polymerase 1 inhibitor","target":"heart diseases","id":"48868"},{"source":"ErbB-2 antagonist","target":"metaplasia","id":"48869"},{"source":"ErbB-2 antagonist","target":"anticancer","id":"48870"},{"source":"ErbB-2 antagonist","target":"liver metastases","id":"48871"},{"source":"ErbB-2 antagonist","target":"atrial flutter","id":"48872"},{"source":"ErbB-2 antagonist","target":"breast tumor","id":"48873"},{"source":"ErbB-2 antagonist","target":"antidiabetic","id":"48874"},{"source":"ErbB-2 antagonist","target":"teratogenesis","id":"48875"},{"source":"ErbB-2 antagonist","target":"breast tumor","id":"48876"},{"source":"ErbB-2 antagonist","target":"heart failure","id":"48877"},{"source":"ErbB-2 antagonist","target":"gilbert disease","id":"48878"},{"source":"ErbB-2 antagonist","target":"diabetes mellitus","id":"48879"},{"source":"ErbB-2 antagonist","target":"antidiabetic","id":"48880"},{"source":"ErbB-2 antagonist","target":"asthma","id":"48881"},{"source":"ErbB-2 antagonist","target":"copd","id":"48882"},{"source":"ErbB-2 antagonist","target":"heart failure","id":"48883"},{"source":"ErbB-2 antagonist","target":"residual neoplasm","id":"48884"},{"source":"ErbB-2 antagonist","target":"antiallergic","id":"48885"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"48886"},{"source":"ErbB-2 antagonist","target":"breast neoplasms","id":"48887"},{"source":"ErbB-2 antagonist","target":"hypersensitivity","id":"48888"},{"source":"ErbB-2 antagonist","target":"inflammation","id":"48889"},{"source":"ErbB-2 antagonist","target":"multiple sclerosis","id":"48890"},{"source":"ErbB-2 antagonist","target":"triple-negative breast cancer","id":"48891"},{"source":"ErbB-2 antagonist","target":"diabetes mellitus","id":"48892"},{"source":"ErbB-2 antagonist","target":"cardiac disease","id":"48893"},{"source":"ErbB-2 antagonist","target":"unstable angina","id":"48894"},{"source":"ErbB-2 antagonist","target":"diabetes mellitus","id":"48895"},{"source":"ErbB-2 antagonist","target":"anti-inflammatory","id":"48896"},{"source":"ErbB-2 antagonist","target":"arthritis","id":"48897"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"48898"},{"source":"ErbB-2 antagonist","target":"cardiac conditions","id":"48899"},{"source":"ErbB-2 antagonist","target":"solid malignancy","id":"48900"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"48901"},{"source":"ErbB-2 antagonist","target":"myocardial infarction","id":"48902"},{"source":"ErbB-2 antagonist","target":"neoplasm metastasis","id":"48903"},{"source":"ErbB-2 antagonist","target":"teratogenic","id":"48904"},{"source":"ErbB-2 antagonist","target":"anti-inflammatory","id":"48905"},{"source":"ErbB-2 antagonist","target":"metaplasia","id":"48906"},{"source":"ErbB-2 antagonist","target":"diabetes mellitus","id":"48907"},{"source":"ErbB-2 antagonist","target":"cardiac arrhythmias","id":"48908"},{"source":"ErbB-2 antagonist","target":"liver metastases","id":"48909"},{"source":"ErbB-2 antagonist","target":"gilbert disease","id":"48910"},{"source":"ErbB-2 antagonist","target":"hypoglycemic","id":"48911"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"48912"},{"source":"ErbB-2 antagonist","target":"hypoglycemic","id":"48913"},{"source":"ErbB-2 antagonist","target":"cardiac arrhythmias","id":"48914"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"48915"},{"source":"ErbB-2 antagonist","target":"insulin resistance","id":"48916"},{"source":"ErbB-2 antagonist","target":"aneurysm","id":"48917"},{"source":"ErbB-2 antagonist","target":"chronic obstructive pulmonary disease","id":"48918"},{"source":"ErbB-2 antagonist","target":"hypertension","id":"48919"},{"source":"ErbB-2 antagonist","target":"anticancer","id":"48920"},{"source":"ErbB-2 antagonist","target":"antiarthritic","id":"48921"},{"source":"ErbB-2 antagonist","target":"heart diseases","id":"48922"},{"source":"Gluconeogenesis inhibitor","target":"metaplasia","id":"48923"},{"source":"Gluconeogenesis inhibitor","target":"anticancer","id":"48924"},{"source":"Gluconeogenesis inhibitor","target":"liver metastases","id":"48925"},{"source":"Gluconeogenesis inhibitor","target":"atrial flutter","id":"48926"},{"source":"Gluconeogenesis inhibitor","target":"breast tumor","id":"48927"},{"source":"Gluconeogenesis inhibitor","target":"antidiabetic","id":"48928"},{"source":"Gluconeogenesis inhibitor","target":"teratogenesis","id":"48929"},{"source":"Gluconeogenesis inhibitor","target":"breast tumor","id":"48930"},{"source":"Gluconeogenesis inhibitor","target":"heart failure","id":"48931"},{"source":"Gluconeogenesis inhibitor","target":"gilbert disease","id":"48932"},{"source":"Gluconeogenesis inhibitor","target":"diabetes mellitus","id":"48933"},{"source":"Gluconeogenesis inhibitor","target":"antidiabetic","id":"48934"},{"source":"Gluconeogenesis inhibitor","target":"asthma","id":"48935"},{"source":"Gluconeogenesis inhibitor","target":"copd","id":"48936"},{"source":"Gluconeogenesis inhibitor","target":"heart failure","id":"48937"},{"source":"Gluconeogenesis inhibitor","target":"residual neoplasm","id":"48938"},{"source":"Gluconeogenesis inhibitor","target":"antiallergic","id":"48939"},{"source":"Gluconeogenesis inhibitor","target":"carcinoma","id":"48940"},{"source":"Gluconeogenesis inhibitor","target":"breast neoplasms","id":"48941"},{"source":"Gluconeogenesis inhibitor","target":"hypersensitivity","id":"48942"},{"source":"Gluconeogenesis inhibitor","target":"inflammation","id":"48943"},{"source":"Gluconeogenesis inhibitor","target":"multiple sclerosis","id":"48944"},{"source":"Gluconeogenesis inhibitor","target":"triple-negative breast cancer","id":"48945"},{"source":"Gluconeogenesis inhibitor","target":"diabetes mellitus","id":"48946"},{"source":"Gluconeogenesis inhibitor","target":"cardiac disease","id":"48947"},{"source":"Gluconeogenesis inhibitor","target":"unstable angina","id":"48948"},{"source":"Gluconeogenesis inhibitor","target":"diabetes mellitus","id":"48949"},{"source":"Gluconeogenesis inhibitor","target":"anti-inflammatory","id":"48950"},{"source":"Gluconeogenesis inhibitor","target":"arthritis","id":"48951"},{"source":"Gluconeogenesis inhibitor","target":"residual tumor","id":"48952"},{"source":"Gluconeogenesis inhibitor","target":"cardiac conditions","id":"48953"},{"source":"Gluconeogenesis inhibitor","target":"solid malignancy","id":"48954"},{"source":"Gluconeogenesis inhibitor","target":"carcinoma","id":"48955"},{"source":"Gluconeogenesis inhibitor","target":"myocardial infarction","id":"48956"},{"source":"Gluconeogenesis inhibitor","target":"neoplasm metastasis","id":"48957"},{"source":"Gluconeogenesis inhibitor","target":"teratogenic","id":"48958"},{"source":"Gluconeogenesis inhibitor","target":"anti-inflammatory","id":"48959"},{"source":"Gluconeogenesis inhibitor","target":"metaplasia","id":"48960"},{"source":"Gluconeogenesis inhibitor","target":"diabetes mellitus","id":"48961"},{"source":"Gluconeogenesis inhibitor","target":"cardiac arrhythmias","id":"48962"},{"source":"Gluconeogenesis inhibitor","target":"liver metastases","id":"48963"},{"source":"Gluconeogenesis inhibitor","target":"gilbert disease","id":"48964"},{"source":"Gluconeogenesis inhibitor","target":"hypoglycemic","id":"48965"},{"source":"Gluconeogenesis inhibitor","target":"residual tumor","id":"48966"},{"source":"Gluconeogenesis inhibitor","target":"hypoglycemic","id":"48967"},{"source":"Gluconeogenesis inhibitor","target":"cardiac arrhythmias","id":"48968"},{"source":"Gluconeogenesis inhibitor","target":"residual tumor","id":"48969"},{"source":"Gluconeogenesis inhibitor","target":"insulin resistance","id":"48970"},{"source":"Gluconeogenesis inhibitor","target":"aneurysm","id":"48971"},{"source":"Gluconeogenesis inhibitor","target":"chronic obstructive pulmonary disease","id":"48972"},{"source":"Gluconeogenesis inhibitor","target":"hypertension","id":"48973"},{"source":"Gluconeogenesis inhibitor","target":"anticancer","id":"48974"},{"source":"Gluconeogenesis inhibitor","target":"antiarthritic","id":"48975"},{"source":"Gluconeogenesis inhibitor","target":"heart diseases","id":"48976"},{"source":"NA","target":"metaplasia","id":"48977"},{"source":"NA","target":"anticancer","id":"48978"},{"source":"NA","target":"liver metastases","id":"48979"},{"source":"NA","target":"atrial flutter","id":"48980"},{"source":"NA","target":"breast tumor","id":"48981"},{"source":"NA","target":"antidiabetic","id":"48982"},{"source":"NA","target":"teratogenesis","id":"48983"},{"source":"NA","target":"breast tumor","id":"48984"},{"source":"NA","target":"heart failure","id":"48985"},{"source":"NA","target":"gilbert disease","id":"48986"},{"source":"NA","target":"diabetes mellitus","id":"48987"},{"source":"NA","target":"antidiabetic","id":"48988"},{"source":"NA","target":"asthma","id":"48989"},{"source":"NA","target":"copd","id":"48990"},{"source":"NA","target":"heart failure","id":"48991"},{"source":"NA","target":"residual neoplasm","id":"48992"},{"source":"NA","target":"antiallergic","id":"48993"},{"source":"NA","target":"carcinoma","id":"48994"},{"source":"NA","target":"breast neoplasms","id":"48995"},{"source":"NA","target":"hypersensitivity","id":"48996"},{"source":"NA","target":"inflammation","id":"48997"},{"source":"NA","target":"multiple sclerosis","id":"48998"},{"source":"NA","target":"triple-negative breast cancer","id":"48999"},{"source":"NA","target":"diabetes mellitus","id":"49000"},{"source":"NA","target":"cardiac disease","id":"49001"},{"source":"NA","target":"unstable angina","id":"49002"},{"source":"NA","target":"diabetes mellitus","id":"49003"},{"source":"NA","target":"anti-inflammatory","id":"49004"},{"source":"NA","target":"arthritis","id":"49005"},{"source":"NA","target":"residual tumor","id":"49006"},{"source":"NA","target":"cardiac conditions","id":"49007"},{"source":"NA","target":"solid malignancy","id":"49008"},{"source":"NA","target":"carcinoma","id":"49009"},{"source":"NA","target":"myocardial infarction","id":"49010"},{"source":"NA","target":"neoplasm metastasis","id":"49011"},{"source":"NA","target":"teratogenic","id":"49012"},{"source":"NA","target":"anti-inflammatory","id":"49013"},{"source":"NA","target":"metaplasia","id":"49014"},{"source":"NA","target":"diabetes mellitus","id":"49015"},{"source":"NA","target":"cardiac arrhythmias","id":"49016"},{"source":"NA","target":"liver metastases","id":"49017"},{"source":"NA","target":"gilbert disease","id":"49018"},{"source":"NA","target":"hypoglycemic","id":"49019"},{"source":"NA","target":"residual tumor","id":"49020"},{"source":"NA","target":"hypoglycemic","id":"49021"},{"source":"NA","target":"cardiac arrhythmias","id":"49022"},{"source":"NA","target":"residual tumor","id":"49023"},{"source":"NA","target":"insulin resistance","id":"49024"},{"source":"NA","target":"aneurysm","id":"49025"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"49026"},{"source":"NA","target":"hypertension","id":"49027"},{"source":"NA","target":"anticancer","id":"49028"},{"source":"NA","target":"antiarthritic","id":"49029"},{"source":"NA","target":"heart diseases","id":"49030"},{"source":"ErbB-2 antagonist","target":"metaplasia","id":"49031"},{"source":"ErbB-2 antagonist","target":"anticancer","id":"49032"},{"source":"ErbB-2 antagonist","target":"liver metastases","id":"49033"},{"source":"ErbB-2 antagonist","target":"atrial flutter","id":"49034"},{"source":"ErbB-2 antagonist","target":"breast tumor","id":"49035"},{"source":"ErbB-2 antagonist","target":"antidiabetic","id":"49036"},{"source":"ErbB-2 antagonist","target":"teratogenesis","id":"49037"},{"source":"ErbB-2 antagonist","target":"breast tumor","id":"49038"},{"source":"ErbB-2 antagonist","target":"heart failure","id":"49039"},{"source":"ErbB-2 antagonist","target":"gilbert disease","id":"49040"},{"source":"ErbB-2 antagonist","target":"diabetes mellitus","id":"49041"},{"source":"ErbB-2 antagonist","target":"antidiabetic","id":"49042"},{"source":"ErbB-2 antagonist","target":"asthma","id":"49043"},{"source":"ErbB-2 antagonist","target":"copd","id":"49044"},{"source":"ErbB-2 antagonist","target":"heart failure","id":"49045"},{"source":"ErbB-2 antagonist","target":"residual neoplasm","id":"49046"},{"source":"ErbB-2 antagonist","target":"antiallergic","id":"49047"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"49048"},{"source":"ErbB-2 antagonist","target":"breast neoplasms","id":"49049"},{"source":"ErbB-2 antagonist","target":"hypersensitivity","id":"49050"},{"source":"ErbB-2 antagonist","target":"inflammation","id":"49051"},{"source":"ErbB-2 antagonist","target":"multiple sclerosis","id":"49052"},{"source":"ErbB-2 antagonist","target":"triple-negative breast cancer","id":"49053"},{"source":"ErbB-2 antagonist","target":"diabetes mellitus","id":"49054"},{"source":"ErbB-2 antagonist","target":"cardiac disease","id":"49055"},{"source":"ErbB-2 antagonist","target":"unstable angina","id":"49056"},{"source":"ErbB-2 antagonist","target":"diabetes mellitus","id":"49057"},{"source":"ErbB-2 antagonist","target":"anti-inflammatory","id":"49058"},{"source":"ErbB-2 antagonist","target":"arthritis","id":"49059"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"49060"},{"source":"ErbB-2 antagonist","target":"cardiac conditions","id":"49061"},{"source":"ErbB-2 antagonist","target":"solid malignancy","id":"49062"},{"source":"ErbB-2 antagonist","target":"carcinoma","id":"49063"},{"source":"ErbB-2 antagonist","target":"myocardial infarction","id":"49064"},{"source":"ErbB-2 antagonist","target":"neoplasm metastasis","id":"49065"},{"source":"ErbB-2 antagonist","target":"teratogenic","id":"49066"},{"source":"ErbB-2 antagonist","target":"anti-inflammatory","id":"49067"},{"source":"ErbB-2 antagonist","target":"metaplasia","id":"49068"},{"source":"ErbB-2 antagonist","target":"diabetes mellitus","id":"49069"},{"source":"ErbB-2 antagonist","target":"cardiac arrhythmias","id":"49070"},{"source":"ErbB-2 antagonist","target":"liver metastases","id":"49071"},{"source":"ErbB-2 antagonist","target":"gilbert disease","id":"49072"},{"source":"ErbB-2 antagonist","target":"hypoglycemic","id":"49073"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"49074"},{"source":"ErbB-2 antagonist","target":"hypoglycemic","id":"49075"},{"source":"ErbB-2 antagonist","target":"cardiac arrhythmias","id":"49076"},{"source":"ErbB-2 antagonist","target":"residual tumor","id":"49077"},{"source":"ErbB-2 antagonist","target":"insulin resistance","id":"49078"},{"source":"ErbB-2 antagonist","target":"aneurysm","id":"49079"},{"source":"ErbB-2 antagonist","target":"chronic obstructive pulmonary disease","id":"49080"},{"source":"ErbB-2 antagonist","target":"hypertension","id":"49081"},{"source":"ErbB-2 antagonist","target":"anticancer","id":"49082"},{"source":"ErbB-2 antagonist","target":"antiarthritic","id":"49083"},{"source":"ErbB-2 antagonist","target":"heart diseases","id":"49084"},{"source":"NA","target":"metaplasia","id":"49085"},{"source":"NA","target":"anticancer","id":"49086"},{"source":"NA","target":"liver metastases","id":"49087"},{"source":"NA","target":"atrial flutter","id":"49088"},{"source":"NA","target":"breast tumor","id":"49089"},{"source":"NA","target":"antidiabetic","id":"49090"},{"source":"NA","target":"teratogenesis","id":"49091"},{"source":"NA","target":"breast tumor","id":"49092"},{"source":"NA","target":"heart failure","id":"49093"},{"source":"NA","target":"gilbert disease","id":"49094"},{"source":"NA","target":"diabetes mellitus","id":"49095"},{"source":"NA","target":"antidiabetic","id":"49096"},{"source":"NA","target":"asthma","id":"49097"},{"source":"NA","target":"copd","id":"49098"},{"source":"NA","target":"heart failure","id":"49099"},{"source":"NA","target":"residual neoplasm","id":"49100"},{"source":"NA","target":"antiallergic","id":"49101"},{"source":"NA","target":"carcinoma","id":"49102"},{"source":"NA","target":"breast neoplasms","id":"49103"},{"source":"NA","target":"hypersensitivity","id":"49104"},{"source":"NA","target":"inflammation","id":"49105"},{"source":"NA","target":"multiple sclerosis","id":"49106"},{"source":"NA","target":"triple-negative breast cancer","id":"49107"},{"source":"NA","target":"diabetes mellitus","id":"49108"},{"source":"NA","target":"cardiac disease","id":"49109"},{"source":"NA","target":"unstable angina","id":"49110"},{"source":"NA","target":"diabetes mellitus","id":"49111"},{"source":"NA","target":"anti-inflammatory","id":"49112"},{"source":"NA","target":"arthritis","id":"49113"},{"source":"NA","target":"residual tumor","id":"49114"},{"source":"NA","target":"cardiac conditions","id":"49115"},{"source":"NA","target":"solid malignancy","id":"49116"},{"source":"NA","target":"carcinoma","id":"49117"},{"source":"NA","target":"myocardial infarction","id":"49118"},{"source":"NA","target":"neoplasm metastasis","id":"49119"},{"source":"NA","target":"teratogenic","id":"49120"},{"source":"NA","target":"anti-inflammatory","id":"49121"},{"source":"NA","target":"metaplasia","id":"49122"},{"source":"NA","target":"diabetes mellitus","id":"49123"},{"source":"NA","target":"cardiac arrhythmias","id":"49124"},{"source":"NA","target":"liver metastases","id":"49125"},{"source":"NA","target":"gilbert disease","id":"49126"},{"source":"NA","target":"hypoglycemic","id":"49127"},{"source":"NA","target":"residual tumor","id":"49128"},{"source":"NA","target":"hypoglycemic","id":"49129"},{"source":"NA","target":"cardiac arrhythmias","id":"49130"},{"source":"NA","target":"residual tumor","id":"49131"},{"source":"NA","target":"insulin resistance","id":"49132"},{"source":"NA","target":"aneurysm","id":"49133"},{"source":"NA","target":"chronic obstructive pulmonary disease","id":"49134"},{"source":"NA","target":"hypertension","id":"49135"},{"source":"NA","target":"anticancer","id":"49136"},{"source":"NA","target":"antiarthritic","id":"49137"},{"source":"NA","target":"heart diseases","id":"49138"},{"source":"Oncology: Breast","target":"NA","id":"49139"},{"source":"Oncology: Breast","target":"Colony stimulating factor 1 receptor antagonist","id":"49140"},{"source":"Oncology: Breast","target":"NA","id":"49141"},{"source":"Oncology: Breast","target":"NA","id":"49142"},{"source":"Oncology: Breast","target":"NA","id":"49143"},{"source":"Oncology: Breast","target":"Microtubule stimulant","id":"49144"},{"source":"Oncology: Breast","target":"Heat shock protein 90 antagonist","id":"49145"},{"source":"Oncology: Breast","target":"Taxane","id":"49146"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"49147"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"49148"},{"source":"Oncology: Breast","target":"NA","id":"49149"},{"source":"Oncology: Breast","target":"Insulin-like growth factor 1 antagonist","id":"49150"},{"source":"Oncology: Breast","target":"C-kit inhibitor","id":"49151"},{"source":"Oncology: Breast","target":"NA","id":"49152"},{"source":"Oncology: Breast","target":"NA","id":"49153"},{"source":"Oncology: Breast","target":"ADP ribose polymerase 1 inhibitor","id":"49154"},{"source":"Oncology: Breast","target":"NA","id":"49155"},{"source":"Oncology: Breast","target":"Angiogenesis inhibitor","id":"49156"},{"source":"Oncology: Breast","target":"NA","id":"49157"},{"source":"Oncology: Breast","target":"Beta tubulin antagonist","id":"49158"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"49159"},{"source":"Oncology: Breast","target":"Biguanide","id":"49160"},{"source":"Oncology: Breast","target":"Tubulin inhibitor","id":"49161"},{"source":"Oncology: Breast","target":"NA","id":"49162"},{"source":"Oncology: Breast","target":"NA","id":"49163"},{"source":"Oncology: Breast","target":"Angiopoietin inhibitor","id":"49164"},{"source":"Oncology: Breast","target":"NA","id":"49165"},{"source":"Oncology: Breast","target":"Angiopoietin inhibitor","id":"49166"},{"source":"Oncology: Breast","target":"ADP ribose polymerase 1 inhibitor","id":"49167"},{"source":"Oncology: Breast","target":"ErbB-2 antagonist","id":"49168"},{"source":"Oncology: Breast","target":"Gluconeogenesis inhibitor","id":"49169"},{"source":"Oncology: Breast","target":"NA","id":"49170"},{"source":"Oncology: Breast","target":"ErbB-2 antagonist","id":"49171"},{"source":"Oncology: Breast","target":"NA","id":"49172"},{"source":"pembrolizumab","target":"Merck & Co.","id":"49173"},{"source":"carboplatin","target":"Merck & Co.","id":"49174"},{"source":"cisplatin","target":"Merck & Co.","id":"49175"},{"source":"etoposide (intravenous)","target":"Merck & Co.","id":"49176"},{"source":"UNK : Indication","target":"pembrolizumab","id":"49177"},{"source":"UNK : Indication","target":"carboplatin","id":"49178"},{"source":"UNK : Indication","target":"cisplatin","id":"49179"},{"source":"UNK : Indication","target":"etoposide (intravenous)","id":"49180"},{"source":"sclc","target":"pembrolizumab","id":"49181"},{"source":"sclc","target":"carboplatin","id":"49182"},{"source":"sclc","target":"cisplatin","id":"49183"},{"source":"sclc","target":"etoposide (intravenous)","id":"49184"},{"source":"solid tumors","target":"pembrolizumab","id":"49185"},{"source":"solid tumors","target":"carboplatin","id":"49186"},{"source":"solid tumors","target":"cisplatin","id":"49187"},{"source":"solid tumors","target":"etoposide (intravenous)","id":"49188"},{"source":"anticancer","target":"pembrolizumab","id":"49189"},{"source":"anticancer","target":"carboplatin","id":"49190"},{"source":"anticancer","target":"cisplatin","id":"49191"},{"source":"anticancer","target":"etoposide (intravenous)","id":"49192"},{"source":"carcinoma","target":"pembrolizumab","id":"49193"},{"source":"carcinoma","target":"carboplatin","id":"49194"},{"source":"carcinoma","target":"cisplatin","id":"49195"},{"source":"carcinoma","target":"etoposide (intravenous)","id":"49196"},{"source":"solid malignancy","target":"pembrolizumab","id":"49197"},{"source":"solid malignancy","target":"carboplatin","id":"49198"},{"source":"solid malignancy","target":"cisplatin","id":"49199"},{"source":"solid malignancy","target":"etoposide (intravenous)","id":"49200"},{"source":"lung cancer","target":"pembrolizumab","id":"49201"},{"source":"lung cancer","target":"carboplatin","id":"49202"},{"source":"lung cancer","target":"cisplatin","id":"49203"},{"source":"lung cancer","target":"etoposide (intravenous)","id":"49204"},{"source":"residual tumor","target":"pembrolizumab","id":"49205"},{"source":"residual tumor","target":"carboplatin","id":"49206"},{"source":"residual tumor","target":"cisplatin","id":"49207"},{"source":"residual tumor","target":"etoposide (intravenous)","id":"49208"},{"source":"carcinoma","target":"pembrolizumab","id":"49209"},{"source":"carcinoma","target":"carboplatin","id":"49210"},{"source":"carcinoma","target":"cisplatin","id":"49211"},{"source":"carcinoma","target":"etoposide (intravenous)","id":"49212"},{"source":"anticancer","target":"pembrolizumab","id":"49213"},{"source":"anticancer","target":"carboplatin","id":"49214"},{"source":"anticancer","target":"cisplatin","id":"49215"},{"source":"anticancer","target":"etoposide (intravenous)","id":"49216"},{"source":"lung neoplasms","target":"pembrolizumab","id":"49217"},{"source":"lung neoplasms","target":"carboplatin","id":"49218"},{"source":"lung neoplasms","target":"cisplatin","id":"49219"},{"source":"lung neoplasms","target":"etoposide (intravenous)","id":"49220"},{"source":"solid tumors","target":"pembrolizumab","id":"49221"},{"source":"solid tumors","target":"carboplatin","id":"49222"},{"source":"solid tumors","target":"cisplatin","id":"49223"},{"source":"solid tumors","target":"etoposide (intravenous)","id":"49224"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"49225"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"49226"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"49227"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"49228"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49229"},{"source":"Immune checkpoint inhibitor","target":"solid malignancy","id":"49230"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"49231"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"49232"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49233"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"49234"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"49235"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"49236"},{"source":"NA","target":"UNK : Indication","id":"49237"},{"source":"NA","target":"sclc","id":"49238"},{"source":"NA","target":"solid tumors","id":"49239"},{"source":"NA","target":"anticancer","id":"49240"},{"source":"NA","target":"carcinoma","id":"49241"},{"source":"NA","target":"solid malignancy","id":"49242"},{"source":"NA","target":"lung cancer","id":"49243"},{"source":"NA","target":"residual tumor","id":"49244"},{"source":"NA","target":"carcinoma","id":"49245"},{"source":"NA","target":"anticancer","id":"49246"},{"source":"NA","target":"lung neoplasms","id":"49247"},{"source":"NA","target":"solid tumors","id":"49248"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"49249"},{"source":"Anticancer immunotherapy","target":"sclc","id":"49250"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"49251"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"49252"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49253"},{"source":"Anticancer immunotherapy","target":"solid malignancy","id":"49254"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"49255"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"49256"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49257"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"49258"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"49259"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"49260"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"49261"},{"source":"CD19 antagonist","target":"sclc","id":"49262"},{"source":"CD19 antagonist","target":"solid tumors","id":"49263"},{"source":"CD19 antagonist","target":"anticancer","id":"49264"},{"source":"CD19 antagonist","target":"carcinoma","id":"49265"},{"source":"CD19 antagonist","target":"solid malignancy","id":"49266"},{"source":"CD19 antagonist","target":"lung cancer","id":"49267"},{"source":"CD19 antagonist","target":"residual tumor","id":"49268"},{"source":"CD19 antagonist","target":"carcinoma","id":"49269"},{"source":"CD19 antagonist","target":"anticancer","id":"49270"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"49271"},{"source":"CD19 antagonist","target":"solid tumors","id":"49272"},{"source":"NA","target":"UNK : Indication","id":"49273"},{"source":"NA","target":"sclc","id":"49274"},{"source":"NA","target":"solid tumors","id":"49275"},{"source":"NA","target":"anticancer","id":"49276"},{"source":"NA","target":"carcinoma","id":"49277"},{"source":"NA","target":"solid malignancy","id":"49278"},{"source":"NA","target":"lung cancer","id":"49279"},{"source":"NA","target":"residual tumor","id":"49280"},{"source":"NA","target":"carcinoma","id":"49281"},{"source":"NA","target":"anticancer","id":"49282"},{"source":"NA","target":"lung neoplasms","id":"49283"},{"source":"NA","target":"solid tumors","id":"49284"},{"source":"NA","target":"UNK : Indication","id":"49285"},{"source":"NA","target":"sclc","id":"49286"},{"source":"NA","target":"solid tumors","id":"49287"},{"source":"NA","target":"anticancer","id":"49288"},{"source":"NA","target":"carcinoma","id":"49289"},{"source":"NA","target":"solid malignancy","id":"49290"},{"source":"NA","target":"lung cancer","id":"49291"},{"source":"NA","target":"residual tumor","id":"49292"},{"source":"NA","target":"carcinoma","id":"49293"},{"source":"NA","target":"anticancer","id":"49294"},{"source":"NA","target":"lung neoplasms","id":"49295"},{"source":"NA","target":"solid tumors","id":"49296"},{"source":"NA","target":"UNK : Indication","id":"49297"},{"source":"NA","target":"sclc","id":"49298"},{"source":"NA","target":"solid tumors","id":"49299"},{"source":"NA","target":"anticancer","id":"49300"},{"source":"NA","target":"carcinoma","id":"49301"},{"source":"NA","target":"solid malignancy","id":"49302"},{"source":"NA","target":"lung cancer","id":"49303"},{"source":"NA","target":"residual tumor","id":"49304"},{"source":"NA","target":"carcinoma","id":"49305"},{"source":"NA","target":"anticancer","id":"49306"},{"source":"NA","target":"lung neoplasms","id":"49307"},{"source":"NA","target":"solid tumors","id":"49308"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"49309"},{"source":"Cell cycle inhibitor","target":"sclc","id":"49310"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"49311"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"49312"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"49313"},{"source":"Cell cycle inhibitor","target":"solid malignancy","id":"49314"},{"source":"Cell cycle inhibitor","target":"lung cancer","id":"49315"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"49316"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"49317"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"49318"},{"source":"Cell cycle inhibitor","target":"lung neoplasms","id":"49319"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"49320"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"49321"},{"source":"Oncology: Lung","target":"NA","id":"49322"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"49323"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"49324"},{"source":"Oncology: Lung","target":"NA","id":"49325"},{"source":"Oncology: Lung","target":"NA","id":"49326"},{"source":"Oncology: Lung","target":"NA","id":"49327"},{"source":"Oncology: Lung","target":"Cell cycle inhibitor","id":"49328"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"49329"},{"source":"Non-Small Cell","target":"NA","id":"49330"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"49331"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"49332"},{"source":"Non-Small Cell","target":"NA","id":"49333"},{"source":"Non-Small Cell","target":"NA","id":"49334"},{"source":"Non-Small Cell","target":"NA","id":"49335"},{"source":"Non-Small Cell","target":"Cell cycle inhibitor","id":"49336"},{"source":"pembrolizumab","target":"Merck & Co.","id":"49337"},{"source":"bevacizumab","target":"Merck & Co.","id":"49338"},{"source":"cetuximab","target":"Merck & Co.","id":"49339"},{"source":"5-fluorouracil","target":"Merck & Co.","id":"49340"},{"source":"irinotecan (IV)","target":"Merck & Co.","id":"49341"},{"source":"leucovorin","target":"Merck & Co.","id":"49342"},{"source":"leucovorin","target":"Merck & Co.","id":"49343"},{"source":"Spectrum","target":"Merck & Co.","id":"49344"},{"source":"oxaliplatin (IV)","target":"Merck & Co.","id":"49345"},{"source":"UNK : Indication","target":"pembrolizumab","id":"49346"},{"source":"UNK : Indication","target":"bevacizumab","id":"49347"},{"source":"UNK : Indication","target":"cetuximab","id":"49348"},{"source":"UNK : Indication","target":"5-fluorouracil","id":"49349"},{"source":"UNK : Indication","target":"irinotecan (IV)","id":"49350"},{"source":"UNK : Indication","target":"leucovorin","id":"49351"},{"source":"UNK : Indication","target":"leucovorin","id":"49352"},{"source":"UNK : Indication","target":"Spectrum","id":"49353"},{"source":"UNK : Indication","target":"oxaliplatin (IV)","id":"49354"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"49355"},{"source":"colorectal neoplasms","target":"bevacizumab","id":"49356"},{"source":"colorectal neoplasms","target":"cetuximab","id":"49357"},{"source":"colorectal neoplasms","target":"5-fluorouracil","id":"49358"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"49359"},{"source":"colorectal neoplasms","target":"leucovorin","id":"49360"},{"source":"colorectal neoplasms","target":"leucovorin","id":"49361"},{"source":"colorectal neoplasms","target":"Spectrum","id":"49362"},{"source":"colorectal neoplasms","target":"oxaliplatin (IV)","id":"49363"},{"source":"antidepressant","target":"pembrolizumab","id":"49364"},{"source":"antidepressant","target":"bevacizumab","id":"49365"},{"source":"antidepressant","target":"cetuximab","id":"49366"},{"source":"antidepressant","target":"5-fluorouracil","id":"49367"},{"source":"antidepressant","target":"irinotecan (IV)","id":"49368"},{"source":"antidepressant","target":"leucovorin","id":"49369"},{"source":"antidepressant","target":"leucovorin","id":"49370"},{"source":"antidepressant","target":"Spectrum","id":"49371"},{"source":"antidepressant","target":"oxaliplatin (IV)","id":"49372"},{"source":"antianaemic","target":"pembrolizumab","id":"49373"},{"source":"antianaemic","target":"bevacizumab","id":"49374"},{"source":"antianaemic","target":"cetuximab","id":"49375"},{"source":"antianaemic","target":"5-fluorouracil","id":"49376"},{"source":"antianaemic","target":"irinotecan (IV)","id":"49377"},{"source":"antianaemic","target":"leucovorin","id":"49378"},{"source":"antianaemic","target":"leucovorin","id":"49379"},{"source":"antianaemic","target":"Spectrum","id":"49380"},{"source":"antianaemic","target":"oxaliplatin (IV)","id":"49381"},{"source":"microsatellite instability","target":"pembrolizumab","id":"49382"},{"source":"microsatellite instability","target":"bevacizumab","id":"49383"},{"source":"microsatellite instability","target":"cetuximab","id":"49384"},{"source":"microsatellite instability","target":"5-fluorouracil","id":"49385"},{"source":"microsatellite instability","target":"irinotecan (IV)","id":"49386"},{"source":"microsatellite instability","target":"leucovorin","id":"49387"},{"source":"microsatellite instability","target":"leucovorin","id":"49388"},{"source":"microsatellite instability","target":"Spectrum","id":"49389"},{"source":"microsatellite instability","target":"oxaliplatin (IV)","id":"49390"},{"source":"colonic neoplasms","target":"pembrolizumab","id":"49391"},{"source":"colonic neoplasms","target":"bevacizumab","id":"49392"},{"source":"colonic neoplasms","target":"cetuximab","id":"49393"},{"source":"colonic neoplasms","target":"5-fluorouracil","id":"49394"},{"source":"colonic neoplasms","target":"irinotecan (IV)","id":"49395"},{"source":"colonic neoplasms","target":"leucovorin","id":"49396"},{"source":"colonic neoplasms","target":"leucovorin","id":"49397"},{"source":"colonic neoplasms","target":"Spectrum","id":"49398"},{"source":"colonic neoplasms","target":"oxaliplatin (IV)","id":"49399"},{"source":"carcinoma","target":"pembrolizumab","id":"49400"},{"source":"carcinoma","target":"bevacizumab","id":"49401"},{"source":"carcinoma","target":"cetuximab","id":"49402"},{"source":"carcinoma","target":"5-fluorouracil","id":"49403"},{"source":"carcinoma","target":"irinotecan (IV)","id":"49404"},{"source":"carcinoma","target":"leucovorin","id":"49405"},{"source":"carcinoma","target":"leucovorin","id":"49406"},{"source":"carcinoma","target":"Spectrum","id":"49407"},{"source":"carcinoma","target":"oxaliplatin (IV)","id":"49408"},{"source":"carcinoma","target":"pembrolizumab","id":"49409"},{"source":"carcinoma","target":"bevacizumab","id":"49410"},{"source":"carcinoma","target":"cetuximab","id":"49411"},{"source":"carcinoma","target":"5-fluorouracil","id":"49412"},{"source":"carcinoma","target":"irinotecan (IV)","id":"49413"},{"source":"carcinoma","target":"leucovorin","id":"49414"},{"source":"carcinoma","target":"leucovorin","id":"49415"},{"source":"carcinoma","target":"Spectrum","id":"49416"},{"source":"carcinoma","target":"oxaliplatin (IV)","id":"49417"},{"source":"anticancer","target":"pembrolizumab","id":"49418"},{"source":"anticancer","target":"bevacizumab","id":"49419"},{"source":"anticancer","target":"cetuximab","id":"49420"},{"source":"anticancer","target":"5-fluorouracil","id":"49421"},{"source":"anticancer","target":"irinotecan (IV)","id":"49422"},{"source":"anticancer","target":"leucovorin","id":"49423"},{"source":"anticancer","target":"leucovorin","id":"49424"},{"source":"anticancer","target":"Spectrum","id":"49425"},{"source":"anticancer","target":"oxaliplatin (IV)","id":"49426"},{"source":"colorectal neoplasms","target":"pembrolizumab","id":"49427"},{"source":"colorectal neoplasms","target":"bevacizumab","id":"49428"},{"source":"colorectal neoplasms","target":"cetuximab","id":"49429"},{"source":"colorectal neoplasms","target":"5-fluorouracil","id":"49430"},{"source":"colorectal neoplasms","target":"irinotecan (IV)","id":"49431"},{"source":"colorectal neoplasms","target":"leucovorin","id":"49432"},{"source":"colorectal neoplasms","target":"leucovorin","id":"49433"},{"source":"colorectal neoplasms","target":"Spectrum","id":"49434"},{"source":"colorectal neoplasms","target":"oxaliplatin (IV)","id":"49435"},{"source":"depression","target":"pembrolizumab","id":"49436"},{"source":"depression","target":"bevacizumab","id":"49437"},{"source":"depression","target":"cetuximab","id":"49438"},{"source":"depression","target":"5-fluorouracil","id":"49439"},{"source":"depression","target":"irinotecan (IV)","id":"49440"},{"source":"depression","target":"leucovorin","id":"49441"},{"source":"depression","target":"leucovorin","id":"49442"},{"source":"depression","target":"Spectrum","id":"49443"},{"source":"depression","target":"oxaliplatin (IV)","id":"49444"},{"source":"anemia","target":"pembrolizumab","id":"49445"},{"source":"anemia","target":"bevacizumab","id":"49446"},{"source":"anemia","target":"cetuximab","id":"49447"},{"source":"anemia","target":"5-fluorouracil","id":"49448"},{"source":"anemia","target":"irinotecan (IV)","id":"49449"},{"source":"anemia","target":"leucovorin","id":"49450"},{"source":"anemia","target":"leucovorin","id":"49451"},{"source":"anemia","target":"Spectrum","id":"49452"},{"source":"anemia","target":"oxaliplatin (IV)","id":"49453"},{"source":"EGFR antagonist","target":"UNK : Indication","id":"49454"},{"source":"EGFR antagonist","target":"colorectal neoplasms","id":"49455"},{"source":"EGFR antagonist","target":"antidepressant","id":"49456"},{"source":"EGFR antagonist","target":"antianaemic","id":"49457"},{"source":"EGFR antagonist","target":"microsatellite instability","id":"49458"},{"source":"EGFR antagonist","target":"colonic neoplasms","id":"49459"},{"source":"EGFR antagonist","target":"carcinoma","id":"49460"},{"source":"EGFR antagonist","target":"carcinoma","id":"49461"},{"source":"EGFR antagonist","target":"anticancer","id":"49462"},{"source":"EGFR antagonist","target":"colorectal neoplasms","id":"49463"},{"source":"EGFR antagonist","target":"depression","id":"49464"},{"source":"EGFR antagonist","target":"anemia","id":"49465"},{"source":"NA","target":"UNK : Indication","id":"49466"},{"source":"NA","target":"colorectal neoplasms","id":"49467"},{"source":"NA","target":"antidepressant","id":"49468"},{"source":"NA","target":"antianaemic","id":"49469"},{"source":"NA","target":"microsatellite instability","id":"49470"},{"source":"NA","target":"colonic neoplasms","id":"49471"},{"source":"NA","target":"carcinoma","id":"49472"},{"source":"NA","target":"carcinoma","id":"49473"},{"source":"NA","target":"anticancer","id":"49474"},{"source":"NA","target":"colorectal neoplasms","id":"49475"},{"source":"NA","target":"depression","id":"49476"},{"source":"NA","target":"anemia","id":"49477"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"49478"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"49479"},{"source":"Immune checkpoint inhibitor","target":"antidepressant","id":"49480"},{"source":"Immune checkpoint inhibitor","target":"antianaemic","id":"49481"},{"source":"Immune checkpoint inhibitor","target":"microsatellite instability","id":"49482"},{"source":"Immune checkpoint inhibitor","target":"colonic neoplasms","id":"49483"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49484"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49485"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"49486"},{"source":"Immune checkpoint inhibitor","target":"colorectal neoplasms","id":"49487"},{"source":"Immune checkpoint inhibitor","target":"depression","id":"49488"},{"source":"Immune checkpoint inhibitor","target":"anemia","id":"49489"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"49490"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"49491"},{"source":"Anticancer immunotherapy","target":"antidepressant","id":"49492"},{"source":"Anticancer immunotherapy","target":"antianaemic","id":"49493"},{"source":"Anticancer immunotherapy","target":"microsatellite instability","id":"49494"},{"source":"Anticancer immunotherapy","target":"colonic neoplasms","id":"49495"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49496"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49497"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"49498"},{"source":"Anticancer immunotherapy","target":"colorectal neoplasms","id":"49499"},{"source":"Anticancer immunotherapy","target":"depression","id":"49500"},{"source":"Anticancer immunotherapy","target":"anemia","id":"49501"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"49502"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"49503"},{"source":"CD19 antagonist","target":"antidepressant","id":"49504"},{"source":"CD19 antagonist","target":"antianaemic","id":"49505"},{"source":"CD19 antagonist","target":"microsatellite instability","id":"49506"},{"source":"CD19 antagonist","target":"colonic neoplasms","id":"49507"},{"source":"CD19 antagonist","target":"carcinoma","id":"49508"},{"source":"CD19 antagonist","target":"carcinoma","id":"49509"},{"source":"CD19 antagonist","target":"anticancer","id":"49510"},{"source":"CD19 antagonist","target":"colorectal neoplasms","id":"49511"},{"source":"CD19 antagonist","target":"depression","id":"49512"},{"source":"CD19 antagonist","target":"anemia","id":"49513"},{"source":"UPA","target":"UNK : Indication","id":"49514"},{"source":"UPA","target":"colorectal neoplasms","id":"49515"},{"source":"UPA","target":"antidepressant","id":"49516"},{"source":"UPA","target":"antianaemic","id":"49517"},{"source":"UPA","target":"microsatellite instability","id":"49518"},{"source":"UPA","target":"colonic neoplasms","id":"49519"},{"source":"UPA","target":"carcinoma","id":"49520"},{"source":"UPA","target":"carcinoma","id":"49521"},{"source":"UPA","target":"anticancer","id":"49522"},{"source":"UPA","target":"colorectal neoplasms","id":"49523"},{"source":"UPA","target":"depression","id":"49524"},{"source":"UPA","target":"anemia","id":"49525"},{"source":"NA","target":"UNK : Indication","id":"49526"},{"source":"NA","target":"colorectal neoplasms","id":"49527"},{"source":"NA","target":"antidepressant","id":"49528"},{"source":"NA","target":"antianaemic","id":"49529"},{"source":"NA","target":"microsatellite instability","id":"49530"},{"source":"NA","target":"colonic neoplasms","id":"49531"},{"source":"NA","target":"carcinoma","id":"49532"},{"source":"NA","target":"carcinoma","id":"49533"},{"source":"NA","target":"anticancer","id":"49534"},{"source":"NA","target":"colorectal neoplasms","id":"49535"},{"source":"NA","target":"depression","id":"49536"},{"source":"NA","target":"anemia","id":"49537"},{"source":"Angiogenesis inhibitor","target":"UNK : Indication","id":"49538"},{"source":"Angiogenesis inhibitor","target":"colorectal neoplasms","id":"49539"},{"source":"Angiogenesis inhibitor","target":"antidepressant","id":"49540"},{"source":"Angiogenesis inhibitor","target":"antianaemic","id":"49541"},{"source":"Angiogenesis inhibitor","target":"microsatellite instability","id":"49542"},{"source":"Angiogenesis inhibitor","target":"colonic neoplasms","id":"49543"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"49544"},{"source":"Angiogenesis inhibitor","target":"carcinoma","id":"49545"},{"source":"Angiogenesis inhibitor","target":"anticancer","id":"49546"},{"source":"Angiogenesis inhibitor","target":"colorectal neoplasms","id":"49547"},{"source":"Angiogenesis inhibitor","target":"depression","id":"49548"},{"source":"Angiogenesis inhibitor","target":"anemia","id":"49549"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"UNK : Indication","id":"49550"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"colorectal neoplasms","id":"49551"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"antidepressant","id":"49552"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"antianaemic","id":"49553"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"microsatellite instability","id":"49554"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"colonic neoplasms","id":"49555"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"49556"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"carcinoma","id":"49557"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anticancer","id":"49558"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"colorectal neoplasms","id":"49559"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"depression","id":"49560"},{"source":"Vascular endothelial growth factor (VEGF)receptor antagonist","target":"anemia","id":"49561"},{"source":"NA","target":"UNK : Indication","id":"49562"},{"source":"NA","target":"colorectal neoplasms","id":"49563"},{"source":"NA","target":"antidepressant","id":"49564"},{"source":"NA","target":"antianaemic","id":"49565"},{"source":"NA","target":"microsatellite instability","id":"49566"},{"source":"NA","target":"colonic neoplasms","id":"49567"},{"source":"NA","target":"carcinoma","id":"49568"},{"source":"NA","target":"carcinoma","id":"49569"},{"source":"NA","target":"anticancer","id":"49570"},{"source":"NA","target":"colorectal neoplasms","id":"49571"},{"source":"NA","target":"depression","id":"49572"},{"source":"NA","target":"anemia","id":"49573"},{"source":"NA","target":"UNK : Indication","id":"49574"},{"source":"NA","target":"colorectal neoplasms","id":"49575"},{"source":"NA","target":"antidepressant","id":"49576"},{"source":"NA","target":"antianaemic","id":"49577"},{"source":"NA","target":"microsatellite instability","id":"49578"},{"source":"NA","target":"colonic neoplasms","id":"49579"},{"source":"NA","target":"carcinoma","id":"49580"},{"source":"NA","target":"carcinoma","id":"49581"},{"source":"NA","target":"anticancer","id":"49582"},{"source":"NA","target":"colorectal neoplasms","id":"49583"},{"source":"NA","target":"depression","id":"49584"},{"source":"NA","target":"anemia","id":"49585"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"49586"},{"source":"Thymidylate synthase inhibitor","target":"colorectal neoplasms","id":"49587"},{"source":"Thymidylate synthase inhibitor","target":"antidepressant","id":"49588"},{"source":"Thymidylate synthase inhibitor","target":"antianaemic","id":"49589"},{"source":"Thymidylate synthase inhibitor","target":"microsatellite instability","id":"49590"},{"source":"Thymidylate synthase inhibitor","target":"colonic neoplasms","id":"49591"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"49592"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"49593"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"49594"},{"source":"Thymidylate synthase inhibitor","target":"colorectal neoplasms","id":"49595"},{"source":"Thymidylate synthase inhibitor","target":"depression","id":"49596"},{"source":"Thymidylate synthase inhibitor","target":"anemia","id":"49597"},{"source":"Oncology: Colorectal","target":"EGFR antagonist","id":"49598"},{"source":"Oncology: Colorectal","target":"NA","id":"49599"},{"source":"Oncology: Colorectal","target":"Immune checkpoint inhibitor","id":"49600"},{"source":"Oncology: Colorectal","target":"Anticancer immunotherapy","id":"49601"},{"source":"Oncology: Colorectal","target":"CD19 antagonist","id":"49602"},{"source":"Oncology: Colorectal","target":"UPA","id":"49603"},{"source":"Oncology: Colorectal","target":"NA","id":"49604"},{"source":"Oncology: Colorectal","target":"Angiogenesis inhibitor","id":"49605"},{"source":"Oncology: Colorectal","target":"Vascular endothelial growth factor (VEGF)receptor antagonist","id":"49606"},{"source":"Oncology: Colorectal","target":"NA","id":"49607"},{"source":"Oncology: Colorectal","target":"NA","id":"49608"},{"source":"Oncology: Colorectal","target":"Thymidylate synthase inhibitor","id":"49609"},{"source":"pembrolizumab","target":"Merck & Co.","id":"49610"},{"source":"cisplatin","target":"Merck & Co.","id":"49611"},{"source":"radiation therapy","target":"Merck & Co.","id":"49612"},{"source":"UNK : Indication","target":"pembrolizumab","id":"49613"},{"source":"UNK : Indication","target":"cisplatin","id":"49614"},{"source":"UNK : Indication","target":"radiation therapy","id":"49615"},{"source":"carcinoma","target":"pembrolizumab","id":"49616"},{"source":"carcinoma","target":"cisplatin","id":"49617"},{"source":"carcinoma","target":"radiation therapy","id":"49618"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"49619"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"49620"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"49621"},{"source":"residual tumor","target":"pembrolizumab","id":"49622"},{"source":"residual tumor","target":"cisplatin","id":"49623"},{"source":"residual tumor","target":"radiation therapy","id":"49624"},{"source":"skin neoplasms","target":"pembrolizumab","id":"49625"},{"source":"skin neoplasms","target":"cisplatin","id":"49626"},{"source":"skin neoplasms","target":"radiation therapy","id":"49627"},{"source":"carcinoma","target":"pembrolizumab","id":"49628"},{"source":"carcinoma","target":"cisplatin","id":"49629"},{"source":"carcinoma","target":"radiation therapy","id":"49630"},{"source":"squamous cell neoplasms","target":"pembrolizumab","id":"49631"},{"source":"squamous cell neoplasms","target":"cisplatin","id":"49632"},{"source":"squamous cell neoplasms","target":"radiation therapy","id":"49633"},{"source":"residual tumor","target":"pembrolizumab","id":"49634"},{"source":"residual tumor","target":"cisplatin","id":"49635"},{"source":"residual tumor","target":"radiation therapy","id":"49636"},{"source":"carcinoma","target":"pembrolizumab","id":"49637"},{"source":"carcinoma","target":"cisplatin","id":"49638"},{"source":"carcinoma","target":"radiation therapy","id":"49639"},{"source":"anticancer","target":"pembrolizumab","id":"49640"},{"source":"anticancer","target":"cisplatin","id":"49641"},{"source":"anticancer","target":"radiation therapy","id":"49642"},{"source":"carcinoma","target":"pembrolizumab","id":"49643"},{"source":"carcinoma","target":"cisplatin","id":"49644"},{"source":"carcinoma","target":"radiation therapy","id":"49645"},{"source":"head and neck neoplasms","target":"pembrolizumab","id":"49646"},{"source":"head and neck neoplasms","target":"cisplatin","id":"49647"},{"source":"head and neck neoplasms","target":"radiation therapy","id":"49648"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"49649"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49650"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"49651"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"49652"},{"source":"Immune checkpoint inhibitor","target":"skin neoplasms","id":"49653"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49654"},{"source":"Immune checkpoint inhibitor","target":"squamous cell neoplasms","id":"49655"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"49656"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49657"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"49658"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49659"},{"source":"Immune checkpoint inhibitor","target":"head and neck neoplasms","id":"49660"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"49661"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49662"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"49663"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"49664"},{"source":"Anticancer immunotherapy","target":"skin neoplasms","id":"49665"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49666"},{"source":"Anticancer immunotherapy","target":"squamous cell neoplasms","id":"49667"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"49668"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49669"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"49670"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49671"},{"source":"Anticancer immunotherapy","target":"head and neck neoplasms","id":"49672"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"49673"},{"source":"CD19 antagonist","target":"carcinoma","id":"49674"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"49675"},{"source":"CD19 antagonist","target":"residual tumor","id":"49676"},{"source":"CD19 antagonist","target":"skin neoplasms","id":"49677"},{"source":"CD19 antagonist","target":"carcinoma","id":"49678"},{"source":"CD19 antagonist","target":"squamous cell neoplasms","id":"49679"},{"source":"CD19 antagonist","target":"residual tumor","id":"49680"},{"source":"CD19 antagonist","target":"carcinoma","id":"49681"},{"source":"CD19 antagonist","target":"anticancer","id":"49682"},{"source":"CD19 antagonist","target":"carcinoma","id":"49683"},{"source":"CD19 antagonist","target":"head and neck neoplasms","id":"49684"},{"source":"UPA","target":"UNK : Indication","id":"49685"},{"source":"UPA","target":"carcinoma","id":"49686"},{"source":"UPA","target":"squamous cell neoplasms","id":"49687"},{"source":"UPA","target":"residual tumor","id":"49688"},{"source":"UPA","target":"skin neoplasms","id":"49689"},{"source":"UPA","target":"carcinoma","id":"49690"},{"source":"UPA","target":"squamous cell neoplasms","id":"49691"},{"source":"UPA","target":"residual tumor","id":"49692"},{"source":"UPA","target":"carcinoma","id":"49693"},{"source":"UPA","target":"anticancer","id":"49694"},{"source":"UPA","target":"carcinoma","id":"49695"},{"source":"UPA","target":"head and neck neoplasms","id":"49696"},{"source":"NA","target":"UNK : Indication","id":"49697"},{"source":"NA","target":"carcinoma","id":"49698"},{"source":"NA","target":"squamous cell neoplasms","id":"49699"},{"source":"NA","target":"residual tumor","id":"49700"},{"source":"NA","target":"skin neoplasms","id":"49701"},{"source":"NA","target":"carcinoma","id":"49702"},{"source":"NA","target":"squamous cell neoplasms","id":"49703"},{"source":"NA","target":"residual tumor","id":"49704"},{"source":"NA","target":"carcinoma","id":"49705"},{"source":"NA","target":"anticancer","id":"49706"},{"source":"NA","target":"carcinoma","id":"49707"},{"source":"NA","target":"head and neck neoplasms","id":"49708"},{"source":"NA","target":"UNK : Indication","id":"49709"},{"source":"NA","target":"carcinoma","id":"49710"},{"source":"NA","target":"squamous cell neoplasms","id":"49711"},{"source":"NA","target":"residual tumor","id":"49712"},{"source":"NA","target":"skin neoplasms","id":"49713"},{"source":"NA","target":"carcinoma","id":"49714"},{"source":"NA","target":"squamous cell neoplasms","id":"49715"},{"source":"NA","target":"residual tumor","id":"49716"},{"source":"NA","target":"carcinoma","id":"49717"},{"source":"NA","target":"anticancer","id":"49718"},{"source":"NA","target":"carcinoma","id":"49719"},{"source":"NA","target":"head and neck neoplasms","id":"49720"},{"source":"Oncology: Head/Neck","target":"Immune checkpoint inhibitor","id":"49721"},{"source":"Oncology: Head/Neck","target":"Anticancer immunotherapy","id":"49722"},{"source":"Oncology: Head/Neck","target":"CD19 antagonist","id":"49723"},{"source":"Oncology: Head/Neck","target":"UPA","id":"49724"},{"source":"Oncology: Head/Neck","target":"NA","id":"49725"},{"source":"Oncology: Head/Neck","target":"NA","id":"49726"},{"source":"pembrolizumab","target":"Merck & Co.","id":"49727"},{"source":"carboplatin","target":"Merck & Co.","id":"49728"},{"source":"cyclophosphamide","target":"Merck & Co.","id":"49729"},{"source":"unspecified","target":"Merck & Co.","id":"49730"},{"source":"pegylated liposomal doxorubicin","target":"Merck & Co.","id":"49731"},{"source":"epirubicin","target":"Merck & Co.","id":"49732"},{"source":"nab-paclitaxel (IV)","target":"Merck & Co.","id":"49733"},{"source":"surgical intervention","target":"Merck & Co.","id":"49734"},{"source":"UNK : Indication","target":"pembrolizumab","id":"49735"},{"source":"UNK : Indication","target":"carboplatin","id":"49736"},{"source":"UNK : Indication","target":"cyclophosphamide","id":"49737"},{"source":"UNK : Indication","target":"unspecified","id":"49738"},{"source":"UNK : Indication","target":"pegylated liposomal doxorubicin","id":"49739"},{"source":"UNK : Indication","target":"epirubicin","id":"49740"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"49741"},{"source":"UNK : Indication","target":"surgical intervention","id":"49742"},{"source":"anticancer","target":"pembrolizumab","id":"49743"},{"source":"anticancer","target":"carboplatin","id":"49744"},{"source":"anticancer","target":"cyclophosphamide","id":"49745"},{"source":"anticancer","target":"unspecified","id":"49746"},{"source":"anticancer","target":"pegylated liposomal doxorubicin","id":"49747"},{"source":"anticancer","target":"epirubicin","id":"49748"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"49749"},{"source":"anticancer","target":"surgical intervention","id":"49750"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"49751"},{"source":"triple-negative breast cancer","target":"carboplatin","id":"49752"},{"source":"triple-negative breast cancer","target":"cyclophosphamide","id":"49753"},{"source":"triple-negative breast cancer","target":"unspecified","id":"49754"},{"source":"triple-negative breast cancer","target":"pegylated liposomal doxorubicin","id":"49755"},{"source":"triple-negative breast cancer","target":"epirubicin","id":"49756"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"49757"},{"source":"triple-negative breast cancer","target":"surgical intervention","id":"49758"},{"source":"residual tumor","target":"pembrolizumab","id":"49759"},{"source":"residual tumor","target":"carboplatin","id":"49760"},{"source":"residual tumor","target":"cyclophosphamide","id":"49761"},{"source":"residual tumor","target":"unspecified","id":"49762"},{"source":"residual tumor","target":"pegylated liposomal doxorubicin","id":"49763"},{"source":"residual tumor","target":"epirubicin","id":"49764"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"49765"},{"source":"residual tumor","target":"surgical intervention","id":"49766"},{"source":"breast neoplasms","target":"pembrolizumab","id":"49767"},{"source":"breast neoplasms","target":"carboplatin","id":"49768"},{"source":"breast neoplasms","target":"cyclophosphamide","id":"49769"},{"source":"breast neoplasms","target":"unspecified","id":"49770"},{"source":"breast neoplasms","target":"pegylated liposomal doxorubicin","id":"49771"},{"source":"breast neoplasms","target":"epirubicin","id":"49772"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"49773"},{"source":"breast neoplasms","target":"surgical intervention","id":"49774"},{"source":"metastatic","target":"pembrolizumab","id":"49775"},{"source":"metastatic","target":"carboplatin","id":"49776"},{"source":"metastatic","target":"cyclophosphamide","id":"49777"},{"source":"metastatic","target":"unspecified","id":"49778"},{"source":"metastatic","target":"pegylated liposomal doxorubicin","id":"49779"},{"source":"metastatic","target":"epirubicin","id":"49780"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"49781"},{"source":"metastatic","target":"surgical intervention","id":"49782"},{"source":"carcinoma","target":"pembrolizumab","id":"49783"},{"source":"carcinoma","target":"carboplatin","id":"49784"},{"source":"carcinoma","target":"cyclophosphamide","id":"49785"},{"source":"carcinoma","target":"unspecified","id":"49786"},{"source":"carcinoma","target":"pegylated liposomal doxorubicin","id":"49787"},{"source":"carcinoma","target":"epirubicin","id":"49788"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"49789"},{"source":"carcinoma","target":"surgical intervention","id":"49790"},{"source":"breast neoplasms","target":"pembrolizumab","id":"49791"},{"source":"breast neoplasms","target":"carboplatin","id":"49792"},{"source":"breast neoplasms","target":"cyclophosphamide","id":"49793"},{"source":"breast neoplasms","target":"unspecified","id":"49794"},{"source":"breast neoplasms","target":"pegylated liposomal doxorubicin","id":"49795"},{"source":"breast neoplasms","target":"epirubicin","id":"49796"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"49797"},{"source":"breast neoplasms","target":"surgical intervention","id":"49798"},{"source":"neoplasm metastasis","target":"pembrolizumab","id":"49799"},{"source":"neoplasm metastasis","target":"carboplatin","id":"49800"},{"source":"neoplasm metastasis","target":"cyclophosphamide","id":"49801"},{"source":"neoplasm metastasis","target":"unspecified","id":"49802"},{"source":"neoplasm metastasis","target":"pegylated liposomal doxorubicin","id":"49803"},{"source":"neoplasm metastasis","target":"epirubicin","id":"49804"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"49805"},{"source":"neoplasm metastasis","target":"surgical intervention","id":"49806"},{"source":"anticancer","target":"pembrolizumab","id":"49807"},{"source":"anticancer","target":"carboplatin","id":"49808"},{"source":"anticancer","target":"cyclophosphamide","id":"49809"},{"source":"anticancer","target":"unspecified","id":"49810"},{"source":"anticancer","target":"pegylated liposomal doxorubicin","id":"49811"},{"source":"anticancer","target":"epirubicin","id":"49812"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"49813"},{"source":"anticancer","target":"surgical intervention","id":"49814"},{"source":"tnbc","target":"pembrolizumab","id":"49815"},{"source":"tnbc","target":"carboplatin","id":"49816"},{"source":"tnbc","target":"cyclophosphamide","id":"49817"},{"source":"tnbc","target":"unspecified","id":"49818"},{"source":"tnbc","target":"pegylated liposomal doxorubicin","id":"49819"},{"source":"tnbc","target":"epirubicin","id":"49820"},{"source":"tnbc","target":"nab-paclitaxel (IV)","id":"49821"},{"source":"tnbc","target":"surgical intervention","id":"49822"},{"source":"triple-negative breast cancer","target":"pembrolizumab","id":"49823"},{"source":"triple-negative breast cancer","target":"carboplatin","id":"49824"},{"source":"triple-negative breast cancer","target":"cyclophosphamide","id":"49825"},{"source":"triple-negative breast cancer","target":"unspecified","id":"49826"},{"source":"triple-negative breast cancer","target":"pegylated liposomal doxorubicin","id":"49827"},{"source":"triple-negative breast cancer","target":"epirubicin","id":"49828"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"49829"},{"source":"triple-negative breast cancer","target":"surgical intervention","id":"49830"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"49831"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"49832"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"49833"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"49834"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"49835"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"49836"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"49837"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"49838"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"49839"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"49840"},{"source":"Immune checkpoint inhibitor","target":"tnbc","id":"49841"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"49842"},{"source":"NA","target":"UNK : Indication","id":"49843"},{"source":"NA","target":"anticancer","id":"49844"},{"source":"NA","target":"triple-negative breast cancer","id":"49845"},{"source":"NA","target":"residual tumor","id":"49846"},{"source":"NA","target":"breast neoplasms","id":"49847"},{"source":"NA","target":"metastatic","id":"49848"},{"source":"NA","target":"carcinoma","id":"49849"},{"source":"NA","target":"breast neoplasms","id":"49850"},{"source":"NA","target":"neoplasm metastasis","id":"49851"},{"source":"NA","target":"anticancer","id":"49852"},{"source":"NA","target":"tnbc","id":"49853"},{"source":"NA","target":"triple-negative breast cancer","id":"49854"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"49855"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"49856"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"49857"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"49858"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"49859"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"49860"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"49861"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"49862"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"49863"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"49864"},{"source":"Anticancer immunotherapy","target":"tnbc","id":"49865"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"49866"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"49867"},{"source":"CD19 antagonist","target":"anticancer","id":"49868"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"49869"},{"source":"CD19 antagonist","target":"residual tumor","id":"49870"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"49871"},{"source":"CD19 antagonist","target":"metastatic","id":"49872"},{"source":"CD19 antagonist","target":"carcinoma","id":"49873"},{"source":"CD19 antagonist","target":"breast neoplasms","id":"49874"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"49875"},{"source":"CD19 antagonist","target":"anticancer","id":"49876"},{"source":"CD19 antagonist","target":"tnbc","id":"49877"},{"source":"CD19 antagonist","target":"triple-negative breast cancer","id":"49878"},{"source":"NA","target":"UNK : Indication","id":"49879"},{"source":"NA","target":"anticancer","id":"49880"},{"source":"NA","target":"triple-negative breast cancer","id":"49881"},{"source":"NA","target":"residual tumor","id":"49882"},{"source":"NA","target":"breast neoplasms","id":"49883"},{"source":"NA","target":"metastatic","id":"49884"},{"source":"NA","target":"carcinoma","id":"49885"},{"source":"NA","target":"breast neoplasms","id":"49886"},{"source":"NA","target":"neoplasm metastasis","id":"49887"},{"source":"NA","target":"anticancer","id":"49888"},{"source":"NA","target":"tnbc","id":"49889"},{"source":"NA","target":"triple-negative breast cancer","id":"49890"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"49891"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"49892"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"49893"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"49894"},{"source":"Beta tubulin antagonist","target":"breast neoplasms","id":"49895"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"49896"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"49897"},{"source":"Beta tubulin antagonist","target":"breast neoplasms","id":"49898"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"49899"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"49900"},{"source":"Beta tubulin antagonist","target":"tnbc","id":"49901"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"49902"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"49903"},{"source":"Microtubule stimulant","target":"anticancer","id":"49904"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"49905"},{"source":"Microtubule stimulant","target":"residual tumor","id":"49906"},{"source":"Microtubule stimulant","target":"breast neoplasms","id":"49907"},{"source":"Microtubule stimulant","target":"metastatic","id":"49908"},{"source":"Microtubule stimulant","target":"carcinoma","id":"49909"},{"source":"Microtubule stimulant","target":"breast neoplasms","id":"49910"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"49911"},{"source":"Microtubule stimulant","target":"anticancer","id":"49912"},{"source":"Microtubule stimulant","target":"tnbc","id":"49913"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"49914"},{"source":"NA","target":"UNK : Indication","id":"49915"},{"source":"NA","target":"anticancer","id":"49916"},{"source":"NA","target":"triple-negative breast cancer","id":"49917"},{"source":"NA","target":"residual tumor","id":"49918"},{"source":"NA","target":"breast neoplasms","id":"49919"},{"source":"NA","target":"metastatic","id":"49920"},{"source":"NA","target":"carcinoma","id":"49921"},{"source":"NA","target":"breast neoplasms","id":"49922"},{"source":"NA","target":"neoplasm metastasis","id":"49923"},{"source":"NA","target":"anticancer","id":"49924"},{"source":"NA","target":"tnbc","id":"49925"},{"source":"NA","target":"triple-negative breast cancer","id":"49926"},{"source":"NA","target":"UNK : Indication","id":"49927"},{"source":"NA","target":"anticancer","id":"49928"},{"source":"NA","target":"triple-negative breast cancer","id":"49929"},{"source":"NA","target":"residual tumor","id":"49930"},{"source":"NA","target":"breast neoplasms","id":"49931"},{"source":"NA","target":"metastatic","id":"49932"},{"source":"NA","target":"carcinoma","id":"49933"},{"source":"NA","target":"breast neoplasms","id":"49934"},{"source":"NA","target":"neoplasm metastasis","id":"49935"},{"source":"NA","target":"anticancer","id":"49936"},{"source":"NA","target":"tnbc","id":"49937"},{"source":"NA","target":"triple-negative breast cancer","id":"49938"},{"source":"NA","target":"UNK : Indication","id":"49939"},{"source":"NA","target":"anticancer","id":"49940"},{"source":"NA","target":"triple-negative breast cancer","id":"49941"},{"source":"NA","target":"residual tumor","id":"49942"},{"source":"NA","target":"breast neoplasms","id":"49943"},{"source":"NA","target":"metastatic","id":"49944"},{"source":"NA","target":"carcinoma","id":"49945"},{"source":"NA","target":"breast neoplasms","id":"49946"},{"source":"NA","target":"neoplasm metastasis","id":"49947"},{"source":"NA","target":"anticancer","id":"49948"},{"source":"NA","target":"tnbc","id":"49949"},{"source":"NA","target":"triple-negative breast cancer","id":"49950"},{"source":"Taxane","target":"UNK : Indication","id":"49951"},{"source":"Taxane","target":"anticancer","id":"49952"},{"source":"Taxane","target":"triple-negative breast cancer","id":"49953"},{"source":"Taxane","target":"residual tumor","id":"49954"},{"source":"Taxane","target":"breast neoplasms","id":"49955"},{"source":"Taxane","target":"metastatic","id":"49956"},{"source":"Taxane","target":"carcinoma","id":"49957"},{"source":"Taxane","target":"breast neoplasms","id":"49958"},{"source":"Taxane","target":"neoplasm metastasis","id":"49959"},{"source":"Taxane","target":"anticancer","id":"49960"},{"source":"Taxane","target":"tnbc","id":"49961"},{"source":"Taxane","target":"triple-negative breast cancer","id":"49962"},{"source":"Radical formation stimulant","target":"UNK : Indication","id":"49963"},{"source":"Radical formation stimulant","target":"anticancer","id":"49964"},{"source":"Radical formation stimulant","target":"triple-negative breast cancer","id":"49965"},{"source":"Radical formation stimulant","target":"residual tumor","id":"49966"},{"source":"Radical formation stimulant","target":"breast neoplasms","id":"49967"},{"source":"Radical formation stimulant","target":"metastatic","id":"49968"},{"source":"Radical formation stimulant","target":"carcinoma","id":"49969"},{"source":"Radical formation stimulant","target":"breast neoplasms","id":"49970"},{"source":"Radical formation stimulant","target":"neoplasm metastasis","id":"49971"},{"source":"Radical formation stimulant","target":"anticancer","id":"49972"},{"source":"Radical formation stimulant","target":"tnbc","id":"49973"},{"source":"Radical formation stimulant","target":"triple-negative breast cancer","id":"49974"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"49975"},{"source":"Oncology: Breast","target":"NA","id":"49976"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"49977"},{"source":"Oncology: Breast","target":"CD19 antagonist","id":"49978"},{"source":"Oncology: Breast","target":"NA","id":"49979"},{"source":"Oncology: Breast","target":"Beta tubulin antagonist","id":"49980"},{"source":"Oncology: Breast","target":"Microtubule stimulant","id":"49981"},{"source":"Oncology: Breast","target":"NA","id":"49982"},{"source":"Oncology: Breast","target":"NA","id":"49983"},{"source":"Oncology: Breast","target":"NA","id":"49984"},{"source":"Oncology: Breast","target":"Taxane","id":"49985"},{"source":"Oncology: Breast","target":"Radical formation stimulant","id":"49986"},{"source":"Ad5/3-D24-RGD cancer therapy","target":"Targovax {Oncos Therapeutics}","id":"49987"},{"source":"Ad5/3-D24-RGD cancer therapy","target":"Theradex Systems","id":"49988"},{"source":"Oncos Therapeutics (u)","target":"Targovax {Oncos Therapeutics}","id":"49989"},{"source":"Oncos Therapeutics (u)","target":"Theradex Systems","id":"49990"},{"source":"cisplatin","target":"Targovax {Oncos Therapeutics}","id":"49991"},{"source":"cisplatin","target":"Theradex Systems","id":"49992"},{"source":"cyclophosphamide","target":"Targovax {Oncos Therapeutics}","id":"49993"},{"source":"cyclophosphamide","target":"Theradex Systems","id":"49994"},{"source":"Baxter","target":"Targovax {Oncos Therapeutics}","id":"49995"},{"source":"Baxter","target":"Theradex Systems","id":"49996"},{"source":"pemetrexed disodium","target":"Targovax {Oncos Therapeutics}","id":"49997"},{"source":"pemetrexed disodium","target":"Theradex Systems","id":"49998"},{"source":"psoriasis","target":"Ad5/3-D24-RGD cancer therapy","id":"49999"},{"source":"psoriasis","target":"Oncos Therapeutics (u)","id":"50000"},{"source":"psoriasis","target":"cisplatin","id":"50001"},{"source":"psoriasis","target":"cyclophosphamide","id":"50002"},{"source":"psoriasis","target":"Baxter","id":"50003"},{"source":"psoriasis","target":"pemetrexed disodium","id":"50004"},{"source":"UNK : Indication","target":"Ad5/3-D24-RGD cancer therapy","id":"50005"},{"source":"UNK : Indication","target":"Oncos Therapeutics (u)","id":"50006"},{"source":"UNK : Indication","target":"cisplatin","id":"50007"},{"source":"UNK : Indication","target":"cyclophosphamide","id":"50008"},{"source":"UNK : Indication","target":"Baxter","id":"50009"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"50010"},{"source":"residual tumor","target":"Ad5/3-D24-RGD cancer therapy","id":"50011"},{"source":"residual tumor","target":"Oncos Therapeutics (u)","id":"50012"},{"source":"residual tumor","target":"cisplatin","id":"50013"},{"source":"residual tumor","target":"cyclophosphamide","id":"50014"},{"source":"residual tumor","target":"Baxter","id":"50015"},{"source":"residual tumor","target":"pemetrexed disodium","id":"50016"},{"source":"skin neoplasms","target":"Ad5/3-D24-RGD cancer therapy","id":"50017"},{"source":"skin neoplasms","target":"Oncos Therapeutics (u)","id":"50018"},{"source":"skin neoplasms","target":"cisplatin","id":"50019"},{"source":"skin neoplasms","target":"cyclophosphamide","id":"50020"},{"source":"skin neoplasms","target":"Baxter","id":"50021"},{"source":"skin neoplasms","target":"pemetrexed disodium","id":"50022"},{"source":"mesothelial","target":"Ad5/3-D24-RGD cancer therapy","id":"50023"},{"source":"mesothelial","target":"Oncos Therapeutics (u)","id":"50024"},{"source":"mesothelial","target":"cisplatin","id":"50025"},{"source":"mesothelial","target":"cyclophosphamide","id":"50026"},{"source":"mesothelial","target":"Baxter","id":"50027"},{"source":"mesothelial","target":"pemetrexed disodium","id":"50028"},{"source":"anticancer","target":"Ad5/3-D24-RGD cancer therapy","id":"50029"},{"source":"anticancer","target":"Oncos Therapeutics (u)","id":"50030"},{"source":"anticancer","target":"cisplatin","id":"50031"},{"source":"anticancer","target":"cyclophosphamide","id":"50032"},{"source":"anticancer","target":"Baxter","id":"50033"},{"source":"anticancer","target":"pemetrexed disodium","id":"50034"},{"source":"solid tumors","target":"Ad5/3-D24-RGD cancer therapy","id":"50035"},{"source":"solid tumors","target":"Oncos Therapeutics (u)","id":"50036"},{"source":"solid tumors","target":"cisplatin","id":"50037"},{"source":"solid tumors","target":"cyclophosphamide","id":"50038"},{"source":"solid tumors","target":"Baxter","id":"50039"},{"source":"solid tumors","target":"pemetrexed disodium","id":"50040"},{"source":"mesothelial","target":"Ad5/3-D24-RGD cancer therapy","id":"50041"},{"source":"mesothelial","target":"Oncos Therapeutics (u)","id":"50042"},{"source":"mesothelial","target":"cisplatin","id":"50043"},{"source":"mesothelial","target":"cyclophosphamide","id":"50044"},{"source":"mesothelial","target":"Baxter","id":"50045"},{"source":"mesothelial","target":"pemetrexed disodium","id":"50046"},{"source":"mesothelial","target":"Ad5/3-D24-RGD cancer therapy","id":"50047"},{"source":"mesothelial","target":"Oncos Therapeutics (u)","id":"50048"},{"source":"mesothelial","target":"cisplatin","id":"50049"},{"source":"mesothelial","target":"cyclophosphamide","id":"50050"},{"source":"mesothelial","target":"Baxter","id":"50051"},{"source":"mesothelial","target":"pemetrexed disodium","id":"50052"},{"source":"arthritis","target":"Ad5/3-D24-RGD cancer therapy","id":"50053"},{"source":"arthritis","target":"Oncos Therapeutics (u)","id":"50054"},{"source":"arthritis","target":"cisplatin","id":"50055"},{"source":"arthritis","target":"cyclophosphamide","id":"50056"},{"source":"arthritis","target":"Baxter","id":"50057"},{"source":"arthritis","target":"pemetrexed disodium","id":"50058"},{"source":"antiarthritic","target":"Ad5/3-D24-RGD cancer therapy","id":"50059"},{"source":"antiarthritic","target":"Oncos Therapeutics (u)","id":"50060"},{"source":"antiarthritic","target":"cisplatin","id":"50061"},{"source":"antiarthritic","target":"cyclophosphamide","id":"50062"},{"source":"antiarthritic","target":"Baxter","id":"50063"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"50064"},{"source":"pleural mesothelioma","target":"Ad5/3-D24-RGD cancer therapy","id":"50065"},{"source":"pleural mesothelioma","target":"Oncos Therapeutics (u)","id":"50066"},{"source":"pleural mesothelioma","target":"cisplatin","id":"50067"},{"source":"pleural mesothelioma","target":"cyclophosphamide","id":"50068"},{"source":"pleural mesothelioma","target":"Baxter","id":"50069"},{"source":"pleural mesothelioma","target":"pemetrexed disodium","id":"50070"},{"source":"carcinoma","target":"Ad5/3-D24-RGD cancer therapy","id":"50071"},{"source":"carcinoma","target":"Oncos Therapeutics (u)","id":"50072"},{"source":"carcinoma","target":"cisplatin","id":"50073"},{"source":"carcinoma","target":"cyclophosphamide","id":"50074"},{"source":"carcinoma","target":"Baxter","id":"50075"},{"source":"carcinoma","target":"pemetrexed disodium","id":"50076"},{"source":"psoriasis","target":"Ad5/3-D24-RGD cancer therapy","id":"50077"},{"source":"psoriasis","target":"Oncos Therapeutics (u)","id":"50078"},{"source":"psoriasis","target":"cisplatin","id":"50079"},{"source":"psoriasis","target":"cyclophosphamide","id":"50080"},{"source":"psoriasis","target":"Baxter","id":"50081"},{"source":"psoriasis","target":"pemetrexed disodium","id":"50082"},{"source":"anticancer","target":"Ad5/3-D24-RGD cancer therapy","id":"50083"},{"source":"anticancer","target":"Oncos Therapeutics (u)","id":"50084"},{"source":"anticancer","target":"cisplatin","id":"50085"},{"source":"anticancer","target":"cyclophosphamide","id":"50086"},{"source":"anticancer","target":"Baxter","id":"50087"},{"source":"anticancer","target":"pemetrexed disodium","id":"50088"},{"source":"solid tumors","target":"Ad5/3-D24-RGD cancer therapy","id":"50089"},{"source":"solid tumors","target":"Oncos Therapeutics (u)","id":"50090"},{"source":"solid tumors","target":"cisplatin","id":"50091"},{"source":"solid tumors","target":"cyclophosphamide","id":"50092"},{"source":"solid tumors","target":"Baxter","id":"50093"},{"source":"solid tumors","target":"pemetrexed disodium","id":"50094"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"50095"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"50096"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"50097"},{"source":"Dihydrofolate reductase inhibitor","target":"skin neoplasms","id":"50098"},{"source":"Dihydrofolate reductase inhibitor","target":"mesothelial","id":"50099"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"50100"},{"source":"Dihydrofolate reductase inhibitor","target":"solid tumors","id":"50101"},{"source":"Dihydrofolate reductase inhibitor","target":"mesothelial","id":"50102"},{"source":"Dihydrofolate reductase inhibitor","target":"mesothelial","id":"50103"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"50104"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"50105"},{"source":"Dihydrofolate reductase inhibitor","target":"pleural mesothelioma","id":"50106"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"50107"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"50108"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"50109"},{"source":"Dihydrofolate reductase inhibitor","target":"solid tumors","id":"50110"},{"source":"NA","target":"psoriasis","id":"50111"},{"source":"NA","target":"UNK : Indication","id":"50112"},{"source":"NA","target":"residual tumor","id":"50113"},{"source":"NA","target":"skin neoplasms","id":"50114"},{"source":"NA","target":"mesothelial","id":"50115"},{"source":"NA","target":"anticancer","id":"50116"},{"source":"NA","target":"solid tumors","id":"50117"},{"source":"NA","target":"mesothelial","id":"50118"},{"source":"NA","target":"mesothelial","id":"50119"},{"source":"NA","target":"arthritis","id":"50120"},{"source":"NA","target":"antiarthritic","id":"50121"},{"source":"NA","target":"pleural mesothelioma","id":"50122"},{"source":"NA","target":"carcinoma","id":"50123"},{"source":"NA","target":"psoriasis","id":"50124"},{"source":"NA","target":"anticancer","id":"50125"},{"source":"NA","target":"solid tumors","id":"50126"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"psoriasis","id":"50127"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"UNK : Indication","id":"50128"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"residual tumor","id":"50129"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"skin neoplasms","id":"50130"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"mesothelial","id":"50131"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"50132"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"solid tumors","id":"50133"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"mesothelial","id":"50134"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"mesothelial","id":"50135"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"arthritis","id":"50136"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"antiarthritic","id":"50137"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"pleural mesothelioma","id":"50138"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"carcinoma","id":"50139"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"psoriasis","id":"50140"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"anticancer","id":"50141"},{"source":"Granulocyte macrophage colony stimulating factor agonist","target":"solid tumors","id":"50142"},{"source":"NA","target":"psoriasis","id":"50143"},{"source":"NA","target":"UNK : Indication","id":"50144"},{"source":"NA","target":"residual tumor","id":"50145"},{"source":"NA","target":"skin neoplasms","id":"50146"},{"source":"NA","target":"mesothelial","id":"50147"},{"source":"NA","target":"anticancer","id":"50148"},{"source":"NA","target":"solid tumors","id":"50149"},{"source":"NA","target":"mesothelial","id":"50150"},{"source":"NA","target":"mesothelial","id":"50151"},{"source":"NA","target":"arthritis","id":"50152"},{"source":"NA","target":"antiarthritic","id":"50153"},{"source":"NA","target":"pleural mesothelioma","id":"50154"},{"source":"NA","target":"carcinoma","id":"50155"},{"source":"NA","target":"psoriasis","id":"50156"},{"source":"NA","target":"anticancer","id":"50157"},{"source":"NA","target":"solid tumors","id":"50158"},{"source":"NA","target":"psoriasis","id":"50159"},{"source":"NA","target":"UNK : Indication","id":"50160"},{"source":"NA","target":"residual tumor","id":"50161"},{"source":"NA","target":"skin neoplasms","id":"50162"},{"source":"NA","target":"mesothelial","id":"50163"},{"source":"NA","target":"anticancer","id":"50164"},{"source":"NA","target":"solid tumors","id":"50165"},{"source":"NA","target":"mesothelial","id":"50166"},{"source":"NA","target":"mesothelial","id":"50167"},{"source":"NA","target":"arthritis","id":"50168"},{"source":"NA","target":"antiarthritic","id":"50169"},{"source":"NA","target":"pleural mesothelioma","id":"50170"},{"source":"NA","target":"carcinoma","id":"50171"},{"source":"NA","target":"psoriasis","id":"50172"},{"source":"NA","target":"anticancer","id":"50173"},{"source":"NA","target":"solid tumors","id":"50174"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"50175"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"50176"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"50177"},{"source":"Thymidylate synthase inhibitor","target":"skin neoplasms","id":"50178"},{"source":"Thymidylate synthase inhibitor","target":"mesothelial","id":"50179"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"50180"},{"source":"Thymidylate synthase inhibitor","target":"solid tumors","id":"50181"},{"source":"Thymidylate synthase inhibitor","target":"mesothelial","id":"50182"},{"source":"Thymidylate synthase inhibitor","target":"mesothelial","id":"50183"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"50184"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"50185"},{"source":"Thymidylate synthase inhibitor","target":"pleural mesothelioma","id":"50186"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"50187"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"50188"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"50189"},{"source":"Thymidylate synthase inhibitor","target":"solid tumors","id":"50190"},{"source":"Oncology: Mesothelioma","target":"Dihydrofolate reductase inhibitor","id":"50191"},{"source":"Oncology: Mesothelioma","target":"NA","id":"50192"},{"source":"Oncology: Mesothelioma","target":"Granulocyte macrophage colony stimulating factor agonist","id":"50193"},{"source":"Oncology: Mesothelioma","target":"NA","id":"50194"},{"source":"Oncology: Mesothelioma","target":"NA","id":"50195"},{"source":"Oncology: Mesothelioma","target":"Thymidylate synthase inhibitor","id":"50196"},{"source":"ipilimumab","target":"(Other Hospital/Academic/Medical Center)","id":"50197"},{"source":"ipilimumab","target":"Bristol-Myers Squibb","id":"50198"},{"source":"ipilimumab","target":"Ono Pharmaceutical","id":"50199"},{"source":"nivolumab (a)","target":"(Other Hospital/Academic/Medical Center)","id":"50200"},{"source":"nivolumab (a)","target":"Bristol-Myers Squibb","id":"50201"},{"source":"nivolumab (a)","target":"Ono Pharmaceutical","id":"50202"},{"source":"carboplatin","target":"(Other Hospital/Academic/Medical Center)","id":"50203"},{"source":"carboplatin","target":"Bristol-Myers Squibb","id":"50204"},{"source":"carboplatin","target":"Ono Pharmaceutical","id":"50205"},{"source":"cisplatin","target":"(Other Hospital/Academic/Medical Center)","id":"50206"},{"source":"cisplatin","target":"Bristol-Myers Squibb","id":"50207"},{"source":"cisplatin","target":"Ono Pharmaceutical","id":"50208"},{"source":"gemcitabine hydrochloride","target":"(Other Hospital/Academic/Medical Center)","id":"50209"},{"source":"gemcitabine hydrochloride","target":"Bristol-Myers Squibb","id":"50210"},{"source":"gemcitabine hydrochloride","target":"Ono Pharmaceutical","id":"50211"},{"source":"nivolumab (a)","target":"(Other Hospital/Academic/Medical Center)","id":"50212"},{"source":"nivolumab (a)","target":"Bristol-Myers Squibb","id":"50213"},{"source":"nivolumab (a)","target":"Ono Pharmaceutical","id":"50214"},{"source":"companion diagnostic","target":"(Other Hospital/Academic/Medical Center)","id":"50215"},{"source":"companion diagnostic","target":"Bristol-Myers Squibb","id":"50216"},{"source":"companion diagnostic","target":"Ono Pharmaceutical","id":"50217"},{"source":"Dako","target":"(Other Hospital/Academic/Medical Center)","id":"50218"},{"source":"Dako","target":"Bristol-Myers Squibb","id":"50219"},{"source":"Dako","target":"Ono Pharmaceutical","id":"50220"},{"source":"nab-paclitaxel (IV)","target":"(Other Hospital/Academic/Medical Center)","id":"50221"},{"source":"nab-paclitaxel (IV)","target":"Bristol-Myers Squibb","id":"50222"},{"source":"nab-paclitaxel (IV)","target":"Ono Pharmaceutical","id":"50223"},{"source":"pemetrexed disodium","target":"(Other Hospital/Academic/Medical Center)","id":"50224"},{"source":"pemetrexed disodium","target":"Bristol-Myers Squibb","id":"50225"},{"source":"pemetrexed disodium","target":"Ono Pharmaceutical","id":"50226"},{"source":"UNK : Indication","target":"ipilimumab","id":"50227"},{"source":"UNK : Indication","target":"nivolumab (a)","id":"50228"},{"source":"UNK : Indication","target":"carboplatin","id":"50229"},{"source":"UNK : Indication","target":"cisplatin","id":"50230"},{"source":"UNK : Indication","target":"gemcitabine hydrochloride","id":"50231"},{"source":"UNK : Indication","target":"nivolumab (a)","id":"50232"},{"source":"UNK : Indication","target":"companion diagnostic","id":"50233"},{"source":"UNK : Indication","target":"Dako","id":"50234"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"50235"},{"source":"UNK : Indication","target":"pemetrexed disodium","id":"50236"},{"source":"anti-hiv","target":"ipilimumab","id":"50237"},{"source":"anti-hiv","target":"nivolumab (a)","id":"50238"},{"source":"anti-hiv","target":"carboplatin","id":"50239"},{"source":"anti-hiv","target":"cisplatin","id":"50240"},{"source":"anti-hiv","target":"gemcitabine hydrochloride","id":"50241"},{"source":"anti-hiv","target":"nivolumab (a)","id":"50242"},{"source":"anti-hiv","target":"companion diagnostic","id":"50243"},{"source":"anti-hiv","target":"Dako","id":"50244"},{"source":"anti-hiv","target":"nab-paclitaxel (IV)","id":"50245"},{"source":"anti-hiv","target":"pemetrexed disodium","id":"50246"},{"source":"antiarthritic","target":"ipilimumab","id":"50247"},{"source":"antiarthritic","target":"nivolumab (a)","id":"50248"},{"source":"antiarthritic","target":"carboplatin","id":"50249"},{"source":"antiarthritic","target":"cisplatin","id":"50250"},{"source":"antiarthritic","target":"gemcitabine hydrochloride","id":"50251"},{"source":"antiarthritic","target":"nivolumab (a)","id":"50252"},{"source":"antiarthritic","target":"companion diagnostic","id":"50253"},{"source":"antiarthritic","target":"Dako","id":"50254"},{"source":"antiarthritic","target":"nab-paclitaxel (IV)","id":"50255"},{"source":"antiarthritic","target":"pemetrexed disodium","id":"50256"},{"source":"azoospermia","target":"ipilimumab","id":"50257"},{"source":"azoospermia","target":"nivolumab (a)","id":"50258"},{"source":"azoospermia","target":"carboplatin","id":"50259"},{"source":"azoospermia","target":"cisplatin","id":"50260"},{"source":"azoospermia","target":"gemcitabine hydrochloride","id":"50261"},{"source":"azoospermia","target":"nivolumab (a)","id":"50262"},{"source":"azoospermia","target":"companion diagnostic","id":"50263"},{"source":"azoospermia","target":"Dako","id":"50264"},{"source":"azoospermia","target":"nab-paclitaxel (IV)","id":"50265"},{"source":"azoospermia","target":"pemetrexed disodium","id":"50266"},{"source":"non-small-cell lung","target":"ipilimumab","id":"50267"},{"source":"non-small-cell lung","target":"nivolumab (a)","id":"50268"},{"source":"non-small-cell lung","target":"carboplatin","id":"50269"},{"source":"non-small-cell lung","target":"cisplatin","id":"50270"},{"source":"non-small-cell lung","target":"gemcitabine hydrochloride","id":"50271"},{"source":"non-small-cell lung","target":"nivolumab (a)","id":"50272"},{"source":"non-small-cell lung","target":"companion diagnostic","id":"50273"},{"source":"non-small-cell lung","target":"Dako","id":"50274"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"50275"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"50276"},{"source":"psoriasis","target":"ipilimumab","id":"50277"},{"source":"psoriasis","target":"nivolumab (a)","id":"50278"},{"source":"psoriasis","target":"carboplatin","id":"50279"},{"source":"psoriasis","target":"cisplatin","id":"50280"},{"source":"psoriasis","target":"gemcitabine hydrochloride","id":"50281"},{"source":"psoriasis","target":"nivolumab (a)","id":"50282"},{"source":"psoriasis","target":"companion diagnostic","id":"50283"},{"source":"psoriasis","target":"Dako","id":"50284"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"50285"},{"source":"psoriasis","target":"pemetrexed disodium","id":"50286"},{"source":"gilbert disease","target":"ipilimumab","id":"50287"},{"source":"gilbert disease","target":"nivolumab (a)","id":"50288"},{"source":"gilbert disease","target":"carboplatin","id":"50289"},{"source":"gilbert disease","target":"cisplatin","id":"50290"},{"source":"gilbert disease","target":"gemcitabine hydrochloride","id":"50291"},{"source":"gilbert disease","target":"nivolumab (a)","id":"50292"},{"source":"gilbert disease","target":"companion diagnostic","id":"50293"},{"source":"gilbert disease","target":"Dako","id":"50294"},{"source":"gilbert disease","target":"nab-paclitaxel (IV)","id":"50295"},{"source":"gilbert disease","target":"pemetrexed disodium","id":"50296"},{"source":"hiv infections","target":"ipilimumab","id":"50297"},{"source":"hiv infections","target":"nivolumab (a)","id":"50298"},{"source":"hiv infections","target":"carboplatin","id":"50299"},{"source":"hiv infections","target":"cisplatin","id":"50300"},{"source":"hiv infections","target":"gemcitabine hydrochloride","id":"50301"},{"source":"hiv infections","target":"nivolumab (a)","id":"50302"},{"source":"hiv infections","target":"companion diagnostic","id":"50303"},{"source":"hiv infections","target":"Dako","id":"50304"},{"source":"hiv infections","target":"nab-paclitaxel (IV)","id":"50305"},{"source":"hiv infections","target":"pemetrexed disodium","id":"50306"},{"source":"liver neoplasms","target":"ipilimumab","id":"50307"},{"source":"liver neoplasms","target":"nivolumab (a)","id":"50308"},{"source":"liver neoplasms","target":"carboplatin","id":"50309"},{"source":"liver neoplasms","target":"cisplatin","id":"50310"},{"source":"liver neoplasms","target":"gemcitabine hydrochloride","id":"50311"},{"source":"liver neoplasms","target":"nivolumab (a)","id":"50312"},{"source":"liver neoplasms","target":"companion diagnostic","id":"50313"},{"source":"liver neoplasms","target":"Dako","id":"50314"},{"source":"liver neoplasms","target":"nab-paclitaxel (IV)","id":"50315"},{"source":"liver neoplasms","target":"pemetrexed disodium","id":"50316"},{"source":"non-small-cell lung","target":"ipilimumab","id":"50317"},{"source":"non-small-cell lung","target":"nivolumab (a)","id":"50318"},{"source":"non-small-cell lung","target":"carboplatin","id":"50319"},{"source":"non-small-cell lung","target":"cisplatin","id":"50320"},{"source":"non-small-cell lung","target":"gemcitabine hydrochloride","id":"50321"},{"source":"non-small-cell lung","target":"nivolumab (a)","id":"50322"},{"source":"non-small-cell lung","target":"companion diagnostic","id":"50323"},{"source":"non-small-cell lung","target":"Dako","id":"50324"},{"source":"non-small-cell lung","target":"nab-paclitaxel (IV)","id":"50325"},{"source":"non-small-cell lung","target":"pemetrexed disodium","id":"50326"},{"source":"acquired immunodeficiency syndrome","target":"ipilimumab","id":"50327"},{"source":"acquired immunodeficiency syndrome","target":"nivolumab (a)","id":"50328"},{"source":"acquired immunodeficiency syndrome","target":"carboplatin","id":"50329"},{"source":"acquired immunodeficiency syndrome","target":"cisplatin","id":"50330"},{"source":"acquired immunodeficiency syndrome","target":"gemcitabine hydrochloride","id":"50331"},{"source":"acquired immunodeficiency syndrome","target":"nivolumab (a)","id":"50332"},{"source":"acquired immunodeficiency syndrome","target":"companion diagnostic","id":"50333"},{"source":"acquired immunodeficiency syndrome","target":"Dako","id":"50334"},{"source":"acquired immunodeficiency syndrome","target":"nab-paclitaxel (IV)","id":"50335"},{"source":"acquired immunodeficiency syndrome","target":"pemetrexed disodium","id":"50336"},{"source":"liver metastases","target":"ipilimumab","id":"50337"},{"source":"liver metastases","target":"nivolumab (a)","id":"50338"},{"source":"liver metastases","target":"carboplatin","id":"50339"},{"source":"liver metastases","target":"cisplatin","id":"50340"},{"source":"liver metastases","target":"gemcitabine hydrochloride","id":"50341"},{"source":"liver metastases","target":"nivolumab (a)","id":"50342"},{"source":"liver metastases","target":"companion diagnostic","id":"50343"},{"source":"liver metastases","target":"Dako","id":"50344"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"50345"},{"source":"liver metastases","target":"pemetrexed disodium","id":"50346"},{"source":"sclc","target":"ipilimumab","id":"50347"},{"source":"sclc","target":"nivolumab (a)","id":"50348"},{"source":"sclc","target":"carboplatin","id":"50349"},{"source":"sclc","target":"cisplatin","id":"50350"},{"source":"sclc","target":"gemcitabine hydrochloride","id":"50351"},{"source":"sclc","target":"nivolumab (a)","id":"50352"},{"source":"sclc","target":"companion diagnostic","id":"50353"},{"source":"sclc","target":"Dako","id":"50354"},{"source":"sclc","target":"nab-paclitaxel (IV)","id":"50355"},{"source":"sclc","target":"pemetrexed disodium","id":"50356"},{"source":"psoriasis","target":"ipilimumab","id":"50357"},{"source":"psoriasis","target":"nivolumab (a)","id":"50358"},{"source":"psoriasis","target":"carboplatin","id":"50359"},{"source":"psoriasis","target":"cisplatin","id":"50360"},{"source":"psoriasis","target":"gemcitabine hydrochloride","id":"50361"},{"source":"psoriasis","target":"nivolumab (a)","id":"50362"},{"source":"psoriasis","target":"companion diagnostic","id":"50363"},{"source":"psoriasis","target":"Dako","id":"50364"},{"source":"psoriasis","target":"nab-paclitaxel (IV)","id":"50365"},{"source":"psoriasis","target":"pemetrexed disodium","id":"50366"},{"source":"arthritis","target":"ipilimumab","id":"50367"},{"source":"arthritis","target":"nivolumab (a)","id":"50368"},{"source":"arthritis","target":"carboplatin","id":"50369"},{"source":"arthritis","target":"cisplatin","id":"50370"},{"source":"arthritis","target":"gemcitabine hydrochloride","id":"50371"},{"source":"arthritis","target":"nivolumab (a)","id":"50372"},{"source":"arthritis","target":"companion diagnostic","id":"50373"},{"source":"arthritis","target":"Dako","id":"50374"},{"source":"arthritis","target":"nab-paclitaxel (IV)","id":"50375"},{"source":"arthritis","target":"pemetrexed disodium","id":"50376"},{"source":"azoospermia","target":"ipilimumab","id":"50377"},{"source":"azoospermia","target":"nivolumab (a)","id":"50378"},{"source":"azoospermia","target":"carboplatin","id":"50379"},{"source":"azoospermia","target":"cisplatin","id":"50380"},{"source":"azoospermia","target":"gemcitabine hydrochloride","id":"50381"},{"source":"azoospermia","target":"nivolumab (a)","id":"50382"},{"source":"azoospermia","target":"companion diagnostic","id":"50383"},{"source":"azoospermia","target":"Dako","id":"50384"},{"source":"azoospermia","target":"nab-paclitaxel (IV)","id":"50385"},{"source":"azoospermia","target":"pemetrexed disodium","id":"50386"},{"source":"carcinoma","target":"ipilimumab","id":"50387"},{"source":"carcinoma","target":"nivolumab (a)","id":"50388"},{"source":"carcinoma","target":"carboplatin","id":"50389"},{"source":"carcinoma","target":"cisplatin","id":"50390"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"50391"},{"source":"carcinoma","target":"nivolumab (a)","id":"50392"},{"source":"carcinoma","target":"companion diagnostic","id":"50393"},{"source":"carcinoma","target":"Dako","id":"50394"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"50395"},{"source":"carcinoma","target":"pemetrexed disodium","id":"50396"},{"source":"solid tumors","target":"ipilimumab","id":"50397"},{"source":"solid tumors","target":"nivolumab (a)","id":"50398"},{"source":"solid tumors","target":"carboplatin","id":"50399"},{"source":"solid tumors","target":"cisplatin","id":"50400"},{"source":"solid tumors","target":"gemcitabine hydrochloride","id":"50401"},{"source":"solid tumors","target":"nivolumab (a)","id":"50402"},{"source":"solid tumors","target":"companion diagnostic","id":"50403"},{"source":"solid tumors","target":"Dako","id":"50404"},{"source":"solid tumors","target":"nab-paclitaxel (IV)","id":"50405"},{"source":"solid tumors","target":"pemetrexed disodium","id":"50406"},{"source":"carcinoma","target":"ipilimumab","id":"50407"},{"source":"carcinoma","target":"nivolumab (a)","id":"50408"},{"source":"carcinoma","target":"carboplatin","id":"50409"},{"source":"carcinoma","target":"cisplatin","id":"50410"},{"source":"carcinoma","target":"gemcitabine hydrochloride","id":"50411"},{"source":"carcinoma","target":"nivolumab (a)","id":"50412"},{"source":"carcinoma","target":"companion diagnostic","id":"50413"},{"source":"carcinoma","target":"Dako","id":"50414"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"50415"},{"source":"carcinoma","target":"pemetrexed disodium","id":"50416"},{"source":"gilbert syndrome","target":"ipilimumab","id":"50417"},{"source":"gilbert syndrome","target":"nivolumab (a)","id":"50418"},{"source":"gilbert syndrome","target":"carboplatin","id":"50419"},{"source":"gilbert syndrome","target":"cisplatin","id":"50420"},{"source":"gilbert syndrome","target":"gemcitabine hydrochloride","id":"50421"},{"source":"gilbert syndrome","target":"nivolumab (a)","id":"50422"},{"source":"gilbert syndrome","target":"companion diagnostic","id":"50423"},{"source":"gilbert syndrome","target":"Dako","id":"50424"},{"source":"gilbert syndrome","target":"nab-paclitaxel (IV)","id":"50425"},{"source":"gilbert syndrome","target":"pemetrexed disodium","id":"50426"},{"source":"neoplasm metastasis","target":"ipilimumab","id":"50427"},{"source":"neoplasm metastasis","target":"nivolumab (a)","id":"50428"},{"source":"neoplasm metastasis","target":"carboplatin","id":"50429"},{"source":"neoplasm metastasis","target":"cisplatin","id":"50430"},{"source":"neoplasm metastasis","target":"gemcitabine hydrochloride","id":"50431"},{"source":"neoplasm metastasis","target":"nivolumab (a)","id":"50432"},{"source":"neoplasm metastasis","target":"companion diagnostic","id":"50433"},{"source":"neoplasm metastasis","target":"Dako","id":"50434"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"50435"},{"source":"neoplasm metastasis","target":"pemetrexed disodium","id":"50436"},{"source":"lung neoplasms","target":"ipilimumab","id":"50437"},{"source":"lung neoplasms","target":"nivolumab (a)","id":"50438"},{"source":"lung neoplasms","target":"carboplatin","id":"50439"},{"source":"lung neoplasms","target":"cisplatin","id":"50440"},{"source":"lung neoplasms","target":"gemcitabine hydrochloride","id":"50441"},{"source":"lung neoplasms","target":"nivolumab (a)","id":"50442"},{"source":"lung neoplasms","target":"companion diagnostic","id":"50443"},{"source":"lung neoplasms","target":"Dako","id":"50444"},{"source":"lung neoplasms","target":"nab-paclitaxel (IV)","id":"50445"},{"source":"lung neoplasms","target":"pemetrexed disodium","id":"50446"},{"source":"residual tumor","target":"ipilimumab","id":"50447"},{"source":"residual tumor","target":"nivolumab (a)","id":"50448"},{"source":"residual tumor","target":"carboplatin","id":"50449"},{"source":"residual tumor","target":"cisplatin","id":"50450"},{"source":"residual tumor","target":"gemcitabine hydrochloride","id":"50451"},{"source":"residual tumor","target":"nivolumab (a)","id":"50452"},{"source":"residual tumor","target":"companion diagnostic","id":"50453"},{"source":"residual tumor","target":"Dako","id":"50454"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"50455"},{"source":"residual tumor","target":"pemetrexed disodium","id":"50456"},{"source":"metastatic","target":"ipilimumab","id":"50457"},{"source":"metastatic","target":"nivolumab (a)","id":"50458"},{"source":"metastatic","target":"carboplatin","id":"50459"},{"source":"metastatic","target":"cisplatin","id":"50460"},{"source":"metastatic","target":"gemcitabine hydrochloride","id":"50461"},{"source":"metastatic","target":"nivolumab (a)","id":"50462"},{"source":"metastatic","target":"companion diagnostic","id":"50463"},{"source":"metastatic","target":"Dako","id":"50464"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"50465"},{"source":"metastatic","target":"pemetrexed disodium","id":"50466"},{"source":"anticancer","target":"ipilimumab","id":"50467"},{"source":"anticancer","target":"nivolumab (a)","id":"50468"},{"source":"anticancer","target":"carboplatin","id":"50469"},{"source":"anticancer","target":"cisplatin","id":"50470"},{"source":"anticancer","target":"gemcitabine hydrochloride","id":"50471"},{"source":"anticancer","target":"nivolumab (a)","id":"50472"},{"source":"anticancer","target":"companion diagnostic","id":"50473"},{"source":"anticancer","target":"Dako","id":"50474"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"50475"},{"source":"anticancer","target":"pemetrexed disodium","id":"50476"},{"source":"lung cancer","target":"ipilimumab","id":"50477"},{"source":"lung cancer","target":"nivolumab (a)","id":"50478"},{"source":"lung cancer","target":"carboplatin","id":"50479"},{"source":"lung cancer","target":"cisplatin","id":"50480"},{"source":"lung cancer","target":"gemcitabine hydrochloride","id":"50481"},{"source":"lung cancer","target":"nivolumab (a)","id":"50482"},{"source":"lung cancer","target":"companion diagnostic","id":"50483"},{"source":"lung cancer","target":"Dako","id":"50484"},{"source":"lung cancer","target":"nab-paclitaxel (IV)","id":"50485"},{"source":"lung cancer","target":"pemetrexed disodium","id":"50486"},{"source":"solid tumors","target":"ipilimumab","id":"50487"},{"source":"solid tumors","target":"nivolumab (a)","id":"50488"},{"source":"solid tumors","target":"carboplatin","id":"50489"},{"source":"solid tumors","target":"cisplatin","id":"50490"},{"source":"solid tumors","target":"gemcitabine hydrochloride","id":"50491"},{"source":"solid tumors","target":"nivolumab (a)","id":"50492"},{"source":"solid tumors","target":"companion diagnostic","id":"50493"},{"source":"solid tumors","target":"Dako","id":"50494"},{"source":"solid tumors","target":"nab-paclitaxel (IV)","id":"50495"},{"source":"solid tumors","target":"pemetrexed disodium","id":"50496"},{"source":"Dihydrofolate reductase inhibitor","target":"UNK : Indication","id":"50497"},{"source":"Dihydrofolate reductase inhibitor","target":"anti-hiv","id":"50498"},{"source":"Dihydrofolate reductase inhibitor","target":"antiarthritic","id":"50499"},{"source":"Dihydrofolate reductase inhibitor","target":"azoospermia","id":"50500"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"50501"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"50502"},{"source":"Dihydrofolate reductase inhibitor","target":"gilbert disease","id":"50503"},{"source":"Dihydrofolate reductase inhibitor","target":"hiv infections","id":"50504"},{"source":"Dihydrofolate reductase inhibitor","target":"liver neoplasms","id":"50505"},{"source":"Dihydrofolate reductase inhibitor","target":"non-small-cell lung","id":"50506"},{"source":"Dihydrofolate reductase inhibitor","target":"acquired immunodeficiency syndrome","id":"50507"},{"source":"Dihydrofolate reductase inhibitor","target":"liver metastases","id":"50508"},{"source":"Dihydrofolate reductase inhibitor","target":"sclc","id":"50509"},{"source":"Dihydrofolate reductase inhibitor","target":"psoriasis","id":"50510"},{"source":"Dihydrofolate reductase inhibitor","target":"arthritis","id":"50511"},{"source":"Dihydrofolate reductase inhibitor","target":"azoospermia","id":"50512"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"50513"},{"source":"Dihydrofolate reductase inhibitor","target":"solid tumors","id":"50514"},{"source":"Dihydrofolate reductase inhibitor","target":"carcinoma","id":"50515"},{"source":"Dihydrofolate reductase inhibitor","target":"gilbert syndrome","id":"50516"},{"source":"Dihydrofolate reductase inhibitor","target":"neoplasm metastasis","id":"50517"},{"source":"Dihydrofolate reductase inhibitor","target":"lung neoplasms","id":"50518"},{"source":"Dihydrofolate reductase inhibitor","target":"residual tumor","id":"50519"},{"source":"Dihydrofolate reductase inhibitor","target":"metastatic","id":"50520"},{"source":"Dihydrofolate reductase inhibitor","target":"anticancer","id":"50521"},{"source":"Dihydrofolate reductase inhibitor","target":"lung cancer","id":"50522"},{"source":"Dihydrofolate reductase inhibitor","target":"solid tumors","id":"50523"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"50524"},{"source":"Immune checkpoint inhibitor","target":"anti-hiv","id":"50525"},{"source":"Immune checkpoint inhibitor","target":"antiarthritic","id":"50526"},{"source":"Immune checkpoint inhibitor","target":"azoospermia","id":"50527"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"50528"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"50529"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"50530"},{"source":"Immune checkpoint inhibitor","target":"hiv infections","id":"50531"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"50532"},{"source":"Immune checkpoint inhibitor","target":"non-small-cell lung","id":"50533"},{"source":"Immune checkpoint inhibitor","target":"acquired immunodeficiency syndrome","id":"50534"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"50535"},{"source":"Immune checkpoint inhibitor","target":"sclc","id":"50536"},{"source":"Immune checkpoint inhibitor","target":"psoriasis","id":"50537"},{"source":"Immune checkpoint inhibitor","target":"arthritis","id":"50538"},{"source":"Immune checkpoint inhibitor","target":"azoospermia","id":"50539"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"50540"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"50541"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"50542"},{"source":"Immune checkpoint inhibitor","target":"gilbert syndrome","id":"50543"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"50544"},{"source":"Immune checkpoint inhibitor","target":"lung neoplasms","id":"50545"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"50546"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"50547"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"50548"},{"source":"Immune checkpoint inhibitor","target":"lung cancer","id":"50549"},{"source":"Immune checkpoint inhibitor","target":"solid tumors","id":"50550"},{"source":"NA","target":"UNK : Indication","id":"50551"},{"source":"NA","target":"anti-hiv","id":"50552"},{"source":"NA","target":"antiarthritic","id":"50553"},{"source":"NA","target":"azoospermia","id":"50554"},{"source":"NA","target":"non-small-cell lung","id":"50555"},{"source":"NA","target":"psoriasis","id":"50556"},{"source":"NA","target":"gilbert disease","id":"50557"},{"source":"NA","target":"hiv infections","id":"50558"},{"source":"NA","target":"liver neoplasms","id":"50559"},{"source":"NA","target":"non-small-cell lung","id":"50560"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"50561"},{"source":"NA","target":"liver metastases","id":"50562"},{"source":"NA","target":"sclc","id":"50563"},{"source":"NA","target":"psoriasis","id":"50564"},{"source":"NA","target":"arthritis","id":"50565"},{"source":"NA","target":"azoospermia","id":"50566"},{"source":"NA","target":"carcinoma","id":"50567"},{"source":"NA","target":"solid tumors","id":"50568"},{"source":"NA","target":"carcinoma","id":"50569"},{"source":"NA","target":"gilbert syndrome","id":"50570"},{"source":"NA","target":"neoplasm metastasis","id":"50571"},{"source":"NA","target":"lung neoplasms","id":"50572"},{"source":"NA","target":"residual tumor","id":"50573"},{"source":"NA","target":"metastatic","id":"50574"},{"source":"NA","target":"anticancer","id":"50575"},{"source":"NA","target":"lung cancer","id":"50576"},{"source":"NA","target":"solid tumors","id":"50577"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"50578"},{"source":"Anticancer immunotherapy","target":"anti-hiv","id":"50579"},{"source":"Anticancer immunotherapy","target":"antiarthritic","id":"50580"},{"source":"Anticancer immunotherapy","target":"azoospermia","id":"50581"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"50582"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"50583"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"50584"},{"source":"Anticancer immunotherapy","target":"hiv infections","id":"50585"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"50586"},{"source":"Anticancer immunotherapy","target":"non-small-cell lung","id":"50587"},{"source":"Anticancer immunotherapy","target":"acquired immunodeficiency syndrome","id":"50588"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"50589"},{"source":"Anticancer immunotherapy","target":"sclc","id":"50590"},{"source":"Anticancer immunotherapy","target":"psoriasis","id":"50591"},{"source":"Anticancer immunotherapy","target":"arthritis","id":"50592"},{"source":"Anticancer immunotherapy","target":"azoospermia","id":"50593"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"50594"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"50595"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"50596"},{"source":"Anticancer immunotherapy","target":"gilbert syndrome","id":"50597"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"50598"},{"source":"Anticancer immunotherapy","target":"lung neoplasms","id":"50599"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"50600"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"50601"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"50602"},{"source":"Anticancer immunotherapy","target":"lung cancer","id":"50603"},{"source":"Anticancer immunotherapy","target":"solid tumors","id":"50604"},{"source":"CD19 antagonist","target":"UNK : Indication","id":"50605"},{"source":"CD19 antagonist","target":"anti-hiv","id":"50606"},{"source":"CD19 antagonist","target":"antiarthritic","id":"50607"},{"source":"CD19 antagonist","target":"azoospermia","id":"50608"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"50609"},{"source":"CD19 antagonist","target":"psoriasis","id":"50610"},{"source":"CD19 antagonist","target":"gilbert disease","id":"50611"},{"source":"CD19 antagonist","target":"hiv infections","id":"50612"},{"source":"CD19 antagonist","target":"liver neoplasms","id":"50613"},{"source":"CD19 antagonist","target":"non-small-cell lung","id":"50614"},{"source":"CD19 antagonist","target":"acquired immunodeficiency syndrome","id":"50615"},{"source":"CD19 antagonist","target":"liver metastases","id":"50616"},{"source":"CD19 antagonist","target":"sclc","id":"50617"},{"source":"CD19 antagonist","target":"psoriasis","id":"50618"},{"source":"CD19 antagonist","target":"arthritis","id":"50619"},{"source":"CD19 antagonist","target":"azoospermia","id":"50620"},{"source":"CD19 antagonist","target":"carcinoma","id":"50621"},{"source":"CD19 antagonist","target":"solid tumors","id":"50622"},{"source":"CD19 antagonist","target":"carcinoma","id":"50623"},{"source":"CD19 antagonist","target":"gilbert syndrome","id":"50624"},{"source":"CD19 antagonist","target":"neoplasm metastasis","id":"50625"},{"source":"CD19 antagonist","target":"lung neoplasms","id":"50626"},{"source":"CD19 antagonist","target":"residual tumor","id":"50627"},{"source":"CD19 antagonist","target":"metastatic","id":"50628"},{"source":"CD19 antagonist","target":"anticancer","id":"50629"},{"source":"CD19 antagonist","target":"lung cancer","id":"50630"},{"source":"CD19 antagonist","target":"solid tumors","id":"50631"},{"source":"NA","target":"UNK : Indication","id":"50632"},{"source":"NA","target":"anti-hiv","id":"50633"},{"source":"NA","target":"antiarthritic","id":"50634"},{"source":"NA","target":"azoospermia","id":"50635"},{"source":"NA","target":"non-small-cell lung","id":"50636"},{"source":"NA","target":"psoriasis","id":"50637"},{"source":"NA","target":"gilbert disease","id":"50638"},{"source":"NA","target":"hiv infections","id":"50639"},{"source":"NA","target":"liver neoplasms","id":"50640"},{"source":"NA","target":"non-small-cell lung","id":"50641"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"50642"},{"source":"NA","target":"liver metastases","id":"50643"},{"source":"NA","target":"sclc","id":"50644"},{"source":"NA","target":"psoriasis","id":"50645"},{"source":"NA","target":"arthritis","id":"50646"},{"source":"NA","target":"azoospermia","id":"50647"},{"source":"NA","target":"carcinoma","id":"50648"},{"source":"NA","target":"solid tumors","id":"50649"},{"source":"NA","target":"carcinoma","id":"50650"},{"source":"NA","target":"gilbert syndrome","id":"50651"},{"source":"NA","target":"neoplasm metastasis","id":"50652"},{"source":"NA","target":"lung neoplasms","id":"50653"},{"source":"NA","target":"residual tumor","id":"50654"},{"source":"NA","target":"metastatic","id":"50655"},{"source":"NA","target":"anticancer","id":"50656"},{"source":"NA","target":"lung cancer","id":"50657"},{"source":"NA","target":"solid tumors","id":"50658"},{"source":"NA","target":"UNK : Indication","id":"50659"},{"source":"NA","target":"anti-hiv","id":"50660"},{"source":"NA","target":"antiarthritic","id":"50661"},{"source":"NA","target":"azoospermia","id":"50662"},{"source":"NA","target":"non-small-cell lung","id":"50663"},{"source":"NA","target":"psoriasis","id":"50664"},{"source":"NA","target":"gilbert disease","id":"50665"},{"source":"NA","target":"hiv infections","id":"50666"},{"source":"NA","target":"liver neoplasms","id":"50667"},{"source":"NA","target":"non-small-cell lung","id":"50668"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"50669"},{"source":"NA","target":"liver metastases","id":"50670"},{"source":"NA","target":"sclc","id":"50671"},{"source":"NA","target":"psoriasis","id":"50672"},{"source":"NA","target":"arthritis","id":"50673"},{"source":"NA","target":"azoospermia","id":"50674"},{"source":"NA","target":"carcinoma","id":"50675"},{"source":"NA","target":"solid tumors","id":"50676"},{"source":"NA","target":"carcinoma","id":"50677"},{"source":"NA","target":"gilbert syndrome","id":"50678"},{"source":"NA","target":"neoplasm metastasis","id":"50679"},{"source":"NA","target":"lung neoplasms","id":"50680"},{"source":"NA","target":"residual tumor","id":"50681"},{"source":"NA","target":"metastatic","id":"50682"},{"source":"NA","target":"anticancer","id":"50683"},{"source":"NA","target":"lung cancer","id":"50684"},{"source":"NA","target":"solid tumors","id":"50685"},{"source":"Thymidylate synthase inhibitor","target":"UNK : Indication","id":"50686"},{"source":"Thymidylate synthase inhibitor","target":"anti-hiv","id":"50687"},{"source":"Thymidylate synthase inhibitor","target":"antiarthritic","id":"50688"},{"source":"Thymidylate synthase inhibitor","target":"azoospermia","id":"50689"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"50690"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"50691"},{"source":"Thymidylate synthase inhibitor","target":"gilbert disease","id":"50692"},{"source":"Thymidylate synthase inhibitor","target":"hiv infections","id":"50693"},{"source":"Thymidylate synthase inhibitor","target":"liver neoplasms","id":"50694"},{"source":"Thymidylate synthase inhibitor","target":"non-small-cell lung","id":"50695"},{"source":"Thymidylate synthase inhibitor","target":"acquired immunodeficiency syndrome","id":"50696"},{"source":"Thymidylate synthase inhibitor","target":"liver metastases","id":"50697"},{"source":"Thymidylate synthase inhibitor","target":"sclc","id":"50698"},{"source":"Thymidylate synthase inhibitor","target":"psoriasis","id":"50699"},{"source":"Thymidylate synthase inhibitor","target":"arthritis","id":"50700"},{"source":"Thymidylate synthase inhibitor","target":"azoospermia","id":"50701"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"50702"},{"source":"Thymidylate synthase inhibitor","target":"solid tumors","id":"50703"},{"source":"Thymidylate synthase inhibitor","target":"carcinoma","id":"50704"},{"source":"Thymidylate synthase inhibitor","target":"gilbert syndrome","id":"50705"},{"source":"Thymidylate synthase inhibitor","target":"neoplasm metastasis","id":"50706"},{"source":"Thymidylate synthase inhibitor","target":"lung neoplasms","id":"50707"},{"source":"Thymidylate synthase inhibitor","target":"residual tumor","id":"50708"},{"source":"Thymidylate synthase inhibitor","target":"metastatic","id":"50709"},{"source":"Thymidylate synthase inhibitor","target":"anticancer","id":"50710"},{"source":"Thymidylate synthase inhibitor","target":"lung cancer","id":"50711"},{"source":"Thymidylate synthase inhibitor","target":"solid tumors","id":"50712"},{"source":"CTLA4 antagonist","target":"UNK : Indication","id":"50713"},{"source":"CTLA4 antagonist","target":"anti-hiv","id":"50714"},{"source":"CTLA4 antagonist","target":"antiarthritic","id":"50715"},{"source":"CTLA4 antagonist","target":"azoospermia","id":"50716"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"50717"},{"source":"CTLA4 antagonist","target":"psoriasis","id":"50718"},{"source":"CTLA4 antagonist","target":"gilbert disease","id":"50719"},{"source":"CTLA4 antagonist","target":"hiv infections","id":"50720"},{"source":"CTLA4 antagonist","target":"liver neoplasms","id":"50721"},{"source":"CTLA4 antagonist","target":"non-small-cell lung","id":"50722"},{"source":"CTLA4 antagonist","target":"acquired immunodeficiency syndrome","id":"50723"},{"source":"CTLA4 antagonist","target":"liver metastases","id":"50724"},{"source":"CTLA4 antagonist","target":"sclc","id":"50725"},{"source":"CTLA4 antagonist","target":"psoriasis","id":"50726"},{"source":"CTLA4 antagonist","target":"arthritis","id":"50727"},{"source":"CTLA4 antagonist","target":"azoospermia","id":"50728"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"50729"},{"source":"CTLA4 antagonist","target":"solid tumors","id":"50730"},{"source":"CTLA4 antagonist","target":"carcinoma","id":"50731"},{"source":"CTLA4 antagonist","target":"gilbert syndrome","id":"50732"},{"source":"CTLA4 antagonist","target":"neoplasm metastasis","id":"50733"},{"source":"CTLA4 antagonist","target":"lung neoplasms","id":"50734"},{"source":"CTLA4 antagonist","target":"residual tumor","id":"50735"},{"source":"CTLA4 antagonist","target":"metastatic","id":"50736"},{"source":"CTLA4 antagonist","target":"anticancer","id":"50737"},{"source":"CTLA4 antagonist","target":"lung cancer","id":"50738"},{"source":"CTLA4 antagonist","target":"solid tumors","id":"50739"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"50740"},{"source":"Beta tubulin antagonist","target":"anti-hiv","id":"50741"},{"source":"Beta tubulin antagonist","target":"antiarthritic","id":"50742"},{"source":"Beta tubulin antagonist","target":"azoospermia","id":"50743"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"50744"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"50745"},{"source":"Beta tubulin antagonist","target":"gilbert disease","id":"50746"},{"source":"Beta tubulin antagonist","target":"hiv infections","id":"50747"},{"source":"Beta tubulin antagonist","target":"liver neoplasms","id":"50748"},{"source":"Beta tubulin antagonist","target":"non-small-cell lung","id":"50749"},{"source":"Beta tubulin antagonist","target":"acquired immunodeficiency syndrome","id":"50750"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"50751"},{"source":"Beta tubulin antagonist","target":"sclc","id":"50752"},{"source":"Beta tubulin antagonist","target":"psoriasis","id":"50753"},{"source":"Beta tubulin antagonist","target":"arthritis","id":"50754"},{"source":"Beta tubulin antagonist","target":"azoospermia","id":"50755"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"50756"},{"source":"Beta tubulin antagonist","target":"solid tumors","id":"50757"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"50758"},{"source":"Beta tubulin antagonist","target":"gilbert syndrome","id":"50759"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"50760"},{"source":"Beta tubulin antagonist","target":"lung neoplasms","id":"50761"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"50762"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"50763"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"50764"},{"source":"Beta tubulin antagonist","target":"lung cancer","id":"50765"},{"source":"Beta tubulin antagonist","target":"solid tumors","id":"50766"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"50767"},{"source":"Microtubule stimulant","target":"anti-hiv","id":"50768"},{"source":"Microtubule stimulant","target":"antiarthritic","id":"50769"},{"source":"Microtubule stimulant","target":"azoospermia","id":"50770"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"50771"},{"source":"Microtubule stimulant","target":"psoriasis","id":"50772"},{"source":"Microtubule stimulant","target":"gilbert disease","id":"50773"},{"source":"Microtubule stimulant","target":"hiv infections","id":"50774"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"50775"},{"source":"Microtubule stimulant","target":"non-small-cell lung","id":"50776"},{"source":"Microtubule stimulant","target":"acquired immunodeficiency syndrome","id":"50777"},{"source":"Microtubule stimulant","target":"liver metastases","id":"50778"},{"source":"Microtubule stimulant","target":"sclc","id":"50779"},{"source":"Microtubule stimulant","target":"psoriasis","id":"50780"},{"source":"Microtubule stimulant","target":"arthritis","id":"50781"},{"source":"Microtubule stimulant","target":"azoospermia","id":"50782"},{"source":"Microtubule stimulant","target":"carcinoma","id":"50783"},{"source":"Microtubule stimulant","target":"solid tumors","id":"50784"},{"source":"Microtubule stimulant","target":"carcinoma","id":"50785"},{"source":"Microtubule stimulant","target":"gilbert syndrome","id":"50786"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"50787"},{"source":"Microtubule stimulant","target":"lung neoplasms","id":"50788"},{"source":"Microtubule stimulant","target":"residual tumor","id":"50789"},{"source":"Microtubule stimulant","target":"metastatic","id":"50790"},{"source":"Microtubule stimulant","target":"anticancer","id":"50791"},{"source":"Microtubule stimulant","target":"lung cancer","id":"50792"},{"source":"Microtubule stimulant","target":"solid tumors","id":"50793"},{"source":"NA","target":"UNK : Indication","id":"50794"},{"source":"NA","target":"anti-hiv","id":"50795"},{"source":"NA","target":"antiarthritic","id":"50796"},{"source":"NA","target":"azoospermia","id":"50797"},{"source":"NA","target":"non-small-cell lung","id":"50798"},{"source":"NA","target":"psoriasis","id":"50799"},{"source":"NA","target":"gilbert disease","id":"50800"},{"source":"NA","target":"hiv infections","id":"50801"},{"source":"NA","target":"liver neoplasms","id":"50802"},{"source":"NA","target":"non-small-cell lung","id":"50803"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"50804"},{"source":"NA","target":"liver metastases","id":"50805"},{"source":"NA","target":"sclc","id":"50806"},{"source":"NA","target":"psoriasis","id":"50807"},{"source":"NA","target":"arthritis","id":"50808"},{"source":"NA","target":"azoospermia","id":"50809"},{"source":"NA","target":"carcinoma","id":"50810"},{"source":"NA","target":"solid tumors","id":"50811"},{"source":"NA","target":"carcinoma","id":"50812"},{"source":"NA","target":"gilbert syndrome","id":"50813"},{"source":"NA","target":"neoplasm metastasis","id":"50814"},{"source":"NA","target":"lung neoplasms","id":"50815"},{"source":"NA","target":"residual tumor","id":"50816"},{"source":"NA","target":"metastatic","id":"50817"},{"source":"NA","target":"anticancer","id":"50818"},{"source":"NA","target":"lung cancer","id":"50819"},{"source":"NA","target":"solid tumors","id":"50820"},{"source":"NA","target":"UNK : Indication","id":"50821"},{"source":"NA","target":"anti-hiv","id":"50822"},{"source":"NA","target":"antiarthritic","id":"50823"},{"source":"NA","target":"azoospermia","id":"50824"},{"source":"NA","target":"non-small-cell lung","id":"50825"},{"source":"NA","target":"psoriasis","id":"50826"},{"source":"NA","target":"gilbert disease","id":"50827"},{"source":"NA","target":"hiv infections","id":"50828"},{"source":"NA","target":"liver neoplasms","id":"50829"},{"source":"NA","target":"non-small-cell lung","id":"50830"},{"source":"NA","target":"acquired immunodeficiency syndrome","id":"50831"},{"source":"NA","target":"liver metastases","id":"50832"},{"source":"NA","target":"sclc","id":"50833"},{"source":"NA","target":"psoriasis","id":"50834"},{"source":"NA","target":"arthritis","id":"50835"},{"source":"NA","target":"azoospermia","id":"50836"},{"source":"NA","target":"carcinoma","id":"50837"},{"source":"NA","target":"solid tumors","id":"50838"},{"source":"NA","target":"carcinoma","id":"50839"},{"source":"NA","target":"gilbert syndrome","id":"50840"},{"source":"NA","target":"neoplasm metastasis","id":"50841"},{"source":"NA","target":"lung neoplasms","id":"50842"},{"source":"NA","target":"residual tumor","id":"50843"},{"source":"NA","target":"metastatic","id":"50844"},{"source":"NA","target":"anticancer","id":"50845"},{"source":"NA","target":"lung cancer","id":"50846"},{"source":"NA","target":"solid tumors","id":"50847"},{"source":"Cell cycle inhibitor","target":"UNK : Indication","id":"50848"},{"source":"Cell cycle inhibitor","target":"anti-hiv","id":"50849"},{"source":"Cell cycle inhibitor","target":"antiarthritic","id":"50850"},{"source":"Cell cycle inhibitor","target":"azoospermia","id":"50851"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"50852"},{"source":"Cell cycle inhibitor","target":"psoriasis","id":"50853"},{"source":"Cell cycle inhibitor","target":"gilbert disease","id":"50854"},{"source":"Cell cycle inhibitor","target":"hiv infections","id":"50855"},{"source":"Cell cycle inhibitor","target":"liver neoplasms","id":"50856"},{"source":"Cell cycle inhibitor","target":"non-small-cell lung","id":"50857"},{"source":"Cell cycle inhibitor","target":"acquired immunodeficiency syndrome","id":"50858"},{"source":"Cell cycle inhibitor","target":"liver metastases","id":"50859"},{"source":"Cell cycle inhibitor","target":"sclc","id":"50860"},{"source":"Cell cycle inhibitor","target":"psoriasis","id":"50861"},{"source":"Cell cycle inhibitor","target":"arthritis","id":"50862"},{"source":"Cell cycle inhibitor","target":"azoospermia","id":"50863"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"50864"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"50865"},{"source":"Cell cycle inhibitor","target":"carcinoma","id":"50866"},{"source":"Cell cycle inhibitor","target":"gilbert syndrome","id":"50867"},{"source":"Cell cycle inhibitor","target":"neoplasm metastasis","id":"50868"},{"source":"Cell cycle inhibitor","target":"lung neoplasms","id":"50869"},{"source":"Cell cycle inhibitor","target":"residual tumor","id":"50870"},{"source":"Cell cycle inhibitor","target":"metastatic","id":"50871"},{"source":"Cell cycle inhibitor","target":"anticancer","id":"50872"},{"source":"Cell cycle inhibitor","target":"lung cancer","id":"50873"},{"source":"Cell cycle inhibitor","target":"solid tumors","id":"50874"},{"source":"Taxane","target":"UNK : Indication","id":"50875"},{"source":"Taxane","target":"anti-hiv","id":"50876"},{"source":"Taxane","target":"antiarthritic","id":"50877"},{"source":"Taxane","target":"azoospermia","id":"50878"},{"source":"Taxane","target":"non-small-cell lung","id":"50879"},{"source":"Taxane","target":"psoriasis","id":"50880"},{"source":"Taxane","target":"gilbert disease","id":"50881"},{"source":"Taxane","target":"hiv infections","id":"50882"},{"source":"Taxane","target":"liver neoplasms","id":"50883"},{"source":"Taxane","target":"non-small-cell lung","id":"50884"},{"source":"Taxane","target":"acquired immunodeficiency syndrome","id":"50885"},{"source":"Taxane","target":"liver metastases","id":"50886"},{"source":"Taxane","target":"sclc","id":"50887"},{"source":"Taxane","target":"psoriasis","id":"50888"},{"source":"Taxane","target":"arthritis","id":"50889"},{"source":"Taxane","target":"azoospermia","id":"50890"},{"source":"Taxane","target":"carcinoma","id":"50891"},{"source":"Taxane","target":"solid tumors","id":"50892"},{"source":"Taxane","target":"carcinoma","id":"50893"},{"source":"Taxane","target":"gilbert syndrome","id":"50894"},{"source":"Taxane","target":"neoplasm metastasis","id":"50895"},{"source":"Taxane","target":"lung neoplasms","id":"50896"},{"source":"Taxane","target":"residual tumor","id":"50897"},{"source":"Taxane","target":"metastatic","id":"50898"},{"source":"Taxane","target":"anticancer","id":"50899"},{"source":"Taxane","target":"lung cancer","id":"50900"},{"source":"Taxane","target":"solid tumors","id":"50901"},{"source":"Oncology: Lung","target":"Dihydrofolate reductase inhibitor","id":"50902"},{"source":"Oncology: Lung","target":"Immune checkpoint inhibitor","id":"50903"},{"source":"Oncology: Lung","target":"NA","id":"50904"},{"source":"Oncology: Lung","target":"Anticancer immunotherapy","id":"50905"},{"source":"Oncology: Lung","target":"CD19 antagonist","id":"50906"},{"source":"Oncology: Lung","target":"NA","id":"50907"},{"source":"Oncology: Lung","target":"NA","id":"50908"},{"source":"Oncology: Lung","target":"Thymidylate synthase inhibitor","id":"50909"},{"source":"Oncology: Lung","target":"CTLA4 antagonist","id":"50910"},{"source":"Oncology: Lung","target":"Beta tubulin antagonist","id":"50911"},{"source":"Oncology: Lung","target":"Microtubule stimulant","id":"50912"},{"source":"Oncology: Lung","target":"NA","id":"50913"},{"source":"Oncology: Lung","target":"NA","id":"50914"},{"source":"Oncology: Lung","target":"Cell cycle inhibitor","id":"50915"},{"source":"Oncology: Lung","target":"Taxane","id":"50916"},{"source":"Non-Small Cell","target":"Dihydrofolate reductase inhibitor","id":"50917"},{"source":"Non-Small Cell","target":"Immune checkpoint inhibitor","id":"50918"},{"source":"Non-Small Cell","target":"NA","id":"50919"},{"source":"Non-Small Cell","target":"Anticancer immunotherapy","id":"50920"},{"source":"Non-Small Cell","target":"CD19 antagonist","id":"50921"},{"source":"Non-Small Cell","target":"NA","id":"50922"},{"source":"Non-Small Cell","target":"NA","id":"50923"},{"source":"Non-Small Cell","target":"Thymidylate synthase inhibitor","id":"50924"},{"source":"Non-Small Cell","target":"CTLA4 antagonist","id":"50925"},{"source":"Non-Small Cell","target":"Beta tubulin antagonist","id":"50926"},{"source":"Non-Small Cell","target":"Microtubule stimulant","id":"50927"},{"source":"Non-Small Cell","target":"NA","id":"50928"},{"source":"Non-Small Cell","target":"NA","id":"50929"},{"source":"Non-Small Cell","target":"Cell cycle inhibitor","id":"50930"},{"source":"Non-Small Cell","target":"Taxane","id":"50931"},{"source":"eftilagimod alfa (u)","target":"Immutep {Prima Biomed/Immutep}","id":"50932"},{"source":"nab-paclitaxel (IV)","target":"Immutep {Prima Biomed/Immutep}","id":"50933"},{"source":"UNK : Indication","target":"eftilagimod alfa (u)","id":"50934"},{"source":"UNK : Indication","target":"nab-paclitaxel (IV)","id":"50935"},{"source":"gilbert disease","target":"eftilagimod alfa (u)","id":"50936"},{"source":"gilbert disease","target":"nab-paclitaxel (IV)","id":"50937"},{"source":"amenorrheic","target":"eftilagimod alfa (u)","id":"50938"},{"source":"amenorrheic","target":"nab-paclitaxel (IV)","id":"50939"},{"source":"alopecia","target":"eftilagimod alfa (u)","id":"50940"},{"source":"alopecia","target":"nab-paclitaxel (IV)","id":"50941"},{"source":"residual tumor","target":"eftilagimod alfa (u)","id":"50942"},{"source":"residual tumor","target":"nab-paclitaxel (IV)","id":"50943"},{"source":"liver metastases","target":"eftilagimod alfa (u)","id":"50944"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"50945"},{"source":"liver metastases","target":"eftilagimod alfa (u)","id":"50946"},{"source":"liver metastases","target":"nab-paclitaxel (IV)","id":"50947"},{"source":"breast neoplasms","target":"eftilagimod alfa (u)","id":"50948"},{"source":"breast neoplasms","target":"nab-paclitaxel (IV)","id":"50949"},{"source":"gilbert disease","target":"eftilagimod alfa (u)","id":"50950"},{"source":"gilbert disease","target":"nab-paclitaxel (IV)","id":"50951"},{"source":"metastatic","target":"eftilagimod alfa (u)","id":"50952"},{"source":"metastatic","target":"nab-paclitaxel (IV)","id":"50953"},{"source":"carcinoma","target":"eftilagimod alfa (u)","id":"50954"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"50955"},{"source":"amenorrheic","target":"eftilagimod alfa (u)","id":"50956"},{"source":"amenorrheic","target":"nab-paclitaxel (IV)","id":"50957"},{"source":"neoplasm metastasis","target":"eftilagimod alfa (u)","id":"50958"},{"source":"neoplasm metastasis","target":"nab-paclitaxel (IV)","id":"50959"},{"source":"carcinoma","target":"eftilagimod alfa (u)","id":"50960"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"50961"},{"source":"anticancer","target":"eftilagimod alfa (u)","id":"50962"},{"source":"anticancer","target":"nab-paclitaxel (IV)","id":"50963"},{"source":"triple-negative breast cancer","target":"eftilagimod alfa (u)","id":"50964"},{"source":"triple-negative breast cancer","target":"nab-paclitaxel (IV)","id":"50965"},{"source":"liver neoplasms","target":"eftilagimod alfa (u)","id":"50966"},{"source":"liver neoplasms","target":"nab-paclitaxel (IV)","id":"50967"},{"source":"carcinoma","target":"eftilagimod alfa (u)","id":"50968"},{"source":"carcinoma","target":"nab-paclitaxel (IV)","id":"50969"},{"source":"Immune checkpoint inhibitor","target":"UNK : Indication","id":"50970"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"50971"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"50972"},{"source":"Immune checkpoint inhibitor","target":"alopecia","id":"50973"},{"source":"Immune checkpoint inhibitor","target":"residual tumor","id":"50974"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"50975"},{"source":"Immune checkpoint inhibitor","target":"liver metastases","id":"50976"},{"source":"Immune checkpoint inhibitor","target":"breast neoplasms","id":"50977"},{"source":"Immune checkpoint inhibitor","target":"gilbert disease","id":"50978"},{"source":"Immune checkpoint inhibitor","target":"metastatic","id":"50979"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"50980"},{"source":"Immune checkpoint inhibitor","target":"amenorrheic","id":"50981"},{"source":"Immune checkpoint inhibitor","target":"neoplasm metastasis","id":"50982"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"50983"},{"source":"Immune checkpoint inhibitor","target":"anticancer","id":"50984"},{"source":"Immune checkpoint inhibitor","target":"triple-negative breast cancer","id":"50985"},{"source":"Immune checkpoint inhibitor","target":"liver neoplasms","id":"50986"},{"source":"Immune checkpoint inhibitor","target":"carcinoma","id":"50987"},{"source":"Anticancer immunotherapy","target":"UNK : Indication","id":"50988"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"50989"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"50990"},{"source":"Anticancer immunotherapy","target":"alopecia","id":"50991"},{"source":"Anticancer immunotherapy","target":"residual tumor","id":"50992"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"50993"},{"source":"Anticancer immunotherapy","target":"liver metastases","id":"50994"},{"source":"Anticancer immunotherapy","target":"breast neoplasms","id":"50995"},{"source":"Anticancer immunotherapy","target":"gilbert disease","id":"50996"},{"source":"Anticancer immunotherapy","target":"metastatic","id":"50997"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"50998"},{"source":"Anticancer immunotherapy","target":"amenorrheic","id":"50999"},{"source":"Anticancer immunotherapy","target":"neoplasm metastasis","id":"51000"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"51001"},{"source":"Anticancer immunotherapy","target":"anticancer","id":"51002"},{"source":"Anticancer immunotherapy","target":"triple-negative breast cancer","id":"51003"},{"source":"Anticancer immunotherapy","target":"liver neoplasms","id":"51004"},{"source":"Anticancer immunotherapy","target":"carcinoma","id":"51005"},{"source":"Beta tubulin antagonist","target":"UNK : Indication","id":"51006"},{"source":"Beta tubulin antagonist","target":"gilbert disease","id":"51007"},{"source":"Beta tubulin antagonist","target":"amenorrheic","id":"51008"},{"source":"Beta tubulin antagonist","target":"alopecia","id":"51009"},{"source":"Beta tubulin antagonist","target":"residual tumor","id":"51010"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"51011"},{"source":"Beta tubulin antagonist","target":"liver metastases","id":"51012"},{"source":"Beta tubulin antagonist","target":"breast neoplasms","id":"51013"},{"source":"Beta tubulin antagonist","target":"gilbert disease","id":"51014"},{"source":"Beta tubulin antagonist","target":"metastatic","id":"51015"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"51016"},{"source":"Beta tubulin antagonist","target":"amenorrheic","id":"51017"},{"source":"Beta tubulin antagonist","target":"neoplasm metastasis","id":"51018"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"51019"},{"source":"Beta tubulin antagonist","target":"anticancer","id":"51020"},{"source":"Beta tubulin antagonist","target":"triple-negative breast cancer","id":"51021"},{"source":"Beta tubulin antagonist","target":"liver neoplasms","id":"51022"},{"source":"Beta tubulin antagonist","target":"carcinoma","id":"51023"},{"source":"Microtubule stimulant","target":"UNK : Indication","id":"51024"},{"source":"Microtubule stimulant","target":"gilbert disease","id":"51025"},{"source":"Microtubule stimulant","target":"amenorrheic","id":"51026"},{"source":"Microtubule stimulant","target":"alopecia","id":"51027"},{"source":"Microtubule stimulant","target":"residual tumor","id":"51028"},{"source":"Microtubule stimulant","target":"liver metastases","id":"51029"},{"source":"Microtubule stimulant","target":"liver metastases","id":"51030"},{"source":"Microtubule stimulant","target":"breast neoplasms","id":"51031"},{"source":"Microtubule stimulant","target":"gilbert disease","id":"51032"},{"source":"Microtubule stimulant","target":"metastatic","id":"51033"},{"source":"Microtubule stimulant","target":"carcinoma","id":"51034"},{"source":"Microtubule stimulant","target":"amenorrheic","id":"51035"},{"source":"Microtubule stimulant","target":"neoplasm metastasis","id":"51036"},{"source":"Microtubule stimulant","target":"carcinoma","id":"51037"},{"source":"Microtubule stimulant","target":"anticancer","id":"51038"},{"source":"Microtubule stimulant","target":"triple-negative breast cancer","id":"51039"},{"source":"Microtubule stimulant","target":"liver neoplasms","id":"51040"},{"source":"Microtubule stimulant","target":"carcinoma","id":"51041"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"UNK : Indication","id":"51042"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"gilbert disease","id":"51043"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"amenorrheic","id":"51044"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"alopecia","id":"51045"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"residual tumor","id":"51046"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"liver metastases","id":"51047"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"liver metastases","id":"51048"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"breast neoplasms","id":"51049"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"gilbert disease","id":"51050"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"metastatic","id":"51051"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"carcinoma","id":"51052"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"amenorrheic","id":"51053"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"neoplasm metastasis","id":"51054"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"carcinoma","id":"51055"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"anticancer","id":"51056"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"triple-negative breast cancer","id":"51057"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"liver neoplasms","id":"51058"},{"source":"Lymphocyte-activation gene 3 antagonist","target":"carcinoma","id":"51059"},{"source":"Taxane","target":"UNK : Indication","id":"51060"},{"source":"Taxane","target":"gilbert disease","id":"51061"},{"source":"Taxane","target":"amenorrheic","id":"51062"},{"source":"Taxane","target":"alopecia","id":"51063"},{"source":"Taxane","target":"residual tumor","id":"51064"},{"source":"Taxane","target":"liver metastases","id":"51065"},{"source":"Taxane","target":"liver metastases","id":"51066"},{"source":"Taxane","target":"breast neoplasms","id":"51067"},{"source":"Taxane","target":"gilbert disease","id":"51068"},{"source":"Taxane","target":"metastatic","id":"51069"},{"source":"Taxane","target":"carcinoma","id":"51070"},{"source":"Taxane","target":"amenorrheic","id":"51071"},{"source":"Taxane","target":"neoplasm metastasis","id":"51072"},{"source":"Taxane","target":"carcinoma","id":"51073"},{"source":"Taxane","target":"anticancer","id":"51074"},{"source":"Taxane","target":"triple-negative breast cancer","id":"51075"},{"source":"Taxane","target":"liver neoplasms","id":"51076"},{"source":"Taxane","target":"carcinoma","id":"51077"},{"source":"Oncology: Breast","target":"Immune checkpoint inhibitor","id":"51078"},{"source":"Oncology: Breast","target":"Anticancer immunotherapy","id":"51079"},{"source":"Oncology: Breast","target":"Beta tubulin antagonist","id":"51080"},{"source":"Oncology: Breast","target":"Microtubule stimulant","id":"51081"},{"source":"Oncology: Breast","target":"Lymphocyte-activation gene 3 antagonist","id":"51082"},{"source":"Oncology: Breast","target":"Taxane","id":"51083"}],"nodes":[{"id":"Oncology: CNS","label":"Oncology: CNS","color":"blue","x":"0.9875288038952308","y":"0.06267583726389593","size":"10.651668842475031"},{"id":"Glioblastoma","label":"Glioblastoma","color":"blue","x":"0.6420731010760128","y":"0.03662648626994398","size":"6.989700043360188"},{"id":"Oncology: Melanoma","label":"Oncology: Melanoma","color":"blue","x":"1.0034431279174538","y":"0.14705322347889832","size":"12.140673970143945"},{"id":"Oncology: Colorectal","label":"Oncology: Colorectal","color":"blue","x":"0.05747068663409188","y":"0.1268870457561568","size":"11.047575072713155"},{"id":"Oncology: Metastatic Cancer","label":"Oncology: Metastatic Cancer","color":"blue","x":"-0.2739346005967195","y":"0.002851056028682053","size":"7.592569699389438"},{"id":"Oncology: Pancreas","label":"Oncology: Pancreas","color":"blue","x":"-0.38490768974274087","y":"0.04330509362606676","size":"9.647094628571464"},{"id":"Oncology: Head/Neck","label":"Oncology: Head/Neck","color":"blue","x":"1.2090126093184683","y":"0.052512074695449086","size":"11.741524315240802"},{"id":"Oncology: Lung","label":"Oncology: Lung","color":"blue","x":"0.9166643388249915","y":"0.014262693920736647","size":"13.212322601210607"},{"id":"Non-Small Cell","label":"Non-Small Cell","color":"blue","x":"0.6802284076437413","y":"0.02617953226776257","size":"13.212322601210607"},{"id":"Oncology: Ovarian","label":"Oncology: Ovarian","color":"blue","x":"0.607553908437803","y":"0.038357108008290626","size":"10.715074001270475"},{"id":"Oncology: Breast","label":"Oncology: Breast","color":"blue","x":"0.7956127012182652","y":"0.04532310091903189","size":"11.846079287050715"},{"id":"Oncology: Leukemia","label":"Oncology: Leukemia","color":"blue","x":"0.49428519931084086","y":"0.05800896618629753","size":"7.156818820794937"},{"id":"Acute Myelogenous","label":"Acute Myelogenous","color":"blue","x":"1.2060941422553089","y":"0.11112294729419128","size":"6.808639180087964"},{"id":"Oncology: Prostate","label":"Oncology: Prostate","color":"blue","x":"-0.12750345994369","y":"0.10306007209244905","size":"9.316614300602279"},{"id":"Oncology: Renal","label":"Oncology: Renal","color":"blue","x":"-0.15023138322844695","y":"0.05063096631024527","size":"11.087419721069532"},{"id":"Oncology: Cervical","label":"Oncology: Cervical","color":"blue","x":"-0.13868673887766725","y":"0.052911547079389665","size":"7.720340221751378"},{"id":"Oncology: Esophageal","label":"Oncology: Esophageal","color":"blue","x":"0.4667030801403365","y":"0.0022872893424312423","size":"9.818939136727776"},{"id":"Oncology: Gastric","label":"Oncology: Gastric","color":"blue","x":"0.7662477085070687","y":"0.14187652843123336","size":"9.956130378462474"},{"id":"Oncology: Liver","label":"Oncology: Liver","color":"blue","x":"0.25995041759678955","y":"0.12927499177125087","size":"9.621396430309408"},{"id":"Oncology: Mesothelioma","label":"Oncology: Mesothelioma","color":"blue","x":"-0.2802607899227467","y":"0.06781244779214103","size":"7.898917983084051"},{"id":"Infectious Disease: HPV","label":"Infectious Disease: HPV","color":"blue","x":"0.11183872511521337","y":"0.1314935555039063","size":"6.611096473669597"},{"id":"Oncology: Endometrial","label":"Oncology: Endometrial","color":"blue","x":"0.35094917725794567","y":"0.008709573460111064","size":"9.346158598654881"},{"id":"Oncology: Soft Tissue Sarcoma","label":"Oncology: Soft Tissue Sarcoma","color":"blue","x":"0.48758241391302065","y":"0.10260720480953653","size":"8.450980400142567"},{"id":"Oncology: Bladder","label":"Oncology: Bladder","color":"blue","x":"0.9290463917282366","y":"0.03712853070789885","size":"10.44952555719699"},{"id":"Oncology: Multiple Myeloma","label":"Oncology: Multiple Myeloma","color":"blue","x":"-0.3867209653095084","y":"0.09548848495515246","size":"7.898917983084051"},{"id":"Oncology: (N/A)","label":"Oncology: (N/A)","color":"blue","x":"0.4854454069672381","y":"0.11807081079559967","size":"10.41392685158225"},{"id":"Oncology: Thyroid","label":"Oncology: Thyroid","color":"blue","x":"1.0999841757461137","y":"0.025768475952296952","size":"4.515449934959718"},{"id":"Oncology: Skin","label":"Oncology: Skin","color":"blue","x":"0.29843132634007635","y":"0.0995187937600986","size":"3.8907562519182184"},{"id":"Basal Cell Carcinoma","label":"Basal Cell Carcinoma","color":"blue","x":"0.8891494678612673","y":"0.12192458700406357","size":"3.8907562519182184"},{"id":"Chronic Lymphocytic","label":"Chronic Lymphocytic","color":"blue","x":"0.38814487564713956","y":"0.02974041103177137","size":"3.494850021680094"},{"id":"Oncology: Lymphoma","label":"Oncology: Lymphoma","color":"blue","x":"0.27999967419414357","y":"0.058633057299360476","size":"9.3753063169585"},{"id":"Hodgkin's","label":"Hodgkin's","color":"blue","x":"0.5998255138533914","y":"0.10292534837023672","size":"9.3753063169585"},{"id":"Infectious Disease: Respiratory Infections","label":"Infectious Disease: Respiratory Infections","color":"blue","x":"-0.3068893556928566","y":"0.09115892758591052","size":"1.505149978319906"},{"id":"Vaccines (Infectious Disease): Respiratory Vaccines","label":"Vaccines (Infectious Disease): Respiratory Vaccines","color":"blue","x":"-0.07094811043432131","y":"0.08505036244239872","size":"1.505149978319906"},{"id":"Oncology: Myelodysplastic Syndrome","label":"Oncology: Myelodysplastic Syndrome","color":"blue","x":"0.6063608562985787","y":"0.008129019000579307","size":"1.505149978319906"},{"id":"Medulloblastoma","label":"Medulloblastoma","color":"blue","x":"0.0713403440517556","y":"0.050677457423283875","size":"3.010299956639812"},{"id":"Other","label":"Other","color":"blue","x":"0.1444071801008317","y":"0.05456622157154956","size":"3.010299956639812"},{"id":"Oncology: Osteosarcoma","label":"Oncology: Osteosarcoma","color":"blue","x":"0.9077121881651014","y":"0.042978847260429096","size":"3.010299956639812"},{"id":"UNK : Indication","label":"UNK : Indication","color":"orange","x":"0.23269319790443382","y":"0.4294825689148982","size":"16.222622557850418"},{"id":"anticancer","label":"anticancer","color":"orange","x":"1.1557619822267122","y":"0.5333052968846894","size":"17.43781280128189"},{"id":"carcinoma","label":"carcinoma","color":"orange","x":"0.43523376563650534","y":"0.427454967635939","size":"18.887496597951824"},{"id":"glioblastoma","label":"glioblastoma","color":"orange","x":"0.9505576473808688","y":"0.4944130594840619","size":"9.256291743595376"},{"id":"melanoma","label":"melanoma","color":"orange","x":"-0.2801161526836956","y":"0.537232390867338","size":"14.429631699007155"},{"id":"skin neoplasms","label":"skin neoplasms","color":"orange","x":"0.9021546952875197","y":"0.4836884871609896","size":"14.947249088333459"},{"id":"colorectal neoplasms","label":"colorectal neoplasms","color":"orange","x":"0.8182160536966585","y":"0.4314746858602942","size":"13.584188616497624"},{"id":"colorectal cancer","label":"colorectal cancer","color":"orange","x":"0.5693519918589458","y":"0.5181376335596215","size":"11.087419721069532"},{"id":"liver metastases","label":"liver metastases","color":"orange","x":"0.6262350249306268","y":"0.4388612748739896","size":"14.45210509400457"},{"id":"colonic neoplasms","label":"colonic neoplasms","color":"orange","x":"0.3353452417947839","y":"0.5296016404410282","size":"12.083202536691404"},{"id":"neoplasm metastasis","label":"neoplasm metastasis","color":"orange","x":"1.1562452570266846","y":"0.4782459948855624","size":"15.987781065767683"},{"id":"liver neoplasms","label":"liver neoplasms","color":"orange","x":"0.6344904970108933","y":"0.47944767226784585","size":"13.82834277379507"},{"id":"metastatic","label":"metastatic","color":"orange","x":"0.48285800096140935","y":"0.48811803180817614","size":"15.939013193592098"},{"id":"pancreatic cancer","label":"pancreatic cancer","color":"orange","x":"-0.2999243204257801","y":"0.5146584121697738","size":"10.923457154087995"},{"id":"pancreatic neoplasms","label":"pancreatic neoplasms","color":"orange","x":"0.6789262357941377","y":"0.44286512479140144","size":"10.699395432006183"},{"id":"non-small-cell lung","label":"non-small-cell lung","color":"orange","x":"1.1866323198295925","y":"0.49571780179160024","size":"15.579715884695275"},{"id":"head and neck cancer","label":"head and neck cancer","color":"orange","x":"1.0671443302137384","y":"0.4107565759546436","size":"10.552948551496243"},{"id":"ovarian cancer","label":"ovarian cancer","color":"orange","x":"1.3387183432110272","y":"0.4921582586058309","size":"12.852714699409486"},{"id":"ovarian neoplasms","label":"ovarian neoplasms","color":"orange","x":"1.2409325354844472","y":"0.46719749136871785","size":"12.881706751028965"},{"id":"head and neck neoplasms","label":"head and neck neoplasms","color":"orange","x":"0.329763782160493","y":"0.5144804608267496","size":"12.625224035184226"},{"id":"triple-negative breast cancer","label":"triple-negative breast cancer","color":"orange","x":"0.009858465500228397","y":"0.4528147338955148","size":"13.649871428497777"},{"id":"breast neoplasms","label":"breast neoplasms","color":"orange","x":"0.35622771034875317","y":"0.41668676430229823","size":"13.887134111946558"},{"id":"residual tumor","label":"residual tumor","color":"orange","x":"-0.32516257603557724","y":"0.41762796778664596","size":"16.770542195737004"},{"id":"residual neoplasm","label":"residual neoplasm","color":"orange","x":"-0.27904382113083603","y":"0.4880082220812382","size":"9.286662482156343"},{"id":"acute","label":"acute","color":"orange","x":"0.9792931988874598","y":"0.4823373451824284","size":"10.667694541851088"},{"id":"unknown primary","label":"unknown primary","color":"orange","x":"0.9315486877425652","y":"0.44361012592432375","size":"12.592569699389438"},{"id":"leukemia","label":"leukemia","color":"orange","x":"0.1655103746753514","y":"0.5067951427459358","size":"10.586356478278823"},{"id":"myeloid","label":"myeloid","color":"orange","x":"-0.04143892735189797","y":"0.4967660968704604","size":"8.31378915840787"},{"id":"prostate cancer","label":"prostate cancer","color":"orange","x":"0.16440244247001107","y":"0.47504667205429246","size":"10.77668018732531"},{"id":"castration-resistant prostatic neoplasms","label":"castration-resistant prostatic neoplasms","color":"orange","x":"0.2798625112450686","y":"0.48074425950818017","size":"11.060938022019789"},{"id":"bone diseases","label":"bone diseases","color":"orange","x":"0.7248185623087446","y":"0.47532022733328794","size":"9.194245453686277"},{"id":"anti-inflammatory","label":"anti-inflammatory","color":"orange","x":"-0.12105401478188599","y":"0.4484772881327284","size":"12.06649882040626"},{"id":"asthma","label":"asthma","color":"orange","x":"-0.06555937104331871","y":"0.48091205344808763","size":"9.933858671331224"},{"id":"antiallergic","label":"antiallergic","color":"orange","x":"0.20214877425232197","y":"0.4478973679154841","size":"10.60286965602925"},{"id":"hypersensitivity","label":"hypersensitivity","color":"orange","x":"0.380289418216092","y":"0.48708904797010544","size":"10.043000858809588"},{"id":"inflammation","label":"inflammation","color":"orange","x":"0.47389138829153316","y":"0.5232418386403754","size":"11.631679304643757"},{"id":"analgesic","label":"analgesic","color":"orange","x":"1.2015465915466887","y":"0.4392919646620532","size":"9.286662482156343"},{"id":"antiemetic","label":"antiemetic","color":"orange","x":"1.3758003454685575","y":"0.4457848593020641","size":"5.569716761534184"},{"id":"pain","label":"pain","color":"orange","x":"0.7785266033517377","y":"0.42769011776397337","size":"9.286662482156343"},{"id":"vomiting","label":"vomiting","color":"orange","x":"1.0159509156789452","y":"0.4201261099227967","size":"5.569716761534184"},{"id":"anti-tumor","label":"anti-tumor","color":"orange","x":"-0.10461845900996491","y":"0.5266926262788015","size":"12.921656121837655"},{"id":"kidney neoplasms","label":"kidney neoplasms","color":"orange","x":"-0.24145754957856935","y":"0.514170679970964","size":"11.836779605130094"},{"id":"renal cancer","label":"renal cancer","color":"orange","x":"0.48904826019073194","y":"0.5295069403880037","size":"12.132556306822877"},{"id":"renal cell","label":"renal cell","color":"orange","x":"-0.057460541192237036","y":"0.4014514618365513","size":"11.3707892463184"},{"id":"primary peritoneal cancer","label":"primary peritoneal cancer","color":"orange","x":"0.16678850340372636","y":"0.4593779257209338","size":"9.256291743595376"},{"id":"anti-hiv","label":"anti-hiv","color":"orange","x":"0.5360545459858674","y":"0.41538436741863083","size":"12.341736652060787"},{"id":"squamous cell neoplasms","label":"squamous cell neoplasms","color":"orange","x":"1.2162557196772898","y":"0.5396515806079841","size":"13.481781943666661"},{"id":"hiv infections","label":"hiv infections","color":"orange","x":"0.7944945300329052","y":"0.490462462451158","size":"12.349110079890815"},{"id":"uterine cervical neoplasms","label":"uterine cervical neoplasms","color":"orange","x":"1.085986017436808","y":"0.4318843846032806","size":"10.552948551496243"},{"id":"mesothelial","label":"mesothelial","color":"orange","x":"0.9582812063548432","y":"0.4690071867772594","size":"11.324089115047682"},{"id":"solid tumors","label":"solid tumors","color":"orange","x":"0.13399883827647036","y":"0.5237677705743597","size":"15.124479800537426"},{"id":"acquired immunodeficiency syndrome","label":"acquired immunodeficiency syndrome","color":"orange","x":"0.7482183526375137","y":"0.4322309834619408","size":"12.326914257242091"},{"id":"esophageal cancer","label":"esophageal cancer","color":"orange","x":"0.48389659222367093","y":"0.4123568029388699","size":"10.715074001270475"},{"id":"liver cancer","label":"liver cancer","color":"orange","x":"0.3932696375334473","y":"0.5475598617058068","size":"10.359410036530628"},{"id":"cervical cancer","label":"cervical cancer","color":"orange","x":"1.327323389876974","y":"0.4034905294783909","size":"9.911356165197843"},{"id":"pharyngeal neoplasms","label":"pharyngeal neoplasms","color":"orange","x":"0.5842920002084371","y":"0.43255920596967046","size":"12.631696386949221"},{"id":"esophageal neoplasms","label":"esophageal neoplasms","color":"orange","x":"0.5962273865279228","y":"0.5233707859116439","size":"8.890756251918218"},{"id":"peritoneal neoplasms","label":"peritoneal neoplasms","color":"orange","x":"1.3243883081902357","y":"0.5366760679120228","size":"10.284524256682364"},{"id":"stomach neoplasms","label":"stomach neoplasms","color":"orange","x":"1.3076425927717221","y":"0.49973972517920184","size":"10.77668018732531"},{"id":"sclc","label":"sclc","color":"orange","x":"-0.11138416862682082","y":"0.4506563788598389","size":"13.894372360013698"},{"id":"hepatocellular","label":"hepatocellular","color":"orange","x":"0.7292187648758934","y":"0.43250363979248757","size":"10.359410036530628"},{"id":"solid malignancy","label":"solid malignancy","color":"orange","x":"-0.07194632409077423","y":"0.4401640026171758","size":"12.463801945134188"},{"id":"gastric cancer","label":"gastric cancer","color":"orange","x":"0.327397189590836","y":"0.40427158650377476","size":"8.537850880489682"},{"id":"hpv type","label":"hpv type","color":"orange","x":"1.1275747612447624","y":"0.4723451871733911","size":"9.88861802644424"},{"id":"infectious disease","label":"infectious disease","color":"orange","x":"0.5191267693759793","y":"0.42981439073337335","size":"7.456808469171364"},{"id":"papilloma","label":"papilloma","color":"orange","x":"0.44183281144119885","y":"0.49573351279257794","size":"11.3707892463184"},{"id":"communicable diseases","label":"communicable diseases","color":"orange","x":"0.12715532427362525","y":"0.5435792767759665","size":"7.456808469171364"},{"id":"hypertension","label":"hypertension","color":"orange","x":"1.037765831756142","y":"0.5120910167779574","size":"10.683602835782033"},{"id":"hemorrhage","label":"hemorrhage","color":"orange","x":"0.6052016818816686","y":"0.4792262129322446","size":"9.097719677709344"},{"id":"bleeding","label":"bleeding","color":"orange","x":"-0.08663496775422158","y":"0.41218910418771393","size":"9.097719677709344"},{"id":"psoriasis","label":"psoriasis","color":"orange","x":"0.11957208112351819","y":"0.4384354918322082","size":"13.820880661951653"},{"id":"antihypertensive","label":"antihypertensive","color":"orange","x":"-0.11302074936150736","y":"0.41150036646112187","size":"9.542425094393248"},{"id":"lung neoplasms","label":"lung neoplasms","color":"orange","x":"1.352233448096279","y":"0.5437389866372073","size":"13.167342277897934"},{"id":"antiarrhythmic","label":"antiarrhythmic","color":"orange","x":"1.1469181211251342","y":"0.45327116249349336","size":"6.15224460689137"},{"id":"cardiac arrhythmias","label":"cardiac arrhythmias","color":"orange","x":"0.7616781172807814","y":"0.4835161394527719","size":"10.552948551496243"},{"id":"antiarthritic","label":"antiarthritic","color":"orange","x":"0.5575796900121515","y":"0.44393630711067883","size":"13.079750258282006"},{"id":"hypopigmentation","label":"hypopigmentation","color":"orange","x":"0.553481753317641","y":"0.4362312256855893","size":"7.955323035132496"},{"id":"gilbert disease","label":"gilbert disease","color":"orange","x":"0.701174532004563","y":"0.4405635475669642","size":"13.299581000349253"},{"id":"multiple sclerosis","label":"multiple sclerosis","color":"orange","x":"0.9616259350447312","y":"0.5025739931576937","size":"10.064186123525861"},{"id":"alopecia","label":"alopecia","color":"orange","x":"0.5644432393980341","y":"0.43406030549193897","size":"11.780129285965613"},{"id":"arthritis","label":"arthritis","color":"orange","x":"0.6047565170483566","y":"0.5028899153456904","size":"13.131701836875212"},{"id":"vitiligo","label":"vitiligo","color":"orange","x":"0.4240044095500726","y":"0.5262600714301423","size":"7.955323035132496"},{"id":"gilbert syndrome","label":"gilbert syndrome","color":"orange","x":"0.006625579195353559","y":"0.493737558850655","size":"11.79917741169944"},{"id":"lung cancer","label":"lung cancer","color":"orange","x":"1.0616139611436264","y":"0.5263618586407179","size":"10.7460955632769"},{"id":"diabetes mellitus","label":"diabetes mellitus","color":"orange","x":"-0.0641161567809912","y":"0.4345098776937849","size":"12.258932177621451"},{"id":"antidiabetic","label":"antidiabetic","color":"orange","x":"1.2981761121041373","y":"0.43701330724483795","size":"10.7460955632769"},{"id":"inflammatory breast cancer","label":"inflammatory breast cancer","color":"orange","x":"1.1017121503520553","y":"0.49719469678135175","size":"6.15224460689137"},{"id":"tnbc","label":"tnbc","color":"orange","x":"0.7920883664056793","y":"0.4861401595492555","size":"10.7460955632769"},{"id":"sarcoma","label":"sarcoma","color":"orange","x":"0.28339060707211944","y":"0.41048243331556433","size":"12.559416804894372"},{"id":"spasm","label":"spasm","color":"orange","x":"0.8110777000359581","y":"0.4792852573845542","size":"9.43245362586241"},{"id":"inflammatory bowel diseases","label":"inflammatory bowel diseases","color":"orange","x":"0.45781235296968353","y":"0.5015447770386667","size":"11.537480189566065"},{"id":"peptic ulcer","label":"peptic ulcer","color":"orange","x":"1.3666005709224784","y":"0.49929579779314887","size":"7.955323035132496"},{"id":"endometrial neoplasms","label":"endometrial neoplasms","color":"orange","x":"0.125997547368012","y":"0.5128022953827923","size":"10.16711877743475"},{"id":"endometrioid","label":"endometrioid","color":"orange","x":"0.7428149693445512","y":"0.46903702016956944","size":"10.377734806962655"},{"id":"antiulcer","label":"antiulcer","color":"orange","x":"0.9589551558399108","y":"0.4235624729944986","size":"7.955323035132496"},{"id":"soft tissue neoplasms","label":"soft tissue neoplasms","color":"orange","x":"0.3788741711194373","y":"0.5312929160556568","size":"9.515449934959717"},{"id":"antithrombotic","label":"antithrombotic","color":"orange","x":"-0.008244275669058554","y":"0.4149304198080262","size":"6.712113404111031"},{"id":"thrombosis","label":"thrombosis","color":"orange","x":"1.3393980938216687","y":"0.4337408498532451","size":"6.712113404111031"},{"id":"uterine cancer","label":"uterine cancer","color":"orange","x":"0.41796687081470735","y":"0.492309803294514","size":"6.712113404111031"},{"id":"lipomatous","label":"lipomatous","color":"orange","x":"0.9495439419420113","y":"0.49958919139888514","size":"5.880456295278407"},{"id":"heart failure","label":"heart failure","color":"orange","x":"0.5930015541284619","y":"0.49863460220411504","size":"11.494265382048534"},{"id":"unstable angina","label":"unstable angina","color":"orange","x":"0.912316242294448","y":"0.4464764311721959","size":"9.3753063169585"},{"id":"myocardial infarction","label":"myocardial infarction","color":"orange","x":"0.8091136749889272","y":"0.42653126446034234","size":"9.3753063169585"},{"id":"malignancies","label":"malignancies","color":"orange","x":"0.16374482620731806","y":"0.5466490712586081","size":"8.740940135031002"},{"id":"bladder cancer","label":"bladder cancer","color":"orange","x":"0.8435050839489173","y":"0.4357799267950524","size":"11.139433523068368"},{"id":"malaria","label":"malaria","color":"orange","x":"0.2587508445972441","y":"0.44879250893602096","size":"12.435691877385933"},{"id":"urinary bladder neoplasms","label":"urinary bladder neoplasms","color":"orange","x":"-0.15944005169119832","y":"0.4402206413445646","size":"11.87374173005052"},{"id":"brain metastases","label":"brain metastases","color":"orange","x":"0.7129093451624617","y":"0.49425062127845193","size":"11.202746241412997"},{"id":"microsatellite instability","label":"microsatellite instability","color":"orange","x":"0.7507568003282716","y":"0.4152400638314037","size":"9.933858671331224"},{"id":"neurologic dysfunction","label":"neurologic dysfunction","color":"orange","x":"1.254339848725879","y":"0.5155767169321491","size":"4.771212547196624"},{"id":"neurologic manifestations","label":"neurologic manifestations","color":"orange","x":"-0.17925067940383468","y":"0.5301191443482284","size":"6.15224460689137"},{"id":"colon cancer","label":"colon cancer","color":"orange","x":"-0.024617775308133583","y":"0.4483803732382804","size":"5.880456295278407"},{"id":"cerebellar neoplasms","label":"cerebellar neoplasms","color":"orange","x":"1.3802239203012858","y":"0.5142667468458025","size":"11.113582355737917"},{"id":"lymphoma","label":"lymphoma","color":"orange","x":"0.8615196350031884","y":"0.5337165030843778","size":"13.81339281863718"},{"id":"plasma cell","label":"plasma cell","color":"orange","x":"1.1776100642493534","y":"0.5373828123983276","size":"10.303489201768059"},{"id":"multiple myeloma","label":"multiple myeloma","color":"orange","x":"0.8055906568146749","y":"0.40521955282718586","size":"9.865639267998493"},{"id":"proteinuria","label":"proteinuria","color":"orange","x":"-0.37803817486388613","y":"0.4273374060433429","size":"7.235790156711096"},{"id":"neoplastic","label":"neoplastic","color":"orange","x":"0.10531599999323854","y":"0.5497143950670678","size":"8.580016718173995"},{"id":"amenorrheic","label":"amenorrheic","color":"orange","x":"0.43981388102056523","y":"0.4652583213460245","size":"10.993285434772114"},{"id":"infertility","label":"infertility","color":"orange","x":"-0.07012259589880604","y":"0.41202573863971537","size":"5.569716761534184"},{"id":"sterility","label":"sterility","color":"orange","x":"-0.08807535698785046","y":"0.5086809009335808","size":"5.569716761534184"},{"id":"abdominal metastasis","label":"abdominal metastasis","color":"orange","x":"1.2485459857461632","y":"0.5071379627631805","size":"7.156818820794937"},{"id":"abdominal neoplasms","label":"abdominal neoplasms","color":"orange","x":"0.8420488526019474","y":"0.4406286554566515","size":"7.156818820794937"},{"id":"fallopian tube neoplasms","label":"fallopian tube neoplasms","color":"orange","x":"0.3289351772564412","y":"0.49495497949253897","size":"11.90105620855803"},{"id":"antianaemic","label":"antianaemic","color":"orange","x":"0.7082347266488798","y":"0.44823732240449604","size":"10.923457154087995"},{"id":"dehydration","label":"dehydration","color":"orange","x":"-0.04176285439003996","y":"0.5154362328339448","size":"4.225490200071284"},{"id":"anemia","label":"anemia","color":"orange","x":"-0.005610227078386765","y":"0.5045396197623239","size":"11.22756333907075"},{"id":"pleural mesothelioma","label":"pleural mesothelioma","color":"orange","x":"0.4259657404189549","y":"0.5174639159710188","size":"7.5257498915995305"},{"id":"vascular headaches","label":"vascular headaches","color":"orange","x":"1.0483852304448271","y":"0.5293805786827886","size":"7.31198998949478"},{"id":"brain disease","label":"brain disease","color":"orange","x":"-0.07413969564062584","y":"0.4975409395319832","size":"7.31198998949478"},{"id":"migraine disorders","label":"migraine disorders","color":"orange","x":"-0.31313753335834676","y":"0.5325419916661333","size":"5.880456295278407"},{"id":"central nervous system diseases","label":"central nervous system diseases","color":"orange","x":"-0.17622304545785164","y":"0.48663814927580995","size":"6.808639180087964"},{"id":"antimigraine","label":"antimigraine","color":"orange","x":"1.0752667138745369","y":"0.5214882300862973","size":"5.880456295278407"},{"id":"lymph node metastasis","label":"lymph node metastasis","color":"orange","x":"1.1193040095456206","y":"0.4394527978349744","size":"5.206963425791125"},{"id":"depression","label":"depression","color":"orange","x":"-0.09790438894956438","y":"0.4919383470880304","size":"8.661968799114844"},{"id":"copd","label":"copd","color":"orange","x":"1.362181624388938","y":"0.49325751361021664","size":"10.126529326323851"},{"id":"antidepressant","label":"antidepressant","color":"orange","x":"0.5096703896300043","y":"0.4348459961070743","size":"8.661968799114844"},{"id":"chronic obstructive pulmonary disease","label":"chronic obstructive pulmonary disease","color":"orange","x":"0.3315560991922047","y":"0.5326042177384078","size":"10.431799153373742"},{"id":"clear cell","label":"clear cell","color":"orange","x":"0.9432652092673222","y":"0.4615954623957006","size":"7.841008620334975"},{"id":"glandular and epithelial","label":"glandular and epithelial","color":"orange","x":"0.7711281406156869","y":"0.4336019087273699","size":"10.41392685158225"},{"id":"serous","label":"serous","color":"orange","x":"1.1804688998914967","y":"0.46553820270529955","size":"6.712113404111031"},{"id":"mucinous","label":"mucinous","color":"orange","x":"1.287208488670508","y":"0.4955754430852609","size":"5.395906230238125"},{"id":"mouth neoplasms","label":"mouth neoplasms","color":"orange","x":"0.3127308377787134","y":"0.515955947508336","size":"8.580016718173995"},{"id":"atrial fibrillation","label":"atrial fibrillation","color":"orange","x":"0.6382392116277655","y":"0.5112441738975632","size":"5"},{"id":"kidney cancer","label":"kidney cancer","color":"orange","x":"0.14083915665455676","y":"0.40412760068702386","size":"5"},{"id":"hypertrophy","label":"hypertrophy","color":"orange","x":"1.1227914850518332","y":"0.45996648983904653","size":"5.395906230238125"},{"id":"refractory myeloma","label":"refractory myeloma","color":"orange","x":"0.5553594854965738","y":"0.4012973262461711","size":"7.841008620334975"},{"id":"pleural effusion","label":"pleural effusion","color":"orange","x":"0.6434175638203019","y":"0.4018584339669376","size":"6.505149978319906"},{"id":"edema","label":"edema","color":"orange","x":"1.2353995315816528","y":"0.42702587947182397","size":"5.206963425791125"},{"id":"hydrothorax","label":"hydrothorax","color":"orange","x":"0.3956111534055548","y":"0.485076922294175","size":"5.73064017839119"},{"id":"bone metastasis","label":"bone metastasis","color":"orange","x":"-0.023030923925156488","y":"0.43979415833973373","size":"10.431799153373742"},{"id":"peau d'orange","label":"peau d'orange","color":"orange","x":"0.8409278123900881","y":"0.4769302598279918","size":"3.8907562519182184"},{"id":"erythema exudativum multiforme","label":"erythema exudativum multiforme","color":"orange","x":"1.3732610426227803","y":"0.5392555333624003","size":"5.206963425791125"},{"id":"thyroid neoplasms","label":"thyroid neoplasms","color":"orange","x":"0.274412740915515","y":"0.5036761336685283","size":"6.712113404111031"},{"id":"thyroid cancer","label":"thyroid cancer","color":"orange","x":"0.7679314556450176","y":"0.45469474248568426","size":"4.225490200071284"},{"id":"peritoneal mesothelioma","label":"peritoneal mesothelioma","color":"orange","x":"-0.11792017180732217","y":"0.4741749081707179","size":"4.225490200071284"},{"id":"neurologic symptoms","label":"neurologic symptoms","color":"orange","x":"-0.3467957687411702","y":"0.44134087183404136","size":"4.771212547196624"},{"id":"hematologic neoplasms","label":"hematologic neoplasms","color":"orange","x":"0.8196316824575072","y":"0.5469528090026122","size":"6.505149978319906"},{"id":"basal cell neoplasms","label":"basal cell neoplasms","color":"orange","x":"0.7368420777715923","y":"0.452372796343195","size":"9.225490200071285"},{"id":"epstein-barr","label":"epstein-barr","color":"orange","x":"0.906274821340957","y":"0.4137228057799202","size":"4.515449934959718"},{"id":"infectious mononucleosis","label":"infectious mononucleosis","color":"orange","x":"-0.19228560737449044","y":"0.4438147051160421","size":"4.515449934959718"},{"id":"bundle branch block","label":"bundle branch block","color":"orange","x":"0.09772984591079303","y":"0.40232383608688516","size":"7.31198998949478"},{"id":"urologic neoplasms","label":"urologic neoplasms","color":"orange","x":"0.8648952583386913","y":"0.41816583910858","size":"6.712113404111031"},{"id":"cancer of the urinary tract","label":"cancer of the urinary tract","color":"orange","x":"0.5165341079581964","y":"0.4264186237878685","size":"6.712113404111031"},{"id":"essential thrombocythemia","label":"essential thrombocythemia","color":"orange","x":"-0.04099944987768339","y":"0.4864257317991724","size":"4.225490200071284"},{"id":"lymphocytic","label":"lymphocytic","color":"orange","x":"0.6941651100125701","y":"0.5245349191474181","size":"6.15224460689137"},{"id":"myelofibrosis","label":"myelofibrosis","color":"orange","x":"0.7107457341116732","y":"0.5441198062068455","size":"8.360489289678588"},{"id":"b-cell","label":"b-cell","color":"orange","x":"-0.09285547085024293","y":"0.45756215520161103","size":"8.360489289678588"},{"id":"dlbcl","label":"dlbcl","color":"orange","x":"0.1739349783796162","y":"0.44207651126409564","size":"7.5257498915995305"},{"id":"wm","label":"wm","color":"orange","x":"-0.16402884673011844","y":"0.4017854228971379","size":"4.225490200071284"},{"id":"lymphoid","label":"lymphoid","color":"orange","x":"-0.030875064092729054","y":"0.43433054270531807","size":"4.225490200071284"},{"id":"lymphadenopathy","label":"lymphadenopathy","color":"orange","x":"-0.34873904922598953","y":"0.4175950424077486","size":"4.225490200071284"},{"id":"waldenstrom macroglobulinemia","label":"waldenstrom macroglobulinemia","color":"orange","x":"0.37816191217428613","y":"0.5242509689064527","size":"5.569716761534184"},{"id":"polycythemia vera","label":"polycythemia vera","color":"orange","x":"0.6407764389450028","y":"0.5216919921656553","size":"4.225490200071284"},{"id":"thrombocytopenia","label":"thrombocytopenia","color":"orange","x":"1.26954185904163","y":"0.4197792436602558","size":"4.225490200071284"},{"id":"lymphatic diseases","label":"lymphatic diseases","color":"orange","x":"0.8269388719584696","y":"0.40440792057005515","size":"6.15224460689137"},{"id":"neuropathy","label":"neuropathy","color":"orange","x":"1.2392301697288943","y":"0.45930975324334994","size":"9.911356165197843"},{"id":"splenomegaly","label":"splenomegaly","color":"orange","x":"-0.15441252969418565","y":"0.4681922670843353","size":"4.225490200071284"},{"id":"hodgkin disease","label":"hodgkin disease","color":"orange","x":"0.20571404146971622","y":"0.5228804442107169","size":"8.217263382430938"},{"id":"hematologic malignancy","label":"hematologic malignancy","color":"orange","x":"0.45280368388128084","y":"0.46067002695665316","size":"4.225490200071284"},{"id":"non-hodgkin","label":"non-hodgkin","color":"orange","x":"0.1282697501563867","y":"0.47664116521722993","size":"9.515449934959717"},{"id":"insulinoma","label":"insulinoma","color":"orange","x":"0.9083831982290804","y":"0.4346037319343021","size":"4.225490200071284"},{"id":"gastrointestinal stromal tumors","label":"gastrointestinal stromal tumors","color":"orange","x":"0.9187543096464916","y":"0.4292285982630509","size":"6.15224460689137"},{"id":"cancer squamous cell","label":"cancer squamous cell","color":"orange","x":"0.682002953618134","y":"0.484207397845315","size":"5.73064017839119"},{"id":"larynx cancer","label":"larynx cancer","color":"orange","x":"-0.2702769405142571","y":"0.5412206988205588","size":"8.779374278362457"},{"id":"oropharyngeal cancer","label":"oropharyngeal cancer","color":"orange","x":"0.12762772993378851","y":"0.4073745892891242","size":"9.569069261918584"},{"id":"hpv testing","label":"hpv testing","color":"orange","x":"1.30883762332294","y":"0.4161117142191628","size":"7.720340221751378"},{"id":"chronic hepatitis b","label":"chronic hepatitis b","color":"orange","x":"-0.38225139827558624","y":"0.4418932197890517","size":"11.190230515643977"},{"id":"hcc","label":"hcc","color":"orange","x":"1.1535377273585137","y":"0.4933553549336978","size":"9.865639267998493"},{"id":"liver diseases","label":"liver diseases","color":"orange","x":"0.7173512855823216","y":"0.42582465577566864","size":"9.842414742769677"},{"id":"liver cirrhosis","label":"liver cirrhosis","color":"orange","x":"1.265822050827223","y":"0.45214925853036303","size":"9.346158598654881"},{"id":"condylomata acuminata","label":"condylomata acuminata","color":"orange","x":"0.39565992565070035","y":"0.49157045787116027","size":"6.393768004764144"},{"id":"autoimmune diseases","label":"autoimmune diseases","color":"orange","x":"0.6045830968088108","y":"0.41107214081829463","size":"10.303489201768059"},{"id":"aml","label":"aml","color":"orange","x":"0.9793410178642001","y":"0.4801135078067896","size":"6.808639180087964"},{"id":"hematologic diseases","label":"hematologic diseases","color":"orange","x":"0.932019979442402","y":"0.40259337929384087","size":"8.266062568876718"},{"id":"hepatic metastases","label":"hepatic metastases","color":"orange","x":"1.0228126331548058","y":"0.523050476443996","size":"8.360489289678588"},{"id":"inflamed","label":"inflamed","color":"orange","x":"1.0394573384908778","y":"0.43925179288111615","size":"6.2763625255165305"},{"id":"human immunodeficiency virus","label":"human immunodeficiency virus","color":"orange","x":"0.28782082508956935","y":"0.4457436756206215","size":"9.225490200071285"},{"id":"respiratory tract infections","label":"respiratory tract infections","color":"orange","x":"0.7448294559205435","y":"0.4549566825857579","size":"5"},{"id":"infected with hiv","label":"infected with hiv","color":"orange","x":"1.1915170506094919","y":"0.4464354520062343","size":"5"},{"id":"pneumococcal infections","label":"pneumococcal infections","color":"orange","x":"1.0552286819022159","y":"0.4754739136746813","size":"5"},{"id":"interstitial lung diseases","label":"interstitial lung diseases","color":"orange","x":"0.26856961502732374","y":"0.4193958657461442","size":"8.779374278362457"},{"id":"second primary neoplasms","label":"second primary neoplasms","color":"orange","x":"-0.29254800428546474","y":"0.5218426469958044","size":"6.15224460689137"},{"id":"allergies","label":"allergies","color":"orange","x":"-0.15294360489442835","y":"0.410240188110809","size":"4.771212547196624"},{"id":"hiv) 1","label":"hiv) 1","color":"orange","x":"0.4532445881609333","y":"0.4792537457446184","size":"7.31198998949478"},{"id":"rcc","label":"rcc","color":"orange","x":"0.448113566718277","y":"0.4434372789329096","size":"10.484550065040281"},{"id":"typhoid fever","label":"typhoid fever","color":"orange","x":"1.2038357170854332","y":"0.47431496916057175","size":"5.206963425791125"},{"id":"immunologic deficiency syndromes","label":"immunologic deficiency syndromes","color":"orange","x":"1.0613831905142865","y":"0.45858470148250774","size":"3.8907562519182184"},{"id":"pituitary insufficiency","label":"pituitary insufficiency","color":"orange","x":"0.6651950033235752","y":"0.4079645826460466","size":"3.8907562519182184"},{"id":"hypothyroidism","label":"hypothyroidism","color":"orange","x":"0.14075363790688017","y":"0.4392583641214934","size":"5.206963425791125"},{"id":"thyroid diseases","label":"thyroid diseases","color":"orange","x":"0.7094360670816349","y":"0.5054708730872338","size":"3.8907562519182184"},{"id":"yellow fever","label":"yellow fever","color":"orange","x":"-0.17882330596116985","y":"0.5018780747016957","size":"3.8907562519182184"},{"id":"parotitis","label":"parotitis","color":"orange","x":"-0.3488469449632101","y":"0.47475342984093344","size":"3.8907562519182184"},{"id":"influenza a (h1n1)","label":"influenza a (h1n1)","color":"orange","x":"-0.26852318195408703","y":"0.4027117758239433","size":"6.611096473669597"},{"id":"shingles","label":"shingles","color":"orange","x":"0.5086719385703748","y":"0.4998912170319989","size":"3.8907562519182184"},{"id":"pneumonitis","label":"pneumonitis","color":"orange","x":"-0.3848635945609943","y":"0.5171426521141675","size":"6.90105620855803"},{"id":"mumps","label":"mumps","color":"orange","x":"0.555405583643096","y":"0.43610029780686227","size":"3.8907562519182184"},{"id":"chickenpox","label":"chickenpox","color":"orange","x":"0.48596694425533055","y":"0.5126864399438006","size":"5.206963425791125"},{"id":"rubella","label":"rubella","color":"orange","x":"0.9821846335368127","y":"0.5222036139909589","size":"3.8907562519182184"},{"id":"rabies","label":"rabies","color":"orange","x":"-0.03996589339893453","y":"0.4379656910772316","size":"3.8907562519182184"},{"id":"measles","label":"measles","color":"orange","x":"1.3527938194486706","y":"0.4432895344263013","size":"6.020599913279624"},{"id":"skin cancer","label":"skin cancer","color":"orange","x":"-0.051168596938004185","y":"0.5162017963614887","size":"5.73064017839119"},{"id":"cancer in situ","label":"cancer in situ","color":"orange","x":"0.8399776564216153","y":"0.43150504403008655","size":"3.8907562519182184"},{"id":"hypopituitarism","label":"hypopituitarism","color":"orange","x":"0.034803497534570016","y":"0.41480051179532124","size":"3.8907562519182184"},{"id":"pneumonia","label":"pneumonia","color":"orange","x":"1.0993565064810746","y":"0.43350229468535845","size":"6.90105620855803"},{"id":"herpes zoster","label":"herpes zoster","color":"orange","x":"0.2954853233062151","y":"0.4149347000593868","size":"3.8907562519182184"},{"id":"astrocytoma","label":"astrocytoma","color":"orange","x":"-0.24792872859753762","y":"0.4618695152795917","size":"6.989700043360188"},{"id":"neuroendocrine tumors","label":"neuroendocrine tumors","color":"orange","x":"1.3856399642595705","y":"0.47457588928926703","size":"5.206963425791125"},{"id":"carcinoid tumors","label":"carcinoid tumors","color":"orange","x":"0.8893977217508138","y":"0.5270315709279534","size":"5.206963425791125"},{"id":"salivary gland neoplasms","label":"salivary gland neoplasms","color":"orange","x":"0.9633499987729479","y":"0.54569254389849","size":"5.395906230238125"},{"id":"npc","label":"npc","color":"orange","x":"0.22207067492857108","y":"0.4736360123138754","size":"7.156818820794937"},{"id":"gbm","label":"gbm","color":"orange","x":"0.029951700967980555","y":"0.520408491661384","size":"6.2763625255165305"},{"id":"parotid neoplasms","label":"parotid neoplasms","color":"orange","x":"0.22841026611892262","y":"0.4280007220047597","size":"5.395906230238125"},{"id":"cellulitis","label":"cellulitis","color":"orange","x":"1.0419382781684141","y":"0.44755256441735464","size":"5.569716761534184"},{"id":"deafness","label":"deafness","color":"orange","x":"0.5732076163153961","y":"0.5190869750394773","size":"6.393768004764144"},{"id":"transitional","label":"transitional","color":"orange","x":"0.37264216282198265","y":"0.5252018793553103","size":"8.31378915840787"},{"id":"hearing loss","label":"hearing loss","color":"orange","x":"0.7992524634295994","y":"0.5401509524690873","size":"6.393768004764144"},{"id":"thoracic neoplasms","label":"thoracic neoplasms","color":"orange","x":"0.07101600478993286","y":"0.5233705208645147","size":"4.225490200071284"},{"id":"thoracic tumours","label":"thoracic tumours","color":"orange","x":"1.0697221725241923","y":"0.41718331372386736","size":"4.225490200071284"},{"id":"malabsorption syndromes","label":"malabsorption syndromes","color":"orange","x":"0.8833315202795662","y":"0.4344931357397679","size":"6.393768004764144"},{"id":"antiparkinsonian","label":"antiparkinsonian","color":"orange","x":"0.9292917528001252","y":"0.5462500474718447","size":"6.393768004764144"},{"id":"parkinson disease","label":"parkinson disease","color":"orange","x":"1.0002500409856707","y":"0.4534199498213836","size":"6.393768004764144"},{"id":"stem cell transplantation","label":"stem cell transplantation","color":"orange","x":"1.0130203160251874","y":"0.4730054535189608","size":"10.16711877743475"},{"id":"biliary tract neoplasms","label":"biliary tract neoplasms","color":"orange","x":"-0.011683009743146122","y":"0.5005147402709894","size":"4.515449934959718"},{"id":"diffuse","label":"diffuse","color":"orange","x":"1.2463338383424407","y":"0.5057216494624225","size":"6.2763625255165305"},{"id":"hypercalcemia","label":"hypercalcemia","color":"orange","x":"0.41267957483729284","y":"0.4033659998355726","size":"5.206963425791125"},{"id":"plasmacytoma","label":"plasmacytoma","color":"orange","x":"0.12027828138827085","y":"0.42147802690476976","size":"6.611096473669597"},{"id":"hepatic dysfunction","label":"hepatic dysfunction","color":"orange","x":"0.1874457094001018","y":"0.4059544933844763","size":"5.206963425791125"},{"id":"barrett esophagus","label":"barrett esophagus","color":"orange","x":"0.7466878021354999","y":"0.4844790658684133","size":"7.5257498915995305"},{"id":"endometrial cancer","label":"endometrial cancer","color":"orange","x":"0.40177401769413484","y":"0.5189096744383219","size":"8.010299956639813"},{"id":"sezary syndrome","label":"sezary syndrome","color":"orange","x":"0.14128860903257373","y":"0.4103794276673232","size":"5.206963425791125"},{"id":"mycosis fungoides","label":"mycosis fungoides","color":"orange","x":"0.08333122793949721","y":"0.5281531309276499","size":"5.206963425791125"},{"id":"cystic fibrosis","label":"cystic fibrosis","color":"orange","x":"0.19846328915154482","y":"0.5307939396368483","size":"5.206963425791125"},{"id":"mycoses","label":"mycoses","color":"orange","x":"-0.1759410865557072","y":"0.45311034589743304","size":"5.206963425791125"},{"id":"liver transplants","label":"liver transplants","color":"orange","x":"0.4701755068270274","y":"0.46853087290076434","size":"7.456808469171364"},{"id":"urogenital neoplasms","label":"urogenital neoplasms","color":"orange","x":"0.19491808756351042","y":"0.5301356104214752","size":"4.771212547196624"},{"id":"hepatorenal syndrome","label":"hepatorenal syndrome","color":"orange","x":"1.027208287578023","y":"0.42585024801910204","size":"4.771212547196624"},{"id":"necrosis","label":"necrosis","color":"orange","x":"0.3379369988652668","y":"0.48520406121364035","size":"6.808639180087964"},{"id":"liver tumor","label":"liver tumor","color":"orange","x":"0.2872913258638062","y":"0.4124662802906787","size":"6.808639180087964"},{"id":"azoospermia","label":"azoospermia","color":"orange","x":"0.7172011934838958","y":"0.4460570376403051","size":"9.818939136727776"},{"id":"fallopian tube cancer","label":"fallopian tube cancer","color":"orange","x":"0.9018051528043325","y":"0.4228845351493279","size":"7.592569699389438"},{"id":"follicular","label":"follicular","color":"orange","x":"-0.03368307209414573","y":"0.5319204181419682","size":"6.505149978319906"},{"id":"nhl","label":"nhl","color":"orange","x":"1.2908810964597577","y":"0.48880547771211375","size":"6.505149978319906"},{"id":"ischemia","label":"ischemia","color":"orange","x":"1.2963550568379398","y":"0.5464946319537354","size":"5"},{"id":"cessation of menses","label":"cessation of menses","color":"orange","x":"-0.3053283168775057","y":"0.40523458126367096","size":"6.2763625255165305"},{"id":"tonsillar neoplasms","label":"tonsillar neoplasms","color":"orange","x":"0.4824717066419078","y":"0.47747931783914616","size":"5.206963425791125"},{"id":"tonsil cancers","label":"tonsil cancers","color":"orange","x":"0.783932085898416","y":"0.5325371224980753","size":"5.206963425791125"},{"id":"sjogren's syndrome","label":"sjogren's syndrome","color":"orange","x":"-0.07697699089791005","y":"0.5374527268460464","size":"5.206963425791125"},{"id":"joint diseases","label":"joint diseases","color":"orange","x":"0.7401863198039971","y":"0.41074725083699914","size":"5.206963425791125"},{"id":"hepatitis c virus","label":"hepatitis c virus","color":"orange","x":"0.7041413202564115","y":"0.5403220064753644","size":"7.456808469171364"},{"id":"guillain-barre syndrome","label":"guillain-barre syndrome","color":"orange","x":"0.960540412777064","y":"0.40721856641745846","size":"5.206963425791125"},{"id":"crohn disease","label":"crohn disease","color":"orange","x":"0.344050015856807","y":"0.4925053178300556","size":"5.206963425791125"},{"id":"systemic lupus erythematosus","label":"systemic lupus erythematosus","color":"orange","x":"1.2615319372360583","y":"0.4382176645104041","size":"5.206963425791125"},{"id":"stevens-johnson syndrome","label":"stevens-johnson syndrome","color":"orange","x":"0.7564436381942028","y":"0.5161555007030292","size":"5.206963425791125"},{"id":"hcv","label":"hcv","color":"orange","x":"1.108433477670702","y":"0.48921157680025207","size":"8.063919283598677"},{"id":"demyelinating","label":"demyelinating","color":"orange","x":"0.22979622309388342","y":"0.4943668298899129","size":"6.611096473669597"},{"id":"residual cancer","label":"residual cancer","color":"orange","x":"0.7655063564273841","y":"0.4821015498638338","size":"5.206963425791125"},{"id":"crohn's","label":"crohn's","color":"orange","x":"0.4047359983759518","y":"0.4067219221025761","size":"5.206963425791125"},{"id":"bladder tumor","label":"bladder tumor","color":"orange","x":"0.18443960367231077","y":"0.41509045443618975","size":"5.206963425791125"},{"id":"arthropathies","label":"arthropathies","color":"orange","x":"0.634095235646605","y":"0.43704008080851997","size":"5.206963425791125"},{"id":"toxic epidermal necrolysis","label":"toxic epidermal necrolysis","color":"orange","x":"0.5227102640557122","y":"0.5178207408687929","size":"5.206963425791125"},{"id":"connective tissue diseases","label":"connective tissue diseases","color":"orange","x":"-0.24437714272929628","y":"0.47519159535977157","size":"5.206963425791125"},{"id":"systemic scleroderma","label":"systemic scleroderma","color":"orange","x":"1.25334475735779","y":"0.49435321467780846","size":"6.611096473669597"},{"id":"ulcerative colitis","label":"ulcerative colitis","color":"orange","x":"0.46802618155880277","y":"0.49885719235848525","size":"5.206963425791125"},{"id":"thyroiditis","label":"thyroiditis","color":"orange","x":"0.40969064321302745","y":"0.5182515877770091","size":"5.206963425791125"},{"id":"myasthenia gravis","label":"myasthenia gravis","color":"orange","x":"0.6426977260867706","y":"0.4232796719355882","size":"5.206963425791125"},{"id":"mantle-cell","label":"mantle-cell","color":"orange","x":"0.6200271505972277","y":"0.4056226741523593","size":"5.206963425791125"},{"id":"mycobacterium infections","label":"mycobacterium infections","color":"orange","x":"-0.00012615304326457633","y":"0.4954728405581875","size":"5.206963425791125"},{"id":"t-cell","label":"t-cell","color":"orange","x":"0.9795921432657939","y":"0.4124430280016441","size":"6.020599913279624"},{"id":"hsct","label":"hsct","color":"orange","x":"0.05925769652759788","y":"0.4309784751068412","size":"5.206963425791125"},{"id":"tuberculosis","label":"tuberculosis","color":"orange","x":"-0.31341792283903364","y":"0.5367133667546529","size":"5.206963425791125"},{"id":"marginal zone","label":"marginal zone","color":"orange","x":"-0.03662041548171352","y":"0.5367022879606599","size":"5.206963425791125"},{"id":"aids","label":"aids","color":"orange","x":"1.1870003721344122","y":"0.4791567688274314","size":"4.515449934959718"},{"id":"hiv seropositivity","label":"hiv seropositivity","color":"orange","x":"-0.14412962008876928","y":"0.47821015497280583","size":"4.515449934959718"},{"id":"ks","label":"ks","color":"orange","x":"0.799215359625381","y":"0.5102734107077471","size":"4.515449934959718"},{"id":"kaposi","label":"kaposi","color":"orange","x":"1.2903281702645353","y":"0.4453644040728826","size":"4.515449934959718"},{"id":"neutropenia","label":"neutropenia","color":"orange","x":"-0.3151891571336408","y":"0.4555540898417466","size":"4.515449934959718"},{"id":"thoracentesis","label":"thoracentesis","color":"orange","x":"0.3542729902547333","y":"0.47271874829159466","size":"4.225490200071284"},{"id":"neuroblastoma","label":"neuroblastoma","color":"orange","x":"1.068703719486019","y":"0.4801296286192014","size":"5.569716761534184"},{"id":"metaplasia","label":"metaplasia","color":"orange","x":"-0.1438225367895296","y":"0.5059276925777719","size":"10.923457154087995"},{"id":"cutaneous","label":"cutaneous","color":"orange","x":"0.784731502122993","y":"0.43118362370886254","size":"3.8907562519182184"},{"id":"myelodysplastic syndromes","label":"myelodysplastic syndromes","color":"orange","x":"0.35780404428262297","y":"0.47895851323866634","size":"4.225490200071284"},{"id":"pancreatitis","label":"pancreatitis","color":"orange","x":"-0.34777205359410945","y":"0.48251201596129945","size":"4.225490200071284"},{"id":"epithelial tumors","label":"epithelial tumors","color":"orange","x":"0.7224715877671593","y":"0.526544052907923","size":"4.225490200071284"},{"id":"salivary gland cancer","label":"salivary gland cancer","color":"orange","x":"-0.23210376871008231","y":"0.5400407182721175","size":"4.225490200071284"},{"id":"medulloblastoma","label":"medulloblastoma","color":"orange","x":"0.2734560431353756","y":"0.49451608086752746","size":"3.8907562519182184"},{"id":"unconjugated hyperbilirubinemia","label":"unconjugated hyperbilirubinemia","color":"orange","x":"1.323813951264587","y":"0.5401094448668234","size":"7.31198998949478"},{"id":"kidney tumor","label":"kidney tumor","color":"orange","x":"-0.036503360408689844","y":"0.5253802118353603","size":"3.8907562519182184"},{"id":"soft tissue metastases","label":"soft tissue metastases","color":"orange","x":"1.0822710785940812","y":"0.5374136457478329","size":"3.8907562519182184"},{"id":"menstruation disturbances","label":"menstruation disturbances","color":"orange","x":"1.38402263499317","y":"0.4578410570492851","size":"6.808639180087964"},{"id":"prostate disorders","label":"prostate disorders","color":"orange","x":"0.917884740210563","y":"0.49800645523437054","size":"6.020599913279624"},{"id":"menstruation disorders","label":"menstruation disorders","color":"orange","x":"0.10193423051721129","y":"0.47751116672247895","size":"6.808639180087964"},{"id":"prostatic diseases","label":"prostatic diseases","color":"orange","x":"0.3635755758459545","y":"0.4342599982763851","size":"6.020599913279624"},{"id":"breast tumor","label":"breast tumor","color":"orange","x":"0.029144943263896717","y":"0.5239922020861867","size":"10.569716761534185"},{"id":"anti-hepatitis b","label":"anti-hepatitis b","color":"orange","x":"1.0262916826855086","y":"0.4570844451997887","size":"3.8907562519182184"},{"id":"hbv","label":"hbv","color":"orange","x":"0.5815283944184106","y":"0.5020984295458263","size":"3.8907562519182184"},{"id":"atrial flutter","label":"atrial flutter","color":"orange","x":"0.4025752176625757","y":"0.5422711939988921","size":"8.779374278362457"},{"id":"teratogenesis","label":"teratogenesis","color":"orange","x":"1.079501863927815","y":"0.48964105442521066","size":"8.779374278362457"},{"id":"cardiac disease","label":"cardiac disease","color":"orange","x":"0.45742892568619625","y":"0.5237999069145998","size":"8.779374278362457"},{"id":"cardiac conditions","label":"cardiac conditions","color":"orange","x":"0.2830038828452786","y":"0.44331908622786215","size":"8.779374278362457"},{"id":"teratogenic","label":"teratogenic","color":"orange","x":"0.573754088915543","y":"0.5041767405967671","size":"8.779374278362457"},{"id":"hypoglycemic","label":"hypoglycemic","color":"orange","x":"0.7487949529537024","y":"0.4736871172614825","size":"10.265392217417098"},{"id":"insulin resistance","label":"insulin resistance","color":"orange","x":"0.4283714625608774","y":"0.48135609027257154","size":"8.779374278362457"},{"id":"aneurysm","label":"aneurysm","color":"orange","x":"-0.18670182394538762","y":"0.40220788694039017","size":"8.779374278362457"},{"id":"heart diseases","label":"heart diseases","color":"orange","x":"1.3605959157212217","y":"0.5453860444103245","size":"8.779374278362457"},{"id":"Immune checkpoint inhibitor","label":"Immune checkpoint inhibitor","color":"green","x":"0.368594542924265","y":"0.32556305232472293","size":"18.442544038282605"},{"id":"Anticancer immunotherapy","label":"Anticancer immunotherapy","color":"green","x":"0.3515185611160096","y":"0.201861376532458","size":"18.47346463165742"},{"id":"NA","label":"NA","color":"green","x":"-0.0021154646436007396","y":"0.3333834029386381","size":"19.34997000060871"},{"id":"Vascular endothelial growth factor (VEGF)receptor antagonist","label":"Vascular endothelial growth factor (VEGF)receptor antagonist","color":"green","x":"-0.22052856870765825","y":"0.2510708423706022","size":"12.02416858309969"},{"id":"Angiogenesis inhibitor","label":"Angiogenesis inhibitor","color":"green","x":"0.32587242542430056","y":"0.34965456165828124","size":"13.49050272811695"},{"id":"CD19 antagonist","label":"CD19 antagonist","color":"green","x":"0.9823865195601225","y":"0.34833828914178944","size":"18.442544038282605"},{"id":"PD-1 antagonist","label":"PD-1 antagonist","color":"green","x":"0.1780968232870735","y":"0.25511564731095715","size":"7.31198998949478"},{"id":"Apoptosis stimulant","label":"Apoptosis stimulant","color":"green","x":"0.5192443134130422","y":"0.27396340567110516","size":"10.206963425791125"},{"id":"Immunostimulant","label":"Immunostimulant","color":"green","x":"1.1883604359725561","y":"0.33457383094312243","size":"14.493625907947468"},{"id":"Lymphocyte-activation gene 3 antagonist","label":"Lymphocyte-activation gene 3 antagonist","color":"green","x":"0.9032685708308217","y":"0.32297532869927603","size":"8.96195844749127"},{"id":"T helper cell stimulant","label":"T helper cell stimulant","color":"green","x":"1.0605465773957135","y":"0.20194609300520025","size":"11.190230515643977"},{"id":"Histamine receptor antagonist","label":"Histamine receptor antagonist","color":"green","x":"1.2369445871958769","y":"0.34488381404062257","size":"6.989700043360188"},{"id":"UPA","label":"UPA","color":"green","x":"1.2657024993626271","y":"0.26237903474176993","size":"14.077888741621337"},{"id":"IAP antagonist","label":"IAP antagonist","color":"green","x":"0.34240978225096325","y":"0.26149039133472485","size":"10.284524256682364"},{"id":"ErbB-2 antagonist","label":"ErbB-2 antagonist","color":"green","x":"0.5806204204315255","y":"0.328514922203921","size":"10.77668018732531"},{"id":"Galectin-3 antagonist","label":"Galectin-3 antagonist","color":"green","x":"-0.27108067890318766","y":"0.20659140990693312","size":"9.3753063169585"},{"id":"Indoleamine-pyrrole 2","label":"Indoleamine-pyrrole 2","color":"green","x":"0.1218773080231002","y":"0.24663203360698574","size":"12.172844520170994"},{"id":"Dihydrofolate reductase inhibitor","label":"Dihydrofolate reductase inhibitor","color":"green","x":"0.5654055069802821","y":"0.21771264841484128","size":"12.701647373954367"},{"id":"Thymidylate synthase inhibitor","label":"Thymidylate synthase inhibitor","color":"green","x":"-0.004393037961087032","y":"0.28346821841264663","size":"13.771741678555093"},{"id":"Stromal cell-derived factor 1 antagonist","label":"Stromal cell-derived factor 1 antagonist","color":"green","x":"0.006125302769065866","y":"0.32593234963440953","size":"6.90105620855803"},{"id":"CTLA4 antagonist","label":"CTLA4 antagonist","color":"green","x":"0.7166552110095423","y":"0.2884009505292062","size":"12.435691877385933"},{"id":"Immunosuppressant","label":"Immunosuppressant","color":"green","x":"-0.38220958005534406","y":"0.2727787636528532","size":"12.07486673985409"},{"id":"Platelet aggregation inhibitor","label":"Platelet aggregation inhibitor","color":"green","x":"1.0855402320702991","y":"0.3375929342523952","size":"7.592569699389438"},{"id":"Thromboxane synthase inhibitor","label":"Thromboxane synthase inhibitor","color":"green","x":"-0.002056904065678211","y":"0.20200626091026982","size":"7.592569699389438"},{"id":"Free radical scavenger","label":"Free radical scavenger","color":"green","x":"0.4300655383803535","y":"0.31712516457429346","size":"7.592569699389438"},{"id":"Reducing agent","label":"Reducing agent","color":"green","x":"0.5468397495274513","y":"0.21943320467580152","size":"9.488135456452207"},{"id":"Prostaglandin synthase inhibitor","label":"Prostaglandin synthase inhibitor","color":"green","x":"0.5300010940006645","y":"0.2989873002798775","size":"7.592569699389438"},{"id":"H+ K+ transporting ATPase inhibitor","label":"H+ K+ transporting ATPase inhibitor","color":"green","x":"1.282345889134989","y":"0.295710257811527","size":"7.592569699389438"},{"id":"Vitamin D agonist","label":"Vitamin D agonist","color":"green","x":"0.2801652770635186","y":"0.32834406854417875","size":"9.746950033224564"},{"id":"Platelet-derived growth factor (PDGF) receptor antagonist","label":"Platelet-derived growth factor (PDGF) receptor antagonist","color":"green","x":"0.125817119605604","y":"0.2773821994158584","size":"6.15224460689137"},{"id":"Beta tubulin antagonist","label":"Beta tubulin antagonist","color":"green","x":"-0.37910065233372","y":"0.3287262573972193","size":"13.633636045132862"},{"id":"Microtubule stimulant","label":"Microtubule stimulant","color":"green","x":"0.709746250667971","y":"0.2898920046846601","size":"14.13361260084496"},{"id":"Cell cycle inhibitor","label":"Cell cycle inhibitor","color":"green","x":"1.0641862559462114","y":"0.28137334978495127","size":"12.326914257242091"},{"id":"Taxane","label":"Taxane","color":"green","x":"1.3023569837037197","y":"0.20669860807006715","size":"14.13361260084496"},{"id":"Tubulin inhibitor","label":"Tubulin inhibitor","color":"green","x":"0.1151730052786834","y":"0.24659077019407896","size":"13.378891708370427"},{"id":"Histone deacetylase inhibitor","label":"Histone deacetylase inhibitor","color":"green","x":"-0.3246073519718906","y":"0.3208844027477254","size":"9.225490200071285"},{"id":"Interferon receptor agonist","label":"Interferon receptor agonist","color":"green","x":"-0.3507630024603155","y":"0.28352828539859115","size":"8.817139967814686"},{"id":"Granulocyte macrophage colony stimulating factor agonist","label":"Granulocyte macrophage colony stimulating factor agonist","color":"green","x":"-0.36524502395981717","y":"0.3044842760055023","size":"10.993285434772114"},{"id":"CXC chemokine receptor 4 antagonist","label":"CXC chemokine receptor 4 antagonist","color":"green","x":"0.2925316809401694","y":"0.2526374383579228","size":"7.385606273598312"},{"id":"Immune checkpoint stimulant","label":"Immune checkpoint stimulant","color":"green","x":"1.170945752827457","y":"0.30469935899871525","size":"11.641898017193688"},{"id":"Interleukin 2 receptor agonist","label":"Interleukin 2 receptor agonist","color":"green","x":"-0.1507854343051162","y":"0.20288432846840465","size":"8.217263382430938"},{"id":"Biguanide","label":"Biguanide","color":"green","x":"1.3363798044521578","y":"0.2696741935118938","size":"9.865639267998493"},{"id":"Gluconeogenesis inhibitor","label":"Gluconeogenesis inhibitor","color":"green","x":"0.3813483872753471","y":"0.2834990441938451","size":"9.865639267998493"},{"id":"MEK inhibitor","label":"MEK inhibitor","color":"green","x":"-0.07718475020393317","y":"0.2775417219075189","size":"9.43245362586241"},{"id":"Tumour necrosis factor alpha antagonist","label":"Tumour necrosis factor alpha antagonist","color":"green","x":"-0.19381579561232604","y":"0.31125669031962017","size":"8.494850021680094"},{"id":"B7-H3 antagonist","label":"B7-H3 antagonist","color":"green","x":"-0.15969597984626793","y":"0.2490564932890019","size":"9.064566783214277"},{"id":"Toll-like receptor 9 agonist","label":"Toll-like receptor 9 agonist","color":"green","x":"0.7645640850776598","y":"0.2927928384004921","size":"10.951658490851457"},{"id":"Inducible T-cell costimulator agonist","label":"Inducible T-cell costimulator agonist","color":"green","x":"0.536583889629684","y":"0.3468972521123309","size":"8.817139967814686"},{"id":"Vinca alkaloid","label":"Vinca alkaloid","color":"green","x":"0.566541480394571","y":"0.26395455730283124","size":"9.064566783214277"},{"id":"Colony stimulating factor 1 receptor antagonist","label":"Colony stimulating factor 1 receptor antagonist","color":"green","x":"-0.1570088357265059","y":"0.3366343746092978","size":"12.091506456598726"},{"id":"C-kit inhibitor","label":"C-kit inhibitor","color":"green","x":"-0.23637690781577905","y":"0.23268271681262997","size":"12.435691877385933"},{"id":"Disease modifying antirheumatic drug","label":"Disease modifying antirheumatic drug","color":"green","x":"0.7077236363032549","y":"0.23492293541791706","size":"7.592569699389438"},{"id":"EGFR antagonist","label":"EGFR antagonist","color":"green","x":"0.525041077304158","y":"0.2636344932177059","size":"11.359208032682496"},{"id":"Angiopoietin inhibitor","label":"Angiopoietin inhibitor","color":"green","x":"0.2621462655340811","y":"0.27907097483629784","size":"11.79917741169944"},{"id":"Hedgehog pathway inhibitor","label":"Hedgehog pathway inhibitor","color":"green","x":"-0.21439060180812006","y":"0.2600092185683251","size":"7.841008620334975"},{"id":"Radical formation stimulant","label":"Radical formation stimulant","color":"green","x":"0.5427590098170427","y":"0.22550656196237023","size":"8.494850021680094"},{"id":"Macrophage stimulant","label":"Macrophage stimulant","color":"green","x":"0.06364266462106805","y":"0.2922056947595962","size":"9.162544563531181"},{"id":"Corticosteroid agonist","label":"Corticosteroid agonist","color":"green","x":"0.43652513362699014","y":"0.3414108546390679","size":"9.621396430309408"},{"id":"Luteinizing hormone releasing hormone (LHRH) agonist","label":"Luteinizing hormone releasing hormone (LHRH) agonist","color":"green","x":"0.2585012980414642","y":"0.2232665829534802","size":"8.31378915840787"},{"id":"Interferon alpha 2b agonist","label":"Interferon alpha 2b agonist","color":"green","x":"-0.3475631794256476","y":"0.28480000343641176","size":"8.360489289678588"},{"id":"CD40 agonist","label":"CD40 agonist","color":"green","x":"1.2650940399216564","y":"0.3107283681364513","size":"9.162544563531181"},{"id":"Hyaluronidase stimulant","label":"Hyaluronidase stimulant","color":"green","x":"-0.045662772672087404","y":"0.22776375097536597","size":"8.537850880489682"},{"id":"General pump inhibitor","label":"General pump inhibitor","color":"green","x":"0.8953105664482386","y":"0.24234496958281188","size":"7.720340221751378"},{"id":"ADP ribose polymerase 1 inhibitor","label":"ADP ribose polymerase 1 inhibitor","color":"green","x":"1.13924403738312","y":"0.2165668951027803","size":"11.382309020866222"},{"id":"Ribonucleoside diphosphate reductase inhibitor","label":"Ribonucleoside diphosphate reductase inhibitor","color":"green","x":"0.6681684577473399","y":"0.26113381422604176","size":"5.73064017839119"},{"id":"Bispecific T cell engager","label":"Bispecific T cell engager","color":"green","x":"0.812449656294316","y":"0.3081759622998343","size":"6.020599913279624"},{"id":"DKK-1 inhibitor","label":"DKK-1 inhibitor","color":"green","x":"1.1052181990014778","y":"0.30962017808266123","size":"8.854260058210722"},{"id":"Carcinoembryonic antigen inhibitor","label":"Carcinoembryonic antigen inhibitor","color":"green","x":"0.4843450259032756","y":"0.34663004732498215","size":"7.720340221751378"},{"id":"Interleukin 12 agonist","label":"Interleukin 12 agonist","color":"green","x":"1.3408154901798284","y":"0.34644592095418003","size":"7.156818820794937"},{"id":"Glucocorticoid-induced TNFR-related protein agonist","label":"Glucocorticoid-induced TNFR-related protein agonist","color":"green","x":"0.7320230741548208","y":"0.2503818511679904","size":"7.31198998949478"},{"id":"CD137 agonist","label":"CD137 agonist","color":"green","x":"0.8327387876019015","y":"0.3352546823880128","size":"7.592569699389438"},{"id":"Delta-like 4 antagonist","label":"Delta-like 4 antagonist","color":"green","x":"0.07441692150278051","y":"0.2482743103528564","size":"6.2763625255165305"},{"id":"RORC RAR-related orphan receptor C gamma-t inhibitor","label":"RORC RAR-related orphan receptor C gamma-t inhibitor","color":"green","x":"0.23007397221618958","y":"0.2536833815683774","size":"7.720340221751378"},{"id":"Lysine (K)-specific demethylase 1A inhibitor","label":"Lysine (K)-specific demethylase 1A inhibitor","color":"green","x":"-0.1603553967145703","y":"0.2685773337082683","size":"6.15224460689137"},{"id":"Androgen receptor antagonist","label":"Androgen receptor antagonist","color":"green","x":"0.999530796244311","y":"0.24010371092041694","size":"7.781512503836437"},{"id":"Selective estrogen receptor modulator","label":"Selective estrogen receptor modulator","color":"green","x":"1.2882600260612733","y":"0.2229340966361205","size":"9.064566783214277"},{"id":"Estrogen receptor antagonist","label":"Estrogen receptor antagonist","color":"green","x":"1.247472389298082","y":"0.2053159571727105","size":"9.064566783214277"},{"id":"Aromatase inhibitor","label":"Aromatase inhibitor","color":"green","x":"1.077693345206217","y":"0.2500976333315473","size":"6.393768004764144"},{"id":"Heat shock protein 90 antagonist","label":"Heat shock protein 90 antagonist","color":"green","x":"0.5542937644250809","y":"0.24677100862912787","size":"8.740940135031002"},{"id":"Insulin-like growth factor 1 antagonist","label":"Insulin-like growth factor 1 antagonist","color":"green","x":"0.21116797550153693","y":"0.20644344857367616","size":"8.740940135031002"},{"id":"Oryx GmbH & Co.","label":"Oryx GmbH & Co.","color":"red","x":"0.6695221772008317","y":"0.8940179524639116","size":"3.494850021680094"},{"id":"Viralytics {Psiron}","label":"Viralytics {Psiron}","color":"red","x":"1.1099776189213564","y":"0.8530128488136255","size":"5.395906230238125"},{"id":"University of Mainz","label":"University of Mainz","color":"red","x":"1.2841653464734772","y":"0.8185058934264203","size":"3.010299956639812"},{"id":"(Other Hospital/Academic/Medical Center)","label":"(Other Hospital/Academic/Medical Center)","color":"red","x":"1.3120729751011697","y":"0.8671199491581099","size":"9.404067961403957"},{"id":"Merck & Co.","label":"Merck & Co.","color":"red","x":"0.854633686407821","y":"0.8387870091288093","size":"13.374305703689057"},{"id":"Immutep {Prima Biomed/Immutep}","label":"Immutep {Prima Biomed/Immutep}","color":"red","x":"0.12496903419081612","y":"0.8470895879952286","size":"4.771212547196624"},{"id":"Generex Biotechnology/Antigen Express","label":"Generex Biotechnology/Antigen Express","color":"red","x":"1.154118809907302","y":"0.9256235980560732","size":"4.225490200071284"},{"id":"SELLAS Life Sciences Group","label":"SELLAS Life Sciences Group","color":"red","x":"-0.2891403365470693","y":"0.8217662902580116","size":"4.225490200071284"},{"id":"Advaxis","label":"Advaxis","color":"red","x":"1.1326106767725161","y":"0.8307075581911336","size":"5"},{"id":"Medivir","label":"Medivir","color":"red","x":"0.6852298916162218","y":"0.884308487957518","size":"4.225490200071284"},{"id":"MacroGenics","label":"MacroGenics","color":"red","x":"0.12870538207455678","y":"0.8056223770275401","size":"3.494850021680094"},{"id":"Genexine","label":"Genexine","color":"red","x":"-0.03326274536650964","y":"0.8102187035470358","size":"3.494850021680094"},{"id":"(Other Cooperative Group)","label":"(Other Cooperative Group)","color":"red","x":"0.19726623963766782","y":"0.8249750679828219","size":"8.740940135031002"},{"id":"Earle A. Chiles Research Institute - EACRI","label":"Earle A. Chiles Research Institute - EACRI","color":"red","x":"0.9868775325693322","y":"0.8772189197985157","size":"2.385606273598312"},{"id":"Galectin Therapeutics {Pro-Pharmaceuticals}","label":"Galectin Therapeutics {Pro-Pharmaceuticals}","color":"red","x":"1.3562997274783848","y":"0.8255363004972216","size":"2.385606273598312"},{"id":"Providence Cancer Center at Providence Portland Medical Center","label":"Providence Cancer Center at Providence Portland Medical Center","color":"red","x":"0.4654199564984292","y":"0.8726998390220855","size":"2.385606273598312"},{"id":"IO Biotech","label":"IO Biotech","color":"red","x":"1.0196575307075804","y":"0.8823867954934735","size":"5.569716761534184"},{"id":"Neon Therapeutics","label":"Neon Therapeutics","color":"red","x":"-0.37647321296250336","y":"0.8140469488905853","size":"5.206963425791125"},{"id":"NOXXON Pharm AG","label":"NOXXON Pharm AG","color":"red","x":"0.06388431348480522","y":"0.883900885546071","size":"2.385606273598312"},{"id":"Regeneron","label":"Regeneron","color":"red","x":"-0.10226753109117209","y":"0.9158311613578317","size":"5.206963425791125"},{"id":"Sanofi {Sanofi-Aventis}","label":"Sanofi {Sanofi-Aventis}","color":"red","x":"1.1369839226465752","y":"0.9038059836598743","size":"5.206963425791125"},{"id":"BerGenBio","label":"BerGenBio","color":"red","x":"-0.3430380232470871","y":"0.8942049704219651","size":"5.206963425791125"},{"id":"Eli Lilly","label":"Eli Lilly","color":"red","x":"0.5871389402308194","y":"0.8119058554681124","size":"6.712113404111031"},{"id":"MD Anderson Cancer Center","label":"MD Anderson Cancer Center","color":"red","x":"0.6242824777683711","y":"0.8717943111221471","size":"6.989700043360188"},{"id":"University of Texas","label":"University of Texas","color":"red","x":"1.1391623447452819","y":"0.8021400435429825","size":"7.156818820794937"},{"id":"Syndax","label":"Syndax","color":"red","x":"1.1619749573806293","y":"0.9092085072475878","size":"3.010299956639812"},{"id":"BriaCell","label":"BriaCell","color":"red","x":"-0.21484032352644458","y":"0.8447188108307507","size":"5.880456295278407"},{"id":"Oncolytics Biotech","label":"Oncolytics Biotech","color":"red","x":"1.0721637623708211","y":"0.8428374369912722","size":"5"},{"id":"X4 Pharmaceuticals","label":"X4 Pharmaceuticals","color":"red","x":"0.04498633327689944","y":"0.9284750267901155","size":"3.8907562519182184"},{"id":"BioLineRx","label":"BioLineRx","color":"red","x":"0.4429764550489525","y":"0.8453012345769082","size":"2.385606273598312"},{"id":"Abramson Cancer Center at  University of Pennsylvania Medical Center","label":"Abramson Cancer Center at  University of Pennsylvania Medical Center","color":"red","x":"0.6471210900685485","y":"0.8831951773127709","size":"2.385606273598312"},{"id":"Nektar Therapeutics","label":"Nektar Therapeutics","color":"red","x":"0.16841613082750057","y":"0.8249466931168178","size":"3.494850021680094"},{"id":"Targovax {Oncos Therapeutics}","label":"Targovax {Oncos Therapeutics}","color":"red","x":"-0.2869569204335724","y":"0.9272992605997454","size":"6.15224460689137"},{"id":"Array BioPharma","label":"Array BioPharma","color":"red","x":"0.12791728701676747","y":"0.9408813862086474","size":"5.880456295278407"},{"id":"National Institutes of Health/National Cancer Institute","label":"National Institutes of Health/National Cancer Institute","color":"red","x":"0.048639291925389294","y":"0.8417422888725474","size":"8.890756251918218"},{"id":"Roswell Park Cancer Institute","label":"Roswell Park Cancer Institute","color":"red","x":"0.3956354345593683","y":"0.9180222515970516","size":"4.515449934959718"},{"id":"European Institute of Oncology","label":"European Institute of Oncology","color":"red","x":"1.2781396786425472","y":"0.8803960357303717","size":"4.225490200071284"},{"id":"H. Lee Moffitt Cancer Center and Research Institute","label":"H. Lee Moffitt Cancer Center and Research Institute","color":"red","x":"-0.31808820646675345","y":"0.8708326897247238","size":"4.225490200071284"},{"id":"Nestle Health Science/Prometheus Laboratories","label":"Nestle Health Science/Prometheus Laboratories","color":"red","x":"0.367579576211238","y":"0.8296403810523396","size":"3.010299956639812"},{"id":"(Other Academic Cancer Center)","label":"(Other Academic Cancer Center)","color":"red","x":"0.37558951130461765","y":"0.945712768760426","size":"3.8907562519182184"},{"id":"Angimmune","label":"Angimmune","color":"red","x":"1.2001119310165125","y":"0.8586829593334266","size":"4.225490200071284"},{"id":"Karyopharm Therapeutics","label":"Karyopharm Therapeutics","color":"red","x":"1.0969771554712673","y":"0.8619202955537513","size":"3.494850021680094"},{"id":"University of Leeds","label":"University of Leeds","color":"red","x":"0.09590291136557816","y":"0.8225972641388584","size":"5.206963425791125"},{"id":"UK","label":"UK","color":"red","x":"0.1915220076804372","y":"0.8250347427516092","size":"5.206963425791125"},{"id":"Dynavax Technologies","label":"Dynavax Technologies","color":"red","x":"1.364574072687273","y":"0.8245501395849532","size":"2.385606273598312"},{"id":"GlaxoSmithKline","label":"GlaxoSmithKline","color":"red","x":"0.23948304439099571","y":"0.9433280967925517","size":"5.880456295278407"},{"id":"Institut National de la Sante et de la Recherche Medicale (INSERM)","label":"Institut National de la Sante et de la Recherche Medicale (INSERM)","color":"red","x":"1.0337493337433967","y":"0.8848596974368208","size":"2.385606273598312"},{"id":"AstraZeneca/Acerta Pharma","label":"AstraZeneca/Acerta Pharma","color":"red","x":"1.3034215954937782","y":"0.8111147220406816","size":"2.385606273598312"},{"id":"Daiichi Sankyo/Plexxikon","label":"Daiichi Sankyo/Plexxikon","color":"red","x":"0.6785720885871989","y":"0.8778996538548531","size":"2.385606273598312"},{"id":"Eisai","label":"Eisai","color":"red","x":"-0.034019090139005004","y":"0.8474513763840339","size":"6.020599913279624"},{"id":"PDS Biotechnology","label":"PDS Biotechnology","color":"red","x":"0.04909883291776068","y":"0.8163665259393964","size":"2.385606273598312"},{"id":"Pfizer","label":"Pfizer","color":"red","x":"0.5598246154235729","y":"0.9058338802603454","size":"6.808639180087964"},{"id":"Biothera","label":"Biothera","color":"red","x":"0.7651850182656372","y":"0.8122018365776967","size":"6.393768004764144"},{"id":"NewLink Genetics","label":"NewLink Genetics","color":"red","x":"1.2739359096306966","y":"0.8928908379130844","size":"4.515449934959718"},{"id":"Incyte Corporation","label":"Incyte Corporation","color":"red","x":"1.0139304504403188","y":"0.8248144809781723","size":"7.898917983084051"},{"id":"University of Wisconsin","label":"University of Wisconsin","color":"red","x":"1.287040475313366","y":"0.8454023364107301","size":"3.010299956639812"},{"id":"EORTC Melanoma Group","label":"EORTC Melanoma Group","color":"red","x":"0.09364540134303662","y":"0.8700966500407006","size":"2.385606273598312"},{"id":"Apexigen","label":"Apexigen","color":"red","x":"-0.16668568784957982","y":"0.935458937266553","size":"2.385606273598312"},{"id":"Halozyme Therapeutics","label":"Halozyme Therapeutics","color":"red","x":"0.9121836556494187","y":"0.9238559021876054","size":"5.569716761534184"},{"id":"Amgen","label":"Amgen","color":"red","x":"0.58685051251813","y":"0.8960212730675264","size":"5.206963425791125"},{"id":"(Other government agency)","label":"(Other government agency)","color":"red","x":"0.78832387100333","y":"0.8191046963694525","size":"3.494850021680094"},{"id":"Royal Marsden NHS Trust","label":"Royal Marsden NHS Trust","color":"red","x":"1.0897287395176725","y":"0.9467898330222001","size":"2.385606273598312"},{"id":"Novartis","label":"Novartis","color":"red","x":"1.1633574675389804","y":"0.8459558305020998","size":"4.515449934959718"},{"id":"(Other Industry Sponsor)","label":"(Other Industry Sponsor)","color":"red","x":"0.9102894098761105","y":"0.8536762378995022","size":"5.880456295278407"},{"id":"Tesaro","label":"Tesaro","color":"red","x":"0.6804828495434703","y":"0.9440739646636533","size":"3.010299956639812"},{"id":"Calithera Biosciences","label":"Calithera Biosciences","color":"red","x":"0.3842231902167231","y":"0.8344146431398937","size":"3.010299956639812"},{"id":"AdaptImmune","label":"AdaptImmune","color":"red","x":"1.2464628732008425","y":"0.8557361073987335","size":"4.225490200071284"},{"id":"Moderna Therapeutics","label":"Moderna Therapeutics","color":"red","x":"0.025813820525325326","y":"0.9185775368125442","size":"3.494850021680094"},{"id":"Leap Therapeutics {HealthCare Pharmaceuticals {Dekkun}}","label":"Leap Therapeutics {HealthCare Pharmaceuticals {Dekkun}}","color":"red","x":"1.3210562217473383","y":"0.8468896740305893","size":"3.494850021680094"},{"id":"Bionomics","label":"Bionomics","color":"red","x":"0.4280686788047681","y":"0.8204480263942788","size":"2.385606273598312"},{"id":"Affimed {Affimed Therapeutics AG}","label":"Affimed {Affimed Therapeutics AG}","color":"red","x":"-0.07724960299449063","y":"0.8948323600882888","size":"3.494850021680094"},{"id":"Provectus Biopharmaceuticals","label":"Provectus Biopharmaceuticals","color":"red","x":"0.3072225007995167","y":"0.9291408059173323","size":"2.385606273598312"},{"id":"Agenus {Antigenics}","label":"Agenus {Antigenics}","color":"red","x":"1.2705418553510028","y":"0.8344668956680747","size":"3.494850021680094"},{"id":"Teclison/Cheery Pharma","label":"Teclison/Cheery Pharma","color":"red","x":"0.4751197847162692","y":"0.8755277573713758","size":"5.206963425791125"},{"id":"Bavarian Nordic","label":"Bavarian Nordic","color":"red","x":"0.3313985608343763","y":"0.8283630156597781","size":"0"},{"id":"OncoSec","label":"OncoSec","color":"red","x":"1.3045885873961127","y":"0.856419465846879","size":"3.010299956639812"},{"id":"ImmunoGen","label":"ImmunoGen","color":"red","x":"0.033377686936848894","y":"0.9016526325797841","size":"3.8907562519182184"},{"id":"Immune Design","label":"Immune Design","color":"red","x":"0.6745116807344589","y":"0.8128191265469895","size":"3.010299956639812"},{"id":"Leap Therapeutics/Macrocure","label":"Leap Therapeutics/Macrocure","color":"red","x":"0.2007566035345914","y":"0.8530999750637352","size":"5.569716761534184"},{"id":"Medical Health Research Infrastructure Council (MHRIC - Australia","label":"Medical Health Research Infrastructure Council (MHRIC - Australia","color":"red","x":"0.7933505829105245","y":"0.8400353721973046","size":"3.8907562519182184"},{"id":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","label":"Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute","color":"red","x":"0.8102904642972768","y":"0.8311956082015008","size":"4.515449934959718"},{"id":"University of Pittsburgh","label":"University of Pittsburgh","color":"red","x":"0.5980200740463981","y":"0.9283432589774986","size":"3.494850021680094"},{"id":"Celgene","label":"Celgene","color":"red","x":"0.582711027655046","y":"0.8656830813529172","size":"2.385606273598312"},{"id":"OncoMed","label":"OncoMed","color":"red","x":"0.9220730875749907","y":"0.8550599512199982","size":"2.385606273598312"},{"id":"Mayo Clinic","label":"Mayo Clinic","color":"red","x":"1.3612465964211813","y":"0.8055735571855587","size":"3.8907562519182184"},{"id":"National Cancer Research Institute","label":"National Cancer Research Institute","color":"red","x":"0.9918681288498139","y":"0.8417828746004026","size":"3.8907562519182184"},{"id":"University of Virginia","label":"University of Virginia","color":"red","x":"-0.10383430157721457","y":"0.8196029894741836","size":"3.010299956639812"},{"id":"Lycera","label":"Lycera","color":"red","x":"0.35411057495052706","y":"0.8042552362549106","size":"3.494850021680094"},{"id":"Northwestern University","label":"Northwestern University","color":"red","x":"0.32258555062462063","y":"0.9035483216618343","size":"2.385606273598312"},{"id":"4SC","label":"4SC","color":"red","x":"-0.15344627348744128","y":"0.9100589828391052","size":"2.385606273598312"},{"id":"Massachusetts General Hospital","label":"Massachusetts General Hospital","color":"red","x":"1.1699641642642575","y":"0.8602114615644195","size":"5.206963425791125"},{"id":"University of California Davis","label":"University of California Davis","color":"red","x":"-0.07772143895313044","y":"0.925295072664912","size":"3.010299956639812"},{"id":"AbbVie","label":"AbbVie","color":"red","x":"0.061643539998167296","y":"0.9005011079755086","size":"8.494850021680094"},{"id":"TetraLogic Pharmaceuticals","label":"TetraLogic Pharmaceuticals","color":"red","x":"0.380649006898884","y":"0.8628910333081659","size":"3.494850021680094"},{"id":"Checkmate Pharmaceuticals","label":"Checkmate Pharmaceuticals","color":"red","x":"0.2107848042562967","y":"0.8396657604903641","size":"3.8907562519182184"},{"id":"Columbia University Medical Center","label":"Columbia University Medical Center","color":"red","x":"0.18819673353422733","y":"0.8578426325268936","size":"2.385606273598312"},{"id":"Seattle Genetics","label":"Seattle Genetics","color":"red","x":"0.8295240115254758","y":"0.9316051748385121","size":"3.494850021680094"},{"id":"Medical College of Wisconsin Cancer Center","label":"Medical College of Wisconsin Cancer Center","color":"red","x":"0.7642820085917434","y":"0.8291816739999206","size":"3.494850021680094"},{"id":"The Cleveland Clinic Foundation","label":"The Cleveland Clinic Foundation","color":"red","x":"-0.12521317885223798","y":"0.8621146498561878","size":"3.494850021680094"},{"id":"Jonsson Comprehensive Cancer Center","label":"Jonsson Comprehensive Cancer Center","color":"red","x":"0.49538199704866387","y":"0.8227882877142615","size":"3.494850021680094"},{"id":"UCLA","label":"UCLA","color":"red","x":"0.47301752476033426","y":"0.8265568278418769","size":"3.494850021680094"},{"id":"University Health Network","label":"University Health Network","color":"red","x":"-0.3650383764688035","y":"0.8565903042800604","size":"2.385606273598312"},{"id":"Toronto/Princess Margaret Cancer Centre {Princess Margaret Hospital}","label":"Toronto/Princess Margaret Cancer Centre {Princess Margaret Hospital}","color":"red","x":"0.31090511585725106","y":"0.8010681876979268","size":"2.385606273598312"},{"id":"Breast International Group","label":"Breast International Group","color":"red","x":"-0.04767468388791252","y":"0.8419918620978857","size":"3.494850021680094"},{"id":"University of Edinburgh","label":"University of Edinburgh","color":"red","x":"0.4678694270061365","y":"0.8486142899207679","size":"2.385606273598312"},{"id":"University of Glasgow","label":"University of Glasgow","color":"red","x":"0.14221344567517308","y":"0.827040815890895","size":"2.385606273598312"},{"id":"Leicester","label":"Leicester","color":"red","x":"0.45464741621647015","y":"0.890596830302359","size":"2.385606273598312"},{"id":"United Kingdom","label":"United Kingdom","color":"red","x":"0.9580368924782658","y":"0.9320175411172975","size":"2.385606273598312"},{"id":"University of Southampton","label":"University of Southampton","color":"red","x":"-0.2646469402098187","y":"0.8319134608947077","size":"2.385606273598312"},{"id":"Verastem","label":"Verastem","color":"red","x":"0.15997462369337473","y":"0.8143662019879191","size":"2.385606273598312"},{"id":"Bristol-Myers Squibb","label":"Bristol-Myers Squibb","color":"red","x":"-0.2518415761634938","y":"0.9417043146394446","size":"5.569716761534184"},{"id":"PsiOxus","label":"PsiOxus","color":"red","x":"0.29445969296804625","y":"0.8050774022958203","size":"2.385606273598312"},{"id":"Delcath Systems","label":"Delcath Systems","color":"red","x":"-0.02567534628184842","y":"0.9413569678534836","size":"3.8907562519182184"},{"id":"Medco Health Solutions","label":"Medco Health Solutions","color":"red","x":"1.0530755130977996","y":"0.8381136986714521","size":"3.8907562519182184"},{"id":"Washington University School of Medicine","label":"Washington University School of Medicine","color":"red","x":"-0.18755178325253027","y":"0.8391831540692478","size":"3.494850021680094"},{"id":"University of Louisville","label":"University of Louisville","color":"red","x":"1.228181764447281","y":"0.9426724494910375","size":"3.010299956639812"},{"id":"Boehringer Ingelheim","label":"Boehringer Ingelheim","color":"red","x":"1.2108550102566809","y":"0.8383748535152293","size":"2.385606273598312"},{"id":"Sarcoma Alliance for Research through Collaboration","label":"Sarcoma Alliance for Research through Collaboration","color":"red","x":"1.0891085982887545","y":"0.8625689233177632","size":"3.010299956639812"},{"id":"Idera Pharmaceuticals {Hybridon}","label":"Idera Pharmaceuticals {Hybridon}","color":"red","x":"0.23240300468314562","y":"0.9459746708515488","size":"3.494850021680094"},{"id":"American College of Radiology Imaging Network (ACRIN)","label":"American College of Radiology Imaging Network (ACRIN)","color":"red","x":"1.2455342114228956","y":"0.8479324867180534","size":"6.808639180087964"},{"id":"Theradex Systems","label":"Theradex Systems","color":"red","x":"0.8008798169549729","y":"0.943102311627217","size":"4.225490200071284"},{"id":"Ono Pharmaceutical","label":"Ono Pharmaceutical","color":"red","x":"1.1832533258000837","y":"0.9484407001730146","size":"5.206963425791125"},{"id":"parvovirus H-1","label":"parvovirus H-1","color":"purple","x":"1.2788505253247724","y":"0.7359822386240293","size":"3.8907562519182184"},{"id":"Oryx (u)","label":"Oryx (u)","color":"purple","x":"1.0004773436637537","y":"0.7176458862224743","size":"3.8907562519182184"},{"id":"bevacizumab","label":"bevacizumab","color":"purple","x":"1.0635840330640947","y":"0.6081059047788102","size":"10.761441721915281"},{"id":"pembrolizumab","label":"pembrolizumab","color":"purple","x":"0.18557092744269815","y":"0.6447083574140989","size":"18.288624771025543"},{"id":"CVA-21 (IV) (u)","label":"CVA-21 (IV) (u)","color":"purple","x":"-0.0651102402611704","y":"0.7439484022297519","size":"7.720340221751378"},{"id":"DCVax-L","label":"DCVax-L","color":"purple","x":"0.8254333414869586","y":"0.7006419975838099","size":"5.569716761534184"},{"id":"CRC (u)","label":"CRC (u)","color":"purple","x":"-0.036286047524904885","y":"0.7353237192071359","size":"5.569716761534184"},{"id":"pelareorep (u)","label":"pelareorep (u)","color":"purple","x":"0.5642706369352568","y":"0.6308035590240495","size":"7.592569699389438"},{"id":"UNK : Drug","label":"UNK : Drug","color":"purple","x":"-0.23569976839469262","y":"0.6637661543786828","size":"15.917772668094308"},{"id":"eftilagimod alfa (u)","label":"eftilagimod alfa (u)","color":"purple","x":"0.7605260997390904","y":"0.6708548964551048","size":"8.817139967814686"},{"id":"AE-37 (u)","label":"AE-37 (u)","color":"purple","x":"0.3629843178512617","y":"0.7281525497664854","size":"6.393768004764144"},{"id":"galinpepimut-S (u)","label":"galinpepimut-S (u)","color":"purple","x":"0.8246177955101985","y":"0.65098063736214","size":"8.266062568876718"},{"id":"Lm-LLO-PSA vaccine","label":"Lm-LLO-PSA vaccine","color":"purple","x":"-0.31039867444478714","y":"0.7257619890675935","size":"8.010299956639813"},{"id":"Advaxis (u)","label":"Advaxis (u)","color":"purple","x":"0.3477353451560002","y":"0.7061096264649193","size":"8.010299956639813"},{"id":"undisclosed - analgesic","label":"undisclosed - analgesic","color":"purple","x":"-0.3738699747494959","y":"0.6578693343655234","size":"9.256291743595376"},{"id":"undisclosed - antiemetic agent","label":"undisclosed - antiemetic agent","color":"purple","x":"0.6520199620077385","y":"0.7197002769942702","size":"7.07486673985409"},{"id":"undisclosed - antihistamine","label":"undisclosed - antihistamine","color":"purple","x":"0.32552301403061784","y":"0.6163561509641677","size":"7.07486673985409"},{"id":"CH-296 (u)","label":"CH-296 (u)","color":"purple","x":"0.49887976923530036","y":"0.6943546568061099","size":"5"},{"id":"nivolumab (a)","label":"nivolumab (a)","color":"purple","x":"0.41423033461672437","y":"0.7416114303821855","size":"12.091506456598726"},{"id":"birinapant (u)","label":"birinapant (u)","color":"purple","x":"0.9146425680262398","y":"0.6200171046088556","size":"10.126529326323851"},{"id":"margetuximab (u)","label":"margetuximab (u)","color":"purple","x":"0.744529850050236","y":"0.7458979257490519","size":"6.15224460689137"},{"id":"CIN vaccine","label":"CIN vaccine","color":"purple","x":"0.06458207276961897","y":"0.6186651217808911","size":"8.450980400142567"},{"id":"Genexine (u)","label":"Genexine (u)","color":"purple","x":"1.1261016105483865","y":"0.7133497349913147","size":"6.2763625255165305"},{"id":"GR-MD-02 (u)","label":"GR-MD-02 (u)","color":"purple","x":"0.38580574844787546","y":"0.6987420863424512","size":"7.898917983084051"},{"id":"IO-102 (u)","label":"IO-102 (u)","color":"purple","x":"-0.1392587034656908","y":"0.6113372474187913","size":"6.15224460689137"},{"id":"undisclosed - chemotherapy","label":"undisclosed - chemotherapy","color":"purple","x":"0.8570300535920541","y":"0.6261502702706805","size":"7.781512503836437"},{"id":"NEO-PV-01 (u)","label":"NEO-PV-01 (u)","color":"purple","x":"-0.17661753976161085","y":"0.7429894284195125","size":"8.701813447471219"},{"id":"carboplatin","label":"carboplatin","color":"purple","x":"0.8761776972458717","y":"0.6355349034575816","size":"13.915943455376286"},{"id":"pemetrexed disodium","label":"pemetrexed disodium","color":"purple","x":"1.3046960513849708","y":"0.7375545568955983","size":"12.212398845322243"},{"id":"poly-ICLC","label":"poly-ICLC","color":"purple","x":"0.014422822071065766","y":"0.6417102521855095","size":"10.187132489703119"},{"id":"olaptesed pegol (IV) (u)","label":"olaptesed pegol (IV) (u)","color":"purple","x":"0.08066301301571305","y":"0.6329312909170878","size":"6.90105620855803"},{"id":"cemiplimab (u)","label":"cemiplimab (u)","color":"purple","x":"0.30851751387157306","y":"0.6203199210491533","size":"7.592569699389438"},{"id":"cisplatin","label":"cisplatin","color":"purple","x":"0.9522725590191881","y":"0.6219333420292262","size":"13.309063427686304"},{"id":"ipilimumab","label":"ipilimumab","color":"purple","x":"-0.2622964316934818","y":"0.683029986858281","size":"12.05809852981615"},{"id":"bemcentinib (u)","label":"bemcentinib (u)","color":"purple","x":"-0.18635060519584898","y":"0.6788783150766124","size":"9.316614300602279"},{"id":"aspirin","label":"aspirin","color":"purple","x":"-0.3603457990524592","y":"0.6547402520748458","size":"7.456808469171364"},{"id":"curcumin","label":"curcumin","color":"purple","x":"-0.3282180021213515","y":"0.7451861914458927","size":"7.456808469171364"},{"id":"cyclophosphamide","label":"cyclophosphamide","color":"purple","x":"1.160606232221243","y":"0.6644509000865967","size":"11.954675535516897"},{"id":"lansoprazole","label":"lansoprazole","color":"purple","x":"0.38409504835877023","y":"0.6189754409650897","size":"7.456808469171364"},{"id":"radiation therapy","label":"radiation therapy","color":"purple","x":"-0.3601774228468529","y":"0.6487166245525107","size":"12.435691877385933"},{"id":"undisclosed - vitamin D analog","label":"undisclosed - vitamin D analog","color":"purple","x":"0.10237379542645714","y":"0.6658024219318636","size":"7.456808469171364"},{"id":"olaratumab (a)","label":"olaratumab (a)","color":"purple","x":"1.3331002756953476","y":"0.636111689393988","size":"6.2763625255165305"},{"id":"gemcitabine hydrochloride","label":"gemcitabine hydrochloride","color":"purple","x":"-0.26908340506957856","y":"0.6823688020100582","size":"11.393768004764144"},{"id":"nab-paclitaxel (IV)","label":"nab-paclitaxel (IV)","color":"purple","x":"1.2717533705675899","y":"0.6880286344317532","size":"13.764082155941358"},{"id":"paricalcitol","label":"paricalcitol","color":"purple","x":"1.1693298218696118","y":"0.6835077339584765","size":"8.217263382430938"},{"id":"injectable","label":"injectable","color":"purple","x":"0.3186299774497832","y":"0.6478281005836227","size":"8.217263382430938"},{"id":"AbbVie2","label":"AbbVie2","color":"purple","x":"0.8976602590442091","y":"0.7111298836257024","size":"8.494850021680094"},{"id":"surgical intervention","label":"surgical intervention","color":"purple","x":"0.35266180013399834","y":"0.6150746604309797","size":"12.196663469151314"},{"id":"docetaxel","label":"docetaxel","color":"purple","x":"-0.07981110833702176","y":"0.7253161964002806","size":"11.855339311358682"},{"id":"entinostat (u)","label":"entinostat (u)","color":"purple","x":"-0.3155513894203247","y":"0.7115386297283666","size":"7.456808469171364"},{"id":"breast cancer vaccine","label":"breast cancer vaccine","color":"purple","x":"1.051560648747218","y":"0.6520960257450213","size":"7.592569699389438"},{"id":"BriaCell (u)","label":"BriaCell (u)","color":"purple","x":"1.3196628006161941","y":"0.6183128631415195","size":"7.592569699389438"},{"id":"interferon alpha-2b","label":"interferon alpha-2b","color":"purple","x":"-0.34022745257321957","y":"0.6949743262010557","size":"8.621379348003945"},{"id":"unspecified","label":"unspecified","color":"purple","x":"1.0772919454880738","y":"0.6587892786598692","size":"12.72653558232912"},{"id":"5-fluorouracil","label":"5-fluorouracil","color":"purple","x":"1.0278351126802932","y":"0.6749346932846267","size":"11.288392874345924"},{"id":"leucovorin","label":"leucovorin","color":"purple","x":"1.3517628853859254","y":"0.6722957934805162","size":"9.697596263093093"},{"id":"irinotecan (IV)","label":"irinotecan (IV)","color":"purple","x":"0.23748689153156982","y":"0.6583024957998547","size":"11.57985172728459"},{"id":"X4P-001 (u)","label":"X4P-001 (u)","color":"purple","x":"1.2561233046936289","y":"0.6905871862876279","size":"6.15224460689137"},{"id":"BKT-140 (u)","label":"BKT-140 (u)","color":"purple","x":"0.2539584464880546","y":"0.6526572379895081","size":"6.15224460689137"},{"id":"Aduro (u)","label":"Aduro (u)","color":"purple","x":"1.3401218671490494","y":"0.6631284791264526","size":"7.5257498915995305"},{"id":"atezolizumab (a)","label":"atezolizumab (a)","color":"purple","x":"0.773505737835307","y":"0.6058976340074734","size":"6.989700043360188"},{"id":"NKTR-214 (u)","label":"NKTR-214 (u)","color":"purple","x":"1.3892298052663086","y":"0.7073762494632502","size":"6.989700043360188"},{"id":"metformin 500mg (u)","label":"metformin 500mg (u)","color":"purple","x":"-0.20108323782746262","y":"0.7317387460069094","size":"9.911356165197843"},{"id":"Ad5/3-D24-RGD cancer therapy","label":"Ad5/3-D24-RGD cancer therapy","color":"purple","x":"-0.3798777261944795","y":"0.6741141472270161","size":"7.841008620334975"},{"id":"Oncos Therapeutics (u)","label":"Oncos Therapeutics (u)","color":"purple","x":"1.015690430884143","y":"0.6297742599951023","size":"7.841008620334975"},{"id":"binimetinib (u)","label":"binimetinib (u)","color":"purple","x":"-0.3558468354751125","y":"0.7091877805120237","size":"8.537850880489682"},{"id":"oxaliplatin (IV)","label":"oxaliplatin (IV)","color":"purple","x":"0.6750394328593619","y":"0.6963979679657787","size":"9.346158598654881"},{"id":"bleomycin","label":"bleomycin","color":"purple","x":"0.5713207791810786","y":"0.656432074912459","size":"7.456808469171364"},{"id":"electrochemotherapy","label":"electrochemotherapy","color":"purple","x":"1.0856433377829766","y":"0.6053463077873787","size":"8.217263382430938"},{"id":"aldesleukin (a)","label":"aldesleukin (a)","color":"purple","x":"0.8232746088426179","y":"0.6792667392224081","size":"6.2763625255165305"},{"id":"sodium chloride 0.9%","label":"sodium chloride 0.9%","color":"purple","x":"0.3925369795372727","y":"0.7357233489701629","size":"9.225490200071285"},{"id":"Resimmune (u)","label":"Resimmune (u)","color":"purple","x":"0.34404158005367586","y":"0.669160095681828","size":"7.07486673985409"},{"id":"lenalidomide (a)","label":"lenalidomide (a)","color":"purple","x":"1.3803048520951287","y":"0.6371722542423269","size":"8.661968799114844"},{"id":"enoblituzumab (u)","label":"enoblituzumab (u)","color":"purple","x":"1.318962927902317","y":"0.6068265758326088","size":"8.580016718173995"},{"id":"SD-101 (intratumoral) (u)","label":"SD-101 (intratumoral) (u)","color":"purple","x":"0.5971711670562774","y":"0.6637399895150378","size":"7.31198998949478"},{"id":"radiosurgery","label":"radiosurgery","color":"purple","x":"0.029279047231758226","y":"0.6641004064355861","size":"8.167342277897934"},{"id":"GSK-3359609 (u)","label":"GSK-3359609 (u)","color":"purple","x":"-0.09420444584905685","y":"0.7342987722767802","size":"8.450980400142567"},{"id":"vinflunine (iv)","label":"vinflunine (iv)","color":"purple","x":"-0.351104646468517","y":"0.6974653317440483","size":"6.505149978319906"},{"id":"acalabrutinib (a)","label":"acalabrutinib (a)","color":"purple","x":"-0.153189765615216","y":"0.6967419152234393","size":"8.740940135031002"},{"id":"pexidartinib (u)","label":"pexidartinib (u)","color":"purple","x":"0.14796667297899485","y":"0.7467040566685197","size":"10.484550065040281"},{"id":"cetuximab","label":"cetuximab","color":"purple","x":"0.8405999881554469","y":"0.7153046510011627","size":"11.288392874345924"},{"id":"methotrexate (IV)","label":"methotrexate (IV)","color":"purple","x":"1.2334061932087392","y":"0.6475341643790267","size":"7.592569699389438"},{"id":"companion diagnostic","label":"companion diagnostic","color":"purple","x":"1.3851244404282996","y":"0.6952755886630123","size":"9.488135456452207"},{"id":"lenvatinib (capsule) (a)","label":"lenvatinib (capsule) (a)","color":"purple","x":"0.05769658422545776","y":"0.6371174344754833","size":"10.284524256682364"},{"id":"PDS-0101 (u)","label":"PDS-0101 (u)","color":"purple","x":"-0.14397925586056645","y":"0.6240450442334914","size":"5.880456295278407"},{"id":"vinorelbine","label":"vinorelbine","color":"purple","x":"0.5448295148581606","y":"0.6713360926988358","size":"8.167342277897934"},{"id":"glasdegib (oral) (u)","label":"glasdegib (oral) (u)","color":"purple","x":"-0.2751216476928032","y":"0.6623487815477294","size":"7.720340221751378"},{"id":"azacitidine (iv)","label":"azacitidine (iv)","color":"purple","x":"1.3004814909156792","y":"0.6638806001584142","size":"9.194245453686277"},{"id":"cytarabine","label":"cytarabine","color":"purple","x":"0.08581711070450132","y":"0.6134733534042386","size":"7.720340221751378"},{"id":"daunorubicin","label":"daunorubicin","color":"purple","x":"0.8743128834307439","y":"0.6970483654568896","size":"7.720340221751378"},{"id":"BTH-1677 (u)","label":"BTH-1677 (u)","color":"purple","x":"-0.3541395935241243","y":"0.602235962334661","size":"9.225490200071285"},{"id":"dexamethasone","label":"dexamethasone","color":"purple","x":"0.48857006042311085","y":"0.7021109758301664","size":"9.59539046188037"},{"id":"folic acid","label":"folic acid","color":"purple","x":"0.5324907767864036","y":"0.6931360836323746","size":"6.611096473669597"},{"id":"vitamin B12","label":"vitamin B12","color":"purple","x":"1.0615639901875877","y":"0.6815956515110583","size":"6.611096473669597"},{"id":"pneumococcal polyvalent polysaccharide vaccine (im)","label":"pneumococcal polyvalent polysaccharide vaccine (im)","color":"purple","x":"-0.12377416976966349","y":"0.7022334866660627","size":"7.657394585211276"},{"id":"Merck (a)","label":"Merck (a)","color":"purple","x":"-0.12573582630519636","y":"0.6662407631959721","size":"5.395906230238125"},{"id":"15-valent","label":"15-valent","color":"purple","x":"0.7649828486276884","y":"0.6648918669396547","size":"5.395906230238125"},{"id":"Merck (u)","label":"Merck (u)","color":"purple","x":"0.7680870066954133","y":"0.6176396162145228","size":"5.395906230238125"},{"id":"13-valent (IM)","label":"13-valent (IM)","color":"purple","x":"1.260200003696851","y":"0.6699389364454934","size":"5.395906230238125"},{"id":"Wyeth","label":"Wyeth","color":"purple","x":"1.248481903834807","y":"0.6446411639940188","size":"5.395906230238125"},{"id":"erlotinib","label":"erlotinib","color":"purple","x":"0.3965974284090294","y":"0.6777168609642142","size":"7.156818820794937"},{"id":"gefitinib","label":"gefitinib","color":"purple","x":"-0.3857162655156816","y":"0.723926213074492","size":"7.156818820794937"},{"id":"indoximod (u)","label":"indoximod (u)","color":"purple","x":"-0.06200583422161493","y":"0.6764613983308481","size":"7.156818820794937"},{"id":"epacadostat (u)","label":"epacadostat (u)","color":"purple","x":"0.7229800265713591","y":"0.6601808451990651","size":"11.692282468023024"},{"id":"pTVG-HP (u)","label":"pTVG-HP (u)","color":"purple","x":"0.35454593356391645","y":"0.7363134416305037","size":"7.31198998949478"},{"id":"undisclosed - GnRH analog","label":"undisclosed - GnRH analog","color":"purple","x":"-0.30957303202284536","y":"0.7151210954272379","size":"7.31198998949478"},{"id":"peginterferon alfa-2b (a)","label":"peginterferon alfa-2b (a)","color":"purple","x":"0.6731090106576694","y":"0.6052273710542846","size":"6.989700043360188"},{"id":"pazopanib (tablet)","label":"pazopanib (tablet)","color":"purple","x":"1.2278346338679647","y":"0.6558468248207642","size":"8.010299956639813"},{"id":"sunitinib malate","label":"sunitinib malate","color":"purple","x":"-0.3376670963893648","y":"0.6967374099593501","size":"8.926649175053836"},{"id":"CVA-21 (intratumoral) (u)","label":"CVA-21 (intratumoral) (u)","color":"purple","x":"0.021259518342297556","y":"0.715823389386093","size":"7.456808469171364"},{"id":"APX-005M (u)","label":"APX-005M (u)","color":"purple","x":"1.344959229547765","y":"0.6620237337024917","size":"6.393768004764144"},{"id":"PEGPH20","label":"PEGPH20","color":"purple","x":"0.34667928524872776","y":"0.7050606632838752","size":"9.515449934959717"},{"id":"Halozyme (u)","label":"Halozyme (u)","color":"purple","x":"0.6359629892122156","y":"0.7323447030609649","size":"9.515449934959717"},{"id":"piroxicam","label":"piroxicam","color":"purple","x":"0.00812318489927405","y":"0.6343074789805305","size":"7.592569699389438"},{"id":"proton pump inhibitors","label":"proton pump inhibitors","color":"purple","x":"0.6568335747288574","y":"0.6876627013658421","size":"7.592569699389438"},{"id":"vitespen (intradermal) (u)","label":"vitespen (intradermal) (u)","color":"purple","x":"0.9276007405606286","y":"0.6137216820662539","size":"5.569716761534184"},{"id":"temozolomide (IV)","label":"temozolomide (IV)","color":"purple","x":"1.2126156370267198","y":"0.6115891764737347","size":"5.569716761534184"},{"id":"talimogene laherparepvec (intratumoral) (a)","label":"talimogene laherparepvec (intratumoral) (a)","color":"purple","x":"0.4266076143194037","y":"0.6942487359221159","size":"7.456808469171364"},{"id":"dabrafenib (capsule) (a)","label":"dabrafenib (capsule) (a)","color":"purple","x":"0.6585788475134524","y":"0.62776048743073","size":"7.456808469171364"},{"id":"trametinib (tablet) (a)","label":"trametinib (tablet) (a)","color":"purple","x":"-0.16404924288146885","y":"0.7425244204618813","size":"7.456808469171364"},{"id":"niraparib (a)","label":"niraparib (a)","color":"purple","x":"0.8313973910268946","y":"0.6462945093615223","size":"6.611096473669597"},{"id":"CB-1158 (u)","label":"CB-1158 (u)","color":"purple","x":"0.6902771967122634","y":"0.6990992955100499","size":"8.890756251918218"},{"id":"vorinostat (a)","label":"vorinostat (a)","color":"purple","x":"-0.09927905396064801","y":"0.7264113467644926","size":"6.712113404111031"},{"id":"NY-ESO-1 T cells","label":"NY-ESO-1 T cells","color":"purple","x":"-0.04475141962900947","y":"0.6475135031673255","size":"6.020599913279624"},{"id":"Adaptimmune (u)","label":"Adaptimmune (u)","color":"purple","x":"0.27707979073999817","y":"0.6444106787854726","size":"6.020599913279624"},{"id":"fludarabine","label":"fludarabine","color":"purple","x":"0.9113928015343742","y":"0.7151123430814335","size":"6.020599913279624"},{"id":"ramucirumab (a)","label":"ramucirumab (a)","color":"purple","x":"0.00218142898360707","y":"0.689653710713539","size":"7.07486673985409"},{"id":"blinatumomab (IV) (a)","label":"blinatumomab (IV) (a)","color":"purple","x":"0.534332226579803","y":"0.7148606013514689","size":"6.020599913279624"},{"id":"pomalidomide (capsule)","label":"pomalidomide (capsule)","color":"purple","x":"0.2056386835271456","y":"0.6935391403266449","size":"5.73064017839119"},{"id":"mRNA-4157 (u)","label":"mRNA-4157 (u)","color":"purple","x":"-0.3187277172111731","y":"0.6418608168231583","size":"9.933858671331224"},{"id":"LY-2812176 (u)","label":"LY-2812176 (u)","color":"purple","x":"1.0975019544567437","y":"0.6250221205815584","size":"8.661968799114844"},{"id":"BNC-105 (u)","label":"BNC-105 (u)","color":"purple","x":"0.8390594267868219","y":"0.6811479173501777","size":"5.206963425791125"},{"id":"axitinib (a)","label":"axitinib (a)","color":"purple","x":"-0.13117969821669773","y":"0.6343913587453428","size":"6.393768004764144"},{"id":"pegzilarginase (u)","label":"pegzilarginase (u)","color":"purple","x":"0.6001468065371334","y":"0.7364009314688365","size":"8.266062568876718"},{"id":"AFM-13 (u)","label":"AFM-13 (u)","color":"purple","x":"0.32597633050080504","y":"0.6915226753733313","size":"6.989700043360188"},{"id":"Genentech (gamma1b) (SC) (a)","label":"Genentech (gamma1b) (SC) (a)","color":"purple","x":"0.5402696451624043","y":"0.6899811456449626","size":"6.611096473669597"},{"id":"Provecta (u)","label":"Provecta (u)","color":"purple","x":"0.4210551411844142","y":"0.6991852052354772","size":"4.515449934959718"},{"id":"AGEN-1884 (u)","label":"AGEN-1884 (u)","color":"purple","x":"0.9384599757770287","y":"0.6931496369032313","size":"8.450980400142567"},{"id":"tirapazamine (intra-arterial) (u)","label":"tirapazamine (intra-arterial) (u)","color":"purple","x":"0.509297625794974","y":"0.7040236573953633","size":"8.167342277897934"},{"id":"Gelfoam","label":"Gelfoam","color":"purple","x":"0.7563251950177707","y":"0.6250461119957204","size":"8.167342277897934"},{"id":"Lipiodol","label":"Lipiodol","color":"purple","x":"0.41289954262073864","y":"0.6004483680211324","size":"8.167342277897934"},{"id":"falimarev","label":"falimarev","color":"purple","x":"0.3575710079449514","y":"0.6682071989305735","size":"0"},{"id":"inalimarev (u)","label":"inalimarev (u)","color":"purple","x":"1.3467537409778172","y":"0.7459415299108267","size":"0"},{"id":"eribulin mesylate (a)","label":"eribulin mesylate (a)","color":"purple","x":"0.9986991549352793","y":"0.6132259563320347","size":"7.5257498915995305"},{"id":"necitumumab (a)","label":"necitumumab (a)","color":"purple","x":"0.1393841906492172","y":"0.6984291576789069","size":"5.73064017839119"},{"id":"tavokinogene telsaplasmid (u)","label":"tavokinogene telsaplasmid (u)","color":"purple","x":"-0.23067944781547278","y":"0.7308850444292452","size":"5.73064017839119"},{"id":"tabelecleucel (u)","label":"tabelecleucel (u)","color":"purple","x":"0.7066749626269919","y":"0.6515790147059447","size":"4.771212547196624"},{"id":"mirvetuximab soravtansine (u)","label":"mirvetuximab soravtansine (u)","color":"purple","x":"-0.36032109968203313","y":"0.6200367612438928","size":"6.808639180087964"},{"id":"pegylated liposomal doxorubicin","label":"pegylated liposomal doxorubicin","color":"purple","x":"-0.12625659055379762","y":"0.7483093832001657","size":"10.44952555719699"},{"id":"ARRY-382 (u)","label":"ARRY-382 (u)","color":"purple","x":"-0.0902926245913509","y":"0.6753502490276483","size":"7.898917983084051"},{"id":"ID-G100 (u)","label":"ID-G100 (u)","color":"purple","x":"-0.20789009022527039","y":"0.6584830424058743","size":"6.808639180087964"},{"id":"TRX-518 (u)","label":"TRX-518 (u)","color":"purple","x":"0.1800430497612498","y":"0.6968664025470273","size":"7.31198998949478"},{"id":"doxorubicin HCL","label":"doxorubicin HCL","color":"purple","x":"1.1435610948031656","y":"0.657543228653007","size":"6.393768004764144"},{"id":"MK-1966 (u)","label":"MK-1966 (u)","color":"purple","x":"0.8139224776152769","y":"0.6158631142509039","size":"5.569716761534184"},{"id":"GSK-3174998 (u)","label":"GSK-3174998 (u)","color":"purple","x":"0.6065322579808585","y":"0.7155325850754823","size":"8.266062568876718"},{"id":"utomilumab (u)","label":"utomilumab (u)","color":"purple","x":"0.8646639747438754","y":"0.658282616618158","size":"7.841008620334975"},{"id":"demcizumab (u)","label":"demcizumab (u)","color":"purple","x":"0.43213445545908397","y":"0.7422002103432521","size":"6.15224460689137"},{"id":"13-valent pneumococcal conjugate vaccine","label":"13-valent pneumococcal conjugate vaccine","color":"purple","x":"1.2354255205480733","y":"0.6378359156729864","size":"8.31378915840787"},{"id":"autologous dendritic cells (u)","label":"autologous dendritic cells (u)","color":"purple","x":"-0.0756462874465249","y":"0.7398585190973507","size":"8.31378915840787"},{"id":"6 melanoma helper peptide vaccine (u)","label":"6 melanoma helper peptide vaccine (u)","color":"purple","x":"0.5630992948070161","y":"0.7321662628581678","size":"5.73064017839119"},{"id":"AMG-820 (u)","label":"AMG-820 (u)","color":"purple","x":"-0.046008362605296615","y":"0.7338120022455581","size":"6.611096473669597"},{"id":"Spectrum","label":"Spectrum","color":"purple","x":"0.6769183748647791","y":"0.712441821407735","size":"6.90105620855803"},{"id":"capecitabine","label":"capecitabine","color":"purple","x":"-0.21282283507333632","y":"0.630640359049281","size":"8.740940135031002"},{"id":"LYC-55716 (u)","label":"LYC-55716 (u)","color":"purple","x":"0.2521408885317244","y":"0.6330124333576989","size":"7.592569699389438"},{"id":"undisclosed - antiretroviral (ARV) agent (a)","label":"undisclosed - antiretroviral (ARV) agent (a)","color":"purple","x":"0.2922265108443212","y":"0.6145282070410967","size":"8.996702747267909"},{"id":"guadecitabine (u)","label":"guadecitabine (u)","color":"purple","x":"-0.2652844001298759","y":"0.67405294808721","size":"6.90105620855803"},{"id":"4SC-202 (u)","label":"4SC-202 (u)","color":"purple","x":"-0.21744765874764785","y":"0.6021046654437119","size":"6.15224460689137"},{"id":"abemaciclib (capsule) (a)","label":"abemaciclib (capsule) (a)","color":"purple","x":"-0.1862213457851952","y":"0.6089615657078773","size":"9.346158598654881"},{"id":"PVX-410 (u)","label":"PVX-410 (u)","color":"purple","x":"0.3843873904765153","y":"0.6732668358137088","size":"8.701813447471219"},{"id":"Montanide","label":"Montanide","color":"purple","x":"-0.15254368807590182","y":"0.7035353535946719","size":"8.701813447471219"},{"id":"Oncovir","label":"Oncovir","color":"purple","x":"1.3252140745621597","y":"0.6831556163207372","size":"8.701813447471219"},{"id":"afatinib (a)","label":"afatinib (a)","color":"purple","x":"0.3628687262137061","y":"0.6934940438323481","size":"8.31378915840787"},{"id":"b-vedotin","label":"b-vedotin","color":"purple","x":"0.815794713614516","y":"0.6627287971452592","size":"7.657394585211276"},{"id":"ARB-1598 (intratumoral) (u)","label":"ARB-1598 (intratumoral) (u)","color":"purple","x":"0.44396485922295353","y":"0.6624152304355684","size":"6.90105620855803"},{"id":"ARB-1598 (SC) (u)","label":"ARB-1598 (SC) (u)","color":"purple","x":"0.9457105337894476","y":"0.7447949215631005","size":"5.395906230238125"},{"id":"TG-02","label":"TG-02","color":"purple","x":"1.1342225934673782","y":"0.7094998876010207","size":"6.15224460689137"},{"id":"Targovax (u)","label":"Targovax (u)","color":"purple","x":"0.9471628187357248","y":"0.6480883813246949","size":"6.15224460689137"},{"id":"GM-CSF","label":"GM-CSF","color":"purple","x":"1.1174715820279053","y":"0.6975185430707016","size":"6.15224460689137"},{"id":"crizotinib (IV) (u)","label":"crizotinib (IV) (u)","color":"purple","x":"-0.0212049081297892","y":"0.708614476577906","size":"6.2763625255165305"},{"id":"trastuzumab (IV)","label":"trastuzumab (IV)","color":"purple","x":"0.33146205436607973","y":"0.714765113113755","size":"9.3753063169585"},{"id":"defactinib (u)","label":"defactinib (u)","color":"purple","x":"0.10067581057230651","y":"0.7100901983333482","size":"8.217263382430938"},{"id":"enadenotucirev (u)","label":"enadenotucirev (u)","color":"purple","x":"-0.1542380222760115","y":"0.7474949245453085","size":"7.720340221751378"},{"id":"melphalan hydrochloride","label":"melphalan hydrochloride","color":"purple","x":"-0.37462176115409473","y":"0.633250180831718","size":"6.611096473669597"},{"id":"Delcath Systems (u)","label":"Delcath Systems (u)","color":"purple","x":"0.6565598266939863","y":"0.7479324598951917","size":"6.611096473669597"},{"id":"dacarbazine","label":"dacarbazine","color":"purple","x":"0.24702993108815657","y":"0.6399688872592154","size":"6.611096473669597"},{"id":"everolimus","label":"everolimus","color":"purple","x":"0.34882890954515505","y":"0.6654989440274154","size":"6.808639180087964"},{"id":"enzalutamide (capsule)","label":"enzalutamide (capsule)","color":"purple","x":"0.12545108613091577","y":"0.6871103626696754","size":"7.781512503836437"},{"id":"olaparib (capsule)","label":"olaparib (capsule)","color":"purple","x":"-0.038031564651993366","y":"0.7089480829836188","size":"6.505149978319906"},{"id":"prednisone","label":"prednisone","color":"purple","x":"0.8485324025964807","y":"0.7253841049005767","size":"6.505149978319906"},{"id":"IMO-2125 (intratumoral) (u)","label":"IMO-2125 (intratumoral) (u)","color":"purple","x":"1.0284016009068644","y":"0.7370718697698814","size":"7.31198998949478"},{"id":"anastrozole (tablet)","label":"anastrozole (tablet)","color":"purple","x":"-0.15000498780696092","y":"0.6305659544979109","size":"6.505149978319906"},{"id":"exemestane","label":"exemestane","color":"purple","x":"-0.006221678141149822","y":"0.6890487046198782","size":"6.505149978319906"},{"id":"goserelin","label":"goserelin","color":"purple","x":"0.9017448253728981","y":"0.6026332076145975","size":"6.505149978319906"},{"id":"letrozole","label":"letrozole","color":"purple","x":"0.6451486064833711","y":"0.7029528034399816","size":"6.505149978319906"},{"id":"leuprorelin","label":"leuprorelin","color":"purple","x":"0.2602746178556324","y":"0.6129803391248958","size":"6.505149978319906"},{"id":"Abbott","label":"Abbott","color":"purple","x":"0.8339788607768635","y":"0.6966788101483985","size":"6.505149978319906"},{"id":"tamoxifen citrate (tablet)","label":"tamoxifen citrate (tablet)","color":"purple","x":"-0.03650793769469857","y":"0.6844714280593343","size":"6.505149978319906"},{"id":"fulvestrant (IM)","label":"fulvestrant (IM)","color":"purple","x":"-0.10587541804225453","y":"0.6190056772824469","size":"7.781512503836437"},{"id":"ganetespib (u)","label":"ganetespib (u)","color":"purple","x":"1.2137586467787285","y":"0.6327359184189973","size":"8.817139967814686"},{"id":"ganitumab (u)","label":"ganitumab (u)","color":"purple","x":"0.33373319269051","y":"0.6431422340303898","size":"8.817139967814686"},{"id":"MK-2206 (u)","label":"MK-2206 (u)","color":"purple","x":"1.386089288678675","y":"0.7281298216749826","size":"8.817139967814686"},{"id":"neratinib (a)","label":"neratinib (a)","color":"purple","x":"0.35822312807879825","y":"0.7419102222976197","size":"8.817139967814686"},{"id":"patritumab (u)","label":"patritumab (u)","color":"purple","x":"0.35558493682029996","y":"0.6608827828141312","size":"8.817139967814686"},{"id":"pertuzumab (a)","label":"pertuzumab (a)","color":"purple","x":"-0.12258730892286657","y":"0.6762690167147131","size":"8.817139967814686"},{"id":"talazoparib (u)","label":"talazoparib (u)","color":"purple","x":"0.7178780315069893","y":"0.683671137682975","size":"8.817139967814686"},{"id":"trastuzumab emtansine (a)","label":"trastuzumab emtansine (a)","color":"purple","x":"0.12049957717844267","y":"0.645375204614889","size":"8.817139967814686"},{"id":"trebananib (u)","label":"trebananib (u)","color":"purple","x":"-0.09893978638126166","y":"0.6432110363854658","size":"8.817139967814686"},{"id":"veliparib (u)","label":"veliparib (u)","color":"purple","x":"1.0975281400901946","y":"0.6860761454277697","size":"8.817139967814686"},{"id":"etoposide (intravenous)","label":"etoposide (intravenous)","color":"purple","x":"0.7702089534440129","y":"0.69631612101642","size":"5.73064017839119"},{"id":"epirubicin","label":"epirubicin","color":"purple","x":"-0.2443624183561425","y":"0.6305775084537815","size":"5.73064017839119"},{"id":"Baxter","label":"Baxter","color":"purple","x":"0.3776278017463938","y":"0.6384405502125017","size":"6.393768004764144"},{"id":"Dako","label":"Dako","color":"purple","x":"0.019345627795576692","y":"0.6158510364327667","size":"7.456808469171364"}]};